PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Abebe, SM; Berhane, Y; Worku, A; Alemu, S				Abebe, Solomon Mekonnen; Berhane, Yemane; Worku, Alemayehu; Alemu, Shitay			Increasing Trends of Diabetes Mellitus and Body Weight: A Ten Year Observation at Gondar University Teaching Referral Hospital, Northwest Ethiopia	PLOS ONE			English	Article							EPIDEMIOLOGY; PREVALENCE; AFRICA; AGE	Background: Diabetes mellitus is becoming one of the major causes of premature adult mortality in developing countries. However, there is a very little documentation of the morbidity trend in such countries. Objective: To assess the ten-year trend of diabetes mellitus at Gondar University Teaching Referral Hospital, northwest Ethiopia. Methods: A hospital-based retrospective record review was done at the main referral hospital in northwest Ethiopia. Data were obtained from medical records of all registered diabetic patients in the Diabetic Follow up Clinic between 2000 and 2009. An Extended Mantel-Haenzel chi-square test for the linear trend was used to examine the trend over time. Result: Out of the total 354,524 patients who visited the Outpatient Department of the hospital during the study period, 1553 (4.4/1000) were diabetes patients, of which 50.1% was type 1 and 49.9% type 2 diabetes mellitus. The average increase in the proportion of both Type 1 and Type 2 diabetes mellitus cases between 2000 and 2009 was 125%. The mean (+/- SD) age for Type 1 diabetes mellitus was 29.1 (+/- 12), and 53.5 (+/- 12) for Type 2 diabetes. Overall 42.5% of the diabetes mellitus patients were female and 31.7% were rural residents. The mean body mass index for both type of diabetes mellitus increased from 15.9 to 18.3 kg for type 1 and from 23.8 to 24.6 for type 2 between 2000 and 2009, respectively. Conclusion: The number of diabetes mellitus cases seen at Gondar Referral Hospital is rising steadily. A comprehensive diabetes prevention, treatment, and care program is needed to improve the quality of life of the increasing diabetes mellitus cases in Ethiopia.	[Abebe, Solomon Mekonnen] Univ Gondar, Coll Med & Hlth Sci, Gondar, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health; Addis Ababa University	Abebe, SM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Gondar, Ethiopia.	solomekonnen@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar; Addis Continental Institute of Public Health	University of Gondar; Addis Continental Institute of Public Health	The authors would like to express their heartfelt thanks to the University of Gondar and the Addis Continental Institute of Public Health for funding and supporting this project.	Adem Amir, 2011, Ethiop Med J, V49, P231; Azevedo M, 2008, INT J DIABETES DEV C, V28, P101, DOI 10.4103/0973-3930.45268; Dabelea D, 2006, DIABETES CARE, V29, P290, DOI 10.2337/diacare.29.02.06.dc05-1339; Gimenez M, 2007, DIABETES CARE, V30, P1593, DOI 10.2337/dc06-2578; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Kalk WJ, 2010, INT J DIABETES MELLI, V2, DOI [10.1016/j.ijdm.2010.10.003, DOI 10.1016/J.IJDM.2010.10.003]; Marshall SM, 2006, BMJ-BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Mehuys E, 2008, PHARM WORLD SCI, V30, P51, DOI 10.1007/s11096-007-9140-0; Melaku Zenebe, 2006, Ethiop Med J, V44, P33; MKS M.D, 2008, INTERNET J HLTH, V7; Motala AA, 2009, ETHNIC DIS, V19; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Palta Mari, 2009, WMJ, V108, P231; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zaoui Salah, 2007, Sante, V17, P15	20	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60081	10.1371/journal.pone.0060081	http://dx.doi.org/10.1371/journal.pone.0060081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536904	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200052
J	Paquet, M; Covas, R; Chastel, O; Parenteau, C; Doutrelant, C				Paquet, Matthieu; Covas, Rita; Chastel, Olivier; Parenteau, Charline; Doutrelant, Claire			Maternal Effects in Relation to Helper Presence in the Cooperatively Breeding Sociable Weaver	PLOS ONE			English	Article							EGG SIZE; LIFE-HISTORY; REPRODUCTIVE SUCCESS; PHILETAIRUS-SOCIUS; INVESTMENT STRATEGIES; CORTICOSTERONE LEVELS; OFFSPRING SURVIVAL; STRESS HORMONES; YOLK ANDROGENS; SEX-RATIO	In egg laying species, breeding females may adjust the allocation of nutrients or other substances into eggs in order to maximise offspring or maternal fitness. Cooperatively breeding species offer a particularly interesting context in which to study maternal allocation because helpers create predictably improved conditions during offspring development. Some recent studies on cooperative species showed that females assisted by helpers produced smaller eggs, as the additional food brought by the helpers appeared to compensate for this reduction in egg size. However, it remains unclear how common this effect might be. Also currently unknown is whether females change egg composition when assisted by helpers. This effect is predicted by current maternal allocation theory, but has not been previously investigated. We studied egg mass and contents in sociable weavers (Philetairus socius). We found that egg mass decreased with group size, while fledgling mass did not vary, suggesting that helpers may compensate for the reduced investment in eggs. We found no differences in eggs' carotenoid contents, but females assisted by helpers produced eggs with lower hormonal content, specifically testosterone, androstenedione (A4) and corticosterone levels. Taken together, these results suggest that the environment created by helpers can influence maternal allocation and potentially offspring phenotypes.	[Paquet, Matthieu; Doutrelant, Claire] CEFE CNRS, Montpellier, France; [Covas, Rita] CIBIO, Res Ctr Biodivers & Genet Resources, Vairao, Portugal; [Covas, Rita] Univ Cape Town, Percy Fitzpatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Covas, Rita] Univ Porto, Dept Biol, Fac Sci, P-4100 Oporto, Portugal; [Chastel, Olivier; Parenteau, Charline] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS)	Paquet, M (corresponding author), CEFE CNRS, 1919 Route Mende, Montpellier, France.	matthieu.paquet@cefe.cnrs.fr	Covas, Rita/G-2242-2018; Paquet, Matthieu/H-5507-2019	Covas, Rita/0000-0001-7130-144X; Paquet, Matthieu/0000-0003-1182-2299	Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa; Portuguese Science and Technology Foundation [FCT PTDC/BIA-BEC/103818/2008]; French Agence Nationale de la Recherche [09-JCJC-0050-01]; French-Portuguese exchange programme PESSOA	Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); French Agence Nationale de la Recherche(French National Research Agency (ANR)); French-Portuguese exchange programme PESSOA	Funding was provided by the Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa, the Portuguese Science and Technology Foundation (FCT PTDC/BIA-BEC/103818/2008 to RC) and the French Agence Nationale de la Recherche (09-JCJC-0050-01 to CD). Additional funding during analyses and writing up was provided by the French-Portuguese exchange programme PESSOA to RC and CD and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton TG, 2005, P ROY SOC B-BIOL SCI, V272, P1351, DOI 10.1098/rspb.2005.3081; Bernardo J, 1996, AM ZOOL, V36, P216; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Canestrari D, 2011, J EVOLUTION BIOL, V24, P1870, DOI 10.1111/j.1420-9101.2011.02313.x; CAREY C, 1980, CONDOR, V82, P335, DOI 10.2307/1367405; Cariello MO, 2006, HORM BEHAV, V49, P654, DOI 10.1016/j.yhbeh.2005.12.007; Chastel O, 2005, GEN COMP ENDOCR, V140, P33, DOI 10.1016/j.ygcen.2004.10.012; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Clutton-Brock T. H., 1988, REPROD SUCCESS; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Covas R, 2006, BEHAV ECOL SOCIOBIOL, V60, P323, DOI 10.1007/s00265-006-0168-2; Covas R, 2004, AUK, V121, P1199, DOI 10.1642/0004-8038(2004)121[1199:JAASIT]2.0.CO;2; Covas R, 2002, P ROY SOC B-BIOL SCI, V269, P1905, DOI 10.1098/rspb.2002.2106; Covas R, 2002, LIFE HIST EVOLUTION; Covas R, 2008, BEHAV ECOL SOCIOBIOL, V63, P103, DOI 10.1007/s00265-008-0640-2; Covas R, 2011, ANIM BEHAV, V81, P121, DOI 10.1016/j.anbehav.2010.09.022; Crawley M. J, 2002, STAT COMPUTING INTRO; De Fraipont M, 2000, J ANIM ECOL, V69, P404, DOI 10.1046/j.1365-2656.2000.00405.x; Dean WRJ, 2001, J ARID ENVIRON, V47, P101, DOI 10.1006/jare.2000.0693; Deville AS, 2009, CONSEQUENCES REPROD; Doutrelant C, 2004, BEHAV ECOL SOCIOBIOL, V56, P149, DOI 10.1007/s00265-004-0756-y; Doutrelant C, 2007, ANIM BEHAV, V74, P739, DOI 10.1016/j.anbehav.2006.11.033; Eguchi K, 2002, J ANIM ECOL, V71, P123, DOI 10.1046/j.0021-8790.2001.00585.x; Emlen S.T., 1991, P301; Ewen JG, 2009, P NATL ACAD SCI USA, V106, P12798, DOI 10.1073/pnas.0902575106; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Gil D, 2007, AM NAT, V169, P802, DOI 10.1086/516652; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Griesser M, 2008, BEHAV ECOL, V19, P317, DOI 10.1093/beheco/arm131; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Hayward LS, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1026, DOI 10.1086/432854; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Khan MZ, 2002, BEHAV ECOL SOCIOBIOL, V51, P336, DOI 10.1007/s00265-001-0441-3; Koenig WD, 2009, BEHAV ECOL SOCIOBIOL, V63, P1659, DOI 10.1007/s00265-009-0773-y; Komdeur J, 2006, ETHOLOGY, V112, P729, DOI 10.1111/j.1439-0310.2006.01243.x; Legge S, 2000, J ANIM ECOL, V69, P714, DOI 10.1046/j.1365-2656.2000.00429.x; MACLEAN G L, 1973, Ostrich, V44, P176, DOI 10.1080/00306525.1973.9639158; MACLEAN G L, 1973, Ostrich, V44, P254, DOI 10.1080/00306525.1973.9639162; Malueg AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P687, DOI 10.1007/s00265-008-0702-5; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; McCormick MI, 1998, ECOLOGY, V79, P1873, DOI 10.1890/0012-9658(1998)079[1873:BIMSIA]2.0.CO;2; McDonald PG, 2009, ANIM BEHAV, V77, P369, DOI 10.1016/j.anbehav.2008.10.009; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; Mendelsohn J. M., 1997, ATLAS SO AFRICAN BIR, P534; Meylan S, 2005, HORM BEHAV, V48, P44, DOI 10.1016/j.yhbeh.2004.11.022; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Nager RG, 2001, J AVIAN BIOL, V32, P159, DOI 10.1034/j.1600-048X.2001.320209.x; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Olsson M, 2008, J EXP BIOL, V211, P1257, DOI 10.1242/jeb.015065; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; RICKLEFS RE, 1977, AUK, V94, P350; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Ruiz X, 2000, J AVIAN BIOL, V31, P567, DOI 10.1034/j.1600-048X.2000.310416.x; Russell AF, 2008, P R SOC B, V275, P29, DOI 10.1098/rspb.2007.0821; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Russell AF, 2009, PHILOS T R SOC B, V364, P1143, DOI 10.1098/rstb.2008.0298; Sachser N, 2011, NEUROSCI BIOBEHAV R, V35, P1518, DOI 10.1016/j.neubiorev.2010.09.002; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sandell MI, 2007, J AVIAN BIOL, V38, P284, DOI 10.1111/j.2007.0908-8857.03640.x; Santos ESA, 2011, ETHOLOGY, V117, P547, DOI 10.1111/j.1439-0310.2011.01905.x; Schwabl H, 2012, AGE, V34, P87, DOI 10.1007/s11357-011-9222-8; Segers FHID, 2012, P ROY SOC B-BIOL SCI, V279, P1241, DOI 10.1098/rspb.2011.1290; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Spottiswoode CN, 2005, BEHAV ECOLOGY TROPIC; Stearns S.C., 1992, pi; Strand A, 1998, COMP BIOCHEM PHYS A, V119, P963, DOI 10.1016/S1095-6433(98)00011-7; Taborsky B, 2007, BEHAV ECOL, V18, P652, DOI 10.1093/beheco/arm026; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Tschirren B, 2007, AM NAT, V169, P87, DOI 10.1086/509945; van Dijk R, 2012, OECOLOGIA; Vezina F, 2002, PHYSIOL BIOCHEM ZOOL, V75, P377, DOI 10.1086/343137; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WHITE FN, 1975, IBIS, V117, P171, DOI 10.1111/j.1474-919X.1975.tb04205.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Woxvold IA, 2005, J ANIM ECOL, V74, P1039, DOI 10.1111/j.1365-2656.2005.01001.x; [No title captured]	96	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59336	10.1371/journal.pone.0059336	http://dx.doi.org/10.1371/journal.pone.0059336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536872	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200020
J	Smid, HGOM; Bruggeman, R; Martens, S				Smid, Henderikus G. O. M.; Bruggeman, Richard; Martens, Sander			Fragmented Perception: Slower Space-Based but Faster Object-Based Attention in Recent-Onset Psychosis with and without Schizophrenia	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; VISUAL-ATTENTION; PROCESSING SPEED; BRAIN MECHANISMS; ORGANIZATION; DEFICITS; IMPAIRMENT; MEMORY; DISENGAGEMENT; INFORMATION	Background: Schizophrenia is associated with impairments of the perception of objects, but how this affects higher cognitive functions, whether this impairment is already present after recent onset of psychosis, and whether it is specific for schizophrenia related psychosis, is not clear. We therefore tested the hypothesis that because schizophrenia is associated with impaired object perception, schizophrenia patients should differ in shifting attention between objects compared to healthy controls. To test this hypothesis, a task was used that allowed us to separately observe space-based and object-based covert orienting of attention. To examine whether impairment of object-based visual attention is related to higher order cognitive functions, standard neuropsychological tests were also administered. Method: Patients with recent onset psychosis and normal controls performed the attention task, in which space-and object-based attention shifts were induced by cue-target sequences that required reorienting of attention within an object, or reorienting attention between objects. Results: Patients with and without schizophrenia showed slower than normal spatial attention shifts, but the object-based component of attention shifts in patients was smaller than normal. Schizophrenia was specifically associated with slowed right-to-left attention shifts. Reorienting speed was significantly correlated with verbal memory scores in controls, and with visual attention scores in patients, but not with speed-of-processing scores in either group. Conclusions: deficits of object-perception and spatial attention shifting are not only associated with schizophrenia, but are common to all psychosis patients. Schizophrenia patients only differed by having abnormally slow right-to-left visual field reorienting. Deficits of object-perception and spatial attention shifting are already present after recent onset of psychosis. Studies investigating visual spatial attention should take into account the separable effects of space-based and object-based shifting of attention. Impaired reorienting in patients was related to impaired visual attention, but not to deficits of processing speed and verbal memory.	[Smid, Henderikus G. O. M.; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, NL-9713 AV Groningen, Netherlands; [Martens, Sander] Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Smid, HGOM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, NL-9713 AV Groningen, Netherlands.	H.G.O.M.Smid@umcg.nl		Bruggeman, Richard/0000-0002-3238-8471; Martens, Sander/0000-0001-8237-7984	Department of Psychiatry, University Medical Center Groningen	Department of Psychiatry, University Medical Center Groningen	This research was financed by the Department of Psychiatry, University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Buchholz J, 2005, BRAIN COGNITION, V57, P30, DOI 10.1016/j.bandc.2004.08.017; Bustillo JR, 1997, AM J PSYCHIAT, V154, P647; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Cirillo MA, 2003, NEUROPSYCHOL REV, V13, P43, DOI 10.1023/A:1023870821631; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Doniger GM, 2002, ARCH GEN PSYCHIAT, V59, P1011, DOI 10.1001/archpsyc.59.11.1011; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; EGLY R, 1994, PSYCHOL SCI, V5, P380, DOI 10.1111/j.1467-9280.1994.tb00289.x; Fuentes LJ, 1999, SCHIZOPHR RES, V40, P75, DOI 10.1016/S0920-9964(99)00044-4; JONIDES J, 1984, PSYCHOL BULL, V96, P29, DOI 10.1037/0033-2909.96.1.29; Kanwisher N., 1992, CURR DIR PSYCHOL SCI, V1, P26; Knowles EEM, 2010, AM J PSYCHIAT, V167, P828, DOI 10.1176/appi.ajp.2010.09070937; Leeson VC, 2010, SCHIZOPHRENIA BULL, V36, P400, DOI 10.1093/schbul/sbn100; LIOTTI M, 1993, J PSYCHIATR RES, V27, P119, DOI 10.1016/0022-3956(93)90056-8; Luck SJ, 2006, SCHIZOPHR RES, V85, P174, DOI 10.1016/j.schres.2006.03.040; Maruff P, 1998, PSYCHOL MED, V28, P1091, DOI 10.1017/S0033291798007132; MARUFF P, 1995, NEUROPSYCHOLOGIA, V33, P1205, DOI 10.1016/0028-3932(95)00037-4; Mass R, 2000, SCHIZOPHRENIA BULL, V26, P167, DOI 10.1093/oxfordjournals.schbul.a033437; MORAN MJ, 1992, BIOL PSYCHIAT, V32, P617, DOI 10.1016/0006-3223(92)90074-A; Muller NG, 2003, J NEUROSCI, V23, P9812; NESTOR PG, 1992, J ABNORM PSYCHOL, V101, P682, DOI 10.1037/0021-843X.101.4.682; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; PLACE EJS, 1980, J ABNORM PSYCHOL, V89, P409; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1988, ARCH GEN PSYCHIAT, V45, P814; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; STRAUSS ME, 1991, PSYCHIAT RES, V37, P139, DOI 10.1016/0165-1781(91)90071-V; Uhlhaas PJ, 2007, SCHIZOPHRENIA BULL, V33, P142, DOI 10.1093/schbul/sbl047; Uhlhaas PJ, 2005, PSYCHOL BULL, V131, P618, DOI 10.1037/0033-2909.131.4.618; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; VECERA SP, 1994, J EXP PSYCHOL GEN, V123, P146, DOI 10.1037/0096-3445.123.2.146; Wigal SB, 1997, NEUROPSYCHOLOGIA, V35, P1519, DOI 10.1016/S0028-3932(97)00087-0	40	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59983	10.1371/journal.pone.0059983	http://dx.doi.org/10.1371/journal.pone.0059983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536901	gold, Green Submitted, Green Published			2022-12-27	WOS:000317397200049
J	Van Steenkiste, N; Tessens, B; Willems, W; Backeljau, T; Jondelius, U; Artois, T				Van Steenkiste, Niels; Tessens, Bart; Willems, Wim; Backeljau, Thierry; Jondelius, Ulf; Artois, Tom			A Comprehensive Molecular Phylogeny of Dalytyphloplanida (Platyhelminthes: Rhabdocoela) Reveals Multiple Escapes from the Marine Environment and Origins of Symbiotic Relationships	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; ULTRASTRUCTURE; SPERM; INTERRELATIONSHIPS; SPERMIOGENESIS; TURBELLARIA; MORPHOLOGY; PARASITISM; FLATWORMS; ALIGNMENT	In this study we elaborate the phylogeny of Dalytyphloplanida based on complete 18S rDNA (156 sequences) and partial 28S rDNA (125 sequences), using a Maximum Likelihood and a Bayesian Inference approach, in order to investigate the origin of a limnic or limnoterrestrial and of a symbiotic lifestyle in this large group of rhabditophoran flatworms. The results of our phylogenetic analyses and ancestral state reconstructions indicate that dalytyphloplanids have their origin in the marine environment and that there was one highly successful invasion of the freshwater environment, leading to a large radiation of limnic and limnoterrestrial dalytyphloplanids. This monophyletic freshwater clade, Limnotyphloplanida, comprises the taxa Dalyelliidae, Temnocephalida, and most Typhloplanidae. Temnocephalida can be considered ectosymbiotic Dalyelliidae as they are embedded within this group. Secondary returns to brackish water and marine environments occurred relatively frequently in several dalyeliid and typhloplanid taxa. Our phylogenies also show that, apart from the Limnotyphloplanida, there have been only few independent invasions of the limnic environment, and apparently these were not followed by spectacular speciation events. The distinct phylogenetic positions of the symbiotic taxa also suggest multiple origins of commensal and parasitic life strategies within Dalytyphloplanida. The previously established higher-level dalytyphloplanid clades are confirmed in our topologies, but many of the traditional families are not monophyletic. Alternative hypothesis testing constraining the monophyly of these families in the topologies and using the approximately unbiased test, also statistically rejects their monophyly.	[Van Steenkiste, Niels; Tessens, Bart; Willems, Wim; Artois, Tom] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Backeljau, Thierry] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Dept Invertebrates, Brussels, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium; [Jondelius, Ulf] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Hasselt University; University of Antwerp; Royal Belgian Institute of Natural Sciences; Royal Belgian Institute of Natural Sciences; Swedish Museum of Natural History	Van Steenkiste, N (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Dept Fisheries & Oceans, Nanaimo, BC V9R 5K6, Canada.	niels_van_steenkiste@hotmail.com	Jondelius, Ulf/AAF-7943-2020; Artois, Tom/O-7349-2017	Jondelius, Ulf/0000-0003-2847-2192; Artois, Tom/0000-0002-2491-7273	Flemish Research Foundation (FWO Vlaanderen); Special Research Foundation (BOF) grant of Hasselt University;  [G.08.208]	Flemish Research Foundation (FWO Vlaanderen)(FWO); Special Research Foundation (BOF) grant of Hasselt University; 	NVS and BT have been benefitting from a grant (aspirant) of the Flemish Research Foundation (FWO Vlaanderen). WW is supported by a Special Research Foundation (BOF) grant of Hasselt University. This paper is also a contribution to the Flemish Research Foundation (FWO) project G.08.208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ax P., 1957, Verh Deutsch Zool Ges Hamburg, V1956, P428; Ax P, 2008, AKAD WISSENSCHAFT MN, V1; Ax P, 1952, FAUNA MITT NORDDEUT, VI, P18; AX PETER, 1960, ZEITSCHR WISS ZOOL, V163, P210; Barbeitos MS, 2010, P NATL ACAD SCI USA, V107, P11877, DOI 10.1073/pnas.0914380107; Beklemishev VN, 1927, ZOOLOGISCHES JAHRBUC, V54, P87; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Cannon L.R.G., 1986, P15; CANNON LRG, 1982, ZOOL SCR, V11, P173, DOI 10.1111/j.1463-6409.1982.tb00530.x; Damborenea MC, 2001, BELG J ZOOL, V131, P167; Doignon G, 2006, BELG J ZOOL, V136, P101; Ehlers U., 1972, Mikrofauna Meeresbodens, VNo. 11, P3; Ehlers U., 1989, Microfauna Marina, V5, P189; Ehlers U, 1985, PHYLOGENETISCHE SYST; EHLERS U, 1981, MIKROFAUNA MEERERSBO, V83, P1; Ehlers Ulrich, 1993, Microfauna Marina, V8, P65; FINDENEGG INGO, 1930, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V59, P73; Hochberg R, 2003, RAFFLES B ZOOL, V51, P1; Hochberg Rick, 2002, Zootaxa, V44, P1; Iomini C, 1999, FOLIA PARASIT, V46, P199; JENNINGS JB, 1978, BIOL BULL, V155, P542, DOI 10.2307/1540789; Jennings JB, 1997, INT J PARASITOL, V27, P679, DOI 10.1016/S0020-7519(97)00010-6; Joffe BI, 1998, HYDROBIOLOGIA, V383, P263, DOI 10.1023/A:1003438321560; JONDELIUS U, 1992, ZOOL SCR, V21, P93, DOI 10.1111/j.1463-6409.1992.tb00312.x; JONDELIUS U, 1992, ZOOL SCR, V21, P223, DOI 10.1111/j.1463-6409.1992.tb00325.x; JONDELIUS U, 1993, CAN J ZOOL, V71, P298, DOI 10.1139/z93-042; Jondelius Ulf, 1997, P187; Karling T, 1974, FAUNA FENN HELSINKI, V27, P1; KARLING T G, 1972, Zoologica Scripta, V1, P251, DOI 10.1111/j.1463-6409.1972.tb00575.x; KARLING TG, 1986, ZOOL SCR, V15, P201, DOI 10.1111/j.1463-6409.1986.tb00223.x; KARLING TOR G., 1956, ARKIV ZOOL, V10, P331; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kolasa J, 1977, ACTA ZOOL FENN, V154, P82; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Littlewood DTJ, 2000, MOL PHYLOGENET EVOL, V16, P449, DOI 10.1006/mpev.2000.0802; Littlewood DTJ, 1999, BIOL J LINN SOC, V68, P257, DOI 10.1111/j.1095-8312.1999.tb01169.x; Littlewood DTJ, 1999, BIOL J LINN SOC, V66, P75, DOI 10.1111/j.1095-8312.1999.tb01918.x; LUTHER A, 1946, ACTA ZOOL FENN, V46, P3; Luther A, 1955, ACTA ZOOL FENN, V87, P1; Luther A., 1948, ACTA ZOOL FENN, V55, P3; LUTHER ALEX, 1962, FAUNA FENNICA, V12, P1; Marcus E, 1954, PAP AVULS DEP ZOOL S, V11, P419; Meixner J., 1938, TIERWELT NORD OSTSEE, V33, P1; MEIXNER JOSEF, 1926, ZEITSCH MORPH U OKOL TIERE, V5, P577, DOI 10.1007/BF00408292; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Noren M, 2002, ZOOL SCR, V31, P403, DOI 10.1046/j.1463-6409.2002.00082.x; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Nylander JAA, 2011, BURNTREES V0 1 9 PER; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Rieger R.M., 1974, BIOL TURBELLARIA, P23; Risen J. U., 1961, Archiv fuer Hydrobiologie, V57, P464; ROHDE K, 1993, INT J PARASITOL, V23, P705, DOI 10.1016/0020-7519(93)90067-9; Rohde K, 1997, INT J PARASITOL, V27, P739, DOI 10.1016/S0020-7519(97)00014-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOCKAERT E. R., 1996, METHODS EXAMINATION, P221; Schockaert ER, 2008, HYDROBIOLOGIA, V595, P41, DOI 10.1007/s10750-007-9002-8; Schultz TR, 1999, SYST BIOL, V48, P651, DOI 10.1080/106351599260229; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SOPOTTEHLERS B, 1995, ZOOMORPHOLOGY, V115, P41, DOI 10.1007/BF00397933; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Therriault TW, 1999, ARCH HYDROBIOL, V144, P371; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Van Steenkiste N, 2010, ZOOL SCI, V27, P285, DOI 10.2108/zsj.27.285; WATSON NA, 1993, PARASITOL RES, V79, P322, DOI 10.1007/BF00932189; Watson Nikki A., 2001, Systematics Association Special Volume Series, V60, P217; Willems WR, 2006, ZOOL SCR, V35, P1, DOI 10.1111/j.1463-6409.2005.00216.x; Willems WR, 2005, NEW ZEAL J ZOOL, V32, P79, DOI 10.1080/03014223.2005.9518400; Willems WR, 2005, THESIS LIMBURGS U CE; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zamparo D, 2001, ZOOL SCR, V30, P59, DOI 10.1046/j.1463-6409.2001.00050.x	82	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59917	10.1371/journal.pone.0059917	http://dx.doi.org/10.1371/journal.pone.0059917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536894	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200042
J	Bugga, L; McDaniel, IE; Engie, L; Armstrong, JA				Bugga, Lakshmi; McDaniel, Ivy E.; Engie, Liana; Armstrong, Jennifer A.			The Drosophila melanogaster CHD1 Chromatin Remodeling Factor Modulates Global Chromosome Structure and Counteracts HP1a and H3K9me2	PLOS ONE			English	Article							TRANSCRIPTION; PROTEIN; GENE; ELONGATION; INTERACTS; POLYCOMB; COMPLEX; BRAHMA; H3.3	CHD1 is a conserved chromatin remodeling factor that localizes to active genes and functions in nucleosome assembly and positioning as well as histone turnover. Mouse CHD1 is required for the maintenance of stem cell pluripotency while human CHD1 may function as a tumor suppressor. To investigate the action of CHD1 on higher order chromatin structure in differentiated cells, we examined the consequences of loss of CHD1 and over-expression of CHD1 on polytene chromosomes from salivary glands of third instar Drosophila melanogaster larvae. We observed that chromosome structure is sensitive to the amount of this remodeler. Loss of CHD1 resulted in alterations of chromosome structure and an increase in the heterochromatin protein HP1a, while over-expression of CHD1 disrupted higher order chromatin structure and caused a decrease in levels of HP1a. Over-expression of an ATPase inactive form of CHD1 did not result in severe chromosomal defects, suggesting that the ATPase activity is required for this in vivo phenotype. Interestingly, changes in CHD1 protein levels did not correlate with changes in the levels of the euchromatin mark H3K4me3 or elongating RNA Polymerase II. Thus, while CHD1 is localized to transcriptionally active regions of the genome, it can function to alter the levels of HP1a, perhaps through changes in methylation of H3K9.	[Bugga, Lakshmi; McDaniel, Ivy E.; Engie, Liana; Armstrong, Jennifer A.] Scripps Coll, Pitzer Coll, Claremont McKenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College; Scripps College	Armstrong, JA (corresponding author), Scripps Coll, Pitzer Coll, Claremont McKenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA.	jarmstrong@kecksci.claremont.edu			National Science Foundation [MCB 0949024, DMS 0634592]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (MCB 0949024). L.A. acknowledges support from the National Science Foundation (DMS 0634592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Armstrong JA, 2005, GENETICS, V170, P1761, DOI 10.1534/genetics.105.041327; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Au TJ, 2011, MOL CELL BIOL, V31, P4454, DOI 10.1128/MCB.05931-11; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Corona DFV, 2004, METHOD ENZYMOL, V377, P70; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ehrensberger AH, 2011, P NATL ACAD SCI USA, V108, P10115, DOI 10.1073/pnas.1101449108; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fasulo B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002878; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; Hennig BP, 2012, EMBO REP, V13, P997, DOI 10.1038/embor.2012.146; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Johansen KM, 2009, METHODS, V48, P387, DOI 10.1016/j.ymeth.2009.02.019; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lavrov S, 2004, METH MOL B, V247, P289; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Morettini S, 2011, NUCLEIC ACIDS RES, V39, P3103, DOI 10.1093/nar/gkq1298; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Podhraski V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010120; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Radman-Livaja M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002811; Rebeiz M, 2004, DEV BIOL, V271, P431, DOI 10.1016/j.ydbio.2004.04.011; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Sebald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043144; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Siriaco G, 2009, GENETICS, V182, P661, DOI 10.1534/genetics.109.102053; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stephens GE, 2004, METHOD ENZYMOL, V376, P372; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59496	10.1371/journal.pone.0059496	http://dx.doi.org/10.1371/journal.pone.0059496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533627	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400064
J	Buglioni, S; Di Filippo, F; Terrenato, I; Casini, B; Gallo, E; Marandino, F; Maini, CL; Pasqualoni, R; Botti, C; Di Filippo, S; Pescarmona, E; Mottolese, M				Buglioni, Simonetta; Di Filippo, Franco; Terrenato, Irene; Casini, Beatrice; Gallo, Enzo; Marandino, Ferdinando; Maini, Carlo L.; Pasqualoni, Rossella; Botti, Claudio; Di Filippo, Simona; Pescarmona, Edoardo; Mottolese, Marcella			Quantitative Molecular Analysis of Sentinel Lymph Node May Be Predictive of Axillary Node Status in Breast Cancer Classified by Molecular Subtypes	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; ONE-STEP; RAPID IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE ASSESSMENT; METASTASES; DIAGNOSIS; BIOPSY; MICROMETASTASES; EXPRESSION; MANAGEMENT	To determine the performance of intraoperative one-step nucleic acid amplification (OSNA) assay in detecting sentinel lymph node metastases compared to postoperative histology taking into account breast cancer molecular classification and to evaluate whether the level of cytokeratin 19 mRNA copy number may be useful in predicting the likelihood of a positive axillary lymph node dissection. OSNA assay was performed in a prospective series of 903 consecutive sentinel lymph nodes from 709 breast cancer patients using 2 alternate slices of each sentinel lymph node. The remaining 2 slices were investigated by histology. Cytokeratin 19 mRNA copy number, which distinguishes negative cases (<250 copies), micrometastases (+, >= 250 <= 5000 copies) and macrometastases (++, >5000 copies), was compared to axillary lymph node dissection status and to the biological tumor profile. Concordance between OSNA and histopathology was 95%, specificity 95% and sensitivity 93%. Multiple Corresponce Analysis and logistic regression evidenced that positive axillary lymph node dissection was significantly associated with a higher cytokeratin 19 mRNA copy number (>5000; p<0.0001), HER2 subtype (p = 0.007) and lymphovascular invasion (p<0.0001). Conversely, breast cancer patients with cytokeratin 19 mRNA copy number <2000 mostly presented a luminal subtype and a negative axillary lymph node dissection. We confirmed that OSNA assay can provide standardized and reproducible results and that it represents a fast and quantitative tool for intraoperative evaluation of sentinel lymph node. Omission of axillary lymph node dissection could be proposed in patients presenting a sentinel lymph node with a cytokeratin 19 mRNA copy number <2000 and a Luminal tumor phenotype.	[Buglioni, Simonetta; Casini, Beatrice; Gallo, Enzo; Marandino, Ferdinando; Pescarmona, Edoardo; Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Di Filippo, Franco; Botti, Claudio; Di Filippo, Simona] Regina Elena Inst Canc Res, Dept Surg, Rome, Italy; [Terrenato, Irene] Regina Elena Inst Canc Res, Rome, Italy; [Maini, Carlo L.; Pasqualoni, Rossella] Regina Elena Inst Canc Res, Dept Nucl Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Buglioni, S (corresponding author), Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.	buglioni@ifo.it	Terrenato, Irene/B-1308-2017; Gallo, Enzo/AAB-3121-2020; MARANDINO, FERDINANDO/AAB-2537-2019; Botti, Claudio/AAC-9786-2022	Terrenato, Irene/0000-0002-0187-9323; Gallo, Enzo/0000-0002-4938-4071; CASINI, BEATRICE/0000-0002-9038-0179; Pescarmona, Edoardo/0000-0002-0443-9331; buglioni, simonetta/0000-0002-5066-1523; Botti, Claudio/0000-0002-5814-6876				Baba S, 2011, BREAST CANC; Beach RA, 2003, APPL IMMUNOHISTO M M, V11, P45, DOI 10.1097/00022744-200303000-00008; Bernet L, 2011, HISTOPATHOLOGY, V58, P863, DOI 10.1111/j.1365-2559.2011.03836.x; Castellano I, 2012, ANN SURG, V255, P334, DOI 10.1097/SLA.0b013e31823000ed; Cserni G, 2005, CANCER, V103, P358, DOI 10.1002/cncr.20760; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Ellis IO, 2003, PATHOLOGY GENETICS T, P9; Feldman S, 2011, CANCER-AM CANCER SOC, V117, P2599, DOI 10.1002/cncr.25822; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Galimberti V, 2012, BREAST CANCER RES TR, V131, P819, DOI 10.1007/s10549-011-1486-2; Godey F, 2012, BREAST CANCER RES TR, V131, P509, DOI 10.1007/s10549-011-1808-4; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greenacre Michael, 1984, THEORY APPL CORRES A; Homma K, 2011, CANCER; Khaddage A, 2011, ANTICANCER RES, V31, P585; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; Layfield DM, 2011, BRIT J SURG, V98, P4, DOI 10.1002/bjs.7229; Le Frere-Belda MA, 2012, INT J CANCER, V130, P2377, DOI 10.1002/ijc.26291; Lebart L., 1984, MULTIVARIATE DESCRIP; Leikola JP, 2005, CANCER, V104, P14, DOI 10.1002/cncr.21133; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Ohi Y, 2012, BR J CANC; Osako T, 2011, BRIT J CANCER, V105, P1197, DOI 10.1038/bjc.2011.350; Osako T, 2011, CANCER-AM CANCER SOC, V117, P4365, DOI 10.1002/cncr.26060; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Laia BV, 2011, DIAGN MOL PATHOL, V20, P18, DOI 10.1097/PDM.0b013e3181eb9b30; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Visser M, 2008, INT J CANCER, V122, P2562, DOI 10.1002/ijc.23451; Wasif N, 2010, ARCH SURG-CHICAGO, V145, P161, DOI 10.1001/archsurg.2009.269; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	38	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58823	10.1371/journal.pone.0058823	http://dx.doi.org/10.1371/journal.pone.0058823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533593	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400030
J	Lindegaard, B; Hvid, T; Grondahl, T; Frosig, C; Gerstoft, J; Hojman, P; Pedersen, BK				Lindegaard, Birgitte; Hvid, Thine; Grondahl, Thomas; Frosig, Christian; Gerstoft, Jan; Hojman, Pernille; Pedersen, Bente Klarlund			Expression of Fibroblast Growth Factor-21 in Muscle Is Associated with Lipodystrophy, Insulin Resistance and Lipid Disturbances in Patients with HIV	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; SERUM FGF21 LEVELS; ADIPOSE-TISSUE; PPAR-ALPHA; GLUCOSE; FAT; METABOLISM; SENSITIVITY; LIVER; AKT	Background: Fibroblast growth factor (FGF)-21 is a novel regulator of glucose and lipid metabolism. Recently, increased FGF-21 mRNA expression in muscle was found in patients with type 2 diabetes, but the role for FGF-21 in muscle is not well understood. Patients with HIV-infection and lipodystrophy are characterised by various degree of lipid-driven insulin resistance. We hypothesized that muscle FGF-21 mRNA would be altered in HIV patients with lipodystrophy. Design: Twenty-five HIV-infected men with lipodystrophy (LD) and 15 age-matched healthy controls, received an oral glucose tolerance test and a euglycemic-hyperinsulinemic clamp (50 mU/m2/min) combined with 6,6-H-2 glucose infusion. Muscle biopsies were obtained and FGF-21 mRNA and glycogen synthase (GS) activity were measured. Results: Subjects with HIV were insulin resistant compared with non-HIV subjects. Compared to controls, HIV subjects demonstrated a twofold increase of plasma FGF-21 from 70.4 +/- 56.8 pg/ml vs 109.1 +/- 71.8 pg/ml, respectively (p = 0.04) and an eight-fold increase in muscular FGF-21 mRNA expression (p = 0.001). Muscle FGF-21 mRNA correlated inversely with the rate of disappearance of glucose during insulin clamp (r = -0.54, p = 0.0009), and the GS fractional velocity in muscle (r = -0.39, p = 0.03), and directly with fasting insulin (r = 0.50, p = 0.0022), HOMA-IR (r = 0.47, p = 0.004), triglycerides (r = 0.60. P = 0.0001), waist-to-hip ratio (r = 0.51, p = 0.0001) and limb fat mass (-0.46, p = 0.004), but not to plasma FGF-21. Conclusion: FGF-21 mRNA is increased in skeletal muscle in HIV patients and correlates to whole-body (primarily reflecting muscle) insulin resistance, but not to plasma FGF-21. Those findings add to the evidence that FGF-21 is a myokine and may suggest that muscle FGF-21 is working in a local manner.	[Lindegaard, Birgitte; Hvid, Thine; Grondahl, Thomas; Hojman, Pernille; Pedersen, Bente Klarlund] Rigshosp, Dept Infect Dis, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Lindegaard, Birgitte; Hvid, Thine; Grondahl, Thomas; Frosig, Christian; Hojman, Pernille; Pedersen, Bente Klarlund] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark; [Lindegaard, Birgitte; Gerstoft, Jan; Hojman, Pernille; Pedersen, Bente Klarlund] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Frosig, Christian] Inst Exercise & Sport Sci, Dept Human Physiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Lindegaard, B (corresponding author), Rigshosp, Dept Infect Dis, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark.	blm@rh.dk	Frøsig, Christian/A-3750-2015; Pedersen, Bente Klarlund/AGR-3217-2022; Lindegaard, Birgitte/AGY-9629-2022	Frøsig, Christian/0000-0001-9302-9328; Pedersen, Bente Klarlund/0000-0001-6508-6288; Lindegaard, Birgitte/0000-0002-5236-8427	Danish National Research Foundation [02-512-55]; Danish Medical Research Council [22-04-0588]; Commission of the European Communities [223576 - MYOAGE]; Lundbeck Foundation; Danish AIDS Foundation; Novo Nordisk Foundation; Direktor Emil Hertz og Hustru Inger Hertz' Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for L gevidenskabens fremme; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commission of the European Communities(European Commission); Lundbeck Foundation(Lundbeckfonden); Danish AIDS Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Direktor Emil Hertz og Hustru Inger Hertz' Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for L gevidenskabens fremme; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). This study was further supported by the Danish Medical Research Council (# 22-04-0588), the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE), the Lundbeck Foundation, the Danish AIDS Foundation, the Novo Nordisk Foundation, Direktor Emil Hertz og Hustru Inger Hertz' Fond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Fonden for L gevidenskabens fremme. CIM is part of the UNIK Project: Food, Fitness and Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Domingo P, 2010, AIDS, V24, P2629, DOI 10.1097/QAD.0b013e3283400088; Gallego-Escuredo JM, 2012, JAIDS-J ACQ IMM DEF, V61, P527, DOI 10.1097/QAI.0b013e318271c2c7; Haugaard SB, 2005, DIABETES, V54, P3474, DOI 10.2337/diabetes.54.12.3474; Haugaard SB, 2005, EUR J ENDOCRINOL, V152, P103, DOI 10.1530/eje.1.01835; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lee MS, 2012, METABOLISM; Lindegaard B, 2008, J CLIN ENDOCR METAB, V93, P3860, DOI 10.1210/jc.2007-2733; Lindegaard B, 2007, DIABETES, V56, P2070, DOI 10.2337/db07-0144; Maagaard A, 2006, ANTIVIR THER, V11, P601; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meininger G, 2002, METABOLISM, V51, P260, DOI 10.1053/meta.2002.29999; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Reeds DN, 2006, AM J PHYSIOL-ENDOC M, V290, pE47, DOI 10.1152/ajpendo.00236.2005; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Torriani M, 2006, J APPL PHYSIOL, V100, P609, DOI 10.1152/japplphysiol.00797.2005; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Vienberg SG, 2012, EUR J ENDOCRINOL, V167, P49, DOI 10.1530/EJE-12-0039; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	34	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e55632	10.1371/journal.pone.0055632	http://dx.doi.org/10.1371/journal.pone.0055632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533568	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400006
J	Abe, T; Ishimatsu, S; Tokuda, Y				Abe, Toshikazu; Ishimatsu, Shinichi; Tokuda, Yasuharu			Descriptive Analysis of Patients' EMS Use Related to Severity in Tokyo: A Population-Based Observational Study	PLOS ONE			English	Article							AMBULANCE TRANSPORTS; HEALTH-CARE; TRAUMA; SYSTEM; JAPAN; COST	Introduction: Few studies are available on the clinical characteristics of patients using emergency medical transports in Japan. In this study, we aimed to investigate reasons for emergency medical transports and their relation to clinical severity. Methods: We conducted a 3-year population-based observational study of patients transported by ambulance to emergency departments (ED) in the capital of Japan, Tokyo, which has a population of about 13 million. Demographic data, reasons for transport, and the severity of initial assessment at ED were recorded. Logistic regression was used to determine the odds of the clinical severity of each reason for transport. Results: The number of emergency medical transports in the three-year study period was 1,832,637. Mean age was 53 +/- 26. Males were 976,142 (53%). Overall, 92% of all transported patients were in a mild or moderate medical state and patients with the 17 most frequent reasons for transport occupied 82% (1,506,017) of all transports. Pain was the most frequent reason for transport, followed by traffic accident. Considering all the patients and their reasons for transport, patients whose reason was pain or a traffic accident (29% of all patients) were in a relatively mild state compared with patients with other reasons for transport. Patients in an altered mental state in the prehospital setting (6.8% of all patients) were in a more severe medical state than other patients. Conclusions: In Tokyo, Japan, 92% of transported patients were in a mild or moderate medical state. In particular, most patients from traffic accidents were in a mild state, even though traffic accidents were the second most frequent reason for transport. Patients in an altered mental state were most likely to be in a severe medical state.	[Abe, Toshikazu] Univ Tsukuba, Dept Emergency Med, Mito Kyodo Gen Hosp, Mito, Ibaraki, Japan; [Ishimatsu, Shinichi] St Lukes Int Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Tokuda, Yasuharu] Univ Tsukuba, Inst Clin Med, Grad Sch Comprehens Human Sci, Mito, Ibaraki, Japan	University of Tsukuba; St. Luke's International Hospital; University of Tsukuba	Abe, T (corresponding author), Univ Tsukuba, Dept Emergency Med, Mito Kyodo Gen Hosp, Mito, Ibaraki, Japan.	mican-philia@sunny.ocn.ne.jp	Abe, Toshikazu/ABH-1639-2021		St. Luke's Life Science Institute Research grant, Japan	St. Luke's Life Science Institute Research grant, Japan	We are supported by St. Luke's Life Science Institute Research grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe T, 2008, EMERG MED J, V25, P769, DOI 10.1136/emj.2007.056960; Billittier AJ, 1996, ACAD EMERG MED, V3, P1046; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; CamassoRichardson K, 1997, ACAD EMERG MED, V4, P1137, DOI 10.1111/j.1553-2712.1997.tb03696.x; Chernew ME, 2008, AM J MANAG CARE, V14, P412; Koenig KL, 1996, ACAD EMERG MED, V3, P989, DOI 10.1111/j.1553-2712.1996.tb03339.x; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Ministry of Education Culture S Science and Technology of Japan/Ministry of Health Labour and Welfare of Japan, 2006, GUIDELINE EPIDEMIOLO; Ohshige K, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-21; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; SIU AL, 1986, NEW ENGL J MED, V315, P1259, DOI 10.1056/NEJM198611133152005; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; Tokuda Y, 2010, J EPIDEMIOL, V20, P468, DOI 10.2188/jea.JE20090210	14	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59738	10.1371/journal.pone.0059738	http://dx.doi.org/10.1371/journal.pone.0059738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527262	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600091
J	Mazieres, J; Catherinne, C; Delfour, O; Gouin, S; Rouquette, I; Delisle, MB; Prevot, G; Escamilla, R; Didier, A; Persing, DH; Bates, M; Michot, B				Mazieres, Julien; Catherinne, Caroline; Delfour, Olivier; Gouin, Sandrine; Rouquette, Isabelle; Delisle, Marie-Bernadette; Prevot, Gregoire; Escamilla, Roger; Didier, Alain; Persing, David H.; Bates, Mike; Michot, Bernard			Alternative Processing of the U2 Small Nuclear RNA Produces a 19-22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum	PLOS ONE			English	Article							MICRORNA EXPRESSION; NONCODING RNAS; POSTTRANSCRIPTIONAL MODIFICATION; CIRCULATING MICRORNAS; TRANSCRIPTOME; SNRNA; ASSOCIATION; PROTEINS; AGO1	RNU2 exists in two functional forms (RNU2-1 and RNU2-2) distinguishable by the presence of a unique 4-bases motif. Detailed investigation of datasets obtained from deep sequencing of five human lung primary tumors revealed that both forms express at a high rate a 19-22nt fragment (miR-U2-1 and -2) from its 3' region and contains the 4-bases motif. Deep sequencing of independent pools of serum samples from healthy donors and lung cancer patients revealed that miR-U2-1 and -2 are pervasively processed in lung tissue by means of endonucleolytic cleavages and stably exported to the blood. Then, microarrays hybridization experiments of matched normal/tumor samples revealed a significant over-expression of miR-U2-1 in 14 of 18 lung primary tumors. Subsequently, qRT-PCR of miR-U2-1 using serum from 62 lung cancer patients and 96 various controls demonstrated that its expression levels identify lung cancer patients with 79% sensitivity and 80% specificity. miR-U2-1 expression correlated with the presence or absence of lung cancer in patients with chronic obstructive pulmonary disease (COPD), other diseases of the lung - not cancer, and in healthy controls. These data suggest that RNU2-1 is a new bi-functional ncRNA that produces a 19-22nt fragment which may be useful in detecting lung cancer non-invasively in high risk patients.	[Mazieres, Julien; Gouin, Sandrine; Prevot, Gregoire; Escamilla, Roger; Didier, Alain] Univ Toulouse 3, CHU Toulouse, Hop Larrey, Serv Pneumol, F-31062 Toulouse, France; [Catherinne, Caroline; Delfour, Olivier; Michot, Bernard] Cepheid Europe, Maurens Scopont, France; [Rouquette, Isabelle; Delisle, Marie-Bernadette] CHU Toulouse, Hop Rangueil, Serv Anat Pathol, Toulouse, France; [Persing, David H.; Bates, Mike] Cepheid USA, Sunnyvale, CA USA	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Michot, B (corresponding author), Cepheid Europe, Maurens Scopont, France.	bernard.michot@cepheid.com	MAZIERES, JULIEN/M-3986-2014; Rouquette, Isabelle/AAE-6986-2019	MAZIERES, JULIEN/0000-0002-5921-7613	Midi-Pyrenees Regional Council	Midi-Pyrenees Regional Council(Region Occitanie)	This program, more particularly blood collection, was supported by a grant from the Midi-Pyrenees Regional Council. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baraniskin A, 2013, INT J CANCER, V132, pE48, DOI 10.1002/ijc.27791; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; DELFOUR O, 2007, MIRNA BIOL FUNCTION, P335; Deryusheva S, 2012, RNA, V18, P31, DOI 10.1261/rna.030106.111; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Findeiss S, 2011, BIOL CHEM, V392, P305, DOI 10.1515/BC.2011.043; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020517; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huang Q, 1997, MOL CELL BIOL, V17, P7178, DOI 10.1128/MCB.17.12.7178; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jaladat Y, 2011, RNA BIOL, V8, P372, DOI 10.4161/rna.8.3.15386; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Karijolich J, 2010, RNA BIOL, V7, P192, DOI 10.4161/rna.7.2.11207; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langenberger D, 2010, BIOCOMPUT-PAC SYM, P80; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nicoloso M, 1996, J MOL BIOL, V260, P178, DOI 10.1006/jmbi.1996.0391; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; PAN ZQ, 1989, GENE DEV, V3, P1887, DOI 10.1101/gad.3.12a.1887; Parisi C, 2011, FEBS LETT, V585, P2965, DOI 10.1016/j.febslet.2011.08.003; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Rederstorff M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq057; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Smalheiser NR, 2011, RNA, V17, P166, DOI 10.1261/rna.2123811; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Valadkhan S, 2010, RNA BIOL, V7, P345, DOI 10.4161/rna.7.3.12089; Valadkhan S, 2009, P NATL ACAD SCI USA, V106, P11901, DOI 10.1073/pnas.0902020106; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	63	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60134	10.1371/journal.pone.0060134	http://dx.doi.org/10.1371/journal.pone.0060134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527303	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600120
J	Schrauwen, EJA; Bestebroer, TM; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM; Herfst, S				Schrauwen, Eefje J. A.; Bestebroer, Theo M.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Herfst, Sander			Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments	PLOS ONE			English	Article							SWINE-ORIGIN H1N1; INCREASED PATHOGENICITY; A VIRUS; FERRETS; H3N2; TRANSMISSION; REPLICATION; GENERATION	Highly pathogenic avian influenza H5N1 viruses have devastated the poultry industry in many countries of the eastern hemisphere. Occasionally H5N1 viruses cross the species barrier and infect humans, sometimes with a severe clinical outcome. When this happens, there is a chance of reassortment between H5N1 and human influenza viruses. To assess the potential of H5N1 viruses to reassort with contemporary human influenza viruses (H1N1, H3N2 and pandemic H1N1), we used an in vitro selection method to generate reassortant viruses, that contained the H5 hemagglutinin gene, and that have a replication advantage in vitro. We found that the neuraminidase and matrix gene segments of human influenza viruses were preferentially selected by H5 viruses. However, these H5 reassortant viruses did not show a marked increase in replication in MDCK cells and human bronchial epithelial cells. In ferrets, inoculation with a mixture of H5N1-pandemic H1N1 reassortant viruses resulted in outgrowth of reassortant H5 viruses that had incorporated the neuraminidase and matrix gene segment of pandemic 2009 H1N1. This virus was not transmitted via aerosols or respiratory droplets to naive recipient ferrets. Altogether, these data emphasize the potential of avian H5N1 viruses to reassort with contemporary human influenza viruses. The neuraminidase and matrix gene segments of human influenza viruses showed the highest genetic compatibility with HPAI H5N1 virus.	[Schrauwen, Eefje J. A.; Bestebroer, Theo M.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Herfst, Sander] Erasmus MC, Virosci Lab, Postgrad Sch Mol Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Herfst, S (corresponding author), Erasmus MC, Virosci Lab, Postgrad Sch Mol Med, Rotterdam, Netherlands.	s.herfst@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172	National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIH) [HHSN266200700010C]; ERC Advanced Research Grant "FLUPLAN" [250136]	National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ERC Advanced Research Grant "FLUPLAN"	This work was financed through National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIH) contract HHSN266200700010C and ERC Advanced Research Grant "FLUPLAN" (#250136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodewes R, 2012, J GEN VIROL, V93, P1645, DOI 10.1099/vir.0.042671-0; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Karber G, 1931, EXP PATHOL PHARM, V162, P480; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; WHO, 2012, CONF HUM CAS AV INFL	27	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59889	10.1371/journal.pone.0059889	http://dx.doi.org/10.1371/journal.pone.0059889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527283	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600104
J	Horani, A; Ferkol, TW; Shoseyov, D; Wasserman, MG; Oren, YS; Kerem, B; Amirav, I; Cohen-Cymberknoh, M; Dutcher, SK; Brody, SL; Elpeleg, O; Kerem, E				Horani, Amjad; Ferkol, Thomas W.; Shoseyov, David; Wasserman, Mollie G.; Oren, Yifat S.; Kerem, Batsheva; Amirav, Israel; Cohen-Cymberknoh, Malena; Dutcher, Susan K.; Brody, Steven L.; Elpeleg, Orly; Kerem, Eitan			LRRC6 Mutation Causes Primary Ciliary Dyskinesia with Dynein Arm Defects	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; LEUCINE-RICH REPEAT; KARTAGENER-SYNDROME; PROTEOMIC ANALYSIS; BEAT FREQUENCY; SITUS-INVERSUS; GENE; PROTEIN; IDENTIFICATION; CELLS	Despite recent progress in defining the ciliome, the genetic basis for many cases of primary ciliary dyskinesia (PCD) remains elusive. We evaluated five children from two unrelated, consanguineous Palestinian families who had PCD with typical clinical features, reduced nasal nitric oxide concentrations, and absent dynein arms. Linkage analyses revealed a single common homozygous region on chromosome 8 and one candidate was conserved in organisms with motile cilia. Sequencing revealed a single novel mutation in LRRC6 (Leucine-rich repeat containing protein 6) that fit the model of autosomal recessive genetic transmission, leading to a change of a highly conserved amino acid from aspartic acid to histidine (Asp146His). LRRC6 was localized to the cytoplasm and was up-regulated during ciliogenesis in human airway epithelial cells in a Foxj1-dependent fashion. Nasal epithelial cells isolated from affected individuals and shRNA-mediated silencing in human airway epithelial cells, showed reduced LRRC6 expression, absent dynein arms, and slowed cilia beat frequency. Dynein arm proteins were either absent or mislocalized to the cytoplasm in airway epithelial cells from a primary ciliary dyskinesia subject. These findings suggest that LRRC6 plays a role in dynein arm assembly or trafficking and when mutated leads to primary ciliary dyskinesia with laterality defects.	[Horani, Amjad; Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Shoseyov, David; Cohen-Cymberknoh, Malena; Kerem, Eitan] Hadassah Hebrew Univ, Med Ctr, Dept Pediat, Jerusalem, Israel; [Wasserman, Mollie G.; Brody, Steven L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Oren, Yifat S.; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Amirav, Israel] Ziv Med Ctr, Dept Pediat, Safed, Israel; [Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel	Washington University (WUSTL); Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center; Washington University (WUSTL); Hebrew University of Jerusalem; Ziv Medical Center; Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center	Horani, A (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	horani_a@kids.wustl.edu	Amirav, Israel/I-9286-2019	Amirav, Israel/0000-0002-6917-5285	Children's Discovery Institute; National Institutes of Health (NIH) [HL082657, HL056244, GM32843]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056244, R01HL082657, R29HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032843] Funding Source: NIH RePORTER	Children's Discovery Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were funded by the Children's Discovery Institute (SLB, SKD, TWF) and National Institutes of Health (NIH) awards HL082657 (TWF), HL056244 (SLB), GM32843 (SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Jain R, 2012, AM J RESP CELL MOL, V46, P446, DOI 10.1165/rcmb.2011-0107OC; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Morgan GW, 2005, MOL CELL BIOL, V25, P3774, DOI 10.1128/MCB.25.9.3774-3783.2005; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ostrowski LE, 2010, AM J RESP CELL MOL, V43, P55, DOI 10.1165/rcmb.2009-0118OC; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Walker WT, 2012, EUR RESPIR J, V40, P1024, DOI 10.1183/09031936.00176111; Wessels MW, 2003, PRENATAL DIAG, V23, P239, DOI 10.1002/pd.551; Xue JC, 2000, BIOL REPROD, V62, P1278, DOI 10.1095/biolreprod62.5.1278; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	52	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59436	10.1371/journal.pone.0059436	http://dx.doi.org/10.1371/journal.pone.0059436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527195	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100134
J	Murias, JM; Dey, A; Campos, OA; Estaki, M; Hall, KE; Melling, CWJ; Noble, EG				Murias, Juan M.; Dey, Adwitia; Campos, Oscar A.; Estaki, Mehrbod; Hall, Katharine E.; Melling, Christopher W. J.; Noble, Earl G.			High-Intensity Endurance Training Results in Faster Vessel-Specific Rate of Vasorelaxation in Type 1 Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; VITAMIN-C IMPROVES; NITRIC-OXIDE; RESISTANCE EXERCISE; ARTERIAL COMPLIANCE; VASCULAR FUNCTION; SMOOTH-MUSCLE; DYSFUNCTION; ADAPTATION; RELAXATION	This study examined the effects of 6 weeks of moderate-(MD) and high-intensity endurance training (HD) and resistance training (RD) on the vasorelaxation responsiveness of the aorta, iliac, and femoral vessels in type 1 diabetic (D) rats. Vasorelaxation to acetylcholine was modeled as a mono-exponential function. A potential mediator of vasorelaxation, endothelial nitric oxide synthase (e-NOS) was determined by Western blots. Vessel lumen-to-wall ratios were calculated from H&E stains. The vasorelaxation time-constant (tau) (s) was smaller in control (C) (7.2 +/- 3.7) compared to D (9.1 +/- 4.4) and it was smaller in HD (5.4 +/- 1.5) compared to C, D, RD (8.3 +/- 3.7) and MD (8.7 +/- 3.8) (p<0.05). The rate of vasorelaxation (%.s(-1)) was larger in HD (2.7 +/- 1.2) compared to C (2.0 +/- 1.2), D (2.0 +/- 1.5), RD (2.0 +/- 1.0), and MD (2.0 +/- 1.2) (p<0.05). tau vasorelaxation was smaller in the femoral (6.9 +/- 3.7) and iliac (6.9 +/- 4.7) than the aorta (9.0 +/- 5.0) (p<0.05). The rate of vasorelaxation was progressively larger from the femoral (3.1 +/- 1.4) to the iliac (2.0 +/- 0.9) and to the aorta (1.3 +/- 0.5) (p<0.05). e-NOS content (% of positive control) was greater in HD (104 +/- 90) compared to C (71 +/- 64), D (85 +/- 65), RD (69 +/- 43), and MD (76 +/- 44) (p<0.05). e-NOS normalized to lumen-to-wall ratio (%.mm(-1)) was larger in the femoral (11.7 +/- 11.1) compared to the aorta (3.2 +/- 1.9) (p<0.05). Although vasorelaxation responses were vessel-specific, high-intensity endurance training was the most effective exercise modality in restoring the diabetes-related loss of vascular responsiveness. Changes in the vasoresponsiveness seem to be endothelium-dependent as evidenced by the greater e-NOS content in HD and the greater normalized e-NOS content in the smaller vessels.	[Murias, Juan M.; Dey, Adwitia; Campos, Oscar A.; Estaki, Mehrbod; Melling, Christopher W. J.; Noble, Earl G.] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Hall, Katharine E.; Melling, Christopher W. J.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Noble, Earl G.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Noble, EG (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.	enoble@uwo.ca	Dey, Adwitia/M-4693-2019	Dey, Adwitia/0000-0003-1974-0116; Murias, Juan/0000-0002-6460-6453	Canadian Institutes of Health Research (CIHR) [CCT- 83029, 217532]; Ontario Ministry of Research and Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was supported by the Canadian Institutes of Health Research (CIHR - # CCT- 83029 and CIHR - # 217532). JMM was supported by a Postdoctoral fellowship from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 1997, SPORTS MED, V24, P221, DOI 10.2165/00007256-199724040-00001; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Beckman JA, 2003, AM J PHYSIOL-HEART C, V285, pH2392, DOI 10.1152/ajpheart.00403.2003; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Behnke BJ, 2010, J APPL PHYSIOL, V108, P14, DOI 10.1152/japplphysiol.00970.2009; Bergholm R, 1999, ATHEROSCLEROSIS, V145, P341, DOI 10.1016/S0021-9150(99)00089-1; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; da Silva CA, 2012, DIABETES RES CLIN PR, V95, P237, DOI 10.1016/j.diabres.2011.09.034; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gass G, 2004, MED SCI SPORT EXER, V36, P1811, DOI 10.1249/01.MSS.0000142405.51319.FB; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Haram PM, 2006, EUR J CARDIOV PREV R, V13, P585, DOI 10.1097/01.hjr.0000198920.57685.76; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; HATTORI Y, 1991, AM J PHYSIOL, V261, pH1086, DOI 10.1152/ajpheart.1991.261.4.H1086; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; IANUZZO CD, 1982, J APPL PHYSIOL, V52, P1471, DOI 10.1152/jappl.1982.52.6.1471; Johnson LR, 2001, J APPL PHYSIOL, V90, P1102, DOI 10.1152/jappl.2001.90.3.1102; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; Kim E, 2006, J ENDOCRINOL, V188, P263, DOI 10.1677/joe.1.06501; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Liao FL, 2006, TRENDS PHARMACOL SCI, V27, P287, DOI 10.1016/j.tips.2006.04.001; Mahajan H, 2004, DIABETOLOGIA, V47, P2226, DOI 10.1007/s00125-004-1580-7; Maiorana A, 2001, J AM COLL CARDIOL, V38, P860, DOI 10.1016/S0735-1097(01)01439-5; Maiorana A, 2001, MED SCI SPORT EXER, V33, P2022, DOI 10.1097/00005768-200112000-00008; MATSUMOTO A, 1994, LANCET, V343, P849, DOI 10.1016/S0140-6736(94)92047-8; McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146; Melling CWJ, 2013, DIABETES METAB; MERIMEE TJ, 1990, NEW ENGL J MED, V322, P978, DOI 10.1056/NEJM199004053221406; Muller-Delp JM, 2002, AM J PHYSIOL-HEART C, V283, pH1662, DOI 10.1152/ajpheart.00004.2002; Murias JM, 2013, AM J PHYSL REGUL INT; Murias JM, 2013, DIABETES VASC DIS RE, V10, P179, DOI 10.1177/1479164112454758; Poelkens F, 2007, APPL PHYSIOL NUTR ME, V32, P670, DOI 10.1139/H07-048; Rakobowchuk M, 2005, EXP PHYSIOL, V90, P645, DOI 10.1113/expphysiol.2004.029504; Rakobowchuk M, 2005, J APPL PHYSIOL, V98, P2185, DOI 10.1152/japplphysiol.01290.2004; Reusch JEB, 2011, J CLIN ENDOCR METAB, V96, P2367, DOI 10.1210/jc.2010-3011; Rodrigues GJ, 2008, NITRIC OXIDE-BIOL CH, V18, P176, DOI 10.1016/j.niox.2007.12.002; Roseguini BT, 2010, MICROCIRCULATION, V17, P83, DOI 10.1111/j.1549-8719.2009.00005.x; Sallam N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/149678; STAMLER JS, 1994, CIRCULATION, V89, P2035, DOI 10.1161/01.CIR.89.5.2035; Thijssen DHJ, 2011, ATHEROSCLEROSIS, V217, P415, DOI 10.1016/j.atherosclerosis.2011.03.003; Timimi FK, 1998, J AM COLL CARDIOL, V31, P552, DOI 10.1016/S0735-1097(97)00536-6; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Ulker S, 2003, HYPERTENSION, V41, P534, DOI 10.1161/01.HYP.0000057421.28533.37; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008	52	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59678	10.1371/journal.pone.0059678	http://dx.doi.org/10.1371/journal.pone.0059678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527249	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100157
J	Rolfo, A; Giuffrida, D; Nuzzo, AM; Pierobon, D; Cardaropoli, S; Piccoli, E; Giovarelli, M; Todros, T				Rolfo, Alessandro; Giuffrida, Domenica; Nuzzo, Anna Maria; Pierobon, Daniele; Cardaropoli, Simona; Piccoli, Ettore; Giovarelli, Mirella; Todros, Tullia			Pro-Inflammatory Profile of Preeclamptic Placental Mesenchymal Stromal Cells: New Insights into the Etiopathogenesis of Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MIGRATION INHIBITORY FACTOR; NECROSIS-FACTOR-ALPHA; MONOCYTE CHEMOTACTIC PROTEIN-3; NATURAL-KILLER-CELLS; OXIDATIVE STRESS; STEM-CELLS; TROPHOBLAST CELLS; NORMAL-PREGNANCY; GENE-EXPRESSION	The objective of the present study was to evaluate whether placental mesenchymal stromal cells (PDMSCs) derived from normal and preeclamptic (PE) chorionic villous tissue presented differences in their cytokines expression profiles. Moreover, we investigated the effects of conditioned media from normal and PE-PDMSCs on the expression of pro-inflammatory Macrophage migration Inhibitory Factor (MIF), Vascular Endothelial Growth Factor (VEGF), soluble FMS-like tyrosine kinase-1 (sFlt-1) and free beta-human Chorionic Gonadotropin (beta hCG) by normal term villous explants. This information will help to understand whether anomalies in PE-PDMSCs could cause or contribute to the anomalies typical of preeclampsia. Methods: Chorionic villous PDMSCs were isolated from severe preeclamptic (n = 12) and physiological control term (n = 12) placentae. Control and PE-PDMSCs's cytokines expression profiles were determined by Cytokine Array. Control and PE-PDMSCs were plated for 72 h and conditioned media (CM) was collected. Physiological villous explants (n = 48) were treated with control or PE-PDMSCs CM for 72 h and processed for mRNA and protein isolation. MIF, VEGF and sFlt-1 mRNA and protein expression were analyzed by Real Time PCR and Western Blot respectively. Free bhCG was assessed by immunofluorescent. Results: Cytokine array showed increased release of pro-inflammatory cytokines by PE relative to control PDMSCs. Physiological explants treated with PE-PDMSCs CM showed significantly increased MIF and sFlt-1 expression relative to untreated and control PDMSCs CM explants. Interestingly, both control and PE-PDMSCs media induced VEGF mRNA increase while only normal PDMSCs media promoted VEGF protein accumulation. PE-PDMSCs CM explants released significantly increased amounts of free bhCG relative to normal PDMSCs CM ones. Conclusions: Herein, we reported elevated production of pro-inflammatory cytokines by PE-PDMSCs. Importantly, PE PDMSCs induced a PE-like phenotype in physiological villous explants. Our data clearly depict chorionic mesenchymal stromal cells as central players in placental physiopathology, thus opening to new intriguing perspectives for the treatment of human placental-related disorders as preeclampsia.	[Rolfo, Alessandro; Cardaropoli, Simona; Piccoli, Ettore; Todros, Tullia] Univ Turin, Dept Surg Sci, Turin, Italy; [Giuffrida, Domenica; Nuzzo, Anna Maria; Todros, Tullia] OIRM S Anna Hosp, Dept Obstet & Neonatol, Turin, Italy; [Pierobon, Daniele; Giovarelli, Mirella] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Pierobon, Daniele; Giovarelli, Mirella] San Giovanni Battista Hosp, CERMS, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Rolfo, A (corresponding author), Univ Turin, Dept Surg Sci, Turin, Italy.	rolfolab@gmail.com	Rolfo, Alessandro/L-1089-2019; Cardaropoli, Simona/AAC-5885-2019	Rolfo, Alessandro/0000-0001-6730-8067; Cardaropoli, Simona/0000-0002-8927-8900; Todros, Tullia/0000-0003-3016-1510; Piccoli, Ettore/0000-0002-6395-4122; Nuzzo, Anna Maria/0000-0001-9115-2007; Giovarelli, Mirella/0000-0002-7397-3466	Regione Piemonte within the program for "Ricerca Sanitaria Finalizzata" [DD n.204 30042009]; Fondazione Cariplo [2011-0495]; University of Turin; Regione Piemonte; Compagnia di San Paolo	Regione Piemonte within the program for "Ricerca Sanitaria Finalizzata"; Fondazione Cariplo(Fondazione Cariplo); University of Turin; Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo)	This study was supported by Regione Piemonte within the program for "Ricerca Sanitaria Finalizzata 2009" (grant # DD n.204 30042009) and Fondazione Cariplo (grant # 2011-0495). Dr. Alessandro Rolfo is supported by University of Turin, Regione Piemonte and Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200; Arcuri F, 1999, BIOL REPROD, V60, P1299, DOI 10.1095/biolreprod60.6.1299; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BAKER PN, 1995, OBSTET GYNECOL, V86, P815, DOI 10.1016/0029-7844(95)00259-T; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Beckmann I, 2004, HYPERTENS PREGNANCY, V23, P319, DOI 10.1081/PRG-200030334; Benian A, 2008, INT J GYNECOL OBSTET, V100, P228, DOI 10.1016/j.ijgo.2007.09.023; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P13741, DOI 10.1073/pnas.162491699; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cardaropoli S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639342; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chang CJ, 2006, STEM CELLS, V24, P2466, DOI 10.1634/stemcells.2006-0071; CHESLEY LC, 1985, OBSTET GYNECOL, V65, P423; Chung JY, 2004, J CLIN ENDOCR METAB, V89, P2484, DOI 10.1210/jc.2003-031580; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Croy BA, 2002, J REPROD IMMUNOL, V57, P151, DOI 10.1016/S0165-0378(02)00005-0; Croy BA, 2000, J SOC GYNECOL INVEST, V7, P12, DOI 10.1016/S1071-5576(99)00049-0; CUNNINGHAM FG, 1992, NEW ENGL J MED, V326, P927; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Djurovic S, 1997, CLIN GENET, V52, P371; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gammill HS, 2007, FRONT BIOSCI-LANDMRK, V12, P2403, DOI 10.2741/2242; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Guimond MJ, 1998, J EXP MED, V187, P217, DOI 10.1084/jem.187.2.217; Hayman R, 1999, J SOC GYNECOL INVEST, V6, P3, DOI 10.1016/S1071-5576(98)00044-6; Hefler L, 2000, ACTA OBSTET GYN SCAN, V79, P77, DOI 10.1034/j.1600-0412.2000.079001077.x; Hirokawa J, 1998, J BIOCHEM, V123, P733; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Hwang JH, 2010, CYTOKINE, V49, P95, DOI 10.1016/j.cyto.2009.08.013; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Jelkmann W, 2001, CLIN CHEM, V47, P617; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; King A, 2000, PLACENTA, V21, pS81, DOI 10.1053/plac.1999.0520; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Lee SB, 2010, AM J PATHOL, V176, P710, DOI 10.2353/ajpath.2010.090513; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li CD, 2007, CELL TISSUE RES, V330, P437, DOI 10.1007/s00441-007-0504-5; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingston JC, 2000, AM J OBSTET GYNECOL, V183, P1554, DOI 10.1067/mob.2000.108022; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; Lyall F, 1997, BRIT J OBSTET GYNAEC, V104, P223, DOI 10.1111/j.1471-0528.1997.tb11050.x; Maymo J.L., PLACENTA S2, V32, pS146; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nautiyal J, 2004, AM J REPROD IMMUNOL, V52, P8, DOI 10.1111/j.1600-0897.2004.00176.x; Naylor KE, 2003, J CLIN ENDOCR METAB, V88, P5361, DOI 10.1210/jc.2003-030486; Nedeau AE, 2008, EXP CELL RES, V314, P2176, DOI 10.1016/j.yexcr.2008.04.007; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; Norris W, 2011, PLACENTA, V32, pS182, DOI 10.1016/j.placenta.2011.01.009; Olsen RN, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.006; Pang ZJ, 2008, AM J REPROD IMMUNOL, V60, P19, DOI 10.1111/j.1600-0897.2008.00586.x; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Pijnenborg R, 1998, PLACENTA, V19, P569; Rajashekhar G, 2003, MOL REPROD DEV, V64, P397, DOI 10.1002/mrd.10229; Rajashekhar G, 2002, MOL REPROD DEV, V62, P159, DOI 10.1002/mrd.10116; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reister F, 1999, PLACENTA, V20, P229, DOI 10.1053/plac.1998.0373; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; Sagawa N, 2002, ENDOCRINE, V19, P65, DOI 10.1385/ENDO:19:1:65; Shaarawy M, 2001, J SOC GYNECOL INVEST, V8, P27, DOI 10.1016/S1071-5576(00)00091-5; Sharkey AM, 1996, EUR J CLIN INVEST, V26, P1182, DOI 10.1046/j.1365-2362.1996.830605.x; Shibata E, 2001, PLACENTA, V22, P566, DOI 10.1053/plac.2001.0693; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Simpson H, 2002, PLACENTA, V23, P44, DOI 10.1053/plac.2001.0746; SMARASON AK, 1993, BRIT J OBSTET GYNAEC, V100, P943, DOI 10.1111/j.1471-0528.1993.tb15114.x; Soleymanlou N, 2005, CELL DEATH DIFFER, V12, P441, DOI 10.1038/sj.cdd.4401593; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Stenczer B, 2010, CLIN CHEM LAB MED, V48, P181, DOI 10.1515/CCLM.2010.042; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Todros T, 2007, PLACENTA, V28, P1123, DOI 10.1016/j.placenta.2007.06.003; Todros T, 2005, EUR J OBSTET GYN R B, V123, P162, DOI 10.1016/j.ejogrb.2005.03.014; Todt JC, 1996, AM J REPROD IMMUNOL, V36, P65; Toffoli B, 2011, ATHEROSCLEROSIS, V218, P61, DOI 10.1016/j.atherosclerosis.2011.05.019; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Vitoratos N, EUR J OBSTET GYNECOL, V154, P141; Wang YP, 1996, J REPROD IMMUNOL, V32, P157, DOI 10.1016/S0165-0378(96)00998-9; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	96	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59403	10.1371/journal.pone.0059403	http://dx.doi.org/10.1371/journal.pone.0059403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527185	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100126
J	Ho, CL; Yang, CY; Lin, WJ; Lin, CH				Ho, Chia-Lin; Yang, Chih-Yung; Lin, Wen-Jie; Lin, Chi-Hung			Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 Modulates Local ATP-Induced Calcium Signaling in Human HaCaT Keratinocytes	PLOS ONE			English	Article							PURINERGIC RECEPTORS; EXTRACELLULAR ATP; P2Y RECEPTORS; NTPDASE1; RELEASE; PROLIFERATION; MECHANISMS; EXPRESSION; CELLS; DIFFERENTIATION	Keratinocytes are the major building blocks of the human epidermis. In many physiological and pathophysiological conditions, keratinocytes release adenosine triphosphate (ATP) as an autocrine/paracrine mediator that regulates cell proliferation, differentiation, and migration. ATP receptors have been identified in various epidermal cell types; therefore, extracellular ATP homeostasis likely determines its long-term, trophic effects on skin health. We investigated the possibility that human keratinocytes express surface-located enzymes that modulate ATP concentration, as well as the corresponding receptor activation, in the pericellular microenvironment. We observed that the human keratinocyte cell line HaCaT released ATP and hydrolyzed extracellular ATP. Interestingly, ATP hydrolysis resulted in adenosine diphosphate (ADP) accumulation in the extracellular space. Pharmacological inhibition by ARL 67156 or gene silencing of the endogenous ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) isoform 2 resulted in a 25% reduction in both ATP hydrolysis and ADP formation. Using intracellular calcium as a reporter, we found that although NTPDase2 hydrolyzed ATP and generated sustainable ADP levels, only ATP contributed to increased intracellular calcium via P2Y2 receptor activation. Furthermore, knocking down NTPDase2 potentiated the nanomolar ATP-induced intracellular calcium increase, suggesting that NTPDase2 globally attenuates nucleotide concentration in the pericellular microenvironment as well as locally shields receptors in the vicinity from being activated by extracellular ATP. Our findings reveal an important role of human keratinocyte NTPDase2 in modulating nucleotide signaling in the extracellular milieu of human epidermis.	[Ho, Chia-Lin; Yang, Chih-Yung; Lin, Wen-Jie; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Yung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital	Lin, CH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	linch@ym.edu.tw			Ministry of Education; National Science Council [NSC 101-2319-B-010-001, NSC 101-2325-B-010-013]	Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Education under the "Aim for the Top University Project" and by the National Science Council Research Grant (NSC 101-2319-B-010-001 and NSC 101-2325-B-010-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Castillo C, 2005, MOL PHARMACOL, V67, P114, DOI 10.1124/mol.104.006908; Alvarado-Castillo C, 2002, MOL PHARMACOL, V62, P521, DOI 10.1124/mol.62.3.521; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Baroni A, 2012, CLIN DERMATOL, V30, P257, DOI 10.1016/j.clindermatol.2011.08.007; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulais N, 2008, EUR J DERMATOL, V18, P119, DOI 10.1684/ejd.2008.0348; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2011, J INVEST DERMATOL; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Celleno L, 2009, NUTRITIONAL COSMETICS: BEAUTY FROM WITHIN, P3, DOI 10.1016/B978-0-8155-2029-0.50008-9; Chen BC, 1996, BRIT J PHARMACOL, V119, P1628, DOI 10.1111/j.1476-5381.1996.tb16082.x; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Holzer AM, 2004, J CUTAN MED SURG, V8, P90, DOI 10.1177/120347540400800203; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Jhandier MN, 2005, J BIOL CHEM, V280, P22986, DOI 10.1074/jbc.M412371200; Kauffenstein G, 2010, BRIT J PHARMACOL, V159, P576, DOI 10.1111/j.1476-5381.2009.00566.x; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Knight GE, 2009, ENCY NEUROSCIENCE, P1245, DOI DOI 10.1016/B978-008045046-9.00693-8; Kobayashi D, 2007, EUR J PHARMACOL, V573, P249, DOI 10.1016/j.ejphar.2007.07.058; Kobayashi D, 2006, J PHARMACOL SCI, V102, P368, DOI 10.1254/jphs.FP0060669; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Munkonda MN, 2007, BIOCHEM PHARMACOL, V74, P1524, DOI 10.1016/j.bcp.2007.07.033; Pastore S, 2007, J INVEST DERMATOL, V127, P660, DOI 10.1038/sj.jid.5700591; Powell J., 2006, WOMENS HLTH MED, V3, P130, DOI [10.1383/wohm.2006.3.3.130, DOI 10.1383/WOHM.2006.3.3.130]; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Satoh E, 2011, J TOXICOL SCI, V36, P741, DOI 10.2131/jts.36.741; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Tsutsumi M, 2011, EXP DERMATOL, V20, P464, DOI 10.1111/j.1600-0625.2011.01276.x; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Volonte C, 2006, PHARMACOL THERAPEUT, V112, P264, DOI 10.1016/j.pharmthera.2005.04.012; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wickert RR, 2006, AM J INFECT CONTROL, V34, pS98, DOI 10.1016/j.ajic.2006.05.295; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	58	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57666	10.1371/journal.pone.0057666	http://dx.doi.org/10.1371/journal.pone.0057666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536768	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100014
J	Nagase, S; Yamanari, M; Tanaka, R; Yasui, T; Miura, M; Iwasaki, T; Goto, H; Yasuno, Y				Nagase, Satoko; Yamanari, Masahiro; Tanaka, Ryosuke; Yasui, Takeshi; Miura, Masahiro; Iwasaki, Takuya; Goto, Hiroshi; Yasuno, Yoshiaki			Anisotropic Alteration of Scleral Birefringence to Uniaxial Mechanical Strain	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE HEAD; COLLAGEN; FIBER; GLAUCOMA; ORGANIZATION; CORNEA; MATRIX; DAMAGE; EYES	Purpose: To investigate the relationship between scleral mechanical properties, its birefringence, and the anisotropy of birefringence alteration in respect of the direction of the strain by using PS-OCT. Methods: The scleral birefringence of thirty-nine porcine eyes was measured with a prototype PS-OCT. A rectangle strip of sclera with a width of 4 mm was dissected at the temporal region 5 mm apart from the optic nerve head. The strain and force were measured with a uniaxial tension tester as the sample was stretched with a speed of 1.8 mm/min after preconditioning. The birefringence of the sample was measured by PS-OCT at the center of the sample before applying, denoted as inherent birefringence, and after applying stretching of 6.5% strain. The birefringence alteration was obtained by these two measurements and correlations between birefringence and elastic parameters, tangent modulus, and structural stiffness were examined. Twenty and 19 porcine eyes were stretched in meridional or equatorial directions, respectively. Results: A moderate positive correlation was found between the inherent birefringence and the structural stiffness. A moderate positive correlation was also found between the inherent birefringence and the tangent modulus. The birefringence increased by strains. Marginal significance was found in the birefringence alteration between meridional and equatorial strains, where the mean birefringence elevation by meridional strain was higher than that by equatorial strain. Conclusions: The birefringence was found to be altered by applying strain and also be related with inherent birefringence. This implies the birefringence of the sclera of the in vivo eye also could be affected by its mechanical property.	[Nagase, Satoko; Miura, Masahiro; Iwasaki, Takuya] Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, Ami, Ibaraki, Japan; [Nagase, Satoko; Yamanari, Masahiro; Miura, Masahiro; Iwasaki, Takuya; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan; [Yamanari, Masahiro; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan; [Yamanari, Masahiro] Tomey Corp, Nagoya, Aichi, Japan; [Tanaka, Ryosuke] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan; [Yasui, Takeshi] Univ Tokushima, Inst Sci & Technol, Tokushima, Japan; [Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608402, Japan	Tokyo Medical University; University of Tsukuba; Osaka University; Tokushima University; Tokyo Medical University	Yasuno, Y (corresponding author), Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Yasuno, Yoshiaki/F-2586-2011; Yamanari, Masahiro/B-3147-2010	Yasuno, Yoshiaki/0000-0003-1645-7948; Yamanari, Masahiro/0000-0001-9873-2151; Yasui, Takeshi/0000-0001-7742-6155	Japan Science Technology Agency; Tomey Corp.	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Tomey Corp.	Financial support for this study was provided in part by Japan Science Technology Agency. YY had financial interest in Tomey Corp. MY is an employee of Tomey Corp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Yasuno and Yamanari are supported by a research grant from Tomey Corp. through their institution. Yamanari is now employee of Tomey Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; de Boer JF, 2002, J BIOMED OPT, V7, P359, DOI 10.1117/1.1483879; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Duan L, 2011, OPT EXPRESS, V19, P16330, DOI 10.1364/OE.19.016330; Eilaghi A, 2010, J BIOMECH, V43, P1696, DOI 10.1016/j.jbiomech.2010.02.031; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Fung YC, 1994, J BIOMECH ENG-T ASME, V61, P1007, DOI [10.1115/1.2901550, DOI 10.1115/1.2901550]; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Gotzinger E, 2008, OPT EXPRESS, V16, P16410, DOI 10.1364/OE.16.016410; HERNANDEZ MR, 1987, AM J OPHTHALMOL, V104, P567, DOI 10.1016/0002-9394(87)90165-6; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; KEELEY FW, 1984, EXP EYE RES, V39, P533, DOI 10.1016/0014-4835(84)90053-8; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lim Y, 2011, BIOMED OPT EXPRESS, V2, P2392, DOI 10.1364/BOE.2.002892; LU SY, 1994, J OPT SOC AM A, V11, P766, DOI 10.1364/JOSAA.11.000766; Makita S, 2010, OPT EXPRESS, V18, P854, DOI 10.1364/OE.18.000854; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Sakai S, 2011, BIOMED OPT EXPRESS, V2, P2623, DOI 10.1364/BOE.2.002623; Sevim MS, 2012, J GLAUCOMA; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Yamanari M, 2013, PLOS ONE IN PRESS; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651; Yasui T, 2009, APPL OPTICS, V48, pD88, DOI 10.1364/AO.48.000D88	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58716	10.1371/journal.pone.0058716	http://dx.doi.org/10.1371/journal.pone.0058716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536816	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100083
J	Sender, V; Lang, LD; Stamme, C				Sender, Vicky; Lang, Linda; Stamme, Cordula			Surfactant Protein-A Modulates LPS-Induced TLR4 Localization and Signaling via beta-Arrestin 2	PLOS ONE			English	Article							KAPPA-B-ALPHA; TOLL-LIKE RECEPTORS; ALVEOLAR MACROPHAGES; PULMONARY SURFACTANT; GOLGI-APPARATUS; INFLAMMATORY RESPONSE; CELLULAR-RESPONSE; LIPOPOLYSACCHARIDE; MICE; EXPRESSION	The soluble C-type lectin surfactant protein (SP)-A mediates lung immune responses partially via its direct effects on alveolar macrophages (AM), the main resident leukocytes exposed to antigens. SP-A modulates the AM threshold of lipopolysaccharide (LPS) activity towards an anti-inflammatory phenotype both in vitro and in vivo through various mechanisms. LPS responses are tightly regulated via distinct pathways including subcellular TLR4 localization and thus ligand sensing. The cytosolic scaffold and signaling protein beta-arrestin 2 acts as negative regulator of LPS-induced TLR4 activation. Here we show that SP-A neither increases TLR4 abundancy nor co-localizes with TLR4 in primary AM. SP-A significantly reduces the LPS-induced co-localization of TLR4 with the early endosome antigen (EEA) 1 by promoting the co-localization of TLR4 with the post-Golgi compartment marker Vti1b in freshly isolated AM from rats and wild-type (WT) mice, but not in beta-arrestin 2(-/-) AM. Compared to WT mice pulmonary LPS-induced TNF-alpha release in beta-arrestin 2(-/-) mice is accelerated and enhanced and exogenous SP-A fails to inhibit both lung LPS-induced TNF-alpha release and TLR4/EEA1 positioning. SP-A, but not LPS, enhances beta-arrestin 2 protein expression in a time-dependent manner in primary rat AM. The constitutive expression of beta-arrestin 2 in AM from SP-A(-/-) mice is significantly reduced compared to SP-A(+/+) mice and is rescued by SP-A. Prolonged endosome retention of LPS-induced TLR4 in AM from SP-A(-/-) mice is restored by exogenous SP-A, and is antagonized by beta-arrestin 2 blocking peptides. LPS induces beta-arrestin 2/TLR4 association in primary AM which is further enhanced by SP-A. The data demonstrate that SP-A modulates LPS-induced TLR4 trafficking and signaling in vitro and in vivo engaging beta-arrestin 2.	[Sender, Vicky; Lang, Linda; Stamme, Cordula] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Cellular Pneumol, Borstel, Germany; [Stamme, Cordula] Univ Hosp Lubeck, Dept Anesthesiol, Lubeck, Germany	Forschungszentrum Borstel; University of Lubeck	Stamme, C (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Cellular Pneumol, Borstel, Germany.	cstamme@fz-borstel.de		Sender, Vicky/0000-0003-2174-946X	German Research Council (DFG) [609/2-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG, Grant 609/2-1 to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002; [Anonymous], GLOB BURD DIS 2004 U; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crowther JE, 2006, AM J PHYSIOL-LUNG C, V290, pL334, DOI 10.1152/ajplung.00267.2005; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; GALANOS C, 1975, EUR J BIOCHEM, V54, P603, DOI 10.1111/j.1432-1033.1975.tb04172.x; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; George CLS, 2008, INFECT IMMUN, V76, P380, DOI 10.1128/IAI.01043-07; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kagan JC, 2010, IMMUNITY, V33, P578, DOI 10.1016/j.immuni.2010.10.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lattin JE, 2009, MOL IMMUNOL, V47, P340, DOI 10.1016/j.molimm.2009.09.012; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Li G, 2002, AM J RESP CELL MOL, V26, P277, DOI 10.1165/ajrcmb.26.3.4584; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moulakakis C, 2007, J IMMUNOL, V179, P4480, DOI 10.4049/jimmunol.179.7.4480; Moulakakis C, 2009, AM J PHYSIOL-LUNG C, V296, pL430, DOI 10.1152/ajplung.90458.2008; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramadas RA, 2009, J IMMUNOL, V182, P1560, DOI 10.4049/jimmunol.182.3.1560; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sender V, 2011, J IMMUNOL, V186, P2397, DOI 10.4049/jimmunol.1002446; Stamme C, 2002, AM J RESP CELL MOL, V27, P353, DOI 10.1165/rcmb.4812; Stamme C, 2000, AM J RESP CELL MOL, V23, P772, DOI 10.1165/ajrcmb.23.6.4083; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang Y, 2007, BLOOD, V110, P952; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; Wu YD, 2004, AM J RESP CELL MOL, V31, P587, DOI 10.1165/rcmb.2004-0003OC; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042	52	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59896	10.1371/journal.pone.0059896	http://dx.doi.org/10.1371/journal.pone.0059896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536892	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200040
J	Manetsch, M; Rahman, MM; Patel, BS; Ramsay, EE; Rumzhum, NN; Alkhouri, H; Ge, Q; Ammit, AJ				Manetsch, Melanie; Rahman, Md. Mostafizur; Patel, Brijeshkumar S.; Ramsay, Emma E.; Rumzhum, Nowshin N.; Alkhouri, Hatem; Ge, Qi; Ammit, Alaina J.			Long-Acting beta(2)-Agonists Increase Fluticasone Propionate-Induced Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1) in Airway Smooth Muscle Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; ALPHA-INDUCED SECRETION; INHALED CORTICOSTEROIDS; BETA(2)-ADRENOCEPTOR AGONISTS; P38 MAPK; EXPRESSION; ASTHMA; TRISTETRAPROLIN; GENE; GLUCOCORTICOIDS	Mitogen-activated protein kinase phosphatase 1 (MKP-1) represses MAPK-driven signalling and plays an important anti-inflammatory role in asthma and airway remodelling. Although MKP-1 is corticosteroid-responsive and increased by cAMP-mediated signalling, the upregulation of this critical anti-inflammatory protein by long-acting beta(2)-agonists and clinically-used corticosteroids has been incompletely examined to date. To address this, we investigated MKP-1 gene expression and protein upregulation induced by two long-acting beta(2)-agonists (salmeterol and formoterol), alone or in combination with the corticosteroid fluticasone propionate (abbreviated as fluticasone) in primary human airway smooth muscle (ASM) cells in vitro. beta(2)-agonists increased MKP-1 protein in a rapid but transient manner, while fluticasone induced sustained upregulation. Together, long-acting beta(2)-agonists increased fluticasone-induced MKP-1 and modulated ASM synthetic function (measured by interleukin 6 (IL-6) and interleukin 8 (IL-8) secretion). As IL-6 expression (like MKP-1) is cAMP/adenylate cyclase-mediated, the long-acting beta(2)-agonist formoterol increased IL-6 mRNA expression and secretion. Nevertheless, when added in combination with fluticasone, beta(2)-agonists significantly repressed IL-6 secretion induced by tumour necrosis factor alpha (TNF alpha). Conversely, as IL-8 is not cAMP-responsive, beta(2)-agonists significantly inhibited TNF alpha-induced IL-8 in combination with fluticasone, where fluticasone alone was without repressive effect. In summary, long-acting beta(2)-agonists increase fluticasone-induced MKP-1 in ASM cells and repress synthetic function of this immunomodulatory airway cell type.	[Manetsch, Melanie; Rahman, Md. Mostafizur; Patel, Brijeshkumar S.; Ramsay, Emma E.; Rumzhum, Nowshin N.; Alkhouri, Hatem; Ammit, Alaina J.] Univ Sydney, Fac Pharm, Resp Res Grp, Sydney, NSW 2006, Australia; [Ge, Qi] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Ammit, AJ (corresponding author), Univ Sydney, Fac Pharm, Resp Res Grp, Sydney, NSW 2006, Australia.	alaina.ammit@sydney.edu.au	Alkhouri, Hatem/AAG-3390-2021; Patel, Brijesh/AAN-3151-2021; Patel, Brijeshkumar S/AAS-6488-2021; Ge, Qi/D-3988-2013	Alkhouri, Hatem/0000-0002-5569-704X; Patel, Brijesh/0000-0002-9980-1021; Ramsay, Emma/0000-0001-7273-5397; Ammit, Alaina/0000-0003-0555-2544	National Health and Medical Research Council of Australia [570856]; Senglet Stiftung - Switzerland; Endeavour Postgraduate Award - Australia; International Postgraduate Research Scholarship - Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senglet Stiftung - Switzerland; Endeavour Postgraduate Award - Australia(Australian GovernmentDepartment of Industry, Innovation and Science); International Postgraduate Research Scholarship - Australia(Australian Government)	This research was funded by a project grant (570856) from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by PhD scholarships to MM (Senglet Stiftung - Switzerland), to MMR (Endeavour Postgraduate Award - Australia) and NNR (International Postgraduate Research Scholarship - Australia). The authors wish to thank our colleagues in the Respiratory Research Group at the University of Sydney. We acknowledge the collaborative effort of the cardiopulmonary transplant team and the pathologists at St Vincent's Hospital, Sydney, and the thoracic physicians and pathologists at Royal Prince Alfred Hospital, Concord Repatriation Hospital and Strathfield Private Hospital and Healthscope Pathology, Sydney.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ammit AJ, 2000, AM J RESP CELL MOL, V23, P794, DOI 10.1165/ajrcmb.23.6.4184; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Che WC, 2012, BBA-MOL CELL RES, V1823, P1658, DOI 10.1016/j.bbamcr.2012.06.011; Chung KF, 2009, EUR J CLIN PHARMACOL, V65, P853, DOI 10.1007/s00228-009-0682-z; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; Essilfie-Quaye S, 2011, RESP MED, V105, P1784, DOI 10.1016/j.rmed.2011.08.020; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Johnson PRA, 1995, PULM PHARMACOL, V8, P43, DOI 10.1006/pulp.1995.1006; Kang BN, 2008, AM J PHYSIOL-LUNG C, V295, pL186, DOI 10.1152/ajplung.00352.2007; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Knobloch J, 2010, J PHARMACOL EXP THER, V335, P788, DOI 10.1124/jpet.110.166843; KWAK SP, 1994, J BIOL CHEM, V269, P3596; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Manetsch M, 2012, BRIT J PHARMACOL, V166, P2049, DOI 10.1111/j.1476-5381.2012.01923.x; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; O'Byrne PM, 2008, CHEST, V134, P1192, DOI 10.1378/chest.08-1018; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200	33	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59635	10.1371/journal.pone.0059635	http://dx.doi.org/10.1371/journal.pone.0059635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533638	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400075
J	Zoufaly, A; Cramer, JP; Vettorazzi, E; Sayk, F; Bremer, JP; Koop, I; de Weerth, A; Schmiedel, S; Jordan, S; Fraedrich, K; Asselborn, NH; Nitschke, M; Neumann-Grutzeck, C; Magnus, T; Ruther, C; Fellermann, K; Stahl, RK; Wegscheider, K; Lohse, AW				Zoufaly, Alexander; Cramer, Jakob P.; Vettorazzi, Eik; Sayk, Friedhelm; Bremer, Jan P.; Koop, Irmtraut; de Weerth, Andreas; Schmiedel, Stefan; Jordan, Sabine; Fraedrich, Katharina; Asselborn, Niels H.; Nitschke, Martin; Neumann-Grutzeck, Christine; Magnus, Tim; Ruether, Christoph; Fellermann, Klaus; Stahl, Rolf K.; Wegscheider, Karl; Lohse, Ansgar W.			Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTBREAK; CHILDREN; GERMANY	The outbreak of Shiga toxin producing E. coli O104:H4 in northern Germany in 2011 was one of the largest worldwide and involved mainly adults. Post-diarrheal hemolytic uremic syndrome (HUS) occurred in 22% of STEC positive patients. This study's aim was to assess risk factors for HUS in STEC-infected patients and to develop a score from routine hospital parameters to estimate patient risks for developing HUS. In a cohort analysis, adult patients with STEC infection were included in five participating hospitals in northern Germany between May and July 2011. Clinical data were obtained from questionnaires and medical records, laboratory data were extracted from hospitals' electronic data systems. HUS was defined as thrombocytopenia, hemolytic anemia and acute renal dysfunction. Random forests and multivariate logistic regression were used to identify risk factors for HUS and develop a score using the estimated coefficients as weights. Among 259 adults with STEC infection, vomiting (OR 3.48, 95% CI 1.88-6.53), visible blood in stools (OR 3.91,95% CI1.20-16.01), age above 75 years (OR 3.27, 95% CI 1.12-9.70) and elevated leukocyte counts (OR 1.20, 95% CI 1.10-1.31, per 1000 cells/mm(3)) were identified as independent risk factors for HUS. A score using these variables has an area under the ROC curve of 0.74 (95% CI 0.68-0.80). Vomiting, visible blood in stools, higher leukocyte counts, and higher age indicate increased risk for developing HUS. A score using these variables might help to identify high risk patients who potentially benefit from aggressive pre-emptive treatment to prevent or mitigate the devastating consequences of HUS.	[Zoufaly, Alexander; Cramer, Jakob P.; Schmiedel, Stefan; Jordan, Sabine; Fraedrich, Katharina; Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, Dept Med Gastroenterol & Hepatol Infect Dis & Tro, Hamburg, Germany; [Vettorazzi, Eik; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Sayk, Friedhelm; Asselborn, Niels H.; Nitschke, Martin; Fellermann, Klaus] Univ Schleswig Holstein, Dept Internal Med 1, Lubeck, Germany; [Bremer, Jan P.; Neumann-Grutzeck, Christine; Ruether, Christoph] Asklepios Klin Altona, Dept Med 1, Hamburg, Germany; [Koop, Irmtraut] Amalie Sieveking Hosp, Dept Med, Hamburg, Germany; [de Weerth, Andreas] Agaples Diakonieklinikum, Dept Internal Med, Hamburg, Germany; [Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stahl, Rolf K.] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; Asklepios Klinik Altona; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zoufaly, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Gastroenterol & Hepatol Infect Dis & Tro, Hamburg, Germany.	a.zoufaly@uke.de	Nitschke, Martin/ABA-9388-2021; Bremer, Phillip/AAE-7842-2020; Vettorazzi, Eik/B-8130-2019	Nitschke, Martin/0000-0002-2716-7527; Vettorazzi, Eik/0000-0002-3737-6402				[Anonymous], 2012, EURO SURVEILL, P17; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Balestracci A, 2012, PEDIATR NEPHROL, V27, P1407, DOI 10.1007/s00467-012-2158-0; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2003, MANUAL SETTING USING; Buteau C, 2000, PEDIATR INFECT DIS J, V19, P642, DOI 10.1097/00006454-200007000-00012; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Loos S, 2012, CLIN INFECT DIS; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Team R. D. C, 2011, R LANG ENV STAT COMP; Tserenpuntsag B, 2005, EMERG INFECT DIS, V11, P1955, DOI 10.3201/eid1112.050607; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59209	10.1371/journal.pone.0059209	http://dx.doi.org/10.1371/journal.pone.0059209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533606	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400043
J	Oettler, J; Schmid, VS; Zankl, N; Rey, O; Dress, A; Heinze, J				Oettler, Jan; Schmid, Volker S.; Zankl, Niko; Rey, Olivier; Dress, Andreas; Heinze, Juergen			Fermat's Principle of Least Time Predicts Refraction of Ant Trails at Substrate Borders	PLOS ONE			English	Article							HARVESTER ANTS; RECRUITMENT; MATTER	Fermat's principle of least time states that light rays passing through different media follow the fastest (and not the most direct) path between two points, leading to refraction at medium borders. Humans intuitively employ this rule, e. g., when a lifeguard has to infer the fastest way to traverse both beach and water to reach a swimmer in need. Here, we tested whether foraging ants also follow Fermat's principle when forced to travel on two surfaces that differentially affected the ants' walking speed. Workers of the little fire ant, Wasmannia auropunctata, established "refracted" pheromone trails to a food source. These trails deviated from the most direct path, but were not different to paths predicted by Fermat's principle. Our results demonstrate a new aspect of decentralized optimization and underline the versatility of the simple yet robust rules governing the self-organization of group-living animals.	[Oettler, Jan; Schmid, Volker S.; Zankl, Niko; Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany; [Rey, Olivier] Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Dress, Andreas] Chinese Acad Sci, Chinese Acad Sci Max Planck Gesell Partner Inst C, Shanghai, Peoples R China; [Dress, Andreas] Infinity3 GmbH, Bielefeld, Germany	University of Regensburg; Institut de Recherche pour le Developpement (IRD); Chinese Academy of Sciences; Max Planck Society	Oettler, J (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	joettler@gmail.com	Rey, olivier/R-5453-2016	Rey, olivier/0000-0003-3699-7204; Schmid, Volker/0000-0002-9553-9935				ACOSTA FJ, 1995, AM NAT, V145, P389, DOI 10.1086/285746; Bernadou A, 2008, J INSECT PHYSIOL, V54, P534, DOI 10.1016/j.jinsphys.2007.12.001; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Ducatelle F, 2010, SWARM INTELL-US, V4, P173, DOI 10.1007/s11721-010-0040-x; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Dussutour A, 2009, J EXP BIOL, V212, P2337, DOI 10.1242/jeb.029827; Dussutour A, 2006, BEHAV ECOL SOCIOBIOL, V61, P17, DOI 10.1007/s00265-006-0233-x; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; Foucaud J, 2010, EVOL APPL, V3, P363, DOI 10.1111/j.1752-4571.2010.00119.x; Ganem J, 1989, PHYS TEACH, V36, P76; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Jackson DE, 2007, CURR BIOL, V17, pR1063, DOI 10.1016/j.cub.2007.10.031; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; Kretz T, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03012; Krieger MJB, 2000, NATURE, V406, P992, DOI 10.1038/35023164; Lowe S., 2000, ENCY BIOL INVASIONS; NONACS P, 1990, ECOLOGY, V71, P1886, DOI 10.2307/1937596; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Robinson EJH, 2005, NATURE, V438, P442, DOI 10.1038/438442a; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; Vonshak M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1667, DOI 10.1007/s00265-009-0775-9; Zar JH., 2010, BIOSTAT ANAL, V5th	29	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59739	10.1371/journal.pone.0059739	http://dx.doi.org/10.1371/journal.pone.0059739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527263	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600092
J	Rauert-Wunderlich, H; Siegmund, D; Maier, E; Giner, T; Bargou, RC; Wajant, H; Stuhmer, T				Rauert-Wunderlich, Hilka; Siegmund, Daniela; Maier, Eduard; Giner, Tina; Bargou, Ralf C.; Wajant, Harald; Stuehmer, Thorsten			The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NF kappa B Transcription Factors	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; KINASE; PATHWAYS; IDENTIFICATION; TARGET	Multiple myeloma (MM) displays an NFkB activity-related gene expression signature and about 20% of primary MM samples harbor genetic alterations conducive to intrinsic NFkB signaling activation. The relevance of blocking the classical versus the alternative NFkB signaling pathway and the molecular execution mechanisms involved, however, are still poorly understood. Here, we comparatively tested NFkB activity abrogation through TPCA-1 (an IKK2 inhibitor), BAY 11-7082 (an IKK inhibitor poorly selective for IKK1 and IKK2), and MLN4924 (an NEDD8 activating enzyme (NAE)-inhibitor), and analyzed their anti-MM activity. Whereas TPCA-1 interfered selectively with activation of the classical NFkB pathway, the other two compounds inhibited classical and alternative NFkB signaling without significant discrimination. Noteworthy, whereas TPCA-1 and MLN4924 elicited rather mild anti-MM effects with slight to moderate cell death induction after 1 day BAY 117082 was uniformly highly toxic to MM cell lines and primary MM cells. Treatment with BAY 11-7082 induced rapid cell swelling and its initial effects were blocked by necrostatin-1 or the ROS scavenger BHA, but a lasting protective effect was not achieved even with additional blockade of caspases. Because MLN4924 inhibits the alternative NFkB pathway downstream of IKK1 at the level of p100 processing, the quite discordant effects between MLN4924 and BAY 11-7082 must thus be due to blockade of IKK1-mediated NF kappa B-independent necrosis-inhibitory functions or represent an off-target effect of BAY 11-7082. In accordance with the latter, we further observed that concomitant knockdown of IKK1 and IKK2 did not have any major short-term adverse effect on the viability of MM cells.	[Rauert-Wunderlich, Hilka; Siegmund, Daniela; Wajant, Harald] Univ Wurzburg, Dept Internal Med 2, Div Mol Internal Med, D-97070 Wurzburg, Germany; [Maier, Eduard; Bargou, Ralf C.; Stuehmer, Thorsten] Univ Wurzburg, Dept Internal Med 2, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Giner, Tina] Univ Wurzburg, Dept Dermatol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Wajant, H (corresponding author), Univ Wurzburg, Dept Internal Med 2, Div Mol Internal Med, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	Deutsche Forschungsgemeinschaft (Bonn, Germany) [KFO 216]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Bonn, Germany; KFO 216) (web address:www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2004, ONCOGENE, V23, P2540, DOI 10.1038/sj.onc.1207366; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bao B, 2012, BBA-REV CANCER, V1825, P160, DOI 10.1016/j.bbcan.2011.11.002; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Hideshima T, 2006, CLIN CANCER RES, V12, P5887, DOI 10.1158/1078-0432.CCR-05-2501; Hideshima T, 2009, BLOOD, V113, P5228, DOI 10.1182/blood-2008-06-161505; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jourdan M, 2007, BRIT J HAEMATOL, V138, P160, DOI 10.1111/j.1365-2141.2007.06629.x; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; Meng XB, 2010, BRIT J HAEMATOL, V148, P487, DOI 10.1111/j.1365-2141.2009.07988.x; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Watanabe M, 2005, INT J CANCER, V114, P32, DOI 10.1002/ijc.20688; White DE, 2008, CANCER LETT, V268, P212, DOI 10.1016/j.canlet.2008.03.045	28	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59292	10.1371/journal.pone.0059292	http://dx.doi.org/10.1371/journal.pone.0059292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527154	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600068
J	Xiang, H; Wang, Y; Nie, SF				Xiang, Hao; Wang, Ying; Nie, Shaofa			Meta-Analysis of the Association between Insulin-Like Growth Factor Binding Protein 3 Genetic Polymorphisms and Colorectal Cancer Susceptibility	PLOS ONE			English	Article							IGF-BINDING; FACTOR-I; RISK; INSULIN-LIKE-GROWTH-FACTOR-1	Insulin-like growth factor binding protein 3 (IGFBP-3) plays an important role in the development and progress of cancers. The association between IGFBP-3 polymorphisms and colorectal cancer remains controversial and ambiguous. The aim of this study is to explore the association between IGFBP3 A-202C and Gly32Ala polymorphisms and colorectal cancer susceptibility using meta-analyisi. Case-control studies on the association between IGFBP3 A-202C and Gly32Ala polymorphisms and colorectal cancer, which had sufficient data for estimating an odds ratio (OR) with 95% confidence interval (CI), were included in the meta-analysis. Abstracts, case reports, editorials, and review articles were excluded. Heterozygous and homozygous mutants were compared with the wild types to estimate combined OR values and 95% CIs with Review Manager 5.0. Six eligible studies were included, with 3157 patients and 6027 controls for A-202C and 1711 patients and 2995 controls for Gly32Ala. No significant association was found in all genetic models (for A-202C, AC vs. AA, OR = 0.99(0.88-1.11), CC vs. AA, OR = 1.06(0.92-1.22), dominant model, OR = 0.98(0.88-1.09), recessive model, OR = 0.94(0.84-1.05); and for Gly32Ala polymorphism, GC vs. GG, OR = 1.10(0.92-1.31), CC vs. GG, OR = 0.93(0.76-1.14), dominant model, OR = 1.05(0.89-1.24), recessive model, OR = 0.90(0.77-1.05)). The results suggest that the IGFBP3 A-202C and Gly32Ala polymorphisms are not associated with colorectal cancer susceptibility.	[Xiang, Hao; Wang, Ying] Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Xiang, Hao] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China; [Nie, Shaofa] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Nie, Shaofa] Huazhong Univ Sci & Technol, Minist Educ, Sch Publ Hlth, Key Lab Environm & Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, H (corresponding author), Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430072, Peoples R China.	Xianghao@whu.edu.cn	Wang, Ying/AAP-8234-2021	Wang, Ying/0000-0002-6058-9131				Bustin SA, 2001, TRENDS MOL MED, V7, P447, DOI 10.1016/S1471-4914(01)02104-9; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; CHEN JC, 1994, J CELL PHYSIOL, V158, P69, DOI 10.1002/jcp.1041580110; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feik E, 2010, CANCER CAUSE CONTROL, V21, P91, DOI 10.1007/s10552-009-9438-4; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Harrela M, 1996, J CLIN INVEST, V98, P2612, DOI 10.1172/JCI119081; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jernstrom H, 2001, CANCER EPIDEM BIOMAR, V10, P377; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1319, DOI 10.1158/1055-9965.EPI-04-0847; Li L, 2010, MOL BIOL REP, V37, P127, DOI 10.1007/s11033-009-9552-0; Little J, 2011, PLOS ONE, V6; Morimoto LM, 2005, CANCER EPIDEM BIOMAR, V14, P1204, DOI 10.1158/1055-9965.EPI-04-0695; Pechlivanis S, 2007, CANCER DETECT PREV, V31, P408, DOI 10.1016/j.cdp.2007.10.001; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P1206; Vorwerk P, 1998, J CLIN ENDOCR METAB, V83, P1392, DOI 10.1210/jc.83.4.1392; Wong HL, 2008, GUT, V57, P1090, DOI 10.1136/gut.2007.140855; Xiang H, 2009, J TOXICOL ENV HEAL A, V72, P706, DOI 10.1080/15287390902841060; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	26	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59665	10.1371/journal.pone.0059665	http://dx.doi.org/10.1371/journal.pone.0059665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527244	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600086
J	Weise, LD; Panfilov, AV				Weise, Louis D.; Panfilov, Alexander V.			A Discrete Electromechanical Model for Human Cardiac Tissue: Effects of Stretch-Activated Currents and Stretch Conditions on Restitution Properties and Spiral Wave Dynamics	PLOS ONE			English	Article							MECHANOELECTRIC FEEDBACK; MYOCARDIAL STRETCH; REENTRANT ACTIVITY; EXCITATION; CHANNELS; SYSTEM; DEFIBRILLATION; MECHANISMS; PACEMAKERS; ALTERNANS	We introduce an electromechanical model for human cardiac tissue which couples a biophysical model of cardiac excitation (Tusscher, Noble, Noble, Panfilov, 2006) and tension development (adjusted Niederer, Hunter, Smith, 2006 model) with a discrete elastic mass-lattice model. The equations for the excitation processes are solved with a finite difference approach, and the equations of the mass-lattice model are solved using Verlet integration. This allows the coupled problem to be solved with high numerical resolution. Passive mechanical properties of the mass-lattice model are described by a generalized Hooke's law for finite deformations (Seth material). Active mechanical contraction is initiated by changes of the intracellular calcium concentration, which is a variable of the electrical model. Mechanical deformation feeds back on the electrophysiology via stretch-activated ion channels whose conductivity is controlled by the local stretch of the medium. We apply the model to study how stretch-activated currents affect the action potential shape, restitution properties, and dynamics of spiral waves, under constant stretch, and dynamic stretch caused by active mechanical contraction. We find that stretch conditions substantially affect these properties via stretch-activated currents. In constantly stretched medium, we observe a substantial decrease in conduction velocity, and an increase of action potential duration; whereas, with dynamic stretch, action potential duration is increased only slightly, and the conduction velocity restitution curve becomes biphasic. Moreover, in constantly stretched medium, we find an increase of the core size and period of a spiral wave, but no change in rotation dynamics; in contrast, in the dynamically stretching medium, we observe spiral drift. Our results may be important to understand how altered stretch conditions affect the heart's functioning.	[Weise, Louis D.] Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands; [Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium	Utrecht University; Ghent University	Weise, LD (corresponding author), Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands.	L.D.Weise@uu.nl	Panfilov, Alexander/G-8459-2016	Panfilov, Alexander/0000-0003-2643-642X	Netherlands Organization for Scientific Research of the research Council for Physical Sciences (EW) [613.000.604]	Netherlands Organization for Scientific Research of the research Council for Physical Sciences (EW)	LDW is funded by the Netherlands Organization for Scientific Research (http://www.nwo.nl) (NWO Grant No. 613.000.604) of the research Council for Physical Sciences (EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLADZE KI, 1987, JETP LETT+, V45, P767; Bourguignon D, 2000, SPRING COMP SCI, P113; Cave DM, 2010, CIRCULATION, V122, pS720, DOI 10.1161/CIRCULATIONAHA.110.970970; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; de Lange E, 2011, BIOPHYS J, V100, P435; de Lange E, 2010, BIOPHYS J, V98, P1129, DOI 10.1016/j.bpj.2009.12.4280; de Tombe PP, 2007, J PHYSIOL-LONDON, V584, P591, DOI 10.1113/jphysiol.2007.138693; Echebarria B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.040902; FRANZ MR, 1992, CIRCULATION, V86, P968, DOI 10.1161/01.CIR.86.3.968; Fritz T, 2009, IFMBE PROC, V22, P2003; GRAY RA, 1995, CIRCULATION, V91, P2454, DOI 10.1161/01.CIR.91.9.2454; GRILL S, 1995, PHYS REV LETT, V75, P3368, DOI 10.1103/PhysRevLett.75.3368; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 1997, J MOL CELL CARDIOL, V29, P1511, DOI 10.1006/jmcc.1997.0392; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; Keldermann RH, 2007, J STAT PHYS, V128, P375, DOI 10.1007/s10955-006-9219-3; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Kohl P, 2003, PROG BIOPHYS MOL BIO, V82, P3, DOI 10.1016/S0079-6107(03)00022-1; Kohl P, 2001, CARDIOVASC RES, V50, P280, DOI 10.1016/S0008-6363(01)00194-8; Kohl P, 1998, CAN J CARDIOL, V14, P111; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Krivtsov A, 1999, Z ANGEW MATH MECH, V79, P419; Kwon O, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046213; LAB MJ, 1982, CIRC RES, V50, P757, DOI 10.1161/01.RES.50.6.757; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Mohr M., 2003, BIOMEDICAL ENG, V48, P6, DOI DOI 10.1515/bmte.2003.48.s1.6; Mohr M, 2006, THESIS FRIDERICIANA; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; Niederer SA, 2008, PROG BIOPHYS MOL BIO, V96, P90, DOI 10.1016/j.pbiomolbio.2007.08.001; Nishimura S, 2006, CARDIOVASC RES, V72, P403, DOI 10.1016/j.cardiores.2006.08.011; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.258104; PANFILOV AV, 1990, PHYS LETT A, V147, P463, DOI 10.1016/0375-9601(90)90607-P; Panfilov AV, 2009, CARDIAC ELECTROPHYSI, P329; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; POOL R, 1990, SCIENCE, V247, P1294, DOI 10.1126/science.2315697; RUDENKO AN, 1983, STUD BIOPHYS, V98, P183; Schargott M, 2007, TRIBOL INT, V40, P937, DOI 10.1016/j.triboint.2006.02.036; Seth BR, 1934, PHILOS T R SOC S-A, V234, P231; Skouibine K, 2000, MATH BIOSCI, V166, P85, DOI 10.1016/S0025-5564(00)00019-5; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Ten Tusscher KHWJ, 2003, AM J PHYSIOL-HEART C, V284, pH542, DOI 10.1152/ajpheart.00608.2002; Trayanova N, 2004, HEART RHYTHM, V1, P67, DOI 10.1016/j.hrthm.2004.01.002; Vahl CF, 1998, J MOL CELL CARDIOL, V30, P957, DOI 10.1006/jmcc.1998.0670; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Vetter FJ, 2001, ANN BIOMED ENG, V29, P414, DOI 10.1114/1.1366670; WANG ZF, 1994, CIRCULATION, V90, P2022, DOI 10.1161/01.CIR.90.4.2022; Weise LD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228104; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027264; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; WINFREE AT, 1989, J THEOR BIOL, V138, P353, DOI 10.1016/S0022-5193(89)80200-0; Zhang YH, 2000, J PHYSIOL-LONDON, V523, P607, DOI 10.1111/j.1469-7793.2000.00607.x; Zhang YB, 2008, PROG BIOPHYS MOL BIO, V97, P367, DOI 10.1016/j.pbiomolbio.2008.02.017	55	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59317	10.1371/journal.pone.0059317	http://dx.doi.org/10.1371/journal.pone.0059317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527160	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100105
J	Fortin, J; Kumar, V; Zhou, X; Wang, Y; Auwerx, J; Schoonjans, K; Boehm, U; Boerboom, D; Bernard, DJ				Fortin, Jerome; Kumar, Vikas; Zhou, Xiang; Wang, Ying; Auwerx, Johan; Schoonjans, Kristina; Boehm, Ulrich; Boerboom, Derek; Bernard, Daniel J.			NR5A2 Regulates Lhb and Fshb Transcription in Gonadotrope-Like Cells In Vitro, but Is Dispensable for Gonadotropin Synthesis and Fertility In Vivo	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; HORMONE BETA-SUBUNIT; ORPHAN NUCLEAR RECEPTOR; OVARIAN GRANULOSA-CELLS; LUTEINIZING-HORMONE; GENE-EXPRESSION; PROMOTER ACTIVITY; TRANSGENIC MICE; BINDING-SITES; PITUITARY	Successful mammalian reproduction depends on proper synthesis of the pituitary-derived glycoprotein hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Several transcription factors cooperate to activate cell-specific and hormone-regulated expression of the gonadotropin beta subunits (Lhb and Fshb). Among these, NR5A1 (steroidogenic factor 1; SF1) has been shown to directly bind to the Lhb promoter, mediate basal and gonadotropin-releasing hormone (GnRH)-stimulated Lhb transcription, and possibly directly regulate Fshb expression. Recently, the closely-related NR5A2 was shown to activate the rat Lhb promoter in vitro. Here, we further characterized the role of NR5A2 in regulating gonadotropin synthesis. Ectopically expressed NR5A2 directly activated the murine Lhb promoter in a manner identical to that of NR5A1, whereas neither factor activated the murine Fshb promoter. In L beta T2 gonadotrope-like cells, depletion of endogenous NR5A1 or NR5A2 impaired basal and GnRH-stimulated Lhb and Fshb transcription. To analyze the physiological role of NR5A2 in gonadotropes in vivo, we generated mice with a gonadotrope-specific deletion of Nr5a2. In contrast with our in vitro data, these mice had normal pituitary Lhb and Fshb expression and intact fertility. Together, our data establish that NR5A2 can act in a non-redundant manner to regulate Lhb and Fshb transcription in vitro, but is dispensable in vivo.	[Fortin, Jerome; Kumar, Vikas; Zhou, Xiang; Wang, Ying; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Kumar, Vikas; Boerboom, Derek] Univ Montreal, Dept Biomed Vet, Ste Hyacinthe, PQ, Canada; [Auwerx, Johan; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Saarland, Germany	McGill University; Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Saarland University	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	daniel.bernard@mcgill.ca	Auwerx, Johan/ABE-9307-2021	Bernard, Daniel/0000-0001-5365-5586; Auwerx, Johan/0000-0002-5065-5393; Schoonjans, Kristina/0000-0003-1247-4265	CIHR [MOP-89991, MOP-102508]; MELS Merit Scholarship; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54-HD28934]	CIHR(Canadian Institutes of Health Research (CIHR)); MELS Merit Scholarship; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research)	JF was supported by a Doctoral Research Award from CIHR. VK was supported by a MELS Merit Scholarship. This work was funded by CIHR operating grants MOP-89991 to DJB/DB and MOP-102508 to DB. DB is the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics. DJB is a Chercheurboursier senior of the Fonds de la recherche en sante du Quebec. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; BARNHART KM, 1994, MOL ENDOCRINOL, V8, P878, DOI 10.1210/me.8.7.878; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Duval DL, 1997, BIOL REPROD, V56, P160, DOI 10.1095/biolreprod56.1.160; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Fortin J, 2009, MOL HUM REPROD, V15, P77, DOI 10.1093/molehr/gan079; Fowkes RC, 2003, MOL ENDOCRINOL, V17, P2177, DOI 10.1210/me.2002-0393; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2008, ENDOCRINOLOGY, V149, P3095, DOI 10.1210/en.2007-0425; Lazarus KA, 2012, J STEROID BIOCHEM, V130, P138, DOI 10.1016/j.jsbmb.2011.12.017; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo A, 2011, J MOL ENDOCRINOL, V47, P45, DOI 10.1530/JME-10-0137; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Pincas H, 2001, MOL ENDOCRINOL, V15, P319, DOI 10.1210/me.15.2.319; Quirk CC, 2003, J BIOL CHEM, V278, P1680, DOI 10.1074/jbc.M209906200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Zhao LP, 2001, DEVELOPMENT, V128, P147; Zheng WM, 2007, J MOL ENDOCRINOL, V38, P207, DOI 10.1677/JME-06-0001	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59058	10.1371/journal.pone.0059058	http://dx.doi.org/10.1371/journal.pone.0059058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536856	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100117
J	Jiang, GY; Fan, CF; Zhang, XP; Dong, QZ; Wang, L; Liu, Y; Dai, SD; Yang, LH; Zhang, Y; Yu, JH; Wang, EH				Jiang, Guiyang; Fan, Chuifeng; Zhang, Xiupeng; Dong, Qianze; Wang, Liang; Liu, Yang; Dai, Shundong; Yang, Lianhe; Zhang, Yong; Yu, Juanhan; Wang, Enhua			Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR MUTATIONS; KINASE INHIBITOR THERAPY; PULMONARY ADENOCARCINOMA; GEFITINIB; GENE; SENSITIVITY; EFFUSION; IMPACT	Background: Epidermal growth factor receptor (EGFR) mutation status is the most valuable indicator in the screening of non-small-cell lung cancer (NSCLC) patients for tyrosine kinase inhibitor (TKI) therapy. Accurate, rapid and economical methods of detecting EGFR mutations have become important. The use of two mutation-specific antibodies targeting the delE746-A750 mutation in exon 19 and L858R mutation in exon 21 makes this task possible, but the lack of consensually acceptable criteria for positive results limits the application of this antibody based mutation detection. Methods: We collected 399 specimens from NSCLC patients (145 resection specimens, 220 biopsy specimens, and 34 cytology specimens) whose EGFR mutation status had been detected by TaqMan PCR assay. Immunohistochemical (IHC) analyses using EGFR mutation-specific antibodies were employed for all samples. After staining and scoring, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated in accordance with different levels of positive grades in comparison with the results of PCR-based assay. Results: In IHC-based analyses, 144 cases were scored 0, 104 cases were scored 1+, 103 cases were scored 2+, and 48 cases were scored 3+. With the molecular-based results were set as the "gold standard", the prevalence of mutation was 6.94% (10/144), 23.08% (24/104), 67.96% (70/103) and 100% (48/48), respectively, for samples with scores 0, 1+, 2+ and 3+. When score 3+ was considered positive, the specificity and PPV were 100%; if only score 0 was considered negative, 93.06% NPV was obtained. Conclusion: Patients with score 3+ have a perfect PPV (100%), and may accept TKI treatment directly without any molecular-based assays. Patients with score 0 had high NPV (93.06%), which could reach 97.22% when the detection of total EGFR was applied. However, samples with score 1+ or 2+ are unreliable and need further verification of EGFR mutation status by molecular-based assays.	[Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	Wang, Liang/AAM-2378-2021	Wang, Liang/0000-0003-4015-9385	National Natural Science Foundation of China [81071905, 81272606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 and 81272606 to EHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini-Spaltro A, 2012, APPL IMMUNOHISTO M M, V20, P356, DOI 10.1097/PAI.0b013e31823e064b; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Dimou A, 2011, AM J PATHOL, V179, P580, DOI 10.1016/j.ajpath.2011.04.031; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Kawahara A, 2011, LUNG CANCER, V74, P35, DOI 10.1016/j.lungcan.2011.02.002; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kim KS, 2005, CLIN CANCER RES, V11, P2244, DOI 10.1158/1078-0432.CCR-04-2081; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Wu SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023303; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhou CC, 2006, CANCER J, V12, P33, DOI 10.1097/00130404-200601000-00007	26	23	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59183	10.1371/journal.pone.0059183	http://dx.doi.org/10.1371/journal.pone.0059183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536868	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100127
J	Tai, V; James, ER; Perlman, SJ; Keeling, PJ				Tai, Vera; James, Erick R.; Perlman, Steve J.; Keeling, Patrick J.			Single-Cell DNA Barcoding Using Sequences from the Small Subunit rRNA and Internal Transcribed Spacer Region Identifies New Species of Trichonympha and Trichomitopsis from the Hindgut of the Termite Zootermopsis angusticollis	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; PARABASALIAN SYMBIONTS; POSITION; MORPHOLOGY; DIVERSITY; EMPHASIS; PSEUDOTRICHONYMPHA; DICTYOPTERA; TERMOPSIDIS; EVOLUTION	To aid in their digestion of wood, lower termites are known to harbour a diverse community of prokaryotes as well as parabasalid and oxymonad protist symbionts. One of the best-studied lower termite gut communities is that of Zootermopsis angusticollis which has been known for almost 100 years to possess 3 species of Trichonympha (T. campanula, T. collaris, and T. sphaerica), 1 species of Trichomitopsis (T. termopsidis), as well as smaller flagellates. We have re-assessed this community by sequencing the small subunit (SSU) rRNA gene and the internal transcribed spacer (ITS) region from a large number of single Trichonympha and Trichomitopsis cells for which morphology was also documented. Based on phylogenetic clustering and sequence divergence, we identify 3 new species: Trichonympha postcylindrica, Trichomitopsis minor, and Trichomitopsis parvus spp. nov. Once identified by sequencing, the morphology of the isolated cells for all 3 new species was re-examined and found to be distinct from the previously described species: Trichonympha postcylindrica can be morphologically distinguished from the other Trichonympha species by an extension on its posterior end, whereas Trichomitopsis minor and T. parvus are smaller than T. termopsidis but similar in size to each other and cannot be distinguished based on morphology using light microscopy. Given that Z. angusticollis has one of the best characterized hindgut communities, the near doubling of the number of the largest and most easily identifiable symbiont species suggests that the diversity of hindgut symbionts is substantially underestimated in other termites as well. Accurate descriptions of the diversity of these microbial communities are essential for understanding hindgut ecology and disentangling the interactions among the symbionts, and molecular barcoding should be a priority for these systems.	[Tai, Vera; James, Erick R.; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Perlman, Steve J.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	University of British Columbia; University of Victoria	Tai, V (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	vera.tai@botany.ubc.ca	t, lf/AAJ-4924-2020; James, Erick R/D-4725-2012	Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Resarch Council of Canada [227301]; Junior Fellow Academy of the Canadian Institute for Advanced Research (CIFAR)	Natural Sciences and Engineering Resarch Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Junior Fellow Academy of the Canadian Institute for Advanced Research (CIFAR)	This work was supported by a grant (227301) from the Natural Sciences and Engineering Resarch Council of Canada (www.nserc.ca). VT was funded through the Junior Fellow Academy of the Canadian Institute for Advanced Research (CIFAR) (www.cifar.ca). PJK and SJP are CIFAR fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth W, 2012, INSECT SOC, V59, P127, DOI 10.1007/s00040-011-0198-2; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Carpenter KJ, 2011, J EUKARYOT MICROBIOL, V58, P426, DOI 10.1111/j.1550-7408.2011.00564.x; Carpenter KJ, 2010, PROTIST, V161, P122, DOI 10.1016/j.protis.2009.06.003; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; Cutler DW, 1919, Q J MICROSC SCI, V63, P555; Dacks JB, 1998, J EUKARYOT MICROBIOL, V45, P445, DOI 10.1111/j.1550-7408.1998.tb05097.x; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039, DOI 10.1128/AEM.63.10.4039-4046.1997; Gerbod D, 2002, MOL PHYLOGENET EVOL, V25, P545, DOI 10.1016/S1055-7903(02)00300-7; Gile GH, 2011, INT J SYST EVOL MICR, V61, P2547, DOI 10.1099/ijs.0.028480-0; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Heiss AA, 2006, PROTIST, V157, P335, DOI 10.1016/j.protis.2006.05.007; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Ikeda-Ohtsubo W, 2009, MOL ECOL, V18, P332, DOI 10.1111/j.1365-294X.2008.04029.x; Imms AD, 1920, PHILOS T R SOC LON B, V209, P75, DOI 10.1098/rstb.1920.0002; KATIYAR SK, 1995, GENE, V152, P27, DOI 10.1016/0378-1119(94)00677-K; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Keeling PJ, 2003, J MOL BIOL, V326, P1337, DOI 10.1016/S0022-2836(03)00057-3; Keeling PJ, 1998, J EUKARYOT MICROBIOL, V45, P643, DOI 10.1111/j.1550-7408.1998.tb04561.x; Kirby H., 1934, TERMITES TERMITE CON, P84; Kirby H. jr., 1932, University of California Publications in Zoology, V37, P349; KIRBY HAROLD, 1931, UNIV CALIFORNIA PUBL ZOOL, V36, P171; KIRBY HAROLD, 1930, UNIV CALIFORNIA PUBL ZOOL, V33, P393; Kitade Osamu, 2004, Microbes and Environments, V19, P215, DOI 10.1264/jsme2.19.215; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; Kofoid C, 1919, U CALIF PUBL ZOOL, V20, P41; Kofoid C, 1919, U CALIF PUBL ZOOL, V20, P99; KOFOID C. A., 1919, Univiversity of California Publications in Zoology, V20, P1; Kofoid C. A, 1919, U CALIF PUBL ZOOL, V20, P21; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Noda S, 2009, MOL PHYLOGENET EVOL, V52, P217, DOI 10.1016/j.ympev.2009.03.011; Ohkuma M, 2000, J EUKARYOT MICROBIOL, V47, P249, DOI 10.1111/j.1550-7408.2000.tb00044.x; Ohkuma M, 2005, MOL PHYLOGENET EVOL, V35, P646, DOI 10.1016/j.ympev.2005.02.013; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2011, J EUKARYOT MICROBIOL, V58, P487, DOI 10.1111/j.1550-7408.2011.00575.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Slamovits CH, 2006, EUKARYOT CELL, V5, P148, DOI 10.1128/EC.5.1.148-154.2006; Slamovits CH, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-34; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042780; Stingl U, 2003, PROTIST, V154, P147, DOI 10.1078/143446103764928530; Strassert JFH, 2012, ENVIRON MICROBIOL, V14, P3259, DOI 10.1111/1462-2920.12012; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; YAMIN MA, 1979, T AM MICROSC SOC, V98, P276, DOI 10.2307/3226032; YAMIN MA, 1979, SOCIOBIOLOGY, V4, P3	50	20	21	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58728	10.1371/journal.pone.0058728	http://dx.doi.org/10.1371/journal.pone.0058728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536818	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100085
J	Wikoff, WR; Frye, RF; Zhu, HJ; Gong, Y; Boyle, S; Churchill, E; Cooper-Dehoff, RM; Beitelshees, AL; Chapman, AB; Fiehn, O; Johnson, JA; Kaddurah-Daouk, R				Wikoff, William R.; Frye, Reginald F.; Zhu, Hongjie; Gong, Yan; Boyle, Stephen; Churchill, Erik; Cooper-Dehoff, Rhonda M.; Beitelshees, Amber L.; Chapman, Arlene B.; Fiehn, Oliver; Johnson, Julie A.; Kaddurah-Daouk, Rima		Pharmacometabolomics Res Network	Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment	PLOS ONE			English	Article							GLOBAL BIOCHEMICAL APPROACH; ETHNIC-DIFFERENCES; DRUG RESPONSE; METABOLOMICS; HYPERTENSION; THERAPY; GENE; MEN; IDENTIFICATION; CHOLESTEROL	Antihypertensive drugs are among the most commonly prescribed drugs for chronic disease worldwide. The response to antihypertensive drugs varies substantially between individuals and important factors such as race that contribute to this heterogeneity are poorly understood. In this study we use metabolomics, a global biochemical approach to investigate biochemical changes induced by the beta-adrenergic receptor blocker atenolol in Caucasians and African Americans. Plasma from individuals treated with atenolol was collected at baseline (untreated) and after a 9 week treatment period and analyzed using a GC-TOF metabolomics platform. The metabolomic signature of atenolol exposure included saturated (palmitic), monounsaturated (oleic, palmitoleic) and polyunsaturated (arachidonic, linoleic) free fatty acids, which decreased in Caucasians after treatment but were not different in African Americans (p < 0.0005, q < 0.03). Similarly, the ketone body 3-hydroxybutyrate was significantly decreased in Caucasians by 33% (p < 0.0001, q < 0.0001) but was unchanged in African Americans. The contribution of genetic variation in genes that encode lipases to the racial differences in atenolol-induced changes in fatty acids was examined. SNP rs9652472 in LIPC was found to be associated with the change in oleic acid in Caucasians (p < 0.0005) but not African Americans, whereas the PLA2G4C SNP rs7250148 associated with oleic acid change in African Americans (p < 0.0001) but not Caucasians. Together, these data indicate that atenolol-induced changes in the metabolome are dependent on race and genotype. This study represents a first step of a pharmacometabolomic approach to phenotype patients with hypertension and gain mechanistic insights into racial variability in changes that occur with atenolol treatment, which may influence response to the drug.	[Wikoff, William R.; Fiehn, Oliver] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Frye, Reginald F.; Gong, Yan; Cooper-Dehoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Frye, Reginald F.; Gong, Yan; Cooper-Dehoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Ctr Pharmacogen, Gainesville, FL USA; [Zhu, Hongjie; Boyle, Stephen; Churchill, Erik; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Beitelshees, Amber L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Chapman, Arlene B.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Kaddurah-Daouk, Rima] Duke Univ, Duke Inst Brain Sci, Durham, NC USA	University of California System; University of California Davis; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; University System of Maryland; University of Maryland Baltimore; Emory University; Duke University	Wikoff, WR (corresponding author), Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA.	wrwikoff@ucdavis.edu; kaddu001@mc.duke.edu		Kaddurah-Daouk, Rima/0000-0003-1858-5732; Frye, Reginald/0000-0002-1841-1401	NIGMS (National Institute of General Medical Sciences) [RC2-GM092729]; National Institutes of Health (Bethesda, MD) [U01 GM074492]; Pharmacogenetics Research Network; K23 [HL091120, HL086558]; CTSA [UL1-RR029890, UL1-RR025008, UL1-RR024150]; Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890, UL1RR024150, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL086558, K23HL091120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492, RC2GM092729] Funding Source: NIH RePORTER	NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); K23; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The metabolomics work was funded by NIGMS (National Institute of General Medical Sciences) grant RC2-GM092729 "Metabolomics Network for Drug Response Phenotype". The PEAR study is supported by a grant from the National Institutes of Health (Bethesda, MD), grant # U01 GM074492, funded as part of the Pharmacogenetics Research Network. Additional support for this work includes: K23 grants HL091120 (ALB) and HL086558 (RCD); CTSA grants UL1-RR029890 (University of Florida), UL1-RR025008 (Emory University), and UL1-RR024150 (Mayo Clinic); and funds from the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo R, 2012, PHARMACOGENET GENOM, V22, P247, DOI 10.1097/FPC.0b013e32835001c9; Barakat H, 2002, METABOLISM, V51, P1514, DOI 10.1053/meta.2002.35589; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Berk ES, 2006, J CLIN ENDOCR METAB, V91, P4099, DOI 10.1210/jc.2005-2411; Brilakis ES, 2008, ATHEROSCLEROSIS, V199, P110, DOI 10.1016/j.atherosclerosis.2007.10.010; Corona G, 2012, J CELL PHYSIOL, V227, P2827, DOI 10.1002/jcp.24003; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; DAY JL, 1979, BRIT MED J, V1, P77, DOI 10.1136/bmj.1.6156.77; DEACON SP, 1978, BRIT J CLIN PHARMACO, V5, P123, DOI 10.1111/j.1365-2125.1978.tb01611.x; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Gupta AK, 2010, AM J HYPERTENS, V23, P1023, DOI 10.1038/ajh.2010.105; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; HOSTETLER KY, 1981, BIOCHEM PHARMACOL, V30, P1121, DOI 10.1016/0006-2952(81)90451-2; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Johnson JA, 2008, CIRCULATION, V118, P1383, DOI 10.1161/CIRCULATIONAHA.107.704023; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; KEYES SR, 1980, J BIOL CHEM, V255, P1357; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Krauss RM, 2008, CIRCULATION, V117, P1537, DOI 10.1161/CIRCULATIONAHA.107.708388; Kurnik D, 2008, PHARMACOGENET GENOM, V18, P895, DOI 10.1097/FPC.0b013e328309733f; Lanman Richard B, 2006, Prev Cardiol, V9, P138, DOI 10.1111/j.1520-037X.2006.05547.x; Ma J, 2008, HYPERTENSION, V51, P1275, DOI 10.1161/HYPERTENSIONAHA.107.107086; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; Messerli FH, 2008, CIRCULATION, V117, P2706, DOI 10.1161/CIRCULATIONAHA.107.695007; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; PAPPU AS, 1985, BIOCHEM PHARMACOL, V34, P521, DOI 10.1016/0006-2952(85)90183-2; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; SAIFER A, 1961, J LIPID RES, V2, P268; Sanchez-Roman I, 2010, REJUV RES, V13, P683, DOI 10.1089/rej.2010.1062; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Sergeant S, 2011, BR J NUTR, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STANLEY JC, 1981, BRIT J ANAESTH, V53, P131, DOI 10.1093/bja/53.2.131; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Thoenes M, 2010, J HUM HYPERTENS, V24, P336, DOI 10.1038/jhh.2009.76; Trupp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038386; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106	51	52	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57639	10.1371/journal.pone.0057639	http://dx.doi.org/10.1371/journal.pone.0057639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536766	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100012
J	Mokuwa, A; Nuijten, E; Okry, F; Teeken, B; Maat, H; Richards, P; Struik, PC				Mokuwa, Alfred; Nuijten, Edwin; Okry, Florent; Teeken, Bela; Maat, Harro; Richards, Paul; Struik, Paul C.			Robustness and Strategies of Adaptation among Farmer Varieties of African Rice (Oryza glaberrima) and Asian Rice (Oryza sativa) across West Africa	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; UPLAND RICE; HISTORY; FUTURE	This study offers evidence of the robustness of farmer rice varieties (Oryza glaberrima and O. sativa) in West Africa. Our experiments in five West African countries showed that farmer varieties were tolerant of sub-optimal conditions, but employed a range of strategies to cope with stress. Varieties belonging to the species Oryza glaberrima - solely the product of farmer agency - were the most successful in adapting to a range of adverse conditions. Some of the farmer selections from within the indica and japonica subspecies of O. sativa also performed well in a range of conditions, but other farmer selections from within these two subspecies were mainly limited to more specific niches. The results contradict the rather common belief that farmer varieties are only of local value. Farmer varieties should be considered by breeding programmes and used (alongside improved varieties) in dissemination projects for rural food security.	[Mokuwa, Alfred; Nuijten, Edwin; Okry, Florent; Teeken, Bela; Maat, Harro; Richards, Paul] Wageningen Univ, Technol & Agrarian Dev Grp, NL-6700 AP Wageningen, Netherlands; [Okry, Florent] Africa Rice Ctr, Cotonou, Benin; [Struik, Paul C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; CGIAR; Africa Rice Center; Wageningen University & Research	Struik, PC (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands.	paul.struik@wur.nl	Maat, Harro/D-2142-2012	Maat, Harro/0000-0001-7338-7910; Richards, Paul/0000-0001-5813-0228; Teeken, Bela/0000-0002-3150-1532	NWO-WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research); CSG (Centre for Society and Genomics); NUFFIC (Netherlands Organisation for International Cooperation in Higher Education); AfricaRice Center	NWO-WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research); CSG (Centre for Society and Genomics); NUFFIC (Netherlands Organisation for International Cooperation in Higher Education); AfricaRice Center	Funding for this study was provided by NWO-WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research), CSG (Centre for Society and Genomics), NUFFIC (Netherlands Organisation for International Cooperation in Higher Education) and AfricaRice Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYDON L, 1981, AFRICA, V51, P658, DOI 10.2307/1158831; CECCARELLI S, 1994, EUPHYTICA, V77, P205, DOI 10.1007/BF02262633; Dingkuhn M, 1999, FIELD CROP RES, V61, P79, DOI 10.1016/S0378-4290(98)00152-X; Futakuchi K., 2009, Agricultural Journal, V4, P96; Hendriks CLL, 2005, DIPIMAGE USER MANUAL; Johnson DE, 1998, WEED RES, V38, P207, DOI 10.1046/j.1365-3180.1998.00092.x; Khan MS, 2011, FIELD CROPS RE UNPUB; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Mercer KL, 2010, EVOL APPL, V3, P480, DOI 10.1111/j.1752-4571.2010.00137.x; Mouser B, 2011, COMM RIC SIERR LEON; Nuijten E, 2007, GENET RESOUR CROP EV, V54, P989, DOI 10.1007/s10722-006-9191-4; Nuijten E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007335; Okry F, J AGRARIAN CHA UNPUB; Okry F, 2011, EXP AGR, V47, P137, DOI 10.1017/S001447971000089X; PORTERES R., 1966, Journal d'Agriculture tropicale, V13, P1; Richards P, 2006, AFR SPECTR, V41, P77; Richards P., 1986, COPING HUNGER HAZARD; Sall S, 1998, AGR SYST, V57, P101, DOI 10.1016/S0308-521X(97)00072-3; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Sultan SE, 1995, ACTA BOT NEERL, V44, P363; SUMI A, 1994, JPN J CROP SCI, V63, P96, DOI 10.1626/jcs.63.96; Teeken B, 2010, 28 INT RIC RES C 8 1; Temudo MP, 2011, HUM ECOL, V39, P309, DOI 10.1007/s10745-011-9404-0	24	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e34801	10.1371/journal.pone.0034801	http://dx.doi.org/10.1371/journal.pone.0034801			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23536754	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100001
J	Elcombe, SE; Naqvi, S; Van den Bosch, MWM; MacKenzie, KF; Cianfanelli, F; Brown, GD; Arthur, JSC				Elcombe, Suzanne E.; Naqvi, Shaista; Van den Bosch, Mirjam W. M.; MacKenzie, Kirsty F.; Cianfanelli, Francesca; Brown, Gordon D.; Arthur, J. Simon C.			Dectin-1 Regulates IL-10 Production via a MSK1/2 and CREB Dependent Pathway and Promotes the Induction of Regulatory Macrophage Markers	PLOS ONE			English	Article							STRESS-INDUCED PHOSPHORYLATION; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTOR-2; CYTOKINE PRODUCTION; DENDRITIC CELLS; TRANSCRIPTION FACTORS; CANDIDA-ALBICANS; IMMUNE-RESPONSES; GENE-EXPRESSION; IN-VIVO	In response to infection by fungal pathogens, the innate immune system recognises specific fungal pathogen associated molecular patterns (PAMPs) via pattern recognition receptors including the C-type lectin dectin-1 and members of the Toll Like Receptor (TLR) family. Stimulation of these receptors leads to the induction of both pro- and anti-inflammatory cytokines. The protein kinases MSK1 and 2 are known to be important in limiting inflammatory cytokine production by macrophages in response to the TLR4 agonist LPS. In this study we show that MSKs are also activated in macrophages by the fungal derived ligand zymosan, as well as the dectin-1 specific agonists curdlan and depleted zymosan, via the ERK1/2 and p38 alpha MAPK pathways. Furthermore, we show that MSKs regulate dectin-1 induced IL-10 production, and that this regulation is dependent on the ability of MSKs to phosphorylate the transcription factor CREB. IL-10 secreted in response to zymosan was able to promote STAT3 phosphorylation via an autocrine feedback loop. Consistent with the decreased IL-10 secretion in MSK1/2 knockout macrophages, these cells also had decreased STAT3 tyrosine phosphorylation relative to wild type controls after stimulation with zymosan. We further show that the reduction in IL-10 production in the MSK1/2 macrophages results in increased secretion of IL-12p40 in response to zymosan relative to wild type controls. The production of high levels of IL-10 but low levels of IL-12 has previously been associated with an M2b or 'regulatory' macrophage phenotype, which was initially described in macrophages stimulated with a combination of immune complexes and LPS. We found that zymosan, via dectin-1 activation, also leads to the expression of SphK1 and LIGHT, markers of a regulatory like phenotype in mouse macrophages. The expression of these makers was further reinforced by the high level of IL-10 secreted in response to zymosan stimulation.	[Elcombe, Suzanne E.; Naqvi, Shaista; Van den Bosch, Mirjam W. M.; MacKenzie, Kirsty F.; Arthur, J. Simon C.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Brown, Gordon D.] Univ Aberdeen, Sch Med & Dent, Inst Mol Sci, Sect Infect & Immun, Aberdeen, Scotland; [MacKenzie, Kirsty F.; Cianfanelli, Francesca; Arthur, J. Simon C.] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee, Scotland	University of Dundee; University of Aberdeen; University of Dundee	Arthur, JSC (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Sir James Black Complex, Dundee, Scotland.	j.s.c.arthur@dundee.ac.uk		Arthur, Simon/0000-0002-8135-1958; Cianfanelli, Francesca Romana/0000-0002-4570-1877; brown, gordon/0000-0002-0287-5383	Medical Research Council; Wellcome Trust; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck KgaA; Janssen Pharmaceutica; Pfizer; Medical Research Council [MC_U127081014] Funding Source: researchfish; MRC [MC_U127081014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck KgaA; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, Wellcome Trust and the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen Pharmaceutica and Pfizer). SE holds a Wellcome Trust clinical PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Filardy AA, 2010, J IMMUNOL, V185, P2044, DOI 10.4049/jimmunol.1000017; Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kelly EK, 2010, J IMMUNOL; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Pattison MJ, 2012, J IMMUNOL, V189, P2784, DOI 10.4049/jimmunol.1200310; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shah N, 2012, CURR ALLERGY ASTHM R, V12, P373, DOI 10.1007/s11882-012-0286-z; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sun L, 2007, INT REV IMMUNOL, V26, P349, DOI 10.1080/08830180701690793; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wingate AD, 2009, GENESIS, V47, P688, DOI 10.1002/dvg.20548; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yoshida R, 2012, BIOCHEM BIOPH RES CO, V423, P247, DOI 10.1016/j.bbrc.2012.05.097	71	65	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							SICI e60086	10.1371/journal.pone.0060086	http://dx.doi.org/10.1371/journal.pone.0060086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533666	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400103
J	Emmert, MY; Weber, B; Wolint, P; Frauenfelder, T; Zeisberger, SM; Behr, L; Sammut, S; Scherman, J; Brokopp, CE; Schwartlander, R; Vogel, V; Vogt, P; Grunenfelder, J; Alkadhi, H; Falk, V; Boss, A; Hoerstrup, SP				Emmert, Maximilian Y.; Weber, Benedikt; Wolint, Petra; Frauenfelder, Thomas; Zeisberger, Steffen M.; Behr, Luc; Sammut, Sebastien; Scherman, Jacques; Brokopp, Chad E.; Schwartlaender, Ruth; Vogel, Viola; Vogt, Peter; Gruenenfelder, Juerg; Alkadhi, Hatem; Falk, Volkmar; Boss, Andreas; Hoerstrup, Simon P.			Intramyocardial Transplantation and Tracking of Human Mesenchymal Stem Cells in a Novel Intra-Uterine Pre-Immune Fetal Sheep Myocardial Infarction Model: A Proof of Concept Study	PLOS ONE			English	Article							IN-UTERO TRANSPLANTATION; CHRONIC ISCHEMIC CARDIOMYOPATHY; IRON-OXIDE PARTICLES; HUMAN CORD BLOOD; BONE-MARROW; PROGENITOR CELLS; ADIPOSE-TISSUE; HUMAN HEPATOCYTES; CARDIAC-DISEASE; OVINE FETUSES	Although stem-cell therapies have been suggested for cardiac-regeneration after myocardial-infarction (MI), key-questions regarding the in-vivo cell-fate remain unknown. While most available animal-models require immunosuppressive-therapy when applying human cells, the fetal-sheep being pre-immune until day 75 of gestation has been proposed for the in-vivo tracking of human cells after intra-peritoneal transplantation. We introduce a novel intra-uterine myocardial-infarction model to track human mesenchymal stem cells after direct intra-myocardial transplantation into the pre-immune fetal-sheep. Thirteen fetal-sheep (gestation age: 70-75 days) were included. Ten animals either received an intra-uterine induction of MI only (n = 4) or MI+intra-myocardial injection (IMI;n = 6) using micron-sized, iron-oxide (MPIO) labeled human mesenchymal stem cells either derived from the adipose-tissue (ATMSCs;n = 3) or the bone-marrow (BMMSCs;n = 3). Three animals received an intra-peritoneal injection (IPI;n = 3; ATMSCs;n = 2/BMMSCs;n = 1). All procedures were performed successfully and follow-up was 7-9 days. To assess human cell-fate, multimodal cell-tracking was performed via MRI and/or Micro-CT, Flow-Cytometry, PCR and immunohistochemistry. After IMI, MRI displayed an estimated amount of 1 x 10(5)-5 x 10(5) human cells within ventricular-wall corresponding to the injection-sites which was further confirmed on Micro-CT. PCR and IHC verified intra-myocardial presence via detection of human-specific beta-2-microglobulin, MHC-1, ALU-Sequence and anti-FITC targeting the fluorochrome-labeled part of the MPIOs. The cells appeared viable, integrated and were found in clusters or in the interstitial-spaces. Flow-Cytometry confirmed intra-myocardial presence, and showed further distribution within the spleen, lungs, kidneys and brain. Following IPI, MRI indicated the cells within the intra-peritoneal-cavity involving the liver and kidneys. Flow-Cytometry detected the cells within spleen, lungs, kidneys, thymus, bone-marrow and intra-peritoneal lavage, but not within the heart. For the first time we demonstrate the feasibility of intra-uterine, intra-myocardial stem-cell transplantation into the pre-immune fetal-sheep after MI. Utilizing cell-tracking strategies comprising advanced imaging-technologies and in-vitro tracking-tools, this novel model may serve as a unique platform to assess human cell-fate after intra-myocardial transplantation without the necessity of immunosuppressive-therapy.	[Emmert, Maximilian Y.; Weber, Benedikt; Wolint, Petra; Zeisberger, Steffen M.; Brokopp, Chad E.; Hoerstrup, Simon P.] Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland; [Emmert, Maximilian Y.; Weber, Benedikt; Wolint, Petra; Brokopp, Chad E.; Gruenenfelder, Juerg; Falk, Volkmar; Hoerstrup, Simon P.] Univ Zurich Hosp, Dept Surg Res, CH-8091 Zurich, Switzerland; [Emmert, Maximilian Y.; Scherman, Jacques; Gruenenfelder, Juerg; Falk, Volkmar; Hoerstrup, Simon P.] Univ Zurich Hosp, Cardiovasc Surg Clin, CH-8091 Zurich, Switzerland; [Frauenfelder, Thomas; Alkadhi, Hatem; Boss, Andreas] Univ Zurich Hosp, Inst Diagnost Radiol, CH-8091 Zurich, Switzerland; [Behr, Luc; Sammut, Sebastien] Inst Mutualiste Montsouris, IMM RECH, Paris, France; [Schwartlaender, Ruth; Vogel, Viola] ETH, Dept Hlth Sci & Technol, Lab Biol Oriented Mat, Zurich, Switzerland; [Vogt, Peter] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Hoerstrup, SP (corresponding author), Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland.	simon_philipp.hoerstrup@usz.ch	Vogt, Peter M./AAL-1332-2020; Boss, Andreas/A-7484-2014; Frauenfelder, Thomas/O-1734-2016; Vogel, Viola/O-8025-2015	Frauenfelder, Thomas/0000-0002-3295-6619; Vogel, Viola/0000-0003-2898-7671; Weber, Benedikt/0000-0002-7217-4590; Falk, Volkmar/0000-0002-7911-8620	SPUM (Special Program University Medicine); Swiss National Science Foundation; 7th Framework Programme, Life Valve, European Commission; European Union 7th Framework Programme as part of the project NanoCARD [229294]; MRC Sandpit Project "Nanomaterials for Stem-cell based Myocardial Regeneration"	SPUM (Special Program University Medicine); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th Framework Programme, Life Valve, European Commission; European Union 7th Framework Programme as part of the project NanoCARD; MRC Sandpit Project "Nanomaterials for Stem-cell based Myocardial Regeneration"	MYE and PW were supported by the SPUM (Special Program University Medicine; Swiss National Science Foundation) and BW was supported by the 7th Framework Programme, Life Valve, European Commission. RS was supported by the European Union 7th Framework Programme as part of the project NanoCARD, grant agreement no. 229294 and the MRC Sandpit Project "Nanomaterials for Stem-cell based Myocardial Regeneration". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey JA, 2004, CIRCULATION, V109, P1401, DOI 10.1161/01.CIR.0000124222.16321.26; Almeida-Porada G, 2000, BLOOD, V95, P3620, DOI 10.1182/blood.V95.11.3620.011k02_3620_3627; Almeida-Porada G, 2004, YONSEI MED J, V45, P7; Almeida-Porada G, 2004, INT J HEMATOL, V79, P1, DOI 10.1007/BF02983526; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; FLAKE AW, 1993, CRIT REV ONCOL HEMAT, V15, P35, DOI 10.1016/1040-8428(93)90019-Z; FLAKE AW, 1986, SCIENCE, V233, P776, DOI 10.1126/science.2874611; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Menasche P, 2002, ANN MED, V34, P314, DOI 10.1080/078538902320772061; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2004, FETAL DIAGN THER, V19, P23, DOI 10.1159/000074255; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Raschzok N, 2008, J CELL MOL MED, V12, P1384, DOI 10.1111/j.1582-4934.2008.00343.x; Raschzok N, 2011, MOL IMAGING BIOL, V13, P613, DOI 10.1007/s11307-010-0405-y; Raschzok N, 2009, TISSUE ENG PART C-ME, V15, P681, DOI 10.1089/ten.tec.2008.0675; Ruggiero A, 2012, EUR RADIOL, V22, P189, DOI 10.1007/s00330-011-2190-7; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schoeberlein A, 2005, AM J OBSTET GYNECOL, V192, P1044, DOI 10.1016/j.ajog.2005.01.031; Schoeberlein A, 2004, AM J OBSTET GYNECOL, V191, P1030, DOI 10.1016/j.ajog.2004.06.042; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shaw SWS, 2011, CELL TRANSPLANT, V20, P1015, DOI 10.3727/096368910X543402; Surbek DV, 2002, AM J OBSTET GYNECOL, V187, P960, DOI 10.1067/mob.2002.126982; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Young AJ, 2003, AM J OBSTET GYNECOL, V189, P698, DOI 10.1067/S0002-9378(03)00716-6; ZANJANI ED, 1994, BLOOD CELLS, V20, P331; Zanjani ED, 1996, INT J HEMATOL, V63, P179; ZANJANI ED, 1994, J CLIN INVEST, V93, P1051, DOI 10.1172/JCI117054	52	15	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57759	10.1371/journal.pone.0057759	http://dx.doi.org/10.1371/journal.pone.0057759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533575	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400012
J	Lafuse, WP; Story, R; Mahylis, J; Gupta, G; Varikuti, S; Steinkamp, H; Oghumu, S; Satoskar, AR				Lafuse, William P.; Story, Ryan; Mahylis, Jocelyn; Gupta, Gaurav; Varikuti, Sanjay; Steinkamp, Heidi; Oghumu, Steve; Satoskar, Abhay R.			Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL VISCERAL LEISHMANIASIS; MESSENGER-RNA EXPRESSION; INTERFERON-GAMMA; IFN-GAMMA; MYELODYSPLASTIC SYNDROMES; KALA-AZAR; ERYTHROID-DIFFERENTIATION; TRANSCRIPTION FACTORS; FACTOR-ALPHA	Leishmania donovani is a parasite that causes visceral leishmaniasis by infecting and replicating in macrophages of the bone marrow, spleen, and liver. Severe anemia and leucopenia is associated with the disease. Although immune defense mechanisms against the parasite have been studied, we have a limited understanding of how L. donovani alters hematopoiesis. In this study, we used Syrian golden hamsters to investigate effects of L. donovani infection on erythropoiesis. Infection resulted in severe anemia and leucopenia by 8 weeks post-infection. Anemia was associated with increased levels of serum erythropoietin, which indicates the hamsters respond to the anemia by producing erythropoietin. We found that infection also increased numbers of BFU-E and CFU-E progenitor populations in the spleen and bone marrow and differentially altered erythroid gene expression in these organs. In the bone marrow, the mRNA expression of erythroid differentiation genes (alpha-globin, beta-globin, ALAS2) were inhibited by 50%, but mRNA levels of erythroid receptor (c-kit, EpoR) and transcription factors (GATA1, GATA2, FOG1) were not affected by the infection. This suggests that infection has a negative effect on differentiation of erythroblasts. In the spleen, erythroid gene expression was enhanced by infection, indicating that the anemia activates a stress erythropoiesis response in the spleen. Analysis of cytokine mRNA levels in spleen and bone marrow found that IFN-gamma mRNA is highly increased by L. donovani infection. Expression of the IFN-gamma inducible cytokine, TNF-related apoptosis-inducing ligand (TRAIL), was also up-regulated. Since TRAIL induces erythroblasts apoptosis, apoptosis of bone marrow erythroblasts from infected hamsters was examined by flow cytometry. Percentage of erythroblasts that were apoptotic was significantly increased by L. donovani infection. Together, our results suggest that L. donovani infection inhibits erythropoiesis in the bone marrow by cytokine-mediated apoptosis of erythroblasts.	[Lafuse, William P.] Ohio State Univ, Dept Microbial Infect & Immun, Wexner Med Ctr, Columbus, OH 43210 USA; [Lafuse, William P.; Satoskar, Abhay R.] Ohio State Univ, Ctr Microbial Interface Biol, Wexner Med Ctr, Columbus, OH 43210 USA; [Story, Ryan; Mahylis, Jocelyn] Ohio State Univ, Sch Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Gupta, Gaurav; Varikuti, Sanjay; Steinkamp, Heidi; Oghumu, Steve; Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University	Satoskar, AR (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Wexner Med Ctr, Columbus, OH 43210 USA.	abhay.satoskar@osumc.edu	Satoskar, Abhay/AAB-7748-2019; Gupta, Gaurav/F-7519-2012; Oghumu, Steve/Z-3320-2019	Gupta, Gaurav/0000-0003-4533-6272; Lafuse, William/0000-0003-1056-3862	NIH [AI092624, AT004160]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded in part through NIH grants AI092624 and AT004160 to ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; ALJURAYYAN NAM, 1995, J TROP PEDIATRICS, V41, P143, DOI 10.1093/tropej/41.3.143; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; ARMEANU S, 1995, J CELL BIOL, V131, P243, DOI 10.1083/jcb.131.1.243; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Banerjee R, 2011, IMMUNOL CELL BIOL, V89, P466, DOI 10.1038/icb.2010.108; BISWAS T, 1992, J PARASITOL, V78, P140, DOI 10.2307/3283701; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; Campioni D, 2005, AM J PATHOL, V166, P557, DOI 10.1016/S0002-9440(10)62277-8; CAUX C, 1992, BLOOD, V79, P2628; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; ELHASSAN AM, 1995, TROP GEOGR MED, V47, P151; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; EVANS TG, 1990, J PARASITOL, V76, P212, DOI 10.2307/3283018; FARRELL JP, 1976, EXP PARASITOL, V40, P89, DOI 10.1016/0014-4894(76)90069-2; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Hailu A, 2004, AM J TROP MED HYG, V71, P561, DOI 10.4269/ajtmh.2004.71.561; HASLE H, 1994, LEUKEMIA LYMPHOMA, V13, P11, DOI 10.3109/10428199409051647; Hofmann WK, 1996, SEMIN HEMATOL, V33, P177; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; Iniguez SR, 2006, ANTIMICROB AGENTS CH, V50, P1195, DOI 10.1128/AAC.50.4.1195-1201.2006; Kumar PV, 2007, J PEDIAT HEMATOL ONC, V29, P77, DOI 10.1097/MPH.0b013e31803076a8; Lammers R, 2002, EXP HEMATOL, V30, P537, DOI 10.1016/S0301-472X(02)00798-1; LEONARD M, 1993, BLOOD, V82, P1071; Li GY, 2008, INT J CLIN EXP PATHO, V1, P169; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAMUS SW, 1985, J CLIN INVEST, V75, P1496, DOI 10.1172/JCI111853; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, EXP PARASITOL, V99, P17, DOI 10.1006/expr.2001.4640; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Oehler L, 1999, EXP HEMATOL, V27, P217, DOI 10.1016/S0301-472X(98)00049-6; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OTT KJ, 1967, J PARASITOL, V53, P641, DOI 10.2307/3276733; Pacheco-Yepez J, 2011, PARASITE IMMUNOL, V33, P56, DOI 10.1111/j.1365-3024.2010.01252.x; Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Perry JM, 2009, BLOOD, V113, P911, DOI 10.1182/blood-2008-03-147892; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X; Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998; Roy SS, 2009, MOL CELL BIOCHEM, V321, P53, DOI 10.1007/s11010-008-9909-z; Santos Mácia A., 2002, Rev. Soc. Bras. Med. Trop., V35, P629, DOI 10.1590/S0037-86822002000600014; Sasaki R, 2000, BIOSCI BIOTECH BIOCH, V64, P1775, DOI 10.1271/bbb.64.1775; Savioli L, 2010, WORKING OVERCOME GLO, P91; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Sen G, 2004, FREE RADICAL RES, V38, P527, DOI 10.1080/10715160410001665253; Sen G, 2001, ANN HEMATOL, V80, P32, DOI 10.1007/s002770000240; Silvestris F, 2002, BLOOD, V99, P1305, DOI 10.1182/blood.V99.4.1305; Smelt SC, 1997, J IMMUNOL, V158, P3813; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; van Weyenbergh J, 2005, BMC INFEC DIS, V5, P113; WICKRAMASINGHE SN, 1987, J CLIN PATHOL, V40, P267, DOI 10.1136/jcp.40.3.267; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Wilson ME, 1996, J IMMUNOL, V156, P2231; WORTHINGTON RE, 1987, EXP HEMATOL, V15, P85; Wu H, 1997, P NATL ACAD SCI USA, V94, P1806, DOI 10.1073/pnas.94.5.1806; Yarali N, 2002, AM J HEMATOL, V71, P191, DOI 10.1002/ajh.10200; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252; ZIJLSTRA EE, 1992, J TROP PEDIATRICS, V38, P17, DOI 10.1093/tropej/38.1.17; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	84	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59509	10.1371/journal.pone.0059509	http://dx.doi.org/10.1371/journal.pone.0059509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533629	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400066
J	Rinner, B; Weinhaeusel, A; Lohberger, B; Froehlich, EV; Pulverer, W; Fischer, C; Meditz, K; Scheipl, S; Trajanoski, S; Guelly, C; Leithner, A; Liegl, B				Rinner, Beate; Weinhaeusel, Andreas; Lohberger, Birgit; Froehlich, Elke Verena; Pulverer, Walter; Fischer, Carina; Meditz, Katharina; Scheipl, Susanne; Trajanoski, Slave; Guelly, Christian; Leithner, Andreas; Liegl, Bernadette			Chordoma Characterization of Significant Changes of the DNA Methylation Pattern	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; BREAST-CANCER; KLOTHO; EXPRESSION; ASSOCIATION; BIOMARKERS	Chordomas are rare mesenchymal tumors occurring exclusively in the midline from clivus to sacrum. Early tumor detection is extremely important as these tumors are resistant to chemotherapy and irradiation. Despite continuous research efforts surgical excision remains the main treatment option. Because of the often challenging anatomic location early detection is important to enable complete tumor resection and to reduce the high incidence of local recurrences. The aim of this study was to explore whether DNA methylation, a well known epigenetic marker, may play a role in chordoma development and if hypermethylation of specific CpG islands may serve as potential biomarkers correlated with SNP analyses in chordoma. The study was performed on tumor samples from ten chordoma patients. We found significant genomic instability by Affymetrix 6.0. It was interesting to see that all chordomas showed a loss of 3q26.32 (PIK 3CA) and 3q27.3 (BCL6) thus underlining the potential importance of the PI3K pathway in chordoma development. By using the AITCpG360 methylation assay we elucidated 20 genes which were hyper/hypomethylated compared to normal blood. The most promising candidates were nine hyper/ hypomethylated genes C3, XIST, TACSTD2, FMR1, HIC1, RARB, DLEC1, KL, and RASSF1. In summary, we have shown that chordomas are characterized by a significant genomic instability and furthermore we demonstrated a characteristic DNA methylation pattern. These findings add new insights into chordoma development, diagnosis and potential new treatment options.	[Rinner, Beate; Fischer, Carina; Meditz, Katharina; Trajanoski, Slave; Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Weinhaeusel, Andreas; Pulverer, Walter] AIT Austrian Inst Technol, Hlth & Environm Dept, Mol Diagnost Unit, Vienna, Austria; [Lohberger, Birgit; Froehlich, Elke Verena; Scheipl, Susanne; Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Liegl, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Austrian Institute of Technology (AIT); Medical University of Graz; Medical University of Graz	Rinner, B (corresponding author), Med Univ Graz, Med Res Ctr, Graz, Austria.	beate.rinner@medunigraz.at; bernadette.liegl-atzwanger@medunigraz.at	Weinhaeusel, Andreas/A-7644-2018	Weinhaeusel, Andreas/0000-0002-9318-1204; Rinner, Beate/0000-0002-6340-4905	Jubilee Fund of the Austrian National Bank [OENB 13459]	Jubilee Fund of the Austrian National Bank	Financial support by the Jubilee Fund of the Austrian National Bank (OENB 13459) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; Catton C, 1996, RADIOTHER ONCOL, V41, P67, DOI 10.1016/S0167-8140(96)91805-8; CAVENEE WK, 1991, CANCER, V67, P2431, DOI 10.1002/1097-0142(19910515)67:10<2431::AID-CNCR2820671005>3.0.CO;2-#; Chamdin A, 2009, TRANSL ONCOL, V2, P128, DOI 10.1593/tlo.08220; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; Dhe-Paganon Sirano, 2011, Int J Biochem Mol Biol, V2, P58; Fletcher CDM, 2002, PATHOLOGY GENETICS T, V5; Hallor KH, 2008, BRIT J CANCER, V98, P434, DOI 10.1038/sj.bjc.6604130; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Lehmann U, 2002, AM J PATHOL, V160, P605, DOI 10.1016/S0002-9440(10)64880-8; Naumann RW, 2011, GYNECOL ONCOL, V123, P411, DOI 10.1016/j.ygyno.2011.08.002; Neumann LC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-380; Nikolaidis G, 2012, CANCER RES, V72, P5692, DOI 10.1158/0008-5472.CAN-12-2309; Ransohoff DF, 2003, SCIENCE, V299, P1679, DOI 10.1126/science.1083158; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Scheipl S, 2012, HISTOPATHOLOGY, V60, P999, DOI 10.1111/j.1365-2559.2012.04186.x; Simon R, 2007, CANCER INFORM, V3, P11; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wang YA, 2006, CANCER BIOL THER, V5, P20, DOI 10.4161/cbt.5.1.2430; Weinhaeusel A, 2010, [No title captured], Patent No. [WO2010086388 A1, 2010086388]; Weinhaeusel A, 2010, Lung cancer methylation markers, Patent No. [PCT/EP2010/051032, 2010051032]; Weinhaeusel A, 2010, [No title captured], Patent No. [WO2010086389 A1, 2010086389]; Weinhaeusel A, 2008, CLIN CHEM, V54, P1537, DOI 10.1373/clinchem.2008.104216; Weinhausel A, 2009, European Patent Application, Patent No. [EP 09450020.4, 09450020]; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345	35	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e56609	10.1371/journal.pone.0056609	http://dx.doi.org/10.1371/journal.pone.0056609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533570	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400007
J	Sobirk, SK; Morgelin, M; Egesten, A; Bates, P; Shannon, O; Collin, M				Sobirk, Sara K.; Morgelin, Matthias; Egesten, Arne; Bates, Paul; Shannon, Oonagh; Collin, Mattias			Human Chemokines as Antimicrobial Peptides with Direct Parasiticidal Effect on Leishmania mexicana In Vitro	PLOS ONE			English	Article							HUMAN MACROPHAGES; EXPRESSION; IMMUNITY	Chemokines and chemokine receptor-mediated effects are important mediators of the immunological response and cure in human leishmaniasis. However, in addition to their signalling properties for leukocytes, many chemokines have also been shown to act directly as antimicrobial peptides on bacteria and fungi. We screened ten human chemokines (CXCL2, CXCL6, CXCL8, CXCL9, CXCL10, CCL2, CCL3, CCL20, CCL27, CCL28) for antimicrobial effects on the promastigote form of the protozoan parasite Leishmania mexicana, and observed direct parasiticidal effects of several, CCL28 being the most potent. Damage to the plasma membrane integrity could be visualised by entrance of propidium iodide, as measured with flow cytometry, and by scanning electron microscopy, which showed morphological changes and aggregation of cells. The findings were in concordance with parasiticidal activity, measured by decreased mitochondrial activity in an MTT-assay. This is the first report of direct antimicrobial activity by chemokines on parasites. This component of immunity against Leishmania parasites identified here warrants further investigation that might lead to new insight in the mechanisms of human infection and/or new therapeutic approaches.	[Sobirk, Sara K.; Morgelin, Matthias; Shannon, Oonagh; Collin, Mattias] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Sobirk, Sara K.] Lund Univ, Lund, Sweden; [Sobirk, Sara K.] Reg Labs Reg Skane, Lund, Sweden; [Egesten, Arne] Lund Univ, Sect Resp Med & Allergol, Dept Clin Sci, Lund, Sweden; [Bates, Paul] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England	Lund University; Lund University; Lund University; Lancaster University	Sobirk, SK (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden.	sara.karlsson_sobirk@med.lu.se	Collin, Mattias/C-6398-2009	Collin, Mattias/0000-0002-6166-7410; Karlsson Sobirk, Sara/0000-0002-3789-0532; Shannon, Oonagh/0000-0001-8291-8189; Bates, Paul/0000-0001-6861-5421	Swedish governmental funding for clinical research (ALF); Swedish Research Council [2010-57X-20240]; Foundations of Wiberg; Foundations of Kock; Foundations of Bergvall; Foundations of Osterlund; Foundations of Hedberg; Foundations of Hedlund; Foundations of Groschinsky; Foundations of Soderberg; Swedish Society for Medicine; Royal Physiograc Society, King Gustaf Vs Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	Swedish governmental funding for clinical research (ALF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Wiberg; Foundations of Kock; Foundations of Bergvall; Foundations of Osterlund; Foundations of Hedberg; Foundations of Hedlund; Foundations of Groschinsky; Foundations of Soderberg; Swedish Society for Medicine; Royal Physiograc Society, King Gustaf Vs Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	SS and MC are supported by Swedish governmental funding for clinical research (ALF). MC is supported by grants from the Swedish Research Council (2010-57X-20240), the Foundations of Wiberg, Kock, Bergvall, Osterlund, Hedberg, Hedlund, Groschinsky, Soderberg, the Swedish Society for Medicine, the Royal Physiograc Society, King Gustaf Vs Memorial Fund, the Medical Faculty at Lund University, and Hansa Medical AB. The funders had no role in preparation of the manuscript or decision to publish.	Aliberti JCS, 1999, INFECT IMMUN, V67, P4819, DOI 10.1128/IAI.67.9.4819-4826.1999; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Brandonisio O, 2002, CLIN EXP MED, V2, P125, DOI 10.1007/s102380200017; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Katzman SD, 2008, J CLIN INVEST, V118, P801, DOI 10.1172/JCI33174; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kutzler MA, 2010, GENE THER, V17, P72, DOI 10.1038/gt.2009.112; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Mannheimer SB, 1996, FEMS IMMUNOL MED MIC, V14, P59, DOI 10.1111/j.1574-695X.1996.tb00268.x; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; Oghumu S, 2010, EXP PARASITOL, V126, P389, DOI 10.1016/j.exppara.2010.02.010; Ritter U, 2002, PARASITE IMMUNOL, V24, P295, DOI 10.1046/j.1365-3024.2002.00467.x; Ritter U, 1996, J INFECT DIS, V173, P699, DOI 10.1093/infdis/173.3.699; Luque-Ortega JR, 2010, METHODS MOL BIOL, V618, P393, DOI 10.1007/978-1-60761-594-1_25; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Verma NK, 2007, EXP PARASITOL, V116, P1, DOI 10.1016/j.exppara.2006.10.007; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yount NY, 2007, BBA-BIOMEMBRANES, V1768, P598, DOI 10.1016/j.bbamem.2006.11.011; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Yung SC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00276	27	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58129	10.1371/journal.pone.0058129	http://dx.doi.org/10.1371/journal.pone.0058129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533582	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000316549400019
J	Fruzangohar, M; Ebrahimie, E; Ogunniyi, AD; Mahdi, LK; Paton, JC; Adelson, DL				Fruzangohar, Mario; Ebrahimie, Esmaeil; Ogunniyi, Abiodun D.; Mahdi, Layla K.; Paton, James C.; Adelson, David L.			Comparative GO: A Web Application for Comparative Gene Ontology and Gene Ontology-Based Gene Selection in Bacteria	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; DATABASE; TOOL; ANNOTATION; DISEASE; TERMS	The primary means of classifying new functions for genes and proteins relies on Gene Ontology (GO), which defines genes/proteins using a controlled vocabulary in terms of their Molecular Function, Biological Process and Cellular Component. The challenge is to present this information to researchers to compare and discover patterns in multiple datasets using visually comprehensible and user-friendly statistical reports. Importantly, while there are many GO resources available for eukaryotes, there are none suitable for simultaneous, graphical and statistical comparison between multiple datasets. In addition, none of them supports comprehensive resources for bacteria. By using Streptococcus pneumoniae as a model, we identified and collected GO resources including genes, proteins, taxonomy and GO relationships from NCBI, UniProt and GO organisations. Then, we designed database tables in PostgreSQL database server and developed a Java application to extract data from source files and loaded into database automatically. We developed a PHP web application based on Model-View-Control architecture, used a specific data structure as well as current and novel algorithms to estimate GO graphs parameters. We designed different navigation and visualization methods on the graphs and integrated these into graphical reports. This tool is particularly significant when comparing GO groups between multiple samples (including those of pathogenic bacteria) from different sources simultaneously. Comparing GO protein distribution among up- or down-regulated genes from different samples can improve understanding of biological pathways, and mechanism(s) of infection. It can also aid in the discovery of genes associated with specific function(s) for investigation as a novel vaccine or therapeutic targets.	[Fruzangohar, Mario; Ebrahimie, Esmaeil; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Ctr Bioinformat & Computat Genet, Adelaide, SA, Australia; [Ebrahimie, Esmaeil; Ogunniyi, Abiodun D.; Mahdi, Layla K.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Ctr Bioinformat & Computat Genet, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Adelson, David L/0000-0003-2404-5636; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Ogunniyi, Abiodun/0000-0001-9308-5629; Mahdi, Layla/0000-0002-5878-8385	National Health and Medical Research Council of Australia (NHMRC) [627142, 565526]; School Divisional PhD Scholarship from The University of Adelaide	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); School Divisional PhD Scholarship from The University of Adelaide	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Project Grant 627142 to JCP and ADO, and NHMRC Program Grant 565526 to JCP. MF is a recipient of School Divisional PhD Scholarship from The University of Adelaide. JCP is a NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	20	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58759	10.1371/journal.pone.0058759	http://dx.doi.org/10.1371/journal.pone.0058759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536820	gold, Green Published, Green Accepted			2022-12-27	WOS:000316251100087
J	Geyer, BC; Larrimore, KE; Kilbourne, J; Kannan, L; Mor, TS				Geyer, Brian C.; Larrimore, Katherine E.; Kilbourne, Jacquelyn; Kannan, Latha; Mor, Tsafrir S.			Reversal of Succinylcholine Induced Apnea with an Organophosphate Scavenging Recombinant Butyrylcholinesterase	PLOS ONE			English	Article							RAPID-SEQUENCE INTUBATION; FRESH-FROZEN PLASMA; HUMAN-SERUM; PROLONGED APNEA; NEUROMUSCULAR BLOCKADE; CHOLINESTERASE; DEFICIENCY; COCAINE; ENZYME; ACETYLCHOLINESTERASE	Background: Concerns about the safety of paralytics such as succinylcholine to facilitate endotracheal intubation limit their use in prehospital and emergency department settings. The ability to rapidly reverse paralysis and restore respiratory drive would increase the safety margin of an agent, thus permitting the pursuit of alternative intubation strategies. In particular, patients who carry genetic or acquired deficiency of butyrylcholinesterase, the serum enzyme responsible for succinylcholine hydrolysis, are susceptible to succinylcholine-induced apnea, which manifests as paralysis, lasting hours beyond the normally brief half-life of succinylcholine. We hypothesized that intravenous administration of plant-derived recombinant BChE, which also prevents mortality in nerve agent poisoning, would rapidly reverse the effects of succinylcholine. Methods: Recombinant butyrylcholinesterase was produced in transgenic plants and purified. Further analysis involved murine and guinea pig models of succinylcholine toxicity. Animals were treated with lethal and sublethal doses of succinylcholine followed by administration of butyrylcholinesterase or vehicle. In both animal models vital signs and overall survival at specified intervals post succinylcholine administration were assessed. Results: Purified plant-derived recombinant human butyrylcholinesterase can hydrolyze succinylcholine in vitro. Challenge of mice with an LD100 of succinylcholine followed by BChE administration resulted in complete prevention of respiratory inhibition and concomitant mortality. Furthermore, experiments in symptomatic guinea pigs demonstrated extremely rapid succinylcholine detoxification with complete amelioration of symptoms and no apparent complications. Conclusions: Recombinant plant-derived butyrylcholinesterase was capable of counteracting and reversing apnea in two complementary models of lethal succinylcholine toxicity, completely preventing mortality. This study of a protein antidote validates the feasibility of protection and treatment of overdose from succinylcholine as well as other biologically active butyrylcholinesterase substrates.	[Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mor, TS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	tsafrir.mor@asu.edu			National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke [U-54-NSO58183-01];  [W81XWH-07-2-0023]	National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); 	This work was funded in part by the National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke under the U-54-NSO58183-01 award, a consortium grant awarded to USAMRICD and contracted to TM under the research cooperative agreement number W81XWH-07-2-0023. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Emergency Physicians (ACEP), 2011, Ann Emerg Med, V58, P113, DOI 10.1016/j.annemergmed.2011.05.005; Ashani Y, 2000, DRUG DEVELOP RES, V50, P298, DOI 10.1002/1098-2299(200007/08)50:3/4<298::AID-DDR13>3.3.CO;2-O; Barker I, 2003, ANAESTHESIA, V58, P1144, DOI 10.1046/j.1365-2044.2003.03516.x; BAULD HW, 1974, BRIT J ANAESTH, V46, P273, DOI 10.1093/bja/46.4.273; BAULD HW, 1983, CAN MED ASSOC J, V128, P894; BEVAN DR, 1983, CAN ANAESTH SOC J, V30, P536, DOI 10.1007/BF03007091; BODLEY PO, 1969, BRIT MED J, V3, P510, DOI 10.1136/bmj.3.5669.510; Bodur E, 2010, BIOCHIMIE, V92, P979, DOI 10.1016/j.biochi.2010.04.010; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Buyel JF, 2013, BIOENGINEERED, V4, P21, DOI 10.4161/bioe.21671; CHRISPIN P, 1995, LANCET, V345, P1248, DOI 10.1016/S0140-6736(95)92036-6; Davis DP, 2008, CAN MED ASSOC J, V178, P1171, DOI 10.1503/cmaj.080234; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Evron T, 2007, FASEB J, V21, P2961, DOI 10.1096/fj.07-8112com; FISHER DM, 1988, ANESTHESIOLOGY, V69, P757, DOI 10.1097/00000542-198811000-00020; FULLER BH, 1990, S AFR MED J, V78, P577; Gao Y, 2004, J PHARMACOL EXP THER, V310, P1046, DOI 10.1124/jpet.104.068122; Garello E, 1999, DIGEST DIS SCI, V44, P782, DOI 10.1023/A:1026678228967; GAULT DT, 1987, BURNS, V13, P208, DOI 10.1016/0305-4179(87)90168-9; GEORGE PM, 1988, CLIN BIOCHEM, V21, P159, DOI 10.1016/0009-9120(88)90003-3; Geyer BC, 2008, CHEM-BIOL INTERACT, V175, P376, DOI 10.1016/j.cbi.2008.04.012; Geyer BC, 2010, P NATL ACAD SCI USA, V107, P20251, DOI 10.1073/pnas.1009021107; Geyer BC, 2010, PLANT BIOTECHNOL J, V8, P873, DOI 10.1111/j.1467-7652.2010.00515.x; GILL RS, 1991, ANAESTHESIA, V46, P1036, DOI 10.1111/j.1365-2044.1991.tb09917.x; Gudzenko V, 2010, RESP CARE, V55, P1026; Hamamoto Yasushi, 2004, Radiat Med, V22, P316; Han TH, 2011, BRIT J ANAESTH, V106, P675, DOI 10.1093/bja/aer023; Harle CC, 2004, ANAESTHESIA, V59, P89, DOI 10.1111/j.1365-2044.2004.03585.x; Herbstritt A, 2012, EMERG MED J, V29, P256, DOI 10.1136/emermed-2012-201100.4; KAO YJ, 1989, ANESTHESIOLOGY, V70, P905, DOI 10.1097/00000542-198906000-00004; Koseoglu V, 1999, BONE MARROW TRANSPL, V24, P1367, DOI 10.1038/sj.bmt.1702097; KRAMER LP, 1982, CAN MED ASSOC J, V127, P1078; Lewis RJ, 1996, SAXS DANGEROUS PROPE; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; Lossius HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9973; Lurie S, 2007, REPROD SCI, V14, P192, DOI 10.1177/1933719107299871; Lynch TJ, 1997, TOXICOL APPL PHARM, V145, P363, DOI 10.1006/taap.1997.8187; Mace SE, 2008, EMERG MED CLIN N AM, V26, P1043, DOI 10.1016/j.emc.2008.10.002; Mallon WK, 2009, J EMERG MED, V37, P183, DOI 10.1016/j.jemermed.2008.07.021; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Masson P, 1997, BIOCHEMISTRY-US, V36, P2266, DOI 10.1021/bi962484a; Masson P, 2009, PROTEIN PEPTIDE LETT, V16, P1215, DOI 10.2174/092986609789071207; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; Merlin MA, 2010, PREHOSP DISASTER MED, V25, P341, DOI 10.1017/S1049023X00008311; METS B, 1990, S AFR MED J, V77, P311; Mollerup HM, 2011, ACTA ANAESTH SCAND, V55, P82, DOI 10.1111/j.1399-6576.2010.02316.x; Mor T.S., 2004, ENCY PLANT CROP SCI, P564; Niazi A, 2004, J CLIN ANESTH, V16, P40, DOI 10.1016/j.jclinane.2003.02.010; Norris JC, 2003, ANAESTHESIA, V58, P1137, DOI 10.1046/j.1365-2044.2003.03503.x; OSTERGAARD D, 1995, ANESTHESIOLOGY, V82, P1295, DOI 10.1097/00000542-199505000-00027; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Ruskin K, 2011, ANESTHESIA EMERGENCI; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Soliday Flanna K, 2010, AANA J, V78, P313; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Strayer RJ, 2010, J EMERG MED, V39, P345, DOI 10.1016/j.jemermed.2009.08.070; VIBYMOGENSEN J, 1978, ACTA ANAESTH SCAND, V22, P371, DOI 10.1111/j.1399-6576.1978.tb01313.x; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Zelicof-Paul A, 2005, CURR OPIN PEDIATR, V17, P355, DOI 10.1097/01.mop.0000162365.64140.b7; Zencirci B, 2010, INT J GEN MED, V3, P375, DOI 10.2147/IJGM.S14365; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955	62	6	7	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59159	10.1371/journal.pone.0059159	http://dx.doi.org/10.1371/journal.pone.0059159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536865	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100124
J	Grimsen, C; Brand, A; Fahle, M				Grimsen, Cathleen; Brand, Andreas; Fahle, Manfred			No Evidence for Prolonged Visible Persistence in Patients with Schizophrenia	PLOS ONE			English	Article							VISUAL BACKWARD-MASKING; PROCESSING DEFICITS; CONTEXTUAL SUPPRESSION; MEDICATION STATUS; SIMULTANEITY; SEGREGATION; SENSITIVITY; DYSFUNCTION; INTEGRATION; MECHANISM	Background: Temporal visual processing is strongly deteriorated in patients with schizophrenia. For example, the interval required between a visual stimulus and a subsequent mask has to be much longer in schizophrenic patients than in healthy controls. We investigated whether this deficit in temporal resolution is accompanied by prolonged visual persistence and/or deficient temporal precision (temporal asynchrony perception). Methodology/Principal Findings: We investigated visual persistence in three experiments. In the first, measuring temporal processing by so-called backward masking, prolonged visible persistence is supposed to decrease performance. In the second experiment, requiring temporal integration, prolonged persistence is supposed to improve performance. In the third experiment, we investigated asynchrony detection, as another measure of temporal resolution. Eighteen patients with schizophrenia and 15 healthy controls participated. Asynchrony detection was intact in the patients. However, patients' performance was inferior compared to healthy controls in the first two experiments. Hence, temporal processing in schizophrenic patients is indeed significantly impaired but this impairment is not caused by prolonged temporal integration. Conclusions/Significance: Our results argue against a generally prolonged visual persistence in patients with schizophrenia. Together with the preserved ability of patients, to detect temporal asynchronies in permanently presented stimuli, the results indicate a more specific deficit in temporal processing of schizophrenic patients.	[Grimsen, Cathleen; Fahle, Manfred] Univ Bremen, Dept Human Neurobiol, D-28359 Bremen, Germany; [Brand, Andreas] Klinikum Bremen Ost, Bremen, Germany; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London EC1V 0HB, England	University of Bremen; Klinikum Bremen-Ost; City University London	Grimsen, C (corresponding author), Univ Bremen, Dept Human Neurobiol, D-28359 Bremen, Germany.	cgrimsen@uni-bremen.de		Grimsen, Cathleen/0000-0003-3985-3695	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	CG was supported by Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Quality and Research, 1998, SCHIZ PAT OUTC RES T; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BRAFF DL, 1982, AM J PSYCHIAT, V139, P1127; Brand A, 2004, EUR ARCH PSY CLIN N, V254, P281, DOI 10.1007/s00406-004-0493-2; Brickenkamp R., 1994, D2 AUFMERKSAMKEITS B; Butler PD, 1996, BIOL PSYCHIAT, V40, P295, DOI 10.1016/0006-3223(96)00007-8; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Butler PD, 2001, AM J PSYCHIAT, V158, P1126, DOI 10.1176/appi.ajp.158.7.1126; Butler PD, 2003, SCHIZOPHR RES, V59, P199, DOI 10.1016/S0920-9964(01)00341-3; Cadenhead KS, 1998, BIOL PSYCHIAT, V43, P132, DOI 10.1016/S0006-3223(97)00316-8; Cadenhead KS, 1997, SCHIZOPHR RES, V28, P51, DOI 10.1016/S0920-9964(97)00085-6; Chkonia E, 2012, PSYCHIAT RES, V198, P235, DOI 10.1016/j.psychres.2012.02.020; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Declaration of Helsinki, 2002, NURS ETHICS, V9, P105; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Foucher JR, 2007, SCHIZOPHR RES, V97, P118, DOI 10.1016/j.schres.2007.08.013; Giersch A, 2009, SCHIZOPHRENIA BULL, V35, P816, DOI 10.1093/schbul/sbn016; Green MF, 2011, PSYCHOL MED, V41, P1489, DOI 10.1017/S003329171000214X; Green MF, 1999, AM J PSYCHIAT, V156, P1367; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P945; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P939; Green MF, 2011, SCHIZOPHRENIA BULL, V37, P700, DOI 10.1093/schbul/sbr051; Grimsen C, 2007, PSYCHIAT RES, V150, P237, DOI 10.1016/j.psychres.2006.03.021; Hahn B, 2011, SCHIZOPHRENIA BULL, V37, P950, DOI 10.1093/schbul/sbp164; Herzog MH, 2004, PSYCHIAT RES, V129, P55, DOI 10.1016/j.psychres.2004.06.008; HIEATT DJ, 1969, BRIT J PSYCHIAT, V115, P477, DOI 10.1192/bjp.115.521.477; HOGBEN JH, 1974, VISION RES, V14, P1059, DOI 10.1016/0042-6989(74)90202-8; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Kandil FI, 2001, EUR J NEUROSCI, V13, P2004, DOI 10.1046/j.0953-816x.2001.01573.x; Keri S, 2000, NEUROSCI LETT, V293, P69, DOI 10.1016/S0304-3940(00)01473-7; Keri S, 2002, J NEUROPSYCH CLIN N, V14, P190, DOI 10.1176/appi.neuropsych.14.2.190; Koelkebeck K, 2005, SCHIZOPHR RES, V78, P261, DOI 10.1016/j.schres.2005.01.017; Lehrl S., 1989, MEHRFACHWAHL WORTSCH; MERRITT RD, 1989, SCHIZOPHRENIA BULL, V15, P573, DOI 10.1093/schbul/15.4.573; Plomp G, 2012, SCHIZOPHR B; Rassovsky Y, 2004, SCHIZOPHR RES, V71, P485, DOI 10.1016/j.schres.2004.02.018; Roinishvili M, 2008, EUR ARCH PSY CLIN N, V258, P210, DOI 10.1007/s00406-007-0780-9; Roinishvili M, 2011, VISION RES, V51, P417, DOI 10.1016/j.visres.2010.12.011; SACCUZZO DP, 1974, J ABNORM PSYCHOL, V83, P512, DOI 10.1037/h0037072; SACCUZZO DP, 1986, SCHIZOPHRENIA BULL, V12, P447, DOI 10.1093/schbul/12.3.447; Schechter I, 2003, SCHIZOPHR RES, V64, P91, DOI 10.1016/S0920-9964(03)00008-2; SCHWARTZ BD, 1988, BIOL PSYCHIAT, V23, P3, DOI 10.1016/0006-3223(88)90101-1; SCHWARTZ BD, 1985, BIOL PSYCHIAT, V20, P1015, DOI 10.1016/0006-3223(85)90200-8; SCHWARTZ BD, 1994, BIOL PSYCHIAT, V36, P662, DOI 10.1016/0006-3223(94)91175-4; SCHWARTZ BD, 1983, BIOL PSYCHIAT, V18, P1311; SCHWARTZ BD, 1982, BIOL PSYCHIAT, V17, P1377; SCHWARTZ BD, 1988, BIOL PSYCHIAT, V23, P664, DOI 10.1016/0006-3223(88)90049-2; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P681, DOI 10.1093/schbul/sbr053; Slaghuis WL, 2004, EXP BRAIN RES, V156, P196, DOI 10.1007/s00221-003-1771-3; Slaghuis WL, 2001, EXP BRAIN RES, V138, P88, DOI 10.1007/s002210100683; Tam WCC, 2004, J NERV MENT DIS, V192, P464, DOI 10.1097/01.nmd.0000131805.72855.a3; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WEISS KM, 1992, PSYCHIAT RES, V44, P203, DOI 10.1016/0165-1781(92)90024-W; YATES AJ, 1966, ANNU REV PSYCHOL, V17, P111, DOI 10.1146/annurev.ps.17.020166.000551	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58940	10.1371/journal.pone.0058940	http://dx.doi.org/10.1371/journal.pone.0058940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WI	23536838	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100103
J	McMurry, AJ; Murphy, SN; MacFadden, D; Weber, G; Simons, WW; Orechia, J; Bickel, J; Wattanasin, N; Gilbert, C; Trevvett, P; Churchill, S; Kohane, IS				McMurry, Andrew J.; Murphy, Shawn N.; MacFadden, Douglas; Weber, Griffin; Simons, William W.; Orechia, John; Bickel, Jonathan; Wattanasin, Nich; Gilbert, Clint; Trevvett, Philip; Churchill, Susanne; Kohane, Isaac S.			SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; INTEGRATING BIOLOGY; CLINICAL-RESEARCH; MYOCARDIAL-INFARCTION; DISCOVERY RESEARCH; DIABETES-MELLITUS; PUBLIC-HEALTH; CARE; INFORMATICS; SYSTEM	Results of medical research studies are often contradictory or cannot be reproduced. One reason is that there may not be enough patient subjects available for observation for a long enough time period. Another reason is that patient populations may vary considerably with respect to geographic and demographic boundaries thus limiting how broadly the results apply. Even when similar patient populations are pooled together from multiple locations, differences in medical treatment and record systems can limit which outcome measures can be commonly analyzed. In total, these differences in medical research settings can lead to differing conclusions or can even prevent some studies from starting. We thus sought to create a patient research system that could aggregate as many patient observations as possible from a large number of hospitals in a uniform way. We call this system the 'Shared Health Research Information Network', with the following properties: (1) reuse electronic health data from everyday clinical care for research purposes, (2) respect patient privacy and hospital autonomy, (3) aggregate patient populations across many hospitals to achieve statistically significant sample sizes that can be validated independently of a single research setting, (4) harmonize the observation facts recorded at each institution such that queries can be made across many hospitals in parallel, (5) scale to regional and national collaborations. The purpose of this report is to provide open source software for multi-site clinical studies and to report on early uses of this application. At this time SHRINE implementations have been used for multi-site studies of autism co-morbidity, juvenile idiopathic arthritis, peripartum cardiomyopathy, colorectal cancer, diabetes, and others. The wide range of study objectives and growing adoption suggest that SHRINE may be applicable beyond the research uses and participating hospitals named in this report.	[McMurry, Andrew J.; MacFadden, Douglas; Simons, William W.; Gilbert, Clint; Trevvett, Philip; Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [McMurry, Andrew J.; Bickel, Jonathan; Kohane, Isaac S.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [McMurry, Andrew J.; Murphy, Shawn N.; Weber, Griffin; Churchill, Susanne; Kohane, Isaac S.] Brigham & Womens Hosp, Natl Ctr Biomed Comp I2b2, Boston, MA 02115 USA; [McMurry, Andrew J.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Murphy, Shawn N.; Wattanasin, Nich; Churchill, Susanne] Res Comp, Partners Healthcare Syst, Boston, MA 02215 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Weber, Griffin] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Weber, Griffin] Harvard Univ, Med Sch Informat Technol, Boston, MA 02115 USA; [Orechia, John] Dana Farber Canc Inst, Clin Res Informat Technol, Boston, MA 02115 USA; [Bickel, Jonathan] Childrens Hosp, Dept Informat Syst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	McMurry, AJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	Andrew_McMurry@hms.harvard.edu		Weber, Griffin/0000-0002-2597-881X; mcmurry, andy/0000-0001-5604-0704	CTSA award (National Institutes of Health/National Center for Research Resources NIH/NCRR) [1UL1RR025758-01]; i2b2 National Center for Biomedical Computing [NIH/NLM U54 LM008748]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	CTSA award (National Institutes of Health/National Center for Research Resources NIH/NCRR); i2b2 National Center for Biomedical Computing; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded in part by the CTSA award (National Institutes of Health/National Center for Research Resources NIH/NCRR 1UL1RR025758-01) and the i2b2 National Center for Biomedical Computing (NIH/NLM U54 LM008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2012, CLIN CLASS SOFTW CCS; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Anderson N, 2011, J AM MED INFORM ASS; Arday DR, 2002, DIABETES CARE, V25, P2230, DOI 10.2337/diacare.25.12.2230; Ashish Naveen, 2010, Front Neuroinform, V4, P118, DOI 10.3389/fninf.2010.00118; Barrat A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228701; Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Brown J, 2009, EFFECTIVE HLTH CARE; Brown JS, 2010, MED CARE, V48, pS45, DOI 10.1097/MLR.0b013e3181d9919f; Brownstein JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000840; CDC, 2011, DIAB SUCC OPP POP BA; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Deshmukh VG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-70; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; FDA website, 1999, DRUG APPR PACK AV RO; Ganslandt T, 2010, APPL CLIN INFORM, P116; Goryachev Sergey, 2008, AMIA Annu Symp Proc, P247; Halevy A., 2006, P 32 INT C VERY LARG, P9; Halevy AY, 2001, VLDB J, V10, P270, DOI 10.1007/s007780100054; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Himes BE, 2009, J AM MED INFORM ASSN, V16, P371, DOI 10.1197/jamia.M2846; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Kohane IS, 2012, J AM MED INFORM ASSN, V19, P181, DOI 10.1136/amiajnl-2011-000492; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mantas G, 2012, J MED SYST, V36, P1107, DOI 10.1007/s10916-010-9573-1; McCusker JP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S2; McMurry AJ, 2007, J AM MED INFORM ASSN, V14, P527, DOI 10.1197/jamia.M2371; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Murphy SN, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P552; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Natter MD, 2012, J AM MED INFORM ASS; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ota Sylvia, 2008, Pediatr Rheumatol Online J, V6, P5, DOI 10.1186/1546-0096-6-5; Palchuk Matvey B, 2010, AMIA Annu Symp Proc, V2010, P577; Patel AA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-37; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409; Prasad V, 2011, FREQUENCY MED REVERS; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Prokosch HU, 2009, METHOD INFORM MED, V48, P38, DOI 10.3414/ME9132; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Reis BY, 2007, J AM MED INFORM ASSN, V14, P581, DOI 10.1197/jamia.M2342; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schadow Gunther, 2003, AMIA Annu Symp Proc, P584; Sherborne AL, 2011, HAEMATOL-HEMATOL J, V96, P1049, DOI 10.3324/haematol.2011.040121; SHRINE Open Source Website, 2011, HARV CAT; Standards and Interoperability Framework, 2012, QUER HLTH REF MAT; Stevens R, 2000, BIOINFORMATICS, V16, P184, DOI 10.1093/bioinformatics/16.2.184; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Tong TJ, 2008, STAT MED, V27, P1960, DOI 10.1002/sim.3237; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; World Wide Web Consortium website, 2008, XML SIGN SYNT PROC; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30	68	80	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e55811	10.1371/journal.pone.0055811	http://dx.doi.org/10.1371/journal.pone.0055811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23533569	Green Published, gold			2022-12-27	WOS:000318334500004
J	Barrow, H; Tam, B; Duckworth, CA; Rhodes, JM; Yu, LG				Barrow, Hannah; Tam, Benjamin; Duckworth, Carrie A.; Rhodes, Jonathan M.; Yu, Lu-Gang			Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer Cells	PLOS ONE			English	Article							FRIEDENREICH CARBOHYDRATE ANTIGEN; O-GLYCOSYLATION; BREAST-CANCER; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; CIRCULATING GALECTIN-3; PROTEIN GLYCOSYLATION; COLORECTAL-CANCER; GOLGI-APPARATUS; CARCINOMA-CELLS; GENE FAMILY	It has long been presumed, though with surprisingly little evidence, a competition between Core 1 Gal-transferase (C1GalT), Core 3 GlcNAc-transferase (C3GnT) and sialyl-transferase (ST6GalNAc-T) for elongation of O-linked mucin-type glycans initiated with GalNAc alpha-Ser/Thr. This study tested this presumption by selective suppression of one of these glycosyltransferases and then analysed the expressions of the enzymatic products of the other three glycosyltransferases. It was found that siRNA suppression of C1GalT markedly reduced the expression of Gal beta 1,3GalNAc alpha- (Core 1) and in the meantime increased the expressions of sialyl-GalNAc alpha- (sialyl-Tn), GalNAc alpha- (Tn) and GlcNAc beta 1,3GalNAc alpha-(Core 3)-associated glycans in human colon cancer HT29 and SW620 cells. This supports a competitive modification of the GalNAc alpha-Ser/Thr between C1GalT, C3GnT and ST6GalNAc-T in O-glycan biosynthesis. As Tn, TF and sialyl-Tn are oncofetal antigens and are over-expressed in most human cancers, this information is useful for the development of glycosyltransferase-targeted therapeutic strategies for cancer treatment.	[Barrow, Hannah; Tam, Benjamin; Duckworth, Carrie A.; Rhodes, Jonathan M.; Yu, Lu-Gang] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Yu, LG (corresponding author), Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England.	lgyu@liv.ac.uk	Duckworth, Carrie/AAC-8361-2020; Duckworth, Carrie A/K-7302-2014	Duckworth, Carrie/0000-0001-9992-7540; Duckworth, Carrie A/0000-0001-9992-7540	North West Cancer Research Fund [CR777]; University of PhD Studentship	North West Cancer Research Fund; University of PhD Studentship	This work was supported in part by a grant (CR777) from the North West Cancer Research Fund and a University of PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bieberich E, 2000, J NEUROCHEM, V74, P2359, DOI 10.1046/j.1471-4159.2000.0742359.x; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Campbell B, 2001, SMITHSONIAN, V32, P18; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Desai PR, 1995, J IMMUNOL METHODS, V188, P175, DOI 10.1016/0022-1759(95)00246-4; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; HUET G, 1995, J CELL SCI, V108, P1275; IKEDA Y, 1993, CANCER RES, V53, P1706; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kellokumpu S, 2002, FEBS LETT, V516, P217, DOI 10.1016/S0014-5793(02)02535-8; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Nakagoe T, 2000, ONCOLOGY-BASEL, V59, P131, DOI 10.1159/000012150; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Takeuchi H, 2002, EUR J BIOCHEM, V269, P6173, DOI 10.1046/j.1432-1033.2002.03334.x; Terasawa K, 1996, CANCER RES, V56, P2229; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5; Yu LG, 1997, INT J CANCER, V73, P424, DOI 10.1002/(SICI)1097-0215(19971104)73:3<424::AID-IJC18>3.3.CO;2-C; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	43	21	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59792	10.1371/journal.pone.0059792	http://dx.doi.org/10.1371/journal.pone.0059792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536887	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200035
J	Cropper, SJ; Kvansakul, JGS; Little, DR				Cropper, Simon J.; Kvansakul, Jessica G. S.; Little, Daniel R.			The Categorisation of Non-Categorical Colours: A Novel Paradigm in Colour Perception	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; REFLECTANCE SPECTRA; EXEMPLAR-RETRIEVAL; RESPONSE SPECTRA; SIMILARITY; VISION; UNIQUE; IDENTIFICATION; GENICULATE; LANGUAGE	In this paper, we investigate a new paradigm for studying the development of the colour 'signal' by having observers discriminate and categorize the same set of controlled and calibrated cardinal coloured stimuli. Notably, in both tasks, each observer was free to decide whether two pairs of colors were the same or belonged to the same category. The use of the same stimulus set for both tasks provides, we argue, an incremental behavioural measure of colour processing from detection through discrimination to categorisation. The measured data spaces are different for the two tasks, and furthermore the categorisation data is unique to each observer. In addition, we develop a model which assumes that the principal difference between the tasks is the degree of similarity between the stimuli which has different constraints for the categorisation task compared to the discrimination task. This approach not only makes sense of the current (and associated) data but links the processes of discrimination and categorisation in a novel way and, by implication, expands upon the previous research linking categorisation to other tasks not limited to colour perception.	[Cropper, Simon J.; Kvansakul, Jessica G. S.; Little, Daniel R.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Cropper, SJ (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	scropper@unimelb.edu.au	Little, Daniel/J-5034-2019	Little, Daniel/0000-0003-3607-5525; Cropper, Simon James/0000-0002-3574-6414; Kvansakul, Jessica/0000-0003-3019-1832	ARC [DP120103120]	ARC(Australian Research Council)	This work was supported by an ARC Discovery Project Grant DP120103120 to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney WD, 1909, P R SOC LOND A-CONTA, V83, P120; Anstis SM, 1983, COLOUR VISION PHYSL, P154; ASHBY FG, 1991, J EXP PSYCHOL GEN, V120, P150, DOI 10.1037/0096-3445.120.2.150; Berlin B., 1969, BASIC COLOR TERMS TH; BORNSTEIN MH, 1973, PSYCHOL BULL, V80, P257, DOI 10.1037/h0034837; BOYNTON RM, 1988, ANNU REV PSYCHOL, V39, P69, DOI 10.1146/annurev.ps.39.020188.000441; Boynton RM, 1975, HDB PERCEPTION, P302; Boynton RM, 1978, HDB PERCEPTION; BURNS SA, 1984, VISION RES, V24, P479, DOI 10.1016/0042-6989(84)90045-2; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; Chichilnisky EJ, 1999, VISION RES, V39, P3444, DOI 10.1016/S0042-6989(99)00033-4; Cohen AL, 2000, J EXP PSYCHOL HUMAN, V26, P1549, DOI 10.1037/0096-1523.26.5.1549; Conway BR, 2009, NEUROSCIENTIST, V15, P274, DOI 10.1177/1073858408331369; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; Cropper SJ, 2006, VISION RES, V46, P724, DOI 10.1016/j.visres.2005.06.034; Cropper SJ, 2005, VISION RES, V45, P865, DOI 10.1016/j.visres.2004.09.043; Cropper SJ, 1996, VISION RES, V36, P2475, DOI 10.1016/0042-6989(95)00299-5; Cropper SJ, 2013, PLOS ONE UNPUB; Danilova MV, 2012, VISION RES, V62, P162, DOI 10.1016/j.visres.2012.04.006; Danilova MV, 2012, J OPT SOC AM A, V29, pA157, DOI 10.1364/JOSAA.29.00A157; Danilova MV, 2010, J VISION, V10, DOI 10.1167/10.1.4; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; DAVIDOFF J, 1986, PERCEPT PSYCHOPHYS, V40, P391, DOI 10.3758/BF03208198; Davidoff J, 2001, TRENDS COGN SCI, V5, P382, DOI 10.1016/S1364-6613(00)01726-5; Davidoff J, 2012, J COGN PSYCHOL, V24, P871, DOI 10.1080/20445911.2012.706603; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P512, DOI 10.1073/pnas.97.1.512; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Eskew RT, 2009, VISION RES, V49, P2686, DOI 10.1016/j.visres.2009.07.005; Fific M, 2008, J EXP PSYCHOL HUMAN, V34, P356, DOI 10.1037/0096-1523.34.2.356; FINDLAY JM, 1978, PERCEPT PSYCHOPHYS, V23, P181, DOI 10.3758/BF03208300; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Goldstone R. L., 2010, INTERDISCIPLINARY RE, V1, P65; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Green DM, 1966, SIGNAL DETECTION THE; Guild J, 1932, PHILOS T R SOC LOND, V230, P149, DOI 10.1098/rsta.1932.0005; Hansen T, 2009, J VIS, V9, p26 21; Hansen T, 2007, J VISION, V7, DOI 10.1167/7.4.2; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Heit E, 2005, J EXP PSYCHOL GEN, V134, P596, DOI 10.1037/0096-3445.134.4.596; Heit E, 2012, PSYCHOL LEARNING MOT; Heit E, 2011, J EXP PSYCHOL GEN, V140, P76, DOI 10.1037/a0021488; Helmholtz H. v., 1925, HELMHOLTZS TREATISE; Hering E., 1878, LEHRE LICHTSINN; Hering E., 1964, OUTLINES THEORY LIGH; Hine TJ, 2012, LAB APPL COGNITIVE R, P175; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Horwitz GD, 2012, NAT NEUROSCI; HURVICH LEO M., 1955, TRANS NEW YORK ACAD SCI, V18, P33; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Hv Helmholtz, 1896, HDB PHYSL OPTIK; INDOW T, 1988, PSYCHOL REV, V95, P456, DOI 10.1037/0033-295X.95.4.456; INDOW T, 1960, J EXP PSYCHOL, V59, P330, DOI 10.1037/h0044796; Indow T, 1972, COLOR METRICS; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; KRAUSKOPF J, 1992, VISION RES, V32, P2165, DOI 10.1016/0042-6989(92)90077-V; KRAUSKOPF J, 1965, SCIENCE, V150, P1477, DOI 10.1126/science.150.3702.1477; Krauskopf J, 1999, COLOR VISION GENES P, P149; LENNIE P, 1990, J NEUROSCI, V10, P649; Little DR, J EXPT PSYCHOL LEARN; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Macmillan N. A., 1991, DETECTION THEORY USE; Maddox WT, 1996, J EXP PSYCHOL HUMAN, V22, P795, DOI 10.1037/0096-1523.22.4.795; Malkoc G, 2012, VISION RES, V62, P75, DOI 10.1016/j.visres.2012.03.018; Marr D., 1982, VISION COMPUTATIONAL; McDermott KC, 2012, J OPT SOC AM A, V29, pA182, DOI 10.1364/JOSAA.29.00A182; Munsell Albert, 1915, ATLAS MUNSELL COLOR; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Nosofsky RM, 1997, PERCEPT PSYCHOPHYS, V59, P1027, DOI 10.3758/BF03205518; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Nosofsky RM, 2012, P NATL ACAD SCI USA, V109, P333, DOI 10.1073/pnas.1111304109; Nosofsky RM, 2011, PSYCHOL REV, V118, P280, DOI 10.1037/a0022494; Ozgen E, 2004, CURR DIR PSYCHOL SCI, V13, P95, DOI 10.1111/j.0963-7214.2004.00282.x; Ozgen E, 2002, J EXP PSYCHOL GEN, V131, P477, DOI 10.1037//0096-3445.131.4.477; Pilling M, 2003, MEM COGNITION, V31, P538, DOI 10.3758/BF03196095; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Romney AK, 2005, P NATL ACAD SCI USA, V102, P16512, DOI 10.1073/pnas.0508172102; Romney AK, 2005, P NATL ACAD SCI USA, V102, P9720, DOI 10.1073/pnas.0503887102; Saunders BAC, 1997, BEHAV BRAIN SCI, V20, P167, DOI 10.1017/S0140525X97001428; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seaborn M, 2005, PATTERN RECOGN, V38, P165, DOI 10.1016/j.patcog.2004.05.001; Shepard R.N., 1992, ADAPTED MIND EVOLUTI, P495; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; SMITH VC, 1972, VISION RES, V12, P2059, DOI 10.1016/0042-6989(72)90058-2; Smithson HE, 2006, VISUAL NEUROSCI, V23, P453, DOI 10.1017/S0952523806233388; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Travis D, 1991, EFFECTIVE COLOR DISP; Valberg A, 2001, VISION RES, V41, P1645, DOI 10.1016/S0042-6989(01)00041-4; WAGNER G, 1972, J OPT SOC AM, V62, P1508, DOI 10.1364/JOSA.62.001508; Wandell BA, 2012, NAT NEUROSCI, V15, P809, DOI 10.1038/nn.3124; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; Webster MA, 2000, J OPT SOC AM A, V17, P1535, DOI 10.1364/JOSAA.17.001535; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WEBSTER MA, 1994, VISION RES, V34, P1993, DOI 10.1016/0042-6989(94)90028-0; Wright O, 2011, NEW DIRECTIONS IN COLOUR STUDIES, P265; Wright W.D., 1929, T OPTICAL SOC, V30, P141, DOI [10.1088/1475-4878/30/4/301, DOI 10.1088/1475-4878/30/4/301]; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G., 1967, COLOR SCI	108	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59945	10.1371/journal.pone.0059945	http://dx.doi.org/10.1371/journal.pone.0059945			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536899	Green Published, gold			2022-12-27	WOS:000317397200047
J	Wolter, T; Steinbrecher, T; Elstner, M				Wolter, Tino; Steinbrecher, Thomas; Elstner, Marcus			Computational Study of Synthetic Agonist Ligands of Ionotropic Glutamate Receptors	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY CALCULATIONS; BINDING DOMAIN; AMPA RECEPTOR; CONFORMATIONAL-CHANGES; ION CHANNELS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; ACTIVATION; GLUR2	Neurological glutamate receptors are among the most important and intensely studied protein ligand binding systems in humans. They are crucial for the functioning of the central nervous system and involved in a variety of pathologies. Apart from the neurotransmitter glutamate, several artificial, agonistic and antagonistic ligands are known. Of particular interest here are novel photoswitchable agonists that would open the field of optogenetics to glutamate receptors. The receptor proteins are complex, membrane-bound multidomain oligomers that undergo large scale functional conformational changes, making detailed studies of their atomic structure challenging. Therefore, a thorough understanding of the microscopic details of ligand binding and receptor activation remains elusive in many cases. This topic has been successfully addressed by theoretical studies in the past and in this paper, we present extensive molecular dynamics simulation and free energy calculation results on the binding of AMPA and an AMPA derivative, which is the basis for designing light-sensitive ligands. We provide a two-step model for ligand binding domain activation and predict binding free energies for novel compounds in good agreement to experimental observations.	[Wolter, Tino; Steinbrecher, Thomas; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany.	marcus.elstner@kit.edu	Elstner, Marcus/H-3463-2013		Deutsche Forschungsgemeinschaft [FOR 1279]; Baden-Wurttemberg Stiftung by the Eliteprogramme for Postdocs	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung by the Eliteprogramme for Postdocs	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 1279, "Protein-based Photoswitches"). TS is indebted to the Baden-Wurttemberg Stiftung for the financial support of this research project by the Eliteprogramme for Postdocs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2007, J BIOL CHEM; Arinaminpathy Y, 2002, BIOPHYS J, V82, P676, DOI 10.1016/S0006-3495(02)75430-1; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Asztely F, 1996, MOL NEUROBIOL, V12, P1, DOI 10.1007/BF02740744; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bjerrum EJ, 2008, PROTEINS, V72, P434, DOI 10.1002/prot.21941; Bondar AN, 2008, J PHYS CHEM B, V112, P14729, DOI 10.1021/jp801916f; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Foster AC, 2006, CURR OPIN PHARMACOL, V6, P7, DOI 10.1016/j.coph.2005.11.005; Frydenvang K, 2009, J BIOL CHEM, V284, P14219, DOI 10.1074/jbc.M808547200; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Giudice E, 2003, NUCLEIC ACIDS RES, V31, P1434, DOI 10.1093/nar/gkg239; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Holm MM, 2005, P NATL ACAD SCI USA, V102, P12053, DOI 10.1073/pnas.0505522102; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jayaraman V, 2000, FEBS LETT, V475, P278, DOI 10.1016/S0014-5793(00)01690-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaye SL, 2006, J BIOL CHEM, V281, P12736, DOI 10.1074/jbc.M512728200; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kubo M, 2004, PROTEINS, V56, P411, DOI 10.1002/prot.20154; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Lee MS, 2006, BIOPHYS J, V90, P864, DOI 10.1529/biophysj.105.071589; Leitgeb M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1850900; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Mendieta J, 2005, BIOCHEMISTRY-US, V44, P14470, DOI 10.1021/bi051084x; Mendieta J, 2001, PROTEINS, V44, P460, DOI 10.1002/prot.1111; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Numano R, 2009, P NATL ACAD SCI USA, V106, P6814, DOI 10.1073/pnas.0811899106; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pietropaolo A, 2011, J COMPUT CHEM, V32, P2627, DOI 10.1002/jcc.21842; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Ravindranathan KP, 2005, J MOL BIOL, V353, P196, DOI 10.1016/j.jmb.2005.08.009; Speranskiy K, 2005, BIOCHEMISTRY-US, V44, P11508, DOI 10.1021/bi050547w; Spiwok V, 2010, CARBOHYD RES, V345, P530, DOI 10.1016/j.carres.2009.12.011; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Vogensen SB, 2007, J MED CHEM, V50, P2408, DOI 10.1021/jm061439q; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	60	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58774	10.1371/journal.pone.0058774	http://dx.doi.org/10.1371/journal.pone.0058774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536824	Green Submitted, gold, Green Published			2022-12-27	WOS:000317397200010
J	Luo, HM; Yang, AM; Schulte, BA; Wargovich, MJ; Wang, GY				Luo, Hongmei; Yang, Aimin; Schulte, Bradley A.; Wargovich, Michael J.; Wang, Gavin Y.			Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage	PLOS ONE			English	Article							PERSISTENT OXIDATIVE STRESS; ONCOGENE-INDUCED SENESCENCE; TUMOR-CELLS; IN-VIVO; CELLULAR SENESCENCE; INDUCED APOPTOSIS; ACCELERATED SENESCENCE; MOLECULAR-MECHANISMS; PANCREATIC-CANCER; HYDROGEN-PEROXIDE	Resveratrol (RV) is a natural component of red wine and grapes that has been shown to be a potential chemopreventive and anticancer agent. However, the molecular mechanisms underlying RV's anticancer and chemopreventive effects are incompletely understood. Here we show that RV treatment inhibits the clonogenic growth of non-small cell lung cancer (NSCLC) cells in a dose-dependent manner. Interestingly, the tumor-suppressive effect of low dose RV was not associated with any significant changes in the expression of cleaved PARP and activated caspase-3, suggesting that low dose RV treatment may suppress tumor cell growth via an apoptosis-independent mechanism. Subsequent studies reveal that low dose RV treatment induces a significant increase in senescence-associated beta-galactosidase (SA-beta-gal) staining and elevated expression of p53 and p21 in NSCLC cells. Furthermore, we show that RV-induced suppression of lung cancer cell growth is associated with a decrease in the expression of EF1A. These results suggest that RV may exert its anticancer and chemopreventive effects through the induction of premature senescence. Mechanistically, RV-induced premature senescence correlates with increased DNA double strand breaks (DSBs) and reactive oxygen species (ROS) production in lung cancer cells. Inhibition of ROS production by N-acetylcysteine (NAC) attenuates RV-induced DNA DSBs and premature senescence. Furthermore, we show that RV treatment markedly induces NAPDH oxidase-5 (Nox5) expression in both A549 and H460 cells, suggesting that RV may increase ROS generation in lung cancer cells through upregulating Nox5 expression. Together, these findings demonstrate that low dose RV treatment inhibits lung cancer cell growth via a previously unappreciated mechanism, namely the induction of premature senescence through ROS-mediated DNA damage.	[Luo, Hongmei; Yang, Aimin; Schulte, Bradley A.; Wang, Gavin Y.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Wargovich, Michael J.] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Wang, GY (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	wangy@musc.edu			NIH [CA138313, HL106451]; American Cancer Society Institutional Research Grant [IRG-97-219-08]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants CA138313 and HL106451 (www.nih.gov). This work was also supported in part by an American Cancer Society Institutional Research Grant (#IRG-97-219-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami AS, 2006, FEBS LETT, V580, P533, DOI 10.1016/j.febslet.2005.12.059; Azmi AS, 2005, FEBS LETT, V579, P3131, DOI 10.1016/j.febslet.2005.04.077; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Bhat KPL, 2001, CANCER RES, V61, P7456; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; Cui J, 2010, PHYTOTHER RES, V24, P1637, DOI 10.1002/ptr.3157; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fukuhara K, 2006, BIOORGAN MED CHEM, V14, P1437, DOI 10.1016/j.bmc.2005.09.070; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Guha P, 2011, J PHARMACOL EXP THER, V336, P206, DOI 10.1124/jpet.110.171983; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Harikumar KB, 2010, INT J CANCER, V127, P257, DOI 10.1002/ijc.25041; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Hussain AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024703; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang H, 2005, MOL CANCER THER, V4, P554, DOI 10.1158/1535-7163.MCT-04-0056; Jones KR, 2005, INT J RADIAT BIOL, V81, P445, DOI 10.1080/09553000500168549; Kao CL, 2009, INT J RADIAT ONCOL, V74, P219, DOI 10.1016/j.ijrobp.2008.12.035; Kim A, 2010, FREE RADICAL BIO MED, V48, P1501, DOI 10.1016/j.freeradbiomed.2010.02.028; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Rajamanickam S, 2008, DRUG DEVELOP RES, V69, P460, DOI 10.1002/ddr.20276; Robb EL, 2008, BIOCHEM BIOPH RES CO, V367, P406, DOI 10.1016/j.bbrc.2007.12.138; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Sale S, 2005, INT J CANCER, V115, P194, DOI 10.1002/ijc.20884; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; SZATROWSKI TP, 1991, CANCER RES, V51, P794; te Poele RH, 2002, CANCER RES, V62, P1876; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Velioglu-Ogunc A, 2009, FREE RADICAL RES, V43, P1060, DOI 10.1080/10715760903171100; Wang Y, 2004, EXP CELL RES, V298, P188, DOI 10.1016/j.yexcr.2004.04.012; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Whitlock NC, 2011, CANCER PREV RES, V4, P116, DOI 10.1158/1940-6207.CAPR-10-0218; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Zhang LX, 2010, EXP CELL RES, V316, P716, DOI 10.1016/j.yexcr.2009.12.008; Zhu W, 2012, FREE RADICAL BIO MED, V52, P314, DOI 10.1016/j.freeradbiomed.2011.10.483	59	119	124	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60065	10.1371/journal.pone.0060065	http://dx.doi.org/10.1371/journal.pone.0060065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533664	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400101
J	Wheeler, D; Redding, AJ; Werren, JH				Wheeler, David; Redding, Amanda J.; Werren, John H.			Characterization of an Ancient Lepidopteran Lateral Gene Transfer	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SILKWORM; EVOLUTION; BACTERIA; INSECTS; RNA	Bacteria to eukaryote lateral gene transfers (LGT) are an important potential source of material for the evolution of novel genetic traits. The explosion in the number of newly sequenced genomes provides opportunities to identify and characterize examples of these lateral gene transfer events, and to assess their role in the evolution of new genes. In this paper, we describe an ancient lepidopteran LGT of a glycosyl hydrolase family 31 gene (GH31) from an Enterococcus bacteria. PCR amplification between the LGT and a flanking insect gene confirmed that the GH31 was integrated into the Bombyx mori genome and was not a result of an assembly error. Database searches in combination with degenerate PCR on a panel of 7 lepidopteran families confirmed that the GH31 LGT event occurred deep within the Order approximately 65-145 million years ago. The most basal species in which the LGT was found is Plutella xylostella (superfamily: Yponomeutoidea). Array data from Bombyx mori shows that GH31 is expressed, and low dN/dS ratios indicates the LGT coding sequence is under strong stabilizing selection. These findings provide further support for the proposition that bacterial LGTs are relatively common in insects and likely to be an underappreciated source of adaptive genetic material.	[Wheeler, David; Redding, Amanda J.; Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Wheeler, D (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	dwheelerau@gmail.com; werr@mail.rochester.edu		Werren, John/0000-0001-9353-2070; Wheeler, David/0000-0001-5538-8119	National Science Foundation [DEB0821936]; National Institutes of Health [GM084917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM084917] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Science Foundation DEB0821936 and National Institutes of Health GM084917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Altincicek B, 2012, BIOL LETTERS, V8, P253, DOI 10.1098/rsbl.2011.0704; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Craig JP, 2008, MOL BIOL EVOL, V25, P2085, DOI 10.1093/molbev/msn141; Dai H, 2008, ACTA BIOCH BIOPH SIN, V40, P790, DOI 10.1093/abbs/40.9.790; Doudoumis V, 2013, J INVERTEBR PATHOL, V112, pS94, DOI 10.1016/j.jip.2012.05.010; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Eskandari R, 2011, CHEM-EUR J, V17, P14817, DOI 10.1002/chem.201102109; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Grimaldi G., 2005, EVOLUTION INSECTS; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Li ZW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-356; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rhainds M, 2009, ANNU REV ENTOMOL, V54, P209, DOI 10.1146/annurev.ento.54.110807.090448; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-248	37	33	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59262	10.1371/journal.pone.0059262	http://dx.doi.org/10.1371/journal.pone.0059262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533610	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400047
J	Cui, W; Ma, J; Wang, XQ; Yang, WJ; Zhang, J; Ji, QH				Cui, Wei; Ma, Jie; Wang, Xingqin; Yang, Wenjuan; Zhang, Jing; Ji, Qiuhe			Free Fatty Acid Induces Endoplasmic Reticulum Stress and Apoptosis of beta-cells by Ca2+/Calpain-2 Pathways	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; HUMAN PANCREATIC-ISLETS; LONG-TERM EXPOSURE; DIABETES-MELLITUS; CALPAIN SYSTEM; RAT ISLETS; GLUCOSE; ACTIVATION; PALMITATE; DEATH	Dysfunction of beta-cells is a major characteristic in the pathogenesis of type 2 diabetes mellitus (T2DM). The combination of obesity and T2DM is associated with elevated plasma free fatty acids (FFAs). However, molecular mechanisms linking FFAs to beta-cell dysfunction remain poorly understood. In the present study, we identified that the major endoplasmic reticulum stress (ERS) marker, Grp78 and ERS-induced apoptotic factor, CHOP, were time-dependently increased by exposure of beta-TC3 cells to FFA. The expression of ATF6 and the phosphorylation levels of PERK and IRE1, which trigger ERS signaling, markedly increased after FFA treatments. FFA treatments increased cell apoptosis by inducing ERS in beta-TC3 cells. We also found that FFA-induced ERS was mediated by the store-operated Ca2+ entry through promoting the association of STIM1 and Orai1. Moreover, calpain-2 was required for FFA-induced expression of CHOP and activation of caspase-12 and caspase-3, thus promoting cell apoptosis in beta-TC3 cells. Together, these results reveal pivotal roles for Ca2+/calpain-2 pathways in modulating FFA-induced beta-TC3 cell ERS and apoptosis.	[Cui, Wei; Yang, Wenjuan; Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China; [Ma, Jie; Wang, Xingqin] Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China; [Zhang, Jing] 371 Cent Hosp Peoples Liberat Army, Xinxiang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ji, QH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China.	jqiuhe@fmmu.edu.cn			National Natural Science Foundation of China [30870948]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (30870948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bikopoulos G, 2008, J ENDOCRINOL, V196, P455, DOI 10.1677/JOE-07-0174; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; GROMADA J, 1995, DIABETOLOGIA, V38, P1025, DOI 10.1007/BF00402171; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Mason TM, 1999, DIABETES, V48, P524, DOI 10.2337/diabetes.48.3.524; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; RANDLE PJ, 1963, LANCET, V1, P785; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Shi YF, 2010, CARDIOVASC TOXICOL, V10, P153, DOI 10.1007/s12012-010-9073-z; Song YQ, 2007, HUM MOL GENET, V16, P2960, DOI 10.1093/hmg/ddm256; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Xu LJ, 2006, J BIOL CHEM, V281, P35567, DOI 10.1074/jbc.M607702200; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	56	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59921	10.1371/journal.pone.0059921	http://dx.doi.org/10.1371/journal.pone.0059921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527285	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600106
J	Faiao-Flores, F; Coelho, PRP; Arruda-Neto, JDT; Maria-Engler, SS; Tiago, M; Capelozzi, VL; Giorgi, RR; Maria, DA				Faiao-Flores, Fernanda; Pinto Coelho, Paulo Rogerio; Toledo Arruda-Neto, Joao Dias; Maria-Engler, Silvya Stuchi; Tiago, Manoela; Capelozzi, Vera Luiza; Giorgi, Ricardo Rodrigues; Maria, Durvanei Augusto			Apoptosis through Bcl-2/Bax and Cleaved Caspase Up-Regulation in Melanoma Treated by Boron Neutron Capture Therapy	PLOS ONE			English	Article							COLLAGEN; CELLS; SUPERFAMILY; IRRADIATION; INHIBITION; EXPRESSION; MICROSCOPY; PATHWAYS; PROTEIN; GLIOMA	Boron neutron capture therapy (BNCT) is a binary treatment involving selective accumulation of boron carriers in a tumor followed by irradiation with a thermal or epithermal neutron beam. The neutron capture reaction with a boron-10 nucleus yields high linear energy transfer (LET) particles, alpha and Li-7, with a range of 5 to 9 mu m. These particles can only travel very short distances and release their damaging energy directly into the cells containing the boron compound. We aimed to evaluate proliferation, apoptosis and extracellular matrix (ECM) modifications of B16F10 melanoma and normal human melanocytes after BNCT. The amounts of soluble collagen and Hsp47, indicating collagen synthesis in the ECM, as well as the cellular markers of apoptosis, were investigated. BNCT decreased proliferation, altered the ECM by decreasing collagen synthesis and induced apoptosis by regulating Bcl-2/Bax in melanoma. Additionally, BNCT also increased the levels of TNF receptor and the cleaved caspases 3, 7, 8 and 9 in melanoma. These results suggest that multiple pathways related to cell death and cell cycle arrest are involved in the treatment of melanoma by BNCT.	[Faiao-Flores, Fernanda; Maria, Durvanei Augusto] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Faiao-Flores, Fernanda; Capelozzi, Vera Luiza] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Pinto Coelho, Paulo Rogerio] Inst Nucl & Energy Res, Sao Paulo, Brazil; [Toledo Arruda-Neto, Joao Dias] Univ Sao Paulo, Inst Phys, Sao Paulo, Brazil; [Toledo Arruda-Neto, Joao Dias] CEPESq Unitalo Italy Brazilian Univ Ctr, Sao Paulo, Brazil; [Maria-Engler, Silvya Stuchi; Tiago, Manoela] Univ Sao Paulo, Dept Clin Chem & Toxicol, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Giorgi, Ricardo Rodrigues] Univ Sao Paulo, Sch Med, Lab Cellular & Mol Endocrinol LIM 25, Sao Paulo, Brazil; [Giorgi, Ricardo Rodrigues] Santo Amaro Univ UNISA, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Maria, DA (corresponding author), Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil.	durvanei@usp.br	Capelozzi, Vera Luiza/C-6363-2013; Engler, Silvya Stuchi Maria/K-5936-2016; Giorgi, Ricardo/J-3504-2012; , Capelozzi/N-1737-2019; GIORGI, RICARDO RODRIGUES/S-2384-2019; Faião-Flores, Fernanda/F-7111-2012; Maria-Engler, Silvya/ABC-2016-2020	Engler, Silvya Stuchi Maria/0000-0003-4771-6041; , Capelozzi/0000-0001-9732-5853; Faião-Flores, Fernanda/0000-0003-3449-9930; Maria-Engler, Silvya/0000-0003-4771-6041; Giorgi, Ricardo/0000-0002-4740-0867; delmonte, samuel/0000-0002-3289-4577	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [Fapesp 2008/56397-8, 2008/58817-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp 2008/56397-8 and 2008/58817-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aromando RF, 2009, J ORAL PATHOL MED, V38, P448, DOI 10.1111/j.1600-0714.2008.00720.x; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; CODERRE JA, 1994, INT J RADIAT ONCOL, V30, P643, DOI 10.1016/0360-3016(92)90951-D; Coelho PRP, 2002, RESEARCH AND DEVELOPMENT IN NEUTRON CAPTURE THERAPY, P197; Dagrosa MA, 2007, INT J RADIAT ONCOL, V69, P1059, DOI 10.1016/j.ijrobp.2007.04.061; Faiao-Flores F, 2011, APPL RADIAT ISOTOPES, V69, P1748, DOI 10.1016/j.apradiso.2011.05.017; Faiao-Flores F, 2011, APPL RADIAT ISOTOPES, V69, P1741, DOI 10.1016/j.apradiso.2011.03.005; Faiao-Flores F, 2013, TOXICOL IN VITRO, V27, P1196, DOI 10.1016/j.tiv.2013.02.006; Faiao-Flores F, 2012, RADIAT ENVIRON BIOPH, V51, P319, DOI 10.1007/s00411-012-0416-y; Fan J, 2012, INT J NEUROSCI, V122, P665, DOI 10.3109/00207454.2012.707714; Francisco Neto Acacio, 2005, Acta Cir. Bras., V20, P134, DOI 10.1590/S0102-86502005000200006; Fujita Y, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-63; Geran RI, 1972, PROTOCOLS SCREENING, P47; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori Y, 2012, J MED CHEM, V55, P6980, DOI 10.1021/jm300749q; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kamida A, 2006, INT J RADIAT BIOL, V82, P21, DOI 10.1080/09553000600570453; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Keagle JN, 2001, WOUND REPAIR REGEN, V9, P378, DOI 10.1046/j.1524-475x.2001.00378.x; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Koren R, 2001, ACTA HISTOCHEM, V103, P151, DOI 10.1078/0065-1281-00587; Ladstein RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-140; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lin YC, 2012, ANTICANCER RES, V32, P2657; LINDEN MD, 1992, AM J CLIN PATHOL, V97, pS4; Masunaga S, 2002, JPN J CANCER RES, V93, P1366, DOI 10.1111/j.1349-7006.2002.tb01246.x; Masunaga S, 2001, INT J RADIAT ONCOL, V51, P828, DOI 10.1016/S0360-3016(01)01695-9; Mendes PFP, 2008, CANCER LETT, V262, P276, DOI 10.1016/j.canlet.2007.12.017; Menichetti L, 2009, APPL RADIAT ISOTOPES, V67, pS336, DOI 10.1016/j.apradiso.2009.03.058; NAGATA K, 1988, J BIOL CHEM, V263, P8344; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKERING JG, 1991, AM J PATHOL, V138, P1225; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Wang P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-661; Wunrau C, 2009, ARTHRITIS RHEUM-US, V60, P2606, DOI 10.1002/art.24782	44	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59639	10.1371/journal.pone.0059639	http://dx.doi.org/10.1371/journal.pone.0059639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527236	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600084
J	Dou, HY; Ma, ET; Yin, LQ; Jin, YH; Wang, HW				Dou, Haoying; Ma, Enting; Yin, Liqun; Jin, Yinghui; Wang, Hongwu			The Association between Gene Polymorphism of TCF7L2 and Type 2 Diabetes in Chinese Han Population: A Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY GENES; VARIANTS; REPLICATION; RISK; MELLITUS	In recent years, it has been widely accepted that transcription factor 7-like 2 (TCF7L2) is associated with type 2 diabetes mellitus (T2DM) in multiple ethnic groups, especially its single nucleotide polymorphisms of rs7903146C/T, rs12255372G/T and rs290487T/C. However, the results previously obtained in Chinese Han population are often inconsistent. For clearing this issue, herein we performed meta-analysis based on the reports that can be found to assess the association. In the metaanalysis, Odds ratio (OR) and 95% confidence interval (95% CI) were calculated with random-effect model or fixed-effect model based on the heterogeneity analysis. The quality of included studies was evaluated by using the Newcastle-Ottawa Scale. The sensitivity analysis was used to confirm the reliability and stability of the meta-analysis. In total, 20 case-control studies with 9122 cases of T2DM and 8017 controls were included. Among these case-control studies, we selected 13 ones on rs7903146 C/T, 5 ones on rs12255372 G/T, 8 ones on rs290487 T/C. The results indicated that rs7903146C/T polymorphism was significantly associated with T2DM (T vs. C, OR = 1.73, 95% CI = 1.39-2.16). There was no evidence that rs12255372G/T and rs290487T/C polymorphisms increased T2DM risk (T vs. G, OR = 1.77, 95% CI = 0.88-3.56; C vs. T, OR = 1.08, 95% CI = 0.93-1.25). Subgroup analysis of different regions proved the relationship between rs7903146C/T polymorphism and T2DM risk in both the northern and the southern China. The association of rs290487 with T2DM was affected by body mass index, whereas the association of rs7903146 and rs290487 with T2DM was influenced neither by age nor by sex. In conclusion, this study indicated that the rs7903146C/T polymorphism of the TCF7L2 gene had a significant effect on T2DM risk in Chinese Han population, with rs12255372G/T and rs290487T/C polymorphisms showing no significant effect.	[Dou, Haoying; Ma, Enting; Jin, Yinghui] Tianjin Univ Tradit Chinese Med, Dept Nursing, Tianjin, Peoples R China; [Yin, Liqun] Tianjin Univ Tradit Chinese Med, Dept Publ Educ, Tianjin, Peoples R China; [Wang, Hongwu] Tianjin Univ Tradit Chinese Med, Dept Tradit Chinese Med, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Dou, HY (corresponding author), Tianjin Univ Tradit Chinese Med, Dept Nursing, Tianjin, Peoples R China.	douhaoying11@126.com			scientific and technological project of Tianjin [033113211]	scientific and technological project of Tianjin	This study was supported by scientific and technological project of Tianjin (No. 033113211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chen GY, 2011, J XIANNING U MED SCI, V25, P103; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; [樊向维 FAN Xiangwei], 2009, [天津医药, Tianjin Medical Journal], V37, P835; Fan XW, 2010, THESIS; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Guinan KJ, 2012, BIOCHEM GENET, V50, P159, DOI 10.1007/s10528-011-9456-2; Hansen L, 2005, DIABETES OBES METAB, V7, P122, DOI 10.1111/j.1463-1326.2004.00396.x; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lehman DM, 2007, DIABETES, V56, P389, DOI 10.2337/db06-0860; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; [娄青林 LOU Qing-lin], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P895; Luo YY, 2009, DIABETES RES CLIN PR, V85, P139, DOI 10.1016/j.diabres.2009.04.024; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; O'Connell D., 2011, EUR J EPIDEMIOL, V25, P603, DOI DOI 10.1007/S10654-010-9491-Z; Palizban A, 2012, CLIN EXP MED, V12, P115, DOI 10.1007/s10238-011-0144-7; Potapov V A, 2010, Genetika, V46, P1123; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Qiao H, 2012, GENE, V495, P115, DOI 10.1016/j.gene.2011.12.055; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; van Vliet-Ostaptchouk JV, 2007, DIABETOLOGIA, V50, P59, DOI 10.1007/s00125-006-0477-z; Wang X, 2010, J XINJIANG MED U, V33, P1162; Wang Z., 2008, THESIS; [汪志红 WANG Zhi-hong], 2009, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V25, P139; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yu M, 2010, CLIN PHARMACOL THER, V87, P330, DOI 10.1038/clpt.2009.242; Zeng QC, 2007, THESIS; Zhang L., 2010, THESIS; Zhang XL, 2012, CHIN J MISDIAGN, V12, P255; Zhang Y, 2009, J PRACTICAL DIABETOL, V5, P27; Zhang Y., 2008, THESIS; Zhao Ting, 2011, MED J QILU, V26, P417; Zheng XY, 2012, MOL BIOL REP, V39, P17, DOI 10.1007/s11033-011-0705-6; [郑晓雅 Zheng Xiaoya], 2011, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V36, P269; Zhu H, ACTA U MED ANHUI, V46, P20; Zou Yun-lian, 2009, CHINA MODERN DOCTOR, V47, P11	54	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59495	10.1371/journal.pone.0059495	http://dx.doi.org/10.1371/journal.pone.0059495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527206	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100140
J	McCoy, SI; Ralph, LJ; Wilson, W; Padian, NS				McCoy, Sandra I.; Ralph, Lauren J.; Wilson, Wema; Padian, Nancy S.			Alcohol Production as an Adaptive Livelihood Strategy for Women Farmers in Tanzania and Its Potential for Unintended Consequences on Women's Reproductive Health	PLOS ONE			English	Article							SOUTH-AFRICA; HIV PREVENTION; RISK; PROGRAM; INTERVENTION; ASSOCIATION; EMPOWERMENT; INFECTION; HIV/AIDS; UGANDA	Background: Although women occupy a central position in agriculture in many developing countries, they face numerous constraints to achieving their full potential including unequal access to assets and limited decision-making authority. We explore the intersection of agricultural livelihoods, food and economic security, and women's sexual and reproductive health in Iringa-Region, Tanzania. Our goal was to understand whether the benefits of supporting women in the agricultural sector might also extend to more distal outcomes, including sexual and reproductive health. Methods: Using the Sustainable Livelihoods Framework to guide data collection, we conducted 13 focus group discussions (FGD) with female (n = 11) and male farmers (n = 2) and 20 in-depth interviews with agricultural extension officers (n = 10) and village agro-dealers (n = 10). Results: Despite providing the majority of agricultural labor, women have limited control over land and earned income and have little bargaining power. In response to these constraints, women adopt adaptive livelihood strategies, such as alcohol production, that allow them to retain control over income and support their households. However, women's central role in alcohol production, in concert with the ubiquitous nature of alcohol consumption, places them at risk by enhancing their vulnerability to unsafe or transactional sex. This represents a dangerous confluence of risk for female farmers, in which alcohol plays an important role in income generation and also facilitates high-risk sexual behavior. Conclusions: Alcohol production and consumption has the potential to both directly and indirectly place women at risk for undesirable sexual and reproductive health outcomes. Group formation, better access to finance, and engaging with agricultural extension officers were identified as potential interventions for supporting women farmers and challenging harmful gender norms. In addition, joint, multi-sectoral approaches from health and agriculture and alternative income-generating strategies for women might better address the complexities of achieving safe and sustainable livelihoods for women in this context.	[McCoy, Sandra I.; Ralph, Lauren J.; Padian, Nancy S.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Wilson, Wema] Inst Management & Entrepreneurship Dev, Dar Es Salaam, Tanzania	University of California System; University of California Berkeley	McCoy, SI (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA.	smccoy@berkeley.edu			International Initiative for Impact Evaluation [OW2.171]; National Institute of Mental Health [K01MH094246]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094246] Funding Source: NIH RePORTER	International Initiative for Impact Evaluation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a grant from the International Initiative for Impact Evaluation (Padian, Grant No. OW2.171, www.3ieimpact.org). Dr. McCoy is supported by Award Number K01MH094246 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato M., 2000, IMPACT PROGRESA WOME; Agarwal B., 1997, FEM ECON, V3, P1, DOI [10.1080/135457097338799, DOI 10.1080/135457097338799]; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; [Anonymous], 2007, AGR DEV; [Anonymous], 2012, STAG 2 COGN BEH TRIA; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Baird SJ, 2012, LANCET; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Browne FA, 2010, CURR OPIN PSYCHIATR, V23, P205, DOI 10.1097/YCO.0b013e32833864eb; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Dancause KN, 2010, SOC SCI MED, V70, P1123, DOI 10.1016/j.socscimed.2009.12.008; *DEP MENT HLTH SUB, 2004, GLOB STAT REP ALC; Department for international Development, 1999, SUST LIV GUID SHEETS; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Economic Commission for Africa, 2006, MIT IMP HIV AIDS SMA; Feldman BS, 2009, STUD FAMILY PLANN, V40, P51, DOI 10.1111/j.1728-4465.2009.00186.x; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Food and Agriculture Organization, 2011, WOM AGR CLOS GEND GA; Food and Agriculture Organization, 1997, WOM SUST FOOD SEC; Food and Agriculture Organization of the United Nations, 2010, GEND LAND RIGHTS DAT; Food and Agriculture Organization of the United Nations, 2003, HIV AIDS AGR IMP RES; Food and Agriculture Organization of the United Nations (FAO), 2011, WOM AGR CLOS GEND GA; Fritz K, 2011, ALCOHOL RISKY SEX BR; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Gillespie S, 2005, INT FOOD POLICY RES; Golla A.M., 2011, UNDERSTANDING MEASUR; Greene M.E., 2010, SYNCHRONIZING GENDER; Greig FE, 2003, AIDS BEHAV, V7, P195, DOI 10.1023/A:1023954526639; Hernandez-Prado B, 2005, IMPACT OPORTUNIDADES; Huerta MC, 2000, PROGRESA MAS OPORTUN, P43; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; Ladmadrid-Figueroa H, 2010, J DEV EFFECT, V2, P74; Levine R., 2008, GIRLS COUNT GLOBAL I; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; Mccall M, 1996, Gend Dev, V4, P29, DOI 10.1080/741922167; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Motsoeneng T, 2012, INSIGHT AFRICAN ALCO; National Bureau of Statistics (NBS), 2007, TANZ HIV AIDS MAL IN; Oyefara J L, 2007, SAHARA J, V4, P626; Papas RK, 2010, AIDS BEHAV, V14, P669, DOI 10.1007/s10461-009-9647-6; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Quisumbing A, 2008, PROMISING APPROACHES; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rural Development Institute, 2009, ANN REPORT; Shapouri S, 2001, TOLL AGR HIV AIDS SU; Sosa-Rubi SG, 2011, HEALTH POLICY PLANN, V26, P496, DOI 10.1093/heapol/czq085; Steklov G, 2006, DEP EC WORKING PAPER; Ulin PR, 2005, QUALITATIVE METHODS; *UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Fund, 2007, WOM EC EMP M NEEDS I; United Nations Population Fund The Center for International Earth Science Information Network, 2007, WOM EC EMP M NEEDS I; United States Agency for International Development, 2009, LAND TEN PROP RIGHTS; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Willis J., 2002, POTENT BREWS SOCIAL; Women's Empowerment in Agriculture Index, 2012, WOMENS EMPOWERMENT A; World Bank, 2009, GEND AGR SOURC; *WORLD BANK, 2007, WORLD DEV REP 2008 A; World Health Assembly, 2007, EV BAS STRAT INT RED; World Health Assembly, 2010, STRAT RED HARMF US A; World Health Organization, 2011, UN REP TANZ GLOB STA	64	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59343	10.1371/journal.pone.0059343	http://dx.doi.org/10.1371/journal.pone.0059343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527167	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100112
J	Song, C; Xu, XB; He, Y; Liu, ZP; Wang, M; Zhang, X; Li, BM; Pan, BX				Song, Chen; Xu, Xiao-Bin; He, Ye; Liu, Zhi-Peng; Wang, Min; Zhang, Xin; Li, Bao-Ming; Pan, Bing-Xing			Stuttering Interneurons Generate Fast and Robust Inhibition onto Projection Neurons with Low Capacity of Short Term Modulation in Mouse Lateral Amygdala	PLOS ONE			English	Article							RAT BASOLATERAL AMYGDALA; CB1 CANNABINOID RECEPTORS; GABAERGIC INTERNEURONS; DISTINCT SUBTYPES; TONIC INHIBITION; GABA RELEASE; PARVALBUMIN; SYNAPSES; CELLS; COLOCALIZATION	The stuttering interneurons (STi) represent one minor subset of interneuron population and exhibit characteristic stuttering firing upon depolarization current injection. While it has been long held that the GABAergic inhibitory transmission largely varies with the subtype identity of presynaptic interneurons, whether such a rule also applies to STi is largely unknown. Here, by paired recording of interneuron and their neighboring projection neuron in lateral amygdala, we found that relative to the fast spiking and late spiking interneurons, the STi-evoked unitary postsynaptic currents onto the projection neurons had markedly larger amplitude, shorter onset latency and faster rising and decay kinetics. The quantal content and the number of vesicles in the readily releasable pool were also larger in synapses made by STi versus other interneurons. Moreover, the short-term plasticity, as reflected by the paired pulse depression and depolarization-induced suppression of inhibition, was the least prominent in the output synapses of STi. Thus, the fast and robust inhibition together with its low capacity of short term modulation may suggest an important role for STi in preventing the overexcitation of the projection neurons and thus gating the information traffic in amygdala.	[Song, Chen; Xu, Xiao-Bin; He, Ye; Liu, Zhi-Peng; Wang, Min; Zhang, Xin; Li, Bao-Ming; Pan, Bing-Xing] Nanchang Univ, Inst Life Sci, Lab Fear & Anxiety Disorder, Nanchang, Peoples R China; [He, Ye] Nanchang Univ, Dept Pharmacol, Nanchang, Peoples R China	Nanchang University; Nanchang University	Pan, BX (corresponding author), Nanchang Univ, Inst Life Sci, Lab Fear & Anxiety Disorder, Nanchang, Peoples R China.	panbingxing@ncu.edu.cn	liu, zhipeng/HCI-3638-2022; LIU, ZHIPENG/GWQ-5972-2022		National Natural Science Foundation of China [8071096, 31160208]; Natural Science Foundation of Jiangxi Province [2011205037]; "Young Scientist Cultivation Project" of Jiangxi Province; "555 Talent Project" of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); "Young Scientist Cultivation Project" of Jiangxi Province; "555 Talent Project" of Jiangxi Province	This research was supported by grants from National Natural Science Foundation of China (8071096, 31160208), Natural Science Foundation of Jiangxi Province (2011205037). During the revision process, the current work gained financial support from the "Young Scientist Cultivation Project" and "555 Talent Project" of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connelly WM, 2010, J NEUROSCI, V30, P14854, DOI 10.1523/JNEUROSCI.3895-10.2010; Davila JC, 2008, J CHEM NEUROANAT, V35, P67, DOI 10.1016/j.jchemneu.2007.06.003; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Heldt SA, 2010, J NEUROSCI, V30, P7139, DOI 10.1523/JNEUROSCI.0693-10.2010; Jasnow AM, 2009, J NEUROPHYSIOL, V101, P1494, DOI 10.1152/jn.91149.2008; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 1999, J NEUROSCI, V19, P4544; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Ma YY, 2012, J NEUROSCI, V32, P983, DOI 10.1523/JNEUROSCI.5007-11.2012; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Marowsky A, 2012, J NEUROSCI, V32, P8611, DOI 10.1523/JNEUROSCI.4404-11.2012; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Mascagni F, 2003, BRAIN RES, V976, P171, DOI 10.1016/S0006-8993(03)02625-8; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; Muller JF, 2007, J COMP NEUROL, V500, P513, DOI 10.1002/cne.21185; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Spampanato J, 2011, NEUROPHARMACOLOGY, V60, P765, DOI 10.1016/j.neuropharm.2010.11.006; STALEY KJ, 1991, SYNAPSE, V9, P219, DOI 10.1002/syn.890090308; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Yoshida T, 2011, P NATL ACAD SCI USA, V108, P3059, DOI 10.1073/pnas.1012875108; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e60154	10.1371/journal.pone.0060154	http://dx.doi.org/10.1371/journal.pone.0060154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527307	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100176
J	Lin, SK; Wang, MJ; Tseng, KY				Lin, Shankung; Wang, Ming Jen; Tseng, Kuo-Yun			Polypyrimidine Tract-Binding Protein Induces p19(Ink4d) Expression and Inhibits the Proliferation of H1299 Cells	PLOS ONE			English	Article							PTB; RNA	The expression of polypyrimidine tract-binding protein (PTB) is up-regulated in many types of cancer. Here, we studied the role of PTB in the growth of non small cell lung cancer cells. Data showed that PTB overexpression inhibited the growth of H1299 cells at least by inhibiting DNA synthesis. Quantitative real-time PCR and Western blot analyses showed that PTB overexpression in H1299 cells specifically induced the expression of p19(Ink4d), an inhibitor of cyclin-dependent kinase 4. Repression of p19(Ink4d) expression partially rescued PTB-caused proliferation inhibition. PTB overexpression also inhibited the growth and induced the expression of p19(Ink4d) mRNA in A549 cells. However, Western blot analyses failed to detect the presence of p19(Ink4d) protein in A549 cells. To address how PTB induced p19(Ink4d) in H1299 cells, we showed that PTB might up-regulate the activity of p19(Ink4d) gene (CDKN2D) promoter. Besides, PTB lacking the RNA recognition motif 3 (RRM3) was less effective in growth inhibition and p19(Ink4d) induction, suggesting that RNA-binding activity of PTB plays an important role in p19(Ink4d) induction. However, immunoprecipitation of ribonuclearprotein complexes plus quantitative real-time PCR analyses showed that PTB might not bind p19(Ink4d) mRNA, suggesting that PTB overexpression might trigger the other RNA-binding protein(s) to bind p19(Ink4d) mRNA. Subsequently, RNA electrophoretic mobility-shift assays revealed a 300-base segment (designated as B2) within the 3'UTR of p19(Ink4d) mRNA, with which the cytoplasmic lysates of PTB-overexpressing cells formed more prominent complexes than did control cell lysates. Insertion of B2 into a reporter construct increased the expression of the chimeric luciferase transcripts in transfected PTB-overexpressing cells but not in control cells; conversely, overexpression of B2-containing reporter construct in PTB-overexpressing cells abolished the induction of p19(Ink4d) mRNA. In sum, we have shown that PTB plays as a negative regulator in H1299 cell proliferation at least by inducing p19(Ink4d) expression at transcriptional and post-transcriptional levels.	[Lin, Shankung; Wang, Ming Jen; Tseng, Kuo-Yun] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli, Taiwan; [Lin, Shankung] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Lin, SK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli, Taiwan.	shankung@nhri.org.tw	Lin, Shan-Kung/B-1062-2010		NHRI, Taiwan	NHRI, Taiwan(National Health Research Institutes - Taiwan)	This work is funded by NHRI, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200; Wang MJ, 2009, J BIOL CHEM, V284, P36500, DOI 10.1074/jbc.M109.008904; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079	14	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58227	10.1371/journal.pone.0058227	http://dx.doi.org/10.1371/journal.pone.0058227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536791	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100037
J	Park, JY; Heo, J; Lee, TJ; Yim, HJ; Yeon, JE; Lim, YS; Seo, MJ; Ahn, SH; Lee, MS				Park, Jun Yong; Heo, Jeong; Lee, Tae Jin; Yim, Hyung Joon; Yeon, Jong Eun; Lim, Young-Suk; Seo, Min Jeong; Ahn, Sang Hoon; Lee, Myung Seok			A Novel Estimation of the Relative Economic Value in Terms of Different Chronic Hepatitis B Treatment Options	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; NATURAL-HISTORY; LAMIVUDINE TREATMENT; ENTECAVIR THERAPY; VIRUS INFECTION; TELBIVUDINE; EPIDEMIOLOGY; CIRRHOSIS; SAFETY; EFFICACY	Background: Prescribers, payors and healthcare decision-makers are increasingly examining the value of treatments. This study aims at analyzing economic value of chronic hepatitis B (CHB) treatment options, which are available in Korea. Methods: CHB infection was simulated using a health-state transition model with disease states defined as mild disease (Ishak F0/F1), fibrosis (F2/F3/F4), advanced fibrosis/cirrhosis (> F4), and complicated disease states (decompensated cirrhosis, hepatocellular carcinoma, liver transplant and death) based on available natural history data. The value of treatment-specific attributes on disease progression/regression was estimated based on published data in terms of events and costs avoided. 5-year treatment duration was assumed except for treatment initiation. Primary model output is the estimated cost savings of entecavir per patient per day of treatment versus the comparator in question for a given CHB patient. Results: The simulation of treating with entecavir versus no treatment predicted improved clinical outcomes for entecavir-treatment patients. In the long term, these clinical benefits translate into cost savings of $3.10 per day of treatment. In naive patient treatment, daily cost savings of using entecavir versus lamivudine or telbivudine was estimated at $2.89 and $1.72, respectively. In the case of suboptimal responders who pre-treated with lamivudine, daily cost saving for patients switching to entecavir was $1.38 per day of treatment compared to patients maintaining on lamivudine. Conclusions: Entecavir exhibits characteristics of a favourable CHB treatment, which directly translates into economic and therapeutic value as opposed to either no treatment or alternative strategies.	[Park, Jun Yong; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Heo, Jeong] Pusan Natl Univ, Sch Med, Dept Internal Med, Pusan, South Korea; [Lee, Tae Jin] Seoul Natl Univ, Sch Publ Hlth & Inst, Seoul, South Korea; [Yim, Hyung Joon; Yeon, Jong Eun] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Lim, Young-Suk] Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea; [Seo, Min Jeong] Monitor Grp Korea, Seoul, South Korea; [Lee, Myung Seok] Hallym Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Hallym University	Ahn, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	Ahnsh@yuhs.ac; leemsmd@hallym.or.kr	Park, Jun Yong/H-7127-2019	Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624	Bristol-Myers Squibb (BMS)	Bristol-Myers Squibb (BMS)(Bristol-Myers Squibb)	This study was sponsored by Bristol-Myers Squibb (BMS). The funders had no role in data interpretation, decision to publish or preparation of the manuscript.	But DYK, 2010, EXPERT OPIN DRUG SAF, V9, P821, DOI 10.1517/14740338.2010.507190; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chang TT, 2004, J GASTROEN HEPATOL, V19, P1276, DOI 10.1111/j.1440-1746.2004.03428.x; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; Choi MS, 2012, GUT LIVER, V6, P241, DOI 10.5009/gnl.2012.6.2.241; Crowley S, 2002, J GASTROEN HEPATOL, V17, P153, DOI 10.1046/j.1440-1746.2002.02673.x; Crowley SJ, 2000, PHARMACOECONOMICS, V17, P409, DOI 10.2165/00019053-200017050-00001; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DRUMMOND M, 1987, ANN INTERN MED, V107, P88, DOI 10.7326/0003-4819-107-1-88; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Heo J, 2012, ANTIVIR THER, V17, P1563, DOI 10.3851/IMP2277; Hsu CW, 2009, J HEPATOL, V50, pS331, DOI 10.1016/S0168-8278(09)60913-2; Idris BI, 2008, EUR J GASTROEN HEPAT, V20, P320, DOI 10.1097/MEG.0b013e3282f340c8; Ignacio Calcagno Juan, 2008, Acta Gastroenterologica Latinoamericana, V38, P260; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Jia-xiu L, 2005, NURS J CHIN PIA, V22, P11; Jones J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13350; Kanwal F, 2006, AM J GASTROENTEROL, V101, P2076, DOI 10.1111/j.1572-0241.2006.00769.x; Kim WR, 2004, LIVER TRANSPLANT, V10, P968, DOI 10.1002/lt.20217; Kobelt G, 2002, HLTH EC INTRO EC EVA; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Lui YYN, 2010, ANTIVIR THER, V15, P145, DOI 10.3851/IMP1496; Suzuki F, 2010, J GASTROEN HEPATOL, V25, P892, DOI 10.1111/j.1440-1746.2009.06161.x; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Veenstra DL, 2007, PHARMACOECONOMICS, V25, P963, DOI 10.2165/00019053-200725110-00006; Yang BM, 2010, DIGEST DIS SCI, V55, P784, DOI 10.1007/s10620-009-0786-4; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956	38	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57900	10.1371/journal.pone.0057900	http://dx.doi.org/10.1371/journal.pone.0057900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536775	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100020
J	Wong, LL; Hirst, SM; Pye, QN; Reilly, CM; Seal, S; McGinnis, JF				Wong, Lily L.; Hirst, Suzanne M.; Pye, Quentin N.; Reilly, Christopher M.; Seal, Sudipta; McGinnis, James F.			Catalytic Nanoceria Are Preferentially Retained in the Rat Retina and Are Not Cytotoxic after Intravitreal Injection	PLOS ONE			English	Article							CELL-POPULATIONS; NANOPARTICLES; DEGENERATION; ROD	Cerium oxide nanoparticles (nanoceria) possess catalytic and regenerative radical scavenging activities. The ability of nanoceria to maintain cellular redox balance makes them ideal candidates for treatment of retinal diseases whose development is tightly associated with oxidative damage. We have demonstrated that our stable water-dispersed nanoceria delay photoreceptor cell degeneration in rodent models and prevent pathological retinal neovascularization in vldlr mutant mice. The objectives of the current study were to determine the temporal and spatial distributions of nanoceria after a single intravitreal injection, and to determine if nanoceria had any toxic effects in healthy rat retinas. Using inductively-coupled plasma mass spectrometry (ICP-MS), we discovered that nanoceria were rapidly taken up by the retina and were preferentially retained in this tissue even after 120 days. We also did not observe any acute or long-term negative effects of nanoceria on retinal function or cytoarchitecture even after this long-term exposure. Because nanoceria are effective at low dosages, nontoxic and are retained in the retina for extended periods, we conclude that nanoceria are promising ophthalmic therapeutics for treating retinal diseases known to involve oxidative stress in their pathogeneses.	[Wong, Lily L.; Pye, Quentin N.; McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Wong, Lily L.; Pye, Quentin N.; McGinnis, James F.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Hirst, Suzanne M.; Reilly, Christopher M.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Hirst, Suzanne M.; Reilly, Christopher M.] Via Coll Osteopath Med, Blacksburg, VA USA; [Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Mech Mat Aerosp Engn Nanosci & Technol Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Grad Coll, Dept Cell Biol, Oklahoma City, OK 73190 USA; [McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Grad Coll, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Virginia Polytechnic Institute & State University; State University System of Florida; University of Central Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wong, LL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Ophthalmol, Oklahoma City, OK 73190 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Nanozymes, Nanozymes/D-8197-2019; Seal, Sudipta/A-7698-2012	Reilly, Chris/0000-0003-4787-7750	National Institutes of Health [R21EY018306, R01EY018724, R15AI072756]; Foundation Fighting Blindness (FFB) [C-NP-0707-0404-UOK08]; National Science Foundation: Chemical, Bioengineering, Environmental, and Transport Systems (NSF: CBET) [0708172]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR06-012]; Presbyterian Health Foundation (PHF); RPB; Research to Prevent Blindness (RPB) SSI award; DMEI/NEI Imaging Core Facility at OUHSC [NIH: P30-EY021725, COBRE-P20 RR017703]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018306, R01EY018724, P30EY021725, R01EY022111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness (FFB); National Science Foundation: Chemical, Bioengineering, Environmental, and Transport Systems (NSF: CBET); Oklahoma Center for the Advancement of Science and Technology (OCAST); Presbyterian Health Foundation (PHF); RPB; Research to Prevent Blindness (RPB) SSI award(Research to Prevent Blindness (RPB)); DMEI/NEI Imaging Core Facility at OUHSC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health R21EY018306 (JFM), R01EY018724 (JFM) (http://www.nei.nih.gov/) and R15AI072756 (CMR) (http://www.fda.gov/Drugs/ScienceResearch/default.htm); the Foundation Fighting Blindness (FFB) C-NP-0707-0404-UOK08 (JFM) (http://www.blindness.org/); the National Science Foundation: Chemical, Bioengineering, Environmental, and Transport Systems (NSF: CBET) 0708172 (SS and JFM) (http://www.nsf.gov/div/index.jsp?org = CBET); Oklahoma Center for the Advancement of Science and Technology (OCAST) HR06-012 (JFM) (http://www.ok.gov/ocast/), unrestricted funds from the Presbyterian Health Foundation (PHF) (http://www.phfokc.com/) and RPB to JFM (http://www.rpbusa.org/rpb/), and an Research to Prevent Blindness (RPB) SSI award to JFM. This work was also supported in part by the DMEI/NEI Imaging Core Facility at OUHSC (NIH: P30-EY021725, COBRE-P20 RR017703) (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Campbell CT, 2005, SCIENCE, V309, P713, DOI 10.1126/science.1113955; Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a; Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hirst SM, 2011, ENVIRON TOXICOL; Hirst SM, 2009, SMALL, V5, P2848, DOI 10.1002/smll.200901048; Hogg R, 2004, CURR EYE RES, V29, P387, DOI 10.1080/02713680490517890; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Inerbaev TM, 2010, J MOL MODEL, V16, P1617, DOI 10.1007/s00894-010-0671-2; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Karakoti A, 2010, CHEM SOC REV, V39, P4422, DOI 10.1039/b919677n; Kim H, 2009, PHARM RES-DORDR, V26, P329, DOI 10.1007/s11095-008-9745-6; Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001; Kong L, 2011, NEUROBIOL DIS, V42, P514, DOI 10.1016/j.nbd.2011.03.004; Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Masland RH, 2011, INVEST OPHTH VIS SCI, V52, P4581, DOI 10.1167/iovs.10-7083; McGinnis JF, 2008, US Patent, Patent No. 7347987; McGinnis JF, 2010, US Patent, Patent No. 7727559; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Perlman I, 2011, WEBVISION ORG RETINA; Pinilla I, 2004, VISION RES, V44, P2467, DOI 10.1016/j.visres.2004.05.020; Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Self WT, 2009, US Patent, Patent No. 7504356; Singh S, 2010, MOL BIOSYST, V6, P1813, DOI 10.1039/c0mb00014k; Thomas DG, 2011, WILEY INTERDISCIP RE; VANBOCKXMEER FM, 1983, BIOCHIM BIOPHYS ACTA, V758, P17, DOI 10.1016/0304-4165(83)90004-1; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Vincent A, 2010, LANGMUIR, V26, P7188, DOI 10.1021/la904285g; Vincent A, 2009, ACS NANO, V3, P1203, DOI 10.1021/nn9000148; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	41	69	70	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58431	10.1371/journal.pone.0058431	http://dx.doi.org/10.1371/journal.pone.0058431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536794	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100050
J	Blomeyer, D; Buchmann, AF; Lascorz, J; Zimmermann, US; Esser, G; Desrivieres, S; Schmidt, MH; Banaschewski, T; Schumann, G; Laucht, M				Blomeyer, Dorothea; Buchmann, Arlette F.; Lascorz, Jesus; Zimmermann, Ulrich S.; Esser, Guenter; Desrivieres, Sylvane; Schmidt, Martin H.; Banaschewski, Tobias; Schumann, Gunter; Laucht, Manfred			Association of PER2 Genotype and Stressful Life Events with Alcohol Drinking in Young Adults	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; GENE; RELIABILITY; DISORDERS; PERIOD; ADOLESCENCE; PREVALENCE; DEPENDENCE; ADDICTION; ADVERSITY	Background: Clock genes govern circadian rhythms and shape the effect of alcohol use on the physiological system. Exposure to severe negative life events is related to both heavy drinking and disturbed circadian rhythmicity. The aim of this study was 1) to extend previous findings suggesting an association of a haplotype tagging single nucleotide polymorphism of PER2 gene with drinking patterns, and 2) to examine a possible role for an interaction of this gene with life stress in hazardous drinking. Methods: Data were collected as part of an epidemiological cohort study on the outcome of early risk factors followed since birth. At age 19 years, 268 young adults (126 males, 142 females) were genotyped for PER2 rs56013859 and were administered a 45-day alcohol timeline follow-back interview and the Alcohol Use Disorders Identification Test (AUDIT). Life stress was assessed as the number of severe negative life events during the past four years reported in a questionnaire and validated by interview. Results: Individuals with the minor G allele of rs56013859 were found to be less engaged in alcohol use, drinking at only 72% of the days compared to homozygotes for the major A allele. Moreover, among regular drinkers, a gene x environment interaction emerged (p = .020). While no effects of genotype appeared under conditions of low stress, carriers of the G allele exhibited less hazardous drinking than those homozygous for the A allele when exposed to high stress. Conclusions: These findings may suggest a role of the circadian rhythm gene PER2 in both the drinking patterns of young adults and in moderating the impact of severe life stress on hazardous drinking in experienced alcohol users. However, in light of the likely burden of multiple tests, the nature of the measures used and the nominal evidence of interaction, replication is needed before drawing firm conclusions.	[Blomeyer, Dorothea; Buchmann, Arlette F.; Schmidt, Martin H.; Banaschewski, Tobias; Laucht, Manfred] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Lascorz, Jesus] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Zimmermann, Ulrich S.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany; [Esser, Guenter; Laucht, Manfred] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Desrivieres, Sylvane; Schumann, Gunter] Kings Coll London, Social Genet & Dev Psychiat Ctr MRC, Inst Psychiat, London WC2R 2LS, England	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Potsdam; University of London; King's College London	Laucht, M (corresponding author), Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.	manfred.laucht@zi-mannheim.de	Desrivieres, Sylvane/B-7399-2011; Zimmermann, Ulrich S/B-9357-2011; Desrivières, Sylvane/ABC-4336-2021; Schumann, Gunter/H-1013-2013; Banaschewski, Tobias/ABE-5985-2020	Desrivieres, Sylvane/0000-0002-9120-7060; Zimmermann, Ulrich S/0000-0001-7900-4992; Desrivières, Sylvane/0000-0002-9120-7060; Banaschewski, Tobias/0000-0003-4595-1144	Deutsche Forschungsgemeinschaft (DFG); Federal Ministry for Education and Research, Baden-Wuerttemberg Consortium for Addiction Research; National Genome Research Network; Medical Research Council [G9817803B] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry for Education and Research, Baden-Wuerttemberg Consortium for Addiction Research; National Genome Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG), the Federal Ministry for Education and Research as part of the Baden-Wuerttemberg Consortium for Addiction Research and from the 'National Genome Research Network'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Agapito M, 2010, ALCOHOL CLIN EXP RES, V34, P1613, DOI 10.1111/j.1530-0277.2010.01246.x; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; Caspi Avshalom, 2010, Am J Psychiatry, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Clarke TK, 2008, ADDICT BIOL, V13, P1, DOI 10.1111/j.1369-1600.2007.00084.x; Clarke TK, 2012, ADDICT BIOL, V17, P202, DOI 10.1111/j.1369-1600.2010.00263.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costanzo PR, 2007, J STUD ALCOHOL DRUGS, V68, P727, DOI 10.15288/jsad.2007.68.727; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Flint J, 2008, CURR OPIN PSYCHIATR, V21, P315, DOI 10.1097/YCO.0b013e328306a791; Gamble KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018395; Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kuntsche E, 2007, J STUD ALCOHOL DRUGS, V68, P76, DOI 10.15288/jsad.2007.68.76; Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Laucht M, 2009, BIOL PSYCHIAT, V66, P102, DOI 10.1016/j.biopsych.2009.02.010; Maier-Diewald W, 1983, MUNICH INTERVIEW ASS; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; Park CL, 2002, J STUD ALCOHOL, V63, P486, DOI 10.15288/jsa.2002.63.486; Perkins HW, 1999, J STUD ALCOHOL, V60, P219, DOI 10.15288/jsa.1999.60.219; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x; Rosenwasser AM, 2005, PHYSIOL BEHAV, V84, P537, DOI 10.1016/j.physbeh.2005.01.016; San Jose B, 2000, ALCOHOL CLIN EXP RES, V24, P1207; Scheurich A, 2005, EUR ADDICT RES, V11, P50, DOI 10.1159/000081417; Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826; Siegmund S, 2005, ALCOHOL CLIN EXP RES, V29, P1139, DOI 10.1097/01.ALC.0000171928.40418.46; SOBELL LC, 1992, ADDICT BEHAV, V17, P507, DOI 10.1016/0306-4603(92)90011-J; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Spanagel R, 2005, ALCOHOL CLIN EXP RES, V29, P1550, DOI 10.1097/01.alc.0000175074.70807.fd; Uhart M, 2009, ADDICT BIOL, V14, P43, DOI 10.1111/j.1369-1600.2008.00131.x; Volk RJ, 1997, ADDICTION, V92, P197, DOI 10.1046/j.1360-0443.1997.9221978.x; WHO, 2001, AUDIT ALCOHOL USE DI; Wills TA, 1985, COPING SUBSTANCE USE, P3; WITTCHEN HU, 1989, J AFFECT DISORDERS, V16, P77, DOI 10.1016/0165-0327(89)90059-1	44	44	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59136	10.1371/journal.pone.0059136	http://dx.doi.org/10.1371/journal.pone.0059136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533602	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400039
J	Choudhry, P; Trede, NS				Choudhry, Priya; Trede, Nikolaus S.			DiGeorge Syndrome Gene tbx1 Functions through wnt11r to Regulate Heart Looping and Differentiation	PLOS ONE			English	Article							OUTFLOW TRACT; CARDIAC DEVELOPMENT; DELETION SYNDROME; PHARYNGEAL ARCH; ZEBRAFISH; MORPHOGENESIS; FIELD; SPECIFICATION; ACTIVATION; MUTATION	DiGeorge syndrome (DGS) is the most common microdeletion syndrome, and is characterized by congenital cardiac, craniofacial and immune system abnormalities. The cardiac defects in DGS patients include conotruncal and ventricular septal defects. Although the etiology of DGS is critically regulated by TBX1 gene, the molecular pathways underpinning TBX1's role in heart development are not fully understood. In this study, we characterized heart defects and downstream signaling in the zebrafish tbx1(-/-) mutant, which has craniofacial and immune defects similar to DGS patients. We show that tbx1(-/-) mutants have defective heart looping, morphology and function. Defective heart looping is accompanied by failure of cardiomyocytes to differentiate normally and failure to change shape from isotropic to anisotropic morphology in the outer curvatures of the heart. This is the first demonstration of tbx1's role in regulating heart looping, cardiomyocyte shape and differentiation, and may explain how Tbx1 regulates conotruncal development in humans. Next we elucidated tbx1's molecular signaling pathway guided by the cardiac phenotype of tbx1(-/-) mutants. We show for the first time that wnt11r (wnt11 related), a member of the non-canonical Wnt pathway, and its downstream effector gene alcama (activated leukocyte cell adhesion molecule a) regulate heart looping and differentiation similarly to tbx1. Expression of both wnt11r and alcama are downregulated in tbx1(-/-) mutants. In addition, both wnt11r(-/-) mutants and alcama morphants have heart looping and differentiation defects similar to tbx1(-/-) mutants. Strikingly, heart looping and differentiation in tbx1(-/-) mutants can be partially rescued by ectopic expression of wnt11r or alcama, supporting a model whereby heart looping and differentiation are regulated by tbx1 in a linear pathway through wnt11r and alcama. This is the first study linking tbx1 and non-canonical Wnt signaling and extends our understanding of DGS and heart development.	[Choudhry, Priya] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Trede, Nikolaus S.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Choudhry, P (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	priya.choudhry@hci.utah.edu; nikolaus.trede@hci.utah.edu	Choudhry, Priya/F-7576-2014	Choudhry, Priya/0000-0002-4438-1576	National Cancer Institute [R01 HD047863-01, P30CA042014]; NIH grant [HG002995]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047863] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 HD047863-01 and by Award Number P30CA042014 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Sarah Hutchinson, Tatjana Piotrowski and Joseph Yost for intellectual contributions. We wish to thank Tatjana Piotrowski for vgo<SUP>tm208</SUP> (tbx1<SUP>-/-</SUP>) mutant zebrafish and the Yost lab for Tg(cmlc2:EGFP) fish. The wnt11r<SUP>fh224/+</SUP> mutant line was obtained from the Moens lab TILLING project, which is supported by NIH grant HG002995. Several plasmids for ISH probes were kind gifts from Sheila Samson and Josh Wythe.	Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Banerjee S, 2011, DEVELOPMENT; Bedada FB, 2005, MOL CELL BIOL, V25, P9509, DOI 10.1128/MCB.25.21.9509-9519.2005; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choudhry P, 2011, DEV BIOL, V349, P483, DOI 10.1016/j.ydbio.2010.11.006; Conlon FL, 2002, GENOME BIOL, V3; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gessert S, 2008, DEV BIOL, V321, P150, DOI 10.1016/j.ydbio.2008.06.013; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kardong KV, 2002, VERTEBRATES COMP ANA; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kispert A, 2011, CARDIOVASC RES; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; MANASEK FJ, 1981, FED PROC, V40, P2011; Martini FH, 2008, CARDIOVASCULAR SYSTE; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Miller CT, 2000, DEVELOPMENT, V127, P3815; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Rohr S, 2008, CIRC RES, V102, pE12, DOI 10.1161/CIRCRESAHA.107.165241; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; Taber LA, 2006, INT J DEV BIOL, V50, P323, DOI 10.1387/ijdb.052045lt; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Tu CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004249; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	63	24	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58145	10.1371/journal.pone.0058145	http://dx.doi.org/10.1371/journal.pone.0058145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533583	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400020
J	Mitani, A; Sasaki, R; Oizumi, M; Uka, T				Mitani, Akinori; Sasaki, Ryo; Oizumi, Masafumi; Uka, Takanori			A Leaky-Integrator Model as a Control Mechanism Underlying Flexible Decision Making during Task Switching	PLOS ONE			English	Article							AREA MT; PERCEPTUAL DECISION; NEURONAL-ACTIVITY; SENSORY NEURONS; NEURAL ACTIVITY; VISUAL-MOTION; CHOICE; DISCRIMINATION; RESPONSES; REFLECTS	The ability to switch between tasks is critical for animals to behave according to context. Although the association between the prefrontal cortex and task switching has been well documented, the ultimate modulation of sensory-motor associations has yet to be determined. Here, we modeled the results of a previous study showing that task switching can be accomplished by communication from distinct populations of sensory neurons. We proposed a leaky-integrator model where relevant and irrelevant information were stored separately in two integrators and task switching was achieved by leaking information from the irrelevant integrator. The model successfully explained both the behavioral and neuronal data. Additionally, the leaky-integrator model showed better performance than an alternative model, where irrelevant information was discarded by decreasing the weight on irrelevant information, when animals initially failed to commit to a task. Overall, we propose that flexible switching is, in part, achieved by actively controlling the amount of leak of relevant and irrelevant information.	[Mitani, Akinori; Sasaki, Ryo; Uka, Takanori] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan; [Mitani, Akinori] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan; [Mitani, Akinori] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Sasaki, Ryo] Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Oizumi, Masafumi] RIKEN, Brain Sci Inst, Lab Math Neurosci, Wako, Saitama, Japan; [Oizumi, Masafumi] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	Juntendo University; University of Tokyo; University of California System; University of California San Diego; University of Rochester; RIKEN; University of Wisconsin System; University of Wisconsin Madison	Uka, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan.	uka@juntendo.ac.jp		Oizumi, Masafumi/0000-0001-8802-2607	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20680022]; High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST, PRESTO; Nakajima Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST, PRESTO(Japan Science & Technology Agency (JST)); Nakajima Foundation	This work was supported by a Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20680022). R. S. was supported by the High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. M.O. was supported by a Grant-in-Aid for JSPS Fellows from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hironori Kumano for his comments on this manuscript. This work was supported by a Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20680022), and JST, PRESTO. AM was supported by a fellowship from the Nakajima Foundation.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brozovic M, 2007, J NEUROSCI, V27, P10588, DOI 10.1523/JNEUROSCI.2685-07.2007; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roitman JD, 2002, J NEUROSCI, V22, P9475; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sasaki R, 2009, NEURON, V62, P147, DOI 10.1016/j.neuron.2009.02.019; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shimazaki H, 2010, J COMPUT NEUROSCI, V29, P171, DOI 10.1007/s10827-009-0180-4; Stoet G, 2009, TRENDS COGN SCI, V13, P228, DOI 10.1016/j.tics.2009.02.002; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59670	10.1371/journal.pone.0059670	http://dx.doi.org/10.1371/journal.pone.0059670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533641	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400078
J	Rachid, CTCC; Santos, AL; Piccolo, MC; Balieiro, FC; Coutinho, HLC; Peixoto, RS; Tiedje, JM; Rosado, AS				Rachid, Caio T. C. C.; Santos, Adriana L.; Piccolo, Marisa C.; Balieiro, Fabiano C.; Coutinho, Heitor L. C.; Peixoto, Raquel S.; Tiedje, James M.; Rosado, Alexandre S.			Effect of Sugarcane Burning or Green Harvest Methods on the Brazilian Cerrado Soil Bacterial Community Structure	PLOS ONE			English	Article							RIBOSOMAL-RNA; DIVERSITY; MANAGEMENT; IMPACT; CARBON; CONSERVATION; RHIZOSPHERE; CULTIVATION; VEGETATION; LIBRARIES	Background: The Brazilian Cerrado is one of the most important biodiversity reservoirs in the world. The sugarcane cultivation is expanding in this biome and necessitates the study of how it may impact the soil properties of the Cerrado. There is a lack of information especially about the impacts of different sugarcane management on the native bacterial communities of Cerrado soil. Therefore, our objective was to evaluate and compare the soil bacterial community structure of the Cerrado vegetation with two sugarcane systems. Methods: We evaluated samples under native vegetation and the impact of the two most commonly used management strategies for sugarcane cultivation (burnt cane and green cane) on this diversity using pyrosequencing and quantitative PCR of the rrs gene (16S rRNA). Results and Conclusions: Nineteen different phyla were identified, with Acidobacteria (approximate to 35%), Proteobacteria (approximate to 24%) and Actinobacteria (approximate to 21%) being the most abundant. Many of the sequences were represented by few operational taxonomic units (OTUs, 3% of dissimilarity), which were found in all treatments. In contrast, there were very strong patterns of local selection, with many OTUs occurring only in one sample. Our results reveal a complex bacterial diversity, with a large fraction of microorganisms not yet described, reinforcing the importance of this biome. As possible sign of threat, the qPCR detected a reduction of the bacterial population in agricultural soils compared with native Cerrado soil communities. We conclude that sugarcane cultivation promoted significant structural changes in the soil bacterial community, with Firmicutes phylum and Acidobacteria classes being the groups most affected.	[Rachid, Caio T. C. C.; Piccolo, Marisa C.] Univ Sao Paulo, Ctr Nucl Energy Agr, Sao Paulo, Brazil; [Rachid, Caio T. C. C.; Santos, Adriana L.; Peixoto, Raquel S.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil; [Balieiro, Fabiano C.; Coutinho, Heitor L. C.] Embrapa Solos, Rio De Janeiro, Brazil; [Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Michigan State University	Rosado, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.	asrosado@micro.ufrj.br	Balieiro, Fabiano/AAQ-5915-2020; dos Santos, Adriana Lopes/J-6960-2019; piccolo, marisa de Cássia/D-6149-2012; dos Santos, Adriana Lopes/B-7252-2018; Rachid, Caio TCC/J-5001-2016; Rosado, Alexandre Soares/G-1955-2012; Peixoto, Raquel/V-2554-2019; Balieiro, Fabiano C/J-4390-2017	dos Santos, Adriana Lopes/0000-0002-0736-4937; piccolo, marisa de Cássia/0000-0003-2163-5630; dos Santos, Adriana Lopes/0000-0002-0736-4937; Rachid, Caio TCC/0000-0003-3115-5702; Rosado, Alexandre Soares/0000-0001-5135-1394; Balieiro, Fabiano C/0000-0002-0229-6672; Peixoto, Raquel/0000-0002-9536-3132	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work received funding from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MCR, 2008, APPL SOIL ECOL, V38, P100, DOI 10.1016/j.apsoil.2007.09.004; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Alef K., 1995, METHODS APPL SOIL MI, DOI DOI 10.1016/B978-0-12-513840-6.X5014-9; Araujo JF, 2012, MICROB ECOL, V64, P760, DOI 10.1007/s00248-012-0057-3; Campos DVB, 2004, 12 INT M INT HUM SUB, V12, P647; CANASAT, 2011, SUG CROP MAPP BRAZ E; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conservation International, 2007, BIOD HOTSP CERR; de Castro AP, 2011, BIOTECHNOL LETT, V33, P2169, DOI 10.1007/s10529-011-0693-6; de Resende AS, 2006, PLANT SOIL, V281, P339, DOI 10.1007/s11104-005-4640-y; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Galdos MV, 2009, GEODERMA, V153, P347, DOI 10.1016/j.geoderma.2009.08.025; Gauder M, 2011, APPL ENERG, V88, P672, DOI 10.1016/j.apenergy.2010.08.020; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Loarie SR, 2011, NAT CLIM CHANGE, V1, P105, DOI [10.1038/nclimate1067, 10.1038/NCLIMATE1067]; Macedo IC, 2008, BIOMASS BIOENERG, V32, P582, DOI 10.1016/j.biombioe.2007.12.006; Pinheiro EFM, 2010, PLANT SOIL, V333, P71, DOI 10.1007/s11104-010-0320-7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Navarrete A. A., 2010, Diversity, V2, P787; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pereira P. A. A., 2012, Agriculture and Food Security, V1; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quirino BF, 2009, MICROBIOL RES, V164, P59, DOI 10.1016/j.micres.2006.12.001; Rachid CTCC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-170; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sano EE, 2008, PESQUI AGROPECU BRAS, V43, P153, DOI 10.1590/S0100-204X2008000100020; Sant'anna SAC, 2009, PEDOSPHERE, V19, P312, DOI 10.1016/S1002-0160(09)60122-3; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Silva AJN, 2007, SOIL TILL RES, V94, P420, DOI 10.1016/j.still.2006.09.002; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Valpassos MAR, 2001, PESQUI AGROPECU BRAS, V36, P1539, DOI 10.1590/S0100-204X2001001200011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	41	39	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59342	10.1371/journal.pone.0059342	http://dx.doi.org/10.1371/journal.pone.0059342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533619	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400056
J	Bailey, DH; Walker, RS; Blomquist, GE; Hill, KR; Hurtado, AM; Geary, DC				Bailey, Drew H.; Walker, Robert S.; Blomquist, Gregory E.; Hill, Kim R.; Hurtado, A. Magdalena; Geary, David C.			Heritability and Fitness Correlates of Personality in the Ache, a Natural-Fertility Population in Paraguay	PLOS ONE			English	Article							EVOLUTIONARY GENETICS; HUNTER-GATHERERS; 5-FACTOR MODEL; BIG 5; PREFERENCES; DISORDERS; QUALITY; CHOICE; COMMON	The current study assessed the heritability of personality in a traditional natural-fertility population, the Ache of eastern Paraguay. Self-reports (n = 110) and other-reports (n = 66) on the commonly used Big Five Personality Inventory (i.e., extraversion, agreeableness, conscientiousness, neuroticism, openness) were collected. Self-reports did not support the Five Factor Model developed with Western samples, and did not correlate with other-reports for three of the five measured personality factors. Heritability was assessed using factors that were consistent across self-and other-reports and factors assessed using other-reports that showed reliabilities similar to those found in Western samples. Analyses of these items in combination with a multi-generation pedigree (n = 2,132) revealed heritability estimates similar to those found in most Western samples, although we were not able to separately estimate the influence of the common environment on these traits. We also assessed relations between personality and reproductive success (RS), allowing for a test of several mechanisms that might be maintaining heritable variation in personality. Phenotypic analyses, based largely on other-reports, revealed that extraverted men had higher RS than other men, but no other dimensions of personality predicted RS in either sex. Mothers with more agreeable children had more children, and parents mated assortatively on personality. Of the evolutionary processes proposed to maintain variation in personality, assortative mating, selective neutrality, and temporal variation in selection pressures received the most support. However, the current study does not rule out other processes affecting the evolution and maintenance of individual differences in human personality.	[Bailey, Drew H.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Walker, Robert S.; Blomquist, Gregory E.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Hill, Kim R.; Hurtado, A. Magdalena] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA	Carnegie Mellon University; University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bailey, DH (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	drewhalbailey@gmail.com			Raymond White Dissertation Year Fellowship	Raymond White Dissertation Year Fellowship	The work was supported by an internal award, the "Raymond White Dissertation Year Fellowship". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Alvergne A, 2010, P NATL ACAD SCI USA, V107, P11745, DOI 10.1073/pnas.1001752107; Apostolou M., 2011, FAMILY SCI, V2, P186; Apostolou M, 2007, EVOL HUM BEHAV, V28, P403, DOI 10.1016/j.evolhumbehav.2007.05.007; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Borkenau P, 2001, J PERS SOC PSYCHOL, V80, P655, DOI 10.1037/0022-3514.80.4.655; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Buss D. M., 2010, EVOLUTION PERSONALIT, P29, DOI [DOI 10.1093/ACPROF:OSO/9780195372090.003.0002, 10.1093/acprof:oso/9780195372090.003.0002]; Buss DM, 2006, BEHAV BRAIN SCI, V29, P409, DOI 10.1017/S0140525X06269097; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; BUSS DM, 1986, J PERS SOC PSYCHOL, V50, P559, DOI 10.1037/0022-3514.50.3.559; Chagnon N.A., 1979, EVOLUTIONARY BIOL HU, P86; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Connelly BS, 2010, PSYCHOL BULL, V136, P1092, DOI 10.1037/a0021212; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; EAVES LJ, 1990, BEHAV GENET, V20, P563, DOI 10.1007/BF01065872; Gangestad SW, 2010, PERS INDIV DIFFER, V49, P289, DOI 10.1016/j.paid.2010.03.005; Gurven M, 2013, J PERS SOC PSYCHOL, V104, P354, DOI 10.1037/a0030841; Gurven M, 2010, CURR ANTHROPOL, V51, P49, DOI 10.1086/648587; Hill, ADAPTIVE RESPONSES N, P139; HILL K, 1989, AM SCI, V77, P436; HILL K, 1984, HUM ECOL, V12, P101, DOI 10.1007/BF01531269; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; HURTADO AM, 1985, HUM ECOL, V13, P1, DOI 10.1007/BF01531086; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Keller M. C., 2010, EVOLUTION PERSONALIT, P280, DOI [10.1093/acprof:oso/9780195372090.001.0001, DOI 10.1093/ACPROF:OSO/9780195372090.001.0001]; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Luo SH, 2005, J PERS SOC PSYCHOL, V88, P304, DOI 10.1037/0022-3514.88.2.304; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MEALEY L, 1995, BEHAV BRAIN SCI, V18, P523, DOI 10.1017/S0140525X00039595; Nettle D, 2005, EVOL HUM BEHAV, V26, P363, DOI 10.1016/j.evolhumbehav.2004.12.004; Nettle D, 2010, EVOLUTION PERSONALIT, P5; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Penke L., 2010, EVOLUTION PERSONALIT, P243, DOI [10.1093/acprof:oso/9780195372090.003.0009, DOI 10.1093/ACPROF:OSO/9780195372090.003.0009]; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Radcliffe-Brown AR, 1927, J R ANTHROPOL INST G, V57, P343, DOI 10.2307/2843708; ROBERTS DF, 1978, ANN HUM GENET, V42, P15, DOI 10.1111/j.1469-1809.1978.tb00928.x; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; TRULL TJ, 1994, J ABNORM PSYCHOL, V103, P350, DOI 10.1037/0021-843X.103.2.350; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Van Os J, 2001, PSYCHOL MED, V31, P1129, DOI 10.1017/S0033291701004044; Verweij KJH, 2012, EVOLUTION, V66, P3238, DOI 10.1111/j.1558-5646.2012.01679.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WILSON DS, 1994, ETHOL SOCIOBIOL, V15, P219; Yeo RA, 2011, BIOL PSYCHIAT, V70, P537, DOI 10.1016/j.biopsych.2011.04.019; Zietsch BP, 2011, AM NAT, V177, P605, DOI 10.1086/659629	53	24	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59325	10.1371/journal.pone.0059325	http://dx.doi.org/10.1371/journal.pone.0059325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527163	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100108
J	Wiles, ET; Lui-Sargent, B; Bell, R; Lessnick, SL				Wiles, Elizabeth T.; Lui-Sargent, Bianca; Bell, Russell; Lessnick, Stephen L.			BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR BCL11B; NURD COMPLEX; DNA-BINDING; EWS-FLI1 ONCOPROTEIN; T-LYMPHOCYTES; TARGET GENE; PROMOTER; TUMORS; REPRESSION; EXPRESSION	The EWS/FLI translocation product is the causative oncogene in Ewing sarcoma and acts as an aberrant transcription factor. EWS/FLI dysregulates gene expression during tumorigenesis by abnormally activating or repressing genes. The expression levels of thousands of genes are affected in Ewing sarcoma, however, it is unknown which of these genes contribute to the transformed phenotype. Here we characterize BCL11B as an up-regulated EWS/FLI target that is necessary for the maintenance of transformation in patient derived Ewing sarcoma cells lines. BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor in Ewing's sarcoma and contributes to the EWS/FLI repressed gene signature. BCL11B repressive activity is mediated by the NuRD co-repressor complex. We further demonstrate that re-expression of SPRY1, a repressed target of BCL11B, limits the transformation capacity of Ewing sarcoma cells. These data define a new pathway downstream of EWS/FLI required for oncogenic maintenance in Ewing sarcoma.	[Wiles, Elizabeth T.; Lessnick, Stephen L.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Lui-Sargent, Bianca; Bell, Russell; Lessnick, Stephen L.] Huntsman Canc Inst, Ctr Childrens Canc Res, Salt Lake City, UT USA; [Lessnick, Stephen L.] Univ Utah, Div Pediat Hematol Oncol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu		Wiles, Elizabeth/0000-0001-7269-7466	NIH/NCI [R01 CA140394, P30 CA042014]; NATIONAL CANCER INSTITUTE [R01CA140394, P30CA042014] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ETW is a Sydney's Incredible Defeat of Ewing's Sarcoma (SIDES) Scholar. This work was supported by NIH/NCI grants R01 CA140394 (to SLL) and P30 CA042014 (to Huntsman Cancer Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, MOL CELL BIOL, V23, P3897, DOI 10.1128/MCB.23.11.3897-3908.2003; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; Grabarczyk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012532; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kominami R, 2012, P JPN ACAD B-PHYS, V88, P72, DOI 10.2183/pjab.88.72; Le Douce V, 2012, NUCLEIC ACIDS RES, V40, P1904, DOI 10.1093/nar/gkr857; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Nagel S, 2003, CANCER RES, V63, P5329; Navarro D, 2010, CARCINOGENESIS, V31, P394, DOI 10.1093/carcin/bgp317; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Sankar S, 2012, ONCOGENE IN PRESS; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Silvany RE, 2000, ONCOGENE, V19, P4523, DOI 10.1038/sj.onc.1203811; Simon R, 2012, EMBO J, V31, P2922, DOI 10.1038/emboj.2012.142; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	55	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59369	10.1371/journal.pone.0059369	http://dx.doi.org/10.1371/journal.pone.0059369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527175	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100119
J	Marceau, AH; Bernstein, DA; Walsh, BW; Shapiro, W; Simmons, LA; Keck, JL				Marceau, Aimee H.; Bernstein, Douglas A.; Walsh, Brian W.; Shapiro, Walker; Simmons, Lyle A.; Keck, James L.			Protein Interactions in Genome Maintenance as Novel Antibacterial Targets	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; BINDING-PROTEIN; SMALL-MOLECULE; CELL-DIVISION; REPLICATION; SSB; REPAIR; RECO; FTSZ	Antibacterial compounds typically act by directly inhibiting essential bacterial enzyme activities. Although this general mechanism of action has fueled traditional antibiotic discovery efforts for decades, new antibiotic development has not kept pace with the emergence of drug resistant bacterial strains. These limitations have severely restricted the therapeutic tools available for treating bacterial infections. Here we test an alternative antibacterial lead-compound identification strategy in which essential protein-protein interactions are targeted rather than enzymatic activities. Bacterial single-stranded DNA-binding proteins (SSBs) form conserved protein interaction "hubs" that are essential for recruiting many DNA replication, recombination, and repair proteins to SSB/DNA nucleoprotein substrates. Three small molecules that block SSB/protein interactions are shown to have antibacterial activity against diverse bacterial species. Consistent with a model in which the compounds target multiple SSB/protein interactions, treatment of Bacillus subtilis cultures with the compounds leads to rapid inhibition of DNA replication and recombination, and ultimately to cell death. The compounds also have unanticipated effects on protein synthesis that could be due to a previously unknown role for SSB/protein interactions in translation or to off-target effects. Our results highlight the potential of targeting protein-protein interactions, particularly those that mediate genome maintenance, as a powerful approach for identifying new antibacterial compounds.	[Marceau, Aimee H.; Bernstein, Douglas A.; Shapiro, Walker; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Walsh, Brian W.; Simmons, Lyle A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	United States National Institutes of Health (NIH) [GM068061]; National Science Foundation [MCB1050948]; NIH [GM07215]; Shapiro scholarship; Shapiro fellowship; Direct For Biological Sciences [1050948] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM068061] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shapiro scholarship; Shapiro fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by United States National Institutes of Health (NIH) grant GM068061 to JLK and National Science Foundation grant MCB1050948 to LAS. AHM was supported in part by an NIH training grant in Molecular Biosciences (GM07215) and a Shapiro scholarship. WBS was supported, in part, by a Shapiro fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEISER SM, 1957, J BACTERIOL, V74, P303, DOI 10.1128/JB.74.3.303-307.1957; Berkmen MB, 2006, MOL MICROBIOL, V62, P57, DOI 10.1111/j.1365-2958.2006.05356.x; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Borjac-Natour JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-4; Bradbury BJ, 2008, CURR OPIN PHARMACOL, V8, P574, DOI 10.1016/j.coph.2008.04.009; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHASE JW, 1984, J BIOL CHEM, V259, P805; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Courcelle CT, 2006, METHOD ENZYMOL, V409, P425, DOI 10.1016/S0076-6879(05)09025-7; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; Klocko AD, 2010, JOVE-J VIS EXP, P1736; KUIL ME, 1990, BIOCHEMISTRY-US, V29, P8184, DOI 10.1021/bi00487a028; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lu D, 2010, P NATL ACAD SCI USA, V107, P633, DOI 10.1073/pnas.0909191107; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MOLINEUX IJ, 1975, NUCLEIC ACIDS RES, V2, P1821, DOI 10.1093/nar/2.10.1821; [National Committee for Clinical Laboratory Standards Nccls], 1999, PREP VAL COMM FROZ H, Vxvi; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Page AN, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.210187; Robinson A, 2012, CURR DRUG TARGETS, V13, P352, DOI 10.2174/138945012799424598; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sambrook J., 2001, MOL CLONING LAB MANU; SAMPSON BA, 1989, GENETICS, V122, P491; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHIMAMOTO N, 1987, NUCLEIC ACIDS RES, V15, P5241, DOI 10.1093/nar/15.13.5241; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; WANG TCV, 1982, J BACTERIOL, V151, P186, DOI 10.1128/JB.151.1.186-192.1982; WANG TV, 1985, MOL GEN GENET, V201, P186, DOI 10.1007/BF00425658; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wright GD, 2012, CHEM BIOL, V19, P3, DOI 10.1016/j.chembiol.2011.10.019; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	51	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58765	10.1371/journal.pone.0058765	http://dx.doi.org/10.1371/journal.pone.0058765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536821	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100088
J	Raymond, JA; Morgan-Kiss, R				Raymond, James A.; Morgan-Kiss, Rachael			Separate Origins of Ice-Binding Proteins in Antarctic Chlamydomonas Species	PLOS ONE			English	Article							SEA-ICE; GREEN-ALGA; LAKE	The green alga Chlamydomonas raudensis is an important primary producer in a number of ice-covered lakes and ponds in Antarctica. A C. raudensis isolate (UWO241) from Lake Bonney in the McMurdo Dry Valleys, like many other Antarctic algae, was found to secrete ice-binding proteins (IBPs), which appear to be essential for survival in icy environments. The IBPs of several Antarctic algae (diatoms, a prymesiophyte, and a prasinophyte) are similar to each other (here designated as type I IBPs) and have been proposed to have bacterial origins. Other IBPs (type II IBPs) that bear no resemblance to type I IBPs, have been found in the Antarctic Chlamydomonas sp. CCMP681, a putative snow alga, raising the possibility that chlamydomonad IBPs developed separately from the IBPs of other algae. To test this idea, we obtained the IBP sequences of C. raudensis UWO241 by sequencing the transcriptome. A large number of transcripts revealed no sequences resembling type II IBPs. Instead, many isoforms resembling type I IBPs were found, and these most closely matched a hypothetical protein from the bacterium Stigmatella aurantiaca. The sequences were confirmed to encode IBPs by the activity of a recombinant protein and by the matching of predicted and observed isoelectric points and molecular weights. Furthermore, a mesophilic sister species, C. raudensis SAG49.72, showed no ice-binding activity or PCR products from UWO241 IBP primers. These results confirm that algal IBPs are required for survival in icy habitats and demonstrate that they have diverse origins that are unrelated to the taxonomic positions of the algae. Last, we show that the C. raudensis UWO241 IBPs can change the structure of ice in a way that could increase the survivability of cells trapped in the ice.	[Raymond, James A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Morgan-Kiss, Rachael] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University System of Ohio; Miami University	Raymond, JA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	raymond@unlv.nevada.edu		Morgan-kiss, Rachael/0000-0003-4783-5358	University of Nevada Las Vegas; National Science Foundation Office of Polar Programs [0631659, 1056396]	University of Nevada Las Vegas; National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was mainly funded with personal funds (JR) with laboratory resources provided by the University of Nevada Las Vegas. This work was supported in part by National Science Foundation Office of Polar Programs Grants 0631659 and 1056396 to RM-K. The funders other than the authors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Koob DD, 1972, ANTARCTIC TERRESTRIA, P51; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; MCKAY CP, 1985, NATURE, V313, P561, DOI 10.1038/313561a0; Morgan-Kiss R, 2002, BBA-BIOMEMBRANES, V1561, P251, DOI 10.1016/S0005-2736(02)00352-8; Morgan-Kiss RM, 2008, EXTREMOPHILES, V12, P701, DOI 10.1007/s00792-008-0176-4; Morgan-Kiss RM, 2005, J PHYCOL, V41, P791, DOI 10.1111/j.1529-8817.2005.04174.x; NEALE PJ, 1995, PLANT CELL PHYSIOL, V36, P253, DOI 10.1093/oxfordjournals.pcp.a078757; Pocock T, 2004, J PHYCOL, V40, P1138, DOI 10.1111/j.1529-8817.2004.04060.x; Pocock T, 2011, J EXP BOT, V62, P1169, DOI 10.1093/jxb/erq347; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Raymond JA, 2001, CRYOBIOLOGY, V43, P63, DOI 10.1006/cryo.2001.2341; Raymond JA, 2000, ANTARCT SCI, V12, P418; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang KW, 2009, P ROY SOC B-BIOL SCI, V276, P81, DOI 10.1098/rspb.2008.0598	21	19	21	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59186	10.1371/journal.pone.0059186	http://dx.doi.org/10.1371/journal.pone.0059186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536869	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100128
J	Subhanova, I; Muchova, L; Lenicek, M; Vreman, HJ; Luksan, O; Kubickova, K; Kreidlova, M; Zima, T; Vitek, L; Urbanek, P				Subhanova, Iva; Muchova, Lucie; Lenicek, Martin; Vreman, Hendrik J.; Luksan, Ondrej; Kubickova, Kristyna; Kreidlova, Miluse; Zima, Tomas; Vitek, Libor; Urbanek, Petr			Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients	PLOS ONE			English	Article							C VIRUS-REPLICATION; HEPATITIS-C; HEME OXYGENASE-1; CARBON-MONOXIDE; OXIDATIVE STRESS; GENE-EXPRESSION; DOWN-REGULATION; INTERFERON; INDUCTION; PROTEIN	Background and Aims: Hepatitis C virus (HCV) infection is associated with systemic oxidative stress. Since the heme catabolic pathway plays an important role in antioxidant protection, we attempted to assess the gene expression of key enzymes of heme catabolism, heme oxygenase 1 (HMOX1), heme oxygenase 2 (HMOX2), and biliverdin reductase A (BLVRA) in the liver and peripheral blood leukocytes (PBL) of patients chronically infected with HCV. Methods: Gene expressions (HMOX1, HMOX2, BLVRA) and HCV RNA were analyzed in PBL of HCV treatment naive patients (n = 58) and controls (n = 55), with a subset of HCV patients having data on hepatic gene expression (n = 35). Based upon the therapeutic outcome, HCV patients were classified as either responders (n = 38) or treatment-failure patients (n = 20). Blood samples in HCV patients were collected at day 0, and week 12, 24, 36, and 48 after the initiation of standard antiviral therapy. Results: Compared to the controls, substantially increased BLVRA expression was detected in PBL (p<0.001) of therapeutically naive HCV patients. mRNA levels of BLVRA in PBL closely correlated with those in liver tissue (r(2) = 0.347, p = 0.03). A marked difference in BLVRA expression in PBL between the sustained responders and patients with treatment failure was detected at week 0 and during the follow-up (p<0.001). Multivariate analysis revealed that BLVRA basal expression in PBL was an independent predictor for sustained virological response (OR 15; 95% CI 1.05-214.2; P = 0.046). HMOX1/2 expression did not have any effect on the treatment outcome. Conclusion: Our results suggest that patients with chronic HCV infection significantly upregulate BLVRA expression in PBL. The lack of BLVRA overexpression is associated with non-responsiveness to standard antiviral therapy; whereas, HMOX1/2 does not seem to have any predictive potential.	[Subhanova, Iva; Muchova, Lucie; Lenicek, Martin; Kreidlova, Miluse; Zima, Tomas; Vitek, Libor] Charles Univ Prague, Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Subhanova, Iva; Muchova, Lucie; Lenicek, Martin; Kreidlova, Miluse; Zima, Tomas; Vitek, Libor] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Vreman, Hendrik J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Luksan, Ondrej] Inst Clin & Expt Med, Ctr Expt Med, Prague, Czech Republic; [Kubickova, Kristyna; Urbanek, Petr] Charles Univ Prague, Dept Internal Med, Fac Med 1, Prague, Czech Republic; [Vitek, Libor] Charles Univ Prague, Dept Internal Med 4, Fac Med 1, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Stanford University; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Charles University Prague	Subhanova, I (corresponding author), Charles Univ Prague, Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic.	iva.subhanova@seznam.cz	Vitek, Libor/A-2645-2008; Muchova, Lucie/I-3805-2017; Urbanek, Petr/F-4363-2017; Kubickova, Kristyna/G-5915-2017; Luksan, Ondrej/O-6465-2019; Luksan, Ondrej/O-6468-2019; Zima, Tomas/F-6760-2017; Subhanova, Iva/I-3872-2017; Lenicek, Martin/A-5495-2009; Kreidlova, Miluse/I-6284-2017	Vitek, Libor/0000-0002-5318-0151; Muchova, Lucie/0000-0003-2082-1060; Urbanek, Petr/0000-0002-1506-1135; Kubickova, Kristyna/0000-0003-1257-9171; Zima, Tomas/0000-0001-8518-6972; Subhanova, Iva/0000-0001-5721-4577; Lenicek, Martin/0000-0001-6242-3488; Kreidlova, Miluse/0000-0002-9472-6894	Czech Ministry of Health [IGA MZ NT/13092-4/2012]	Czech Ministry of Health(Ministry of Health, Czech Republic)	This study was supported by grant IGA MZ NT/13092-4/2012 from the Czech Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2004, J INFECT DIS, V190, P1109, DOI 10.1086/423488; Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Carriere M, 2007, J MED VIROL, V79, P155, DOI 10.1002/jmv.20773; Ding B, 2011, FASEB J, V25, P301, DOI 10.1096/fj.10-166454; Florczyk UM, 2008, PHARMACOL REP, V60, P38; Frankova S, 2012, GASTROENTEROLOGIE HE, V66, pS17; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghaziani T, 2006, J HEPATOL, V45, P5, DOI 10.1016/j.jhep.2005.12.020; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Huang C, 2008, J NATL MED ASSOC, V100, P1425, DOI 10.1016/S0027-9684(15)31542-X; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Li LY, 2003, GASTROENTEROLOGY, V125, P460, DOI 10.1016/S0016-5085(03)00906-5; Maines MD, 2010, CURR DRUG TARGETS, V11, P1586; Maines MD, 2001, ADV EXP MED BIOL, V502, P249; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Nemecek V, 2003, Cent Eur J Public Health, V11 Suppl, pS54; Nemecek V, 2009, EPIDEMIOL MIKROBI IM, V58, P63; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Peterhans E, 1997, BIOL TRACE ELEM RES, V56, P107, DOI 10.1007/BF02778986; Sass G, 2004, HEPATOLOGY, V40, P1128, DOI 10.1002/hep.20450; Sass G, 2003, HEPATOLOGY, V38, P909, DOI 10.1053/jhep.2003.50386; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Vreman HJ, 1988, CURRENT PROTOCOLS TO, P921; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; WANG JT, 1992, J INFECT DIS, V166, P1167, DOI 10.1093/infdis/166.5.1167; Wen F, 2008, CELL BIOL TOXICOL, V24, P175, DOI 10.1007/s10565-007-9027-9; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; World Health Organization (WHO), HEP C; YAMAGUCHI T, 1994, J BIOL CHEM, V269, P24343; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491; Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921	40	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57555	10.1371/journal.pone.0057555	http://dx.doi.org/10.1371/journal.pone.0057555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536765	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100011
J	Simpson, AJR; Reiss, JD				Simpson, Andrew J. R.; Reiss, Joshua D.			The Dynamic Range Paradox: A Central Auditory Model of Intensity Change Detection	PLOS ONE			English	Article							AMPLITUDE-MODULATION; NERVE-FIBERS; PURE-TONES; DISCRIMINATION; LEVEL; LOUDNESS; SENSITIVITY; INCREMENT; ADAPTATION; DECREMENTS	In this paper we use empirical loudness modeling to explore a perceptual sub-category of the dynamic range problem of auditory neuroscience. Humans are able to reliably report perceived intensity (loudness), and discriminate fine intensity differences, over a very large dynamic range. It is usually assumed that loudness and intensity change detection operate upon the same neural signal, and that intensity change detection may be predicted from loudness data and vice versa. However, while loudness grows as intensity is increased, improvement in intensity discrimination performance does not follow the same trend and so dynamic range estimations of the underlying neural signal from loudness data contradict estimations based on intensity just-noticeable difference (JND) data. In order to account for this apparent paradox we draw on recent advances in auditory neuroscience. We test the hypothesis that a central model, featuring central adaptation to the mean loudness level and operating on the detection of maximum central-loudness rate of change, can account for the paradoxical data. We use numerical optimization to find adaptation parameters that fit data for continuous-pedestal intensity change detection over a wide dynamic range. The optimized model is tested on a selection of equivalent pseudo-continuous intensity change detection data. We also report a supplementary experiment which confirms the modeling assumption that the detection process may be modeled as rate-of-change. Data are obtained from a listening test (N = 10) using linearly ramped increment-decrement envelopes applied to pseudo-continuous noise with an overall level of 33 dB SPL. Increments with half-ramp durations between 5 and 50,000 ms are used. The intensity JND is shown to increase towards long duration ramps (p<10(-6)). From the modeling, the following central adaptation parameters are derived; central dynamic range of 0.215 sones, 95% central normalization, and a central loudness JND constant of 5.5x10(-5) sones per ms. Through our findings, we argue that loudness reflects peripheral neural coding, and the intensity JND reflects central neural coding.	[Simpson, Andrew J. R.; Reiss, Joshua D.] Queen Mary Univ London, Ctr Digital Mus, London, England	University of London; Queen Mary University London	Simpson, AJR (corresponding author), Queen Mary Univ London, Ctr Digital Mus, London, England.	andy.simpson@eecs.qmul.ac.uk			Engineering and Physical Sciences Research Council Doctoral Training Account studentship at Queen Mary University of London	Engineering and Physical Sciences Research Council Doctoral Training Account studentship at Queen Mary University of London	The first author was supported by a Engineering and Physical Sciences Research Council Doctoral Training Account (www.epsrc.ac.uk) studentship at Queen Mary University of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Allen JB, 1997, J ACOUST SOC AM, V102, P3628, DOI 10.1121/1.420150; BUUS S, 1990, J ACOUST SOC AM, V87, P2643, DOI 10.1121/1.399057; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; EVANS EF, 1980, EXP BRAIN RES, V40, P115; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; Fletcher H, 1922, PHYS REV, V19, P553, DOI 10.1103/PhysRev.19.553; FLORENTINE M, 1981, J ACOUST SOC AM, V70, P1646, DOI 10.1121/1.387219; Gallun FJ, 2006, J ACOUST SOC AM, V119, P3919, DOI 10.1121/1.2200136; Glasberg BR, 2002, J AUDIO ENG SOC, V50, P331; Glasberg BR, 2001, HEARING RES, V155, P41, DOI 10.1016/S0378-5955(01)00244-1; HELLMAN WS, 1990, J ACOUST SOC AM, V87, P1255, DOI 10.1121/1.398801; Hellman WS, 2001, J ACOUST SOC AM, V109, P2098, DOI 10.1121/1.1366373; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; MCGILL WJ, 1968, J ACOUST SOC AM, V44, P576, DOI 10.1121/1.1911123; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; MILLER GA, 1947, J ACOUST SOC AM, V19, P609, DOI 10.1121/1.1916528; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Neely ST, 1998, PSYCHOPHYSICAL PHYSL, P458; Oxenham AJ, 1997, J ACOUST SOC AM, V102, P1779, DOI 10.1121/1.420086; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Pienkowski M, 2009, HEARING RES, V253, P107, DOI 10.1016/j.heares.2009.03.013; Plack CJ, 2006, J ACOUST SOC AM, V119, P3950, DOI 10.1121/1.2198184; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; Riesz RR, 1928, PHYS REV, V31, P0867, DOI 10.1103/PhysRev.31.867; SACHS MB, 1974, J ACOUST SOC AM, V56, P1835, DOI 10.1121/1.1903521; VIEMEISTER NF, 1988, J ACOUST SOC AM, V84, P172, DOI 10.1121/1.396961; VIEMEISTER NF, 1983, SCIENCE, V221, P1206, DOI 10.1126/science.6612337; Weber E. H., 1846, HANDWORTERBUCH PHYSL, VIII/2, P481; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; Wojtczak M, 1999, J ACOUST SOC AM, V106, P1917, DOI 10.1121/1.427940	35	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57497	10.1371/journal.pone.0057497	http://dx.doi.org/10.1371/journal.pone.0057497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23536749	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900105
J	Albouy, G; Sterpenich, V; Vandewalle, G; Darsaud, A; Gais, S; Rauchs, G; Desseilles, M; Boly, M; Thanh, DV; Balteau, E; Degueldre, C; Phillips, C; Luxen, A; Maquet, P				Albouy, Genevieve; Sterpenich, Virginie; Vandewalle, Gilles; Darsaud, Annabelle; Gais, Steffen; Rauchs, Geraldine; Desseilles, Martin; Boly, Melanie; Thanh Dang-Vu; Balteau, Evelyne; Degueldre, Christian; Phillips, Christophe; Luxen, Andre; Maquet, Pierre			Interaction between Hippocampal and Striatal Systems Predicts Subsequent Consolidation of Motor Sequence Memory	PLOS ONE			English	Article							SLOW-WAVE SLEEP; PREFRONTAL CORTEX; SKILLED PERFORMANCE; TIME-COURSE; BRAIN; FMRI; ACQUISITION; PLASTICITY; IMPLICIT; DISSOCIATION	The development of fast and reproducible motor behavior is a crucial human capacity. The aim of the present study was to address the relationship between the implementation of consistent behavior during initial training on a sequential motor task (the Finger Tapping Task) and subsequent sleep-dependent motor sequence memory consolidation, using functional magnetic resonance imaging (fMRI) and total sleep deprivation protocol. Our behavioral results indicated significant offline gains in performance speed after sleep whereas performance was only stabilized, but not enhanced, after sleep deprivation. At the cerebral level, we previously showed that responses in the caudate nucleus increase, in parallel to a decrease in its functional connectivity with frontal areas, as performance became more consistent. Here, the strength of the competitive interaction, assessed through functional connectivity analyses, between the caudate nucleus and hippocampo-frontal areas during initial training, predicted delayed gains in performance at retest in sleepers but not in sleep-deprived subjects. Moreover, during retest, responses increased in the hippocampus and medial prefrontal cortex in sleepers whereas in sleep-deprived subjects, responses increased in the putamen and cingulate cortex. Our results suggest that the strength of the competitive interplay between the striatum and the hippocampus, participating in the implementation of consistent motor behavior during initial training, conditions subsequent motor sequence memory consolidation. The latter process appears to be supported by a reorganisation of cerebral activity in hippocampo-neocortical networks after sleep.	[Albouy, Genevieve; Sterpenich, Virginie; Vandewalle, Gilles; Darsaud, Annabelle; Gais, Steffen; Rauchs, Geraldine; Desseilles, Martin; Boly, Melanie; Thanh Dang-Vu; Balteau, Evelyne; Degueldre, Christian; Phillips, Christophe; Luxen, Andre; Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Albouy, Genevieve] Univ Lyon, Lyon, France	University of Liege	Maquet, P (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	pmaquet@ulg.ac.be	ALBOUY, Genevieve/K-5350-2015; RAUCHS, Géraldine/L-7921-2015; ALBOUY, Genevieve/P-4723-2019; Phillips, Christophe/M-3025-2017	ALBOUY, Genevieve/0000-0002-5437-023X; RAUCHS, Géraldine/0000-0001-7128-2189; ALBOUY, Genevieve/0000-0002-5437-023X; Phillips, Christophe/0000-0002-4990-425X; Vandewalle, Gilles/0000-0003-2483-2752; Desseilles, Martin/0000-0003-4748-3401; Sterpenich, Virginie/0000-0002-2125-833X; Dang Vu, Thien Thanh/0000-0002-7235-2721; Boly, Melanie/0000-0001-9584-0907; , Pierre/0000-0003-3106-3357	Belgian F.N.R.S.; Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; French 'Ministere de la Recherche'; PAI/IAP Interuniversity Pole of Attraction Grant; F.N.R.S.; Fondation Fyssen	Belgian F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; French 'Ministere de la Recherche'(Ministry of Research, France); PAI/IAP Interuniversity Pole of Attraction Grant; F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Fondation Fyssen	This study was supported by the Belgian F.N.R.S., the Fondation Medicale Reine Elisabeth, the Research Fund of ULg, and PAI/IAP Interuniversity Pole of Attraction. GA was first supported by a PhD grant from the French 'Ministere de la Recherche' and then supported by a PAI/IAP Interuniversity Pole of Attraction Grant. VS, GV, MD, MB, TDV, EB and PM were supported by F.N.R.S. AD and GR were supported by the Fondation Fyssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; Destrebecqz A, 2003, COGNITIVE BRAIN RES, V16, P391, DOI 10.1016/S0926-6410(03)00053-3; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moses SN, 2010, HIPPOCAMPUS, V20, P894, DOI 10.1002/hipo.20735; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2010, NEUROIMAGE, V49, P694, DOI 10.1016/j.neuroimage.2009.08.055; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Penhune VB, 2005, NEUROIMAGE, V26, P801, DOI 10.1016/j.neuroimage.2005.02.041; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Press DZ, 2005, BRAIN RES COGN BRAIN; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rickard TC, 1999, J EXP PSYCHOL LEARN, V25, P532, DOI 10.1037/0278-7393.25.2.532; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503	52	74	74	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59490	10.1371/journal.pone.0059490	http://dx.doi.org/10.1371/journal.pone.0059490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533626	Green Published, gold			2022-12-27	WOS:000316549400063
J	Chen, ZY; Wang, B; Hu, J; Yang, WS; Cao, ZJ; Zhuo, RX; Li, WX; Wu, YL				Chen, Zongyun; Wang, Bin; Hu, Jun; Yang, Weishan; Cao, Zhijian; Zhuo, Renxi; Li, Wenxin; Wu, Yingliang			SjAPI, the First Functionally Characterized Ascaris-Type Protease Inhibitor from Animal Venoms	PLOS ONE			English	Article							KUNITZ-TYPE PROTEASE; CHYMOTRYPSIN ELASTASE; TRYPSIN-INHIBITOR; POTASSIUM CHANNEL; MOLECULAR-STRUCTURE; SERINE; ISOINHIBITORS; LUMBRICOIDES; PEPTIDE; SPECIFICITY	Background: Serine protease inhibitors act as modulators of serine proteases, playing important roles in protecting animal toxin peptides from degradation. However, all known serine protease inhibitors discovered thus far from animal venom belong to the Kunitz-type subfamily, and whether there are other novel types of protease inhibitors in animal venom remains unclear. Principal Findings: Here, by screening scorpion venom gland cDNA libraries, we identified the first Ascaris-type animal toxin family, which contains four members: Scorpiops jendeki Ascaris-type protease inhibitor (SjAPI), Scorpiops jendeki Ascaris-type protease inhibitor 2 (SjAPI-2), Chaerilus tricostatus Ascaris-type protease inhibitor (CtAPI), and Buthus martensii Ascaris-type protease inhibitor (BmAPI). The detailed characterization of Ascaris-type peptide SjAPI from the venom gland of scorpion Scorpiops jendeki was carried out. The mature peptide of SjAPI contains 64 residues and possesses a classical Ascaris-type cysteine framework reticulated by five disulfide bridges, different from all known protease inhibitors from venomous animals. Enzyme and inhibitor reaction kinetics experiments showed that recombinant SjAPI was a dual function peptide with alpha-chymotrypsin- and elastase-inhibiting properties. Recombinant SjAPI inhibited alpha-chymotrypsin with a Ki of 97.1 nM and elastase with a Ki of 3.7 mu M, respectively. Bioinformatics analyses and chimera experiments indicated that SjAPI contained the unique short side chain functional residues "AAV" and might be a useful template to produce new serine protease inhibitors. Conclusions/Significance: To our knowledge, SjAPI is the first functionally characterized animal toxin peptide with an Ascaris-type fold. The structural and functional diversity of animal toxins with protease-inhibiting properties suggested that bioactive peptides from animal venom glands might be a new source of protease inhibitors, which will accelerate the development of diagnostic and therapeutic agents for human diseases that target diverse proteases.	[Chen, Zongyun; Wang, Bin; Hu, Jun; Yang, Weishan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Chen, Zongyun; Zhuo, Renxi] Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Dept Chem, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; ylwu@whu.edu.cn			National Basic Research Program of China [2010CB529800, 2009CB918600]; National High Technology Research and Development Program of China [2012AA020304]; China Postdoctoral Science Foundation [2012M511659]; National Natural Sciences Foundation of China [30530140, 31071942, 30900265, 30973636, 90813017]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2010CB529800 and 2009CB918600), National High Technology Research and Development Program of China (2012AA020304), the China Postdoctoral Science Foundation (2012M511659), and the National Natural Sciences Foundation of China (30530140, 31071942, 30900265, 30973636, and 90813017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIN DR, 1984, ARCH BIOCHEM BIOPHYS, V232, P143, DOI 10.1016/0003-9861(84)90530-7; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Fook JMSLL, 2005, LIFE SCI, V76, P2881, DOI 10.1016/j.lfs.2004.10.053; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gomes CEM, 2005, PLANT PHYSIOL BIOCH, V43, P1095, DOI 10.1016/j.plaphy.2005.11.004; GRASBERGER BL, 1994, STRUCTURE, V2, P669, DOI 10.1016/S0969-2126(00)00067-8; GRONENBORN AM, 1990, BIOCHEMISTRY-US, V29, P183, DOI 10.1021/bi00453a025; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; He YY, 2008, PEPTIDES, V29, P1692, DOI 10.1016/j.peptides.2008.05.025; HOOGSTRATEN CG, 1995, PROTEIN SCI, V4, P2289, DOI 10.1002/pro.5560041106; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Jin XA, 2011, PARASITOL RES, V108, P287, DOI 10.1007/s00436-010-2055-z; Kim H, 2008, J MOL BIOL, V376, P184, DOI 10.1016/j.jmb.2007.11.089; Lee HJ, 2003, PROTEIN EXPRES PURIF, V31, P99, DOI 10.1016/S1046-5928(03)00160-8; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Liu JH, 1996, BIOCHEMISTRY-US, V35, P1516, DOI 10.1021/bi952466d; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036; Mignogna G, 1996, PROTEIN SCI, V5, P357; Minagawa S, 1997, COMP BIOCHEM PHYS B, V118, P381, DOI 10.1016/S0305-0491(97)00174-0; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; PEANASKY RJ, 1984, ARCH BIOCHEM BIOPHYS, V232, P127, DOI 10.1016/0003-9861(84)90528-9; PEANASKY RJ, 1984, ARCH BIOCHEM BIOPHYS, V232, P135, DOI 10.1016/0003-9861(84)90529-0; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Rios-Steiner JL, 2007, J MOL BIOL, V371, P774, DOI 10.1016/j.jmb.2007.05.042; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Wu YL, 2004, BIOPHYS J, V87, P105, DOI 10.1529/biophysj.103.039156; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zeng XC, 2000, TOXICON, V38, P893, DOI 10.1016/S0041-0101(99)00192-0; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhao YM, 2012, P NATL ACAD SCI USA, V109, P1542, DOI 10.1073/pnas.1109912109	41	30	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57529	10.1371/journal.pone.0057529	http://dx.doi.org/10.1371/journal.pone.0057529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533574	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400011
J	Fuke, T; Mizuno, S; Nagai, T; Hasegawa, T; Horikawa, R; Miyoshi, Y; Muroya, K; Kondoh, T; Numakura, C; Sato, S; Nakabayashi, K; Tayama, C; Hata, K; Sano, S; Matsubara, K; Kagami, M; Yamazawa, K; Ogata, T				Fuke, Tomoko; Mizuno, Seiji; Nagai, Toshiro; Hasegawa, Tomonobu; Horikawa, Reiko; Miyoshi, Yoko; Muroya, Koji; Kondoh, Tatsuro; Numakura, Chikahiko; Sato, Seiji; Nakabayashi, Kazuhiko; Tayama, Chiharu; Hata, Kenichiro; Sano, Shinichiro; Matsubara, Keiko; Kagami, Masayo; Yamazawa, Kazuki; Ogata, Tsutomu			Molecular and Clinical Studies in 138 Japanese Patients with Silver-Russell Syndrome	PLOS ONE			English	Article							MATERNAL UNIPARENTAL DISOMY; IMPRINTING CENTER REGION; DNA METHYLATION; CHROMOSOME 17Q23-Q24; GENETIC ETIOLOGY; CTCF-BINDING; FETAL-GROWTH; CELL-GROWTH; H19; SUPPRESSOR	Background: Recent studies have revealed relative frequency and characteristic phenotype of two major causative factors for Silver-Russell syndrome (SRS), i.e. epimutation of the H19-differentially methylated region (DMR) and uniparental maternal disomy 7 (upd(7)mat), as well as multilocus methylation abnormalities and positive correlation between methylation index and body and placental sizes in H19-DMR epimutation. Furthermore, rare genomic alterations have been found in a few of patients with idiopathic SRS. Here, we performed molecular and clinical findings in 138 Japanese SRS patients, and examined these matters. Methodology/Principal Findings: We identified H19-DMR epimutation in cases 1-43 (group 1), upd(7)mat in cases 44-52 (group 2), and neither H19-DMR epimutation nor upd(7) mat in cases 53-138 (group 3). Multilocus analysis revealed hyper- or hypomethylated DMRs in 2.4% of examined DMRs in group 1; in particular, an extremely hypomethylated ARHI-DMR was identified in case 13. Oligonucleotide array comparative genomic hybridization identified a similar to 3.86 Mb deletion at chromosome 17q24 in case 73. Epigenotype-phenotype analysis revealed that group 1 had more reduced birth length and weight, more preserved birth occipitofrontal circumference (OFC), more frequent body asymmetry and brachydactyly, and less frequent speech delay than group 2. The degree of placental hypoplasia was similar between the two groups. In group 1, the methylation index for the H19-DMR was positively correlated with birth length and weight, present height and weight, and placental weight, but with neither birth nor present OFC. Conclusions/Significance: The results are grossly consistent with the previously reported data, although the frequency of epimutations is lower in the Japanese SRS patients than in the Western European SRS patients. Furthermore, the results provide useful information regarding placental hypoplasia in SRS, clinical phenotypes of the hypomethylated ARHI-DMR, and underlying causative factors for idiopathic SRS.	[Fuke, Tomoko; Sano, Shinichiro; Matsubara, Keiko; Kagami, Masayo; Yamazawa, Kazuki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Fuke, Tomoko; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Mizuno, Seiji] Aichi Human Serv Ctr, Cent Hosp, Dept Pediat, Nagoya, Aichi, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Horikawa, Reiko] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo, Japan; [Miyoshi, Yoko] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Muroya, Koji] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Kanagawa, Japan; [Kondoh, Tatsuro] Misakaenosono Mutsumi Dev Med & Welf Ctr, Div Dev Disabil, Isahaya, Japan; [Numakura, Chikahiko] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 99023, Japan; [Sato, Seiji] Saitama Municipal Hosp, Dept Pediat, Saitama, Japan; [Nakabayashi, Kazuhiko; Tayama, Chiharu; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Sano, Shinichiro; Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Center for Child Health & Development - Japan; Keio University; Dokkyo Medical University; National Center for Child Health & Development - Japan; Osaka University; Yamagata University; National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine	Ogata, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan.	tomogata@hama-med.ac.jp	Hasegawa, Tomonobu/L-3331-2013; Muroya, Koji/J-1304-2016	Muroya, Koji/0000-0002-1810-9894; Yamazawa, Kazuki/0000-0003-4895-2759; Ogata, Tsutomu/0000-0001-7178-9991; Kagami, Masayo/0000-0003-3020-455X	Japan Society for the Promotion of Science [22249010, 21028026]; Research on Rare and Intractable Diseases from Ministry of Health, Labor and Welfare [H24-042]; National Center for Child Health and Development [23A-1]; Grants-in-Aid for Scientific Research [22249010, 22227002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research on Rare and Intractable Diseases from Ministry of Health, Labor and Welfare; National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research (A) (22249010) and Research (B) (21028026) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), by Grant for Research on Rare and Intractable Diseases (H24-042) from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/), and by Grant for National Center for Child Health and Development (23A-1) (http://www.ncchd.go.jp/English/Englishtop.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Albrecht S, 1996, J NEUROPATH EXP NEUR, V55, P1270, DOI 10.1097/00005072-199612000-00011; Arima T, 2005, NUCLEIC ACIDS RES, V33, P2650, DOI 10.1093/nar/gki555; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Begemann M, 2012, AM J MED GENET A, V158A, P423, DOI 10.1002/ajmg.a.34412; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Binder G, 2011, BEST PRACT RES CL EN, V25, P153, DOI 10.1016/j.beem.2010.06.005; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; Brena RM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj017; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Dorr S, 2001, GENOMICS, V71, P174, DOI 10.1006/geno.2000.6413; Dorr S, 2001, HUM GENET, V109, P479, DOI 10.1007/s004390100605; Eggermann T, 2008, CLIN GENET, V74, P486, DOI 10.1111/j.1399-0004.2008.01057.x; Eggermann T, 2010, AM J MED GENET C, V154C, P355, DOI 10.1002/ajmg.c.30274; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Fisher AM, 2002, HUM GENET, V111, P290, DOI 10.1007/s00439-002-0787-2; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Fuke-Sato T, 2012, AM J MED GENET A, V158A, P465, DOI 10.1002/ajmg.a.34404; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hannula K, 2001, AM J HUM GENET, V68, P247, DOI 10.1086/316937; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hitchins MP, 2001, J MED GENET, V38, P810, DOI 10.1136/jmg.38.12.810; Hiura H, 2012, HUM REPROD, V27, P2541, DOI 10.1093/humrep/des197; Huang J, 2009, MOL CARCINOGEN, V48, P130, DOI 10.1002/mc.20461; Juan V, 2000, NUCLEIC ACIDS RES, V28, P1221, DOI 10.1093/nar/28.5.1221; Kagami M, 2008, PLACENTA, V29, P760, DOI 10.1016/j.placenta.2008.06.001; Kotzot D, 2000, EUR J PEDIATR, V159, P247, DOI 10.1007/s004310050064; Kotzot D, 2008, EUR J MED GENET, V51, P444, DOI 10.1016/j.ejmg.2008.06.001; Matsubara K, 2011, J HUM GENET, V56, P566, DOI 10.1038/jhg.2011.59; MIDRO AT, 1993, CLIN GENET, V44, P53; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Robinson WP, 2000, BIOESSAYS, V22, P452; Shaffer Lisa G., 2001, Genetics in Medicine, V3, P206, DOI 10.1097/00125817-200105000-00011; Spengler S, 2010, J MED GENET, V47, P356, DOI 10.1136/jmg.2009.070052; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Tang HL, 2012, J GASTROEN HEPATOL, V27, P1395, DOI 10.1111/j.1440-1746.2012.07146.x; Turner CLS, 2010, EUR J HUM GENET, V18, P648, DOI 10.1038/ejhg.2009.246; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wakeling EL, 2010, J MED GENET, V47, P760, DOI 10.1136/jmg.2010.079111; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Yamazawa K, 2010, J MED GENET, V47, P782, DOI 10.1136/jmg.2010.079343; Yamazawa K, 2008, J MOL MED, V86, P1171, DOI 10.1007/s00109-008-0377-4; Yamazawa K, 2008, AM J MED GENET A, V146A, P514, DOI 10.1002/ajmg.a.32125; Yamazawa K, 2011, J HUM GENET, V56, P91, DOI 10.1038/jhg.2010.142; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270	50	47	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60105	10.1371/journal.pone.0060105	http://dx.doi.org/10.1371/journal.pone.0060105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533668	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400105
J	Mildner, M; Hacker, S; Haider, T; Gschwandtner, M; Werba, G; Barresi, C; Zimmermann, M; Golabi, B; Tschachler, E; Ankersmit, HJ				Mildner, Michael; Hacker, Stefan; Haider, Thomas; Gschwandtner, Maria; Werba, Gregor; Barresi, Caterina; Zimmermann, Matthias; Golabi, Bahar; Tschachler, Erwin; Ankersmit, Hendrik Jan			Secretome of Peripheral Blood Mononuclear Cells Enhances Wound Healing	PLOS ONE			English	Article							STEM-CELLS; CONDITIONED MEDIUM; IN-VITRO; FIBROBLAST; MECHANISMS; PROMOTE; ULCERS; MEDIA	Non-healing skin ulcers are often resistant to most common therapies. Treatment with growth factors has been demonstrated to improve closure of chronic wounds. Here we investigate whether lyophilized culture supernatant of freshly isolated peripheral blood mononuclear cells (PBMC) is able to enhance wound healing. PBMC from healthy human individuals were prepared and cultured for 24 hours. Supernatants were collected, dialyzed and lyophilized (SECPBMC). Six mm punch biopsy wounds were set on the backs of C57BL/6J-mice and SECPBMC containing emulsion or controls were applied daily for three days. Morphology and neo-angiogenesis were analyzed by H&E-staining and CD31 immuno-staining, respectively. In vitro effects on diverse skin cells were investigated by migration assays, cell cycle analysis, and tube formation assay. Signaling pathways were analyzed by Western blot analysis. Application of SECPBMC on 6 mm punch biopsy wounds significantly enhanced wound closure. H&E staining of the wounds after 6 days revealed that wound healing was more advanced after application of SECPBMC containing emulsion. Furthermore, there was a massive increase in CD31 positive cells, indicating enhanced neo-angiogenesis. In primary human fibroblasts (FB) and keratinocytes (KC) migration but not proliferation was induced. In endothelial cells (EC) SECPBMC induced proliferation and tube-formation in a matrigel-assay. In addition, SECPBMC treatment of skin cells led to the induction of multiple signaling pathways involved in cell migration, proliferation and survival. In summary, we could show that emulsions containing the secretome of PBMC derived from healthy individuals accelerates wound healing in a mouse model and induce wound healing associated mechanisms in human primary skin cells. The formulation and use of such emulsions might therefore represent a possible novel option for the treatment of non-healing skin ulcers.	[Mildner, Michael; Gschwandtner, Maria; Barresi, Caterina; Tschachler, Erwin] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Hacker, Stefan] Med Univ Vienna, Dept Plast Surg, Vienna, Austria; [Hacker, Stefan; Haider, Thomas; Zimmermann, Matthias; Golabi, Bahar; Ankersmit, Hendrik Jan] Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Haider, Thomas; Zimmermann, Matthias; Golabi, Bahar; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Werba, Gregor] Med Univ Vienna, Dept Surg, Vienna, Austria; [Tschachler, Erwin] Ctr Rech & Invest Epiderm & Sensorielles CE RIES, Neuilly, France	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Ankersmit, HJ (corresponding author), Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria.	hendrik.ankersmit@meduniwien.ac.at	Haider, Thomas/AAN-2616-2021; Zimmermann, Matthias/AAE-9681-2020	Haider, Thomas/0000-0003-3192-8453; Werba, Gregor/0000-0003-1464-9065; Hacker, Stefan/0000-0002-6376-4687; Tschachler, Erwin/0000-0002-0248-1798; Zimmermann, Matthias/0000-0002-4610-7853; Mildner, Michael/0000-0002-6892-925X; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Gschwandtner, Maria/0000-0002-7944-7475	Christian Doppler Research Association; APOSIENCE AG; Medical University of Vienna; Austrian Science Fund FWF [T545-B19]	Christian Doppler Research Association; APOSIENCE AG; Medical University of Vienna; Austrian Science Fund FWF(Austrian Science Fund (FWF))	This study was funded by the Christian Doppler Research Association, APOSIENCE AG, and the Medical University of Vienna. Maria Gschwandtner was supported by a grant from the Austrian Science Fund FWF: T545-B19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The Medical University of Vienna has claimed financial interest (Patent number: PCT/EP09/67534, filed 18 Dec 2008; Patent name: PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE). Hendrik Jan Ankersmit is a shareholder of APOSIENCE AG, which owns the rights to commercialize SECPBMC for therapeutic use. All other authors declare that they have no conflict of interest. APOSIENCE AG is a funder of this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Ankersmit HJ, 2009, EUR J CLIN INVEST, V39, P445, DOI 10.1111/j.1365-2362.2009.02111.x; Asai J, 2006, J DERMATOL, V33, P349, DOI 10.1111/j.1346-8138.2006.00081.x; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Demircan PC, 2011, CYTOTHERAPY, V13, P1205, DOI 10.3109/14653249.2011.605351; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; HOLZINGER C, 1994, EUR J VASCULAR SURG, V8, P351, DOI 10.1016/S0950-821X(05)80155-0; Horn AP, 2009, NEUROSCI RES, V63, P35, DOI 10.1016/j.neures.2008.10.001; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P1283, DOI 10.1007/s00395-011-0224-6; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P645, DOI 10.1007/s00395-011-0173-0; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Sander AL, 2011, J SURG RES, V165, P165, DOI 10.1016/j.jss.2009.07.003; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Tasso R, 2012, INVEST OPHTH VIS SCI, V53, P786, DOI 10.1167/iovs.11-8211; Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Watson SL, 2010, BRIT J OPHTHALMOL, V94, P1067, DOI 10.1136/bjo.2009.165837; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007	30	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60103	10.1371/journal.pone.0060103	http://dx.doi.org/10.1371/journal.pone.0060103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533667	gold, Green Published			2022-12-27	WOS:000316549400104
J	Verdoliva, V; Senatore, C; Polci, ML; Rossi, S; Cordella, M; Carlucci, G; Marchetti, P; Antonini-Cappellini, G; Facchiano, A; D'Arcangelo, D; Facchiano, F				Verdoliva, Vincenzo; Senatore, Cinzia; Polci, Maria Letizia; Rossi, Stefania; Cordella, Martina; Carlucci, Giuseppe; Marchetti, Paolo; Antonini-Cappellini, Giancarlo; Facchiano, Antonio; D'Arcangelo, Daniela; Facchiano, Francesco			Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; IN-VITRO; GEL-ELECTROPHORESIS; LUNG-CANCER; CELL-LINES; MELANOMA; BIOMARKERS; CHROMATOGRAPHY; EXPRESSION; IDENTIFICATION	Recently developed proteomic technologies allow to profile thousands of proteins within a high-throughput approach towards biomarker discovery, although results are not as satisfactory as expected. In the present study we demonstrate that serum proteome denaturation is a key underestimated feature; in fact, a new differential denaturation protocol better discriminates serum proteins according to their electrophoretic mobility as compared to single-denaturation protocols. Sixty nine different denaturation treatments were tested and the 3 most discriminating ones were selected (TRIDENT analysis) and applied to human sera, showing a significant improvement of serum protein discrimination as confirmed by MALDITOF/ MS and LC-MS/MS identification, depending on the type of denaturation applied. Thereafter sera from mice and patients carrying cutaneous melanoma were analyzed through TRIDENT. Nine and 8 protein bands were found differentially expressed in mice and human melanoma sera, compared to healthy controls (p<0.05); three of them were found, for the first time, significantly modulated: alpha 2macroglobulin (down-regulated in melanoma, p<0.001), Apolipoprotein-E and Apolipoprotein-A1 (both up-regulated in melanoma, p<0.04), both in mice and humans. The modulation was confirmed by immunological methods. Other less abundant proteins (e.g. gelsolin) were found significantly modulated (p<0.05). Conclusions: i) serum proteome contains a large amount of information, still neglected, related to proteins folding; ii) a careful serum denaturation may significantly improve analytical procedures involving complex protein mixtures; iii) serum differential denaturation protocol highlights interesting proteomic differences between cancer and healthy sera.	[Verdoliva, Vincenzo; Senatore, Cinzia; Polci, Maria Letizia; Rossi, Stefania; Cordella, Martina; Carlucci, Giuseppe; Facchiano, Francesco] Ist Super Sanita, Dip Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Marchetti, Paolo] Univ Roma La Sapienza, Osped S Andrea, Azienda Osped St Andrea, Rome, Italy; [Antonini-Cappellini, Giancarlo] IDI IRCCS, Ist Ricovero & Cura Carattere Sci, Ist Dermopat Immacolata, Div Oncol & Oncol Dermatol 4, Rome, Italy; [Facchiano, Antonio; D'Arcangelo, Daniela] IDI IRCCS, Ist Ricovero & Cura Carattere Sci, Ist Dermopat Immacolata, Lab Dermatol Applicata, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Facchiano, F (corresponding author), Ist Super Sanita, Dip Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	francesco.facchiano@iss.it	Facchiano, Antonio/J-4744-2012; Marchetti, Paolo/J-9890-2018; Facchiano, Francesco/K-8716-2016; Facchiano, Antonio/K-5984-2016; Cordella, Martina/GYV-3261-2022; Marchetti, Paolo/K-1469-2016; D'Arcangelo, Daniela/K-6533-2016; Rossi, Stefania/J-8328-2016	Facchiano, Antonio/0000-0002-4243-2392; Marchetti, Paolo/0000-0002-9064-8761; Facchiano, Francesco/0000-0003-4313-0617; Facchiano, Antonio/0000-0002-4243-2392; D'Arcangelo, Daniela/0000-0002-7862-3289; Rossi, Stefania/0000-0002-8854-7072; Carlucci, Giuseppe/0000-0001-7494-335X	Italy-USA Oncoproteomics Program; Italian Health Ministry	Italy-USA Oncoproteomics Program; Italian Health Ministry(Ministry of Health, Italy)	This work was supported by the Italy-USA Oncoproteomics Program and by the Italian Health Ministry. The support of the Proteomic Facility at Istituto Superiore di Sanita for Complex Protein Mixture (CPM) Analysis is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025352; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Arinola Ganiyu, 2006, Reprod Biol, V6, P265; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bernhard OK, 2007, J PROTEOME RES, V6, P987, DOI 10.1021/pr0604559; Boschetti E, 2009, J CHROMATOGR A, V1216, P1215, DOI 10.1016/j.chroma.2008.11.098; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Chan KC., 2004, CLIN PROTEOM, V1, P101, DOI [DOI 10.1385/CP:1:2:101, 10.1385/CP:1:2:101]; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chromy BA, 2004, J PROTEOME RES, V3, P1120, DOI 10.1021/pr049921p; Di Girolamo F, 2011, J PROTEOMICS, V74, P589, DOI 10.1016/j.jprot.2011.01.013; DOOLITTLE R F, 1975, P109; Facchiano F, 2006, MOL ENDOCRINOL, V20, P2806, DOI 10.1210/me.2005-0322; Faraone D, 2009, NEOPLASIA, V11, P732, DOI 10.1593/neo.09408; Findeisen P, 2009, J CLIN ONCOL, V27, P2199, DOI 10.1200/JCO.2008.18.0554; Haddy N, 2002, EUR J HUM GENET, V10, P841, DOI 10.1038/sj.ejhg.5200864; Harthun NL, 1998, J IMMUNOTHER, V21, P85, DOI 10.1097/00002371-199803000-00001; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Hoagland LFM, 2007, CANCER-AM CANCER SOC, V110, P2260, DOI 10.1002/cncr.23049; KANCHA RK, 1994, ONCOL RES, V6, P365; Katerinaki E, 2003, BRIT J CANCER, V89, P1123, DOI 10.1038/sj.bjc.6601257; Leiviska J, 2011, CLIN CHIM ACTA, V412, P1146, DOI 10.1016/j.cca.2011.03.015; Lentini A, 2000, MELANOMA RES, V10, P435, DOI 10.1097/00008390-200010000-00005; Li SQ, 2007, J PROTEOME RES, V6, P150, DOI 10.1021/pr0603102; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Lisowska-Myjak B, 2006, ACTA DIABETOL, V43, P88, DOI 10.1007/s00592-006-0220-8; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; LIZONOVA A, 1990, J CELL BIOCHEM, V43, P315, DOI 10.1002/jcb.240430404; Longo C, 2011, EXP DERMATOL, V20, P29, DOI 10.1111/j.1600-0625.2010.01187.x; Lopez JL, 2007, J CHROMATOGR B, V849, P190, DOI 10.1016/j.jchromb.2006.11.049; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Mouawad R, 2010, MELANOMA RES, V20, P67, DOI 10.1097/CMR.0b013e328335a8c1; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Ping PP, 2005, PROTEOMICS, V5, P3506, DOI 10.1002/pmic.200500140; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Ray S, 2011, PROTEOMICS, V11, P2139, DOI 10.1002/pmic.201000460; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Witzmann FA, 2006, EXPERT OPIN DRUG MET, V2, P103, DOI 10.1517/17425255.2.1.103; Yang Y, 2003, J IMMUNOL, V171, P2734, DOI 10.4049/jimmunol.171.5.2734; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang HT, 2011, INT J MOL SCI, V12, P1505, DOI 10.3390/ijms12031505	45	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57104	10.1371/journal.pone.0057104	http://dx.doi.org/10.1371/journal.pone.0057104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533572	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400009
J	Chateau, ML; Denton, PW; Swanson, MD; McGowan, I; Garcia, JV				Chateau, Morgan L.; Denton, Paul W.; Swanson, Michael D.; McGowan, Ian; Garcia, J. Victor			Rectal Transmission of Transmitted/Founder HIV-1 Is Efficiently Prevented by Topical 1% Tenofovir in BLT Humanized Mice	PLOS ONE			English	Article							ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; IMMUNODEFICIENCY-VIRUS TYPE-1; HERPES-SIMPLEX-VIRUS; T-CELL RESPONSES; PHASE-III TRIAL; VAGINAL GEL; REVERSE-TRANSCRIPTASE; ANAL INTERCOURSE; DOUBLE-BLIND; INFECTION	Rectal microbicides are being developed to prevent new HIV infections in both men and women. We focused our in vivo preclinical efficacy study on rectally-applied tenofovir. BLT humanized mice (n = 43) were rectally inoculated with either the primary isolate HIV-1(JRCSF) or the MSM-derived transmitted/founder (T/F) virus HIV-1(THRO) within 30 minutes following treatment with topical 1% tenofovir or vehicle. Under our experimental conditions, in the absence of drug treatment we observed 50% and 60% rectal transmission by HIV-1(JRCSF) and HIV-1(THRO), respectively. Topical tenofovir reduced rectal transmission to 8% (1/12; log rank p = 0.03) for HIV-1(JRCSF) and 0% (0/6; log rank p = 0.02) for HIV-1(THRO). This is the first demonstration that any human T/F HIV-1 rectally infects humanized mice and that transmission of the T/F virus can be efficiently blocked by rectally applied 1% tenofovir. These results obtained in BLT mice, along with recent ex vivo, Phase 1 trial and non-human primate reports, provide a critically important step forward in the development of tenofovir-based rectal microbicides.	[Chateau, Morgan L.; Denton, Paul W.; Swanson, Michael D.; Garcia, J. Victor] Univ N Carolina, Ctr AIDS Res, Dept Internal Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [McGowan, Ian] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA USA	University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Garcia, JV (corresponding author), Univ N Carolina, Ctr AIDS Res, Dept Internal Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	victor_garcia@med.unc.edu	M, i/HCI-9242-2022; M, Ian/AAP-1032-2021	M, Ian/0000-0002-6470-8476; Denton, Paul/0000-0003-2458-8147	Combination HIV Antiretroviral Rectal Microbicide (CHARM) Program [U19 AI082637]; UNC Center for AIDS Research [P30 AI50410];  [T32CA009156];  [F32AI100775];  [AI073146]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U19AI082637, R01AI073146, F32AI100775] Funding Source: NIH RePORTER	Combination HIV Antiretroviral Rectal Microbicide (CHARM) Program; UNC Center for AIDS Research; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by: U19 AI082637 Combination HIV Antiretroviral Rectal Microbicide (CHARM) Program (Ian McGowan, PI), T32CA009156 and F32AI100775 (MS), AI073146 (JVG) and the UNC Center for AIDS Research P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abdool Karim Q, 2010, 18 INT AIDS C VIEN A; Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; [Anonymous], 2012, TRUV PREP FACT SHEET; [Anonymous], 19 C RETR OPP INF SE; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Chang H, 2012, GENES IMMUN, V13, P399, DOI 10.1038/gene.2012.16; Chateau M, 2012, J VIROL; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2012, NEW ENGL J MED, V367, P459, DOI 10.1056/NEJMe1207438; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Denton PW, 2012, MUCOSAL IMMUNOL, V5, P555, DOI 10.1038/mi.2012.31; Denton PW, 2012, TRENDS MICROBIOL, V20, P268, DOI 10.1016/j.tim.2012.03.007; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Dezzutti CS, 2012, ANTIVIR RES, V96, P221, DOI 10.1016/j.antiviral.2012.08.004; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Feinberg J, 2012, ANN INTERN MED; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Hendrix CW, 2012, CURR OPIN HIV AIDS E; Hu Z, 2012, CELL MOL IMMUNOL, V9, P232, DOI 10.1038/cmi.2011.63; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P1265, DOI 10.2105/AJPH.88.8.1265-a; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landovitz Raphael J, 2007, Top HIV Med, V15, P99; Lane T, 2006, AIDS, V20, P123, DOI 10.1097/01.aids.0000198083.55078.02; Long BR, 2012, J VIROL, V86, P3327, DOI 10.1128/JVI.06676-11; Ma SD, 2012, J VIROL, V86, P7976, DOI 10.1128/JVI.00770-12; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McGowan I, 2012, CURR OPIN HIV AIDS, V7, P526, DOI 10.1097/COH.0b013e3283582bc2; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; McGowan I, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P85, DOI 10.1016/B978-0-12-374235-3.00004-2; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; Mosher William D, 2005, Adv Data, P1; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Phillips DM, 1998, CONTRACEPTION, V57, P341, DOI 10.1016/S0010-7824(98)00040-7; Power K.A., 2012, SCI TRANSL MED, V4; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Singer R, 2011, J VIROL, V85, P5504, DOI 10.1128/JVI.02422-10; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tabet SR, 1999, SEX TRANSM DIS, V26, P564, DOI 10.1097/00007435-199911000-00005; Tan DHS, 2012, INT J WOMENS HEALTH, V4, P341, DOI 10.2147/IJWH.S27601; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; US-CDC, 2010, HIV AIDS SURVEILLANC, V22; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; Wheeler LA, 2011, J CLIN INVEST, V121, P2401, DOI 10.1172/JCI45876; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; WHO-UNAIDS, 2011, PROGR REP 2011 GLOB; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	94	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60024	10.1371/journal.pone.0060024	http://dx.doi.org/10.1371/journal.pone.0060024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527295	Green Published, gold, Green Accepted			2022-12-27	WOS:000317562600112
J	Caine, EA; Partidos, CD; Santangelo, JD; Osorio, JE				Caine, Elizabeth A.; Partidos, Charalambos D.; Santangelo, Joseph D.; Osorio, Jorge E.			Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; INFECTION; CHILDREN; STRAIN; EFFICACY; IMMUNITY; DISEASE; MUSCLE	Non-polio enteroviruses, including enterovirus 71 (EV71), have caused severe and fatal cases of hand, foot and mouth disease (HFMD) in the Asia-Pacific region. The development of a vaccine or antiviral against these pathogens has been hampered by the lack of a reliable small animal model. In this study, a mouse adapted EV71 strain was produced by conducting serial passages through A129 (alpha/beta interferon (IFN) receptor deficient) and AG129 (alpha/beta, gamma IFN receptor deficient) mice. A B2 sub genotype of EV71 was inoculated intraperitoneally (i.p.) into neonatal AG129 mice and brain-harvested virus was subsequently passaged through 12 and 15 day-old A129 mice. When tested in 10 week-old AG129 mice, this adapted strain produced 100% lethality with clinical signs including limb paralysis, eye irritation, loss of balance, and death. This virus caused only 17% mortality in same age A129 mice, confirming that in the absence of a functional IFN response, adult AG129 mice are susceptible to infection by adapted EV71 isolates. Subsequent studies in adult AG129 and young A129 mice with the adapted EV71 virus examined the efficacy of an inactivated EV71 candidate vaccine and determined the role of humoral immunity in protection. Passive transfer of rabbit immune sera raised against the EV71 vaccine provided protection in a dose dependent manner in 15 day-old A129 mice. Intramuscular injections (i.m.) in five week-old AG129 mice with the alum adjuvanted vaccine also provided protection against the mouse adapted homologous strain. No clinical signs of disease or mortality were observed in vaccinated animals, which received a prime-and-boost, whereas 71% of control animals were euthanized after exhibiting systemic clinical signs (P<0.05). The development of this animal model will facilitate studies on EV71 pathogenesis, antiviral testing, the evaluation of immunogenicity and efficacy of vaccine candidates, and has the potential to establish correlates of protection studies.	[Caine, Elizabeth A.; Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Partidos, Charalambos D.; Osorio, Jorge E.] Inviragen Inc, Madison, WI USA; [Santangelo, Joseph D.] Inviragen Inc, Singapore, Singapore	University of Wisconsin System; University of Wisconsin Madison	Caine, EA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	ecaine@wisc.edu			School of Veterinary Medicine at the University of Wisconsin-Madison	School of Veterinary Medicine at the University of Wisconsin-Madison	This work was supported by the School of Veterinary Medicine at the University of Wisconsin-Madison. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WPRO HAND FOOT MOUTH; [Anonymous], 2012, WHO GLOBAL ALERT RES; Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Brewoo JN, 2012, VACCINE, V30, P1513, DOI 10.1016/j.vaccine.2011.11.072; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Hao B., 2012, FA YI XUE ZA ZHI, V28, P91; Hao Bo, 2012, Fa Yi Xue Za Zhi, V28, P85; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Komatsu T, 1996, J NEUROIMMUNOL, V68, P101, DOI 10.1016/0165-5728(96)00083-5; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; REED L. J., 1938, AMER JOUR HYG, V27, P493; REN RB, 1992, J INFECT DIS, V166, P747, DOI 10.1093/infdis/166.4.747; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; SUTTER RW, 1995, ANN NY ACAD SCI, V754, P289, DOI 10.1111/j.1749-6632.1995.tb44462.x; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wang W, 2011, MICROBES INFECT, V13, P862, DOI 10.1016/j.micinf.2011.04.004; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Zaini Z, 2012, VIRUS RES; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025	35	30	36	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59501	10.1371/journal.pone.0059501	http://dx.doi.org/10.1371/journal.pone.0059501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527208	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100141
J	Gilbert, NM; Lewis, WG; Lewis, AL				Gilbert, Nicole M.; Lewis, Warren G.; Lewis, Amanda L.			Clinical Features of Bacterial Vaginosis in a Murine Model of Vaginal Infection with Gardnerella vaginalis	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; TRICHOMONAS-VAGINALIS; NEISSERIA-GONORRHOEAE; SIALIDASE ACTIVITY; ESCHERICHIA-COLI; IMMUNOGLOBULIN-A; PRETERM DELIVERY; EPITHELIAL-CELLS; WOMEN; VAGINITIS	Bacterial vaginosis (BV) is a dysbiosis of the vaginal flora characterized by a shift from a Lactobacillus-dominant environment to a polymicrobial mixture including Actinobacteria and Gram-negative bacilli. BV is a common vaginal condition in women and is associated with increased risk of sexually transmitted infection and adverse pregnancy outcomes such as preterm birth. Gardnerella vaginalis is one of the most frequently isolated bacterial species in BV. However, there has been much debate in the literature concerning the contribution of G. vaginalis to the etiology of BV, since it is also present in a significant proportion of healthy women. Here we present a new murine vaginal infection model with a clinical isolate of G. vaginalis. Our data demonstrate that this model displays key features used clinically to diagnose BV, including the presence of sialidase activity and exfoliated epithelial cells with adherent bacteria (reminiscent of clue cells). G. vaginalis was capable of ascending uterine infection, which correlated with the degree of vaginal infection and level of vaginal sialidase activity. The host response to G. vaginalis infection was characterized by robust vaginal epithelial cell exfoliation in the absence of histological inflammation. Our analyses of clinical specimens from women with BV revealed a measureable epithelial exfoliation response compared to women with normal flora, a phenotype that, to our knowledge, is measured here for the first time. The results of this study demonstrate that G. vaginalis is sufficient to cause BV phenotypes and suggest that this organism may contribute to BV etiology and associated complications. This is the first time vaginal infection by a BV associated bacterium in an animal has been shown to parallel the human disease with regard to clinical diagnostic features. Future studies with this model should facilitate investigation of important questions regarding BV etiology, pathogenesis and associated complications.	[Gilbert, Nicole M.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Warren G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Gilbert, Nicole/0000-0003-4830-3257; Lewis, Amanda/0000-0001-6195-3030	March of Dimes; Barnes-Jewish Hospital Foundation; American Heart Association; NIH [P50DK064540-11]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Barnes-Jewish Hospital Foundation; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a Basil O' Connor award from the March of Dimes (to ALL), a Translational Research Pilot Grant funded by the Barnes-Jewish Hospital Foundation (to ALL and WGL), and a postdoctoral fellowship from the American Heart Association (to NMG). The study was also supported in part by NIH grant P50DK064540-11 (PI: Hultgren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; Alnaif B, 2001, J Low Genit Tract Dis, V5, P7, DOI 10.1046/j.1526-0976.2001.51002.x; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; BASU J, 1992, AM J OBSTET GYNECOL, V167, P1904, DOI 10.1016/0002-9378(92)91795-C; BENITO R, 1986, J MED MICROBIOL, V21, P357, DOI 10.1099/00222615-21-4-357; BERARDIGRASSIAS L, 1988, EUR J CLIN MICROBIOL, V7, P406, DOI 10.1007/BF01962348; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; BLACKWELL A, 1982, BRIT J VENER DIS, V58, P387; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003; Cauci S, 2002, J INFECT DIS, V185, P1614, DOI 10.1086/340417; Cauci Sabina, 2004, Curr Infect Dis Rep, V6, P450, DOI 10.1007/s11908-004-0064-8; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; COOK RL, 1989, J INFECT DIS, V160, P490, DOI 10.1093/infdis/160.3.490; Crouch ML, 1999, MICROBIOL-SGM, V145, P2835, DOI 10.1099/00221287-145-10-2835; Dahlblom Victor, 2012, J Infect Public Health, V5, P133, DOI 10.1016/j.jiph.2011.11.007; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; DEBOER JM, 1988, CAN J MICROBIOL, V34, P757; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Fagundes CT, 2011, MICROBES INFECT, V13, P1121, DOI 10.1016/j.micinf.2011.07.012; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; FUKUSHI Y, 1979, INVEST UROL, V17, P61; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giraldo PC, 2012, AM J REPROD IMMUNOL, V67, P198, DOI 10.1111/j.1600-0897.2011.01093.x; Gonzalez Pedraza Aviles A, 1999, Rev Latinoam Microbiol, V41, P25; Hang L, 1999, J IMMUNOL, V162, P3037; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Trinh HT, 2011, PLANTA MED, V77, P1996, DOI 10.1055/s-0031-1280094; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Joo HM, 2011, INT IMMUNOPHARMACOL, V11, P1758, DOI 10.1016/j.intimp.2011.07.002; Justice SS, 2012, CELL HOST MICROBE, V11, P4, DOI 10.1016/j.chom.2012.01.001; Kaul R, 2007, J INFECT DIS, V196, P1692, DOI 10.1086/522006; KRISTIANSEN FV, 1987, BRIT J OBSTET GYNAEC, V94, P979, DOI 10.1111/j.1471-0528.1987.tb02273.x; Lewis AL, 2012, CELLULAR MICROBIOLOG; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Liu YR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00052; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Mahendrappa KB, 2010, INDIAN PEDIATR, V47, P629, DOI 10.1007/s13312-010-0129-8; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Marrs CN, 2012, MICROBES INFECT, V14, P500, DOI 10.1016/j.micinf.2011.12.009; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; MONAHAN JJ, 1975, ANAL BIOCHEM, V63, P620, DOI 10.1016/0003-2697(75)90390-5; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Pires R, 2010, ANTIMICROB AGENTS CH, V54, P2677, DOI 10.1128/AAC.01536-09; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Sarantis H, 2012, INFECT IMMUN, V80, P345, DOI 10.1128/IAI.05702-11; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Teixeira GS, 2012, J MED MICROBIOL, V61, P1074, DOI 10.1099/jmm.0.041962-0; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Tosun I, 2007, MIKROBIYOL BUL, V41, P21; Udayalaxmi J, 2011, INDIAN J MED MICROBI, V29, P165, DOI 10.4103/0255-0857.81798; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Villegas H, 1997, ARCH ANDROLOGY, V39, P147, DOI 10.3109/01485019708987913; Villegas-castrejon H, 1992, Arch AIDS Res, V6, P177; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; Weissenbacher T, 2010, ARCH GYNECOL OBSTET, V281, P77, DOI 10.1007/s00404-009-1072-6; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Yano J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046311; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	105	77	82	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59539	10.1371/journal.pone.0059539	http://dx.doi.org/10.1371/journal.pone.0059539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527214	Green Published, gold			2022-12-27	WOS:000317562100145
J	Hu, D; Weiner, HL; Ritz, J				Hu, Dan; Weiner, Howard L.; Ritz, Jerome			Identification of Cytolytic CD161(-)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NATURAL-KILLER-CELLS; DENDRITIC CELLS; SELF-TOLERANCE; EXPRESSION; SUBSET; CD27; STIMULATION; LYMPHOCYTES; BIOLOGY	We previously developed methods for establishing CD8 regulatory T cell (Treg) clones from normal human peripheral blood and demonstrated that these clones were capable of killing T cell receptor (TCR)-activated autologous CD4 T cells. Based on phenotypic and functional characterization of the CD8 Treg clones, we have identified a corresponding population of endogenous CD8 Treg in normal human peripheral blood. These cells appear morphologically as large lymphocytes with abundant cytoplasm and have the following unique phenotype: CD3(+)CD8(+)CD161(-)CD56(+). The majority of CD8 Treg express CD45RA and CD62L with low or negative expression of CD45RO, CD25, CD27, CD28 and CCR7. The expression of CD94 and NKG2a on CD8 Treg was elevated compared to conventional CD8 T cells. Following in vitro activation, this T cell subset is capable of killing TCR-activated CD4 T cells. These studies identify an endogenous CD8 Treg population in humans and it will now be possible to characterize these cells in a variety of clinical conditions.	[Hu, Dan; Weiner, Howard L.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Hu, Dan; Ritz, Jerome] Dana Farber Canc Inst, Div Hematol Malignancies, Canc Vaccine Ctr, Boston, MA 02115 USA; [Hu, Dan; Weiner, Howard L.; Ritz, Jerome] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Ritz, J (corresponding author), Dana Farber Canc Inst, Div Hematol Malignancies, Canc Vaccine Ctr, Boston, MA 02115 USA.	Jerome_Ritz@dfci.harvard.edu	Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669	National Institutes of Health [AI29530, CA142106]; National Multiple Sclerosis Society; NATIONAL CANCER INSTITUTE [P01CA142106, R01CA183560, R01CA183559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by National Institutes of Health (AI29530 and CA142106 to J.R.) and the National Multiple Sclerosis Society (to H. L. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2007, J IMMUNOL, V179, P221, DOI 10.4049/jimmunol.179.1.221; BALLAS ZK, 1990, J IMMUNOL, V145, P1039; BAUME DM, 1990, CELL IMMUNOL, V131, P352, DOI 10.1016/0008-8749(90)90260-X; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Carrasco J, 2006, BLOOD, V108, P2897, DOI 10.1182/blood-2005-11-007237; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Correale J, 2008, J NEUROIMMUNOL, V195, P121, DOI 10.1016/j.jneuroim.2007.12.004; Elrefaei M, 2007, J IMMUNOL, V178, P3265, DOI 10.4049/jimmunol.178.5.3265; GRIFFIN JD, 1983, J IMMUNOL, V130, P2947; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; HERCEND T, 1985, J CLIN INVEST, V75, P932, DOI 10.1172/JCI111794; HINTZEN RQ, 1993, J IMMUNOL, V151, P2426; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Hu D, 2012, EUR J IMMUNOL, V42, P69, DOI 10.1002/eji.201141618; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANIER LL, 1994, J IMMUNOL, V153, P2417; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; RITZ J, 1985, SCIENCE, V228, P1540, DOI 10.1126/science.2409597; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; SCHMIDT RE, 1986, J EXP MED, V164, P351, DOI 10.1084/jem.164.1.351; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59545	10.1371/journal.pone.0059545	http://dx.doi.org/10.1371/journal.pone.0059545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527216	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100146
J	Windau, K; Viertlboeck, BC; Gobel, TW				Windau, Katharina; Viertlboeck, Birgit C.; Goebel, Thomas W.			The Turkey Ig-Like Receptor Family: Identification, Expression and Function	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNE-RESPONSES; MULTIGENE FAMILY; COMPLEX ENCODES; FC-RECEPTOR; CHICKEN; EVOLUTION; GENES; CLUSTER; DIVERSE	The chicken leukocyte receptor complex located on microchromosome 31 encodes the chicken Ig-like receptors (CHIR), a vastly expanded gene family which can be further divided into three subgroups: activating CHIR-A, bifunctional CHIR-AB and inhibitory CHIR-B. Here, we investigated the presence of CHIR homologues in other bird species. The available genome databases of turkey, duck and zebra finch were screened with different strategies including BLAST searches employing various CHIR sequences, and keyword searches. We could not identify CHIR homologues in the distantly related zebra finch and duck, however, several partial and complete sequences of CHIR homologues were identified on chromosome 3 of the turkey genome. They were designated as turkey Ig-like receptors (TILR). Using cDNA derived from turkey blood and spleen RNA, six full length TILR could be amplified and further divided according to the typical sequence features into one activating TILR-A, one inhibitory TILR-B and four bifunctional TILR-AB. Since the TILR-AB sequences all displayed the critical residues shown to be involved in binding to IgY, we next confirmed the IgY binding using a soluble TILR-AB1-huIg fusion protein. This fusion protein reacted with IgY derived from various gallinaceous birds, but not with IgY from other bird species. Finally, we tested various mab directed against CHIR for their crossreactivity with either turkey or duck leukocytes. Whereas no staining was detectable with duck cells, the CHIR-AB1 specific mab 8D12 and the CHIR-A2 specific mab 13E2 both reacted with a leukocyte subpopulation that was further identified as thrombocytes by double immunofluorescence employing B-cell, T-cell and thrombocyte specific reagents. In summary, although the turkey harbors similar LRC genes as the chicken, their distribution seems to be distinct with predominance on thrombocytes rather than lymphocytes.	[Windau, Katharina; Viertlboeck, Birgit C.; Goebel, Thomas W.] Univ Munich, Inst Anim Physiol, Dept Vet Sci, Munich, Germany	University of Munich	Gobel, TW (corresponding author), Univ Munich, Inst Anim Physiol, Dept Vet Sci, Munich, Germany.	goebel@lmu.de			Deutsche Forschungsgemeinschaft [GO489/3-7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft grant no. GO489/3-7, website: dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Gobel TWF, 2000, CURR TOP MICROBIOL, V248, P303; Gobel TWF, 1996, EUR J IMMUNOL, V26, P1743, DOI 10.1002/eji.1830260812; Hammond JA, 2009, J IMMUNOL, V182, P3618, DOI 10.4049/jimmunol.0803026; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; Laun K, 2006, PLOS GENET, V2, P707, DOI 10.1371/journal.pgen.0020073; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Li Z, 1999, POULTRY SCI, V78, P1526, DOI 10.1093/ps/78.11.1526; Lochner KM, 2010, MOL IMMUNOL, V47, P1956, DOI 10.1016/j.molimm.2010.05.001; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; MacDonald MRW, 2007, CYTOGENET GENOME RES, V117, P195, DOI 10.1159/000103180; MAGOR KE, 1992, J IMMUNOL, V149, P2627; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Parham P, 2010, J MED PRIMATOL, V39, P194, DOI 10.1111/j.1600-0684.2010.00432.x; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Purzel J, 2009, J IMMUNOL, V183, P4554, DOI 10.4049/jimmunol.0901699; Rubbenstroth D, 2010, DEV COMP IMMUNOL, V34, P518, DOI 10.1016/j.dci.2009.12.011; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; Schreiner B, 2012, DEV COMP IMMUNOL, V36, P566, DOI 10.1016/j.dci.2011.09.013; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; Stafford JL, 2006, IMMUNOGENETICS, V58, P758, DOI 10.1007/s00251-006-0134-1; Takahashi T, 2004, EUR J IMMUNOL, V34, P773, DOI 10.1002/eji.200324695; Taylor AI, 2008, J BIOL CHEM, V283, P16384, DOI 10.1074/jbc.M801321200; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Viertlboeck BC, 2004, J IMMUNOL, V173, P7385, DOI 10.4049/jimmunol.173.12.7385; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; Viertlboeck BC, 2011, VET IMMUNOL IMMUNOP, V144, P1, DOI 10.1016/j.vetimm.2011.07.001; Viertlboeck BC, 2010, DEV COMP IMMUNOL, V34, P866, DOI 10.1016/j.dci.2010.03.007; Viertlboeck BC, 2009, J IMMUNOL, V182, P6985, DOI 10.4049/jimmunol.0803060; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Yoder JA, 2001, P NATL ACAD SCI USA, V98, P6771, DOI 10.1073/pnas.121101598; Yoder JA, 2011, IMMUNOGENETICS, V63, P123, DOI 10.1007/s00251-010-0506-4	39	5	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59577	10.1371/journal.pone.0059577	http://dx.doi.org/10.1371/journal.pone.0059577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527222	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600064
J	Fakhar, K; Hastings, E; Butson, CR; Foote, KD; Zeilman, P; Okun, MS				Fakhar, Kaihan; Hastings, Erin; Butson, Christopher R.; Foote, Kelly D.; Zeilman, Pam; Okun, Michael S.			Management of Deep Brain Stimulator Battery Failure: Battery Estimators, Charge Density, and Importance of Clinical Symptoms	PLOS ONE			English	Article							PULSE GENERATORS; DYSTONIA	Objective: We aimed in this investigation to study deep brain stimulation (DBS) battery drain with special attention directed toward patient symptoms prior to and following battery replacement. Background: Previously our group developed web-based calculators and smart phone applications to estimate DBS battery life (http://mdc.mbi.ufl.edu/surgery/dbs-battery-estimator). Methods: A cohort of 320 patients undergoing DBS battery replacement from 2002-2012 were included in an IRB approved study. Statistical analysis was performed using SPSS 20.0 (IBM, Armonk, NY). Results: The mean charge density for treatment of Parkinson's disease was 7.2 mu C/cm(2)/phase (SD = 3.82), for dystonia was 17.5 mu C/cm(2)/phase (SD = 8.53), for essential tremor was 8.3 mu C/cm(2)/phase (SD = 4.85), and for OCD was 18.0 mu C/cm(2)/phase (SD = 4.35). There was a significant relationship between charge density and battery life (r = -.59, p,. 001), as well as total power and battery life (r = -.64, p<.001). The UF estimator (r=.67, p<.001) and the Medtronic helpline (r=.74, p<.001) predictions of battery life were significantly positively associated with actual battery life. Battery status indicators on Soletra and Kinetra were poor predictors of battery life. In 38 cases, the symptoms improved following a battery change, suggesting that the neurostimulator was likely responsible for symptom worsening. For these cases, both the UF estimator and the Medtronic helpline were significantly correlated with battery life (r=.65 and r=.70, respectively, both p<.001). Conclusions: Battery estimations, charge density, total power and clinical symptoms were important factors. The observation of clinical worsening that was rescued following neurostimulator replacement reinforces the notion that changes in clinical symptoms can be associated with battery drain.	[Fakhar, Kaihan; Hastings, Erin; Foote, Kelly D.; Zeilman, Pam; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA; [Fakhar, Kaihan; Hastings, Erin; Foote, Kelly D.; Zeilman, Pam; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, Gainesville, FL USA; [Butson, Christopher R.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Butson, Christopher R.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin; Medical College of Wisconsin	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA.	okun@neurology.ufl.edu	Butson, Christopher/J-8034-2013	Butson, Christopher/0000-0002-2319-1263; Okun, Michael/0000-0002-6247-9358; Foote, Kelly/0000-0002-2436-4138; Hastings Monari, Erin/0000-0002-4075-3360	NIH; NPF; UF Foundation; Michael J. Fox Foundation; Parkinson Alliance, Smallwood Foundation; USF CME office; PeerView; Vanderbilt University; Medtronic; ANS/St. Jude	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; UF Foundation; Michael J. Fox Foundation; Parkinson Alliance, Smallwood Foundation; USF CME office; PeerView; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude	Dr. Foote has received research grants from NIH, NPF, and the UF Foundation. Dr. Foote has previously received honoraria, but in the past >36 months has received no support from industry including travel. The institution has received donations of medical devices for studies Dr. Foote has been involved in. Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past >36 months has received no support from industry including travel. Dr. Okun has received royalties for publications with Demos, Manson, and Cambridge (movement disorders books). Dr. Okun has participated in CME activities on movement disorders sponsored by the USF CME office, PeerView, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesch F, 2005, MOVEMENT DISORD, V20, P64, DOI 10.1002/mds.20354; Bin-Mahfoodh M, 2003, STEREOT FUNCT NEUROS, V80, P56, DOI 10.1159/000075161; Blahak C, 2011, EUR J NEUROL, V18, P872, DOI 10.1111/j.1468-1331.2010.03290.x; Butson CR, 2007, CLIN NEUROPHYSIOL, V118, P1889, DOI 10.1016/j.clinph.2007.05.061; Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Favilla CG, 2012, BRAIN, V135, P1455, DOI 10.1093/brain/aws026; Isaias IU, 2009, ARCH NEUROL-CHICAGO, V66, P465, DOI 10.1001/archneurol.2009.20; Medtronic, 2006, KIN DUAL PROGR NEUR; Medtronic, 2006, SOL NEUR DEEP BRAIN; Montuno MA, 2012, ALGORITHM MANAGEMENT; Ondo WG, 2007, PARKINSONISM RELAT D, V13, P240, DOI 10.1016/j.parkreldis.2006.11.002; Quinn GP, 2003, EXPT DESIGN DATA ANA; Shah RS, 2010, J CLIN NEUROL, V6, P167, DOI 10.3988/jcn.2010.6.4.167; Tarsy MD, 2008, CURR CLIN NEUROL, P1, DOI 10.1007/978-1-59745-360-8; Vora AK, 2011, BRAIN STIMUL	16	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58665	10.1371/journal.pone.0058665	http://dx.doi.org/10.1371/journal.pone.0058665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536810	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100077
J	Konig, K; Meder, L; Kroger, C; Diehl, L; Florin, A; Rommerscheidt-Fuss, U; Kahl, P; Wardelmann, E; Magin, TM; Buettner, R; Heukamp, LC				Koenig, Katharina; Meder, Lydia; Kroeger, Cornelia; Diehl, Linda; Florin, Alexandra; Rommerscheidt-Fuss, Ursula; Kahl, Philip; Wardelmann, Eva; Magin, Thomas M.; Buettner, Reinhard; Heukamp, Lukas C.			Loss of the Keratin Cytoskeleton Is Not Sufficient to Induce Epithelial Mesenchymal Transition in a Novel KRAS Driven Sporadic Lung Cancer Mouse Model	PLOS ONE			English	Article							SMALL-CELL-CARCINOMA; ACTIVATION; EXPRESSION; SYNAPTOPHYSIN; TUMORIGENESIS; CHROMOGRANIN; KINASE	Epithelial-to-mesenchymal transition (EMT), the phenotypical change of cells from an epithelial to a mesenchymal type, is thought to be a key event in invasion and metastasis of adenocarcinomas. These changes involve loss of keratin expression as well as loss of cell polarity and adhesion. We here aimed to determine whether the loss of keratin expression itself drives increased invasion and metastasis in adenocarcinomas and whether keratin loss leads to the phenotypic changes associated with EMT. Therefore, we employed a recently described murine model in which conditional deletion of the Keratin cluster II by Cre-recombinase leads to the loss of the entire keratinmultiprotein family. These mice were crossed into a newly generated Cre-recombinase inducible KRAS-driven murine lung cancer model to examine the effect of keratin loss on morphology, invasion and metastasis as well as expression of EMT related genes in the resulting tumors. We here clearly show that loss of a functional keratin cytoskeleton did not significantly alter tumor morphology or biology in terms of invasion, metastasis, proliferation or tumor burden and did not lead to induction of EMT. Further, tumor cells did not induce synchronously expression of vimentin, which is often seen in EMT, to compensate for keratin loss. In summary, our data suggest that changes in cell shape and migration that underlie EMT are dependent on changes in signaling pathways that cause secondary changes in keratin expression and organization. Thus, we conclude that loss of the keratin cytoskeleton per se is not sufficient to causally drive EMT in this tumor model.	[Koenig, Katharina; Meder, Lydia; Florin, Alexandra; Rommerscheidt-Fuss, Ursula; Kahl, Philip; Wardelmann, Eva; Buettner, Reinhard; Heukamp, Lukas C.] Univ Cologne, Inst Pathol, Cologne, Germany; [Kroeger, Cornelia] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Diehl, Linda] Univ Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany; [Magin, Thomas M.] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Magin, Thomas M.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	University of Cologne; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Bonn; Leipzig University; Leipzig University	Heukamp, LC (corresponding author), Univ Cologne, Inst Pathol, Joseph Stelzmann Str 9, Cologne, Germany.	lukas.heukamp@uk-koeln.de	Heukamp, Lukas C/A-8338-2013; Heukamp, Lukas/G-9967-2012	Meder, Lydia/0000-0002-9547-5812; Heukamp, Lukas/0000-0002-3388-3482	German research council [SFB 832]; German cancer Aid via the CIO Cologne/Bonn	German research council(German Research Foundation (DFG)); German cancer Aid via the CIO Cologne/Bonn	The work was funded by the German research council via SFB 832, Projekt A5 and Z1 and the German cancer Aid via the CIO Cologne/Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu YW, 1996, AM J PATHOL, V148, P63; Chun MGH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001120; DELEIJ L, 1985, CANCER RES, V45, P6024; GAZDAR AF, 1980, CANCER RES, V40, P3502; Heukamp LC, 2003, PATHOL RES PRACT, V199, P159, DOI 10.1016/S0344-0338(04)70367-2; Heukamp LC, 2001, INT J CANCER, V91, P385, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1051>3.0.CO;2-Z; JENSEN SM, 1990, CANCER RES, V50, P6068; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kashiwagi K, 2012, PATHOL INT, V62, P232, DOI 10.1111/j.1440-1827.2011.02781.x; Kroger C, 2011, AM J PATHOL, V178, P1578, DOI 10.1016/j.ajpath.2010.12.055; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lyons SK, 2003, CANCER RES, V63, P7042; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; NAITO S, 1980, VIRCHOWS ARCH A, V387, P251, DOI 10.1007/BF00454828; Okayama H, 2012, INT J CANC; Peifer M, 2012, NAT GENET; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reichelt J, 2004, J INVEST DERMATOL, V123, P973, DOI 10.1111/j.0022-202X.2004.23426.x; Seltmann K, 2012, J INVEST DERMATOL; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; Stahl S, 2009, IMMUNOL LETT, V123, P31, DOI 10.1016/j.imlet.2009.01.011; VERBEECK MAE, 1992, PATHOBIOLOGY, V60, P136, DOI 10.1159/000163712; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610	30	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57996	10.1371/journal.pone.0057996	http://dx.doi.org/10.1371/journal.pone.0057996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536778	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100022
J	Russell, JD; Scalf, M; Book, AJ; Ladror, DT; Vierstra, RD; Smith, LM; Coon, JJ				Russell, Jason D.; Scalf, Mark; Book, Adam J.; Ladror, Daniel T.; Vierstra, Richard D.; Smith, Lloyd M.; Coon, Joshua J.			Characterization and Quantification of Intact 26S Proteasome Proteins by Real-Time Measurement of Intrinsic Fluorescence Prior to Top-down Mass Spectrometry	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; POSTTRANSLATIONAL MODIFICATIONS; QUANTITATIVE-ANALYSIS; 20S PROTEASOME; PROTEOMICS; IDENTIFICATION; YEAST; IONIZATION; DSS1; EFFICIENCY	Quantification of gas-phase intact protein ions by mass spectrometry (MS) is impeded by highly-variable ionization, ion transmission, and ion detection efficiencies. Therefore, quantification of proteins using MS-associated techniques is almost exclusively done after proteolysis where peptides serve as proxies for estimating protein abundance. Advances in instrumentation, protein separations, and informatics have made large-scale sequencing of intact proteins using top-down proteomics accessible to the proteomics community; yet quantification of proteins using a top-down workflow has largely been unaddressed. Here we describe a label-free approach to determine the abundance of intact proteins separated by nanoflow liquid chromatography prior to MS analysis by using solution-phase measurements of ultraviolet light-induced intrinsic fluorescence (UV-IF). UV-IF is measured directly at the electrospray interface just prior to the capillary exit where proteins containing at least one tryptophan residue are readily detected. UV-IF quantification was demonstrated using commercially available protein standards and provided more accurate and precise protein quantification than MS ion current. We evaluated the parallel use of UV-IF and top-down tandem MS for quantification and identification of protein subunits and associated proteins from an affinity-purified 26 S proteasome sample from Arabidopsis thaliana. We identified 26 unique proteins and quantified 13 tryptophan-containing species. Our analyses discovered previously unidentified N-terminal processing of the beta 6 (PBF1) and beta 7 (PBG1) subunit - such processing of PBG1 may generate a heretofore unknown additional protease active site upon cleavage. In addition, our approach permitted the unambiguous identification and quantification both isoforms of the proteasome-associated protein DSS1.	[Russell, Jason D.; Scalf, Mark; Ladror, Daniel T.; Smith, Lloyd M.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Book, Adam J.; Vierstra, Richard D.; Coon, Joshua J.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Russell, Jason D.; Smith, Lloyd M.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Coon, JJ (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	jcoon@chem.wisc.edu			NIH NHGRI grants [P01 GM081629, P50 HG004952]; Chemical Sciences, Geosciences and Biosciences Division, Basic Energy Sciences Program of the US Department of Energy [DE-FG02-88ER13968]; NIH Ruth L. Kirschstein Predoctoral Fellowship [F31NS054563]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054563] Funding Source: NIH RePORTER	NIH NHGRI grants; Chemical Sciences, Geosciences and Biosciences Division, Basic Energy Sciences Program of the US Department of Energy(United States Department of Energy (DOE)); NIH Ruth L. Kirschstein Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH NHGRI (http://www.genome.gov/) grants P01 GM081629 and P50 HG004952 to LMS and JJC, a Chemical Sciences, Geosciences and Biosciences Division, Basic Energy Sciences Program of the US Department of Energy (http://science.energy.gov/bes/) grant (DE-FG02-88ER13968) to RDV, and an NIH (http://www.nih.gov/) Ruth L. Kirschstein Predoctoral Fellowship (F31NS054563) to AJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends R, 2007, MOL CELL PROTEOMICS, V6, P1907, DOI 10.1074/mcp.M700152-MCP200; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Book AJ, 2010, J BIOL CHEM, V285, P25554, DOI 10.1074/jbc.M110.136622; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; CAGNEY G, 2003, PROTEOME SCI, V1, P1; Callis PR, 2004, J PHYS CHEM B, V108, P4248, DOI 10.1021/jp0310551; Cech NB, 2001, MASS SPECTROM REV, V20, P362, DOI 10.1002/mas.10008; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; Chen XY, 2003, ANAL CHEM, V75, P5944, DOI 10.1021/ac030127h; Collier TS, 2008, ANAL CHEM, V80, P4994, DOI 10.1021/ac800254z; Collier TS, 2010, J AM SOC MASS SPECTR, V21, P879, DOI 10.1016/j.jasms.2010.01.031; Cui WD, 2011, ANALYST, V136, P3854, DOI 10.1039/c1an15286f; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Du Y, 2006, ANAL CHEM, V78, P686, DOI 10.1021/ac050993p; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Ferguson JT, 2009, J AM SOC MASS SPECTR, V20, P1743, DOI 10.1016/j.jasms.2009.05.014; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; FOLEY JP, 1987, ANAL CHEM, V59, P1984, DOI 10.1021/ac00142a019; Fu HY, 1998, GENETICS, V149, P677; Garcia BA, 2010, J AM SOC MASS SPECTR, V21, P193, DOI 10.1016/j.jasms.2009.10.014; Guan SH, 2010, J AM SOC MASS SPECTR, V21, P455, DOI 10.1016/j.jasms.2009.11.011; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; Halgand F, 2011, ANAL CHEM, V83, P7306, DOI 10.1021/ac200994c; Hung CW, 2012, ANAL CHEM, V84, P161, DOI 10.1021/ac202243r; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Ji QC, 2003, ANAL CHEM, V75, P7008, DOI 10.1021/ac034930n; Jorgenson JW, 2010, ANNU REV ANAL CHEM, V3, P129, DOI 10.1146/annurev.anchem.1.031207.113014; Karabacak NM, 2009, MOL CELL PROTEOMICS, V8, P846, DOI 10.1074/mcp.M800099-MCP200; Kelleher NL, 2012, J AM SOC MASS SPECTR, V23, P1617, DOI 10.1007/s13361-012-0469-9; Kellie JF, 2012, ANAL CHEM, V84, P209, DOI 10.1021/ac202384v; Kim T, 2000, ANAL CHEM, V72, P2247, DOI 10.1021/ac991412x; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; LeDuc R. D., 2007, CURR PROTOC BIOINFOR, V19; LeDuc RD, 2004, NUCLEIC ACIDS RES, V32, pW340, DOI 10.1093/nar/gkh447; Lee JE, 2009, J AM SOC MASS SPECTR, V20, P2183, DOI 10.1016/j.jasms.2009.08.001; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Macek B, 2006, MOL CELL PROTEOMICS, V5, P949, DOI 10.1074/mcp.T500042-MCP200; Makarov A, 2009, J AM SOC MASS SPECTR, V20, P1486, DOI 10.1016/j.jasms.2009.03.024; MANT CT, 1989, J CHROMATOGR, V476, P363, DOI 10.1016/S0021-9673(01)93882-8; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Mazur MT, 2010, P NATL ACAD SCI USA, V107, P7728, DOI 10.1073/pnas.0910776107; McAlister GC, 2008, J PROTEOME RES, V7, P3127, DOI 10.1021/pr800264t; O'Connor PB, 2006, RAPID COMMUN MASS SP, V20, P259, DOI 10.1002/rcm.2307; Page JS, 2007, J AM SOC MASS SPECTR, V18, P1582, DOI 10.1016/j.jasms.2007.05.018; Page JS, 2009, J AM SOC MASS SPECTR, V20, P2265, DOI 10.1016/j.jasms.2009.08.018; PAJOT P, 1976, EUR J BIOCHEM, V63, P263, DOI 10.1111/j.1432-1033.1976.tb10228.x; Parks BA, 2007, ANAL CHEM, V79, P7984, DOI 10.1021/ac070553t; Ruan Q, 2011, ANAL CHEM, V83, P8937, DOI 10.1021/ac201540t; Russell JD, 2011, ANAL CHEM, V83, P2187, DOI 10.1021/ac103023q; Schriemer DC, 1997, ANAL CHEM, V69, P4176, DOI 10.1021/ac9707794; Scigelova M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009431; Sharma S, 2007, J PROTEOME RES, V6, P602, DOI 10.1021/pr060354a; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Sluszny C, 2005, ELECTROPHORESIS, V26, P4197, DOI 10.1002/elps.200500348; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tian ZX, 2010, PROTEOMICS, V10, P3610, DOI 10.1002/pmic.201000367; Tolmachev AV, 2009, INT J MASS SPECTROM, V287, P32, DOI 10.1016/j.ijms.2008.10.010; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vellaichamy A, 2010, ANAL CHEM, V82, P1234, DOI 10.1021/ac9021083; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Waanders LF, 2007, J AM SOC MASS SPECTR, V18, P2058, DOI 10.1016/j.jasms.2007.09.001; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang YJ, 2005, J PROTEOME RES, V4, P36, DOI 10.1021/pr049876l; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371; Zheng LN, 2011, J ANAL ATOM SPECTROM, V26, P1233, DOI 10.1039/c1ja00008j	71	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58157	10.1371/journal.pone.0058157	http://dx.doi.org/10.1371/journal.pone.0058157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536786	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100029
J	Schwede, M; Spentzos, D; Bentink, S; Hofmann, O; Haibe-Kains, B; Harrington, D; Quackenbush, J; Culhane, AC				Schwede, Matthew; Spentzos, Dimitrios; Bentink, Stefan; Hofmann, Oliver; Haibe-Kains, Benjamin; Harrington, David; Quackenbush, John; Culhane, Aedin C.			Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; POLY(ADP-RIBOSE) POLYMERASE; P53 STATUS; LOW-GRADE; METASTASIS; MUTATION; PATHOGENESIS; INHIBITION; SIGNATURE; TUMORS	Although ovarian cancer is often initially chemotherapy-sensitive, the vast majority of tumors eventually relapse and patients die of increasingly aggressive disease. Cancer stem cells are believed to have properties that allow them to survive therapy and may drive recurrent tumor growth. Cancer stem cells or cancer-initiating cells are a rare cell population and difficult to isolate experimentally. Genes that are expressed by stem cells may characterize a subset of less differentiated tumors and aid in prognostic classification of ovarian cancer. The purpose of this study was the genomic identification and characterization of a subtype of ovarian cancer that has stem cell-like gene expression. Using human and mouse gene signatures of embryonic, adult, or cancer stem cells, we performed an unsupervised bipartition class discovery on expression profiles from 145 serous ovarian tumors to identify a stem-like and more differentiated subgroup. Subtypes were reproducible and were further characterized in four independent, heterogeneous ovarian cancer datasets. We identified a stem-like subtype characterized by a 51-gene signature, which is significantly enriched in tumors with properties of Type II ovarian cancer; high grade, serous tumors, and poor survival. Conversely, the differentiated tumors share properties with Type I, including lower grade and mixed histological subtypes. The stem cell-like signature was prognostic within high-stage serous ovarian cancer, classifying a small subset of high-stage tumors with better prognosis, in the differentiated subtype. In multivariate models that adjusted for common clinical factors (including grade, stage, age), the subtype classification was still a significant predictor of relapse. The prognostic stem-like gene signature yields new insights into prognostic differences in ovarian cancer, provides a genomic context for defining Type I/II subtypes, and potential gene targets which following further validation may be valuable in the clinical management or treatment of ovarian cancer.	[Schwede, Matthew; Bentink, Stefan; Haibe-Kains, Benjamin; Harrington, David; Quackenbush, John; Culhane, Aedin C.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hofmann, Oliver; Harrington, David; Quackenbush, John; Culhane, Aedin C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Bentink, Stefan] Exosome Diagnost GmbH, Martinsried, Germany; [Haibe-Kains, Benjamin] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Culhane, AC (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	aedin@jimmy.harvard.edu	Culhane, Aedin/AAG-8490-2019; Haibe-Kains, Benjamin/D-3702-2011; Hofmann, Oliver/F-1800-2013	Culhane, Aedin/0000-0002-1395-9734; Haibe-Kains, Benjamin/0000-0002-7684-0079; Hofmann, Oliver/0000-0002-7738-1513; Quackenbush, John/0000-0002-2702-5879	National Institutes of Health [1U19CA148065]; Dana-Farber Cancer Institute Women's Cancers Program; Claudia Adams Barr foundation; NATIONAL CANCER INSTITUTE [U19CA148065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute Women's Cancers Program; Claudia Adams Barr foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by the National Institutes of Health 1U19CA148065 (J.Q., B.H.K.), Dana-Farber Cancer Institute Women's Cancers Program (awarded to A.C.C; M.S, A.C.C.) and the Claudia Adams Barr foundation (J.Q. and A.C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2010, CLIN CANCER RES, V16, P4702, DOI 10.1158/1078-0432.CCR-10-0939; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burgos-Ojeda D, 2012, CANCER LETT, V322, P1, DOI 10.1016/j.canlet.2012.02.002; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Culhane AC, 2009, NUCL ACIDS RES; Curley MD, 2011, FRONT BIOSCI-LANDMRK, V16, P368, DOI 10.2741/3693; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dehari R, 2007, AM J SURG PATHOL, V31, P1007, DOI 10.1097/PAS.0b013e31802cbbe9; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Kwong J, 2009, MOL CANCER THER, V8, P1893, DOI 10.1158/1535-7163.MCT-08-0966; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Pan YM, 2010, PATHOBIOLOGY, V77, P283, DOI 10.1159/000320866; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Sherman MH, 2011, TRENDS CELL BIOL; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; von Heydebreck A, 2001, Bioinformatics, V17 Suppl 1, pS107; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040691; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109; Zhang J, 2010, J CLIN PATHOL, V63, P879, DOI 10.1136/jcp.2009.073593	68	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57799	10.1371/journal.pone.0057799	http://dx.doi.org/10.1371/journal.pone.0057799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536770	Green Published, gold			2022-12-27	WOS:000316251100016
J	Leggett, RM; Ramirez-Gonzalez, RH; Verweij, W; Kawashima, CG; Iqbal, Z; Jones, JDG; Caccamo, M; MacLean, D				Leggett, Richard M.; Ramirez-Gonzalez, Ricardo H.; Verweij, Walter; Kawashima, Cintia G.; Iqbal, Zamin; Jones, Jonathan D. G.; Caccamo, Mario; MacLean, Daniel			Identifying and Classifying Trait Linked Polymorphisms in Non-Reference Species by Walking Coloured de Bruijn Graphs	PLOS ONE			English	Article							NOVO; ALIGNMENT	Single Nucleotide Polymorphisms are invaluable markers for tracing the genetic basis of inheritable traits and the ability to create marker libraries quickly is vital for timely identification of target genes. Next-generation sequencing makes it possible to sample a genome rapidly, but polymorphism detection relies on having a reference genome to which reads can be aligned and variants detected. We present Bubbleparse, a method for detecting variants directly from next-generation reads without a reference sequence. Bubbleparse uses the de Bruijn graph implementation in the Cortex framework as a basis and allows the user to identify bubbles in these graphs that represent polymorphisms, quickly, easily and sensitively. We show that the Bubbleparse algorithm is sensitive and can detect many polymorphisms quickly and that it performs well when compared with polymorphism detection methods based on alignment to a reference in Arabidopsis thaliana. We show that the heuristic can be used to maximise the number of true polymorphisms returned, and with a proof-of-principle experiment show that Bubbleparse is very effective on data from unsequenced wild relatives of potato and enabled us to identify disease resistance linked genes quickly and easily.	[Leggett, Richard M.; Verweij, Walter; Kawashima, Cintia G.; Jones, Jonathan D. G.; MacLean, Daniel] Sainsbury Lab, Norwich, Norfolk, England; [Ramirez-Gonzalez, Ricardo H.; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Iqbal, Zamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); University of Oxford; Wellcome Centre for Human Genetics	MacLean, D (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	dan.maclean@tsl.ac.uk	Ramírez, Ricardo/H-4808-2019; Jones, Jonathan DG/J-5129-2012; MacLean, Dan/C-7046-2013	Ramírez, Ricardo/0000-0001-5745-7085; Jones, Jonathan DG/0000-0002-4953-261X; Iqbal, Zamin/0000-0001-8466-7547; Leggett, Richard/0000-0003-3044-4297; MacLean, Dan/0000-0003-1032-0887	Two Blades Foundation; Gatsby Charitable Foundation; BBSRC; BBSRC [BB/G02197X/1]; Biotechnology and Biological Sciences Research Council [BB/I023798/1, BB/H018697/1] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BB/H018697/1, BBS/E/T/000PR6193, BB/I023798/1] Funding Source: UKRI	Two Blades Foundation; Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding sources: The Two Blades Foundation - http://2blades.org; The Gatsby Charitable Foundation - http://www.gatsby.org.uk; BBSRC - http://www.bbsrc.ac.uk and BBSRC grant BB/G02197X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rauscher GM, THEOR APPL GENET, V112, P674; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	12	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60058	10.1371/journal.pone.0060058	http://dx.doi.org/10.1371/journal.pone.0060058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536903	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200051
J	Ho, CK; Pennings, SC				Ho, Chuan-Kai; Pennings, Steven C.			Preference and Performance in Plant-Herbivore Interactions across Latitude-A Study in US Atlantic Salt Marshes	PLOS ONE			English	Article							LIFE-HISTORY; PALATABILITY; NITROGEN; TEMPERATE; EVOLUTION; DEFENSES; RANGE; SIZE; DETERMINANTS; CONSTRAINTS	High-latitude plants are often more palatable to herbivores than low-latitude conspecifics. Does increased plant palatability lead to better herbivore performance? Our field and laboratory work investigated (A) whether high-latitude plants have traits indicating that they should be higher-quality foods for herbivores; (B) whether geographic differences in plant quality are more important than local adaptation of herbivores. We studied 3 plant species and 6 invertebrate herbivores in U. S. Atlantic Coast. Past studies had shown high-latitude individuals of these plants are more palatable than low-latitude conspecifics. We documented plant traits and herbivore performance (body size) in the field across latitude. We collected individuals from different latitudes for factorial (plant region x herbivore region) laboratory experiments, examining how herbivore performance was affected by plant region, herbivore region, and their interaction (i.e., local adaptation). Field surveys suggested high-latitude plants were likely of higher quality to herbivores. Leaf nitrogen content in all plant species increased toward high latitudes, consistent with lower leaf C/N and higher leaf chlorophyll content at high latitudes. Furthermore, leaf toughness decreased toward higher latitudes in 1 species. The body size of 4 herbivore species increased with latitude, consistent with high-latitude leaves being of higher quality, while 2 grasshopper species showed the opposite pattern, likely due to life-history constraints. In the laboratory, high-latitude plants supported better performance in 4 herbivore species (marginal in the 5th). The geographic region where herbivores were collected affected herbivore performance in all 6 species; however, the pattern was mixed, indicating a lack of local adaptation by herbivores to plants from their own geographic region. Our results suggest that more-palatable plants at high latitudes support better herbivore growth. Given that geographic origin of either plants or herbivores can affect herbivore performance, the nature of plant-herbivore interactions is likely to change if climate change "reshuffles" plant and herbivore populations across latitude.	[Ho, Chuan-Kai] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Ho, Chuan-Kai] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Ho, Chuan-Kai; Pennings, Steven C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	National Taiwan University; National Taiwan University; University of Houston System; University of Houston	Ho, CK (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan.	ckho@ntu.edu.tw	Pennings, Steven C/A-8326-2013	Pennings, Steven C/0000-0003-4757-7125; HO, CHUAN-KAI/0000-0002-6437-0073	Oceanic and Atmospheric Administration (NOAA) National Estuarine Research Reserve System (NERRS) graduate research fellowship (GRF) program [NA04NOS4200137]; National Science Foundation [DEB-0296160, DEB-0709923, OCE99-82133]; NSC [101-2621-B-002-001]; NTU College of Life Science; Division Of Ocean Sciences [1237140] Funding Source: National Science Foundation	Oceanic and Atmospheric Administration (NOAA) National Estuarine Research Reserve System (NERRS) graduate research fellowship (GRF) program; National Science Foundation(National Science Foundation (NSF)); NSC(Ministry of Science and Technology, Taiwan); NTU College of Life Science; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the National Oceanic and Atmospheric Administration (NOAA) National Estuarine Research Reserve System (NERRS) graduate research fellowship (GRF) program (NA04NOS4200137), National Science Foundation (DEB-0296160, DEB-0709923, OCE99-82133), NSC (101-2621-B-002-001), and NTU College of Life Science for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], 2013, PLANTS DAT; BAKUS G J, 1974, Biotropica, V6, P229, DOI 10.2307/2989667; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BERNAYS EA, 1990, ENTOMOL EXP APPL, V54, P53, DOI 10.1007/BF00353986; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Brouillet L., 2013, VASCAN DATABASE VASC; Brown J. H., 1995, MACROECOLOGY; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Chiang Cabrera F, 2012, FLORA MESOAMERICANA, V5; Clissold FJ, 2006, J ANIM ECOL, V75, P1000, DOI 10.1111/j.1365-2656.2006.01122.x; Cogni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029220; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Cronin G, 1997, J CHEM ECOL, V23, P289, DOI 10.1023/B:JOEC.0000006360.36833.13; Cronin JT, 2001, OECOLOGIA, V127, P87, DOI 10.1007/s004420000561; Crozier L, 2003, OECOLOGIA, V135, P648, DOI 10.1007/s00442-003-1219-2; DENNO RF, 1990, ANNU REV ENTOMOL, V35, P489, DOI 10.1146/annurev.en.35.010190.002421; DENNO RF, 1985, ECOLOGY, V66, P1588, DOI 10.2307/1938021; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; Ellers J, 1998, J ANIM ECOL, V67, P318, DOI 10.1046/j.1365-2656.1998.00195.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; FAWCETT MH, 1984, ECOLOGY, V65, P1214, DOI 10.2307/1938329; Funk DJ, 2001, ECOLOGY, V82, P726, DOI 10.1890/0012-9658(2001)082[0726:GVIHSR]2.0.CO;2; FUTUYMA DJ, 1985, ANNU REV ENTOMOL, V30, P217, DOI 10.1146/annurev.en.30.010185.001245; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Goranson CE, 2004, OECOLOGIA, V140, P591, DOI 10.1007/s00442-004-1615-2; Hacker SD, 1997, ECOLOGY, V78, P1990, DOI 10.1890/0012-9658(1997)078[1990:SIODPI]2.0.CO;2; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Ho CK, 2010, AM NAT, V175, P269, DOI 10.1086/649583; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; KETTERSON ED, 1982, AUK, V99, P243; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; MacArthur R.H., 1972, pvii; Marquis RJ, 2012, OECOLOGIA, V169, P811, DOI 10.1007/s00442-012-2249-4; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Missouri Botanical Garden, 2013, TROP; Moreau G, 2003, OECOLOGIA, V135, P391, DOI 10.1007/s00442-003-1213-8; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pennings SC, 2001, ECOLOGY, V82, P1344, DOI 10.1890/0012-9658(2001)082[1344:LDIPPI]2.0.CO;2; PENNINGS SC, 1992, ECOLOGY, V73, P1606, DOI 10.2307/1940014; Pennings SC, 2007, OIKOS, V116, P543, DOI 10.1111/j.2007.0030-1299.15591.x; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; ROSSI AM, 1991, ENVIRON ENTOMOL, V20, P1349, DOI 10.1093/ee/20.5.1349; Salgado CS, 2005, ECOLOGY, V86, P1571, DOI 10.1890/04-1257; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schnitzler I, 2001, OECOLOGIA, V126, P515, DOI 10.1007/s004420000546; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; Stiling Peter, 1998, P22; Strong D., 1984, INSECTS PLANTS COMMU; SWIHART RK, 1994, OIKOS, V70, P427, DOI 10.2307/3545782; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; TURNER RE, 1976, CONTRIB MAR SCI, V20, P47; Wason EL, 2008, ESTUAR COAST, V31, P335, DOI 10.1007/s12237-007-9026-3; White T. C. R., 1993, INADEQUATE ENV NITRO; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	65	12	12	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59829	10.1371/journal.pone.0059829	http://dx.doi.org/10.1371/journal.pone.0059829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533653	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400090
J	Hunter, RM; Isaac, M; Frigiola, A; Blundell, D; Brown, K; Bull, K				Hunter, Rachael Maree; Isaac, Mark; Frigiola, Alessandra; Blundell, David; Brown, Kate; Bull, Kate			Lifetime Costs and Outcomes of Repair of Tetralogy of Fallot Compared to Natural Progression of the Disease: Great Ormond Street Hospital Cohort	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE	Background: Tetralogy of Fallot is a congenital heart disease that requires surgical repair without which survival through childhood is extremely rare. The aim of this paper is to use data from the mandatory follow-up of patients with Tetralogy of Fallot to model the health-related costs and outcomes over the first 55-years of life. Method: A decision analytical model was developed to establish costs and outcomes for patients up to 55 years after diagnosis and first repair of Tetralogy of Fallot compared to natural progression. Data from Adult Congenital Heart Disease (ACHD) centres that follow up Tetralogy of Fallot patients and Great Ormond Street Hospital (GOSH), London, United Kingdom (UK) medical records was used to establish the cost and effectiveness of current interventions. Data from a Czech cohort was used for the natural, no intervention condition. Results: The average cost per patient of a repair for Tetralogy of Fallot was 26,938 pound (SE = 4,140) pound. The full life time cost per patient, with no discount rate, was 65,310 pound (95% CI 64,981- pound 65,729); pound 56,559 pound discounted (95% CI 56,159- pound 56,960) pound. Patients with a repair had an average of 35 Quality Adjusted Life Years (QALYs) per patient over 55 years undiscounted and 20.16 QALYs discounted. If the disorder was left to take its natural course, patients on average had a total of 3 QALYs per patient with no discount rate and 2.30 QALYs discounted. Conclusion: A model has been developed that provides an estimate of the value for money of an expensive repair of a congenital heart disease. The model could be used to test the cost-effectiveness of making amendments to the care pathway.	[Hunter, Rachael Maree] UCL, London, England; [Isaac, Mark; Frigiola, Alessandra; Brown, Kate; Bull, Kate] Great Ormond St Hosp NHS Fdn Trust, London, England; [Blundell, David] Leeds Sch Med, Leeds, W Yorkshire, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leeds	Hunter, RM (corresponding author), UCL, London, England.	r.hunter@ucl.ac.uk	Hunter, Rachael Maree/H-7846-2019	Hunter, Rachael Maree/0000-0002-7447-8934; Blundell, David/0000-0003-2046-3785; Brown, Katherine/0000-0002-0729-4959	Great Ormond Street Hospital Children's Charity; Leeds University	Great Ormond Street Hospital Children's Charity; Leeds University	This project was funded by the Great Ormond Street Hospital Children's Charity. DB was supported by a bursary from Leeds University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akehurst R, 2000, PHARMACOECONOMICS, V17, P443; Al-Ruzzeh S, 2008, ARTIF ORGANS, V32, P891, DOI 10.1111/j.1525-1594.2008.00647.x; Bedard E, 2008, BRIT MED BULL, V85, P151, DOI 10.1093/bmb/ldn005; Briggs A, 2006, DECISION MODELLING H; Brown KL, 2009, J HEART LUNG TRANSPL, V28, P32, DOI 10.1016/j.healun.2008.10.006; Bryan S, 2012, WHAT IS VALUE SOC QA; Central Cardiac Audit Database, 2001, PROC CONG HEART DIS; Department of Health, 2008, MARK FORC FACT INF; DH PbR Finance and Costing Team, 2011, NAT SCHED REF COSTS; DH Vascular Programme Team, 2006, COMM GUID SERV YOUNG; LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152; Stevens K, 2012, PHARMACOECONOMICS, V30, P729, DOI 10.2165/11599120-000000000-00000; Ungerleider RM, 1997, ANN SURG, V225, P779, DOI 10.1097/00000658-199706000-00015; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Wray J, 2012, HEART; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414	18	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59734	10.1371/journal.pone.0059734	http://dx.doi.org/10.1371/journal.pone.0059734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533645	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400082
J	Matheu, MP; Teijaro, JR; Walsh, KB; Greenberg, ML; Marsolais, D; Parker, I; Rosen, H; Oldstone, MBA; Cahalan, MD				Matheu, Melanie P.; Teijaro, John R.; Walsh, Kevin B.; Greenberg, Milton L.; Marsolais, David; Parker, Ian; Rosen, Hugh; Oldstone, Michael B. A.; Cahalan, Michael D.			Three Phases of CD8 T Cell Response in the Lung Following H1N1 Influenza Infection and Sphingosine 1 Phosphate Agonist Therapy	PLOS ONE			English	Article							MHC CLASS-I; DENDRITIC CELLS; LYMPH-NODE; INTERACTION DYNAMICS; ANTIGEN PRESENTATION; VIRUS-INFECTION; MEMORY; ACTIVATION; DIVISION; CD4(+)	Influenza-induced lung edema and inflammation are exacerbated by a positive feedback loop of cytokine and chemokine production termed a 'cytokine storm', a hallmark of increased influenza-related morbidity and mortality. Upon infection, an immune response is rapidly initiated in the lungs and draining lymph node, leading to expansion of virus-specific effector cells. Using two-photon microscopy, we imaged the dynamics of dendritic cells (DC) and virus-specific eGFP(+) CD8(+) T cells in the lungs and draining mediastinal lymph nodes during the first two weeks following influenza infection. Three distinct phases of T cell and CD11c(+) DC behavior were revealed: 1) Priming, facilitated by the arrival of lung DCs in the lymph node and characterized by antigen recognition and expansion of antigen-specific CD8(+) T cells; asymmetric T cell division in contact with DCs was frequently observed. 2) Clearance, during which DCs re-populate the lung and T cells leave the draining lymph node and re-enter the lung tissue where enlarged, motile T cells come into contact with DCs and form long-lived interactions. 3) Maintenance, characterized by T-cell scanning of the lung tissue and dissociation from local antigen presenting cells; the T cells spend less time in association with DCs and migrate rapidly on collagen. A single dose of a sphingosine-1-phosphate receptor agonist, AAL-R, sufficient to suppress influenza-induced cytokine-storm, altered T cell and DC behavior during influenza clearance, delaying T cell division, cellular infiltration in the lung, and suppressing T-DC interactions in the lung. Our results provide a detailed description of T cell and DC choreography and dynamics in the lymph node and the lung during influenza infection. In addition, we suggest that phase lags in T cell and DC dynamics induced by targeting S1P receptors in vivo may attenuate the intensity of the immune response and can be manipulated for therapeutic benefit.	[Matheu, Melanie P.; Greenberg, Milton L.; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Matheu, Melanie P.; Greenberg, Milton L.; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Ctr Immunol, Irvine, CA USA; [Teijaro, John R.; Walsh, Kevin B.; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Marsolais, David; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Marsolais, David] Univ Laval, Dept Med, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Marsolais, David] IUCPQ Res Ctr, Quebec City, PQ, Canada; [Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute; Laval University; Laval University; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	mcahalan@uci.edu		Greenberg, Milton/0000-0001-9451-2311	National Institutes of Health (NIH) at the University of California Irvine (UCI) [GM-41514, GM-48071]; NIH at The Scripps Research Institute (TSRI) [AI 74564, AI O9484, AI05509, MH084512]; NIH training at TSRI [NSO41219, AI00724, AI007364]; American Heart Foundation at TSRI; George E. Hewitt Foundation for Biomedical Research at UCI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009484, U01AI074564, Z01AI000724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R01GM048071, R37GM048071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) at the University of California Irvine (UCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH at The Scripps Research Institute (TSRI); NIH training at TSRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Foundation at TSRI; George E. Hewitt Foundation for Biomedical Research at UCI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health (NIH) RO1 Grants GM-41514 and GM-48071 to Drs. Cahalan and Parker, respectively, at the University of California Irvine (UCI); and by NIH RO1 grants to Drs. Oldstone and Rosen at The Scripps Research Institute (TSRI): AI 74564 (MBAO, HR), AI O9484 (MBAO), AI05509 (HR), MH084512 (HR); and by NIH training grants NSO41219 and AI00724 that provided postdoctoral support for Kevin Walsh at TSRI, and NIH training grant AI007364 to John Teijaro at TSRI; by a postdoctoral fellowship from the American Heart Foundation to John Teijaro at TSRI; and by a postdoctoral fellowship from the George E. Hewitt Foundation for Biomedical Research to Melanie Matheu at UCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Heusch M, 2007, J LEUKOCYTE BIOL, V82, P861, DOI 10.1189/jlb.0307167; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hatem S, 2012, CHEST; Heyland DK, 2005, CRIT CARE MED, V33, P1549, DOI 10.1097/01.CCM.0000168609.98847.50; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Martin-Loeches I, 2011, INTENS CARE MED, V37, P272, DOI 10.1007/s00134-010-2078-z; Masopust D, 2004, IMMUNOL RES, V29, P151, DOI 10.1385/IR:29:1-3:151; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matheu MP, 2012, P NATL ACAD SCI USA, V109, pE1258, DOI 10.1073/pnas.1205150109; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Vinay DS, 2010, CELL IMMUNOL, V264, P18, DOI 10.1016/j.cellimm.2010.05.010; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Walsh KB, 2010, VIROLOGY, V397, P260, DOI 10.1016/j.virol.2009.08.043; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	57	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58033	10.1371/journal.pone.0058033	http://dx.doi.org/10.1371/journal.pone.0058033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533579	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400016
J	Qian, XL; Li, YQ; Yu, B; Gu, F; Liu, FF; Li, WD; Zhang, XM; Fu, L				Qian, Xiao-Long; Li, Ya-Qing; Yu, Bin; Gu, Feng; Liu, Fang-Fang; Li, Wei-Dong; Zhang, Xin-Min; Fu, Li			Syndecan Binding Protein (SDCBP) Is Overexpressed in Estrogen Receptor Negative Breast Cancers, and Is a Potential Promoter for Tumor Proliferation	PLOS ONE			English	Article							SYNTENIN; KINASE; MDA-9/SYNTENIN; ACTIVATION; EXPRESSION; ADHESION; PATHWAY; CELLS	Background: Syndecan binding protein (SDCBP), an adapter protein containing PDZ domains, contributes to the tumorigenicity and metastasis of many malignant tumors, such as malignant melanoma. Our study aimed in revealing the expression profile of SDCBP in breast cancer (BCa) and its role in tumor cell proliferation, and then exploring its value in the targeted treatment of BCa. Methodology/Principal Findings: We first evaluated the SDCBP expression by immunohistochemistry in normal breast and BCa tissues. Then we explored the expression profile of SDCBP in different BCa cell lines. By constructing SDCBP-silenced BCa cell clones, we further assessed the effects of SDCBP suppression on tumor cells in vitro by cell culture and in vivo by tumorigenicity. SDCBP expression was detected in 80.6% (n = 160) of BCa tissues, in contrast to its expression in 13% (n = 23) of normal breast tissues (P<0.001). Among the tumors, the level of its expression was positively correlated with histological grade and tumor staging while negatively correlated with the estrogen receptor (ER) expression. Higher expression of SDCBP was also noted in ER-negative BCa cell lines. It was also identified that SDCBP expression was down-regulated in a dose-dependent mode by 17-beta estradiol in estrogen-responsive MCF-7. Furthermore, SDCBP silence inhibited ER-negative tumor cell growth in vivo and in vitro. Cell cycle studies showed that SDCBP silence increased G1 cell population and resulted in related cell-cycle-regulator changes: up-regulation of p21 and p27 while down-regulation of cyclin E. Conclusion/Significance: Our results suggested that SDCBP played an important role in tumor growth of ER-negative BCas. In these tumors where the estrogen signaling pathway is not available, SDCBP probably contribute to tumor growth through an alternative signaling pathway by promoting tumor cells passing the G1/S checkpoint into the cell cycle. Suppression of SDCBP expression may have its potential to become a targeted therapy for ER-negative BCas.	[Qian, Xiao-Long; Li, Ya-Qing; Gu, Feng; Liu, Fang-Fang; Li, Wei-Dong; Fu, Li] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc Pathol, Tianjin, Peoples R China; [Qian, Xiao-Long; Li, Ya-Qing; Gu, Feng; Liu, Fang-Fang; Li, Wei-Dong; Fu, Li] Tianjin Med Univ, Canc Inst & Hosp, Res Lab, Tianjin, Peoples R China; [Qian, Xiao-Long; Li, Ya-Qing; Gu, Feng; Liu, Fang-Fang; Li, Wei-Dong; Fu, Li] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Qian, Xiao-Long; Li, Ya-Qing; Gu, Feng; Liu, Fang-Fang; Li, Wei-Dong; Fu, Li] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Xin-Min] Temple Univ Hosp & Med Sch, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Fu, Li] 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China; [Yu, Bin] Tian Jin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fu, L (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc Pathol, Tianjin, Peoples R China.	fuli@tijmu.edu.cn			National Natural Science Foundation of China [30930038, 81202101]; Program for Changjiang Scholars and Innovative Research Team of China [IRT0743]; doctoral research foundation of Cancer Hospital of Tianjin Medical University [B1012]; Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education [2010GSI07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); doctoral research foundation of Cancer Hospital of Tianjin Medical University; Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education	This work was supported by National Natural Science Foundation of China (Grant No. 30930038 and No. 81202101), Program for Changjiang Scholars and Innovative Research Team of China (Grant No. IRT0743), doctoral research foundation of Cancer Hospital of Tianjin Medical University (Grant No. B1012), as well as Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education (Grant No. 2010GSI07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2004, GYNECOL ONCOL, V93, P680, DOI 10.1016/j.ygyno.2004.03.021; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Chen XM, 2000, J NATL CANCER I, V92, P1403, DOI 10.1093/jnci/92.17.1403; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Luyten A, 2008, MOL BIOL CELL, V19, P1594, DOI 10.1091/mbc.E07-08-0832; Pang B, 2009, PROSTATE, V69, P1176, DOI 10.1002/pros.20969; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu X, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3182; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743	24	39	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60046	10.1371/journal.pone.0060046	http://dx.doi.org/10.1371/journal.pone.0060046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533663	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400100
J	Quach, TK; Chou, HT; Wang, K; Milledge, GZ; Johnson, CM				Quach, Thanh K.; Chou, Han Ting; Wang, Kun; Milledge, Gaolin Zheng; Johnson, Casonya M.			Genome-Wide Microarrray Analysis Reveals Roles for the REF-1 Family Member HLH-29 in Ferritin Synthesis and Peroxide Stress Response	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; IRON HOMEOSTASIS; TRANSCRIPTION FACTORS; OXIDATIVE STRESS; LIFE-SPAN; CYTOSOLIC ACONITASE; GENE-EXPRESSION; H-GENE; NOTCH	In Caenorhabditis elegans, the six proteins that make up the REF-1 family have been identified as functional homologs of the Hairy/Enhancer of Split (HES) proteins. These transcription factors act in both Notch dependent and Notch-independent pathways to regulate embryonic events during development; however, their post-embryonic functions are not well defined. As a first step toward understanding how the REF-1 family works together to coordinate post-embryonic events, we used gene expression microarray analysis to identify transcriptional targets of HLH-29 in L4/young adult stage animals. Here we show that HLH-29 targets are genes needed for the regulation of growth and lifespan, including genes required for oxidative stress response and fatty acid metabolism, and the ferritin genes, ftn-1 and ftn-2. We show that HLH-29 regulates ftn-1 expression via promoter sequences upstream of the iron-dependent element that is recognized by the hypoxia inducible factor, HIF-1. Additionally, hlh-29 mutants are more resistant to peroxide stress than wild-type animals and ftn-1(RNAi) animals, even in the presence of excess iron. Finally we show that HLH-29 acts parallel to DAF-16 but upstream of the microphthalmia transcription factor ortholog, HLH-30, to regulate ftn-1 expression under normal growth conditions.	[Quach, Thanh K.; Chou, Han Ting; Johnson, Casonya M.] Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30303 USA; [Wang, Kun] NYU, Sch Med, Dept Environm Hlth Sci, Div Biostat, New York, NY USA; [Milledge, Gaolin Zheng] N Carolina Cent Univ, Dept Math & Comp Sci, Durham, NC USA	University System of Georgia; Georgia State University; New York University; University of North Carolina; North Carolina Central University	Johnson, CM (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30303 USA.	cjohnson113@gsu.edu		Johnson, Casonya/0000-0001-9306-9661	National Science Foundation [MCB0919413, MCB1139184]	National Science Foundation(National Science Foundation (NSF))	This research, T. Quach, and K. Wang (grant number MCB0919413) and H. T. Chou (grant number MCB1139184) were supported by grants from the National Science Foundation to C. M. Johnson. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; Alper S, 2001, DEVELOPMENT, V128, P1793; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Baldi A, 2005, CLIN CANCER RES, V11, P3175, DOI 10.1158/1078-0432.CCR-04-0631; Beckstead RB, 2006, CELL, V124, P1137, DOI 10.1016/j.cell.2006.03.001; Berdichevsky A, 2006, CELL CYCLE, V5, P2588, DOI 10.4161/cc.5.22.3513; BRENNER S, 1974, GENETICS, V77, P71; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Cha'on U, 2007, TOXICOL SCI, V96, P194, DOI 10.1093/toxsci/kfl187; Evan TC, TRANSFORMATION MICRO; Felton CM, 2011, J NEUROSCI RES, V89, P1627, DOI 10.1002/jnr.22694; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Giordani A, 2000, J PHOTOCH PHOTOBIO B, V54, P43, DOI 10.1016/S1011-1344(99)00154-2; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Habel ME, 2006, BIOCHEM BIOPH RES CO, V341, P1309, DOI 10.1016/j.bbrc.2006.01.097; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hartman J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2446; Hermann GJ, 2000, DEVELOPMENT, V127, P3429; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito T, 2001, HISTOL HISTOPATHOL, V16, P335, DOI 10.14670/HH-16.335; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Katoh M, 2007, INT J ONCOL, V31, P461; Kim YI, 2004, J MOL BIOL, V342, P421, DOI 10.1016/j.jmb.2004.07.036; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Lanjuin A, 2006, DEV BIOL, V290, P139, DOI 10.1016/j.ydbio.2005.11.018; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Liu X, 2006, BIOL RES, V39, P167, DOI 10.4067/S0716-97602006000100018; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Martinez RLMC, 2010, METRON, V68, P111, DOI 10.1007/BF03263529; McMiller TL, 2007, BBA-GENE STRUCT EXPR, V1769, P5, DOI 10.1016/j.bbaexp.2006.12.001; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nasgashio R, 2011, LUNG CANCER, V74, P405, DOI 10.1016/j.lungcan.2011.04.012; Neves A, 2005, DEV CELL, V8, P867, DOI 10.1016/j.devcel.2005.03.012; Neves A, 2007, DEVELOPMENT, V134, P4459, DOI 10.1242/dev.008680; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Ohishi K, 2006, FREE RADICAL RES, V40, P799, DOI 10.1080/10715760600555027; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Perally S, 2008, J PROTEOME RES, V7, P4557, DOI 10.1021/pr800395x; Priess J, 2005, NOTCH SIGNALING C EL, P10; Romney SJ, 2008, J BIOL CHEM, V283, P716, DOI 10.1074/jbc.M707043200; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Ross JM, 2005, DEV CELL, V8, P881, DOI 10.1016/j.devcel.2005.03.017; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Staal FJT, 2001, STEM CELLS, V19, P165, DOI 10.1634/stemcells.19-3-165; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Valentini S, 2012, MECH AGEING DEV, V133, P282, DOI 10.1016/j.mad.2012.03.003; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; White A, 2012, BIOL OPEN, V1, P261, DOI 10.1242/bio.2012046; WHITE K, 1988, J BIOL CHEM, V263, P8938; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Xi L, 2011, MOL BIOL REP, V38, P4405, DOI 10.1007/s11033-010-0568-2; Yoon JH, 2010, BMB REP, V43, P219, DOI 10.5483/BMBRep.2010.43.3.219; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zheng LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-166	82	10	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59719	10.1371/journal.pone.0059719	http://dx.doi.org/10.1371/journal.pone.0059719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533643	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400080
J	Ding, GC; Piceno, YM; Heuer, H; Weinert, N; Dohrmann, AB; Carrillo, A; Andersen, GL; Castellanos, T; Tebbe, CC; Smalla, K				Ding, Guo-Chun; Piceno, Yvette M.; Heuer, Holger; Weinert, Nicole; Dohrmann, Anja B.; Carrillo, Angel; Andersen, Gary L.; Castellanos, Thelma; Tebbe, Christoph C.; Smalla, Kornelia			Changes of Soil Bacterial Diversity as a Consequence of Agricultural Land Use in a Semi-Arid Ecosystem	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; 16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; DIFFERENT POTATO CULTIVARS; PLANT DIVERSITY; SPECIES RICHNESS; RHIZOSPHERE; NITROGEN; DESERT; GENES	Natural scrublands in semi-arid deserts are increasingly being converted into fields. This results in losses of characteristic flora and fauna, and may also affect microbial diversity. In the present study, the long-term effect (50 years) of such a transition on soil bacterial communities was explored at two sites typical of semi-arid deserts. Comparisons were made between soil samples from alfalfa fields and the adjacent scrublands by two complementary methods based on 16S rRNA gene fragments amplified from total community DNA. Denaturing gradient gel electrophoresis (DGGE) analyses revealed significant effects of the transition on community composition of Bacteria, Actinobacteria, Alpha-and Betaproteobacteria at both sites. PhyloChip hybridization analysis uncovered that the transition negatively affected taxa such as Acidobacteria, Chloroflexi, Acidimicrobiales, Rubrobacterales, Deltaproteobacteria and Clostridia, while Alpha-, Beta-and Gammaproteo-bacteria, Bacteroidetes and Actinobacteria increased in abundance. Redundancy analysis suggested that the community composition of phyla responding to agricultural use (except for Spirochaetes) correlated with soil parameters that were significantly different between the agricultural and scrubland soil. The arable soils were lower in organic matter and phosphate concentration, and higher in salinity. The variation in the bacterial community composition was higher in soils from scrubland than from agriculture, as revealed by DGGE and PhyloChip analyses, suggesting reduced beta diversity due to agricultural practices. The long-term use for agriculture resulted in profound changes in the bacterial community and physicochemical characteristics of former scrublands, which may irreversibly affect the natural soil ecosystem.	[Ding, Guo-Chun; Heuer, Holger; Weinert, Nicole; Smalla, Kornelia] Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Piceno, Yvette M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [Dohrmann, Anja B.; Tebbe, Christoph C.] Johann Heinrich von Thunen Inst TI, Inst Biodivers, Braunschweig, Germany; [Carrillo, Angel; Castellanos, Thelma] Ctr Invest Biol Noroeste, Sc La Paz, Mexico	Julius Kuhn-Institut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Johann Heinrich von Thunen Institute; CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Smalla, K (corresponding author), Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	kornelia.smalla@jki.bund.de	ding, guo-chun/A-6821-2012; Smalla, Kornelia/H-4002-2011; Andersen, Gary/G-2792-2015; Piceno, Yvette/I-6738-2016; Tebbe, Christoph/Q-8545-2017	ding, guo-chun/0000-0001-6702-3782; Andersen, Gary/0000-0002-1618-9827; Piceno, Yvette/0000-0002-7915-4699; Heuer, Holger/0000-0001-6044-8171; ding, guo-chun/0000-0002-5468-5979; Tebbe, Christoph/0000-0003-4861-0214; Carrillo Garcia, Angel Edgardo/0000-0002-9836-9505	German Federal Ministry for Education and Research, Projekttrager DLR [MEX 06/003, 01DN12067]; CONACYT (Concejo Nacional de Ciencia Y Tecnologia) [J110.394]; BMBF project MAQNU [03MS642H]	German Federal Ministry for Education and Research, Projekttrager DLR; CONACYT (Concejo Nacional de Ciencia Y Tecnologia); BMBF project MAQNU	This study was financially supported by the German Federal Ministry for Education and Research, Projekttrager DLR (projects MEX 06/003 and 01DN12067) and CONACYT (Concejo Nacional de Ciencia Y Tecnologia) J110.394 and the BMBF project MAQNU 03MS642H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenta-Quintana JA, 2011, REV CHAPINGO SER CIE, V17, P163, DOI 10.5154/r.rchscfa.2010.11.110; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Calderon FJ, 2001, SOIL SCI SOC AM J, V65, P118, DOI 10.2136/sssaj2001.651118x; Choudhary DK, 2011, BIOTECHNOL LETT, V33, P1905, DOI 10.1007/s10529-011-0662-0; Coria R, 1992, FLORA ICONOGRAFICA B; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Costello EK, 2006, ENVIRON MICROBIOL, V8, P1471, DOI 10.1111/j.1462-2920.2006.01041.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Davis KER, 2011, ENVIRON MICROBIOL, V13, P798, DOI 10.1111/j.1462-2920.2010.02384.x; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Ding GC, 2012, BIOMETRICAL J, V54, P94, DOI 10.1002/bimj.201000164; Entry JA, 2004, ENVIRON MANAGE, V33, pS363, DOI 10.1007/s00267-003-9145-y; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Freeman KR, 2009, ENVIRON MICROBIOL, V11, P674, DOI 10.1111/j.1462-2920.2008.01844.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Gee G.W., 2002, METHODS SOIL ANAL 4, P255, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Giovannoni S, 2004, NATURE, V430, P515, DOI 10.1038/430515a; Gomes NCM, 2005, FEMS MICROBIOL ECOL, V54, P21, DOI 10.1016/j.femsec.2005.02.005; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gruter D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-68; He JZ, 2010, BIOL FERT SOILS, V46, P283, DOI 10.1007/s00374-009-0426-3; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Islam MR, 2009, WORLD J MICROB BIOT, V25, P1115, DOI 10.1007/s11274-009-9959-8; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jackson M.L., 1958, SOIL CHEM ANAL, DOI DOI 10.1002/JPLN.19590850311; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kielak A, 2008, FEMS MICROBIOL ECOL, V63, P372, DOI 10.1111/j.1574-6941.2007.00428.x; Kladivko EJ, 2001, SOIL TILL RES, V61, P61, DOI 10.1016/S0167-1987(01)00179-9; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lo CC, 2010, J ENVIRON SCI HEAL B, V45, P348, DOI [10.1080/03601231003799804, 10.1080/10934520903467873]; Maestre FT, 2006, RESTOR ECOL, V14, P258, DOI 10.1111/j.1526-100X.2006.00128.x; Mahamane L, 2005, AGR ECOSYST ENVIRON, V105, P267, DOI 10.1016/j.agee.2004.03.004; MCLEAN E. O., 1982, AGRONOMY MONOGRAPH, V9, P199, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C12; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; OLSEN SR, 1965, METHODS SOIL CHEM 2, P1035; Peixoto RS, 2010, ANTON LEEUW INT J G, V98, P403, DOI 10.1007/s10482-010-9454-0; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Ramirez-Orduna R, 2008, SMALL RUMINANT RES, V76, P166, DOI 10.1016/j.smallrumres.2007.12.020; Rossmann B, 2012, APPL ENVIRON MICROB, V78, P4933, DOI 10.1128/AEM.00772-12; Salinas-Zavala CA, 2006, INTERCIENCIA, V31, P254; Saygin SD, 2011, ENVIRON MONIT ASSESS, V180, P201, DOI 10.1007/s10661-010-1782-z; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Snyman HA, 1998, J ARID ENVIRON, V39, P645, DOI 10.1006/jare.1998.0387; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhao WZ, 2005, CATENA, V59, P173, DOI 10.1016/j.catena.2004.06.004; Zul D, 2007, APPL ENVIRON MICROB, V73, P6916, DOI 10.1128/AEM.01533-07	76	67	71	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59497	10.1371/journal.pone.0059497	http://dx.doi.org/10.1371/journal.pone.0059497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527207	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600076
J	Ikeda, S; Harada, K; Ohwatashi, A; Kamikawa, Y; Yoshida, A; Kawahira, K				Ikeda, Satoshi; Harada, Katsuhiro; Ohwatashi, Akihiko; Kamikawa, Yurie; Yoshida, Akira; Kawahira, Kazumi			A New Non-Human Primate Model of Photochemically Induced Cerebral Infarction	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; ISCHEMIC-STROKE; LESION; RATS	Background and Purpose: Rat models of photochemically induced cerebral infarction have been readily studied, but to date there are no reports of transcranial photochemically induced infarctions in the marmoset. In this report, we used this non-human primate as a model of cerebral thrombosis and observed the recovery process. Methods: Five common marmosets were used. Cerebral ischemia was produced via intravascular thrombosis induced by an intravenous injection of Rose Bengal and irradiation with green light. After inducing cerebral infarction, we observed the behavior of marmosets via a continuous video recording. We evaluated maximum speed, mean speed, and distance traveled in 1 min. In addition, we evaluated scores for feeding behavior, upper limb grip, and lower limb grip. We confirmed the infarct area after cerebral infarction using 2,3,5-triphenyltetrazolium chloride staining in a separate marmoset. Results: We found functional decreases 2 days after creating the cerebral infarction in all measurements. Total distance traveled, average speed, upper limb score, and feeding behavior score did not recover to pre-infarction levels within 28 days. Maximum speed in 1 min and lower limb score recovered 28 days after infarction as compared to pre-infarction levels. We confirmed the infarct area of 11.4 mmx6.8 mm as stained with 2,3,5-triphenyltetrazolium chloride. Conclusion: We were able to create a primate photothrombosis-induced cerebral infarction model using marmosets and observe functional recovery. We suggest that this is a useful model for basic research of cerebral infarction.	[Ikeda, Satoshi; Harada, Katsuhiro; Ohwatashi, Akihiko; Kamikawa, Yurie; Yoshida, Akira; Kawahira, Kazumi] Kagoshima Univ, Dept Rehabil & Phys Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kagoshima University	Ikeda, S (corresponding author), Kagoshima Univ, Dept Rehabil & Phys Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	ikedas@m2.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [19300192]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 19300192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Chen JL, 2011, STROKE, V42, P3551, DOI 10.1161/STROKEAHA.111.627174; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P315, DOI 10.1007/BF00687262; Erickson CA, 2007, BEHAV BRAIN RES, V179, P208, DOI 10.1016/j.bbr.2007.02.004; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Horinouchi K, 2007, INT J NEUROSCI, V117, P315, DOI 10.1080/00207450600582124; Li L, 2011, EXP NEUROL IN PRESS; Liebigt S, 2012, EXP NEUROL, V233, P776, DOI 10.1016/j.expneurol.2011.11.037; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Marshall JWB, 1996, NEURODEGENERATION, V5, P275, DOI 10.1006/neur.1996.0036; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Sasaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026577; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Warlow C, 2008, STROKE PRACTICAL MAN	20	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60037	10.1371/journal.pone.0060037	http://dx.doi.org/10.1371/journal.pone.0060037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527298	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600115
J	Harpsoe, MC; Jorgensen, KT; Frisch, M; Jess, T				Harpsoe, Maria C.; Jorgensen, Kristian Tore; Frisch, Morten; Jess, Tine			Risk of Inflammatory Bowel Disease According to Self-Rated Health, Pregnancy Course, and Pregnancy Complications: A Study within the Danish National Birth Cohort	PLOS ONE			English	Article							STRESS; WOMEN; AUTOANTIBODIES; MORTALITY; HYPEREMESIS; DEPRESSION; COPENHAGEN; DIAGNOSES; CYTOKINES; COLITIS	Background: Poor self-rated health (SRH) has been connected to immunological changes, and pregnancy complications have been suggested in the etiology of autoimmune diseases including inflammatory bowel disease (IBD). We evaluated the impact of self-rated pre-pregnancy health and pregnancy course, hyperemesis, gestational hypertension, and preeclampsia on risk of IBD. Methods: Information was collected by questionnaires from The Danish National Birth Cohort (enrolment 1996-2002) at 16th and 30th week of pregnancy and 6 months postpartum. A total of 55,699 women were followed from childbirth until development of IBD (using validated National Hospital Discharge Register diagnoses), emigration, death, or end of follow-up, 31st of October, 2011. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards models adjusting for age and evaluating pre-pregnancy BMI, parity, alcohol and tobacco consumption, and socio-occupational status as potential confounders. Results: Risk of IBD increased with decreasing level of self-rated pre-pregnancy health (p = 0.002) and was elevated in women with poor self-rated pregnancy course (HR, 1.61, 95% CI 1.22-2.12). Associations persisted for more than 5 years postpartum. Hyperemesis and preeclampsia were not significantly associated with risk of IBD. Conclusions: This is the first prospective observational study to suggest that poor self-rated health - in general and in relation to pregnancy - is associated with increased risk of IBD even in the long term though results needs further confirmation. Symptoms of specific pregnancy complications were, on the other hand, not significantly associated with risk of IBD.	[Harpsoe, Maria C.; Jorgensen, Kristian Tore; Frisch, Morten; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jorgensen, Kristian Tore] Copenhagen Univ Hosp, Dept Occupat & Environm Med, Bispebjerg Hosp, Copenhagen, Denmark	Statens Serum Institut; Aarhus University; University of Copenhagen; Bispebjerg Hospital	Harpsoe, MC (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	rrh@ssi.dk	Frisch, Morten/E-9206-2016	Frisch, Morten/0000-0002-3864-8860	Aase og Ejnar Danielsen's Foundation; Beckett Foundation; Danish Council of Independent Research [09-066323]	Aase og Ejnar Danielsen's Foundation; Beckett Foundation; Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	The project was supported by unrestricted grants from Aase og Ejnar Danielsen's Foundation and the Beckett Foundation, and a Female Research Leader grant (no. 09-066323) from the Danish Council of Independent Research to Dr. Tine Jess. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2002, AM J EPIDEMIOL, V155, P95, DOI 10.1093/aje/155.1.95; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bortoli A, 2011, ALIMENT PHARM THER, V34, P724, DOI 10.1111/j.1365-2036.2011.04794.x; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; De Boer M, 2005, INFLAMM BOWEL DIS, V11, P400, DOI 10.1097/01.MIB.0000164024.10848.0a; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; Fayers PM, 2002, LANCET, V359, P187, DOI 10.1016/S0140-6736(02)07466-4; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Goodwin TM, 2008, OBSTET GYN CLIN N AM, V35, P401, DOI 10.1016/j.ogc.2008.04.002; Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Invernizzi P, 2009, J AUTOIMMUN, V33, P290, DOI 10.1016/j.jaut.2009.07.008; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Jorgensen KT, 2012, J AUTOIMMUN, V38, pJ120, DOI 10.1016/j.jaut.2011.10.002; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Latham K, 2013, J GERONTOL B-PSYCHOL, V68, P107, DOI 10.1093/geronb/gbs104; Laursen M, 2008, BJOG-INT J OBSTET GY, V115, P354, DOI 10.1111/j.1471-0528.2007.01583.x; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Lyyra TM, 2009, ARCH GERONTOL GERIAT, V48, P14, DOI 10.1016/j.archger.2007.09.004; Lyyra TM, 2006, ARCH GERONTOL GERIAT, V42, P277, DOI 10.1016/j.archger.2005.08.001; Maunder RG, 2008, CURR MOL MED, V8, P247, DOI 10.2174/156652408784533832; Mawdsley JE, 2006, NEUROIMMUNOMODULAT, V13, P327, DOI 10.1159/000104861; Nakata A, 2010, INT J BEHAV MED, V17, P234, DOI 10.1007/s12529-010-9102-0; Neuman MG, 2012, TRANSL RES, V160, P29, DOI 10.1016/j.trsl.2011.09.001; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Rampton D, 2009, DIGEST DIS, V27, P76, DOI 10.1159/000268124; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ross SC, 2011, J PEDIATR GASTR NUTR, V53, P480, DOI 10.1097/MPG.0b013e31822f2c32; Sajadinejad MS, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/106502; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Unden AL, 2007, CLIN SCI, V112, P363, DOI 10.1042/CS20060128; van der Woude CJ, 2010, J CROHNS COLITIS, V4, P493, DOI 10.1016/j.crohns.2010.07.004; van Schaik FD, 2012, GUT; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59698	10.1371/journal.pone.0059698	http://dx.doi.org/10.1371/journal.pone.0059698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527254	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100161
J	Jin, XN; Fu, ZY; Ding, D; Li, WH; Liu, ZH; Tang, JH				Jin, Xining; Fu, Zhiyuan; Ding, Dong; Li, Weihua; Liu, Zonghua; Tang, Jihua			Proteomic Identification of Genes Associated with Maize Grain-Filling Rate	PLOS ONE			English	Article							ORGAN SIZE; ENDOSPERM DEVELOPMENT; PROTEIN; WHEAT; EXPRESSION; PATHWAYS; PLANT; DEHYDROGENASE; EMBRYOGENESIS; GERMINATION	Grain filling during the linear phase contributes most of the dry matter accumulated in the maize kernel, which in turn determines the final grain yield. Endosperms and embryos of three elite maize hybrids (Zhengdan 958, Nongda 108, and Pioneer 335) were sampled 17, 22, 25, and 28 days after pollination, during the linear phase of grain filling, for proteomic analysis to explore the regulatory factors critical for grain filling rate. In total, 39 and 43 protein spots that showed more than 2-fold changes in abundance at P<0.01 between any two sampling stages in the endosperm and embryo were analyzed by protein mass spectrometry. The changing patterns in expression index of these proteins in the endosperm were evenly distributed, whereas up-regulation patterns predominated (74%) in the embryo. Functional analysis revealed that metabolism was the largest category, represented by nine proteins in the endosperm and 12 proteins in the embryo, of the proteins that significantly changed in abundance. Glycolysis, a critical process both for glucose conversion into pyruvate and for release of free energy and reducing power, and proteins related to redox homeostasis were emphasized in the endosperm. Additionally, lipid, nitrogen, and inositol metabolism related to fatty acid biosynthesis and late embryogenesis abundant proteins were emphasized in the embryo. One protein related to cellular redox equilibrium, which showed a more than 50-fold change in abundance and was co-localized with a quantitative trait locus for grain yield on chromosome 1, was further investigated by transcriptional profile implying consistent expression pattern with protein accumulation. The present results provide a first step towards elucidation of the gene network responsible for regulation of grain filling in maize.	[Jin, Xining; Fu, Zhiyuan; Ding, Dong; Li, Weihua; Liu, Zonghua; Tang, Jihua] Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Coll Agron, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Coll Agron, Zhengzhou, Peoples R China.	tangjihua1@163.com		fu, zhiyuan/0000-0002-9078-5133	Major State Basic Research Development Program of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; Key Base Research Project of Henan Province	Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Base Research Project of Henan Province	This work was supported by the Major State Basic Research Development Program of China (2012CB723001,http://www.nsfc.gov.cn) and a grant from the National High Technology Research and Development Program of China (no 2012AA10A305 http://www.863.gov.cn/) and Key Base Research Project of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capristo PR, 2007, AGRON J, V99, P1111, DOI 10.2134/agronj2006.0360; Cordova-Tellez L, 2002, CROP SCI, V42, P1989, DOI 10.2135/cropsci2002.1989; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; El-Kabbani O, 2004, CURR MED CHEM, V11, P465, DOI 10.2174/0929867043455927; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Finnie C, 2002, PLANT PHYSIOL, V129, P1308, DOI 10.1104/pp.003681; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Gasura E, 2010, 2 RUFORUM BIENN M 20; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; HANFT JM, 1986, CROP SCI, V26, P568, DOI 10.2135/cropsci1986.0011183X002600030029x; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; JENNER CF, 1972, ANN BOT-LONDON, V36, P729, DOI 10.1093/oxfordjournals.aob.a084629; Joosen R, 2007, PLANT PHYSIOL, V144, P155, DOI 10.1104/pp.107.098723; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; Kling JG, 1997, MORPHOLOGY GROWTH MA, P36; Koller A, 2002, P NATL ACAD SCI USA, V99, P11969, DOI 10.1073/pnas.172183199; KRIZ AL, 1989, BIOCHEM GENET, V27, P239, DOI 10.1007/BF02401804; Laux T, 2004, PLANT CELL, V16, pS190, DOI 10.1105/tpc.016014; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Ostergaard O, 2002, PROTEOMICS, V2, P733, DOI 10.1002/1615-9861(200206)2:6<733::AID-PROT733>3.0.CO;2-E; Prioul JL, 2008, PLANT BIOTECHNOL J, V6, P855, DOI 10.1111/j.1467-7652.2008.00368.x; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Saini HS, 2000, ADV AGRON, V68, P59; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Skylas DJ, 2001, PROTEOMICS, V1, P1542, DOI 10.1002/1615-9861(200111)1:12<1542::AID-PROT1542>3.0.CO;2-K; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Xu H, 2012, PLANTA, V235, P687, DOI 10.1007/s00425-011-1535-4; Xu SB, 2010, J PROTEOME RES, V9, P4906, DOI 10.1021/pr900954p; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang W, 2008, FIELD CROP RES, V105, P221, DOI 10.1016/j.fcr.2007.10.006; Zahedi M, 2003, J AGR SCI-CAMBRIDGE, V141, P203, DOI 10.1017/S0021859603003411; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313	46	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59353	10.1371/journal.pone.0059353	http://dx.doi.org/10.1371/journal.pone.0059353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527170	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100114
J	Kasim, V; Wu, SR; Taira, K; Miyagishi, M				Kasim, Vivi; Wu, Shourong; Taira, Kazunari; Miyagishi, Makoto			Determination of the Role of DDX3 a Factor Involved in Mammalian RNAi Pathway Using an shRNA-Expression Library	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; HUMAN GENOME; C-ELEGANS; INTERFERENCE; HELICASE; ARGONAUTE2; BODIES; LINE	RNA interference (RNAi) is an endogenous RNA-destruction phenomenon induced by certain double-stranded RNAs (dsRNAs). In RNAi, dsRNAs are processed into small interfering RNAs (siRNAs) which in turn trigger the cleavage of the target mRNA. Here, using a short hairpin RNA-expression library, we identified a DEAD-box helicase 3, DDX3, as an essential factor involved in RNAi pathway and revealed that DDX3 is colocalized with Ago2, an essential factor in RNAi pathway that cleaves target mRNA. Results of experiments with a dominant negative mutant of DDX3 further confirmed that this factor affects the RNAi activity. Together, DDX3 functions to assure mammalian RNAi pathway. Together, our results indicate that DDX3 is a new key molecule to understand the molecular mechanism underlying RNAi pathway in mammals.	[Kasim, Vivi; Wu, Shourong] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Kasim, Vivi; Wu, Shourong; Taira, Kazunari] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Taira, Kazunari] Univ Tokyo, Tokyo, Japan; [Taira, Kazunari] Grad Sch Social Welf, Tokyo, Japan; [Miyagishi, Makoto] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Mol Composite Med Res Grp, Tsukuba, Ibaraki, Japan	Chongqing University; University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Miyagishi, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Mol Composite Med Res Grp, Tsukuba, Ibaraki, Japan.	makoto.miyagishi@aist.go.jp	Miyagishi, Makoto/L-8174-2016	Miyagishi, Makoto/0000-0001-7654-3616; Kasim, Vivi/0000-0001-9182-8230; Wu, Shourong/0000-0001-9650-5465	National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan	National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan	This work was supported in part by the National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Matsumoto S, 2005, J BIOL CHEM, V280, P25687, DOI 10.1074/jbc.M412784200; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Park SH, 1998, CYTOGENET CELL GENET, V81, P178, DOI 10.1159/000015022; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	22	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59445	10.1371/journal.pone.0059445	http://dx.doi.org/10.1371/journal.pone.0059445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527197	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100135
J	Law, JLM; Chen, C; Wong, J; Hockman, D; Santer, DM; Frey, SE; Belshe, RB; Wakita, T; Bukh, J; Jones, CT; Rice, CM; Abrignani, S; Tyrrell, DL; Houghton, M				Law, John Lok Man; Chen, Chao; Wong, Jason; Hockman, Darren; Santer, Deanna M.; Frey, Sharon E.; Belshe, Robert B.; Wakita, Takaji; Bukh, Jens; Jones, Christopher T.; Rice, Charles M.; Abrignani, Sergio; Tyrrell, D. Lorne; Houghton, Michael			A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans	PLOS ONE			English	Article							THERAPEUTIC VACCINES; CELL ENTRY; IN-VIVO; INFECTION; CULTURE; PROSPECTS; PSEUDOPARTICLES; IMMUNIZATION; REPLICATION; ENHANCEMENT	Although a cure for HCV is on the near horizon, emerging drug cocktails will be expensive, associated with side-effects and resistance making a global vaccine an urgent priority given the estimated high incidence of infection around the world. Due to the highly heterogeneous nature of HCV, an effective HCV vaccine which could elicit broadly cross-neutralizing antibodies has represented a major challenge. In this study, we tested for the presence of cross-neutralizing antibodies in human volunteers who were immunized with recombinant glycoproteins gpE1/gpE2 derived from a single HCV strain (HCV1 of genotype 1a). Cross neutralization was tested in Huh-7.5 human hepatoma cell cultures using infectious recombinant HCV (HCVcc) expressing structural proteins of heterologous HCV strains from all known major genotypes, 1-7. Vaccination induced significant neutralizing antibodies against heterologous HCV genotype 1a virus which represents the most common genotype in North America. Of the 16 vaccinees tested, 3 were selected on the basis of strong 1a virus neutralization for testing of broad cross-neutralizing responses. At least 1 vaccinee was shown to elicit broad cross-neutralization against all HCV genotypes. Although observed in only a minority of vaccinees, our results prove the key concept that a vaccine derived from a single strain of HCV can elicit broad cross-neutralizing antibodies against all known major genotypes of HCV and provide considerable encouragement for the further development of a human vaccine against this common, global pathogen.	[Law, John Lok Man; Chen, Chao; Wong, Jason; Hockman, Darren; Santer, Deanna M.; Tyrrell, D. Lorne; Houghton, Michael] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Frey, Sharon E.; Belshe, Robert B.] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program C, Dept Infect Dis, Hvidovre, Denmark; [Bukh, Jens] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Bukh, Jens] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Jones, Christopher T.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Abrignani, Sergio] Ist Nazl Genet Mol, Milan, Italy	University of Alberta; Saint Louis University; National Institute of Infectious Diseases (NIID); University of Copenhagen; University of Copenhagen; University of Copenhagen; Rockefeller University	Law, JLM (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	llaw@ualberta.ca; michael.houghton@ualberta.ca		Houghton, Michael/0000-0003-3762-6771; Bukh, Jens/0000-0002-7815-4806; Abrignani, Sergio/0000-0002-0794-3285; Santer, Deanna/0000-0001-6169-7735	United States of America National Institute of Allergy and Infectious Disease [DMID 01-002]; Public Health Service [AI072613, AI075099]; Starr Foundation; Greenberg Medical Research Institute; Canada Excellence Research Chairs Program; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613, R01AI075099] Funding Source: NIH RePORTER	United States of America National Institute of Allergy and Infectious Disease; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Starr Foundation; Greenberg Medical Research Institute; Canada Excellence Research Chairs Program(Canada Research Chairs); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The United States of America National Institute of Allergy and Infectious Disease for funding of the phase I clinical trial (DMID 01-002) utilizing the recombinant gpE1/gpE2 vaccine manufactured at Novartis. Novartis provided the vaccine. CMR was supported by grants from the Public Health Service (AI072613 and AI075099), the Starr Foundation and the Greenberg Medical Research Institute. MH is supported by the Canada Excellence Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Stamataki Z, 2011, J INFECT DIS, V204, P811, DOI 10.1093/infdis/jir399; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang Y, 2011, VIRUSES-BASEL, V3, P2127, DOI 10.3390/v3112127; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	42	121	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59776	10.1371/journal.pone.0059776	http://dx.doi.org/10.1371/journal.pone.0059776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527266	gold, Green Published			2022-12-27	WOS:000317562100166
J	Yang, CH; Shogren, KL; Goyal, R; Bravo, D; Yaszemski, MJ; Maran, A				Yang, Caihong; Shogren, Kristen L.; Goyal, Ribu; Bravo, Dalibel; Yaszemski, Michael J.; Maran, Avudaiappan			RNA-Dependent Protein Kinase Is Essential for 2-Methoxyestradiol-Induced Autophagy in Osteosarcoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; CANCER-CELLS; APOPTOSIS; DEATH; ACTIVATION; PKR; INDUCTION; STRESS; TUMORIGENESIS; LIPIDATION	Osteosarcoma is the most common primary malignant bone tumor in children and young adults. Surgical resection and adjunctive chemotherapy are the only widely available options of treatment for this disease. Anti-tumor compound 2-Methoxyestradiol (2-ME) triggers cell death through the induction of apoptosis in osteosarcoma cells, but not in normal osteoblasts. In this report, we have investigated whether autophagy plays a role in 2-ME actions on osteosarcoma cells. Transmission electron microscopy imaging shows that 2-ME treatment leads to the accumulation of autophagosomes in human osteosarcoma cells. 2-ME induces the conversion of the microtubule-associated protein LC3-I to LC3-II, a biochemical marker of autophagy that is correlated with the formation of autophagosomes. Conversion to LC3-II is accompanied by protein degradation in 2-ME-treated cells. 2-ME does not induce autophagosome formation in normal primary human osteoblasts. In addition, 2-ME-dependent autophagosome formation in osteosarcoma cells requires ATG7 expression. Furthermore, 2-ME does not induce accumulation of autophagosomes in osteosarcoma cells that express dominant negative mutant RNA-dependent protein kinase (PKR) and are resistant to anti-proliferative and anti-tumor effects of 2-ME. Taken together, our study shows that 2-ME treatment induces PKR-dependent autophagy in osteosarcoma cells, and that autophagy could play an important role in 2-ME-mediated anti-tumor actions and in the control of osteosarcoma.	[Yang, Caihong; Shogren, Kristen L.; Goyal, Ribu; Bravo, Dalibel; Yaszemski, Michael J.; Maran, Avudaiappan] Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA; [Yang, Caihong] Huazhong Univ Sci & Technol, Dept Orthoped, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Mayo Clinic; Huazhong University of Science & Technology	Maran, A (corresponding author), Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA.	maran.avudai@mayo.edu			Mayo Clinic Cancer Center Bridging to Success Award (Fraternal order of Eagles); Mayo Clinic	Mayo Clinic Cancer Center Bridging to Success Award (Fraternal order of Eagles); Mayo Clinic	This work was supported by Mayo Clinic Cancer Center Bridging to Success Award (Fraternal order of Eagles) to AM and the Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Benedikt MB, 2010, J CELL BIOCHEM, V109, P950, DOI 10.1002/jcb.22473; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Garcia GE, 2006, CLIN CANCER RES, V12, P980, DOI 10.1158/1078-0432.CCR-05-2068; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Ge PF, 2009, ACTA PHARMACOL SIN, V30, P1046, DOI 10.1038/aps.2009.71; Gupta A, P NATL ACAD SCI US, V107, P14333; Huang S, AUTOPHAGY, V6, P256; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kang SH, 2006, CANCER RES, V66, P11991, DOI 10.1158/0008-5472.CAN-06-1320; Kennedy AM, 2005, ENDOCRINOLOGY, V146, P201, DOI 10.1210/en.2004-0486; Kirches E, 2009, ANTI-CANCER AGENT ME, V9, P55, DOI 10.2174/187152009787047725; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar AP, 2003, CARCINOGENESIS, V24, P209, DOI 10.1093/carcin/24.2.209; LaVallee TM, 2003, CANCER RES, V63, P468; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; MANN SS, 1994, J BIOL CHEM, V269, P11492; Maran A, 2002, BONE, V30, P393, DOI 10.1016/S8756-3282(01)00681-0; Maran A, 2008, J CELL BIOCHEM, V104, P1937, DOI 10.1002/jcb.21758; Meschini S, 2008, AUTOPHAGY, V4, P1020, DOI 10.4161/auto.6952; Mizushima N, CELL, V140, P313; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mukhopadhyay T, 1997, ONCOGENE, V14, P379, DOI 10.1038/sj.onc.1200835; O'Donovan TR, AUTOPHAGY, V7, P509; Parks M, 2011, MOL CELL ENDOCRINOL, V331, P119, DOI 10.1016/j.mce.2010.08.017; Qadan LR, 2001, BIOCHEM BIOPH RES CO, V285, P1259, DOI 10.1006/bbrc.2001.5320; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Shogren KL, 2007, J BONE MINER RES, V22, P29, DOI 10.1359/JBMR.060914; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; VOSS V, MOL CANC RES, V8, P1002; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wimbauer F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-93	44	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59406	10.1371/journal.pone.0059406	http://dx.doi.org/10.1371/journal.pone.0059406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527187	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100128
J	Zong, XN; Li, H				Zong, Xin-Nan; Li, Hui			Construction of a New Growth References for China Based on Urban Chinese Children: Comparison with the WHO Growth Standards	PLOS ONE			English	Article							BODY-MASS INDEX; PERCENTILE CURVES; SECULAR TRENDS; CDC 2000; WEIGHT; HEIGHT; OVERWEIGHT; STATURE; CITIES; BMI	Introduction: Growth references for Chinese children should be updated due to the positive secular growth trends and the progress of the smoothing techniques. Human growth differs among the various ethnic groups, so comparison of the China references with the WHO standards helps to understand such differences. Methods: The China references, including weight, length/height, head circumference, weight-for-length/height and body mass index (BMI) aged 0-18 years, were constructed based on 69,760 urban infants and preschool children under 7 years and 24,542 urban school children aged 6-20 years derived from two cross-sectional national surveys. The Cole's LMS method is employed for smoothing the growth curves. Results: The merged data sets resulted in a smooth transition at age 6-7 years and continuity of curves from 0 to 18 years. Varying differences were found on the empirical standard deviation (SD) curves in each indicator at nearly all ages between China and WHO. The most noticeable differences occurred in genders, final height and boundary centiles curves. Chinese boys' weight is strikingly heavier than that of the WHO at age 6-10 years. The height is taller than that of the WHO for boys below 15 years and for girls below 13, but is significantly lower when boys over 15 years and girls over 13. BMI is generally higher than that of the WHO for boys at age 6-16 years but appreciably lower for girls at 3-18 years. Conclusions: The differences between China and WHO are mainly caused by the reference populations of different ethnic backgrounds. For practitioners, the choices of the standards/references depend on the population to be assessed and the purpose of the study. The new China references could be applied to facilitate the standardization assessment of growth and nutrition for Chinese children and adolescents in clinical pediatric and public health.	[Zong, Xin-Nan; Li, Hui] Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, H (corresponding author), Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China.	huiligrowth@163.com						Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Freedman DS, 2006, OBESITY, V14, P301, DOI 10.1038/oby.2006.39; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gerver W., 1996, PAEDIAT MORPHOMETRIC; Hamill P V, 1977, Vital Health Stat 11, pi; Huang Y.-C., 2002, J MED SCI, V22, P221; Jeong B.J., 2007, J KOREAN SOC AEROB E, V11, P41; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Ji CY, 2008, AM J HUM BIOL, V20, P530, DOI 10.1002/ajhb.20770; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Leung SSF, 1996, J PAEDIATR CHILD H, V32, P103, DOI 10.1111/j.1440-1754.1996.tb00904.x; Li H, 1999, ANN HUM BIOL, V26, P457, DOI 10.1080/030144699282570; Li H., 2008, NATL GROWTH SURVEY C; Li H, 2011, BIOMED ENVIRON SCI, V24, P1, DOI 10.3967/0895-3988.2011.01.001; [李辉 Li Hui], 2002, [中华儿科杂志, Chinese Journal of Pediatrics], V40, P662; Ma Jun, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P776; Ma J, 2010, PUBLIC HEALTH NUTR, V13, P1990, DOI 10.1017/S1368980010000492; Mei ZG, 2008, J PEDIATR-US, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Pan HQ, 2009, ANN HUM BIOL, V36, P98, DOI 10.1080/03014460802575641; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Xu L, 2010, J BEIJING SPORT U, V33, P63; ZHANG X, 1977, CHIN MED J, V3, P364; Zhang YQ., 2008, CHINESE J CHILD HLTH, V16, P397; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942; Zong XN, 2011, AM J HUM BIOL, V23, P209, DOI 10.1002/ajhb.21105	31	95	101	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59569	10.1371/journal.pone.0059569	http://dx.doi.org/10.1371/journal.pone.0059569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527219	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100148
J	Lin, HJ; Ding, YY; Liu, X; Zhu, WM; Gao, MY; He, N				Lin, Haijiang; Ding, Yingying; Liu, Xing; Zhu, Weiming; Gao, Meiyang; He, Na			Changes in Sexual Behaviors among HIV-Infected Individuals after Their HIV Diagnosis in a Rural Prefecture of Eastern China	PLOS ONE			English	Article							DISCORDANT COUPLES; SOCIAL NETWORK; PUBLIC-HEALTH; PREVENTION; TRANSMISSION; WORKERS; WOMEN; AIDS; MEN	Objective: To describe changes in sexual behaviors among HIV-infected individuals after their HIV diagnosis. Methods: All HIV-infected individuals diagnosed by the end of 2009 in Taizhou Prefecture were invited to participate in this 12-month prospective study. Assessments including the total number and types of sexual contacts, and condom use details for up to their most familiar eight sexual contacts were collected both at enrollment and 12-month follow-up. Results: 262 HIV-infected individuals were eligible for analysis. The total number of sexual contacts reported by participants was 4,017, 1,496 and 356 during the 12-month period prior to HIV diagnosis (T1), the 12-month period prior to the baseline survey (T2), and the 12-month follow-up period (T3), respectively. The difference in the number of sexual contacts between T2 and T1 was -5 in median (IQR -1, -14), and the difference between T3 and T2 was 0 in median (IQR: 0, -6). A larger proportion of spousal or long-term heterosexual contact was reported from T1(27.7%) to T2(42.5%) to T3(76.1%), whereas a smaller proportion of commercial heterosexual contacts was reported from T1 (48.6%) to T2 (33.2%) to T3 (7.0%) as well as a smaller proportion of non-commercial casual homosexual contacts was reported from T2 (8.4%) to T3 (3.8%). The proportion of consistent condom use increased significantly from T1 (9.3%) to T2 (35.3%) to T3 (91.5%). Conclusion: Sexual behaviors did not change in a uniform manner for the participants in our study. Sexual behaviors and sexual networks vis-a`-vis HIV diagnosis and follow-up were associated with the participant's characteristics and HIV infection and treatment status. The overall lesson is that individuals who are unaware of their HIV infection are the main drivers of secondary transmission. Early identification of HIV infection and access to antiretroviral therapy (ART) are both key strategies to the control and prevention.	[Lin, Haijiang; Ding, Yingying; Liu, Xing; Zhu, Weiming; Gao, Meiyang; He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Lin, Haijiang] Taizhou City Ctr Dis Control & Prevent, Taizhou City, Zhejiang, Peoples R China; [Liu, Xing; Zhu, Weiming] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Lin, Haijiang; Ding, Yingying; Liu, Xing; Zhu, Weiming; Gao, Meiyang; He, Na] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China	Fudan University; University of California System; University of California Los Angeles	He, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	ding, yy/HHS-9589-2022		Chinese National Major Research and Technology Project on Infectious Diseases including HIV/AIDS and viral hepatitis [2008ZX10001-003]; Shanghai Municipal Health Bureau [XBR2011043]; Shanghai Leading Disciplinary Project [B118]	Chinese National Major Research and Technology Project on Infectious Diseases including HIV/AIDS and viral hepatitis; Shanghai Municipal Health Bureau; Shanghai Leading Disciplinary Project	This study was supported in part by Chinese National Major Research and Technology Project on Infectious Diseases including HIV/AIDS and viral hepatitis (grant no. 2008ZX10001-003), Shanghai Municipal Health Bureau (grant no. XBR2011043), and the Shanghai Leading Disciplinary Project (grant no. B118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Amaro H, 2005, J HEALTH PSYCHOL, V10, P287, DOI 10.1177/1359105305048780; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Carey MP, 1999, AM J HEALTH PROMOT, V14, P104, DOI 10.4278/0890-1171-14.2.104; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P601; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P412; Chariyeva Z, 2013, AIDS BEHAV, V17, P813, DOI 10.1007/s10461-011-0115-8; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dooley SW, 2007, AM J PREV MED, V33, pS81, DOI 10.1016/j.amepre.2007.04.020; Feinleib JA, 1998, PREV MED, V27, P400, DOI 10.1006/pmed.1998.0270; FOX R, 1987, AIDS, V1, P241; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Inciardi JA, 2005, AIDS CARE, V17, pS88, DOI 10.1080/09540120500121011; Irungu E, 2012, AIDS, V26, P997, DOI 10.1097/QAD.0b013e3283524ca1; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Koopman JS, 1999, AM J PUBLIC HEALTH, V89, P1170, DOI 10.2105/AJPH.89.8.1170; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Lin Hai-Jiang, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1227; Lin HJ, 2013, AM J EPIDEMIOL, V177, P343, DOI 10.1093/aje/kws256; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Morris M, 2004, NETWORK EPIDEMIOLOGY; National Center for AIDS and STD Control and Prevention National Center for Disease Control and Prevention China, 2012, NAT MAN BOOK FREE AN; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Robles R R, 1996, Drugs Soc (New York), V9, P173, DOI 10.1300/J023v09n01_10; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Rotheram-Borus MJ, 2000, J ACQ IMMUN DEF SYND, V25, pS105, DOI 10.1097/00126334-200012152-00004; State Council of People's Republic of China, 2011, CHIN ACT PLAN RED PR; State Council of People's Republic of China, 2010, JOINT FURTH EFF EFF; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wang Ning, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1205; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; World Health Organization, 2007, GUID PROV IN HIV TES; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2010, JAIDS-J ACQ IMM DEF, V53, pS1, DOI 10.1097/QAI.0b013e3181c7d379; Zhu Wei-ming, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P994	48	2	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59575	10.1371/journal.pone.0059575	http://dx.doi.org/10.1371/journal.pone.0059575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZS	23527221	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600063
J	Pages, PB; Facy, O; Mordant, P; Ladoire, S; Magnin, G; Lokiec, F; Ghiringhelli, F; Bernard, A				Pages, Pierre-Benoit; Facy, Olivier; Mordant, Pierre; Ladoire, Sylvain; Magnin, Guy; Lokiec, Francois; Ghiringhelli, Francois; Bernard, Alain			Isolated Lung Perfusion as an Adjuvant Treatment of Colorectal Cancer Lung Metastases: A Preclinical Study in a Pig Model	PLOS ONE			English	Article							PULMONARY METASTASES; PHASE-I; REGIONAL CHEMOTHERAPY; NEOADJUVANT THERAPY; RAT MODEL; GEMCITABINE; MELPHALAN; RESECTION; TRIAL; CARCINOMA	Background: The lung is a frequent site of colorectal cancer (CRC) metastases. After surgical resection, lung metastases recurrences have been related to the presence of micrometastases, potentially accessible to a high dose chemotherapy administered via adjuvant isolated lung perfusion (ILP). We sought to determine in vitro the most efficient drug when administered to CRC cell lines during a short exposure and in vivo its immediate and delayed tolerance when administered via ILP. Methods: First, efficacy of various cytotoxic molecules against a panel of human CRC cell lines was tested in vitro using cytotoxic assay after a 30-minute exposure. Then, early (operative) and delayed (1 month) tolerance of two concentrations of the molecule administered via ILP was tested on 19 adult pigs using hemodynamic, biological and histological criteria. Results: In vitro, gemcitabine (GEM) was the most efficient drug against selected CRC cell lines. In vivo, GEM was administered via ILP at regular (20 mu g/ml) or high (100 mu g/ml) concentrations. GEM administration was associated with transient and dose-dependant pulmonary vasoconstriction, leading to a voluntary decrease in pump inflow in order to maintain a stable pulmonary artery pressure. After this modulation, ILP using GEM was not associated with any systemic leak, systemic damage, and acute or delayed histological pulmonary toxicity. Pharmacokinetics studies revealed dose-dependant uptake associated with heterogenous distribution of the molecule into the lung parenchyma, and persistent cytotoxicity of venous effluent. Conclusions: GEM is effective against CRC cells even after a short exposure. ILP with GEM is a safe and reproducible technique.	[Pages, Pierre-Benoit; Facy, Olivier; Ladoire, Sylvain; Ghiringhelli, Francois] Univ Burgundy, CHU Bocage, INSERM UMR 866, Dijon, France; [Pages, Pierre-Benoit; Bernard, Alain] Univ Burgundy, CHU Bocage, Dept Thorac & Cardiovasc Surg, Dijon, France; [Facy, Olivier] Univ Burgundy, CHU Bocage, Dept Digest Surg, Dijon, France; [Mordant, Pierre] Georges Pompidou European Hosp, Dept Thorac Surg, Paris, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Univ Burgundy, Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Magnin, Guy] Univ Burgundy, CHU Bocage, Dept Anesthesiol, Dijon, France; [Lokiec, Francois] Ctr Rene Huguenin, Dept Pharmacol, St Cloud, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Georges-Francois Leclerc; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Rene Huguenin Hospital	Pages, PB (corresponding author), Univ Burgundy, CHU Bocage, INSERM UMR 866, Dijon, France.	pb.pages@live.fr	facy, olivier/AAQ-2293-2021; Mordant, Pierre/J-3603-2017	facy, olivier/0000-0002-5619-8963; Pages, Pierre-Benoit/0000-0001-5540-6911; ghiringhelli, francois/0000-0002-5465-8305; LADOIRE, Sylvain/0000-0002-0331-9194	French National League against Cancer [SW/SP-116F.2010]; Scientific Committee of the School of Medicine of Dijon, France	French National League against Cancer; Scientific Committee of the School of Medicine of Dijon, France	This work was supported by French National League against Cancer [SW/SP-116F.2010] and the Scientific Committee of the School of Medicine of Dijon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Caffo O, 2010, CANCER CHEMOTH PHARM, V65, P1197, DOI 10.1007/s00280-010-1255-7; Chang AY, 2007, CLIN COLORECTAL CANC, V6, P646, DOI 10.3816/CCC.2007.n.033; Chiang CH, 2001, CLIN SCI, V101, P285, DOI 10.1042/CS20000302; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; De Pas T, 2001, ANN ONCOL, V12, P1651, DOI 10.1023/A:1013163831194; Edwards MS, 2012, COLORECTAL DIS, V14, pe31, DOI 10.1111/j.1463-1318.2011.02765.x; Faivre S, 2002, ANN ONCOL, V13, P1479, DOI 10.1093/annonc/mdf219; Franke UFW, 2004, EUR J CARDIO-THORAC, V26, P800, DOI 10.1016/j.ejcts.2004.04.046; Franke UFW, 2004, EUR J CARDIO-THORAC, V26, P792, DOI 10.1016/j.ejcts.2004.06.008; Grootenboers MJH, 2007, J SURG ONCOL, V96, P583, DOI 10.1002/jso.20838; Grootenboers MJJH, 2006, PERFUSION-UK, V21, P267, DOI 10.1177/0267659106073984; GURNEY H, 1993, ANN ONCOL, V4, P103, DOI 10.1093/oxfordjournals.annonc.a058411; Hatok J, 2009, CLIN EXP MED, V9, P1, DOI 10.1007/s10238-008-0011-3; Hendriks JMH, 2004, ANN THORAC SURG, V78, P1919, DOI 10.1016/j.athoracsur.2004.05.058; Hendriks JMH, 1998, ANN THORAC SURG, V66, P1719, DOI 10.1016/S0003-4975(98)00990-4; Hind D, 2008, HEALTH TECHNOL ASSES, V12, P1; Hind D, 2008, Health Technol Assess, V12, piii; HOUGHTON PJ, 1993, CANCER RES, V53, P2823; Jhawer M, 2000, CANC RES, V68, P1953; Joosten J, 2008, EJSO-EUR J SURG ONC, V34, P895, DOI 10.1016/j.ejso.2008.01.009; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kornmann M, 2000, EUR J SURG ONCOL, V26, P583, DOI 10.1053/ejso.2000.0951; Krueger T, 2006, J THORAC CARDIOV SUR, V132, P304, DOI 10.1016/j.jtcvs.2005.12.072; Lee WS, 2007, INT J COLORECTAL DIS, V22, P699, DOI 10.1007/s00384-006-0218-2; Link KH, 1996, CLIN CANCER RES, V2, P1469; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Mitry E, 2010, GUT, V59, P1383, DOI 10.1136/gut.2010.211557; NG B, 1995, ANN THORAC SURG, V59, P205; Ortega-Deballon P, 2010, ANN SURG ONCOL, V17, P898, DOI 10.1245/s10434-009-0775-z; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Pfannschmidt J, 2007, ANN THORAC SURG, V84, P324, DOI 10.1016/j.athoracsur.2007.02.093; POON MA, 1989, J CLIN ONCOL, V7, P1407, DOI 10.1200/JCO.1989.7.10.1407; Ueda K, 1999, ANTICANCER RES, V19, P141; Vahrmeijer AL, 2000, BRIT J CANCER, V82, P1539; van Putte BP, 2006, ANN THORAC SURG, V82, P1033, DOI 10.1016/j.athoracsur.2006.04.020; Van Putte BP, 2006, THORAC CARDIOV SURG, V54, P129, DOI 10.1055/s-2005-872868; Van Putte BP, 2005, J THORAC CARDIOV SUR, V130, P125, DOI 10.1016/j.jtcvs.2004.07.045; Van Putte BP, 2002, ANN THORAC SURG, V74, P893, DOI 10.1016/S0003-4975(02)03802-X; Van Schil PE, 2008, EUR J CARDIO-THORAC, V33, P486, DOI 10.1016/j.ejcts.2007.12.009; Welter S, 2007, ANN THORAC SURG, V84, P203, DOI 10.1016/j.athoracsur.2007.03.028	41	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59485	10.1371/journal.pone.0059485	http://dx.doi.org/10.1371/journal.pone.0059485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527205	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600060
J	Perello, M; Raingo, J				Perello, Mario; Raingo, Jesica			Leptin Activates Oxytocin Neurons of the Hypothalamic Paraventricular Nucleus in Both Control and Diet-Induced Obese Rodents	PLOS ONE			English	Article							PROTHYROTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCER; FOOD-INTAKE; BRAIN-STEM; SYMPATHETIC TONE; GENE-EXPRESSION; ADIPOSE-TISSUE; TARGET NEURONS; SPINAL-CORD; RECEPTOR	The adipocyte-derived hormone leptin acts in the brain to reduce body weight and fat mass. Recent studies suggest that parvocellular oxytocin (OXT) neurons of the hypothalamic paraventricular nucleus (PVN) can mediate body weight reduction through inhibition of food intake and increased energy expenditure. However, the role of OXT neurons of the PVN as a primary target of leptin has not been investigated. Here, we studied the potential role of OXT neurons of the PVN in leptin-mediated effects on body weight regulation in fasted rats. We demonstrated that intracerebroventricular (ICV) leptin activates STAT3 phosphorylation in OXT neurons of the PVN, showed that this occurs in a subpopulation of OXT neurons that innervate the nucleus of the solitary tract (NTS), and provided further evidence suggesting a role of OXT to mediate leptin's actions on body weight. In addition, our results indicated that OXT neurons are responsive to ICV leptin and mediate leptin effects on body weight in diet induced obese (DIO) rats, which are resistant to the anorectic effects of the hormone. Thus, we conclude that leptin targets a specific subpopulation of parvocellular OXT neurons of the PVN, and that this action may be important for leptin's ability to reduce body weight in both control and obese rats.	[Perello, Mario] Argentine Res Council, Neurophysiol Lab, La Plata, Buenos Aires, Argentina; [Perello, Mario; Raingo, Jesica] Sci Res Commiss Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Raingo, Jesica] Argentine Res Council, Lab Electrophysiol, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina		Perello, M (corresponding author), Argentine Res Council, Neurophysiol Lab, La Plata, Buenos Aires, Argentina.	marioperello@yahoo.com		Perello, Mario/0000-0003-2114-6765	International Brain Research Organization [PICT2010-1954, PICT2011-2142]; National Agency of Scientific and Technological Promotion of Argentina [PICT2010-1589, PICT2011-1816]	International Brain Research Organization; National Agency of Scientific and Technological Promotion of Argentina	This study was supported by International Brain Research Organization, PICT2010-1954 and PICT2011-2142 grants to MP and by PICT2010-1589 and PICT2011-1816 grants to JR of the National Agency of Scientific and Technological Promotion of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blevins JE, 2003, BRAIN RES, V993, P30, DOI 10.1016/j.brainres.2003.08.036; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 2000, J COMP NEUROL, V423, P261; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Friedman Jeffrey M., 2011, Keio Journal of Medicine, V60, P1, DOI 10.2302/kjm.60.1; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Hakansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392; Hakansson ML, 1998, J NEUROSCI, V18, P559; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Huo LH, 2004, ENDOCRINOLOGY, V145, P2516, DOI 10.1210/en.2003-1242; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P529, DOI 10.1016/0031-9384(88)90154-0; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Legradi G, 1997, ENDOCRINOLOGY, V138, P2569, DOI 10.1210/en.138.6.2569; LOUP F, 1989, BRAIN RES, V500, P223, DOI 10.1016/0006-8993(89)90317-X; Maejima Y, 2011, AGING-US, V3, P1169, DOI 10.18632/aging.100408; MERCHENTHALER I, 1994, ACTA BIOL HUNG, V45, P361; Michelini LC, 2001, ANN NY ACAD SCI, V940, P206; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; OLSON BR, 1991, ENDOCRINOLOGY, V129, P785, DOI 10.1210/endo-129-2-785; OLSON BR, 1991, PEPTIDES, V12, P113, DOI 10.1016/0196-9781(91)90176-P; Onaka T, 2012, J NEUROENDOCRINOL, V24, P587, DOI 10.1111/j.1365-2826.2012.02300.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2006, ENDOCRINOLOGY, V147, P2705, DOI 10.1210/en.2005-1609; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Reidy SP, 2002, AM J PHYSIOL-ENDOC M, V282, pE312, DOI 10.1152/ajpendo.00037.2001; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Smith PM, 1998, AM J PHYSIOL-REG I, V275, pR2081, DOI 10.1152/ajpregu.1998.275.6.R2081; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; WHITE JD, 1985, PHYSIOL REV, V65, P553, DOI 10.1152/physrev.1985.65.3.553; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Zhang G, 2011, AM J PHYSIOL-ENDOC M, V301, pE1004, DOI 10.1152/ajpendo.00196.2011	60	58	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59625	10.1371/journal.pone.0059625	http://dx.doi.org/10.1371/journal.pone.0059625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527232	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600069
J	Wu, XJ; Xing, S; Trinkaus, E				Wu, Xiu-Jie; Xing, Song; Trinkaus, Erik			An Enlarged Parietal Foramen in the Late Archaic Xujiayao 11 Neurocranium from Northern China, and Rare Anomalies among Pleistocene Homo	PLOS ONE			English	Article							ALX4 HOMEOBOX GENE; MIDDLE PLEISTOCENE; HUMAN CRANIUM; LOS HUESOS; SKULL; PERMAGNA; OSSIFICATION; PATHOLOGY; CALVARIA; BEHAVIOR	We report here a neurocranial abnormality previously undescribed in Pleistocene human fossils, an enlarged parietal foramen (EPF) in the early Late Pleistocene Xujiayao 11 parietal bones from the Xujiayao (Houjiayao) site, northern China. Xujiayao 11 is a pair of partial posteromedial parietal bones from an adult. It exhibits thick cranial vault bones, arachnoid granulations, a deviated posterior sagittal suture, and a unilateral (right) parietal lacuna with a posteriorly-directed and enlarged endocranial vascular sulcus. Differential diagnosis indicates that the perforation is a congenital defect, an enlarged parietal foramen, commonly associated with cerebral venous and cranial vault anomalies. It was not lethal given the individual's age-at-death, but it may have been associated with secondary neurological deficiencies. The fossil constitutes the oldest evidence in human evolution of this very rare condition (a single enlarged parietal foramen). In combination with developmental and degenerative abnormalities in other Pleistocene human remains, it suggests demographic and survival patterns among Pleistocene Homo that led to an elevated frequency of conditions unknown or rare among recent humans.	[Wu, Xiu-Jie; Xing, Song] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Washington University (WUSTL)	Trinkaus, E (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	trinkaus@artsci.wustl.edu			Chinese Academy of Sciences [KZZD-EW-03, XDA05130100]; National Natural Science Foundation of China [41272034]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the Chinese Academy of Sciences (KZZD-EW-03, XDA05130100) and the National Natural Science Foundation of China (41272034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2007, AM J NEURORADIOL, V28, P314; Alekseev V.P., 1998, PALEOLITHIC SIBERIA, P329; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bartsch O, 1996, AM J HUM GENET, V58, P734; Bonmati A, 2010, P NATL ACAD SCI USA, V107, P18386, DOI 10.1073/pnas.1012131107; Boyd GI, 1930, J ANAT, V65, P108; Buzhilova A. P., 2000, HOMOSUNGIRENSIS UPPE, P441; Cervoni L, 1997, NEUROSURG REV, V20, P51, DOI 10.1007/BF01390526; Chakrabarti I, 2012, IRANIAN J PATH, V7, P203; CHEN T, 1982, ACTA ANTHR SINICA, V1, P91; Chia L.-p., 1979, Vertebrata Palasiatica, V17, P277; Chia LP, 1976, ACTA ARCHAEOL SINICA, V2, P97; Chung HYB, 2010, ULTRASOUND OBST GYN, V36, P521, DOI 10.1002/uog.7731; Crevecoeur I., 2008, EGYPTIAN PREHISTORY, DOI DOI 10.2307/J.CTT9QDWCX; CURRARINO G, 1976, AM J ROENTGENOL, V127, P487, DOI 10.2214/ajr.127.3.487; Dastugue J., 1967, ANTHROPOLOGIE, V71, P479; Derry DE, 1913, J ANAT PHYSL, V48, P417; Dharwal K, 2012, FOLIA MORPHOL, V71, P78; Duday H, 1991, SQUELETTE MOUSTERIEN, V2, p[179, 179]; Fink AM, 2006, AM J NEURORADIOL, V27, P1379; Formicola V, 2004, AM J PHYS ANTHROPOL, V124, P189, DOI 10.1002/ajpa.10273; FRAYER DW, 1988, AM J PHYS ANTHROPOL, V75, P549, DOI 10.1002/ajpa.1330750412; Goldsmith WM, 1922, J HERED, V13, P69, DOI 10.1093/oxfordjournals.jhered.a102158; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Guatelli-Steinberg D, 2013, INT J OSTEOARCHAEOL, V23, P421, DOI 10.1002/oa.1263; Hackett C., 1976, DIAGNOSTIC CRITERIA, DOI 10.1007/978-3-662-06583-9; Hatipoglu HG, 2008, FORENSIC SCI INT, V182, P46, DOI 10.1016/j.forsciint.2008.09.014; Hauser G., 1989, EPIGENETIC VARIANTS; Hoffman JM, 1976, CONTRIB U CALIF ARCH, V30, P41; Hovers E, 2006, INTERD CONTRIB ARCH, P295, DOI 10.1007/0-387-24661-4_16; HUBLIN JJ, 1991, THESIS U BORDEAUX 1; JELINEK J, 1959, ANTHROPOS, V9, P17; Lacy SA, 2012, INT J PALEOPATHOL, V2, P10, DOI 10.1016/j.ijpp.2012.06.003; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.3.CO;2-7; LIPINSKI C, 1974, NEUROPADIATRIE, V5, P376, DOI 10.1055/s-0028-1091718; Liu C., 1992, SCI GEOL SINICA, V1, P87; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lund S, 2006, PHYS EARTH PLANET IN, V156, P194, DOI 10.1016/j.pepi.2005.10.009; Mafart B, 2007, CR PALEVOL, V6, P569, DOI 10.1016/j.crpv.2007.09.019; Mann A, 2006, PERIOD BIOL, V108, P495; Mavrogiannis LA, 2006, EUR J HUM GENET, V14, P151, DOI 10.1038/sj.ejhg.5201526; Meyer V., 2011, PALEO, V22, P207; Nagatomo T., 2009, ACTA ANTHR SINICA, V28, P276; Nawrocki SP, 1991, THESIS SUNY BINGHAMT; Norton CJ, 2008, J HUM EVOL, V55, P164, DOI 10.1016/j.jhevol.2008.02.006; Oliva M, 1996, ARCHEOL ROZHL, V48, P537; Oliva M, 1996, ARCHEOL ROZHL, V48, P353; ORAHILLY R, 1952, AM J ROENTGENOL, V67, P551; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Pamperl R, 1919, DTSCH Z CHIR, V148, P91; PATTE E, 1957, ENFANT NEANDERTHALIE; Politi M, 2005, AM J NEURORADIOL, V26, P2049; Reddy AT, 2000, NEUROLOGY, V54, P1175, DOI 10.1212/WNL.54.5.1175; Rightmire GP, 1996, J HUM EVOL, V31, P21; Shang H, 2010, EARLY MODERN HUMAN T; Skrzat Janusz, 2004, Folia Morphol (Warsz), V63, P67; Spoor F, 1998, AM J PHYS ANTHROPOL, V107, P41, DOI 10.1002/(SICI)1096-8644(199809)107:1<41::AID-AJPA4>3.0.CO;2-G; Stallworthy JA, 1932, J ANAT, V67, P168; Streeter M, 2001, J HUM EVOL, V40, P331, DOI 10.1006/jhev.2001.0460; THOMPSON EM, 1984, J MED GENET, V21, P369, DOI 10.1136/jmg.21.5.369; Tillier AM, 2001, AM J PHYS ANTHROPOL, V114, P166, DOI 10.1002/1096-8644(200102)114:2<166::AID-AJPA1017>3.0.CO;2-3; Tillier AM., 1999, ENFANTS MOUSTERIENS; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E., 2006, EARLY MODERN HUMAN E, P419; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; Tubbs RS, 2003, PEDIATR NEUROSURG, V39, P216, DOI 10.1159/000072475; Valente M, 2004, AM J NEURORADIOL, V25, P1836; Vercellotti G, 2008, J ANTHROPOL SCI, V86, P143; Verna C., 2006, THESIS U BORDEAUX 1; Villotte S, 2011, J HUM EVOL, V61, P117, DOI 10.1016/j.jhevol.2011.01.007; Vlcek E., 1991, ARCHAOLOGIE MUSEUM, V22, P1; WALKER A, 1982, NATURE, V296, P248, DOI 10.1038/296248a0; Walker PL, 2009, AM J PHYS ANTHROPOL, V139, P109, DOI 10.1002/ajpa.21031; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wilkie AOM, 2004, GENEREVIEWS; Wu M, 1980, VERTEBRAT PALASIATIC, V18, P227; Wu Maolin, 1986, Acta Anthropologica Sinica, V5, P220; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Yan F., 1979, SEISMOL GEOL, V1, P72; [叶崇云 Ye Chongyun], 2004, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V20, P1063; Zilberman U, 2004, J HUM EVOL, V46, P647, DOI 10.1016/j.jhevol.2004.02.005	84	35	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59587	10.1371/journal.pone.0059587	http://dx.doi.org/10.1371/journal.pone.0059587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527224	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600066
J	Barthwal, MK; Anzinger, JJ; Xu, Q; Bohnacker, T; Wymann, MP; Kruth, HS				Barthwal, Manoj K.; Anzinger, Joshua J.; Xu, Qing; Bohnacker, Thomas; Wymann, Matthias P.; Kruth, Howard S.			Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RECEPTOR-MEDIATED ENDOCYTOSIS; ATHEROSCLEROTIC LESIONS; APOLIPOPROTEIN-E; MICE DEFICIENT; PHOSPHOINOSITIDE 3-KINASE; HYPERLIPIDEMIC MICE; CULTURED-CELLS; FACTOR OP; MACROPINOCYTOSIS	During atherosclerosis, low-density lipoprotein (LDL)-derived cholesterol accumulates in macrophages to form foam cells. Macrophage uptake of LDL promotes foam cell formation but the mechanism mediating this process is not clear. The present study investigates the mechanism of LDL uptake for macrophage colony-stimulating factor (M-CSF)-differentiated murine bone marrow-derived macrophages. LDL receptor-null (LDLR-/-) macrophages incubated with LDL showed non-saturable accumulation of cholesterol that did not down-regulate for the 24 h examined. Incubation of LDLR-/- macrophages with increasing concentrations of I-125-LDL showed non-saturable macrophage LDL uptake. A 20-fold excess of unlabeled LDL had no effect on I-125-LDL uptake by wild-type macrophages and genetic deletion of the macrophage scavenger receptors CD36 and SRA did not affect I-125-LDL uptake, showing that LDL uptake occurred by fluid-phase pinocytosis independently of receptors. Cholesterol accumulation was inhibited approximately 50% in wild-type and LDLR-/- mice treated with LY294002 or wortmannin, inhibitors of all classes of phosphoinositide 3-kinases (PI3K). Time-lapse, phase-contrast microscopy showed that macropinocytosis, an important fluid-phase uptake pathway in macrophages, was blocked almost completely by PI3K inhibition with wortmannin. Pharmacological inhibition of the class I PI3K isoforms alpha, beta, gamma or delta did not affect macrophage LDL-derived cholesterol accumulation or macropinocytosis. Furthermore, macrophages from mice expressing kinase-dead class I PI3K beta, gamma or delta isoforms showed no decrease in cholesterol accumulation or macropinocytosis when compared with wild-type macrophages. Thus, non-class I PI3K isoforms mediated macropinocytosis in these macrophages. Further characterization of the components necessary for LDL uptake, cholesterol accumulation, and macropinocytosis identified dynamin, microtubules, actin, and vacuolar type H(+)-ATPase as contributing to uptake. However, Pak1, Rac1, and Src-family kinases, which mediate fluid-phase pinocytosis in certain other cell types, were unnecessary. In conclusion, our findings provide evidence that targeting those components mediating macrophage macropinocytosis with inhibitors may be an effective strategy to limit macrophage accumulation of LDL-derived cholesterol in arteries.	[Barthwal, Manoj K.; Anzinger, Joshua J.; Xu, Qing; Kruth, Howard S.] NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; [Bohnacker, Thomas; Wymann, Matthias P.] Univ Basel, Dept Biomed, Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Basel	Kruth, HS (corresponding author), NHLBI, Sect Expt Atherosclerosis, NIH, Bldg 10, Bethesda, MD 20892 USA.	kruthh@nhlbi.nih.gov	Wymann, Matthias P/C-3227-2008; Anzinger, Joshua/GPT-5101-2022	Wymann, Matthias P/0000-0003-3349-4281; Barthwal, Dr.Manoj/0000-0001-7574-482X; Bohnacker, Thomas/0000-0001-5769-4478	Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health; Indo-US Science and Technology Forum; International Atherosclerosis Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL002832] Funding Source: NIH RePORTER	Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health; Indo-US Science and Technology Forum; International Atherosclerosis Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. M. K. B. was supported by a fellowship from the Indo-US Science and Technology Forum and received additional support from the International Atherosclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Anzinger JJ, 2012, J LIPID RES, V53, P34, DOI 10.1194/jlr.M018887; Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Babaev VR, 2000, ARTERIOSCL THROM VAS, V20, P2593, DOI 10.1161/01.ATV.20.12.2593; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; Blajecka K, 2011, CURR DRUG TARGETS, V12, P1056, DOI 10.2174/138945011795677773; Buono C, 2007, J LIPID RES, V48, P2411, DOI 10.1194/jlr.M700170-JLR200; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Cleary JM, 2010, CURR ONCOL REP, V12, P87, DOI 10.1007/s11912-010-0091-6; CLINTON SK, 1992, AM J PATHOL, V140, P301; de Villiers WJS, 1998, ARTERIOSCL THROM VAS, V18, P631, DOI 10.1161/01.ATV.18.4.631; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fumoto S, 2009, MOL PHARMACEUT, V6, P1170, DOI 10.1021/mp900042p; GAMBLE W, 1978, J LIPID RES, V19, P1068; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HOFF HF, 1978, BIOCHEM BIOPH RES CO, V85, P1424, DOI 10.1016/0006-291X(78)91162-2; Huynh J, 2012, CELL SIGNAL, V24, P1753, DOI 10.1016/j.cellsig.2012.04.022; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kruth HS, 2002, J BIOL CHEM, V277, P34573, DOI 10.1074/jbc.M205059200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Murayama T, 1999, CIRCULATION, V99, P1740, DOI 10.1161/01.CIR.99.13.1740; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Qiao JH, 1997, AM J PATHOL, V150, P1687; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Shaposhnik Z, 2010, J LIPID RES, V51, P1962, DOI 10.1194/jlr.M005215; SMITH EB, 1990, EUR HEART J, V11, P72, DOI 10.1093/eurheartj/11.suppl_E.72; SMITH EB, 1983, BIOCHIM BIOPHYS ACTA, V754, P249, DOI 10.1016/0005-2760(83)90139-X; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Veithen A, 1996, J CELL SCI, V109, P2005; Webb NR, 2007, CURR DRUG TARGETS, V8, P1249, DOI 10.2174/138945007783220597; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207	53	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58054	10.1371/journal.pone.0058054	http://dx.doi.org/10.1371/journal.pone.0058054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536783	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100027
J	Wright, AA; Stieglitz, H; Kupersztoch, YM; Paulk, ME; Kim, Y; Katz, IT; Munoz, F; Jimenez, RB; Mutchler, J; Rivera, L; Back, AL; Prigerson, HG				Wright, Alexi A.; Stieglitz, Heather; Kupersztoch, Yankel M.; Paulk, M. Elizabeth; Kim, Yookyung; Katz, Ingrid T.; Munoz, Francisco; Jimenez, Rachel B.; Mutchler, Jan; Rivera, Lorna; Back, Anthony L.; Prigerson, Holly G.			United States Acculturation and Cancer Patients' End-of-Life Care	PLOS ONE			English	Article							STAGE LUNG-CANCER; ETHNIC-DIFFERENCES; SOCIOECONOMIC-STATUS; RACIAL-DIFFERENCES; MEXICAN-AMERICANS; AFRICAN-AMERICAN; CLINICAL-TRIALS; CULTURAL ISSUES; PALLIATIVE CARE; THE-LITERATURE	Background: Culture shapes how people understand illness and death, but few studies examine whether acculturation influences patients' end-of-life treatment preferences and medical care. Methods and Findings: In this multi-site, prospective, longitudinal cohort study of terminally-ill cancer patients and their caregivers (n = 171 dyads), trained interviewers administered the United States Acculturation Scale (USAS). The USAS is a 19-item scale developed to assess the degree of "Americanization" in first generation or non-US born caregivers of terminally-ill cancer patients. We evaluated the internal consistency, concurrent, criterion, and content validity of the USAS. We also examined whether caregivers' USAS scores predicted patients' communication, treatment preferences, and end-of-life medical care in multivariable models that corrected for significant confounding influences (e.g. education, country of origin, English proficiency). The USAS measure was internally consistent (Cronbach alpha = 0.98); and significantly associated with US birthplace (r = 0.66, P < 0.0001). USAS scores were predictive of patients' preferences for prognostic information (AOR = 1.31, 95% CI: 1.00-1.72), but not comfort asking physicians' questions about care (AOR 1.23, 95% CI: 0.87-1.73). They predicted patients' preferences for feeding tubes (AOR = 0.68, 95% CI: 0.49-0.99) and wish to avoid dying in an intensive care unit (AOR = 1.36, 95% CI: 1.05-1.76). Scores indicating greater acculturation were also associated with increased odds of patient participation in clinical trials (AOR = 2.20, 95% CI: 1.28-3.78), compared with lower USAS scores, and greater odds of patients receiving chemotherapy (AOR = 1.59, 95% CI: 1.20-2.12). Conclusion: The USAS is a reliable and valid measure of "Americanization" associated with advanced cancer patients' end-of-life preferences and care. USAS scores indicating greater caregiver acculturation were associated with increased odds of patient participation in cancer treatment (chemotherapy, clinical trials) compared with lower scores. Future studies should examine the effects of acculturation on end-of-life care to identify patient and provider factors that explain these effects and targets for future interventions to improve care (e.g., by designing more culturally-competent health education materials).	[Wright, Alexi A.; Prigerson, Holly G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wright, Alexi A.; Jimenez, Rachel B.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychosocial Epidemiol & Outcomes Res, Boston, MA 02115 USA; [Wright, Alexi A.; Katz, Ingrid T.; Jimenez, Rachel B.; Prigerson, Holly G.] Harvard Univ, Sch Med, Boston, MA USA; [Wright, Alexi A.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; [Stieglitz, Heather] Parkland Ctr Clin Innovat, Dallas, TX USA; [Kupersztoch, Yankel M.; Paulk, M. Elizabeth] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kim, Yookyung] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Katz, Ingrid T.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Munoz, Francisco] Pomona Valley Hosp Med Ctr, Pomona, CA USA; [Jimenez, Rachel B.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Mutchler, Jan; Rivera, Lorna] Univ Massachusetts, Boston, MA 02125 USA; [Back, Anthony L.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Boston; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	Prigerson, HG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	Holly_Prigerson@dfci.harvard.edu	Wright, Alexi/T-5793-2019; Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019	Prigerson, Holly/0000-0002-7075-4268; Katz, Ingrid/0000-0002-3014-238X	National Institute of Mental Health [MH63892]; National Cancer Institute [CA 106370, CA 156732]; Conquer Cancer Foundation of the American Society of Clinical Oncology; National Palliative Care Research Center; American Cancer Society; Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [U54CA156732, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667, R01MH063892] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Conquer Cancer Foundation of the American Society of Clinical Oncology; National Palliative Care Research Center; American Cancer Society(American Cancer Society); Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by the following grants to Dr. Prigerson: MH63892 from the National Institute of Mental Health and CA 106370 and CA 156732 from the National Cancer Institute; by Career Development Awards sponsored by the Conquer Cancer Foundation of the American Society of Clinical Oncology, the National Palliative Care Research Center, and the American Cancer Society to Dr. Wright; and by the Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2004, AM J PUBLIC HEALTH, V94, P1393, DOI 10.2105/AJPH.94.8.1393; Bach PB, 2002, JAMA-J AM MED ASSOC, V287, P2106, DOI 10.1001/jama.287.16.2106; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Blackhall LJ, 2001, J URBAN HEALTH, V78, P59, DOI 10.1093/jurban/78.1.59; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Braun UK, 2008, J NATL MED ASSOC, V100, P1041, DOI 10.1016/S0027-9684(15)31442-5; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Brusamolino E, 1997, ANN NY ACAD SCI, V809, P411, DOI 10.1111/j.1749-6632.1997.tb48104.x; Butow PN, 2011, J CLIN ONCOL, V29, P2801, DOI 10.1200/JCO.2010.34.3335; Butow PN, 2011, SUPPORT CARE CANCER, V19, P281, DOI 10.1007/s00520-010-0817-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Cohen LL, 2008, J PALLIAT MED, V11, P763, DOI 10.1089/jpm.2007.0216; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Cortes DE, 2003, J PSYCHOACTIVE DRUGS, V35, P197, DOI 10.1080/02791072.2003.10400001; CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001; Cykert S, 2010, JAMA-J AM MED ASSOC, V303, P2368, DOI 10.1001/jama.2010.793; Derose KP, 2009, MED CARE RES REV, V66, P355, DOI 10.1177/1077558708330425; DeSanto-Madeya S, 2009, J PALLIAT MED, V12, P1143, DOI 10.1089/jpm.2009.0063; DEYO RA, 1985, AM J PUBLIC HEALTH, V75, P51, DOI 10.2105/AJPH.75.1.51; Equity OoMHaH, 2012, RAC ETHN MIN POP; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Freedman RA, 2009, J CLIN ONCOL, V27, P713, DOI 10.1200/JCO.2008.17.9234; Gessert Charles E., 2001, Ethnicity and Disease, V11, P97; Gordon HS, 2006, CANCER-AM CANCER SOC, V107, P1313, DOI 10.1002/cncr.22122; Grieco EM, 2010, AM COMMUNITY SURVEY; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hoffman HJ, 2011, CANCER-AM CANCER SOC, V117, P3824, DOI 10.1002/cncr.25970; Howerton MW, 2007, CANCER-AM CANCER SOC, V109, P465, DOI 10.1002/cncr.22436; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; KARNOFSKY DA, 1968, CANCER-AM CANCER SOC, V22, P730, DOI 10.1002/1097-0142(196810)22:4<730::AID-CNCR2820220407>3.0.CO;2-H; Kazdaglis G. A., 2010, Eastern Mediterranean Health Journal, V16, P442; Kouri EM, 2010, BREAST CANCER RES TR, V121, P743, DOI 10.1007/s10549-009-0643-3; Lackan NA, 2009, MED CARE, V47, P138, DOI 10.1097/MLR.0b013e3181844dba; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Lin SS, 2002, CANCER, V94, P1175, DOI 10.1002/cncr.10319; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; Mack JW, 2010, ARCH INTERN MED, V170, P1533, DOI 10.1001/archinternmed.2010.322; Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; Matsumura S, 2002, J GEN INTERN MED, V17, P531, DOI 10.1046/j.1525-1497.2002.10734.x; Medicine Io, 1999, UN BURD CANC ASS NIH; Morrison RS, 1998, ARCH INTERN MED, V158, P2493, DOI 10.1001/archinte.158.22.2493; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nielsen SS, 2010, CANCER-AM CANCER SOC, V116, P5497, DOI 10.1002/cncr.25546; Ortega AN, 2007, ARCH INTERN MED, V167, P2354, DOI 10.1001/archinte.167.21.2354; Phipps E, 2003, J CLIN ONCOL, V21, P549, DOI 10.1200/JCO.2003.12.080; Schenker Y, 2007, J GEN INTERN MED, V22, P294, DOI 10.1007/s11606-007-0359-1; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Shi LY, 2011, J HEALTH CARE POOR U, V22, P945, DOI 10.1353/hpu.2011.0079; Smith AK, 2008, J CLIN ONCOL, V26, P4131, DOI 10.1200/JCO.2007.14.8452; Smith AK, 2009, JAMA-J AM MED ASSOC, V301, P1047, DOI 10.1001/jama.2009.308; SOLIS JM, 1990, AM J PUBLIC HEALTH, V80, P11, DOI 10.2105/AJPH.80.Suppl.11; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Thornton JD, 2009, CRIT CARE MED, V37, P89, DOI 10.1097/CCM.0b013e3181926430; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	61	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58663	10.1371/journal.pone.0058663	http://dx.doi.org/10.1371/journal.pone.0058663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WI	23536809	Green Published, Green Accepted, gold			2022-12-27	WOS:000316251100076
J	Pang, WH; Wang, HF; Shi, L; Sun, YQ; Wang, XT; Wang, MM; Li, JF; Wang, HB; Shi, GG				Pang, Wenhui; Wang, Hefeng; Shi, Lei; Sun, Yueqi; Wang, Xiaoting; Wang, Mingming; Li, Jianfeng; Wang, Haibo; Shi, Guanggang			Immunomodulatory Effects of Escherichia coli ATCC 25922 on Allergic Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							HYGIENE HYPOTHESIS; STEM-CELLS; EARLY-LIFE; RHINITIS; ASTHMA; IMMUNOLOGY; MECHANISMS; MICROBIOTA; SYMPTOMS; IMPACT	Background: Hygiene hypothesis demonstrates that the lack of microbial exposure would promote the development of allergic airway disease (AAD). Therefore, the gut microbiota, including Escherichia coli (E. coli), would probably offer a potential strategy for AAD. Objective: To investigate whether E. coli infection is able to suppress the induction of AAD and to elucidate the underlying mechanisms. Methods: Nonpathogenic E. coli ATCC 25922 was infected by gavage before AAD phase in three patterns: 10(8) or 10(6) CFU in neonates or 10(8) CFU in adults. Then mice were sensitized and challenged with ovalbumin (OVA) to induce allergic inflammation in both the upper and lower airways. Hallmarks of AAD, in terms of eosinophil infiltration and goblet cell metaplasia in subepithelial mucosa, Th2 skewing of the immune response, and levels of T regulate cells (Tregs), were examined by histological analysis, ELISA, and flow cytometry, respectively. Results: E. coli, especially neonatally infected with an optimal dose, attenuated allergic responses, including a decrease in nasal rubbing and sneezing, a reduction in eosinophil inflammation and goblet cell metaplasia in subepithelial mucosa, decreased serum levels of OVA-specific IgE, and reduced Th2 (IL-4) cytokines. In contrast, this effect came with an increase of Th1 (IFN-r and IL-2) cytokines, and an enhancement of IL-10-secreting Tregs in paratracheal lymph nodes (PTLN). Conclusion: E. coli suppresses allergic responses in mice, probably via a shift from Th1 to Th2 and/or induction of Tregs. Moreover, this infection is age-and dose-dependent, which may open up novel possibilities for new therapeutic interventions.	[Pang, Wenhui; Shi, Lei; Wang, Xiaoting; Wang, Mingming; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Univ, Prov Hosp, Dept Otorhinolaryngol Head & Neck Surg, Inst Eye & Otorhinolaryngol, Jinan 250100, Peoples R China; [Wang, Hefeng] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; [Sun, Yueqi] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China	Shandong University; Shandong University; Sun Yat Sen University	Shi, GG (corresponding author), Shandong Univ, Prov Hosp, Dept Otorhinolaryngol Head & Neck Surg, Inst Eye & Otorhinolaryngol, Jinan 250100, Peoples R China.	shiguangangent@hotmail.com	Sun, Yueqi/N-4528-2018; Shi, Lei/AAR-5350-2020	Sun, Yueqi/0000-0002-2382-0429; 	Science and Technology Foundation of Shandong Province, China [2007HW104]; Shandong Provincial Natural Science Foundation, China [Y2006C73]; National Natural Science Foundation of China (NSFC) [30801279]	Science and Technology Foundation of Shandong Province, China; Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors thank each named author for their contributions to this work. This study was supported by grants from the Science and Technology Foundation of Shandong Province, China (2007HW104), the Shandong Provincial Natural Science Foundation, China (Y2006C73), and the National Natural Science Foundation of China (NSFC, 30801279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hellings PW, 2001, CLIN EXP ALLERGY, V31, P782, DOI 10.1046/j.1365-2222.2001.01081.x; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenerowicz D, 2012, ANN AGR ENV MED, V19, P475; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Leavy O, 2012, NAT REV IMMUNOL, V12, P319, DOI 10.1038/nri3213; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; LOBRY JR, 1992, J ANTIMICROB CHEMOTH, V29, P121, DOI 10.1093/jac/29.2.121; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Nauta AJ, 2008, EUR J PHARMACOL, V585, P354, DOI 10.1016/j.ejphar.2008.02.094; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Rose MA, 2011, BMC COMPLEM ALTERN M, V3, P11; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sauer A, 2009, J FOOD PROTECT, V72, P937, DOI 10.4315/0362-028X-72.5.937; Savilahti EM, CLIN EXP ALLERGY, V405- 411; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; SHARMA V, 1992, J BACTERIOL, V174, P5057, DOI 10.1128/JB.174.15.5057-5062.1992; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Skapenko Alla, 2007, V136, P87; Smit JJ, 2003, CLIN EXP ALLERGY, V33, P1083, DOI 10.1046/j.1365-2222.2003.01727.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Uri J V, 1994, Acta Microbiol Immunol Hung, V41, P215; Wang DY, 2000, AM J RHINOL, V14, P325, DOI 10.2500/105065800781329483; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yokota E, 2008, INT IMMUNOPHARMACOL, V8, P1083, DOI 10.1016/j.intimp.2008.03.018; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	47	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59174	10.1371/journal.pone.0059174	http://dx.doi.org/10.1371/journal.pone.0059174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536867	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200017
J	Stam, R; Jupe, J; Howden, AJM; Morris, JA; Boevink, PC; Hedley, PE; Huitema, E				Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Morris, Jenny A.; Boevink, Petra C.; Hedley, Pete E.; Huitema, Edgar			Identification and Characterisation CRN Effectors in Phytophthora capsici Shows Modularity and Functional Diversity	PLOS ONE			English	Article							RXLR EFFECTORS; GENOME; SEQUENCE; PROTEINS; DELIVERY; REVEALS; NUCLEUS	Phytophthora species secrete a large array of effectors during infection of their host plants. The Crinkler (CRN) gene family encodes a ubiquitous but understudied class of effectors with possible but as of yet unknown roles in infection. To appreciate CRN effector function in Phytophthora, we devised a simple Crn gene identification and annotation pipeline to improve effector prediction rates. We predicted 84 full-length CRN coding genes and assessed CRN effector domain diversity in sequenced Oomycete genomes. These analyses revealed evidence of CRN domain innovation in Phytophthora and expansion in the Peronosporales. We performed gene expression analyses to validate and define two classes of CRN effectors, each possibly contributing to infection at different stages. CRN localisation studies revealed that P. capsici CRN effector domains target the nucleus and accumulate in specific sub-nuclear compartments. Phenotypic analyses showed that few CRN domains induce necrosis when expressed in planta and that one cell death inducing effector, enhances P. capsici virulence on Nicotiana benthamiana. These results suggest that the CRN protein family form an important class of intracellular effectors that target the host nucleus during infection. These results combined with domain expansion in hemibiotrophic and necrotrophic pathogens, suggests specific contributions to pathogen lifestyles. This work will bolster CRN identification efforts in other sequenced oomycete species and set the stage for future functional studies towards understanding CRN effector functions.	[Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Huitema, Edgar] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Boevink, Petra C.; Hedley, Pete E.; Huitema, Edgar] James Hutton Inst, Dundee Effector Consortium, Dundee, Scotland; [Stam, Remco; Morris, Jenny A.; Boevink, Petra C.; Hedley, Pete E.] James Hutton Inst, Dundee, Scotland	University of Dundee; James Hutton Institute; James Hutton Institute	Stam, R (corresponding author), Univ Dundee, Div Plant Sci, Dundee, Scotland.	e.huitema@dundee.ac.uk	Huitema, Edgar/G-3760-2011; Boevink, Petra/AAO-6498-2021; Hedley, Peter/F-1149-2011; Stam, Remco/AAK-1881-2021	Huitema, Edgar/0000-0002-5766-0830; Boevink, Petra/0000-0002-7021-9097; Hedley, Peter/0000-0003-0866-324X; Stam, Remco/0000-0002-3444-6954	Royal Society of Edinburgh; Marie-Curie; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I00386X/1]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council [BB/I00386X/1] Funding Source: researchfish; BBSRC [BB/I00386X/1] Funding Source: UKRI	Royal Society of Edinburgh; Marie-Curie(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Huitema lab (RS, JJ, AH, EH) is supported by the Royal Society of Edinburgh (co-funded by Marie-Curie) and the Biotechnology and Biological Sciences Research Council (BBSRC, Grant BB/I00386X/1). PH, PB & JM are funded by The Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P9; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Deslandes L., 2012, TRENDS PLANT SCI; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Goodin MM, 2007, PLANT PHYSIOL, V145, P1100, DOI 10.1104/pp.107.106641; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lamour KH, 2012, MOL PLANT MICROBE IN; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Savory EA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035796, 10.1371/journal.pone.0034701]; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003	45	110	117	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59517	10.1371/journal.pone.0059517	http://dx.doi.org/10.1371/journal.pone.0059517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536880	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200028
J	Hwang, M; Garbey, M; Berceli, SA; Wu, RL; Jiang, ZH; Tran-Son-Tay, R				Hwang, Minki; Garbey, Marc; Berceli, Scott A.; Wu, Rongling; Jiang, Zhihua; Roger Tran-Son-Tay			Rule-Based Model of Vein Graft Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE CELLS; SHEAR-STRESS; BYPASS GRAFT; POLYTETRAFLUOROETHYLENE GRAFTS; NEOINTIMAL HYPERPLASIA; PROLIFERATION; ASSOCIATION; EDIFOLIGIDE; PREVENTION; ARTERIAL	When vein segments are implanted into the arterial system for use in arterial bypass grafting, adaptation to the higher pressure and flow of the arterial system is accomplished thorough wall thickening and expansion. These early remodeling events have been found to be closely coupled to the local hemodynamic forces, such as shear stress and wall tension, and are believed to be the foundation for later vein graft failure. To further our mechanistic understanding of the cellular and extracellular interactions that lead to global changes in tissue architecture, a rule-based modeling method is developed through the application of basic rules of behaviors for these molecular and cellular activities. In the current method, smooth muscle cell (SMC), extracellular matrix (ECM), and monocytes are selected as the three components that occupy the elements of a grid system that comprise the developing vein graft intima. The probabilities of the cellular behaviors are developed based on data extracted from in vivo experiments. At each time step, the various probabilities are computed and applied to the SMC and ECM elements to determine their next physical state and behavior. One- and two-dimensional models are developed to test and validate the computational approach. The importance of monocyte infiltration, and the associated effect in augmenting extracellular matrix deposition, was evaluated and found to be an important component in model development. Final model validation is performed using an independent set of experiments, where model predictions of intimal growth are evaluated against experimental data obtained from the complex geometry and shear stress patterns offered by a mid-graft focal stenosis, where simulation results show good agreements with the experimental data.	[Hwang, Minki; Roger Tran-Son-Tay] Univ Florida, Dept Mech Engn, Gainesville, FL 32611 USA; [Hwang, Minki; Roger Tran-Son-Tay] Univ Florida, Dept Aerosp Engn, Gainesville, FL 32611 USA; [Garbey, Marc] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Berceli, Scott A.; Jiang, Zhihua] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Berceli, Scott A.; Jiang, Zhihua] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Wu, Rongling] Penn State Univ, Ctr Stat Genet, Div Biostat, Hershey, PA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Houston System; University of Houston; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tran-Son-Tay, R (corresponding author), Univ Florida, Dept Mech Engn, Gainesville, FL 32611 USA.	rtst@ufl.edu		Berceli, Scott/0000-0003-2257-0111	National Heart, Lung, and Blood Institute of the National Institutes of Health [1R01 HL095508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105764, R01HL095508, U01HL119178] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (Grant Number: 1R01 HL095508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Berceli SA, 2002, J VASC SURG, V36, P1248, DOI 10.1067/mva.2002.128295; Berceli SA, 2006, J SURG RES, V134, P327, DOI 10.1016/j.jss.2005.12.030; Berceli SA, 2009, VASCULAR, V17, pS2, DOI 10.2310/6670.2008.00083; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; CAMBRIA RP, 1987, ANN SURG, V205, P167, DOI 10.1097/00000658-198702000-00011; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Fernandez CM, 2004, ANN BIOMED ENG, V32, P1484, DOI 10.1114/B:ABME.0000049033.65547.cf; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Furuyama T, 2006, J VASC SURG, V43, P1249, DOI 10.1016/j.jvs.2006.02.035; Hoch JR, 1999, SURGERY, V126, P428, DOI 10.1016/S0039-6060(99)70188-1; Hwang M, 2012, BIOMECH MODEL MECHAN, V11, P411, DOI 10.1007/s10237-011-0321-3; Hwang M, 2009, CELL MOL BIOENG, V2, P285, DOI 10.1007/s12195-009-0078-2; Jiang ZH, 2004, AM J PHYSIOL-HEART C, V286, pH240, DOI 10.1152/ajpheart.00760.2003; Jiang ZH, 2007, J VASC SURG, V45, P169, DOI 10.1016/j.jvs.2006.08.049; Jiang ZH, 2009, FEBS LETT, V583, P3536, DOI 10.1016/j.febslet.2009.10.015; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; KOHLER TR, 1991, CIRC RES, V69, P1557, DOI 10.1161/01.RES.69.6.1557; KRAISS LW, 1991, ARTERIOSCLER THROMB, V11, P1844, DOI 10.1161/01.ATV.11.6.1844; Loth F, 2002, J BIOMECH ENG-T ASME, V124, P44, DOI 10.1115/1.1428554; Meyerson SL, 2001, J VASC SURG, V34, P90, DOI 10.1067/mva.2001.114819; PHUPHANICH S, 1985, CANCER RES, V45, P2387; Potten C., 2004, APOPTOSIS LIFE DEATH; SUMPIO BE, 1988, ARCH SURG-CHICAGO, V123, P1233; SUMPIO BE, 1988, J SURG RES, V44, P696, DOI 10.1016/0022-4804(88)90103-5; Tran-Son-Tay R, 2008, ANN BIOMED ENG, V36, P1083, DOI 10.1007/s10439-008-9495-y; Yamamoto M, 2000, AM J PHYSIOL-CELL PH, V279, pC587, DOI 10.1152/ajpcell.2000.279.3.C587; Zhang WD, 1999, J VASC SURG, V30, P169, DOI 10.1016/S0741-5214(99)70189-8; ZWOLAK RM, 1987, J VASC SURG, V5, P126, DOI 10.1067/mva.1987.avs0050126	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57822	10.1371/journal.pone.0057822	http://dx.doi.org/10.1371/journal.pone.0057822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533576	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400013
J	Oz, S; Maercker, C; Breiling, A				Oez, Simin; Maercker, Christian; Breiling, Achim			Embryonic Carcinoma Cells Show Specific Dielectric Resistance Profiles during Induced Differentiation	PLOS ONE			English	Article							NTERA-2 CELLS; NEURONS; ANALOGS; GROWTH	Induction of differentiation in cancer stem cells by drug treatment represents an important approach for cancer therapy. The understanding of the mechanisms that regulate such a forced exit from malignant pluripotency is fundamental to enhance our knowledge of tumour stability. Certain nucleoside analogues, such as 2'-deoxy-5-azacytidine and 1 beta-arabinofuranosylcytosine, can induce the differentiation of the embryonic cancer stem cell line NTERA 2 D1 (NT2). Such induced differentiation is associated with drug-dependent DNA-damage, cellular stress and the proteolytic depletion of stem cell factors. In order to further elucidate the mode of action of these nucleoside drugs, we monitored differentiation-specific changes of the dielectric properties of growing NT2 cultures using electric cell-substrate impedance sensing (ECIS). We measured resistance values of untreated and retinoic acid treated NT2 cells in real-time and compared their impedance profiles to those of cell populations triggered to differentiate with several established substances, including nucleoside drugs. Here we show that treatment with retinoic acid and differentiation-inducing drugs can trigger specific, concentration-dependent changes in dielectric resistance of NT2 cultures, which can be observed as early as 24 hours after treatment. Further, low concentrations of nucleoside drugs induce differentiation-dependent impedance values comparable to those obtained after retinoic acid treatment, whereas higher concentrations induce proliferation defects. Finally, we show that impedance profiles of substance-induced NT2 cells and those triggered to differentiate by depletion of the stem cell factor OCT4 are very similar, suggesting that reduction of OCT4 levels has a dominant function for differentiation induced by nucleoside drugs and retinoic acid. The data presented show that NT2 cells have specific dielectric properties, which allow the early identification of differentiating cultures and real-time label-free monitoring of differentiation processes. This work might provide a basis for further analyses of drug candidates for differentiation therapy of cancers.	[Oez, Simin; Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, Heidelberg, Germany; [Maercker, Christian] Mannheim Univ Appl Sci, Mannheim, Germany; [Maercker, Christian] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Maercker, C (corresponding author), Mannheim Univ Appl Sci, Mannheim, Germany.	c.maercker@hs-mannheim.de; a.breiling@dkfz.de		Breiling, Achim/0000-0002-7928-299X	Ministerium fur Wissenschaft, Forschung und Kunst, Baden Wurttemberg (Kooperatives Promotionskolleg Krankheitsmodelle und Wirkstoffe)	Ministerium fur Wissenschaft, Forschung und Kunst, Baden Wurttemberg (Kooperatives Promotionskolleg Krankheitsmodelle und Wirkstoffe)	This work was supported by the Ministerium fur Wissenschaft, Forschung und Kunst, Baden Wurttemberg (Kooperatives Promotionskolleg Krankheitsmodelle und Wirkstoffe) (http://mwk.baden-wuerttemberg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, LAB INVEST, V50, P147; Angstmann M, 2011, CYTOTHERAPY, V13, P1074, DOI 10.3109/14653249.2011.584863; Bagnaninchi PO, 2011, P NATL ACAD SCI USA, V108, P6462, DOI 10.1073/pnas.1018260108; Bocker MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1826; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; DEGOS L, 1990, LEUKEMIA RES, V14, P717, DOI 10.1016/0145-2126(90)90101-E; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Hong J, 2011, ANALYST, V136, P237, DOI 10.1039/c0an00560f; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Marchal-Victorion S, 2003, MOL CELL NEUROSCI, V24, P198, DOI 10.1016/S1044-7431(03)00161-1; Meland MN, 2010, J NEUROSCI RES, V88, P222, DOI 10.1002/jnr.22171; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Robak T, 2009, CLIN THER, V31, P2349, DOI 10.1016/j.clinthera.2009.11.017; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Simoes PD, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-5; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; von Wangenheim KH, 2008, J CANCER RES CLIN, V134, P725, DOI 10.1007/s00432-008-0381-7; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Zhang RL, 2003, NEUROSCIENCE, V116, P373, DOI 10.1016/S0306-4522(02)00696-6	34	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59895	10.1371/journal.pone.0059895	http://dx.doi.org/10.1371/journal.pone.0059895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533658	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400095
J	Quinnan, GV; Zhang, PF; Dong, M; Chen, H; Feng, YR; Lewis, M; Broder, CC				Quinnan, Gerald V., Jr.; Zhang, Pengfei; Dong, Ming; Chen, Hong; Feng, Yan-Ru; Lewis, Mark; Broder, Christopher C.			Neutralizing Antibody Responses in Macaques Induced by Human Immunodeficiency Virus Type 1 Monovalent or Trivalent Envelope Glycoproteins	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; 2 IMMUNODOMINANT DOMAINS; IMMUNOGLOBULIN G1 B12; V3 LOOP; NEONATAL MACAQUES; CRYSTAL-STRUCTURE; SHIV INFECTION; CD4 BINDING; ENV CLONES; SUBTYPE-C	A major goal of efforts to develop a vaccine to prevent HIV-1 infection is induction of broadly cross-reactive neutralizing antibodies (bcnAb). In previous studies we have demonstrated induction of neutralizing antibodies that did cross-react among multiple primary and laboratory strains of HIV-1, but neutralized with limited potency. In the present study we tested the hypothesis that immunization with multiple HIV-1 envelope glycoproteins (Envs) would result in a more potent and cross-reactive neutralizing response. One Env, CM243(N610Q), was selected on the basis of studies of the effects of single and multiple mutations of the four gp41 glycosylation sites. The other two Envs included R2 (subtype B) and 14/00/4 (subtype F), both of which were obtained from donors with bcnAb. Rhesus monkeys were immunized using a prime boost regimen as in previous studies. Individual groups of monkeys were immunized with either one of the three Envs or all three. The single N610Q and N615Q mutations of CM243 Env did not disrupt protein secretion, processing into, or reactivity with mAbs, unlike other single or multiple deglycosylation mutations. In rabbit studies the N610Q mutation alone or in combination was associated with an enhanced neutralizing response against homologous and heterologous subtype E viruses. In the subsequent monkey study the response induced by the R2 Env regimen was equivalent to the trivalent regimen and superior to the other monovalent regimens against the virus panel used for testing. The 14/00/4 Env induced responses superior to CM243(N610Q). The results indicate that elimination of the glycosylation site near the gp41 loop results in enhanced immunogenicity, but that immunization of monkeys with these three distinct Envs was not more immunogenic than with one.	[Quinnan, Gerald V., Jr.; Zhang, Pengfei; Dong, Ming; Chen, Hong; Feng, Yan-Ru; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lewis, Mark] Bioqual Inc, Rockville, MD USA	Uniformed Services University of the Health Sciences - USA; BIOQUAL Inc.	Quinnan, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	gerald.quinnan@usuhs.edu	Feng, YanRu/AAA-2183-2020; Broder, Christopher/E-1169-2013		National Institutes of Health [AI048280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported here was supported by National Institutes of Health grant number AI048280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirnaert E, 2001, VIROLOGY, V281, P305, DOI 10.1006/viro.2000.0802; BRODER CC, 1994, P NATL ACAD SCI USA, V91, P11699, DOI 10.1073/pnas.91.24.11699; BRODER CC, 1994, SCIENCE, V264, P1156, DOI 10.1126/science.7909959; Cham F, 2006, VIROLOGY, V347, P36, DOI 10.1016/j.virol.2005.11.019; Cham F, 2006, VIROLOGY; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003; Donners H, 2002, AIDS, V16, P501, DOI 10.1097/00002030-200202150-00030; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gorny MK, 1998, AIDS RES HUM RETROV, V14, P213, DOI 10.1089/aid.1998.14.213; Hioe CE, 1997, INT IMMUNOL, V9, P1281, DOI 10.1093/intimm/9.9.1281; HO DD, 1991, J VIROL, V65, P489, DOI 10.1128/JVI.65.1.489-493.1991; Inouye P, 1998, AIDS RES HUM RETROV, V14, P735, DOI 10.1089/aid.1998.14.735; Jeffs SA, 2001, IMMUNOL LETT, V79, P209, DOI 10.1016/S0165-2478(01)00289-9; Kessler JA, 1997, AIDS RES HUM RETROV, V13, P575, DOI 10.1089/aid.1997.13.575; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; MOORE JP, 1995, J VIROL, V69, P122, DOI 10.1128/JVI.69.1.122-130.1995; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Nyambi PN, 2000, J VIROL, V74, P10670, DOI 10.1128/JVI.74.22.10670-10680.2000; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Park EJ, 1998, J VIROL, V72, P7099, DOI 10.1128/JVI.72.9.7099-7107.1998; Park EJ, 1999, J VIROL, V73, P5707, DOI 10.1128/JVI.73.7.5707-5713.1999; Park EJ, 2000, J VIROL, V74, P4183, DOI 10.1128/JVI.74.9.4183-4191.2000; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Quan FS, 2007, VACCINE, V25, P3841, DOI 10.1016/j.vaccine.2007.01.107; Quinnan GV, 2005, J VIROL, V79, P3358, DOI 10.1128/JVI.79.6.3358-3369.2005; Quinnan GV, 1999, AIDS RES HUM RETROV, V15, P561, DOI 10.1089/088922299311088; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; Ruprecht RM, 2001, TRANSFUS CLIN BIOL, V8, P350, DOI 10.1016/S1246-7820(01)00187-2; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Taniguchi Y, 2000, VIROLOGY, V273, P333, DOI 10.1006/viro.2000.0436; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhang PF, 1999, J VIROL, V73, P5225, DOI 10.1128/JVI.73.6.5225-5230.1999; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	67	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59803	10.1371/journal.pone.0059803	http://dx.doi.org/10.1371/journal.pone.0059803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533650	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400087
J	Weisman, A; Bril, V; Ngo, M; Lovblom, LE; Halpern, EM; Orszag, A; Perkins, BA				Weisman, Alanna; Bril, Vera; Ngo, Mylan; Lovblom, Leif E.; Halpern, Elise M.; Orszag, Andrej; Perkins, Bruce A.			Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters	PLOS ONE			English	Article							F-WAVE LATENCY; PERIPHERAL NEUROPATHY; RISK-FACTORS; COMPLICATIONS; MULTICENTER; MORTALITY; STATEMENT; DIAGNOSIS; CRITERIA; SCORES	Objective: Evaluation of diabetic sensorimotor polyneuropathy (DSP) is hindered by the need for complex nerve conduction study (NCS) protocols and lack of predictive biomarkers. We aimed to determine the performance of single and simple combinations of NCS parameters for identification and future prediction of DSP. Materials and Methods: 406 participants (61 with type 1 diabetes and 345 with type 2 diabetes) with a broad spectrum of neuropathy, from none to severe, underwent NCS to determine presence or absence of DSP for cross-sectional (concurrent validity) analysis. The 109 participants without baseline DSP were re-evaluated for its future onset (predictive validity). Performance of NCS parameters was compared by area under the receiver operating characteristic curve (AROC). Results: At baseline there were 246 (60%) Prevalent Cases. After 3.9 years mean follow-up, 25 (23%) of the 109 Prevalent Controls that were followed became Incident DSP Cases. Threshold values for peroneal conduction velocity and sural amplitude potential best identified Prevalent Cases (AROC 0.90 and 0.83, sensitivity 80 and 83%, specificity 89 and 72%, respectively). Baseline tibial F-wave latency, peroneal conduction velocity and the sum of three lower limb nerve conduction velocities (sural, peroneal, and tibial) best predicted 4-year incidence (AROC 0.79, 0.79, and 0.85; sensitivity 79, 70, and 81%; specificity 63, 74 and 77%, respectively). Discussion: Individual NCS parameters or their simple combinations are valid measures for identification and future prediction of DSP. Further research into the predictive roles of tibial F-wave latencies, peroneal conduction velocity, and sum of conduction velocities as markers of incipient nerve injury is needed to risk-stratify individuals for clinical and research protocols.	[Weisman, Alanna; Lovblom, Leif E.; Halpern, Elise M.; Orszag, Andrej; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Bril, Vera; Ngo, Mylan] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada	University of Toronto; University of Toronto	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.	bruce.perkins@uhn.on.ca	Perkins, Bruce A/L-3726-2017; Weisman, Alanna/AAR-7255-2020; BRIL, vera/ABA-6509-2020	Weisman, Alanna/0000-0003-3778-653X; Orszag, Andrej/0000-0002-0027-1607; Lovblom, Leif Erik/0000-0002-6774-8924	Juvenile Diabetes Research Foundation [17-2008-715]; Residency Research Elective from the University of Toronto Internal Medicine Program	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Residency Research Elective from the University of Toronto Internal Medicine Program	This research was supported by the Juvenile Diabetes Research Foundation (www.jdrf.ca) grant 17-2008-715. Bruce A. Perkins was a Canadian Diabetes Association Scholar (www.diabetes.ca). Alanna Weisman was supported by a Residency Research Elective from the University of Toronto Internal Medicine Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; American Association of Electrodiagnostic Medicine, 1999, Muscle Nerve Suppl, V8, pS91; Andersen H, 1997, MUSCLE NERVE, V20, P1296, DOI 10.1002/(SICI)1097-4598(199710)20:10<1296::AID-MUS12>3.0.CO;2-1; BEHSE F, 1977, J NEUROL NEUROSUR PS, V40, P1072, DOI 10.1136/jnnp.40.11.1072; Bolton CF, 2000, CAN J NEUROL SCI, V27, P288, DOI 10.1017/S0317167100001013; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Bril V, 2009, DIABETIC MED, V26, P240, DOI 10.1111/j.1464-5491.2009.02667.x; Bril V, 1999, EUR NEUROL, V41, P8, DOI 10.1159/000052074; Bril V, 2009, DIABETES CARE, V32, P1256, DOI 10.2337/dc08-2110; Callaghan BC, 2011, DIABETES CARE, V34, P635, DOI 10.2337/dc10-0878; Carrington AL, 2002, DIABETES CARE, V25, P2010, DOI 10.2337/diacare.25.11.2010; Charles M, 2010, DIABETES CARE, V33, P2648, DOI 10.2337/dc10-0456; Dyck PJ, 2011, MUSCLE NERVE, V44, P340, DOI 10.1002/mus.22074; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Dyck PJ, 2003, MUSCLE NERVE, V27, P202, DOI 10.1002/mus.10320; Dyck PJ, 2011, DIABETES METAB RES R; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062; GENTILE S, 1995, ACTA DIABETOL, V32, P7, DOI 10.1007/BF00581037; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris SB, 2006, CAN J DIABETES, V30, P131, DOI DOI 10.1016/S1499-2671(06)02005-3; Karsidag S, 2005, DIABETES RES CLIN PR, V67, P211, DOI 10.1016/j.diabres.2004.07.017; Kohara N, 2000, DIABETOLOGIA, V43, P915, DOI 10.1007/s001250051469; LAMONTAGNE A, 1970, J NEUROL NEUROSUR PS, V33, P442, DOI 10.1136/jnnp.33.4.442; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Martin CL, 2010, DIABETES CARE, V33, P2635, DOI 10.2337/dc10-0616; Mythili A, 2010, INT J DIABETES DEV C, V30, P43, DOI 10.4103/0973-3930.60007; Oh S., 2002, NORMAL VALUES COMMON; Orszag A, 2011, DIABETES RES CLIN PR, V93, pE71, DOI 10.1016/j.diabres.2011.05.001; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Pop-Busui R, 2010, CURR DIABETES REP, V10, P276, DOI 10.1007/s11892-010-0120-8; Soedamah-Muthu SS, 2008, DIABETES CARE, V31, P1360, DOI 10.2337/dc08-0107; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Yen AM, 2012, EUR J NEUROL; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	40	44	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58783	10.1371/journal.pone.0058783	http://dx.doi.org/10.1371/journal.pone.0058783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533591	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400028
J	Wood, LJ; Dautenhahn, K; Rainer, A; Robins, B; Lehmann, H; Syrdal, DS				Wood, Luke Jai; Dautenhahn, Kerstin; Rainer, Austen; Robins, Ben; Lehmann, Hagen; Syrdal, Dag Sverre			Robot-Mediated Interviews - How Effective Is a Humanoid Robot as a Tool for Interviewing Young Children?	PLOS ONE			English	Article							PERSONALITY; CONSISTENCY; LISTENERS; BEHAVIOR	Robots have been used in a variety of education, therapy or entertainment contexts. This paper introduces the novel application of using humanoid robots for robot-mediated interviews. An experimental study examines how children's responses towards the humanoid robot KASPAR in an interview context differ in comparison to their interaction with a human in a similar setting. Twenty-one children aged between 7 and 9 took part in this study. Each child participated in two interviews, one with an adult and one with a humanoid robot. Measures include the behavioural coding of the children's behaviour during the interviews and questionnaire data. The questions in these interviews focused on a special event that had recently taken place in the school. The results reveal that the children interacted with KASPAR very similar to how they interacted with a human interviewer. The quantitative behaviour analysis reveal that the most notable difference between the interviews with KASPAR and the human were the duration of the interviews, the eye gaze directed towards the different interviewers, and the response time of the interviewers. These results are discussed in light of future work towards developing KASPAR as an 'interviewer' for young children in application areas where a robot may have advantages over a human interviewer, e. g. in police, social services, or healthcare applications.	[Wood, Luke Jai; Dautenhahn, Kerstin; Rainer, Austen; Robins, Ben; Lehmann, Hagen; Syrdal, Dag Sverre] Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Wood, LJ (corresponding author), Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England.	l.wood@herts.ac.uk	Lehmann, Hagen/D-8782-2018	Wood, Luke/0000-0003-1037-3727; Dautenhahn, Kerstin/0000-0002-9263-3897; Syrdal, Dag Sverre/0000-0002-1339-4382; Lehmann, Hagen/0000-0001-9676-2269				Barlett B., 2004, 5 AUSTR US INT C AUI; Becker-Asano C, 2010, EXPLORING UNCANNY VA, P121; BERLYNE DE, 1958, J EXP PSYCHOL, V55, P289, DOI 10.1037/h0043555; Bethel CL, 2011, SHARING SECRET INTER; BOOMER DS, 1965, LANG SPEECH, V8, P148, DOI 10.1177/002383096500800302; BRENNAN SE, 1995, J MEM LANG, V34, P383, DOI 10.1006/jmla.1995.1017; Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753; Clark Herbert H., 1991, PERSPECT SOC SHARED, P127, DOI DOI 10.1037/10096-006; CLARK HH, 1994, SPEECH COMMUN, V15, P243, DOI 10.1016/0167-6393(94)90075-2; DAHLBACK N, 1993, KNOWL-BASED SYST, V6, P258, DOI 10.1016/0950-7051(93)90017-N; Dautenhahn Kerstin, 2009, Applied Bionics and Biomechanics, V6, P369, DOI 10.1080/11762320903123567; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.3.CO;2-8; Francois D, 2005, SUSTAINING INTERACTI; Ghosh M, 2011, IMPLEMENTATION CARE; Goetz J, 2003, RO-MAN 2003: 12TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P55; Goris K, 2009, PROBO TESTBED HUMAN; GOULD JD, 1983, COMMUN ACM, V26, P295, DOI 10.1145/2163.358100; Green A, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P575, DOI 10.1109/ROMAN.2004.1374824; Kanda T, 2004, HUM-COMPUT INTERACT, V19, P61, DOI 10.1207/s15327051hci1901&2_4; Kerepesi A, 2006, BEHAV PROCESS, V73, P92, DOI 10.1016/j.beproc.2006.04.001; Kose-Bagci H, 2007, DRUM MATE HUMAN HUMA; Kose-Bagci H, 2010, CONNECT SCI, V22, P103, DOI 10.1080/09540090903383189; Kose-Bagci H, 2009, ADV ROBOTICS, V23, P1951, DOI 10.1163/016918609X12518783330360; Kozima H, 2009, INT J SOC ROBOT, V1, P3, DOI 10.1007/s12369-008-0009-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leite I, 2008, ICAT AFFECTIVE GAME, P1229, DOI [10.1145/1402821.1402838, DOI 10.1145/1402821.1402838]; MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac; MAHL George F., 1987, EXPLORATIONS NONVERB; Melson GF, 2009, J APPL DEV PSYCHOL, V30, P92, DOI 10.1016/j.appdev.2008.10.011; NAO Robot, 2011, NAO ROB; Nishio S., 2007, REPRESENTING PERSONA; Observer XT, 2011, OBS XT; Ramirez-Serrano A, 2010, J PHYS AGENTS, P4; Robins B., 2009, P 2009 2 INT C ADV C, P205, DOI [DOI 10.1109/ACHI.2009.32, 10.1109/achi.2009.32]; Robins B, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P180, DOI 10.1109/ROMAN.2008.4600663; Roebers CM, 2002, COGNITIVE DEV, V17, P1085, DOI 10.1016/S0885-2014(02)00075-8; Saldien J., 2008, J PHYS AGENTS, V2, P3, DOI DOI 10.14198/JoPha.2008.2.2.02; Saldien J., 2006, ANTY DEV INTELLIGENT; Scheeff M, 2002, MU S ART SOC SIM ORG, V3, P173; Shahid S., 2011, CHI 2011 VANC BC CAN; Shahid S, 2010, CHILD ROBOT INTERACT; Shriberg EE, 1992, INTONATION CLAUSE IN, V1992; SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002; Spratling R, 2010, APPL NURSING RES; Swerts M, 2010, PLAYING ICAT INVESTI; Tapus A, 2008, INTEL SERV ROBOT, V1, P169, DOI 10.1007/s11370-008-0017-4; Te Boekhorst R, 2008, BEHAV DELAY ROBOT EX, P17; UK Government, 2007, ACH BEST EV CRIM P G, P27; UK Government, 2011, ACH BEST EV CRIM P G, V49, P229; UK Government, 2007, ACH BEST EV CRIM P G, P1; UK Government, 2011, ACH BEST EV CRIM P G, P196; UK Government, 2011, ACH BEST EV CRIM P G, P66; UK Government, 2011, ACH BEST EV CRIM P G; Wainer J., 2010, COLLABORATING KASPAR, P631; Walters ML, 2008, AUTON ROBOT, V24, P159, DOI 10.1007/s10514-007-9058-3; Woods S, 2007, INTERACT STUD, V8, P281, DOI 10.1075/is.8.2.06woo	57	53	53	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59448	10.1371/journal.pone.0059448	http://dx.doi.org/10.1371/journal.pone.0059448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111VQ	23533625	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400062
J	Yu, GM; Zhang, DS; Guo, F; Tan, M; Jiang, X; Jiang, W				Yu, Guimei; Zhang, Dongsheng; Guo, Fei; Tan, Ming; Jiang, Xi; Jiang, Wen			Cryo-EM Structure of a Novel Calicivirus, Tulane Virus	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; BLOOD GROUP ANTIGENS; RAY CRYSTALLOGRAPHIC STRUCTURE; CAPSID PROTEIN FORMS; TURNIP CRINKLE VIRUS; ELECTRON-MICROSCOPY; MOLECULAR SWITCH; MURINE NOROVIRUS; RECEPTOR-BINDING; P-DOMAIN	Tulane virus (TV) is a newly isolated cultivatable calicivirus that infects juvenile rhesus macaques. Here we report a 6.3 angstrom resolution cryo-electron microscopy structure of the TV virion. The TV virion is about 400 angstrom in diameter and consists of a T = 3 icosahedral protein capsid enclosing the RNA genome. 180 copies of the major capsid protein VP1 (similar to 57 KDa) are organized into two types of dimers A/B and C/C and form a thin, smooth shell studded with 90 dimeric protrusions. The overall capsid organization and the capsid protein fold of TV closely resemble that of other caliciviruses, especially of human Norwalk virus, the prototype human norovirus. These close structural similarities support TV as an attractive surrogate for the non-cultivatable human noroviruses. The most distinctive feature of TV is that its C/C dimers are in a highly flexible conformation with significantly reduced interactions between the shell (S) domain and the protruding (P) domain of VP1. A comparative structural analysis indicated that the P domains of TV C/C dimers were much more flexible than those of other caliciviruses. These observations, combined with previous studies on other caliciviruses, led us to hypothesize that the enhanced flexibility of C/C dimer P domains are likely required for efficient calicivirus-host cell interactions and the consequent uncoating and genome release. Residues in the S-P1 hinge between the S and P domain may play a critical role in the flexibility of P domains of C/C dimers.	[Yu, Guimei; Guo, Fei; Jiang, Wen] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Zhang, Dongsheng; Tan, Ming; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Zhang, Dongsheng; Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jiang, W (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.	jiang12@purdue.edu	jiang, wen/GYI-9662-2022	Jiang, Wen/0000-0002-1292-2411	National Institutes of Health (NIH) [R01AI037093, S10RR023011]; USDA [2011-6800330395]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089634, R01AI037093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01AI037093 to WJ and XJ, NIH grant S10RR023011 to WJ, and USDA grant 2011-6800330395 to XJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcena J, 2004, VIROLOGY, V322, P118, DOI 10.1016/j.virol.2004.01.021; Bhella D, 2011, J VIROL, V85, P11381, DOI 10.1128/JVI.05621-11; Chakravarty S, 2005, J VIROL, V79, P554, DOI 10.1128/JVI.79.1.554-568.2005; Chen R, 2004, J VIROL, V78, P6469, DOI 10.1128/JVI.78.12.6469-6479.2004; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; HARAUZ G, 1986, OPTIK, V73, P146; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HOGLE JM, 1986, J MOL BIOL, V191, P625, DOI 10.1016/0022-2836(86)90450-X; Hu ZJ, 2010, PROTEIN CELL, V1, P48, DOI 10.1007/s13238-010-0007-0; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Katpally U, 2008, J VIROL, V82, P2079, DOI 10.1128/JVI.02200-07; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luque D, 2012, J VIROL, V86, P6470, DOI 10.1128/JVI.07050-11; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Matsuura Y, 2001, J GEN VIROL, V82, P1695, DOI 10.1099/0022-1317-82-7-1695; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; SORGER PK, 1986, J MOL BIOL, V191, P639, DOI 10.1016/0022-2836(86)90451-1; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wei C, 2008, J VIROL, V82, P11429, DOI 10.1128/JVI.00696-08; Wirblich C, 1996, J VIROL, V70, P7974, DOI 10.1128/JVI.70.11.7974-7983.1996; Yang C, 2009, J MICROSC-OXFORD, V233, P391, DOI 10.1111/j.1365-2818.2009.03137.x	41	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59817	10.1371/journal.pone.0059817	http://dx.doi.org/10.1371/journal.pone.0059817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533651	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400088
J	Guo, Q; Tao, YL; Chu, D				Guo, Qiang; Tao, Yun-Li; Chu, Dong			Characterization and Comparative Profiling of miRNAs in Invasive Bemisia tabaci (Gennadius) B and Q	PLOS ONE			English	Article							SILKWORM BOMBYX-MORI; MITOCHONDRIAL-DNA MARKERS; STEM-CELLS; BIOTYPE-Q; SHANDONG PROVINCE; EXPRESSION PATTERNS; TRIBOLIUM-CASTANEUM; MICRORNA EXPRESSION; DYNAMIC REGULATION; DRUG-RESISTANCE	Background: MicroRNAs (miRNAs) are small, conserved, non-coding RNAs that post-transcriptionally regulate gene expression. Bemisia tabaci (Gennadius) B and Q are two invasive and dominant whiteflies, and B. tabaci Q has been displacing B in China. Differences in biological traits (fecundity, host range, resistance to insecticides, etc.) as affected by miRNAs might be involved in the displacement. In this study, we performed high-throughput sequencing to identify miRNAs in B. tabaci B and Q. Results: We identified 170 conserved miRNAs and 15 novel candidates, and found significant differences in the expression of miRNAs between B. tabaci B and Q. Conclusion: Expression levels of miRNAs differ in B. tabaci B vs. Q. Additional research is needed to determine whether these differences are related to differences in the biology of B. tabaci B and Q, and whether these differences help explain why B. tabaci Q is displacing B in China.	[Guo, Qiang; Tao, Yun-Li; Chu, Dong] Qingdao Agr Univ, Key Lab Integrated Crop Pest Management Shandong, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Chu, D (corresponding author), Qingdao Agr Univ, Key Lab Integrated Crop Pest Management Shandong, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China.	chinachudong@sina.com	Chu, Dong/AAS-3914-2020; CHU, DONG/AAI-1892-2020	Chu, Dong/0000-0001-5716-4979; 	Natural Science Foundation of China [31071747, 31272105]; National Basic Research and Development Program of China [2009CB119200]; Shandong Provincial Special Fund for "Mount Tai scholars"	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China); Shandong Provincial Special Fund for "Mount Tai scholars"	This work was supported by the Natural Science Foundation of China (Grant No. 31071747; 31272105), the National Basic Research and Development Program of China (2009CB119200) and the Shandong Provincial Special Fund for "Mount Tai scholars". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bracht JR, 2010, DEV BIOL, V348, P210, DOI 10.1016/j.ydbio.2010.10.003; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Chu D, 2007, ENVIRON ENTOMOL, V36, P1290, DOI 10.1603/0046-225X(2007)36[1290:BSADOB]2.0.CO;2; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2010, FLA ENTOMOL, V93, P203, DOI 10.1653/024.093.0209; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haenisch S, 2011, MOL PHARMACOL, V80, P314, DOI 10.1124/mol.110.070714; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Khasdan V, 2005, B ENTOMOL RES, V95, P605, DOI 10.1079/BER2005390; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050001; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Luo QB, 2008, J GENET GENOMICS, V35, P349, DOI 10.1016/S1673-8527(08)60051-X; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mezzanzanica D, 2011, EXPERT REV MOL DIAGN, V11, P277, DOI [10.1586/ERM.11.1, 10.1586/erm.11.1]; Muniz M, 2000, ENTOMOL EXP APPL, V95, P63, DOI 10.1023/A:1003930123626; Muniz M, 2001, ENVIRON ENTOMOL, V30, P720, DOI 10.1603/0046-225X-30.4.720; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shao CG, 2013, GENE, V515, P123, DOI 10.1016/j.gene.2012.11.015; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Surridge AK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-62; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Ueda Shigenori, 2006, Kyushu Byogaichu Kenkyukaiho, V52, P44; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Yu JY, 2009, DEVELOPMENT, V136, P1497, DOI 10.1242/dev.025999; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	87	10	10	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59884	10.1371/journal.pone.0059884	http://dx.doi.org/10.1371/journal.pone.0059884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527280	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600101
J	Parker, D; Prince, A				Parker, Dane; Prince, Alice			Epithelial Uptake of Flagella Initiates Proinflammatory Signaling	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; BACTERIAL FLAGELLIN; ACTIVATES CASPASE-1; RECEPTOR 5; RECOGNITION; SECRETION; CELLS; TLR5	The airway epithelium serves multiple roles in the defense of the lung. Not only does it act as a physical barrier, it acts as a distal extension of the innate immune system. We investigated the role of the airway epithelium in the interaction with flagella, an important virulence factor of the pathogen Pseudomonas aeruginosa, a cause of ventilator associated pneumonia and significant morbidity and mortality in patients with cystic fibrosis. Flagella were required for transmigration across polarized airway epithelial cells and this was a direct consequence of motility, and not a signaling effect. Purified flagella did not alter the barrier properties of the epithelium but were observed to be rapidly endocytosed inside epithelial cells. Neither flagella nor intact P. aeruginosa stimulated epithelial inflammasome signaling. Flagella-dependent signaling required dynamin-based uptake as well as TLR5 and primarily led to the induction of proinflammatory (Tnf, Il6) as well as neutrophil (Cxcl1, Cxcl2, Ccl3) and macrophage (Ccl20) chemokines. Although flagella are important in invasion across the epithelial barrier their shedding in the airway lumen results in epithelial uptake and signaling that has a major role in the initial recruitment of immune cells in the lung.	[Parker, Dane; Prince, Alice] Columbia Univ, Dept Pediat, New York, NY 10027 USA	Columbia University	Parker, D (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	dp2375@columbia.edu	Parker, Dane/AAX-7001-2021	Parker, Dane/0000-0001-7304-3392	National Institutes of Health [R01HL073989]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant R01HL073989 to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Birrell MA, 2011, PHARMACOL THERAPEUT, V130, P364, DOI 10.1016/j.pharmthera.2011.03.007; Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Eaves-Pyles T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024869; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Gerstel U, 2009, CELL MICROBIOL, V11, P842, DOI 10.1111/j.1462-5822.2009.01299.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Isbister GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038739; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Jordan JA, 2001, J IMMUNOL, V167, P7060, DOI 10.4049/jimmunol.167.12.7060; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Lovewell RR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002253; Lu JH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002963; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519, DOI 10.1128/IAI.63.11.4519-4523.1995; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Smith K, 2003, POETRY REV, V93, P5; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tran Hai B, 2012, J Allergy (Cairo), V2012, P819176, DOI 10.1155/2012/819176; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895; Wilson RH, 2012, NAT MED; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	49	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59932	10.1371/journal.pone.0059932	http://dx.doi.org/10.1371/journal.pone.0059932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527288	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600107
J	Saiote, C; Polania, R; Rosenberger, K; Paulus, W; Antal, A				Saiote, Catarina; Polania, Rafael; Rosenberger, Konstantin; Paulus, Walter; Antal, Andrea			High-Frequency TRNS Reduces BOLD Activity during Visuomotor Learning	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; RANDOM NOISE STIMULATION; MOTOR CORTEX; PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN IMAGES; EXCITABILITY; HUMANS; FACILITATION; ACTIVATION	Transcranial direct current stimulation (tDCS) and transcranial random noise stimulation (tRNS) consist in the application of electrical current of small intensity through the scalp, able to modulate perceptual and motor learning, probably by changing brain excitability. We investigated the effects of these transcranial electrical stimulation techniques in the early and later stages of visuomotor learning, as well as associated brain activity changes using functional magnetic resonance imaging (fMRI). We applied anodal and cathodal tDCS, low-frequency and high-frequency tRNS (lf-tRNS, 0.1-100 Hz; hf-tRNS 101-640 Hz, respectively) and sham stimulation over the primary motor cortex (M1) during the first 10 minutes of a visuomotor learning paradigm and measured performance changes for 20 minutes after stimulation ceased. Functional imaging scans were acquired throughout the whole experiment. Cathodal tDCS and hf-tRNS showed a tendency to improve and lf-tRNS to hinder early learning during stimulation, an effect that remained for 20 minutes after cessation of stimulation in the late learning phase. Motor learning-related activity decreased in several regions as reported previously, however, there was no significant modulation of brain activity by tDCS. In opposition to this, hf-tRNS was associated with reduced motor task-related-activity bilaterally in the frontal cortex and precuneous, probably due to interaction with ongoing neuronal oscillations. This result highlights the potential of lf-tRNS and hf-tRNS to differentially modulate visuomotor learning and advances our knowledge on neuroplasticity induction approaches combined with functional imaging methods.	[Saiote, Catarina; Polania, Rafael; Rosenberger, Konstantin; Paulus, Walter; Antal, Andrea] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Polania, Rafael] Univ Zurich, Lab Social & Neural Syst Res, Dept Econ, Zurich, Switzerland	University of Gottingen; University of Zurich	Saiote, C (corresponding author), Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany.	catarina.saiote@med.uni-goettingen.de	Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377; Polania, Rafael/0000-0002-6176-6806	Rose Foundation	Rose Foundation	This study was supported by the Rose Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2011, NEUROPSYCHOLOGIA, V49, P1974, DOI 10.1016/j.neuropsychologia.2011.03.026; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2008, NEUROPSYCHOLOGIA, V46, P3157, DOI 10.1016/j.neuropsychologia.2008.07.007; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chaieb L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/105927; Chaieb L, 2009, EXP BRAIN RES, V198, P439, DOI 10.1007/s00221-009-1938-7; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Freeman DK, 2010, J NEUROPHYSIOL, V104, P2778, DOI 10.1152/jn.00551.2010; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kandel E., 2000, PRINCIPLES NEURAL SC; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Polania R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030971; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Siebner HR, 2010, J PHYSIOL-LONDON, V588, P4851, DOI 10.1113/jphysiol.2010.200857; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	39	29	48	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59669	10.1371/journal.pone.0059669	http://dx.doi.org/10.1371/journal.pone.0059669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527247	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317562600088
J	Schneider, AG; Abdallah, DSA; Butcher, BA; Denkers, EY				Schneider, Anne G.; Abdallah, Delbert S. Abi; Butcher, Barbara A.; Denkers, Eric Y.			Toxoplasma gondii Triggers Phosphorylation and Nuclear Translocation of Dendritic Cell STAT1 while Simultaneously Blocking IFN gamma-Induced STAT1 Transcriptional Activity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INTERFERON-GAMMA; TYROSINE PHOSPHORYLATION; ANTIGEN PRESENTATION; HOST-RESISTANCE; SERINE PHOSPHORYLATION; TARGETED DISRUPTION; MURINE MACROPHAGES; GENE-EXPRESSION; DNA-BINDING	The protozoan Toxoplasma gondii actively modulates cytokine-induced JAK/STAT signaling pathways to facilitate survival within the host, including blocking IFN gamma-mediated STAT1-dependent proinflammatory gene expression. We sought to further characterize inhibition of STAT1 signaling in infected murine dendritic cells (DC) because this cell type has not previously been examined, yet is known to serve as an early target of in vivo infection. Unexpectedly, we discovered that T. gondii infection alone induced sustained STAT1 phosphorylation and nuclear translocation in DC in a parasite strain-independent manner. Maintenance of STAT1 phosphorylation required active invasion but intracellular parasite replication was dispensable. The parasite rhoptry protein ROP16, recently shown to mediate STAT3 and STAT6 phosphorylation, was not required for STAT1 phosphorylation. In combination with IFN gamma, T. gondii induced synergistic STAT1 phosphorylation and binding of aberrant STAT1-containing complexes to IFN gamma consensus sequence oligonucleotides. Despite these findings, parasite infection blocked STAT1 binding to the native promoters of the IFN gamma-inducible genes Irf-1 and Lrg47, along with subsequent gene expression. These results reinforce the importance of parasite-mediated blockade of IFN gamma responses in dendritic cells, while simultaneously showing that T. gondii alone induces STAT1 phosphorylation.	[Schneider, Anne G.; Abdallah, Delbert S. Abi; Butcher, Barbara A.; Denkers, Eric Y.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Denkers, EY (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	eyd1@cornell.edu	denkers, eric/Q-3173-2019		United States National Institutes of Health [AI50617, 5T32RR007059-17]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050617] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States National Institutes of Health (nih.gov) grants AI50617 (EYD) and 5T32RR007059-17 (AGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dubey JP, 2011, INT J PARASITOL, V41, P1139, DOI 10.1016/j.ijpara.2011.06.005; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kaye A, 2011, J PEDIATR HEALTH CAR, V25, P355, DOI 10.1016/j.pedhc.2010.04.008; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Khan IA, 1996, J IMMUNOL, V156, P636; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lang C, 2006, MICROBES INFECT, V8, P1994, DOI 10.1016/j.micinf.2006.02.031; Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Leng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007589; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Luder CGK, 1998, CLIN EXP IMMUNOL, V112, P308; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Luder CGK, 2003, J NEUROIMMUNOL, V134, P12, DOI 10.1016/S0165-5728(02)00320-X; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; MCCABE RE, 1984, J INFECT DIS, V150, P961, DOI 10.1093/infdis/150.6.961; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MURRAY HW, 1985, J IMMUNOL, V134, P1982; MURRAY HW, 1985, J IMMUNOL, V134, P1619; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Rosowski EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051448; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yang TH, 1996, MICROBIOL IMMUNOL, V40, P443, DOI 10.1111/j.1348-0421.1996.tb01091.x; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	62	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60215	10.1371/journal.pone.0060215	http://dx.doi.org/10.1371/journal.pone.0060215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527309	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600125
J	Abranches, E; Bekman, E; Henrique, D				Abranches, Elsa; Bekman, Evguenia; Henrique, Domingos			Generation and Characterization of a Novel Mouse Embryonic Stem Cell Line with a Dynamic Reporter of Nanog Expression	PLOS ONE			English	Article							PLURIPOTENCY FACTORS; PRIMITIVE ENDODERM; SELF-RENEWAL; ES CELLS; EPIBLAST; DIFFERENTIATION; TRANSCRIPTION; NEUROGENESIS; CULTURE; STATE	Background: The pluripotent state in embryonic stem (ES) cells is controlled by a core network of transcription factors that includes Nanog, Oct4 and Sox2. Nanog is required to reach pluripotency during somatic reprogramming and is the only core factor whose overexpression is able to oppose differentiation-promoting signals. Additionally, Nanog expression is known to fluctuate in ES cells, and different levels of Nanog seem to correlate with ES cells' ability to respond to differentiation promoting signals. Elucidating how dynamic Nanog levels are regulated in pluripotent cells and modulate their potential is therefore critical to develop a better understanding of the pluripotent state. Methodology/Principal Findings: We describe the generation and validation of a mouse ES cell line with a novel Nanog reporter (Nd, from Nanog dynamics), containing a BAC transgene where the short-lived fluorescent protein VNP is placed under Nanog regulation. We show that Nanog and VNP have similar half-lives, and that Nd cells provide an accurate and measurable read-out for the dynamic levels of Nanog. Using this reporter, we could show that ES cells with low Nanog levels indeed have higher degree of priming to differentiation, when compared with high-Nanog cells. However, low-Nanog ES cells maintain high levels of Oct4 and Sox2 and can revert to a state of high-Nanog expression, indicating that they are still within the window of pluripotency. We further show that the observed changes in Nanog levels correlate with ES cell morphology and that Nanog dynamic expression is modulated by the cellular environment. Conclusions/Significance: The novel reporter ES cell line here described allows an accurate monitoring of Nanog's dynamic expression in the pluripotent state. This reporter will thus be a valuable tool to obtain quantitative measurements of global gene expression in pluripotent ES cells in different states, allowing a detailed molecular mapping of the pluripotency landscape.	[Abranches, Elsa; Bekman, Evguenia; Henrique, Domingos] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Abranches, Elsa; Bekman, Evguenia; Henrique, Domingos] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Abranches, Elsa; Henrique, Domingos] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Fundacao Champalimaud	Abranches, E (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	elsa.abranches@gmail.com	Henrique, Domingos M/E-5460-2010; Bekman, Evguenia/O-9840-2017; Bekman, Evguenia Pavlovna/AAC-3218-2019; Abranches, Elsa/D-4324-2012	Henrique, Domingos M/0000-0001-8869-1894; Bekman, Evguenia/0000-0002-3963-1358; Bekman, Evguenia Pavlovna/0000-0002-3963-1358; Abranches, Elsa/0000-0003-4493-6065	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/26854/2006, PTDC/SAU-OBD/100664/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was funded by "Fundacao para a Ciencia e a Tecnologia", Portugal (SFRH/BPD/26854/2006 to EA and PTDC/SAU-OBD/100664/2008) (http://alfa.fct.mctes.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; AKESON EC, 2001, CURR PROTOC HUM GENE, pCH4; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rathjen J, 1999, J CELL SCI, V112, P601; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Soncin F, 2011, GENES-BASEL, V2, P229, DOI 10.3390/genes2010229; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Teo A. K., 2011, GENES DEV; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vilas-Boas F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-58; WANG Y, 2010, STEM CELL REV; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67	40	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59928	10.1371/journal.pone.0059928	http://dx.doi.org/10.1371/journal.pone.0059928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527287	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100173
J	Guralp, SA; Murgha, YE; Rouillard, JM; Gulari, E				Guralp, Saadet Albayrak; Murgha, Yusuf E.; Rouillard, Jean-Marie; Gulari, Erdogan			From Design to Screening: A New Antimicrobial Peptide Discovery Pipeline	PLOS ONE			English	Article							SOLUTION PHOTOGENERATED ACIDS; CLASS IIA BACTERIOCINS; LACTOBACILLUS-PLANTARUM; MULTICELLULAR ORGANISMS; VARIABLE RESIDUES; LISTERIA-INNOCUA; CYCLIC-PEPTIDES; PEDIOCIN PA-1; CODON USAGE; PCR	Antimicrobial peptides (AMPs) belong to a class of natural microbicidal molecules that have been receiving great attention for their lower propensity for inducing drug resistance, hence, their potential as alternative drugs to conventional antibiotics. By generating AMP libraries, one can study a large number of candidates for their activities simultaneously in a timely manner. Here, we describe a novel methodology where in silico designed AMP-encoding oligonucleotide libraries are cloned and expressed in a cellular host for rapid screening of active molecules. The combination of parallel oligonucleotide synthesis with microbial expression systems not only offers complete flexibility for sequence design but also allows for economical construction of very large peptide libraries. An application of this approach to discovery of novel AMPs has been demonstrated by constructing and screening a custom library of twelve thousand plantaricin-423 mutants in Escherichia coli. Analysis of selected clones by both Sanger-sequencing and 454 high-throughput sequencing produced a significant amount of data for positionally important residues of plantaricin-423 responsible for antimicrobial activity and, moreover, resulted in identification of many novel variants with enhanced specific activities against Listeria innocua. This approach allows for generation of fully tailored peptide collections in a very cost effective way and will have countless applications from discovery of novel AMPs to gaining fundamental understanding of their biological function and characteristics.	[Guralp, Saadet Albayrak; Murgha, Yusuf E.; Rouillard, Jean-Marie; Gulari, Erdogan] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Rouillard, Jean-Marie] Mycroarray, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Gulari, E (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	gulari@umich.edu			United States National Institutes of Health [5R42GM097003-03, 9R42GM097003-02A1, 1R41HG004103-01]; Gates Foundation [BMGF:02204000005]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R41HG004103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R42GM097003] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the United States National Institutes of Health 5R42GM097003-03, 9R42GM097003-02A1 and 1R41HG004103-01, and Gates Foundation BMGF:02204000005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Choi KC, 2002, BIOTECHNOL LETT, V24, P251, DOI 10.1023/A:1014076426705; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Gao XL, 2001, NUCLEIC ACIDS RES, V29, P4744, DOI 10.1093/nar/29.22.4744; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Gravesen A, 2002, MICROBIOL-SGM, V148, P2361, DOI 10.1099/00221287-148-8-2361; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Islam MR, 2009, MOL MICROBIOL, V72, P1438, DOI 10.1111/j.1365-2958.2009.06733.x; Kamat AS, 1996, FOOD SCI TECHNOL-LEB, V29, P714; Kieny M-P, 2012, EVOLVING THREAT ANTI; Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Miller KW, 1998, APPL ENVIRON MICROB, V64, P1997; Mills S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S7; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Namjoshi S, 2010, BIOPOLYMERS, V94, P673, DOI 10.1002/bip.21476; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Pellois JP, 2000, J COMB CHEM, V2, P355, DOI 10.1021/cc0000139; Poon K, 2000, BIOPHYS CHEM, V84, P205, DOI 10.1016/S0301-4622(00)00106-X; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tominaga T, 2006, APPL ENVIRON MICROB, V72, P1141, DOI 10.1128/AEM.72.2.1141-1147.2006; Tominaga T, 2007, APPL ENVIRON MICROB, V73, P5292, DOI 10.1128/AEM.00558-07; van Reenen CA, 1998, J APPL MICROBIOL, V84, P1131; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	26	27	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59305	10.1371/journal.pone.0059305	http://dx.doi.org/10.1371/journal.pone.0059305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527157	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100103
J	Wilkinson, GS; Johns, PM; Metheny, JD; Baker, RH				Wilkinson, Gerald S.; Johns, Philip M.; Metheny, Jackie D.; Baker, Richard H.			Sex-Biased Gene Expression during Head Development in a Sexually Dimorphic Stalk-Eyed Fly	PLOS ONE			English	Article							CYRTODIOPSIS-DALMANNI DIPTERA; X-CHROMOSOME; DOSAGE COMPENSATION; MEIOTIC DRIVE; GENOMIC ANALYSIS; ORNAMENT SIZE; DROSOPHILA; EVOLUTION; FLIES; SELECTION	Stalk-eyed flies (family Diopsidae) are a model system for studying sexual selection due to the elongated and sexually dimorphic eye-stalks found in many species. These flies are of additional interest because their X chromosome is derived largely from an autosomal arm in other flies. To identify candidate genes required for development of dimorphic eyestalks and investigate how sex-biased expression arose on the novel X, we compared gene expression between males and females using oligonucleotide microarrays and RNA from developing eyestalk tissue or adult heads in the dimorphic diopsid, Teleopsis dalmanni. Microarray analysis revealed sex-biased expression for 26% of 3,748 genes expressed in eye-antennal imaginal discs and concordant sex-biased expression for 86 genes in adult heads. Overall, 415 female-biased and 482 male-biased genes were associated with dimorphic eyestalk development but not differential expression in the adult head. Functional analysis revealed that male-biased genes are disproportionately associated with growth and mitochondrial function while female-biased genes are associated with cell differentiation and patterning or are novel transcripts. With regard to chromosomal effects, dosage compensation occurs by elevated expression of X-linked genes in males. Genes with female-biased expression were more common on the X and less common on autosomes than expected, while male-biased genes exhibited no chromosomal pattern. Rates of protein evolution were lower for female-biased genes but higher for genes that moved on or off the novel X chromosome. These findings cannot be due to meiotic sex chromosome inactivation or by constraints associated with dosage compensation. Instead, they could be consistent with sexual conflict in which female-biased genes on the novel X act primarily to reduce eyespan in females while other genes increase eyespan in both sexes. Additional information on sex-biased gene expression in other tissues and related sexually monomorphic species could confirm this interpretation.	[Wilkinson, Gerald S.; Metheny, Jackie D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Johns, Philip M.] Bard Coll, Biol Program, Annandale On Hudson, NY USA; [Baker, Richard H.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	University System of Maryland; University of Maryland College Park; American Museum of Natural History (AMNH)	Wilkinson, GS (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	wilkinso@umd.edu	Wilkinson, Gerald S./E-4424-2011	Wilkinson, Gerald S./0000-0001-7799-8444	National Science Foundation [DEB-0445047, DEB-0444886, DEB-0951816, DEB-0952260]; Division Of Environmental Biology [0952260, 0951816] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants (DEB-0445047, DEB-0444886, DEB-0951816, and DEB-0952260) from the National Science Foundation (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Baker RH, 2001, EVOLUTION, V55, P1373; Baker RH, 2001, BEHAV ECOL, V12, P732, DOI 10.1093/beheco/12.6.732; Baker RH, 2012, PHILOS T R SOC B, V367, P2357, DOI 10.1098/rstb.2011.0287; Baker RH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001121; Baker RH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-361; Barmina O, 2005, DEV BIOL, V288, P528, DOI 10.1016/j.ydbio.2005.09.052; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Birge LM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-227; Buschbeck EK, 2001, J COMP NEUROL, V433, P486, DOI 10.1002/cne.1155; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Connallon T, 2010, EVOLUTION, V64, P3417, DOI 10.1111/j.1558-5646.2010.01136.x; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Fry CL, 2006, EVOL DEV, V8, P191, DOI 10.1111/j.1525-142X.2006.00089.x; Fry CL, 2004, EVOLUTION, V58, P1622, DOI 10.1111/j.0014-3820.2004.tb01743.x; Gallach M, 2011, TRENDS ECOL EVOL, V26, P222, DOI 10.1016/j.tree.2011.02.004; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Hingle A, 2001, ANIM BEHAV, V61, P589, DOI 10.1006/anbe.2000.1613; Hurley I, 2002, DEV GENES EVOL, V212, P38, DOI 10.1007/s00427-001-0206-z; Husak JF, 2011, FUNCT ECOL, V25, P608, DOI 10.1111/j.1365-2435.2010.01827.x; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johns PM, 2005, P ROY SOC B-BIOL SCI, V272, P2097, DOI 10.1098/rspb.2005.3183; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lande R, 1999, GENET RES, V74, P245, DOI 10.1017/S0016672399004218; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Lercher MJ, 2003, MOL BIOL EVOL, V20, P1113, DOI 10.1093/molbev/msg131; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Mank JE, 2008, AM NAT, V171, P35, DOI 10.1086/523954; Mank JE, 2011, EVOLUTION, V65, P2133, DOI 10.1111/j.1558-5646.2011.01316.x; Mank JE, 2009, AM NAT, V173, P141, DOI 10.1086/595754; Marin I, 1996, NATURE, V383, P160, DOI 10.1038/383160a0; Meier R, 2002, INSECT SYST EVOL, V33, P325, DOI 10.1163/187631202X00181; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Meisel RP, 2011, MOL BIOL EVOL, V28, P1893, DOI 10.1093/molbev/msr010; Meisel RP, 2009, GENOME BIOL EVOL, V1, P176, DOI 10.1093/gbe/evp018; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Pabon C, 2001, BIOTECHNIQUES, V31, P874, DOI 10.2144/01314mt05; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Patten MM, 2009, EVOLUTION, V63, P2888, DOI 10.1111/j.1558-5646.2009.00764.x; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Presgraves DC, 1997, GENETICS, V147, P1169; Prince EG, 2010, GENOME BIOL EVOL, V2, P336, DOI 10.1093/gbe/evq024; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; *SAS I INC, 2003, JMP; Steinemann S, 2007, INSECT MOL BIOL, V16, P167, DOI 10.1111/j.1365-2583.2006.00711.x; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Swallow JG, 2000, J COMP PHYSIOL B, V170, P481, DOI 10.1007/s003600000124; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vibranovski MD, 2009, GENOME RES, V19, P897, DOI 10.1101/gr.088609.108; Vicoso B, 2009, J MOL EVOL, V68, P576, DOI 10.1007/s00239-009-9235-4; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilkinson GS, 2006, J EVOLUTION BIOL, V19, P1851, DOI 10.1111/j.1420-9101.2006.01169.x; Wilkinson Gerald S., 1997, P310, DOI 10.1017/CBO9780511721946.019; Wilkinson GS, 1999, P ROY SOC B-BIOL SCI, V266, P1685, DOI 10.1098/rspb.1999.0832; WILKINSON GS, 1993, GENET RES, V62, P213, DOI 10.1017/S001667230003192X; Wilkinson GS, 2003, GENETICA, V117, P37, DOI 10.1023/A:1022360531703; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Wilkinson GS, 1998, NATURE, V391, P276, DOI 10.1038/34640; Wilkinson GS, 1998, BEHAV ECOL, V9, P525, DOI 10.1093/beheco/9.5.525; Wolfenbarger LL, 2001, EVOLUTION, V55, P103; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	80	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59826	10.1371/journal.pone.0059826	http://dx.doi.org/10.1371/journal.pone.0059826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527273	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100168
J	Shi, C; Liu, Y; Huang, H; Xia, EH; Zhang, HB; Gao, LZ				Shi, Chao; Liu, Yuan; Huang, Hui; Xia, En-Hua; Zhang, Hai-Bin; Gao, Li-Zhi			Contradiction between Plastid Gene Transcription and Function Due to Complex Posttranscriptional Splicing: An Exemplary Study of ycf15 Function and Evolution in Angiosperms	PLOS ONE			English	Article							CHLOROPLAST GENOME SEQUENCE; COMPLETE NUCLEOTIDE-SEQUENCE; INDEPENDENT TRANSFERS; HORIZONTAL TRANSFER; MAXIMUM-LIKELIHOOD; DNA; ORGANIZATION; INFORMATION; GENERATION; THOUSANDS	Plant chloroplast genes are usually co-transcribed while its posttranscriptional splicing is fairly complex and remains largely unsolved. On basis of sequencing the three complete Camellia (Theaceae) chloroplast genomes for the first time, we comprehensively analyzed the evolutionary patterns of ycf15, a plastid gene quite paradoxical in terms of its function and evolution, along the inferred angiosperm phylogeny. Although many species in separate lineages including the three species reported here contained an intact ycf15 gene in their chloroplast genomes, the phylogenetic mixture of both intact and obviously disabled ycf15 genes imply that they are all non-functional. Both intracellular gene transfer (IGT) and horizontal gene transfer (HGT) failed to explain such distributional anomalies. While, transcriptome analyses revealed that ycf15 was transcribed as precursor polycistronic transcript which contained ycf2, ycf15 and antisense trnL-CAA. The transcriptome assembly was surprisingly found to cover near the complete Camellia chloroplast genome. Many non-coding regions including pseudogenes were mapped by multiple transcripts, indicating the generality of pseudogene transcriptions. Our results suggest that plastid DNA posttranscriptional splicing may involve complex cleavage of nonfunctional genes.	[Shi, Chao] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Shi, Chao; Liu, Yuan; Huang, Hui; Xia, En-Hua; Zhang, Hai-Bin; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Shi, Chao; Liu, Yuan; Xia, En-Hua; Zhang, Hai-Bin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Plant Germplasm & Genom Ctr, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn	, 夏恩华/ABD-9329-2020; Xia, Enhua/AAV-4999-2021	Xia, Enhua/0000-0003-3411-9117; Liu, Yuan/0000-0003-4247-3562	Key Project of Natural Science Foundation of Yunnan Province [2010CC011]; Top Talents Program of Yunnan Province [20080A009]; Hundreds Oversea Talents Program of Yunnan Province, Hundreds Talents Program of Chinese Academy of Sciences; Chinese Academy of Science [KSCX2-YW-N-029]; Chinese Department of Science and Technology (973 Program) [2007CB815703]; startup grant of Kunming Institute of Botany, CAS	Key Project of Natural Science Foundation of Yunnan Province; Top Talents Program of Yunnan Province; Hundreds Oversea Talents Program of Yunnan Province, Hundreds Talents Program of Chinese Academy of Sciences; Chinese Academy of Science(Chinese Academy of Sciences); Chinese Department of Science and Technology (973 Program); startup grant of Kunming Institute of Botany, CAS	This work was supported by Key Project of Natural Science Foundation of Yunnan Province (2010CC011), Top Talents Program of Yunnan Province (20080A009), Hundreds Oversea Talents Program of Yunnan Province, Hundreds Talents Program of Chinese Academy of Sciences (CAS), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703) and a startup grant of Kunming Institute of Botany, CAS (to LZ GAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Drummond A, GENEIOUS V5 1; FREYER R, 1993, PLANT J, V4, P621, DOI 10.1046/j.1365-313X.1993.04040621.x; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komine Y, 2002, P NATL ACAD SCI USA, V99, P4085, DOI 10.1073/pnas.052327599; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Legen J, 2002, PLANT J, V31, P171, DOI 10.1046/j.1365-313X.2002.01349.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Maier UG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-36; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mondal TK, 2002, INT J TEA SCI, V1, P28; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.3788705; Odintsova MS, 2003, MOL BIOL+, V37, P649, DOI 10.1023/A:1026020623631; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Salvador ML, 2011, NUCLEIC ACIDS RES, V39, P6213, DOI 10.1093/nar/gkr226; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WOODBURY NW, 1988, CURR GENET, V14, P75, DOI 10.1007/BF00405857; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhelyazkova P, 2012, PLANT AN GEN 20 C JA; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441	57	45	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59620	10.1371/journal.pone.0059620	http://dx.doi.org/10.1371/journal.pone.0059620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527231	gold, Green Submitted, Green Published			2022-12-27	WOS:000316411600068
J	Yu, PP; Pisitkun, T; Wang, GH; Wang, R; Katagiri, Y; Gucek, M; Knepper, MA; Geller, HM				Yu, Panpan; Pisitkun, Trairak; Wang, Guanghui; Wang, Rong; Katagiri, Yasuhiro; Gucek, Marjan; Knepper, Mark A.; Geller, Herbert M.			Global Analysis of Neuronal Phosphoproteome Regulation by Chondroitin Sulfate Proteoglycans	PLOS ONE			English	Article							NEURITE OUTGROWTH; INHIBITORY-ACTIVITY; AXON GROWTH; PHOSPHORYLATION; GUIDANCE; POLYMERIZATION; REGENERATION; RECEPTOR; CELLS; IDENTIFICATION	Chondroitin sulfate proteoglycans (CSPGs) are major components of the extracellular matrix which mediate inhibition of axonal regeneration after injury to the central nervous system (CNS). Several neuronal receptors for CSPGs have recently been identified; however, the signaling pathways by which CSPGs restrict axonal growth are still largely unknown. In this study, we applied quantitative phosphoproteomics to investigate the global changes in protein phosphorylation induced by CSPGs in primary neurons. In combination with isobaric Tags for Relative and Absolute Quantitation (iTRAQ) labeling, strong cation exchange chromatography (SCX) fractionation, immobilized metal affinity chromatography (IMAC) and LC-MS/MS, we identified and quantified 2214 unique phosphopeptides corresponding to 1118 phosphoproteins, with 118 changing significantly in abundance with CSPG treatment. The proteins that were regulated by CSPGs included key components of synaptic vesicle trafficking, axon guidance mediated by semaphorins, integrin signaling, cadherin signaling and EGF receptor signaling pathways. A significant number of the regulated proteins are cytoskeletal and related proteins that have been implicated in regulating neurite growth. Another highly represented protein category regulated by CSPGs is nucleic acid binding proteins involved in RNA post-transcriptional regulation. Together, by screening the overall phosphoproteome changes induced by CSPGs, this data expand our understanding of CSPG signaling, which provides new insights into development of strategies for overcoming CSPG inhibition and promoting axonal regeneration after CNS injury.	[Yu, Panpan; Katagiri, Yasuhiro; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Cell Biol & Physiol Ctr, Div Intramural Res,NIH, Bethesda, MD 20892 USA; [Pisitkun, Trairak; Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Wang, Guanghui; Gucek, Marjan] NHLBI, Prote Core Facil, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Wang, Rong] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA)	Geller, HM (corresponding author), NHLBI, Dev Neurobiol Sect, Cell Biol & Physiol Ctr, Div Intramural Res,NIH, Bldg 10, Bethesda, MD 20892 USA.	geller@helix.nih.gov	Yu, Panpan/A-4962-2013; Knepper, Mark/AAF-8412-2020; Yu, Panpan/M-5718-2019	Pisitkun, Trairak/0000-0001-6677-2271; Geller, Herbert/0000-0002-7048-6144	National Heart, Lung, and Blood Institute (NHLBI) Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006129, ZICHL005903, ZIAHL001285, ZIAHL006128, ZIAHL006021] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was entirely funded through the National Heart, Lung, and Blood Institute (NHLBI) Intramural Program. There were no external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALSAMO J, 1995, J CELL BIOL, V129, P1391, DOI 10.1083/jcb.129.5.1391; Boekhorst J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023276; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Calamia V, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013417; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hoffert JD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014613; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kelly TAN, 2010, J NEUROSCI RES, V88, P3024, DOI 10.1002/jnr.22478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Phanstiel D, 2009, ANAL CHEM, V81, P1693, DOI 10.1021/ac8019202; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saeed F, 2012, INT WORKSH COMP PROT; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sharma K, 2012, EXP NEUROL; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311; Snow DM, 1996, INT J DEV NEUROSCI, V14, P331, DOI 10.1016/0736-5748(96)00017-2; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Ughrin YM, 2003, J NEUROSCI, V23, P175; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Yu PP, 2012, J NEUROCHEM, V120, P1117, DOI 10.1111/j.1471-4159.2011.07638.x; Zhao B, 2012, PROTEOMICS	45	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59285	10.1371/journal.pone.0059285	http://dx.doi.org/10.1371/journal.pone.0059285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527152	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600054
J	Razzaghi, H; Tempczyk-Russell, A; Haubold, K; Santorico, SA; Shokati, T; Christians, U; Churchill, MEA				Razzaghi, Hamid; Tempczyk-Russell, Anna; Haubold, Kurt; Santorico, Stephanie A.; Shokati, Touraj; Christians, Uwe; Churchill, Mair E. A.			Genetic and Structure-Function Studies of Missense Mutations in Human Endothelial Lipase	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; SAN-LUIS-VALLEY; ACTIVATES PPAR-ALPHA; FATTY-ACIDS; INTERFACIAL ACTIVATION; X-RAY; ANTIINFLAMMATORY PROPERTIES; POTENTIAL ROLE; IN-VITRO; HDL	Endothelial lipase (EL) plays a pivotal role in HDL metabolism. We sought to characterize EL and its interaction with HDL as well as its natural variants genetically, functionally and structurally. We screened our biethnic population sample (n = 802) for selected missense mutations (n = 5) and identified T111I as the only common variant. Multiple linear regression analyses in Hispanic subjects revealed an unexpected association between T111I and elevated LDL-C (p-value = 0.012) and total cholesterol (p-value = 0.004). We examined lipase activity of selected missense mutants (n = 10) and found different impacts on EL function, ranging from normal to complete loss of activity. EL-HDL lipidomic analyses indicated that EL has a defined remodeling of HDL without exhaustion of the substrate and a distinct and preference for several fatty acids that are lipid mediators and known for their potent pro- and anti-inflammatory properties. Structural studies using homology modeling revealed a novel alpha/beta motif in the C-domain, unique to EL. The EL dimer was found to have the flexibility to expand and to bind various sizes of HDL particles. The likely impact of the all known missense mutations (n = 18) on the structure of EL was examined using molecular modeling and the impact they may have on EL lipase activity using a novel structure-function slope based on their structural free energy differences. The results of this multidisciplinary approach delineated the impact of EL and its variants on HDL. Moreover, the results suggested EL to have the capacity to modulate vascular health through its role in fatty acid-based signaling pathways.	[Razzaghi, Hamid; Haubold, Kurt] Univ Colorado Denver, Dept Med, Div Cardiol, Aurora, CO 80045 USA; [Tempczyk-Russell, Anna] Accelrys Inc, San Diego, CA USA; [Santorico, Stephanie A.] Univ Colorado Denver, Dept Math & Stat Sci, Denver, CO USA; [Shokati, Touraj; Christians, Uwe] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA; [Churchill, Mair E. A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; BIOVIA; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Razzaghi, H (corresponding author), Univ Colorado Denver, Dept Med, Div Cardiol, Aurora, CO 80045 USA.	razzaghi_hamid@yahoo.com	Churchill, Mair E. A./C-5549-2014; Santorico, Stephanie/L-7009-2015	Churchill, Mair E. A./0000-0003-0862-235X; Santorico, Stephanie/0000-0001-7846-0945	National Institutes of Health-NHLBI [HL-080630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080630] Funding Source: NIH RePORTER	National Institutes of Health-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from National Institutes of Health-NHLBI (HL-080630) to Dr. Hamid Razzaghi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2006, CIRC RES, V98, P490, DOI 10.1161/01.RES.0000205846.46812.be; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Badellino KO, 2006, PLOS MED, V3, P245, DOI 10.1371/journal.pmed.0030022; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P557, DOI 10.1111/j.1432-1033.1980.tb04603.x; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Brown RJ, 2010, CIRC RES, V107, P357, DOI 10.1161/CIRCRESAHA.110.219188; Brown RJ, 2009, J LIPID RES, V50, P1910, DOI 10.1194/jlr.P900020-JLR200; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; BURCHFIEL CM, 1990, AM J EPIDEMIOL, V131, P57, DOI 10.1093/oxfordjournals.aje.a115485; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chen S, 2007, BBA-MOL CELL BIOL L, V1771, P1319, DOI 10.1016/j.bbalip.2007.08.001; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Doolittle MH, 2010, CLIN LIPIDOL, V5, P117, DOI 10.2217/CLP.09.84; Durlach V, 2011, DIABETES METAB, V37, P64, DOI 10.1016/j.diabet.2010.07.010; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; Feyfant E, 2007, PROTEIN SCI, V16, P2030, DOI 10.1110/ps.072855507; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Gauster M, 2005, J LIPID RES, V46, P1517, DOI 10.1194/jlr.M500054-JLR200; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halverstadt A, 2003, METABOLISM, V52, P1505, DOI 10.1016/S0026-0495(03)00284-1; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Hara T, 2011, J LIPID RES, V52, P57, DOI 10.1194/jlr.M008417; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Honig B, 1989, Prog Clin Biol Res, V289, P65; Hutter CM, 2006, ATHEROSCLEROSIS, V185, P78, DOI 10.1016/j.atherosclerosis.2005.05.033; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jahangiri A, 2005, J LIPID RES, V46, P896, DOI 10.1194/jlr.M400212-JLR200; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; JENNENS ML, 1994, J BIOL CHEM, V269, P25470; Jensen MK, 2009, EUR HEART J, V30, P1584, DOI 10.1093/eurheartj/ehp145; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Jung I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-298; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khetarpal SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002393; Kojma Y, 2004, J BIOL CHEM, V279, P54032, DOI 10.1074/jbc.M411112200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; Mank-Seymour AR, 2004, BBA-MOL CELL BIOL L, V1636, P40, DOI 10.1016/j.bbalip.2003.12.001; Maugeais C, 2003, CIRCULATION, V108, P2121, DOI 10.1161/01.CIR.0000092889.24713.DC; McCoy MG, 2002, J LIPID RES, V43, P921; Mitnaul LJ, 2007, J LIPID RES, V48, P472, DOI 10.1194/jlr.D600041-JLR200; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Paradis ME, 2003, J LIPID RES, V44, P1902, DOI 10.1194/jlr.M300118-JLR200; Razzaghi H, 2000, HUM GENET, V107, P257, DOI 10.1007/s004390000367; Razzaghi H, 2001, J MOL GRAPH MODEL, V19, P487, DOI 10.1016/S1093-3263(00)00096-6; Razzaghi Hamid, 2012, Frontiers in Genetics, V3, P89, DOI 10.3389/fgene.2012.00089; Resh MD, 2006, SCI STKE, V359, P1; Riederer M, 2011, ATHEROSCLEROSIS, V214, P338, DOI 10.1016/j.atherosclerosis.2010.11.007; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shimizu M, 2007, CIRC J, V71, P842, DOI 10.1253/circj.71.842; Smith CE, 2009, ATHEROSCLEROSIS, V206, P500, DOI 10.1016/j.atherosclerosis.2009.03.012; Stuhlmeier KM, 1996, EUR J IMMUNOL, V26, P1417, DOI 10.1002/eji.1830260703; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Tang NP, 2008, J LIPID RES, V49, P369, DOI 10.1194/jlr.M700399-JLR200; TEMPCZYK A, 1989, EUR BIOPHYS J BIOPHY, V17, P201, DOI 10.1007/BF00284726; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yamakawa-Kobayashi K, 2003, HUM GENET, V113, P311, DOI 10.1007/s00439-003-0985-6; Yang YQ, 2000, J LIPID RES, V41, P48	81	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e55716	10.1371/journal.pone.0055716	http://dx.doi.org/10.1371/journal.pone.0055716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536757	gold, Green Submitted, Green Published			2022-12-27	WOS:000317397200001
J	Berard, AM; Bedel, A; Le Trequesser, R; Freyburger, G; Nurden, A; Colomer, S; Guerin, V; Vergnes, MC; Becker, F; Camelot, G; Bressolette, L; Lacroix, P; Cambou, JP; Bura-Riviere, A; Emmerich, J; Darmon, M; Deletraz, AM; Mesli, S; Colombies, B; Vanbrugghe, V; Conri, C; Constans, J				Berard, Annie M.; Bedel, Aurelie; Le Trequesser, Remi; Freyburger, Genevieve; Nurden, Alan; Colomer, Sylvie; Guerin, Viviane; Vergnes, Marie-Christine; Becker, Francois; Camelot, Gabriel; Bressolette, Luc; Lacroix, Philippe; Cambou, Jean-Pierre; Bura-Riviere, Alessandra; Emmerich, Joseph; Darmon, Michel; Deletraz, Anne-Marie; Mesli, Samir; Colombies, Brigitte; Vanbrugghe, Virginie; Conri, Claude; Constans, Joel			Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case-Control Study	PLOS ONE			English	Article							THROMBOANGIITIS-OBLITERANS; PLATELET ACTIVATION; CIGARETTE-SMOKING; NATIONAL-HEALTH; MANAGEMENT; COPPER; APOLIPOPROTEIN(A); HOMOCYSTEINE; METAANALYSIS; ASSOCIATION	Background: This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral arterial disease, either peripheral arterial occlusive disease or thromboangiitis obliterans, the two main entities of peripheral arterial disease, and to established whether some of them are specifically associated with one or another of the premature peripheral arterial disease subgroups. Methods and Results: This study included 113 non diabetic patients with premature peripheral arterial disease (diagnosis <45-year old) presenting either a peripheral arterial occlusive disease (N = 64) or a thromboangiitis obliterans (N = 49), and 241 controls matched for age and gender. Both patient groups demonstrated common traits including cigarette smoking, low physical activity, decreased levels of HDL-cholesterol, apolipoprotein A-I, pyridoxal 5'-phosphate (active form of B6 vitamin) and zinc. Premature peripheral arterial occlusive disease was characterized by the presence of a family history of peripheral arterial and carotid artery diseases (OR 2.3 and 5.8 respectively, 95% CI), high lipoprotein (a) levels above 300 mg/L (OR 2.3, 95% CI), the presence of the factor V Leiden (OR 5.1, 95% CI) and the glycoprotein la(807T, 837T, 873A) allele (OR 2.3, 95% CI). In thromboangiitis obliterans group, more patients were regular consumers of cannabis (OR 3.5, 95% CI) and higher levels in plasma copper has been shown (OR 6.5, 95% CI). Conclusions: According to our results from a non exhaustive list of study parameters, we might hypothesize for 1) a genetic basis for premature peripheral arterial occlusive disease development and 2) the prevalence of environmental factors in the development of thromboangiitis obliterans (tobacco and cannabis). Moreover, for the first time, we demonstrated that the 807T/837T/873A allele of platelet glycoprotein la may confer an additional risk for development of peripheral atherosclerosis in premature peripheral arterial occlusive disease.	[Berard, Annie M.; Bedel, Aurelie; Darmon, Michel; Deletraz, Anne-Marie; Mesli, Samir; Colombies, Brigitte] CHU Bordeaux, Serv Biochim, Bordeaux, France; [Berard, Annie M.; Bedel, Aurelie; Darmon, Michel; Deletraz, Anne-Marie; Mesli, Samir; Constans, Joel] Univ Bordeaux, Equipe Rech Univ Facteurs Risque Vasc, Bordeaux, France; [Le Trequesser, Remi] Usines FORD, Blanquefort, France; [Freyburger, Genevieve; Colomer, Sylvie; Guerin, Viviane; Vergnes, Marie-Christine] CHU Bordeaux, Serv Hematol, Bordeaux, France; [Nurden, Alan] CNRS CHU Bordeaux, Bordeaux, France; [Becker, Francois; Camelot, Gabriel] CHU Besancon, Serv Chirurg Vasc Med Interne & Chirurg Gen, F-25030 Besancon, France; [Bressolette, Luc] CHU Brest, Serv Med Interne & Pneumol, F-29285 Brest, France; [Lacroix, Philippe] CHU Limoges, Serv Chirurg Thorac & Cardiovasc & Angiol, Limoges, France; [Cambou, Jean-Pierre; Bura-Riviere, Alessandra] CHU Toulouse, Serv Med Vasc, Toulouse, France; [Emmerich, Joseph] Hop Europeen Georges Pompidou, Serv Med Vasc, Paris, France; [Vanbrugghe, Virginie; Conri, Claude; Constans, Joel] CHU Bordeaux, Serv Med Vasc & Med Interne, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CHU Bordeaux; Universite de Franche-Comte; CHU Besancon; CHU Brest; CHU Limoges; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux	Berard, AM (corresponding author), CHU Bordeaux, Serv Biochim, Bordeaux, France.	annie.berard@u-bordeaux2.fr		BURA-RIVIERE, Alessandra/0000-0001-7469-2407; Darmon, Michael/0000-0003-4198-8038	Fondation de France; Institut d'Athero Thrombose	Fondation de France(Fondation de France); Institut d'Athero Thrombose	This study was supported by grants from the "Fondation de France" (http://www.fondationdefrance.org/) and the "Institut d'Athero Thrombose" (http://www.atherothrombose.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P, 1994, STAT METHODS MED RES, P131; Avcu F, 2000, THROMB RES, V100, P143, DOI 10.1016/S0049-3848(00)00310-8; Barua RS, 2010, ARTERIOSCL THROM VAS, V30, P75, DOI 10.1161/ATVBAHA.109.195024; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Berard AM, 2004, EUR J CLIN NUTR, V58, P881, DOI 10.1038/sj.ejcn.1601890; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bona E, 2007, PROTEOMICS, V7, P1121, DOI 10.1002/pmic.200600712; Cassar K, 2003, J VASC SURG, V38, P99, DOI 10.1016/S0741-5214(03)00129-0; Cheng CH, 2008, NUTRITION, V24, P239, DOI 10.1016/j.nut.2007.12.003; Cifkova R, 2003, J Hypertens, V21, P1779; Constans J, 1998, EUR J CLIN INVEST, V28, P115, DOI 10.1046/j.1365-2362.1998.00254.x; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Criqui MH, 2005, CIRCULATION, V112, P2703, DOI 10.1161/CIRCULATIONAHA.105.546507; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Daskalopoulou SS, 2008, CIRC J, V72, P441, DOI 10.1253/circj.72.441; Dieplinger B, 2007, CLIN CHEM, V53, P1298, DOI 10.1373/clinchem.2007.088013; Ghayour-Mobarhan M, 2008, CLIN LAB, V54, P321; GIRAUD DW, 1995, AM J CLIN NUTR, V62, P104, DOI 10.1093/ajcn/62.1.104; Greenland P, 2000, CIRCULATION, V101, P723; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; Kelly PJ, 2004, STROKE, V35, P12, DOI 10.1161/01.STR.0000106481.59944.2F; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Lane JS, 2006, J VASC SURG, V44, P319, DOI 10.1016/j.jvs.2006.04.015; Makita S, 1996, CIRCULATION, V94, P211; Malecki R, 2009, ATHEROSCLEROSIS, V206, P328, DOI 10.1016/j.atherosclerosis.2009.01.042; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; O'Hare AM, 2004, CIRCULATION, V109, P320, DOI 10.1161/01.CIR.0000114519.75433.DD; PALABRICA TM, 1995, NAT MED, V1, P256, DOI 10.1038/nm0395-256; Peyrot I, 2007, J EUR ACAD DERMATOL, V21, P388, DOI 10.1111/j.1468-3083.2006.01947.x; Piazza G, 2010, CIRCULATION, V121, P1858, DOI 10.1161/CIRCULATIONAHA.110.942383; Rajagopalan S, 2007, J VASC SURG, V46, P485, DOI 10.1016/j.jvs.2007.05.039; Valentine RJ, 2004, J VASC SURG, V39, P351, DOI 10.1016/j.jvs.2003.07.011; Valentine RJ, 1996, J VASC SURG, V23, P53, DOI 10.1016/S0741-5214(05)80035-7; Wang CT, 1996, EUR J CLIN CHEM CLIN, V34, P493; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094; Zintzaras E, 2009, AM J EPIDEMIOL, V170, P1, DOI 10.1093/aje/kwp094	36	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e37882	10.1371/journal.pone.0037882	http://dx.doi.org/10.1371/journal.pone.0037882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533563	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400001
J	Eguchi, T; Watanabe, K; Hara, ES; Ono, M; Kuboki, T; Calderwood, SK				Eguchi, Takanori; Watanabe, Ken; Hara, Emilio Satoshi; Ono, Mitsuaki; Kuboki, Takuo; Calderwood, Stuart K.			OstemiR: A Novel Panel of MicroRNA Biomarkers in Osteoblastic and Osteocytic Differentiation from Mesencymal Stem Cells	PLOS ONE			English	Article							CCN FAMILY PROTEINS; GENE-EXPRESSION; BONE-FORMATION; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; REGULATORY MECHANISM; CTGF/HCS24 GENE; BMP ANTAGONIST; HNRNP A1; GROWTH	MicroRNAs (miRNAs) are small RNA molecules of 21-25 nucleotides that regulate cell behavior through inhibition of translation from mRNA to protein, promotion of mRNA degradation and control of gene transcription. In this study, we investigated the miRNA expression signatures of cell cultures undergoing osteoblastic and osteocytic differentiation from mesenchymal stem cells (MSC) using mouse MSC line KUSA-A1 and human MSCs. Ninety types of miRNA were quantified during osteoblastic/osteocytic differentiation in KUSA-A1 cells utilizing miRNA PCR arrays. Coincidently with mRNA induction of the osteoblastic and osteocytic markers, the expression levels of several dozen miRNAs including miR-30 family, let-7 family, miR-21, miR-16, miR-155, miR-322 and Snord85 were changed during the differentiation process. These miRNAs were predicted to recognize osteogenic differentiation-, stemness-, epinegetics-, and cell cycle-related mRNAs, and were thus designated OstemiR. Among those OstemiR, the miR-30 family was classified into miR-30b/c and miR-30a/d/e groups on the basis of expression patterns during osteogenesis as well as mature miRNA structures. In silico prediction and subsequent qRT-PCR in stable miR-30d transfectants clarified that context-dependent targeting of miR-30d on known regulators of bone formation including osteopontin/spp1, lifr, ccn2/ctgf, ccn1/cyr61, runx2, sox9 as well as novel key factors including lin28a, hnrnpa3, hspa5/grp78, eed and pcgf5. In addition, knockdown of human OstemiR miR-541 increased Osteopontin/SPP1 expression and calcification in hMSC osteoblastic differentiation, indicating that miR-541 is a negative regulator of osteoblastic differentiation. These observations indicate stage-specific roles of OstemiR especially miR-541 and the miR-30 family on novel targets in osteogenesis.	[Eguchi, Takanori] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Japan; [Eguchi, Takanori; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Mol & Cellular Biol,Dept Radiat Oncol, Boston, MA 02215 USA; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Japan; [Hara, Emilio Satoshi; Ono, Mitsuaki; Kuboki, Takuo] Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	National Center for Geriatrics & Gerontology; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Center for Geriatrics & Gerontology; Okayama University	Eguchi, T (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Japan.	teguchi@bidmc.harvard.edu; scalderw@bidmc.harvard.edu	Hara, Emilio Satoshi/ABA-9954-2021	Hara, Emilio Satoshi/0000-0001-7374-3487; Kuboki, Takuo/0000-0003-3756-2835; Eguchi, Takanori/0000-0002-3297-6126	MEXT [22-008]; Takeda Science Foundation; JSPS [20791378, 22249064, 23659899]; National Center for Geriatrics and Gerontology (NCGG) [23-12]; NIH [RO-1CA047407, R01CA119045, RO-1CA094397]; NATIONAL CANCER INSTITUTE [R01CA094397, R01CA047407, R01CA119045] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22249064] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center for Geriatrics and Gerontology (NCGG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TE and KW were supported by Health and Labor Sciences Research Grants for Research on Publicly Essential Drugs and Medical Devices from MEXT (22-008). TE was supported by an Incentive Grant for Medical Research from Takeda Science Foundation and by JSPS Kakenhi Grant-in-Aid for Young Scientists (B) 20791378. KW was supported by the Research Funding for Longevity Sciences (23-12) from National Center for Geriatrics and Gerontology (NCGG). SKC was supported by NIH research grants RO-1CA047407, R01CA119045 and RO-1CA094397. TK was supported by JSPS Kakenhi Grants-in-Aid for Scientific Research (A) 22249064 and for Challenging Exploratory Research 23659899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eguchi T, 2001, J BIOCHEM, V130, P79, DOI 10.1093/oxfordjournals.jbchem.a002965; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Eguchi T, 2007, BIOCHIMIE, V89, P278, DOI 10.1016/j.biochi.2006.12.006; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Halic M, 2009, CELL, V138, P1058, DOI 10.1016/j.cell.2009.08.030; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI 10.1359/JBMR.080615; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Kawashima N, 2005, J BONE MINER METAB, V23, P123, DOI 10.1007/s00774-004-0550-y; Kawata K, 2006, BIOCHEM BIOPH RES CO, V345, P552, DOI 10.1016/j.bbrc.2006.04.109; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kondo S, 2000, BIOCHEM BIOPH RES CO, V278, P119, DOI 10.1006/bbrc.2000.3780; Kramer I, 2012, J BONE MINER RES, V27, P360, DOI 10.1002/jbmr.1492; Kubota S, 2000, ONCOGENE, V19, P4773, DOI 10.1038/sj.onc.1203835; Kubota S, 2003, BONE, V33, P694, DOI 10.1016/S8756-3282(03)00227-8; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Kubota S, 2011, J CELL COMMUN SIGNAL, V5, P209, DOI 10.1007/s12079-011-0123-5; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuda Y, 2001, J BIOL CHEM, V276, P5331, DOI 10.1074/jbc.M008590200; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Mukudai Y, 2005, J BIOL CHEM, V280, P3166, DOI 10.1074/jbc.M411632200; Mukudai Y, 2008, MOL CELL BIOL, V28, P6134, DOI 10.1128/MCB.00495-08; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nielsen AF, 2007, NAT STRUCT MOL BIOL, V14, P572, DOI 10.1038/nsmb0707-572; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Ochi K, 2003, J CELL PHYSIOL, V194, P45, DOI 10.1002/jcp.10185; Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sims NA, 2012, GROWTH FACTORS, V30, P76, DOI 10.3109/08977194.2012.656760; Siomi H, 2009, NAT CELL BIOL, V11, P1049, DOI 10.1038/ncb0909-1049; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Watanabe K, 2010, CLIN REV BONE MINER, V8, P224, DOI 10.1007/s12018-010-9076-0; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhou AD, 2012, ONCOGENE, V31, P2968, DOI 10.1038/onc.2011.461; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	67	123	128	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58796	10.1371/journal.pone.0058796	http://dx.doi.org/10.1371/journal.pone.0058796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533592	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400029
J	Halemano, K; Barrett, BS; Li, SX; Harper, MS; Smith, DS; Heilman, KJ; Santiago, ML				Halemano, Kalani; Barrett, Bradley S.; Li, Sam X.; Harper, Michael S.; Smith, Diana S.; Heilman, Karl J.; Santiago, Mario L.			Fv1 Restriction and Retrovirus Vaccine Immunity in Apobec3-Deficient 129P2 Mice	PLOS ONE			English	Article							MURINE LEUKEMIA VIRUSES; ANTI-FRIEND VIRUS; HIV-1 INFECTION; CAPSID PROTEIN; GENE; MOUSE; PROTECTION; APOBEC3; IDENTIFICATION; FORM	Understanding the host genetics of the immune response in retrovirus infection models could provide insights for basic HIV vaccine discovery. In Friend retrovirus (FV) infection of mice, Fv1 differentially inhibits N-tropic versus B-tropic FV infection by mediating a capsid-dependent post-entry block, Fv2 susceptibility governs splenomegaly induction, and Rfv3 resistance primes a stronger neutralizing antibody response due to more potent Apobec3 activity. Apobec3 polymorphisms in inbred mouse strains correlate with Rfv3 resistance and susceptibility, with one unresolved exception. The 129/OlaHsd (129P2) mouse strain is Fv2 and Rfv3 susceptible based on genotyping, but infection of 129P2 mice with B-tropic FV resulted in strong neutralizing antibody responses and no splenomegaly. Here we confirm that 129P2 mice are Fv1(nr/nr), explaining its resistance to B-tropic FV. Infection of 129P2 mice with NB-tropic FV, which can efficiently infect mice independent of Fv1 genotype, resulted in severe splenomegaly, high levels of viremia and weak neutralizing antibody responses regardless of Apobec3 status. Notably, high-dose B-tropic FV infection of 129P2 Apobec3-deficient mice induced significant adaptive immune responses and conferred high levels of protection following challenge with pathogenic NB-tropic FV. This immunological protection complemented previous studies that N-tropic FV can act as a live-attenuated vaccine in Fv1(b/b) mice. Altogether, the results obtained in 129P2 mice strengthen the conclusion that Rfv3 is encoded by Apobec3, and highlight Fv1 incompatibility as a retroviral vaccine paradigm in mice. Due to its susceptibility to disease that allows for pathogenic challenge studies, B-tropic FV infection of 129P2 mice may be a useful model to study the immunological pathways induced by retroviral capsid restriction.	[Halemano, Kalani; Barrett, Bradley S.; Li, Sam X.; Harper, Michael S.; Smith, Diana S.; Heilman, Karl J.; Santiago, Mario L.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Halemano, Kalani; Li, Sam X.; Santiago, Mario L.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [Harper, Michael S.; Santiago, Mario L.] Univ Colorado Denver, Integrated Dept Immunol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Santiago, ML (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	mario.santiago@ucdenver.edu		Santiago, Mario L./0000-0001-7792-2706	National Institutes of Health [R01 AI090795]; Robert D. Watkins Predoctoral Fellowship of the American Society for Microbiology; Colorado Clinical and Translational Sciences Institute [TL1 TR000155]; Tim Gill Foundation; UCD Early Career Scholar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090795, P30AI027763, R56AI084123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert D. Watkins Predoctoral Fellowship of the American Society for Microbiology; Colorado Clinical and Translational Sciences Institute; Tim Gill Foundation; UCD Early Career Scholar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 AI090795 (M. L. S), the Robert D. Watkins Predoctoral Fellowship of the American Society for Microbiology (K. H.), the Colorado Clinical and Translational Sciences Institute TL1 TR000155 (S. X. L.), the Tim Gill Foundation (M. S. H.), and the UCD Early Career Scholar Program (M. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Barrett BS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002596; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; CHESEBRO B, 1979, P NATL ACAD SCI USA, V76, P425, DOI 10.1073/pnas.76.1.425; Dittmer U, 1998, J VIROL, V72, P6554, DOI 10.1128/JVI.72.8.6554-6558.1998; Dittmer U, 1999, J VIROL, V73, P3753, DOI 10.1128/JVI.73.5.3753-3757.1999; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10; EARL PL, 1986, SCIENCE, V234, P728, DOI 10.1126/science.3490689; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; FRIEND C, 1957, J EXP MED, V105, P307, DOI 10.1084/jem.105.4.307; Halemano K, 2013, IMMUNOL RES, V55, P249, DOI 10.1007/s12026-012-8370-y; HARTLEY JW, 1970, J VIROL, V5, P221, DOI 10.1128/JVI.5.2.221-225.1970; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; Hilditch L, 2011, P NATL ACAD SCI USA, V108, P5771, DOI 10.1073/pnas.1100118108; Jelacic TM, 2008, J VIROL, V82, P419, DOI 10.1128/JVI.01349-07; Jung YT, 2000, J VIROL, V74, P5385, DOI 10.1128/JVI.74.11.5385-5387.2000; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; Kozak CA, 1996, VIROLOGY, V225, P300, DOI 10.1006/viro.1996.0604; Langlois MA, 2009, J VIROL, V83, P11550, DOI 10.1128/JVI.01430-09; Li J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002478; Li K, 2000, VIRUS RES, V67, P153, DOI 10.1016/S0168-1702(00)00142-8; LILLY F, 1970, J NATL CANCER I, V45, P163; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Nishigaki K, 2005, P NATL ACAD SCI USA, V102, P15488, DOI 10.1073/pnas.0506570102; Okeoma CM, 2009, J VIROL, V83, P3029, DOI 10.1128/JVI.02536-08; OU CY, 1983, J VIROL, V48, P779, DOI 10.1128/JVI.48.3.779-784.1983; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; PINCUS T, 1971, J EXP MED, V133, P1234, DOI 10.1084/jem.133.6.1234; ROBERTSON MN, 1991, J VIROL METHODS, V34, P255, DOI 10.1016/0166-0934(91)90105-9; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; ROMMELAERE J, 1979, CELL, V16, P43, DOI 10.1016/0092-8674(79)90186-7; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Santiago ML, 2011, J VIROL, V85, P189, DOI 10.1128/JVI.01838-10; Santiago ML, 2010, J IMMUNOL, V185, P1114, DOI 10.4049/jimmunol.1001143; Sanville B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000974; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Smith DS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002284; Stevens A, 2004, J VIROL, V78, P9592, DOI 10.1128/JVI.78.18.9592-9598.2004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Tsuji-Kawahara S, 2010, J VIROL, V84, P6082, DOI 10.1128/JVI.02516-09; Yap MW, 2007, VIROLOGY, V365, P302, DOI 10.1016/j.virol.2007.04.005	49	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60500	10.1371/journal.pone.0060500	http://dx.doi.org/10.1371/journal.pone.0060500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533681	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400118
J	Kurita, R; Suda, N; Sudo, K; Miharada, K; Hiroyama, T; Miyoshi, H; Tani, K; Nakamura, Y				Kurita, Ryo; Suda, Noriko; Sudo, Kazuhiro; Miharada, Kenichi; Hiroyama, Takashi; Miyoshi, Hiroyuki; Tani, Kenzaburo; Nakamura, Yukio			Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HEMATOPOIETIC STEM; IN-VITRO; YOLK-SAC; TRANSFUSION; ERYTHROPOIESIS; EXPRESSION; ADULT; MEGAKARYOPOIESIS; ABSENCE	Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.	[Kurita, Ryo; Suda, Noriko; Sudo, Kazuhiro; Miharada, Kenichi; Hiroyama, Takashi; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Miyoshi, Hiroyuki] RIKEN BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki, Japan; [Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Mol & Clin Genet,Higashi Ku, Fukuoka 812, Japan	RIKEN; RIKEN; Kyushu University	Nakamura, Y (corresponding author), RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan.	yukionak@brc.riken.jp	Miharada, Kenichi/C-1397-2014; Miyoshi, Hiroyuki/G-9808-2013; Nakamura, Yukio/A-5263-2016	Miharada, Kenichi/0000-0001-8073-4001; Nakamura, Yukio/0000-0001-8056-4946	Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT); MEXT	Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the project for realization of regenerative medicine in the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) and other grants from the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee DJ, 2010, TRANSFUS CLIN BIOL, V17, P104, DOI 10.1016/j.tracli.2010.05.005; Douay L, 2009, CRIT CARE CLIN, V25, P383, DOI 10.1016/j.ccc.2008.12.008; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Fujioka T, 2010, HUM CELL, V23, P113, DOI 10.1111/j.1749-0774.2010.00091.x; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hiroyama T, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/195780; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kurita R, 2008, MOL CELL BIOCHEM, V319, P181, DOI 10.1007/s11010-008-9891-5; Kurita R, 2006, STEM CELLS, V24, P2014, DOI 10.1634/stemcells.2005-0499; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Migliaccio AR, 2009, CURR OPIN HEMATOL, V16, P259, DOI 10.1097/MOH.0b013e32832bcaa2; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sakai H, 2005, AM J PHYSIOL-HEART C, V288, pH2897, DOI 10.1152/ajpheart.01184.2004; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shirasawa T, 2003, J BIOL CHEM, V278, P5035, DOI 10.1074/jbc.M211110200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tober J, 2008, BLOOD, V111, P2636, DOI 10.1182/blood-2007-11-124685; Wong S, 2010, EXP HEMATOL, V38, pe1001; Wong SS, 2010, EXP HEMATOL, V38, P994, DOI 10.1016/j.exphem.2010.07.012; Yi ZH, 2006, PLOS GENET, V2, P129, DOI 10.1371/journal.pgen.0020014	29	223	242	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59890	10.1371/journal.pone.0059890	http://dx.doi.org/10.1371/journal.pone.0059890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533656	Green Published, gold			2022-12-27	WOS:000316549400093
J	Liu, JJ; Wang, YS; Du, WJ; Liu, WH; Liu, F; Zhang, LL; Zhang, MM; Hou, M; Liu, K; Zhang, S; Yu, B				Liu, Jingjin; Wang, Yongshun; Du, Wenjuan; Liu, Wenhua; Liu, Fang; Zhang, Lulu; Zhang, Maomao; Hou, Meng; Liu, Kai; Zhang, Shuo; Yu, Bo			Wnt1 Inhibits Hydrogen Peroxide-Induced Apoptosis in Mouse Cardiac Stem Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN; PROGENITOR CELLS; MECHANISMS; THERAPY; CLONING; ROLES; FATE	Background: Because of their regenerative and paracrine abilities, cardiac stem cells (CSCs) are the most appropriate, optimal and promising candidates for the development of cardiac regenerative medicine strategies. However, native and exogenous CSCs in ischemic hearts are exposed to various pro-apoptotic or cytotoxic factors preventing their regenerative and paracrine abilities. Methods and Results: We examined the effects of H2O2 on mouse CSCs (mCSCs), and observed that hydrogen peroxide (H2O2) treatment induces mCSCs apoptosis via the caspase 3 pathway, in a dose-dependent manner. We then examined the effects of Wnt1 over-expression on H2O2-induced apoptosis in mCSCs and observed that Wnt1 significantly decreased H2O2-induced apoptosis in mCSCs. On the other hand, inhibition of the canonical Wnt pathway by the secreted frizzled related protein 2 (SFRP2) or knockdown of beta-catenin in mCSCs reduced cells resistance to H2O2-induced apoptosis, suggesting that Wnt1 predominantly prevents H2O2-induced apoptosis through the canonical Wnt pathway. Conclusions: Our results provide the first evidences that Wnt1 plays an important role in CSCs' defenses against H2O2-induced apoptosis through the canonical Wnt1/GSK3 beta/beta-catenin signaling pathway.	[Liu, Jingjin; Wang, Yongshun; Du, Wenjuan; Liu, Wenhua; Liu, Fang; Zhang, Lulu; Zhang, Maomao; Hou, Meng; Liu, Kai; Zhang, Shuo; Yu, Bo] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 2, Harbin, Province Heilon, Peoples R China; [Liu, Jingjin; Wang, Yongshun; Du, Wenjuan; Liu, Fang; Zhang, Lulu; Zhang, Maomao; Hou, Meng; Liu, Kai; Zhang, Shuo; Yu, Bo] Educ Minist Myocardial Ischemia Mech & Treatment, Key Labs, Harbin, Province Heilon, Peoples R China; [Liu, Wenhua] Harbin Med Univ, Intens Care Unit ICU Dept, Affiliated Hosp 2, Harbin, Province Heilon, Peoples R China	Harbin Medical University; Harbin Medical University	Yu, B (corresponding author), Harbin Med Univ, Dept Cardiol, Affiliated Hosp 2, Harbin, Province Heilon, Peoples R China.	yubodr@163.com			National Natural Science Foundation of China [30871064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (to BY, Grant No. 30871064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deng L, 2009, CELL PROLIFERAT, V42, P721, DOI 10.1111/j.1365-2184.2009.00639.x; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Holly TA, 1999, J MOL CELL CARDIOL, V31, P1709, DOI 10.1006/jmcc.1999.1006; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang YC, 2009, STEM CELL REV REP, V5, P247, DOI 10.1007/s12015-009-9069-x; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Ladher RK, 2000, DEV BIOL, V218, P183, DOI 10.1006/dbio.1999.9586; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ming M, 2012, J BIOL CHEM, V287, P22683, DOI 10.1074/jbc.M112.342089; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Zhang ZY, 2009, J MOL CELL CARDIOL, V46, P370, DOI 10.1016/j.yjmcc.2008.11.016	39	15	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58883	10.1371/journal.pone.0058883	http://dx.doi.org/10.1371/journal.pone.0058883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533594	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400031
J	Bor, DH; Woolhandler, S; Nardin, R; Brusch, J; Himmelstein, DU				Bor, David H.; Woolhandler, Steffie; Nardin, Rachel; Brusch, John; Himmelstein, David U.			Infective Endocarditis in the US, 1998-2009: A Nationwide Study	PLOS ONE			English	Article							COMPLICATIONS; PREVENTION; DISEASE; STROKE	Background: Previous studies based on local case series estimated the annual incidence of endocarditis in the U. S. at about 4 per 100,000 population. Small-scale studies elsewhere have reported similar incidence rates. However, no nationally-representative population-based studies have verified these estimates. Methods and Findings: Using the 1998-2009 Nationwide Inpatient Sample, which provides diagnoses from about 8 million U. S. hospitalizations annually, we examined endocarditis hospitalizations, bacteriology, co-morbidities, outcomes and costs. Hospital admissions for endocarditis rose from 25,511 in 1998 to 38, 976 in 2009 (12.7 per 100,000 population in 2009). The age-adjusted endocarditis admission rate increased 2.4% annually. The proportion of patients with intra-cardiac devices rose from 13.3% to 18.9%, while the share with drug use and/or HIV fell. Mortality remained stable at about 14.5%, as did cardiac valve replacement (9.6%). Other serious complications increased; 13.3% of patients in 2009 suffered a stroke or CNS infection, and 5.5% suffered myocardial infarction. Amongst cases with identified pathogens, Staphylococcus aureus was the most common, increasing from 37.6% in 1998 to 49.3% in 2009, 53.3% of which were MRSA. Streptococci were mentioned in 24.7% of cases, gram-negatives in 5.6% and Candida species in 1.0%. We detected no inflection in hospitalization rates after changes in prophylaxis recommendations in 2007. Mean age rose from 58.6 to 60.8 years; elderly patients suffered higher rates of myocardial infarction and death, but slightly lower rates of Staphylococcus aureus infections and neurologic complications. Our study relied on clinically diagnosed cases of endocarditis that may not meet strict criteria. Moreover, since some patients are discharged and readmitted during a single episode of endocarditis, our hospitalization figures probably slightly overstate the true incidence of this illness. Conclusions: Endocarditis is more common in the U. S. than previously believed, and is steadily increasing. Preventive efforts should focus on device-associated and health-care-associated infections.	[Bor, David H.; Woolhandler, Steffie; Nardin, Rachel; Brusch, John; Himmelstein, David U.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Dept Med, Cambridge, MA 02138 USA; [Bor, David H.; Brusch, John] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Div Infect Dis, Cambridge, MA 02138 USA; [Woolhandler, Steffie; Himmelstein, David U.] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Nardin, Rachel] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Div Neurol, Cambridge, MA 02138 USA	Harvard University; Cambridge Health Alliance; Harvard University; Cambridge Health Alliance; City University of New York (CUNY) System; Harvard University; Cambridge Health Alliance	Himmelstein, DU (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10021 USA.	dhimmels@hunter.cuny.edu						Agency for Healthcare Research and Quality, 2009, HEALTHC COST UT PROJ; Amodeo MR, 2009, J INFECTION, V59, P387, DOI 10.1016/j.jinf.2009.09.009; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Bureau of the Census, TABL 1 ANN EST RES P; Bureau of the Census, RES POP EST US AG SE; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Cervera C, 2011, ENFERM INFEC MICR CL, V29, P587, DOI 10.1016/j.eimc.2011.05.007; CHERUBIN CE, 1971, AM J MED, V51, P83, DOI 10.1016/0002-9343(71)90326-3; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; GARVEY GJ, 1978, MEDICINE, V57, P105, DOI 10.1097/00005792-197803000-00001; Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dkl121; HART RG, 1990, STROKE, V21, P695, DOI 10.1161/01.STR.21.5.695; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; KANTER MC, 1991, NEUROLOGY, V41, P1015, DOI 10.1212/WNL.41.7.1015; LERNER PI, 1966, NEW ENGL J MED, V274, P388, DOI 10.1056/NEJM196602172740706; LERNER PI, 1966, NEW ENGL J MED, V274, P259, DOI 10.1056/NEJM196602032740506; Martinez-Selles M, 2008, MAYO CLIN PROC, V83, P1213, DOI 10.4065/83.11.1213; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Osler W, 1885, Br Med J, V1, P577; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; SALGADO AV, 1991, STROKE, V22, P1461, DOI 10.1161/01.STR.22.11.1461; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	26	207	213	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60033	10.1371/journal.pone.0060033	http://dx.doi.org/10.1371/journal.pone.0060033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527296	Green Published, gold			2022-12-27	WOS:000317562600113
J	Chen, SC; Su, HM; Tsai, YC; Huang, JC; Chang, JM; Hwang, SJ; Chen, HC				Chen, Szu-Chia; Su, Ho-Ming; Tsai, Yi-Chun; Huang, Jiun-Chi; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CORONARY-HEART-DISEASE; ANKLE BRACHIAL INDEX; LEFT ATRIAL VOLUME; EJECTION FRACTION; MORTALITY; ASSOCIATION; PREDICTION; EPIDEMIOLOGY; CREATININE	The Framingham Risk Score (FRS) was developed to predict coronary heart disease in various populations, and it tended to under-estimate the risk in chronic kidney disease (CKD) patients. Our objectives were to determine whether FRS was associated with cardiovascular events, and to evaluate the role of new risk markers and echocardiographic parameters when they were added to a FRS model. This study enrolled 439 CKD patients. The FRS is used to identify individuals categorically as "low" (<10% of 10-year risk), "intermediate" (10-20% risk) or "high" risk (>= 20% risk). A significant improvement in model prediction was based on the -2 log likelihood ratio statistic and c-statistic. "High" risk (v.s. "low" risk) predicts cardiovascular events either without (hazard ratios [HR] 2.090, 95% confidence interval [CI] 1.144 to 3.818) or with adjustment for clinical, biochemical and echocardiographic parameters (HR 1.924, 95% CI 1.008 to 3.673). Besides, the addition of albumin, hemoglobin, estimated glomerular filtration rate, proteinuria, left atrial diameter >4.7 cm, left ventricular hypertrophy or left ventricular ejection fraction <50% to the FRS model significantly improves the predictive values for cardiovascular events. In CKD patients, "high" risk categorized by FRS predicts cardiovascular events. Novel biomarkers and echocardiographic parameters provide additional predictive values for cardiovascular events. Future study is needed to assess whether risk assessment enhanced by using these biomarkers and echocardiographic parameters might contribute to more effective prediction and better care for patients.	[Chen, Szu-Chia; Tsai, Yi-Chun; Huang, Jiun-Chi; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Su, Ho-Ming; Huang, Jiun-Chi; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Su, Ho-Ming] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chang, JM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.	jemich@kmu.edu.tw	Huang, Jiun-Chi/AAI-2494-2021; 蘇, 河名/AAE-9843-2019	Huang, Jiun-Chi/0000-0002-5897-2860; Su, Ho-Ming/0000-0003-0247-3250	Kaohsiung Medical University Research Foundation [KMU-Q102020]	Kaohsiung Medical University Research Foundation	The research presented in this article is supported by a grant from the Kaohsiung Medical University Research Foundation (KMU-Q102020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SC, 2012, NEPHROL DIAL TRANSPL, V27, P1064, DOI 10.1093/ndt/gfr407; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; CINTRON G, 1993, CIRCULATION, V87, P17; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eckardt KU, 2009, J AM SOC NEPHROL, V20, P2651, DOI 10.1681/ASN.2009060631; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kim SJ, 2011, NEPHROL DIAL TRANSPL, V26, P3732, DOI 10.1093/ndt/gfr118; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mitchell GF, 2004, HYPERTENSION, V43, P151, DOI 10.1161/01.HYP.0000114581.77705.29; Olivero Juan Jorge, 2009, Methodist Debakey Cardiovasc J, V5, P24; Paoletti E, 2005, AM J KIDNEY DIS, V46, P320, DOI 10.1053/j.ajkd.2005.04.031; Ristow B, 2008, AM J CARDIOL, V102, P70, DOI 10.1016/j.amjcard.2008.02.099; Rodriguez-Iturbe B, 2010, EXPERT OPIN PHARMACO, V11, P2687, DOI 10.1517/14656561003796570; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Silaruks S, 2000, PERITON DIALYSIS INT, V20, P461; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Stewart GA, 2005, KIDNEY INT, V67, P17; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1460, DOI 10.1681/ASN.2005111240	36	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60008	10.1371/journal.pone.0060008	http://dx.doi.org/10.1371/journal.pone.0060008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527293	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600110
J	Yin, QQ; Pei, JJ; Xu, S; Luo, DZ; Dong, SQ; Sun, MH; You, L; Sun, ZJ; Liu, XP				Yin, Qing-Qing; Pei, Jin-Jing; Xu, Song; Luo, Ding-Zhen; Dong, Si-Qing; Sun, Meng-Han; You, Li; Sun, Zhi-Jian; Liu, Xue-Ping			Pioglitazone Improves Cognitive Function via Increasing Insulin Sensitivity and Strengthening Antioxidant Defense System in Fructose-Drinking Insulin Resistance Rats	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; INTRACEREBROVENTRICULAR STREPTOZOTOCIN; ACETYLCHOLINESTERASE ACTIVITY; LIPID-PEROXIDATION; MEMORY IMPAIRMENT; PPAR-GAMMA; BRAIN; MODEL	Insulin resistance (IR) links Alzheimer's disease (AD) with oxidative damage, cholinergic deficit, and cognitive impairment. Peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist pioglitazone previously used to treat type 2 diabetes mellitus (T2DM) has also been demonstrated to be effective in anti-inflammatory reaction and anti-oxidative stress in the animal models of AD and other neuroinflammatory diseases. Here, we investigated the effect of pioglitazone on learning and memory impairment and the molecular events that may cause it in fructose-drinking insulin resistance rats. We found that long-term fructose-drinking causes insulin resistance, oxidative stress, down-regulated activity of cholinergic system, and cognitive deficit, which could be ameliorated by pioglitazone administration. The results from the present study provide experimental evidence for using pioglitazone in the treatment of brain damage caused by insulin resistance.	[Yin, Qing-Qing; Luo, Ding-Zhen; Dong, Si-Qing; Sun, Meng-Han; Liu, Xue-Ping] Shandong Univ, Prov Hosp, Dept Senile Neurol, Jinan 250100, Shandong, Peoples R China; [Pei, Jin-Jing] Karolinska Inst, Dept KI Alzheimer Dis Res Ctr, Stockholm, Sweden; [Xu, Song; Sun, Zhi-Jian; Liu, Xue-Ping] Shandong Univ, Prov Hosp, Dept Antiageing, Jinan 250100, Shandong, Peoples R China; [You, Li] Shandong Univ, Dept Cent Lab, Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Karolinska Institutet; Shandong University; Shandong University	Liu, XP (corresponding author), Shandong Univ, Prov Hosp, Dept Senile Neurol, Jinan 250100, Shandong, Peoples R China.	lxp6133@yahoo.com.cn			Research Program to Tackle Key problems of Shandong Province, P. R. China [2006GGB14630, 532 2011YD18081]	Research Program to Tackle Key problems of Shandong Province, P. R. China	This study was supported by the fund from Research Program to Tackle Key problems of Shandong Province, P. R. China (2006GGB14630; 532 2011YD18081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baret G, 2002, EXP CLIN ENDOCR DIAB, V110, P298, DOI 10.1055/s-2002-34593; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Buege J A, 1978, Methods Enzymol, V52, P302; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Galipeau D, 2002, AM J PHYSIOL-HEART C, V283, pH2478, DOI 10.1152/ajpheart.00243.2002; Galipeau DM, 2002, AM J PHYSIOL-HEART C, V283, pH562, DOI 10.1152/ajpheart.00238.2002; Geldmacher DS, 2011, ARCH NEUROL-CHICAGO, V68, P45, DOI 10.1001/archneurol.2010.229; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Hong JH, 2009, CHEM-BIOL INTERACT, V179, P88, DOI 10.1016/j.cbi.2008.12.002; Iwai H, 2003, ENDOCR J, V50, P673, DOI 10.1507/endocrj.50.673; Jiang LY, 2012, CNS NEUROSCI THER, V18, P659, DOI 10.1111/j.1755-5949.2012.00341.x; Juan CC, 2001, BIOCHEM BIOPH RES CO, V289, P1328, DOI 10.1006/bbrc.2001.6132; Kalonia H, 2010, PHARMACOL BIOCHEM BE, V96, P115, DOI 10.1016/j.pbb.2010.04.018; Kaur B, 2009, FUND CLIN PHARMACOL, V23, P557, DOI 10.1111/j.1472-8206.2009.00708.x; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Kumar P, 2008, PHARMACOL REP, V60, P706; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liu XP, 2010, EUR J PHARMACOL, V629, P153, DOI 10.1016/j.ejphar.2009.11.059; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo DZ, 2011, EUR J PHARMACOL, V664, P14, DOI 10.1016/j.ejphar.2011.04.045; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Manschot SM, 2008, J NEUROL SCI, V264, P157, DOI 10.1016/j.jns.2007.08.011; Mehnert H, 1976, Int Z Vitam Ernahrungsforsch Beih, V15, P295; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Nicolakakis N, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00021; Ozbek E, 2010, INT UROL NEPHROL, V42, P579, DOI 10.1007/s11255-009-9645-7; Pathan AR, 2006, LIFE SCI, V79, P2209, DOI 10.1016/j.lfs.2006.07.018; Ramkumar KM, 2004, J MED FOOD, V7, P366, DOI 10.1089/1096620041938579; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Ross AP, 2012, PHYSIOL BEHAV, V106, P133, DOI 10.1016/j.physbeh.2012.01.008; Ross AP, 2009, NEUROBIOL LEARN MEM, V92, P410, DOI 10.1016/j.nlm.2009.05.007; Ruan CJ, 2009, NEUROSCI LETT, V467, P159, DOI 10.1016/j.neulet.2009.10.029; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Saraogi P, 2010, BIOMED PHARMACOTHER; Schmatz R, 2009, EUR J PHARMACOL, V610, P42, DOI 10.1016/j.ejphar.2009.03.032; Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5; Sharma M, 2001, PHARMACOL BIOCHEM BE, V70, P325, DOI 10.1016/S0091-3057(01)00611-6; Siqueira IR, 2005, LIFE SCI, V78, P271, DOI 10.1016/j.lfs.2005.04.044; Sood V, 2000, Diabetes Technol Ther, V2, P429, DOI 10.1089/15209150050194297; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Thirunavukkarasu V, 2004, DIABETES OBES METAB, V6, P200, DOI 10.1111/j.1462-8902.2004.00332.x; Tinahones FJ, 2009, OBESITY, V17, P240, DOI 10.1038/oby.2008.536; Ugochukwu NH, 2006, CLIN CHIM ACTA, V370, P165, DOI 10.1016/j.cca.2006.02.003; Vasudevan H, 2005, AM J PHYSIOL-HEART C, V289, pH1335, DOI 10.1152/ajpheart.00399.2005; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Xiang GQ, 2012, J PHARM PHARM; Xu JQ, 2009, EUR NEUROPSYCHOPHARM, V19, P851, DOI 10.1016/j.euroneuro.2009.07.006; Yang H., 1995, J CLIN ANAL, V13, P125; Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008	56	48	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59313	10.1371/journal.pone.0059313	http://dx.doi.org/10.1371/journal.pone.0059313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527159	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600069
J	Zhen, ZL; Fang, HZ; Liu, J				Zhen, Zonglei; Fang, Huizhen; Liu, Jia			The Hierarchical Brain Network for Face Recognition	PLOS ONE			English	Article							HUMAN NEURAL SYSTEM; PROCESSING NETWORK; FUSIFORM GYRUS; HUMAN AMYGDALA; PERCEPTION; AREA; FMRI; IDENTITY; CORTEX; REPRESENTATIONS	Numerous functional magnetic resonance imaging (fMRI) studies have identified multiple cortical regions that are involved in face processing in the human brain. However, few studies have characterized the face-processing network as a functioning whole. In this study, we used fMRI to identify face-selective regions in the entire brain and then explore the hierarchical structure of the face-processing network by analyzing functional connectivity among these regions. We identified twenty-five regions mainly in the occipital, temporal and frontal cortex that showed a reliable response selective to faces (versus objects) across participants and across scan sessions. Furthermore, these regions were clustered into three relatively independent sub-networks in a face-recognition task on the basis of the strength of functional connectivity among them. The functionality of the sub-networks likely corresponds to the recognition of individual identity, retrieval of semantic knowledge and representation of emotional information. Interestingly, when the task was switched to object recognition from face recognition, the functional connectivity between the inferior occipital gyrus and the rest of the face-selective regions were significantly reduced, suggesting that this region may serve as an entry node in the face-processing network. In sum, our study provides empirical evidence for cognitive and neural models of face recognition and helps elucidate the neural mechanisms underlying face recognition at the network level.	[Zhen, Zonglei; Fang, Huizhen; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Jia] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Liu, J (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Liu, Jia/0000-0003-0383-0934	National Natural Science Foundation of China [91132703, 31230031, 30800295, 31000507]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (91132703, 31230031, 30800295 and 31000507) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Berman MG, 2010, NEUROIMAGE, V50, P56, DOI 10.1016/j.neuroimage.2009.12.024; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calder AJ, 2007, CURR BIOL, V17, P20, DOI 10.1016/j.cub.2006.10.052; Duncan KJ, 2009, NEUROIMAGE, V46, P1018, DOI 10.1016/j.neuroimage.2009.03.014; Duncan KJK, 2011, NEUROIMAGE, V57, P1022, DOI 10.1016/j.neuroimage.2011.05.009; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Fox CJ, 2009, NEUROIMAGE, V44, P569, DOI 10.1016/j.neuroimage.2008.09.011; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gorno-Tempini ML, 2001, NEUROIMAGE, V14, P465, DOI 10.1006/nimg.2001.0811; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Harris A, 2008, J COGNITIVE NEUROSCI, V20, P863, DOI 10.1162/jocn.2008.20509; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Jiang F, 2011, J NEUROPHYSIOL, V106, P2720, DOI 10.1152/jn.00672.2010; Julian JB, 2012, NEUROIMAGE, V60, P2357, DOI 10.1016/j.neuroimage.2012.02.055; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaul C, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00238; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Nichols DF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00028; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Puce A, 1998, J NEUROSCI, V18, P2188; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Swallow KM, 2003, NEUROIMAGE, V20, P1561, DOI 10.1016/S1053-8119(03)00436-1; Tahmasebi AM, 2012, HUM BRAIN MAPP, V33, P938, DOI 10.1002/hbm.21261; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Zhang JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040390; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011	62	84	85	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59886	10.1371/journal.pone.0059886	http://dx.doi.org/10.1371/journal.pone.0059886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527282	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600103
J	Azbel, L; Wickersham, JA; Grishaev, Y; Dvoryak, S; Altice, FL				Azbel, Lyuba; Wickersham, Jeffrey A.; Grishaev, Yevgeny; Dvoryak, Sergey; Altice, Frederick L.			Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the Community	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PUBLIC-HEALTH; HEPATITIS-C; HIV; RISK; EPIDEMIOLOGY; HIV/AIDS; BUPRENORPHINE; POPULATIONS; PREVALENCE	Background: The epidemics of incarceration, substance use disorders (SUDs), and infectious diseases are inextricably intertwined, especially in the Former Soviet Union (FSU). Few objective data documenting this relationship regionally are available. We therefore conducted a comprehensive, representative country-wide prison health survey in Ukraine, where one of the world's most volatile HIV epidemics persists, in order to address HIV prevention and treatment needs. Methods: A nation-wide, multi-site randomly sampled biobehavioral health survey was conducted in four Ukrainian regions in 13 prisons among individuals being released within six months. After consent, participants underwent standardized health assessment surveys and serological testing for HIV, viral hepatitis, and syphilis. Results: Of the 402 participants (mean age = 31.9 years), 20.1% were female. Prevalence of HIV, HCV, HBV, and syphilis was 19.4% (95% CI = 15.5%-23.3%), 60.2% (95% CI = 55.1%-65.4%), 5.2% (95% CI = 3.3%-7.2%), and 10% (95% CI = 7.4%-13.2%), respectively, with regional differences observed; HIV prevalence in the south was 28.6%. Among the 78 HIV-infected inmates, 50.7% were unaware of their HIV status and 44 (56.4%) had CD4<350 cells/mL, of which only five (11%) antiretroviral-eligible inmates were receiving it. Nearly half of the participants (48.7%) reported pre-incarcertion drug injection, primarily of opioids, yet multiple substance use (31.6%) and alcohol use disorders (56.6%) were common and 40.3% met screening criteria for depression. Conclusions: This is the only such representative health study of prisoners in the FSU. This study has important implications for regional prevention and treatment because, unlike elsewhere, there is no recent evidence for reduction in HIV incidence and mortality in the region. The prevalence of infectious diseases and SUDs is high among this sample of prisoners transitioning to the community. It is critical to address pre- and post-release prevention and treatment needs with the development of linkage programs for the continuity of care in the community after release.	[Azbel, Lyuba; Grishaev, Yevgeny; Dvoryak, Sergey] Ukrainian Inst Publ Hlth Policy, Kiev, Ukraine; [Azbel, Lyuba; Wickersham, Jeffrey A.; Altice, Frederick L.] Yale Univ, Sch Med, Dept Internal Med, AIDS Program,Sect Infect Dis, New Haven, CT 06510 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA	Ukrainian Institute on Public Health Policy; Yale University; Yale University	Altice, FL (corresponding author), Yale Univ, Sch Med, Dept Internal Med, AIDS Program,Sect Infect Dis, New Haven, CT 06510 USA.	frederick.altice@yale.edu		dvoryak, sergii/0000-0002-0032-5417	National Institute on Drug Abuse [R01 DA029910, K24 DA017072]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA029910] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse for research (R01 DA029910, Altice, PI) and faculty development (K24 DA017072, Altice, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2012, DON MEM SOBL PRAV ZA; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Borisenko KK, 1999, INT J STD AIDS, V10, P665, DOI 10.1258/0956462991913240; Bruce RD, 2007, INT J DRUG POLICY, V18, P326, DOI 10.1016/j.drugpo.2006.12.011; DeBell D, 2005, BRIT MED J, V331, P216, DOI 10.1136/bmj.331.7510.216; Directorate-general of the Czech prison services, 2003, RES SER EX CZECH PRI; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Eaton WW, 2004, USE PSYCHOL TESTING, V3, P363; *EUROHIV, 2006, HIV AIDS SURV EUR EN; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Grinstead O, 2001, AIDS EDUC PREV, V13, P109, DOI 10.1521/aeap.13.2.109.19737; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; HIV AIDS Alliance in Ukraine, 2006, SOC IMP HIV AIDS UKR; Izenberg JM, 2010, ADDICTION, V105, P569, DOI 10.1111/j.1360-0443.2009.02881.x; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2006, RISK NEGL SEX WORK R, P105; Jurgens Ralf, 2009, HIV AIDS Policy Law Rev, V14, P84; Kelly JA, 2003, INT J STD AIDS, V14, P361, DOI 10.1258/095646203765371231; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Maru DSR, 2007, LANCET INFECT DIS, V7, P568, DOI 10.1016/S1473-3099(07)70190-1; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Springer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038335; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; State Penitentiary Service of Ukraine, 2011, STAT PEN SERV UKR ST; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Tichonova L, 1997, LANCET, V350, P210, DOI 10.1016/S0140-6736(97)01382-2; Tkeshelashvili-Kessler A, 2005, INT J STD AIDS, V16, P61, DOI 10.1258/0956462052932683; Tyrrell S, 2001, STRATIFIED SAMPLING; Ukrainian Institute on Public Health Policy, 2012, MONTHL OP SUBST THER; United Nations Development Programme (UNDP), 2011, VIL SNID TA PRAV LIU; UNODC, 2005, WORLD DRUG REPORT 20; UNODC UNAIDS World-Bank, 2007, HIV PRIS SUBS AFR OP; Uuskula A, 2010, SEX TRANSM INFECT, V86, P6, DOI 10.1136/sti.2009.037044; Vickerman P, 2010, ADDICTION, V105, P311, DOI 10.1111/j.1360-0443.2009.02759.x; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wolitski RJ, 2006, AM J PUBLIC HEALTH, V96, P1854, DOI 10.2105/AJPH.2004.056044; World Health Organization, 2009, RAP ADV ANT THER HIV	56	52	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59643	10.1371/journal.pone.0059643	http://dx.doi.org/10.1371/journal.pone.0059643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527238	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100153
J	Klink, B; Miletic, H; Stieber, D; Huszthy, PC; Valenzuela, JAC; Balss, J; Wang, J; Schubert, M; Sakariassen, PO; Sundstrom, T; Torsvik, A; Aarhus, M; Mahesparan, R; von Deimling, A; Kaderali, L; Niclou, SP; Schrock, E; Bjerkvig, R; Nigro, JM				Klink, Barbara; Miletic, Hrvoje; Stieber, Daniel; Huszthy, Peter C.; Valenzuela, Jaime Alberto Campos; Balss, Joerg; Wang, Jian; Schubert, Manja; Sakariassen, Per Oystein; Sundstrom, Terje; Torsvik, Anja; Aarhus, Mads; Mahesparan, Rupavathana; von Deimling, Andreas; Kaderali, Lars; Niclou, Simone P.; Schroeck, Evelin; Bjerkvig, Rolf; Nigro, Janice M.			A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1	PLOS ONE			English	Article							VASCULAR NICHE; CELLS; EXPRESSION; 2-HYDROXYGLUTARATE; GLIOMAS; SYSTEM; MOUSE	Oligodendroglioma poses a biological conundrum for malignant adult human gliomas: it is a tumor type that is universally incurable for patients, and yet, only a few of the human tumors have been established as cell populations in vitro or as intracranial xenografts in vivo. Their survival, thus, may emerge only within a specific environmental context. To determine the fate of human oligodendroglioma in an experimental model, we studied the development of an anaplastic tumor after intracranial implantation into enhanced green fluorescent protein (eGFP) positive NOD/SCID mice. Remarkably after nearly nine months, the tumor not only engrafted, but it also retained classic histological and genetic features of human oligodendroglioma, in particular cells with a clear cytoplasm, showing an infiltrative growth pattern, and harboring mutations of IDH1 (R132H) and of the tumor suppressor genes, FUBP1 and CIC. The xenografts were highly invasive, exhibiting a distinct migration and growth pattern around neurons, especially in the hippocampus, and following white matter tracts of the corpus callosum with tumor cells accumulating around established vasculature. Although tumors exhibited a high growth fraction in vivo, neither cells from the original patient tumor nor the xenograft exhibited significant growth in vitro over a six-month period. This glioma xenograft is the first to display a pure oligodendroglioma histology and expression of R132H. The unexpected property, that the cells fail to grow in vitro even after passage through the mouse, allows us to uniquely investigate the relationship of this oligodendroglioma with the in vivo microenvironment.	[Klink, Barbara; Schroeck, Evelin] Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Miletic, Hrvoje; Huszthy, Peter C.; Wang, Jian; Sakariassen, Per Oystein; Sundstrom, Terje; Torsvik, Anja; Bjerkvig, Rolf; Nigro, Janice M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Miletic, Hrvoje] Haukeland Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway; [Stieber, Daniel; Niclou, Simone P.; Bjerkvig, Rolf] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Huszthy, Peter C.] Univ Rijeka, Sch Med, Dept Histol & Embryol, Rijeka, Croatia; [Valenzuela, Jaime Alberto Campos; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometrie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Balss, Joerg; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Wang, Jian] Univ Bergen, Oncomatrix Res Lab, Dept Biomed, Jonas Bergen, Norway; [Schubert, Manja] Haukeland Hosp, Dept Clin Med, Neurol Sect, N-5021 Bergen, Norway; [Sundstrom, Terje; Mahesparan, Rupavathana] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Sundstrom, Terje] Univ Bergen, Dept Surg Sci, Bergen, Norway; [Aarhus, Mads] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health; University of Rijeka; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Ruprecht Karls University Heidelberg	Nigro, JM (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	janice.nigro@biomed.uib.no	Niclou, Simone/P-2304-2018; Schubert, Manja/AAJ-9575-2021; von Deimling, Andreas/F-7774-2013; Huszthy, Peter Csaba/H-1414-2016	Niclou, Simone/0000-0002-3417-9534; Schubert, Manja/0000-0003-3592-2470; von Deimling, Andreas/0000-0002-5863-540X; Huszthy, Peter Csaba/0000-0003-0184-8989; Sundstrom, Terje/0000-0002-6503-7141; Torsvik, Anja/0000-0001-8638-8357; Kaderali, Lars/0000-0002-2359-2294; Klink, Barbara/0000-0002-8753-8238	Norwegian Cancer Society [PK01-2009-0349]; Helse-Vest; Haukeland University Hospital; Fonds National Recherche, Luxembourg; Centre de Recherche Public de la Sante, Luxembourg	Norwegian Cancer Society(Norwegian Cancer Society); Helse-Vest; Haukeland University Hospital; Fonds National Recherche, Luxembourg; Centre de Recherche Public de la Sante, Luxembourg	JMN is supported by the Norwegian Cancer Society (PK01-2009-0349 to JMN). The study was further supported by Helse-Vest, the Haukeland University Hospital, Fonds National Recherche, Luxembourg, and the Centre de Recherche Public de la Sante, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Balss J, 2012, ACTA NEUROPATHOL; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Branle F, 2002, CANCER-AM CANCER SOC, V95, P641, DOI 10.1002/cncr.10710; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Calatozzolo C, 2006, CANCER BIOL THER, V5, P827, DOI 10.4161/cbt.5.7.2838; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Claes A, 2008, BRAIN PATHOL, V18, P423, DOI 10.1111/j.1750-3639.2008.00141.x; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Jiao Y, 2012, ONCOTARGET; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kelly JJP, 2010, NEURO-ONCOLOGY, V12, P745, DOI 10.1093/neuonc/noq031; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	46	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59773	10.1371/journal.pone.0059773	http://dx.doi.org/10.1371/journal.pone.0059773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527265	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100165
J	Marshall, A; Lukk, M; Kutter, C; Davies, S; Alexander, G; Odom, DT				Marshall, Aileen; Lukk, Margus; Kutter, Claudia; Davies, Susan; Alexander, Graeme; Odom, Duncan T.			Global Gene Expression Profiling Reveals SPINK1 as a Potential Hepatocellular Carcinoma Marker	PLOS ONE			English	Article							TRYPSIN-INHIBITOR TATI; PRIMARY BILIARY-CIRRHOSIS; RISK-FACTORS; PLASMA OSTEOPONTIN; PROGNOSTIC-FACTOR; CANCER-RISK; HEREDITARY HEMOCHROMATOSIS; AUTOIMMUNE HEPATITIS; EARLY RECURRENCE; LIVER-CANCER	Background: Liver cirrhosis is the most important risk factor for hepatocellular carcinoma (HCC) but the role of liver disease aetiology in cancer development remains under-explored. We investigated global gene expression profiles from HCC arising in different liver diseases to test whether HCC development is driven by expression of common or different genes, which could provide new diagnostic markers or therapeutic targets. Methodology and Principal Findings: Global gene expression profiling was performed for 4 normal (control) livers as well as 8 background liver and 7 HCC from 3 patients with hereditary haemochromatosis (HH) undergoing surgery. In order to investigate different disease phenotypes causing HCC, the data were compared with public microarray repositories for gene expression in normal liver, hepatitis C virus (HCV) cirrhosis, HCV-related HCC (HCV-HCC), hepatitis B virus (HBV) cirrhosis and HBV-related HCC (HBV-HCC). Principal component analysis and differential gene expression analysis were carried out using R Bioconductor. Liver disease-specific and shared gene lists were created and genes identified as highly expressed in hereditary haemochromatosis HCC (HH-HCC) were validated using quantitative RT-PCR. Selected genes were investigated further using immunohistochemistry in 86 HCC arising in liver disorders with varied aetiology. Using a 2-fold cut-off, 9 genes were highly expressed in all HCC, 11 in HH-HCC, 270 in HBV-HCC and 9 in HCV-HCC. Six genes identified by microarray as highly expressed in HH-HCC were confirmed by RT qPCR. Serine peptidase inhibitor, Kazal type 1 (SPINK1) mRNA was very highly expressed in HH-HCC (median fold change 2291, p = 0.0072) and was detected by immunohistochemistry in 91% of HH-HCC, 0% of HH-related cirrhotic or dysplastic nodules and 79% of mixed-aetiology HCC. Conclusion: HCC, arising from diverse backgrounds, uniformly over-express a small set of genes. SPINK1, a secretory trypsin inhibitor, demonstrated potential as a diagnostic HCC marker and should be evaluated in future studies.	[Marshall, Aileen; Lukk, Margus; Kutter, Claudia; Odom, Duncan T.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Marshall, Aileen; Davies, Susan] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Alexander, Graeme] Addenbrookes Hosp, Cambridge Hepatobiliary Unit, Cambridge, England; [Odom, Duncan T.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Marshall, A (corresponding author), Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England.	aileen.marshall@cruk.cam.ac.uk; duncan.odom@cruk.cam.ac.uk	Kutter, Claudia/HHD-1391-2022	Odom, Duncan/0000-0001-6201-5599; Lukk, Margus/0000-0002-0701-5358; Kutter, Claudia/0000-0002-8047-0058	European Research Council; EMBO Young Investigator Program; Cancer Research UK; University of Cambridge; Swiss National Science Foundation; Cambridge Biomedical Campus; Cancer Research UK [15603] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cambridge Biomedical Campus; Cancer Research UK(Cancer Research UK)	The authors receive support from the European Research Council, EMBO Young Investigator Program, (D.T.O.), Cancer Research UK (M. L., C. K.), University of Cambridge (C. K., D.T.O.), Swiss National Science Foundation (C. K.), and the Cambridge Biomedical Campus (A. M.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El Makarem MA, 2011, ANN HEPATOL, V10, P296, DOI 10.1016/S1665-2681(19)31541-8; Alexa A., 2019, TOPGO ENRICHMENT ANA; Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8; Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessa SSE, 2010, ARCH MED RES, V41, P541, DOI 10.1016/j.arcmed.2010.10.007; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Caballeria L, 2001, AM J GASTROENTEROL, V96, P1160; Cavazza A, 2009, HEPATOLOGY, V50, P1162, DOI 10.1002/hep.23095; Dhani NC, 2012, BJU INT, V110, P840, DOI 10.1111/j.1464-410X.2011.10922.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Elmberg M, 2003, GASTROENTEROLOGY, V125, P1733, DOI 10.1053/j.gastro.2003.09.035; Flecken T, 2012, LANGENBECK ARCH SURG, V397, P673, DOI 10.1007/s00423-011-0783-x; Fracanzani AL, 2001, HEPATOLOGY, V33, P647, DOI 10.1053/jhep.2001.22506; Furuse J, 2008, CRIT REV ONCOL HEMAT, V67, P8, DOI 10.1016/j.critrevonc.2008.02.009; Gaber A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-498; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hedstrom J, 2001, SCAND J CLIN LAB INV, V61, P111; HSING AW, 1995, INT J CANCER, V60, P160, DOI 10.1002/ijc.2910600204; HUHTALA ML, 1982, J BIOL CHEM, V257, P13713; Janeiro E, 2012, CLIN CHIM ACTA, V413, P1244, DOI 10.1016/j.cca.2012.04.001; Jhavar S, 2009, BJU INT, V103, P1256, DOI 10.1111/j.1464-410X.2008.08200.x; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Kelloniemi E, 2003, UROLOGY, V62, P249, DOI 10.1016/S0090-4295(03)00329-7; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lamontagne J, 2010, J VIROL, V84, P907, DOI 10.1128/JVI.01249-09; Lee YC, 2007, EUR J CANCER, V43, P736, DOI 10.1016/j.ejca.2006.11.020; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Lukkonen A, 1999, INT J CANCER, V83, P486, DOI 10.1002/(SICI)1097-0215(19991112)83:4<486::AID-IJC9>3.0.CO;2-O; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; OHMACHI Y, 1993, INT J CANCER, V55, P728, DOI 10.1002/ijc.2910550505; Ozkan H, 2011, J CLIN LAB ANAL, V25, P350, DOI 10.1002/jcla.20484; Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852; Paju A, 2001, J UROLOGY, V165, P959, DOI 10.1016/S0022-5347(05)66584-6; Paju A, 2007, EUR UROL, V52, P1670, DOI 10.1016/j.eururo.2007.01.096; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pasanen PA, 1995, ANTICANCER RES, V15, P2731; Qiao SS, 2011, HEPATO-GASTROENTEROL, V58, P1718, DOI 10.5754/hge11124; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Solakidi S, 2004, CLIN BIOCHEM, V37, P56, DOI 10.1016/j.clinbiochem.2003.09.002; Solakidi S, 2003, HISTOL HISTOPATHOL, V18, P1181, DOI 10.14670/HH-18.1181; Soon WW, 2011, EMBO MOL MED, V3, P451, DOI 10.1002/emmm.201100150; STENMAN UH, 1982, INT J CANCER, V30, P53, DOI 10.1002/ijc.2910300110; Stenman UH, 2011, CLIN CHEM, V57, P1474, DOI 10.1373/clinchem.2011.168476; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Stickel F, 2010, GUT, V59, P1303, DOI 10.1136/gut.2009.199661; Teufel A, 2009, WORLD J GASTROENTERO, V15, P578, DOI 10.3748/wjg.15.578; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tonouchi A, 2006, AM J GASTROENTEROL, V101, P1601, DOI 10.1111/j.1572-0241.2006.00612.x; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wiksten JP, 2005, HISTOPATHOLOGY, V46, P380, DOI 10.1111/j.1365-2559.2005.02073.x; Wong RJ, 2011, DIGEST DIS SCI, V56, P578, DOI 10.1007/s10620-010-1444-6; World Heath Organisation Website, 2008, GLOBOCAN 2008 IARC S; Yang HI, 2010, J CLIN ONCOL, V28, P2437, DOI 10.1200/JCO.2009.27.4456; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yasuda E, 2010, HEPATOL RES, V40, P477, DOI 10.1111/j.1872-034X.2010.00624.x; YASUDA T, 1993, GENE, V131, P275; Yeoman AD, 2008, HEPATOLOGY, V48, P863, DOI 10.1002/hep.22432; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023	67	54	58	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59459	10.1371/journal.pone.0059459	http://dx.doi.org/10.1371/journal.pone.0059459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527199	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600058
J	DasSarma, S; Capes, MD; Karan, R; DasSarma, P				DasSarma, Shiladitya; Capes, Melinda D.; Karan, Ram; DasSarma, Priya			Amino Acid Substitutions in Cold-Adapted Proteins from Halorubrum lacusprofundi, an Extremely Halophilic Microbe from Antarctica	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BETA-GALACTOSIDASE; COLWELLIA-PSYCHRERYTHRAEA; ADAPTATION; BACTERIUM; WATER; LIFE; STABILITY; ENZYMES; MODEL	The halophilic Archaeon Halorubrum lacusprofundi, isolated from the perennially cold and hypersaline Deep Lake in Antarctica, was recently sequenced and compared to 12 Haloarchaea from temperate climates by comparative genomics. Amino acid substitutions for 604 H. lacusprofundi proteins belonging to conserved haloarchaeal orthologous groups (cHOGs) were determined and found to occur at 7.85% of positions invariant in proteins from mesophilic Haloarchaea. The following substitutions were observed most frequently: (a) glutamic acid with aspartic acid or alanine; (b) small polar residues with other small polar or non-polar amino acids; (c) small non-polar residues with other small non-polar residues; (d) aromatic residues, especially tryptophan, with other aromatic residues; and (e) some larger polar residues with other similar residues. Amino acid substitutions for a cold-active H. lacusprofundi beta-galactosidase were then examined in the context of a homology modeled structure at residues invariant in homologous enzymes from mesophilic Haloarchaea. Similar substitutions were observed as in the genome-wide approach, with the surface accessible regions of beta-galactosidase displaying reduced acidity and increased hydrophobicity, and internal regions displaying mainly subtle changes among smaller non-polar and polar residues. These findings are consistent with H. lacusprofundi proteins displaying amino acid substitutions that increase structural flexibility and protein function at low temperature. We discuss the likely mechanisms of protein adaptation to a cold, hypersaline environment on Earth, with possible relevance to life elsewhere.	[DasSarma, Shiladitya] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Univ Maryland, Inst Marine & Environm Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	DasSarma, S (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	sdassarma@som.umaryland.edu		Karan, Ram/0000-0003-3867-7482; DasSarma, Shiladitya/0000-0003-4162-2810	National Aeronautics and Space Administration [396 NNX10AP47G]; ASM International Fellowship for Asia	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); ASM International Fellowship for Asia	This work was supported by the National Aeronautics and Space Administration grant 396 NNX10AP47G. RK was partially supported by an ASM International Fellowship for Asia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermark B, 2008, ACTA CRYSTALLOGR D, V64, P368, DOI 10.1107/S0907444908000097; Anderson I, 2012, STAND GENOMIC SCI, V6, P31, DOI 10.4056/sigs.2505605; Anderson I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020237; Ayala-del-Rio HL, 2010, APPL ENVIRON MICROB, V76, P2304, DOI 10.1128/AEM.02101-09; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bergqvist S, 2003, BIOCHEM SOC T, V31, P677, DOI 10.1042/bst0310677; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bowman JP, 2000, FEMS MICROBIOL LETT, V183, P81; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; Capes MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-39; Capes MD, 2011, PLASMID, V65, P77, DOI 10.1016/j.plasmid.2010.11.005; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021; DasSarma S., 2006, MICROBE, V1, P120, DOI 10.1128/microbe.1.120.1; DasSarma S, 2008, MICROBIAL MEGAPLASMI, P3; Dassarma Satyajit L, 2010, Saline Syst, V6, P12, DOI 10.1186/1746-1448-6-12; de Vendittis E, 2008, J THEOR BIOL, V250, P156, DOI 10.1016/j.jtbi.2007.09.006; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; FRANZMANN PD, 1988, SYST APPL MICROBIOL, V11, P20, DOI 10.1016/S0723-2020(88)80044-4; Giaquinto L, 2007, J BACTERIOL, V189, P5738, DOI 10.1128/JB.00395-07; Grzymski JJ, 2006, APPL ENVIRON MICROB, V72, P1532, DOI 10.1128/AEM.72.2.1532-1541.2006; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Karan R, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-3; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Kaufman M, 2012, MARS ROVER FINDS ANC; Khurana KK, 2002, ASTROBIOLOGY, V2, P93, DOI 10.1089/153110702753621376; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; Marion GM, 2003, ASTROBIOLOGY, V3, P785, DOI 10.1089/153110703322736105; McEwen AS, 2011, SCIENCE, V333, P740, DOI 10.1126/science.1204816; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Metpally RPR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-11; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Murray AE, 2012, P NATL ACAD SCI USA, V109, P20626, DOI 10.1073/pnas.1208607109; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Reid IN, 2006, INT J ASTROBIOL, V5, P89, DOI 10.1017/S1473550406002916; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Roh SW, 2010, J BACTERIOL, V192, P4528, DOI 10.1128/JB.00663-10; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Saelensminde G, 2009, EXTREMOPHILES, V13, P11, DOI 10.1007/s00792-008-0192-4; Sato Y, 2008, EXTREMOPHILES, V12, P107, DOI 10.1007/s00792-007-0115-9; Saunders E, 2010, STAND GENOMIC SCI, V2, P107, DOI 10.4056/sigs.681272; SEREDA TJ, 1994, J CHROMATOGR A, V676, P139, DOI 10.1016/0021-9673(94)00371-8; Shumway Matthew V, 2012, Int J Biochem Mol Biol, V3, P209; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-165; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Srimathi S, 2007, EXTREMOPHILES, V11, P505, DOI 10.1007/s00792-007-0062-5; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831	66	44	46	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58587	10.1371/journal.pone.0058587	http://dx.doi.org/10.1371/journal.pone.0058587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536799	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100066
J	Palud, A; Marciniak, C; Montaigne, D; Marechal, X; Ballot, C; Hassoun, SM; Decoster, B; Neviere, R; Lancel, S				Palud, Aurore; Marciniak, Camille; Montaigne, David; Marechal, Xavier; Ballot, Caroline; Hassoun, Sidi Mohamed; Decoster, Brigitte; Neviere, Remi; Lancel, Steve			Macrophage Migration Inhibitory Factor Inhibition Is Deleterious for High-Fat Diet-Induced Cardiac Dysfunction	PLOS ONE			English	Article							TAUTOMERASE ACTIVE-SITE; AUGSBURG CASE-COHORT; METABOLIC SYNDROME; FACTOR MIF; MYOCARDIAL DYSFUNCTION; INSULIN-RESISTANCE; MITOCHONDRIAL; DISEASE; TARGET; CELLS	Aims: Development of metabolic syndrome is associated with impaired cardiac performance, mitochondrial dysfunction and pro-inflammatory cytokine increase, such as the macrophage migration inhibitory factor MIF. Depending on conditions, MIF may exert both beneficial and deleterious effects on the myocardium. Therefore, we tested whether pharmacological inhibition of MIF prevented or worsened metabolic syndrome-induced myocardial dysfunction. Methods and Results: C57BL/6J mice were fed for ten weeks with 60% fat-enriched diet (HFD) or normal diet (ND). MIF inhibition was obtained by injecting mice twice a week with ISO-1, for three consecutive weeks. Then, triglycerides, cholesterol, fat mass, glucose intolerance, insulin resistance, ex vivo cardiac contractility, animal energetic substrate utilization assessed by indirect calorimetry and mitochondrial respiration and biogenesis were evaluated. HFD led to fat mass increase, dyslipidemia, glucose intolerance and insulin resistance. ISO-1 did not alter these parameters. However, MIF inhibition was responsible for HFD-induced cardiac dysfunction worsening. Mouse capacity to increase oxygen consumption in response to exercise was reduced in HFD compared to ND, and further diminished in ISO-1-treated HFD group. Mitochondrial respiration was reduced in HFD mice, treated or not with ISO-1. Compared to ND, mitochondrial biogenesis signaling was upregulated in the HFD as demonstrated by mitochondrial DNA amount and PGC-1 alpha expression. However, this increase in biogenesis was blocked by ISO-1 treatment. Conclusion: MIF inhibition achieved by ISO-1 was responsible for a reduction in HFD-induced mitochondrial biogenesis signaling that could explain majored cardiac dysfunction observed in HFD mice treated with MIF inhibitor.	[Palud, Aurore; Marciniak, Camille; Montaigne, David; Marechal, Xavier; Ballot, Caroline; Hassoun, Sidi Mohamed; Decoster, Brigitte; Neviere, Remi; Lancel, Steve] Univ Lille 2, Dept Physiol, EA4484, Lille, France	Universite de Lille - ISITE; Universite de Lille	Lancel, S (corresponding author), Univ Lille 2, Dept Physiol, EA4484, Lille, France.	steve.lancel@univ-lille2.fr	, Lancel/H-9047-2019; Montaigne, David/R-6066-2018; Marechal, Xavier/R-5762-2018	, Lancel/0000-0002-3292-5433; Montaigne, David/0000-0002-2346-863X; Marechal, Xavier/0000-0001-6399-7811; Neviere, Remi/0000-0002-7966-0110	Universite Lille 2 - Ministere del'Enseignement Superieur et de la Recherche [EA4484]; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais [08480265]; Fondation de France [2009002501]; Fondation Coeur et Arteres [FCA09T6]	Universite Lille 2 - Ministere del'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais(Region Hauts-de-France); Fondation de France(Fondation de France); Fondation Coeur et Arteres	This work was supported by EA4484 - Universite Lille 2 - Ministere del'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais 08480265; Fondation de France 2009002501 and Fondation Coeur et Arteres FCA09T6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Balkau B, 2002, DIABETES METAB, V28, P364; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; BUCALA R, 1994, IMMUNOL LETT, V43, P23, DOI 10.1016/0165-2478(94)00152-9; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hassoun SM, 2008, CRIT CARE MED, V36, P2590, DOI 10.1097/CCM.0b013e3181844276; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; HUE L, 1982, J BIOL CHEM, V257, P4308; Kim HR, 2011, HORM METAB RES, V43, P642, DOI 10.1055/s-0031-1283150; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lancel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041836; Longo KA, 2010, AM J PHYSIOL-REG I, V298, pR747, DOI 10.1152/ajpregu.00476.2009; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Makino A, 2010, ATHEROSCLEROSIS, V213, P573, DOI 10.1016/j.atherosclerosis.2010.09.004; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Rao F, 2009, J MOL CELL CARDIOL, V47, P586, DOI 10.1016/j.yjmcc.2009.08.030; Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Saksida T, 2012, IMMUNOL CELL BIOL, V90, P688, DOI 10.1038/icb.2011.89; Sanchez-Zamora Y, 2010, FASEB J, V24, P2583, DOI 10.1096/fj.09-147066; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Steele JCP, 2002, J ANTIMICROB CHEMOTH, V50, P25, DOI 10.1093/jac/dkf089; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Tong C, 2010, J DIABETES, V2, P267, DOI 10.1111/j.1753-0407.2010.00088.x; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhao XY, 2006, J PHYSIOL BIOCHEM, V62, P1, DOI 10.1007/BF03165800	43	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58718	10.1371/journal.pone.0058718	http://dx.doi.org/10.1371/journal.pone.0058718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536817	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100084
J	Janouskovec, J; Liu, SL; Martone, PT; Carre, W; Leblanc, C; Collen, J; Keeling, PJ				Janouskovec, Jan; Liu, Shao-Lun; Martone, Patrick T.; Carre, Wilfrid; Leblanc, Catherine; Collen, Jonas; Keeling, Patrick J.			Evolution of Red Algal Plastid Genomes: Ancient Architectures, Introns, Horizontal Gene Transfer, and Taxonomic Utility of Plastid Markers	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MITOCHONDRIAL COX1; RHODELLA-VIOLACEA; DNA; RHODOPHYTA; PHYCOERYTHRIN; BIODIVERSITY; ARTEMIS; ORIGIN; RBCL	Red algae have the most gene-rich plastid genomes known, but despite their evolutionary importance these genomes remain poorly sampled. Here we characterize three complete and one partial plastid genome from a diverse range of florideophytes. By unifying annotations across all available red algal plastid genomes we show they all share a highly compact and slowly-evolving architecture and uniquely rich gene complements. Both chromosome structure and gene content have changed very little during red algal diversification, and suggest that plastid-to nucleus gene transfers have been rare. Despite their ancient character, however, the red algal plastids also contain several unprecedented features, including a group II intron in a tRNA-Met gene that encodes the first example of red algal plastid intron maturase - a feature uniquely shared among florideophytes. We also identify a rare case of a horizontally-acquired proteobacterial operon, and propose this operon may have been recruited for plastid function and potentially replaced a nucleus-encoded plastid-targeted paralogue. Plastid genome phylogenies yield a fully resolved tree and suggest that plastid DNA is a useful tool for resolving red algal relationships. Lastly, we estimate the evolutionary rates among more than 200 plastid genes, and assess their usefulness for species and subspecies taxonomy by comparison to well-established barcoding markers such as cox1 and rbcL. Overall, these data demonstrates that red algal plastid genomes are easily obtainable using high-throughput sequencing of total genomic DNA, interesting from evolutionary perspectives, and promising in resolving red algal relationships at evolutionarily-deep and species/subspecies levels.	[Janouskovec, Jan; Martone, Patrick T.; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Liu, Shao-Lun] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Carre, Wilfrid; Leblanc, Catherine; Collen, Jonas] Univ Paris 06, Biol Stn, Roscoff, France; [Carre, Wilfrid] CNRS, Biol Stn, ABiMS, FR2424, Roscoff, France; [Leblanc, Catherine; Collen, Jonas] CNRS, Biol Stn, UMR Marine Plants & Biomol 7139, Roscoff, France	University of British Columbia; Tunghai University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Janouskovec, J (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	janjan.cz@gmail.com	Janouškovec, Jan/ABA-2568-2021	Janouškovec, Jan/0000-0001-6547-749X; Keeling, Patrick/0000-0002-7644-0745	Canadian Institutes for Health Research [MOP-42517]; Taiwan NSC [NSC-101-2621-B-029-004]; Natural Science and Engineering Research Council; Genoscope	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Taiwan NSC(Ministry of Science and Technology, Taiwan); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genoscope	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-42517) to PJK. PJK is a Fellow of the Canadian Institute for Advanced Research. SLL was supported by a Taiwan NSC grant (NSC-101-2621-B-029-004). PTM acknowledges funding provided by the Natural Science and Engineering Research Council. WC, CL and JC would like to thank Genoscope for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD C, 1992, P NATL ACAD SCI USA, V89, P9564, DOI 10.1073/pnas.89.20.9564; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Ciniglia C, 2004, MOL ECOL, V13, P1827, DOI 10.1111/j.1365-294X.2004.02180.x; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Couceiro L, 2011, J PHYCOL, V47, P1258, DOI 10.1111/j.1529-8817.2011.01075.x; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; DESTOMBE C, 1991, CURR GENET, V19, P395, DOI 10.1007/BF00309601; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freshwater DW, 2010, CRYPTOGAMIE ALGOL, V31, P435; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Glockner G, 2000, J MOL EVOL, V51, P382; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hughey JR, 2001, J PHYCOL, V37, P1091, DOI 10.1046/j.1529-8817.2001.01048.x; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lindstrom SC, 2011, PHYCOLOGIA, V50, P661, DOI 10.2216/10-38.1; MANHART JR, 1990, NATURE, V345, P268, DOI 10.1038/345268a0; Martone PT, 2012, J PHYCOL, V48, P859, DOI 10.1111/j.1529-8817.2012.01190.x; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Monde RA, 2000, MOL GEN GENET, V263, P610, DOI 10.1007/s004380051208; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1997, J MOL EVOL, V45, P688, DOI 10.1007/PL00006273; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Richaud C, 1997, P NATL ACAD SCI USA, V94, P11736, DOI 10.1073/pnas.94.21.11736; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saunders GW, 2008, BOTANY, V86, P773, DOI 10.1139/B08-001; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Smith DR, 2012, MOL PHYLOGENET EVOL, V65, P339, DOI 10.1016/j.ympev.2012.06.017; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; Thomas JC, 1999, J BIOL CHEM, V274, P2472, DOI 10.1074/jbc.274.4.2472; Turmel M, 2006, MOL BIOL EVOL, V23, P1324, DOI 10.1093/molbev/msk018; Verbruggen H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-16; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Yang EC, 2006, MOL ECOL NOTES, V6, P533, DOI 10.1111/j.1471-8286.2005.01216.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2006, J PHYCOL, V42, P482, DOI 10.1111/j.1529-8817.2006.00210.x; Yusuf D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-432	56	91	92	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59001	10.1371/journal.pone.0059001	http://dx.doi.org/10.1371/journal.pone.0059001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536846	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200013
J	Tsai, HE; Wu, JC; Kung, ML; Liu, LF; Kuo, LH; Kuo, HM; Chen, SC; Chan, EC; Wu, CS; Tai, MH; Liu, GS				Tsai, Han-En; Wu, Jian-Ching; Kung, Mei-Lang; Liu, Li-Feng; Kuo, Lai-Hsin; Kuo, Hsiao-Mei; Chen, San-Cher; Chan, Elsa C.; Wu, Chieh-Shan; Tai, Ming-Hong; Liu, Guei-Sheung			Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC-FACTOR; DOWN-REGULATION; CANCER CELLS; EXPRESSION; METASTASIS; ACTIVATION; CARCINOMA; PATHWAY; ANGIOGENESIS	Cutaneous malignant melanoma is the fastest increasing malignancy in humans. Hepatoma-derived growth factor (HDGF) is a novel growth factor identified from human hepatoma cell line. HDGF overexpression is correlated with poor prognosis in various types of cancer including melanoma. However, the underlying mechanism of HDGF overexpression in developing melanoma remains unclear. In this study, human melanoma cell lines (A375, A2058, MEL-RM and MM200) showed higher levels of HDGF gene expression, whereas human epidermal melanocytes (HEMn) expressed less. Exogenous application of HDGF stimulated colony formation and invasion of human melanoma cells. Moreover, HDGF overexpression stimulated the degree of invasion and colony formation of B16-F10 melanoma cells whereas HDGF knockdown exerted opposite effects in vitro. To evaluate the effects of HDGF on tumour growth and metastasis in vivo, syngeneic mouse melanoma and metastatic melanoma models were performed by manipulating the gene expression of HDGF in melanoma cells. It was found that mice injected with HDGF-overexpressing melanoma cells had greater tumour growth and higher metastatic capability. In contrast, mice implanted with HDGF-depleted melanoma cells exhibited reduced tumor burden and lung metastasis. Histological analysis of excised tumors revealed higher degree of cell proliferation and neovascularization in HDGF-overexpressing melanoma. The present study provides evidence that HDGF promotes tumor progression of melanoma and targeting HDGF may constitute a novel strategy for the treatment of melanoma.	[Tsai, Han-En; Kuo, Lai-Hsin; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wu, Jian-Ching; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Kung, Mei-Lang] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Kung, Mei-Lang] Natl Sun Yat Sen Univ, Ctr Nanosci & Nanotechnol, Kaohsiung 80424, Taiwan; [Liu, Li-Feng] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Kuo, Hsiao-Mei] Chang Gung Univ, Coll Med, Dept Internal Med, Chang Gung Mem Hosp,Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Chen, San-Cher; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung 80424, Taiwan; [Wu, Chieh-Shan] Kaohsiung Vet Gen Hosp, Div Dermatol, Kaohsiung, Taiwan; [Chan, Elsa C.; Liu, Guei-Sheung] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3010, Australia; [Liu, Guei-Sheung] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic 3010, Australia	National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Centre for Eye Research Australia; University of Melbourne; University of Melbourne	Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.	minghongtai@gmail.com; guei-sheung.liu@unimelb.edu.au	Liu, Guei-Sheung/Q-6472-2018	Liu, Guei-Sheung/0000-0003-3379-724X	National Science Council, Taiwan [NSC 100-2325-B-110-002-MY3, NSC-99-2321-B-110-005]; Kaohsiung Veterans General Hospital, Taiwan [VGHKS-99-036]; University of Melbourne	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital, Taiwan; University of Melbourne(University of Melbourne)	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2325-B-110-002-MY3 and NSC-99-2321-B-110-005); Kaohsiung Veterans General Hospital, Taiwan (VGHKS-99-036); Early Career Researcher grant (from University of Melbourne for G. S. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard K, 2003, CANCER RES, V63, P6716; Bonitsis N., 2006, Experimental Oncology, V28, P187; Chang KC, 2007, INT J CANCER, V121, P1059, DOI 10.1002/ijc.22803; Chen SC, 2012, J PATHOL, V228, P158, DOI 10.1002/path.3988; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Everett AD, 2004, AM J PHYSIOL-LUNG C, V286, pL1194, DOI 10.1152/ajplung.00427.2003; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Guo RR, 2008, BIOL PHARM BULL, V31, P696, DOI 10.1248/bpb.31.696; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; KLAGSBRUN M, 1986, P NATL ACAD SCI USA, V83, P2448, DOI 10.1073/pnas.83.8.2448; Kung ML, 2012, BIOCHEM BIOPH RES CO, V425, P169, DOI 10.1016/j.bbrc.2012.07.060; Lee KH, 2010, ONCOL RES, V19, P67, DOI 10.3727/096504010X12864748215043; Liu GS, 2006, MOL PHARMACOL, V69, P440, DOI 10.1124/mol.105.015404; Liu GS, 2012, FREE RADICAL BIO MED, V52, P1835, DOI 10.1016/j.freeradbiomed.2012.02.040; Mahabeleshwar GH, 2007, SEMIN ONCOL, V34, P555, DOI 10.1053/j.seminoncol.2007.09.009; Mikesh LM, 2010, MELANOMA RES, V20, P485, DOI 10.1097/CMR.0b013e32833fafb4; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; Okuda Y, 2003, CANCER SCI, V94, P1034, DOI 10.1111/j.1349-7006.2003.tb01397.x; Rigel DS, 2000, CA-CANCER J CLIN, V50, P215, DOI 10.3322/canjclin.50.4.215; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Uyama H, 2006, CLIN CANCER RES, V12, P6043, DOI 10.1158/1078-0432.CCR-06-1064; Yamamoto S, 2006, CLIN CANCER RES, V12, P117, DOI 10.1158/1078-0432.CCR-05-1347; Yamamoto S, 2007, ANN SURG ONCOL, V14, P2141, DOI 10.1245/s10434-007-9369-9; Zhang J, 2006, CANCER RES, V66, P18, DOI 10.1158/0008-5472.CAN-04-3905; Zhang XD, 1999, CANCER RES, V59, P2747	31	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59345	10.1371/journal.pone.0059345	http://dx.doi.org/10.1371/journal.pone.0059345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536873	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200021
J	Mendy, M; Peterson, I; Hossin, S; Peto, T; Jobarteh, ML; Jeng-Barry, A; Sidibeh, M; Jatta, A; Moore, SE; Hall, AJ; Whittle, H				Mendy, Maimuna; Peterson, Ingrid; Hossin, Safayet; Peto, Tom; Jobarteh, Momodou L.; Jeng-Barry, Adam; Sidibeh, Mamadi; Jatta, Abdoulie; Moore, Sophie E.; Hall, Andrew J.; Whittle, Hilton			Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; SURFACE-ANTIGEN; CHILDREN BORN; HBV; ANTIBODY; TRIAL; IMMUNIZATION; PREVALENCE; PROTECTION	Objectives: To determine the duration of protection from hepatitis B vaccine given in infancy and early childhood and asses risk factors for HBV infection and chronic infection. Methods: In 1984 infant HBV vaccination was started in two Gambian villages. Cross sectional serological surveys have been undertaken every 4 years to determine vaccine efficacy. In the current survey 84.6% of 1508 eligible participants aged 128 years were tested. A spouse study was conducted in females (aged 14 years and above) and their male partners. Results: Vaccine efficacy against chronic infection with hepatitis B virus was 95.1% (95% confidence interval 91.5% to 97.1%), which did not vary significantly between age groups or village. Efficacy against infection was 85.4% (82.7% to 87.7%), falling significantly with age. Concentrations of hepatitis B antibody fell exponentially with age varying according to peak response: 20 years after vaccination only 17.8% (95% Cl 10.1-25.6) of persons with a low peak response (10-99 mIU/ml) had detectable HBs antibody compared to 27% (21.9% to 32.2%) of those with a high peak response (>999 mIU/ml). Time since vaccination and a low peak response were the strongest risk factors for HBV infections; males were more susceptible, marriage was not a significant risk for females. Hepatitis B DNA was not detected after infection, which tested soley core antibody positive. An undetectable peak antibody response of <10 mIU/ml and a mother who was hepatitis B e antigen positive were powerful risk factors for chronic infection. Conclusions: Adolescents and young adults vaccinated in infancy are at increased risk of hepatitis B infection, but not chronic infection. Married women were not at increased risk. There is no compelling evidence for the use of a booster dose of HBV vaccine in The Gambia.	[Mendy, Maimuna; Peterson, Ingrid; Hossin, Safayet; Peto, Tom; Jobarteh, Momodou L.; Jeng-Barry, Adam; Sidibeh, Mamadi; Jatta, Abdoulie; Whittle, Hilton] MRC Labs, Banjul, Gambia; [Moore, Sophie E.] MRC Keneba, MRC Unit, Banjul, Gambia; [Hall, Andrew J.; Whittle, Hilton] London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Mendy, M (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	mendym@iarc.fr	Mendy, Maimuna/ABD-5038-2021	Peto, Thomas/0000-0003-3197-9891; Jobarteh, Modou Lamin/0000-0002-7350-6980	MRC (UK); Medical Research Council [MC_U190071516, MC_U123292701, MC_U190088489] Funding Source: researchfish; MRC [MC_U123292701, MC_U190088489, MC_U190071516] Funding Source: UKRI	MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC (UK) funded this study with funds allocated to the Viral Disease Program (Scientific Co-ordinating Committee 1134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; ALTER MJ, 1990, MED CLIN N AM, V74, P1529, DOI 10.1016/S0025-7125(16)30493-X; [Anonymous], 2012, HEPATITIS B FACT SHE; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; BEASLEY RP, 1983, HEPATOLOGY, V3, P135; Bulkow LR, 1998, CLIN INFECT DIS, V26, P933, DOI 10.1086/513939; Chang MH, 2000, JAMA-J AM MED ASSOC, V284, P3040, DOI 10.1001/jama.284.23.3040; Chang MH, 2006, J CLIN VIROL, V36, pS45, DOI 10.1016/S1386-6532(06)80008-9; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Huang LM, 1999, HEPATOLOGY, V29, P954, DOI 10.1002/hep.510290349; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LEVINE OS, 1994, EPIDEMIOL REV, V16, P418, DOI 10.1093/oxfordjournals.epirev.a036161; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Lin YC, 2003, J INFECT DIS, V187, P134, DOI 10.1086/345871; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Mendy M, 2008, J MED VIROL, V80, P1537, DOI 10.1002/jmv.21221; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Poovorawan Y, 2010, VACCINE, V28, P730, DOI 10.1016/j.vaccine.2009.10.074; Poovorawan Y, 2009, J INFECT DIS, V200, P33, DOI 10.1086/599331; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012273; Shaw M, 2001, SEX TRANSM INFECT, V77, P358, DOI 10.1136/sti.77.5.358; Shen LP, 2012, VACCINE, V30, P6623, DOI 10.1016/j.vaccine.2012.08.067; Tharmaphornpilas P, 2009, VACCINE, V27, P6110, DOI 10.1016/j.vaccine.2009.08.034; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; van der Sande MAB, 2007, VACCINE, V25, P1509, DOI 10.1016/j.vaccine.2006.10.023; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000753; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Whittle H, 2002, BMJ-BRIT MED J, V325, P569, DOI 10.1136/bmj.325.7364.569; WHITTLE H, 1990, J INFECT DIS, V161, P1112, DOI 10.1093/infdis/161.6.1112; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6; WHITTLE HC, 1983, LANCET, V1, P1203	43	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58029	10.1371/journal.pone.0058029	http://dx.doi.org/10.1371/journal.pone.0058029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533578	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000316549400015
J	Witham, J; Ouboussad, L; Lefevre, PF				Witham, James; Ouboussad, Lylia; Lefevre, Pascal F.			A NF-kappa B-Dependent Dual Promoter-Enhancer Initiates the Lipopolysaccharide-Mediated Transcriptional Activation of the Chicken Lysozyme in Macrophages	PLOS ONE			English	Article							NUCLEASE-HYPERSENSITIVE SITES; HETEROCHROMATIN PROTEIN-1 HP1; BETA-GLOBIN LOCUS; C/EBP-BETA; REGULATORY ELEMENTS; GENE-EXPRESSION; IN-VIVO; INTERGENIC TRANSCRIPTION; CHROMATIN DOMAIN; HISTONE CODE	The transcriptional activation of the chicken lysozyme gene (cLys) by lipopolysaccharide (LPS) in macrophages is dependent on transcription of a LPS-Inducible Non-Coding RNA (LINoCR) triggering eviction of the CCCTC-binding factor (CTCF) from a negative regulatory element upstream of the lysozyme transcription start site. LINoCR is transcribed from a promoter originally characterized as a hormone response enhancer in the oviduct. Herein, we report the characterization of this cis-regulatory element (CRE). In activated macrophages, a 60 bp region bound by NF-kappa B, AP1 and C/EBPb controls this CRE, which is strictly dependent on NF-kappa B binding for its activity in luciferase assays. Moreover, the serine/threonine kinase IKK alpha, known to be recruited by NF-kappa B to NF-kappa B-dependent genes is found at the CRE and within the transcribing regions of both cLys and LINoCR. Such repartition suggests a simultaneous promoter and enhancer activity of this CRE, initiating cLys transcriptional activation and driving CTCF eviction. This recruitment was transient despite persistence of both cLys transcription and NF-kappa B binding to the CRE. Finally, comparing cLys with other LPS-inducible genes indicates that IKK alpha detection within transcribing regions can be correlated with the presence of the elongating form of RNA polymerase II or concentrated in the 39 end of the gene.	[Witham, James; Ouboussad, Lylia; Lefevre, Pascal F.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Lefevre, PF (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Wellcome Trust Brenner Bldg, Leeds, W Yorkshire, England.	p.lefevre@leeds.ac.uk			Biotechnology and Biological Sciences Research Council UK [BB/G001391/1]; Medical Research Council UK [G0801215]; BBSRC; BBSRC [BB/G001391/1] Funding Source: UKRI; MRC [G0801215] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001391/1] Funding Source: researchfish; Medical Research Council [G0801215] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council UK [BB/G001391/1] http://www.bbsrc.ac.uk/home/home.aspx and the Medical Research Council UK [G0801215] http://www.mrc.ac.uk/index.htm. JW is a recipient of a BBSRC studentship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Barton JL, 2009, NUCLEIC ACIDS RES, V37, P6818, DOI 10.1093/nar/gkp728; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bonifer C, 1997, J BIOL CHEM, V272, P26075, DOI 10.1074/jbc.272.42.26075; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chong S, 2002, MOL CELL BIOL, V22, P4667, DOI 10.1128/MCB.22.13.4667-4676.2002; Cui HM, 2001, CANCER RES, V61, P4947; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; FRITTON HP, 1983, NUCLEIC ACIDS RES, V11, P3467, DOI 10.1093/nar/11.11.3467; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; GRAF T, 1992, CELL, V70, P201, DOI 10.1016/0092-8674(92)90096-U; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HECHT A, 1988, EMBO J, V7, P2063, DOI 10.1002/j.1460-2075.1988.tb03046.x; HIGGS DR, 1989, BLOOD, V73, P1081; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kwon SH, 2010, GENE DEV, V24, P2133, DOI 10.1101/gad.1959110; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lefevre P, 2005, J BIOL CHEM, V280, P27552, DOI 10.1074/jbc.M502422200; Lefevre P, 2003, MOL CELL BIOL, V23, P4386, DOI 10.1128/MCB.23.12.4386-4400.2003; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Morishita H, 2009, INT IMMUNOL, V21, P457, DOI 10.1093/intimm/dxp015; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Phi van L, 1996, BIOCHEM J, V313, P39; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; STEINER C, 1987, NUCLEIC ACIDS RES, V15, P4163, DOI 10.1093/nar/15.10.4163; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Tagoh H, 2006, METH MOL B, V325, P285; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Thorne JL, 2012, NUCLEIC ACIDS RES, V40, P7676, DOI 10.1093/nar/gks509; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Venza I, 2009, J BIOL CHEM, V284, P4191, DOI 10.1074/jbc.M805429200; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; Wilczek C, 2009, J BIOL CHEM, V284, P35314, DOI 10.1074/jbc.M109.066175; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	56	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59389	10.1371/journal.pone.0059389	http://dx.doi.org/10.1371/journal.pone.0059389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533622	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400059
J	Schulke, O; Wenzel, S; Ostner, J				Schuelke, Oliver; Wenzel, Svenja; Ostner, Julia			Paternal Relatedness Predicts the Strength of Social Bonds among Female Rhesus Macaques	PLOS ONE			English	Article							KIN RECOGNITION; MACACA-MULATTA; INBREEDING AVOIDANCE; BEHAVIOR; DISCRIMINATION; BIAS	Forming strong, equitable, and enduring social bonds with a few individuals in a group carries adaptive benefits in terms of increased longevity, offspring survival and paternity success in birds and mammals, including humans. These recent insights generated a new interest in the factors creating variation in the strength of social relationships. Whether and how animals discriminate paternal kin from non-kin and bias their social behavior accordingly is being debated. This study explores the relative importance of dominance rank, age, maternal and paternal relatedness in shaping dyadic affiliative relationships in a group of 30 captive rhesus macaque females. The strength of social relationships, measured by the composite sociality index from observational data, was independently predicted in GLMMs by both maternal and paternal relatedness as well as rank similarity. In addition, social bonds between paternal half-sisters were stronger than between distantly related kin suggesting that females biased their affiliative effort towards paternal relatives. Despite identical relatedness coefficients bonds between mothers and their daughters were three times as strong as those between full sisters. Together these results add to the growing body of evidence for paternal kin biases in affiliative behavior and highlight that females prefer descendent over lateral kin.	[Schuelke, Oliver; Wenzel, Svenja; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, D-37073 Gottingen, Germany	University of Gottingen	Schulke, O (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, D-37073 Gottingen, Germany.	oschuel@gwdg.de			German Initiative of Excellence	German Initiative of Excellence	OS and JO were supported by funds from the German Initiative of Excellence to University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1979, BEHAV ECOL SOCIOBIOL, V6, P161, DOI 10.1007/BF00292563; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, R PACKAGE LANGUAGER; Bates D, 2012, R PACKAGE LME4 LINEA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bower S, 2012, J COMP PSYCHOL, V126, P318, DOI 10.1037/a0025081; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Chapais B, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P365; Chapais B, 1997, ANIM BEHAV, V53, P1089, DOI 10.1006/anbe.1996.0365; Chapais B., 1983, PRIMATE SOCIAL RELAT, P208; Chapais Bernard, 1992, P29; Charpentier MJE, 2008, INT J PRIMATOL, V29, P487, DOI 10.1007/s10764-008-9246-9; Charpentier MJE, 2007, ANIM BEHAV, V73, P37, DOI 10.1016/j.anbehav.2006.02.026; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; DEWAAL FBM, 1991, ANIM BEHAV, V41, P383, DOI 10.1016/S0003-3472(05)80839-5; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Field A, 2013, DISCOVERING STAT USI; Fox J, 2012, R COMP APPL REGRESSI; Gouzoules S., 1987, P299; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kapsalis E, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P153; Kapsalis E, 1996, BEHAVIOUR, V133, P1209, DOI 10.1163/156853996X00378; Kawamura S, 1958, JAPANESE MONKEYS, V1, P149; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Kummer H., 1971, PRIMATE SOC; Langergraber KE, 2007, PNAS EARLY EDITION, V104, P1; Nakagawa S, 2004, BIOL REV, V79, P101, DOI 10.1017/S1464793103006249; Parr LA, 2010, J COMP PSYCHOL, V124, P343, DOI 10.1037/a0020545; Perry S, 2008, ANIM BEHAV, V76, P187, DOI 10.1016/j.anbehav.2008.01.020; R Development Core Team, 2010, LANG ENV STAT COMP; Rosenbaum S, 2011, AM J PRIMATOL, V73, P356, DOI 10.1002/ajp.20905; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Schulke O, 2008, AM J PRIMATOL, V70, P695, DOI 10.1002/ajp.20546; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith K, 2003, P ROY SOC B-BIOL SCI, V270, P503, DOI 10.1098/rspb.2002.2277; Sokal RR, 1995, BIOMETRY; van Schaik C.P., 2000, INFANTICIDE MALES IT; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2002, BEHAVIOUR, V139, P371, DOI 10.1163/156853902760102717; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; Widdig A, 2006, BEHAV ECOL SOCIOBIOL, V61, P205, DOI 10.1007/s00265-006-0251-8	53	25	27	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59789	10.1371/journal.pone.0059789	http://dx.doi.org/10.1371/journal.pone.0059789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527268	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600094
J	Berg, A; Zelano, J; Thams, S; Cullheim, S				Berg, Alexander; Zelano, Johan; Thams, Sebastian; Cullheim, Staffan			The Extent of Synaptic Stripping of Motoneurons after Axotomy Is Not Correlated to Activation of Surrounding Glia or Downregulation of Postsynaptic Adhesion Molecules	PLOS ONE			English	Article							MHC CLASS-I; IMMUNOREACTIVE NERVE-TERMINALS; SPINAL MOTONEURONS; MESSENGER-RNA; QUANTITATIVE-ANALYSIS; UNEXPECTED ROLE; DISPLACEMENT; NEUROLIGIN; EXPRESSION; GLUTAMATE	Synapse elimination in the adult central nervous system can be modelled by axotomy of spinal motoneurons which triggers removal of synapses from the cell surface of lesioned motoneurons by processes that remain elusive. Proposed candidate mechanisms are removal of synapses by reactive microglia and astrocytes, based on the remarkable activation of these cell types in the vicinity of motoneurons following axon lesion, and/or decreased expression of synaptic adhesion molecules in lesioned motoneurons. In the present study, we investigated glia activation and adhesion molecule expression in motoneurons in two mouse strains with deviant patterns of synapse elimination following axotomy. Mice deficient in complement protein C3 display a markedly reduced loss of synapses from axotomized motoneurons, whereas mice with impaired function of major histocompatibility complex (MHC) class Ia display an augmented degree of stripping after axotomy. Activation of microglia and astrocytes was assessed by semiquantative immunohistochemistry for Iba 1 (microglia) and GFAP (astrocytes), while expression of synaptic adhesion molecules was determined by in situ hybridization. In spite of the fact that the two mouse strains display very different degrees of synapse elimination, no differences in terms of glial activation or in the downregulation of the studied adhesion molecules (SynCAM1, neuroligin-2,-3 and netrin G-2 ligand) could be detected. We conclude that neither glia activation nor downregulation of synaptic adhesion molecules are correlated to the different extent of the synaptic stripping in the two studied strains. Instead the magnitude of the stripping event is most likely a consequence of a precise molecular signaling, which at least in part is mediated by immune molecules.	[Berg, Alexander; Thams, Sebastian; Cullheim, Staffan] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Zelano, Johan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Berg, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	alexander.berg@ki.se	Zelano, Johan/AAF-1708-2021	Zelano, Johan/0000-0001-9445-4545	Swedish Research Council; Swedish Brain Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Research Council, Swedish Brain Foundation and Karolinska Institutet. The funders' roles were to provide financial support material and salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Berg A, 2010, NEUROREPORT, V21, P782, DOI 10.1097/WNR.0b013e32833cadd8; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Linda H, 2000, J COMP NEUROL, V425, P10; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Ornung G, 1996, J COMP NEUROL, V365, P413; Ornung G, 1998, EXP BRAIN RES, V118, P517, DOI 10.1007/s002210050308; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pekna M, 1998, SCAND J IMMUNOL, V47, P25; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; PIEHL F, 1995, EUR J NEUROSCI, V7, P1739, DOI 10.1111/j.1460-9568.1995.tb00694.x; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SUMNER BEH, 1975, EXP NEUROL, V49, P406, DOI 10.1016/0014-4886(75)90097-7; SVENSSON M, 1993, EXP NEUROL, V120, P123, DOI 10.1006/exnr.1993.1046; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zelano J, 2007, J COMP NEUROL, V503, P308, DOI 10.1002/cne.21382; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59647	10.1371/journal.pone.0059647	http://dx.doi.org/10.1371/journal.pone.0059647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527240	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100154
J	Liu, ZH; Ding, YL; Xiu, LC; Pan, HY; Liang, Y; Zhong, SQ; Liu, WW; Rao, SQ; Kong, DL				Liu, Zheng-hui; Ding, Yuan-lin; Xiu, Liang-chang; Pan, Hai-yan; Liang, Yan; Zhong, Shou-qiang; Liu, Wei-wei; Rao, Shao-qi; Kong, Dan-li			A Meta-Analysis of the Association between TNF-alpha-308G > A Polymorphism and Type 2 Diabetes Mellitus in Han Chinese Population	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE G-308A POLYMORPHISM; INSULIN-RESISTANCE; TNF-ALPHA; LARGE-SCALE; PROMOTER; DISEASE	Objective: A meta-analysis was applied to evaluate the associations between tumor necrosis factor-alpha (TNF-alpha) -308G>A (rs1800629) polymorphism and type 2 diabetes mellitus (T2DM). Methods: Hardy-Weinberg equilibrium (HWE) was employed to test genetic equilibrium among the genotypes of the selected literature. Power analysis was performed with the Power and Sample Size Calculation (PS) program. A fixed or random effect model was used on the basis of heterogeneity. Publication bias was quantified and examined with the Begg's funnel plot test and Egger's linear regression test. The meta-analysis was performed with Review Manager 5.1 and Stata 11.0. Results: There were 10 studies including 1425 T2DM patients and 1116 healthy control subjects involved in this meta-analysis. No significant publication bias was found in the studies. The pooled ORs (95% CIs) for TNF-alpha -308G>A of A vs. G allele and GA+AA vs. GG genotype were 1.63 (1.17-2.25) and 1.47 (1.17-1.85), respectively. Conclusion: This meta-analysis result suggested that TNF-alpha 2308G. A polymorphism was strongly associated with T2DM risk, and A allele at this locus might be a susceptibility allele for the development of T2DM in Han Chinese population.	[Liu, Zheng-hui; Ding, Yuan-lin; Xiu, Liang-chang; Pan, Hai-yan; Liu, Wei-wei; Rao, Shao-qi; Kong, Dan-li] Guangdong Med Coll, Sch Publ Hlth, Dept Epidemiol & Med Stat, Dongguan, Guangdong, Peoples R China; [Liang, Yan; Zhong, Shou-qiang] Maoming Peoples Hosp, Dept Endocrinol & Metab, Maoming, Guangdong, Peoples R China	Guangdong Medical University	Rao, SQ (corresponding author), Guangdong Med Coll, Sch Publ Hlth, Dept Epidemiol & Med Stat, Dongguan, Guangdong, Peoples R China.	paulsrrao@yahoo.com.cn; kdlgdmc@163.com		Rao, Shaoqi/0000-0001-7809-3700	National Natural Science Foundation of China [30830104, 31071166, 81273166]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; Dongguan City Science and Technology Project [2011108101015, 2012105102010, 2012108102058]; Guangdong Medical College [XG1001, XZ1105, STIF201121, STIF201122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Dongguan City Science and Technology Project; Guangdong Medical College	This study was supported by the National Natural Science Foundation of China (grant nos. 30830104, 31071166 and 81273166), Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004), Dongguan City Science and Technology Project (grant nos. 2011108101015, 2012105102010, 2012108102058) and the funds from Guangdong Medical College (grant nos. XG1001, XZ1105, STIF201121 and STIF201122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Boraska V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-69; Chen J, 2009, NINGXIA MED J, V31, P395; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Feng RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018480; Furuta M, 2002, DIABETES RES CLIN PR, V56, P141, DOI 10.1016/S0168-8227(01)00358-8; Grimaldi A, 1999, Rev Prat, V49, P16; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; Han LY, 2011, DIABETOLOGIA, V54, P2303, DOI 10.1007/s00125-011-2202-9; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Ishii T, 2000, METABOLISM, V49, P1616, DOI 10.1053/meta.2000.18560; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Ko GTC, 2003, DIABETIC MED, V20, P167, DOI 10.1046/j.1464-5491.2003.00829_1.x; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee SC, 2000, METABOLISM, V49, P1021, DOI 10.1053/meta.2000.7704; Li HY, 2003, J CLIN ENDOCR METAB, V88, P2767, DOI 10.1210/jc.2002-020506; LICHTENSTEIN MJ, 1987, J CHRON DIS, V40, P893, DOI 10.1016/0021-9681(87)90190-1; Liu HL, 2008, EUR J CLIN PHARMACOL, V64, P663, DOI 10.1007/s00228-008-0483-9; Guzman-Flores JM, 2011, DIS MARKERS, V30, P19, DOI [10.1155/2011/360312, 10.3233/DMA-2011-0759]; Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323; Mukhopadhyaya PN, 2010, GENET MOL RES, V9, P2060, DOI 10.4238/vol9-4gmr883; Mustapic M, 2012, METAB BRAIN DIS, V27, P507, DOI 10.1007/s11011-012-9310-1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; OuYang Y, 2006, MED RECAPITULATE, V12, P229; Pan H.Y., 2006, CHIN J CLIN REHABIL, V10, P72; Perez-Luque E, 2012, CLIN BIOCHEM, V45, P12, DOI 10.1016/j.clinbiochem.2011.09.018; [任瑞珍 Ren Ruizhen], 2003, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V19, P271; Saini V, 2010, WORLD J DIABETES, V1, P68, DOI 10.4239/wjd.v1.i3.68; Shiau MY, 2003, TISSUE ANTIGENS, V61, P393, DOI 10.1034/j.1399-0039.2003.00059.x; Srivastava K, 2011, MUTAT RES-REV MUTAT, V728, P67, DOI 10.1016/j.mrrev.2011.06.002; Sun B, 2006, J TIANJIN MED U, V12, P424; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Vendrell J, 2003, ATHEROSCLEROSIS, V167, P257, DOI 10.1016/S0021-9150(02)00429-X; Wang LL, 2012, CHEM RES CHINESE U, V28, P255; Wu Na, 2010, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V30, P927; Zeggini E, 2005, DIABETOLOGIA, V48, P2013, DOI 10.1007/s00125-005-1902-4; 张平安, 2003, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V21, P146; 王战建, 2005, [中华内科杂志, Chinese Journal of Internal Medicine], V44, P214	40	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59421	10.1371/journal.pone.0059421	http://dx.doi.org/10.1371/journal.pone.0059421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527193	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100132
J	Corcoran, MJ; Wetherbee, BM; Shivji, MS; Potenski, MD; Chapman, DD; Harvey, GM				Corcoran, Mark J.; Wetherbee, Bradley M.; Shivji, Mahmood S.; Potenski, Matthew D.; Chapman, Demian D.; Harvey, Guy M.			Supplemental Feeding for Ecotourism Reverses Diel Activity and Alters Movement Patterns and Spatial Distribution of the Southern Stingray, Dasyatis americana	PLOS ONE			English	Article							HOME-RANGE SIZE; BEHAVIOR; WILDLIFE; DENSITY; ORGANIZATION; POPULATION; RESPONSES; RESOURCE; TOURISM; BIOMASS	Southern stingrays, Dasyatis americana, have been provided supplemental food in ecotourism operations at Stingray City Sandbar (SCS), Grand Cayman since 1986, with this site becoming one of the world's most famous and heavily visited marine wildlife interaction venues. Given expansion of marine wildlife interactive tourism worldwide, there are questions about the effects of such activities on the focal species and their ecosystems. We used a combination of acoustic telemetry and tag-recapture efforts to test the hypothesis that human-sourced supplemental feeding has altered stingray activity patterns and habitat use at SCS relative to wild animals at control sites. Secondarily, we also qualitatively estimated the population size of stingrays supporting this major ecotourism venue. Tag-recapture data indicated that a population of at least 164 stingrays, over 80% female, utilized the small area at SCS for prolonged periods of time. Examination of comparative movements of mature female stingrays at SCS and control sites revealed strong differences between the two groups: The fed animals demonstrated a notable inversion of diel activity, being constantly active during the day with little movement at night compared to the nocturnally active wild stingrays; The fed stingrays utilized significantly (p<0.05) smaller 24 hour activity spaces compared to wild conspecifics, staying in close proximity to the ecotourism site; Fed stingrays showed a high degree of overlap in their core activity spaces compared to wild stingrays which were largely solitary in the spaces utilized (72% vs. 3% overlap respectively). Supplemental feeding has strikingly altered movement behavior and spatial distribution of the stingrays, and generated an atypically high density of animals at SCS which could have downstream fitness costs for individuals and potentially broader ecosystem effects. These findings should help environmental managers plan mitigating measures for existing operations, and develop precautionary policies regarding proposed feeding sites.	[Corcoran, Mark J.; Wetherbee, Bradley M.; Shivji, Mahmood S.; Potenski, Matthew D.; Chapman, Demian D.; Harvey, Guy M.] Nova SE Univ, Guy Harvey Res Inst, Dania, FL USA; [Wetherbee, Bradley M.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	Nova Southeastern University; University of Rhode Island	Shivji, MS (corresponding author), Nova SE Univ, Guy Harvey Res Inst, Dania, FL USA.	mahmood@nova.edu			Guy Harvey Research Institute; Guy Harvey Ocean Foundation; PADI Project Aware; Nova Southeastern University Oceanographic Center; Honda Marine; Digital Angel Corporation	Guy Harvey Research Institute; Guy Harvey Ocean Foundation; PADI Project Aware; Nova Southeastern University Oceanographic Center; Honda Marine; Digital Angel Corporation	This research was supported by the Guy Harvey Research Institute, the Guy Harvey Ocean Foundation, PADI Project Aware and Nova Southeastern University Oceanographic Center. Additional equipment was provided by Honda Marine and Digital Angel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that some funding (equipment) for this study was received from commercial sources (Honda Marine and Digital Angel Corporation), and confirm that this commercial funding does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2000, ECOTOURISM STAT FACT; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bjorge A, 2002, MAR MAMMAL SCI, V18, P438, DOI 10.1111/j.1748-7692.2002.tb01047.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Carpenter KE., 2002, SPECIAL PUBLICATION, P508; Cartamil DP, 2003, MAR BIOL, V142, P841, DOI 10.1007/s00227-003-1014-y; Chapman DD, 2003, ENVIRON BIOL FISH, V68, P241, DOI 10.1023/A:1027332113894; Chatfield C., 2004, ANAL TIME SERIES INT; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; D'Andrea AF, 2004, J MAR RES, V62, P67, DOI 10.1357/00222400460744627; Dill LM, 2003, MAR MAMMAL SCI, V19, P650, DOI 10.1111/j.1748-7692.2003.tb01122.x; DUFFUS DA, 1990, BIOL CONSERV, V53, P213, DOI 10.1016/0006-3207(90)90087-6; Eifler DA, 1996, HERPETOLOGICA, V52, P477; Ewer RF, 1968, ETHNOLOGY MAMMALS; Ferguson A, 2007, AQUAT MICROB ECOL, V48, P175, DOI 10.3354/ame048175; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gaspar C, 2008, CYBIUM, V32, P153; GILLIAM D, 1993, B MAR SCI, V52, P1007; Guttridge TL, 2013, ANIM COGN, V16, P55, DOI 10.1007/s10071-012-0550-6; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Higham J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P1, DOI 10.1079/9781845933456.0001; Hines AH, 1997, J EXP MAR BIOL ECOL, V216, P191, DOI 10.1016/S0022-0981(97)00096-8; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; IMS RA, 1987, J ANIM ECOL, V56, P585, DOI 10.2307/5070; KOFORD RR, 1992, J MAMMAL, V73, P930, DOI 10.2307/1382218; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Linares F, 2006, J EXP MAR BIOL ECOL, V330, P469, DOI 10.1016/j.jembe.2005.09.012; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Lyndaker S, 1987, THESIS COLORADO STAT; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; Metcalfe NB, 1999, J ANIM ECOL, V68, P371, DOI 10.1046/j.1365-2656.1999.00289.x; Milazzo M, 2005, MAR BIOL, V146, P1213, DOI 10.1007/s00227-004-1527-z; Milazzo M, 2006, MAR ECOL PROG SER, V310, P165, DOI 10.3354/meps310165; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; Moreau MA, 2004, MAR FRESHWATER RES, V55, P231, DOI 10.1071/MF03159; NELSON M, 1995, SWIM RAYS GUIDE STIN; Newsome D., 2004, International Journal of Tourism Research, V6, P305, DOI 10.1002/jtr.491; Newsome D, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P255; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; OSTFELD RS, 1986, J ANIM ECOL, V55, P691, DOI 10.2307/4748; Ryan C., 1998, Journal of Sustainable Tourism, V6, P314, DOI 10.1080/09669589808667319; Samson C, 2001, CAN J ZOOL, V79, P633, DOI 10.1139/cjz-79-4-633; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Semeniuk CAD, 2007, ENVIRON MANAGE, V40, P665, DOI 10.1007/s00267-006-0321-8; Semeniuk CAD, 2009, BIOL CONSERV, V142, P1818, DOI 10.1016/j.biocon.2009.03.022; Shackley M., 1998, Journal of Sustainable Tourism, V6, P328, DOI 10.1080/09669589808667320; SNELSON FF, 1988, COPEIA, P729; STRONG WR, 1990, COPEIA, P836, DOI 10.2307/1446449; SULLIVAN TP, 1990, J MAMMAL, V71, P579, DOI 10.2307/1381797; THRUSH SF, 1991, MAR ECOL PROG SER, V69, P245, DOI 10.3354/meps069245; Wetherbee BM, 2001, REV METHODS TECHNOLO, V1, P249; Youth H, 2000, WORLD WATCH, P12	59	79	80	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59235	10.1371/journal.pone.0059235	http://dx.doi.org/10.1371/journal.pone.0059235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZS	23527144	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600053
J	Pastore, S; Lulli, D; Maurelli, R; Dellambra, E; De Luca, C; Korkina, LG				Pastore, Saveria; Lulli, Daniela; Maurelli, Riccardo; Dellambra, Elena; De Luca, Chiara; Korkina, Liudmila G.			Resveratrol Induces Long-Lasting IL-8 Expression and Peculiar EGFR Activation/Distribution in Human Keratinocytes: Mechanisms and Implications for Skin Administration	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PLANT POLYPHENOLS; INFLAMMATORY RESPONSES; CHEMOKINE EXPRESSION; TRANS-RESVERATROL; CELL-MIGRATION; FACTOR-ALPHA; RED WINE; ACTIVATION; INHIBITION	Anti-inflammatory and skin tumour preventing effects of resveratrol have been extensively studied pre-clinically and resveratrol has been proposed for clinical investigations. To provide a basis or/and limitations for topical administration to human skin, molecular mechanisms underlying resveratrol effects towards normal human epidermal keratinocytes (NHEK) were evaluated. NHEK were challenged by either resveratrol alone or by its combination with TNFalpha or TGFalpha, and time-dependent molecular events were monitored. Interleukin 8 (IL-8) expression and its mRNA stability, ERK1/2, p65/RelA, and EGFR phosphorylation were determined. Intracellular distribution of EGFR/P-EGFR was measured in the membrane, cytoplasmic, and nuclear fractions. Specific DNA binding activity of NF kappa B (p65/RelA) and AP-1(c-Fos), NHEK proliferation, and molecular markers of apoptosis/cell cycle were detected. Resveratrol induced delayed, long-lasting and steadily growing IL-8 gene and protein over-expression as well as enhanced EGFR phosphorylation, both abrogated by the EGFR kinase inhibitor PD168393. However, resveratrol did not act as a phosphatase inhibitor. ERK phosphorylation was transiently inhibited at early time-points and activated at 6-24 h. Accordingly, c-Fos-specific DNA binding was increased by resveratrol. Cellular distribution of EGFR/P-EGFR was shifted to membrane and nucleus while cytosolic levels were reduced concomitant with enhanced degradation. Notwithstanding high nuclear levels of EGFR/P-EGFR, spontaneous and TGFalpha-triggered cell proliferation was strongly suppressed by resveratrol mainly through cell cycle arrest. Conclusions/Significance: Resveratrol synergized with TNFa in the induction of delayed, long-lasting IL-8 expression through sustained EGFR-ERK axis activation. The time course indicates that resveratrol metabolites could be implicated. Topical administration of Resv to psoriatic patients over-expressing TNFa, IL-8 and EGFR-ERK in the skin should be cautiously considered. Since high nuclear levels of EGFR correspond to increased risk of tumorigenesis, chronic resveratrol application to the skin may be potentially dangerous. Wound healing acceleration by resveratrol could not be envisaged due to its anti-proliferative effects towards normal keratinocytes.	[Pastore, Saveria; Lulli, Daniela; Maurelli, Riccardo; Dellambra, Elena; De Luca, Chiara; Korkina, Liudmila G.] IDI IRCCS, Inst Dermatol, Lab Tissue Engn & Skin Pathophysiol, Ist Dermopat Immacolata, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Korkina, LG (corresponding author), IDI IRCCS, Inst Dermatol, Lab Tissue Engn & Skin Pathophysiol, Ist Dermopat Immacolata, Rome, Italy.	l.korkina@idi.it	Lulli, Daniela/K-6363-2016; Maurelli, Riccardo/AAA-7723-2020; Dellambra, Elena/A-4005-2014; Lulli, Daniela/AAA-2165-2019	Dellambra, Elena/0000-0002-4329-3312; Lulli, Daniela/0000-0002-6314-4699	Italian Ministry for Health [RC-2011-IDI IRCCS]	Italian Ministry for Health(Ministry of Health, Italy)	The work was financed by grant RC-2011-IDI IRCCS from the Italian Ministry for Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2011, MINI-REV MED CHEM, V11, P1200; Aiyer HS, 2012, J AGR FOOD CHEM; Alexander NS, 2011, LARYNGOSCOPE, V121, P1313, DOI 10.1002/lary.21798; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Azios NG, 2005, NEOPLASIA, V7, P128, DOI 10.1593/neo.04346; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; Beier JI, 2006, FEBS LETT, V580, P1859, DOI 10.1016/j.febslet.2006.02.048; Bhat KPL, 2001, CANCER RES, V61, P7456; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Bove K, 2002, BIOCHEM BIOPH RES CO, V291, P1001, DOI 10.1006/bbrc.2002.6554; Boyer JZ, 2012, J PHOTOCH PHOTOBIO B, V113, P42, DOI 10.1016/j.jphotobiol.2012.04.013; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Cattaneo F, 2011, FREE RADICAL BIO MED, V51, P1126, DOI 10.1016/j.freeradbiomed.2011.05.040; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Chen CY, 1999, J BIOL CHEM, V274, P15320, DOI 10.1074/jbc.274.22.15320; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Cordisco S, 2010, J INVEST DERMATOL, V130, P1048, DOI 10.1038/jid.2009.355; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Erlank H, 2011, FREE RADICAL BIO MED, V51, P2319, DOI 10.1016/j.freeradbiomed.2011.09.033; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Fotiou S, 2010, IN VIVO, V24, P49; Fulda S, 2012, ANTI-CANCER AGENT ME, V12, P874, DOI 10.2174/187152012802650129; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; George J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023395; GILLITZER R, 1991, J INVEST DERMATOL, V97, P73, DOI 10.1111/1523-1747.ep12478128; Herbert KJ, 2012, CHEM-BIOL INTERACT, V198, P38, DOI 10.1016/j.cbi.2012.05.004; Holian O, 2001, J CELL BIOCHEM, P55, DOI 10.1002/jcb.1085; Houser KR, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-6; Hung CF, 2008, BIOL PHARM BULL, V31, P955, DOI 10.1248/bpb.31.955; Hwang MK, 2010, CANCER RES, V70, P6859, DOI 10.1158/0008-5472.CAN-09-4393; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Korkina Liudmila, 2009, Front Biosci (Elite Ed), V1, P123; Kostyuk V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044472; Kubota T, 2003, ANTICANCER RES, V23, P4039; Kwon SJ, 2010, CHEMBIOCHEM, V11, P573, DOI 10.1002/cbic.200900674; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Majumdar APN, 2009, NUTR CANCER, V61, P544, DOI 10.1080/01635580902752262; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Martinez-Carpio PA, 2010, PHOTODERMATOL PHOTO, V26, P250, DOI 10.1111/j.1600-0781.2010.00534.x; Maurelli R, 2006, FASEB J, V20, P1516, DOI 10.1096/fj.05-4480fje; Mikula-Pietrasik J, 2012, FREE RADICAL BIO MED, V52, P2234, DOI 10.1016/j.freeradbiomed.2012.03.014; Morse Linda, 2006, Semin Oncol Nurs, V22, P152, DOI 10.1016/j.soncn.2006.04.005; Nakamura Y, 2001, EXP EYE RES, V72, P511, DOI 10.1006/exer.2000.0979; Pang WJ, 2013, MOL BIOL REP, V40, P129, DOI 10.1007/s11033-012-2041-x; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2000, J INVEST DERMATOL, V115, P1134, DOI 10.1046/j.1523-1747.2000.00149.x; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pastore S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1522, DOI 10.1111/j.1751-1097.2012.01195.x; Pastore S, 2012, ANTIOXID REDOX SIGN, V16, P314, DOI 10.1089/ars.2011.4053; Pastore S, 2011, J DERMATOL SCI, V63, P104, DOI 10.1016/j.jdermsci.2011.04.011; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rubiolo JA, 2012, FOLIA BIOL-PRAGUE, V58, P166; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Scognamiglio I, 2013, INT J PHARMACEUT, V440, P179, DOI 10.1016/j.ijpharm.2012.08.009; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Smoliga JM, 2012, J GERONTOL A-BIOL, V67, P158, DOI 10.1093/gerona/glr062; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Stoll SW, 2001, NEOPLASIA, V3, P339, DOI 10.1038/sj.neo.7900170; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Wu Y, 2013, J EUR ACAD DERMATOL, V27, P345, DOI 10.1111/j.1468-3083.2011.04414.x; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; Zaidi SFH, 2009, BIOL PHARM BULL, V32, P1931, DOI 10.1248/bpb.32.1931; Zhang G, 2007, J CONTROL RELEASE, V123, P141, DOI 10.1016/j.jconrel.2007.08.001; Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]	87	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59632	10.1371/journal.pone.0059632	http://dx.doi.org/10.1371/journal.pone.0059632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527233	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600070
J	Berry, S; Coppieters, W; Davis, S; Burrett, A; Thomas, N; Palmer, D; Kelly, V; Obolonkin, V; Sanders, K; Spelman, R; Georges, M; Lehnert, K; Snell, R				Berry, Sarah; Coppieters, Wouter; Davis, Stephen; Burrett, Alayna; Thomas, Natalie; Palmer, David; Kelly, Van; Obolonkin, Vladimir; Sanders, Kathryn; Spelman, Richard; Georges, Michel; Lehnert, Klaus; Snell, Russell			A Triad of Highly Divergent Polymeric Immunoglobulin Receptor (PIGR) Haplotypes with Major Effect on IgA Concentration in Bovine Milk	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; DNA-SEQUENCING DATA; SERUM IMMUNOGLOBULINS; NATURAL ANTIBODIES; IMMUNE COMPONENTS; MAMMARY-GLAND; COWS; MUTATION; VALIDATION; SIMULATION	The aim of this study was to determine a genetic basis for IgA concentration in milk of Bos taurus. We used a Holstein-Friesian x Jersey F2 crossbred pedigree to undertake a genome-wide search for QTL influencing IgA concentration and yield in colostrum and milk. We identified a single genome-wide significant QTL on chromosome 16, maximising at 4.8 Mbp. The polymeric immunoglobulin receptor gene (PIGR) was within the confidence interval of the QTL. In addition, mRNA expression analysis revealed a liver PIGR expression QTL mapping to the same locus as the IgA quantitative trait locus. Sequencing and subsequent genotyping of the PIGR gene revealed three divergent haplotypes that explained the variance of both the IgA QTL and the PIGR expression QTL. Genetic selection based on these markers will facilitate the production of bovine herds producing milk with higher concentrations of IgA.	[Berry, Sarah; Davis, Stephen; Burrett, Alayna; Thomas, Natalie; Lehnert, Klaus] ViaLactia Biosci, Auckland, New Zealand; [Palmer, David; Kelly, Van; Snell, Russell] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Obolonkin, Vladimir; Sanders, Kathryn; Spelman, Richard] Livestock Improvement Corp, Hamilton, New Zealand; [Coppieters, Wouter; Georges, Michel] Univ Liege B34, Unit Anim Genom, GIGA R, Liege, Belgium; [Coppieters, Wouter; Georges, Michel] Univ Liege B34, Fac Vet Med, Liege, Belgium	University of Auckland; Livestock Improvement Corporation; University of Liege; University of Liege	Berry, S (corresponding author), ViaLactia Biosci, Auckland, New Zealand.	sarah.berry@auckland.ac.nz	Coppieters, Wouter/AAF-5030-2021	Coppieters, Wouter/0000-0001-8109-7825; Knowles, Sarah/0000-0002-2352-9754; Georges, Michel/0000-0003-4124-2375; Kelly, Van/0000-0002-2663-7160; Snell, Russell/0000-0002-8166-4014	Ministry of Business, Innovation and Employment via a FRST Grant	Ministry of Business, Innovation and Employment via a FRST Grant	Funding from this work was received from the Ministry of Business, Innovation and Employment via a FRST Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry SD, 2010, NEW ZEAL VET J, V58, P1, DOI 10.1080/00480169.2010.65053; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Blott S, 2003, GENETICS, V163, P253; BUTLER JE, 1972, CAN J COMPARAT MED, V36, P234; Collin R, 2002, J DAIRY RES, V69, P27, DOI 10.1017/S0022029901005295; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Grignola FE, 1996, GENET SEL EVOL, V28, P491, DOI 10.1051/gse:19960603; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; GUIDRY AJ, 1986, J DAIRY SCI, V69, P1799, DOI 10.3168/jds.S0022-0302(86)80604-X; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Korhonen H, 2000, BRIT J NUTR, V84, pS75; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; MAZENGERA KE, 1985, J DAIRY SCI, V68, P2309, DOI 10.3168/jds.S0022-0302(85)81104-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ploegaert TCW, 2010, J DAIRY SCI, V93, P5467, DOI 10.3168/jds.2010-3264; Porter P, 1972, ELECTROPHORESIS, V1970, P225; R Development Core Team, 2012, R LANG ENV STAT COMP; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Spelman R. J., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P393; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Tarres J, 2007, J DAIRY SCI, V90, P4846, DOI 10.3168/jds.2007-0072; van Knegsel ATM, 2007, J DAIRY SCI, V90, P5490, DOI 10.3168/jds.2007-0289; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VANN RC, 1995, J ANIM SCI, V73, P3044; Wheeler TT, 2007, J MAMMARY GLAND BIOL, V12, P237, DOI 10.1007/s10911-007-9051-7; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; XU SH, 1995, GENETICS, V141, P1189	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57219	10.1371/journal.pone.0057219	http://dx.doi.org/10.1371/journal.pone.0057219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536764	gold, Green Published			2022-12-27	WOS:000316251100010
J	Sartory, G; Cwik, J; Knuppertz, H; Schurholt, B; Lebens, M; Seitz, RJ; Schulze, R				Sartory, Gudrun; Cwik, Jan; Knuppertz, Helge; Schuerholt, Benjamin; Lebens, Morena; Seitz, Ruediger J.; Schulze, Ralf			In Search of the Trauma Memory: A Meta-Analysis of Functional Neuroimaging Studies of Symptom Provocation in Posttraumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MEDIAL PREFRONTAL CORTEX; CHILDHOOD SEXUAL-ABUSE; TOP-DOWN FACILITATION; SCRIPT-DRIVEN IMAGERY; RETROSPLENIAL CORTEX; DISSOCIATIVE RESPONSES; BRAIN ACTIVATION; AMYGDALA; NEUROANATOMY	Notwithstanding some discrepancy between results from neuroimaging studies of symptom provocation in posttraumatic stress disorder (PTSD), there is broad agreement as to the neural circuit underlying this disorder. It is thought to be characterized by an exaggerated amygdalar and decreased medial prefrontal activation to which the elevated anxiety state and concomitant inadequate emotional regulation are attributed. However, the proposed circuit falls short of accounting for the main symptom, unique among anxiety disorders to PTSD, namely, reexperiencing the precipitating event in the form of recurrent, distressing images and recollections. Owing to the technical demands, neuroimaging studies are usually carried out with small sample sizes. A meta-analysis of their findings is more likely to cast light on the involved cortical areas. Coordinate-based meta-analyses employing ES-SDM (Effect Size Signed Differential Mapping) were carried out on 19 studies with 274 PTSD patients. Thirteen of the studies included 145 trauma-exposed control participants. Comparisons between reactions to trauma-related stimuli and a control condition and group comparison of reactions to the trauma-related stimuli were submitted to meta-analysis. Compared to controls and the neutral condition, PTSD patients showed significant activation of the mid-line retrosplenial cortex and precuneus in response to trauma-related stimuli. These midline areas have been implicated in self-referential processing and salient autobiographical memory. PTSD patients also evidenced hyperactivation of the pregenual/anterior cingulate gyrus and bilateral amygdala to trauma-relevant, compared to neutral, stimuli. Patients showed significantly less activation than controls in sensory association areas such as the bilateral temporal gyri and extrastriate area which may indicate that the patients' attention was diverted from the presented stimuli by being focused on the elicited trauma memory. Being involved in associative learning and priming, the retrosplenial cortex may have an important function in relation to trauma memory, in particular, the intrusive reexperiencing of the traumatic event.	[Sartory, Gudrun; Cwik, Jan; Knuppertz, Helge; Schuerholt, Benjamin; Lebens, Morena] Univ Wuppertal, Dept Psychol, Clin Psychol Unit, Wuppertal, Germany; [Seitz, Ruediger J.] Univ Dusseldorf, Neurol Clin, D-40225 Dusseldorf, Germany; [Schulze, Ralf] Univ Wuppertal, Dept Psychol, Stat Unit, Wuppertal, Germany	University of Wuppertal; Heinrich Heine University Dusseldorf; University of Wuppertal	Sartory, G (corresponding author), Univ Wuppertal, Dept Psychol, Clin Psychol Unit, Wuppertal, Germany.	sartory@uni-wuppertal.de	Cwik, Jan Christopher/O-7852-2016	Cwik, Jan Christopher/0000-0002-2290-353X	University of Wuppertal	University of Wuppertal	The study was funded by the University of Wuppertal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Cauda F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013107; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Dastjerdi M, 2010, PNAS, V108, P3023; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Eger E, 2007, CEREB CORTEX, V17, P2123, DOI 10.1093/cercor/bhl119; Ehlers A, 2006, MEMORY, V14, P316, DOI 10.1080/09658210500305876; Ehring T, 2011, J ABNORM PSYCHOL, V120, P234, DOI 10.1037/a0021080; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Elsesser K, 2007, CLIN PSYCHOL PSYCHOT, V14, P464, DOI 10.1002/cpp.545; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Fischer H, 1996, NEUROREPORT, V7, P2081, DOI 10.1097/00001756-199609020-00005; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Gainotti G, 1998, NEUROCASE, V4, P519; Garfinkel SN, 2009, PSYCHIAT ANN, V39, P370, DOI 10.3928/00485713-20090527-01; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2005, BIOL PSYCHIAT, V57, P873, DOI 10.1016/j.biopsych.2005.01.011; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lanius RA, 2007, PSYCHIAT RES-NEUROIM, V155, P45, DOI 10.1016/j.pscychresns.2006.11.006; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Liotti M, 2002, AM J PSYCHIAT, V159, P1830, DOI 10.1176/appi.ajp.159.11.1830; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Osuch EA, 2001, BIOL PSYCHIAT, V50, P246, DOI 10.1016/S0006-3223(01)01107-6; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Radua J, 2012, EUROP PSYCHIAT, DOI [10.1016/j.europsy.2011.04.001, DOI 10.1016/J.EUR0PSY.2011.04.001]; Radua J, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-6; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Robinson S, 2011, BEHAV NEUROSCI, V125, P578, DOI 10.1037/a0024262; Sajonz B, 2010, NEUROIMAGE, V50, P1606, DOI 10.1016/j.neuroimage.2010.01.087; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 1997, ANN NY ACAD SCI, V821, P521, DOI 10.1111/j.1749-6632.1997.tb48320.x; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 1997, ARCH GEN PSYCHIAT, V54, P233; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Summerfield JJ, 2009, NEUROIMAGE, V44, P1188, DOI 10.1016/j.neuroimage.2008.09.033; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Trinkler I, 2009, HIPPOCAMPUS, V19, P718, DOI 10.1002/hipo.20556; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Yang PC, 2004, NEUROSCI LETT, V370, P13, DOI 10.1016/j.neulet.2004.07.033	88	117	120	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58150	10.1371/journal.pone.0058150	http://dx.doi.org/10.1371/journal.pone.0058150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536785	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200004
J	Seth, AK; De la Garza, M; Fang, RC; Hong, SJ; Galiano, RD				Seth, Akhil K.; De la Garza, Mauricio; Fang, Robert C.; Hong, Seok J.; Galiano, Robert D.			Excisional Wound Healing Is Delayed in a Murine Model of Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; QUALITY-OF-LIFE; UNITED-STATES; UREMIA; PREVALENCE; MOUSE; RATS	Background: Approximately 15% of the United States population suffers from chronic kidney disease (CKD), often demonstrating an associated impairment in wound healing. This study outlines the development of a surgical murine model of CKD in order to investigate the mechanisms underlying this impairment. Methods: CKD was induced in mice by partial cauterization of one kidney cortex and contralateral nephrectomy, modifying a previously published technique. After a minimum of 6-weeks, splinted, dorsal excisional wounds were created to permit assessment of wound healing parameters. Wounds were harvested on postoperative days (POD) 0, 3, 7, and 14 for histological, immunofluorescent, and quantitative PCR (qPCR). Results: CKD mice exhibited deranged blood chemistry and hematology profiles, including profound uremia and anemia. Significant decreases in re-epithelialization and granulation tissue deposition rates were found in uremic mice wounds relative to controls. On immunofluorescent analysis, uremic mice demonstrated significant reductions in cellular proliferation (BrdU) and angiogenesis (CD31), with a concurrent increase in inflammation (CD45) as compared to controls. CKD mice also displayed differential expression of wound healing-related genes (VEGF, IL-1 beta, eNOS, iNOS) on qPCR. Conclusions: These findings represent the first reported investigation of cutaneous healing in a CKD animal model. Ongoing studies of this significantly delayed wound healing phenotype include the establishment of renal failure model in diabetic strains to study the combined effects of CKD and diabetes.	[Seth, Akhil K.; De la Garza, Mauricio; Fang, Robert C.; Hong, Seok J.; Galiano, Robert D.] Northwestern Univ, Lab Wound Repair & Regenerat Med, Div Plast & Reconstruct Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Galiano, RD (corresponding author), Northwestern Univ, Lab Wound Repair & Regenerat Med, Div Plast & Reconstruct Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	rgaliano@northwestern.edu			Division of Plastic Surgery at Northwestern University Feinberg School of Medicine	Division of Plastic Surgery at Northwestern University Feinberg School of Medicine	This work was supported by internal funds within the Division of Plastic Surgery at Northwestern University Feinberg School of Medicine. None of the authors have any financial disclosures or commercial associations that may pose a conflict of interest with any information presented in this manuscript. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	AHN ST, 1990, ANN PLAS SURG, V24, P17, DOI 10.1097/00000637-199001000-00004; Alssema M, 2012, DIABETES CARE, V35, P741, DOI 10.2337/dc11-1417; Cheung AHS, 2001, INFECT DIS CLIN N AM, V15, P775, DOI 10.1016/S0891-5520(05)70172-0; COLIN JF, 1979, BRIT J SURG, V66, P793, DOI 10.1002/bjs.1800661113; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; GAGNON RF, 1983, UROL RES, V11, P11, DOI 10.1007/BF00272702; GAGNON RF, 1988, UROL RES, V16, P119, DOI 10.1007/BF00261969; GAGNON RF, 1990, NEPHRON, V54, P70, DOI 10.1159/000185812; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; GILCHREST BA, 1980, LANCET, V2, P1271; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Krasner D, 1998, Ostomy Wound Manage, V44, P38; KURSH ED, 1977, J SURG RES, V23, P37, DOI 10.1016/0022-4804(77)90188-3; LUNDIN AP, 1995, KIDNEY INT, V47, P1775, DOI 10.1038/ki.1995.245; Martens CR, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/267257; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Mylonas AI, 2000, BRIT J ORAL MAX SURG, V38, P35, DOI 10.1054/bjom.1999.0029; NAYMAN J, 1966, ANN SURG, V164, P227, DOI 10.1097/00000658-196608000-00007; Obrador GT, 2002, SEMIN NEPHROL, V22, P441, DOI 10.1053/snep.2002.2002.35962; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; SHINDO K, 1982, JPN J SURG, V12, P46, DOI 10.1007/BF02469015; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; STPETER WL, 2007, J MANAGE CARE PHARM, V13, pS2; Valabhji J, 2012, J RENAL CARE, V38, P99, DOI 10.1111/j.1755-6686.2012.00284.x; Wang SP, 1996, SURGERY, V120, P328, DOI 10.1016/S0039-6060(96)80306-0; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Werdin Frank, 2009, Eplasty, V9, pe19; YUE DK, 1987, DIABETES, V36, P295, DOI 10.2337/diabetes.36.3.295; Zotta E, 2008, J NEPHROL, V21, P947	37	32	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59979	10.1371/journal.pone.0059979	http://dx.doi.org/10.1371/journal.pone.0059979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536900	Green Submitted, gold, Green Published			2022-12-27	WOS:000317397200048
J	Wang, JJ; Li, LL; Zhang, JT; Xie, J; Luo, XP; Yu, DH; Zhao, JZ; Feng, TP; Pang, C; Yin, L; Hu, FL; Zhang, JF; Wang, Y; Wang, Q; Zhai, YJ; You, HF; Zhu, T; Hu, DS				Wang, Jinjin; Li, Linlin; Zhang, Jiatong; Xie, Jing; Luo, Xinping; Yu, Dahai; Zhao, Jingzhi; Feng, Tianping; Pang, Chao; Yin, Lei; Hu, Fulan; Zhang, Jianfeng; Wang, Yan; Wang, Qian; Zhai, Yujia; You, Haifei; Zhu, Tian; Hu, Dongsheng			Association of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) Polymorphisms in TCF7L2 with Type 2 Diabetes in 9,619 Han Chinese Population	PLOS ONE			English	Article							GENETIC-VARIANTS; SUSCEPTIBILITY GENES; MELLITUS; CDKN2A/B; SLC30A8; CDKAL1; ONSET; RISK; AGE	Aims: We aimed to replicate the association of the rs290487 (IVS3C/T) and rs7903146 (IVS3C/T) polymorphisms of transcription factor 7-like 2 (TCF7L2) and type 2 diabetes mellitus (T2DM) in Han Chinese people in Henan province, China. Methods: In all, 1,842 patients with T2DM and 7,777 normal glucose-tolerant controls underwent genotyping for the T2DM-associated variants rs7903146 (IVS3C/T) and rs290487 (IVS3C/T). W performed a meta-analysis of the association of the risk alleles of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) in TCF7L2 and T2DM in Han Chinese by combining previous studies with the present study. Results: We found that T2DM was associated with the CC genotype (1.364, 1.137-1.636, p = 0.001), the recessive model (1.457, 1.156-1.838, p = 0.001) of rs290487 (IVS3C/T) and haplotype CC (1.116, 1.034-1.204, p = 0.004) in Han Chinese. Moreover, our meta-analyses supported the association of the T allele (IVS3C/T) of rs7903146 (1.36, 1.24-1.48; p = 6.404x10(-12)) and T2DM but not the C allele of rs290487 (IVS3C/T) (0.99, 0.85-1.15, p = 0.890) in Han Chinese. We found no interactions between behavioral risk factors (smoking, alcohol drinking, and physical activity) and rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms. Conclusions: The CC genotype and the recessive model of the variant rs290487 (IVS3C/T) and CC haplotype of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) in TCF7L2 may be associated with T2DM in Han Chinese people in Henan province, China.	[Wang, Jinjin; Li, Linlin; Wang, Yan; Wang, Qian; Zhai, Yujia; You, Haifei] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Wang, Jinjin; Xie, Jing; Luo, Xinping; Yu, Dahai; Zhu, Tian; Hu, Dongsheng] Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China; [Zhang, Jiatong] Zhengzhou Univ, Dept Clin Med, Zhengzhou, Henan, Peoples R China; [Zhao, Jingzhi; Feng, Tianping; Pang, Chao; Yin, Lei] Zhengzhou Univ, Affiliated Hosp Henan Mil Reg, Zhengzhou, Henan, Peoples R China; [Hu, Fulan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China; [Zhang, Jianfeng] Henan Armed Police Corps Hosp, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Shenzhen University; Zhengzhou University; Zhengzhou University; Harbin Medical University	Hu, DS (corresponding author), Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China.	dongsheng_hu@hotmail.com		/0000-0001-6694-3587; Yu, Dahai/0000-0002-8449-7725	National Natural Science Foundation of China [81072359]; outpatient clinic of Henan Military Hospital; outpatient clinic of Henan People's Armed Police Corps Hospital; First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); outpatient clinic of Henan Military Hospital; outpatient clinic of Henan People's Armed Police Corps Hospital; First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China	This study was supported by the National Natural Science Foundation of China (contact NO. 81072359) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a grant from the outpatient clinics of Henan Military Hospital, Henan People's Armed Police Corps Hospital and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. We express our gratitude to the instruments mentioned above. Finally, we sincerely thank all of the authors for their work in this study.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2005, DIABETES CARE, V28, pS4; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Cantin B, 2002, ATHEROSCLEROSIS, V163, P261, DOI 10.1016/S0021-9150(02)00034-5; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chen GY, 2011, J XIANNING U MED SCI, V25, P103; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duval A, 2000, CYTOGENET CELL GENET, V88, P264, DOI 10.1159/000015534; International Diabetes Federation IDF diabetes atlas news, 2011, IDF DIAB ATL NEWS; LEDWINA T, 1980, BIOMETRICS, V36, P161, DOI 10.2307/2530507; Lehman DM, 2007, DIABETES, V56, P389, DOI 10.2337/db06-0860; Liu PH, 2009, J CLIN ENDOCR METAB, V94, P3575, DOI 10.1210/jc.2009-0609; Lou Q, 2007, CHIN J DIABETES, V17, P895; Ma C, 2006, THESIS JIANGSU U; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Qiao H, 2012, GENE, V495, P115, DOI 10.1016/j.gene.2011.12.055; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Tang X, 2009, THESIS CHONGQING MED; Wang Y, 2011, CHIN GEN C, P212; Wang Z, 2008, THESIS CHONGQING U; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; World Health Organisation, 2011, DIABETES; Yu M, 2010, CLIN PHARMACOL THER, V87, P330, DOI 10.1038/clpt.2009.242; Zeng Q, 2007, NATL MED J CHINA, P88; Zhang L, 2010, THESIS U S CHINA; Zhang Y, 2008, THESIS ZHONGNAN U; Zhang Y, 2009, THESIS SHANDONG U; Zhao Ting, 2011, MED J QILU, V26, P417; Zheng XY, 2012, MOL BIOL REP, V39, P17, DOI 10.1007/s11033-011-0705-6; Zhu H, 2011, THESIS ANHUI MED U	33	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59053	10.1371/journal.pone.0059053	http://dx.doi.org/10.1371/journal.pone.0059053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536853	Green Submitted, gold, Green Published			2022-12-27	WOS:000317397200014
J	Yokoyama, Y; Kakudate, N; Sumida, F; Matsumoto, Y; Gilbert, GH; Gordan, VV				Yokoyama, Yoko; Kakudate, Naoki; Sumida, Futoshi; Matsumoto, Yuki; Gilbert, Gregg H.; Gordan, Valeria V.			Dentists' Dietary Perception and Practice Patterns in a Dental Practice-Based Research Network	PLOS ONE			English	Article							RESTORATIVE TREATMENT THRESHOLDS; PRIMARY CARIES; ORAL-HEALTH; NUTRITION; ATTITUDES; GUIDELINES; CANCER	Background: Dental caries are largely preventable, and epidemiological evidence for a relationship between diet and oral health is abundant. To date, however, dentists' perceptions about the role of diet and dentists' practice patterns regarding diet counseling have not been clarified. Objective: The purposes of this study were to: (1) examine discordance between dentists' perception of the importance of diet in caries treatment planning and their actual provision of diet counseling to patients, and (2) identify dentists' characteristics associated with their provision of diet counseling. Design: The study used a cross-sectional study design consisting of a questionnaire survey in Japan. Participants: The study queried dentists working in outpatient dental practices who were affiliated with the Dental Practice-Based Research Network Japan (JDPBRN), which aims to allow dentists to investigate research questions and share experiences and expertise (n = 282). Measurement: Dentists were asked about their perceptions on the importance of diet and their practice patterns regarding diet counseling, as well as patient, practice, and dentist background data. Results: The majority of participants (n = 116, 63%) recognized that diet is "more important" to oral health. However, among participants who think diet is "more important" (n = 116), only 48% (n = 56) provide diet counseling to more than 20% of their patients. Multiple logistic regression analysis suggested that several variables were associated with providing diet counseling; dentist gender, practice busyness, percentage of patients interested in caries prevention, caries risk assessment, and percentage of patients who receive blood pressure screening. Conclusions: Some discordance exists between dentists' perception of the importance of diet in caries treatment planning and their actual practice pattern regarding diet counseling to patients. Reducing this discordance may require additional dentist education, including nutritional and systemic disease concepts; patient education to increase perception of the importance of caries prevention; or removing barriers to practices' implementation of counseling.	[Yokoyama, Yoko] Japan Soc Promot Sci, Tokyo, Japan; [Yokoyama, Yoko] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol, Suita, Osaka, Japan; [Kakudate, Naoki] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Kakudate, Naoki] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan; [Sumida, Futoshi] Nagayama Family Dent Clin, Sapporo, Hokkaido, Japan; [Matsumoto, Yuki] Wing Town Dent Clin, Okazaki, Aichi, Japan; [Gilbert, Gregg H.] Univ Alabama Birmingham, Sch Dent, Dept Clin & Community Sci, Birmingham, AL 35294 USA; [Gordan, Valeria V.] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL USA	Japan Society for the Promotion of Science; National Cerebral & Cardiovascular Center - Japan; Stanford University; Kyoto University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Yokoyama, Y (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	info@dentalpbrn.jp		Yokoyama, Yoko/0000-0002-4249-004X	National Institutes of Health [U01-DE-16746, U01-DE-16747, U19-DE-22516]; Japan Society for the Promotion of Science (JSPS), Japan [23- 10883]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE022516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016747, U01DE016746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Certain components of this investigation were supported by National Institutes of Health grants U01-DE-16746, U01-DE-16747, and U19-DE-22516; a Grant-in-Aid for JSPS Fellows Grant number 23- 10883 from the Japan Society for the Promotion of Science (JSPS), Japan. Opinions and assertions contained herein are those of the authors and are not to be construed as necessarily representing the views of the respective organizations or the National Institutes of Health or the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Bader JD, 1997, COMMUNITY DENT ORAL, V25, P97, DOI 10.1111/j.1600-0528.1997.tb00905.x; Centers for Disease Control and Prevention, 2012, PREV DENT CAR COMM P; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Dyer TA, 2006, BRIT DENT J, V200, P679, DOI 10.1038/sj.bdj.4813731; Gilbert GH, 2006, MED CARE, V44, P414, DOI 10.1097/01.mlr.0000207491.28719.93; Gilbert GH, 2008, J AM DENT ASSOC, V139, P74, DOI 10.14219/jada.archive.2008.0024; Gordan VV, 2010, J AM DENT ASSOC, V141, P171, DOI 10.14219/jada.archive.2010.0136; Gordan Valeria V., 2009, General Dentistry, V57, P654; Greenberg BL, 2012, J PUBLIC HEALTH DENT, V72, P28, DOI 10.1111/j.1752-7325.2011.00280.x; Greenberg BL, 2010, J AM DENT ASSOC, V141, P52, DOI 10.14219/jada.archive.2010.0021; Harris R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006540.pub2; Kakudate N, 2012, J DENT RES, V91, P1202, DOI 10.1177/0022034512464778; Kelly SAM, 2008, BRIT DENT J, V205, DOI 10.1038/sj.bdj.2008.655; Kelly SA, 2008, BR DENT J, V205, P196; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Makhija Sonia K., 2009, General Dentistry, V57, P270; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Ministry of Health Labour and Welfare, 2010, SURV PHYS DENT PHARM; Nunn ME, 2009, J DENT RES, V88, P361, DOI 10.1177/0022034509334043; Palacios C, 2009, ORAL DIS, V15, P369, DOI 10.1111/j.1601-0825.2009.01571.x; Riley JL, 2012, J AM DENT ASSOC, V143, P1002, DOI 10.14219/jada.archive.2012.0329; Riley JL, 2011, J AM DENT ASSOC, V142, P429, DOI 10.14219/jada.archive.2011.0199; Scully C, 2007, J AM DENT ASSOC, V138, p7S, DOI 10.14219/jada.archive.2007.0359; Tinanoff Norman, 2002, Pediatr Dent, V24, P543; Touger-Decker R, 2001, J AM DIET ASSOC, V101, P63, DOI 10.1016/S0002-8223(01)00017-7; Touger-Decker R, 2007, J AM DIET ASSOC, V107, P1418, DOI 10.1016/j.jada.2007.06.003; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2012, OR HLTH; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	31	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59615	10.1371/journal.pone.0059615	http://dx.doi.org/10.1371/journal.pone.0059615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536883	gold, Green Published			2022-12-27	WOS:000317397200031
J	Zeng, LY; Zhang, PL; Shi, LL; Yamamoto, V; Lu, WG; Wang, K				Zeng, Liyun; Zhang, Peilin; Shi, Lingling; Yamamoto, Vicky; Lu, Wange; Wang, Kai			Functional Impacts of NRXN1 Knockdown on Neurodevelopment in Stem Cell Models	PLOS ONE			English	Article							COPY-NUMBER VARIATION; AUTISM SPECTRUM DISORDER; PROTEIN INTERACTION NETWORK; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; HUMAN BRAIN; RNA-SEQ; PLURIPOTENT; SCHIZOPHRENIA; GENE	Exonic deletions in NRXN1 have been associated with several neurodevelopmental disorders, including autism, schizophrenia and developmental delay. However, the molecular mechanism by which NRXN1 deletions impact neurodevelopment remains unclear. Here we used human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) as models to investigate the functional impacts of NRXN1 knockdown. We first generated hiPSCs from skin fibroblasts and differentiated them into neural stem cells (NSCs). We reduced NRXN1 expression in NSCs via a controlled shRNAmir-based knockdown system during differentiation, and monitored the transcriptome alteration by RNA-Seq and quantitative PCR at several time points. Interestingly, half reduction of NRXN1 expression resulted in changes of expression levels for the cell adhesion pathway (20 genes, P = 2.8x10(-6)) and neuron differentiation pathway (13 genes, P = 2.1x10(-4)), implicating that single-gene perturbation can impact biological networks important for neurodevelopment. Furthermore, astrocyte marker GFAP was significantly reduced in a time dependent manner that correlated with NRXN1 reduction. This observation was reproduced in both hiPSCs and hESCs. In summary, based on in vitro models, NRXN1 deletions impact several biological processes during neurodevelopment, including synaptic adhesion and neuron differentiation. Our study highlights the utility of stem cell models in understanding the functional roles of copy number variations (CNVs) in conferring susceptibility to neurodevelopmental diseases.	[Zeng, Liyun; Shi, Lingling; Wang, Kai] Univ So Calif, Keck Sch Med, Zilhka Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhang, Peilin; Yamamoto, Vicky; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Yamamoto, Vicky; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu; kaiwang@usc.edu		Zeng, Liyun/0000-0001-5959-8295	Zilkha Neurogenetic Institute; NIH [P30MH089877]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH089877] Funding Source: NIH RePORTER	Zilkha Neurogenetic Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study is supported by start-up funds from the Zilkha Neurogenetic Institute to K. W. and NIH grant P30MH089877 (PI: Levitt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Barker Alison J, 2008, Commun Integr Biol, V1, P207; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; BRENNAND KJ, 2011, NATURE; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Missler M, 1998, J NEUROSCI, V18, P3630; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ross P Joel, 2010, F1000 Biol Rep, V2, P84, DOI 10.3410/B2-84; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Saporta MA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt78; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vaccarino FM, 2011, J CHILD PSYCHOL PSYC, V52, P504, DOI 10.1111/j.1469-7610.2010.02348.x; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	80	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59685	10.1371/journal.pone.0059685	http://dx.doi.org/10.1371/journal.pone.0059685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536886	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200034
J	Chan, DSH; Fu, WC; Wang, MD; Liu, LJ; Leung, CH; Ma, DL				Chan, Daniel Shiu-Hin; Fu, Wai-Chung; Wang, Modi; Liu, Li-Juan; Leung, Chung-Hang; Ma, Dik-Lung			A Highly Selective and Non-Reaction Based Chemosensor for the Detection of Hg2+ Ions Using a Luminescent Iridium(III) Complex	PLOS ONE			English	Article							FLUORESCENT CHEMOSENSOR; MERCURY; STRONTIUM; SENSORS; PROBE; LIGANDS; METALS; ENERGY; DYADS; LEAD	We report herein a novel luminescent iridium(III) complex with two hydrophobic carbon chains as a non-reaction based chemosensor for the detection of Hg2+ ions in aqueous solution (<0.002% of organic solvent attributed to the probe solution). Upon the addition of Hg2+ ions, the emission intensity of the complex was significantly enhanced and this change could be monitored by the naked eye under UV irradiation. The iridium(III) complex shows high specificity for Hg2+ ions over eighteen other cations. The system is capable of detecting micromolar levels of Hg2+ ions, which is within the range of many chemical systems.	[Chan, Daniel Shiu-Hin; Fu, Wai-Chung; Wang, Modi; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Liu, Li-Juan; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China	Hong Kong Baptist University; University of Macau	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wang, Modi/ABG-9659-2021; Fu, Wai Chung/HGC-1135-2022; Fu, Wai-Chung/C-4487-2013	Fu, Wai Chung/0000-0002-7181-0057; Fu, Wai-Chung/0000-0002-7181-0057; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/11-12/009]; Environment and Conservation Fund [3/2010]; Centre for Cancer and Inflammation Research; School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811, HKBU/204612]; Science and Technology Development Fund; Macao SAR [001/2012/A]; University of Macau [SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH, MYRG121(Y1-L2)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund; Centre for Cancer and Inflammation Research; School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); Science and Technology Development Fund(Science and Technology Development Fund (STDF)); Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811 and HKBU/204612), the Science and Technology Development Fund, Macao SAR (001/2012/A) and the University of Macau (SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH and MYRG121(Y1-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley E, 2012, COORDIN CHEM REV, V256, P1762, DOI 10.1016/j.ccr.2012.03.018; BLOCH P, 1981, MED PHYS, V8, P308, DOI 10.1118/1.594876; Bronner C, 2012, CHEM-EUR J, V18, P4041, DOI 10.1002/chem.201103836; Brulatti P, 2012, INORG CHEM, V51, P3813, DOI 10.1021/ic202756w; Chan DSH, 2009, CHEM COMMUN, P7479, DOI 10.1039/b913995h; Chen YQ, 2009, ANALYST, V134, P2081, DOI 10.1039/b910603k; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Clifton Ii JC, 2007, PEDIATR CLIN N AM, V54; DOBROWOLSKI R, 1992, ANALYST, V117, P1165, DOI 10.1039/an9921701165; Fernandez-Hernandez JM, 2011, J AM CHEM SOC, V133, P10543, DOI 10.1021/ja201691b; Ge GP, 2009, J ORGANOMET CHEM, V694, P3050, DOI 10.1016/j.jorganchem.2009.05.037; Guerrero-Martinez A, 2008, INORG CHEM, V47, P9131, DOI 10.1021/ic800849y; Harris HH, 2003, SCIENCE, V301, P1203, DOI 10.1126/science.1085941; Jarzynska G, 2011, J ENVIRON SCI HEAL A, V46, P569, DOI 10.1080/10934529.2011.562816; Jia QX, 2009, INORG CHIM ACTA, V362, P2213, DOI 10.1016/j.ica.2008.09.053; Jia SM, 2011, BIOSENS BIOELECTRON, V27, P148, DOI 10.1016/j.bios.2011.06.032; Kim CY, 2012, J MATER CHEM, DOI [10.1039/C1032JM33084A, DOI 10.1039/C1032JM33084A]; Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a; Leung KH, 2012, RSC ADV, V2, P8273, DOI 10.1039/c2ra21119j; Li CY, 2013, BIOMATERIALS, V34, P1223, DOI 10.1016/j.biomaterials.2012.09.014; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Liu JL, 2011, J AM CHEM SOC, V133, P15276, DOI 10.1021/ja205907y; Liu Y, 2011, INORG CHEM, V50, P5969, DOI 10.1021/ic102481x; Lowry MS, 2004, J AM CHEM SOC, V126, P14129, DOI 10.1021/ja047156+; LUCCHESI CA, 1957, ANAL CHEM, V29, P370, DOI 10.1021/ac60123a012; Ma DL, 2012, COORDIN CHEM REV, V256, P3087, DOI 10.1016/j.ccr.2012.07.005; Ma DL, 2009, J AM CHEM SOC, V131, P1835, DOI 10.1021/ja806045x; Mandal D, 2013, POLYHEDRON, V52, P1109, DOI 10.1016/j.poly.2012.06.060; Mauro M, 2011, DALTON T, V40, P12106, DOI 10.1039/c1dt11251a; Mauro M, 2010, ANGEW CHEM INT EDIT, V49, P1222, DOI 10.1002/anie.200905713; Miao P, 2009, ELECTROCHEM COMMUN, V11, P1904, DOI 10.1016/j.elecom.2009.08.013; Murphy L, 2010, CHEM COMMUN, V46, P8743, DOI 10.1039/c0cc03705b; NELSON A, 1990, BIOCHIM BIOPHYS ACTA, V1021, P205, DOI 10.1016/0005-2736(90)90035-M; Ou DX, 2012, POLYMER, V53, P5691, DOI 10.1016/j.polymer.2012.10.006; Pejovic-Milic A, 2004, MED PHYS, V31, P528, DOI 10.1118/1.1644931; PIETTE M, 1994, SCI TOTAL ENVIRON, V141, P269, DOI 10.1016/0048-9697(94)90033-7; Prokhorov AM, 2012, ANGEW CHEM INT EDIT, V51, P95, DOI 10.1002/anie.201105212; Sancenon F, 2001, TETRAHEDRON LETT, V42, P4321, DOI 10.1016/S0040-4039(01)00671-2; Santoro A, 2011, J AM CHEM SOC, V133, P5248, DOI 10.1021/ja201245s; Sivaraman G, 2012, RSC ADV, V2, P10605, DOI 10.1039/c2ra21202a; SLEVIN PJ, 1972, TALANTA, V19, P307, DOI 10.1016/0039-9140(72)80081-X; Tian XH, 2011, CHEMBIOCHEM, V12, P548, DOI 10.1002/cbic.201000743; Tong BH, 2012, INORG CHIM ACTA, V391, P15, DOI 10.1016/j.ica.2012.05.017; Wadas TJ, 2004, J AM CHEM SOC, V126, P16841, DOI 10.1021/ja047955s; Wang XM, 2012, INT J MOL SCI, V13, P16822, DOI 10.3390/ijms131216822; Wu YQ, 2011, INORG CHEM, V50, P7412, DOI 10.1021/ic102082k; Xu ZC, 2010, CHEM SOC REV, V39, P1996, DOI 10.1039/b916287a; Xu ZC, 2010, CHEM COMMUN, V46, P1679, DOI 10.1039/b924503k; Yang CH, 2012, CHEM MATER, V24, P3684, DOI 10.1021/cm3010453; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Yantasee W, 2007, ENVIRON HEALTH PERSP, V115, P1683, DOI 10.1289/ehp.10190; Yin ZD, 2012, DALTON T, V41, P11340, DOI 10.1039/c2dt30446e; Zhang M, 2012, CHEM COMMUN, V48, P10004, DOI 10.1039/c2cc35185d; Zhao Q, 2008, DALTON T, P3836, DOI 10.1039/b804858d; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zheng H, 2012, ORG LETT, V14, P1986, DOI 10.1021/ol3004047; Zhou J, 2012, CHEM SOC REV, V41, P1323, DOI 10.1039/c1cs15187h	59	19	19	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60114	10.1371/journal.pone.0060114	http://dx.doi.org/10.1371/journal.pone.0060114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533670	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400107
J	Yang, HJ; Kim, N; Seong, KM; Youn, H; Youn, B				Yang, Hee Jung; Kim, Namshin; Seong, Ki Moon; Youn, HyeSook; Youn, BuHyun			Investigation of Radiation-induced Transcriptome Profile of Radioresistant Non-small Cell Lung Cancer A549 Cells Using RNA-seq	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; GROWTH-FACTOR RECEPTOR; MEDIATES RADIORESISTANCE; IONIZING-RADIATION; IDENTIFICATION; BETA; RAS; AKT	Radioresistance is a main impediment to effective radiotherapy for non-small cell lung cancer (NSCLC). Despite several experimental and clinical studies of resistance to radiation, the precise mechanism of radioresistance in NSCLC cells and tissues still remains unclear. This result could be explained by limitation of previous researches such as a partial understanding of the cellular radioresistance mechanism at a single molecule level. In this study, we aimed to investigate extensive radiation responses in radioresistant NSCLC cells and to identify radioresistance-associating factors. For the first time, using RNA-seq, a massive sequencing-based approach, we examined whole-transcriptome alteration in radioresistant NSCLC A549 cells under irradiation, and verified significant radiation-altered genes and their chromosome distribution patterns. Also, bioinformatic approaches (GO analysis and IPA) were performed to characterize the radiation responses in radioresistant A549 cells. We found that epithelial-mesenchymal transition (EMT), migration and inflammatory processes could be meaningfully related to regulation of radiation responses in radioresistant A549 cells. Based on the results of bioinformatic analysis for the radiation-induced transcriptome alteration, we selected seven significant radiation-altered genes (SESN2, FN1, TRAF4, CDKN1A, COX-2, DDB2 and FDXR) and then compared radiation effects in two types of NSCLC cells with different radiosensitivity (radioresistant A549 cells and radiosensitive NCI-H460 cells). Interestingly, under irradiation, COX-2 showed the most significant difference in mRNA and protein expression between A549 and NCI-H460 cells. IR-induced increase of COX-2 expression was appeared only in radioresistant A549 cells. Collectively, we suggest that COX-2 (also known as prostaglandin-endoperoxide synthase 2 (PTGS2)) could have possibility as a putative biomarker for radioresistance in NSCLC cells.	[Yang, Hee Jung; Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Pusan, South Korea; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Seong, Ki Moon] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Div Radiat Effect Res, Seoul, South Korea; [Youn, HyeSook] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul, South Korea	Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Hydro & Nuclear Power; Sejong University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan, South Korea.	bhyoun72@pusan.ac.kr	Kim, Namshin/Q-6491-2017; Seong, Ki Moon/Y-6083-2019	Kim, Namshin/0000-0001-6361-274X; 	Nuclear Research & Development Program [2012-0006383]; Basic Science Research Program through the National Research Foundation of Korea [2012-0003201]; Ministry of Education, Science and Technology	Nuclear Research & Development Program; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Nuclear Research & Development Program (2012-0006383) and by Basic Science Research Program (2012-0003201) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; Begg AC, 2012, SEMIN RADIAT ONCOL, V22, P108, DOI 10.1016/j.semradonc.2011.12.002; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Gao Z, 2008, FREE RADICAL BIO MED, V45, P1501, DOI 10.1016/j.freeradbiomed.2008.08.009; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Grana TM, 2002, CANCER RES, V62, P4142; Grille SJ, 2003, CANCER RES, V63, P2172; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Ishikawa KI, 2006, INT J RADIAT ONCOL, V65, P234, DOI 10.1016/j.ijrobp.2005.12.048; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Klein S, 2009, CURR OPIN CELL BIOL, V21, P185, DOI 10.1016/j.ceb.2008.12.006; Kruse JJCM, 2004, RADIAT RES, V161, P28, DOI 10.1667/RR3097; Lee YS, 2010, INT J RADIAT ONCOL, V77, P858, DOI 10.1016/j.ijrobp.2009.12.076; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCKENNA WG, 1990, CANCER RES, V50, P97; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pawlik A, 2011, RADIAT RES, V175, P66, DOI 10.1667/RR2282.1; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie L, 2011, J CANCER RES CLIN, V137, P1739, DOI 10.1007/s00432-011-1050-9; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yin ZJ, 2011, J SURG RES, V171, P675, DOI 10.1016/j.jss.2010.03.053; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	40	37	46	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59319	10.1371/journal.pone.0059319	http://dx.doi.org/10.1371/journal.pone.0059319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533613	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400050
J	Anukam, KC; Macklaim, JM; Gloor, GB; Reid, G; Boekhorst, J; Renckens, B; van Hijum, SAFT; Siezen, RJ				Anukam, Kingsley C.; Macklaim, Jean M.; Gloor, Gregory B.; Reid, Gregor; Boekhorst, Jos; Renckens, Bernadet; van Hijum, Sacha A. F. T.; Siezen, Roland J.			Genome Sequence of Lactobacillus pentosus KCA1: Vaginal Isolate from a Healthy Premenopausal Woman	PLOS ONE			English	Article							PLANTARUM; WOMEN; IDENTIFICATION; GENE; MICROBIOTA; MECHANISM; ALIGNMENT; BACTERIA; BIOLOGY; SYSTEMS	The vaginal microbiota, in particular Lactobacillus species, play an important role in female health through modulation of immunity, countering pathogens and maintaining a pH below 4.7. We report the isolation and genome sequence of Lactobacillus pentosus strain KCA1 (formally known as L. plantarum) from the vagina of a healthy Nigerian woman. The genome was sequenced using Illumina GA II technology. The resulting 16,920,226 paired-end reads were assembled with the Velvet tool. Contigs were annotated using the RAST server, and manually curated. A comparative analysis with the available genomes of L. pentosus IG1 and L. plantarum WCFS1 showed that over 15% of the predicted functional activities are found only in this strain. The strain has a chromosome sequence of 3,418,159 bp with a G+C content of 46.4%, and is devoid of plasmids. Novel gene clusters or variants of known genes relative to the reference genomes were found. In particular, the strain has loci encoding additional putative mannose phosphotransferase systems. Clusters of genes include those for utilization of hydantoin, isopropylmalate, malonate, rhamnosides, and genes for assimilation of polyglycans, suggesting the metabolic versatility of L. pentosus KCA1. Loci encoding putative phage defense systems were also found including clustered regularly interspaced short palindromic repeats (CRISPRs), abortive infection (Abi) systems and toxin-antitoxin systems (TA). A putative cluster of genes for biosynthesis of a cyclic bacteriocin precursor, here designated as pentocin KCA1 (penA) were identified. These findings add crucial information for understanding the genomic and geographic diversity of vaginal lactobacilli.	[Anukam, Kingsley C.] Univ Benin, TWAS Res Unit, Dept Med Lab Sci, Benin, Edo, Nigeria; [Anukam, Kingsley C.; Macklaim, Jean M.; Gloor, Gregory B.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Macklaim, Jean M.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Boekhorst, Jos; Renckens, Bernadet; van Hijum, Sacha A. F. T.; Siezen, Roland J.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Boekhorst, Jos; Renckens, Bernadet; van Hijum, Sacha A. F. T.; Siezen, Roland J.] TI Food & Nutr, Wageningen, Netherlands; [Boekhorst, Jos; Renckens, Bernadet; van Hijum, Sacha A. F. T.; Siezen, Roland J.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Siezen, Roland J.] Microbial Bioinformat, Ede, Netherlands	University of Benin; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Radboud University Nijmegen; Top Institute Food & Nutrition	Anukam, KC (corresponding author), Univ Benin, TWAS Res Unit, Dept Med Lab Sci, Benin, Edo, Nigeria.	kanukam@gmail.com	Anukam, Kingsley C/H-2719-2019; Gloor, Greg B/D-1671-2013; Siezen, Roland J/P-5745-2015; van Hijum, Sacha/F-6445-2014; Reid, Gregor/ABE-8327-2020	Anukam, Kingsley C/0000-0002-2346-3345; Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380; Boekhorst, Jos/0000-0002-4807-7838; van Hijum, Sacha/0000-0003-0741-2991	Academy of Sciences for the Developing World (TWAS) based in ITALY [09-017RG/BIO/AF/AC_G-UNESCOFR:3240230312]	Academy of Sciences for the Developing World (TWAS) based in ITALY	This work was partly funded by the Academy of Sciences for the Developing World (TWAS) based in ITALY, under the RESEARCH GRANT AGREEMENT (RGA) No. 09-017RG/BIO/AF/AC_G-UNESCOFR:3240230312, awarded to Dr. Kingsley C. Anukam of the Department of Medical Laboratory Science, School of Basic Medical Sciences, University of Benin, Nigeira. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, J BACTERIOL, V193, P4559, DOI 10.1128/JB.05171-11; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Anukam K. C., 2007, Research Journal of Microbiology, V2, P81; Anukam K. C., 2007, International Journal of Dairy Science, V2, P275; Anukam KC, 2006, SEX TRANSM DIS, V33, P59, DOI 10.1097/01.olq.0000175367.15559.c4; Anukam KC, 2009, J MED FOOD, V12, P1177, DOI 10.1089/jmf.2008.0163; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bringel F, 2005, INT J SYST EVOL MICR, V55, P1629, DOI 10.1099/ijs.0.63333-0; Burkholder PR, 1942, P NATL ACAD SCI USA, V28, P285, DOI 10.1073/pnas.28.7.285; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Cohn SE, 2003, MED CLIN N AM, V87, P971, DOI 10.1016/S0025-7125(03)00062-2; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Huang CH, 2010, ANTON LEEUW INT J G, V97, P289, DOI 10.1007/s10482-009-9409-5; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Isono K, 1994, DNA Res, V1, P263, DOI 10.1093/dnares/1.6.263; Kalmokoff ML, 2003, CAN J MICROBIOL, V49, P763, DOI 10.1139/W03-101; Kawai Y, 2009, APPL ENVIRON MICROB, V75, P1324, DOI 10.1128/AEM.02485-08; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; Kim YS, 2002, J BIOCHEM MOL BIOL, V35, P443; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kotani Yoshifumi, 2010, Immun Ageing, V7, P11, DOI 10.1186/1742-4933-7-11; LEER RJ, 1995, MICROBIOL-SGM, V141, P1629, DOI 10.1099/13500872-141-7-1629; Ljungh A, 2009, LACTOBACILLUS MOL BI; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Maldonado-Barragan A, 2011, J BACTERIOL, V193, P5605, DOI 10.1128/JB.05736-11; McMillan A, 2012, REPROD SCI; McMillan A, 2011, COLLOID SURFACE B, V86, P58, DOI 10.1016/j.colsurfb.2011.03.016; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Naser SM, 2007, INT J SYST EVOL MICR, V57, P2777, DOI 10.1099/ijs.0.64711-0; OKADA S, 1986, J GEN APPL MICROBIOL, V32, P57, DOI 10.2323/jgam.32.57; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schwebke Jane R., 2001, Curr Infect Dis Rep, V3, P152, DOI 10.1007/s11908-996-0040-6; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Ward D, 2009, GENOME SEQUENC UNPUB; Welman Alan D., 2009, P331	60	38	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59239	10.1371/journal.pone.0059239	http://dx.doi.org/10.1371/journal.pone.0059239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527145	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100096
J	Fraser, JM; Tulk, SE; Jeans, JA; Campbell, DA; Bibby, TS; Cockshutt, AM				Fraser, Jared M.; Tulk, Sarah E.; Jeans, Jennifer A.; Campbell, Douglas A.; Bibby, Thomas S.; Cockshutt, Amanda M.			Photophysiological and Photosynthetic Complex Changes during Iron Starvation in Synechocystis sp. PCC 6803 and Synechococcus elongatus PCC 7942	PLOS ONE			English	Article							CHLOROPHYLL-BINDING-PROTEIN; CYTOCHROME-C-OXIDASE; ABSORPTION CROSS-SECTION; PHOTOSYSTEM-I; CYANOBACTERIAL PHOTOSYNTHESIS; ANACYSTIS-NIDULANS; ELECTRON-TRANSPORT; NITROGEN-FIXATION; STRESS; ACCLIMATION	Iron is an essential component in many protein complexes involved in photosynthesis, but environmental iron availability is often low as oxidized forms of iron are insoluble in water. To adjust to low environmental iron levels, cyanobacteria undergo numerous changes to balance their iron budget and mitigate the physiological effects of iron depletion. We investigated changes in key protein abundances and photophysiological parameters in the model cyanobacteria Synechococcus PCC 7942 and Synechocystis PCC 6803 over a 120 hour time course of iron deprivation. The iron stress induced protein (IsiA) accumulated to high levels within 48 h of the onset of iron deprivation, reaching a molar ratio of similar to 42 IsiA : Photosystem I in Synechococcus PCC 7942 and similar to 12 IsiA : Photosystem I in Synechocystis PCC 6803. Concomitantly the iron-rich complexes Cytochrome b(6)f and Photosystem I declined in abundance, leading to a decrease in the Photosystem I : Photosystem II ratio. Chlorophyll fluorescence analyses showed a drop in electron transport per Photosystem II in Synechococcus, but not in Synechocystis after iron depletion. We found no evidence that the accumulated IsiA contributes to light capture by Photosystem II complexes.	[Fraser, Jared M.; Tulk, Sarah E.; Jeans, Jennifer A.; Campbell, Douglas A.; Cockshutt, Amanda M.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Bibby, Thomas S.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton, Hants, England	Mount Allison University; NERC National Oceanography Centre; University of Southampton	Cockshutt, AM (corresponding author), Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada.	acockshutt@mta.ca	Campbell, Douglas A./B-3768-2010; Bibby, Thomas/C-9159-2014	Campbell, Douglas A./0000-0001-8996-5463; Bibby, Thomas/0000-0003-1743-473X	Mount Allison Marjorie Young Bell Faculty Fellowship; President's Research and Creativity Activity Fund (AMC); Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; AgriSera AB; Environmental Proteomics NB; New Brunswick Foundation for Innovation; Natural Environment Research Council [NE/F019254/1] Funding Source: researchfish; NERC [NE/F019254/1] Funding Source: UKRI	Mount Allison Marjorie Young Bell Faculty Fellowship; President's Research and Creativity Activity Fund (AMC); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); AgriSera AB; Environmental Proteomics NB; New Brunswick Foundation for Innovation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Mount Allison Marjorie Young Bell Faculty Fellowship and President's Research and Creativity Activity Fund (AMC), The Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Awards (JMF, SET, JAJ) and Canada and New Brunswick Foundations for Innovation (AMC, DAC). AgriSera AB and Environmental Proteomics NB provided antibodies and protein standards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. Cockshutt and D. Campbell own shares of Environmental Proteomics, the company which produced the IsiA and other protein quantitation standards used in this study. Funding in the form of in kind contributions of antibodies and quantitation standards was received from AgriSera AB and Environmental Proteomics NB. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aspinwall CL, 2004, FEBS LETT, V574, P126, DOI 10.1016/j.febslet.2004.08.016; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Barber J, 1999, CURR OPIN STRUC BIOL, V9, P469, DOI 10.1016/S0959-440X(99)80066-9; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Burns RA, 2006, J PHYCOL, V42, P610, DOI 10.1111/j.1529-8817.2006.00220.x; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Dijkman NA, 2002, J PHOTOCH PHOTOBIO B, V66, P179, DOI 10.1016/S1011-1344(02)00236-1; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fromme P, 1996, CURR OPIN STRUC BIOL, V6, P473, DOI 10.1016/S0959-440X(96)80112-6; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1277, DOI 10.1016/j.bbabio.2012.03.014; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Ivanov AG, 2007, BBA-BIOENERGETICS, V1767, P807, DOI 10.1016/j.bbabio.2007.02.006; Ivanov AG, 2006, PLANT PHYSIOL, V141, P1436, DOI 10.1104/pp.106.082339; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Kolber, 1998, BIOCHIM BIOPHYS ACTA, V1367, P88; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; LEONHARDT K, 1992, J GEN MICROBIOL, V138, P1613, DOI 10.1099/00221287-138-8-1613; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; OQUIST G, 1971, PHYSIOL PLANTARUM, V25, P188, DOI 10.1111/j.1399-3054.1971.tb01426.x; PESCHEK GA, 1994, BBA-BIOENERGETICS, V1187, P369, DOI 10.1016/0005-2728(94)90011-6; PESCHEK GA, 1994, FEMS MICROBIOL LETT, V124, P431, DOI 10.1111/j.1574-6968.1994.tb07320.x; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; RUETER JG, 1990, J PHYCOL, V26, P30, DOI 10.1111/j.0022-3646.1990.00030.x; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Schagerl M, 2006, J PLANT PHYSIOL, V163, P709, DOI 10.1016/j.jplph.2005.09.015; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; SCHUBERT H, 1995, PHOTOSYNTHETICA, V31, P517; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Simis SGH, 2012, PHOTOSYNTH RES, V112, P13, DOI 10.1007/s11120-012-9729-6; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Vermaas WFJ, 2001, ENCY LIFE SCI; Yao DCI, 2012, J BIOL CHEM, V287, P682, DOI 10.1074/jbc.M111.320994; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yokono M, 2011, BBA-BIOENERGETICS, V1807, P847, DOI 10.1016/j.bbabio.2011.03.014	44	57	61	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59861	10.1371/journal.pone.0059861	http://dx.doi.org/10.1371/journal.pone.0059861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527279	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100171
J	Horton, NC; Mathew, SO; Mathew, PA				Horton, Nathan C.; Mathew, Stephen O.; Mathew, Porunelloor A.			Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44	PLOS ONE			English	Article							B-ASSOCIATED TRANSCRIPT-3; NATURAL CYTOTOXICITY RECEPTORS; MOLECULAR-PATTERN MOLECULES; CD4(+) T-CELLS; KILLER-CELLS; CANCER-CELLS; ACTIVATION; EXPRESSION; LINES; P53	NK cell function is closely regulated by numerous inhibitory and activating receptors binding corresponding ligands on the surface of target cells, providing vital first line defenses against infections and cancer. NKp44, originally discovered as an activating NK cell receptor, was recently found to elicit inhibitory effects on NK cell effector function through recognition of cell surface PCNA. Other reports have pointed to potential associations between NKp44 and HLA I molecules, as well as HLA I and Damage Associated Molecular Pattern molecules (DAMPs) on the surface of tumor cells. In this report, we have identified novel interaction between HLA I and PCNA on the surface of human tumor cells by confocal microscopy and immunoprecipitation. In addition to previous reports, we show PCNA on the cell surface where novel association with HLA I does not require the presence of NKp44 expressing NK cells and occurs with endogenous PCNA. The association of HLA I and PCNA forms the inhibitory ligand for NKp44, resulting in inhibition of NK cell cytotoxicity. We further postulate NCR ligands are composed of DAMP molecules localized to the cell surface, colocalizing with HLA I, and potentially heparin sulfate proteoglycans.	[Mathew, Porunelloor A.] Univ North Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA; Univ North Texas Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX USA		Mathew, PA (corresponding author), Univ North Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA.	porunelloor.mathew@unthsc.edu	Mathew, Stephen/ABI-4945-2020	Mathew, Stephen/0000-0001-5784-224X	National Institutes of Health [AI 071161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI071161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health (AI 071161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betser-Cohen G, 2010, J IMMUNOL, V184, P2761, DOI 10.4049/jimmunol.0901572; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Campbell KS, 2004, J IMMUNOL, V172, P899, DOI 10.4049/jimmunol.172.2.899; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Fausther-Bovendo H, 2009, AIDS, V23, P1077, DOI 10.1097/QAD.0b013e32832cb26b; Hecht ML, 2009, J PROTEOME RES, V8, P712, DOI 10.1021/pr800747c; Hershkovitz O, 2007, BIOCHEMISTRY-US, V46, P7426, DOI 10.1021/bi7000455; Lanier L L, 1995, Semin Immunol, V7, P75, DOI 10.1006/smim.1995.0011; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liu YX, 2012, PROSTATE, V72, P690, DOI 10.1002/pros.21476; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Medici D, 2012, SEMIN CANCER BIOL, V22, P379, DOI 10.1016/j.semcancer.2012.04.004; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; Naryzhny SN, 2007, FEBS LETT, V581, P4917, DOI 10.1016/j.febslet.2007.09.022; Naryzhny SN, 2010, FEBS LETT, V584, P4292, DOI 10.1016/j.febslet.2010.09.021; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; SHIVAKUMAR CV, 1995, MOL CELL BIOL, V15, P6785; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sivori S, 2000, HUM IMMUNOL, V61, P1055, DOI 10.1016/S0198-8859(00)00201-9; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Specht A, 2008, VIROLOGY, V373, P229, DOI 10.1016/j.virol.2007.11.019; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010	37	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59552	10.1371/journal.pone.0059552	http://dx.doi.org/10.1371/journal.pone.0059552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527218	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100147
J	Mathew, M; Beagley, KW; Timms, P; Polkinghorne, A				Mathew, Marina; Beagley, Kenneth W.; Timms, Peter; Polkinghorne, Adam			Preliminary Characterisation of Tumor Necrosis Factor Alpha and Interleukin-10 Responses to Chlamydia pecorum Infection in the Koala (Phascolarctos cinereus)	PLOS ONE			English	Article							GENITAL-INFECTION; IFN-GAMMA; TNF-ALPHA; IMMUNITY; IL-10; RESOLUTION; POPULATION; CELLS; CONSERVATION; INFLAMMATION	Debilitating infectious diseases caused by Chlamydia are major contributors to the decline of Australia's iconic native marsupial species, the koala (Phascolarctos cinereus). An understanding of koala chlamydial disease pathogenesis and the development of effective strategies to control infections continue to be hindered by an almost complete lack of species-specific immunological reagents. The cell-mediated immune response has been shown to play an influential role in the response to chlamydial infection in other hosts. The objective of this study, hence, was to provide preliminary data on the role of two key cytokines, pro-inflammatory tumour necrosis factor alpha (TNF alpha) and anti-inflammatory interleukin 10 (IL10), in the koala Chlamydia pecorum response. Utilising sequence homology between the cytokine sequences obtained from several recently sequenced marsupial genomes, this report describes the first mRNA sequences of any koala cytokine and the development of koala specific TNF alpha and IL10 real-time PCR assays to measure the expression of these genes from koala samples. In preliminary studies comparing wild koalas with overt chlamydial disease, previous evidence of C. pecorum infection or no signs of C. pecorum infection, we revealed strong but variable expression of TNF alpha and IL10 in wild koalas with current signs of chlamydiosis. The description of these assays and the preliminary data on the cell-mediated immune response of koalas to chlamydial infection paves the way for future studies characterising the koala immune response to a range of its pathogens while providing reagents to assist with measuring the efficacy of ongoing attempts to develop a koala chlamydial vaccine.	[Mathew, Marina; Beagley, Kenneth W.; Timms, Peter; Polkinghorne, Adam] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Polkinghorne, A (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	a.polkinghorne@qut.edu.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Polkinghorne, Adam/0000-0002-6567-2962; Timms, Peter/0000-0002-1682-0025; Polkinghorne, Adam/0000-0002-6803-9222	ARC [LP0990147]; Queensland Government National and International Research Allowances Programme	ARC(Australian Research Council); Queensland Government National and International Research Allowances Programme	This work was financially supported by an ARC linkage grant LP0990147, as well as the Queensland Government National and International Research Allowances Programme scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN AS, 1984, AUST VET J, V61, P413, DOI 10.1111/j.1751-0813.1984.tb07182.x; Campbell LA, 2005, INFECT IMMUN, V73, P3164, DOI 10.1128/IAI.73.5.3164-3165.2005; CANFIELD PJ, 1991, AUST VET J, V68, P167, DOI 10.1111/j.1751-0813.1991.tb03171.x; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; COCKRAM F A, 1981, Journal of Wildlife Diseases, V17, P497; COCKRAM FA, 1974, AUST VET J, V50, P82, DOI 10.1111/j.1751-0813.1974.tb05265.x; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Debattista J, 2002, IMMUNOL LETT, V81, P205, DOI 10.1016/S0165-2478(02)00036-6; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Gordon Greg, 2006, Australian Zoologist, V33, P345; Gupta R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-84; Hemsley S, 1997, J COMP PATHOL, V116, P273, DOI 10.1016/S0021-9975(97)80003-5; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Koala species listing, 2012, KOALA SPECIES LISTIN; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; MCCOLL KA, 1984, VET REC, V115, P655, DOI 10.1136/vr.115.25-26.655; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ohman H, 2006, GENES IMMUN, V7, P243, DOI 10.1038/sj.gene.6364293; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; RANK RG, 1985, INFECT IMMUN, V48, P847, DOI 10.1128/IAI.48.3.847-849.1985; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rey-Ladino J, 2005, INFECT IMMUN, V73, P1568, DOI 10.1128/IAI.73.3.1568-1577.2005; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Schumacher A, 2002, ATHEROSCLEROSIS, V164, P153, DOI 10.1016/S0021-9150(02)00043-6; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; TRACEY KJ, 1990, J CLIN INVEST, V86, P2014, DOI 10.1172/JCI114937; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; WHITE NA, 1994, WILDLIFE RES, V21, P41, DOI 10.1071/WR9940041; WILKINSON R, 1992, VET IMMUNOL IMMUNOP, V33, P237, DOI 10.1016/0165-2427(92)90184-R; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Yang X, 1999, J IMMUNOL, V162, P1010; Yang X, 1996, J IMMUNOL, V156, P4338	44	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59958	10.1371/journal.pone.0059958	http://dx.doi.org/10.1371/journal.pone.0059958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527290	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100174
J	de Jonge, RCJ; Sanders, MS; Terwee, CB; Heymans, MW; Gemke, RJBJ; Koomen, I; Spanjaard, L; van Furth, AM				de Jonge, Rogier C. J.; Sanders, Marieke S.; Terwee, Caroline B.; Heymans, Martijn W.; Gemke, Reinoud J. B. J.; Koomen, Irene; Spanjaard, Lodewijk; van Furth, A. Marceline			Independent Validation of an Existing Model Enables Prediction of Hearing Loss after Childhood Bacterial Meningitis	PLOS ONE			English	Article							EXTERNAL VALIDATION; DIAGNOSTIC RESEARCH; PROGNOSTIC MODEL; CLINICAL EXAMPLE; MISSING VALUES; SCHOOL-AGE; CHILDREN; IMPUTATION; IMPAIRMENT; RULES	Objective: This study aimed external validation of a formerly developed prediction model identifying children at risk for hearing loss after bacterial meningitis (BM). Independent risk factors included in the model are: duration of symptoms prior to admission, petechiae, cerebral spinal fluid (CSF) glucose level, Streptococcus pneumoniae and ataxia. Validation helps to evaluate whether the model has potential in clinical practice. Study design: 116 Dutch school-age BM survivors were included in the validation cohort and screened for sensorineural hearing loss (>25 dB). Risk factors were obtained from medical records. The model was applied to the validation cohort and its performance was compared with the development cohort. Validation was performed by application of the model on the validation cohort and by assessment of discrimination and goodness of fit. Calibration was evaluated by testing deviations in intercept and slope. Multiple imputation techniques were used to deal with missing values. Results: Risk factors were distributed equally between both cohorts. Discriminative ability (Area Under the Curve, AUC) of the model was 0.84 in the development and 0.78 in the validation cohort. Hosmer-Lemeshow test for goodness of fit was not significant in the validation cohort, implying good fit concerning the similarity of expected and observed cases. There were no significant differences in calibration slope and intercept. Sensitivity and negative predicted value were high, while specificity and positive predicted value were low which is comparable with findings in the development cohort. Conclusions: Performance of the model remained good in the validation cohort. This prediction model might be used as a screening tool and can help to identify those children that need special attention and a long follow-up period or more frequent auditory testing.	[de Jonge, Rogier C. J.; Sanders, Marieke S.; van Furth, A. Marceline] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Infect Dis Immunol & Rheumatol, Amsterdam, Netherlands; [de Jonge, Rogier C. J.] Erasmus MC, Sophia Childrens Hosp, Dept Neonatol, Rotterdam, Netherlands; [Sanders, Marieke S.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol, Immunogenet Lab, Amsterdam, Netherlands; [Sanders, Marieke S.] St Antonius Hosp, Dept Gen Med, Nieuwegein, Netherlands; [Terwee, Caroline B.; Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Terwee, Caroline B.; Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Koomen, Irene] Westfriesgasthuis, Dept Pediat, Hoorn, Netherlands; [Spanjaard, Lodewijk] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Jonge, RCJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat Infect Dis Immunol & Rheumatol, Amsterdam, Netherlands.	r.c.j.dejonge@erasmusmc.nl	de Jonge, R./M-9912-2014	de Jonge, R./0000-0003-0595-1983; Heymans, Martijn/0000-0002-3889-0921; Terwee, Caroline/0000-0003-4570-2826; Van Furth, Marceline/0000-0003-1666-8956				Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Biesheuvel CJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-48; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; BROOKHOUSER PE, 1988, LARYNGOSCOPE, V98, P940; Commandeur AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-259; Dodds A, 1997, ARCH DIS CHILD, V76, P139, DOI 10.1136/adc.76.2.139; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; FORTNUM H, 1993, BRIT J AUDIOL, V27, P43, DOI 10.3109/03005369309077889; FORTNUM HM, 1992, ARCH DIS CHILD, V67, P1128, DOI 10.1136/adc.67.9.1128; Husain E, 2006, CLIN INVEST MED, V29, P131; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Janssen KJM, 2009, CLIN CHEM, V55, P994, DOI 10.1373/clinchem.2008.115345; Jayarajan V, 1999, J LARYNGOL OTOL, V113, P1011, DOI 10.1017/S0022215100145852; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koomen I, 2003, PEDIATRICS, V112, P1049, DOI 10.1542/peds.112.5.1049; Landgraf JM, 1996, CHQ USERS MANUAL; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Maguire JL, 2011, PEDIATRICS; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Merkus P, 2007, Ned Tijdschr Geneeskd, V151, P1209; Merkus P, 2010, OTOL NEUROTOL; Moeller MP, 2007, EAR HEARING, V28, P740, DOI 10.1097/AUD.0b013e318157f07f; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Netherlands Reference Laboratory for Bacterial Meningitis, 2010, BACT MEN NETH ANN RE; Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM), 2011, BACT MEN NETH ANN RE; Oostenbrink R, 2002, SCAND J INFECT DIS, V34, P379, DOI 10.1080/00365540110080179; PELTOLA H, 1983, REV INFECT DIS, V5, P71; Raat H, 2002, J CLIN EPIDEMIOL, V55, P67, DOI 10.1016/S0895-4356(01)00411-5; Richardson MP, 1997, ARCH DIS CHILD, V76, P134, DOI 10.1136/adc.76.2.134; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Steyerberg E., 2009, CLIN PREDICTION MODE; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van Well GTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035837; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2009, J CLIN EPIDEMIOL; Wellman MB, 2003, OTOL NEUROTOL, V24, P907, DOI 10.1097/00129492-200311000-00015; World Health Organization, 2008, GLOB BURD DIS 2004 U; Worsoe L, 2010, CLIN INFECT DIS, V51, P917, DOI 10.1086/656409; Yoshinaga-Itano C, 1999, OTOLARYNG CLIN N AM, V32, P1089, DOI 10.1016/S0030-6665(05)70196-1	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58707	10.1371/journal.pone.0058707	http://dx.doi.org/10.1371/journal.pone.0058707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536814	Green Published, gold			2022-12-27	WOS:000316251100081
J	Dolk, T; Liepelt, R; Prinz, W; Fiehler, K				Dolk, Thomas; Liepelt, Roman; Prinz, Wolfgang; Fiehler, Katja			Visual Experience Determines the Use of External Reference Frames in Joint Action Control	PLOS ONE			English	Article							S-R COMPATIBILITY; ACTION CO-REPRESENTATION; OTHERS ACTIONS; HAND CORRESPONDENCE; ACTION-BLIND; WOODEN HAND; PERCEPTION; GAZE; PARIETAL; SYSTEM	Vision plays a crucial role in human interaction by facilitating the coordination of one's own actions with those of others in space and time. While previous findings have demonstrated that vision determines the default use of reference frames, little is known about the role of visual experience in coding action-space during joint action. Here, we tested if and how visual experience influences the use of reference frames in joint action control. Dyads of congenitally-blind, blindfolded-sighted, and seeing individuals took part in an auditory version of the social Simon task, which required each participant to respond to one of two sounds presented to the left or right of both participants. To disentangle the contribution of external-agent-based and response-based-reference frames during joint action, participants performed the task with their respective response (right) hands uncrossed or crossed over one another. Although the location of the auditory stimulus was completely task-irrelevant, participants responded overall faster when the stimulus location spatially corresponded to the required response side than when they were spatially non-corresponding: a phenomenon known as the social Simon effect (SSE). In sighted participants, the SSE occurred irrespective of whether hands were crossed or uncrossed, suggesting the use of external, response-based reference frames. Congenitally-blind participants also showed an SSE, but only with uncrossed hands. We argue that congenitally-blind people use both agent-based and response-based reference frames resulting in conflicting spatial information when hands are crossed and, thus, canceling out the SSE. These results imply that joint action control functions on the basis of external reference frames independent of the presence or (transient/permanent) absence of vision. However, the type of external reference frames used for organizing motor control in joint action seems to be determined by visual experience.	[Dolk, Thomas; Prinz, Wolfgang] Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Leipzig, Germany; [Liepelt, Roman] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Fiehler, Katja] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany	Max Planck Society; University of Munster; Justus Liebig University Giessen	Dolk, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Leipzig, Germany.	dolk@cbs.mpg.de; katja.fiehler@psychol.uni-giessen.de		Liepelt, Roman/0000-0002-4656-6267				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boucher Jean-David, 2012, Front Neurorobot, V6, P3, DOI 10.3389/fnbot.2012.00003; Dittrich K, 2012, ATTEN PERCEPT PSYCHO, V74, P911, DOI 10.3758/s13414-012-0304-1; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Fiehler K, 2009, NEUROPSYCHOLOGIA, V47, P897, DOI 10.1016/j.neuropsychologia.2008.12.023; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Grynszpan O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00094; Guagnano D, 2010, COGNITION, V114, P348, DOI 10.1016/j.cognition.2009.10.008; Harrar V, 2010, EXP BRAIN RES, V203, P615, DOI 10.1007/s00221-010-2252-0; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 1997, ADV PSYCHOL, V118, P281; Hommel B, 2010, EFFORTLESS ATTENTION, P121, DOI DOI 10.7551/MITPRESS/9780262013840.003.0006; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Innocenti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036390; Keith GP, 2010, J NEUROPHYSIOL, V103, P117, DOI 10.1152/jn.91191.2008; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; LANDAU B, 1981, SCIENCE, V213, P1275, DOI 10.1126/science.7268438; Lehrl S, 1984, MEHRFACH WORTSCHATZ; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2012, NEUROPSYCHOLOGIA, V50, P3775, DOI 10.1016/j.neuropsychologia.2012.10.027; Liepelt R, 2013, PSYCHOL RES-PSYCH FO, V77, P240, DOI 10.1007/s00426-012-0425-0; Liepelt R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00086; Liepelt R, 2011, PSYCHOL RES-PSYCH FO, V75, P366, DOI 10.1007/s00426-010-0314-3; Liepelt R, 2008, NEUROIMAGE, V43, P784, DOI 10.1016/j.neuroimage.2008.08.007; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Muller BCN, 2011, NEUROPSYCHOLOGIA, V49, P1373, DOI 10.1016/j.neuropsychologia.2011.01.022; Occelli V, 2013, PSYCHOL BULL, V139, P189, DOI 10.1037/a0028416; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Ramsey R, 2012, PSYCHOL RES-PSYCH FO, V76, P494, DOI 10.1007/s00426-011-0393-9; Reuschel J, 2012, J NEUROSCI, V32, P2422, DOI 10.1523/JNEUROSCI.2714-11.2012; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Roswarski TE, 2003, PSYCHOL RES-PSYCH FO, V67, P43, DOI 10.1007/s00426-002-0107-4; Ruys KI, 2010, J EXP SOC PSYCHOL, V46, P1130, DOI 10.1016/j.jesp.2010.05.016; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schilbach L, 2011, SOC COGN AFFECT NEUR, V6, P393, DOI 10.1093/scan/nsq067; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2005, COGN NEUROPSYCHOL, V22, P433, DOI 10.1080/02643290442000121; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1970, J EXP PSYCHOL, V86, P97, DOI 10.1037/h0029783; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; Stenzel A, 2012, J EXP PSYCHOL HUMAN, V38, P1073, DOI 10.1037/a0029493; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Tsai CC, 2007, PSYCHOL SCI, V18, P1058, DOI 10.1111/j.1467-9280.2007.02025.x; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; Welsh TN, 2009, HUM MOVEMENT SCI, V28, P726, DOI 10.1016/j.humov.2009.07.006	58	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59008	10.1371/journal.pone.0059008	http://dx.doi.org/10.1371/journal.pone.0059008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WI	23536848	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100110
J	Fraternale, A; Crinelli, R; Casabianca, A; Paoletti, MF; Orlandi, C; Carloni, E; Smietana, M; Palamara, AT; Magnani, M				Fraternale, Alessandra; Crinelli, Rita; Casabianca, Anna; Paoletti, Maria Filomena; Orlandi, Chiara; Carloni, Elisa; Smietana, Michael; Palamara, Anna Teresa; Magnani, Mauro			Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages	PLOS ONE			English	Article							FACTOR-KAPPA-B; GLUTATHIONE REDOX; AIRWAY HYPERRESPONSIVENESS; POTENT ANTIOXIDANT; CUTTING EDGE; IFN-GAMMA; ACTIVATION; TRANSCRIPTION; RESPONSES; PROTEIN	Background: The aim of this study was to investigate the molecular mechanisms involved in the production of Th1 cytokines, namely IL-12 and IL-27, when the intra-macrophage redox state was altered by different chemical entities such as GSH-C4, which is reduced glutathione carrying an aliphatic chain, or I-152, a pro-drug of N-acetyl-cysteine (NAC) and beta-mercaptoethylamine. We had already demonstrated that GSH-C4 and I-152 could shift the immune response towards Th1 in Ovalbumin-immunized mice as well as enhance Th1 response in HIV-1 Tat-immunized mice. Methodology/Principal Findings: By a new high performance liquid chromatography method, we found that 20 mM GSH-C4 provided a number of thiol species in the form of GSH, while 20 mM I-152 decreased GSH and increased the thiols in the form of NAC and I-152. Under these experimental conditions, GSH-C4 and I-152 enhanced and suppressed respectively the mRNA expression levels of IL-12 p40 induced by LPS/IFN-gamma as assessed by Real-Time PCR. The protein production of IL-12 p40 was increased by GSH-C4 and decreased by I-152 as determined by Enzyme-linked immunosorbent assay. Western immunoblot and electrophoretic mobility shift assays revealed that Nuclear Factor -kB (NF-kB) activation was inhibited by I-152 and prolonged by GSH-C4. Twenty mM I-152 stimulated IL-27 p28 gene expression and sustained Signal Transducer and Activator of Transcription (STAT)-mediated interferon regulator factor 1 (IRF-1) de novo synthesis. By contrast, 20 mM GSH-C4 did not exert any effect on IL-27 p28 gene expression. Conclusions and Significance: an increase in the intra-macrophage redox state by GSH-C4 and I-152 enhances Th1 cytokine production although the chemical structure and the intra-cellular metabolism influence differently signalling pathways involved in IL-27 or IL-12 production. GSH-C4 and I-152 may be used as Th1 immunomodulators in some pathologies and in ageing where GSH depletion may contribute to the Th1/Th2 imbalance, and in new immunization strategies.	[Fraternale, Alessandra; Crinelli, Rita; Casabianca, Anna; Paoletti, Maria Filomena; Orlandi, Chiara; Carloni, Elisa; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Smietana, Michael] Univ Montpellier 2, Univ Montpellier 1, CNRS, Inst Biomol Max Mousseron,UMR 5247, Montpellier, France; [Palamara, Anna Teresa] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, Dept Publ Hlth & Infect Dis, Rome, Italy; [Palamara, Anna Teresa] San Raffaele Pisana Sci Inst Res Hospitalizat & H, Rome, Italy	University of Urbino; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Fondazione Cenci Bolognetti; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Fraternale, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	alessandra.fraternale@uniurb.it	Smietana, Michael/F-7828-2016; Magnani, Mauro/A-1919-2008	Smietana, Michael/0000-0001-8132-7221; orlandi, chiara/0000-0003-3288-7286; Fraternale, Alessandra/0000-0002-7893-3842; Magnani, Mauro/0000-0001-6456-6626; Crinelli, Rita/0000-0002-1235-8910; Carloni, Elisa/0000-0003-1178-9353; PALAMARA, ANNA TERESA/0000-0001-8330-4381	FIRB (Investment fund of basic research) Project Idee Progettuali [RBIP067F9E 007, prot. 2008BP25KN_001, 2010-2011-prot. 2010PHT9NF_004]	FIRB (Investment fund of basic research) Project Idee Progettuali	This work was supported by the FIRB (Investment fund of basic research) Project 2006 Idee Progettuali (RBIP067F9E 007, PRIN (Research projects of national interest) 2008 prot. 2008BP25KN_001 granted to M. Magnani and PRIN (Research projects of national interest) 2010-2011-prot. 2010PHT9NF_004 granted to A. Fraternale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2000, RESPIRATION, V67, P662, DOI 10.1159/000056297; Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Beutler E., 1984, RED CELL METABOLISM, P131; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Crinelli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038139; Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x; Dunston CR, 2010, CLIN EXP IMMUNOL, V161, P407, DOI 10.1111/j.1365-2249.2010.04213.x; Fratemale A, 2008, ANTIVIR RES, V77, P120, DOI 10.1016/j.antiviral.2007.11.004; Fraternale A, 2011, VACCINE, V29, P6823, DOI 10.1016/j.vaccine.2011.07.101; Fraternale A, 2010, VACCINE, V28, P7676, DOI 10.1016/j.vaccine.2010.09.033; FROSCH S, 1993, EUR J IMMUNOL, V23, P1430, DOI 10.1002/eji.1830230704; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ichiki H, 2005, BIOCHEM BIOPH RES CO, V334, P1141, DOI 10.1016/j.bbrc.2005.07.007; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Kamide Y, 2011, ALLERGY, V66, P1183, DOI 10.1111/j.1398-9995.2011.02611.x; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Koike Y, 2007, AM J RESP CELL MOL, V37, P322, DOI 10.1165/rcmb.2006-0423OC; Li YQ, 2006, ACTA PHARMACOL SIN, V27, P339, DOI 10.1111/j.1745-7254.2006.00264.x; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murata Y, 2002, MOL IMMUNOL, V38, P747, DOI 10.1016/S0161-5890(01)00111-0; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Oiry J, 2004, J MED CHEM, V47, P1789, DOI 10.1021/jm030374d; Oiry J, 2001, BIOORG MED CHEM LETT, V11, P1189, DOI 10.1016/S0960-894X(01)00171-8; Palamara Anna Teresa, 2004, Antiviral Chemistry & Chemotherapy, V15, P83; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Preynat-Seauve O, 2003, CELL STRESS CHAPERON, V8, P162, DOI 10.1379/1466-1268(2003)008<0162:OSIIEI>2.0.CO;2; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Salsman SJ, 2005, ANTIOXID REDOX SIGN, V7, P1078, DOI 10.1089/ars.2005.7.1078; Seidel P, 2011, EUR RESPIR J, V38, P1444, DOI 10.1183/09031936.00129610; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sgarbanti R, 2011, ANTIOXID REDOX SIGN, V15, P593, DOI 10.1089/ars.2010.3512; Short S, 1996, EUR J IMMUNOL, V26, P3015, DOI 10.1002/eji.1830261229; Smith JK, 2012, FREE RADICAL BIO MED, V52, P1101, DOI 10.1016/j.freeradbiomed.2011.12.025; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Utsugi M, 2002, J LEUKOCYTE BIOL, V71, P339; Weiskopf D, 2010, J LEUKOCYTE BIOL, V87, P1; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818	51	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57866	10.1371/journal.pone.0057866	http://dx.doi.org/10.1371/journal.pone.0057866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536773	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100019
J	Fujii, W; Kano, K; Sugiura, K; Naito, K				Fujii, Wataru; Kano, Kiyoshi; Sugiura, Koji; Naito, Kunihiko			Repeatable Construction Method for Engineered Zinc Finger Nuclease Based on Overlap Extension PCR and TA-Cloning	PLOS ONE			English	Article							KNOCKOUT RATS; GENE; GENERATION; DESIGN; SYSTEM	Zinc finger nuclease (ZFN) is a useful tool for endogenous site-directed genome modification. The development of an easier, less expensive and repeatedly usable construction method for various sequences of ZFNs should contribute to the further widespread use of this technology. Here, we establish a novel construction method for ZFNs. Zinc finger (ZF) fragments were synthesized by PCR using short primers coding DNA recognition helices of the ZF domain. DNA-binding domains composed of 4 to 6 ZFs were synthesized by overlap extension PCR of these PCR products, and the DNA-binding domains were joined with a nuclease vector by TA cloning. The short primers coding unique DNA recognition helices can be used repeatedly for other ZFN constructions. By using this novel OLTA (OverLap extension PCR and TA-cloning) method, arbitrary ZFN vectors were synthesized within 3 days, from the designing to the sequencing of the vector. Four different ZFN sets synthesized by OLTA showed nuclease activities at endogenous target loci. Genetically modified mice were successfully generated using ZFN vectors constructed by OLTA. This method, which enables the construction of intended ZFNs repeatedly and inexpensively in a short period of time, should contribute to the advancement of ZFN technology.	[Fujii, Wataru; Sugiura, Koji; Naito, Kunihiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, Tokyo, Japan; [Kano, Kiyoshi] Yamaguchi Univ, Dev Biol Lab, Joint Fac Vet Med, Yamaguchi, Japan; [Kano, Kiyoshi] Yamaguchi Univ, United Grad Sch Vet Sci, BSCTR, Yamaguchi, Japan	University of Tokyo; Yamaguchi University; Yamaguchi University	Fujii, W (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, Tokyo, Japan.	wtrfj.watarufujii@gmail.com; aknaito@mail.ecc.u-tokyo.ac.jp	Sugiura, Koji/AAE-2966-2019	Sugiura, Koji/0000-0001-8945-3353; Fujii, Wataru/0000-0002-6438-7350	Japan Society for the Promotion of Science [11J02886, 22380147, 24658232]; Grants-in-Aid for Scientific Research [11J02886] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS Fellows (11J02886 to WF), Grant-in-Aid for Scientific Research (no. 22380147 to KN) and Grant-in-Aid for Challenging Exploratory Research (no. 24658232 to KN) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Bhakta MS, 2013, GENOME RES IN PRESS; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Mackay JP, 2010, ENG ZINC FINGER PROT; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Naito K, 1999, J MAMM OVA RES, V16, P154; Osborn MJ, 2011, HUM GENE THER, V22, P1155, DOI 10.1089/hum.2011.072; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Salles FJ, 1999, METH MOL B, V118, P441; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shimizu Y, 2011, BIOCHEMISTRY-US, V50, P5033, DOI 10.1021/bi200393g; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	39	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59801	10.1371/journal.pone.0059801	http://dx.doi.org/10.1371/journal.pone.0059801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536890	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200038
J	Gomez, G; Pei, JW; Mwangi, W; Adams, LG; Rice-Ficht, A; Ficht, TA				Gomez, Gabriel; Pei, Jianwu; Mwangi, Waithaka; Adams, L. Garry; Rice-Ficht, Allison; Ficht, Thomas A.			Immunogenic and Invasive Properties of Brucella melitensis 16M Outer Membrane Protein Vaccine Candidates Identified via a Reverse Vaccinology Approach	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COMPLEX CLASS-I; INTRACELLULAR PATHOGEN; NITRIC-OXIDE; BALB/C MICE; HELA-CELLS; PERITONEAL-MACROPHAGES; MURINE MACROPHAGES; DEFICIENT MICE; ABORTUS	Brucella is the etiologic agent of brucellosis, one of the most common and widely distributed zoonotic diseases. Its highly infectious nature, the insidious, systemic, chronic, debilitating aspects of the disease and the lack of an approved vaccine for human use in the United States are features that make Brucella a viable threat to public health. One of the main impediments to vaccine development is identification of suitable antigens. In order to identify antigens that could potentially be used in a vaccine formulation, we describe a multi-step antigen selection approach. We initially used an algorithm (Vaxign) to predict ORF encoding outer membrane proteins with antigenic determinants. Differential gene expression during acute infection and published evidence for a role in virulence were used as criteria for down-selection of the candidate antigens that resulted from in silico prediction. This approach resulted in the identification of nine Brucella melitensis outer membrane proteins, 5 of which were recombinantly expressed and used for validation. Omp22 and Hia had the highest in silico scores for adhesin probability and also conferred invasive capacity to E. coli overexpressing recombinant proteins. With the exception of FlgK in the goat, all proteins reacted to pooled sera from exposed goats, mice, and humans. BtuB, Hia and FlgK stimulated a mixed Th1-Th2 response in splenocytes from immunized mice while BtuB and Hia elicited NO release from splenocytes of S19 immunized mice. The results support the applicability of the current approach to the identification of antigens with immunogenic and invasive properties. Studies to assess immunogenicity and protective efficacy of individual proteins in the mouse are currently underway.	[Gomez, Gabriel; Pei, Jianwu; Mwangi, Waithaka; Adams, L. Garry; Rice-Ficht, Allison; Ficht, Thomas A.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77840 USA; [Rice-Ficht, Allison] Texas A&M Univ, Dept Cellular & Mol Med, Hlth Sci Ctr, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Gomez, G (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77840 USA.	ggomez@cvm.tamu.edu			United States Army Medical Research and Material Command-Congressional Special Interest [W81XWH-10-1-125]; Department of Homeland Security-Center for Foreign Animal and Zoonotic Diseases [2007-ST-104-00002]	United States Army Medical Research and Material Command-Congressional Special Interest; Department of Homeland Security-Center for Foreign Animal and Zoonotic Diseases	This work was supported by a grant from United States Army Medical Research and Material Command-Congressional Special Interest (W81XWH-10-1-125). GG was supported by a training grant from Department of Homeland Security-Center for Foreign Animal and Zoonotic Diseases (2007-ST-104-00002). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Adone R, 2012, VACCINE, V30, P3992, DOI 10.1016/j.vaccine.2012.04.009; ARAYA LN, 1990, INFECT IMMUN, V58, P254, DOI 10.1128/IAI.58.1.254-256.1990; ARAYA LN, 1989, J IMMUNOL, V143, P3330; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Bossi P, 2004, Euro Surveill, V9, P33, DOI 10.2807/esm.09.12.00506-en; CHOMEL BB, 1994, J INFECT DIS, V170, P1216, DOI 10.1093/infdis/170.5.1216; CLOECKAERT A, 1992, INFECT IMMUN, V60, P312, DOI 10.1128/IAI.60.1.312-315.1992; Cloeckaert A, 2002, VET MICROBIOL, V90, P229, DOI 10.1016/S0378-1135(02)00211-0; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; DING AH, 1988, J IMMUNOL, V141, P2407; ECKMAN MR, 1975, JAMA-J AM MED ASSOC, V232, P636, DOI 10.1001/jama.232.6.636; ELZER PH, 1994, IMMUNOLOGY, V82, P651; Ferrero MC, 2009, MICROBES INFECT, V11, P476, DOI 10.1016/j.micinf.2009.01.010; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Frey J, 2007, VACCINE, V25, P5598, DOI 10.1016/j.vaccine.2006.11.058; Samartino CG, 2010, AM J PATHOL, V176, P1323, DOI 10.2353/ajpath.2010.090503; Giambartolomei GH, 2002, J INFECT DIS, V186, P252, DOI 10.1086/341449; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Goel D, 2012, MOL IMMUNOL, V51, P159, DOI 10.1016/j.molimm.2012.02.126; Gross A, 1998, INFECT IMMUN, V66, P1309, DOI 10.1128/IAI.66.4.1309-1316.1998; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; He YQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/297505; Hernandez-Castro R, 2008, MICROB PATHOGENESIS, V44, P28, DOI 10.1016/j.micpath.2007.08.008; Hoft DF, 2011, CELL MICROBIOL, V13, P934, DOI 10.1111/j.1462-5822.2011.01609.x; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Ko J, 2002, J IMMUNOL, V168, P2433, DOI 10.4049/jimmunol.168.5.2433; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Liang L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000673; Lopez-Urrutia L, 2000, INFECT IMMUN, V68, P1740, DOI 10.1128/IAI.68.3.1740-1745.2000; Lowry JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017425; Lucero NE, 2008, EPIDEMIOL INFECT, V136, P496, DOI 10.1017/S0950268807008795; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; MARQUIS H, 1993, INFECT IMMUN, V61, P3785, DOI 10.1128/IAI.61.9.3785-3790.1993; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Martinez-Becerra FJ, 2012, INFECT IMMUN, V80, P1222, DOI 10.1128/IAI.06174-11; Miraglia MC, 2012, MICROBES INFECT; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Murphy E, 2002, FEMS IMMUNOL MED MIC, V33, P191, DOI 10.1111/j.1574-695X.2002.tb00590.x; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pasquevich KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016203; Perkins SD, 2010, FEMS MICROBIOL REV, V34, P379, DOI 10.1111/j.1574-6976.2010.00211.x; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; Rossetti CA, 2011, MICROB PATHOGENESIS, V51, P338, DOI 10.1016/j.micpath.2011.07.006; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Skendros P, 2011, MICROBES INFECT, V13, P134, DOI 10.1016/j.micinf.2010.10.015; TAYLOR JP, 1989, AM J EPIDEMIOL, V130, P160, DOI 10.1093/oxfordjournals.aje.a115308; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Watanabe K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-212; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WILLIAMS E, 1970, LANCET, V1, P1220; Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142; Yingst S, 2003, CRIT REV MICROBIOL, V29, P313, DOI 10.1080/713608012; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	68	31	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59751	10.1371/journal.pone.0059751	http://dx.doi.org/10.1371/journal.pone.0059751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533646	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400083
J	He, Y; Dai, SJ; Dufresne, CP; Zhu, N; Pang, QY; Chen, SX				He, Yan; Dai, Shaojun; Dufresne, Craig P.; Zhu, Ning; Pang, Qiuying; Chen, Sixue			Integrated Proteomics and Metabolomics of Arabidopsis Acclimation to Gene-Dosage Dependent Perturbation of Isopropylmalate Dehydrogenases	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; CHAIN-ELONGATION; GLUCOSINOLATE; BIOSYNTHESIS; IDENTIFICATION; ASSIMILATION; PROTEINS; PART; QUANTIFICATION; HOMEOSTASIS	Maintaining metabolic homeostasis is critical for plant growth and development. Here we report proteome and metabolome changes when the metabolic homeostasis is perturbed due to gene-dosage dependent mutation of Arabidopsis isopropylmalate dehydrogenases (IPMDHs). By integrating complementary quantitative proteomics and metabolomics approaches, we discovered that gradual ablation of the oxidative decarboxylation step in leucine biosynthesis caused imbalance of amino acid homeostasis, redox changes and oxidative stress, increased protein synthesis, as well as a decline in photosynthesis, which led to rearrangement of central metabolism and growth retardation. Disruption of IPMDHs involved in aliphatic glucosinolate biosynthesis led to synchronized increase of both upstream and downstream biosynthetic enzymes, and concomitant repression of the degradation pathway, indicating metabolic regulatory mechanisms in controlling glucosinolate biosynthesis.	[He, Yan; Dai, Shaojun; Zhu, Ning; Pang, Qiuying; Chen, Sixue] Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32611 USA; [He, Yan; Dai, Shaojun; Zhu, Ning; Pang, Qiuying; Chen, Sixue] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA; [Dai, Shaojun; Pang, Qiuying] Northeast Forestry Univ, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Alkali Soil Nat Environm Sci Ctr, Harbin, Heilongjiang, Peoples R China; [Dufresne, Craig P.] Thermo Fisher Sci Inc, Unity Lab Serv, W Palm Beach, FL USA; [Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northeast Forestry University - China; Thermo Fisher Scientific; State University System of Florida; University of Florida	Chen, SX (corresponding author), Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32611 USA.	schen@ufl.edu	CHEN, SI/GZL-4800-2022		National Science Foundation [0845162]; China Scholarship Council	National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council)	This research was supported by a National Science Foundation CAREER Award (0845162 to S. Chen). Y. He and Q. Pang were Ph. D. students supported by the NSF grant. S. Dai and Q. Pang also received funding from the China Scholarship Council for conducting research in the USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsky D, 2010, AMINO ACIDS, V39, P1067, DOI 10.1007/s00726-010-0681-5; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Chen YZ, 2012, MOL PLANT, V5, P1138, DOI 10.1093/mp/sss034; Chen YZ, 2011, COMPUT BIOL CHEM, V35, P10, DOI 10.1016/j.compbiolchem.2010.12.002; Cho HJ, 2000, PLANT PHYSIOL, V123, P1069, DOI 10.1104/pp.123.3.1069; Vivancos PD, 2011, PLANT PHYSIOL, V157, P256, DOI 10.1104/pp.111.181024; Dutilleul C, 2005, PLANT PHYSIOL, V139, P64, DOI 10.1104/pp.105.066399; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FALCO SC, 1995, BIO-TECHNOL, V13, P577, DOI 10.1038/nbt0695-577; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Fischer WN, 1998, TRENDS PLANT SCI, V3, P188, DOI 10.1016/S1360-1385(98)01231-X; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; He Y, 2011, J BIOL CHEM, V286, P28794, DOI 10.1074/jbc.M111.262519; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2010, PLANT CELL PHYSIOL, V51, P1480, DOI 10.1093/pcp/pcq113; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Klein M, 2009, PHYSIOL PLANTARUM, V135, P140, DOI 10.1111/j.1399-3054.2008.01182.x; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lee HM, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-130; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Sams CE, 2011, J AM SOC HORTIC SCI, V136, P23, DOI 10.21273/JASHS.136.1.23; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schippers JHM, 2010, PLANT SCI, V179, P307, DOI 10.1016/j.plantsci.2010.06.012; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Toler HD, 2007, J AM SOC HORTIC SCI, V132, P14, DOI 10.21273/JASHS.132.1.14; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Wenger CD, 2011, NAT METHODS, V8, P933, DOI [10.1038/NMETH.1716, 10.1038/nmeth.1716]; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhu MM, 2012, J PROTEOME RES, V11, P3728, DOI 10.1021/pr300213k; Zhu XH, 2003, PLANT CELL, V15, P845, DOI 10.1105/tpc.009647	52	17	17	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57118	10.1371/journal.pone.0057118	http://dx.doi.org/10.1371/journal.pone.0057118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533573	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400010
J	Jiang, BH; Li, DF; Deng, YP; Teng, FK; Chen, J; Xue, S; Kong, XQ; Luo, C; Shen, X; Jiang, HL; Xu, F; Yang, WG; Yin, J; Wang, YH; Chen, H; Wu, WY; Liu, X; Guo, DA				Jiang, Baohong; Li, Defang; Deng, Yanping; Teng, Fukang; Chen, Jing; Xue, Song; Kong, Xiangqian; Luo, Cheng; Shen, Xu; Jiang, Hualiang; Xu, Feng; Yang, Wengang; Yin, Jun; Wang, Yanhui; Chen, Hui; Wu, Wanying; Liu, Xuan; Guo, De-an			Salvianolic Acid A, a Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							DIASTOLIC DYSFUNCTION; TISSUE INHIBITOR; HEART-FAILURE; FIBROSIS; FIBROBLAST; METALLOPROTEINASE-1; MYOFIBROBLASTS; MILTIORRHIZAE; ACTIVATION; EXPRESSION	Cardiac fibrosis is a deleterious consequence of hypertension which may further advance to heart failure and increased matrix metalloproteinase-9 (MMP-9) contributes to the underlying mechanism. Therefore, new therapeutic strategies to attenuate the effects of MMP-9 are urgently needed. In the present study, we characterize salvianolic acid A (SalA) as a novel MMP-9 inhibitor at molecular, cellular and animal level. We expressed a truncated form of MMP-9 which contains only the catalytic domain (MMP-9 CD), and used this active protein for enzymatic kinetic analysis and Biacore detection. Data generated from these assays indicated that SalA functioned as the strongest competitive inhibitor of MMP-9 among 7 phenolic acids from Salvia miltiorrhiza. In neonatal cardiac fibroblast, SalA inhibited fibroblast migration, blocked myofibroblast transformation, inhibited secretion of intercellular adhesion molecule (ICAM), interleukin-6 (IL-6) and soluble vascular cell adhesion molecule-1 (sVCAM-1) as well as collagen induced by MMP-9 CD. Functional effects of SalA inhibition on MMP-9 was further confirmed in cultured cardiac H9c2 cell overexpressing MMP-9 in vitro and in heart of spontaneously hypertensive rats (SHR) in vivo. Moreover, SalA treatment in SHR resulted in decreased heart fibrosis and attenuated heart hypertrophy. These results indicated that SalA is a novel inhibitor of MMP-9, thus playing an inhibitory role in hypertensive fibrosis. Further studies to develop SalA and its analogues for their potential clinical application of cardioprotection are warranted.	[Jiang, Baohong; Li, Defang; Deng, Yanping; Teng, Fukang; Chen, Jing; Kong, Xiangqian; Luo, Cheng; Shen, Xu; Jiang, Hualiang; Wang, Yanhui; Chen, Hui; Wu, Wanying; Liu, Xuan; Guo, De-an] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Li, Defang] China Pharmaceut Univ, Coll Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Teng, Fukang; Xu, Feng; Yin, Jun; Wang, Yanhui; Chen, Hui] Shenyang Pharmaceut Univ, Shenyang, Peoples R China; [Xue, Song; Yang, Wengang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiovasc Surg, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; China Pharmaceutical University; Shenyang Pharmaceutical University; Shanghai Jiao Tong University	Jiang, BH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	jiangbh@mail.shcnc.ac.cn; daguo@mail.shcnc.ac.cn	Kong, Xiangqian/J-4500-2017; zhou, ju/M-3255-2017	Kong, Xiangqian/0000-0002-9596-7825; Li, Defang/0000-0003-4151-9151; Jiang, Baohong/0000-0002-8573-1536	National Natural Science Foundation of China [81173587, 91029704]; State Key Laboratory of Drug Research [SIMM1203KF-04]; National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program" [2013ZX09103002-024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Drug Research; National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program"	This work was supported by National Natural Science Foundation of China (Grant No: 81173587 and 91029704), State Key Laboratory of Drug Research (Grant No: SIMM1203KF-04) and National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program" (Grant No: 2013ZX09103002-024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Chiao YA, 2012, CARDIOVASC RES, V96, P444, DOI 10.1093/cvr/cvs275; Dorman Gyorgy, 2007, Recent Pat Cardiovasc Drug Discov, V2, P186, DOI 10.2174/157489007782418964; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; Georgescu SP, 2011, AM J PHYSIOL-CELL PH, V301, pC1046, DOI 10.1152/ajpcell.00211.2011; GOLDBERG B, 1964, J CELL BIOL, V22, P227, DOI 10.1083/jcb.22.1.227; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Jiang Baohong, 2010, BMC Pharmacology, V10, P10, DOI 10.1186/1471-2210-10-10; Jiang BH, 2009, FOOD CHEM TOXICOL, V47, P1538, DOI 10.1016/j.fct.2009.03.038; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Liao WQ, 2009, BIOL CELL, V101, P263, DOI 10.1042/BC20080117; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Qu FN, 2008, BIOL PHARM BULL, V31, P501, DOI 10.1248/bpb.31.501; Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280; Tayebjee MH, 2004, AM J HYPERTENS, V17, P770, DOI 10.1016/j.amjhyper.2004.06.023; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Yabanoglu S, 2009, J MOL CELL CARDIOL, V46, P518, DOI 10.1016/j.yjmcc.2008.12.019; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8	23	53	59	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59621	10.1371/journal.pone.0059621	http://dx.doi.org/10.1371/journal.pone.0059621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533637	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400074
J	Probyn, ME; Parsonson, KR; Gardebjer, EM; Ward, LC; Wlodek, ME; Anderson, ST; Moritz, KM				Probyn, Megan E.; Parsonson, Kylie R.; Gardebjer, Emelie M.; Ward, Leigh C.; Wlodek, Mary E.; Anderson, Stephen T.; Moritz, Karen M.			Impact of Low Dose Prenatal Ethanol Exposure on Glucose Homeostasis in Sprague-Dawley Rats Aged up to Eight Months	PLOS ONE			English	Article							INSULIN-SECRETION; FETAL-GROWTH; IN-UTERO; METABOLIC SYNDROME; DIABETES-MELLITUS; PERINATAL-PERIOD; PREGNANT RATS; ADULT SHEEP; TOLERANCE; ALCOHOL	Excessive exposure to alcohol prenatally has a myriad of detrimental effects on the health and well-being of the offspring. It is unknown whether chronic low-moderate exposure of alcohol prenatally has similar and lasting effects on the adult offspring's health. Using our recently developed Sprague-Dawley rat model of 6% chronic prenatal ethanol exposure, this study aimed to determine if this modest level of exposure adversely affects glucose homeostasis in male and female offspring aged up to eight months. Plasma glucose concentrations were measured in late fetal and postnatal life. The pancreas of 30 day old offspring was analysed for beta-cell mass. Glucose handling and insulin action was measured at four months using an intraperitoneal glucose tolerance test and insulin challenge, respectively. Body composition and metabolic gene expression were measured at eight months. Despite normoglycaemia in ethanol consuming dams, ethanol-exposed fetuses were hypoglycaemic at embryonic day 20. Ethanol-exposed offspring were normoglycaemic and normoinsulinaemic under basal fasting conditions and had normal pancreatic b-cell mass at postnatal day 30. However, during a glucose tolerance test, male ethanol-exposed offspring were hyperinsulinaemic with increased first phase insulin secretion. Female ethanol-exposed offspring displayed enhanced glucose clearance during an insulin challenge. Body composition and hepatic, muscle and adipose tissue metabolic gene expression levels at eight months were not altered by prenatal ethanol exposure. Low-moderate chronic prenatal ethanol exposure has subtle, sex specific effects on glucose homeostasis in the young adult rat. As aging is associated with glucose dysregulation, further studies will clarify the long lasting effects of prenatal ethanol exposure.	[Probyn, Megan E.; Parsonson, Kylie R.; Gardebjer, Emelie M.; Anderson, Stephen T.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ward, Leigh C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia	University of Queensland; University of Queensland; University of Melbourne	Probyn, ME (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	k.moritz@uq.edu.au	Parsonson, Kylie R/J-9466-2014; wlodek, Mary/A-8939-2019; Anderson, Stephen T/F-5281-2013; Ward, Leigh C/A-4834-2010; Moritz, Karen/G-2508-2015; Ward, Leigh C/L-4461-2019	wlodek, Mary/0000-0002-8490-9099; Anderson, Stephen T/0000-0002-1176-4394; Ward, Leigh C/0000-0003-2378-279X; Moritz, Karen/0000-0002-8085-0034; 	National Health and Medical Research Council of Australia [ID511162]; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by the National Health and Medical Research Council of Australia (grant ID511162) and the Diabetes Australia Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 1996, CLIN CHIM ACTA, V246, P149, DOI 10.1016/0009-8981(96)06234-1; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; CASTELLS S, 1981, DEV PHARMACOL THERAP, V3, P232, DOI 10.1159/000457447; Chen L, 2004, AM J PHYSIOL-REG I, V286, pR554, DOI 10.1152/ajpregu.00076.2003; Chen L, 2003, METABOLISM, V52, P454, DOI 10.1053/meta.2003.50073; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; Coppari R, NAT REV DRUG DISCOV, V11, P692; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; Fowden AL, 2001, FETAL GROWTH AND DEVELOPMENT, P44; FREINKEL N, 1963, J CLIN INVEST, V42, P1112, DOI 10.1172/JCI104797; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; Giglia Roslyn C, 2008, Breastfeed Rev, V16, P17; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Holemans K, 1996, J SOC GYNECOL INVEST, V3, P71, DOI 10.1016/1071-5576(95)00046-1; Hernandez MI, 2011, ARQ BRAS ENDOCRINOL, V55, P583, DOI 10.1590/S0004-27302011000800012; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Kalhan S, 2000, SEMIN PERINATOL, V24, P94, DOI 10.1053/sp.2000.6360; Kind KL, 2003, AM J PHYSIOL-REG I, V284, pR140, DOI 10.1152/ajpregu.00587.2001; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; LOPEZTEJERO D, 1989, ALCOHOL, V6, P469, DOI 10.1016/0741-8329(89)90054-2; Martin MA, 1997, AM J PHYSIOL-ENDOC M, V272, pE634, DOI 10.1152/ajpendo.1997.272.4.E634; MCEVOY RC, 1980, BIOL NEONATE, V38, P248; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Probyn ME, 2012, REPROD IN PRESS 0123; Rueda-Clausen CF, 2011, SEMIN REPROD MED, V29, P197, DOI 10.1055/s-0031-1275520; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Siebel AL, 2010, J DEV ORIG HLTH DIS, V1, P234, DOI 10.1017/S2040174410000383; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Siler SQ, 1998, AM J PHYSIOL-ENDOC M, V275, pE897, DOI 10.1152/ajpendo.1998.275.5.E897; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; SINGH SP, 1984, J LAB CLIN MED, V104, P176; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Somm E, 2009, MOL CELL ENDOCRINOL, V304, P69, DOI 10.1016/j.mce.2009.02.026; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sumida KD, 2004, ALCOHOL ALCOHOLISM, V39, P418, DOI 10.1093/alcalc/agh082; TESTAR X, 1988, ALCOHOL CLIN EXP RES, V12, P197, DOI 10.1111/j.1530-0277.1988.tb00179.x; Todd SE, 2009, PEDIATR RES, V65, P409, DOI 10.1203/PDR.0b013e3181975efa; Vickers MH, 2007, CURR DRUG TARGETS, V8, P923; VILLARROYA F, 1985, GEN PHARMACOL, V16, P415, DOI 10.1016/0306-3623(85)90208-3; Ward LC, 2009, SCAND J LAB ANIM SCI, V36, P253; WITEKJANUSEK L, 1986, AM J PHYSIOL, V251, pE178, DOI 10.1152/ajpendo.1986.251.2.E178; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2007, AM J PHYSIOL-REG I, V292, pR1926, DOI 10.1152/ajpregu.00822.2006	56	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59718	10.1371/journal.pone.0059718	http://dx.doi.org/10.1371/journal.pone.0059718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533642	gold, Green Published			2022-12-27	WOS:000316549400079
J	MacFadden, BJ				MacFadden, Bruce J.			Dispersal of Pleistocene Equus (Family Equidae) into South America and Calibration of GABI 3 Based on Evidence from Tarija, Bolivia	PLOS ONE			English	Article							MAMMALIA; CLIMATE; HORSES	The dispersal of Equus into South America during the Great American Biotic Interchange (GABI) represented a major event for Pleistocene land-mammal age chronology on that continent. It has been argued that this dispersal occurred during the late Pleistocene, similar to 0.125 Ma, and it defines the base of the Lujanian South American Land Mammal Age (SALMA). In this scenario, Equus dispersed during the fourth and latest recognized phase of the interchange, i.e., GABI 4. Although Equus was widely distributed in South America during the Pleistocene, only a few localities are calibrated by independent chronostratigraphic data. In this paper, new biostratigraphic evidence documents that Equus occurs from 15 superposed faunal horizons or zones throughout the Tolomosa Formation at Tarija, Bolivia. This biostratigraphic sequence is independently calibrated to occur between similar to 0.99 to <0.76 Ma during the middle Pleistocene Ensenadan SALMA and coincident with GABI 3, not GABI 4. Tarija remains the only well calibrated Ensenadan locality at which Equus is found. The new biostratigraphic data presented here are unambiguous and document the earlier (pre-Lujanian) occurrence of this genus in South America. The hypothesized dispersal of the genus Equus into South America at similar to 0.125 Ma is no longer supportable in light of the new biostratigraphic evidence presented here. The new data from Tarija thus have continent-wide implications for the origins and biogeography of Equus in South America as well as the calibration of GABI 3.	Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	MacFadden, BJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	bmacfadd@flmnh.ufl.edu						ALBERDI MT, 1993, ZOOL J LINN SOC-LOND, V108, P1; Alberdi MT, 2004, SERIE MONOGRAFICA, V3, P269; Azzaroli A, 1998, PALAEONTOGRAPHIA ITALICA, VOL LXXXV, 1998, P1; Boule M, 1920, MAMMIFERES FOSSILES; Cione A.L., 2005, GEOLOG A RECURSOS MI, P183; Cione AL, 1999, QUATERNARY SOUTH AM, V12, P23; Cione Alberto L., 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P257; Coltorti M, 2007, NATURWISSENSCHAFTEN, V94, P288, DOI 10.1007/s00114-006-0196-9; Flynn J.J., 1995, SOC SEDIMENTARY GEOL, V54, P317, DOI 10.2110/pec.95.04.0317; FRAILEY D., 1980, OCCASIONAL PAPERS MU, V85, P1; Gee J.S., 2007, TREATISE GEOPHYS GEO, P455, DOI [10.1016/B978-044452748-6.00097-3, DOI 10.1016/B978-044452748-6.00097-3, DOI 10.1016/B978-044452748-6-00097-3]; Hoffstetter R., 1986, P218; HOFFSTETTER ROBERT, 1963, BULL MUS NAT HIST NATUR, V35, P194; HOFFSTETTER ROBERT, 1952, MEM SOC GEOL FRANCE, V66, P1; MacFadden B.J., 1987, Journal of Vertebrate Paleontology, V7, P325; MacFadden BJ, 1997, J VERTEBR PALEONTOL, V17, P199, DOI 10.1080/02724634.1997.10010964; MACFADDEN BJ, 1986, PALEOBIOLOGY, V12, P355, DOI 10.1017/S0094837300003109; MacFadden BJ, 1998, J VERTEBR PALEONTOL, V18, P673, DOI 10.1080/02724634.1998.10011095; MACFADDEN BJ, 1983, QUATERNARY RES, V19, P172, DOI 10.1016/0033-5894(83)90003-0; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; MacFadden BJ, 2000, QUATERNARY RES, V54, P121, DOI 10.1006/qres.2000.2146; MACFADDEN BJ, 1989, EVOLUTION PERISSODAC, P128; MacFadden BJ, 2013, QUATERNARY RES, V79, P268, DOI 10.1016/j.yqres.2012.12.009; Gasparini GM, 2010, ALCHERINGA, V34, P7, DOI 10.1080/03115510903277717; Marshall L., 1984, PALAEOVERTEBRATA, P1, DOI DOI 10.1016/S0016-6995(84)80130-8; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; Oppenheim V, 1943, J GEOL, V51, P548, DOI 10.1086/625185; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Simpson GG., 1980, SPLENDID ISOLATION C, P266; Skinner M.F., 1972, Bulletin Am Mus nat Hist, V148, P1; Soibelzon E, 2009, QUATERN INT, V210, P51, DOI 10.1016/j.quaint.2009.06.030; TAKAI F, 1982, RES I EVOLUTIONARY B, V3, P1; Takai F., 1984, RES I EVOLUTIONARY B, V4, P1; The University of Florida (UF) Florida Museum of Natural History (FLMNH), VERT COLL DAT; Tonni EP, 2009, QUATERN INT, V210, P57, DOI 10.1016/j.quaint.2009.06.015; WEBB SD, 1991, PALEOBIOLOGY, V17, P266, DOI 10.1017/S0094837300010605; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; Yoshida A., 1982, RES I EVOL BIOL, P57	39	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59277	10.1371/journal.pone.0059277	http://dx.doi.org/10.1371/journal.pone.0059277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527150	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600066
J	Bremen, P; Middlebrooks, JC				Bremen, Peter; Middlebrooks, John C.			Weighting of Spatial and Spectro-Temporal Cues for Auditory Scene Analysis by Human Listeners	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCES; RHYTHMIC MASKING RELEASE; SOUND LOCALIZATION; DIRECTIONAL SENSITIVITY; INFORMATIONAL MASKING; COCKTAIL PARTY; SEGREGATION; SEPARATION; SPEECH; ATTENTION	The auditory system creates a neuronal representation of the acoustic world based on spectral and temporal cues present at the listener's ears, including cues that potentially signal the locations of sounds. Discrimination of concurrent sounds from multiple sources is especially challenging. The current study is part of an effort to better understand the neuronal mechanisms governing this process, which has been termed "auditory scene analysis". In particular, we are interested in spatial release from masking by which spatial cues can segregate signals from other competing sounds, thereby overcoming the tendency of overlapping spectra and/or common temporal envelopes to fuse signals with maskers. We studied detection of pulsed tones in free-field conditions in the presence of concurrent multi-tone non-speech maskers. In "energetic" masking conditions, in which the frequencies of maskers fell within the +/- 1/3-octave band containing the signal, spatial release from masking at low frequencies (similar to 600 Hz) was found to be about 10 dB. In contrast, negligible spatial release from energetic masking was seen at high frequencies (similar to 4000 Hz). We observed robust spatial release from masking in broadband "informational" masking conditions, in which listeners could confuse signal with masker even though there was no spectral overlap. Substantial spatial release was observed in conditions in which the onsets of the signal and all masker components were synchronized, and spatial release was even greater under asynchronous conditions. Spatial cues limited to high frequencies (>1500 Hz), which could have included interaural level differences and the better-ear effect, produced only limited improvement in signal detection. Substantially greater improvement was seen for low-frequency sounds, for which interaural time differences are the dominant spatial cue.	[Bremen, Peter; Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol, Irvine, CA 92717 USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Bremen, Peter; Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Middlebrooks, JC (corresponding author), Univ Calif Irvine, Dept Otolaryngol, Irvine, CA 92717 USA.	middlebj@uci.edu		Bremen, Peter/0000-0003-1709-6224	National Institutes of Health [R01-DC000420]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by National Institutes of Health Grant No. R01-DC000420 (JCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; Blauert J., 1997, SPATIAL HEARING PSYC; Bregman A. S., 1999, AUDITORY SCENE ANAL; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Cherry CE, 1953, J ACOUST SOC AM, V25, P975, DOI [10.1121/1.1907229, DOI 10.1121/1.1907229]; COLBURN H, 1978, HDB PERCEPTION, V4, P467; CULLING JF, 1995, J ACOUST SOC AM, V98, P785, DOI 10.1121/1.413571; Darwin CJ, 1999, J EXP PSYCHOL HUMAN, V25, P617, DOI 10.1037/0096-1523.25.3.617; Devore S, 2010, J NEUROSCI, V30, P7826, DOI 10.1523/JNEUROSCI.5517-09.2010; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; Harrington IA, 2008, HEARING RES, V240, P22, DOI 10.1016/j.heares.2008.02.004; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kidd G, 1998, J ACOUST SOC AM, V104, P422, DOI 10.1121/1.423246; Kidd G., 2007, SPRINGER HDB AUDITOR, P143, DOI DOI 10.1007/978-0-387-71305-2_; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUTFI RA, 1990, J ACOUST SOC AM, V88, P2607, DOI 10.1121/1.399980; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; MIDDLEBROOKS JC, 1989, J ACOUST SOC AM, V86, P89, DOI 10.1121/1.398224; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Middlebrooks JC, 2012, J ACOUST SOC AM, V132, P3896, DOI 10.1121/1.4764879; Rakerd B, 2010, J ACOUST SOC AM, V128, P3052, DOI 10.1121/1.3493447; Sach AJ, 2004, PERCEPT PSYCHOPHYS, V66, P1379, DOI 10.3758/BF03195005; Schwartz A, 2012, J ACOUST SOC AM, V132, P357, DOI 10.1121/1.4718637; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; SPIEGEL MF, 1979, J ACOUST SOC AM, V66, P1356, DOI 10.1121/1.383530; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Turgeon M, 2005, J EXP PSYCHOL HUMAN, V31, P939, DOI 10.1037/0096-1523.31.5.939; Turgeon M, 2002, J ACOUST SOC AM, V111, P1819, DOI 10.1121/1.1453450; Yost William A, 1997, BINAURAL SPATIAL HEA, P329; ZUREK PM, 1993, ACOUSTICAL FACTORS A, P255	33	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59815	10.1371/journal.pone.0059815	http://dx.doi.org/10.1371/journal.pone.0059815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527271	gold, Green Published			2022-12-27	WOS:000317562100167
J	Kumimoto, RW; Siriwardana, CL; Gayler, KK; Risinger, JR; Siefers, N; Holt, BF				Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Gayler, Krystal K.; Risinger, Jan R.; Siefers, Nicholas; Holt, Ben F., III			NUCLEAR FACTOR Y Transcription Factors Have Both Opposing and Additive Roles in ABA-Mediated Seed Germination	PLOS ONE			English	Article							PREDICTING GENE-FUNCTION; FACTOR NF-Y; ARABIDOPSIS-THALIANA; STRESS-RESPONSE; CCAAT BOX; INFORMATION RESOURCE; NETWORK INTEGRATION; REGULATORY ELEMENTS; PROMOTER SEQUENCES; NODULE DEVELOPMENT	In the model organism Arabidopsis thaliana the heterotrimeric transcription factor NUCLEAR FACTOR Y (NF-Y) has been shown to play multiple roles in facilitating plant growth and development. Although NF-Y itself represents a multi-protein transcriptional complex, recent studies have shown important interactions with other transcription factors, especially those in the bZIP family. Here we add to the growing evidence that NF-Y and bZIP form common complexes to affect many processes. We carried out transcriptional profiling on nf-yc mutants and through subsequent analyses found an enrichment of bZIP binding sites in the promoter elements of misregulated genes. Using NF-Y as bait, yeast two hybrid assays yielded interactions with bZIP proteins that are known to control ABA signaling. Accordingly, we find that plants mutant for several NF-Y subunits show characteristic phenotypes associated with the disruption of ABA signaling. While previous reports have shown additive roles for NF-YC family members in photoperiodic flowering, we found that they can have opposing roles in ABA signaling. Collectively, these results demonstrated the importance and complexity of NF-Y in the integration of environmental and hormone signals.	[Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Gayler, Krystal K.; Risinger, Jan R.; Siefers, Nicholas; Holt, Ben F., III] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Holt, BF (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	benholt@ou.edu		Siriwardana, Chamindika/0000-0002-7746-9427	National Science Foundation [IOS-0920258]; Oklahoma Center for the Advancement of Science and Technology [PSB10-013]; Direct For Biological Sciences [1149822] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under Grant No. IOS-0920258. Additional assistance was provided by the Oklahoma Center for the Advancement of Science and Technology under Grant No. PSB10-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Burkle Lukas, 2005, Funct Integr Genomics, V5, P175, DOI 10.1007/s10142-005-0134-5; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Calvenzani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042902; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; Chen H, 2011, PLANT SIGNAL BEHAV, V6, P123, DOI 10.4161/psb.6.1.14231; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Zanetti ME, 2010, PLANT CELL, V22, P4142, DOI 10.1105/tpc.110.079137; FINKELSTEIN RR, 1994, PLANT PHYSIOL, V105, P1203, DOI 10.1104/pp.105.4.1203; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim SY, 2006, PHYSIOL PLANTARUM, V126, P519, DOI 10.1111/j.1399-3054.2005.00601.x; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2012, TRENDS PLANT SCI; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li C, 2011, PLANT J; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Malamy JE, 1997, DEVELOPMENT, V124, P33; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Perry SE, 2003, BIOTECHNIQUES, V35, P278, DOI 10.2144/03352bm06; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rozen S, 2000, Methods Mol Biol, V132, P365; Sharma PD, 2011, MOL BIOL REP, V38, P5147, DOI 10.1007/s11033-010-0664-3; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Stephenson TJ, 2010, FUNCT INTEGR GENOMIC, V10, P265, DOI 10.1007/s10142-010-0158-3; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x	82	33	40	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59481	10.1371/journal.pone.0059481	http://dx.doi.org/10.1371/journal.pone.0059481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527203	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100139
J	Li, Q; Qu, HQ				Li, Quan; Qu, Hui-Qi			Human Coding Synonymous Single Nucleotide Polymorphisms at Ramp Regions of mRNA Translation	PLOS ONE			English	Article							SECONDARY STRUCTURE; MUTATIONS; EFFICIENCY; SELECTION; GENE	According to the ramp model of mRNA translation, the first 50 codons favor rare codons and have slower speed of translation. This study aims to detect translational selection on coding synonymous single nucleotide polymorphisms (sSNP) to support the ramp theory. We investigated fourfold degenerate site (FFDS) sSNPs with A <-> G or C <-> T substitutions in human genome for distribution bias of synonymous codons (SC), grouped by CpG or non-CpG sites. Distribution bias of sSNPs between the 3rd similar to 50th codons and the 51st similar to remainder codons at non-CpG sites were observed. In the 3rd similar to 50th codons, G -> A sSNPs at non-CpG sites are favored than A -> G sSNPs [P = 2.89x10(-3)], and C -> T at non-CpG sites are favored than T -> C sSNPs [P = 8.50x10(-3)]. The favored direction of SC usage change is from more frequent SCs to less frequent SCs. The distribution bias is more obvious in synonymous substitutions CG(G -> A), AC(C -> T), and CT(C -> T). The distribution bias of sSNPs in human genome, i.e. frequent SCs to less frequent SCs is favored in the 3rd similar to 50th codons, indicates translational selection on sSNPs in the ramp regions of mRNA templates.	[Li, Quan] McGill Univ, Montreal Childrens Hosp, Endocrine Genet Lab, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Qu, Hui-Qi] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77225 USA	McGill University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Qu, HQ (corresponding author), Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77225 USA.	huiqi.qu@uth.tmc.edu	Qu, Hui-Qi/B-4719-2009; Li, Quan/B-3605-2009	Qu, Hui-Qi/0000-0001-9317-4488; 	Eli Lilly Canada; University of Texas School of Public Health	Eli Lilly Canada(Eli Lilly); University of Texas School of Public Health	L.Q. holds a fellowship from Eli Lilly Canada, and H.Q.Q. is supported by intramural funding from the University of Texas School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behura SK, 2012, BIOL REV; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Qu HQ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-213; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Strachan T, 1999, HUMAN MOL GENETICS; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Waldman YY, 2011, GENOME BIOL EVOL, V3, P749, DOI 10.1093/gbe/evr076	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59706	10.1371/journal.pone.0059706	http://dx.doi.org/10.1371/journal.pone.0059706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527255	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100162
J	Luppa, M; Luck, T; Ritschel, F; Angermeyer, MC; Villringer, A; Riedel-Heller, SG				Luppa, Melanie; Luck, Tobias; Ritschel, Franziska; Angermeyer, Matthias C.; Villringer, Arno; Riedel-Heller, Steffi G.			Depression and Incident Dementia. An 8-Year Population-Based Prospective Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; ALZHEIMERS-DISEASE; RISK-FACTOR; SYMPTOMS; DECLINE; METAANALYSIS; PREVALENCE; ICD-10; MOOD	Aims: The aim of the study was to investigate the impact of depression (categorical diagnosis; major depression, MD) and depressive symptoms (dimensional diagnosis and symptom patterns) on incident dementia in the German general population. Methods: Within the Leipzig Longitudinal Study of the Aged (LEILA 75+), a representative sample of 1,265 individuals aged 75 years and older were interviewed every 1.5 years over 8 years (mean observation time 4.3 years; mean number of visits 4.2). Cox proportional hazards and binary logistic regressions were used to estimate the effect of baseline depression and depressive symptoms on incident dementia. Results: The incidence of dementia was 48 per 1,000 person-years (95% confidence interval (CI) 45-51). Depressive symptoms (Hazard ratio HR 1.03, 95% CI 1.01-1.05), and in particular mood-related symptoms (HR 1.08, 95% CI 1.03-1.14), showed a significant impact on the incidence of dementia only in univariate analysis, but not after adjustment for cognitive and functional impairment. MD showed only a significant impact on incidence of dementia in Cox proportional hazards regression, but not in binary logistic regression models. Discussion: The present study using different diagnostic measures of depression on future dementia found no clear significant associations of depression and incident dementia. Further in-depth investigation would help to understand the nature of depression in the context of incident dementia.	[Luppa, Melanie; Luck, Tobias; Ritschel, Franziska; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Luck, Tobias] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Angermeyer, Matthias C.] Ctr Publ Mental Hlth, Goesing Aw, Austria; [Angermeyer, Matthias C.] Univ Cagliary, Dept Publ Hlth, Cagliari, Italy; [Villringer, Arno] Univ Leipzig, Max Planck Inst Human Cognit & Brain Sci, D-04109 Leipzig, Germany; [Villringer, Arno] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany; [Riedel-Heller, Steffi G.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany	Leipzig University; McGill University; University of Cagliari; Leipzig University; Max Planck Society; Leipzig University; Leipzig University	Luppa, M (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Melanie.Luppa@medizin.uni-leipzig.de	Luppa, Melanie/AAQ-7338-2021; Riedel-Heller, Steffi/ABG-1537-2021	Luck, Tobias/0000-0001-7551-4397; Villringer, Arno/0000-0003-2604-2404	AgeMooDe study [01GY1155A]; European Union; European Regional Development Fund(ERDF); Free State of Saxony within the framework of the excellence initiative; Interdisciplinary Centre for Clinical Research Leipzig [C07]; German Research Foundation [Lu 1730/1-1]	AgeMooDe study; European Union(European Commission); European Regional Development Fund(ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; Interdisciplinary Centre for Clinical Research Leipzig; German Research Foundation(German Research Foundation (DFG))	This work is published in affiliation with LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig, and the Study on Late-Life Depression in Primary Care (AgeMooDe study, grant: 01GY1155A). LIFE is funded by means of the European Union, by the European Regional Development Fund(ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. Role of funding source: The field work was funded by the Interdisciplinary Centre for Clinical Research Leipzig (Project C07). The funding body had no further role in study design; in the collection, analysis and interpretation of data; in writing of the report; and the decision to submit the paper for publication. Tobias Luck was supported by a research fellowship of the German Research Foundation (grant: Lu 1730/1-1).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Becker JT, 2009, AM J GERIAT PSYCHIAT, V17, P653, DOI 10.1097/JGP.0b013e3181aad1fe; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Chen RL, 2008, BRIT J PSYCHIAT, V193, P373, DOI 10.1192/bjp.bp.107.044974; Coyne JC, 2012, J PSYCHOSOM RES, V73, P401, DOI 10.1016/j.jpsychores.2012.09.016; Dal Forno G, 2005, ANN NEUROL, V57, P381, DOI 10.1002/ana.20405; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Ganguli M, 2006, ARCH GEN PSYCHIAT, V63, P153, DOI 10.1001/archpsyc.63.2.153; Geerlings MI, 2000, BRIT J PSYCHIAT, V176, P568, DOI 10.1192/bjp.176.6.568; Hautzinger M, 2012, ALLGEMEINE DEPRESSIO, V2nd; Heser K, 2012, PSYCHOL MED IN PRESS; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Luppa M, 2011, PSYCHIAT PRAX, V38, P185, DOI 10.1055/s-0030-1248496; Matschinger H, 2000, INT J METH PSYCH RES, V9, P199; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Potter GG, 2007, NEUROLOGIST, V13, P105, DOI 10.1097/01.nrl.0000252947.15389.a9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riedel-Heller SG, 2001, BRIT J PSYCHIAT, V179, P250, DOI 10.1192/bjp.179.3.250; Riedel-Heller SG, 2011, PSYCHIAT PRAX, V38, P317, DOI 10.1055/s-0031-1276937; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Schneekloth U, 1996, HELP NEED CARE I RES; Spitzer R. L., 1987, STRUCTURED CLIN INTE; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; Sweet RA, 2004, NEUROPSYCHOPHARMACOL, V29, P2242, DOI 10.1038/sj.npp.1300554; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Watson LC, 2003, J FAM PRACTICE, V52, P956; Weyerer S., 1992, DIAGNOSTICA, V38, P354; Wilson RS, 2002, NEUROLOGY, V59, P364, DOI 10.1212/WNL.59.3.364; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; ZAUDIG M, 1991, PSYCHOL MED, V21, P225, DOI 10.1017/S0033291700014811	37	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59246	10.1371/journal.pone.0059246	http://dx.doi.org/10.1371/journal.pone.0059246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527147	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100098
J	Sirgel, FA; Warren, RM; Bottger, EC; Klopper, M; Victor, TC; van Helden, PD				Sirgel, Frederick A.; Warren, Robin M.; Boettger, Erik C.; Klopper, Marisa; Victor, Thomas C.; van Helden, Paul D.			The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPICIN-RESISTANCE; CROSS-RESISTANCE; RPOB MUTATIONS; SUSCEPTIBILITY; GENE; ETHAMBUTOL; STRAINS	Genetically related Mycobacterium tuberculosis strains with alterations at codon 516 in the rpoB gene were observed amongst a substantial number of patients with drug resistant tuberculosis in the Eastern Cape Province (ECP) of South Africa. Mutations at codon 516 are usually associated with lower level rifampicin (RIF) resistance, while susceptibility to rifabutin (RFB) remains intact. This study was conducted to assess the rationale for using RFB as a substitution for RIF in the treatment of MDR and XDR tuberculosis outbreaks. Minimum inhibitory concentrations (MICs) of 34 drug resistant clinical isolates of M tuberculosis were determined by MGIT 960 and correlated with rpoB mutations. RFB MICs ranged from 0.125 to 0.25 mu g/ml in the 34 test isolates thereby confirming phenotypic susceptibility as per critical concentration (CC) of 0.5 mu g/ml. The corresponding RIF MICs ranged between 5 and 15 mu g/ml, which is well above the CC of 1.0 mu g/ml. Molecular-based drug susceptibility testing provides important pharmacogenetic insight by demonstrating a direct correlation between defined rpoB mutation and the level of RFB susceptibility. We suggest that isolates with marginally reduced susceptibility as compared to the epidemiological cut-off for wild-type strains (0.064 mu g/ml), but lower than the current CC (<= 0.5 mu g/ml), are categorised as intermediate. Two breakpoints (0.064 mu g/ml and 0.5 mu g/ml) are recommended to distinguish between susceptible, intermediate and RFB resistant strains. This concept may assist clinicians and policy makers to make objective therapeutic decisions, especially in situations where therapeutic options are limited. The use of RFB in the ECP may improve therapeutic success and consequently minimise the risk of ongoing transmission of drug resistant M. tuberculosis strains.	[Sirgel, Frederick A.; Warren, Robin M.; Klopper, Marisa; Victor, Thomas C.; van Helden, Paul D.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Fac Hlth Sci, ZA-7600 Stellenbosch, South Africa; [Boettger, Erik C.] Univ Zurich, Inst Med Mikrobiol, Zurich, Switzerland; [Boettger, Erik C.] Univ Zurich, Natl Zentrum Mykobakterien, Zurich, Switzerland	National Research Foundation - South Africa; Stellenbosch University; University of Zurich; University of Zurich	Sirgel, FA (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Fac Hlth Sci, ZA-7600 Stellenbosch, South Africa.	fas@sun.ac.za	Klopper, Marisa/U-9887-2018; Böttger, Erik C./F-6175-2011	Klopper, Marisa/0000-0002-9318-8289; Warren, Robin/0000-0001-5741-7358	National Research Foundation of South Africa; Medical Research Council of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa(South African Medical Research Council)	The work was supported by the National Research Foundation of South Africa and the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeby K, 2012, B WORLD HEALTH ORGAN, V90, P693, DOI 10.2471/BLT.11.096644; Anthony Richard M, 2005, Ann Clin Microbiol Antimicrob, V4, P9, DOI 10.1186/1476-0711-4-9; Bahrmand AR, 2009, J CLIN MICROBIOL, V47, P2744, DOI 10.1128/JCM.r00548-09; Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; Chen HY, 2012, J CLIN MICROBIOL, V50, P2085, DOI 10.1128/JCM.00652-12; Jo KW, 2013, RESP MED, V107, P292, DOI 10.1016/j.rmed.2012.10.021; Klopper M, 2013, EMERGING IN IN PRESS, V19; Kunin CM, 1996, CLIN INFECT DIS, V22, pS3, DOI 10.1093/clinids/22.Supplement_1.S3; Mudge Stephen M., 2008, P1; Patra SK, 2010, INDIAN J CLIN BIOCHE, V25, P315, DOI 10.1007/s12291-010-0065-3; Perlman DC, 2005, CLIN INFECT DIS, V41, P1638, DOI 10.1086/498024; Sirgel FA, 2012, CHEMOTHERAPY, V58, P358, DOI 10.1159/000343474; Sirgel FA, 2012, J ANTIMICROB CHEMOTH, V67, P1088, DOI 10.1093/jac/dks033; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Tan YJ, 2012, J CLIN MICROBIOL, V50, P81, DOI 10.1128/JCM.05092-11; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; van Ingen J, 2011, INT J TUBERC LUNG D, V15, P990, DOI 10.5588/ijtld.10.0127; van Ingen J, 2011, LANCET INFECT DIS, V11, P585, DOI 10.1016/S1473-3099(11)70200-6; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Yoshida S, 2010, J INFECT CHEMOTHER, V16, P360, DOI 10.1007/s10156-010-0057-5; Zaczek A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-10	24	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59414	10.1371/journal.pone.0059414	http://dx.doi.org/10.1371/journal.pone.0059414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527189	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000317562100129
J	Beck, TF; Shchelochkov, OA; Yu, ZY; Kim, BJ; Hernandez-Garcia, A; Zaveri, HP; Bishop, C; Overbeek, PA; Stockton, DW; Justice, MJ; Scott, DA				Beck, Tyler F.; Shchelochkov, Oleg A.; Yu, Zhiyin; Kim, Bum Jun; Hernandez-Garcia, Andres; Zaveri, Hitisha P.; Bishop, Colin; Overbeek, Paul A.; Stockton, David W.; Justice, Monica J.; Scott, Daryl A.			Novel Frem1-Related Mouse Phenotypes and Evidence of Genetic Interactions with Gata4 and Slit3	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; FRASER-SYNDROME; MYELENCEPHALIC BLEBS; PROTEIN-STRUCTURE; NG2 PROTEOGLYCAN; MOTA SYNDROME; VI COLLAGEN; MUTATIONS; STABILITY; MODEL	The FRAS1-related extracellular matrix 1 (FREM1) gene encodes an extracellular matrix protein that plays a critical role in the development of multiple organ systems. In humans, recessive mutations in FREM1 cause eye defects, congenital diaphragmatic hernia, renal anomalies and anorectal malformations including anteriorly placed anus. A similar constellation of findings-microphthalmia, cryptophthalmos, congenital diaphragmatic hernia, renal agenesis and rectal prolapse-have been described in FREM1-deficient mice. In this paper, we identify a homozygous Frem1 missense mutation (c.1687A>T, p.Ile563Phe) in an N-ethyl-N-nitrosourea (ENU)-derived mouse strain, crf11, with microphthalmia, cryptophthalmos, renal agenesis and rectal prolapse. This mutation affects a highly conserved residue in FREM1's third CSPG domain. The p.Ile563Phe change is predicted to be deleterious and to cause decreased FREM1 protein stability. The crf11 allele also fails to complement the previously described eyes2 allele of Frem1 (p.Lys826*) providing further evidence that the crf11 phenotype is due to changes affecting Frem1 function. We then use mice bearing the crf11 and eyes2 alleles to identify lung lobulation defects and decreased anogenital distance in males as novel phenotypes associated with FREM1 deficiency in mice. Due to phenotypic overlaps between FREM1-deficient mice and mice that are deficient for the retinoic acid-responsive transcription factor GATA4 and the extracellular matrix protein SLIT3, we also perform experiments to look for in vivo genetic interactions between the genes that encode these proteins. These experiments reveal that Frem1 interacts genetically with Gata4 in the development of lung lobulation defects and with Slit3 in the development of renal agenesis. These results demonstrate that FREM1-deficient mice faithfully recapitulate many of the phenotypes seen in individuals with FREM1 deficiency and that variations in GATA4 and SLIT3 expression modulate some FREM1-related phenotypes in mice.	[Beck, Tyler F.; Yu, Zhiyin; Kim, Bum Jun; Hernandez-Garcia, Andres; Zaveri, Hitisha P.; Overbeek, Paul A.; Justice, Monica J.; Scott, Daryl A.] Baylor Coll Med, Dept Mol Genet, Houston, TX 77030 USA; [Beck, Tyler F.; Yu, Zhiyin; Kim, Bum Jun; Hernandez-Garcia, Andres; Zaveri, Hitisha P.; Overbeek, Paul A.; Justice, Monica J.; Scott, Daryl A.] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA; [Overbeek, Paul A.; Scott, Daryl A.] Baylor Coll Med, Houston, TX 77030 USA; [Shchelochkov, Oleg A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Bishop, Colin] Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Stockton, David W.] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Stockton, David W.] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Iowa; Wake Forest University; Wayne State University; Wayne State University	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol Genet, Houston, TX 77030 USA.	dscott@bcm.edu	HERNANDEZ-GARCIA, ANDRES/B-9051-2014	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Beck, Tyler/0000-0002-7373-0640; Overbeek, Paul/0000-0001-9784-2084	National Institutes of Health (NIH) [R01HD064667, U01HD39372, R03EY014854]; BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5P30 HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064667, P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD039372] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY014854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health (NIH; http://www.nih.gov/) grants R01HD064667 to DAS, U01HD39372 to MJJ and R03EY014854 to DWS. The project described was also supported by the BCM IDDRC, grant number 5P30 HD024064 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Al-Gazali LI, 2002, CLIN DYSMORPHOL, V11, P33, DOI 10.1097/00019605-200201000-00007; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Beck TF, 2012, HUM MOL GENET; Blanc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041643; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; CENTER EM, 1992, HISTOL HISTOPATHOL, V7, P231; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Fryns JP, 2001, GENET COUNSEL, V12, P101; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Hampton Brittany Star, 2009, Med Health R I, V92, P5; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Hughes IA, 2012, SEMIN REPROD MED, V30, P432, DOI [10.1055/s-0032-1324728, 10.1016/S0140-6736(12)60071-3]; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; Kiyozumi D, 2012, J CELL BIOL, V197, P677, DOI 10.1083/jcb.201203065; Lehraiki A, 2011, TOXICOL IN VITRO, V25, P1542, DOI 10.1016/j.tiv.2011.05.017; Li CM, 2007, AM J MED GENET A, V143A, P853, DOI 10.1002/ajmg.a.31446; Little CC, 1923, AM J ROENTGENOL RADI, V10, P975; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; MARLES SL, 1992, AM J MED GENET, V42, P793, DOI 10.1002/ajmg.1320420609; Mateo RK, 2012, MOL VIS, V18, P1301; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NISHIYAMA A, 1993, MOL BIOL CELL, V4, P1097, DOI 10.1091/mbc.4.11.1097; Pask AJ, 2005, MOL ENDOCRINOL, V19, P972, DOI 10.1210/me.2004-0192; Petrou P, 2005, J BIOL CHEM, V280, P10350, DOI 10.1074/jbc.M412368200; Petrou P, 2007, EXP CELL RES, V313, P910, DOI 10.1016/j.yexcr.2006.12.008; PHILIP N, 1991, EUR J PEDIATR, V150, P726, DOI 10.1007/BF01958765; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Pitera JE, 2012, J AM SOC NEPHROL, V23, P1790, DOI 10.1681/ASN.2012020146; Pitera JE, 2008, HUM MOL GENET, V17, P3953, DOI 10.1093/hmg/ddn297; Probst FJ, 2010, METHOD ENZYMOL, V477, P297, DOI 10.1016/S0076-6879(10)77015-4; Short K, 2007, IUBMB LIFE, V59, P427, DOI 10.1080/15216540701510581; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Slavotinek AM, 2011, J MED GENET, V48, P375, DOI 10.1136/jmg.2011.089631; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Stoll C, 2008, GENET COUNSEL, V19, P331; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; THOMAS IT, 1986, AM J MED GENET, V25, P85, DOI 10.1002/ajmg.1320250111; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Timmer JR, 2005, P NATL ACAD SCI USA, V102, P11746, DOI 10.1073/pnas.0505404102; van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x; VARNUM DS, 1981, J HERED, V72, P293, DOI 10.1093/oxfordjournals.jhered.a109505; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Vogel MJ, 2012, J MED GENET, V49, P303, DOI 10.1136/jmedgenet-2011-100590; Vogel MJ, 2012, J MED GENET; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wat MJ, 2012, HUM MOL GENET, V21, P4115, DOI 10.1093/hmg/dds241; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; WINTER RM, 1990, CLIN GENET, V37, P494; WINTER RM, 1988, J MED GENET, V25, P480, DOI 10.1136/jmg.25.7.480; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	64	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58830	10.1371/journal.pone.0058830	http://dx.doi.org/10.1371/journal.pone.0058830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536828	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100093
J	Carpi, A; Rossi, G; Nicolini, A; Iervasi, G; Russo, M; Mechanick, J				Carpi, Angelo; Rossi, Giuseppe; Nicolini, Andrea; Iervasi, Giorgio; Russo, Matteo; Mechanick, Jeffrey			Does Large Needle Aspiration Biopsy Add Pain to the Thyroid Nodule Evaluation?	PLOS ONE			English	Article							PREOPERATIVE SELECTION; MICROFOLLICULAR NODULE; SUSPECTED CANCER; CYTOLOGY; PERFORMANCE; DIAGNOSIS; HISTOLOGY	Thyroid large needle aspiration biopsy is disregarded because it is thought to be associated with pain. This is in contrast with our 32 years long experience. We surveyed reports of pain in patients examined with fine needle aspiration biopsy (78, 87.2% women, mean age 59 years) or FNAB+large needle aspiration biopsy (48, 87.5% women, mean age 60 years). Each patient was questioned regarding a) no unpleasant sensation (score "0"); b) unpleasant sensation ("1"); c) mild pain (no analgesic used; "2"); or d) pain (analgesic used; "3"). The mean size of the needle used was for FNAB 22.3 +/- 0.7 or 20.8 +/- 1 gauge in the fine needle aspiration or fine needle aspiration plus large needle aspiration biopsy group, respectively (p<.0001). The number of percutaneous punctures was higher in the fine needle aspiration plus large needle aspiration biopsy group. However, the pain score in the fine needle aspiration biopsy or fine needle aspiration biopsy plus large needle aspiration biopsy group was not significantly different. Large needle aspiration biopsy after fine needle aspiration biopsy does not add any discomfort or pain and therefore in light of the demonstrable benefits, should be included in clinical algorithms for the evaluation of thyroid nodules.	[Carpi, Angelo; Nicolini, Andrea] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Natl Res Council, Unit epidemiol & Biostat, I-56100 Pisa, Italy; [Rossi, Giuseppe; Iervasi, Giorgio] G Monasterio Fdn, Pisa, Italy; [Iervasi, Giorgio] CNR, Inst Clin Physiol, Natl Res Council, I-56100 Pisa, Italy; [Russo, Matteo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Russo, Matteo] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy; [Mechanick, Jeffrey] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Sapienza University Rome; IRCCS San Raffaele Pisana; Icahn School of Medicine at Mount Sinai	Carpi, A (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	angelo.carpi@med.unipi.it	Rossi, Giuseppe/G-7838-2012	Nicolini, Andrea/0000-0002-5178-9510				Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Carpi A, 2008, CANCER LETT, V264, P163, DOI 10.1016/j.canlet.2008.02.056; Carpi A, 2007, HISTOPATHOLOGY, V51, P249, DOI 10.1111/j.1365-2559.2007.02764.x; Carpi A, 2006, BRIT J CANCER, V95, P204, DOI 10.1038/sj.bjc.6603232; Carpi A, 2005, BIOMED PHARMACOTHER, V59, P517, DOI 10.1016/j.biopha.2005.04.003; Carpi A, 2000, AM J CLIN PATHOL, V113, P872, DOI 10.1309/JCU6-Y4DC-LEVM-HBFJ; Carpi A, 2004, BIOMED PHARMACOTHER, V58, P351, DOI 10.1016/j.biopha.2004.05.003; Carpi A, 1996, J CLIN ONCOL, V14, P1704, DOI 10.1200/JCO.1996.14.5.1704; Carpi A, 1998, BIOMED PHARMACOTHER, V52, P303, DOI 10.1016/S0753-3322(98)80025-5; Carpi A, 2011, HISTOPATHOLOGY, V59, P892, DOI 10.1111/j.1365-2559.2011.04014.x; Carpi A, 2010, ANN MED, V42, P70, DOI 10.3109/07853890903439778; Gasbarri A, 2004, BIOMED PHARMACOTHER, V58, P356, DOI 10.1016/j.biopha.2004.05.004; Gharib H, 2008, EUR J ENDOCRINOL, V159, P493, DOI 10.1530/EJE-08-0135; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; GHARIB H, 2008, ENDOCR PRACT, V14, P802; Hamburger JL, 1979, PATHOLOGICAL EVALUAT, P74; Hamburger Joel I., 1996, P447; Lo Gerfo P, 1989, DIAGNOSTIC METHODS C, P205; Martin HE, 1930, ANN SURG, V92, P169, DOI 10.1097/00000658-193008000-00002; MILLER JM, 1985, CANCER, V55, P2812, DOI 10.1002/1097-0142(19850615)55:12<2812::AID-CNCR2820551216>3.0.CO;2-N	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58016	10.1371/journal.pone.0058016	http://dx.doi.org/10.1371/journal.pone.0058016			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536779	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100023
J	Murakoshi, T; Masuda, T; Utsumi, K; Tsubota, K; Wada, Y				Murakoshi, Takuma; Masuda, Tomohiro; Utsumi, Ken; Tsubota, Kazuo; Wada, Yuji			Glossiness and Perishable Food Quality: Visual Freshness Judgment of Fish Eyes Based on Luminance Distribution	PLOS ONE			English	Article							IMAGE STATISTICS; REFRACTIVE-INDEX; PERCEPTION; EVALUATE; REPRESENTATION; PREFERENCE; COLOR	Background: Previous studies have reported the effects of statistics of luminance distribution on visual freshness perception using pictures which included the degradation process of food samples. However, these studies did not examine the effect of individual differences between the same kinds of food. Here we elucidate whether luminance distribution would continue to have a significant effect on visual freshness perception even if visual stimuli included individual differences in addition to the degradation process of foods. Methodology/principal findings: We took pictures of the degradation of three fishes over 3.29 hours in a controlled environment, then cropped square patches of their eyes from the original images as visual stimuli. Eleven participants performed paired comparison tests judging the visual freshness of the fish eyes at three points of degradation. Perceived freshness scores (PFS) were calculated using the Bradley-Terry Model for each image. The ANOVA revealed that the PFS for each fish decreased as the degradation time increased; however, the differences in the PFS between individual fish was larger for the shorter degradation time, and smaller for the longer degradation time. A multiple linear regression analysis was conducted in order to determine the relative importance of the statistics of luminance distribution of the stimulus images in predicting PFS. The results show that standard deviation and skewness in luminance distribution have a significant influence on PFS. Conclusions/significance: These results show that even if foodstuffs contain individual differences, visual freshness perception and changes in luminance distribution correlate with degradation time.	[Murakoshi, Takuma; Masuda, Tomohiro; Utsumi, Ken; Wada, Yuji] Natl Agr & Food Res Org, Natl Food Res Inst, Food Funct Div, Ibaraki, Japan; [Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Keio University	Wada, Y (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Food Funct Div, Ibaraki, Japan.	yujiwd@affrc.go.jp			Japan Society for Promotion of Science [23730718, 22300072]; Grants-in-Aid for Scientific Research [22300072] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grant-in-aids for Young Scientists (B) from the Japan Society for Promotion of Science 23730718 and Grant-in-Aid for Scientific Research (B) from the Japan Society for Promotion of Science: 22300072, awarded to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Arce-Lopera C, 2013, FOOD QUAL PREFER, V27, P202, DOI 10.1016/j.foodqual.2012.03.005; Arce-Lopera C, 2012, I-PERCEPTION, V3, P338, DOI 10.1068/i0471; Baixas-Nogueras S, 2003, J FOOD SCI, V68, P1067, DOI 10.1111/j.1365-2621.2003.tb08289.x; Ben-gigirey B, 1999, J FOOD SCI, V64, P20, DOI 10.1111/j.1365-2621.1999.tb09853.x; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P2319, DOI 10.1093/cercor/bhp298; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P433, DOI 10.1093/cercor/bhp111; Courcoux P, 1997, FOOD QUAL PREFER, V8, P353, DOI 10.1016/S0950-3293(97)00004-9; Gokoglu N, 2004, EUR FOOD RES TECHNOL, V218, P295, DOI 10.1007/s00217-003-0844-7; Goto E, 2011, AM J OPHTHALMOL, V151, P691, DOI 10.1016/j.ajo.2010.09.027; Halbrendt C, 1995, AM J AGR ECON, V77, P1313, DOI 10.2307/1243367; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Huss H. H., 1988, FAO FISHERIES SERIES, V29; Kentridge RW, 2012, CORTEX, V48, P1244, DOI 10.1016/j.cortex.2012.01.011; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; Lebiedzinska Anna, 2006, Polish Journal of Food and Nutrition Sciences, V15, P91; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Olafsdottir G, 1997, TRENDS FOOD SCI TECH, V8, P258, DOI 10.1016/S0924-2244(97)01049-2; Peneau S, 2007, POSTHARVEST BIOL TEC, V45, P20, DOI 10.1016/j.postharvbio.2007.02.001; Sakano Y, 2010, J VISION, V10, DOI 10.1167/10.9.15; Tani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054549; Wada Y, 2010, APPETITE, V54, P363, DOI 10.1016/j.appet.2010.01.002; WAGNER MW, 1965, SCIENCE, V148, P1473, DOI 10.1126/science.148.3676.1473; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13; Yapar A, 1998, FOOD RES INT, V31, P693, DOI 10.1016/S0963-9969(99)00047-2	27	24	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58994	10.1371/journal.pone.0058994	http://dx.doi.org/10.1371/journal.pone.0058994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536845	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100108
J	Scheetz, TE; Fingert, JH; Wang, K; Kuehn, MH; Knudtson, KL; Alward, WLM; Boldt, HC; Russell, SR; Folk, JC; Casavant, TL; Braun, TA; Clark, AF; Stone, EM; Sheffield, VC				Scheetz, Todd E.; Fingert, John H.; Wang, Kai; Kuehn, Markus H.; Knudtson, Kevin L.; Alward, Wallace L. M.; Boldt, H. Culver; Russell, Stephen R.; Folk, James C.; Casavant, Thomas L.; Braun, Terry A.; Clark, Abbot F.; Stone, Edwin M.; Sheffield, Val C.			A Genome-Wide Association Study for Primary Open Angle Glaucoma and Macular Degeneration Reveals Novel Loci	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; OCULAR HYPERTENSION TREATMENT; TRANSCRIPTION FACTOR GENE; COMMON VARIANTS; SEQUENCE VARIANTS; WDR36 GENE; ONSET; RISK; SUSCEPTIBILITY; MAPS	Glaucoma and age-related macular degeneration (AMD) are the two leading causes of visual loss in the United States. We utilized a novel study design to perform a genome-wide association for both primary open angle glaucoma (POAG) and AMD. This study design utilized a two-stage process for hypothesis generation and validation, in which each disease cohort was utilized as a control for the other. A total of 400 POAG patients and 400 AMD patients were ascertained and genotyped at 500,000 loci. This study identified a novel association of complement component 7 (C7) to POAG. Additionally, an association of central corneal thickness, a known risk factor for POAG, was found to be associated with ribophorin II (RPN2). Linked monogenic loci for POAG and AMD were also evaluated for evidence of association, none of which were found to be significantly associated. However, several yielded putative associations requiring validation. Our data suggest that POAG is more genetically complex than AMD, with no common risk alleles of large effect.	[Scheetz, Todd E.; Fingert, John H.; Kuehn, Markus H.; Alward, Wallace L. M.; Boldt, H. Culver; Russell, Stephen R.; Folk, James C.; Casavant, Thomas L.; Braun, Terry A.; Stone, Edwin M.; Sheffield, Val C.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Scheetz, Todd E.; Casavant, Thomas L.; Braun, Terry A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Scheetz, Todd E.; Casavant, Thomas L.; Braun, Terry A.] Univ Iowa, Ctr Bioinformat & Computat Biol, Iowa City, IA USA; [Wang, Kai] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Knudtson, Kevin L.] Univ Iowa, DNA Core Facil, Iowa City, IA USA; [Casavant, Thomas L.] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Clark, Abbot F.] Univ Iowa, Dept Cell Biol & Anat, Iowa City, IA USA; [Clark, Abbot F.] Univ N Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Iowa City, IA 52242 USA; [Stone, Edwin M.; Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of North Texas System; University of North Texas Health Science Center; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Fingert, John/F-8787-2012; Alward, Wallace/AAY-4149-2020; Fingert, John/AAX-4750-2021	Fingert, John/0000-0002-0377-0479; Fingert, John/0000-0002-0377-0479; Alward, Wallace/0000-0001-6368-9018; Boldt, H. Culver/0000-0002-7292-2093; Sheffield, Val/0000-0002-6282-0835; Kuehn, Markus/0000-0003-3940-198X; Stone, Edwin M./0000-0003-3343-4414; Russell, Stephen/0000-0003-3776-1367; Folk, James/0000-0002-6271-2906; Scheetz, Todd/0000-0002-1965-5811	National Institutes of Health [R01-EY-010564, R01-EY-016822, R01-EY-018825]; Carver Endowment for Molecular Ophthalmology; Research to Prevent Blindness (Department of Ophthalmology, University of Iowa); Foundation Fighting Blindness; Alcon Research, Ltd. (Ft. Worth, Texas); Alcon Research Ltd; NATIONAL EYE INSTITUTE [R01EY019485, R01EY016822, R01EY018825, R01EY022044, R01EY024259, R01EY010564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Endowment for Molecular Ophthalmology; Research to Prevent Blindness (Department of Ophthalmology, University of Iowa)(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Alcon Research, Ltd. (Ft. Worth, Texas); Alcon Research Ltd(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health [R01-EY-010564 to VCS, R01-EY-016822 to EMS, R01-EY-018825 to JHF]; the Carver Endowment for Molecular Ophthalmology to EMS and VCS; Research to Prevent Blindness (Department of Ophthalmology, University of Iowa, Career Development Awards to TES and JHF, and the Lew Wasserman Award to WLMA); and Foundation Fighting Blindness. VCS and EMS are investigators of the Howard Hughes Medical Institute. Alcon Research, Ltd. (Ft. Worth, Texas) provided funds for the purchase of the SNP genotyping chips used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by Alcon Research Ltd, specifically in acquisition of the genotyping arrays. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Affymetrix, 2009, AFF POW TOOLS; Affymetrix, 2007, BRLMM P GEN CALL MET; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Allingham RR, 2005, INVEST OPHTH VIS SCI, V46, P2002, DOI 10.1167/iovs.04-1477; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas DC, 2010, OPHTHALMOLOGY, V117, P500, DOI 10.1016/j.ophtha.2009.08.032; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daiger S. P., 1998, IOVS, V39, pS295; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fan BJ, 2007, MOL VIS, V13, P779; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Fingert JH, 2012, HUM MOL GENET; Fingert JH, 2007, ARCH OPHTHALMOL-CHIC, V125, P434, DOI 10.1001/archopht.125.3.434-b; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Firasat S, 2008, MOL VIS, V14, P1659; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson J, 2010, BRIT J OPHTHALMOL, V94, P1382, DOI 10.1136/bjo.2010.182568; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gordon MO, 1999, ARCH OPHTHALMOL-CHIC, V117, P573; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Graber JJ, 2009, PHARMACOL THERAPEUT, V121, P147, DOI 10.1016/j.pharmthera.2008.10.001; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; Hewitt AW, 2006, AM J OPHTHALMOL, V142, P324, DOI 10.1016/j.ajo.2006.02.041; Hewitt AW, 2006, CLIN EXP OPHTHALMOL, V34, P472, DOI 10.1111/j.1442-9071.2006.01268.x; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kuehn MH, 2008, EXP EYE RES, V87, P89, DOI 10.1016/j.exer.2008.04.012; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Libby RT, 2005, ANNU REV GENOM HUM G, V6, P15, DOI 10.1146/annurev.genom.6.080604.162209; Liu Y, AM J HUM GENET, V86, P500; Liu Y, AM J HUM GENET, V86, P498; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; MORGAN BP, 1989, BIOCHEM J, V264, P1; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilov I, 2002, 3 GENETIC LOCUS GLC3, P43; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Ulmer M, 2012, INVEST OPHTHALMOL VI; Wang DY, 2006, INVEST OPHTH VIS SCI, V47, P5315, DOI 10.1167/iovs.06-0179; Wang K, 2009, GENET EPIDEMIOL, V33, P637, DOI 10.1002/gepi.20415; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Wiggs JL, 2004, AM J HUM GENET, V74, P1314, DOI 10.1086/421533; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Wirtz MK, 1999, ARCH OPHTHALMOL-CHIC, V117, P237; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zhang H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-51	91	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58657	10.1371/journal.pone.0058657	http://dx.doi.org/10.1371/journal.pone.0058657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536807	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100074
J	Schumm, P; Schumm, W; Scoglio, C				Schumm, Phillip; Schumm, Walter; Scoglio, Caterina			Impact of Preventive Responses to Epidemics in Rural Regions	PLOS ONE			English	Article							INFLUENZA VACCINE; VIRUS; TRANSMISSION; ROBUSTNESS; RESPECT; SPREAD	Various epidemics have arisen in rural locations through human-animal interaction, such as the H1N1 outbreak of 2009. Through collaboration with local government officials, we have surveyed a rural county and its communities and collected a dataset characterizing the rural population. From the respondents' answers, we build a social (face-to-face) contact network. With this network, we explore the potential spread of epidemics through a Susceptible-Latent-Infected-Recovered (SLIR) disease model. We simulate an exact model of a stochastic SLIR Poisson process with disease parameters representing a typical influenza-like illness. We test vaccine distribution strategies under limited resources. We examine global and location-based distribution strategies, as a way to reach critical individuals in the rural setting. We demonstrate that locations can be identified through contact metrics for use in vaccination strategies to control contagious diseases.	[Schumm, Phillip; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA; [Schumm, Walter] Kansas State Univ, Dept Family Studies & Human Sci, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Scoglio, C (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA.	caterina@ksu.edu	Schumm, Walter/AAF-4347-2020; Schumm, Walter/H-5051-2019	Schumm, Walter/0000-0003-3097-3551; Scoglio, Caterina/0000-0003-4486-9229	Center for Engagement and Community Development at Kansas State University [DMS-1201427]; National Science Foundation; Kansas State University Open Access Publishing Fund; Direct For Mathematical & Physical Scien [1201427] Funding Source: National Science Foundation	Center for Engagement and Community Development at Kansas State University; National Science Foundation(National Science Foundation (NSF)); Kansas State University Open Access Publishing Fund; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been supported by the Center for Engagement and Community Development at Kansas State University, and by the National Science Foundation under Award DMS-1201427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Steven Kubler and other officials of the City of Chanute for helpful discussion and information. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	[Anonymous], 1978, MAIL TELEPHONE SURVE; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Campbell H, 2010, SURVEYS STUDY EPIDEM; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; CDC, 2012, CDC SEAS INFL FLU WH; CDC, 2012, CDC SEAS INFL FLU Q; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; Dillman DA, 1999, MAIL INTERNET SURVEY; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Ghani A, 2010, PLOS CURR, V1; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Kooij RE, 2009, LECT NOTES COMPUT SC, V5550, P562, DOI 10.1007/978-3-642-01399-7_44; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Scoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011569; Smyth JD, 2010, AM BEHAV SCI, V53, P1423, DOI 10.1177/0002764210361695; Smyth JoleneD., 2008, INTERNET MAIL MIXED; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Youssef M, 2011, J COMPUT SCI-NETH, V2, P286, DOI 10.1016/j.jocs.2011.03.001	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59028	10.1371/journal.pone.0059028	http://dx.doi.org/10.1371/journal.pone.0059028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536851	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100113
J	Shen, C; Delahanty, RJ; Gao, YT; Lu, W; Xiang, YB; Zheng, Y; Cai, QY; Zheng, W; Shu, XO; Long, JR				Shen, Chong; Delahanty, Ryan J.; Gao, Yu-Tang; Lu, Wei; Xiang, Yong-Bing; Zheng, Ying; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou; Long, Jirong			Evaluating GWAS-Identified SNPs for Age at Natural Menopause among Chinese Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCI; PANCREATIC-CANCER; RISK; FRAMINGHAM; MENARCHE; PATHWAYS; ASH2L	Background: Age at natural menopause (ANM) is a complex trait with high heritability and is associated with several major hormonal-related diseases. Recently, several genome-wide association studies (GWAS), conducted exclusively among women of European ancestry, have discovered dozens of genetic loci influencing ANM. No study has been conducted to evaluate whether these findings can be generalized to Chinese women. Methodology/Principal Findings: We evaluated the index single nucleotide polymorphisms (SNPs) in 19 GWAS-identified genetic susceptibility loci for ANM among 3,533 Chinese women who had natural menopause. We also investigated 3 additional SNPs which were in LD with the index SNP in European-ancestry but not in Asian-ancestry populations. Two genetic risk scores (GRS) were calculated to summarize SNPs across multiple loci one for all SNPs tested (GRSall), and one for SNPs which showed association in our study (GRSsel). All 22 SNPs showed the same association direction as previously reported. Eight SNPs were nominally statistically significant with P <= 0.05: rs4246511 (RHBDL2), rs12461110 (NLRP11), rs2307449 (POLG), rs12611091 (BRSK1), rs1172822 (BRSK1), rs365132 (UIMC1), rs2720044 (ASH2L), and rs7246479 (TMEM150B). Especially, SNPs rs4246511, rs365132, rs1172822, and rs7246479 remained significant even after Bonferroni correction. Significant associations were observed for GRS. Women in the highest quartile began menopause 0.7 years (P = 3.24 x 10(-9)) and 0.9 years (P = 4.61 x 10(-11)) later than those in the lowest quartile for GRSsel and GRSall, respectively. Conclusions: Among the 22 investigated SNPs, eight showed associations with ANM (P<0.05) in our Chinese population. Results from this study extend some recent GWAS findings to the Asian-ancestry population and may guide future efforts to identify genetic determination of menopause.	[Shen, Chong; Delahanty, Ryan J.; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou; Long, Jirong] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shen, Chong; Delahanty, Ryan J.; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou; Long, Jirong] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Lu, Wei; Zheng, Ying] Shanghai Inst Prevent Med, Shanghai Municipal Ctr Dis Prevent & Control, Shanghai, Peoples R China	Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention	Long, JR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.	Jirong.Long@vanderbilt.edu	Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022; zhang, weihua/GXV-1334-2022; gao, yi/HCI-8298-2022; Lu, Wei/AAE-2921-2022; Zheng, Wei/O-3351-2013	Lu, Wei/0000-0002-4150-8674; Zheng, Wei/0000-0003-1226-070X; Long, Jirong/0000-0002-7433-9766	US National Institutes of Health [R01CA124558, R01CA064277, R01CA070867, R01CA090899, R01CA092585]; Ingram professorship funds; Allen Foundation funds; Vanderbilt University Clinical and Translational Science Award from the National Center for Research Resources/National Institutes of Health [1 UL1 RR024975]; Fogarty International Center [D43 TW008313]; FOGARTY INTERNATIONAL CENTER [D43TW008313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA092585, R01CA070867, R01CA090899, R01CA124558, R01CA064277] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ingram professorship funds; Allen Foundation funds; Vanderbilt University Clinical and Translational Science Award from the National Center for Research Resources/National Institutes of Health; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by the US National Institutes of Health (grants R01CA124558, R01CA064277, R01CA070867, and R01CA090899 to Dr. Wei Zheng and R01CA092585 to Dr. Xiao Ou Shu), Ingram professorship funds and research award funds to Drs. Wei Zheng and Xiao Ou Shu, Allen Foundation funds to Dr. Xiao Ou Shu, and a Vanderbilt University Clinical and Translational Science Award (grant 1 UL1 RR024975) from the National Center for Research Resources/National Institutes of Health to Dr. Jirong Long. Dr. Chong Sheng was supported by a training grant from the Fogarty International Center (D43 TW008313 to Dr. Xiao Ou Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Burger HG, 1996, BAILLIERE CLIN OB GY, V10, P347, DOI 10.1016/S0950-3552(96)80019-8; Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P401, DOI 10.1007/s00127-002-0569-0; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; Copeland William C, 2003, ScientificWorldJournal, V3, P34; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Delahanty RJ, 2011, AM J EPIDEMIOL, V174, P1115, DOI 10.1093/aje/kwr233; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Lei XJ, 2009, J MOL BIOL, V394, P815, DOI 10.1016/j.jmb.2009.10.025; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rodriguez-Asiain A, 2011, BBA-MOL CELL BIOL L, V1811, P1124, DOI 10.1016/j.bbalip.2011.10.004; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; van Noord PAH, 1999, J CLIN EPIDEMIOL, V52, P1290; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Velde ERT, 1998, MATURITAS, V30, P119	32	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58766	10.1371/journal.pone.0058766	http://dx.doi.org/10.1371/journal.pone.0058766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536822	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200009
J	Bonfield, JK; Mahoney, MV				Bonfield, James K.; Mahoney, Matthew V.			Compression of FASTQ and SAM Format Sequencing Data	PLOS ONE			English	Article							GENOMIC SEQUENCE; QUALITY SCORES	Storage and transmission of the data produced by modern DNA sequencing instruments has become a major concern, which prompted the Pistoia Alliance to pose the SequenceSqueeze contest for compression of FASTQ files. We present several compression entries from the competition, Fastqz and Samcomp/Fqzcomp, including the winning entry. These are compared against existing algorithms for both reference based compression (CRAM, Goby) and non-reference based compression (DSRC, BAM) and other recently published competition entries (Quip, SCALCE). The tools are shown to be the new Pareto frontier for FASTQ compression, offering state of the art ratios at affordable CPU costs. All programs are freely available on SourceForge. Fastqz: https://sourceforge.net/projects/fastqz/, fqzcomp: https://sourceforge.net/projects/fqzcomp/, and samcomp: https://sourceforge.net/projects/samcomp/.	[Bonfield, James K.] Wellcome Trust Sanger Inst, Cambridge, England; [Mahoney, Matthew V.] Dell Inc, Round Rock, TX USA	Wellcome Trust Sanger Institute; Dell Incorporated	Bonfield, JK (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	jkb@sanger.ac.uk		Bonfield, James/0000-0002-6447-4112	Wellcome Trust [098051]; Dell Inc.; Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Dell Inc.; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [098051] and Dell Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The statement of the work being supported by Wellcome Trust and Dell Inc. is there solely as they covered the salaries of the authors during the time of the program development. Neither the Wellcome Trust nor Dell Inc. hold any patents on this work, nor do they intend to. Please also note that the programs are available under a BSD-2 open source licence, meaning they are free with no restrictions. MM is employed by Dell Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asnani H., 2012, ARXIV12075184; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cochrane G, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-2; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Daily K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-514; Deorowicz S, 2011, BIOINFORMATICS, V27, P860, DOI 10.1093/bioinformatics/btr014; Deutsch P., 1996, ZLIB COMPRESSED DATA; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Giancarlo R, 2009, BIOINFORMATICS, V25, P1575, DOI 10.1093/bioinformatics/btp117; Grassi E, 2012, IEEE ACM T IN PRESS; Hach F., 2012, BIOINFORMATICS; Jeon YJ, 2011, EVOL BIOINFORM, V7, P1, DOI 10.4137/EBO.S6618; Jones DC, 2012, NUCL ACIDS IN PRESS; KOLMOGOROV AN, 1968, IEEE T INFORM THEORY, V14, P662, DOI 10.1109/TIT.1968.1054210; Kozanitis C, 2011, J COMPUT BIOL, V18, P401, DOI 10.1089/cmb.2010.0253; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahoney M, 2005, CS200516; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Pinho AJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1124; Sakib MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028251; Shannon C. E., 1949, MATH THEORY COMMUNIC; Tembe W, 2010, BIOINFORMATICS, V26, P2192, DOI 10.1093/bioinformatics/btq346; von Haeseler A, 2012, NUCL ACIDS RES; Wan R, 2012, BIOINFORMATICS, V28, P628, DOI 10.1093/bioinformatics/btr689; WITTEN IH, 1987, COMMUN ACM, V30, P520, DOI 10.1145/214762.214771; Ziv J, 1978, IEEE T INFORM THEORY, VIT-24	32	125	141	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59190	10.1371/journal.pone.0059190	http://dx.doi.org/10.1371/journal.pone.0059190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533605	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400042
J	Bontell, I; Haggblom, A; Bratt, G; Albert, J; Sonnerborg, A				Bontell, Irene; Haggblom, Amanda; Bratt, Goran; Albert, Jan; Sonnerborg, Anders			Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997-2011	PLOS ONE			English	Article							INDIVIDUALS; COHORT	Objective: Describe trends in antiretroviral treatments and drug resistance mutations among Swedish HIV-patients over time 1997-2011. Methods: Treatment histories, viral sequences, and demographic and clinical data were retrieved from the national database InfCareHIV. All ART-experienced patients were included (N = 6537), while resistance tests were restricted to those obtained >= 90 days after ART start. This cohort is fully representative for Sweden since the database covers virtually all diagnosed HIV-patients since the start of the epidemic. Patients were grouped according to the year of first ART, and treatments and mutations were analyzed by calendar year. Results: The prevalence of major drug resistance mutations decreased dramatically over time, most rapidly between 2003 and 2007. Since then there has been a continued slow decrease for NRTI- and PI-associated mutations with an overall prevalence among all ART-experienced patients at 1.1% (NRTI) and 0.3% (PI) in 2011. NNRTI resistance reached the lowest level in 2007-2009 (0.6%), but is now increasing (0.9% in 2011). Patients with first ART exposure before 2001 are still highly overrepresented among those with PI and, to a lesser extent, NRTI resistance. In contrast, almost half of the patients with NNRTI mutations in 2011 initiated their first ART after 2007. Conclusions: Tremendous improvements in ART options and knowledge have resulted in rapidly declining levels of resistance, and most of the current NRTI and PI mutations are found among patients with a history of suboptimal treatments. However, NNRTI resistance is increasing and is primarily found in patients infected in low-and middle-income countries who initiated ART in recent years. It is plausible that these patients were infected with resistant strains and it is therefore suggested that resource-rich countries like Sweden should test for resistance in minor quasispecies or use PI-based first-line regimens in patients who are at increased risk of carrying resistant virus.	[Bontell, Irene; Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst Huddinge, Dept Med, Stockholm, Sweden; [Bratt, Goran] Stockholm South Gen Hosp, Dept Clin Sci & Educ, Stockholm, Sweden; [Albert, Jan] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst Huddinge, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet	Bontell, I (corresponding author), Karolinska Inst Huddinge, Dept Med, Stockholm, Sweden.	irene.bontell@ki.se	Sönnerborg, Anders/W-2011-2019	Sönnerborg, Anders/0000-0001-8928-3374	Swedish Physicians against AIDS Research Foundation [FO2009-0016]; Marie Curie GlobalART [246599]; Swedish Research Council; Abbott Scandinavia; EU [223131]; Lars Hierta Memorial Foundation [FO2010-0436]; Swedish National Board of Health and Welfare [SLS-101181]	Swedish Physicians against AIDS Research Foundation; Marie Curie GlobalART; Swedish Research Council(Swedish Research CouncilEuropean Commission); Abbott Scandinavia; EU(European Commission); Lars Hierta Memorial Foundation; Swedish National Board of Health and Welfare	This study was funded by grants from the Swedish Physicians against AIDS Research Foundation (FO2009-0016), Marie Curie GlobalART (#246599), The Swedish Research Council, Abbott Scandinavia, EU-FP7 CHAIN (#223131), the Lars Hierta Memorial Foundation (FO2010-0436), and the Swedish National Board of Health and Welfare (SLS-101181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Di Giambenedetto S, 2007, ANTIVIR THER, V12, P835; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Sista P, 2009, J CLIN VIROL, V44, P190, DOI 10.1016/j.jcv.2008.12.005; Tamalet C, 2003, AIDS, V17, P2383, DOI 10.1097/00002030-200311070-00014; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728	11	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59337	10.1371/journal.pone.0059337	http://dx.doi.org/10.1371/journal.pone.0059337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533618	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400055
J	Ma, C; Muranyi, M; Chu, CH; Zhang, JH; Chu, WM				Ma, Chi; Muranyi, Marianna; Chu, Catherine H.; Zhang, Jianhua; Chu, Wen-Ming			Involvement of DNA-PKcs in the IL-6 and IL-12 Response to CpG-ODN Is Mediated by Its Interaction with TRAF6 in Dendritic Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; TLR9; OLIGODEOXYNUCLEOTIDES; INTERFERON; ACTIVATION; REQUIRES; ROLES; KU	CpG-ODN stimulates dendritic cells (DCs) to produce cytokines, which are important for pathogenesis of autoimmune disorders and vaccine strategy for cancer. CpG-ODN activates the TLR9/MyD88/TRAF6 cascade leading to activation of IKK-NF-kappa B and JNK, which are critical for production of pro-inflammatory cytokines. However, whether other molecules are involved in activation of CpG-ODN signaling is still not clear. Here we report that the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is involved in this activation process. DNA-PKcs-deficient DCs exhibited a defect in the IL-6 and IL-12 response to CpG-ODN in a dose- and time-dependent manner. Loss of DNA-PKcs impaired phosphorylation of IKK, I kappa B alpha, NF-kappa B and JNK in response to CpG-ODN. Interestingly, CpG-ODN was able to bind DNA-PKcs and induce its association and co-localization with TRAF6 in the absence of TLR9. Our data suggest that DNA-PKcs is a player in CpG-ODN signaling and may explain why DNA-PKcs is implicated in the pathogenic process of autoimmune disease.	[Ma, Chi; Muranyi, Marianna; Chu, Catherine H.; Zhang, Jianhua; Chu, Wen-Ming] Univ Hawaii, Canc Biol Program, Ctr Canc, Honolulu, HI 96822 USA; [Zhang, Jianhua] Shanghai Jiao Tong Univ, Dept Pediat, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Cancer Research Center of Hawaii; University of Hawaii System; Shanghai Jiao Tong University	Chu, WM (corresponding author), Univ Hawaii, Canc Biol Program, Ctr Canc, Honolulu, HI 96822 USA.	wchu@cc.hawaii.edu			NIH [R01AI54128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054128] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the NIH (R01AI54128 to WMC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Jafri F, 2001, J IMMUNOL METHODS, V251, P53, DOI 10.1016/S0022-1759(01)00294-0; Jundi M, 2012, IMMUNOBIOLOGY, V217, P375, DOI 10.1016/j.imbio.2011.07.007; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Krumbach R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pt7; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lartigue A, 2006, J IMMUNOL, V177, P1349, DOI 10.4049/jimmunol.177.2.1349; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Morio T, 1999, IMMUNITY, V11, P339, DOI 10.1016/S1074-7613(00)80109-0; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Smith GCM, 1999, BIOCHEM SOC SYMP, P91; Wang H, 2005, CURR PHARM DESIGN, V11, P2889, DOI 10.2174/1381612054546707; Yotsumoto S, 2008, J IMMUNOL, V180, P809, DOI 10.4049/jimmunol.180.2.809	20	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58072	10.1371/journal.pone.0058072	http://dx.doi.org/10.1371/journal.pone.0058072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533581	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400018
J	Li, DD; Cai, Q; Ma, L; Wang, ML; Ma, JQ; Zhang, WB; Pan, YC; Wang, L				Li, Dandan; Cai, Qi; Ma, Lan; Wang, Meilin; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin			Association between MMP-1 g.-1607dupG Polymorphism and Periodontitis Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1 PROMOTER; SINGLE-NUCLEOTIDE POLYMORPHISM; TISSUE INHIBITORS; GENETIC POLYMORPHISMS; BRAZILIAN POPULATION; CHINESE POPULATION; EPIDEMIOLOGY; INFECTIONS; EXPRESSION; SEVERITY	Background: Matrix metalloproteinase-1 (MMP-1) plays an important role during the destruction of periodontal tissue. Although multiple studies had focused on the association between MMP-1 g.-1607dupG and periodontitis susceptibility, the results remained inconclusive. The purpose of this meta-analysis was to explore its role in the development of periodontitis. Methods: Retrieved studies from Pubmed, Web of Science, Medline and Google Scholar Search regarding MMP-1 g.1607dupG and periodontitis susceptibility were included into the final analysis with definite selection and exclusion criteria. Overall and stratified analyses based on disease type, severity, ethnicity and smoking status were performed. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the association between MMP-1 g.-1607dupG and periodontitis susceptibility, while Q test and Egger's test were adopted respectively to assess heterogeneity among studies and publication bias. Results: A total of 1580 periodontitis cases and 1386 controls in 11 case-control studies were included in the meta-analysis. The pooled results showed significant association between periodontitis susceptibility and MMP-1 g.-1607dupG polymorphism in homozygote (2G/2G versus 1G/1G, OR = 1.50, 95% CI = 1.02-2.20) and dominant model analysis (2G/2G+2G/1G versus 1G/1G, OR = 1.28, 95% CI = 1.04-1.57). For subgroups by type of periodontitis, increased risk of chronic periodontitis was observed on heterozygote (2G/1G versus 1G/1G, OR = 2.01, 95% CI = 1.58-2.56) and dominant model (OR = 1.27, 95% CI = 1.03-1.57). Furthermore, similar association was also detected in severe chronic periodontitis (2G/2G versus 1G/1G, OR = 2.15, 95% CI = 1.35-3.43; 2G/2G+2G/1G versus 1G/1G, OR = 1.64, 95% CI = 1.12-2.39; 2G/2G versus 2G/1G+1G/1G, OR = 1.86, 95% CI = 1.31-2.64). Conclusions: Our meta-analysis demonstrated that MMP-1 g.-1607dupG polymorphism was associated with chronic periodontitis, especially the severity of the disease condition.	[Li, Dandan; Cai, Qi; Ma, Lan; Wang, Meilin; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Ma, Lan; Wang, Meilin] Nanjing Med Univ, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Pan, YC (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	393774987@qq.com; nydwlktz@gmail.com			National Natural Science Foundation of China [30973361, 81170981, 81000457]; Natural Science Foundation of JiangSu Province [81000457]; Natural Science Foundation for Colleges and Universities in JiangSu Province [10kJB320004]; Project of State Key Laboratory of Oral Diseases [SKLODSCU2009KF05]; Priority Academic Program Development of JiangSu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Colleges and Universities in JiangSu Province; Project of State Key Laboratory of Oral Diseases; Priority Academic Program Development of JiangSu Higher Education Institutions (PAPD)	This study was supported in part by the National Natural Science Foundation of China (30973361, 81170981 and 81000457), Natural Science Foundation of JiangSu Province (81000457), Natural Science Foundation for Colleges and Universities in JiangSu Province (10kJB320004), Project of State Key Laboratory of Oral Diseases (SKLODSCU2009KF05) and Project Funded by the Priority Academic Program Development of JiangSu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Astolfi CM, 2006, J CLIN PERIODONTOL, V33, P699, DOI 10.1111/j.1600-051X.2006.00979.x; Benoist HM, 2011, J PERIODONTAL IMPLAN, V41, P279, DOI 10.5051/jpis.2011.41.6.279; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Cao Z, 2006, TISSUE ANTIGENS, V68, P38, DOI 10.1111/j.1399-0039.2006.00615.x; Cao ZG, 2005, J PERIODONTAL RES, V40, P427, DOI 10.1111/j.1600-0765.2005.00806.x; Contreras A, 2001, ORAL MICROBIOL IMMUN, V16, P63, DOI 10.1034/j.1399-302x.2001.160111.x; Dasanayake Ananda P, 2003, Dent Clin North Am, V47, P115, DOI 10.1016/S0011-8532(02)00056-3; de Souza AP, 2003, J CLIN PERIODONTOL, V30, P154, DOI 10.1034/j.1600-051X.2003.300202.x; Deng H, 2011, J CLIN PERIODONTOL, V38, P199, DOI 10.1111/j.1600-051X.2010.01685.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22; Ding C, 2012, ARCH ORAL BIOL, V57, P585, DOI 10.1016/j.archoralbio.2012.01.016; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ejeil AL, 2003, J PERIODONTOL, V74, P188, DOI 10.1902/jop.2003.74.2.188; Hannas AR, 2007, ACTA ODONTOL SCAND, V65, P1, DOI 10.1080/00016350600963640; Holla LI, 2004, J CLIN PERIODONTOL, V31, P685, DOI 10.1111/j.1600-051X.2004.00547.x; Itagaki M, 2004, J CLIN PERIODONTOL, V31, P764, DOI 10.1111/j.1600-051X.2004.00553.x; LEE W, 1995, J PERIODONTAL RES, V30, P23, DOI 10.1111/j.1600-0765.1995.tb01249.x; Loo WTY, 2011, ARCH ORAL BIOL; Luczyszyn SM, 2012, ARCH ORAL BIOL; Mealey BL, 1999, PERIODONTOL 2000, V21, P197, DOI 10.1111/j.1600-0757.1999.tb00176.x; Mealey Brian L, 2003, Dent Today, V22, P107; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Pirhan D, 2008, J CLIN PERIODONTOL, V35, P862, DOI 10.1111/j.1600-051X.2008.01302.x; Ravanti L, 2000, INT J MOL MED, V6, P391; Repeke CE, 2009, J CLIN PERIODONTOL, V36, P726, DOI 10.1111/j.1600-051X.2009.01447.x; Rutter JL, 1998, CANCER RES, V58, P5321; Scannapieco Frank A, 2003, Dent Today, V22, P79; Silva N, 2008, J CLIN PERIODONTOL, V35, P206, DOI 10.1111/j.1600-051X.2007.01190.x; Sorsa T, 2004, ORAL DIS, V10, P311, DOI 10.1111/j.1601-0825.2004.01038.x; Ustun K, 2008, J CLIN PERIODONTOL, V35, P1013, DOI 10.1111/j.1600-051X.2008.01313.x; Verstappen J, 2006, J DENT RES, V85, P1074, DOI 10.1177/154405910608501202; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yamazaki K, 2005, J PERIODONTAL RES, V40, P53, DOI 10.1111/j.1600-0765.2004.00772.x; Yoshie H, 2007, PERIODONTOL 2000, V43, P102, DOI 10.1111/j.1600-0757.2006.00164.x	37	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59513	10.1371/journal.pone.0059513	http://dx.doi.org/10.1371/journal.pone.0059513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527212	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600078
J	Ding, X; Lee, SW				Ding, Xiaoyu; Lee, Seong-Whan			Changes of Functional and Effective Connectivity in Smoking Replenishment on Deprived Heavy Smokers: A Resting-State fMRI Study	PLOS ONE			English	Article							INDEPENDENT COMPONENTS; CAUSAL CONNECTIVITY; SPECTRAL-DOMAIN; NEURAL-NETWORKS; BRAIN-FUNCTION; NICOTINE; ADDICTION; ATTENTION; CORTEX; NONSMOKERS	Previous researches have explored the changes of functional connectivity caused by smoking with the aid of fMRI. This study considers not only functional connectivity but also effective connectivity regarding both brain networks and brain regions by using a novel analysis framework that combines independent component analysis (ICA) and Granger causality analysis (GCA). We conducted a resting-state fMRI experiment in which twenty-one heavy smokers were scanned in two sessions of different conditions: smoking abstinence followed by smoking satiety. In our framework, group ICA was firstly adopted to obtain the spatial patterns of the default-mode network (DMN), executive-control network (ECN), and salience network (SN). Their associated time courses were analyzed using GCA, showing that the effective connectivity from SN to DMN was reduced and that from ECN/DMN to SN was enhanced after smoking replenishment. A paired t-test on ICA spatial patterns revealed functional connectivity variation in regions such as the insula, parahippocampus, precuneus, anterior cingulate cortex, supplementary motor area, and ventromedial/dorsolateral prefrontal cortex. These regions were later selected as the regions of interest (ROIs), and their effective connectivity was investigated subsequently using GCA. In smoking abstinence, the insula showed the increased effective connectivity with the other ROIs; while in smoking satiety, the parahippocampus had the enhanced inter-area effective connectivity. These results demonstrate our hypothesis that for deprived heavy smokers, smoking replenishment takes effect on both functional and effective connectivity. Moreover, our analysis framework could be applied in a range of neuroscience studies.	[Ding, Xiaoyu] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Korea University; Korea University	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	swlee@image.korea.ac.kr			World Class University (WCU) Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [R31-10008, 2012-005741]; Korea Science and Engineering Foundation (KOSEF)	World Class University (WCU) Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This work was supported in part by the World Class University (WCU) Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, under grant R31-10008; and in part by the Korea Science and Engineering Foundation (KOSEF) Grant funded by the Ministry of Education, Science, and Technology, under grant 2012-005741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Dagher A, 2009, BRAIN RES, V1293, P40, DOI 10.1016/j.brainres.2009.07.048; Davey CE, 2013, HUM BRAIN MAPP, V34, P1999, DOI 10.1002/hbm.22043; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Ding X, 2012, IEEE SYS MAN CYBERN, P571, DOI 10.1109/ICSMC.2012.6377786; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Ettinger U, 2009, NEUROIMAGE, V45, P549, DOI 10.1016/j.neuroimage.2008.12.029; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Janes AC, 2012, DRUG ALCOHOL DEPEN, V125, P252, DOI 10.1016/j.drugalcdep.2012.02.020; Janes AC, 2010, NEUROPSYCHOPHARMACOL, V35, P2339, DOI 10.1038/npp.2010.103; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kim DY, 2011, NEUROSCI LETT, V498, P57, DOI 10.1016/j.neulet.2011.04.062; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Omvik Per, 1996, Blood Pressure, V5, P71, DOI 10.3109/08037059609062111; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tanabe J, 2011, PSYCHOPHARMACOLOGY, V216, P287, DOI 10.1007/s00213-011-2221-8; Tomasi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010815; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005	47	69	72	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59331	10.1371/journal.pone.0059331	http://dx.doi.org/10.1371/journal.pone.0059331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527165	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100110
J	Fliegauf, M; Sonnen, AFP; Kremer, B; Henneke, P				Fliegauf, Manfred; Sonnen, Andreas F. -P.; Kremer, Bernhard; Henneke, Philipp			Mucociliary Clearance Defects in a Murine In Vitro Model of Pneumococcal Airway Infection	PLOS ONE			English	Article							PNEUMOLYSIN-NEGATIVE MUTANT; PLANAR CELL POLARITY; CILIARY BEAT PATTERN; STREPTOCOCCUS-PNEUMONIAE; HYDROGEN-PEROXIDE; INNATE DEFENSE; EPITHELIUM; BRAIN; ACTIN; COLONIZATION	Mucociliary airway clearance is an innate defense mechanism that protects the lung from harmful effects of inhaled pathogens. In order to escape mechanical clearance, airway pathogens including Streptococcus pneumoniae (pneumococcus) are thought to inactivate mucociliary clearance by mechanisms such as slowing of ciliary beating and lytic damage of epithelial cells. Pore-forming toxins like pneumolysin, may be instrumental in these processes. In a murine in vitro airway infection model using tracheal epithelial cells grown in air-liquid interface cultures, we investigated the functional consequences on the ciliated respiratory epithelium when the first contact with pneumococci is established. High-speed video microscopy and live-cell imaging showed that the apical infection with both wildtype and pneumolysin-deficient pneumococci caused insufficient fluid flow along the epithelial surface and loss of efficient clearance, whereas ciliary beat frequency remained within the normal range. Three-dimensional confocal microscopy demonstrated that pneumococci caused specific morphologic aberrations of two key elements in the F-actin cytoskeleton: the junctional F-actin at the apical cortex of the lateral cell borders and the apical F-actin, localized within the planes of the apical cell sides at the ciliary bases. The lesions affected the columnar shape of the polarized respiratory epithelial cells. In addition, the planar architecture of the entire ciliated respiratory epithelium was irregularly distorted. Our observations indicate that the mechanical supports essential for both effective cilia strokes and stability of the epithelial barrier were weakened. We provide a new model, where - in pneumococcal infection - persistent ciliary beating generates turbulent fluid flow at non-planar distorted epithelial surface areas, which enables pneumococci to resist mechanical cilia-mediated clearance.	[Fliegauf, Manfred; Sonnen, Andreas F. -P.; Kremer, Bernhard; Henneke, Philipp] Univ Med Ctr Freiburg, CCI, Freiburg, Germany; [Fliegauf, Manfred; Sonnen, Andreas F. -P.; Kremer, Bernhard; Henneke, Philipp] Univ Freiburg, D-79106 Freiburg, Germany; [Fliegauf, Manfred; Henneke, Philipp] Univ Med Ctr Freiburg, Dept Paediat & Adolescent Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Fliegauf, M (corresponding author), Univ Med Ctr Freiburg, CCI, Freiburg, Germany.	manfred.fliegauf@uniklinik-freiburg.de			German Federal Ministry of Education and Research [BMBF 01 EO0803]; DFG [HE 3127/5-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This study was supported by the German Federal Ministry of Education and Research (BMBF 01 EO0803) and by DFG grant HE 3127/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bailey KL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-49; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Calbo E, 2010, INT J ANTIMICROB AG, V35, P107, DOI 10.1016/j.ijantimicag.2009.10.002; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Feldman C, 2007, INT J INFECT DIS, V11, P11, DOI 10.1016/j.ijid.2005.09.002; FELDMAN C, 1990, MICROB PATHOGENESIS, V9, P275, DOI 10.1016/0882-4010(90)90016-J; Feldman C, 2002, RESP MED, V96, P580, DOI 10.1053/rmed.2002.1316; Francis RJB, 2009, AM J PHYSIOL-LUNG C, V296, pL1067, DOI 10.1152/ajplung.00001.2009; Garcia-Suarez MD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-3; Gudis D, 2012, AM J RHINOL ALLERGY, V26, P1, DOI 10.2500/ajra.2012.26.3716; Hammerschmidt S, 2006, ADV INFECT DIS COMMU, P139; Happel KI, 2004, SEMIN RESP CRIT CARE, V25, P43, DOI 10.1055/s-2004-822304; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hirst RA, 2004, INFECT IMMUN, V72, P6694, DOI 10.1128/IAI.72.11.6694-6698.2004; Hirst RA, 2003, INFECT IMMUN, V71, P6095, DOI 10.1128/IAI.71.10.6095-6100.2003; Hirst RA, 2000, PEDIATR RES, V47, P381, DOI 10.1203/00006450-200003000-00016; Hirst RA, 2000, INFECT IMMUN, V68, P1557, DOI 10.1128/IAI.68.3.1557-1562.2000; Hornef Mathias W., 2005, V86, P72, DOI 10.1159/000086652; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; Kadioglu A, 2010, MOL ORAL MICROBIOL, V25, P50, DOI 10.1111/j.2041-1014.2009.00561.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Melkamu T, 2009, J MEMBRANE BIOL, V229, P101, DOI 10.1007/s00232-009-9175-3; Mohammed BJ, 1999, MICROB PATHOGENESIS, V27, P303, DOI 10.1006/mpat.1999.0306; O'Callaghan CL, 2008, NEUROSCI LETT, V439, P56, DOI 10.1016/j.neulet.2008.04.095; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; RAYNER CFJ, 1995, INFECT IMMUN, V63, P442, DOI 10.1128/IAI.63.2.442-447.1995; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen JC, 2012, INT FORUM ALLERGY RH, V2, P104, DOI 10.1002/alr.21002; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Smith DJ, 2008, RESP PHYSIOL NEUROBI, V163, P178, DOI 10.1016/j.resp.2008.03.006; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; STEINFORT C, 1989, INFECT IMMUN, V57, P2006, DOI 10.1128/IAI.57.7.2006-2013.1989; Thomas B, 2009, EUR RESPIR J, V34, P401, DOI 10.1183/09031936.00153308; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wallingford JB, 2010, CURR OPIN CELL BIOL, V22, P597, DOI 10.1016/j.ceb.2010.07.011; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068	54	29	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59925	10.1371/journal.pone.0059925	http://dx.doi.org/10.1371/journal.pone.0059925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527286	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100172
J	Frascoli, F; Hughes, BD; Zaman, MH; Landman, KA				Frascoli, Federico; Hughes, Barry D.; Zaman, Muhammad H.; Landman, Kerry A.			A Computational Model for Collective Cellular Motion in Three Dimensions: General Framework and Case Study for Cell Pair Dynamics	PLOS ONE			English	Article							TRACTION FORCES; CONTINUUM MODEL; ADHESION FORCES; MIGRATION; CANCER; SIMULATION; INVASION; GROWTH; TISSUE; MATHEMATICS	Cell migration in healthy and diseased systems is a combination of single and collective cell motion. While single cell motion has received considerable attention, our understanding of collective cell motion remains elusive. A new computational framework for the migration of groups of cells in three dimensions is presented, which focuses on the forces acting at the microscopic scale and the interactions between cells and their extracellular matrix (ECM) environment. Cell-cell adhesion, resistance due to the ECM and the factors regulating the propulsion of each cell through the matrix are considered. In particular, our approach emphasizes the role of receptors that mediate cell-cell and cell-matrix interactions, and examines how variation in their properties induces changes in cellular motion. As an important case study, we analyze two interacting cells. Our results show that the dynamics of cell pairs depends on the magnitude and the stochastic nature of the forces. Stronger intercellular stability is generally promoted by surface receptors that move. We also demonstrate that matrix resistance, cellular stiffness and intensity of adhesion contribute to migration behaviors in different ways, with memory effects present that can alter pair motility. If adhesion weakens with time, our findings show that cell pair break-up depends strongly on the way cells interact with the matrix. Finally, the motility for cells in a larger cluster (size 50 cells) is examined to illustrate the full capabilities of the model and to stress the role of cellular pairs in complex cellular structures. Overall, our framework shows how properties of cells and their environment influence the stability and motility of cellular assemblies. This is an important step in the advancement of the understanding of collective motility, and can contribute to knowledge of complex biological processes involving migration, aggregation and detachment of cells in healthy and diseased systems.	[Frascoli, Federico; Hughes, Barry D.; Landman, Kerry A.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Melbourne; Boston University	Frascoli, F (corresponding author), Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia.	ffrascoli@unimelb.edu.au	Frascoli, Federico/D-1592-2009; Hughes, Barry Douglas/AAB-9382-2020	Hughes, Barry Douglas/0000-0003-3594-4303; Frascoli, Federico/0000-0003-4159-6229	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Arciero JC, 2011, BIOPHYS J, V100, P535, DOI 10.1016/j.bpj.2010.11.083; Basan M, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026014; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; Drasdo D, 2007, J STAT PHYS, V128, P287, DOI 10.1007/s10955-007-9289-x; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Gerisch A, 2008, J THEOR BIOL, V250, P684, DOI 10.1016/j.jtbi.2007.10.026; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jeon J, 2010, BIOPHYS J, V98, P37, DOI 10.1016/j.bpj.2009.10.002; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Orsello CE, 2001, TRENDS BIOTECHNOL, V19, P310, DOI 10.1016/S0167-7799(01)01692-4; Ouaknin GY, 2009, BIOPHYS J, V97, P1811, DOI 10.1016/j.bpj.2009.05.064; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Rangarajan R, 2008, CELL ADHES MIGR, V2, P106, DOI 10.4161/cam.2.2.6211; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Revenu C, 2009, CURR OPIN GENET DEV, V19, P338, DOI 10.1016/j.gde.2009.04.007; Ricart BG, 2011, BIOPHYS J, V101, P2620, DOI 10.1016/j.bpj.2011.09.022; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Shebanova O, 2012, BIOTECHNOL J, V7, P397, DOI 10.1002/biot.201100188; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Tracqui P, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/5/056701; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vargas DA, 2011, ANN BIOMED ENG, V39, P2068, DOI 10.1007/s10439-011-0290-9; Vitorino P, 2011, MOL CELL BIOL, V31, P342, DOI 10.1128/MCB.00800-10; Weder G, 2009, BIOINTERPHASES, V4, P27, DOI 10.1116/1.3139962; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; Yang TY, 2010, CELL MOL BIOENG, V3, P190, DOI 10.1007/s12195-010-0115-1; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	60	20	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59249	10.1371/journal.pone.0059249	http://dx.doi.org/10.1371/journal.pone.0059249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527148	Green Published, gold			2022-12-27	WOS:000317562100099
J	Larson, E; Terry, HP; Canevari, MM; Stepp, CE				Larson, Eric; Terry, Howard P.; Canevari, Margaux M.; Stepp, Cara E.			Categorical Vowel Perception Enhances the Effectiveness and Generalization of Auditory Feedback in Human-Machine-Interfaces	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; SPEECH; DISCRIMINATION; CATEGORIZATION; BCI	Human-machine interface (HMI) designs offer the possibility of improving quality of life for patient populations as well as augmenting normal user function. Despite pragmatic benefits, utilizing auditory feedback for HMI control remains underutilized, in part due to observed limitations in effectiveness. The goal of this study was to determine the extent to which categorical speech perception could be used to improve an auditory HMI. Using surface electromyography, 24 healthy speakers of American English participated in 4 sessions to learn to control an HMI using auditory feedback (provided via vowel synthesis). Participants trained on 3 targets in sessions 1-3 and were tested on 3 novel targets in session 4. An "established categories with text cues" group of eight participants were trained and tested on auditory targets corresponding to standard American English vowels using auditory and text target cues. An "established categories without text cues" group of eight participants were trained and tested on the same targets using only auditory cuing of target vowel identity. A "new categories" group of eight participants were trained and tested on targets that corresponded to vowel-like sounds not part of American English. Analyses of user performance revealed significant effects of session and group (established categories groups and the new categories group), and a trend for an interaction between session and group. Results suggest that auditory feedback can be effectively used for HMI operation when paired with established categorical (native vowel) targets with an unambiguous cue.	[Larson, Eric] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Terry, Howard P.; Canevari, Margaux M.; Stepp, Cara E.] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Stepp, Cara E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Washington; University of Washington Seattle; Boston University; Boston University	Stepp, CE (corresponding author), Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA.	cstepp@bu.edu	Stepp, Cara/AAQ-6425-2020; Larson, Eric/AAL-8819-2020	Larson, Eric/0000-0003-4782-5360	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) [T32DC000018, 1F32DC012456]; Boston University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012456, T32DC000018] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Boston University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) training grants T32DC000018 and 1F32DC012456 (EDL), and an Undergraduate Teaching and Scholarship Grant from Boston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; BORNSTEIN MH, 1973, PSYCHOL BULL, V80, P257, DOI 10.1037/h0034837; Cook Perry R., 1999, COMPUTER; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Francis AL, 2007, J SPEECH LANG HEAR R, V50, P1445, DOI 10.1044/1092-4388(2007/100); Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Goudbeek M, 2009, J EXP PSYCHOL HUMAN, V35, P1913, DOI 10.1037/a0015781; Guenther FH, 1999, J ACOUST SOC AM, V106, P2900, DOI 10.1121/1.428112; Guenther FH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008218; Higashi H, 2011, IEEE ENG MED BIO, P4576, DOI 10.1109/IEMBS.2011.6091133; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hinterberger T, 2007, BRAIN COMPUTER INTER, V52, P43; Iverson P, 2003, COGNITION, V87, pB47, DOI 10.1016/S0010-0277(02)00198-1; IVERSON P, 1995, J ACOUST SOC AM, V97, P553, DOI 10.1121/1.412280; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Krauledat M, 2004, P ANN INT IEEE EMBS, V26, P4511; Leuthardt EC, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036004; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Lopez-Gordo MA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036013; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Oscari F, 2012, EXP BRAIN RES, V221, P33, DOI 10.1007/s00221-012-3144-2; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Wade T, 2005, J ACOUST SOC AM, V118, P2618, DOI 10.1121/1.2011156	25	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59860	10.1371/journal.pone.0059860	http://dx.doi.org/10.1371/journal.pone.0059860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527278	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100170
J	Manfe, V; Biskup, E; Willumsgaard, A; Skov, AG; Palmieri, D; Gasparini, P; Lagana, A; Woetmann, A; Odum, N; Croce, CM; Gniadecki, R				Manfe, Valentina; Biskup, Edyta; Willumsgaard, Ayalah; Skov, Anne Guldhammer; Palmieri, Dario; Gasparini, Pierluigi; Lagana, Alessandro; Woetmann, Anders; Odum, Niels; Croce, Carlo Maria; Gniadecki, Robert			cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas	PLOS ONE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; C-MYC; PHASE-II; MYELOID-LEUKEMIA; EXPRESSION; REPRESSION; MICRORNAS; DIFFERENTIATION; PROLIFERATION; DYSREGULATION	Successful/effective cancer therapy in low grade lymphoma is often hampered by cell resistance to anti-neoplastic agents. The crucial mechanisms responsible for this phenomenon are poorly understood. Overcoming resistance of tumor cells to anticancer agents, such as proteasome inhibitors, could improve their clinical efficacy. Using cutaneous T-cell lymphoma (CTCL) as a model of the chemotherapy-resistant peripheral lymphoid malignancy, we demonstrated that resistance to proteasome inhibition involved a signaling between the oncogene cMyc and miR-125b-5p. Bortezomib repressed cMyc and simultaneously induced miR-125b-5p that exerted a cytoprotective effect through the downmodulation of MAD4. Overexpression of cMyc repressed miR-125b-5p transcription and sensitized lymphoma cells to bortezomib. The central role of miR-125b-5p was further confirmed in a mouse model of T-cell lymphoma, where xenotransplantation of human CTCL cells overexpressing miR-125b-5p resulted in enhanced tumor growth and a shorter median survival. Our findings describe a novel mechanism through which miR-125b-5p not only regulates tumor growth in vivo, but also increases cellular resistance to proteasome inhibitors via modulation of MAD4.	[Manfe, Valentina; Biskup, Edyta; Skov, Anne Guldhammer; Gniadecki, Robert] Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark; [Willumsgaard, Ayalah; Woetmann, Anders; Odum, Niels] Univ Copenhagen, Inst Med Microbiol & Immunol, Copenhagen, Denmark; [Palmieri, Dario; Gasparini, Pierluigi; Lagana, Alessandro; Croce, Carlo Maria] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Woetmann, Anders; Odum, Niels; Gniadecki, Robert] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Copenhagen	Manfe, V (corresponding author), Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.	valentinamanfe@libero.it	Gasparini, Pierluigi/ABA-2811-2021; Young, Richard A/F-6495-2012; Gniadecki, Robert/A-5696-2010; Palmieri, Dario/I-1677-2019; Biskup, Edyta/O-4632-2015; Woetmann, Anders/AAJ-3171-2020	Gasparini, Pierluigi/0000-0001-8311-8845; Young, Richard A/0000-0001-8855-8647; Gniadecki, Robert/0000-0002-2310-8300; Biskup, Edyta/0000-0002-5510-2712; Palmieri, Dario/0000-0002-0797-4268; Woetmann, Anders/0000-0002-3008-735X	Aage Bangs Foundation; Novo Nordisk Foundation; Kraeftens Bekaempelse; NATIONAL CANCER INSTITUTE [P01CA129242] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC0002036] Funding Source: researchfish	Aage Bangs Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kraeftens Bekaempelse; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from Aage Bangs Foundation, Novo Nordisk Foundation and Kraeftens Bekaempelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisone GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038508; Biskup E, 2012, BR J DERMATOL; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Calin GA, 2006, LEUKEMIA RES, V30, P653, DOI 10.1016/j.leukres.2005.10.017; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chapiro E, 2010, LEUKEMIA, V24, P1362, DOI 10.1038/leu.2010.93; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Fassina A, 2012, LAB INVEST, V92, P1574, DOI 10.1038/labinvest.2012.129; Fuchs SY, 2008, PIGM CELL MELANOMA R, V21, P9, DOI 10.1111/j.1755-148X.2007.00438.x; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gibcus JH, 2011, J PATHOL, V225, P609, DOI 10.1002/path.2958; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; Goy A, 2005, J CLIN ONCOL, V23, P667, DOI 10.1200/JCO.2005.03.108; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guo XL, 2007, LEUKEMIA LYMPHOMA, V48, P1200, DOI 10.1080/10428190701342018; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Hendry L, 2004, LEUKEMIA LYMPHOMA, V45, P945, DOI 10.1080/10428190310001639489; Horwitz SM, 2008, CLIN LYMPHOMA MYELOM, V8, pS187, DOI 10.3816/CLM.2008.s.015; Horwitz Steven M, 2008, J Natl Compr Canc Netw, V6, P436; Hurlin PJ, 1996, EMBO J, V15, P2030, DOI 10.1002/j.1460-2075.1996.tb00555.x; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; KALTOFT K, 1987, ARCH DERMATOL RES, V279, P293, DOI 10.1007/BF00431220; KANAVAROS P, 1994, PATHOL RES PRACT, V190, P767, DOI 10.1016/S0344-0338(11)80423-1; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Krejsgaard T, 2010, EXP DERMATOL, V19, P1096, DOI 10.1111/j.1600-0625.2010.01138.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar S, 2008, BLOOD, V112, P2177, DOI 10.1182/blood-2008-07-167767; Manfe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029541; Manni I, 2002, BRIT J CANCER, V86, P477, DOI 10.1038/sj.bjc.6600065; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rizzo M, 2012, NUCLEIC ACID THER, V22, P283, DOI 10.1089/nat.2012.0343; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Wilcox RA, 2011, AM J HEMATOL, V86, P929, DOI 10.1002/ajh.22139; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	57	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59390	10.1371/journal.pone.0059390	http://dx.doi.org/10.1371/journal.pone.0059390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527180	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100124
J	Mazaris, AD; Papanikolaou, AD; Barbet-Massin, M; Kallimanis, AS; Jiguet, F; Schmeller, DS; Pantis, JD				Mazaris, Antonios D.; Papanikolaou, Alexandra D.; Barbet-Massin, Morgane; Kallimanis, Athanasios S.; Jiguet, Frederic; Schmeller, Dirk S.; Pantis, John D.			Evaluating the Connectivity of a Protected Areas' Network under the Prism of Global Change: The Efficiency of the European Natura 2000 Network for Four Birds of Prey	PLOS ONE			English	Article							LAND-USE CHANGE; CLIMATE-CHANGE; LANDSCAPE CONNECTIVITY; HABITAT PATCHES; PROJECTED IMPACTS; LONG-DISTANCE; DISPERSAL; BIODIVERSITY; CORRIDORS; PREDICT	Climate and land use changes are major threats to biodiversity. To preserve biodiversity, networks of protected areas have been established worldwide, like the Natura 2000 network across the European Union (EU). Currently, this reserve network consists of more than 26000 sites covering more than 17% of EU terrestrial territory. Its efficiency to mitigate the detrimental effects of land use and climate change remains an open research question. Here, we examined the potential current and future geographical ranges of four birds of prey under scenarios of both land use and climate changes. By using graph theory, we examined how the current Natura 2000 network will perform in regard to the conservation of these species. This approach determines the importance of a site in regard to the total network and its connectivity. We found that sites becoming unsuitable due to climate change are not a random sample of the network, but are less connected and contribute less to the overall connectivity than the average site and thus their loss does not disrupt the full network. Hence, the connectivity of the remaining network changed only slightly from present day conditions. Our findings highlight the need to establish species-specific management plans with flexible conservation strategies ensuring protection under potential future range expansions. Aquila pomarina is predicted to disappear from the southern part of its range and to become restricted to northeastern Europe. Gyps fulvus, Aquila chrysaetos, and Neophron percnopterus are predicted to locally lose some suitable sites; hence, some isolated small populations may become extinct. However, their geographical range and metapopulation structure will remain relatively unaffected throughout Europe. These species would benefit more from an improved habitat quality and management of the existing network of protected areas than from increased connectivity or assisted migration.	[Mazaris, Antonios D.; Papanikolaou, Alexandra D.; Pantis, John D.] Aristotle Univ Thessaloniki, Dept Ecol, Sch Biol, GR-54006 Thessaloniki, Greece; [Barbet-Massin, Morgane] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Kallimanis, Athanasios S.] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Jiguet, Frederic] UPMC, Museum Natl Hist Nat, CNRS, UMR Conservat Especes Restaurat & Suivi Populat 7, Paris, France; [Schmeller, Dirk S.] UFZ Helmholtz Ctr Environm Res, Nat Conservat Dept, Leipzig, Germany	Aristotle University of Thessaloniki; Yale University; University of Ioannina; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Mazaris, AD (corresponding author), Aristotle Univ Thessaloniki, Dept Ecol, Sch Biol, GR-54006 Thessaloniki, Greece.	amazaris@bio.auth.gr	Kallimanis, Athanasios/H-4618-2013; Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Kallimanis, Athanasios/0000-0001-7103-9971; Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933; Mazaris, Antonios/0000-0002-4961-5490	SCALES [226852]; BIRDCHANGE from the European Commission [FP7-PEOPLE-2011-IOF]	SCALES; BIRDCHANGE from the European Commission	The work of ADM, ADP, ASK, FJ, DSS and JDP was supported by SCALES ('Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales'; EU FP7 project #226852). The work of MB-M was supported by the BIRDCHANGE project (FP7-PEOPLE-2011-IOF) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barbet-Massin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018228; BirdLife International, 2012, SPEC FACTSH AQ CHRYS; Bode M, 2008, ECOL MODEL, V214, P201, DOI 10.1016/j.ecolmodel.2008.02.040; Bodin O, 2007, LANDSCAPE ECOL, V22, P31, DOI 10.1007/s10980-006-9015-0; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Diamond SE, 2011, ECOLOGY, V92, P1005, DOI 10.1890/i0012-9658-92-5-1005; Elorriaga J, 2009, J RAPTOR RES, V43, P142, DOI 10.3356/JRR-08-53.1; Eros T, 2012, LANDSCAPE ECOL, V27, P303, DOI 10.1007/s10980-011-9659-2; European Environment Agency, 2011, EUR PROT AR NAT 2000; Evans D, 2012, NATURE CONSERVATION, V1, P11, DOI DOI 10.3897/NATURECONSERVATION.1.1808; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Gilarranz LJ, 2012, J THEOR BIOL, V297, P11, DOI 10.1016/j.jtbi.2011.11.027; Gurrutxaga M, 2011, LANDSCAPE URBAN PLAN, V101, P310, DOI 10.1016/j.landurbplan.2011.02.036; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joshi PK, 2011, BIODIVERS CONSERV, V20, P3393, DOI 10.1007/s10531-011-0123-z; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Laita A, 2010, BIOL CONSERV, V143, P1212, DOI 10.1016/j.biocon.2010.02.029; Li TA, 2010, LANDSCAPE ECOL, V25, P839, DOI 10.1007/s10980-010-9461-6; Lookingbill TR, 2010, ECOL APPL, V20, P427, DOI 10.1890/09-0073.1; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Mazaris AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2397; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Minor ES, 2010, CONSERV BIOL, V24, P1549, DOI 10.1111/j.1523-1739.2010.01558.x; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moilanen A, 2011, J APPL ECOL, V48, P1543, DOI 10.1111/j.1365-2664.2011.02062.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; PETERS RL, 1992, ISSUES SCI TECHNOL, V8, P66; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Ribeiro R, 2011, LANDSCAPE ECOL, V26, P673, DOI 10.1007/s10980-011-9592-4; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2011, FOREST ECOL MANAG, V262, P150, DOI 10.1016/j.foreco.2011.03.017; Saura S, 2011, ECOL INDIC, V11, P407, DOI 10.1016/j.ecolind.2010.06.011; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Scharlemann JPW, 2004, GLOBAL CHANGE BIOL, V10, P2046, DOI 10.1111/j.1365-2486.2004.00860.x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vasas V, 2009, LANDSCAPE ECOL, V24, P581, DOI 10.1007/s10980-009-9346-8; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x	62	64	67	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59640	10.1371/journal.pone.0059640	http://dx.doi.org/10.1371/journal.pone.0059640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527237	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100152
J	Day, SL; Odem-Davis, K; Mandaliya, KN; Jerome, KR; Cook, L; Masese, LN; Scott, J; Kim, HN; Graham, SM; McClelland, RS				Day, Summer L.; Odem-Davis, Katherine; Mandaliya, Kishorchandra N.; Jerome, Keith R.; Cook, Linda; Masese, Linnet N.; Scott, John; Kim, H. Nina; Graham, Susan M.; McClelland, R. Scott			Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy	PLOS ONE			English	Article							LAMIVUDINE RESISTANCE; DISEASE PROGRESSION; DRUG-RESISTANCE; MUTATIONS; INFECTION; GENOTYPES; HBV; VARIANTS; ANTIGEN; COHORT	Background: Sub-Saharan Africa carries a high burden of co-infection with HIV-1 and hepatitis B virus (HBV). In this region, individuals with HIV-1/HBV co-infection on antiretroviral therapy (ART) frequently receive lamivudine as the only agent active against HBV, raising concerns for development of HBV resistance to lamivudine. We aimed to determine the prevalence, clinical, and virologic outcomes of chronic HBV infection, including HBV resistance to lamivudine, in a cohort of HIV-1 seropositive Kenyan women on long-term ART. Methods: In this prospective cohort study, HIV-1 seropositive women initiated three-drug ART regimens that included lamivudine as the single drug active against HBV. Archived samples were tested for HBsAg, with further testing to determine HBeAg seroprevalence, HBV DNA suppression, and lamivudine resistance. We estimated the prevalence of chronic HBV and examined associations between HBV co-infection and clinical and virologic outcomes with chi-square tests, logistic regression, Kaplan-Meier and Cox regression. Results: In a cohort of 159 women followed for a median of 3.4 years (interquartile range 1.4-4.5), 11 (6.9%; 95%CI 3.1-10.7) had chronic HBV infection. Of these, 9 (82%) achieved undetectable plasma HBV DNA levels. One woman developed lamivudine resistance, for an incidence of 3 per 100 person-years. The HBV co-infected women were at greater risk for abnormal ALT elevations compared to HIV-1 mono-infected women (HR 2.37; 95%CI 1.1-5.3). There were no differences between HBV-infected and uninfected women in mortality, CD4 count, or HIV-1 RNA suppression. Conclusion: The prevalence of chronic HBV in this cohort was similar to recent studies from other African populations. Given our long-term follow-up, lamivudine resistance was lower than expected for HIV-1/HBV co-infected patients. Improved screening for HBV and extended follow-up of HIV-1/HBV co-infected individuals are needed to better understand the impact of different ART regimens on clinical outcomes in this population.	[Day, Summer L.; Scott, John; Kim, H. Nina; Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Odem-Davis, Katherine; Masese, Linnet N.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Odem-Davis, Katherine; Jerome, Keith R.; Cook, Linda] Fred Hutchison Canc Res Ctr, Seattle, WA USA; [Mandaliya, Kishorchandra N.] Pathcare Labs, Mombasa, Kenya; [Jerome, Keith R.; Cook, Linda] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Nairobi; University of Washington; University of Washington Seattle	McClelland, RS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mcclell@uw.edu	Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686; Masese, Linnet/0000-0003-4704-9154	National Institutes of Health (NIH) [R01-AI58698, P30-AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI058698] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) (grant R01-AI58698 supplement). Infrastructure support for the Mombasa Field Site was received from the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30-AI027757). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2003, J HEPATOL, V38, P315, DOI 10.1016/S0168-8278(02)00410-5; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Buti M, 2002, J HEPATOL, V36, P445, DOI 10.1016/S0168-8278(01)00283-5; Ford N, 2010, CURR OPIN HIV AIDS, V5, P38, DOI 10.1097/COH.0b013e3283339b41; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Kao JH, 2002, J HEPATOL, V36, P303, DOI 10.1016/S0168-8278(01)00246-X; Kim HN, 2011, J VIRAL HEPATITIS, V18, pE447, DOI 10.1111/j.1365-2893.2011.01466.x; Kouanfack C, 2012, ANTIVIR THER, V17, P321, DOI 10.3851/IMP1911; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; La'ulu SL, 2006, AM J CLIN PATHOL, V125, P748, DOI 10.1309/K5EM795VNGGFGBXX; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Li XD, 2011, CHINESE MED J-PEKING, V124, P4178, DOI 10.3760/cma.j.issn.0366-6999.2011.24.011; Liu CJ, 2005, LIVER INT, V25, P1097, DOI 10.1111/j.1478-3231.2005.01177.x; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; McClelland RS, 2006, AIDS, V20, P1969, DOI 10.1097/01.aids.0000247119.12327.e6; Modi AA, 2007, AIDS REV, V9, P25; Moerman B, 2004, Clin Lab, V50, P159; Moskovitz DN, 2005, J VIRAL HEPATITIS, V12, P398, DOI 10.1111/j.1365-2893.2005.00613.x; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramos B, 2007, JAIDS-J ACQ IMM DEF, V44, P557, DOI 10.1097/QAI.0b013e3180314b46; Shaikh T, 2012, CAN J GASTROENTEROL, V26, P148, DOI 10.1155/2012/936259; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561; Suzuki F, 2003, INTERVIROLOGY, V46, P182, DOI 10.1159/000071460; UNAIDS, 2010, GLOB REP UNAIDS REP, P1; WHO, 2010, ANT THER HIV INF AD; Wongprasit P, 2010, AIDS PATIENT CARE ST, V24, P205, DOI 10.1089/apc.2009.0322; Wu F, 2012, HEPATOB PANCREAT DIS, V11, P172, DOI 10.1016/S1499-3872(12)60144-1; Zollner B, 2002, CLIN INFECT DIS, V34, P1273, DOI 10.1086/339959; Zollner B, 2001, J MED VIROL, V65, P659, DOI 10.1002/jmv.2087	39	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59346	10.1371/journal.pone.0059346	http://dx.doi.org/10.1371/journal.pone.0059346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527168	Green Submitted, gold, Green Published			2022-12-27	WOS:000316411600055
J	Yang, MJ; Sim, S; Jeon, JH; Jeong, E; Kim, HC; Park, YJ; Kim, IB				Yang, Myung Jae; Sim, Sooyeon; Jeon, Ji Hyun; Jeong, Eojin; Kim, Hyoung-Chin; Park, Yong-Jin; Kim, In-Beom			Mitral and Tufted Cells Are Potential Cellular Targets of Nitration in the Olfactory Bulb of Aged Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; CEREBRAL-CORTEX; RAT-BRAIN; LIPOFUSCIN ACCUMULATION; ALZHEIMERS-DISEASE; TYROSINE NITRATION; FREE-RADICALS; AGING RETINA; NITROTYROSINE	Olfactory sensory function declines with age; though, the underlying molecular changes that occur in the olfactory bulb (OB) are relatively unknown. An important cellular signaling molecule involved in the processing, modulation, and formation of olfactory memories is nitric oxide (NO). However, excess NO can result in the production of peroxynitrite to cause oxidative and nitrosative stress. In this study, we assessed whether changes in the expression of 3-nitrotyrosine (3-NT), a neurochemical marker of peroxynitrite and thus oxidative damage, exists in the OB of young, adult, middle-aged, and aged mice. Our results demonstrate that OB 3-NT levels increase with age in normal C57BL/6 mice. Moreover, in aged mice, 3-NT immunoreactivity was found in some blood vessels and microglia throughout the OB. Notably, large and strongly immunoreactive puncta were found in mitral and tufted cells, and these were identified as lipofuscin granules. Additionally, we found many small-labeled puncta within the glomeruli of the glomerular layer and in the external plexiform layer, and these were localized to mitochondria and discrete segments of mitral and tufted dendritic plasma membranes. These results suggest that mitral and tufted cells are potential cellular targets of nitration, along with microglia and blood vessels, in the OB during aging.	[Yang, Myung Jae; Park, Yong-Jin] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Otolaryngol Head & Neck Surg, Suwon, Gyeonggi Do, South Korea; [Sim, Sooyeon; Jeon, Ji Hyun; Jeong, Eojin; Kim, In-Beom] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Hyoung-Chin] Korea Res Inst Biosci & Biotechnol, Ochang Branch, Biomed Mouse Resource Ctr, Ochang Eup, Chungcheongbuk, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, YJ (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Otolaryngol Head & Neck Surg, Suwon, Gyeonggi Do, South Korea.	yp@catholic.ac.kr; ibkimmd@catholic.ac.kr	Kim, In-Beom/A-6728-2011		Rural Development Administration, Korea [PJ007186]	Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by the Biogreen 21 Program (Grant No. # PJ007186) of the Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Blanco S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-78; Bolan EA, 2000, J NEUROSCI, V20, P4798; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Bustamante J, 2008, NEUROCHEM RES, V33, P1216, DOI 10.1007/s11064-007-9570-z; Calabrese V, 2000, NEUROCHEM RES, V25, P1315, DOI 10.1023/A:1007604414773; Camici O, 1997, MOL CELL BIOCHEM, V175, P71, DOI 10.1023/A:1006889328983; Chung YH, 2002, BRAIN RES, V951, P316, DOI 10.1016/S0006-8993(02)03261-4; Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doty RL, 1991, ANN N Y ACAD SCI, V640, P20; DOWSON JH, 1982, BRIT J PSYCHIAT, V140, P142, DOI 10.1192/bjp.140.2.142; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; Getchell ML, 2001, CHEM SENSES, V26, P1114; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HINDS JW, 1979, J COMP NEUROL, V184, P811, DOI 10.1002/cne.901840412; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Hwang SJ, 2010, J MOL HISTOL, V41, P129, DOI 10.1007/s10735-010-9268-4; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kincer JF, 2002, J BIOL CHEM, V277, P23525, DOI 10.1074/jbc.M202465200; KIRSTEIN CL, 1991, BRAIN RES, V543, P341, DOI 10.1016/0006-8993(91)90047-Y; Kosaka T, 2007, NEUROSCI RES, V57, P165, DOI 10.1016/j.neures.2006.10.005; Kraemer S, 2004, PHYSIOL BEHAV, V81, P435, DOI 10.1016/j.physbeh.2004.01.012; Lee JJ, 2008, NEUROSCI LETT, V447, P37, DOI 10.1016/j.neulet.2008.09.074; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu P, 2004, NEUROBIOL AGING, V25, P547, DOI 10.1016/j.neurobiolaging.2003.07.003; Lowe G, 2008, NEUROSCIENCE, V153, P842, DOI 10.1016/j.neuroscience.2008.03.003; MACRIDES F, 1983, CHEM NEUROANATOMY, P391; Maneen MJ, 2006, STROKE, V37, P894, DOI 10.1161/01.STR.0000204043.18592.0d; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Maruyama W, 2001, J AM AGING ASSOC, V24, P11, DOI 10.1007/s11357-001-0002-8; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Molina-Holgado E, 2001, EUR J NEUROSCI, V13, P493, DOI 10.1046/j.0953-816x.2000.01412.x; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Okere CO, 2000, EUR J NEUROSCI, V12, P4552, DOI 10.1046/j.0953-816X.2000.01325.x; Philpot BD, 1998, EXP BRAIN RES, V118, P205, DOI 10.1007/s002210050273; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Quinn JF, 2007, NEUROBIOL AGING, V28, P213, DOI 10.1016/j.neurobiolaging.2005.12.014; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shin CM, 2002, BRAIN RES, V931, P194, DOI 10.1016/S0006-8993(01)03391-1; Siles E, 2002, BRAIN RES, V956, P385, DOI 10.1016/S0006-8993(02)03575-8; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; STREHLER BL, 1959, J GERONTOL, V14, P430, DOI 10.1093/geronj/14.4.430; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996; Uttenthal LO, 1998, MICROSC RES TECHNIQ, V43, P75, DOI 10.1002/(SICI)1097-0029(19981001)43:1<75::AID-JEMT11>3.0.CO;2-0; Vaishnav RA, 2007, J NEUROSCI RES, V85, P373, DOI 10.1002/jnr.21130; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	78	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59673	10.1371/journal.pone.0059673	http://dx.doi.org/10.1371/journal.pone.0059673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527248	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600073
J	Tofteland, S; Naseer, U; Lislevand, JH; Sundsfjord, A; Samuelsen, O				Tofteland, Stale; Naseer, Umaer; Lislevand, Jan Helge; Sundsfjord, Arnfinn; Samuelsen, Orjan			A Long-Term Low-Frequency Hospital Outbreak of KPC-Producing Klebsiella pneumoniae Involving Intergenus Plasmid Diffusion and a Persisting Environmental Reservoir	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; HYDROLYZING BETA-LACTAMASE; SEQUENCE TYPE 258; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; RESISTANT-KLEBSIELLA; RISK-FACTORS; CARBAPENEM RESISTANCE; ENTEROBACTER-CLOACAE; STRAIN	Background: To study the molecular characteristics of a long-term, low frequency outbreak of bla(KPC-2) in a low prevalence setting involving the hospital environment. Methodology/Principal Findings: KPC-producing bacteria were screened by selective chromogenic agar and Real-Time PCR. The presence of antibiotic resistance genes was ascribed by PCRs and subsequent sequencing, and the KPC-producing isolates were phylogenetically typed using PFGE and multi-locus sequence typing. Bla(KPC-2)-plasmids were identified and analysed by S1-nuclease-PFGE hybridization and PCR based replicon typing. A similar to 97 kb IncFII plasmid was seen to carry bla(KPC-2) in all of the clinical isolates, in one of the isolates recovered from screened patients (1/136), and in the Klebsiella pneumoniae and Enterobacter asburiae isolates recovered from the environment (sinks) in one intensive care unit. The K. pneumoniae strain ST258 was identified in 6 out of 7 patients. An intergenus spread to E. asburiae and an interspecies spread to two different K. pneumoniae clones (ST27 and ST461) of the bla(KPC-2) plasmid was discovered. K. pneumoniae ST258 and genetically related E. asburiae strains were found in isolates of both human and environmental origins. Conclusions/Significance: We document a clonal transmission of the K. pneumoniae ST258 strain, and an intergenus plasmid diffusion of the IncFII plasmid carrying bla(KPC-2) in this outbreak. A major reservoir in the patient population could not be unveiled. However, the identification of a persisting environmental reservoir of strains with molecular determinants linked to human isolates, suggests a possible role of the environment in the maintenance of this long-term outbreak.	[Tofteland, Stale; Lislevand, Jan Helge] Sorlandet Hosp HF, Dept Clin Microbiol, Kristiansand, Norway; [Naseer, Umaer; Sundsfjord, Arnfinn; Samuelsen, Orjan] Univ Hosp North Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance, Tromso, Norway; [Naseer, Umaer; Sundsfjord, Arnfinn] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Tofteland, S (corresponding author), Sorlandet Hosp HF, Dept Clin Microbiol, Kristiansand, Norway.	staale.tofteland@sshf.no	Sundsfjord, Arnfinn/F-9668-2018; Samuelsen, Ørjan/K-9068-2019	Sundsfjord, Arnfinn/0000-0002-3728-2270; Samuelsen, Ørjan/0000-0002-5525-2614	SArlandet Hospital HF; Northern Norway Regional Health Authority Medical Research Programme	SArlandet Hospital HF; Northern Norway Regional Health Authority Medical Research Programme	The study was supported by a fellowship from SArlandet Hospital HF and a research grant from the Northern Norway Regional Health Authority Medical Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Baraniak A, 2011, ANTIMICROB AGENTS CH, V55, P5493, DOI 10.1128/AAC.05118-11; Bennett JW, 2009, ANTIMICROB AGENTS CH, V53, P292, DOI 10.1128/AAC.00931-08; BINGEN EH, 1993, J CLIN MICROBIOL, V31, P179, DOI 10.1128/JCM.31.2.179-184.1993; Cai JC, 2008, ANTIMICROB AGENTS CH, V52, P2014, DOI 10.1128/AAC.01539-07; Calfee D, 2008, INFECT CONT HOSP EP, V29, P966, DOI 10.1086/590661; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Curiao T, 2010, J ANTIMICROB CHEMOTH, V65, P1608, DOI 10.1093/jac/dkq174; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P5370, DOI 10.1128/AAC.05202-11; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; D'Agata EMC, 1999, J CLIN MICROBIOL, V37, P3065; de Jong EHJ, 2012, 22 EUR C CLIN MICR I; Dominguez MC, 2011, 51 INT C ANT AG CHEM; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Folkehelseinstituttet, 2009, FOR KONTR SPREDN MUL; Hindiyeh M, 2008, J CLIN MICROBIOL, V46, P2879, DOI 10.1128/JCM.00661-08; Hobson RP, 1996, J HOSP INFECT, V33, P249, DOI 10.1016/S0195-6701(96)90011-0; Hota S, 2009, INFECT CONT HOSP EP, V30, P25, DOI 10.1086/592700; Hussein K, 2009, INFECT CONT HOSP EP, V30, P666, DOI 10.1086/598244; Kac G, 2004, INFECT CONT HOSP EP, V25, P852, DOI 10.1086/502308; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Lowe C, 2012, EMERG INFECT DIS, V18, P1242, DOI 10.3201/eid1808.111268; Lucet JC, 1996, CLIN INFECT DIS, V22, P430, DOI 10.1093/clinids/22.3.430; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 1998, ANTIMICROB AGENTS CH, V42, P53, DOI 10.1128/AAC.42.1.53; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Rasheed JK, 2008, J CLIN MICROBIOL, V46, P2066, DOI 10.1128/JCM.02038-07; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Sidjabat HE, 2009, CLIN INFECT DIS, V49, P1736, DOI 10.1086/648077; Skippen I, 2006, J HOSP INFECT, V64, P115, DOI 10.1016/j.jhin.2006.05.010; Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, EUCAST CLIN BREAKP T; Velasco C, 2009, J HOSP INFECT, V73, P157, DOI 10.1016/j.jhin.2009.06.013; Wendt C, 2010, EUR J CLIN MICROBIOL, V29, P563, DOI 10.1007/s10096-010-0896-0; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2010, J CLIN MICROBIOL, V48, P2271, DOI 10.1128/JCM.02301-09	49	78	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59015	10.1371/journal.pone.0059015	http://dx.doi.org/10.1371/journal.pone.0059015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536849	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100111
J	Wang, W; Wang, YJ; Gong, FQ; Zhu, WH; Fu, SL				Wang, Wei; Wang, Yujia; Gong, Fangqi; Zhu, Weihua; Fu, Songling			MTHFR C677T Polymorphism and Risk of Congenital Heart Defects: Evidence from 29 Case-Control and TDT Studies	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MUTATION; SINGLE-NUCLEOTIDE-POLYMORPHISMS; ASSOCIATION; DISEASE; GENE; HOMOCYSTEINE; MALFORMATIONS; GENOTYPE	Background: Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme for folate metabolism in humans; it is encoded by the MTHFR gene. Several studies have assessed the association between MTHFR C677T polymorphism and the risk of congenital heart defects (CHDs), while the results were inconsistent. Methods and Findings: Multiple electronic databases were searched to identify relevant studies published up to July 22, 2012. Data from case-control and TDT studies were integrated in an allelic model using the Catmap and Metafor software. Twenty-nine publications were included in this meta-analysis. The overall meta-analysis showed significant association between MTHFR C677T polymorphism and CHDs risk in children with heterogeneity (P-heterogeneity = 0.000) and publication bias (P-egger = 0.039), but it turned into null after the trim-and-fill method was implemented (OR = 1.12, 95% CI = 0.95-1.31). Nevertheless, positive results were obtained after stratified by ethnicity and sample size in all subgroups except the mixed population. For mothers, there was significant association between the variant and CHDs without heterogeneity ((Pheterogeneity) = 0.150, OR = 1.16, 95% CI = 1.05-1.29) and publication bias (P-egger = 0.981). However, the results varied across each subgroup in the stratified analysis of ethnicity and sample size. Conclusions: Both infant and maternal MTHFR C677T polymorphisms may contribute to the risk of CHDs.	[Wang, Wei; Gong, Fangqi; Zhu, Weihua; Fu, Songling] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China; [Wang, Yujia] CRCHUM Hop Notre Dame, Ctr Hosp Univ Montreal, Montreal, PQ, Canada	Zhejiang University; Universite de Montreal	Gong, FQ (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China.	gongfangqi63@gmail.com			National Natural Science Foundation of China [30872799, 30973223, 81270177]; Zhejiang Province innovation team for early screening and intervention of birth defects [2010R50045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province innovation team for early screening and intervention of birth defects	This work is supported, in part, by grants from The National Natural Science Foundation of China (30872799, 30973223, 81270177) and Zhejiang Province innovation team for early screening and intervention of birth defects (2010R50045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderrabano-Saucedo NA, 2012, PEDIAT CARDIOL; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galdieri LC, 2007, ARCH MED RES, V38, P212, DOI 10.1016/j.arcmed.2006.09.012; Garcia-Fragoso Lourdes, 2010, Int J Genet Mol Biol, V2, P43; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Gong T, 2009, MATERN CHILD HLTH J, V24, P3117; GOYETTE P, 1995, AM J HUM GENET, V56, P1052; Hall J, 1998, EUR J PEDIATR, V157, P445, DOI 10.1007/s004310050850; Hobbs CA, 2006, J MED GENET, V43, P162, DOI 10.1136/jmg.2005.032656; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hu L, 2009, J HIGH ALTITUDE MED, V19, P30; Jiang S, 2012, CARDIOVASC THER; Junker R, 2001, CARDIOVASC RES, V51, P251, DOI 10.1016/S0008-6363(01)00286-3; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Khare A, 2006, NEW ENGL J MED, V355, P206; Kuehl K, 2010, BIRTH DEFECTS RES A, V88, P101, DOI 10.1002/bdra.20630; Lee CN, 2005, ACTA OBSTET GYN SCAN, V84, P1134, DOI 10.1111/j.0001-6349.2005.00611.x; Li Dong, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P700; Li Y, 2005, ACTA BIOCH BIOPH SIN, V37, P75, DOI 10.1093/abbs/37.2.75; LIU F, 2005, CHIN J CONT PEDIAT, V7, P99; Liu YS, 2007, CHIN J CARDIOVASC RE, V5, P210; Marinho Claudia, 2009, Rev Port Cardiol, V28, P809; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub2; McBride KL, 2004, BIRTH DEFECTS RES A, V70, P825, DOI 10.1002/bdra.20049; Nurk E, 2004, AM J MED, V117, P26, DOI 10.1016/j.amjmed.2004.01.019; Peng Ting, 2009, Journal of Environment and Health, V26, P687; Pereira AC, 2005, INT J CARDIOL, V105, P15, DOI 10.1016/j.ijcard.2004.10.049; Shaw GM, 2005, AM J MED GENET A, V138A, P21, DOI 10.1002/ajmg.a.30924; Sibani S, 2000, HUM MUTAT, V15, P280, DOI 10.1002/(SICI)1098-1004(200003)15:3<280::AID-HUMU9>3.3.CO;2-9; Storti S, 2003, CLIN CHEM LAB MED, V41, P276, DOI 10.1515/CCLM.2003.043; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; van Driel LMJW, 2008, BIRTH DEFECTS RES A, V82, P474, DOI 10.1002/bdra.20463; Wenstrom KD, 2001, AM J OBSTET GYNECOL, V184, P806, DOI 10.1067/mob.2001.113845; Wintner S, 2007, PRENATAL DIAG, V27, P704, DOI 10.1002/pd.1761; Xu J, 2010, CARDIOL YOUNG, V20, P318, DOI 10.1017/S1047951110000247; Yan L, 2003, J PEKING U, V35, P448; Yan L, 2003, CHIN J DIS CONTROL P, V7, P94; Yin M, 2012, ANN HUM GENET, V76, P9, DOI 10.1111/j.1469-1809.2011.00687.x; Zhong Q.A., 2006, GUANGXI MED J, P1140; Zhu WL, 2006, MOL HUM REPROD, V12, P51, DOI 10.1093/molehr/gah252	40	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58041	10.1371/journal.pone.0058041	http://dx.doi.org/10.1371/journal.pone.0058041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536781	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100025
J	Galbiati, S; Damin, F; Pinzani, P; Mancini, I; Vinci, S; Chiari, M; Orlando, C; Cremonesi, L; Ferrari, M				Galbiati, Silvia; Damin, Francesco; Pinzani, Pamela; Mancini, Irene; Vinci, Serena; Chiari, Marcella; Orlando, Claudio; Cremonesi, Laura; Ferrari, Maurizio			A New Microarray Substrate for Ultra-Sensitive Genotyping of KRAS and BRAF Gene Variants in Colorectal Cancer	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; DNA MICROARRAYS; MUTATIONS; INTERFERENCE; SILICON; SLIDES; TRIAL; CHIP	Molecular diagnostics of human cancers may increase accuracy in prognosis, facilitate the selection of the optimal therapeutic regimen, improve patient outcome, reduce costs of treatment and favour development of personalized approaches to patient care. Moreover sensitivity and specificity are fundamental characteristics of any diagnostic method. We developed a highly sensitive microarray for the detection of common KRAS and BRAF oncogenic mutations. In colorectal cancer, KRAS and BRAF mutations have been shown to identify a cluster of patients that does not respond to anti-EGFR therapies; the identification of these mutations is therefore clinically extremely important. To verify the technical characteristics of the microarray system for the correct identification of the KRAS mutational status at the two hotspot codons 12 and 13 and of the BRAF(V600E) mutation in colorectal tumor, we selected 75 samples previously characterized by conventional and CO-amplification at Lower Denaturation temperature-PCR (COLD-PCR) followed by High Resolution Melting analysis and direct sequencing. Among these samples, 60 were collected during surgery and immediately steeped in RNAlater while the 15 remainders were formalin-fixed and paraffin-embedded (FFPE) tissues. The detection limit of the proposed method was different for the 7 KRAS mutations tested and for the V600E BRAF mutation. In particular, the microarray system has been able to detect a minimum of about 0.01% of mutated alleles in a background of wild-type DNA. A blind validation displayed complete concordance of results. The excellent agreement of the results showed that the new microarray substrate is highly specific in assigning the correct genotype without any enrichment strategy.	[Galbiati, Silvia; Cremonesi, Laura; Ferrari, Maurizio] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, Genom Unit Diag Human Pathol, I-20132 Milan, Italy; [Damin, Francesco; Chiari, Marcella] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy; [Pinzani, Pamela; Mancini, Irene; Vinci, Serena; Orlando, Claudio] Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, Florence, Italy; [Ferrari, Maurizio] Univ Vita Salute San Raffaele, Milan, Italy; [Ferrari, Maurizio] Diagnost & Ric San Raffaele SpA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Florence; Vita-Salute San Raffaele University	Galbiati, S (corresponding author), Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, Genom Unit Diag Human Pathol, I-20132 Milan, Italy.	galbiati.silvia@hsr.it	Pinzani, P./K-7022-2018; Galbiati, Silvia/AAC-1218-2019; Damin, Francesco/AAL-8998-2021; Mancini, Irene/K-2126-2018	Pinzani, P./0000-0003-4017-3574; Galbiati, Silvia/0000-0003-1642-8506; Damin, Francesco/0000-0003-1780-7823; Mancini, Irene/0000-0002-7814-6435; Chiari, Marcella/0000-0002-4670-1430				Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cretich M, 2008, SENSOR ACTUAT B-CHEM, V132, P258, DOI 10.1016/j.snb.2008.01.033; Cretich M, 2010, ANAL BIOCHEM, V397, P84, DOI 10.1016/j.ab.2009.09.050; Cretich M, 2009, ANAL CHEM, V81, P5197, DOI 10.1021/ac900658c; Eng C, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2009-0167; Ferrari F, 2006, HUM MUTAT, V27, P201, DOI 10.1002/humu.20294; Fouque B, 2005, BIOSENS BIOELECTRON, V20, P2335, DOI 10.1016/j.bios.2004.08.009; Galbiati S, 2008, ELECTROPHORESIS, V29, P4714, DOI 10.1002/elps.200800242; Ho-Pun-Cheung A, 2006, LAB INVEST, V86, P304, DOI 10.1038/labinvest.3700387; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Mancini I, 2010, J MOL DIAGN, V12, P705, DOI 10.2353/jmoldx.2010.100018; Marquette CA, 2007, TALANTA, V71, P1312, DOI 10.1016/j.talanta.2006.06.039; Moiseev L, 2006, P NATL ACAD SCI USA, V103, P2623, DOI 10.1073/pnas.0511214103; Moutereau S, 2004, HUM MUTAT, V23, P621, DOI 10.1002/humu.20045; Oliviero G, 2008, ANAL CHIM ACTA, V630, P161, DOI 10.1016/j.aca.2008.09.069; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Pinzani P, 2011, CLIN CHIM ACTA, V412, P901, DOI 10.1016/j.cca.2011.01.014; Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Stenirri S, 2004, CLIN CHEM, V50, P1336, DOI 10.1373/clinchem.2004.033241; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Volle JN, 2003, BIOSENS BIOELECTRON, V19, P457, DOI 10.1016/S0956-5663(03)00201-X	27	13	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59939	10.1371/journal.pone.0059939	http://dx.doi.org/10.1371/journal.pone.0059939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536897	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200045
J	Giovanini, J; Kroll, AJ; Jones, JE; Altman, B; Arnett, EB				Giovanini, Jack; Kroll, Andrew J.; Jones, Jay E.; Altman, Bob; Arnett, Edward B.			Effects of Management Intervention on Post-Disturbance Community Composition: An Experimental Analysis Using Bayesian Hierarchical Models	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; FUEL-REDUCTION TREATMENTS; GREEN-TREE RETENTION; DOUGLAS-FIR FORESTS; ACTIVE CROWN FIRE; SPECIES RICHNESS; NATURAL DISTURBANCES; ECOSYSTEM SERVICES; OUTBREAKS CHANGE; NEST SURVIVAL	As human demand for ecosystem products increases, management intervention may become more frequent after environmental disturbances. Evaluations of ecological responses to cumulative effects of management interventions and natural disturbances provide critical decision-support tools for managers who strive to balance environmental conservation and economic development. We conducted an experiment to evaluate the effects of salvage logging on avian community composition in lodgepole pine (Pinus contorta) forests affected by beetle outbreaks in Oregon, USA, 1996-1998. Treatments consisted of the removal of lodgepole pine snags only, and live trees were not harvested. We used a Bayesian hierarchical model to quantify occupancy dynamics for 27 breeding species, while accounting for variation in the detection process. We examined how magnitude and precision of treatment effects varied when incorporating prior information from a separate intervention study that occurred in a similar ecological system. Regardless of which prior we evaluated, we found no evidence that the harvest treatment had a negative impact on species richness, with an estimated average of 0.2-2.2 more species in harvested stands than unharvested stands. Estimated average similarity between control and treatment stands ranged from 0.82-0.87 (1 indicating complete similarity between a pair of stands) and suggested that treatment stands did not contain novel assemblies of species responding to the harvesting prescription. Estimated treatment effects were positive for twenty-four (90%) of the species, although the credible intervals contained 0 in all cases. These results suggest that, unlike most post-fire salvage logging prescriptions, selective harvesting after beetle outbreaks may meet multiple management objectives, including the maintenance of avian community richness comparable to what is found in unharvested stands. Our results provide managers with prescription alternatives to respond to severe beetle outbreaks that continue to occur across extensive portions of the dry forests of western North America.	[Giovanini, Jack; Jones, Jay E.] Weyerhaeuser NR, Stat Math & Operat Res, Federal Way, WA USA; [Kroll, Andrew J.] Weyerhaeuser NR, Timberlands Technol, Federal Way, WA USA; [Altman, Bob] Amer Bird Conservancy, Corvallis, OR USA; [Arnett, Edward B.] Theodore Roosevelt Conservat Partnership, Washington, DC USA		Kroll, AJ (corresponding author), Weyerhaeuser NR, Timberlands Technol, Federal Way, WA USA.	aj.kroll@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X				Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; [Anonymous], [No title captured]; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Berlik MM, 2002, J BIOGEOGR, V29, P1557, DOI 10.1046/j.1365-2699.2002.00768.x; Beschta RL, 2004, CONSERV BIOL, V18, P957, DOI 10.1111/j.1523-1739.2004.00495.x; BIBBY CJ, 1987, ACTA OECOL-OEC GEN, V8, P103; Bonnot TW, 2009, FOREST ECOL MANAG, V259, P220, DOI 10.1016/j.foreco.2009.10.021; Brais S, 2000, FOREST ECOL MANAG, V137, P231, DOI 10.1016/S0378-1127(99)00331-X; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brewer JS, 2012, ECOL APPL, V22, P442, DOI 10.1890/11-0386.1; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Cahall RE, 2009, FOREST ECOL MANAG, V257, P1119, DOI 10.1016/j.foreco.2008.11.019; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Campbell S., 1996, PNWGTR381 USDA FOR S; Castro J, 2010, CONSERV BIOL, V24, P810, DOI 10.1111/j.1523-1739.2009.01382.x; Cook JG, 1995, WILDLIFE SOC B, V23, P711; Dale V, 2005, ECOLOGICAL RESPONSES; Dale VH, 2000, ECOL APPL, V10, P639; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Eklund A, 2009, WEST J APPL FOR, V24, P67, DOI 10.1093/wjaf/24.2.67; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fernandez C, 2008, FOREST ECOL MANAG, V255, P1294, DOI 10.1016/j.foreco.2007.10.034; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Ford CR, 2011, ECOL APPL, V21, P2049, DOI 10.1890/10-2246.1; Franklin J.F., 1973, GEN TECHNICAL REPORT; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gaines W, 2010, FOREST SCI, V56, P88; Gandhi KJK, 2008, FOREST ECOL MANAG, V256, P1104, DOI 10.1016/j.foreco.2008.06.011; Garrard GE, 2012, J ANIM ECOL, V81, P14, DOI 10.1111/j.1365-2656.2011.01891.x; Gelman A., 2004, BAYESIAN DATA ANAL; Gitzen RA, 2007, FOREST ECOL MANAG, V251, P142, DOI 10.1016/j.foreco.2007.05.028; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Hagar J, 2004, FOREST ECOL MANAG, V199, P333, DOI 10.1016/j.foreco.2004.05.054; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hessburg P.F., 1994, PNWGTR327 USDA FOR S; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; Hunter WC, 2001, WILDLIFE SOC B, V29, P440; Hutto RL, 2006, CONSERV BIOL, V20, P984, DOI 10.1111/j.1523-1739.2006.00494.x; Hutto RL, 2006, CONDOR, V108, P817, DOI 10.1650/0010-5422(2006)108[817:TEOPSL]2.0.CO;2; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; Johnson DW, 2005, FOREST ECOL MANAG, V220, P155, DOI 10.1016/j.foreco.2005.08.011; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; Jones JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043290; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; KLOCK GO, 1975, J SOIL WATER CONSERV, V30, P78; Kotliar NB, 2002, STUD AVIAN BIOL-SER, P49; Kroll AJ, 2012, J WILDLIFE MANAGE, V76, P1188, DOI 10.1002/jwmg.353; Kroll AJ, 2010, FOREST ECOL MANAG, V260, P1599, DOI 10.1016/j.foreco.2010.08.009; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lain EJ, 2008, FOREST ECOL MANAG, V256, P863, DOI 10.1016/j.foreco.2008.05.018; Lindenmayer DB, 2006, CONSERV BIOL, V20, P949, DOI 10.1111/j.1523-1739.2006.00497.x; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; McCarthy MA, 2008, AM NAT, V172, P216, DOI 10.1086/588074; McIver James D., 2001, Western Journal of Applied Forestry, V16, P159; Megahan W. F., 1972, USDA Forest Service Research Paper, Intermountain Forest and Range Experiment Station; Moran CJ, 2012, ECOLOGY, V93, P939; Nelson JL, 2008, FOREST ECOL MANAG, V256, P388, DOI 10.1016/j.foreco.2008.04.035; Nordin J, 2008, CAN J FOREST RES, V38, P3139, DOI 10.1139/X08-140; Parkins JR, 2007, GLOBAL ENVIRON CHANG, V17, P460, DOI 10.1016/j.gloenvcha.2007.01.003; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Peterson CJ, 2008, ECOL APPL, V18, P407, DOI 10.1890/07-0603.1; Radeloff VC, 2000, ECOL APPL, V10, P233, DOI 10.1890/1051-0761(2000)010[0233:EOIDOL]2.0.CO;2; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Ralph CJ, 1993, PSWGTR144 USDA US FO; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Saab V.S., 1998, RMRSRP11 USDA FOR SE, P17, DOI [10.2737/RMRS-RP-11, DOI 10.2737/RMRS-RP-11]; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Simard M, 2012, ECOLOGY, V93, P946; Soderstrom B, 2009, FOREST ECOL MANAG, V257, P215, DOI 10.1016/j.foreco.2008.08.030; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Spring DA, 2008, FOREST ECOL MANAG, V255, P3857, DOI 10.1016/j.foreco.2008.03.033; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; U.S. Forest Service, 1989, LAND RES MAN PLAN FR; U.S. Forest Service, 1990, WIN NAT FOR LAND RES; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volland L.A., 1985, R6ECOL1041985 USDA F; Walton A., 2013, PROVINCIAL LEVEL PRO; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	90	12	12	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59900	10.1371/journal.pone.0059900	http://dx.doi.org/10.1371/journal.pone.0059900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533659	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400096
J	Hayward, A; Ghazal, A; Andersson, G; Andersson, L; Jern, P				Hayward, Alexander; Ghazal, Awaisa; Andersson, Goran; Andersson, Leif; Jern, Patric			ZBED Evolution: Repeated Utilization of DNA Transposons as Regulators of Diverse Host Functions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; BINDING PROTEINS; DOMESTICATION; ELEMENTS; GENES; EXPRESSION; MUTATION; MUSCLE; DOMAIN	ZBED genes originate from domesticated hAT DNA transposons and encode regulatory proteins of diverse function in vertebrates. Here we reveal the evolutionary relationship between ZBED genes and demonstrate that they are derived from at least two independent domestication events in jawed vertebrate ancestors. We show that ZBEDs form two monophyletic clades, one of which has expanded through several independent duplications in host lineages. Subsequent diversification of ZBED genes has facilitated regulation of multiple diverse fundamental functions. In contrast to known examples of transposable element exaptation, our results demonstrate a novel unprecedented capacity for the repeated utilization of a family of transposable element-derived protein domains sequestered as regulators during the evolution of diverse host gene functions in vertebrates. Specifically, ZBEDs have contributed to vertebrate regulatory innovation through the donation of modular DNA and protein interacting domains. We identify that C7ORF29, ZBED2, 3, 4, and ZBEDX form a monophyletic group together with ZBED6, that is distinct from ZBED1 genes. Furthermore, we show that ZBED5 is related to Buster DNA transposons and is phylogenetically separate from other ZBEDs. Our results offer new insights into the evolution of regulatory pathways, and suggest that DNA transposons have contributed to regulatory complexity during genome evolution in vertebrates.	[Hayward, Alexander; Andersson, Leif; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Ghazal, Awaisa; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Sci Life Lab, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Hayward, A (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	Alexander.Hayward@imbim.uu.se; Patric.Jern@imbim.uu.se	Andersson, Goran/AAK-6564-2020; Jern, Patric/AAR-2133-2021	Andersson, Goran/0000-0001-5131-3144; Jern, Patric/0000-0003-3393-5825; Hayward, Alexander/0000-0001-7413-718X	Swedish Research Council (FORMAS); Wenner-Gren Foundation; Foundation for Strategic Research	Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); Wenner-Gren Foundation; Foundation for Strategic Research	This work was funded by the Swedish Research Council (FORMAS), the Wenner-Gren Foundation, and the Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Arensburger P, 2011, GENETICS, V188, P45, DOI 10.1534/genetics.111.126813; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson RO, 2011, J VIROL, V85, P12043, DOI 10.1128/JVI.00867-11; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kojima KK, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-12; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043128; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Saghizadeh M, 2011, MOL VIS, V17, P2011; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108	36	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59940	10.1371/journal.pone.0059940	http://dx.doi.org/10.1371/journal.pone.0059940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533661	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400098
J	Liu, S; Cipriano, LE; Holodniy, M; Goldhaber-Fiebert, JD				Liu, Shan; Cipriano, Lauren E.; Holodniy, Mark; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States	PLOS ONE			English	Article							QUALITY-OF-LIFE; VIRUS-INFECTION; VIROLOGICAL RESPONSE; VIRAL-HEPATITIS; ALL-CAUSE; POPULATION; MORTALITY; PEGINTERFERON; UTILITIES; DIAGNOSIS	Background: No consensus exists on screening to detect the estimated 2 million Americans unaware of their chronic hepatitis C infections. Advisory groups differ, recommending birth-cohort screening for baby boomers, screening only high-risk individuals, or no screening. We assessed one-time risk assessment and screening to identify previously undiagnosed 40-74 year-olds given newly available hepatitis C treatments. Methods and Findings: A Markov model evaluated alternative risk-factor guided and birth-cohort screening and treatment strategies. Risk factors included drug use history, blood transfusion before 1992, and multiple sexual partners. Analyses of the National Health and Nutrition Examination Survey provided sex-, race-, age-, and risk-factor-specific hepatitis C prevalence and mortality rates. Nine strategies combined screening (no screening, risk-factor guided screening, or birth-cohort screening) and treatment (standard therapy-peginterferon alfa and ribavirin, Interleukin-28B-guided (IL28B) triple-therapy-standard therapy plus a protease inhibitor, or universal triple therapy). Response-guided treatment depended on HCV genotype. Outcomes include discounted lifetime costs (2010 dollars) and quality adjusted life-years (QALYs). Compared to no screening, risk-factor guided and birth-cohort screening for 50 year-olds gained 0.7 to 3.5 quality adjusted life-days and cost $168 to $568 per person. Birth-cohort screening provided more benefit per dollar than risk-factor guided screening and cost $65,749 per QALY if followed by universal triple therapy compared to screening followed by IL28B-guided triple therapy. If only 10% of screen-detected, eligible patients initiate treatment at each opportunity, birth-cohort screening with universal triple therapy costs $241,100 per QALY. Assuming treatment with triple therapy, screening all individuals aged 40-64 years costs less than $100,000 per QALY. Conclusions: The cost-effectiveness of one-time birth-cohort hepatitis C screening for 40-64 year olds is comparable to other screening programs, provided that the healthcare system has sufficient capacity to deliver prompt treatment and appropriate follow-on care to many newly screen-detected individuals.	[Liu, Shan; Cipriano, Lauren E.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Holodniy, Mark] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Stanford Hlth Policy, Ctr Hlth Policy & Primary Care, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Stanford Hlth Policy, Ctr Outcomes Res, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Liu, S (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	shanliu@stanford.edu	Neilan, Brett A/I-5767-2012; Liu, Sheng/K-2815-2013; Dittmann, Elke/B-4742-2018; Cipriano, Lauren E/C-3521-2017	Neilan, Brett A/0000-0001-6113-772X; Dittmann, Elke/0000-0002-7549-7918; Cipriano, Lauren E/0000-0001-5568-4516; Holodniy, Mark/0000-0002-6655-7982; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Stanford Graduate Fellowship; Social Sciences and Humanities Research Council of Canada; Institute for Operations Research and the Management Sciences; Department of Veterans Affairs; National Institutes of Health National Institute on Aging [K01 AG037593-01A1];  [R01 DA15612-016]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Institute for Operations Research and the Management Sciences; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	SL is supported by a Stanford Graduate Fellowship. LEC is supported by a doctoral scholarship from the Social Sciences and Humanities Research Council of Canada and by the Seth Bonder Scholarship for Applied Operations Research in Health Services from the Institute for Operations Research and the Management Sciences. MH is supported by the Department of Veterans Affairs and supported in part by R01 DA15612-016. JDGF is supported in part by a National Institutes of Health National Institute on Aging Career Development Award (K01 AG037593-01A1; principal investigator, JDGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Arias E, 2006, NATL VITAL STAT REPO; Armstrong EP, 2004, CURR MED RES OPIN, V20, P671, DOI 10.1185/030079904125003485; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Birnkrant D, 2011, 201917 NDA FOOD DRUG; Bureau of Labor Statistics website, 2010, NAT OCC EMPL WAG EST; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Chou R, 2004, ANN INTERN MED, V140, P465, DOI 10.7326/0003-4819-140-6-200403160-00014; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Di Martino V, 2011, J VIRAL HEPATITIS, V18, P493, DOI 10.1111/j.1365-2893.2011.01476.x; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Fischer LR, 2000, ARCH INTERN MED, V160, P1665, DOI 10.1001/archinte.160.11.1665; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H, Vxxiii; Gretch DR, 1997, HEPATOLOGY, V26, pS43, DOI 10.1002/hep.510260708; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Gupta S, 2011, 18 C RETR OPP INF CR; Heeswijk RV, 2011, 18 C RETR OPP INF CR; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; HYLAND CA, 1992, TRANSFUSION MED, V2, P207, DOI 10.1111/j.1365-3148.1992.tb00157.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Levin J., 2010, TELAPREVIR COMBINATI; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mallette C, 2008, AM J GASTROENTEROL, V103, P131, DOI 10.1111/j.1572-0241.2007.01522.x; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McHutchison JG, 2009, NEW ENGL J MED, V361, P1027; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Merck, 2011, FDA ANT DRUGS ADV CO; Mitra D, 2010, VALUE HEALTH, V13, P479, DOI 10.1111/j.1524-4733.2009.00691.x; Narasimhan G, 2006, J VIRAL HEPATITIS, V13, P783, DOI 10.1111/j.1365-2893.2006.00763.x; National Cancer Institute, SEER CANC STAT FACT; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Pollack A., 2011, NY TIMES; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poret AW, 2002, DIS MANAG, V5, P95; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Siddiqui FA, 2008, HEPATOL INT, V2, P376, DOI 10.1007/s12072-008-9086-x; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Stephens CJM, 2010, ADVERSE EVENT RELATE; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thomson Corporation, 2009, RED BOOK PHARM FUND; U.S. Census Bureau website, US CENS 2009 POP EST; United States Department of Veterans Affairs website, 2011, FED SUPPL SCHED DRUG; USPSTF website, USPSTF SCREEN HEP C; Vertex Pharmaceuticals, 2011, 201917 NDA VERT PHAR; Walter SR, 2011, J HEPATOL, V54, P879, DOI 10.1016/j.jhep.2010.08.035; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511	63	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58975	10.1371/journal.pone.0058975	http://dx.doi.org/10.1371/journal.pone.0058975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533595	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400032
J	Lu, TX; Lim, EJ; Itskovich, S; Besse, JA; Plassard, AJ; Mingler, MK; Rothenberg, JA; Fulkerson, PC; Aronow, BJ; Rothenberg, ME				Lu, Thomas X.; Lim, Eun-Jin; Itskovich, Svetlana; Besse, John A.; Plassard, Andrew J.; Mingler, Melissa K.; Rothenberg, Joelle A.; Fulkerson, Patricia C.; Aronow, Bruce J.; Rothenberg, Marc E.			Targeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth	PLOS ONE			English	Article							MICRORNA-21 TARGETS; GENE; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; INFLAMMATION; NETWORK; VIVO	MiR-21 is one of the most up-regulated miRNAs in multiple allergic diseases associated with eosinophilia and has been shown to positively correlate with eosinophil levels. Herein, we show that miR-21 is up-regulated during IL-5-driven eosinophil differentiation from progenitor cells in vitro. Targeted ablation of miR-21 leads to reduced eosinophil progenitor cell growth. Furthermore, miR-21(-/-) eosinophil progenitor cells have increased apoptosis as indicated by increased levels of annexin V positivity compared to miR-21(+/+) eosinophil progenitor cells. Indeed, miR-21(-/-) mice have reduced blood eosinophil levels in vivo and reduced eosinophil colony forming unit capacity in the bone marrow. Using gene expression microarray analysis, we identified dysregulation of genes involved in cell proliferation (e, g, Ms4a3, Grb7), cell cycle and immune response as the most significant pathways affected by miR-21 in eosinophil progenitors. These results demonstrate that miR-21 can regulate the development of eosinophils by influencing eosinophil progenitor cell growth. Our findings have identified one of the first miRNAs with a role in regulating eosinophil development.	[Lu, Thomas X.; Lim, Eun-Jin; Itskovich, Svetlana; Besse, John A.; Mingler, Melissa K.; Rothenberg, Joelle A.; Fulkerson, Patricia C.; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45221 USA; [Lu, Thomas X.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Med Scientist Training Program, Cincinnati, OH USA; [Plassard, Andrew J.; Aronow, Bruce J.] Univ Cincinnati, Coll Med, Dept Pediat, Div Biomed Informat,Cincinnati Childrens Hosp Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45221 USA.	Rothenberg@cchmc.org		Besse, John/0000-0002-9874-5822; Lu, Thomas/0000-0001-9712-180X	National Heart Lung and Blood Institute [F30HL104892]; Albert J. Ryan Foundation; NIH [R01AI083450, R37AI045898]; Campaign Urging Research for Eosinophilic Disease (CURED); Buckeye Foundation; Food Allergy Project/Food Allergy Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL104892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI045898, R01AI083450] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Albert J. Ryan Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease (CURED); Buckeye Foundation; Food Allergy Project/Food Allergy Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Ruth L. Kirschstein National Research Service Award for individual predoctoral M.D./Ph.D. fellows F30HL104892 from the National Heart Lung and Blood Institute (T.X.L.) and the Ryan Fellowship from Albert J. Ryan Foundation (T.X.L.). Additionally, this work was supported by NIH R01AI083450 (M.E.R.), R37AI045898 (M.E.R.), the Campaign Urging Research for Eosinophilic Disease (CURED); the Buckeye Foundation; and the Food Allergy Project/Food Allergy Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuthota P, 2012, SEMIN HEMATOL, V49, P113, DOI 10.1053/j.seminhematol.2012.01.005; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fulkerson PC, 2006, P NATL ACAD SCI USA, V103, P16418, DOI 10.1073/pnas.0607863103; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Jia D, 2008, GASTROENTEROLOGY, V135, P1687, DOI 10.1053/j.gastro.2008.07.026; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Lu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040676; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Mavi P, 2012, AM J PHYSIOL-GASTR L, V302, pG1347, DOI 10.1152/ajpgi.00013.2012; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Tan JX, 2011, INT J CANCER, V128, P1303, DOI 10.1002/ijc.25460; Wang YJ, 2010, CLIN CANCER RES, V16, P2529, DOI 10.1158/1078-0432.CCR-10-0018; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	32	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59397	10.1371/journal.pone.0059397	http://dx.doi.org/10.1371/journal.pone.0059397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533623	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400060
J	Ma, N; Huang, J; Hua, BZ				Ma, Na; Huang, Jing; Hua, Baozhen			Functional Morphology and Sexual Dimorphism of Mouthparts of the Short-Faced Scorpionfly Panorpodes kuandianensis (Mecoptera: Panorpodidae)	PLOS ONE			English	Article							HEAD MORPHOLOGY; INSECTA; PHYLOGENY; BIOLOGY; FOOD	Mouthparts are closely associated with the feeding behavior and feeding habits of insects. The features of mouthparts frequently provide important traits for evolutionary biologists and systematists. The short-faced scorpionflies (Panorpodidae) are distinctly different from other families of Mecoptera by their extremely short rostrum. However, their feeding habits are largely unknown so far. In this study, the mouthpart morphology of Panorpodes kuandianensis Zhong et al., 2011 was investigated using scanning electron microscopy and histological techniques. The mandibulate mouthparts are situated at the tip of the short rostrum. The clypeus and labrum are short and lack distinct demarcation between them. The epipharynx is furnished with sublateral and median sensilla patches. The blade-shaped mandibles are sclerotized and symmetrical, bearing apical teeth and serrate inner margins. The maxilla and labium retain the structures of the typical pattern of biting insects. The hirsute galea, triangular pyramid-shaped lacinia, and labial palps are described in detail at ultrastructural level for the first time. Abundant sensilla are distributed on the surface of maxillary and labial palps. The sexual dimorphism of mouthparts is found in Panorpodes for the first time, mainly exhibiting on the emargination of the labrum and apical teeth of mandibles. Based on the features of mouthparts, the potential feeding strategy and feeding mechanism are briefly discussed in Panorpodes.	[Ma, Na] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Ma, Na; Huang, Jing; Hua, Baozhen] Northwest A&F Univ, Educ Minist, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Hua, BZ (corresponding author), Northwest A&F Univ, Educ Minist, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125]; China Postdoctoral Science Foundation [2012M520085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (grant number 31172125) to Baozhen Hua and the China Postdoctoral Science Foundation (grant number 2012M520085) to Na Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz O, 2003, ACTA ZOOL-STOCKHOLM, V84, P179, DOI 10.1046/j.1463-6395.2003.00147.x; Beutel RG, 2008, J ZOOL SYST EVOL RES, V46, P346, DOI 10.1111/j.1439-0469.2008.00473.x; Beutel RG, 2006, J MORPHOL, V267, P536, DOI 10.1002/jmor.10261; Beutel RG, 2008, ARTHROPOD STRUCT DEV, V37, P418, DOI 10.1016/j.asd.2008.02.002; Bicha WJ, 2010, ZOOTAXA, P61; Brues CT, 1939, SCIENCE, V90, P145, DOI 10.1126/science.90.2329.145; Byers GW, 1997, J KANSAS ENTOMOL SOC, V70, P313; Byers GW, 2005, J KANSAS ENTOMOL SOC, V78, P71, DOI 10.2317/040120.1; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CARPENTER F. M., 1931, BULL MUS COMP ZOOL HARVARD COLL, V72, P205; Carpenter F. M., 1953, Psyche Cambridge Mass, V60, P28, DOI 10.1155/1953/90470; Crampton G. C., 1921, Annals of the Entomological Society of America, V14, P65; Dallai R, 2003, ZOOMORPHOLOGY, V122, P211, DOI 10.1007/s00435-003-0087-y; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DEEMING JC, 1981, ZOOL J LINN SOC-LOND, V71, P159, DOI 10.1111/j.1096-3642.1981.tb01128.x; Ferris G. F., 1939, Microentomology Stanford University, V4, P79; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Gorb SN, 1997, J MORPHOL, V234, P213, DOI 10.1002/(SICI)1097-4687(199712)234:3<213::AID-JMOR1>3.0.CO;2-A; Gullan P.J., 2010, INSECTS OUTLINE ENTO; HEDDERGOTT H., 1938, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V65, P229; Hepburn H. R., 1969, Kansas University Science Bulletin, V48, P721; Hua Bao-zhen, 2004, Entomotaxonomia, V26, P284; Huang J, 2011, MICRON, V42, P498, DOI 10.1016/j.micron.2011.01.011; Imms A. D., 1944, QUART JOUR MICROSC SCI, V85, P73; ISSIKI SYUTI, 1933, JAPANESE JOUR ZOOL, V4, P315; Jervis MA, 1998, BIOL J LINN SOC, V63, P461, DOI 10.1111/j.1095-8312.1998.tb00326.x; Kaltenbach A, 1978, HDB ZOOLOGIE, V4, P1; Kingsolver J.G., 1995, P32; Krenn Harald W., 2007, Arthropod Systematics & Phylogeny, V65, P7; Krenn HW, 2005, ARTHROPOD STRUCT DEV, V34, P1, DOI 10.1016/j.asd.2004.10.002; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Liu SY, 2009, MICRON, V40, P899, DOI 10.1016/j.micron.2009.05.009; Miyake T., 1913, J COLL AGR IMPERIAL, V4, P268; MULKERN GB, 1967, ANNU REV ENTOMOL, V12, P59, DOI 10.1146/annurev.en.12.010167.000423; Nakahara W, 1922, PSYCHE, V29, P212; Otanes F. Q., 1922, Annals of the Entomological Society of America, V15, P310; Palmer Christopher M., 2010, Terrestrial Arthropod Reviews, V3, P111, DOI 10.1163/187498310X519716; Palmer CM, 2005, J INSECT BEHAV, V18, P209, DOI 10.1007/s10905-005-0476-9; Pollmann C, 2008, ORG DIVERS EVOL, V8, P77, DOI 10.1016/j.ode.2006.12.001; Rast GF, 2001, NEUROSCIENCE, V108, P167, DOI 10.1016/S0306-4522(01)00406-7; Smith TR, 2005, FLA ENTOMOL, V88, P204, DOI 10.1653/0015-4040(2005)088[0204:MMOSFG]2.0.CO;2; Steiner P., 1930, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V17, P1, DOI 10.1007/BF00406253; Tan J, 2008, ZOOTAXA, P59; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WILLMANN R, 1987, SYST ENTOMOL, V12, P519, DOI 10.1111/j.1365-3113.1987.tb00222.x; Zhong W, 2011, ZOOTAXA, P47	46	14	16	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60351	10.1371/journal.pone.0060351	http://dx.doi.org/10.1371/journal.pone.0060351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533677	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400114
J	Mayer, FL; Wilson, D; Hube, B				Mayer, Francois L.; Wilson, Duncan; Hube, Bernhard			Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRANSCRIPTIONAL RESPONSE; CALCINEURIN INHIBITORS; GENE-EXPRESSION; HSP90 FUNCTION; IN-VIVO; RESISTANCE; STRESS; MORPHOGENESIS; EPIDEMIOLOGY	Systemic infections of humans with the fungal pathogen Candida albicans are associated with a high mortality rate. Currently, efficient treatment of these infections is hampered by the relatively low number of available antifungal drugs. We recently identified the small heat shock protein Hsp21 in C. albicans and demonstrated its fundamental role for environmental stress adaptation and fungal virulence. Hsp21 was found in several pathogenic Candida species but not in humans. This prompted us to investigate the effects of a broad range of different antifungal drugs on an Hsp21-null C. albicans mutant strain. Our results indicate that combinatorial therapy targeting Hsp21, together with specific antifungal drug targets, has strong synergistic potential. In addition, we demonstrate that Hsp21 is required for tolerance to ethanol-induced stress and induction of filamentation in response to pharmacological inhibition of Hsp90. These findings might pave the way for the development of new treatment strategies against Candida infections.	[Mayer, Francois L.; Wilson, Duncan; Hube, Bernhard] Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany; [Hube, Bernhard] Univ Klinikum, Ctr Sepsis Control & Care, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Hube, B (corresponding author), Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany.	Bernhard.Hube@hki-jena.de		Hube, Bernhard/0000-0002-6028-0425; Mayer, Francois/0000-0002-6800-9429; Wilson, Duncan/0000-0001-6617-0123	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol) [BMBF 0315 901 B]; European Commission through the FINSysB Marie Curie Initial Training Network [PITN-GA-2008-214004]; Center for Sepsis Control and Care (CSCC) [BMBF 01EO1002]; Deutsche Forschungsgemeinschaft [DFG Hu 528/15, 16, 17]	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol); European Commission through the FINSysB Marie Curie Initial Training Network; Center for Sepsis Control and Care (CSCC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	FLM and BH were supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC). DW and BH were supported by the ERA-NET PathoGenoMics Program (Candicol; BMBF 0315 901 B). BH was also funded by the European Commission through the FINSysB Marie Curie Initial Training Network (PITN-GA-2008-214004), by the Center for Sepsis Control and Care (CSCC; BMBF 01EO1002), and by the Deutsche Forschungsgemeinschaft (DFG Hu 528/15, 16 and 17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Booth N, 1930, BIOCHEM J, V24, P1699, DOI 10.1042/bj0241699; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2009, MOL MICROBIOL, V72, P216, DOI 10.1111/j.1365-2958.2009.06640.x; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fu MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042894; Hodgetts S, 2008, J ANTIMICROB CHEMOTH, V61, P1132, DOI 10.1093/jac/dkn075; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lewis JA, 2010, GENETICS, V186, P1197, DOI 10.1534/genetics.110.121871; Lindquist S, 1992, CURR OPIN GENET DEV, V2, P748, DOI 10.1016/S0959-437X(05)80135-2; Lis M, 2010, FEMS YEAST RES, V10, P579, DOI 10.1111/j.1567-1364.2010.00638.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Mayer FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038584; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Odds FC., 1988, CANDIDA CANDIDOSIS; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Ramsdale M, 2008, MOL BIOL CELL, V19, P4393, DOI 10.1091/mbc.E07-09-0946; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Robbins N, 2012, CELL REP, V2, P878, DOI 10.1016/j.celrep.2012.08.035; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Senn H, 2012, MOL BIOL CELL, V23, P268, DOI 10.1091/mbc.E11-08-0729; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Spellberg B., 2012, CANDIDA CANDIDIASIS, P225; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; SWOBODA RK, 1995, INFECT IMMUN, V63, P4506, DOI 10.1128/IAI.63.11.4506-4514.1995; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Uppuluri P, 2008, ANTIMICROB AGENTS CH, V52, P1127, DOI 10.1128/AAC.01397-07; Wachtler B, 2011, ANTIMICROB AGENTS CH, V55, P4436, DOI 10.1128/AAC.00144-11; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	52	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60417	10.1371/journal.pone.0060417	http://dx.doi.org/10.1371/journal.pone.0060417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533680	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400117
J	McClure, M; Kim, E; Bickhart, D; Null, D; Cooper, T; Cole, J; Wiggans, G; Ajmone-Marsan, P; Colli, L; Santus, E; Liu, GE; Schroeder, S; Matukumalli, L; Van Tassell, C; Sonstegard, T				McClure, Matthew; Kim, Euisoo; Bickhart, Derek; Null, Daniel; Cooper, Tabatha; Cole, John; Wiggans, George; Ajmone-Marsan, Paolo; Colli, Licia; Santus, Enrico; Liu, George E.; Schroeder, Steve; Matukumalli, Lakshmi; Van Tassell, Curt; Sonstegard, Tad			Fine Mapping for Weaver Syndrome in Brown Swiss Cattle and the Identification of 41 Concordant Mutations across NRCAM, PNPLA8 and CTTNBP2	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CELL-ADHESION; GENE; ASSOCIATION; CORTACTIN; PATHOLOGY; PROMOTER; REGIONS; DISEASE; SYSTEM	Bovine Progressive Degenerative Myeloencephalopathy (Weaver Syndrome) is a recessive neurological disease that has been observed in the Brown Swiss cattle breed since the 1970's in North America and Europe. Bilateral hind leg weakness and ataxia appear in afflicted animals at 6 to 18 months of age, and slowly progresses to total loss of hind limb control by 3 to 4 years of age. While Weaver has previously been mapped to Bos taurus autosome (BTA) 4:46-56 Mb and a diagnostic test based on the 6 microsatellite (MS) markers is commercially available, neither the causative gene nor mutation has been identified; therefore misdiagnosis can occur due to recombination between the diagnostic MS markers and the causative mutation. Analysis of 34,980 BTA 4 SNPs genotypes derived from the Illumina BovineHD assay for 20 Brown Swiss Weaver carriers and 49 homozygous normal bulls refined the Weaver locus to 48-53 Mb. Genotyping of 153 SNPs, identified from whole genome sequencing of 10 normal and 10 carrier animals, across a validation set of 841 animals resulted in the identification of 41 diagnostic SNPs that were concordant with the disease. Except for one intergenic SNP all are associated with genes expressed in nervous tissues: 37 distal to NRCAM, one non-synonymous (serine to asparagine) in PNPLA8, one synonymous and one non-synonymous (lysine to glutamic acid) in CTTNBP2. Haplotype and imputation analyses of 7,458 Brown Swiss animals with Illumina BovineSNP50 data and the 41 diagnostic SNPs resulted in the identification of only one haplotype concordant with the Weaver phenotype. Use of this haplotype and the diagnostic SNPs more accurately identifies Weaver carriers in both Brown Swiss purebred and influenced herds.	[McClure, Matthew; Kim, Euisoo; Bickhart, Derek; Liu, George E.; Schroeder, Steve; Matukumalli, Lakshmi; Van Tassell, Curt; Sonstegard, Tad] ARS, USDA, ANRI, Bovine Funct Genom Lab, Beltsville, MD 20705 USA; [Null, Daniel; Cooper, Tabatha; Cole, John; Wiggans, George] ARS, USDA, ANRI, Anim Improvement Programs Lab, Beltsville, MD USA; [Ajmone-Marsan, Paolo; Colli, Licia] Univ Cattolica S Cuore Piacenza, Ist Zootecn, Piacenza, Italy; [Ajmone-Marsan, Paolo; Colli, Licia] Univ Cattolica S Cuore Piacenza, BioDNA Ctr Ric Biodiversita & DNA Ant, Piacenza, Italy; [Santus, Enrico] Italian Brown Swiss Assoc, Assoc Nazl Allevatori Bovini Razza Bruna, Bussolengo, Italy	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sonstegard, T (corresponding author), ARS, USDA, ANRI, Bovine Funct Genom Lab, Beltsville, MD 20705 USA.	tad.sonstegard@ars.usda.gov	Van Tassell, Curtis P./O-4247-2019; Cole, John B./J-8571-2014; Liu, George/K-3371-2019; Colli, Licia/AAC-2985-2021; AJMONE MARSAN, Paolo/M-2466-2018	Van Tassell, Curtis P./0000-0002-8416-2087; Cole, John B./0000-0003-1242-4401; Liu, George/0000-0003-0192-6705; Schroeder, Steven/0000-0001-9103-5150; Bickhart, Derek/0000-0003-2223-9285; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Brown Swiss Association USA & Bovine Functional Genomics Lab - Internal Funds off CRIS [1265-31000-098-00D, 19T]	Brown Swiss Association USA & Bovine Functional Genomics Lab - Internal Funds off CRIS	Genotyping funding was provided from the Brown Swiss Association USA & Bovine Functional Genomics Lab - Internal Funds off CRIS 1265-31000-098-00D and 19T, Enhancing Genetic Merit of Dairy Cattle through Genome Selection and Analysis and Implementation of Whole Genome Selection in Brown Swiss Cattle, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2007, INHERITED DISORDERS; BAIRD JD, 1988, CAN VET J, V29, P370; Baldrighi M, 1992, DOCUMENTI VET, V1992, P73; Bickhart DM, 2012, GENOMICS PR IN PRESS; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Braun U, 1987, Tierarztl Prax, V15, P139; Brown Swiss Association U, 2011, GEN ABN BROWN SWISS; Caroli A, 2008, J DAIRY SCI, V91, P354, DOI 10.3168/jds.2007-0420; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Cerutti F, 2006, DEV CARORA BREED, P00; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Cheon Y, 2012, BBA-MOL CELL BIOL L, V1821, P1278, DOI 10.1016/j.bbalip.2012.02.003; Cingolani P., 2011, SNPEFF VARIANT EFFEC; Denise SK, 2005, GENETIC ANAL WEAVER, V4; DOLL K, 1993, TIERAERZTL UMSCHAU, V48, P467; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; HOESCHELE I, 1990, J DAIRY SCI, V73, P2503, DOI 10.3168/jds.S0022-0302(90)78936-9; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hsueh YP, 2012, COMMUNICATIVE INTEGR, V5, P0; Hutcheson Holli B, 2004, BMC Med Genet, V5, P12, DOI 10.1186/1471-2350-5-12; Illumina Inc, 2011, GOLDENGATE BOVINE3K; Illumina Inc, 2010, BOVINEHD GEN BEADCH; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEIPOLD HW, 1973, VET MED SM ANIM CLIN, V68, P645; Leipold HW, 1983, BOVINE PRACT, V18, P133; Leipold HW, 1984, GENETIC DIS, P194; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu George E., 2008, Genomics Proteomics & Bioinformatics, V6, P129, DOI 10.1016/S1672-0229(09)60001-2; Lustig M, 2001, J COMP NEUROL, V434, P13, DOI 10.1002/cne.1161; Manatrinon S, 2009, ARCH TIERZUCHT, V52, P230, DOI 10.5194/aab-52-230-2009; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Neogen Corporation, 2012, GENESEEK GEN PROF DA; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Pamphlett R, 2011, J NEUROSCI METH, V197, P297, DOI 10.1016/j.jneumeth.2011.02.028; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sambrook J., 2002, MOL CLONING LAB MANU; Spahr S. L., 1995, DAIRY COW TODAY US T; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stuart L. D., 1983, Bovine Practitioner, V18, P129; TROYER D, 1992, J COMP PATHOL, V107, P305, DOI 10.1016/0021-9975(92)90006-G; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden P.M., 2011, FINDHAP F90; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wiggans GR, 2012, J DAIRY SCI, V95, P1552, DOI 10.3168/jds.2011-4985; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wiggans GR, 2010, J DAIRY SCI, V93, P2287, DOI 10.3168/jds.2009-2773; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Wu C-H, 2012, NATURE; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	62	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59251	10.1371/journal.pone.0059251	http://dx.doi.org/10.1371/journal.pone.0059251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527149	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600065
J	Westfall, S; Aguilar-Valles, A; Mongrain, V; Luheshi, GN; Cermakian, N				Westfall, Susan; Aguilar-Valles, Argel; Mongrain, Valerie; Luheshi, Giamal N.; Cermakian, Nicolas			Time-Dependent Effects of Localized Inflammation on Peripheral Clock Gene Expression in Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; SUPRACHIASMATIC NUCLEUS; CIRCADIAN CLOCK; BODY-TEMPERATURE; FACTOR-ALPHA; ELECTRICAL-ACTIVITY; TNF-ALPHA; INTERLEUKIN-6; RECEPTOR	Many aspects of the immune system, including circulating cytokine levels as well as counts and function of various immune cell types, present circadian rhythms. Notably, the mortality rate of animals subjected to high doses of lipopolysaccharide is dependent on the time of treatment. In addition, the severity of symptoms of various inflammatory conditions follows a daily rhythmic pattern. The mechanisms behind the crosstalk between the circadian and immune systems remain elusive. Here we demonstrate that localized inflammation induced by turpentine oil (TURP) causes a time-dependent induction of interleukin (IL)-6 and has time-, gene-and tissue-specific effects on clock gene expression. More precisely, TURP blunts the peak of Per1 and Per2 expression in the liver while in other tissues, the expression nadir is elevated. In contrast, Rev-erb alpha expression remains relatively unaffected by TURP treatment. Co-treatment with the anti-inflammatory agent IL-1 receptor antagonist (IL-1Ra) did not alter the response of Per2 to TURP treatment in liver, despite the reduced induction of fever and IL-6 serum levels. This indicates that the TURP-mediated changes of Per2 in the liver might be due to factors other than systemic IL-6 and fever. Accordingly, IL-6 treatment had no effect on clock gene expression in HepG2 liver carcinoma cells. Altogether, we show that localized inflammation causes significant time-dependent changes in peripheral circadian clock gene expression, via a mechanism likely involving mediators independent from IL-6 and fever.	[Westfall, Susan; Aguilar-Valles, Argel; Mongrain, Valerie; Luheshi, Giamal N.; Cermakian, Nicolas] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Westfall, Susan; Aguilar-Valles, Argel; Luheshi, Giamal N.; Cermakian, Nicolas] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Mongrain, Valerie; Luheshi, Giamal N.; Cermakian, Nicolas] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University; McGill University	Cermakian, N (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	nicolas.cermakian@mcgill.ca	Aguilar-Valles, Argel/B-4259-2009; Mongrain, Valérie/A-3931-2012	Aguilar-Valles, Argel/0000-0002-2272-1138; Cermakian, Nicolas/0000-0003-4517-9131	Canadian Institutes for Health Research (CIHR) [MOP-84441, MOP-119322]; Fonds de la Recherche en Sante du Quebec (FRSQ); McGill University Faculty of Medicine Award; FRSQ; NSERC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); McGill University Faculty of Medicine Award; FRSQ(Fonds de la Recherche en Sante du Quebec); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes for Health Research (CIHR) operating grants (MOP-84441, MOP-119322), Fonds de la Recherche en Sante du Quebec (FRSQ) Salary Awards (NC), a McGill University Faculty of Medicine Award (NC), a FRSQ graduate scholarship (SW) and FRSQ and NSERC fellowships (VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad VC, 2008, SLEEP MED REV, V12, P211, DOI 10.1016/j.smrv.2007.09.001; Aguilar-Valles A, 2012, PSYCHONEUROENDOCRINO, V37, P956, DOI 10.1016/j.psyneuen.2011.11.003; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Born J, 1997, J IMMUNOL, V158, P4454; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Carvalho-Sousa Claudia Emanuele, 2011, Front Endocrinol (Lausanne), V2, P10, DOI 10.3389/fendo.2011.00010; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; COOPER AL, 1994, AM J PHYSIOL-REG I, V267, pR1431, DOI 10.1152/ajpregu.1994.267.6.R1431; Cutolo M, 2006, ANN NY ACAD SCI, V1069, P289, DOI 10.1196/annals.1351.027; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; FISCHER E, 1992, J CLIN INVEST, V89, P1551, DOI 10.1172/JCI115748; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hood S, 2011, NEUROSCIENCE, V186, P65, DOI 10.1016/j.neuroscience.2011.04.045; HRUSHESKY WJM, 1994, J EXP MED, V180, P1059, DOI 10.1084/jem.180.3.1059; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Josephs MD, 2000, AM J PHYSIOL-REG I, V278, pR824, DOI 10.1152/ajpregu.2000.278.4.R824; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kwak Y, 2008, J BIOL RHYTHM, V23, P150, DOI 10.1177/0748730407313355; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lee YJ, 2010, MICROBIOL IMMUNOL, V54, P542, DOI 10.1111/j.1348-0421.2010.00249.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luheshi G, 1996, AM J PHYSIOL-ENDOC M, V270, pE91, DOI 10.1152/ajpendo.1996.270.1.E91; Luheshi GN, 1997, AM J PHYSIOL-REG I, V272, pR862, DOI 10.1152/ajpregu.1997.272.3.R862; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Marpegan L, 2009, CHRONOBIOL INT, V26, P1430, DOI 10.3109/07420520903408358; Mathias S, 2000, NEUROENDOCRINOLOGY, V71, P375, DOI 10.1159/000054558; Mendoza J, 2011, J NEUROENDOCRINOL, V23, P28, DOI 10.1111/j.1365-2826.2010.02072.x; Mitsuyama K, 2007, ANTICANCER RES, V27, P3749; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Motzkus D, 2000, FEBS LETT, V486, P315, DOI 10.1016/S0014-5793(00)02315-2; Murphy BA, 2007, BRAIN BEHAV IMMUN, V21, P467, DOI 10.1016/j.bbi.2006.11.002; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Ohdo S, 2001, NAT MED, V7, P356, DOI 10.1038/85507; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; PERRETTI M, 1993, BRIT J PHARMACOL, V110, P868, DOI 10.1111/j.1476-5381.1993.tb13893.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sachot C, 2004, J PHYSIOL-LONDON, V561, P263, DOI 10.1113/jphysiol.2004.074351; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sarraf P, 1997, J EXP MED, V185, P171, DOI 10.1084/jem.185.1.171; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Semaeva E, 2010, J IMMUNOL, V184, P4547, DOI 10.4049/jimmunol.0902049; SEVERINSEN T, 1991, J THERM BIOL, V16, P167, DOI 10.1016/0306-4565(91)90039-5; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sheikh N, 2007, LAB INVEST, V87, P713, DOI 10.1038/labinvest.3700553; Sheikh N, 2006, LAB INVEST, V86, P800, DOI 10.1038/labinvest.3700435; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Skloot GS, 2002, MT SINAI J MED, V69, P140; Smolensky MH, 2007, ADV DRUG DELIVER REV, V59, P852, DOI 10.1016/j.addr.2007.08.016; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; SPINAS GA, 1991, J INFECT DIS, V163, P89, DOI 10.1093/infdis/163.1.89; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Tamura EK, 2009, J PINEAL RES, V46, P268, DOI 10.1111/j.1600-079X.2008.00657.x; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Turnbull AV, 2003, ENDOCRINOLOGY, V144, P1894, DOI 10.1210/en.2002-220964; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vansteensel MJ, 2005, EUR J NEUROSCI, V21, P2958, DOI 10.1111/j.1460-9568.2005.04131.x; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yamamura Y, 2010, CHRONOBIOL INT, V27, P213, DOI 10.3109/07420521003769111; Zhang J, 1999, EUR J NEUROSCI, V11, P2651, DOI 10.1046/j.1460-9568.1999.00682.x; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	80	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59808	10.1371/journal.pone.0059808	http://dx.doi.org/10.1371/journal.pone.0059808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527270	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600096
J	Jiang, ZH; Zhou, X; Michal, JJ; Wu, XL; Zhang, LF; Zhang, M; Ding, B; Liu, B; Manoranjan, VS; Neill, JD; Harhay, GP; Kehrli, ME; Miller, LC				Jiang, Zhihua; Zhou, Xiang; Michal, Jennifer J.; Wu, Xiao-Lin; Zhang, Lifan; Zhang, Ming; Ding, Bo; Liu, Bang; Manoranjan, Valipuram S.; Neill, John D.; Harhay, Gregory P.; Kehrli, Marcus E., Jr.; Miller, Laura C.			Reactomes of Porcine Alveolar Macrophages Infected with Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							ANTIBODY REPERTOIRE DEVELOPMENT; IMMUNE-RESPONSE; PROINFLAMMATORY CYTOKINES; INNATE IMMUNITY; SERIAL ANALYSIS; PRRS VIRUS; B-CELLS; GENES; DYSREGULATION; MECHANISMS	Porcine reproductive and respiratory syndrome (PRRS) has devastated pig industries worldwide for many years. It is caused by a small RNA virus (PRRSV), which targets almost exclusively pig monocytes or macrophages. In the present study, five SAGE (serial analysis of gene expression) libraries derived from 0 hour mock-infected and 6, 12, 16 and 24 hours PRRSV-infected porcine alveolar macrophages (PAMs) produced a total 643,255 sequenced tags with 91,807 unique tags. Differentially expressed (DE) tags were then detected using the Bayesian framework followed by gene/mRNA assignment, arbitrary selection and manual annotation, which determined 699 DE genes for reactome analysis. The DAVID, KEGG and REACTOME databases assigned 573 of the DE genes into six biological systems, 60 functional categories and 504 pathways. The six systems are: cellular processes, genetic information processing, environmental information processing, metabolism, organismal systems and human diseases as defined by KEGG with modification. Self-organizing map (SOM) analysis further grouped these 699 DE genes into ten clusters, reflecting their expression trends along these five time points. Based on the number one functional category in each system, cell growth and death, transcription processes, signal transductions, energy metabolism, immune system and infectious diseases formed the major reactomes of PAMs responding to PRRSV infection. Our investigation also focused on dominant pathways that had at least 20 DE genes identified, multi-pathway genes that were involved in 10 or more pathways and exclusively-expressed genes that were included in one system. Overall, our present study reported a large set of DE genes, compiled a comprehensive coverage of pathways, and revealed system-based reactomes of PAMs infected with PRRSV. We believe that our reactome data provides new insight into molecular mechanisms involved in host genetic complexity of antiviral activities against PRRSV and lays a strong foundation for vaccine development to control PRRS incidence in pigs.	[Jiang, Zhihua; Zhou, Xiang; Michal, Jennifer J.; Zhang, Lifan; Zhang, Ming; Ding, Bo] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wu, Xiao-Lin] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI USA; [Liu, Bang] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China; [Manoranjan, Valipuram S.] Washington State Univ, Dept Math, Pullman, WA 99164 USA; [Neill, John D.] ARS, Ruminant Dis & Immunol Res Unit, USDA, Natl Anim Dis Ctr, Ames, IA USA; [Harhay, Gregory P.] ARS, Anim Hlth Res Unit, US Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [Kehrli, Marcus E., Jr.; Miller, Laura C.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	Washington State University; University of Wisconsin System; University of Wisconsin Madison; Huazhong Agricultural University; Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Jiang, ZH (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	jiangz@wsu.edu; laura.miller@ars.usda.gov	Harhay, Gregory/AAC-5411-2022; Manoranjan, valipuram/AAB-1498-2021; Jiang, Zhihua/A-3378-2008; Wu, Xiaolin/GPX-5124-2022; Miller, Laura/B-2268-2017	Harhay, Gregory/0000-0002-0129-6822; Jiang, Zhihua/0000-0003-1986-088X; Wu, Xiaolin/0000-0002-5604-9220; Kehrli, Marcus/0000-0003-4850-5211; Miller, Laura/0000-0002-8946-9416; , Lifan/0000-0002-8166-9173	National Pork Board [06-122]; USDA [2008-55620-19132]; China Scholarship Council	National Pork Board; USDA(United States Department of Agriculture (USDA)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Pork Board #06-122, USDA ARS and PRRS CAP, USDA NIFA Award 2008-55620-19132. Mr. Xiang Zhou is recipient of the China Scholarship Council assistantship for a joint Ph.D. program between Washington State University, USA and Huazhong Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Albina E, 1997, VET RES, V28, P305; ALBINA E, 1994, VET REC, V134, P567, DOI 10.1136/vr.134.22.567; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Butler JE, 2008, J IMMUNOL, V180, P2347, DOI 10.4049/jimmunol.180.4.2347; Butler JE, 2007, J IMMUNOL, V178, P6320, DOI 10.4049/jimmunol.178.10.6320; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Chiou MT, 2000, VET MICROBIOL, V71, P9, DOI 10.1016/S0378-1135(99)00159-5; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Fu H, 2012, GLIA; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; GOYAL SM, 1993, J VET DIAGN INVEST, V5, P656, DOI 10.1177/104063879300500435; Gudmundsdottir I, 2009, VIRUS RES, V145, P145, DOI 10.1016/j.virusres.2009.06.009; Han J, 2010, J VIROL, V84, P10102, DOI 10.1128/JVI.01208-10; Hardwick JM, 2001, CELL DEATH DIFFER, V8, P109, DOI 10.1038/sj.cdd.4400820; Haykin S., 1999, NEURAL NETWORKS COMP; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Lu Q, 2012, J PROTEOME RES, V11, P2890, DOI 10.1021/pr201266z; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McOrist S, 2011, REV SCI TECH OIE, V30, P961; Miller LC, 2008, DEV BIOLOGICALS, V132, P169, DOI 10.1159/000317157; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Miller LC, 2004, ARCH VIROL, V149, P2453, DOI 10.1007/s00705-004-0377-9; MURTAUGH MP, 1995, ARCH VIROL, V140, P1451, DOI 10.1007/BF01322671; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Oglesbee MJ, 2002, VIRAL IMMUNOL, V15, P399, DOI 10.1089/088282402760312296; Overend C, 2007, J GEN VIROL, V88, P925, DOI 10.1099/vir.0.82585-0; Park BK, 1997, AM J VET RES, V58, P257; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Patton JB, 2009, VIRUS RES, V140, P161, DOI 10.1016/j.virusres.2008.12.002; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Ryan JG, 2008, CURR TOP MICROBIOL, V321, P169; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Sang Yongming, 2011, Animal Health Research Reviews, V12, P149, DOI 10.1017/S1466252311000144; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shi XB, 2010, VIRUS RES, V153, P151, DOI 10.1016/j.virusres.2010.07.028; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Sun XZ, 2012, VACCINE, V30, P3646, DOI 10.1016/j.vaccine.2012.03.038; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gucht S, 2004, VET IMMUNOL IMMUNOP, V102, P165, DOI 10.1016/j.vetimm.2004.09.006; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; Wu XL, 2004, GENE, V340, P213, DOI 10.1016/j.gene.2004.06.038; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Yaneva R, 2010, MOL IMMUNOL, V47, P649, DOI 10.1016/j.molimm.2009.10.008; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947	64	26	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59229	10.1371/journal.pone.0059229	http://dx.doi.org/10.1371/journal.pone.0059229			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527143	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100095
J	Arnold, R; Pussell, BA; Pianta, TJ; Grinius, V; Lin, CSY; Kiernan, MC; Howells, J; Jardine, MJ; Krishnan, AV				Arnold, Ria; Pussell, Bruce A.; Pianta, Timothy J.; Grinius, Virginija; Lin, Cindy S-Y.; Kiernan, Matthew C.; Howells, James; Jardine, Meg J.; Krishnan, Arun V.			Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease	PLOS ONE			English	Article							ONLINE HEMODIAFILTRATION; BETA-2-MICROGLOBULIN LEVELS; AXONAL EXCITABILITY; PARATHYROID-HORMONE; MYELINATED AXONS; NEUROPATHY; MECHANISMS; PARAMETERS; CONDUCTION; MORTALITY	Objectives: Peripheral neuropathy is the most common neurological complication in end-stage kidney disease. While high flux hemodialysis (HFHD) and hemodiafiltration (HDF) have become the preferred options for extracorporeal dialysis therapy, the effects of these treatments on nerve excitability have not yet been examined. Methods: An observational proof-of-concept study of nerve excitability and neuropathy was undertaken in an incident dialysis population (n = 17) receiving either HFHD or HDF. Nerve excitability techniques were utilised to assess nerve ion channel function and membrane potential, in conjunction with clinical assessment and standard nerve conduction studies. A mathematical model of axonal excitability was used to investigate the underlying basis of the observed changes. Nerve excitability was recorded from the median nerve, before, during and after a single dialysis session and correlated with corresponding biochemical markers. Differences in nerve excitability were compared to normal controls with longitudinal follow-up over an 18 month period. Results: Nerve excitability was performed in patient cohorts treated with either HFHD (n = 9) or online HDF (n = 8), with similar neuropathy status. Nerve excitability measures in HDF-treated patients were significantly closer to normal values compared to HFHD patients obtained over the course of a dialysis session (p < 0.05). Longitudinal studies revealed stability of nerve excitability findings, and thus maintenance of improved nerve function in the HDF group. Conclusions: This study has provided evidence that nerve excitability in HDF-treated patients is significantly closer to normal values prior to dialysis, across a single dialysis session and at longitudinal follow-up. These findings offer promise for the management of neuropathy in ESKD and should be confirmed in randomised trials.	[Arnold, Ria; Lin, Cindy S-Y.; Krishnan, Arun V.] Univ New S Wales, Translat Neurosci Facil, Sydney, NSW, Australia; [Pussell, Bruce A.; Pianta, Timothy J.; Grinius, Virginija] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia; [Pussell, Bruce A.; Pianta, Timothy J.; Kiernan, Matthew C.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Kiernan, Matthew C.] Neurosci Res Australia, Sydney, NSW, Australia; [Howells, James] Univ Sydney, Sydney, NSW 2006, Australia; [Howells, James] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia; [Jardine, Meg J.] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia; [Jardine, Meg J.] George Inst Global Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Neuroscience Research Australia; University of Sydney; University of Sydney; Concord Repatriation General Hospital; George Institute for Global Health; University of Sydney	Krishnan, AV (corresponding author), Univ New S Wales, Translat Neurosci Facil, Sydney, NSW, Australia.	arun.krishnan@unsw.edu.au	Kiernan, Matthew C/E-4460-2011; Jardine, Meg/AFR-1699-2022; Jardine, Meg/AAS-1864-2020	Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Kiernan, Matthew/0000-0001-9054-026X; Pianta, Timothy/0000-0002-9196-4889; Arnold, Ria/0000-0002-7469-6587; Lin, Cindy Shin-Yi/0000-0003-2379-7369; Krishnan, Arun/0000-0001-8883-8825	University of New South Wales; National Health and Medical Research Council of Australia [568680, 630425]; Jacquot Research Establishment Award	University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Establishment Award	RA and TP were each supported by an Australian Postgraduate Award from the University of New South Wales. AK was supported by a Career Development Award from the National Health and Medical Research Council of Australia (grant 568680). MJ was supported by a Jacquot Research Establishment Award. Grant support was provided by the National Health and Medical Research Council of Australia (grant 630425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABB AL, 1981, AM J KIDNEY DIS, V1, P46, DOI 10.1016/S0272-6386(81)80011-X; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; Bostock H, 2004, NEPHROL DIAL TRANSPL, V19, P1054, DOI 10.1093/ndt/gfh093; BOSTOCK H, 1991, J PHYSIOL-LONDON, V441, P537, DOI 10.1113/jphysiol.1991.sp018766; BURKE D, 1993, MUSCLE NERVE, V16, P1025, DOI 10.1002/mus.880161005; Canaud B, 2006, KIDNEY INT, V69, P2087, DOI 10.1038/sj.ki.5000447; Carracedo J, 2006, J AM SOC NEPHROL, V17, P2315, DOI 10.1681/ASN.2006020105; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Eknoyan G, 1997, KIDNEY INT, V52, P1395; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Filiopoulos V, 2008, AM J NEPHROL, V28, P949, DOI 10.1159/000142724; GOLDSTEIN DA, 1978, J CLIN INVEST, V62, P88, DOI 10.1172/JCI109118; Guth HJ, 2003, INT J ARTIF ORGANS, V26, P181, DOI 10.1177/039139880302600301; Hojs-Fabjan T, 2006, WIEN KLIN WOCHENSCHR, V118, P29, DOI 10.1007/s00508-006-0547-8; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Jankelowitz SK, 2007, J PHYSIOL-LONDON, V581, P927, DOI 10.1113/jphysiol.2006.123661; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2002, BRAIN, V125, P1366, DOI 10.1093/brain/awf123; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Krishnan AV, 2008, J PERIPHER NERV SYST, V13, P7, DOI 10.1111/j.1529-8027.2008.00155.x; Krishnan AV, 2007, MUSCLE NERVE, V35, P273, DOI 10.1002/mus.20713; Krishnan AV, 2006, BRAIN, V129, P1585, DOI 10.1093/brain/awl099; Krishnan AV, 2009, NAT REV NEUROL, V5, P542, DOI 10.1038/nrneurol.2009.138; Krishnan AV, 2006, J NEUROL NEUROSUR PS, V77, P548, DOI 10.1136/jnnp.2005.079988; Krishnan AV, 2005, BRAIN, V128, P2164, DOI 10.1093/brain/awh558; Laaksonen S, 2002, MUSCLE NERVE, V25, P884, DOI 10.1002/mus.10159; Ledebo I, 2008, CLIN KIDNEY J, V1, P403, DOI 10.1093/ndtplus/sfn148; Lehning EJ, 1996, J NEUROCHEM, V66, P493; Lin CSY, 2008, BRAIN, V131, P2510, DOI 10.1093/brain/awn152; Lin CSY, 2011, ARCH NEUROL-CHICAGO, V68, P862, DOI 10.1001/archneurol.2011.137; Lin CL, 2001, BLOOD PURIFICAT, V19, P301, DOI 10.1159/000046958; MALBERTI F, 1991, BLOOD PURIFICAT, V9, P285, DOI 10.1159/000170026; Park SB, 2009, J CLIN ONCOL, V27, P1243, DOI 10.1200/JCO.2008.19.3425; Schiffl H, 2007, EUR J MED RES, V12, P26; SLATOPOLSKY E, 1980, AM J PHYSIOL, V239, pF1, DOI 10.1152/ajprenal.1980.239.1.F1; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Tilki HE, 2009, J ELECTROMYOGR KINES, V19, P500, DOI 10.1016/j.jelekin.2007.10.011; Van den Neucker K, 1998, Electromyogr Clin Neurophysiol, V38, P467; Vogel W, 1995, AXON; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344, DOI 10.1681/ASN.V11122344	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59055	10.1371/journal.pone.0059055	http://dx.doi.org/10.1371/journal.pone.0059055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536855	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100116
J	Barbier, EB; Georgiou, IY; Enchelmeyer, B; Reed, DJ				Barbier, Edward B.; Georgiou, Ioannis Y.; Enchelmeyer, Brian; Reed, Denise J.			The Value of Wetlands in Protecting Southeast Louisiana from Hurricane Storm Surges	PLOS ONE			English	Article							ECOSYSTEM SERVICES; COASTAL WETLANDS; RESTORATION; DAMAGE; MODEL	The Indian Ocean tsunami in 2004 and Hurricanes Katrina and Rita in 2005 have spurred global interest in the role of coastal wetlands and vegetation in reducing storm surge and flood damages. Evidence that coastal wetlands reduce storm surge and attenuate waves is often cited in support of restoring Gulf Coast wetlands to protect coastal communities and property from hurricane damage. Yet interdisciplinary studies combining hydrodynamic and economic analysis to explore this relationship for temperate marshes in the Gulf are lacking. By combining hydrodynamic analysis of simulated hurricane storm surges and economic valuation of expected property damages, we show that the presence of coastal marshes and their vegetation has a demonstrable effect on reducing storm surge levels, thus generating significant values in terms of protecting property in southeast Louisiana. Simulations for four storms along a sea to land transect show that surge levels decline with wetland continuity and vegetation roughness. Regressions confirm that wetland continuity and vegetation along the transect are effective in reducing storm surge levels. A 0.1 increase in wetland continuity per meter reduces property damages for the average affected area analyzed in southeast Louisiana, which includes New Orleans, by $99-$133, and a 0.001 increase in vegetation roughness decreases damages by $24-$43. These reduced damages are equivalent to saving 3 to 5 and 1 to 2 properties per storm for the average area, respectively.	[Barbier, Edward B.; Enchelmeyer, Brian] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Georgiou, Ioannis Y.; Reed, Denise J.] Univ New Orleans, Dept Earth & Environm Sci, New Orleans, LA 70148 USA; [Georgiou, Ioannis Y.; Reed, Denise J.] Univ New Orleans, Pontchartrain Inst Environm Sci, New Orleans, LA 70148 USA	University of Wyoming; University of Louisiana System; University of New Orleans; University of Louisiana System; University of New Orleans	Barbier, EB (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu			Coastal Restoration and Enhancement through Science and Technology (CREST) Program, an alliance of academic institutions within southern Louisiana and Mississippi [CREST10-6]	Coastal Restoration and Enhancement through Science and Technology (CREST) Program, an alliance of academic institutions within southern Louisiana and Mississippi	Research for this paper was funded by financial support from the Coastal Restoration and Enhancement through Science and Technology (CREST) Program, an alliance of academic institutions within southern Louisiana and Mississippi, under Grant Contract # CREST10-6 (http://www.gulfcrest.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Badola R, 2005, ENVIRON CONSERV, V32, P1; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Bayas JCL, 2011, P NATL ACAD SCI USA, V108, P18612, DOI 10.1073/pnas.1013516108; Bengtsson A, 2007, NAT HAZARD EARTH SYS, V7, P515, DOI 10.5194/nhess-7-515-2007; Burrus R. T., 2001, COST ENG ANN ARBOR T, V43, P38; Coastal Protection & Restoration Authority of Louisiana, 2012, LOUIS COMPR MAST PLA; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Dutta D, 2003, J HYDROL, V277, P24, DOI 10.1016/S0022-1694(03)00084-2; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; FARBER S, 1987, J ENVIRON ECON MANAG, V14, P143, DOI 10.1016/0095-0696(87)90012-X; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Gulf Coast Ecosystem Recovery Task Force 2011Gulf Coast Ecosystem Recovery Task Force, 2011, GULF MEX REG EC REST; Katz RW, 2002, J APPL METEOROL, V41, P754, DOI 10.1175/1520-0450(2002)041<0754:SMOHD>2.0.CO;2; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Loder NM, 2009, ESTUAR COAST SHELF S, V84, P625, DOI 10.1016/j.ecss.2009.07.036; Merz B, 2004, NAT HAZARD EARTH SYS, V4, P153, DOI 10.5194/nhess-4-153-2004; Merz B, 2010, NAT HAZARD EARTH SYS, V10, P1697, DOI 10.5194/nhess-10-1697-2010; Pistrika AK, 2010, NAT HAZARDS, V54, P413, DOI 10.1007/s11069-009-9476-y; Resio D.T., 2007, WHITE PAPER ESTIMATI; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Twilley R.R., 2007, COASTAL WETLANDS GLO; US Army Corps of Engineers (USACE), 2006, CAT RES DEPTH DAM FU; Valiela I., 2009, GLOBAL LOSS COASTAL, P109; Vigdor J, 2008, J ECON PERSPECT, V22, P135, DOI 10.1257/jep.22.4.135; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Westerink JJ, 2007, FLOOD INSURANCE STUD	33	128	132	5	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58715	10.1371/journal.pone.0058715	http://dx.doi.org/10.1371/journal.pone.0058715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536815	Green Published, gold			2022-12-27	WOS:000316251100082
J	Kharitonenkov, A; Beals, JM; Micanovic, R; Strifler, BA; Rathnachalam, R; Wroblewski, VJ; Li, S; Koester, A; Ford, AM; Coskun, T; Dunbar, JD; Cheng, CC; Frye, CC; Bumol, TF; Moller, DE				Kharitonenkov, Alexei; Beals, John M.; Micanovic, Radmila; Strifler, Beth A.; Rathnachalam, Radhakrishnan; Wroblewski, Victor J.; Li, Shun; Koester, Anja; Ford, Amy M.; Coskun, Tamer; Dunbar, James D.; Cheng, Christine C.; Frye, Christopher C.; Bumol, Thomas F.; Moller, David E.			Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; INDUCED OBESE MICE; BENZYL ALCOHOL; FGF RECEPTOR; BETA-KLOTHO; AGGREGATION; STABILITY; YEAST	Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad variety of metabolic abnormalities, such as type 2 diabetes, obesity, hepatic steatosis, and cardiovascular disease. Human recombinant wild type FGF21 (FGF21) has been shown to ameliorate metabolic disorders in rodents and non-human primates. However, development of FGF21 as a drug is challenging and requires re-engineering of its amino acid sequence to improve protein expression and formulation stability. Here we report the design and characterization of a novel FGF21 variant, LY2405319. To enable the development of a potential drug product with a once-daily dosing profile, in a preserved, multi-use formulation, an additional disulfide bond was introduced in FGF21 through Leu118Cys and Ala134Cys mutations. FGF21 was further optimized by deleting the four N-terminal amino acids, His-Pro-Ile-Pro (HPIP), which was subject to proteolytic cleavage. In addition, to eliminate an O-linked glycosylation site in yeast a Ser167Ala mutation was introduced, thus allowing large-scale, homogenous protein production in Pichia pastoris. Altogether re-engineering of FGF21 led to significant improvements in its biopharmaceutical properties. The impact of these changes was assessed in a panel of in vitro and in vivo assays, which confirmed that biological properties of LY2405319 were essentially identical to FGF21. Specifically, subcutaneous administration of LY2405319 in ob/ob and diet-induced obese (DIO) mice over 7-14 days resulted in a 25-50% lowering of plasma glucose coupled with a 10-30% reduction in body weight. Thus, LY2405319 exhibited all the biopharmaceutical and biological properties required for initiation of a clinical program designed to test the hypothesis that administration of exogenous FGF21 would result in effects on disease-related metabolic parameters in humans.	[Kharitonenkov, Alexei; Beals, John M.; Micanovic, Radmila; Strifler, Beth A.; Rathnachalam, Radhakrishnan; Wroblewski, Victor J.; Li, Shun; Koester, Anja; Ford, Amy M.; Coskun, Tamer; Dunbar, James D.; Cheng, Christine C.; Frye, Christopher C.; Bumol, Thomas F.; Moller, David E.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Kharitonenkov, A (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	a.kharch@lilly.com	Coskun, Tamer/AAR-8422-2021					Adams AC, 2012, MOL METAB, DOI 101016/jmolmet201208007; Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Coskun T, 2012, DIABETOLOGIA, V55, pS17; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fransson J, 1997, PHARM RES-DORDR, V14, P606, DOI 10.1023/A:1012101027814; Higgins DR, 1998, METH MOL B, V103, P1; IDF Diabetes Atlas, 2011, IDF DIAB ATL; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Lam XM, 1997, PHARMACEUT RES, V14, P725, DOI 10.1023/A:1012190120061; Maa YF, 1996, INT J PHARM, V140, P155, DOI 10.1016/0378-5173(96)04577-2; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Moller DE, 2012, CELL METAB, V15, P19, DOI 10.1016/j.cmet.2011.10.012; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Remmele RL, 1998, PHARMACEUT RES, V15, P200; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Thirumangalathu R, 2006, J PHARM SCI-US, V95, P1480, DOI 10.1002/jps.20619; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Waterham HR, 1997, J CELL BIOL, V139, P1419, DOI 10.1083/jcb.139.6.1419; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Ye Xian-long, 2012, Yaoxue Xuebao, V47, P897; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	38	117	130	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58575	10.1371/journal.pone.0058575	http://dx.doi.org/10.1371/journal.pone.0058575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536797	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100064
J	Menz, MHM; Phillips, RD; Dixon, KW; Peakall, R; Didham, RK				Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.; Peakall, Rod; Didham, Raphael K.			Mate-Searching Behaviour of Common and Rare Wasps and the Implications for Pollen Movement of the Sexually Deceptive Orchids They Pollinate	PLOS ONE			English	Article							REPRODUCTIVE-BEHAVIOR; CALADENIA ORCHIDACEAE; GENETIC-ANALYSIS; EVOLUTION; INFLORESCENCES; SPECIALIZATION; HYMENOPTERA; AUSTRALIA; SYSTEM; RARITY	Pollinator behaviour directly affects patterns of pollen movement and outcrossing rates in plants. In orchids pollinated by sexual deception of insects, patterns of pollen movement are primarily determined by the mate-searching behaviour of the deceived males. Here, using a capture-mark-recapture study (CMR) and dietary analysis, we compare mate-searching behaviour in relation to local abundance of two pollinator species and explore the implications for pollen movement in sexually deceptive Drakaea (Orchidaceae). Drakaea are pollinated solely by the sexual deception of male thynnine wasps. The rare Drakaea elastica and widespread D. livida occur sympatrically and are pollinated by the rare but locally common Zaspilothynnus gilesi, and the widespread and abundant Z. nigripes, respectively. Local abundance was significantly different with Z. nigripes twice as abundant as Z. gilesi. For the 653 marked wasps, there was no significant difference in median movement distance between Z. gilesi and Z. nigripes. However, the maximum movement distance was twice as high for Z. gilesi (556 m) compared with Z. nigripes (267 m). This is up to three times greater than previously reported for thynnines in CMR studies. Recapture rates were six times higher in Z. gilesi (57%) compared to Z. nigripes (9%). Pollen loads and wasp longevity were similar, suggesting that this difference in recapture rate arises due to differences in the number of males moving at a scale >500 m rather than through diet or mortality. Differences in the frequency of longer movements may arise due to variation in the spatial distribution of the wingless females. We predict that pollen movement will largely be restricted to within populations of Drakaea (<500 m), with few movements between populations (>500 m).	[Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.] Bot Gardens & Pk Author, Kings Pk & Bot Garden, Perth, WA, Australia; [Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Menz, Myles H. M.; Phillips, Ryan D.; Peakall, Rod] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Ecosyst Sci, Ctr Environm & Life Sci, Perth, WA, Australia	University of Western Australia; Australian National University; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Menz, MHM (corresponding author), Bot Gardens & Pk Author, Kings Pk & Bot Garden, Perth, WA, Australia.	myles.menz@bgpa.wa.gov.au	Phillips, Ryan/HDM-9720-2022; Didham, Raphael K/B-5953-2011; Menz, Myles H. M./AAP-6756-2020; Dixon, Kingsley W/A-8133-2016; Menz, Myles/A-2238-2017; Peakall, Rod/C-9623-2009; Menz, Myles/HHZ-9580-2022	Menz, Myles H. M./0000-0002-3347-5411; Dixon, Kingsley W/0000-0001-5989-2929; Menz, Myles/0000-0002-3347-5411; Peakall, Rod/0000-0001-9407-8404; Menz, Myles/0000-0002-3347-5411	Holsworth Wildlife Research Endowment; Main Roads Western Australia; Australian Research Council (ARC) [LP098338]	Holsworth Wildlife Research Endowment; Main Roads Western Australia; Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Holsworth Wildlife Research Endowment, Main Roads Western Australia and an Australian Research Council (ARC) Linkage Grant (LP098338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2000, J NAT HIST, V34, P629, DOI 10.1080/002229300299480; Alcock J, 2005, J NAT HIST, V39, P2809, DOI 10.1080/00222930500114384; ALCOCK J, 1981, J KANSAS ENTOMOL SOC, V54, P681; ALCOCK J, 1978, ZOOL J LINN SOC-LOND, V64, P293, DOI 10.1111/j.1096-3642.1978.tb01075.x; Bowman A., 2010, R PACKAGE SM NONPARA; BROWN AP, 1998, W AUSTR THREATENED F; BURRELL R. W., 1935, JOUR NEW YORK ENT SOC, V43, P19; Department of Environment and Conservation, 2008, GLOSS LEAF HAMM ORCH; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Ellis AG, 2010, AM NAT, V176, pE143, DOI 10.1086/656487; Gaskett AC, 2011, BIOL REV, V86, P33, DOI 10.1111/j.1469-185X.2010.00134.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Given BB, 1953, T R ENTOMOL SOC LOND, V105, P1; Goh MZ, 2010, ANIM BEHAV, V80, P391, DOI 10.1016/j.anbehav.2010.05.021; *GOV W AUSTR, 2000, BUSH FOR, V1; Griffiths KE, 2011, MOL PHYLOGENET EVOL, V59, P195, DOI 10.1016/j.ympev.2011.02.004; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hopper SD, 2007, AUST SYST BOT, V20, P252, DOI 10.1071/SB06033; JANVIER HIPPOLYTE, 1933, ANN SCI NAT ZOOL, V16, P209; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PAULUS HF, 1990, ISRAEL J BOT, V39, P43; Peakall R, 1996, EVOLUTION, V50, P2207, DOI 10.1111/j.1558-5646.1996.tb03611.x; PEAKALL R, 1990, FUNCT ECOL, V4, P159, DOI 10.2307/2389335; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2004, BEHAV ECOL SOCIOBIOL, V56, P579, DOI 10.1007/s00265-004-0816-3; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips RD, 2013, J ECOL, V101, P826, DOI 10.1111/1365-2745.12068; Phillips RD, 2011, J ECOL, V99, P858, DOI 10.1111/j.1365-2745.2011.01797.x; Phillips RD, 2011, J BIOGEOGR, V38, P487, DOI 10.1111/j.1365-2699.2010.02413.x; Phillips RD, 2009, AUST J BOT, V57, P287, DOI 10.1071/BT08154; PYKE GH, 1981, ANIM BEHAV, V29, P889, DOI 10.1016/S0003-3472(81)80025-5; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; SMITH T J R, 1970, Journal of the Australian Entomological Society, V9, P196; SMITH T J R, 1971, Journal of the Australian Entomological Society, V10, P265; SMITH T J R, 1970, Journal of the Australian Entomological Society, V9, P183; Stoutamire W., 1975, American Orchid Society Bulletin, V44, P226; STOUTAMIRE WP, 1983, AUST J BOT, V31, P383, DOI 10.1071/BT9830383; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Vereecken NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4786, DOI 10.1098/rspb.2012.1804; Wand M, 2011, KERNSMOOTH FUNCTIONS; Whitehead MR, 2013, BEHAV ECOL, V24, P162, DOI 10.1093/beheco/ars149; Whitehead MR, 2012, AGR FOREST ENTOMOL, V14, P171, DOI 10.1111/j.1461-9563.2011.00556.x; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; WOOLLER RD, 1983, AUST WILDLIFE RES, V10, P443	51	19	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59111	10.1371/journal.pone.0059111	http://dx.doi.org/10.1371/journal.pone.0059111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536860	Green Published, gold			2022-12-27	WOS:000316251100120
J	Putaporntip, C; Hughes, AL; Jongwutiwes, S				Putaporntip, Chaturong; Hughes, Austin L.; Jongwutiwes, Somchai			Low Level of Sequence Diversity at Merozoite Surface Protein-1 Locus of Plasmodium ovale curtisi and P. ovale wallikeri from Thai Isolates	PLOS ONE			English	Article							POSITIVE SELECTION; KNOWLESI MALARIA; VIVAX; PARASITE; RECOMBINATION; MACAQUES; HUMANS; GENE	Background: The merozoite surface protein-1 (MSP-1) is a candidate target for the development of blood stage vaccines against malaria. Polymorphism in MSP-1 can be useful as a genetic marker for strain differentiation in malarial parasites. Although sequence diversity in the MSP-1 locus has been extensively analyzed in field isolates of Plasmodium falciparum and P. vivax, the extent of variation in its homologues in P. ovale curtisi and P. ovale wallikeri, remains unknown. Methodology/Principal Findings: Analysis of the mitochondrial cytochrome b sequences of 10 P. ovale isolates from symptomatic malaria patients from diverse endemic areas of Thailand revealed co-existence of P. ovale curtisi (n = 5) and P. ovale wallikeri (n = 5). Direct sequencing of the PCR-amplified products encompassing the entire coding region of MSP-1 of P. ovale curtisi (PocMSP-1) and P. ovale wallikeri (PowMSP-1) has identified 3 imperfect repeated segments in the former and one in the latter. Most amino acid differences between these proteins were located in the interspecies variable domains of malarial MSP-1. Synonymous nucleotide diversity (pi(S)) exceeded nonsynonymous nucleotide diversity (pi(N)) for both PocMSP-1 and PowMSP-1, albeit at a non-significant level. However, when MSP-1 of both these species was considered together, pi(S) was significantly greater than pi(N) (p<0.0001), suggesting that purifying selection has shaped diversity at this locus prior to speciation. Phylogenetic analysis based on conserved domains has placed PocMSP-1 and PowMSP-1 in a distinct bifurcating branch that probably diverged from each other around 4.5 million years ago. Conclusion/Significance: The MSP-1 sequences support that P. ovale curtisi and P. ovale wallikeri are distinct species. Both species are sympatric in Thailand. The low level of sequence diversity in PocMSP-1 and PowMSP-1 among Thai isolates could stem from persistent low prevalence of these species, limiting the chance of outcrossing at this locus.	[Putaporntip, Chaturong; Jongwutiwes, Somchai] Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok 10330, Thailand; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Chulalongkorn University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Putaporntip, C (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok 10330, Thailand.	p.chaturong@gmail.com			Thailand Research Fund [RSA5480008]; United States National Institutes of Health [GM43940]; Government Research Budget; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940] Funding Source: NIH RePORTER	Thailand Research Fund(Thailand Research Fund (TRF)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government Research Budget; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Thailand Research Fund (grant nos. RSA5480008) to CP; Government Research Budget (fiscal year 2012) to CP and SJ; and GM43940 from the United States National Institutes of Health to ALH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birkenmeyer L, 2010, AM J TROP MED HYG, V82, P996, DOI 10.4269/ajtmh.2010.09-0022; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Conway DJ, 2007, CLIN MICROBIOL REV, V20, P188, DOI 10.1128/CMR.00021-06; Dinko B, 2013, INT J PARAS IN PRESS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fancony C, 2012, ANTIMICROB AGENTS CH, V56, P5271, DOI 10.1128/AAC.00559-12; Garhnam PCC, 1966, MALARIA PARASITES OT; HOLDER AA, 1988, PROG ALLERGY, V41, P72; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; Hughes AL, 2010, MOL PHYLOGENET EVOL, V57, P135, DOI 10.1016/j.ympev.2010.06.004; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jongwutiwes S, 2010, VACCINE, V28, P3112, DOI 10.1016/j.vaccine.2010.02.062; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Nei M., 1987, MOL EVOLUTIONARY GEN; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Polley SD, 2005, MOL BIOCHEM PARASIT, V142, P25, DOI 10.1016/j.molbiopara.2005.02.012; Putaporntip C, 2006, MOL BIOCHEM PARASIT, V146, P105, DOI 10.1016/j.molbiopara.2005.11.001; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Putaporntip C, 2010, MOL ECOL, V19, P3466, DOI 10.1111/j.1365-294X.2010.04756.x; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Sawai H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-52; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Stephens J. W., 1922, Annals of Tropical Medicine and Parasitology, V16, P383; Sutherland CJ, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P607, DOI 10.1016/B978-0-12-384890-1.00022-4; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tachibana M, 2002, MOL BIOCHEM PARASIT, V122, P223, DOI 10.1016/S0166-6851(02)00101-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tordrup D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-15; Tosi AJ, 2003, EVOLUTION, V57, P1419; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411	37	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58962	10.1371/journal.pone.0058962	http://dx.doi.org/10.1371/journal.pone.0058962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536840	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100105
J	Zhang, J; Wu, XH; Yu, YM; Luo, DS				Zhang, Jie; Wu, Xiaohong; Yu, Yanmei; Luo, Daisheng			A Method of Neighbor Classes Based SVM Classification for Optical Printed Chinese Character Recognition	PLOS ONE			English	Article								In optical printed Chinese character recognition (OPCCR), many classifiers have been proposed for the recognition. Among the classifiers, support vector machine (SVM) might be the best classifier. However, SVM is a classifier for two classes. When it is used for multi-classes in OPCCR, its computation is time-consuming. Thus, we propose a neighbor classes based SVM (NC-SVM) to reduce the computation consumption of SVM. Experiments of NC-SVM classification for OPCCR have been done. The results of the experiments have shown that the NC-SVM we proposed can effectively reduce the computation time in OPCCR.	[Zhang, Jie; Wu, Xiaohong; Yu, Yanmei; Luo, Daisheng] Sichuan Univ, Sch Elect & Informat Engn, Image Informat Inst, Chengdu 610064, Peoples R China	Sichuan University	Yu, YM (corresponding author), Sichuan Univ, Sch Elect & Informat Engn, Image Informat Inst, Chengdu 610064, Peoples R China.	yuyanmei@scu.edu.cn						[Anonymous], 2013, LIBSVM LIB SUPPORT V; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang F, 2004, IEEE SYS MAN CYBERN, P4738; Chen R, 2006, PROCEEDINGS OF THE FIFTH IEEE INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS, VOLS 1 AND 2, P547; Chiu HP, 1999, PATTERN RECOGN, V32, P1947, DOI 10.1016/S0031-3203(99)00003-5; Dong JX, 2005, PATTERN RECOGN LETT, V26, P1849, DOI 10.1016/j.patrec.2005.03.006; Fu C, 2012, DECISION TREE ACCELE, DOI [10.5772/52227, DOI 10.5772/52227]; Impedovo D, 2012, P 13 INT C FRONT HAN, P661; John CP, 2000, LARGE MARGIN DAGS MU, P547; Kim JW, 1999, PATTERN RECOGN LETT, V20, P285, DOI 10.1016/S0167-8655(98)00147-0; KIMURA F, 1987, IEEE T PATTERN ANAL, V9, P149, DOI 10.1109/TPAMI.1987.4767881; Lam Hong Lee, 2010, Journal of Applied Sciences, V10, P1841, DOI 10.3923/jas.2010.1841.1858; Lee CN, 1998, PATTERN RECOGN, V31, P651, DOI 10.1016/S0031-3203(97)00080-0; Lee HJ, 2005, PROC INT CONF DOC, P710; Liu CL, 2007, IEEE T PATTERN ANAL, V29, P1465, DOI 10.1109/TPAMI.2007.1090; Liu CL, 2008, STUD COMPUT INTELL, V90, P139; Shin JP, 2002, PATTERN RECOGN LETT, V23, P601, DOI 10.1016/S0167-8655(01)00136-2; Su YM, 2004, INT C PATT RECOG, P351, DOI 10.1109/ICPR.2004.1334216; Su YM, 2003, IEEE T SYST MAN CY A, V33, P386, DOI 10.1109/TSMCA.2003.817054; Su YM, 2003, PATTERN RECOGN, V36, P635, DOI 10.1016/S0031-3203(02)00086-9; Tseng CC, 1998, PATTERN RECOGN LETT, V19, P953, DOI 10.1016/S0167-8655(98)00071-3; Tseng YH, 1998, PATTERN RECOGN, V31, P1601, DOI 10.1016/S0031-3203(98)00043-0; Wang N, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P1403, DOI 10.1109/IIH-MSP.2008.118; Wei Xiong, 2009, 2009 4th IEEE Conference on Industrial Electronics and Applications, P3597, DOI 10.1109/ICIEA.2009.5138876; Xia TW, 2011, ADV INTEL SOFT COMPU, V106, P219; Zaidi N. A., 2010, Proceedings 2010 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2010), P196, DOI 10.1109/DICTA.2010.44; Zeng J, 2006, INT C PATT RECOG, P868; Zeng J, 2010, INFORM SCIENCES, V180, P301, DOI 10.1016/j.ins.2009.09.011; Zhang H., 2006, IEEE INT C COMP VIS, V2, P2126; Zhang Yankun, 2003, Journal of Systems Engineering and Electronics, V14, P73; Zhao L., 2007, 2007 IEEE INT C SYST, P3604	31	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57928	10.1371/journal.pone.0057928	http://dx.doi.org/10.1371/journal.pone.0057928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536777	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100021
J	Balana, B; Bahima, L; Bodhinathan, K; Taura, JJ; Taylor, NM; Nettleton, MY; Ciruela, F; Slesinger, PA				Balana, Bartosz; Bahima, Laia; Bodhinathan, Karthik; Taura, Jaume J.; Taylor, Natalie M.; Nettleton, Margaret Y.; Ciruela, Francisco; Slesinger, Paul A.			Ras-Association Domain of Sorting Nexin 27 Is Critical for Regulating Expression of GIRK Potassium Channels	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; PROTEIN; TRAFFICKING; ROLES; ACTIVATION; ENDOSOMES; RECEPTORS; INTERACT; RALGDS; SNX27	G protein-gated inwardly rectifying potassium (GIRK) channels play an important role in regulating neuronal excitability. Sorting nexin 27b (SNX27b), which reduces surface expression of GIRK channels through a PDZ domain interaction, contains a putative Ras-association (RA) domain with unknown function. Deleting the RA domain in SNX27b (SNX27b-Delta RA) prevents the down-regulation of GIRK2c/GIRK3 channels. Similarly, a point mutation (K305A) in the RA domain disrupts regulation of GIRK2c/GIRK3 channels and reduces H-Ras binding in vitro. Finally, the dominant-negative H-Ras (S17N) occludes the SNX27b-dependent decrease in surface expression of GIRK2c/GIRK3 channels. Thus, the presence of a functional RA domain and the interaction with Ras-like G proteins comprise a novel mechanism for modulating SNX27b control of GIRK channel surface expression and cellular excitability.	[Balana, Bartosz; Bahima, Laia; Bodhinathan, Karthik; Taura, Jaume J.; Taylor, Natalie M.; Nettleton, Margaret Y.; Slesinger, Paul A.] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Slesinger, Paul A.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA; [Bahima, Laia; Ciruela, Francisco] Univ Barcelona, Unitat Farmacol, Dept Patol & Terapeut Expt, Barcelona, Spain	Salk Institute; Icahn School of Medicine at Mount Sinai; University of Barcelona	Ciruela, F (corresponding author), Univ Barcelona, Unitat Farmacol, Dept Patol & Terapeut Expt, Barcelona, Spain.	fciruela@ub.edu; paul.slesinger@mssm.edu	Ciruela, F./A-5096-2013; Bodhinathan, Karthik/B-9693-2009	Ciruela, F./0000-0003-0832-3739; Bodhinathan, Karthik/0000-0003-2938-9008	National Institute on Drug Abuse [DA019022]; National Institute on Alcohol Abuse and Alcoholism [AA018734]; Instituto de Salud Carlos III [PY-1278/08-2]; San Diego Foundation [C-2011-00207]; American Heart Association [12POST9830002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); San Diego Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funds from National Institute on Drug Abuse (DA019022; PAS) and National Institute on Alcohol Abuse and Alcoholism (AA018734; PAS), Instituto de Salud Carlos III (PY-1278/08-2; LB), the Blasker-Rose-Miah fund of The San Diego Foundation (C-2011-00207; BB) and the American Heart Association Postdoctoral Fellowship (12POST9830002; KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balana B, 2011, P NATL ACAD SCI US; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V359, P848, DOI 10.1016/j.bbrc.2007.05.162; Mizutani R, 2011, GENE EXPR PATTERNS, V11, P33, DOI 10.1016/j.gep.2010.08.007; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nassirpour R, 2007, CHANNELS, V1, P331, DOI 10.4161/chan.5191; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	31	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59800	10.1371/journal.pone.0059800	http://dx.doi.org/10.1371/journal.pone.0059800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536889	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200037
J	Yamamoto, T; Yoshimatsu, H; Yamamoto, N; Narushima, M; Iida, T; Koshima, I				Yamamoto, Takumi; Yoshimatsu, Hidehiko; Yamamoto, Nana; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Side-to-End Lymphaticovenular Anastomosis through Temporary Lymphatic Expansion	PLOS ONE			English	Article							LOWER-EXTREMITY LYMPHEDEMA; INDOCYANINE GREEN LYMPHOGRAPHY; INTRAVASCULAR STENTING METHOD; STAGE	Objective: The number of bypasses is the most important factor in lymphaticovenular anastomosis (LVA) for lymphedema treatment. Side-to-end (S-E) LVA, which can bypass bidirectional lymph flows via one anastomosis, is considered to be the most efficient bypass, but creation of lateral window to a small lymphatic vessel is technically demanding. To overcome the difficulty, we introduced S-E anastomosis through temporary lymphatic expansion (SEATTLE) procedure in S-E LVA. Methods: This was a retrospective observational study set in a teaching hospital. Forty eight lower extremity lymphedema (LEL) patients underwent LVA. S-E LVAs were performed with (SEATTLE group) or without (non-SEATTLE group) temporary lymphatic expansion. S-E LVAs were evaluated to compare anastomosis result in SEATTLE and non-SEATTLE groups. Results: S-E LVAs resulted in 44 anastomoses in SEATTLE group (n = 25) and 37 anastomoses in non-SEATTLE group (n = 23). LEL index reduction in SEATTLE group was significantly greater than that in non-SEATTLE group (16.5 +/- 14.5 vs. 10.9 +/- 11.8, P = 0.041). Success rate of S-E LVA in SEATTLE group was significantly higher than that in non-SEATTLE group (95.5% vs 81.1%, P = 0.040). Thirty seven of 44 (84.1%) lymph vessels in SEATTLE group were successfully dilated by temporary lymphatic expansion maneuver. All of 9 failed S-E LVAs used a lymphatic vessel with diameter of 0.35 mm or smaller. Conclusions: The SEATTLE procedure facilitates S-E LVA by a simple and easy maneuver. When the diameter of the lymphatic vessel is 0.35 mm or smaller even after the temporary lymphatic expansion maneuver, S-E LVA is not recommended due to relatively high failure rate.	[Yamamoto, Takumi; Yoshimatsu, Hidehiko; Yamamoto, Nana; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan	University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	tyamamoto-tky@umin.ac.jp	Yamamoto, Takumi/Y-7658-2019; Yoshimatsu, Hidehiko/AAA-8955-2020		Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	The grant was provided by Takeda Science Foundation (http://www.takeda-sci.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, orb preparation of the manuscript.	[Anonymous], 2009, LYMPHOLOGY, V42, P51; Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707; Chang DW, 2010, PLAST RECONSTR SURG, V126, P752, DOI 10.1097/PRS.0b013e3181e5f6a9; Devoogdt N, 2010, EUR J OBSTET GYN R B, V149, P3, DOI 10.1016/j.ejogrb.2009.11.016; Koshima I, 2004, ANN PLAS SURG, V53, P261, DOI 10.1097/01.sap.0000120319.89926.07; Koshima I, 2003, J RECONSTR MICROSURG, V19, P209; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437, DOI 10.1055/s-2006-947150; McNeely ML, 2011, CANCER-AM CANCER SOC, V117, P1136, DOI 10.1002/cncr.25513; Nagase Takashi, 2005, Int J Clin Oncol, V10, P304, DOI 10.1007/s10147-005-0518-5; Narushima M, 2010, PLAST RECONSTR SURG, V125, P935, DOI 10.1097/PRS.0b013e3181cb64da; Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; YAMADA Y, 1969, Nagoya Journal of Medical Science, V32, P1; Yamamoto T, 2012, MICROSURGERY; Yamamoto T, 2012, ANN PLAST SURG; Yamamoto T, ANN PLAST S IN PRESS; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011	23	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59523	10.1371/journal.pone.0059523	http://dx.doi.org/10.1371/journal.pone.0059523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536881	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200029
J	Alhosin, M; Anselm, E; Rashid, S; Kim, JH; Madeira, SVF; Bronner, C; Schini-Kerth, VB				Alhosin, Mahmoud; Anselm, Eric; Rashid, Sherzad; Kim, Jong Hun; Frota Madeira, Socorro Vanesca; Bronner, Christian; Schini-Kerth, Valerie B.			Redox-Sensitive Up-Regulation of eNOS by Purple Grape Juice in Endothelial Cells: Role of PI3-Kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-ARTERY-DISEASE; FORKHEAD TRANSCRIPTION FACTOR; EDHF-MEDIATED RELAXATIONS; WINE POLYPHENOLS; HYDROGEN-PEROXIDE; SMOOTH-MUSCLE; DEPENDENT VASORELAXATION; SIGNALING PATHWAYS; GENE-EXPRESSION	The vascular protective effect of grape-derived polyphenols has been attributable, in part, to their direct action on blood vessels by stimulating the endothelial formation of nitric oxide (NO). The aim of the present study was to determine whether Concord grape juice (CGJ), which contains high levels of polyphenols, stimulates the expression of endothelial NO synthase (eNOS) in porcine coronary artery endothelial cells and, if so, to determine the signaling pathway involved. CGJ dose- and time-dependently increased eNOS mRNA and protein levels and this effect is associated with an increased formation of NO in endothelial cells. The stimulatory effect of CGJ on eNOS mRNA is not associated with an increased eNOS mRNA stability and inhibited by antioxidants such as MnTMPyP, PEG-catalase, and catalase, and by wortmannin (an inhibitor of PI3-kinase), SB 203580 (an inhibitor of p38 MAPK), and SP 600125 (an inhibitor of JNK). Moreover, CGJ induced the formation of reactive oxygen species (ROS) in endothelial cells and this effect is inhibited by MnTMPyP, PEG-catalase, and catalase. The CGJ-induced the phosphorylation of p38 MAPK and JNK kinases is abolished by MnTMPyP. CGJ induced phosphorylation of transcription factors FoxO1 and FoxO3a, which regulate negatively eNOS expression, and this effect is prevented by MnTMPyP, PEG-catalase, wortmannin, SB203580 and SP600125. Moreover, chromatin immunoprecipitation assay indicated that the FoxO3a protein is associated with the eNOS promoter in control cells and that CGJ induced its dissociation. Thus, the present study indicates that CGJ up-regulates the expression of eNOS mRNA and protein leading to an increased formation of NO in endothelial cells. The stimulatory effect of CGJ is a redox-sensitive event involving PI3-kinase/Akt, p38 MAPK and JNK pathways, and the inactivation of the FoxO transcription factors, FoxO1 and FoxO3a, thereby preventing their repression of the eNOS gene.	[Alhosin, Mahmoud; Anselm, Eric; Rashid, Sherzad; Kim, Jong Hun; Frota Madeira, Socorro Vanesca; Bronner, Christian; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, Illkirch Graffenstaden, France; [Frota Madeira, Socorro Vanesca] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade Federal do Ceara	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Bronner, Christian/R-8488-2016; Alhosin, Mahmoud/AAD-5782-2020; Alhosin, Mahmoud/H-8101-2017	Bronner, Christian/0000-0002-3101-9279; Alhosin, Mahmoud/0000-0003-2147-1445; Gaban, Socorro Vanesca Frota/0000-0002-1815-2446	Welch Foods, Inc. (Concord, MA, USA)	Welch Foods, Inc. (Concord, MA, USA)	This work was supported, in part, by a research grant from Welch Foods, Inc. (Concord, MA, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akagawa M, 2003, BIOSCI BIOTECH BIOCH, V67, P2632, DOI 10.1271/bbb.67.2632; Albers AR, 2004, ARTERIOSCL THROM VAS, V24, pE179, DOI 10.1161/01.ATV.0000143479.97844.af; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai H, 2004, J MOL CELL CARDIOL, V37, P121, DOI 10.1016/j.yjmcc.2004.04.012; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Chou EJ, 2001, AM J CARDIOL, V88, P553, DOI 10.1016/S0002-9149(01)01738-6; de Moura RS, 2002, J PHARM PHARMACOL, V54, P1515, DOI 10.1211/002235702153; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Fitzpatrick DF, 2000, J AGR FOOD CHEM, V48, P6384, DOI 10.1021/jf0009347; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; Hashimoto M, 2001, AM J CARDIOL, V88, P1457, DOI 10.1016/S0002-9149(01)02137-3; Iijima K, 2000, CIRCULATION, V101, P805, DOI 10.1161/01.CIR.101.7.805; Iijima K, 2002, CIRCULATION, V105, P2404, DOI 10.1161/01.CIR.0000016349.36385.FB; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Li HG, 2004, J PHARMACOL EXP THER, V310, P926, DOI 10.1124/jpet.104.066639; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Ndiaye M, 2004, FASEB J, V18, DOI 10.1096/fj.04-2146fje; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; O'Byrne DJ, 2002, AM J CLIN NUTR, V76, P1367, DOI 10.1093/ajcn/76.6.1367; Park YK, 2004, BIOFACTORS, V22, P145, DOI 10.1002/biof.5520220128; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; ROBINSON GLWG, 1994, MOL CELL BIOL, V14, P6704, DOI 10.1128/MCB.14.10.6704; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Soares de Moura R, 2008, J VASC RES IN PRESS; Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050; Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034; Teichert AM, 1998, BBA-GENE STRUCT EXPR, V1443, P352, DOI 10.1016/S0167-4781(98)00236-X; Ullrich V, 2000, BIOCHEM BIOPH RES CO, V278, P1, DOI 10.1006/bbrc.2000.3733; VENEMA RC, 1994, BBA-GENE STRUCT EXPR, V1218, P413, DOI 10.1016/0167-4781(94)90195-3; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; Wallerath T, 2003, J AM COLL CARDIOL, V41, P471, DOI 10.1016/S0735-1097(02)02826-7; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Whelan AP, 2004, INTERN MED J, V34, P224, DOI 10.1111/j.1444-0903.2004.00507.x; Wolin MS, 2000, ARTERIOSCL THROM VAS, V20, P1430, DOI 10.1161/01.ATV.20.6.1430; Wollny T, 1999, BRIT J PHARMACOL, V127, P747, DOI 10.1038/sj.bjp.0702586	49	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57883	10.1371/journal.pone.0057883	http://dx.doi.org/10.1371/journal.pone.0057883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533577	Green Published, gold			2022-12-27	WOS:000316549400014
J	Ottet, MC; Schaer, M; Cammoun, L; Schneider, M; Debbane, M; Thiran, JP; Eliez, S				Ottet, Marie-Christine; Schaer, Marie; Cammoun, Leila; Schneider, Maude; Debbane, Martin; Thiran, Jean-Philippe; Eliez, Stephan			Reduced Fronto-Temporal and Limbic Connectivity in the 22q11.2 Deletion Syndrome: Vulnerability Markers for Developing Schizophrenia?	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; WHITE-MATTER; VELOCARDIOFACIAL SYNDROME; PSYCHOTIC SYMPTOMS; CEREBRAL-CORTEX; BRAIN; CHILDREN; ADOLESCENTS; CINGULATE; INTEGRITY	The 22q11.2 deletion syndrome (22q11DS) is a widely recognized genetic model allowing the study of neuroanatomical biomarkers that underlie the risk for developing schizophrenia. Recent advances in magnetic resonance image analyses enable the examination of structural connectivity integrity, scarcely used in the 22q11DS field. This framework potentially provides evidence for the disconnectivity hypothesis of schizophrenia in this high-risk population. In the present study, we quantify the whole brain white matter connections in 22q11DS using deterministic tractography. Diffusion Tensor Imaging was acquired in 30 affected patients and 30 age-and gender-matched healthy participants. The Human Connectome technique was applied to register white matter streamlines with cortical anatomy. The number of fibers (streamlines) was used as a measure of connectivity for comparison between groups at the global, lobar and regional level. All statistics were corrected for age and gender. Results showed a 10% reduction of the total number of fibers in patients compared to controls. After correcting for this global reduction, preserved connectivity was found within the right frontal and right parietal lobes. The relative increase in the number of fibers was located mainly in the right hemisphere. Conversely, an excessive reduction of connectivity was observed within and between limbic structures. Finally, a disproportionate reduction was shown at the level of fibers connecting the left fronto-temporal regions. We could therefore speculate that the observed disruption to fronto-temporal connectivity in individuals at risk of schizophrenia implies that fronto-temporal disconnectivity, frequently implicated in the pathogenesis of schizophrenia, could precede the onset of symptoms and, as such, constitutes a biomarker of the vulnerability to develop psychosis. On the contrary, connectivity alterations in the limbic lobe play a role in a wide range of psychiatric disorders and therefore seem to be less specific in defining schizophrenia.	[Ottet, Marie-Christine; Schaer, Marie; Schneider, Maude; Debbane, Martin; Eliez, Stephan] Univ Geneva, Sch Med, OMP, CH-1211 Geneva, Switzerland; [Ottet, Marie-Christine; Cammoun, Leila; Thiran, Jean-Philippe] Swiss Fed Inst Technol EPFL, Signal Proc Lab LTS5, Lausanne, Vaud, Switzerland; [Debbane, Martin] Univ Geneva, Adolescence Clin Psychol Res Unit, Geneva, Switzerland; [Eliez, Stephan] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva	Ottet, MC (corresponding author), Univ Geneva, Sch Med, OMP, CH-1211 Geneva, Switzerland.	marie-christine.ottet@unige.ch		Debbane, Martin/0000-0002-4677-8753; Schneider, Maude/0000-0001-7147-8915; Thiran, Jean-Philippe/0000-0003-2938-9657; Schaer, Marie/0000-0001-8479-6365	Swiss National Research Fund [3200-063135.00/1, 3232-063134.00/1, PP0033-102864, 32473B-121996]; Swiss National Science Foundation [51AU40_125759]; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundation Leenaards; foundation Louis-Jeantet	Swiss National Research Fund(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundation Leenaards; foundation Louis-Jeantet	The Swiss National Research Fund (www.snf.ch) to Dr. Stephan Eliez (3200-063135.00/1, 3232-063134.00/1, PP0033-102864 and 32473B-121996), and by the National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases" financed by the Swiss National Science Foundation (no 51AU40_125759) and by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities and the EPFL, as well as the foundations Leenaards and Louis-Jeantet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FD, 2011, SCHIZOPHR RES, V132, P75, DOI 10.1016/j.schres.2011.07.017; Baker K, 2005, ART NEWS, V104, P158; Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; Barnea-Goraly N, 2005, COGNITIVE BRAIN RES, V25, P735, DOI 10.1016/j.cogbrainres.2005.09.013; Barnea-Goraly N, 2003, AM J PSYCHIAT, V160, P1863, DOI 10.1176/appi.ajp.160.10.1863; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Brebion G, 2002, PSYCHIAT RES, V112, P27, DOI 10.1016/S0165-1781(02)00187-7; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cammoun L, 2011, J NEUROSCI METHODS; Campbell LE, 2010, AUST NZ J PSYCHIAT, V44, P364, DOI 10.3109/00048670903489882; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Debbane M, 2008, PSYCHOL MED, V38, P811, DOI 10.1017/S003329170700222X; Debbane M, 2006, SCHIZOPHR RES, V84, P187, DOI 10.1016/j.schres.2006.01.019; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dufour F, 2008, NEUROPSYCHOLOGIA, V46, P2986, DOI 10.1016/j.neuropsychologia.2008.06.012; Eliez S, 2000, AM J PSYCHIAT, V157, P409, DOI 10.1176/appi.ajp.157.3.409; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Gigandet X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004006; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kates WR, 2004, J CHILD NEUROL, V19, P337, DOI 10.1177/088307380401900506; Keshavan MS, 2007, INT REV PSYCHIATR, V19, P399, DOI 10.1080/09540260701486233; Kiehl TR, 2009, CEREB CORTEX, V19, P153, DOI 10.1093/cercor/bhn066; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Li LC, 2012, HUM BRAIN MAPP, V33, P1894, DOI 10.1002/hbm.21332; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Reiss AL, 2000, MENT RETARD DEV D R, V6, P186, DOI 10.1002/1098-2779(2000)6:3<186::AID-MRDD6>3.0.CO;2-9; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Schaer M, 2010, J NEURODEV DISORD, V2, P224, DOI 10.1007/s11689-010-9061-4; Schaer M, 2009, SCHIZOPHR RES, V115, P182, DOI 10.1016/j.schres.2009.09.016; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Simon TJ, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-25; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stoddard J, 2011, J NEURODEV DISORD, V3, P76, DOI 10.1007/s11689-010-9070-3; Sun H, 2007, IEEE T MED IMAGING, V26, P1166, DOI 10.1109/TMI.2007.900322; Takei K, 2009, SCHIZOPHR RES, V114, P119, DOI 10.1016/j.schres.2009.05.012; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013	67	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58429	10.1371/journal.pone.0058429	http://dx.doi.org/10.1371/journal.pone.0058429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533586	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400023
J	Wen, L; Chen, XZ; Yang, K; Chen, ZX; Zhang, B; Chen, JP; Zhou, ZG; Mo, XM; Hu, JK				Wen, Lei; Chen, Xin-Zu; Yang, Kun; Chen, Zhi-Xin; Zhang, Bo; Chen, Jia-Ping; Zhou, Zong-Guang; Mo, Xian-Ming; Hu, Jian-Kun			Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review	PLOS ONE			English	Article							IDENTIFICATION; PROTEIN; EXPANSION; SURFACE; GROWTH	Objective: To investigate the correlation between CD133-positive gastric cancer and clinicopathological features and its impact on survival. Methods: A search in the Medline and Chinese CNKI (up to 1 Dec 2011) was performed using the following keywords gastric cancer, CD133, AC133, prominin-1 etc. Electronic searches were supplemented by hand searching reference lists, abstracts and proceedings from meetings. Outcomes included overall survival and various clinicopathological features. Results: A total of 773 gastric cancer patients from 7 studies were included. The median rate of CD133 expression by immunohistochemistry (IHC) was 44.8% (15.2%-57.4%) from 5 studies, and that by reverse transcription polymerase chain reaction (RT-PCR) was 91.3% (66.7%-100%) from 4 studies. The accumulative 5-year overall survival rates of CD133-positive and CD133-negative patients were 21.4% and 55.7%, respectively. Meta-analysis showed that CD133-positive patients had a significant worse 5-year overall survival compared to the negative ones (OR = 0.20, 95% CI 0.14-0.29, P<0.00001). With respect to clinicopathological features, CD133 overexpression by IHC method was closely correlated with tumor size, N stage, lymphatic/vascular infiltration, as well as TNM stage. Conclusion: CD133-positive gastric cancer patients had worse prognosis, and was associated with common clinicopathological poor prognostic factors.	[Wen, Lei; Chen, Xin-Zu; Yang, Kun; Chen, Zhi-Xin; Zhang, Bo; Chen, Jia-Ping; Zhou, Zong-Guang; Mo, Xian-Ming; Hu, Jian-Kun] Sichuan Univ, Dept Gastrointestinal Surg, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Hu, JK (corresponding author), Sichuan Univ, Dept Gastrointestinal Surg, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Chen, Xin-Zu/K-2988-2019; Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/C-2515-2009	Chen, Xin-Zu/0000-0002-7619-6244; , Zongguang/0000-0002-7616-1199	National Natural Science Foundation of China [81071777]; Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; New Century Excellent Talents in University support program, Ministry of Education of China [2012SCU-NCET-11-0343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China; New Century Excellent Talents in University support program, Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	Domestic support from (1) National Natural Science Foundation of China (no. 81071777); (2) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (no. 2011SCU04B19); and (3) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bang YJ, 2010, LANCET, V376, P1302; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Boegl M, 2009, BRIT J CANCER, V100, P1365, DOI 10.1038/sj.bjc.6605001; Chen T, 2012, CELL RES, V22, P248, DOI 10.1038/cr.2011.109; Chen XZ, 2008, WORLD J GASTROENTERO, V14, P2715, DOI 10.3748/wjg.14.2715; Chen XZ, 2012, MOL BIOL REP, V39, P9031, DOI 10.1007/s11033-012-1774-x; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fernandez JC, 2004, CANCER INVEST, V22, P878, DOI 10.1081/CNV-200039658; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hibi K, 2010, ANTICANCER RES, V30, P1201; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Horst D, 2009, EUR J CANCER, V45, P2034, DOI 10.1016/j.ejca.2009.04.004; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Li YZ, 2008, WORLD CHINESE J DIGE, V16, P3167; Liao XN, 2011, J CHINESE PRACTICAL, V25, P355; Lu RQ, 2011, CLIN J BASES CLIN GE, V18, P1265; Maeda S, 2008, BRIT J CANCER, V98, P1389, DOI 10.1038/sj.bjc.6604307; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Shimada M, 2010, J GASTROENTEROL, V45, P896, DOI 10.1007/s00535-010-0235-3; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Singh SK, 2003, CANCER RES, V63, P5821; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Tang BiFeng, 2008, Chinese Clinical Oncology, V13, P495; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; [严家来 Yan Jialai], 2011, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V29, P112; Yang K, 2011, INT J BIOL MARKER, V26, P173, DOI 10.5301/JBM.2011.8551; Yong CS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-95; Yu GZ, 2009, J CANCER RES CLIN, V135, P1331, DOI 10.1007/s00432-009-0574-8; Yu JW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-141; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang P, 2011, CHIN J BASES CLIN GE, V18, P281; [张鹏 ZHANG Peng], 2010, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V30, P213; Zhao P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-218; 季加孚, 2003, [实用肿瘤杂志, Journal of Practical oncology], V18, P341	46	56	63	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59154	10.1371/journal.pone.0059154	http://dx.doi.org/10.1371/journal.pone.0059154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533603	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400040
J	Mazzone, PJ; Obuchowski, N; Phillips, M; Risius, B; Bazerbashi, B; Meziane, M				Mazzone, Peter J.; Obuchowski, Nancy; Phillips, Michael; Risius, Barbara; Bazerbashi, Bana; Meziane, Moulay			Lung Cancer Screening with Computer Aided Detection Chest Radiography: Design and Results of a Randomized, Controlled Trial	PLOS ONE			English	Article							PULMONARY NODULES; CLINICAL-TRIALS; RADIOLOGISTS; PERFORMANCE; TOMOGRAPHY; SIZE	Introduction: The sensitivity of CT based lung cancer screening for the detection of early lung cancer is balanced by the high number of benign lung nodules identified, the unknown consequences of radiation from the test, and the potential costs of a CT based screening program. CAD chest radiography may improve the sensitivity of standard chest radiography while minimizing the risks of CT based screening. Methods: Study subjects were age 40-75 years with 10+ pack-years of smoking and/or an additional risk for developing lung cancer. Subjects were randomized to receive a PA view chest radiograph or placebo control (went through the process of being imaged but were not imaged). Images were reviewed first without then with the assistance of CAD. Actionable nodules were reported and additional evaluation was tracked. The primary outcome was the rate of developing symptomatic advanced stage lung cancer. Results: 1,424 subjects were enrolled. 710 received a CAD chest radiograph, 29 of whom were found to have an actionable lung nodule on prevalence screening. Of the 15 subjects who had a chest CT performed for additional evaluation, a lung nodule was confirmed in 4, 2 of which represented lung cancer. Both of the cancers were seen by the radiologist unaided and were identified by the CAD chest radiograph. The cumulative incidence of symptomatic advanced lung cancer was 0.42 cases per 100 person-years in the control arm; there were no events in the screening arm. Conclusions: Further evaluation is necessary to determine if CAD chest radiography has a role as a lung cancer screening tool.	[Mazzone, Peter J.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Obuchowski, Nancy] Cleveland Clin, Cleveland, OH 44106 USA; [Phillips, Michael; Risius, Barbara; Bazerbashi, Bana] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Meziane, Moulay] Cleveland Clin, Imaging Inst, Abu Dhabi, U Arab Emirates	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Mazzone, PJ (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	mazzonp@ccf.org	Mazzone, Peter/AAW-5401-2021	Mazzone, Peter/0000-0003-2121-0595	Ohio Department of Development [TECH 06-55]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Ohio Department of Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The trial was funded by the Ohio Department of Development, TECH 06-55. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Das M, 2006, RADIOLOGY, V241, P564, DOI 10.1148/radiol.2412051139; Gopal M, 2010, J THORAC ONCOL, V5, P1233, DOI 10.1097/JTO.0b013e3181e0b977; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Manser RL, 2003, THORAX, V58, P784, DOI 10.1136/thorax.58.9.784; Mazzone Peter J, 2007, Curr Oncol Rep, V9, P265, DOI 10.1007/s11912-007-0032-1; Mazzone PJ, 2010, CURR ONCOL REP, V12, P226, DOI 10.1007/s11912-010-0111-6; Meziane M, 2011, AM J ROENTGENOL, V196, pW542, DOI 10.2214/AJR.10.5048; Meziane M, 2012, J THORAC IMAG, V27, P58, DOI 10.1097/RTI.0b013e3181f240bc; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Obuchowski NA, 2008, CONTEMP CLIN TRIALS, V29, P466, DOI 10.1016/j.cct.2007.10.007; Sahiner B, 2009, ACAD RADIOL, V16, P1518, DOI 10.1016/j.acra.2009.08.006; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	14	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59650	10.1371/journal.pone.0059650	http://dx.doi.org/10.1371/journal.pone.0059650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527241	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600085
J	Scott, WR; Gelegen, C; Chandarana, K; Karra, E; Yousseif, A; Amouyal, C; Choudhury, AI; Andreelli, F; Withers, DJ; Batterham, RL				Scott, William R.; Gelegen, Cigdem; Chandarana, Keval; Karra, Efthimia; Yousseif, Ahmed; Amouyal, Chloe; Choudhury, Agharul I.; Andreelli, Fabrizio; Withers, Dominic J.; Batterham, Rachel L.			Differential Pre-mRNA Splicing Regulates Nnat Isoforms in the Hypothalamus after Gastric Bypass Surgery in Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; BARIATRIC SURGERY; INSULIN-SECRETION; GENE-EXPRESSION; ADIPOSE-TISSUE; BODY-WEIGHT; PC12 CELLS; NEURONATIN; OBESITY; LEPTIN	Background: Neuronatin (NNAT) is an endoplasmic reticulum proteolipid implicated in intracellular signalling. Nnat is highly-expressed in the hypothalamus, where it is acutely regulated by nutrients and leptin. Nnat pre-mRNA is differentially spliced to create Nnat-alpha and -beta isoforms. Genetic variation of NNAT is associated with severe obesity. Currently, little is known about the long-term regulation of Nnat. Methods: Expression of Nnat isoforms were examined in the hypothalamus of mice in response to acute fast/feed, chronic caloric restriction, diet-induced obesity and modified gastric bypass surgery. Nnat expression was assessed in the central nervous system and gastrointestinal tissues. RTqPCR was used to determine isoform-specific expression of Nnat mRNA. Results: Hypothalamic expression of both Nnat isoforms was comparably decreased by overnight and 24-h fasting. Nnat expression was unaltered in diet-induced obesity, or subsequent switch to a calorie restricted diet. Nnat isoforms showed differential expression in the hypothalamus but not brainstem after bypass surgery. Hypothalamic Nnat-beta expression was significantly reduced after bypass compared with sham surgery (P = 0.003), and was positively correlated with post-operative weight-loss (R-2 = 0.38, P = 0.01). In contrast, Nnat-alpha expression was not suppressed after bypass surgery (P = 0.19), and expression did not correlate with reduction in weight after surgery (R-2 = 0.06, P = 0.34). Hypothalamic expression of Nnat-b correlated weakly with circulating leptin, but neither isoform correlated with fasting gut hormone levels post-surgery. Nnat expression was detected in brainstem, brown-adipose tissue, stomach and small intestine. Conclusions: Nnat expression in hypothalamus is regulated by short-term nutrient availability, but unaltered by diet-induced obesity or calorie restriction. While Nnat isoforms in the hypothalamus are co-ordinately regulated by acute nutrient supply, after modified gastric bypass surgery Nnat isoforms show differential expression. These results raise the possibility that in the radically altered nutrient and hormonal milieu created by bypass surgery, resultant differential splicing of Nnat pre-mRNA may contribute to weight-loss.	[Scott, William R.; Gelegen, Cigdem; Chandarana, Keval; Karra, Efthimia; Yousseif, Ahmed; Batterham, Rachel L.] UCL, Obes Res Ctr, Rayne Inst, Dept Med, London, England; [Choudhury, Agharul I.; Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Metab Signalling Grp, Ctr Clin Sci, MRC, London, England; [Amouyal, Chloe; Andreelli, Fabrizio] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Inst Natl Sante & Rech Med,Cardiometab Dept, Paris, France	University of London; King's College London; University College London; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Batterham, RL (corresponding author), UCL, Obes Res Ctr, Rayne Inst, Dept Med, London, England.	r.batterham@ucl.ac.uk	Withers, Dominic J/D-7671-2014	Withers, Dominic J/0000-0002-8009-7521; Scott, William/0000-0001-5467-114X; Batterham, Rachel/0000-0002-5477-8585	Rosetrees Trust; National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC [MC_U120097114, G108/551, MR/K002414/1] Funding Source: UKRI; Medical Research Council [MR/K002414/1, G108/551, MC_U120097114] Funding Source: researchfish; National Institute for Health Research [ACF-2009-18-005] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Rosetrees Trust (http://www.rosetreestrust.co.uk/) and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arava Y, 1999, DIABETES, V48, P552, DOI 10.2337/diabetes.48.3.552; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Chandarana K, 2009, GASTROENTEROLOGY, V136, P2115, DOI 10.1053/j.gastro.2009.02.047; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Gloy VL, 2010, ENDOCRINOLOGY, V151, P4280, DOI 10.1210/en.2010-0439; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; John RM, 2001, DEV BIOL, V236, P387, DOI 10.1006/dbio.2001.0327; JOSEPH R, 1995, BRAIN RES, V690, P92, DOI 10.1016/0006-8993(95)00621-V; Joseph R, 1996, BRAIN RES, V738, P32, DOI 10.1016/0006-8993(96)00768-8; Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kim S, 2007, P NATL ACAD SCI USA, V104, P16627, DOI 10.1073/pnas.0707797104; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Li XZ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-175; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mzhavia N, 2008, DIABETES, V57, P2774, DOI 10.2337/db07-1746; Niwa H, 1997, ENDOCRINOLOGY, V138, P1419, DOI 10.1210/en.138.4.1419; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Scott WR, 2011, AM J PHYSIOL-REG I, V301, pR15, DOI 10.1152/ajpregu.00038.2011; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Simpson KA, 2010, ENDOCRIN METAB CLIN, V39, P729, DOI 10.1016/j.ecl.2010.08.001; Siu IW, 2008, NEURO-ONCOLOGY, V10, P716, DOI 10.1215/15228517-2008-038; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Zheng S, 2002, DEV BRAIN RES, V136, P101, DOI 10.1016/S0165-3806(02)00348-6	45	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59407	10.1371/journal.pone.0059407	http://dx.doi.org/10.1371/journal.pone.0059407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527188	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600071
J	Shirai, A; Masuda, S				Shirai, Atsushi; Masuda, Sunao			Numerical Simulation of Passage of a Neutrophil through a Rectangular Channel with a Moderate Constriction	PLOS ONE			English	Article							CYLINDRICAL CAPILLARY VESSEL; PULMONARY CAPILLARIES; TRANSIT CHARACTERISTICS; MECHANICAL-PROPERTIES; HUMAN-LEUKOCYTES; SHEET-FLOW; BLOOD-FLOW; CELL; LUNG; DEFORMATION	The authors have previously presented a mathematical model to predict transit time of a neutrophil through an alveolar capillary segment which was modeled as an axisymmetric arc-shaped constriction settled in a cylindrical straight pipe to investigate the influence of entrance curvature of a capillary on passage of the cell. The axially asymmetric cross section of a capillary also influences the transit time because it requires three-dimensional deformation of a cell when it passes through the capillary and could lead to plasma leakage between the cell surface and the capillary wall. In this study, a rectangular channel was introduced, the side walls of which were moderately constricted, as a representative of axially asymmetric capillaries. Dependence of transit time of a neutrophil passing through the constriction on the constriction geometry, i.e., channel height, throat width and curvature radius of the constriction, was numerically investigated, the transit time being compared with that through the axisymmetric model. It was found that the transit time is dominated by the throat hydraulic diameter and curvature radius of the constriction and that the throat aspect ratio little affects the transit time with a certain limitation, indicating that if an appropriate curvature radius is chosen, such a rectangular channel model can be substituted for an axisymmetric capillary model having the same throat hydraulic diameter in terms of the transit time by choosing an appropriate curvature radius. Thus, microchannels fabricated by the photolithography technique, whose cross section is generally rectangular, are expected to be applicable to in vitro model experiments of neutrophil retention and passage in the alveolar capillaries.	[Shirai, Atsushi] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi, Japan; [Masuda, Sunao] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shirai, A (corresponding author), Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi, Japan.	shirai@ifs.tohoku.ac.jp			Tohoku University Global COE Program on World Center of Education and Research for Trans-disciplinary Flow Dynamics [JSPS KAKENHI] [17760130, 23560184]	Tohoku University Global COE Program on World Center of Education and Research for Trans-disciplinary Flow Dynamics [JSPS KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Tohoku University Global COE Program on World Center of Education and Research for Trans-disciplinary Flow Dynamics [JSPS KAKENHI Grant Number 17760130 and 23560184 (http://www.jsps.go.jp/english/index.html)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad M, 2010, P 14 INT C MIN SYST, P235; [Anonymous], 1997, BIOMECHANICS CIRCULA; BAGGE U, 1977, ADV MICROCIRCULAT, V7, P29; Bathe M, 2002, BIOPHYS J, V83, P1917, DOI 10.1016/S0006-3495(02)73955-6; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Dhadwal A, 1997, J APPL PHYSIOL, V83, P1711, DOI 10.1152/jappl.1997.83.5.1711; DONG C, 1988, J BIOMECH ENG-T ASME, V110, P27, DOI 10.1115/1.3108402; DOWNEY GP, 1988, J APPL PHYSIOL, V65, P1861, DOI 10.1152/jappl.1988.65.4.1861; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; FENTON BM, 1985, PFLUG ARCH EUR J PHY, V403, P396, DOI 10.1007/BF00589252; FUNG YC, 1972, CIRC RES, V30, P470, DOI 10.1161/01.RES.30.4.470; FUNG YC, 1969, J APPL PHYSIOL, V26, P472, DOI 10.1152/jappl.1969.26.4.472; GEBB SA, 1995, J APPL PHYSIOL, V79, P493, DOI 10.1152/jappl.1995.79.2.493; GUNTHEROTH WG, 1982, J APPL PHYSIOL, V53, P510, DOI 10.1152/jappl.1982.53.2.510; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; HOCHMUTH RM, 1993, BIOPHYS J, V64, P1596, DOI 10.1016/S0006-3495(93)81530-3; HOGG JC, 1988, J APPL PHYSIOL, V65, P1217, DOI 10.1152/jappl.1988.65.3.1217; HOGG JC, 1994, J APPL PHYSIOL, V77, P1795, DOI 10.1152/jappl.1994.77.4.1795; HOGG JC, 1995, ANNU REV PHYSIOL, V57, P97, DOI 10.1146/annurev.ph.57.030195.000525; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; Huang YQ, 2001, J APPL PHYSIOL, V90, P545, DOI 10.1152/jappl.2001.90.2.545; Kan HC, 1999, ANN BIOMED ENG, V27, P648, DOI 10.1114/1.214; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LIEN DC, 1987, J APPL PHYSIOL, V62, P1236, DOI 10.1152/jappl.1987.62.3.1236; PRESSON RG, 1995, J APPL PHYSIOL, V79, P382, DOI 10.1152/jappl.1995.79.2.382; Redenbach DM, 1997, AM J PHYSIOL-LUNG C, V273, pL733, DOI 10.1152/ajplung.1997.273.4.L733; SCHMIDSCHONBEIN GW, 1981, BIOPHYS J, V36, P243, DOI 10.1016/S0006-3495(81)84726-1; Shirai A, 2003, JSME INT J C-MECH SY, V46, P1198, DOI 10.1299/jsmec.46.1198; Shirai A, 2002, JSME INT J C-MECH SY, V45, P974, DOI 10.1299/jsmec.45.974; Shirai A, 2005, P ASME 2005 SUMM BIO; Shirai Atsushi, 2007, Technol Health Care, V15, P131; Shirai Atsushi, 2005, Technol Health Care, V13, P301; SKALAK R, 1990, J BIOMECH ENG-T ASME, V112, P295, DOI 10.1115/1.2891187; SOBIN SS, 1970, CIRC RES, V26, P397, DOI 10.1161/01.RES.26.3.397; TOZEREN A, 1992, BIOPHYS J, V63, P700, DOI 10.1016/S0006-3495(92)81660-0; Tran-Son-Tay R, 1998, MED BIOL ENG COMPUT, V36, P246, DOI 10.1007/BF02510753; TRANSONTAY R, 1994, J BIOMECH ENG-T ASME, V116, P172, DOI 10.1115/1.2895716; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004; YEUNG A, 1989, BIOPHYS J, V56, P139, DOI 10.1016/S0006-3495(89)82659-1; ZHELEV DV, 1994, BIOPHYS J, V67, P696, DOI 10.1016/S0006-3495(94)80529-6	43	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59416	10.1371/journal.pone.0059416	http://dx.doi.org/10.1371/journal.pone.0059416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527190	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600072
J	Chen, GD; Liu, YX; Ma, J; Zheng, Z; Wei, YM; McIntyre, CL; Zheng, YL; Liu, CJ				Chen, Guangdeng; Liu, Yaxi; Ma, Jun; Zheng, Zhi; Wei, Yuming; McIntyre, C. Lynne; Zheng, You-Liang; Liu, Chunji			A Novel and Major Quantitative Trait Locus for Fusarium Crown Rot Resistance in a Genotype of Wild Barley (Hordeum spontaneum L.)	PLOS ONE			English	Article							ESTIMATING DISEASE LOSSES; LINKAGE MAP; BREAD WHEAT; VULGARE L.; PLANT HEIGHT; HEAD BLIGHT; PSEUDOGRAMINEARUM; POPULATION; QTL; SEVERITY	Fusarium crown rot (FCR), caused by various Fusarium species, is a destructive disease of cereal crops in semiarid regions worldwide. As part of our contribution to the development of Fusarium resistant cultivars, we identified several novel sources of resistance by systematically assessing barley genotypes representing different geographical origins and plant types. One of these sources of resistance was investigated in this study by generating and analysing two populations of recombinant inbred lines. A major locus conferring FCR resistance, designated as Qcrs.cpi-4H, was detected in one of the populations (mapping population) and the effects of the QTL was confirmed in the other population. The QTL was mapped to the distal end of chromosome arm 4HL and it is effective against both of the Fusarium isolates tested, one F. pseudograminearum and the other F. graminearum. The QTL explains up to 45.3% of the phenotypic variance. As distinct from an earlier report which demonstrated co-locations of loci conferring FCR resistance and plant height in barley, a correlation between these two traits was not detected in the mapping population. However, as observed in a screen of random genotypes, an association between FCR resistance and plant growth rate was detected and a QTL controlling the latter was detected near the Qcrs.cpi-4H locus in the mapping population. Existing data indicate that, although growth rate may affect FCR resistance, different genes at this locus are likely involved in controlling these two traits.	[Chen, Guangdeng; Liu, Yaxi; Ma, Jun; Zheng, Zhi; McIntyre, C. Lynne; Liu, Chunji] CSIRO Plant Ind, St Lucia, Qld, Australia; [Chen, Guangdeng; Liu, Yaxi; Wei, Yuming; Zheng, You-Liang] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Ma, Jun; Zheng, Zhi] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University; University of Western Australia	Zheng, YL (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China.	ylzheng@sicau.edu.cn; chunji.liu@csiro.au	McIntyre, Cathrine/AAT-9596-2021; Liu, Chunji/B-5243-2009; McIntyre, Cathrine L/F-5782-2011; Zheng, Zhi/C-4110-2017	McIntyre, Cathrine/0000-0002-1991-1299; McIntyre, Cathrine L/0000-0002-1991-1299; Zheng, Zhi/0000-0002-1493-1995	Grains Research and Development Corporation [CSP00149]	Grains Research and Development Corporation(Grains R&D Corp)	This work was supported by the Grains Research and Development Corporation grant CSP00149 (CL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; [Anonymous], 2004, MAPQTL VERSION 5 0 S; Burgess LW, 1996, AUSTRALAS PLANT PATH, V25, P229, DOI 10.1071/AP96042; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Chen GD, 2012, THEOR APPL GENET, V125, P1385, DOI 10.1007/s00122-012-1918-3; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Hogg AC, 2010, PHYTOPATHOLOGY, V100, P49, DOI 10.1094/PHYTO-100-1-0049; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kirkegaard JA, 2004, AUST J AGR RES, V55, P321, DOI 10.1071/AR03178; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Liu YX, 2012, PLANT BREEDING, V131, P728, DOI 10.1111/j.1439-0523.2012.02008.x; Liu YX, 2012, J PHYTOPATHOL, V160, P412, DOI 10.1111/j.1439-0434.2012.01920.x; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Poole GJ, 2012, THEOR APPL GENET, V125, P91, DOI 10.1007/s00122-012-1818-6; Ramsay L, 2000, GENETICS, V156, P1997; Sato K, 2009, HEREDITY, V103, P110, DOI 10.1038/hdy.2009.57; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Van Ooijen JW., 2006, JOINTMAP 4 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Worl A., 1987, WHEAT BREEDING, P129, DOI [10.1007/978-94-009-3131-2_6, DOI 10.1007/978-94-009-3131-2_6]	31	27	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58040	10.1371/journal.pone.0058040	http://dx.doi.org/10.1371/journal.pone.0058040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536780	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100024
J	Lu, XY; Fan, JH; Yan, Y; Wang, XD				Lu, Xuyang; Fan, Jihui; Yan, Yan; Wang, Xiaodan			Responses of Soil CO2 Fluxes to Short-Term Experimental Warming in Alpine Steppe Ecosystem, Northern Tibet	PLOS ONE			English	Article							CARBON-DIOXIDE; TEMPERATURE-DEPENDENCE; BOREAL FOREST; RESPIRATION; EFFLUX; PLANTATION; COMMUNITY; PATTERNS; BALANCE; ENGLAND	Soil carbon dioxide (CO2) emission is one of the largest fluxes in the global carbon cycle. Therefore small changes in the size of this flux can have a large effect on atmospheric CO2 concentrations and potentially constitute a powerful positive feedback to the climate system. Soil CO2 fluxes in the alpine steppe ecosystem of Northern Tibet and their responses to short-term experimental warming were investigated during the growing season in 2011. The results showed that the total soil CO2 emission fluxes during the entire growing season were 55.82 and 104.31 g C m(-2) for the control and warming plots, respectively. Thus, the soil CO2 emission fluxes increased 86.86% with the air temperature increasing 3.74 degrees C. Moreover, the temperature sensitivity coefficient (Q(10)) of the control and warming plots were 2.10 and 1.41, respectively. The soil temperature and soil moisture could partially explain the temporal variations of soil CO2 fluxes. The relationship between the temporal variation of soil CO2 fluxes and the soil temperature can be described by exponential equation. These results suggest that warming significantly promoted soil CO2 emission in the alpine steppe ecosystem of Northern Tibet and indicate that this alpine ecosystem is very vulnerable to climate change. In addition, soil temperature and soil moisture are the key factors that controls soil organic matter decomposition and soil CO2 emission, but temperature sensitivity significantly decreases due to the rise in temperature.	[Lu, Xuyang; Fan, Jihui; Yan, Yan; Wang, Xiaodan] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China; [Lu, Xuyang; Fan, Jihui] Chinese Acad Sci, Inst Mt Hazards & Environm, Wetland Ecosyst Observat & Expt Stn, Xainza, Tibet, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Lu, XY (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China.	xylu@imde.ac.cn; wxd@imde.ac.cn		Lu, Xuyang/0000-0001-6653-6009	National Natural Science Foundation of China [41001177, 41201053]; One Hundred Young Persons Project of Institute of Mountain Hazards and Environment [SDSQB-2010-02]; 135 Strategic Program of the Institute of Mountain Hazards and Environment [sds-135-1203-03]; Action-plan of the Chinese Academy of Sciences (CAS) for West Development [KZCX2-XB3-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Young Persons Project of Institute of Mountain Hazards and Environment; 135 Strategic Program of the Institute of Mountain Hazards and Environment; Action-plan of the Chinese Academy of Sciences (CAS) for West Development	This work was supported by the National Natural Science Foundation of China (Grant No. 41001177 and 41201053), the One Hundred Young Persons Project of Institute of Mountain Hazards and Environment (Grant No. SDSQB-2010-02), the 135 Strategic Program of the Institute of Mountain Hazards and Environment (Grant No. sds-135-1203-03), and the Action-plan of the Chinese Academy of Sciences (CAS) for West Development (Grant No. KZCX2-XB3-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril A, 2005, FOREST ECOL MANAG, V206, P399, DOI 10.1016/j.foreco.2004.11.014; Alm J, 1999, ECOLOGY, V80, P161, DOI 10.1890/0012-9658(1999)080[0161:CBOABB]2.0.CO;2; Almagro M, 2009, SOIL BIOL BIOCHEM, V41, P594, DOI 10.1016/j.soilbio.2008.12.021; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Bronson DR, 2008, GLOBAL CHANGE BIOL, V14, P856, DOI 10.1111/j.1365-2486.2007.01508.x; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Cross A, 2010, GEODERMA, V157, P126, DOI 10.1016/j.geoderma.2010.04.003; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Falk M, 2005, AGR FOREST METEOROL, V135, P269, DOI 10.1016/j.agrformet.2005.12.005; Gao QZ, 2010, QUATERN INT, V226, P143, DOI 10.1016/j.quaint.2009.10.035; Gao QZ, 2009, RESTOR ECOL, V17, P320, DOI 10.1111/j.1526-100X.2009.00527.x; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Hirota M, 2006, ECOSYSTEMS, V9, P673, DOI 10.1007/s10021-006-0029-x; Hollister RD, 2006, ARCT ANTARCT ALP RES, V38, P206, DOI 10.1657/1523-0430(2006)38[206:STATRT]2.0.CO;2; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; King AJ, 2008, SOIL BIOL BIOCHEM, V40, P2605, DOI 10.1016/j.soilbio.2008.06.026; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Lu XY, 2012, ARCT ANTARCT ALP RES, V44, P188, DOI 10.1657/1938-4246-44.2.188; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Pihlatie M, 2007, TELLUS B, V59, P458, DOI 10.1111/j.1600-0889.2007.00278.x; Pregitzer K, 2006, OECOLOGIA, V148, P503, DOI 10.1007/s00442-006-0381-8; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Schindlbacher A, 2008, PLANT SOIL, V303, P323, DOI 10.1007/s11104-007-9511-2; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Shi PL, 2006, AGR FOREST METEOROL, V137, P220, DOI 10.1016/j.agrformet.2006.02.008; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sullivan B, 2008, FOREST ECOL MANAG, V255, P4047, DOI 10.1016/j.foreco.2008.03.051; Taneva L, 2006, GLOBAL CHANGE BIOL, V12, P983, DOI 10.1111/j.1365-2486.2006.01147.x; Van Oijen M, 1999, GLOB CHANGE BIOL, V5, P411, DOI 10.1046/j.1365-2486.1999.00233.x; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wu G, 2007, COLLOID SURFACE B, V60, P250, DOI 10.1016/j.colsurfb.2007.06.022; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	47	41	44	12	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59054	10.1371/journal.pone.0059054	http://dx.doi.org/10.1371/journal.pone.0059054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536854	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100115
J	Morel, CM; Thang, ND; Erhart, A; Xa, NX; Grietens, KP; Hung, LX; Thuan, LK; Ky, PV; Hung, NM; Coosemans, M; D'Alessandro, U; Mills, A				Morel, Chantal M.; Ngo Duc Thang; Erhart, Annette; Nguyen Xuan Xa; Grietens, Koen Peeters; Le Xuan Hung; Le Khan Thuan; Pham Van Ky; Nguyen Manh Hung; Coosemans, Marc; D'Alessandro, Umberto; Mills, Anne			Cost-Effectiveness of Long-Lasting Insecticide-Treated Hammocks in Preventing Malaria in South-Central Vietnam	PLOS ONE			English	Article							FOREST MALARIA; NETS; CHALLENGE; MORTALITY; TRIAL	Background: Despite much success in reducing the burden of malaria in Vietnam, pockets of malaria persist and eliminating them remains an important development goal. In central Vietnam, insecticide-treated hammocks have recently been introduced to help counter the disease in the highly forested, mountainous areas, where other measures have so far been unsuccessful. This study assesses the cost-effectiveness of using long-lasting insecticide-treated hammocks in this area. Methods and Findings: This cost-effectiveness study was run alongside a randomized control trial testing the efficacy of the long-lasting insecticide-treated hammocks. Data were collected through an exit survey, a household survey, expenditure records and key informant interviews. The study estimates that under normal (non-trial) conditions the total net societal cost per malaria episode averted in using long-lasting insecticide-treated hammocks in this area was 126 USD. Cost per hammock, including insecticidal netting, sewing, transport, and distribution was found to be approximately 11.76 USD per hammock. Average savings per episode averted were estimated to be $14.60 USD for the health system and 14.37 USD for households (including both direct and indirect cost savings). The study estimates that the annual financial outlay required of government to implement this type of programme to be 3.40 USD per person covered per year. Conclusion: The study finds that the use of a hammock intervention could represent good value for money to help prevent malaria in more remote areas, where traditional control measures such as insecticide-treated bednets and indoor residual spraying are insufficient or inappropriate to control malaria. However, the life span of the hammock-the number of years over which it effectively deters mosquitoes-has a significant impact on the cost-effectiveness of the intervention and study results should be interpreted in light of the evidence on effectiveness gathered in the years to come.	[Morel, Chantal M.] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England; [Ngo Duc Thang; Nguyen Xuan Xa; Le Xuan Hung; Le Khan Thuan; Nguyen Manh Hung] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, Annette; Grietens, Koen Peeters; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Pham Van Ky] Ninh Thuan Prov Ctr Malariol Parasitol & Entomol, Phan Rang, Vietnam; [Mills, Anne] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School Economics & Political Science; Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine	Morel, CM (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	C.M.Morel@lse.ac.uk	D'Alessandro, Umberto/D-3457-2015; Peeters Grietens, Koen/G-7028-2019; Morel, Chantal M/R-8243-2017	D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Morel, Chantal M/0000-0003-3984-9741; Mills, Anne/0000-0001-9863-9950	Belgium Corporation; Belgian Corporation	Belgium Corporation; Belgian Corporation	Grant provided by Belgium Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; It should be noted that the funding for this project came from a commercial establishment (Belgian Corporation), however, the authors have no ties with the establishment in terms of employment, consultancy, patents, products in development or marketed products, etc. Also, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bhatia MR, 2004, SOC SCI MED, V59, P525, DOI 10.1016/j.socscimed.2003.11.005; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Goodman CA, HLTH POLICY PLAN, V14, P301; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Grietens KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-23; Kamolratanakul P, 2001, AM J TROP MED HYG, V65, P279, DOI 10.4269/ajtmh.2001.65.279; Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x; Markwardt R, 2008, THAILAND SE ASIAN S1, V39; Morel CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-166; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; *NIMPE, 2008, ANN REP NAT MAL CONT; Peeters Grietens K, 2005, SOCIOCULTURAL STUDY; PICARD J, 1993, T ROY SOC TROP MED H, V87, P53, DOI 10.1016/0035-9203(93)90176-Q; Prothero RM, 1999, SINGAPORE J TROP GEO, V20, P76, DOI 10.1111/1467-9493.00044; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Thang ND, 2008, MALARIA CENTRAL VIET; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x	21	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58205	10.1371/journal.pone.0058205	http://dx.doi.org/10.1371/journal.pone.0058205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536790	gold, Green Published, Green Accepted			2022-12-27	WOS:000316251100033
J	Calzada, JE; Saldana, A; Rigg, C; Valderrama, A; Romero, L; Chaves, LF				Calzada, Jose E.; Saldana, Azael; Rigg, Chystrie; Valderrama, Anayansi; Romero, Luz; Fernando Chaves, Luis			Changes in Phlebotomine Sand Fly Species Composition Following Insecticide Thermal Fogging in a Rural Setting of Western Panama	PLOS ONE			English	Article							FLIES DIPTERA PSYCHODIDAE; AMERICAN TEGUMENTARY LEISHMANIASIS; NEOTROPICAL RAIN-FOREST; CUTANEOUS LEISHMANIASIS; ENDEMIC AREA; VISCERAL LEISHMANIASIS; VESICULAR STOMATITIS; LIGHT-TRAPS; SANDFLIES; DIVERSITY	American Cutaneous Leishmaniasis, ACL, is a zoonotic disease with a large richness of co-occurring vector species in transmission foci. Here, we describe changes in patterns of phlebotomine sand fly (Diptera: Psychodidae: Phlebotominae) species composition at the village of Trinidad de Las Minas, Capira, Panama, a hyperendemic focus of ACL transmission, subjected to a vector control intervention with insecticide thermal fogging (ITF). Our study setting consisted of 24 houses, 12 subjected to two rounds of ITF and 12 kept as control. During 15 months (April 2010- June 2011) we monitored sand fly species composition and abundance with modified HP light traps inside (domicile) and outside (peridomicile) the studied houses. From 5628 sand flies collected, we were able to identify 5617 of the samples into 24 species, a number of species close to 25 +/- 1.6, the estimate from the Chao2 Index. The most abundant species were Lutzomya trapidoi (20%), Lu. gomezi (20%) and Lu. triramula (20%). Cluster analyses showed that most of the 24 houses had high similarity in relative abundance patterns of the six most common species, with only few peripheral houses not following the main cluster pattern. We also found that species richness was decreased to 22 species in the fogged houses, of which only 19 were found in the domiciliary environment. Changes in species richness were especially notorious at the end of the wet season. Our results suggest that species richness can decrease following ITF in domiciliary environments, primarily affecting the less common species.	[Calzada, Jose E.; Saldana, Azael; Rigg, Chystrie; Romero, Luz] Inst Conmemorativo Gorgas Estudios Salud, Dept Parasitol, Panama City, Panama; [Valderrama, Anayansi] Inst Conmemorativo Gorgas Estudios Salud, Dept Entomol, Panama City, Panama; [Fernando Chaves, Luis] Univ Nacl, Programa Invest Enfermedades Trop, Heredia, Costa Rica; [Fernando Chaves, Luis] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan	Instituto Conmemorativo Gorgas de Estudios de la Salud; Instituto Conmemorativo Gorgas de Estudios de la Salud; Universidad Nacional Costa Rica; Hokkaido University	Chaves, LF (corresponding author), Univ Nacl, Programa Invest Enfermedades Trop, Heredia, Costa Rica.	lchaves@ees.hokudai.ac.jp	Valderrama, Anayansi/AAX-9196-2021; Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Rigg, Chystrie A./0000-0002-2426-6511; Saldana, Azael/0000-0002-5653-1332	SENACYT grant [CCP06-040]; Netropica grant [04-N-2010]; Nagasaki University Cooperative Grant; Japan Society for the Promotion of Science	SENACYT grant; Netropica grant; Nagasaki University Cooperative Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work received financial support from SENACYT grant CCP06-040, Netropica grant 04-N-2010, Nagasaki University Cooperative Grant and Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER B, 1995, AM J TROP MED HYG, V52, P354, DOI 10.4269/ajtmh.1995.52.354; Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; ALEXANDER B, 1995, MED VET ENTOMOL, V9, P273, DOI 10.1111/j.1365-2915.1995.tb00133.x; Alexander B, 2001, MED VET ENTOMOL, V15, P364, DOI 10.1046/j.0269-283x.2001.00322.x; ALEXANDER JB, 1987, J MED ENTOMOL, V24, P552, DOI 10.1093/jmedent/24.5.552; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Carvalho GML, 2010, J MED ENTOMOL, V47, P972, DOI 10.1603/ME09127; CHANIOTIS BN, 1971, J MED ENTOMOL, V8, P339, DOI 10.1093/jmedent/8.4.339; CHANIOTIS BN, 1983, J MED ENTOMOL, V20, P222, DOI 10.1093/jmedent/20.2.222; CHANIOTIS BN, 1982, J MED ENTOMOL, V19, P1, DOI 10.1093/jmedent/19.1.1; CHANIOTIS BN, 1972, J MED ENTOMOL, V9, P91, DOI 10.1093/jmedent/9.1.91; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Chaves LF, 2004, ACTA TROP, V92, P219, DOI 10.1016/j.actatropica.2004.08.001; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; Christensen HA, 1999, AM J TROP MED HYG, V60, P54, DOI 10.4269/ajtmh.1999.60.54; CHRISTENSEN HA, 1983, J MED ENTOMOL, V20, P463, DOI 10.1093/jmedent/20.5.463; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Carvalho GMD, 2011, J MED ENTOMOL, V48, P764, DOI 10.1603/ME10258; Faiman R, 2009, J VECTOR ECOL, V34, P114, DOI 10.1111/j.1948-7134.2009.00014.x; FAIRCHILD G. B., 1959, ANN ENT SOC AMER, V52, P121, DOI 10.1093/aesa/52.2.121; FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P119, DOI 10.1590/S0074-02761987000100019; FELICIANGELI M D, 1988, Memorias do Instituto Oswaldo Cruz, V83, P393, DOI 10.1590/S0074-02761988000300019; FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P125, DOI 10.1590/S0074-02761987000100020; FELICIANGELI MD, 1994, MED VET ENTOMOL, V8, P317, DOI 10.1111/j.1365-2915.1994.tb00095.x; Chaves LF, 2011, B MALARIOL SALUD AMB, V51, P35; FERRO C, 1995, J MED ENTOMOL, V32, P527, DOI 10.1093/jmedent/32.4.527; Galati EAB, 2001, MEM I OSWALDO CRUZ, V96, P641, DOI 10.1590/S0074-02762001000500008; Geiser RM, 2010, B ENTOMOL RES, V100, P153, DOI 10.1017/S0007485309006919; HERRER A, 1975, SCIENCE, V190, P154, DOI 10.1126/science.1101379; HERRERO MV, 1994, J MED ENTOMOL, V31, P912, DOI 10.1093/jmedent/31.6.912; Jimenez AE, 2000, J MED ENTOMOL, V37, P216, DOI 10.1603/0022-2585-37.2.216; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kirby MJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-33; Krebs CJ, 1998, ECOLOGICAL METHODOLO, V2; LAWYER PG, 1987, J MED ENTOMOL, V24, P347, DOI 10.1093/jmedent/24.3.347; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; Miranda A, 2009, AM J TROP MED HYG, V81, P565, DOI 10.4269/ajtmh.2009.08-0265; MORRISON AC, 1993, J MED ENTOMOL, V30, P427, DOI 10.1093/jmedent/30.2.427; Pinto IS, 2010, J VECTOR ECOL, V35, P325, DOI 10.1111/j.1948-7134.2010.00090.x; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Quintana MG, 2010, J MED ENTOMOL, V47, P1003, DOI 10.1603/ME09072; Rotureau B, 2006, AM J TROP MED HYG, V75, P62, DOI 10.4269/ajtmh.2006.75.62; RUTLEDGE LC, 1975, ENVIRON ENTOMOL, V4, P71, DOI 10.1093/ee/4.1.71; RUTLEDGE LC, 1976, ENVIRON ENTOMOL, V5, P1149, DOI 10.1093/ee/5.6.1149; RUTLEDGE LC, 1975, J MED ENTOMOL, V12, P179, DOI 10.1093/jmedent/12.2.179; Salomon OD, 2004, J MED ENTOMOL, V41, P33, DOI 10.1603/0022-2585-41.1.33; Salomon OD, 2003, MEM I OSWALDO CRUZ, V98, P185, DOI 10.1590/S0074-02762003000200004; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P578, DOI 10.1590/S0074-02762008000600011; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P282, DOI 10.1590/S0074-02762008005000016; Schmidtmann ET, 2002, J MED ENTOMOL, V39, P680, DOI 10.1603/0022-2585-39.4.680; Fernandez MS, 2012, ACTA TROP, V122, P16, DOI 10.1016/j.actatropica.2011.11.006; Travi BL, 2002, J MED ENTOMOL, V39, P451, DOI 10.1603/0022-2585-39.3.451; Valderrama A, 2011, MEM I OSWALDO CRUZ, V106, P1024, DOI 10.1590/S0074-02762011000800021; Wheeler AS, 1996, MED VET ENTOMOL, V10, P295, DOI 10.1111/j.1365-2915.1996.tb00747.x; Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162; Young DG, 1994, GUIDE IDENTIFICATION	61	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53289	10.1371/journal.pone.0053289	http://dx.doi.org/10.1371/journal.pone.0053289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23536748	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500059
J	Adler, M; Murani, E; Brunner, R; Ponsuksili, S; Wimmers, K				Adler, Marcel; Murani, Eduard; Brunner, Ronald; Ponsuksili, Siriluck; Wimmers, Klaus			Transcriptomic Response of Porcine PBMCs to Vaccination with Tetanus Toxoid as a Model Antigen	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; INTERFERON-GAMMA; IMMUNE-RESPONSE; UP-REGULATION; SELECTION; BLOOD; STIMULATION; CELLS; QTL	The aim of the present study was to characterize in vivo genome-wide transcriptional responses to immune stimulation in order to get insight into the resulting changes of allocation of resources. Vaccination with tetanus toxoid was used as a model for a mixed Th1 and Th2 immune response in pig. Expression profiles of PBMCs (peripheral blood mononuclear cells) before and at 12 time points over a period of four weeks after initial and booster vaccination at day 14 were studied by use of Affymetrix GeneChip microarrays and Ingenuity Pathway Analysis (IPA). The transcriptome data in total comprised more than 5000 genes with different transcript abundances (DE-genes). Within the single time stages the numbers of DE-genes were between several hundred and more than 1000. Ingenuity Pathway Analysis mainly revealed canonical pathways of cellular immune response and cytokine signaling as well as a broad range of processes in cellular and organismal growth, proliferation and development, cell signaling, biosynthesis and metabolism. Significant changes in the expression profiles of PBMCs already occurred very early after immune stimulation. At two hours after the first vaccination 679 DE-genes corresponding to 110 canonical pathways of cytokine signaling, cellular immune response and other multiple cellular functions were found. Immune competence and global disease resistance are heritable but difficult to measure and to address by breeding. Besides QTL mapping of immune traits gene expression profiling facilitates the detection of functional gene networks and thus functional candidate genes.	[Adler, Marcel; Murani, Eduard; Brunner, Ronald; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Grp Funct Genome Anal, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study is part of the project GeneDialog (FUGATOplus, FKZ 0315130 A) which is funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi In-Soo, 2002, J Vet Sci, V3, P97; Edfors-Lilja I, 1998, J IMMUNOL, V161, P829; ELGHAZALI GEB, 1993, EUR J IMMUNOL, V23, P2740, DOI 10.1002/eji.1830231103; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Huang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028768; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; LOGGEN HG, 1983, J MED PRIMATOL, V12, P192; Mallard BA, 1998, P 6 WORLD C GEN APPL; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Ojha S, 2008, VET RES, V39, DOI 10.1051/vetres:2007042; Ponsuksili S, 2008, DEV BIOLOGICALS, V132, P185, DOI 10.1159/000317159; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Regnstrom K., 2002, Pharmacogenomics Journal, V2, P57, DOI 10.1038/sj.tpj.6500080; Regnstrom K, 2003, VACCINE, V21, P2307, DOI 10.1016/S0264-410X(03)00103-8; Reiner G, 2009, APPL ANIM BEHAV SCI, V118, P217, DOI 10.1016/j.applanim.2009.02.011; Robinson K, 2004, INFECT IMMUN, V72, P2753, DOI 10.1128/IAI.72.5.2753-2761.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suradhat S, 2003, J GEN VIROL, V84, P2755, DOI 10.1099/vir.0.19230-0; Suradhat S, 2003, J GEN VIROL, V84, P453, DOI 10.1099/vir.0.18698-0; Swaggerty CL, 2009, FOODBORNE PATHOG DIS, V6, P777, DOI 10.1089/fpd.2009.0307; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Uddin MJ, 2010, MAMM GENOME, V21, P409, DOI 10.1007/s00335-010-9269-3; Wang YF, 2007, GENOMICS, V90, P72, DOI 10.1016/j.ygeno.2007.03.018; Wang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-437; Wattrang E, 2005, ANIM GENET, V36, P337, DOI 10.1111/j.1365-2052.2005.01315.x; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Wilkie BN, 1997, PROGRESS IN PIG SCIENCE, P29; Wilkinson JM, 2012, J ANIM SCI; Wimmers K, 2009, INT J IMMUNOGENET, V36, P141, DOI 10.1111/j.1744-313X.2009.00838.x; Yancy H, 2001, VET IMMUNOL IMMUNOP, V79, P41, DOI 10.1016/S0165-2427(01)00247-1	35	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58306	10.1371/journal.pone.0058306	http://dx.doi.org/10.1371/journal.pone.0058306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536793	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200006
J	Steinweg, JM; Jagadamma, S; Frerichs, J; Mayes, MA				Steinweg, J. Megan; Jagadamma, Sindhu; Frerichs, Joshua; Mayes, Melanie A.			Activation Energy of Extracellular Enzymes in Soils from Different Biomes	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; THERMODYNAMIC PARAMETERS; PSYCHROPHILIC ENZYMES; THEORETICAL-MODEL; PHENOL OXIDASE; KINETICS; PEROXIDASE; DECOMPOSITION; LACCASE; CARBON	Enzyme dynamics are being incorporated into soil carbon cycling models and accurate representation of enzyme kinetics is an important step in predicting belowground nutrient dynamics. A scarce number of studies have measured activation energy (E-a) in soils and fewer studies have measured E-a in arctic and tropical soils, or in subsurface soils. We determined the E-a for four typical lignocellulose degrading enzymes in the A and B horizons of seven soils covering six different soil orders. We also elucidated which soil properties predicted any measurable differences in E-a. beta-glucosidase, cellobiohydrolase, phenol oxidase and peroxidase activities were measured at five temperatures, 4, 21, 30, 40, and 60 degrees C. E-a was calculated using the Arrhenius equation. b-glucosidase and cellobiohydrolase E-a values for both A and B horizons in this study were similar to previously reported values, however we could not make a direct comparison for B horizon soils because of the lack of data. There was no consistent relationship between hydrolase enzyme E-a and the environmental variables we measured. Phenol oxidase was the only enzyme that had a consistent positive relationship between E-a and pH in both horizons. The E-a in the arctic and subarctic zones for peroxidase was lower than the hydrolases and phenol oxidase values, indicating peroxidase may be a rate limited enzyme in environments under warming conditions. By including these six soil types we have increased the number of soil oxidative enzyme E-a values reported in the literature by 50%. This study is a step towards better quantifying enzyme kinetics in different climate zones.	[Steinweg, J. Megan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Steinweg, J. Megan; Jagadamma, Sindhu; Mayes, Melanie A.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Jagadamma, Sindhu; Mayes, Melanie A.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA; [Frerichs, Joshua] Univ Tennessee, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Steinweg, JM (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	steinwegjm@ornl.gov	Jagadamma, Sindhu/F-7168-2012	Jagadamma, Sindhu/0000-0003-4831-3308	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL) [DE-AC05-00OR22725]; U.S. Government [DE-AC05-00OR22725]	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Government	This research was funded by the Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL), managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. Collection and processing of soil samples from Brazil was supported by CNPq. The submitted manuscript has been authored by a contractor of the U.S. Government under contract DE-AC05-00OR22725. Accordingly, the U.S. Government retains a nonexclusive, royalty-free license to publish or reproduce the published form of this contribution, or allow others to do so, for U. S. Government purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas N, 2001, BIORESOURCE TECHNOL, V80, P29, DOI 10.1016/S0960-8524(01)00063-3; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BROWNPETERSON NJ, 1993, J BACTERIOL, V175, P4197, DOI 10.1128/JB.175.13.4197-4202.1993; BURNS RG, 1986, SPECIAL PUBLICATION, V1, P429; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Dane JD, 2004, HYDROMETER METHOD 4, P278; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P1347, DOI 10.1016/0038-0717(94)90216-X; Di Nardo C, 2004, SOIL BIOL BIOCHEM, V36, P1539, DOI 10.1016/j.soilbio.2004.07.013; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Feller G, 2003, CELL MOL LIFE SCI, V60, P648, DOI 10.1007/s00018-003-2155-3; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Ghori MI, 2011, BRAZ J MICROBIOL, V42, P22, DOI 10.1590/S1517-83822011000100003; GIANFREDA L, 1992, SOIL BIOL BIOCHEM, V24, P51, DOI 10.1016/0038-0717(92)90241-O; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Goncalves EM, 2007, J FOOD ENG, V81, P693, DOI 10.1016/j.jfoodeng.2007.01.011; HEWSON WD, 1975, CAN J CHEM, V53, P1928, DOI 10.1139/v75-268; Hochachka P. W., 1984, BIOCH ADAPTATION; Huston AL, 2000, ENVIRON MICROBIOL, V2, P383, DOI 10.1046/j.1462-2920.2000.00118.x; Koch O, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002983; KUZNETSOV AM, 1987, FEBS LETT, V215, P219, DOI 10.1016/0014-5793(87)80149-7; Lawrence CR, 2009, SOIL BIOL BIOCHEM, V41, P1923, DOI 10.1016/j.soilbio.2009.06.016; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; MCCLAUGHERTY CA, 1990, SOIL BIOL BIOCHEM, V22, P29, DOI 10.1016/0038-0717(90)90056-6; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nannipieri P., 1996, HUMIC SUBSTANCES TER, P293, DOI DOI 10.1016/B978-044481516-3/50008-6; Niemetz R, 2003, PHYTOCHEMISTRY, V62, P301, DOI 10.1016/S0031-9422(02)00557-5; Parham JA, 2000, SOIL BIOL BIOCHEM, V32, P1183, DOI 10.1016/S0038-0717(00)00034-1; Quiquampoix H, 2000, BOOK SOIL P, P171; SARKAR JM, 1989, SOIL BIOL BIOCHEM, V21, P223, DOI 10.1016/0038-0717(89)90098-9; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Shi W, 2011, SOIL BIOL, V22, P43, DOI 10.1007/978-3-642-14225-3_3; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Steinweg JM, 2008, SOIL BIOL BIOCHEM, V40, P2722, DOI 10.1016/j.soilbio.2008.07.002; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Stursova M, 2011, PLANT SOIL, V338, P99, DOI 10.1007/s11104-010-0296-3; Toscano G, 2003, ENZYME MICROB TECH, V33, P47, DOI 10.1016/S0141-0229(03)00080-2; Trasar-Cepeda C, 2007, SOIL BIOL BIOCHEM, V39, P311, DOI 10.1016/j.soilbio.2006.08.002; Wallenstein M, 2011, SOIL BIOL, V22, P245, DOI 10.1007/978-3-642-14225-3_13; Wallenstein MD, 2008, SOIL BIOL BIOCHEM, V40, P2098, DOI 10.1016/j.soilbio.2008.01.024; Wang G, 2012, ECOLOGICAL IN PRESS; Wang GS, 2012, FEMS MICROBIOL ECOL, V81, P610, DOI 10.1111/j.1574-6941.2012.01389.x; Wang GS, 2012, SOIL BIOL BIOCHEM, V48, P28, DOI 10.1016/j.soilbio.2012.01.011; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	49	37	38	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59943	10.1371/journal.pone.0059943	http://dx.doi.org/10.1371/journal.pone.0059943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536898	gold, Green Published			2022-12-27	WOS:000317397200046
J	Hsu, YH; Dumlao, DS; Cao, J; Dennis, EA				Hsu, Yuan-Hao; Dumlao, Darren S.; Cao, Jian; Dennis, Edward A.			Assessing Phospholipase A(2) Activity toward Cardiolipin by Mass Spectrometry	PLOS ONE			English	Article							CYTOCHROME-C; HEART; INHIBITION; MITOCHONDRIA; MECHANISM; RELEASE; LUPUS; HYDROLYSIS; ANTIBODIES; DECREASE	Cardiolipin, a major component of mitochondria, is critical for mitochondrial functioning including the regulation of cytochrome c release during apoptosis and proper electron transport. Mitochondrial cardiolipin with its unique bulky amphipathic structure is a potential substrate for phospholipase A(2) (PLA(2)) in vivo. We have developed mass spectrometric methodology for analyzing PLA(2) activity toward various cardiolipin forms and demonstrate that cardiolipin is a substrate for sPLA(2), cPLA(2) and iPLA(2), but not for Lp-PLA(2). Our results also show that none of these PLA(2)s have significant PLA(1) activities toward dilyso-cardiolipin. To understand the mechanism of cardiolipin hydrolysis by PLA(2), we also quantified the release of monolyso-cardiolipin and dilyso-cardiolipin in the PLA(2) assays. The sPLA(2)s caused an accumulation of dilyso-cardiolipin, in contrast to iPLA(2) which caused an accumulation of monolyso-cardiolipin. Moreover, cardiolipin inhibits iPLA(2) and cPLA(2), and activates sPLA(2) at low mol fractions in mixed micelles of Triton X-100 with the substrate 1-palmitoyl-2-arachidonyl-sn-phosphtidylcholine. Thus, cardiolipin functions as both a substrate and a regulator of PLA(2) activity and the ability to assay the various forms of PLA(2) is important in understanding its function.	[Hsu, Yuan-Hao] Tunghai Univ, Dept Chem, Taichung 40704, Taiwan; [Hsu, Yuan-Hao; Dumlao, Darren S.; Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Dumlao, Darren S.; Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Tunghai University; University of California System; University of California San Diego; University of California System; University of California San Diego	Hsu, YH (corresponding author), Tunghai Univ, Dept Chem, Taichung 40704, Taiwan.	howardhsu@thu.edu.tw; edennis@ucsd.edu	hsu, yuan-hao/B-5744-2009; Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	LIPID [U54 GM 069338, RO-1 GM 50, 501-38]; National Science Council, Taiwan [101-2113-M-029-001-MY2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM020501] Funding Source: NIH RePORTER	LIPID; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the LIPID MAPS Large Scale Collaborative "Glue" Grant U54 GM 069338 and RO-1 GM 50,501-38 to EAD, and National Science Council, Taiwan (101-2113-M-029-001-MY2) to YHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Barbayianni E, 2009, BIOORGAN MED CHEM, V17, P4833, DOI 10.1016/j.bmc.2009.03.069; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buckland AG, 1998, BBA-LIPID LIPID MET, V1390, P65, DOI 10.1016/S0005-2760(97)00170-7; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CIRINO G, 1989, EUR J PHARMACOL, V166, P505, DOI 10.1016/0014-2999(89)90364-6; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; DAMERAU B, 1975, N-S ARCH PHARMACOL, V287, P141, DOI 10.1007/BF00510446; Deguchi H, 2000, P NATL ACAD SCI USA, V97, P1743, DOI 10.1073/pnas.97.4.1743; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; EBLE KS, 1990, J BIOL CHEM, V265, P19434; EDWARDS T, 1993, LANCET, V342, P989, DOI 10.1016/0140-6736(93)92035-R; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; HARRIS EN, 1984, CLIN EXP RHEUMATOL, V2, P47; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; HUGHES GRV, 1983, BRIT MED J, V287, P1088, DOI 10.1136/bmj.287.6399.1088; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kokotos G, 2010, J MED CHEM, V53, P3602, DOI 10.1021/jm901872v; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Liou JY, 2005, EXP CELL RES, V306, P75, DOI 10.1016/j.yexcr.2005.01.011; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; MARINETTI GV, 1964, BIOCHIM BIOPHYS ACTA, V84, P55, DOI 10.1016/0926-6542(64)90100-3; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1; PAWLOSKY RJ, 1992, J LIPID RES, V33, P1711; Rand JH, 1998, BLOOD, V92, P1652, DOI 10.1182/blood.V92.5.1652.417k21_1652_1660; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646	46	43	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59267	10.1371/journal.pone.0059267	http://dx.doi.org/10.1371/journal.pone.0059267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533611	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400048
J	Agudelo, D; Sanyakamdhorn, S; Nafisi, S; Tajmir-Riahi, HA				Agudelo, Daniel; Sanyakamdhorn, Sriwanna; Nafisi, Shoherh; Tajmir-Riahi, Heidar-Ali			Transporting Antitumor Drug Tamoxifen and Its Metabolites, 4-Hydroxytamoxifen and Endoxifen by Chitosan Nanoparticles	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; DENDRIMERS; DELIVERY; CYP2D6	Synthetic and natural polymers are often used as drug delivery systems in vitro and in vivo. Biodegradable chitosan of different sizes were used to encapsulate antitumor drug tamoxifen (Tam) and its metabolites 4-hydroxytamoxifen (4-Hydroxytam) and endoxifen (Endox). The interactions of tamoxifen and its metabolites with chitosan 15, 100 and 200 KD were investigated in aqueous solution, using FTIR, fluorescence spectroscopic methods and molecular modeling. The structural analysis showed that tamoxifen and its metabolites bind chitosan via both hydrophilic and hydrophobic contacts with overall binding constants of Ktam-ch-15 = 8.7 (+/- 0.5) x 10(3) M-1, Ktam-ch-100 = 5.9 (+/- 0.4) x 10(5) M-1, Ktam-ch-200 = 2.4 (+/- 0.4) x 10(5) M-1 and Khydroxytam-ch-15 = 2.6(+/- 0.3) x 10(4) M-1, Khydroxytam - ch-100 = 5.2 (+/- 0.7) x 10(6) M-1 and Khydroxytam-ch-200 = 5.1 (+/- 0.5) x 10(5) M-1, Kendox-ch-15 = 4.1 (+/- 0.4) x 10(3) M-1, Kendox-ch-100 = 1.2 (+/- 0.3) x 10(6) M-1 and Kendox-ch-200 = 4.7 (+/- 0.5) x 10(5) M-1 with the number of drug molecules bound per chitosan (n) 2.8 to 0.5. The order of binding is ch-100>200>15 KD with stronger complexes formed with 4-hydroxytamoxifen than tamoxifen and endoxifen. The molecular modeling showed the participation of polymer charged NH2 residues with drug OH and NH2 groups in the drug-polymer adducts. The free binding energies of -3.46 kcal/mol for tamoxifen, -3.54 kcal/mol for 4-hydroxytamoxifen and -3.47 kcal/mol for endoxifen were estimated for these drug-polymer complexes. The results show chitosan 100 KD is stronger carrier for drug delivery than chitosan-15 and chitosan-200 KD.	[Agudelo, Daniel; Sanyakamdhorn, Sriwanna; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Biol Chem, Trois Rivieres, PQ GA9 5H7, Canada; [Nafisi, Shoherh] San Jose State Univ, Dept Chem, San Jose, CA 95192 USA	University of Quebec; University of Quebec Trois Rivieres; California State University System; San Jose State University	Nafisi, S (corresponding author), San Jose State Univ, Dept Chem, San Jose, CA 95192 USA.	drshnafisi@gmail.com; heidar-ali.tajmir-riahi@uqtr.ca		Agudelo Pinto, Daniel Steven/0000-0002-8794-4279	NSERC (Natural Science and Engineering Research Council of Canada) Canada	NSERC (Natural Science and Engineering Research Council of Canada) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC (Natural Science and Engineering Research Council of Canada) Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Bijl MJ, 2009, BREAST CANCER RES TR, V118, P125, DOI 10.1007/s10549-008-0272-2; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; Brauch H, 2009, EUR J CANCER, V45, P2274, DOI 10.1016/j.ejca.2009.05.032; Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8; Charbonneau DM, 2010, J PHYS CHEM B, V114, P1148, DOI 10.1021/jp910077h; Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Engelke M, 2001, BIOPHYS CHEM, V90, P157, DOI 10.1016/S0301-4622(01)00139-9; Fauq AH, 2010, BIOORG MED CHEM LETT, V20, P3036, DOI 10.1016/j.bmcl.2010.03.117; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Furlanut M, 2007, THER DRUG MONIT, V29, P349, DOI 10.1097/FTD.0b013e318067ded7; Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009; Hayes TG, 2009, EXPERT OPIN PHARMACO, V10, P2499, DOI 10.1517/14656560903200634; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Huang DC, 2010, EARLY DETECTION TREA; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Jordan VC, 2008, EUR J CANCER, V44, P30, DOI 10.1016/j.ejca.2007.11.002; Jordan VC, 2007, STEROIDS, V72, P829, DOI 10.1016/j.steroids.2007.07.009; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LIEN EA, 1991, CANCER RES, V51, P4837; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; Manikrao A.M., 2012, J COMPUT METHODS MOL, V2, P29; Mao SR, 2004, INT J PHARMACEUT, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019; Nabholtz JM, 2006, REV RECENT CLIN TRIA, V1, P237, DOI 10.2174/157488706778250069; Pacheco N, 2011, BIOMACROMOLECULES, V12, P3285, DOI 10.1021/bm200750t; Palpandi C, 2009, INT J MED MED SCI, V1, P198, DOI DOI 10.1353/LAN.2017.0015; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Sanyakamdhorn S, 2013, BIOMACROMOLECULES, V14, P557, DOI 10.1021/bm3018577; Saranya N, 2011, INT J BIOL MACROMOL, V48, P234, DOI 10.1016/j.ijbiomac.2010.11.013; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Shu Z.Z., 2009, INT J PHARMACEUT, V201, P51; Skovstrup S, 2010, BIOMACROMOLECULES, V11, P3196, DOI 10.1021/bm100736w; Spears M, 2009, EXPERT OPIN THER TAR, V13, P665, DOI 10.1517/14728220902911509; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002	40	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60250	10.1371/journal.pone.0060250	http://dx.doi.org/10.1371/journal.pone.0060250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527310	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600126
J	Park, H; Kim, JS; Chung, CK				Park, Hame; Kim, June Sic; Chung, Chun Kee			Differential Beta-Band Event-Related Desynchronization during Categorical Action Sequence Planning	PLOS ONE			English	Article							PACED FINGER MOVEMENTS; PREMOTOR CORTEX; MOTOR IMAGERY; EEG; COMPLEXITY; REPRESENTATION; INFORMATION; INHIBITION; ARTIFACTS; REMOVAL	A primate study reported the existence of neurons from the dorso-lateral prefrontal cortex which fired prior to executing categorical action sequences. The authors suggested these activities may represent abstract level information. Here, we aimed to find the neurophysiological representation of planning categorical action sequences at the population level in healthy humans. Previous human studies have shown beta-band event-related desynchronization (ERD) during action planning in humans. Some of these studies showed different levels of ERD according to different types of action preparation. Especially, the literature suggests that variations in cognitive factors rather than physical factors (force, direction, etc) modulate the level of beta-ERD. We hypothesized that the level of beta-band power will differ according to planning of different categorical sequences. We measured magnetoencephalography (MEG) from 22 subjects performing 11 four-sequence actions - each consisting of one or two of three simple actions - in 3 categories; 'Paired (ooxx)', 'Alternative (oxox)' and 'Repetitive (oooo)' ('o' and 'x' each denoting one of three simple actions). Time-frequency representations were calculated for each category during the planning period, and the corresponding beta-power time-courses were compared. We found beta-ERD during the planning period for all subjects, mostly in the contralateral fronto-parietal areas shortly after visual cue onset. Power increase (transient rebound) followed ERD in 20 out of 22 subjects. Amplitudes differed among categories in 20 subjects for both ERD and transient rebound. In 18 out of 20 subjects 'Repetitive' category showed the largest ERD and rebound. The current result suggests that beta-ERD in the contralateral frontal/motor/parietal areas during planning is differentiated by the category of action sequences.	[Park, Hame; Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ Hosp, MEG Ctr, Dept Neurosurg, Seoul 110744, South Korea; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Kim, June Sic] Seoul Natl Univ, Sensory Organ Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Chung, CK (corresponding author), Seoul Natl Univ Hosp, MEG Ctr, Dept Neurosurg, Seoul 110744, South Korea.	chungc@snu.ac.kr	Chung, Chun Kee/J-5650-2012; Kim, June Sic/F-8069-2013	Chung, Chun Kee/0000-0003-3485-2327; 	National Research Foundation of Korea (NRF); Korea government (MEST) [20120000180]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (20120000180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/840416; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Calmels C, 2006, BRAIN TOPOGR, V19, P77, DOI 10.1007/s10548-006-0014-x; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cassim F, 2000, CLIN NEUROPHYSIOL, V111, P2032, DOI 10.1016/S1388-2457(00)00455-7; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Fairhall SL, 2007, CONSCIOUS COGN, V16, P221, DOI 10.1016/j.concog.2006.05.005; Flexer A, 2005, NEURAL NETWORKS, V18, P998, DOI 10.1016/j.neunet.2005.03.012; Gladwin TE, 2008, CORTEX, V44, P521, DOI 10.1016/j.cortex.2007.10.005; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hamandi K, 2011, CLIN NEUROPHYSIOL, V122, P2128, DOI 10.1016/j.clinph.2011.04.017; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Hoshi E, 2007, NEUROSCI RES, V58, pS34, DOI 10.1016/j.neures.2007.06.199; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Khan MA, 2006, Q J EXP PSYCHOL, V59, P524, DOI 10.1080/02724980443000809; Khan MA, 2008, ACTA PSYCHOL, V127, P154, DOI 10.1016/j.actpsy.2007.04.001; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Lisman J, 2010, CURR BIOL, V20, pR490, DOI 10.1016/j.cub.2010.04.011; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Magrab E, 2005, ENG GUIDE METLAB; Mima T, 1999, NEUROSCI LETT, V275, P77, DOI 10.1016/S0304-3940(99)00734-X; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Moroney R, 2008, J COMPUT NEUROSCI, V25, P501, DOI 10.1007/s10827-008-0091-9; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; Muller-Gerking J, 2000, CLIN NEUROPHYSIOL, V111, P1353, DOI 10.1016/S1388-2457(00)00345-X; Ng THB, 2011, EXP BRAIN RES, V208, P189, DOI 10.1007/s00221-010-2470-5; Pfurtscheller G, 2008, EUR J NEUROSCI, V28, P1419, DOI 10.1111/j.1460-9568.2008.06441.x; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rueckriegel SM, 2008, INT J DEV NEUROSCI, V26, P655, DOI 10.1016/j.ijdevneu.2008.07.015; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; STANCAK A, 1995, NEUROSCI LETT, V196, P21, DOI 10.1016/0304-3940(95)11827-J; Stancak A, 1996, COGNITIVE BRAIN RES, V4, P171, DOI 10.1016/S0926-6410(96)00031-6; Tanaka M, 2011, BRAIN RES, V1412, P37, DOI 10.1016/j.brainres.2011.07.021; TANJI J, 1987, NATURE, V327, P618, DOI 10.1038/327618a0; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; Walsh E, 2010, NEUROPSYCHOLOGIA, V48, P619, DOI 10.1016/j.neuropsychologia.2009.10.026; Yamagata T, 2009, J NEUROPHYSIOL, V102, P3280, DOI 10.1152/jn.00452.2009; Yamagata T, 2008, NEUROSCI RES, V61, pS97; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	50	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59544	10.1371/journal.pone.0059544	http://dx.doi.org/10.1371/journal.pone.0059544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527215	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600061
J	Burgos, JM; Risso, MG; Breniere, SF; Barnabe, C; Campetella, O; Leguizamon, MS				Burgos, Juan M.; Risso, Marikena G.; Frederique Breniere, Simone; Barnabe, Christian; Campetella, Oscar; Susana Leguizamon, Maria			Differential Distribution of Genes Encoding the Virulence Factor Trans-Sialidase along Trypanosoma cruzi Discrete Typing Units	PLOS ONE			English	Article							MULTILOCUS ENZYME ELECTROPHORESIS; CHRONIC CHAGAS-DISEASE; HOST T-LYMPHOCYTES; MOLECULAR EPIDEMIOLOGY; POTENTIAL IMPLICATIONS; POPULATION-STRUCTURE; CLINICAL FORMS; LINEAGE-I; VARIABILITY; EXPRESSION	Trypanosoma cruzi the agent of Chagas disease is a monophyletic but heterogeneous group conformed by several Discrete Typing Units (DTUs) named TcI to TcVI characterized by genetic markers. The trans-sialidase (TS) is a virulence factor involved in cell invasion and pathogenesis that is differentially expressed in aggressive and less virulent parasite stocks. Genes encoding TS-related proteins are included in a large family divided in several groups but only one of them contains TS genes. Two closely related genes differing in a T/C transition encode the enzymatically active TS (aTS) and a lectin-like TS (iTS). We quantified the aTS/iTS genes from TcII and TcVI aggressive and TcI low virulent strains and found variable aTS number (1-32) per haploid genome. In spite of being low TS enzyme-expressers, TcI strains carry 28-32 aTS gene copies. The intriguing absence of iTS genes in TcI strains together with the presence of aTS/iTS in TcII and TcVI strains (virulent) were observed. Moreover, after sequencing aTS/iTS from 38 isolates collected along the Americas encompassing all DTUs, the persistent absence of the iTS gene in TcI, TcIII and TcIV was found. In addition, the sequence clustering together with T/C transition analysis correlated to DTUs of T. cruzi. The consistence of TS results with both evolutionary genome models proposed for T. cruzi, namely the "Two Hybridization" and the "Three Ancestor" was discussed and reviewed to fit present findings. Parasite stocks to attempt genetic KO or to assay the involvement of iTS in parasite biology and virulence are finally available.	[Burgos, Juan M.; Risso, Marikena G.; Susana Leguizamon, Maria] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina; [Frederique Breniere, Simone; Barnabe, Christian] IRD, Unite Rech MIVEGEC, La Paz, Bolivia; [Campetella, Oscar; Susana Leguizamon, Maria] Univ Nacl San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	University of Buenos Aires; Institut de Recherche pour le Developpement (IRD)	Leguizamon, MS (corresponding author), Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina.	sleguiza@fmed.uba.ar	Barnabé, Christian/R-2904-2016; Breniere, Simone Frederique/J-9214-2016	Barnabé, Christian/0000-0003-1857-0741; Campetella, Oscar/0000-0002-7018-375X; Breniere, Simone Frederique/0000-0003-4385-3989; Burgos, Juan Miguel/0000-0002-3617-3486	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina; National Institutes of Health (NIH) [R01AI075589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075589] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina, and National Institutes of Health (NIH) [Grant R01AI075589 to OC]. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JMB, MGR, OC and MSL are Researchers from CONICET, Argentina.	Anez N, 2004, TROP MED INT HEALTH, V9, P1319, DOI 10.1111/j.1365-3156.2004.01333.x; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bhattacharyya T, 2010, INT J PARASITOL, V40, P921, DOI 10.1016/j.ijpara.2010.01.002; Bosseno MF, 2002, J CLIN MICROBIOL, V40, P627, DOI 10.1128/JCM.40.2.627-632.2002; Breniere SF, 2002, MEM I OSWALDO CRUZ, V97, P289, DOI 10.1590/S0074-02762002000300002; Breniere SF, 2003, PARASITOLOGY, V127, P273, DOI 10.1017/S0031182003003573; Breniere SF, 1997, MEM I OSWALDO CRUZ, V92, P401, DOI 10.1590/S0074-02761997000300018; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Buscaglia CA, 1996, BBA-GENE STRUCT EXPR, V1309, P53, DOI 10.1016/S0167-4781(96)00140-6; Buschiazzo A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002474; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; CAMPETELLA O, 1992, PARASITOL TODAY, V8, P378, DOI 10.1016/0169-4758(92)90175-2; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Diosque P, 2003, INT J PARASITOL, V33, P997, DOI 10.1016/S0020-7519(03)00139-5; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Garzon EA, 2002, T ROY SOC TROP MED H, V96, P378, DOI 10.1016/S0035-9203(02)90367-6; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Lages-Silva E, 2006, J CLIN MICROBIOL, V44, P2167, DOI 10.1128/JCM.02124-05; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leguizamon MS, 1999, J INFECT DIS, V180, P1398, DOI 10.1086/315001; Lima L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038385; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; LUQUETTI AO, 1986, T ROY SOC TROP MED H, V80, P462, DOI 10.1016/0035-9203(86)90347-0; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mathieu-Daude F, 2007, PARASITOL RES, V101, P1355, DOI 10.1007/s00436-007-0651-3; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; MILES MA, 1981, LANCET, V1, P1338; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Oppezzo P, 2011, BBA-PROTEINS PROTEOM, V1814, P1154, DOI 10.1016/j.bbapap.2011.04.012; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Risso MG, 2007, PARASITOLOGY, V134, P503, DOI 10.1017/S0031182006001752; Risso MG, 2011, AM J TROP MED HYG, V84, P78, DOI 10.4269/ajtmh.2011.10-0177; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Soares RP, 2012, AM J TROP MED HYG, V87, P87, DOI 10.4269/ajtmh.2012.12-0015; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; Todeschin AR, 2002, J BIOL CHEM, V277, P45962, DOI 10.1074/jbc.M203185200; Todeschini AR, 2002, J IMMUNOL, V168, P5192, DOI 10.4049/jimmunol.168.10.5192; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	56	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58967	10.1371/journal.pone.0058967	http://dx.doi.org/10.1371/journal.pone.0058967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536842	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100107
J	Chen, YL; Hu, NT				Chen, Yih-Lin; Hu, Nien-Tai			Function-Related Positioning of the Type II Secretion ATPase of Xanthomonas campestris pv. campestris	PLOS ONE			English	Article							PROTEIN SECRETION; OUTER-MEMBRANE; CHOLERA-TOXIN; PILUS; COMPLEX; SYSTEM; BIOGENESIS; GENE; EPSL; ARCHITECTURE	Gram-negative bacteria use the type II secretion (T2S) system to secrete exoproteins for attacking animal or plant cells or to obtain nutrients from the environment. The system is unique in helping folded proteins traverse the outer membrane. The secretion machine comprises multiple proteins spanning the cell envelope and a cytoplasmic ATPase. Activity of the ATPase, when copurified with the cytoplasmic domain of an interactive ATPase partner, is stimulated by an acidic phospholipid, suggesting the membrane-associated ATPase is actively engaged in secretion. How the stimulated ATPase activity is terminated when secretion is complete is unclear. We fused the T2S ATPase of Xanthomonas campestris pv. campestris, the causal agent of black rot in the crucifers, with fluorescent protein and found that the ATPase in secretion-proficient cells was mainly diffused in cytoplasm. Focal spots at the cell periphery were detectable only in a few cells. The discrete foci were augmented in abundance and intensity when the secretion channel was depleted and the exoprotein overproduced. The foci abundance was inversely related to secretion efficiency of the secretion channel. Restored function of the secretion channel paralleled reduced ATPase foci abundance. The ATPase foci colocalized with the secretion channel. The ATPase may be transiently associated with the T2S machine by alternating between a cytoplasmic and a machine-associated state in a secretion-dependent manner. This provides a logical means for terminating the ATPase activity when secretion is completed. Function-related dynamic assembly may be the essence of the T2S machine.	[Chen, Yih-Lin; Hu, Nien-Tai] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan	National Chung Hsing University	Hu, NT (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	nthu@nchu.edu.tw			National Science Council of the Republic of China [NSC97-2321-B-005-011, NSC98-2321-B-005-002, NSC99-2321-B-005-001, NSC100-2321-B-005-001, NSC101-2321-B-005-001]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was funded by grants from the National Science Council of the Republic of China: NSC97-2321-B-005-011, NSC98-2321-B-005-002, NSC99-2321-B-005-001, NSC100-2321-B-005-001 and NSC101-2321-B-005-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; HU NT, 1992, J BACTERIOL, V174, P2679, DOI 10.1128/jb.174.8.2679-2687.1992; Hu NT, 1998, MICROBIOL-SGM, V144, P1479, DOI 10.1099/00221287-144-6-1479; HU NT, 1992, J GEN MICROBIOL, V138, P1647, DOI 10.1099/00221287-138-8-1647; Hwang JW, 2003, J BACTERIOL, V185, P6695, DOI 10.1128/JB.185.22.6695-6701.2003; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; KAMOUN S, 1992, MOL MICROBIOL, V6, P809, DOI 10.1111/j.1365-2958.1992.tb01531.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Lee HM, 2001, J BACTERIOL, V183, P528, DOI 10.1128/JB.183.2.528-535.2001; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59123	10.1371/journal.pone.0059123	http://dx.doi.org/10.1371/journal.pone.0059123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536861	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100121
J	Deng, RH; Gu, GX; Wang, DP; Tai, Q; Wu, LW; Ju, WQ; Zhu, XF; Guo, ZY; He, XS				Deng, Ronghai; Gu, Guangxiang; Wang, Dongping; Tai, Qiang; Wu, Linwei; Ju, Weiqiang; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun			Machine Perfusion versus Cold Storage of Kidneys Derived from Donation after Cardiac Death: A Meta-Analysis	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; PRESERVATION; TRANSPLANTATION; MULTICENTER; DONORS	Background: In response to the increased organ shortage, organs derived from donation after cardiac death (DCD) donors are becoming an acceptable option once again for clinical use in transplantation. However, transplant outcomes in cases where DCD organs are used are not as favorable as those from donation after brain death or living donors. Different methods of organ preservation are a key factor that may influence the outcomes of DCD kidney transplantation. Methods: We compared the transplant outcomes in patients receiving DCD kidneys preserved by machine perfusion (MP) or by static cold storage (CS) preservation by conducting a meta-analysis. The MEDLINE, EMBASE and Cochrane Library databases were searched. All studies reporting outcomes for MP versus CS preserved DCD kidneys were further considered for inclusion in this meta-analysis. Odds ratios and 95% confidence intervals (CI) were calculated to compare the pooled data between groups that were transplanted with kidneys that were preserved by MP or CS. Results: Four prospective, randomized, controlled trials, involving 175 MP and 176 CS preserved DCD kidney transplant recipients, were included. MP preserved DCD kidney transplant recipients had a decreased incidence of delayed graft function (DGF) with an odd ration of 0.56 (95% CI = 0.36-0.86, P = 0.008) compared to CS. However, no significant differences were seen between the two technologies in incidence of primary non-function, one year graft survival, or one year patient survival. Conclusions: MP preservation of DCD kidneys is superior to CS in terms of reducing DGF rate post-transplant. However, primary non-function, one year graft survival, and one year patient survival were not affected by the use of MP or CS for preservation.	[Deng, Ronghai; Gu, Guangxiang; Wang, Dongping; Tai, Qiang; Wu, Linwei; Ju, Weiqiang; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Guo, ZY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Ministry of Health [2010159]; National Natural Science Foundation of China [30972951, 81102244, 81102245, 81170448]; Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education [20100171110063, 20110171120077]; Science and Technology Planning Key Clinical Project of Guangdong Province [2011A030400005]; Project by Division of Medical Service Management of Ministry of Health, China; Special Fund for Science Research by Ministry of Health [201002004]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education; Science and Technology Planning Key Clinical Project of Guangdong Province; Project by Division of Medical Service Management of Ministry of Health, China; Special Fund for Science Research by Ministry of Health	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021008), the Key Clinical Project from the Ministry of Health (2010159), the National Natural Science Foundation of China (30972951, 81102244, 81102245, and 81170448), the Special Fund for Science Research by Ministry of Health (201002004), the Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education (20100171110063 and 20110171120077), the Science and Technology Planning Key Clinical Project of Guangdong Province (2011A030400005), and Project by Division of Medical Service Management of Ministry of Health (2010), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barklin A, 2009, ACTA ANAESTH SCAND, V53, P425, DOI 10.1111/j.1399-6576.2008.01879.x; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; Cantafio AW, 2011, CLIN TRANSPLANT, V25, pE530, DOI 10.1111/j.1399-0012.2011.01477.x; Groen H, 2012, AM J TRANSPLANT, V12, P1824, DOI 10.1111/j.1600-6143.2012.04030.x; Jochmans I, 2010, ANN SURG, V252, P756, DOI 10.1097/SLA.0b013e3181ffc256; Kokkinos C, 2007, TRANSPLANTATION, V83, P1193, DOI 10.1097/01.tp.0000261710.53848.51; Kootstra G, 2007, NAT CLIN PRACT NEPHR, V3, P154, DOI 10.1038/ncpneph0426; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; MARSHALL VC, 1977, MED J AUSTRALIA, V2, P353, DOI 10.5694/j.1326-5377.1977.tb117701.x; MATSUNO N, 1994, TRANSPLANTATION, V57, P293; Moers C, 2007, TRANSPL INT, V20, P567, DOI 10.1111/j.1432-2277.2007.00455.x; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Moustafellos P, 2007, TRANSPL P, V39, P1323, DOI 10.1016/j.transproceed.2006.11.026; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Plata-Munoz JJ, 2008, TRANSPL INT, V21, P899, DOI 10.1111/j.1432-2277.2008.00685.x; ROWINSKI W, 1993, TRANSPLANT P, V25, P1511; St Peter SD, 2002, LANCET, V359, P604, DOI 10.1016/S0140-6736(02)07749-8; van der Vliet JA, 2001, TRANSPLANT P, V33, P847, DOI 10.1016/S0041-1345(00)02343-5; Watson CJE, 2010, AM J TRANSPLANT, V10, P1991, DOI 10.1111/j.1600-6143.2010.03165.x; Wight J, 2003, Health Technol Assess, V7, P1; Wight JP, 2003, CLIN TRANSPLANT, V17, P293, DOI 10.1034/j.1399-0012.2003.00077.x; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	23	45	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e56368	10.1371/journal.pone.0056368	http://dx.doi.org/10.1371/journal.pone.0056368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536758	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100003
J	Mueller, CE; Lundalv, T; Middelburg, JJ; van Oevelen, D				Mueller, Christina E.; Lundalv, Tomas; Middelburg, Jack J.; van Oevelen, Dick			The Symbiosis between Lophelia pertusa and Eunice norvegica Stimulates Coral Calcification and Worm Assimilation	PLOS ONE			English	Article							COLD-WATER CORALS; OCEAN ACIDIFICATION; INORGANIC CARBON; ROCKALL BANK; REEF; MECHANISMS; DEEP; COMMUNITY; ATLANTIC; SCLERACTINIA	We investigated the interactions between the cold-water coral Lophelia pertusa and its associated polychaete Eunice norvegica by quantifying carbon (C) and nitrogen (N) budgets of tissue assimilation, food partitioning, calcification and respiration using C-13 and N-15 enriched algae and zooplankton as food sources. During incubations both species were kept either together or in separate chambers to study the net outcome of their interaction on the above mentioned processes. The stable isotope approach also allowed us to follow metabolically derived tracer C further into the coral skeleton and therefore estimate the effect of the interaction on coral calcification. Results showed that food assimilation by the coral was not significantly elevated in presence of E. norvegica but food assimilation by the polychaete was up to 2 to 4 times higher in the presence of the coral. The corals kept assimilation constant by increasing the consumption of smaller algae particles less favored by the polychaete while the assimilation of Artemia was unaffected by the interaction. Total respiration of tracer C did not differ among incubations, although E. norvegica enhanced coral calcification up to 4 times. These results together with the reported high abundance of E. norvegica in cold-water coral reefs, indicate that the interactions between L. pertusa and E. norvegica can be of high importance for ecosystem functioning.	[Mueller, Christina E.; van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Ecosyst Studies, Yerseke, Netherlands; [Lundalv, Tomas] Univ Gothenburg, Sven Loven Ctr Marine Sci, Stromstad, Sweden; [Middelburg, Jack J.] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Gothenburg; Utrecht University	Mueller, CE (corresponding author), Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Ecosyst Studies, Yerseke, Netherlands.	Christina.Mueller@nioz.nl	Lundälv, Tomas/O-7121-2019; Middelburg, Jack/B-4951-2011	Middelburg, Jack/0000-0003-3601-9072	European Community	European Community(European Commission)	This research was carried out within the CALMARO Project (www.calmaro.eu), a European Marie Curie Initial Training Network (ITN), supported by funding under the Seventh Framework Programme of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann KL, 1996, J EXP BIOL, V199, P1743; Addicott JF, 1984, MUTUALISTIC INTERACT; Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Allemand D, 1998, J EXP BIOL, V201, P2001; Anderson MJ, 2005, USER GUIDE COMPUTER; Bergsma GS, 2011, MAR BIOL, V158, P2267, DOI 10.1007/s00227-011-1731-6; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P., 1995, SARSIA, V80, P145, DOI [10.1080/00364827.1995.10413586, DOI 10.1080/00364827.1995.10413586]; Dales RP, 1957, INTERACTIONS ORGANIS; de Bary Anton, 1879, VORTRAG VERSAMMLUNG, P1; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; Duineveld GCA, 2007, B MAR SCI, V81, P449; Duineveld GCA, 2012, MAR ECOL PROG SER, V444, P97, DOI 10.3354/meps09430; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Freiwald A., 2004, COLD WATER CORAL REE; Furla P, 2000, J EXP BIOL, V203, P3445; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; HERNDL GJ, 1985, MAR ECOL PROG SER, V22, P101, DOI 10.3354/meps022101; Jonsson LG, 2004, MAR ECOL PROG SER, V284, P163, DOI 10.3354/meps284163; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; Maier C, 2012, P ROY SOC B-BIOL SCI, V279, P1716, DOI 10.1098/rspb.2011.1763; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Martin D, 1988, OCEANOGRAPHY MARINE, V36, P217; MIYAJIMA T, 1995, LIMNOL OCEANOGR, V40, P994, DOI 10.4319/lo.1995.40.5.0994; Moodley L, 2000, MAR ECOL PROG SER, V202, P289, DOI 10.3354/meps202289; Mortensen P.B., 2006, PROC 10 INT CORAL RE, V1868, P1849; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Naumann MS, 2011, J EXP BIOL, V214, P3570, DOI 10.1242/jeb.061390; Naumann MS, 2009, MAR ECOL PROG SER, V385, P65, DOI 10.3354/meps08073; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; PATTON WK, 1967, BIOL BULL, V132, P56, DOI 10.2307/1539878; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; RINKEVICH B, 1985, OECOLOGIA, V66, P100, DOI 10.1007/BF00378559; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, J MAR BIOL ASSOC UK, V85, P813, DOI 10.1017/S0025315405011756; Shimeta J, 1997, J EXP MAR BIOL ECOL, V209, P47, DOI 10.1016/S0022-0981(96)02684-6; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; TAMBUTTE E, 1995, MAR BIOL, V122, P453, DOI 10.1007/BF00350879; Tsounis G, 2010, MAR ECOL PROG SER, V398, P149, DOI 10.3354/meps08312; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P149, DOI 10.1017/S0025315400046245; WINSNES IM, 1989, ZOOL SCR, V18, P483, DOI 10.1111/j.1463-6409.1989.tb00142.x; ZIBROWIUS H, 1975, J MAR BIOL ASSOC UK, V55, P83, DOI 10.1017/S0025315400015769	58	26	27	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58660	10.1371/journal.pone.0058660	http://dx.doi.org/10.1371/journal.pone.0058660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536808	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100075
J	Ning, ZY; Zheng, ZW; Hao, WB; Duan, CH; Li, W; Wang, YY; Li, M; Luo, SH				Ning, Zhangyong; Zheng, Zewei; Hao, Wenbo; Duan, Chaohui; Li, Wei; Wang, Yuanyuan; Li, Ming; Luo, Shuhong			The N Terminus of Orf Virus-Encoded Protein 002 Inhibits Acetylation of NF-kappa B p65 by Preventing Ser(276) Phosphorylation	PLOS ONE			English	Article							SIGNALING PATHWAY; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; KINASE-1 MSK1; TRANSACTIVATION; SUBUNIT; BINDING; CELLS; PKAC	Orf virus-encoded protein 002 (ORFV002) inhibits NF-kappa B signaling pathway by decreasing the acetylation of NF-kappa B-p65 through interference of NF-kappa B p659s association with NF-kappa B p300. However, the precise mechanism of how ORFV002 interferes with the NF-kappa B p65/p300 association is still unknown. Due to similarities of the amino acid sequences of ORFV002 and the adenovirus type 12 (Ad12) E1A protein (E1A-12), we hypothesized that the N-terminal 52 amino acids of ORFV002 might play an important role in this inhibition and constructed several in-frame fusions of ORFV002 to an enhanced green fluorescent protein (EGFP) reporter, including C-terminal and N-terminal deletion mutants of ORFV002. When the N-terminus of ORFV002 was absent, the localization of ORFV002 shifted mainly from the nucleus to the cytoplasm, and it's inhibition of NF-kappa B transactivation was lost. NF-kappa B p65 Lys(310) acetylation and Ser(276) phosphorylation were detected in co-transfection experiments with NF-kappa B p65 and ORFV002 or its mutants with, or without, the N-terminal region. The results showed that the N-terminus of ORFV002 plays a crucial role in inhibiting both the acetylation and phosphorylation of NF-kappa B p65. Further investigation indicated that ORFV002 and its C-terminal deletion mutants interfered with NF-kappa B p65 (Ser(276)) phosphorylation induced by mitogen-and stress-activated protein kinase-1 (MSK1) and the interaction between NF-kappa B p65 and MSK1. Since phosphorylated NF-kappa B p65 recruits transcriptional co-activators such as p300 and CBP, we concluded that the N-terminus of ORFV002 inhibits acetylation of NF-kappa B p65 by blocking phosphorylation of NF-kappa B p65 at Ser(276).	[Ning, Zhangyong; Luo, Shuhong] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zheng, Zewei; Hao, Wenbo; Li, Wei; Wang, Yuanyuan; Li, Ming; Luo, Shuhong] Southern Med Univ, Sch Biotechnol, Inst Antibody Engn, Guangzhou, Guangdong, Peoples R China; [Duan, Chaohui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Immunol Lab, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; Southern Medical University - China; Sun Yat Sen University	Luo, SH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	sluo815@gmail.com			National Natural Science Foundation of China (NSFC) [31070138, 31170147]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the grant (no. 31070138 and no. 31170147) from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salam S, 2008, J CUTAN PATHOL, V35, P603, DOI 10.1111/j.1600-0560.2007.00857.x; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Diel DG, 2011, J VIROL, V85, P2037, DOI 10.1128/JVI.02236-10; Diel DG, 2011, J VIROL, V85, P264, DOI 10.1128/JVI.01149-10; Diel DG, 2010, J VIROL, V84, P3962, DOI 10.1128/JVI.02291-09; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Guan H, 2008, J VIROL, V82, P40, DOI 10.1128/JVI.01579-07; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Jiao JF, 2010, J VIROL, V84, P7668, DOI 10.1128/JVI.02317-09; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; MCCLURKIN AW, 1974, ARCH GES VIRUSFORSCH, V45, P285, DOI 10.1007/BF01249692; McElroy MC, 2007, VET J, V174, P663, DOI 10.1016/j.tvjl.2006.10.024; Mercer AA, 2006, VIRUS RES, V116, P146, DOI 10.1016/j.virusres.2005.09.011; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vikoren T, 2008, VET MICROBIOL, V127, P10, DOI 10.1016/j.vetmic.2007.07.029; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	24	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58854	10.1371/journal.pone.0058854	http://dx.doi.org/10.1371/journal.pone.0058854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536830	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100095
J	Vitelli, A; Quirion, MR; Lo, CY; Misplon, JA; Grabowska, AK; Pierantoni, A; Ammendola, V; Price, GE; Soboleski, MR; Cortese, R; Colloca, S; Nicosia, A; Epstein, SL				Vitelli, Alessandra; Quirion, Mary R.; Lo, Chia-Yun; Misplon, Julia A.; Grabowska, Agnieszka K.; Pierantoni, Angiolo; Ammendola, Virginia; Price, Graeme E.; Soboleski, Mark R.; Cortese, Riccardo; Colloca, Stefano; Nicosia, Alfredo; Epstein, Suzanne L.			Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus	PLOS ONE			English	Article							CD8(+) T-CELLS; NEUTRALIZING ANTIBODIES; A VIRUS; GENE; NUCLEOPROTEIN; IMMUNOGENICITY; IMMUNITY; LYMPHOCYTES; DNA; HEMAGGLUTININ	Among approximately 1000 adenoviruses from chimpanzees and bonobos studied recently, the Pan Adenovirus type 3 (PanAd3, isolated from a bonobo, Pan paniscus) has one of the best profiles for a vaccine vector, combining potent transgene immunogenicity with minimal pre-existing immunity in the human population. In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein (NP) and matrix 1 (M1). We then studied antibody and T cell responses as well as protection from challenge infection in a mouse model. A single intranasal administration of PanAd3-NPM1 vaccine induced strong antibody and T cell responses, and protected against high dose lethal influenza virus challenge. Thus PanAd3 is a promising candidate vector for vaccines, including universal influenza vaccines.	[Quirion, Mary R.; Lo, Chia-Yun; Misplon, Julia A.; Price, Graeme E.; Soboleski, Mark R.; Epstein, Suzanne L.] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Gene Therapy & Immunogen Branch, Bethesda, MD 20892 USA; [Vitelli, Alessandra; Grabowska, Agnieszka K.; Pierantoni, Angiolo; Ammendola, Virginia; Cortese, Riccardo; Colloca, Stefano; Nicosia, Alfredo] Okairos, Rome, Italy; [Nicosia, Alfredo] Ctr Ingn Genet & Biotecnol Avanzate CEINGE, Naples, Italy; [Nicosia, Alfredo] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy	US Food & Drug Administration (FDA); CEINGE Biotecnologie Avanzate; University of Naples Federico II	Epstein, SL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Gene Therapy & Immunogen Branch, Bethesda, MD 20892 USA.	suzanne.epstein@fda.hhs.gov		Epstein, Suzanne/0000-0002-6311-6890; Misplon, Julia/0000-0001-9614-5922	Okairos; CBER, FDA	Okairos; CBER, FDA	Research funding was provided by Okairos and by CBER, FDA. Authors from Okairos are employees of and/or shareholders in Okairos, which is developing vectored vaccines for malaria and other diseases. All decisions concerning study design, data collection and analysis, decision to publish, and preparation of the manuscript were those of the authors, with concurrence of all authors.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ALTMULLER A, 1989, J GEN VIROL, V70, P2111, DOI 10.1099/0022-1317-70-8-2111; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Deng YP, 1997, J IMMUNOL, V158, P1507; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Matthews DA, 1999, J GEN VIROL, V80, P345, DOI 10.1099/0022-1317-80-2-345; McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232; MITTAL SK, 1995, VIROLOGY, V213, P131, DOI 10.1006/viro.1995.1553; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Peruzzi D, 2009, VACCINE, V27, P1293, DOI 10.1016/j.vaccine.2008.12.051; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Roy S, 2004, HUM GENE THER, V15, P519, DOI 10.1089/10430340460745838; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Smith JS, 2004, GENE THER, V11, P431, DOI 10.1038/sj.gt.3302149; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Takamura S, 2010, J EXP MED, V207, P1153, DOI 10.1084/jem.20090283; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xu ZZ, 1997, VIROLOGY, V230, P62, DOI 10.1006/viro.1997.8452; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Yewdell JW, 1989, INFLUENZA VIRUSES, P361; Zhi Y, 2006, HUM GENE THER, V17, P500, DOI 10.1089/hum.2006.17.500; Zhong WM, 2000, J IMMUNOL, V164, P3274, DOI 10.4049/jimmunol.164.6.3274	47	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e55435	10.1371/journal.pone.0055435	http://dx.doi.org/10.1371/journal.pone.0055435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536756	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100002
J	Dunn, MR; Stevens, DW; Forman, JS; Connell, A				Dunn, Matthew R.; Stevens, Darren W.; Forman, Jeffrey S.; Connell, Amelia			Trophic Interactions and Distribution of Some Squaliforme Sharks, Including New Diet Descriptions for Deania calcea and Squalus acanthias	PLOS ONE			English	Article							DEMERSAL FISH COMMUNITY; DEEP-SEA SHARKS; SPINY DOGFISH; NEW-ZEALAND; CHATHAM RISE; CONTINENTAL-SLOPE; FEEDING ECOLOGY; PREDATION MORTALITY; ETMOPTERUS-BAXTERI; SOUTH-ISLAND	Squaliforme sharks are a common but relatively vulnerable bycatch in many deep water fisheries. Eleven species of squaliforme shark are commonly caught at depths of 200-1200 m on Chatham Rise, New Zealand, and their diversity suggests they might occupy different niches. The diets of 133 Deania calcea and 295 Squalus acanthias were determined from examination of stomach contents. The diet of D. calcea was characterised by mesopelagic fishes, and S. acanthias by benthic to pelagic fishes, but was more adaptive and included likely scavenging. Multivariate analyses found the most important predictors of diet variability in S. acanthias were year, bottom temperature, longitude, and fish weight. The diet of the nine other commonly caught squaliforme sharks was reviewed, and the spatial and depth distribution of all species on Chatham Rise described from research bottom trawl survey catches. The eleven species had a variety of different diets, and depth and location preferences, consistent with niche separation to reduce interspecific competition. Four trophic groups were identified, characterised by: mesopelagic fishes and invertebrates (Centroselachus crepidater, D. calcea, and Etmopterus lucifer); mesopelagic and benthopelagic fishes and invertebrates (Centroscymnus owstoni, Etmopterus baxteri); demersal and benthic fishes (Centrophorus squamosus, Dalatias licha, Proscymnodon plunketi); and a generalist diet of fishes and invertebrates (S. acanthias). The trophic levels of the species in each of the four groups were estimated as 4.18-4.24, 4.20-4.23, 4.24-4.48, and 3.84 respectively. The diet of Oxynotus bruniensis and Squalus griffini are unknown. The different niches occupied by different species are likely to influence their vulnerability to bottom trawl fisheries. Some species may benefit from fisheries through an increased availability of scavenged prey.	[Dunn, Matthew R.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Stevens, Darren W.; Forman, Jeffrey S.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	Victoria University Wellington; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Dunn, MR (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	matthew.dunn@vuw.ac.nz			New Zealand Ministry for Primary Industries [ZBD2004-02]; New Zealand Foundation for Research, Science and Technology [C01X0501]; NIWA [FIPR1201]	New Zealand Ministry for Primary Industries; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); NIWA	This work was funded by the New Zealand Ministry for Primary Industries project ZBD2004-02, the New Zealand Foundation for Research, Science and Technology project C01X0501 (Coasts & Oceans OBI, IO2), and NIWA project FIPR1201. The New Zealand Ministry for Primary Industries had a role in determining the availability of the samples and scope of the study, and allowing the research to be published, but had no role in the design and completion of the data collection and analysis, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MK, 2002, ENVIRON BIOL FISH, V63, P193; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Avsar D, 2001, ESTUAR COAST SHELF S, V52, P269, DOI 10.1006/ecss.2000.0749; BABA O, 1987, B JPN SOC SCI FISH, V53, P417; Baird SJ, 2012, 88 NZ AQ ENV BIOD MI; Belleggia M, 2012, HYDROBIOLOGIA, V684, P57, DOI 10.1007/s10750-011-0967-y; BLABER SJM, 1987, MAR BIOL, V95, P345, DOI 10.1007/BF00409564; Blackwell RG, 2010, 57 NZ AQ ENV BIOD MI; Bowman RE, 2000, 155 NOAA NMFSNE; Bulman CM, 2002, MAR FRESHWATER RES, V53, P59, DOI 10.1071/MF01057; Bundy A, 2011, J FISH BIOL, V78, P514, DOI 10.1111/j.1095-8649.2010.02868.x; Capape C, 2008, VIE MILIEU, V58, P57; CARRASSON M, 1992, MAR ECOL PROG SER, V82, P21, DOI 10.3354/meps082021; Clark MR, 2000, FISH RES, V45, P217, DOI 10.1016/S0165-7836(99)00121-6; CLARK MR, 1989, J FISH BIOL, V35, P465, DOI 10.1111/j.1095-8649.1989.tb02999.x; Compagno LJV., 1984, FAO FISH SYNOP, P20; Connell AM, 2010, NEW ZEAL J MAR FRESH, V44, P289, DOI 10.1080/00288330.2010.515232; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Demirhan SA, 2007, FISH RES, V85, P210, DOI 10.1016/j.fishres.2007.02.009; Doonan IJ, 2011, 201120 NZ FISH ASS M; Dunn MR, 2009, NEW ZEAL J MAR FRESH, V43, P1103, DOI 10.1080/00288330.2009.9626533; Dunn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013647; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Dunn MR, 2010, MAR ECOL PROG SER, V407, P209, DOI 10.3354/meps08580; EBERT DA, 1992, S AFR J MARINE SCI, V12, P601; Ellis JR, 1996, J MAR BIOL ASSOC UK, V76, P89, DOI 10.1017/S0025315400029039; Forman JS, 2012, J FISH BIOL, V80, P1546, DOI 10.1111/j.1095-8649.2012.03255.x; Francis MP, 1998, MAR FRESHWATER RES, V49, P579, DOI 10.1071/MF97076; FUJITA T, 1995, MAR BIOL, V123, P219; GARRICK J. A. F., 1959, TRANS ROY SOC NEW ZEALAND, V87, P271; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; Gorley C.K., 2006, GETTING STARTED PRIM; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Hallett CS, 2011, ICES J MAR SCI, V68, P157, DOI 10.1093/icesjms/fsq143; HANCHET S, 1991, J FISH BIOL, V39, P313, DOI 10.1111/j.1095-8649.1991.tb04365.x; Jones MRL, 2008, NEW ZEAL J MAR FRESH, V42, P333, DOI 10.1080/00288330809509961; Karachle PK, 2010, RAPPORT COMMISSION I, V39, P553; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Laptikhovsky VV, 2001, J MAR BIOL ASSOC UK, V81, P1015, DOI 10.1017/S0025315401004994; Last P. R., 2009, SHARKS RAYS AUSTR, V2; LIVINGSTON ME, 1990, NEW ZEAL J MAR FRESH, V24, P503, DOI 10.1080/00288330.1990.9516442; Macpherson E., 1979, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V25-26, P49; MACPHERSON E, 1987, S AFR J MARINE SCI, V5, P585, DOI 10.2989/025776187784522432; MAUCHLINE J, 1983, MAR BIOL, V75, P269, DOI 10.1007/BF00406012; McClatchie S, 2003, DEEP-SEA RES PT I, V50, P1263, DOI 10.1016/S0967-0637(03)00128-6; McMillan PJ, 2011, 68 NZ AQ ENV BIOD MI; Ministry for Primary Industries, 2012, REP FISH ASS PLEN MA; Ministry for Primary Industries, 2008, NAT PLAN ACT SHARKS; Moustahfid H, 2009, ICES J MAR SCI, V66, P445, DOI 10.1093/icesjms/fsn217; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; O'Driscoll RL, 2011, 201147 NZ FISH ASS M; Pasquaud S, 2010, ESTUAR COAST SHELF S, V86, P237, DOI 10.1016/j.ecss.2009.11.019; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pinkas L, 1971, FISH B CALIF DEP FIS; Preciado I, 2009, J FISH BIOL, V75, P1331, DOI 10.1111/j.1095-8649.2009.02367.x; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Ryer CH, 2004, ICES J MAR SCI, V61, P1157, DOI 10.1016/j.icesjms.2004.06.004; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stevens DW, 2011, MAR BIOL, V158, P59, DOI 10.1007/s00227-010-1542-1; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TANASICHUK RW, 1991, CAN J FISH AQUAT SCI, V48, P2118, DOI 10.1139/f91-251; Tirasin EM, 1999, MAR ECOL PROG SER, V182, P243; Tyrrell MC, 2008, ICES J MAR SCI, V65, P1689, DOI 10.1093/icesjms/fsn185; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wetherbee BM, 2000, FISH B-NOAA, V98, P189; White WT, 2012, J FISH BIOL, V80, P897, DOI 10.1111/j.1095-8649.2012.03268.x; YANO K, 1984, B JPN SOC SCI FISH, V50, P249	67	15	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59938	10.1371/journal.pone.0059938	http://dx.doi.org/10.1371/journal.pone.0059938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536896	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200044
J	Sabater, L; Hoftberger, R; Boronat, A; Saiz, A; Dalmau, J; Graus, F				Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Dalmau, Josep; Graus, Francesc			Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer	PLOS ONE			English	Article							EATON-MYASTHENIC-SYNDROME; CALCIUM-CHANNEL ANTIBODIES; LIMBIC ENCEPHALITIS; DISORDERS; ANTIGENS; SUBUNITS; TUMOR	The goal of this study is to determine whether patients with paraneoplastic cerebellar degeneration (PCD) and small-cell lung cancer (SCLC) have a specific repertoire of antibodies, if SOX1 antibodies (SOX1-ab) can predict the presence of SCLC, and if antibodies to cell surface antigens occur in this syndrome. Antibody analysis was done using immunohistochemistry on rat brain, immunoblot with recombinant antigens, screening of cDNA expression libraries, and immunolabeling of live neurons in 39 patients with PCD and SCLC. VGCC-ab were measured by RIA, and SOX1-ab, Hu-ab, and ZIC4-ab by immunoblot. Lambert-Eaton myastenic syndrome (LEMS) was present in 10 of 23 patients with electrophysiological studies. At least one antibody was detected in 72% of patients. The individual frequencies were: 49% SOX1-ab, 44% VGCC-ab, 31% Hu-ab, and 13% ZIC4-ab. SOX1-ab occurred in 76% of patients with VGCC-ab and 27% of those without VGCC-ab (p = 0.0036). SOX1-ab were not found in 39 patients with sporadic late-onset cerebellar ataxia, 23 with cerebellar ataxia and glutamic acid decarboxylase antibodies, and 73 with PCD and cancer types other than SCLC (31 without onconeural antibodies, 25 with Yo-ab, 17 with Tr-ab). Five patients (13%) had antibodies against unknown neuronal cell surface antigens but none of them improved with immunotherapy. One serum immunoreacted against the axon initial segment of neurons and another serum against ELKS1, a protein highly expressed in the cerebellum that interacts with the beta4-subunit of the VGCC. In conclusion, 72% of patients with PCD and SCLC had one or more antibodies that indicate the presence of this tumor. In these patients, VGCC-ab and SOX1-ab occur tightly associated. SOX1-ab are predictors of SCLC in ataxia patients with a specificity of 100% and sensitivity of 49%. Unlike limbic encephalitis with SCLC, antibodies to cell surface antigens other than VGCC-ab, are infrequent and do not predict response to treatment.	[Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Graus, Francesc] Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain; [Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Graus, Francesc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Dalmau, Josep] Hosp Clin Barcelona, Inst Catalana Recerca & Estudis Avancats ICREA, IDIBAPS, Barcelona, Spain; [Dalmau, Josep] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Pennsylvania	Sabater, L (corresponding author), Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain.	lisabate@clinic.ub.es	Graus, Francesc/K-9904-2018; Sabater, Lidia/U-7570-2019; Saiz, Albert/K-8236-2014; Sabater, Lidia/C-7627-2018	Saiz, Albert/0000-0002-5793-8791; Dalmau, Josep/0000-0001-5856-2813; Graus, Francesc/0000-0002-8924-8322; Sabater, Lidia/0000-0001-8556-6166	Fondo de Investigaciones Sanitarias. Madrid. Spain [FIS PS09/0193]; Fonds zur Forderung der wissenschaftlichen Forschung, Austria [J3230]; NIH [RO1NS077851]; NCI [RO1CA089054]; Fondo de Investigaciones Sanitarias (FIS) [11/01780]; Fundacio la Marato de TV3; Euroimmun; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA089054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077851] Funding Source: NIH RePORTER	Fondo de Investigaciones Sanitarias. Madrid. Spain(Instituto de Salud Carlos III); Fonds zur Forderung der wissenschaftlichen Forschung, Austria(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fundacio la Marato de TV3; Euroimmun; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study has been supported in part by Fondo de Investigaciones Sanitarias. Madrid. Spain (#FIS PS09/0193 FG), the Fonds zur Forderung der wissenschaftlichen Forschung, Austria, Project J3230 (RH), and NIH RO1NS077851, NCI RO1CA089054, Fondo de Investigaciones Sanitarias (FIS, 11/01780), and Fundacio la Marato de TV3 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Dalmau has a research grant from Euroimmun, and receives royalties from patents for the use of Ma2 and NMDAR as autoantibody tests. He has no financial competing interests such as ownership of stocks or shares, paid employment or consultancy, board membership, travel grants and honoraria for speaking or participation at meetings, products in development or marketed products, or gifts of any kind etc. The relation of Dr. Dalmau with the company Euroimmun does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the other contributors have any conflicts of interest.	Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Billings SE, 2012, NEUROREPORT, V23, P49, DOI 10.1097/WNR.0b013e32834e7deb; Boronat A, 2011, NEUROLOGY, V76, P795, DOI 10.1212/WNL.0b013e31820e7b8d; Chen RS, 2007, CELL BIOCHEM BIOPHYS, V47, P178, DOI 10.1007/s12013-007-0002-0; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Lorenzoni PJ, 2008, J NEUROL SCI, V270, P194, DOI 10.1016/j.jns.2008.02.004; Maddison P, 1998, J NEUROL NEUROSUR PS, V65, P213, DOI 10.1136/jnnp.65.2.213; Mason WP, 1997, BRAIN, V120, P1279, DOI 10.1093/brain/120.8.1279; Pellkofer HL, 2009, MUSCLE NERVE, V40, P305, DOI 10.1002/mus.21315; Pellkofer HL, 2008, J NEUROIMMUNOL, V204, P136, DOI 10.1016/j.jneuroim.2008.08.002; Sabater L, 2008, J NEUROIMMUNOL, V196, P188, DOI 10.1016/j.jneuroim.2008.03.013; Sabater L, 2008, NEUROLOGY, V70, P924, DOI 10.1212/01.wnl.0000281663.81079.24; Shams'ili S, 2009, NEUROSCI LETT, V467, P169, DOI 10.1016/j.neulet.2009.10.031; Titulaer MJ, 2009, J CLIN ONCOL, V27, P4260, DOI 10.1200/JCO.2008.20.6169; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Voltz R, 1999, MUSCLE NERVE, V22, P119, DOI 10.1002/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5	20	49	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60438	10.1371/journal.pone.0060438	http://dx.doi.org/10.1371/journal.pone.0060438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536908	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200056
J	Li, CH; Wang, TZ; Li, Y; Zheng, YH; Jiang, GM				Li, Cai-Hong; Wang, Tian-Zuo; Li, Yong; Zheng, Yan-Hai; Jiang, Gao-Ming			Flixweed Is More Competitive than Winter Wheat under Ozone Pollution: Evidences from Membrane Lipid Peroxidation, Antioxidant Enzymes and Biomass	PLOS ONE			English	Article							CARBON-DIOXIDE; SURFACE OZONE; AMBIENT OZONE; RESPONSES; IMPACTS; GROWTH; SENSITIVITY; EXPOSURE; STRESS; CHINA	To investigate the effects of ozone on winter wheat and flixweed under competition, two species were exposed to ambient, elevated and high [O-3] for 30 days, planted singly or in mixculture. Eco-physiological responses were examined at different [O-3] and fumigating time. Ozone reduced the contents of chlorophyll, increased the accumulation of H2O2 and malondialdehyde in both wheat and flixweed. The effects of competition on chlorophyll content of wheat emerged at elevated and high [O-3], while that of flixweed emerged only at high [O-3]. The increase of H2O2 and malondialdehyde of flixweed was less than that of wheat under the same condition. Antioxidant enzyme activities of wheat and flixweed were seriously depressed by perennial and serious treatment using O-3. However, short-term and moderate fumigation increased the activities of SOD and POD of wheat, and CAT of flixweed. The expression levels of antioxidant enzymes related genes provided explanation for these results. Furthermore, the increase of CAT expression of flixweed was much higher than that of SOD and POD expression of wheat. Ozone and competition resulted in significant reductions in biomass and grain yield in both winter wheat and flixweed. However, the negative effects on flixweed were less than wheat. Our results demonstrated that winter wheat is more sensitive to O-3 and competition than flixweed, providing valuable data for further investigation on responses of winter wheat to ozone pollution, in particular combined with species competition.	[Li, Cai-Hong; Wang, Tian-Zuo; Li, Yong; Zheng, Yan-Hai; Jiang, Gao-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Cai-Hong; Li, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, GM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	jgm@ibcas.ac.cn	Li, Yong/A-4000-2013; Wang, Tianzuo/C-7291-2013	Li, Yong/0000-0001-9146-8044; Wang, Tianzuo/0000-0001-9374-6167; Li, Caihong/0000-0002-5908-4777	Innovative Group Grant of Natural Science Foundation of China [30521002]; National Natural Science Foundation of China [30200165]	Innovative Group Grant of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was co-funded by the Innovative Group Grant of Natural Science Foundation of China (No. 30521002) and the National Natural Science Foundation of China (No. 30200165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Agrawal M, 2005, NATL ACAD SCI LETT, V28, P93; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Aunan K, 2000, AMBIO, V29, P294, DOI 10.1639/0044-7447(2000)029[0294:SOICAI]2.0.CO;2; Bernardi R, 2004, BIOL PLANTARUM, V48, P41, DOI 10.1023/B:BIOP.0000024273.35976.cb; Biswas DK, 2008, J EXP BOT, V59, P951, DOI 10.1093/jxb/ern022; Biswas DK, 2008, GLOBAL CHANGE BIOL, V14, P46, DOI 10.1111/j.1365-2486.2007.01477.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calatayud A, 2003, PLANT PHYSIOL BIOCH, V41, P839, DOI 10.1016/S0981-9428(03)00123-2; Callaway RM, 2000, SCIENCE, V290, P2075; Crous KY, 2006, ENVIRON EXP BOT, V58, P169, DOI 10.1016/j.envexpbot.2005.07.007; Cui HL, 2008, WEED SCI, V56, P775, DOI 10.1614/WS-08-058.1; Dermody O, 2006, NEW PHYTOL, V169, P145, DOI 10.1111/j.1469-8137.2005.01565.x; Emberson LD, 2009, ATMOS ENVIRON, V43, P1945, DOI 10.1016/j.atmosenv.2009.01.005; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Galant A, 2012, NEW PHYTOL, V194, P220, DOI 10.1111/j.1469-8137.2011.04037.x; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Grantz DA, 2003, ENVIRON POLLUT, V126, P331, DOI 10.1016/S0269-7491(03)00246-X; Herbinger K, 2002, PLANT PHYSIOL BIOCH, V40, P691, DOI 10.1016/S0981-9428(02)01410-9; Inada H, 2012, PHYSIOL PLANTARUM, V146, P217, DOI 10.1111/j.1399-3054.2012.01618.x; Jin MB, 2001, J ENVIRON SCI-CHINA, V13, P233; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; Krupa S, 2001, PLANT DIS, V85, P4, DOI 10.1094/PDIS.2001.85.1.4; LAISK A, 1989, PLANT PHYSIOL, V90, P1163, DOI 10.1104/pp.90.3.1163; Li J, 2011, BIOCHEM SYST ECOL, V39, P56, DOI 10.1016/j.bse.2010.12.022; Loiacono FV, 2012, OMICS, V16, P160, DOI 10.1089/omi.2011.0099; Long SP, 2012, GLOBAL CHANGE BIOL, V18, P1489, DOI 10.1111/j.1365-2486.2012.02676.x; Morgan PB, 2006, NEW PHYTOL, V170, P333, DOI 10.1111/j.1469-8137.2006.01679.x; Novak K, 2008, ENVIRON EXP BOT, V62, P212, DOI 10.1016/j.envexpbot.2007.08.008; Pleijel H, 2012, GLOBAL CHANGE BIOL, V18, P596, DOI 10.1111/j.1365-2486.2011.2489.x; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Shrestha A, 2005, CROP SCI, V45, P1587, DOI 10.2135/cropsci2004.0619; Stepien P, 2005, PHYSIOL PLANTARUM, V125, P31, DOI 10.1111/j.1399-3054.2005.00534.x; Tingey DT, 2002, WATER AIR SOIL POLL, V139, P325, DOI 10.1023/A:1015802823398; Uprety DC, 1998, J SCI IND RES INDIA, V57, P266; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; Wagg S, 2012, ENVIRON POLLUT, V165, P91, DOI 10.1016/j.envpol.2012.02.010; Wang XK, 2007, ENVIRON POLLUT, V148, P390, DOI 10.1016/j.envpol.2006.12.014; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; Woldeamlak A, 2001, NETH J AGR SCI, V49, P95, DOI 10.1016/S1573-5214(01)80018-X; Xu X, 2010, WEED SCI, V58, P179; Yuan L, 1999, ENVIRON EXP BOT, V41, P47, DOI 10.1016/S0098-8472(98)00049-5; Zheng YH, 2012, PLANT PHYSIOL BIOCH, V52, P169, DOI 10.1016/j.plaphy.2012.01.007	47	11	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60109	10.1371/journal.pone.0060109	http://dx.doi.org/10.1371/journal.pone.0060109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533669	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400106
J	Soares, P; Abrantes, D; Rito, T; Thomson, N; Radivojac, P; Li, B; Macaulay, V; Samuels, DC; Pereira, L				Soares, Pedro; Abrantes, Diogo; Rito, Teresa; Thomson, Noel; Radivojac, Predrag; Li, Biao; Macaulay, Vincent; Samuels, David C.; Pereira, Luisa			Evaluating Purifying Selection in the Mitochondrial DNA of Various Mammalian Species	PLOS ONE			English	Article							TIME DEPENDENCY; SUBSTITUTION RATE; MTDNA VARIATION; MUTATION-RATE; NATURAL-SELECTION; EVOLUTION; RATES; SEQUENCES; PATHOGENICITY; INFERENCE	Mitochondrial DNA (mtDNA), the circular DNA molecule inside the mitochondria of all eukaryotic cells, has been shown to be under the effect of purifying selection in several species. Traditional testing of purifying selection has been based simply on ratios of nonsynonymous to synonymous mutations, without considering the relative age of each mutation, which can be determined by phylogenetic analysis of this non-recombining molecule. The incorporation of a mutation time-ordering from phylogeny and of predicted pathogenicity scores for nonsynonymous mutations allow a quantitative evaluation of the effects of purifying selection in human mtDNA. Here, by using this additional information, we show that purifying selection undoubtedly acts upon the mtDNA of other mammalian species/genera, namely Bos sp., Canis lupus, Mus musculus, Orcinus orca, Pan sp. and Sus scrofa. The effects of purifying selection were comparable in all species, leading to a significant major proportion of nonsynonymous variants with higher pathogenicity scores in the younger branches of the tree. We also derive recalibrated mutation rates for age estimates of ancestors of these various species and proposed a correction curve in order to take into account the effects of selection. Understanding this selection is fundamental to evolutionary studies and to the identification of deleterious mutations.	[Soares, Pedro; Abrantes, Diogo; Rito, Teresa; Pereira, Luisa] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Oporto, Portugal; [Thomson, Noel; Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland; [Radivojac, Predrag; Li, Biao] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Samuels, David C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Pereira, Luisa] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; University of Glasgow; Indiana University System; Indiana University Bloomington; Vanderbilt University; Universidade do Porto	Soares, P (corresponding author), Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Oporto, Portugal.	pedroa@ipatimup.pt	Rito, Teresa/AAC-9041-2019; Samuels, David/AHC-8381-2022; Soares, Pedro A/G-9422-2011; Samuels, David C/A-5393-2008; Pereira, Luisa/H-3050-2011; Rito, Teresa/O-7726-2014	Rito, Teresa/0000-0002-8374-6347; Samuels, David/0000-0003-3529-7791; Soares, Pedro A/0000-0002-2807-690X; Samuels, David C/0000-0003-3529-7791; Pereira, Luisa/0000-0002-4271-1527; Rito, Teresa/0000-0002-8374-6347; Abrantes, Diogo/0000-0003-3038-1732	FCT, the Portuguese Foundation for Science and Technology [SFRH/BPD/64233/2009, PTDC/CS-ANT/113832/2009]; FCT; Luso-American Development Foundation; Fundação para a Ciência e a Tecnologia [PTDC/CS-ANT/113832/2009] Funding Source: FCT	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Luso-American Development Foundation; Fundação para a Ciência e a Tecnologia	FCT, the Portuguese Foundation for Science and Technology, supported this work through the personal grant to PS (SFRH/BPD/64233/2009) and TR (under the project PTDC/CS-ANT/113832/2009). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT (www.fct.pt). LP and PS had a mobility grant from The Luso-American Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; BANDELT HJ, 1995, GENETICS, V141, P743; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fernandes F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-230; Forster P, 1996, AM J HUM GENET, V59, P935; Freitas F, 2009, MITOCHONDRION, V9, P36, DOI 10.1016/j.mito.2008.11.003; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gissi C, 2000, MOL BIOL EVOL, V17, P1022, DOI 10.1093/oxfordjournals.molbev.a026383; Goios A, 2008, ELECTROPHORESIS, V29, P4795, DOI 10.1002/elps.200800313; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nachman MW, 1996, GENETICS, V142, P953; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen R, 1999, GENETICS, V153, P497; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Penny D, 2012, MOL BIOL EVOL; Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225; Pereira L, 2004, FORENSIC SCI INT, V141, P99, DOI 10.1016/j.forsciint.2003.12.014; Pereira L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-53; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Subramanian S, 2011, GENOME BIOL EVOL, V3, P1324, DOI 10.1093/gbe/evr108; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wang ZF, 2011, MOL BIOL EVOL, V28, P1553, DOI 10.1093/molbev/msq336; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	71	37	37	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58993	10.1371/journal.pone.0058993	http://dx.doi.org/10.1371/journal.pone.0058993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533597	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000316549400034
J	Stevenson, JL; Gernsbacher, MA				Stevenson, Jennifer L.; Gernsbacher, Morton Ann			Abstract Spatial Reasoning as an Autistic Strength	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; PERVASIVE DEVELOPMENTAL DISORDER; WEAK CENTRAL COHERENCE; EMBEDDED FIGURES TEST; ASPERGER-SYNDROME; INFANTILE-AUTISM; VERBAL-ABILITY; BLOCK DESIGN; SPECTRUM DISORDERS; GENDER-DIFFERENCES	Autistic individuals typically excel on spatial tests that measure abstract reasoning, such as the Block Design subtest on intelligence test batteries and the Raven's Progressive Matrices nonverbal test of intelligence. Such well-replicated findings suggest that abstract spatial processing is a relative and perhaps absolute strength of autistic individuals. However, previous studies have not systematically varied reasoning level - concrete vs. abstract - and test domain - spatial vs. numerical vs. verbal, which the current study did. Autistic participants (N = 72) and non-autistic participants (N = 72) completed a battery of 12 tests that varied by reasoning level (concrete vs. abstract) and domain (spatial vs. numerical vs. verbal). Autistic participants outperformed non-autistic participants on abstract spatial tests. Non-autistic participants did not outperform autistic participants on any of the three domains (spatial, numerical, and verbal) or at either of the two reasoning levels (concrete and abstract), suggesting similarity in abilities between autistic and non-autistic individuals, with abstract spatial reasoning as an autistic strength.	[Stevenson, Jennifer L.] Ursinus Coll, Dept Psychol, Collegeville, PA 19426 USA; [Gernsbacher, Morton Ann] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stevenson, JL (corresponding author), Ursinus Coll, Dept Psychol, Collegeville, PA 19426 USA.	jstevenson@ursinus.edu	Stevenson, Jennifer L/O-4812-2016	Stevenson, Jennifer L/0000-0002-3896-461X; Gernsbacher, Morton Ann/0000-0003-0397-3329	Vilas Research Trust from the University of Wisconsin-Madison	Vilas Research Trust from the University of Wisconsin-Madison	The Vilas Research Trust from the University of Wisconsin-Madison to MAG supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MH, 1991, J AUTISM DEV DISORD, V21, P483, DOI 10.1007/BF02206872; ASARNOW RF, 1987, J CHILD PSYCHOL PSYC, V28, P273, DOI 10.1111/j.1469-7610.1987.tb00210.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; BARTAK L, 1975, BRIT J PSYCHIAT, V126, P127, DOI 10.1192/bjp.126.2.127; Bolte S, 2008, J NEURAL TRANSM, V115, P545, DOI 10.1007/s00702-007-0850-1; Bolte S, 2009, J AUTISM DEV DISORD, V39, P678, DOI 10.1007/s10803-008-0667-2; Bolte S, 2004, INTELLIGENCE, V32, P121, DOI 10.1016/j.intell.2003.11.002; Bolte S, 2002, COMPR PSYCHIAT, V43, P325, DOI 10.1053/comp.2002.33490; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Dawson M, 2011, PLOS ONE; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; de Bruin EI, 2006, J ABNORM CHILD PSYCH, V34, P263, DOI 10.1007/s10802-005-9018-3; Dennis M, 1999, J AUTISM DEV DISORD, V29, P5, DOI 10.1023/A:1025962431132; Edgin JO, 2005, J AUTISM DEV DISORD, V35, P729, DOI 10.1007/s10803-005-0020-y; Ehlers S, 1997, J CHILD PSYCHOL PSYC, V38, P207, DOI 10.1111/j.1469-7610.1997.tb01855.x; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Else-Quest NM, 2010, PSYCHOL BULL, V136, P103, DOI 10.1037/a0018053; Freeman BJ, 1985, J PSYCHOEDUCATIONAL, V4, P357, DOI DOI 10.1177/0734282985; Fugard AJB, 2011, AUTISM, V15, P327, DOI 10.1177/1362361310371798; Gilchrist A, 2001, J CHILD PSYCHOL PSYC, V42, P227, DOI 10.1111/1469-7610.00714; Goldstein G, 2002, ARCH CLIN NEUROPSYCH, V17, P461, DOI 10.1016/S0887-6177(01)00129-9; Grandin T, 2009, PHILOS T R SOC B, V364, P1437, DOI 10.1098/rstb.2008.0297; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P1278, DOI 10.1007/s10803-009-0740-5; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P670, DOI 10.1007/s10803-008-0658-3; Hagen E. P., 2001, COGNITIVE ABILITIES; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; Holdnack J, 2011, ASSESSMENT, V18, P192, DOI 10.1177/1073191110394771; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Keehn B, 2009, J AUTISM DEV DISORD, V39, P383, DOI 10.1007/s10803-008-0608-0; Koyama T, 2007, PSYCHIAT CLIN NEUROS, V61, P99, DOI 10.1111/j.1440-1819.2007.01617.x; Koyama T, 2006, J AUTISM DEV DISORD, V36, P373, DOI 10.1007/s10803-006-0075-4; Koyama T, 2008, PSYCHIAT CLIN NEUROS, V62, P691, DOI 10.1111/j.1440-1819.2008.01871.x; Koyama T, 2009, J AUTISM DEV DISORD, V39, P135, DOI 10.1007/s10803-008-0610-6; LINCOLN AJ, 1988, J AUTISM DEV DISORD, V18, P505, DOI 10.1007/BF02211870; LOCKYER L, 1970, BRIT J SOC CLIN PSYC, V9, P152, DOI 10.1111/j.2044-8260.1970.tb00654.x; MARSHALEK B, 1983, INTELLIGENCE, V7, P107, DOI 10.1016/0160-2896(83)90023-5; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Mayes SD, 2003, J AUTISM DEV DISORD, V33, P329, DOI 10.1023/A:1024462719081; Mayes SD, 2008, J AUTISM DEV DISORD, V38, P428, DOI 10.1007/s10803-007-0410-4; Merchan-Naranjo J, 2011, J AUTISM DEV DISORD; MINSHEW NJ, 1994, ARCH CLIN NEUROPSYCH, V9, P31, DOI 10.1016/0887-6177(94)90012-4; Minshew NJ, 2005, J AUTISM DEV DISORD, V35, P45, DOI 10.1007/s10803-004-1030-x; Minshew NJ, 2002, NEUROPSYCHOLOGY, V16, P327, DOI 10.1037//0894-4105.16.3.327; Morgan B, 2003, DEV PSYCHOL, V39, P646, DOI 10.1037/0012-1649.39.4.646; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Narita T, 1987, ADV BIOL PSYCHIAT, V16, P156; Noterdaeme M, 2010, EUR CHILD ADOLES PSY, V19, P475, DOI 10.1007/s00787-009-0057-0; Nyden A, 2001, DEV MED CHILD NEUROL, V43, P165, DOI 10.1017/S0012162201000329; OHTA M, 1987, J AUTISM DEV DISORD, V17, P45, DOI 10.1007/BF01487259; Pellicano E, 2006, DEV PSYCHOPATHOL, V18, P77, DOI 10.1017/S0954579406060056; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Raven J.C., 1998, ADV PROGR MATRICES; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Reips UD, 2001, BEHAV RES METH INS C, V33, P201, DOI 10.3758/BF03195366; Ropar D, 2007, J AUTISM DEV DISORD, V37, P270, DOI 10.1007/s10803-006-0166-2; RUMSEY JM, 1988, J CLIN EXP NEUROPSYC, V10, P201, DOI 10.1080/01688638808408236; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; Sinclair J., 1999, WHY I DISLIKE PERSON; Snow R., 1984, ADV PSYCHOL HUMAN IN, P47; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Spek AA, 2008, J AUTISM DEV DISORD, V38, P782, DOI 10.1007/s10803-007-0446-5; Stewart ME, 2009, AUTISM, V13, P133, DOI 10.1177/1362361308098515; SZATMARI P, 1990, J AM ACAD CHILD PSY, V29, P130, DOI 10.1097/00004583-199001000-00021; TYMCHUK AJ, 1977, J MENT DEFIC RES, V21, P133; Vallejo MA, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.1.e2; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2012, WECHSLER PRESCHOOL P, VFourth; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams DL, 2006, NEUROPSYCHOLOGY, V20, P21, DOI 10.1037/0894-4105.20.1.21	80	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59329	10.1371/journal.pone.0059329	http://dx.doi.org/10.1371/journal.pone.0059329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533615	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400052
J	Biino, G; Parati, G; Concas, MP; Adamo, M; Angius, A; Vaccargiu, S; Pirastu, M				Biino, Ginevra; Parati, Gianfranco; Concas, Maria Pina; Adamo, Mauro; Angius, Andrea; Vaccargiu, Simona; Pirastu, Mario			Environmental and Genetic Contribution to Hypertension Prevalence: Data from an Epidemiological Survey on Sardinian Genetic Isolates	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; UNITED-STATES; EUROPEAN COUNTRIES; GENOMEWIDE SEARCH; LINKAGE ANALYSIS; HERITABILITY; POPULATION; TRAITS; DIFFERENTIATION; MANAGEMENT	Background and Objectives: Hypertension represents a major cause of cardiovascular morbidity and mortality worldwide but its prevalence has been shown to vary in different countries. The reasons for such differences are still matter of debate, the relative contributions given by environmental and genetic factors being still poorly defined. We estimated the current prevalence, distribution and determinants of hypertension in isolated Sardinian populations and also investigated the environmental and genetic contribution to hypertension prevalence taking advantage of the characteristics of such populations. Methods and Results: An epidemiological survey with cross-sectional design was carried out measuring blood pressure in 9845 inhabitants of 10 villages of Ogliastra region between 2002 and 2008. Regression analysis for assessing blood pressure determinants and variance component models for estimating heritability were performed. Overall 38.8% of this population had hypertension, its prevalence varying significantly by age, sex and among villages taking into account age and sex structure of their population. About 50% of hypertensives had prior cardiovascular disease. High blood pressure was independently associated with age, obesity related factors, heart rate, total cholesterol, alcohol consumption, low education and smoking status, all these factors contributing more in women than in men. Heritability was 27% for diastolic and 36% for systolic blood pressure, its contribution being significantly higher in men (57%) than in women (46%). Finally, the genetic correlation between systolic and diastolic blood pressure was 0.74, indicating incomplete pleiotropy. Conclusion: Genetic factors involved in the expression of blood pressure traits account for about 30% of the phenotypic variance, but seem to play a larger role in men; comorbidities and environmental factors remain of predominant importance, but seem to contribute much more in women.	[Biino, Ginevra; Angius, Andrea; Vaccargiu, Simona; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, Sassari, Italy; [Biino, Ginevra; Concas, Maria Pina] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Parati, Gianfranco] S Luca Hosp, Dept Cardiol, Ist Auxol Italiano, Milan, Italy; [Parati, Gianfranco] Univ Milano Bicocca, Chair Cardiol, Milan, Italy; [Parati, Gianfranco] Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy; [Adamo, Mauro; Pirastu, Mario] Shardna Life Sci, Pula, Italy; [Angius, Andrea] Natl Res Council Italy, Inst Genet & Biomed Res, Monserrato, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Auxologico Italiano; University of Milano-Bicocca; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Biino, G (corresponding author), Natl Res Council Italy, Inst Populat Genet, Sassari, Italy.	biino@igm.cnr.it	Biino, Ginevra/B-5334-2013; Concas, Maria Pina/K-2266-2018; Angius, Andrea/P-9549-2015; Parati, Gianfranco/K-7151-2016; Angius, Andrea/B-8966-2015; Adamo, Mauro/AAA-6491-2019	Biino, Ginevra/0000-0002-9936-946X; Concas, Maria Pina/0000-0003-3598-2537; Angius, Andrea/0000-0003-2596-6461; Parati, Gianfranco/0000-0001-9402-7439; Adamo, Mauro/0000-0001-9072-3648; Angius, Andrea/0000-0001-9372-1162	Italian Ministry of Education, University and Research [MERIT RBNE08NKH7_007]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from the Italian Ministry of Education, University and Research (MERIT RBNE08NKH7_007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; [Anonymous], 2003, J HYPERTENSION, V21, P1011; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Bharucha NE, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-1; Biino G, 2005, HUM GENET, V116, P152, DOI 10.1007/s00439-004-1231-6; Bochud M, 2005, HYPERTENSION, V45, P445, DOI 10.1161/01.HYP.0000156538.59873.86; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Brown WM, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S32; Campbell NRC, 2002, CAN J CARDIOL, V18, P591; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Dominiczak AF, 2004, CLIN EXP HYPERTENS, V26, P611, DOI 10.1081/CEH-200031939; Doris PA, 2011, CARDIOVASC THER, V29, P37, DOI 10.1111/j.1755-5922.2010.00246.x; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Estoppey D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-114; Falchi M, 2004, AM J HUM GENET, V75, P1015, DOI 10.1086/426155; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Geleijnse JM, 1996, J HYPERTENS, V14, P737, DOI 10.1097/00004872-199606000-00009; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; GROPPELLI A, 1990, J HYPERTENS, V8, pS35; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lloyd-Jones DM, 2002, HYPERTENSION, V40, P640, DOI 10.1161/01.HYP.0000035855.44620.DA; MANCIA G, 1993, HYPERTENSION, V21, P510, DOI 10.1161/01.HYP.21.4.510; Martin LJ, 2002, GENET EPIDEMIOL, V22, P105, DOI 10.1002/gepi.0135; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; Mocci E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-81; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Prodi DA, 2004, CHEM SENSES, V29, P697, DOI 10.1093/chemse/bjh074; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wong ND, 2003, AM HEART J, V145, P888, DOI 10.1016/S0002-8703(02)94787-3; World Health Organization, 2012, WORLD HLTH STAT 2012; Yagil Y, 2005, CURR OPIN NEPHROL HY, V14, P141, DOI 10.1097/00041552-200503000-00009	42	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59612	10.1371/journal.pone.0059612	http://dx.doi.org/10.1371/journal.pone.0059612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527229	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600081
J	Kirshenbaum, GS; Dawson, N; Mullins, JGL; Johnston, TH; Drinkhill, MJ; Edwards, IJ; Fox, SH; Pratt, JA; Brotchie, JM; Roder, JC; Clapcote, SJ				Kirshenbaum, Greer S.; Dawson, Neil; Mullins, Jonathan G. L.; Johnston, Tom H.; Drinkhill, Mark J.; Edwards, Ian J.; Fox, Susan H.; Pratt, Judith A.; Brotchie, Jonathan M.; Roder, John C.; Clapcote, Steven J.			Alternating Hemiplegia of Childhood-Related Neural and Behavioural Phenotypes in Na+,K+-ATPase alpha 3 Missense Mutant Mice	PLOS ONE			English	Article							RAPID-ONSET DYSTONIA; DE-NOVO MUTATIONS; K+-ATPASE; LATENT INHIBITION; PARKINSONISM RDP; NA+ INTERACTION; ATP1A3; ISOFORM; MOUSE; MIGRAINE	Missense mutations in ATP1A3 encoding Na+,K+-ATPase alpha 3 have been identified as the primary cause of alternating hemiplegia of childhood (AHC), a motor disorder with onset typically before the age of 6 months. Affected children tend to be of short stature and can also have epilepsy, ataxia and learning disability. The Na+,K+-ATPase has a well-known role in maintaining electrochemical gradients across cell membranes, but our understanding of how the mutations cause AHC is limited. Myshkin mutant mice carry an amino acid change (I810N) that affects the same position in Na+,K+-ATPase alpha 3 as I810S found in AHC. Using molecular modelling, we show that the Myshkin and AHC mutations display similarly severe structural impacts on Na+,K+-ATPase alpha 3, including upon the K+ pore and predicted K+ binding sites. Behavioural analysis of Myshkin mice revealed phenotypic abnormalities similar to symptoms of AHC, including motor dysfunction and cognitive impairment. 2-DG imaging of Myshkin mice identified compromised thalamocortical functioning that includes a deficit in frontal cortex functioning (hypofrontality), directly mirroring that reported in AHC, along with reduced thalamocortical functional connectivity. Our results thus provide validation for missense mutations in Na+,K+-ATPase alpha 3 as a cause of AHC, and highlight Myshkin mice as a starting point for the exploration of disease mechanisms and novel treatments in AHC.	[Kirshenbaum, Greer S.; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kirshenbaum, Greer S.; Roder, John C.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Dawson, Neil; Pratt, Judith A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Mullins, Jonathan G. L.] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales; [Johnston, Tom H.; Fox, Susan H.; Brotchie, Jonathan M.] Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Drinkhill, Mark J.] Univ Leeds, Div Cardiovasc & Neuronal Remodelling, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Edwards, Ian J.; Clapcote, Steven J.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Strathclyde; Swansea University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Leeds; University of Leeds	Clapcote, SJ (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	s.j.clapcote@leeds.ac.uk	Dawson, Neil/W-5557-2019; Roder, John/G-6468-2013; Johnston, Tom H/D-2531-2018	Dawson, Neil/0000-0003-0123-897X; Johnston, Tom H/0000-0002-1537-8175; Mullins, Jonathan/0000-0003-0144-2962; Edwards, Ian/0000-0001-6066-4392; Kirshenbaum, Greer/0000-0001-6408-6606; Brotchie, Jonathan/0000-0003-2337-0816	Bachmann-Strauss Dystonia & Parkinsonism Foundation; Canadian Institutes of Health Research [MOP-94856]; Amalgamated Transit Union, Local 113; Cure Parkinson's Trust; Ontario Mental Health Foundation Research Studentship; Canada Research Chair (Tier 1)	Bachmann-Strauss Dystonia & Parkinsonism Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amalgamated Transit Union, Local 113; Cure Parkinson's Trust; Ontario Mental Health Foundation Research Studentship; Canada Research Chair (Tier 1)(Canada Research Chairs)	This work was supported by the Bachmann-Strauss Dystonia & Parkinsonism Foundation (www.dystonia-parkinsons.org) [to SJC], the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) [MOP-94856] and the Amalgamated Transit Union, Local 113 (wemovetoronto.ca) [to JCR], and The Cure Parkinson's Trust (www.cureparkinsons.org.uk) [to JMB]. GSK was supported by an Ontario Mental Health Foundation Research Studentship (www.omhf.on.ca), and JCR was supported by a Canada Research Chair (Tier 1) (www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Dawson N, 2014, CEREB CORTEX, V24, P452, DOI 10.1093/cercor/bhs322; Dawson N, 2013, SCHIZOPHRENIA BULL, V39, P366, DOI 10.1093/schbul/sbr144; Dawson N, 2012, SCHIZOPHRENIA BULL, V38, P457, DOI 10.1093/schbul/sbq090; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Ferrari P, 2006, AM J PHYSIOL-REG I, V290, pR529, DOI 10.1152/ajpregu.00518.2005; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Heo S, 2012, NEUROCHEM INT, V61, P702, DOI 10.1016/j.neuint.2012.07.006; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Hua S, 1998, MOVEMENT DISORD, V13, P40; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Lombardero M, 2007, INT J EXP PATHOL, V88, P165, DOI 10.1111/j.1365-2613.2007.00528.x; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Padilla-Coreano N, 2012, NEUROPHARMACOLOGY, V62, P457, DOI 10.1016/j.neuropharm.2011.08.037; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; PURVES D, 1995, BEHAV NEUROSCI, V109, P366, DOI 10.1037/0735-7044.109.2.366; R Core Team, 2020, R LANG ENV STAT COMP; REILLY S, 1993, BEHAV NEUROSCI, V107, P996, DOI 10.1037/0735-7044.107.6.996; Richter A, 1998, MOVEMENT DISORD, V13, P718, DOI 10.1002/mds.870130419; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Sasaki M, 2009, BRAIN DEV-JPN, V31, P20, DOI 10.1016/j.braindev.2008.03.008; Shafer ME, 2005, APPL NEUROPSYCHOL, V12, P49, DOI 10.1207/s15324826an1201_8; SILVER K, 1993, NEUROLOGY, V43, P36, DOI 10.1212/WNL.43.1_Part_1.36; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Szatanik M, 2008, NEUROGENETICS, V9, P237, DOI 10.1007/s10048-008-0136-2; Tulogdi A, 2012, BRAIN RES BULL, V88, P359, DOI 10.1016/j.brainresbull.2012.04.001; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Van Huysse JW, 2011, AM J PHYSIOL-HEART C, V301, pH2147, DOI 10.1152/ajpheart.01216.2010; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Winocur G, 1998, BEHAV NEUROSCI, V112, P89, DOI 10.1037/0735-7044.112.1.89; Xie G, 2010, J BIOL CHEM, V285, P32160, DOI 10.1074/jbc.M110.153676; Yao WG, 2005, ENDOCRINE, V26, P117, DOI 10.1385/ENDO:26:2:117; Yokoi F, 2006, J BIOCHEM, V140, P141, DOI 10.1093/jb/mvj138; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027	65	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60141	10.1371/journal.pone.0060141	http://dx.doi.org/10.1371/journal.pone.0060141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527305	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000317562600122
J	Zhi, F; Dong, HF; Jia, XF; Guo, WJ; Lu, HT; Yang, YL; Ju, HX; Zhang, XJ; Hu, YQ				Zhi, Feng; Dong, Haifeng; Jia, Xuefeng; Guo, Wenjie; Lu, Huiting; Yang, Yilin; Ju, Huangxian; Zhang, Xueji; Hu, Yiqiao			Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro	PLOS ONE			English	Article							CANCER DRUG-RESISTANCE; BREAST-CANCER; CO-DELIVERY; DOWN-REGULATION; NANOPARTICLES; DOXORUBICIN; CELLS; SIRNA; MICRORNA; TRANSPORTERS	Multidrug resistance (MDR) is a major impediment to successful cancer chemotherapy. Co-delivery of novel MDR-reversing agents and anticancer drugs to cancer cells holds great promise for cancer treatment. MicroRNA-21 (miR-21) overexpression is associated with the development and progression of MDR in breast cancer, and it is emerging as a novel and promising MDR-reversing target. In this study, a multifunctional nanocomplex, composed of polyethylenimine (PEI)/poly(sodium 4-styrenesulfonates) (PSS)/graphene oxide (GO) and termed PPG, was prepared using the layer-by-layer assembly method to evaluate the reversal effects of PPG as a carrier for adriamycin (ADR) along with miR-21 targeted siRNA (anti-miR-21) in cancer drug resistance. ADR was firstly loaded onto the PPG surface (PPG(ADR)) by physical mixing and anti-miR-21 was sequentially loaded onto PPG(ADR) through electric absorption to form (anti-miR-21)PPG(ADR). Cell experiments showed that PPG significantly enhanced the accumulation of ADR in MCF-7/ADR cells (an ADR resistant breast cancer cell line) and exhibited much higher cytotoxicity than free ADR, suggesting that PPG could effectively reverse ADR resistance of MCF-7/ADR. Furthermore, the enhanced therapeutic efficacy of PPG could be correlated with effective silencing of miR-21 and with increased accumulation of ADR in drug-resistant tumor cells. The endocytosis study confirmed that PPG could effectively carry drug molecules into cells via the caveolae and clathrin-mediated endocytosis pathways. These results suggest that this PPG could be a potential and efficient non-viral vector for reversing MDR, and the strategy of combining anticancer drugs with miRNA therapy to overcome MDR could be an attractive approach in cancer treatment.	[Zhi, Feng; Jia, Xuefeng; Guo, Wenjie; Hu, Yiqiao] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Dong, Haifeng; Lu, Huiting; Zhang, Xueji] Univ Sci & Technol Beijing, Res Ctr Bioengn & Sensing Technol, Beijing 100083, Peoples R China; [Ju, Huangxian] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Dept Chem, Nanjing 210008, Jiangsu, Peoples R China; [Zhi, Feng; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Peoples R China	Nanjing University; University of Science & Technology Beijing; Nanjing University; Soochow University - China	Ju, HX (corresponding author), Nanjing Univ, State Key Lab Analyt Chem Life Sci, Dept Chem, Nanjing 210008, Jiangsu, Peoples R China.	hxju@nju.edu.cn; zhangxueji@ustb.edu.cn; huyiqiao.nju@gmail.com	Guo, Wenjie/AAQ-7553-2020; zhang, xueji/ABE-6497-2020; zhang, xueji/B-1904-2010; Ju, Huangxian/B-2265-2010	zhang, xueji/0000-0002-0035-3821; Ju, Huangxian/0000-0002-6741-5302	National Natural Science Foundation of China [31071046, 21135002, 21121091]; Changzhou Science Development Project [CS20092015, CS20102010]; Changzhou Health Bureau Key Project [ZD200903, ZD201007]; National Basic Research Program of China [2010CB732400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science Development Project; Changzhou Health Bureau Key Project; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31071046, 21135002, 21121091), Changzhou Science Development Project (CS20092015, CS20102010), Changzhou Health Bureau Key Project (ZD200903, ZD201007), National Basic Research Program of China (2010CB732400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae Y, 2007, J CONTROL RELEASE, V122, P324, DOI 10.1016/j.jconrel.2007.05.038; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Cao N, 2011, BIOMATERIALS, V32, P2222, DOI 10.1016/j.biomaterials.2010.11.061; Chen BA, 2010, INT J NANOMED, V5, P437; Dong HF, 2011, BIOMATERIALS, V32, P3875, DOI 10.1016/j.biomaterials.2011.02.001; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Greco F, 2009, ADV DRUG DELIVER REV, V61, P1203, DOI 10.1016/j.addr.2009.05.006; Hu CMJ, 2009, CURR DRUG METAB, V10, P836, DOI 10.2174/138920009790274540; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Iorio MV, 2011, BREAST, V20, pS63, DOI 10.1016/S0960-9776(11)70297-1; Jeong HK, 2009, J PHYS CHEM C, V113, P13060, DOI 10.1021/jp9026282; Jiang JA, 2010, EUR J PHARM BIOPHARM, V76, P170, DOI 10.1016/j.ejpb.2010.06.011; Kim H, 2011, BIOCONJUGATE CHEM, V22, P2558, DOI 10.1021/bc200397j; Kim JH, 2011, J BIOTECHNOL, V155, P287, DOI 10.1016/j.jbiotec.2011.07.014; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee CH, 2010, METHODS MOL BIOL, V596, P325, DOI 10.1007/978-1-60761-416-6_14; Li JM, 2012, BIOMATERIALS, V33, P2780, DOI 10.1016/j.biomaterials.2011.12.035; Liu PF, 2012, BIOMATERIALS, V33, P4403, DOI 10.1016/j.biomaterials.2012.02.041; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Lu CH, 2010, CHEM COMMUN, V46, P3116, DOI 10.1039/b926893f; MacDiarmid JA, 2009, NAT BIOTECHNOL, V27, P643, DOI 10.1038/nbt.1547; Mei M, 2010, TECHNOL CANCER RES T, V9, P77, DOI 10.1177/153303461000900109; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; Park JS, 2012, BIOMATERIALS, V33, P8600, DOI 10.1016/j.biomaterials.2012.08.008; Ren TB, 2012, POLYM CHEM-UK, V3, P2561, DOI 10.1039/c2py20343j; Ren Y, 2010, J BIOMAT SCI-POLYM E, V21, P303, DOI 10.1163/156856209X415828; Sahoo NG, 2011, CHEM COMMUN, V47, P5235, DOI 10.1039/c1cc00075f; Shapira A, 2011, DRUG RESIST UPDATE, V14, P150, DOI 10.1016/j.drup.2011.01.003; Soma CE, 2000, BIOMATERIALS, V21, P1; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; Spankuch B, 2006, CANCER RES, V66, P5836, DOI 10.1158/0008-5472.CAN-06-0343; Stein WD, 2004, CURR DRUG TARGETS, V5, P333, DOI 10.2174/1389450043345489; Su WP, 2012, INT J NANOMED, V7, P4269, DOI 10.2147/IJN.S33666; Sun TM, 2011, ACS NANO, V5, P1483, DOI 10.1021/nn103349h; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; Tan B, 2000, CURR OPIN ONCOL, V12, P450, DOI 10.1097/00001622-200009000-00011; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Wang ZX, 2011, ARCH MED RES, V42, P281, DOI 10.1016/j.arcmed.2011.06.008; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiong XB, 2011, ACS NANO, V5, P5202, DOI 10.1021/nn2013707; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522; Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782; Zhou L, 2011, CHEM-EUR J, V17, P12084, DOI 10.1002/chem.201003078	51	98	100	1	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60034	10.1371/journal.pone.0060034	http://dx.doi.org/10.1371/journal.pone.0060034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527297	Green Published, gold			2022-12-27	WOS:000317562600114
J	Urra, X; Arino, H; Llull, L; Amaro, S; Obach, V; Cervera, A; Chamorro, A				Urra, Xabier; Arino, Helena; Llull, Laura; Amaro, Sergio; Obach, Victor; Cervera, Alvaro; Chamorro, Angel			The Outcome of Patients with Mild Stroke Improves after Treatment with Systemic Thrombolysis	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; GUIDELINES; THERAPY; TRIAL; SCALE	Introduction: In up to one third of patients with mild stroke suitable to receive systemic thrombolysis the treatment is not administered because the treating physicians estimate a good spontaneous recovery. However, it is not settled whether the fate of these patients is equivalent to those who are thrombolysed. Methods: We analyzed 203 consecutive patients (134 men and 69 women, mean age 69614 years) without premorbid disability and a NIHSS score <= 5 at admission [median 3 (IQR 2-4)]. Intravenous thrombolysis was administered within 4.5 hours from stroke onset (n = 119), or it was withheld (n = 84) whenever the treating physician predicted a spontaneous recovery. The baseline risk factors, clinical course, infarction volume, bleeding complications, and functional outcome at 3 months were analyzed and declared to a Web-based registry which was accessible to the local Health Authorities. Results: Expectedly, not thrombolysed patients had the mildest strokes at admission [median 2 (IQR 1-3.75)]. At day 2 to 5, the infarct volume on DWI-MRI was similar in both groups. There were no symptomatic cerebral bleedings in the study. An ordinal regression model adjusted for baseline stroke severity showed that thrombolysis was associated with a greater proportion of patients who shifted down on the modified Rankin Scale score at 3 months (OR 2.66; 95% CI 1.49-4.74, p = 0.001). Conclusions: Intravenous thrombolysis seems to be safe in patients with mild stroke and may be associated with improved outcome compared with untreated patients. These results support the evaluation of the efficacy of intravenous thrombolysis in mild stroke patients in randomized clinical trials.	[Urra, Xabier; Arino, Helena; Llull, Laura; Amaro, Sergio; Obach, Victor; Cervera, Alvaro; Chamorro, Angel] Hosp Clin Barcelona, Funct Unit Cerebrovasc Dis, Barcelona, Spain; [Urra, Xabier; Amaro, Sergio; Cervera, Alvaro; Chamorro, Angel] Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Chamorro, Angel] Univ Barcelona, Sch Med, Dept Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Chamorro, A (corresponding author), Hosp Clin Barcelona, Funct Unit Cerebrovasc Dis, Barcelona, Spain.	achamorro@clinic.ub.es	Ariño, Helena/C-3248-2018; Urra, Xabier/B-7637-2019	Ariño, Helena/0000-0003-4036-1671; Urra, Xabier/0000-0002-4763-5252				Abilleira S, 2011, STROKE, V42, P2001, DOI 10.1161/STROKEAHA.110.605030; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Baumann CR, 2006, STROKE, V37, P1332, DOI 10.1161/01.STR.0000217272.38455.a2; Broderick JP, 2005, ANN EMERG MED, V46, P243, DOI 10.1016/j.annemergmed.2005.02.013; Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hassan AE, 2010, SOUTH MED J, V103, P398, DOI 10.1097/SMJ.0b013e3181d7814a; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Khatri P, 2012, STROKE, V43, P560, DOI 10.1161/STROKEAHA.110.593897; Khatri P, 2011, STROKE, V42, pE66; Khatri P, 2010, STROKE, V41, P2581, DOI 10.1161/STROKEAHA.110.593632; Kohrmann M, 2009, CEREBROVASC DIS, V27, P160, DOI 10.1159/000185607; Leira EC, 2012, STROKE, V43, P782, DOI 10.1161/STROKEAHA.111.620674; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith EE, 2011, STROKE, V42, P3110, DOI 10.1161/STROKEAHA.111.613208; Strbian D, 2013, INT J STROKE, V8, P293, DOI 10.1111/j.1747-4949.2012.00808.x; Sun MC, 2011, ISRN NEUROL; Willey JZ, 2011, J STROKE CEREBROVASC, DOI [10.1016/j.jstrokecerebro-vasdis.2011.09.005, DOI 10.1016/J.JSTROKECEREBRO-VASDIS.2011.09.005]; Wityk RJ, 2001, ARCH NEUROL-CHICAGO, V58, P571, DOI 10.1001/archneur.58.4.571	27	30	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59420	10.1371/journal.pone.0059420	http://dx.doi.org/10.1371/journal.pone.0059420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527192	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100131
J	Ruiz-Cooley, RI; Ballance, LT; McCarthy, MD				Ruiz-Cooley, Rocio I.; Ballance, Lisa T.; McCarthy, Matthew D.			Range Expansion of the Jumbo Squid in the NE Pacific: delta N-15 Decrypts Multiple Origins, Migration and Habitat Use	PLOS ONE			English	Article							NITROGEN ISOTOPIC COMPOSITION; DOSIDICUS-GIGAS CEPHALOPODA; TROPHIC RELATIONSHIPS; VARIABILITY; DELTA-C-13; POSITION; MARGIN; SEA	Coincident with climate shifts and anthropogenic perturbations, the highly voracious jumbo squid Dosidicus gigas reached unprecedented northern latitudes along the NE Pacific margin post 1997-98. The physical or biological drivers of this expansion, as well as its ecological consequences remain unknown. Here, novel analysis from both bulk tissues and individual amino acids (Phenylalanine; Phe and Glutamic acid; Glu) in both gladii and muscle of D. gigas captured in the Northern California Current System (NCCS) documents for the first time multiple geographic origins and migration. Phe delta N-15 values, a proxy for habitat baseline delta N-15 values, confirm at least three different geographic origins that were initially detected by highly variable bulk delta N-15 values in gladii for squid at small sizes (< 30 cm gladii length). In contrast, bulk delta N-15 values from gladii of large squid (> 60 cm) converged, indicating feeding in a common ecosystem. The strong latitudinal gradient in Phe delta N-15 values from composite muscle samples further confirmed residency at a point in time for large squid in the NCCS. These results contrast with previous ideas, and indicate that small squid are highly migratory, move into the NCCS from two or more distinct geographic origins, and use this ecosystem mainly for feeding. These results represent the first direct information on the origins, immigration and habitat use of this key "invasive'' predator in the NCCS, with wide implications for understanding both the mechanisms of periodic D. gigas population range expansions, and effects on ecosystem trophic structure.	[Ruiz-Cooley, Rocio I.] NOAA, Natl Res Council, La Jolla, CA USA; [Ruiz-Cooley, Rocio I.; Ballance, Lisa T.] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Ruiz-Cooley, Rocio I.; McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz	Ruiz-Cooley, RI (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	rcooley@ucsc.edu	Ballance, Lisa/AAF-5472-2020					Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Barlow J, 2007, FISH B-NOAA, V105, P509; Bizikov VA, 1991, SQUID AGE DETERMINAT, P39; Bjorkstedt EP, 2011, CAL COOP OCEAN FISH, V52, P36; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Braid HE, 2012, MAR BIOL, V159, P25, DOI 10.1007/s00227-011-1786-4; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Clark FN, 1936, CALIF FISH GAME, V22, P143; Croker R.S., 1937, CALIF FISH GAME, V23, P246; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Field JC, 2013, DEEP-SEA RES PT II, V95, P37, DOI 10.1016/j.dsr2.2012.09.006; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Holmes J, 2008, CAL COOP OCEAN FISH, V49, P86; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; LIU KK, 1989, LIMNOL OCEANOGR, V34, P820, DOI 10.4319/lo.1989.34.5.0820; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Nigmatullin CM, 2008, J MAR BIOL ASSOC UK, V1, P1; Olson RJ, 2010, PROG OCEANOGR, V86, P124, DOI 10.1016/j.pocean.2010.04.026; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearcy WG, 2002, PROG OCEANOGR, V54, P399, DOI 10.1016/S0079-6611(02)00060-5; Pimentel MS, 2012, MAR BIOL, V159, P2051, DOI 10.1007/s00227-012-1991-9; Popp BN, 2007, TERR ECOL SER, V1, P173; Reid J.L., 1958, CALCOFI REP, P27; Rodhouse PG, 2008, CAL COOP OCEAN FISH, V49, P83; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Ruiz-Cooley RI, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00094.1; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; SHCHETINNIKOV AS, 1989, ZOOL ZH, V68, P28; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Sigman D. M., 2005, GLOBAL BIOGEOCHEM CY, V19; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Staaf DJ, 2011, MAR ECOL PROG SER, V441, P165, DOI 10.3354/meps09389; Staaf DJ, 2010, MAR ECOL PROG SER, V418, P165, DOI 10.3354/meps08829; Stewart JS, 2012, DEEP SEA RES; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Watson W, 2011, NMFSSWFSC481 NTM; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	46	38	44	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59651	10.1371/journal.pone.0059651	http://dx.doi.org/10.1371/journal.pone.0059651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527242	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600072
J	Dhillon, CN; Subramaniam, H; Mulokozi, G; Rambeloson, Z; Klemm, R				Dhillon, Christina Nyhus; Subramaniam, Hamsa; Mulokozi, Generose; Rambeloson, Zo; Klemm, Rolf			Overestimation of Vitamin A Supplementation Coverage from District Tally Sheets Demonstrates Importance of Population-Based Surveys for Program Improvement: Lessons from Tanzania	PLOS ONE			English	Article								Background: Tanzania has conducted a national twice-yearly Vitamin A supplementation (VAS) campaign since 2001. Administrative coverage rates based on tally sheets consistently report >90% coverage; however the accuracy of these rates are uncertain due to potential errors in tally sheets and their aggregation, incomplete or inaccurate reporting from distribution sites, and underestimating the target population. Objectives: The post event coverage survey in Mainland Tanzania sought to validate tally-sheet based national coverage estimates of VAS and deworming for the June 2010 mass distribution round, and to characterize children missed by the national campaign. Methods: WHO/EPI randomized cross-sectional cluster sampling methodology was adapted for this study, using 30 clusters by 40 individuals (n = 1200), in addition to key informant interviews. Households with children 6-59 months of age were included in the study (12-59 months for deworming analysis). Chi-squared tests and logistic regression analysis were used to test differences between children reached and not reached by VAS. Data was collected within six weeks of the June 2010 round. Results: A total of 1203 children, 58 health workers, 30 village leaders and 45 community health workers were sampled. Preschool VAS coverage was 65% (95% CI: 62.7-68.1), approximately 30% lower than tally-sheet coverage estimates. Factors associated with not receiving VAS were urban residence [OR = 3.31; p = 0.01], caretakers who did not hear about the campaign [OR = 48.7; p<0.001], and Muslim households [OR, 3.25; p<0.01]. There were no significant differences in VAS coverage by child sex or age, or maternal age or education. Conclusion: Coverage estimation for vitamin A supplementation programs is one of most powerful indicators of program success. National VAS coverage based on a tally-sheet system overestimated VAS coverage by similar to 30%. There is a need for representative population-based coverage surveys to complement and validate tally-sheet estimates.	[Dhillon, Christina Nyhus; Subramaniam, Hamsa] Helen Keller Int Tanzania, Dar Es Salaam, Tanzania; [Klemm, Rolf] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Rambeloson, Zo; Klemm, Rolf] A2Z, AED FHI360, Washington, DC USA; [Mulokozi, Generose] Tanzania Food & Nutr Ctr, Dar Es Salaam, Tanzania	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dhillon, CN (corresponding author), Helen Keller Int Tanzania, Dar Es Salaam, Tanzania.	cnyhus@hki.org			United States Agency for International Development (USAID) [GHS-A-00-05-00012-00]; Academy for Educational Development [FHI360]; Canadian International Development Agency (CIDA)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Academy for Educational Development; Canadian International Development Agency (CIDA)	This study was conducted by the Helen Keller International-Tanzania in collaboration with the A2Z: The USAID Micronutrient and Child Blindness Project. Funding for the study was provided by the United States Agency for International Development (USAID) under the terms of Cooperative Agreement number GHS-A-00-05-00012-00 with the Academy for Educational Development (FHI360), and by the Canadian International Development Agency (CIDA). Funding agencies had no role in the design and implementation of the study or in the analysis and interpretation of the data and preparation of the manuscript.	Aguayo Victor M., 2005, Food and Nutrition Bulletin, V26, P348; [Anonymous], 2000, EP INF; Dalmiya N., 2007, VITAMIN SUPPLEMENTAT; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Mugyabuso J, 2007, POPULATION BASED ASS; National Bureau of Statistics of Tanzania ICF Macro, 2011, TANZ DEM HLTH SURV 2; Ross DA, 2002, J NUTR, V132, p2902S, DOI 10.1093/jn/132.9.2902S; Rutstein S. O., 2004, DHS WEALTH INDEX; StataCorp, 2013, STAT STAT SOFTW REL	9	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58629	10.1371/journal.pone.0058629	http://dx.doi.org/10.1371/journal.pone.0058629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536804	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100071
J	Islam, MA; Sundaraj, K; Ahmad, RB; Ahamed, NU				Islam, Md Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Ahamed, Nizam Uddin			Mechanomyogram for Muscle Function Assessment: A Review	PLOS ONE			English	Review							SURFACE ELECTROMYOGRAPHY; BICEPS-BRACHII; TORQUE; FREQUENCY; FATIGUE; SIGNALS; STIMULATION; RESPONSES; AMPLITUDE; CLASSIFICATION	Background: Mechanomyography (MMG) has been extensively applied in clinical and experimental practice to examine muscle characteristics including muscle function (MF), prosthesis and/or switch control, signal processing, physiological exercise, and medical rehabilitation. Despite several existing MMG studies of MF, there has not yet been a review of these. This study aimed to determine the current status on the use of MMG in measuring the conditions of MFs. Methodology/Principal Findings: Five electronic databases were extensively searched for potentially eligible studies published between 2003 and 2012. Two authors independently assessed selected articles using an MS-Word based form created for this review. Several domains (name of muscle, study type, sensor type, subject's types, muscle contraction, measured parameters, frequency range, hardware and software, signal processing and statistical analysis, results, applications, authors' conclusions and recommendations for future work) were extracted for further analysis. From a total of 2184 citations 119 were selected for full-text evaluation and 36 studies of MFs were identified. The systematic results find sufficient evidence that MMG may be used for assessing muscle fatigue, strength, and balance. This review also provides reason to believe that MMG may be used to examine muscle actions during movements and for monitoring muscle activities under various types of exercise paradigms. Conclusions/Significance: Overall judging from the increasing number of articles in recent years, this review reports sufficient evidence that MMG is increasingly being used in different aspects of MF. Thus, MMG may be applied as a useful tool to examine diverse conditions of muscle activity. However, the existing studies which examined MMG for MFs were confined to a small sample size of healthy population. Therefore, future work is needed to investigate MMG, in examining MFs between a sufficient number of healthy subjects and neuromuscular patients.	[Islam, Md Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Ahamed, Nizam Uddin] Univ Malaysia Perlis, AI Rehab Res Grp, Arau, Perlis, Malaysia	Universiti Malaysia Perlis	Islam, MA (corresponding author), Univ Malaysia Perlis, AI Rehab Res Grp, Kompleks Pauh Putra, Arau, Perlis, Malaysia.	anamulislam.phd@gmail.co	Sundaraj, Kenneth/AAD-1783-2019; Rather, R A/J-3509-2019; Ahmad, RB/U-3211-2019; Ahmad, Badlishah/A-4703-2019; Ahamed, Nizam Uddin/J-6248-2012	Sundaraj, Kenneth/0000-0001-7221-0072; Ahmad, RB/0000-0002-4862-2728; Ahmad, Badlishah/0000-0002-4862-2728; Ahamed, Nizam Uddin/0000-0003-0497-7356; Islam, Md. Anamul/0000-0001-6214-7081				Al-Zahrani E, 2009, J ELECTROMYOGR KINES, V19, P695, DOI 10.1016/j.jelekin.2007.12.007; Alves N, 2008, J ELECTROMYOGR KINES, V18, P509, DOI 10.1016/j.jelekin.2006.11.010; Alves N, 2008, IEEE T BIO-MED ENG, V55, P765, DOI 10.1109/TBME.2007.902223; Alves N, 2010, MED ENG PHYS, V32, P940, DOI 10.1016/j.medengphy.2010.06.003; Alves N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-23; Alves N, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-22; Alves N, 2010, PHYSIOL MEAS, V31, P461, DOI 10.1088/0967-3334/31/4/001; Anderson E, 2010, SPINE J, V10, p1S; Armstrong WJ, 2011, J ELECTROMYOGR KINES, V21, P803, DOI 10.1016/j.jelekin.2011.05.011; Armstrong WJ, 2010, J ELECTROMYOGR KINES, V20, P726, DOI 10.1016/j.jelekin.2010.02.002; Beck T. W., 2010, TECHNICAL ASPECTS SU, P95; Beck TW, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-67; Beck TW, 2007, J ELECTROMYOGR KINES, V17, P1, DOI 10.1016/j.jelekin.2005.12.002; Beck TW, 2009, PHYSIOL MEAS, V30, P1465, DOI 10.1088/0967-3334/30/12/012; Beck TW, 2005, J ELECTROMYOGR KINES, V15, P190, DOI 10.1016/j.jelekin.2004.08.007; Cescon C, 2006, J ELECTROMYOGR KINES, V16, P17, DOI 10.1016/j.jelekin.2005.02.005; Cescon C, 2008, MED BIOL ENG COMPUT, V46, P871, DOI 10.1007/s11517-008-0357-4; Chen X, 2011, EUR J APPL PHYSL, V13, P13; Cho YJ, 2012, INT J IND ERGONOM, V42, P287, DOI 10.1016/j.ergon.2012.02.004; Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416; Dillon MA, 2011, CLIN KINESIOLOGY J A, V65; Dordevic S, 2011, SENSORS-BASEL, V11, P9411, DOI 10.3390/s111009411; Ebersole KT, 2008, J ATHL TRAINING, V43, P152, DOI 10.4085/1062-6050-43.2.152; Esposito F, 2011, J ELECTROMYOGR KINES, V21, P795, DOI 10.1016/j.jelekin.2011.07.012; Faller L, 2009, REV BRAS FISIOTER, V13, P422, DOI 10.1590/S1413-35552009005000057; Gobbo M, 2006, EUR J APPL PHYSIOL, V97, P9, DOI 10.1007/s00421-006-0134-8; Gregori B, 2003, MED BIOL ENG COMPUT, V41, P665, DOI 10.1007/BF02349974; Hendrix CR, 2010, J NEUROSCI METH, V194, P64, DOI 10.1016/j.jneumeth.2010.07.006; Hendrix CR, 2010, J NEUROSCI METH, V187, P1, DOI 10.1016/j.jneumeth.2009.11.019; Herda TJ, 2010, J ELECTROMYOGR KINES, V20, P787, DOI 10.1016/j.jelekin.2010.01.004; Ioi H, 2006, ORTHOD WAVES, V65, P15, DOI 10.1016/j.odw.2005.12.002; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kawakami S, 2012, J NEUROSCI METH, V203, P157, DOI 10.1016/j.jneumeth.2011.09.026; Krizaj D, 2008, J ELECTROMYOGR KINES, V18, P645, DOI 10.1016/j.jelekin.2007.01.008; Krueger E, 2011, IEEE ENG MED BIO, P7242, DOI 10.1109/IEMBS.2011.6091830; Kumar DK, 2009, MECHANOMYOGRAM IDENT, P408; Lei KF, 2011, IEEE SYS MAN CYBERN, P585, DOI 10.1109/ICSMC.2011.6083774; Madeleine P, 2006, MED BIOL ENG COMPUT, V44, P290, DOI 10.1007/s11517-006-0036-2; Malek MH, 2012, PHYS MED REH CLIN N, V23, P23, DOI 10.1016/j.pmr.2011.11.005; Malek MH, 2011, MUSCLE NERVE, V44, P424, DOI 10.1002/mus.22116; Malek MH, 2010, MUSCLE NERVE, V42, P394, DOI 10.1002/mus.21686; Malek MH, 2009, J NEUROSCI METH, V181, P89, DOI 10.1016/j.jneumeth.2009.04.026; Mamaghani Nasser Koleini, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P131; Marek SM, 2005, J ATHL TRAINING, V40, P94; Martin Ma Y-E, 2009, THESIS MASSEY U AUCK; Matta TTd, 2005, REV BRAS MED ESPORTE, V11, P306; Mckay WPS, 2007, EUR J APPL PHYSIOL, V102, P107, DOI 10.1007/s00421-007-0578-5; Mckay WPS, 2006, EUR J APPL PHYSIOL, V98, P566, DOI 10.1007/s00421-006-0301-y; Orizio C, 2006, MECHANOMYOGRAPHY WIL, P1; Orizio C, 2008, J NEUROSCI METH, V173, P59, DOI 10.1016/j.jneumeth.2008.05.012; Posatskiy AO, 2012, J ELECTROMYOGR KINES, V22, P320, DOI 10.1016/j.jelekin.2011.09.004; Qi LP, 2011, J ELECTROMYOGR KINES, V21, P128, DOI 10.1016/j.jelekin.2010.09.006; Reza MF, 2005, J NEUROSCI METH, V149, P164, DOI 10.1016/j.jneumeth.2005.05.013; Ryan ED, 2007, J NEUROSCI METH, V161, P212, DOI 10.1016/j.jneumeth.2006.11.007; Scheeren EM, 2010, IEEE ENG MED BIO, P3970, DOI 10.1109/IEMBS.2010.5627986; Scheeren EM, 2010, J MED BIOL ENG, V30, P373, DOI 10.5405/jmbe.757; Shi J, 2010, J REHABIL RES DEV, V47, P87, DOI 10.1682/JRRD.2009.03.0031; Simoneau EM, 2012, MUSCLE NERVE, V45, P92, DOI 10.1002/mus.22257; Simunic B, 2011, MED SCI SPORT EXER, V43, P1619, DOI 10.1249/MSS.0b013e31821522d0; Tanaka M, 2011, STUDY EVALUATION MUS, P741; Taylor PE, 2010, CLASSIFYING HUMAN MO, P339; Tian SL, 2010, J BIOMECH, V43, P551, DOI 10.1016/j.jbiomech.2009.09.034; Trager G, 2006, CAN J ANAESTH, V53, P130, DOI 10.1007/BF03021816; Uchiyama T, 2011, MED BIOL ENG COMPUT, V49, P1035, DOI 10.1007/s11517-011-0752-0; Xie H-B, 2009, DETECTION CHAOS HUMA, P4379; Xie HB, 2010, J BIOMECH, V43, P1224, DOI 10.1016/j.jbiomech.2009.11.035; Xie HB, 2009, PHYSIOL MEAS, V30, P441, DOI 10.1088/0967-3334/30/5/002; Yoshimi Hidehiro, 2009, Head Face Med, V5, P7, DOI 10.1186/1746-160X-5-7; Youn W, 2010, MED BIOL ENG COMPUT, V48, P1149, DOI 10.1007/s11517-010-0641-y; Zuniga JM, 2010, J ELECTROMYOGR KINES, V20, P719, DOI 10.1016/j.jelekin.2010.01.001	70	52	54	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58902	10.1371/journal.pone.0058902	http://dx.doi.org/10.1371/journal.pone.0058902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536834	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100099
J	Payne, NL; Snelling, EP; Semmens, JM; Gillanders, BM				Payne, Nicholas L.; Snelling, Edward P.; Semmens, Jayson M.; Gillanders, Bronwyn M.			Mechanisms of Population Structuring in Giant Australian Cuttlefish Sepia apama	PLOS ONE			English	Article							SPAWNING AGGREGATION; GAIT TRANSITION; METABOLIC-RATE; ENERGETICS; SQUID; CONNECTIVITY; CONSTRAINTS; TELEMETRY; MOLLUSCA; BEHAVIOR	While a suite of approaches have been developed to describe the scale, rate and spatial structure of exchange among populations, a lack of mechanistic understanding will invariably compromise predictions of population-level responses to ecosystem modification. In this study, we measured the energetics and sustained swimming capacity of giant Australian cuttlefish Sepia apama and combined these data with information on the life-history strategy, behaviour and circulation patterns experienced by the species to predict scales of connectivity throughout parts of their range. The swimming capacity of adult and juvenile S. apama was poor compared to most other cephalopods, with most individuals incapable of maintaining swimming above 15 cm s(-1). Our estimate of optimal swimming speed (6-7 cm s(-1)) and dispersal potential were consistent with the observed fine-scale population structure of the species. By comparing observed and predicted population connectivity, we identified several mechanisms that are likely to have driven fine-scale population structure in this species, which will assist in the interpretation of future population declines.	[Payne, Nicholas L.; Snelling, Edward P.; Gillanders, Bronwyn M.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Payne, Nicholas L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Adelaide; University of New South Wales Sydney; University of Tasmania	Payne, NL (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia.	n.payne@unsw.edu.au	Payne, Nicholas/E-7811-2013; Gillanders, Bronwyn/B-4218-2013	Gillanders, Bronwyn/0000-0002-7680-2240; Semmens, Jayson/0000-0003-1742-6692; Payne, Nicholas/0000-0002-5274-471X	Field Naturalists Society of South Australia; Australian Geographic Society; Santos Ltd.; ANZ Holsworth Foundation; Australian Research Council [DP0344717]; ARC [LP100100367, FT100100767]	Field Naturalists Society of South Australia; Australian Geographic Society; Santos Ltd.; ANZ Holsworth Foundation; Australian Research Council(Australian Research Council); ARC(Australian Research Council)	Funding was provided by The Field Naturalists Society of South Australia, Australian Geographic Society, Santos Ltd., The ANZ Holsworth Foundation, and an Australian Research Council Discovery Grant (DP0344717). NLP was supported by an ARC Linkage grant (LP100100367) and BMG by an ARC Future Fellowship (FT100100767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JP, 2004, MAR FRESHW BEHAV PHY, V37, P217, DOI 10.1080/102362400016579; Aitken JP, 2005, J EXP MAR BIOL ECOL, V320, P77, DOI 10.1016/j.jembe.2004.12.040; Bell W. H, 1970, Rep. Fish. Res. Bd Can., VNo. 195, P1; BRETT JR, 1967, J FISH RES BOARD CAN, V24, P1731, DOI 10.1139/f67-142; Cannas M, 2006, J FISH BIOL, V69, P1612, DOI 10.1111/j.1095-8649.2006.01225.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Gillanders BM, 2002, CAN J FISH AQUAT SCI, V59, P669, DOI 10.1139/F02-040; Grigoriou P, 2009, MAR BIOL, V156, P2473, DOI 10.1007/s00227-009-1272-4; Hall K.C., 2010, ESTIMATED ABUNDANCE; Hall KC, 2007, REV FISH BIOL FISHER, V17, P367, DOI 10.1007/s11160-007-9045-y; Hall KC, 2002, MAR BIOL, V140, P533; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Hanlon RT, 2007, AM NAT, V169, P543, DOI 10.1086/512106; HE P, 1988, J FISH BIOL, V33, P255, DOI 10.1111/j.1095-8649.1988.tb05468.x; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kampf J, 2009, DESALIN WATER TREAT, V2, P325; Kampf J, 2010, J COASTAL RES, V26, P1047, DOI 10.2112/JCOASTRES-D-10-00043.1; Kassahn KS, 2003, MAR BIOL, V143, P947, DOI 10.1007/s00227-003-1141-5; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Melzner F, 2007, COMP BIOCHEM PHYS A, V146, P149, DOI 10.1016/j.cbpa.2006.07.023; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; O'Dor R, 2002, INTEGR COMP BIOL, V42, P1065, DOI 10.1093/icb/42.5.1065; O'Dor R.K., 1987, P109; O'Dor R.K., 1998, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V376, P77; O'Dor RK, 2002, B MAR SCI, V71, P601; ODOR RK, 1993, NATURE, V362, P626, DOI 10.1038/362626a0; ODOR RK, 1992, S AFR J MARINE SCI, V12, P225; ODOR RK, 1986, CAN J ZOOL, V64, P1591, DOI 10.1139/z86-241; ODOR RK, 1991, J EXP BIOL, V160, P93; Payne NL, 2011, MAR ECOL PROG SER, V436, P169, DOI 10.3354/meps09235; Payne NL, 2011, J ANIM ECOL, V80, P422, DOI 10.1111/j.1365-2656.2010.01758.x; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Payne NL, 2011, OECOLOGIA, V165, P341, DOI 10.1007/s00442-010-1729-7; Riley J.P., 1971, INTRO MARINE CHEM; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Semmens JM, 2007, REV FISH BIOL FISHER, V17, P401, DOI 10.1007/s11160-007-9048-8; STOREY KB, 1979, J COMP PHYSIOL, V131, P311, DOI 10.1007/BF00688806; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; WEBBER DM, 1986, J EXP BIOL, V126, P205; [No title captured]	44	6	7	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58694	10.1371/journal.pone.0058694	http://dx.doi.org/10.1371/journal.pone.0058694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536813	gold, Green Published			2022-12-27	WOS:000316251100080
J	Preza, GC; Pinon, R; Ganz, T; Nemeth, E				Preza, Gloria Cuevas; Pinon, Rogelio; Ganz, Tomas; Nemeth, Elizabeta			Cellular Catabolism of the Iron-Regulatory Peptide Hormone Hepcidin	PLOS ONE			English	Article							SERUM HEPCIDIN; FERROPORTIN; MEMBRANE; BINDING; INTERNALIZATION; TEMPERATURE; MACROPHAGES; ENDOCYTOSIS; FLUIDITY; RECEPTOR	Hepcidin, a 25-amino acid peptide hormone, is the principal regulator of plasma iron concentrations. Hepcidin binding to its receptor, the iron exporter ferroportin, induces ferroportin internalization and degradation, thus blocking iron efflux from cells into plasma. The aim of this study was to characterize the fate of hepcidin after binding to ferroportin. We show that hepcidin is taken up by ferroportin-expressing cells in a temperature-and pH-dependent manner, and degraded together with its receptor. When Texas red-labeled hepcidin (TR-Hep) was added to ferroportin-GFP (Fpn-GFP) expressing cells, confocal microscopy showed co-localization of TR-Hep with Fpn-GFP. Using flow cytometry, we showed that the peptide was almost completely degraded by 24 h after its addition, but that lysosomal inhibitors completely prevented degradation of both ferroportin and hepcidin. In addition, using radio-labeled hepcidin and HPLC analysis we show that hepcidin is not recycled, and that only degradation products are released from the cells. Together these results show that the hormone hepcidin and its receptor ferroportin are internalized together and trafficked to lysosomes where both are degraded.	[Preza, Gloria Cuevas] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Pinon, Rogelio; Ganz, Tomas; Nemeth, Elizabeta] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nemeth, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	enemeth@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469	National Institutes of Health [R01 DK 082717]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK 082717 (to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATRUDA JM, 1979, J BIOL CHEM, V254, P2619; Auriac A, 2010, HAEMATOL-HEMATOL J, V95, P1269, DOI 10.3324/haematol.2009.019992; CARONE FA, 1982, J LAB CLIN MED, V100, P1; CARPENTIER JL, 1986, EXPERIENTIA, V42, P734, DOI 10.1007/BF01941519; Clark RJ, 2011, CHEM BIOL, V18, P336, DOI 10.1016/j.chembiol.2010.12.009; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rice AE, 2009, J MOL BIOL, V386, P717, DOI 10.1016/j.jmb.2008.12.063; SPINEDI A, 1993, BIOCHEM PHARMACOL, V46, P1521, DOI 10.1016/0006-2952(93)90318-Q; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Zaritsky J, 2010, CLIN J AM SOC NEPHRO, V5, P1010, DOI 10.2215/CJN.08161109	23	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58934	10.1371/journal.pone.0058934	http://dx.doi.org/10.1371/journal.pone.0058934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536837	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100102
J	Li, HX; Fan, HX; Wang, Z; Zheng, JH; Cao, WW				Li, Haixia; Fan, Haixia; Wang, Zhu; Zheng, Jinhua; Cao, Wenwu			Potentiation of Scutellarin on Human Tongue Carcinoma Xenograft by Low-Intensity Ultrasound	PLOS ONE			English	Article							LOW-LEVEL ULTRASOUND; IN-VITRO; SONODYNAMIC THERAPY; CANCER-CHEMOTHERAPY; FOCUSED ULTRASOUND; CELLS; DELIVERY; PERMEABILIZATION; SONOSENSITIZER; DRUGS	Scutellarin 7-O-beta-D-glucuronide (scutellarin) has shown great potential as a chemotherapeutic agent for cancer treatment, but only at high dosage. Here we investigate the possibility of using low intensity ultrasound to reduce the scutellarin dosage. Ultrasound intensities of 1.0 W/cm(2) and 0.05 W/cm(2) were used for in vivo and in vitro experiments, respectively, and a very low dosage of scutellarin (15 nM) was used. Tumor-bearing Balb/c mice and SAS human-tongue squamous carcinoma cell suspensions were used for the in vivo and in vitro experiments, respectively. Each kind of subjects was divided into control, ultrasound-alone, scutellarin-alone, and combined ultrasound-scutellarin treatment groups. Only the combined treatment showed strong anticancer effects. In the in vivo case, the combined treatment significantly delayed tumor growth, initiated cellular chromatin changes (including a decrease in the number of cytoplasmic organelles and fragmentation of condensed nuclear chromatin), inhibited tumor angiogenesis and lymphangiogenesis, stopped cancer-cell proliferation, decreased MMP-2 and MMP-9 expression levels and caused cancer-cell apoptosis. In the in vitro case, the combined treatment produced cancer cell-shape irregularity in a manner seriously fractured microvilli, inhibited cancer-cell migratory and invasion activities, and induced cancer-cell apoptosis. Because the combined treatment did not increase intracellular ROS production, scutellarin is not a sonosensitizer so that the anticancer effect is not through sonodynamic therapy. Low-intensity ultrasound is merely increasing the permeability of scutellarin into cancer cells. Based on our results, one may perform localized chemotherapy using much reduced dosage of the drug with the help of low intensity ultrasound, which will greatly minimize side effects.	[Li, Haixia; Wang, Zhu; Zheng, Jinhua; Cao, Wenwu] Harbin Inst Technol, Lab Sono & Phototheranost Technol, Harbin 150006, Heilongjiang, Peoples R China; [Li, Haixia; Fan, Haixia; Zheng, Jinhua] Harbin Med Univ, Dept Anat, Coll Basic Med Sci, Harbin, Heilongjiang, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Institute of Technology; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, WW (corresponding author), Harbin Inst Technol, Lab Sono & Phototheranost Technol, Harbin 150006, Heilongjiang, Peoples R China.	dzk@psu.edu	金华, 郑/GWM-7529-2022; Cao, Wenwu/F-6091-2012	Cao, Wenwu/0000-0002-2447-1486	scientific and technical key task of Heilongjiang Provence, China [GC10C306]	scientific and technical key task of Heilongjiang Provence, China	This research was supported by the scientific and technical key task of Heilongjiang Provence, China with the fund number of GC10C306. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Feril LB, 2008, J MED ULTRASON, V35, P161, DOI 10.1007/s10396-008-0195-x; Gao ZXZ, 2010, BIOCHEM BIOPH RES CO, V400, P151, DOI 10.1016/j.bbrc.2010.08.034; Goh D, 2005, J AGR FOOD CHEM, V53, P8197, DOI 10.1021/jf051506+; Griffin XL, 2012, COCHRANE DB SYST REV, V2; Hancock H, 2009, CLIN EXP METASTAS, V26, P729, DOI 10.1007/s10585-009-9272-9; Harrison GH, 1996, ULTRASOUND MED BIOL, V22, P355, DOI 10.1016/0301-5629(95)02053-5; Huang D, 2004, CANCER SCI, V95, P845, DOI 10.1111/j.1349-7006.2004.tb02192.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koch MO, 2007, J UROLOGY, V178, P2366, DOI 10.1016/j.juro.2007.08.014; Li HX, 2010, ONCOL REP, V24, P1153, DOI 10.3892/or_00000967; Li YS, 2008, CANCER LETT, V266, P156, DOI 10.1016/j.canlet.2008.02.041; Mazeron R, 2009, ORAL ONCOL, V45, P402, DOI 10.1016/j.oraloncology.2009.01.010; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Miller DL, 2006, ULTRASOUND MED BIOL, V32, P1097, DOI 10.1016/j.ultrasmedbio.2006.03.013; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Nomikou N, 2010, CANCER LETT, V288, P94, DOI 10.1016/j.canlet.2009.06.028; Oosterhof GON, 1997, EUR UROL, V32, P91, DOI 10.1159/000480887; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Schroeder A, 2009, CHEM PHYS LIPIDS, V162, P1, DOI 10.1016/j.chemphyslip.2009.08.003; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Song W, 2011, ANTICANCER RES, V31, P39; Specenier PM, 2009, ORAL ONCOL, V45, P409, DOI 10.1016/j.oraloncology.2008.05.014; Suh SJ, 2007, PHYTOTHER RES, V21, P135, DOI 10.1002/ptr.2010; Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4; Teicher BA, 2002, TUMOR MODEL CANC RES, P407; Wang RS, 2010, BIOMED PHARMACOTHER, V64, P309, DOI 10.1016/j.biopha.2009.09.011; Weidner N, 1991, NEW ENGL J MED, V32, P1, DOI DOI 10.1056/NEJM19910103; Yu T, 2001, ULTRASONICS, V39, P307, DOI 10.1016/S0041-624X(01)00051-8; Yu TH, 2006, TECHNOL CANCER RES T, V5, P51, DOI 10.1177/153303460600500107; Yu TH, 2004, ULTRASON SONOCHEM, V11, P95, DOI 10.1016/S1350-4177(03)00157-3; Zolochevska Olga, 2012, Front Biosci (Schol Ed), V4, P988; Zolochevska O, 2011, HUM GENE THER, V22, P1537, DOI 10.1089/hum.2011.076	37	36	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59473	10.1371/journal.pone.0059473	http://dx.doi.org/10.1371/journal.pone.0059473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536878	Green Published, gold			2022-12-27	WOS:000317397200026
J	Bellou, E; Maraki, M; Magkos, F; Botonaki, H; Panagiotakos, DB; Kavouras, SA; Sidossis, LS				Bellou, Elena; Maraki, Maria; Magkos, Faidon; Botonaki, Helena; Panagiotakos, Demosthenes B.; Kavouras, Stavros A.; Sidossis, Labros S.			Effect of Acute Negative and Positive Energy Balance on Basal Very-Low Density Lipoprotein Triglyceride Metabolism in Women	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; VLDL-TRIGLYCERIDE; SHORT-TERM; TRIACYLGLYCEROL CONCENTRATIONS; CALORIE RESTRICTION; ENDURANCE EXERCISE; MODERATE EXERCISE; HEALTHY-MEN; WEIGHT-LOSS; YOUNG MEN	Background: Acute reduction in dietary energy intake reduces very low-density lipoprotein triglyceride (VLDL-TG) concentration. Although chronic dietary energy surplus and obesity are associated with hypertriglyceridemia, the effect of acute overfeeding on VLDL-TG metabolism is not known. Objective: The aim of the present study was to investigate the effects of acute negative and positive energy balance on VLDL-TG metabolism in healthy women. Design: Ten healthy women (age: 22.0+/-2.9 years, BMI: 21.2+/-1.3 kg/m(2)) underwent a stable isotopically labeled tracer infusion study to determine basal VLDL-TG kinetics after performing, in random order, three experimental trials on the previous day: i) isocaloric feeding (control) ii) hypocaloric feeding with a dietary energy restriction of 2.89+/-0.42 MJ and iii) hypercaloric feeding with a dietary energy surplus of 2.91+/-0.32 MJ. The three diets had the same macronutrient composition. Results: Fasting plasma VLDL-TG concentrations decreased by similar to 26% after hypocaloric feeding relative to the control trial (P = 0.037), owing to decreased hepatic VLDL-TG secretion rate (by 21%, P = 0.023) and increased VLDL-TG plasma clearance rate (by similar to 12%, P = 0.016). Hypercaloric feeding increased plasma glucose concentration (P = 0.042) but had no effect on VLDL-TG concentration and kinetics compared to the control trial. Conclusion: Acute dietary energy deficit (similar to 3MJ) leads to hypotriglyceridemia via a combination of decreased hepatic VLDL-TG secretion and increased VLDL-TG clearance. On the other hand, acute dietary energy surplus (similar to 3MJ) does not affect basal VLDL-TG metabolism but disrupts glucose homeostasis in healthy women.	[Bellou, Elena; Maraki, Maria; Magkos, Faidon; Botonaki, Helena; Panagiotakos, Demosthenes B.; Kavouras, Stavros A.; Sidossis, Labros S.] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Magkos, Faidon] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Magkos, Faidon] Washington Univ, Sch Med, Atkins Ctr Excellence Obes Med, St Louis, MO USA; [Kavouras, Stavros A.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Sidossis, Labros S.] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Inst Translat Sci, Galveston, TX 77555 USA; [Sidossis, Labros S.] Univ Texas Med Branch, Shriners Hosp Children, Galveston, TX 77555 USA	Harokopio University Athens; Washington University (WUSTL); Washington University (WUSTL); University of Arkansas System; University of Arkansas Fayetteville; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sidossis, LS (corresponding author), Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.	lasidoss@utmb.edu	, stavros.kavouras@asu.edu/X-3170-2018; Sidossis, Labros/AAN-9546-2021; Panagiotakos, Demosthenes/M-9167-2019; Panagiotakos, Demosthenes/C-9776-2013; Magkos, Faidon/B-4384-2010; Magkos, Faidon/CAA-9939-2022; Panagiotakos, Demosthenes/K-8294-2019	, stavros.kavouras@asu.edu/0000-0001-7485-8112; Sidossis, Labros/0000-0001-8313-7966; Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Magkos, Faidon/0000-0002-1312-7364; Magkos, Faidon/0000-0002-1312-7364; Maraki, Maria/0000-0001-8229-1400	Department of Nutrition and Dietetics of Harokopio University; Hellenic Heart Foundation; Greek Governmental Institute of Scholarships; Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000071]; Shriners Hospital for Children [SSF 84090]; Sealy Center on Aging, University of Texas Medical Branch at Galveston; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	Department of Nutrition and Dietetics of Harokopio University; Hellenic Heart Foundation; Greek Governmental Institute of Scholarships; Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health; Shriners Hospital for Children; Sealy Center on Aging, University of Texas Medical Branch at Galveston; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Graduate Program, Department of Nutrition and Dietetics of Harokopio University, the Hellenic Heart Foundation and the Greek Governmental Institute of Scholarships (E.B.). Support also came from the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences, National Institutes of Health, the Shriners Hospital for Children (SSF 84090) and from the Sealy Center on Aging, University of Texas Medical Branch at Galveston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellou E, 2013, MED SCI SPORT EXER, V45, P455, DOI 10.1249/MSS.0b013e318278183e; BOER P, 1984, AM J PHYSIOL, V247, pF632, DOI 10.1152/ajprenal.1984.247.4.F632; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Burton FL, 2008, INT J OBESITY, V32, P481, DOI 10.1038/sj.ijo.0803754; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; GINSBERG HN, 1985, J CLIN INVEST, V75, P614, DOI 10.1172/JCI111739; HILL JO, 1990, J LIPID RES, V31, P407; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; KESANIEMI YA, 1985, ARTERIOSCLEROSIS, V5, P153, DOI 10.1161/01.ATV.5.2.153; Lemieux S, 1999, J LIPID RES, V40, P2111; Lin PH, 2003, AM J CLIN NUTR, V77, P639, DOI 10.1093/ajcn/77.3.639; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Magkos F, 2008, J APPL PHYSIOL, V105, P1228, DOI 10.1152/japplphysiol.90761.2008; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V291, pE1243, DOI 10.1152/ajpendo.00246.2006; Maraki M, 2009, BRIT J NUTR, V101, P408, DOI 10.1017/S0007114508012233; Maraki M, 2010, CLIN NUTR, V29, P459, DOI 10.1016/j.clnu.2009.10.007; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; MELISH J, 1980, AM J PHYSIOL, V239, pE354, DOI 10.1152/ajpendo.1980.239.5.E354; Minehira K, 2003, OBES RES, V11, P1096, DOI 10.1038/oby.2003.150; Mittendorfer B, 2003, AM J PHYSIOL-ENDOC M, V284, pE549, DOI 10.1152/ajpendo.00379.2002; Mittendorfer B, 2001, AM J CLIN NUTR, V73, P892; Miyashita M, 2008, BRIT J NUTR, V99, P1076, DOI 10.1017/S0007114507853438; Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572; Patterson BW, 2002, J LIPID RES, V43, P223; REICHL D, 1990, EUR HEART J, V11, P230, DOI 10.1093/eurheartj/11.suppl_E.230; Sobrecases H, 2010, DIABETES METAB, V36, P244, DOI 10.1016/j.diabet.2010.03.003; Sock ETN, 2010, BRIT J NUTR, V103, P939, DOI 10.1017/S0007114509992819; Teran-Garcia M, 2004, ATHEROSCLEROSIS, V173, P277, DOI 10.1016/j.athersclerosis.2003.12.016; Yamada T, 2008, CLIN CHIM ACTA, V388, P28, DOI 10.1016/j.cca.2007.09.022; Yiannis TE, 2007, METABOLISM, V56, P1037, DOI 10.1016/j.metabol.2007.03.012	33	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60251	10.1371/journal.pone.0060251	http://dx.doi.org/10.1371/journal.pone.0060251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533676	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400113
J	Brown, CJ; Millstein, J; Williams, CJ; Wichman, HA				Brown, Celeste J.; Millstein, Jack; Williams, Christopher J.; Wichman, Holly A.			Selection Affects Genes Involved in Replication during Long-Term Evolution in Experimental Populations of the Bacteriophage phi X174	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; H SPIKE PROTEIN; PARALLEL EVOLUTION; ADAPTIVE EVOLUTION; HOST-RANGE; ADAPTATION; MUTATIONS; TRANSCRIPTION; RECOGNITION; EXPRESSION	Observing organisms that evolve in response to strong selection over very short time scales allows the determination of the molecular mechanisms underlying adaptation. Although dissecting these molecular mechanisms is expensive and time-consuming, general patterns can be detected from repeated experiments, illuminating the biological processes involved in evolutionary adaptation. The bacteriophage phi X174 was grown for 50 days in replicate chemostats under two culture conditions: Escherichia coli C as host growing at 37 degrees C and Salmonella typhimurium as host growing at 43.5 degrees C. After 50 days, greater than 20 substitutions per chemostat had risen to detectable levels. Of the 97 substitutions, four occurred in all four chemostats, five arose in both culture conditions, eight arose in only the high temperature S. typhimurium chemostats, and seven arose only in the E. coli chemostats. The remaining substitutions were detected only in a single chemostat, however, almost half of these have been seen in other similar experiments. Our findings support previous studies that host recognition and capsid stability are two biological processes that are modified during adaptation to novel hosts and high temperature. Based upon the substitutions shared across both environments, it is apparent that genome replication and packaging are also affected during adaptation to the chemostat environment, rather than to temperature or host per se. This environment is characterized by a large number of phage and very few hosts, leading to competition among phage within the host. We conclude from these results that adaptation to a high density environment selects for changes in genome replication at both protein and DNA sequence levels.	[Brown, Celeste J.; Millstein, Jack; Wichman, Holly A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Brown, Celeste J.; Millstein, Jack; Williams, Christopher J.; Wichman, Holly A.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Williams, Christopher J.] Univ Idaho, Dept Stat Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Brown, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	celesteb@uidaho.edu			National Institutes of Health [NCRR P20RR16448, 8P20GM103397]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by grants NCRR P20RR16448, 8P20GM103397 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI K, 1981, P NATL ACAD SCI-BIOL, V78, P69, DOI 10.1073/pnas.78.1.69; AZUMA J, 1980, J BIOCHEM, V88, P525, DOI 10.1093/oxfordjournals.jbchem.a132999; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Betancourt AJ, 2009, GENETICS, V181, P1535, DOI 10.1534/genetics.107.085837; Bollback JP, 2009, GENETICS, V181, P225, DOI 10.1534/genetics.107.085225; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Bravo A, 2005, FEMS MICROBIOL REV, V29, P25, DOI 10.1016/j.femsre.2004.06.003; Brown CJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-378; Bull JJ, 2008, HEREDITY, V100, P453, DOI 10.1038/sj.hdy.6801087; Bull JJ, 2006, AM NAT, V167, pE39, DOI 10.1086/499374; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Cherwa JE, 2011, J MOL BIOL, V412, P387, DOI 10.1016/j.jmb.2011.07.070; Cherwa JE, 2011, VIROLOGY, V411, P9, DOI 10.1016/j.virol.2010.12.026; Crill WD, 2000, GENETICS, V154, P27; Dennehy JJ, 2007, EVOLUTION, V61, P2516, DOI 10.1111/j.1558-5646.2007.00205.x; Dickins B, 2009, GENOME BIOL EVOL, V1, P294, DOI 10.1093/gbe/evp029; EISENBERG S, 1980, PROC R SOC SER B-BIO, V210, P337, DOI 10.1098/rspb.1980.0138; EKECHUKWU MC, 1995, GENETICS, V140, P1167; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fane B., 2006, BACTERIOPHAGES, P129; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; FRANCKE B, 1972, P NATL ACAD SCI USA, V69, P475, DOI 10.1073/pnas.69.2.475; FUJISAWA H, 1977, J VIROL, V21, P506, DOI 10.1128/JVI.21.2.506-515.1977; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Hayashi M., 1988, BACTERIOPHAGES, V2, P1; HAYASHI MN, 1983, J VIROL, V48, P186, DOI 10.1128/JVI.48.1.186-196.1983; HENRY TJ, 1974, P NATL ACAD SCI USA, V71, P1549, DOI 10.1073/pnas.71.4.1549; Higgins J.J., 2004, INTRO MODERN NONPARA; Inagaki M, 2003, FEMS MICROBIOL LETT, V226, P221, DOI 10.1016/S0378-1097(03)00601-3; JAZWINSKI SM, 1975, VIROLOGY, V66, P283, DOI 10.1016/0042-6822(75)90198-1; JAZWINSKI SM, 1975, VIROLOGY, V66, P268, DOI 10.1016/0042-6822(75)90197-X; JAZWINSKI SM, 1975, VIROLOGY, V66, P294, DOI 10.1016/0042-6822(75)90199-3; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Knies JL, 2006, PLOS BIOL, V4, P1257, DOI 10.1371/journal.pbio.0040201; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; MCKENNA R, 1992, ACTA CRYSTALLOGR B, V48, P499, DOI 10.1107/S0108768192001344; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Ordonez P, 2012, ANTIMICROB AGENTS CH, V56, P2581, DOI 10.1128/AAC.06307-11; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Ruboyianes MV, 2009, J VIROL, V83, P9952, DOI 10.1128/JVI.01077-09; Sachs JL, 2005, P NATL ACAD SCI USA, V102, P390, DOI 10.1073/pnas.0405738102; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SINSHEIMER RL, 1991, BIOESSAYS, V13, P89, DOI 10.1002/bies.950130209; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; TESSMAN ES, 1976, J VIROL, V20, P400, DOI 10.1128/JVI.20.2.400-412.1976; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; VANDERAVOORT HGAM, 1984, J VIROL, V50, P533, DOI 10.1128/JVI.50.2.533-540.1984; VANDERAVOORT HGAM, 1982, J VIROL, V42, P1; VANDERENDE A, 1982, EUR J BIOCHEM, V124, P245; VANMANSFELD ADM, 1986, NUCLEIC ACIDS RES, V14, P1845; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053; Yano H, 2012, J BACTERIOL, V194, P1533, DOI 10.1128/JB.06395-11; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	64	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60401	10.1371/journal.pone.0060401	http://dx.doi.org/10.1371/journal.pone.0060401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533679	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400116
J	DeNiro, M; Al-Mohanna, FH; Alsmadi, O; Al-Mohanna, FA				DeNiro, Michael; Al-Mohanna, Falah H.; Alsmadi, Osama; Al-Mohanna, Futwan A.			The Nexus between VEGF and NF kappa B Orchestrates a Hypoxia-Independent Neovasculogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL NEOVASCULARIZATION; ACTIVATION; EXPRESSION; YC-1; CANCER; ALPHA; MOUSE; RATS	Nuclear Factor-Kappa B [NF kappa B] activation triggers the elevation of various pro-angiogenic factors that contribute to the development and progression of diabetic vasculopathies. It has been demonstrated that vascular endothelial growth factor [VEGF] activates NF kappa B signaling pathway. Under the ischemic microenvironments, hypoxia-inducible factor-1 [HIF-1] upregulates the expression of several proangiogenic mediators, which play crucial roles in ocular pathologies. Whereas YC-1, a soluble guanylyl cyclase [sGC] agonist, inhibits HIF-1 and NF kappa B signaling pathways in various cell and animal models. Throughout this investigation, we examined the molecular link between VEGF and NF kappa B under a hypoxia-independent microenvironment in human retinal microvascular endothelial cells [hRMVECs]. Our data indicate that VEGF promoted retinal neovasculogenesis via NF kappa B activation, enhancement of its DNA-binding activity, and upregulating NF kappa B/p65, SDF-1, CXCR4, FAK, alpha V beta 3, alpha 5 beta 1, EPO, ET-1, and MMP-9 expression. Conversely, YC-1 impaired the activation of NF kappa B and its downstream signaling pathways, via attenuating I kappa B kinase phosphorylation, degradation and activation, and thus suppressing p65 phosphorylation, nuclear translocation, and inhibiting NF kappa B-DNA binding activity. We report for the first time that the nexus between VEGF and NF kappa B is implicated in coordinating a scheme that upregulates several proangiogenic molecules, which promotes retinal neovasculogenesis. Our data may suggest the potential use of YC-1 to attenuate the deleterious effects that are associated with hypoxia/ischemia-independent retinal vasculopathies.	[DeNiro, Michael] King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia; [DeNiro, Michael] Johns Hopkins Med, Wilmer Eye Inst, Baltimore, MD USA; [DeNiro, Michael; Al-Mohanna, Falah H.] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia; [Alsmadi, Osama] Dasman Diabet Inst, Dasman Genome Ctr, Kuwait, Kuwait; [Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan A.] Al Faisal Univ, Coll Med, Riyadh, Saudi Arabia	King Khaled Eye Specialist Hospital; Johns Hopkins University; Johns Hopkins Medicine; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University	DeNiro, M (corresponding author), King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia.	mdeniro@kkesh.med.sa			King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre	King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre	This study was supported by King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia (http://www.kkesh.med.sa/kkeshweb/en/), and King Faisal Specialist Hospital and Research Centre (http://www.kfshrc.edu.sa/wps/portal/En). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Balamurugan AN, 2003, PANCREAS, V26, P102, DOI 10.1097/00006676-200301000-00021; Campochiaro P, 2010, RETINA TODAY S, P4; Chang MS, 2004, MOL PHARMACOL, V66, P561; CLERMONT AC, 1994, INVEST OPHTH VIS SCI, V35, P981; DeNiro M, 2010, MOL PHARMACOL, V77, P348, DOI 10.1124/mol.109.061366; DeNiro M, 2009, EXP EYE RES, V89, P700, DOI 10.1016/j.exer.2009.06.013; DeNiro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050360; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Dikov MM, 2001, CANCER RES, V61, P2015; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; Huang YT, 2005, MOL CANCER THER, V4, P1628, DOI 10.1158/1535-7163.MCT-05-0090; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keunen JEE, 2002, RETINA-J RET VIT DIS, V22, P371, DOI 10.1097/00006982-200206000-00023; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Kowluru RA, 2002, CURR EYE RES, V24, P123, DOI 10.1076/ceyr.24.2.123.8158; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Tilton RG, 1997, J CLIN INVEST, V99, P2192, DOI 10.1172/JCI119392; Wright WS, 2011, EXP EYE RES, V93, P437, DOI 10.1016/j.exer.2011.06.003	27	14	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59021	10.1371/journal.pone.0059021	http://dx.doi.org/10.1371/journal.pone.0059021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533599	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400036
J	Horvath, DJ; Radin, JN; Cho, SH; Washington, MK; Algood, HMS				Horvath, Dennis J., Jr.; Radin, Jana N.; Cho, Sung Hoon; Washington, M. Kay; Algood, Holly M. Scott			The Interleukin-17 Receptor B Subunit Is Essential for the Th2 Response to Helicobacter pylori, but Not for Control of Bacterial Burden	PLOS ONE			English	Article							REGULATORY T-CELLS; VACCINE-INDUCED IMMUNITY; FAMILY-MEMBERS; INFECTION; IL-17; GASTRITIS; COLONIZATION; EXPRESSION; ABSENCE; MICE	Helicobacter pylori infection leads to an inflammatory response in 100% of infected individuals. The inflammatory cells which are recruited to the gastric mucosa during infection produce several pro-and anti-inflammatory cytokines including several cytokines in the interleukin-17 family. The anti-inflammatory cytokine, interleukin 25 (IL-25, also known as IL-17E), signals through a receptor, which is a heterotrimeric receptor comprised of two IL-17 receptor A subunits and an IL-17 receptor B subunit. Previous studies in our laboratory demonstrated that IL-17RA is required to control infection with Helicobacter pylori in the mouse model. Moreover, the absence of IL-17 receptor A leads to a significant B cell infiltrate and a remarkable increase in lymphoid follicle formation in response to infection compared to infection in wild-type mice. We hypothesized that IL-25, which requires both IL-17 receptor A and IL-17 receptor B for signaling, may play a role in control of inflammation in the mouse model of Helicobacter pylori infection. IL-17 receptor B deficient mice, IL-17 receptor A deficient mice and wildtype mice were infected with Helicobacter pylori (strains SS1 and PMSS1). At several time points H. pylori-infected mice were sacrificed to investigate their ability to control infection and inflammation. Moreover, the effects of IL-17 receptor B deficiency on T helper cytokine expression and H. pylori-specific serum antibody responses were measured. IL-17 receptor B-/- mice (unlike IL-17 receptor A-/- mice) exhibited similar or modest changes in gastric colonization, inflammation, and Th1 and Th17 helper cytokine responses to wild-type mice infected with Helicobacter pylori. However, H. pylori-infected IL-17 receptor B-/- mice have reduced expression of IL-4 and lower serum IgG1 and IgG2a levels compared to infected IL-17 receptor A-/- and wild-type mice. These data indicate that signaling through the IL-17 receptor B subunit is not necessary for control of Helicobacter pylori in our model.	[Algood, Holly M. Scott] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Horvath, Dennis J., Jr.; Radin, Jana N.; Algood, Holly M. Scott] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Cho, Sung Hoon; Washington, M. Kay; Algood, Holly M. Scott] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Algood, HMS (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA.	holly.m.algood@vanderbilt.edu			Department of Veterans Affairs, Veterans Health Administration Office of Research and Development (Biomedical Laboratory Research and Development) (HMSA); National Institutes of Health [P30DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000915] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration Office of Research and Development (Biomedical Laboratory Research and Development) (HMSA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These data are based upon work supported by the Department of Veterans Affairs, Veterans Health Administration Office of Research and Development (Biomedical Laboratory Research and Development) (HMSA). These data are the result of work supported with resources at the VA Tennessee Valley Healthcare System. Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health grant P30DK058404. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhiani AA, 2004, J IMMUNOL, V173, P3348, DOI 10.4049/jimmunol.173.5.3348; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen W, 1999, SCAND J GASTROENTERO, V34, P987; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; DeLyria ES, 2011, HELICOBACTER, V16, P169, DOI 10.1111/j.1523-5378.2011.00839.x; Delyria ES, 2008, GASTROENTEROLOGY; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Eaton KA, 1999, INFECT IMMUN, V67, P4594, DOI 10.1128/IAI.67.9.4594-4602.1999; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Hosseini ME, 2010, INDIAN J MED MICROBI, V28, P40, DOI 10.4103/0255-0857.58727; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kabir S, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2010.00812.x; Kandulski A, 2008, HELICOBACTER, V13, P295, DOI 10.1111/j.1523-5378.2008.00612.x; Kido M, 2010, INFECT IMMUN, V78, P108, DOI 10.1128/IAI.00762-09; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Marotti B, 2008, DIGEST LIVER DIS, V40, P240, DOI 10.1016/j.dld.2007.11.021; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Orsini B, 2007, INT J IMMUNOPATH PH, V20, P809, DOI 10.1177/039463200702000417; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Pappo J, 1999, INFECT IMMUN, V67, P337, DOI 10.1128/IAI.67.1.337-341.1999; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Raghavan S, 2004, SCAND J IMMUNOL, V60, P82, DOI 10.1111/j.0300-9475.2004.01447.x; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Raghavan Sukanya, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P71; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Roth KA, 1999, J IMMUNOL, V163, P1490; Serrano C, 2013, MUCOSAL IMMUNOL; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thompson LJ, 2004, INFECT IMMUN, V72, P4668, DOI 10.1128/IAI.72.8.4668-4679.2004; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	52	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60363	10.1371/journal.pone.0060363	http://dx.doi.org/10.1371/journal.pone.0060363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533678	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400115
J	Jaarsma, R; de Vries, RSM; de Boer, AH				Jaarsma, Rinse; de Vries, Rozemarijn S. M.; de Boer, Albertus H.			Effect of Salt Stress on Growth, Na+ Accumulation and Proline Metabolism in Potato (Solanum tuberosum) Cultivars	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; THELLUNGIELLA-HALOPHILA; DELTA(1)-PYRROLINE-5-CARBOXYLATE SYNTHETASE; SALINITY TOLERANCE; GENE-EXPRESSION; TRANSPORT; PLANTS; NACL; OVEREXPRESSION; HOMEOSTASIS	Potato (Solanum tuberosum) is a major crop world-wide and the productivity of currently used cultivars is strongly reduced at high soil salt levels. We compared the response of six potato cultivars to increased root NaCl concentrations. Cuttings were grown hydroponically and treated with 0 mM, 60 mM and 180 mM NaCl for one week. Growth reduction on salt was strongest for the cultivars Mozart and Mona Lisa with a severe senescence response at 180 mM NaCl and Mozart barely survived the treatment. The cultivars Desiree and Russett Burbank were more tolerant showing no senescence after salt treatment. A clear difference in Na+ homeostasis was observed between sensitive and tolerant cultivars. The salt sensitive cultivar Mozart combined low Na+ levels in root and stem with the highest leaf Na+ concentration of all cultivars, resulting in a high Na+ shoot distribution index (SDI) for Mozart as compared to Desiree. Overall, a positive correlation between salt tolerance and stem Na+ accumulation was found and the SDI for Na+ points to a role of stem Na+ accumulation in tolerance. In stem tissue, Mozart accumulated more H2O2 and less proline compared to the tolerant cultivars. Analysis of the expression of proline biosynthesis genes in Mozart and Desiree showed a clear reduction in proline dehydrogenase (PDH) expression in both cultivars and an increase in pyrroline-5-carboxylate synthetase 1 (P5CS1) gene expression in Desiree, but not in Mozart. Taken together, current day commercial cultivars show promising differences in salt tolerance and the results suggest that mechanisms of tolerance reside in the capacity of Na+ accumulation in stem tissue, resulting in reduced Na+ transport to the leaves.	[Jaarsma, Rinse; de Vries, Rozemarijn S. M.; de Boer, Albertus H.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Biol Struct, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Boer, AH (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Biol Struct, Amsterdam, Netherlands.	a.h.de.boer@vu.nl			Dutch Technology Foundation (STW) [07912]	Dutch Technology Foundation (STW)(Technologiestichting STW)	This research was funded by the Dutch Technology Foundation (STW), fund 07912 (http://www.stw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaei K, 2009, J INTEGR PLANT BIOL, V51, P1095, DOI 10.1111/j.1744-7909.2009.00886.x; Arvin MJ, 2008, J AGRIC SCI TECHNOL, V10, P33; Baxter I, 2010, PLOS GENET, P6; Benavides MP, 2000, AUST J PLANT PHYSIOL, V27, P273; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Garthwaite AJ, 2005, J EXP BOT, V56, P2365, DOI 10.1093/jxb/eri229; Ghars MA, 2008, J PLANT PHYSIOL, V165, P588, DOI 10.1016/j.jplph.2007.05.014; GORHAM J, 1990, J EXP BOT, V41, P1095, DOI 10.1093/jxb/41.9.1095; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Hmida-Sayari A, 2005, PLANT SCI, V169, P746, DOI 10.1016/j.plantsci.2005.05.025; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Kant S, 2006, PLANT CELL ENVIRON, V29, P1220, DOI 10.1111/j.1365-3040.2006.01502.x; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Mansour MMF, 1998, PLANT PHYSIOL BIOCH, V36, P767, DOI 10.1016/S0981-9428(98)80028-4; Matysik J, 2002, MOL MECH QUENCHING R; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; Queiros F, 2009, J EXP BOT, V60, P1363, DOI 10.1093/jxb/erp011; Rahnama H, 2004, ACTA PHYSIOL PLANT, V26, P263, DOI 10.1007/s11738-004-0016-9; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Vaidyanathan H, 2003, PLANT SCI, V165, P1411, DOI 10.1016/j.plantsci.2003.08.005; Volkov V, 2006, PLANT J, V48, P342, DOI 10.1111/j.1365-313X.2006.02876.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	37	83	95	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60183	10.1371/journal.pone.0060183	http://dx.doi.org/10.1371/journal.pone.0060183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533673	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400110
J	Khan, WA; Uddin, MJ; Ismail, AIM				Khan, Waqar A.; Uddin, Md Jashim; Ismail, A. I. Md.			Hydrodynamic and Thermal Slip Effect on Double-Diffusive Free Convective Boundary Layer Flow of a Nanofluid Past a Flat Vertical Plate in the Moving Free Stream	PLOS ONE			English	Article							POROUS-MEDIUM; RAREFIED-GAS; FORCED-CONVECTION; HEAT-TRANSFER; SURFACE HEAT; MOMENTUM; CHANNEL; FLUX	The effects of hydrodynamic and thermal slip boundary conditions on the double-diffusive free convective flow of a nanofluid along a semi-infinite flat solid vertical plate are investigated numerically. It is assumed that free stream is moving. The governing boundary layer equations are non-dimensionalized and transformed into a system of nonlinear, coupled similarity equations. The effects of the controlling parameters on the dimensionless velocity, temperature, solute and nanofluid concentration as well as on the reduced Nusselt number, reduced Sherwood number and the reduced nanoparticle Sherwood number are investigated and presented graphically. To the best of our knowledge, the effects of hydrodynamic and thermal slip boundary conditions have not been investigated yet. It is found that the reduced local Nusselt, local solute and the local nanofluid Sherwood numbers increase with hydrodynamic slip and decrease with thermal slip parameters.	[Khan, Waqar A.] Natl Univ Sci & Technol, Pakistan Navy Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Uddin, Md Jashim; Ismail, A. I. Md.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Uddin, Md Jashim] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh	National University of Sciences & Technology - Pakistan; Universiti Sains Malaysia; American International University Bangladesh (AIUB)	Khan, WA (corresponding author), Natl Univ Sci & Technol, Pakistan Navy Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X				Aziz A, 2012, INT J THERM SCI, V52, P83, DOI 10.1016/j.ijthermalsci.2011.10.001; Aziz A, 2010, COMMUN NONLINEAR SCI, V15, P573, DOI 10.1016/j.cnsns.2009.04.026; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; CHENG P, 1977, J GEOPHYS RES, V82, P2040, DOI 10.1029/JB082i014p02040; Choi S. U. S., 1995, MAT SCI, V231, P99; Fang TG, 2005, APPL MATH LETT, V18, P487, DOI 10.1016/j.aml.2004.08.006; Hak G.M, 2002, FLOW PHYS MEMS HDB; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Khan WA, 2011, INT J THERM SCI, V50, P2154, DOI 10.1016/j.ijthermalsci.2011.05.022; Khan WA, 2011, INT J THERM SCI, V50, P1207, DOI 10.1016/j.ijthermalsci.2011.02.015; Khare R, 2006, INT J HEAT MASS TRAN, V49, P3401, DOI 10.1016/j.ijheatmasstransfer.2006.03.005; Kim BH, 2010, MICROFLUID NANOFLUID, V9, P31, DOI 10.1007/s10404-009-0515-5; Kuznetsov AV, 2011, INT J THERM SCI, V50, P712, DOI 10.1016/j.ijthermalsci.2011.01.003; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Kuznetsov AV, 2009, TRANSPORT POROUS MED, V76, P345, DOI 10.1007/s11242-008-9250-8; KUZNETSOV AV, 2010, TRANSPORT POROUS MED, V85, P657; Li D., 2008, ENCY MICROFLUIDICS N; Martin MJ, 2006, J THERMOPHYS HEAT TR, V20, P710, DOI 10.2514/1.22968; Matthews MT, 2007, IMA J APPL MATH, V72, P894, DOI 10.1093/imamat/hxm051; Maxwell J.C., 1879, PHILOS T R SOC LONDO, V170, P231, DOI DOI 10.1098/RSTL.1879.0067; Nguyen NT, 2009, FUNDAMENTALS APPL MI; Nield DA, 2006, TRANSPORT POROUS MED, V64, P161, DOI 10.1007/s11242-005-2341-x; Nield DA, 2011, INT J HEAT MASS TRAN, V54, P374, DOI 10.1016/j.ijheatmasstransfer.2010.09.034; Petravic J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2911924; Troian SM, 1997, NATURE, V389; Uddin MJ, 2012, TRANSPORT POROUS MED, V92, P867, DOI 10.1007/s11242-011-9938-z; Uddin MJ, 2012, MATH PROB ENG, V2012	27	80	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e54024	10.1371/journal.pone.0054024	http://dx.doi.org/10.1371/journal.pone.0054024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533566	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400004
J	Perse, M; Injac, R; Erman, A				Perse, Martina; Injac, Rade; Erman, Andreja			Oxidative Status and Lipofuscin Accumulation in Urothelial Cells of Bladder in Aging Mice	PLOS ONE			English	Article							ELECTROKINETIC CAPILLARY CHROMATOGRAPHY; NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; FREE-RADICALS; STRESS; DIFFERENTIATION; LIPOPOLYSACCHARIDE; ANTIOXIDANTS; CYTOKINES; OXALATE	Age-related changes in various tissues have been associated with the onset of a number of age-related diseases, including inflammation and cancer. Bladder cancer, for instance, is a disease that mainly afflicts middle-aged or elderly people and is mostly of urothelial origin. Although research on age-related changes of long-lived post-mitotic cells such as neurons is rapidly progressing, nothing is known about age-related changes in the urothelium of the urinary bladder, despite all the evidence confirming the important role of oxidative stress in urinary bladder pathology. The purpose of this study was thus to investigate the oxidative status and age-related changes in urothelial cells of the urinary bladder of young (2 months) and aging (20 months) mice by means of various methods. Our results demonstrated that healthy young urothelium possesses a powerful antioxidant defence system that functions as a strong defence barrier against reactive species. In contrast, urothelial cells of aging bladder show significantly decreased total antioxidant capacity and significantly increased levels of lipid peroxides (MDA) and iNOS, markers of oxidative stress. Our study demonstrates for the first time that ultrastructural alterations in mitochondria and accumulation of lipofuscin, known to be one of the aging pigments, can clearly be found in superficial urothelial cells of the urinary bladder in aging mice. Since the presence of lipofuscin in the urothelium has not yet been reported, we applied various methods to confirm our finding. Our results reveal changes in the oxidative status and structural alterations to superficial urothelial cells similar to those of other long-lived post-mitotic cells.	[Perse, Martina] Univ Ljubljana, Fac Med, Ctr Med Expt, Inst Pathol, Ljubljana, Slovenia; [Injac, Rade] Univ Ljubljana, Inst Pharmaceut Biol, Fac Pharm, Ljubljana, Slovenia; [Erman, Andreja] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana	Erman, A (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	andreja.erman@mf.uni-lj.si	Perse, Martina/AAS-2898-2020		Slovenian Research Agency (ARRS) [P3-0108]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	The study was supported by Slovenian Research Agency (ARRS) grant P3-0108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Austin PF, 2003, J UROLOGY, V170, P645, DOI 10.1097/01.ju.0000068727.22429.e8; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Committee for medicinal products for human use, 2010, CPMP QWP EWP 1401 98; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Erman A, 2004, HISTOCHEM CELL BIOL, V121, P63, DOI 10.1007/s00418-003-0600-x; Erman A, 2001, HISTOCHEM CELL BIOL, V115, P309; Erman A, 2009, J HISTOCHEM CYTOCHEM, V57, P721, DOI 10.1369/jhc.2009.953349; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Injac R, 2008, ANAL CHIM ACTA, V620, P150, DOI 10.1016/j.aca.2008.05.007; Injac R, 2007, ANAL CHIM ACTA, V594, P119, DOI 10.1016/j.aca.2007.05.003; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; JOST SP, 1989, VIRCHOWS ARCH B, V57, P27, DOI 10.1007/BF02899062; JOST SP, 1986, VIRCHOWS ARCH B, V51, P65, DOI 10.1007/BF02899016; LINDEMAN JHN, 1989, PEDIATR RES, V26, P20, DOI 10.1203/00006450-198907000-00008; Malini MM, 2000, PHARMACOL RES, V41, P413, DOI 10.1006/phrs.1999.0601; MARTIN BF, 1972, J ANAT, V112, P433; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mungrue Imran N, 2002, Heart Fail Rev, V7, P407, DOI 10.1023/A:1020762401408; Naidoo N, 2011, AGING CELL, V10, P640, DOI 10.1111/j.1474-9726.2011.00699.x; Olsson LE, 1998, J PHARMACOL EXP THER, V284, P1203; Rink M, 2012, UROLOGE, V51, P820, DOI 10.1007/s00120-011-2769-2; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Romih R, 2008, APPL IMMUNOHISTO M M, V16, P239, DOI 10.1097/PAI.0b013e31812e513d; Saito M, 2002, EUR J PHARMACOL, V454, P81, DOI 10.1016/S0014-2999(02)02471-8; Sindler AL, 2011, AGING CELL, V10, P429, DOI 10.1111/j.1474-9726.2011.00679.x; Terman A, 1998, MECH AGEING DEV, V104, P277, DOI 10.1016/S0047-6374(98)00073-6; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; Thamilselvan S, 2003, UROL RES, V31, P3, DOI 10.1007/s00240-002-0286-x; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vovk T, 2009, BIOL PHARM BULL, V32, P801, DOI 10.1248/bpb.32.801; Yalcin O, 2004, BJU INT, V93, P863, DOI 10.1111/j.1464-410X.2003.04729.x	41	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59638	10.1371/journal.pone.0059638	http://dx.doi.org/10.1371/journal.pone.0059638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527235	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600083
J	Rono, B; Engelholm, LH; Lund, LR; Hald, A				Rono, Birgitte; Engelholm, Lars Henning; Lund, Leif Roge; Hald, Andreas			Gender Affects Skin Wound Healing in Plasminogen Deficient Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; UROKINASE; ACTIVATOR; RECEPTOR; EXPRESSION; FIBRIN; MIGRATION; ESTROGEN; COLLAGEN; GROWTH	The fibrinolytic activity of plasmin plays a fundamental role in resolution of blood clots and clearance of extravascular deposited fibrin in damaged tissues. These vital functions of plasmin are exploited by malignant cells to accelerate tumor growth and facilitate metastases. Mice lacking functional plasmin thus display decreased tumor growth in a variety of cancer models. Interestingly, this role of plasmin has, in regard to skin cancer, been shown to be restricted to male mice. It remains to be clarified whether gender also affects other phenotypic characteristics of plasmin deficiency or if this gender effect is restricted to skin cancer. To investigate this, we tested the effect of gender on plasmin dependent immune cell migration, accumulation of hepatic fibrin depositions, skin composition, and skin wound healing. Gender did not affect immune cell migration or hepatic fibrin accumulation in neither wildtype nor plasmin deficient mice, and the existing differences in skin composition between males and females were unaffected by plasmin deficiency. In contrast, gender had a marked effect on the ability of plasmin deficient mice to heal skin wounds, which was seen as an accelerated wound closure in female versus male plasmin deficient mice. Further studies showed that this gender effect could not be reversed by ovariectomy, suggesting that female sex-hormones did not mediate the accelerated skin wound healing in plasmin deficient female mice. Histological examination of healed wounds revealed larger amounts of fibrotic scars in the provisional matrix of plasmin deficient male mice compared to female mice. These fibrotic scars correlated to an obstruction of cell infiltration of the granulation tissue, which is a prerequisite for wound healing. In conclusion, the presented data show that the gender dependent effect of plasmin deficiency is tissue specific and may be secondary to already established differences between genders, such as skin thickness and composition.	[Rono, Birgitte] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Rono, Birgitte; Lund, Leif Roge; Hald, Andreas] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Engelholm, Lars Henning; Hald, Andreas] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Hald, Andreas] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	Lund University; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hald, A (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.	ahald@finsenlab.dk		Engelholm, Lars/0000-0002-6616-1232	Lundbeck Foundation; Danish Cancer Society; Cancerforskningsfonden af 1989; Ludvig og Franciska Andersens Legat; Dagmar Marshalls Foundation; Fabrikant Einar Willumsens Mindelegat; Aase og Ejnar Danielsens Fond	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Cancerforskningsfonden af 1989; Ludvig og Franciska Andersens Legat; Dagmar Marshalls Foundation; Fabrikant Einar Willumsens Mindelegat; Aase og Ejnar Danielsens Fond	The authors would like to acknowledge the following foundations for their financial support: The Lundbeck Foundation, The Danish Cancer Society, Cancerforskningsfonden af 1989, Ludvig og Franciska Andersens Legat, Dagmar Marshalls Foundation, Fabrikant Einar Willumsens Mindelegat, Aase og Ejnar Danielsens Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam S, 1999, SURGERY, V125, P587, DOI 10.1067/msy.1999.98254; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; Bator JM, 1998, EXP CELL RES, V242, P110, DOI 10.1006/excr.1998.4065; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x; Frossing S, 2010, EXP DERMATOL, V19, pE234, DOI 10.1111/j.1600-0625.2009.01062.x; Gilliver SC, 2010, J STEROID BIOCHEM, V120, P105, DOI 10.1016/j.jsbmb.2009.12.015; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Grandas OH, 2009, J VASC SURG, V49, P185, DOI 10.1016/j.jvs.2008.07.080; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Green KA, 2006, DEV BIOL, V299, P164, DOI 10.1016/j.ydbio.2006.07.021; Hald A, 2012, FASEB J; Hald A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/157894; Hald A, 2011, DIS MODEL MECH, V4, P212, DOI 10.1242/dmm.005801; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Heissig B, 2007, CELL STEM CELL, V1, P658, DOI 10.1016/j.stem.2007.10.012; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Island E, 1999, WOUND REPAIR REGEN, V7, P467, DOI 10.1046/j.1524-475X.1999.00467.x; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Juncker-Jensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016954; Larmann J, 2010, ANESTHESIOLOGY, V113, P610, DOI 10.1097/ALN.0b013e3181e99bfc; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Lund LR, 2000, DEVELOPMENT, V127, P4481; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mehta R, 2008, HAEMOPHILIA, V14, P1261, DOI 10.1111/j.1365-2516.2008.01825.x; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Palumbo JS, 2003, BLOOD, V102, P2819, DOI 10.1182/blood-2003-03-0881; Pins GD, 2000, J INVEST DERMATOL, V114, P647, DOI 10.1046/j.1523-1747.2000.00858.x; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Schuster V, 2007, J THROMB HAEMOST, V5, P2315, DOI 10.1111/j.1538-7836.2007.02776.x; Schuster V, 2003, SURV OPHTHALMOL, V48, P369, DOI 10.1016/S0039-6257(03)00056-0; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Swaisgood CM, 2000, AM J PATHOL, V157, P177, DOI 10.1016/S0002-9440(10)64529-4; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Weckroth M, 2004, BRIT J DERMATOL, V151, P1189, DOI 10.1111/j.1365-2133.2004.06261.x	47	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59942	10.1371/journal.pone.0059942	http://dx.doi.org/10.1371/journal.pone.0059942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527289	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600108
J	Singh, AN; Yadav, P; Dubey, VK				Singh, Abhay Narayan; Yadav, Prity; Dubey, Vikash Kumar			cDNA Cloning and Molecular Modeling of Procerain B, a Novel Cysteine Endopeptidase Isolated from Calotropis procera	PLOS ONE			English	Article							ENZYME APPLICATIONS; PROTEASES; PROTEINASES; ROLES; LATEX; MILK	Procerain B, a novel cysteine protease (endopeptidase) isolated from Calotropis procera belongs to Asclepiadaceae family. Purification of the enzyme, biochemical characterization and potential applications are already published by our group. Here, we report cDNA cloning, complete amino acid sequencing and molecular modeling of procerain B. The derived amino acid sequence showed high sequence homology with other papain like plant cysteine proteases of peptidase C1A superfamily. The three dimensional structure of active procerain B was modeled by homology modeling using X-ray crystal structure of actinidin (PDB ID: 3P5U), a cysteine protease from the fruits of Actinidia arguta. The structural aspect of the enzyme is also discussed.	[Singh, Abhay Narayan; Yadav, Prity; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Dubey, VK (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	vdubey@iitg.ernet.in	Dubey, Vikash Kumar/B-3542-2008	Dubey, Vikash Kumar/0000-0002-4281-2504; Dubey, Vikash Kumar/0000-0002-3870-2660; NARAYAN SINGH, ABHAY/0000-0001-6875-9775	Indian Institute of Technology Guwahati	Indian Institute of Technology Guwahati	Research fellowship and facilities to ANS and PY provided by Indian Institute of Technology Guwahati are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLYNG D, 1991, J CHEM TECHNOL BIOT, V50, P321; Bernholdt HF, 1975, ENZYMES FOOD PROCESS; Chakravorty D, 2011, EXTREMOPHILES, V15, P89, DOI 10.1007/s00792-010-0337-0; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Dubey VK, 2007, AFR J BIOTECHNOL, V6, P1077; Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3; Galante YA, 2003, CURR ORG CHEM, V7, P1399, DOI 10.2174/1385272033486468; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liggieri C, 2009, ACTA BIOCH BIOPH SIN, V41, P154, DOI 10.1093/abbs/gmn018; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Mladenovic M, 2008, J AM CHEM SOC, V130, P8696, DOI 10.1021/ja711043x; Mottram JC, 1998, CURR OPIN MICROBIOL, V1, P455, DOI 10.1016/S1369-5274(98)80065-9; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Singh AN, 2010, PROCESS BIOCHEM, V45, P399, DOI 10.1016/j.procbio.2009.10.014; Singh AN, 2011, APPL BIOCHEM BIOTECH, V164, P573, DOI 10.1007/s12010-011-9158-6; Tanksale AM, 1998, MICROBIOLOGY MOL BIO, V62, P597; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Uchikoba T, 1996, APPL BIOCHEM BIOTECH, V56, P325, DOI 10.1007/BF02786962; Yogavel M, 2010, ACTA CRYSTALLOGR D, V66, P1323, DOI 10.1107/S0907444910040394	24	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59806	10.1371/journal.pone.0059806	http://dx.doi.org/10.1371/journal.pone.0059806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527269	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600095
J	Boonyaratanakornkit, J; Schomacker, H; Collins, P; Schmidt, A				Boonyaratanakornkit, Jim; Schomacker, Henrick; Collins, Peter; Schmidt, Alexander			Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System	PLOS ONE			English	Article							ALG-2-INTERACTING PROTEIN ALIX; SENDAI-VIRUS; C-PROTEIN; VACCINE CANDIDATES; BINDING PARTNER; P/C GENE; ATTENUATING MUTATIONS; REVERSE GENETICS; BRO1 DOMAIN; WILD-TYPE	The cellular ESCRT (endosomal sorting complex required for transport) system functions in cargo-sorting, in the formation of intraluminal vesicles that comprise multivesicular bodies (MVB), and in cytokinesis, and this system can be hijacked by a number of enveloped viruses to promote budding. The respiratory pathogen human parainfluenza virus type I (HPIV1) encodes a nested set of accessory C proteins that play important roles in down-regulating viral transcription and replication, in suppressing the type I interferon (IFN) response, and in suppressing apoptosis. Deletion or mutation of the C proteins attenuates HPIV1 in vivo, and such mutants are being evaluated preclinically and clinically as vaccines. We show here that the C proteins interact and co-localize with the cellular protein Alix, which is a member of the class E vacuolar protein sorting (Vps) proteins that assemble at endosomal membranes into ESCRT complexes. The HPIV1 C proteins interact with the Bro1 domain of Alix at a site that is also required for the interaction between Alix and Chmp4b, a subunit of ESCRT-III. The C proteins are ubiquitinated and subjected to proteasome-mediated degradation, but the interaction with Alix(Bro1) protects the C proteins from degradation. Neither over-expression nor knock-down of Alix expression had an effect on HPIV1 replication, although this might be due to the large redundancy of Alix-like proteins. In contrast, knocking down the expression of Chmp4 led to an approximately 100-fold reduction in viral titer during infection with wild-type (WT) HPIV1. This level of reduction was similar to that observed for the viral mutant, P(C-) HPIV1, in which expression of the C proteins were knocked out. Chmp4 is capable of out-competing the HPIV1 C proteins for binding Alix. Together, this suggests a possible model in which Chmp4, through Alix, recruits the C proteins to a common site on intracellular membranes and facilitates budding.	[Boonyaratanakornkit, Jim; Schomacker, Henrick; Collins, Peter; Schmidt, Alexander] NIAID, Infect Dis Lab, RNA Viruses Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schmidt, A (corresponding author), NIAID, Infect Dis Lab, RNA Viruses Sect, NIH, Bethesda, MD 20892 USA.	as337y@gmail.com			Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000327] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bartlett EJ, 2005, VACCINE, V23, P4631, DOI 10.1016/j.vaccine.2005.04.035; Bartlett EJ, 2006, VACCINE, V24, P2674, DOI 10.1016/j.vaccine.2005.10.047; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Boonyaratanakornkit JB, 2009, J VIROL, V83, P1892, DOI 10.1128/JVI.01373-08; Bousse T, 2006, VIRUS RES, V121, P23, DOI 10.1016/j.virusres.2006.03.012; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; Crinelli R, 2008, MOL CELL BIOCHEM, V318, P129, DOI 10.1007/s11010-008-9864-8; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Forster J, 2004, EUR J PEDIATR, V163, P709, DOI 10.1007/s00431-004-1523-9; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Gosselin-Grenet AS, 2007, VIROLOGY, V365, P101, DOI 10.1016/j.virol.2007.03.039; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gottlieb J, 2009, TRANSPLANTATION, V87, P1530, DOI 10.1097/TP.0b013e3181a4857d; Grogan CC, 2001, VIROLOGY, V288, P96, DOI 10.1006/viro.2001.1068; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hui DS, 2008, THORAX, V63, P690, DOI 10.1136/thx.2007.090951; Ichioka F, 2008, FEBS J, V275, P682, DOI 10.1111/j.1742-4658.2007.06230.x; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Itoh M, 1997, J GEN VIROL, V78, P3207, DOI 10.1099/0022-1317-78-12-3207; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Katoh K, 2004, ARCH BIOCHEM BIOPHYS, V421, P159, DOI 10.1016/j.abb.2003.09.038; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; MURPHY BR, 1988, VIRUS RES, V11, P1, DOI 10.1016/0168-1702(88)90063-9; Newman JT, 2004, J VIROL, V78, P2017, DOI 10.1128/JVI.78.4.2017-2028.2004; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Schmidt AC, 2011, EXPERT REV RESP MED, V5, P515, DOI [10.1586/ers.11.32, 10.1586/ERS.11.32]; Schomacker H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028382; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Van Cleve W, 2006, VIROLOGY, V352, P61, DOI 10.1016/j.virol.2006.04.011; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59462	10.1371/journal.pone.0059462	http://dx.doi.org/10.1371/journal.pone.0059462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527201	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100137
J	Carruthers, MD; Nicholson, PA; Tracy, EN; Munson, RS				Carruthers, Michael D.; Nicholson, Paul A.; Tracy, Erin N.; Munson, Robert S., Jr.			Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition	PLOS ONE			English	Article							EPITHELIAL-CELLS; BIOFILM FORMATION; ABIOTIC SURFACES; PROTEIN PLAYS; EXPRESSION; RESISTANT; PATHOGEN; MUTANTS; DNA; INACTIVATION	Type VI secretion systems(T6SS) are a class of macromolecular secretion machines that are utilized by a number of bacteria for inter-bacterial competition or to elicit responses in eukaryotic cells. Acinetobacter baumannii is an opportunistic pathogen that causes severe infections in humans. These infections, including pneumonia and bacteremia, are important, as they are often associated with hospitals and medical-settings where they disproportionally affect critically ill patients like those residing in intensive care units. While it is known that A. baumannii genomes carry genes whose predicted products have homology with T6SS-associated gene products from other bacteria, and secretion of a major T6SS structural protein Hcp has been demonstrated, no additional work on an A. baumannii T6SS has been reported. Herein, we demonstrated that A. baumannii strain M2 secretes Hcp and this secretion was dependent upon TssB, an ortholog of a bacteriophage contractile sheath protein, confirming that strain M2 produces a functional T6SS. Additionally, we demonstrated that the ability of strain M2 to out-compete Escherichia coli was reliant upon the products of tssB and hcp. Collectively, our data have provided the first evidence demonstrating function in inter-bacterial competition, for a T6SS produced by A. baumannii.	[Munson, Robert S., Jr.] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Pediat, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Munson, RS (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43210 USA.	robert.munson@nationwidechildrens.org	Munson, Jr, Robert/E-3710-2011	Munson, Jr, Robert/0000-0002-3204-3019	Research Institute at Nationwide Children's Hospital	Research Institute at Nationwide Children's Hospital(Ohio State University)	This research was supported by discretionary funds to RSM from The Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo A, 2007, EUR J CLIN MICROBIOL, V26, P793, DOI 10.1007/s10096-007-0371-8; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Brossard KA, 2012, INFECT IMMUN, V80, P228, DOI 10.1128/IAI.05913-11; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; English G, 2012, MOL MICROBIOL; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar A, 2010, J MICROBIOL METH, V82, P296, DOI 10.1016/j.mimet.2010.07.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McConnell MJ, 2012, FEMS MICROBIOL REV; Mulder DT, 2012, INFECT IMMUN, V80, P1996, DOI 10.1128/IAI.06205-11; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	56	87	90	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59388	10.1371/journal.pone.0059388	http://dx.doi.org/10.1371/journal.pone.0059388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527179	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100123
J	Geiselhardt, S; Yoneya, K; Blenn, B; Drechsler, N; Gershenzon, J; Kunze, R; Hilker, M				Geiselhardt, Sven; Yoneya, Kinuyo; Blenn, Beatrice; Drechsler, Navina; Gershenzon, Jonathan; Kunze, Reinhard; Hilker, Monika			Egg Laying of Cabbage White Butterfly (Pieris brassicae) on Arabidopsis thaliana Affects Subsequent Performance of the Larvae	PLOS ONE			English	Article							ALIPHATIC GLUCOSINOLATE BIOSYNTHESIS; INSECT EGGS; SPECIALIST HERBIVORE; INDIRECT DEFENSE; GENE-EXPRESSION; PLANT DEFENSE; DEPOSITION; OVIPOSITION; HYDROLYSIS; ARREST	Plant resistance to the feeding by herbivorous insects has recently been found to be positively or negatively influenced by prior egg deposition. Here we show how crucial it is to conduct experiments on plant responses to herbivory under conditions that simulate natural insect behaviour. We used a well-studied plant - herbivore system, Arabidopsis thaliana and the cabbage white butterfly Pieris brassicae, testing the effects of naturally laid eggs (rather than egg extracts) and allowing larvae to feed gregariously as they do naturally (rather than placing single larvae on plants). Under natural conditions, newly hatched larvae start feeding on their egg shells before they consume leaf tissue, but access to egg shells had no effect on subsequent larval performance in our experiments. However, young larvae feeding gregariously on leaves previously laden with eggs caused less feeding damage, gained less weight during the first 2 days, and suffered twice as high a mortality until pupation compared to larvae feeding on plants that had never had eggs. The concentration of the major anti-herbivore defences of A. thaliana, the glucosinolates, was not significantly increased by oviposition, but the amount of the most abundant member of this class, 4-methylsulfinylbutyl glucosinolate was 1.8-fold lower in larval-damaged leaves with prior egg deposition compared to damaged leaves that had never had eggs. There were also few significant changes in the transcript levels of glucosinolate metabolic genes, except that egg deposition suppressed the feeding-induced up-regulation of FMOGS-OX2, a gene encoding a flavin monooxygenase involved in the last step of 4-methylsulfinylbutyl glucosinolate biosynthesis. Hence, our study demonstrates that oviposition does increase A. thaliana resistance to feeding by subsequently hatching larvae, but this cannot be attributed simply to changes in glucosinolate content.	[Geiselhardt, Sven; Yoneya, Kinuyo; Blenn, Beatrice; Hilker, Monika] Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany; [Drechsler, Navina; Kunze, Reinhard] Free Univ Berlin, Inst Biol Appl Genet, Berlin, Germany; [Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society	Geiselhardt, S (corresponding author), Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany.	sven.geiselhardt@fu-berlin.de	Gershenzon, Jonathan/K-1331-2013	Gershenzon, Jonathan/0000-0002-1812-1551; Geiselhardt, Sven/0000-0001-9058-8589; Kunze, Reinhard/0000-0002-3304-5550	Dahlem Centre of Plant Sciences (DCPS), Freie Universitat Berlin; German Academic Exchange Service (DAAD); German Research Foundation (DFG)	Dahlem Centre of Plant Sciences (DCPS), Freie Universitat Berlin; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG))	ND was supported by a grant of the Dahlem Centre of Plant Sciences (DCPS), Freie Universitat Berlin (www.dcps.fu-berlin.de). KY was supported by the German Academic Exchange Service (DAAD) (www.daad.de). BB was supported by the German Research Foundation (DFG) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; Beyaert I, 2012, P ROY SOC B-BIOL SCI, V279, P101, DOI 10.1098/rspb.2011.0468; Blenn B, 2012, J CHEM ECOL, V38, P882, DOI 10.1007/s10886-012-0132-8; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Choh Y, 2006, J CHEM ECOL, V32, P2073, DOI 10.1007/s10886-006-9130-z; DAVIES CR, 1985, OECOLOGIA, V67, P278, DOI 10.1007/BF00384299; De Puysseleyr V, 2011, ARTHROPOD-PLANT INTE, V5, P71, DOI 10.1007/s11829-010-9117-0; Deshpande SA, 2012, ENTOMOL EXP APPL, V144, P172, DOI 10.1111/j.1570-7458.2012.01275.x; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P981, DOI 10.1016/S0305-1978(01)00045-X; Fatouros NE, 2005, ENTOMOL EXP APPL, V115, P207, DOI 10.1111/j.1570-7458.2005.00245.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Galis I, 2009, PLANT CELL ENVIRON, V32, P617, DOI 10.1111/j.1365-3040.2008.01862.x; Gigolashvili T, 2009, PHYTOCHEM REV, V8, P3, DOI 10.1007/s11101-008-9112-6; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Karban R, 2002, INDUCED RESPONSES HE; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037420; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas-Barbosa D, 2013, FUNCT ECOL, V27, P245, DOI 10.1111/1365-2435.12004; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mumm R, 2008, J CHEM ECOL, V34, P1311, DOI 10.1007/s10886-008-9534-z; Petzold-Maxwell J, 2011, ECOL ENTOMOL, V36, P700, DOI 10.1111/j.1365-2311.2011.01315.x; Schaller A., 2008, INDUCED PLANT RESIST; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Textor S, 2009, PHYTOCHEM REV, V8, P149, DOI 10.1007/s11101-008-9117-1; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101	39	40	41	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59661	10.1371/journal.pone.0059661	http://dx.doi.org/10.1371/journal.pone.0059661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527243	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100155
J	Hung, CC; Chiou, MH; Teng, YN; Hsieh, YW; Huang, CL; Lane, HY				Hung, Chin-Chuan; Chiou, Mu-Han; Teng, Yu-Ning; Hsieh, Yow-Wen; Huang, Chieh-Liang; Lane, Hsien-Yuan			Functional Impact of ABCB1 Variants on Interactions between P-Glycoprotein and Methadone	PLOS ONE			English	Article							OPIOID-DEPENDENT INDIVIDUALS; MDR1 MULTIDRUG TRANSPORTER; INJECTION-DRUG USERS; BLOOD-BRAIN-BARRIER; GENETIC POLYMORPHISMS; PROTEASE INHIBITORS; INTESTINAL-ABSORPTION; EFFLUX TRANSPORTERS; PLASMA-LEVELS; MAINTENANCE	Methadone is a widely used substitution therapy for opioid addiction. Large inter-individual variability has been observed in methadone maintenance dosages and P-glycoprotein (P-gp) was considered to be one of the major contributors. To investigate the mechanism of P-gp's interaction with methadone, as well as the effect of genetic variants on the interaction, Flp-In (TM)-293 cells stably transfected with various genotypes of human P-gp were established in the present study. The RNA and protein expression levels of human P-gp were confirmed by real-time quantitative RT-PCR and western blot, respectively. Utilizing rhodamine 123 efflux assay and calcein-AM uptake study, methadone was demonstrated to be an inhibitor of wild-type human P-gp via non-competitive kinetic (IC50 = 2.17 +/- 0.10 mu M), while the variant-type human P-gp, P-gp with 1236T-2677T-3435T genotype and P-gp with 1236T-2677A-3435T genotype, showed less inhibition potency (IC50 = 2.97 +/- 0.09 mu M and 4.43 +/- 1.10 mu M, respectively) via uncompetitive kinetics. Methadone also stimulated P-gp ATPase and inhibited verapamil-stimulated P-gp ATPase activity under therapeutic concentrations. These results may provide a possible explanation for higher methadone dosage requirements in patients carrying variant-type of P-gp and revealed the possible drug-drug interactions in patients who receive concomitant drugs which are also P-gp substrates.	[Hung, Chin-Chuan; Teng, Yu-Ning; Hsieh, Yow-Wen] China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan; [Hung, Chin-Chuan; Teng, Yu-Ning] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Chiou, Mu-Han] Cathay Gen Hosp, Dept Pharm, Taipei, Taiwan; [Huang, Chieh-Liang; Lane, Hsien-Yuan] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Lane, Hsien-Yuan] China Med Univ, Coll Med, Inst Clin Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Cathay General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, CC (corresponding author), China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan.	cc0206hung@gmail.com; hylane@gmail.com	Yu-Ning, Teng/AAS-8002-2021		National Science Council, Taiwan [NSC-99-2320-B-039-005-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; National Health Research Institutes [NHRI-101A1-PDCO-131214]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Health Research Institutes(National Health Research Institutes, Japan)	The authors extend their sincere thanks to National Science Council, Taiwan (NSC-99-2320-B-039-005-MY3), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004) and National Health Research Institutes (NHRI-101A1-PDCO-1312141) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 1999, AIDS, V13, P957, DOI 10.1097/00002030-199905280-00012; Anderson PL, 2009, J ANTIMICROB CHEMOTH, V64, P1071, DOI 10.1093/jac/dkp317; ANGGARD E, 1975, CLIN PHARMACOL THER, V17, P258; Antoniou T, 2002, ANN PHARMACOTHER, V36, P1598, DOI 10.1345/aph.1A447; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bierman WFW, 2010, J ANTIMICROB CHEMOTH, V65, P1672, DOI 10.1093/jac/dkq209; Bouer R, 1999, FUNDAM CLIN PHARM, V13, P494, DOI 10.1111/j.1472-8206.1999.tb00009.x; Brown Randy, 2004, WMJ, V103, P20; Bruce RD, 2010, INT J DRUG POLICY, V21, P122, DOI 10.1016/j.drugpo.2009.10.004; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Corsi KF, 2009, J SUBST ABUSE TREAT, V37, P120, DOI 10.1016/j.jsat.2008.11.004; Crettol S, 2008, CLIN PHARMACOL THER, V83, P668, DOI 10.1038/sj.clpt.6100305; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Dagenais C, 2004, BIOCHEM PHARMACOL, V67, P269, DOI 10.1016/j.bcp.2003.08.027; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Hassan HE, 2009, J PHARM SCI-US, V98, P4928, DOI 10.1002/jps.21770; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259; Hung CC, 2011, PHARMACOGENOMICS, V12, P1525, DOI [10.2217/PGS.11.96, 10.2217/pgs.11.96]; Hung CC, 2011, INVEST NEW DRUG, V29, P1337, DOI 10.1007/s10637-010-9496-1; Kapur BM, 2011, CRIT REV CL LAB SCI, V48, P171, DOI 10.3109/10408363.2011.620601; Kerb R, 2006, CANCER LETT, V234, P4, DOI 10.1016/j.canlet.2005.06.051; Kharasch ED, 2004, BRIT J CLIN PHARMACO, V57, P600, DOI 10.1111/j.1365-2125.2003.02053.x; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Lane HY, 2001, J CLIN PSYCHIAT, V62, P812, DOI 10.4088/JCP.v62n1010; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Li YF, 2008, MOL DIAGN THER, V12, P109, DOI 10.1007/BF03256276; Linardi RL, 2013, J VET PHARMACOL THER, V36, P43, DOI 10.1111/j.1365-2885.2012.01390.x; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Mercer SL, 2011, CURR TOP MED CHEM, V11, P1157; Ortega I, 2007, PHARM RES-DORDR, V24, P1299, DOI 10.1007/s11095-007-9251-2; Pal D, 2006, LIFE SCI, V78, P2131, DOI 10.1016/j.lfs.2005.12.010; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Perloff MD, 2000, AIDS, V14, P1287, DOI 10.1097/00002030-200006160-00034; Rodriguez M, 2004, J PHARM PHARMACOL, V56, P367, DOI 10.1211/0022357022782; Rodriguez-Novoa S, 2007, AIDS, V21, P41, DOI 10.1097/QAD.0b013e328011d7c1; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Stormer E, 2001, DRUG METAB DISPOS, V29, P954; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Tetrault JM, 2012, DRUGS, V72, P217, DOI 10.2165/11597520-000000000-00000; Tian JN, 2012, PHARMACOGENOMICS, V13, P879, DOI [10.2217/PGS.12.69, 10.2217/pgs.12.69]; Tournier N, 2010, INT J NEUROPSYCHOPH, V13, P905, DOI 10.1017/S1461145709990848; Vishnuvardhan D, 2003, AIDS, V17, P1092, DOI 10.1097/00002030-200305020-00023; Wang JS, 2004, PSYCHOPHARMACOLOGY, V173, P132, DOI 10.1007/s00213-003-1718-1	49	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59419	10.1371/journal.pone.0059419	http://dx.doi.org/10.1371/journal.pone.0059419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527191	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100130
J	Jain, S; Yoon, SY; Leung, L; Knoferle, J; Huang, YD				Jain, Sachi; Yoon, Seo Yeon; Leung, Laura; Knoferle, Johanna; Huang, Yadong			Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEPENDENT IMPAIRMENT; CORTICAL-NEURONS; TRANSGENIC MICE; TYPE-4 ALLELE; E EXPRESSION; DENSITY; E3; SUSCEPTIBILITY; DYSFUNCTION	Apolipoprotein (apo) E4 is the leading genetic risk factor for Alzheimer's disease (AD), and it has a gene dose-dependent effect on the risk and age of onset of AD. Although apoE4 is primarily produced by astrocytes in the brain, neurons can also produce apoE4 under stress conditions. ApoE4 is known to inhibit neurite outgrowth and spine development in vitro and in vivo, but the potential influence of apoE4's cellular source on dendritic arborization and spine development has not yet been investigated. In this study, we report impairments in dendritic arborization and a loss of spines, especially thin (learning) and mushroom (memory) spines, in the hippocampus and entorhinal cortex of 19-21-month-old female neuron-specific-enolase (NSE)-apoE4 and apoE4-knockin (KI) mice compared to their respective apoE3-expressing counterparts. In general, NSE-apoE4 mice had more severe and widespread deficits in dendritic arborization as well as spine density and morphology than apoE4-KI mice. The loss of dendritic spines, especially mushroom spines, occurred in NSE-apoE4 mice as early as 7-8 months of age. In contrast, glial fibrillary acidic protein (GFAP)-apoE4 mice, which express apoE4 solely in astrocytes, did not have impairments in their dendrite arborization or spine density and morphology compared to GFAP-apoE3 mice at both ages. These results indicate that the effects of apoE4 on dendrite arborization, spine density, and spine morphology depend critically on its cellular source, with neuronal apoE4 having more detrimental effects than astrocytic apoE4.	[Jain, Sachi; Yoon, Seo Yeon; Leung, Laura; Knoferle, Johanna; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Jain, Sachi; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Leung, Laura; Knoferle, Johanna; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	yhuang@gladstone.ucsf.edu			J. David Gladstone Institutes; National Institute of Health [P01 AG022074]; National Science Foundation; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by The J. David Gladstone Institutes, the grant P01 AG022074 from the National Institute of Health, the National Science Foundation, and gifts from the S. D. Bechtel, Jr. Foundation and the Hellman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Buttini M, 1999, J NEUROSCI, V19, P4867; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046340; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Roses Allen D, 2006, Alzheimers Dement, V2, P59, DOI 10.1016/j.jalz.2005.12.001; Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Teter B, 1999, J NEUROCHEM, V73, P2613, DOI 10.1046/j.1471-4159.1999.0732613.x; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; von Gunten A, 2006, NEUROBIOL AGING, V27, P270, DOI 10.1016/j.neurobiolaging.2005.02.008; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006	46	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59478	10.1371/journal.pone.0059478	http://dx.doi.org/10.1371/journal.pone.0059478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527202	Green Published, gold			2022-12-27	WOS:000317562100138
J	Wang, SY; Luo, J; Murphy, RW; Wu, SF; Zhu, CL; Gao, Y; Zhang, YP				Wang, Shu-Yan; Luo, Jing; Murphy, Robert W.; Wu, Shi-Fang; Zhu, Chun-Ling; Gao, Yun; Zhang, Ya-Ping			Origin of Chinese Goldfish and Sequential Loss of Genetic Diversity Accompanies New Breeds	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MITOCHONDRIAL GENOME; STATISTICAL TESTS; SOFTWARE PACKAGE; DNA; EVOLUTION; SELECTION; CARP; HYPOTHESIS; INFERENCE	Background: Goldfish, Carassius auratus, have experienced strong anthropogenic selection during their evolutionary history, generating a tremendous extent of morphological variation relative to that in native Carassius. To locate the geographic origin of goldfish, we analyzed nucleotide sequences from part of the control region (CR) and the entire cytochrome b (Cytb) mitochondrial DNA genes for 234 goldfish and a large series of native specimens. Four important morphological characteristics used in goldfish taxonomy-body shape, dorsal fin, eye shape, and tailfin-were selected for hypothesis-testing to identify those that better correspond to evolutionary history. Principal Finding: Haplotypes of goldfish rooted in two sublineages (C5 and C6), which contained the haplotypes of native C. a. auratus from southern China. Values of F-ST and N-m revealed a close relationship between goldfish and native C. a. auratus from the lower Yangtze River. An extraordinary, stepwise loss of genetic diversity was detected from native fish to goldfish and from Grass-goldfish relative to other breeds. Significantly negative results for the tests of Tajima's D and Fu and Li's D* and F* were identified in goldfish, including the Grass breed. The results identified eye-shape as being the least informative character for grouping goldfish with respect to their evolutionary history. Fisher's exact test identified matrilineal constraints on domestication. Conclusions: Chinese goldfish have a matrilineal origin from native southern Chinese C. a. auratus, especially the lineages from the lower Yangtze River. Anthropogenic selection of the native Carassius eliminated aesthetically unappealing goldfish and this action appeared to be responsible for the stepwise decrease in genetic diversity of domesticated goldfish, a process similar to that reported for the domestication of pigs, rice, and maize. The three-breed taxonomy-Grass-goldfish, Egg-goldfish, and Wen-goldfish-better reflected the history of domestication.	[Wang, Shu-Yan; Murphy, Robert W.; Wu, Shi-Fang; Zhu, Chun-Ling; Gao, Yun; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Wang, Shu-Yan; Murphy, Robert W.; Wu, Shi-Fang; Zhu, Chun-Ling; Gao, Yun; Zhang, Ya-Ping] Chinese Acad Sci, Yunnan Lab Mol Biol Domest Anim, Kunming Inst Zool, Kunming, Peoples R China; [Wang, Shu-Yan] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Luo, Jing; Zhang, Ya-Ping] Yunnan Univ, Coll Life Sci, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yunnan University; Royal Ontario Museum	Gao, Y (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China.	gaoy@mail.kiz.ac.cn; zhangyp@mail.kiz.ac.cn		Murphy, Robert/0000-0001-8555-2338	State Key Basic Research and Development Plan [2007CB411600]; Bureau of Science and Technology of Yunnan Province [2008GA001]; Chinese Academy of Sciences; State Key Laboratory of Genetic Resources and Evolution; Natural Sciences and Engineering Research Council (Canada) [3148]	State Key Basic Research and Development Plan; Bureau of Science and Technology of Yunnan Province; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Genetic Resources and Evolution; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the State Key Basic Research and Development Plan (2007CB411600), Bureau of Science and Technology of Yunnan Province (2008GA001), and 'Western Light programme' of the Chinese Academy of Sciences to Y.G. and J.L. was funded by the State Key Laboratory of Genetic Resources and Evolution, and Natural Sciences and Engineering Research Council (Canada) Discovery Grant 3148 to R. W. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Berg LS., 1949, FRESHWATER FISHES US, P467; BREWSTER B, 2004, KEEPING GOLDFISH; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Chen Z, 1959, DOMESTICATION VARIAT; Cherfas NB., 1981, GENETIC BASES FISH S, P255; Drucker EG, 2001, J EXP BIOL, V204, P2943; Eschmeyer W.N., 1998, SPECIAL PUBLICATION, V1; Eschmeyer William N, 1998, SPECIAL PUBLICATION, V1-3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu Y, 1981, FRESHWATER FISHERIES, V6, P15; FU YX, 1993, GENETICS, V133, P693; Gao Y, 2012, J BIOGEOGR, V39, P2264, DOI 10.1111/j.1365-2699.2012.02755.x; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; GOLDMAN N, 1993, J MOL EVOL, V37, P650; Gui J., 1997, B NATURAL NATL SCI F, V11, P11; Gui J.F, 2007, GENETIC BASIS ARTIFI; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026416; Jiang Y.G., 1983, ACTA HYDROBIOL SIN, V8, P1; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Komiyama T, 2009, GENE, V430, P5, DOI 10.1016/j.gene.2008.10.019; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li J, 2010, HEREDITY, V105, P274, DOI 10.1038/hdy.2009.191; LI PU, 1959, CHINESE JOUR ZOOL, V3, P248; Liang Qianjin, 1994, Zoological Research, V15, P68; Luo J, 1999, BIOCHEM GENET, V37, P267, DOI 10.1023/A:1018751008848; Meng QW., 1995, FISH TAXONOMY; Meyer Axel, 1993, Biochemistry and Molecular Biology of Fishes, V2, P1; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Nakamura M., 1969, CYPRINID FISHES JAPA; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2009, TRACER V1 9; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smartt J, 2001, GOLDFISH VARIETIES G; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TZENG CS, 1992, NUCLEIC ACIDS RES, V20, P4853, DOI 10.1093/nar/20.18.4853; Wang C.Y., 2000, CHINESE GOLDFISH; Wang CY, 1982, J GENET GENOMICS, V9, P238; Wang CY, 1985, B BIOL FR BELG, V12, P11; Wang CY, 1983, B BIOL FR BELG, V3, P29; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WHEELER A, 1977, J BIOGEOGR, V4, P1, DOI 10.2307/3038124; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhu HP, 2006, CHROMOSOME RES, V14, P767, DOI 10.1007/s10577-006-1083-0; [朱雪莲 ZHU Xue-lian], 2010, [大连水产学院学报, Journal of Dalian Fisheries College], V25, P153	55	29	35	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59571	10.1371/journal.pone.0059571	http://dx.doi.org/10.1371/journal.pone.0059571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527220	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100149
J	Xi, B; Chen, M; Chandak, GR; Shen, Y; Yan, L; He, J; Mou, SH				Xi, Bo; Chen, Man; Chandak, Giriraj R.; Shen, Yue; Yan, Li; He, Juan; Mou, Si-Hua			STK39 Polymorphism Is Associated with Essential Hypertension: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; EAST ASIANS; GENETIC-VARIANTS; DISEASE; CHINESE; RISK; REPLICATION; SPAK; BIAS	Background: A recent genome-wide association study identified STK39as a candidate gene for blood pressure (BP) in Europeans. Subsequently, several studies have attempted to replicate the association across different ethnic populations. However, the results have been inconsistent. Objective and Methods: We performed a meta-analysis to elucidate the association between the STK39 rs3754777 polymorphism (or proxy) and hypertension. Published literature from PubMed and Embase databases were retrieved and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed-or random-effects model. Results: Using appropriate inclusion/exclusion criteria, we identified 10 studies that included 21, 863 hypertensive cases and 24, 480 controls from different ethnicities. The meta-analysis showed a significant association of STK39 rs3754777 variant with hypertension (OR = 1.10, 95% CI = 1.06-1.15, p = 7.95x10(-6)). Further subgroup analysis by ethnicity suggested that the association was significant in Europeans (OR = 1.08, 95% CI = 1.03-1.14, p = 0.002) and in East Asians (OR = 1.16, 95% CI = 1.07-1.25, p = 4.34x10(-4)), but not in Africans (OR = 1.01, 95% CI 0.80-1.27, p = 0.932). We further confirmed the positive association by sensitivity analysis. No publication bias was detected (Begg's test, p = 0.721; Egger's test, p = 0.744). Conclusions: The present meta-analysis confirms the significant association of STK39 polymorphism with susceptibility to hypertension in Europeans and East Asians. Future studies should include gene-gene and gene-environment interactions to investigate the identified association.	[Xi, Bo] Shandong Univ, Sch Publ Hlth, Inst Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Chen, Man] Chengdu Med Coll, Sch Lab Med, Chengdu, Peoples R China; [Chandak, Giriraj R.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Shen, Yue] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Yan, Li] Dalian Med Univ, Dept Social Med & Hlth Serv Management, Dalian, Peoples R China; [He, Juan] Kunming Gen Hosp Chengdu Mil Commend, Dept Pharm, Kunming, Peoples R China; [Mou, Si-Hua] Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Peoples R China	Shandong University; Chengdu Medical College; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Capital Institute of Pediatrics (CIP); Dalian Medical University; Taizhou University	Mou, SH (corresponding author), Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Peoples R China.	sihuamou@163.com		Chandak, Giriraj Ratan/0000-0002-3095-9453	Foundation for Outstanding Young Scientist in Shandong Province [BS2011YY026]; Independent Innovation Foundation of Shandong University [2010GN046]	Foundation for Outstanding Young Scientist in Shandong Province; Independent Innovation Foundation of Shandong University	This study was supported by the Foundation for Outstanding Young Scientist in Shandong Province (BS2011YY026) and the Independent Innovation Foundation of Shandong University (2010GN046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen LY, 2012, INT J CARDIOL, V154, P122, DOI 10.1016/j.ijcard.2010.09.007; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cunnington MS, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-135; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fava C, 2011, J HYPERTENS, V29, P484, DOI 10.1097/HJH.0b013e328342b2c1; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kidambi S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-27; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; MANTEL N, 1959, J NATL CANCER I, V22, P719; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Niu WQ, 2011, J HUM HYPERTENS, V25, P278, DOI 10.1038/jhh.2010.114; Persu A, 2011, J HYPERTENS, V29, P434, DOI 10.1097/HJH.0b013e328344b6b3; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rhee MY, 2011, HYPERTENS RES, V34, P606, DOI 10.1038/hr.2010.278; Tanira M, 2005, J HUM HYPERTENS, V19, P7, DOI 10.1038/sj.jhh.1001780; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Xi B, 2012, ATHEROSCLEROSIS, V225, P376, DOI 10.1016/j.atherosclerosis.2012.10.027; Xi B, 2013, INT J CARDIOL, V165, P577, DOI 10.1016/j.ijcard.2012.09.032; Xi B, 2013, METABOLISM, V62, P196, DOI 10.1016/j.metabol.2012.07.008; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Xi B, 2012, BLOOD PRESSURE, V21, P134, DOI 10.3109/08037051.2012.632845; Xu J, 2013, J HUM HYPERTENS, V27, P294, DOI 10.1038/jhh.2012.46	28	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59584	10.1371/journal.pone.0059584	http://dx.doi.org/10.1371/journal.pone.0059584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527223	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600065
J	Tijms, BM; Moller, C; Vrenken, H; Wink, AM; de Haan, W; van der Flier, WM; Stam, CJ; Scheltens, P; Barkhof, F				Tijms, Betty M.; Moller, Christiane; Vrenken, Hugo; Wink, Alle Meije; de Haan, Willem; van der Flier, Wiesje M.; Stam, Cornelis J.; Scheltens, Philip; Barkhof, Frederik			Single-Subject Grey Matter Graphs in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; FALSE DISCOVERY RATE; CORTICAL THICKNESS; FUNCTIONAL CONNECTIVITY; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; ANATOMICAL NETWORKS; NATIONAL INSTITUTE; GENETIC RISK	Coordinated patterns of cortical morphology have been described as structural graphs and previous research has demonstrated that properties of such graphs are altered in Alzheimer's disease (AD). However, it remains unknown how these alterations are related to cognitive deficits in individuals, as such graphs are restricted to group-level analysis. In the present study we investigated this question in single-subject grey matter networks. This new method extracts large-scale structural graphs where nodes represent small cortical regions that are connected by edges when they show statistical similarity. Using this method, unweighted and undirected networks were extracted from T1 weighted structural magnetic resonance imaging scans of 38 AD patients (19 female, average age 72 +/- 4 years) and 38 controls (19 females, average age 72 +/- 4 years). Group comparisons of standard graph properties were performed after correcting for grey matter volumetric measurements and were correlated to scores of general cognitive functioning. AD networks were characterised by a more random topology as indicated by a decreased small world coefficient (p = 3.53x10(-5)), decreased normalized clustering coefficient (p = 7.25x10(-6)) and decreased normalized path length (p = 1.91x10(-7)). Reduced normalized path length explained significantly (p = 0.004) more variance in measurements of general cognitive decline (32%) in comparison to volumetric measurements (9%). Altered path length of the parahippocampal gyrus, hippocampus, fusiform gyrus and precuneus showed the strongest relationship with cognitive decline. The present results suggest that single-subject grey matter graphs provide a concise quantification of cortical structure that has clinical value, which might be of particular importance for disease prognosis. These findings contribute to a better understanding of structural alterations and cognitive dysfunction in AD.	[Tijms, Betty M.; Moller, Christiane; de Haan, Willem; van der Flier, Wiesje M.; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Tijms, Betty M.; Moller, Christiane; de Haan, Willem; van der Flier, Wiesje M.; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Vrenken, Hugo; Wink, Alle Meije; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, MEG, Amsterdam, Netherlands; [van der Flier, Wiesje M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Tijms, BM (corresponding author), Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands.	b.tijms@vumc.nl	Wink, Alle Meije/R-6403-2017; Barkhof, Frederik/AAJ-6226-2020; Tijms, Betty M./I-2218-2019; de Haan, Willem/T-1217-2019; Scheltens, Philip/AAL-9631-2020	Wink, Alle Meije/0000-0002-8197-0118; Barkhof, Frederik/0000-0003-3543-3706; Tijms, Betty M./0000-0002-2612-1797; Scheltens, Philip/0000-0002-1046-6408; van der Flier, Wiesje/0000-0001-8766-6224; de Haan, Willem/0000-0003-3876-1764; Stam, Cornelis/0000-0001-9163-7274	Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	This study was conducted at the VUmc Alzheimer center that is part of the neurodegeneration research program of the Neuroscience Campus Amsterdam. The VUmc Alzheimer center is supported by Alzheimer Nederland and Stichting VUmc fonds. The clinical database structure was developed with funding from Stichting Dioraphte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Burggren AC, 2002, AM J GERIAT PSYCHIAT, V10, P44, DOI 10.1176/appi.ajgp.10.1.44; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Dai D, 2011, LECT NOTES COMPUT SC, V7009, P193, DOI 10.1007/978-3-642-24319-6_24; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; FERRER I, 1995, NEUROSCIENCE, V66, P189, DOI 10.1016/0306-4522(94)00584-R; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2005, ANAT EMBRYOL, V210, P411, DOI 10.1007/s00429-005-0041-5; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mitchell AJ, 2008, INT J GERIATR PSYCH, V23, P1191, DOI 10.1002/gps.2053; Mormino EC, 2011, CEREB CORTEX, V21, P2399, DOI 10.1093/cercor/bhr025; Nikou C, 1999, PATTERN RECOGN, V32, P1351, DOI 10.1016/S0031-3203(98)00167-8; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Paus T, 1996, CEREB CORTEX, V6, P207, DOI 10.1093/cercor/6.2.207; Penney GP, 1998, LECT NOTES COMPUT SC, V1496, P1153, DOI 10.1007/BFb0056305; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Ridgway GR, 2012, NEUROLOGY, V79, P80, DOI 10.1212/WNL.0b013e31825dce28; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosenbloom MH, 2011, NEUROLOGY, V76, P1789, DOI 10.1212/WNL.0b013e31821cccad; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shiino A, 2006, NEUROIMAGE, V33, P17, DOI 10.1016/j.neuroimage.2006.06.010; Smit DJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036896; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Takashima A, 2009, J ALZHEIMERS DIS, V17, P729, DOI 10.3233/JAD-2009-1090; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; VanCourt T, 2005, CAMP 2005: SEVENTH INTERNATIONAL WORKSHOP ON COMPUTER ARCHITECTURE FOR MACHINE PERCEPTION , PROCEEDINGS, P153; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weese J, 1999, LECT NOTES COMPUT SC, V1679, P656; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021935	94	84	84	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58921	10.1371/journal.pone.0058921	http://dx.doi.org/10.1371/journal.pone.0058921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536835	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100100
J	Geng, LY; Chaudhuri, A; Talmon, G; Wisecarver, JL; Wang, J				Geng, Liying; Chaudhuri, Anathbandhu; Talmon, Geoffrey; Wisecarver, James L.; Wang, Jing			TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLORECTAL-CANCER; EXPRESSION; RECEPTOR; RESISTANCE; AUTOCRINE; CELLS; MALIGNANCY; MUTATION; PATHWAY	The FET cell line, derived from an early stage colon carcinoma, is non-tumorigenic in athymic nude mice. Engineered FET cells that express TGF-alpha (FET alpha) display constitutively active EGFR/ErbB signaling. These cells readily formed xenograft tumors in athymic nude mice. Importantly, FET alpha cells retained their response to TGF-beta-mediated growth inhibition, and, like the parental FET cells, expression of a dominant negative TGF-beta type II receptor (DNRII) in FET alpha cells (FET alpha/DNRII) abrogated responsiveness to TGF-beta-induced growth inhibition and apoptosis under stress conditions in vitro and increased metastatic potential in an orthotopic model in vivo, which indicates metastasis suppressor activity of TGF-beta signaling in this model. Cancer angiogenesis is widely regarded as a key attribute for tumor formation and progression. Here we show that TGF-beta signaling inhibits expression of vascular endothelial growth factor A (VEGFA) and that loss of autocrine TGF-beta in FET alpha/DNRII cells resulted in increased expression of VEGFA. Regulation of VEGFA expression by TGF-beta is not at the transcriptional level but at the post-transcriptional level. Our results indicate that TGF-beta decreases VEGFA protein stability through ubiquitination and degradation in a PKA-and Smad3-dependent and Smad2-independent pathway. Immunohistochemical (IHC) analyses of orthotopic tumors showed significantly reduced TGF-beta signaling, increased CD31 and VEGFA staining in tumors of FET alpha/DNRII cells as compared to those of vector control cells. These results indicate that inhibition of TGF-beta signaling increases VEGFA expression and angiogenesis, which could potentially contribute to enhanced metastasis of those cells in vivo. IHC studies performed on human colon adenocarcinoma specimens showed that TGF-beta signaling is inversely correlated with VEGFA expression, indicating that TGF-beta-mediated suppression of VEGFA expression exists in colon cancer patients.	[Geng, Liying; Chaudhuri, Anathbandhu; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Talmon, Geoffrey; Wisecarver, James L.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	jjwang@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017	Chaudhuri, Anathbandhu/0000-0003-4833-3077	National Institutes of Health [P20RR018759, R01CA140988-01]; NATIONAL CANCER INSTITUTE [R01CA140988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants P20RR018759 and R01CA140988-01 (http://projectreporter.nih.gov/project_info_description.cfm?aid=8215881&icde=14708223&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bertolini F, 2011, BRIT J CANCER, V104, P1079, DOI 10.1038/bjc.2011.43; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fleming N, 2012, CANC RES; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Klinger M, 2010, ANN SURG ONCOL, V17, P2059, DOI 10.1245/s10434-010-0972-9; Losi L, 2007, ONCOL REP, V17, P1095; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Qian D, 2004, MOL REPROD DEV, V68, P198, DOI 10.1002/mrd.20061; Rajput A, 2007, CANCER RES, V67, P665, DOI 10.1158/0008-5472.CAN-06-2773; Riedel K, 2007, ARCH MED RES, V38, P45, DOI 10.1016/j.arcmed.2006.04.010; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068; Valdes F, 2002, MOL CANCER RES, V1, P68; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; WU SP, 1993, CELL GROWTH DIFFER, V4, P115; WU SP, 1992, J CELL BIOL, V116, P187, DOI 10.1083/jcb.116.1.187; Ye SC, 1999, CANCER RES, V59, P4725; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	36	50	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59918	10.1371/journal.pone.0059918	http://dx.doi.org/10.1371/journal.pone.0059918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536895	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200043
J	Juan-Mateu, J; Gonzalez-Quereda, L; Rodriguez, MJ; Verdura, E; Lazaro, K; Jou, C; Nascimento, A; Jimenez-Mallebrera, C; Colomer, J; Monges, S; Lubieniecki, F; Foncuberta, ME; Pascual-Pascual, SI; Molano, J; Baiget, M; Gallano, P				Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Jou, Cristina; Nascimento, Andres; Jimenez-Mallebrera, Cecilia; Colomer, Jaume; Monges, Soledad; Lubieniecki, Fabiana; Eugenia Foncuberta, Maria; Ignacio Pascual-Pascual, Samuel; Molano, Jesus; Baiget, Montserrat; Gallano, Pia			Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NONSENSE MUTATION; MESSENGER-RNA; VARIABLE PHENOTYPES; SOMATIC MOSAICISM; SEQUENCE MOTIFS; MOLECULAR-BASIS; GENE; EXON; PROTEIN	DMD nonsense and frameshift mutations lead to severe Duchenne muscular dystrophy while in-frame mutations lead to milder Becker muscular dystrophy. Exceptions are found in 10% of cases and the production of alternatively spliced transcripts is considered a key modifier of disease severity. Several exonic mutations have been shown to induce exon-skipping, while splice site mutations result in exon-skipping or activation of cryptic splice sites. However, factors determining the splicing pathway are still unclear. Point mutations provide valuable information regarding the regulation of pre-mRNA splicing and elements defining exon identity in the DMD gene. Here we provide a comprehensive analysis of 98 point mutations related to clinical phenotype and their effect on muscle mRNA and dystrophin expression. Aberrant splicing was found in 27 mutations due to alteration of splice sites or splicing regulatory elements. Bioinformatics analysis was performed to test the ability of the available algorithms to predict consequences on mRNA and to investigate the major factors that determine the splicing pathway in mutations affecting splicing signals. Our findings suggest that the splicing pathway is highly dependent on the interplay between splice site strength and density of regulatory elements.	[Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Baiget, Montserrat; Gallano, Pia] Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain; [Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Baiget, Montserrat; Gallano, Pia] CIBERER U705, Barcelona, Spain; [Juan-Mateu, Jonas] Univ Barcelona, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Serv Anat Patol, Barcelona, Spain; [Nascimento, Andres; Jimenez-Mallebrera, Cecilia; Colomer, Jaume] Hosp St Joan de Deu, Serv Neurol, Unitat Patol Neuromuscular, Barcelona, Spain; [Monges, Soledad] Hosp Nacl Pediat Garrahan, Serv Neuropediat, Buenos Aires, DF, Argentina; [Lubieniecki, Fabiana] Hosp Nacl Pediat Garrahan, Serv Patol, Buenos Aires, DF, Argentina; [Eugenia Foncuberta, Maria] Hosp Nacl Pediat Garrahan, Serv Genet, Buenos Aires, DF, Argentina; [Ignacio Pascual-Pascual, Samuel] Hosp Univ Materno Infantil La Paz, Serv Neurol Pediat, Madrid, Spain; [Molano, Jesus] Hosp Univ Materno Infantil La Paz, Unidad Genet Mol, Madrid, Spain; [Molano, Jesus] Hosp Univ Materno Infantil La Paz, CIBERER U753, Madrid, Spain	Hospital of Santa Creu i Sant Pau; University of Barcelona; University of Barcelona; University of Barcelona; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gallano, P (corresponding author), Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain.	pgallano@santpau.cat	Gonzalez, Lidia/E-7669-2013; Jiménez-Mallebrera, Cecilia/F-5030-2016	Gonzalez, Lidia/0000-0003-0715-6414; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; FONCUBERTA, MARIA EUGENIA/0000-0003-1054-7715; Molano Mateos, Jesus/0000-0002-9289-1239; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121; Verdura, Edgard/0000-0003-3856-2060; Juan-Mateu, Jonas/0000-0001-9749-6441	Fondo de Investigacion Sanitaria [PI08/0347]; CIBER de Enfermedades Raras initiatives of Instituto de Salud Carlos III [U-705)]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBER de Enfermedades Raras initiatives of Instituto de Salud Carlos III	This study was supported by grants from Fondo de Investigacion Sanitaria (PI08/0347) and CIBER de Enfermedades Raras (U-705) initiatives of Instituto de Salud Carlos III (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fajkusova L, 2001, NEUROMUSCULAR DISORD, V11, P133, DOI 10.1016/S0960-8966(00)00169-3; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Ginjaar IB, 2000, EUR J HUM GENET, V8, P793, DOI 10.1038/sj.ejhg.5200535; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Habara Y, 2009, J MED GENET, V46, P542, DOI 10.1136/jmg.2008.061259; Helderman-van den Enden ATJM, 2003, NEUROMUSCULAR DISORD, V13, P317, DOI 10.1016/S0960-8966(02)00285-7; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Juan-Mateu J, 2011, CLIN GENETICS; Juan-Mateu J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-82; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kesari A, 2009, AM J MED GENET A, V149A, P1499, DOI 10.1002/ajmg.a.32891; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Melis MA, 1998, HUM MUTAT, pS137; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nishiyama A, 2008, ANN HUM GENET, V72, P717, DOI 10.1111/j.1469-1809.2008.00468.x; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Popplewell LJ, 2010, NEUROMUSCULAR DISORD, V20, P102, DOI 10.1016/j.nmd.2009.10.013; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tran VK, 2006, J MED GENET, V43, P924, DOI 10.1136/jmg.2006.042317; Tuffery-Giraud S, 2005, EUR J HUM GENET, V13, P1254, DOI 10.1038/sj.ejhg.5201478; Tuffery-Giraud S, 1999, HUM MUTAT, V14, P359, DOI 10.1002/(SICI)1098-1004(199911)14:5<359::AID-HUMU1>3.3.CO;2-B; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2005, GENOME RES, V15, P768, DOI 10.1101/gr.3217705; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	56	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59916	10.1371/journal.pone.0059916	http://dx.doi.org/10.1371/journal.pone.0059916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536893	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200041
J	Rackoff, LA; Bok, K; Green, KY; Kapikian, AZ				Rackoff, Lauren A.; Bok, Karin; Green, Kim Y.; Kapikian, Albert Z.			Epidemiology and Evolution of Rotaviruses and Noroviruses from an Archival WHO Global Study in Children (1976-79) with Implications for Vaccine Design	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; VP7 GENE; GENOTYPE; NORWALK; STRAIN; VIRUS; G9; GASTROENTERITIS; PARTICLE; IMMUNOGENICITY	Prompted by the discovery of new gastrointestinal viruses, the NIH, NIAID and WHO investigated the etiology of acute diarrhea that occurred from 1976-1979 in a global cohort of infants and young children. Rotaviruses were found to be major pathogens worldwide, whereas the Norwalk virus could not be detected using a radioimmunoassay. The aim of this study is to re-evaluate the role and diversity of rotaviruses and noroviruses in the original cohort using more sensitive current technologies. Stools collected from Asia, Africa, and South America (n = 485) were evaluated for viral genotypes by RT-PCR and sequencing. Rotaviruses were detected in 28.9% and noroviruses in 9.7% of the specimens, with G1 rotaviruses and GII noroviruses accounting for the majority of each respective virus. Various strains in this study predated the currently assigned dates of discovery for their particular genotype, and in addition, two noroviruses (KL45 and T091) could not be assigned to current genotypes. Phylogenetic analyses demonstrated a relative constancy in circulating rotavirus genotypes over time, with several genotypes from this study becoming established in the current repertoire of viral species. Similarly, GII noroviruses have maintained dominance, with GII. 4 noroviruses continuing as a predominant genotype over time. Taken together, the complex molecular epidemiology of rotaviruses and noroviruses circulating in the 1970's is consistent with current patterns, an important consideration in the design of multivalent vaccines to control these viruses.	[Rackoff, Lauren A.; Bok, Karin; Green, Kim Y.; Kapikian, Albert Z.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Green, KY (corresponding author), NIAID, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kgreen@niaid.nih.gov			Division of Intramural Research (DIR) of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897, ZIAAI000341] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the Division of Intramural Research (DIR) of NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, Bull World Health Organ, V58, P183; [Anonymous], 1979, Bull World Health Organ, V57, P719; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atmar RL, 2012, EXPERT REV VACCINES, V11, P1023, DOI [10.1586/erv.12.78, 10.1586/ERV.12.78]; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; BISHOP RF, 1973, NEW ENGL J MED, V289, P1096; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Cook N, 2004, J INFECTION, V48, P289, DOI 10.1016/j.jinf.2004.01.018; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; Gallimore CI, 2004, J CLIN MICROBIOL, V42, P1396, DOI 10.1128/JCM.42.4.1396-1401.2004; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GORZIGLIA M, 1988, J VIROL, V62, P2978, DOI 10.1128/JVI.62.8.2978-2984.1988; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1408, DOI 10.1128/JCM.32.5.1408-1409.1994; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Green K, 2007, FIELDS VIROLOGY, P949; GREENBERG HB, 1978, J MED VIROL, V2, P97, DOI 10.1002/jmv.1890020204; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hoshino Y, 2004, J VIROL, V78, P7795, DOI 10.1128/JVI.78.14.7795-7802.2004; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; da Silva MFM, 2011, J MED VIROL, V83, P357, DOI 10.1002/jmv.21968; Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268; Martinez-Laso J, 2009, J CLIN VIROL, V44, P52, DOI 10.1016/j.jcv.2008.08.022; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; National Institute of Allergy and Infectious Diseases (U.S.A.), 1979, ANN REP PROGR ACT NA; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Patton JT, 2012, DISCOV MED, V13, P85; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramirez K, 2012, CLIN IMMUNOL, V144, P98, DOI 10.1016/j.clim.2012.05.006; Santos N, 2005, J CLIN MICROBIOL, V43, P4064, DOI 10.1128/JCM.43.8.4064-4069.2005; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Stupka JA, 2007, J MED VIROL, V79, P838, DOI 10.1002/jmv.20841; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan M, 2012, NANOMEDICINE-UK, V7, P889, DOI [10.2217/nnm.12.62, 10.2217/NNM.12.62]; Tate JE, 2010, EXPERT REV VACCINES, V9, P395, DOI [10.1586/erv.10.17, 10.1586/ERV.10.17]; Tate JE, 2011, LANCET INFECT DIS; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; YOLKEN RH, 1980, YALE J BIOL MED, V53, P85; Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	61	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59394	10.1371/journal.pone.0059394	http://dx.doi.org/10.1371/journal.pone.0059394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536875	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200023
J	Wang, LL; Pasha, Z; Wang, SY; Li, N; Feng, YL; Lu, G; Millard, RW; Ashraf, M				Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad			Protein Kinase G1 alpha Overexpression Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CYCLIC-GMP; BONE-MARROW; ISCHEMIC CARDIOMYOPATHY; GROWTH-FACTOR; PHOSPHODIESTERASE-5 INHIBITION; NITRIC-OXIDE; CGMP; EXPRESSION; TRANSPLANTATION	Background: We hypothesized that overexpression of cGMP-dependent protein kinase type 1 alpha (PKG1 alpha) could mimic the effect of tadalafil on the survival of bone marrow derived mesenchymal stem cells (MSCs) contributing to regeneration of the ischemic heart. Methods and Results: MSCs from male rats were transduced with adenoviral vector encoding for PKG1 alpha ((MSCs)-M-PKG1 alpha). Controls included native MSCs ((MSCs)-M-Nat) and MSCs transduced with an empty vector ((MSCs)-M-Null). PKG1 alpha activity was increased approximately 20, 5 and 16 fold respectively in (MSCs)-M-PKG1 alpha. (MSCs)-M-PKG1 alpha showed improved survival under oxygen and glucose deprivation (OGD) which was evidenced by lower LDH release, caspase-3/7 activity and number of positive TUNEL cells. Anti-apoptotic proteins pAkt, pGSK3 beta, and Bcl-2 were significantly increased in (MSCs)-M-PKG1 alpha compared to (MSCs)-M-Nat and (MSCs)-M-Null. Higher release of multiple prosurvival and angiogenic factors such as HGF, bFGF, SDF-1 and Ang-1 was observed in (MSCs)-M-PKG1 alpha before and after OGD. In a female rat model of acute myocardial infarction, (MSCs)-M-PKG1 alpha group showed higher survival compared with (MSCs)-M-Null group at 3 and 7 days after transplantation as determined by TUNEL staining and sry-gene quantitation by real-time PCR. Increased anti-apoptotic proteins and paracrine factors in vitro were also identified. Immunostaining for cardiac troponin I combined with GFP showed increased myogenic differentiation of (MSCs)-M-PKG1 alpha. At 4 weeks after transplantation, compared to DMEM group and (MSCs)-M-Null group, (MSCs)-M-PKG1 alpha group showed increased blood vessel density in infarct and peri-infarct areas (62.5 +/- 7.7; 68.8 +/- 7.3 per microscopic view, p < 0.05) and attenuated infarct size (27.2 +/- 2.5%, p < 0.01). Heart function indices including ejection fraction (52.1 +/- 2.2%, p < 0.01) and fractional shortening (24.8%+/- 1.3%, p < 0.01) were improved significantly in (MSCs)-M-PKG1 alpha group. Conclusion: Overexpression of PKG1 alpha transgene could be a powerful approach to improve MSCs survival and their angiomyogenic potential in the infarcted heart.	[Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA; [Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ashraf, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA.	ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL095375, HL087246]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095375, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL095375, HL087246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, PROTEIN EXPRES PURIF, V79, P271, DOI 10.1016/j.pep.2011.05.001; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; DRAIJER R, 1995, CIRC RES, V77, P897, DOI 10.1161/01.RES.77.5.897; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2010, AM J PHYSIOL-HEART C, V299, pH1395, DOI 10.1152/ajpheart.00437.2010; Hoke NN, 2012, STEM CELLS, V30, P326, DOI 10.1002/stem.789; House SL, 2003, CIRCULATION, V108, P3140, DOI 10.1161/01.CIR.0000105723.91637.1C; Jang YH, 2012, CARDIOVASC THER, V30, P264, DOI 10.1111/j.1755-5922.2011.00301.x; Jiang YB, 2010, BASIC RES CARDIOL, V105, P431, DOI 10.1007/s00395-009-0079-2; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Makkar RR, 2005, J CARDIOVASC PHARM T, V10, P225, DOI 10.1177/107424840501000403; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Noort WA, 2010, PANMINERVA MED, V52, P27; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Soff GA, 1997, J CLIN INVEST, V100, P2580, DOI 10.1172/JCI119801; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Yang YJ, 2009, ARTERIOSCL THROM VAS, V29, P2076, DOI 10.1161/ATVBAHA.109.189662; Yang ZJ, 2006, GENE THER, V13, P1564, DOI 10.1038/sj.gt.3302820; Yang ZJ, 2009, MOL BIOL REP, V36, P1323, DOI 10.1007/s11033-008-9315-3; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C	46	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60087	10.1371/journal.pone.0060087	http://dx.doi.org/10.1371/journal.pone.0060087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536905	Green Submitted, gold, Green Published			2022-12-27	WOS:000317397200053
J	Whitaker, JA; Mirtskhulava, V; Kipiani, M; Harris, DA; Tabagari, N; Kempker, RR; Blumberg, HM				Whitaker, Jennifer A.; Mirtskhulava, Veriko; Kipiani, Maia; Harris, Drew A.; Tabagari, Nino; Kempker, Russell R.; Blumberg, Henry M.			Prevalence and Incidence of Latent Tuberculosis Infection in Georgian Healthcare Workers	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; GUIDELINES; UPDATE	Background: Tuberculosis is a major occupational hazard in low and middle-income countries. Limited data exist on serial testing of healthcare workers (HCWs) with interferon-gamma release assays (IGRAs) for latent tuberculosis infection (LTBI), especially in low and middle-income countries. We sought to evaluate the rates of and risk factors for LTBI prevalence and LTBI test conversion among HCWs using the tuberculin skin test (TST) and QuantiFERON-TB Gold in-tube assay (QFT-GIT). Methods: A prospective longitudinal study was conducted among HCWs in the country of Georgia. Subjects completed a questionnaire, and TST and QFT-GIT tests were performed. LTBI testing was repeated 6-26 months after baseline testing. Results: Among 319 HCWs enrolled, 89% reported prior BCG vaccination, and 60% worked in TB healthcare facilities (HCFs). HCWs from TB HCFs had higher prevalence of positive QFT-GIT and TST than those from non-TB HCFs: 107/194 (55%) vs. 30/125 (31%) QFT-GIT positive (p<0.0001) and 128/189 (69%) vs. 64/119 (54%) TST positive (p = 0.01). There was fair agreement between TST and QFT-GIT (kappa = 0.42, 95% CI 0.31-0.52). In multivariate analysis, frequent contact with TB patients was associated with increased risk of positive QFT-GIT (aOR 3.04, 95% CI 1.79-5.14) but not positive TST. Increasing age was associated with increased risk of positive QFT-GIT (aOR 1.05, 95% CI 1.01-1.09) and TST (aOR 1.05, 95% CI 1.01-1.10). High rates of HCW conversion were seen: the QFT-GIT conversion rate was 22.8/100 person-years, and TST conversion rate was 17.1/100 person-years. In multivariate analysis, female HCWs had decreased risk of TST conversion (aOR 0.05, 95% CI 0.01-0.43), and older HCWs had increased risk of QFT-GIT conversion (aOR 1.07 per year, 95% CI 1.01-1.13). Conclusion: LTBI prevalence and LTBI test conversion rates were high among Georgian HCWs, especially among those working at TB HCFs. These data highlight the need for increased implementation of TB infection control measures.	[Whitaker, Jennifer A.; Mirtskhulava, Veriko; Kempker, Russell R.; Blumberg, Henry M.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Mirtskhulava, Veriko; Kipiani, Maia] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Harris, Drew A.] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA USA; [Mirtskhulava, Veriko; Tabagari, Nino] David Tvildiani Med Univ, AIETI Med Sch, Tbilisi, Georgia; [Whitaker, Jennifer A.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Whitaker, Jennifer A.] Mayo Clin, Div Infect Dis, Rochester, MN USA	Emory University; Emory University; Mayo Clinic; Mayo Clinic	Whitaker, JA (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	whitaker.jennifer@mayo.edu	Mirtskhulava, Veriko/AAE-9815-2020; Blumberg, Henry/W-2156-2019	Mirtskhulava, Veriko/0000-0002-7394-4876; Blumberg, Henry/0000-0002-3110-2443; Harris, Drew/0000-0002-3735-7017	National Institutes of Health (NIH) Fogarty International Center [D43TW007124, D43TW007124-06S1]; Atlanta Clinical and Translational Science Institute [NIH/NCATS UL1TR000454]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Atlanta Clinical and Translational Science Institute; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the National Institutes of Health (NIH) Fogarty International Center [D43TW007124 and D43TW007124-06S1], the Atlanta Clinical and Translational Science Institute [NIH/NCATS UL1TR000454], and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; [Anonymous], GUID PREV TUB HLTH C; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Blumberg HM, 2005, JAMA-J AM MED ASSOC, V293, P2776, DOI 10.1001/jama.293.22.2776; BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones-Lopez EC, 2005, INT J TUBERC LUNG D, V9, P591; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kleinbaum DG, 2010, LOGISTIC REGRESSION, P203; Kraemer H C, 1992, Stat Methods Med Res, V1, P183, DOI 10.1177/096228029200100204; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Members of the Ad Hoc Committee for the Guidelines for Preventing the Transmission fo Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings, 1996, CAN COMMUN DIS REP, V22, pI; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Natl TB Advisory Comm, 2007, COMMUN DIS INTELL, V31, P404; Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Rafiza S, 2012, INT J TUBERC LUNG D, V16, P163, DOI 10.5588/ijtld.11.0364; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; *WHO, 2006, TUB INF CONTR ER EXP; *WHO, 2012, TUB COUNTR PROF; World Health Organization, 2011, TUB IGRA TB TESTS PO; Yoshiyama T, 2009, EPIDEMIOL INFECT, V137, P1691, DOI 10.1017/S0950268809002751; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	31	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58202	10.1371/journal.pone.0058202	http://dx.doi.org/10.1371/journal.pone.0058202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536789	Green Published, gold			2022-12-27	WOS:000317397200005
J	Goulart, C; da Silva, TR; Rodriguez, D; Politano, WR; Leite, LCC; Darrieux, M				Goulart, Cibelly; da Silva, Thais Raquel; Rodriguez, Dunia; Politano, Walter Rodrigo; Leite, Luciana C. C.; Darrieux, Michelle			Characterization of Protective Immune Responses Induced by Pneumococcal Surface Protein A in Fusion with Pneumolysin Derivatives	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; VIRULENCE PROTEINS; COMPLEMENT DEPOSITION; ELICIT PROTECTION; CONJUGATE VACCINE; HOST-DEFENSE; CELL-WALL; PSPA; MICE; IMMUNIZATION	Pneumococcal surface protein A (PspA) and Pneumolysin derivatives (Pds) are important vaccine candidates, which can confer protection in different models of pneumococcal infection. Furthermore, the combination of these two proteins was able to increase protection against pneumococcal sepsis in mice. The present study investigated the potential of hybrid proteins generated by genetic fusion of PspA fragments to Pds to increase cross-protection against fatal pneumococcal infection. Pneumolisoids were fused to the N-terminus of clade 1 or clade 2 pspA gene fragments. Mouse immunization with the fusion proteins induced high levels of antibodies against PspA and Pds, able to bind to intact pneumococci expressing a homologous PspA with the same intensity as antibodies to rPspA alone or the co-administered proteins. However, when antibody binding to pneumococci with heterologous PspAs was examined, antisera to the PspA-Pds fusion molecules showed stronger antibody binding and C3 deposition than antisera to co-administered proteins. In agreement with these results, antisera against the hybrid proteins were more effective in promoting the phagocytosis of bacteria bearing heterologous PspAs in vitro, leading to a significant reduction in the number of bacteria when compared to co-administered proteins. The respective antisera were also capable of neutralizing the lytic activity of Pneumolysin on sheep red blood cells. Finally, mice immunized with fusion proteins were protected against fatal challenge with pneumococcal strains expressing heterologous PspAs. Taken together, the results suggest that PspA-Pd fusion proteins comprise a promising vaccine strategy, able to increase the immune response mediated by cross-reactive antibodies and complement deposition to heterologous strains, and to confer protection against fatal challenge.	[Goulart, Cibelly; Rodriguez, Dunia; Leite, Luciana C. C.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Goulart, Cibelly; Leite, Luciana C. C.] Programa Posgrad Interunidades Biotecnol USP IPT, Sao Paulo, Brazil; [da Silva, Thais Raquel; Politano, Walter Rodrigo; Darrieux, Michelle] Univ Sao Francisco, Lab Biol Celular & Mol, BR-12900000 Braganca Paulista, SP, Brazil	Instituto Butantan; Universidade Sao Francisco	Leite, LCC (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	lccleite@butantan.gov.br	Goulart, Cibelly/B-6666-2014; Rodriguez Soto, Dunia Del Carmen/J-4305-2014; Leite, Luciana/D-1353-2012; Darrieux, Michelle/AAZ-7747-2020; Darrieux, Michelle/E-9371-2016; Goulart, Cibelly/F-4265-2014	Rodriguez Soto, Dunia Del Carmen/0000-0001-9779-1280; Leite, Luciana/0000-0003-0156-1312; Darrieux, Michelle/0000-0002-7829-3435; Darrieux, Michelle/0000-0002-7829-3435; Goulart, Cibelly/0000-0003-2981-1934	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Fundacao Butantan	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Balachandran P, 2001, J BACTERIOL, V183, P3108, DOI 10.1128/JB.183.10.3108-3116.2001; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Nguyen CT, 2011, VACCINE, V29, P5731, DOI 10.1016/j.vaccine.2011.05.095; Csordas FCL, 2008, VACCINE, V26, P2925, DOI 10.1016/j.vaccine.2008.03.038; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Ferreira DM, 2006, FEMS IMMUNOL MED MIC, V46, P291, DOI 10.1111/j.1574-695X.2006.00040.x; Ferreira DM, MICROB PATHOG, V48, P205; Goulart C, 2011, VACCINE, V29, P1634, DOI 10.1016/j.vaccine.2010.12.074; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Kono M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027102; Ljutic B, 2012, VACCINE, V30, P2981, DOI 10.1016/j.vaccine.2012.02.038; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Oliveira MLS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010863; PATON JC, 1991, INFECT IMMUN, V59, P2297, DOI 10.1128/IAI.59.7.2297-2304.1991; Price KE, 2012, J BACTERIOL, V194, P3651, DOI 10.1128/JB.00114-12; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; RODRIGUEZ D, 1992, BRAZ J MED BIOL RES, V25, P823; Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Wu KF, 2010, INFECT IMMUN, V78, P1276, DOI 10.1128/IAI.00473-09; Xin W, 2009, INFECT IMMUN, V77, P4518, DOI 10.1128/IAI.00486-09	47	40	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59605	10.1371/journal.pone.0059605	http://dx.doi.org/10.1371/journal.pone.0059605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533636	gold, Green Submitted, Green Published			2022-12-27	WOS:000316549400073
J	Guo, YX; Li, G; Hu, YN; Kang, D; Wang, DX; Yang, GH				Guo, Yaoxin; Li, Gang; Hu, Youning; Kang, Di; Wang, Dexiang; Yang, Gaihe			Regeneration of Betula albosinensis in Strip Clearcut and Uncut Forests of the Qinling Mountains in China	PLOS ONE			English	Article							WOLONG NATURAL RESERVE; ALBO-SINENSIS; PATTERNS; DYNAMICS; GROWTH; SICHUAN; BAMBOO; TREES; GERMINATION; DISTURBANCE	To contribute to a better understanding of the regeneration strategy of Betula albosinensis forests and the likely reasons behind either the successful recovery or failure after strip clearcutting, we compared the population structures and spatial patterns of B. albosinensis in eight B. albosinensis stands in Qinling Mountains, China. Four cut and four uncut stands were selected, and each sampled using a single large plot (0.25 ha). Results indicated that, on the one hand, B. albosinensis recruitment was scarce (average of 48 stems ha(-1)) in the uncut stands, relative to the mature population (average of 259 stems ha(-1)), suggesting a failure of recruitment. On the other hand, the subsequent regeneration approximately 50 years after the strip clearcutting showed that the density of the target species seedlings and saplings has increased significantly, and the current average density of seedlings and saplings was 156 stems ha(-1). The clumped spatial pattern of B. albosinensis suggested that their regeneration was highly dependent on canopy disturbance. However, recruitment remained poor in the uncut stands because most gaps were small in scale. The successful regeneration of sunlight-loving B. albosinensis after strip clearcutting was attributed to the exposed land and availability of more sunlight. Bamboo density did not influence B. albosinensis recruitment in the uncut stands. However, stand regeneration was impeded after strip clearcutting; thus, removing bamboo is essential in improving the competitive status of B. albosinensis at the later stage of forest regeneration after clearcutting. The moderate severity of disturbance resulting from strip clearcutting reversed the degeneration trend of primary B. albosinensis stands. This outcome can help strike a balance between forest conservation and the demand for wood products by releasing space and exposing the forested land for recruitment. Life history traits and spatiotemporal disturbance magnitude are important factors to consider in implementing effective B. albosinensis regeneration strategies.	[Guo, Yaoxin; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Li, Gang] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Hu, Youning; Kang, Di; Wang, Dexiang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn		Kang, Di/0000-0003-4255-8689	National Basic Sci-Tech Special Fund of China [2007FY110800]	National Basic Sci-Tech Special Fund of China	This research was funded by the Key Program of the National Basic Sci-Tech Special Fund of China (2007FY110800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison TD, 2003, FOREST ECOL MANAG, V182, P285, DOI 10.1016/S0378-1127(03)00066-5; [Anonymous], [No title captured]; Antos JA, 2002, OECOLOGIA, V130, P126, DOI 10.1007/s004420100787; BASNET K, 1992, BIOTROPICA, V24, P31, DOI 10.2307/2388471; Cullen LE, 2001, J ECOL, V89, P1061, DOI 10.1111/j.1365-2745.2001.00628.x; Dang HS, 2010, FOREST ECOL MANAG, V259, P547, DOI 10.1016/j.foreco.2009.11.011; Gonzalez ME, 2002, PLANT ECOL, V161, P59, DOI 10.1023/A:1020378822847; Guo Yao-xin, 2011, Yingyong Shengtai Xuebao, V22, P2574; KOHYAMA T, 1984, OECOLOGIA, V62, P156, DOI 10.1007/BF00379008; Li ZY, 2002, FOREST XIAOLONG MOUN; Lin Yue, 2008, Zhiwu Shengtai Xuebao, V32, P1335, DOI 10.3773/j.issn.1005-264x.2008.06.014; Liu SJ, 2004, CHINESE J APPL ECOLO, V15, P1; Min ZL, 1989, COMPREHENSIVE SUVEY; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; NAKAMURA T, 1985, VEGETATIO, V64, P15, DOI 10.1007/BF00033450; Narukawa Y, 2002, J VEG SCI, V2, P413; Osumi K, 1997, FOREST ECOL MANAG, V93, P235, DOI 10.1016/S0378-1127(96)03963-1; PEET RK, 1981, VEGETATIO, V45, P3; Penuelas J, 2007, ECOGRAPHY, V30, P829, DOI 10.1111/j.2007.0906-7590.05247.x; PETERSON CJ, 1992, AM J BOT, V79, P1209, DOI 10.2307/2445046; Ren Jian-Yi, 2008, Zhiwu Shengtai Xuebao, V32, P883, DOI 10.3773/j.issn.1005-264x.2008.04.017; Ren Y., 2006, BIODIVERSITY CONVERS; Shannon C. E., 1949, MATH THEORY COMMUNIC; [苏建文 SU Jianwen], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P195; Takahashi A., 2008, Journal of the Japanese Forest Society, V90, P1, DOI 10.4005/jjfs.90.1; Takahashi K, 1999, J VEG SCI, V10, P833, DOI 10.2307/3237308; Taylor AH, 1996, VEGETATIO, V124, P25, DOI 10.1007/BF00045141; Taylor AH, 2006, FOREST ECOL MANAG, V223, P303, DOI 10.1016/j.foreco.2005.11.010; TAYLOR AH, 1988, VEGETATIO, V78, P141, DOI 10.1007/BF00033423; TAYLOR AH, 1988, J ECOL, V76, P1204, DOI 10.2307/2260643; VEBLEN TT, 1979, J ECOL, V67, P809, DOI 10.2307/2259216; VEBLEN TT, 1981, J BIOGEOGR, V8, P211, DOI 10.2307/2844678; Wang W, 2006, FOREST ECOL MANAG, V234, P107, DOI 10.1016/j.foreco.2006.06.028; Wu Yan, 2004, Yingyong Shengtai Xuebao, V15, P2229; Yahner R.H., 2000, E DECIDUOUS FOREST E; ZHANG YQ, 1989, SHAANXI FOREST; Zhu Z. C., 1991, J WUHAN BOT RES, V9, P169	38	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59375	10.1371/journal.pone.0059375	http://dx.doi.org/10.1371/journal.pone.0059375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533621	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400058
J	Sedding, DG; Widmer-Teske, R; Mueller, A; Stieger, P; Daniel, JM; Gunduz, D; Pullamsetti, S; Nef, H; Moellmann, H; Troidl, C; Hamm, C; Braun-Dullaeus, R				Sedding, Daniel G.; Widmer-Teske, Rebecca; Mueller, Andreas; Stieger, Philipp; Daniel, Jan-Marcus; Guenduez, Dursun; Pullamsetti, Soni; Nef, Holger; Moellmann, Helge; Troidl, Christian; Hamm, Christian; Braun-Dullaeus, Ruediger			Role of the Phosphatase PTEN in Early Vascular Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR-SUPPRESSOR; NEOINTIMA FORMATION; ANGIOTENSIN-II; TENSIN HOMOLOG; APOPTOSIS; PATHWAY; PROLIFERATION; KINASE; INJURY	Background: The phosphatase PTEN represents an important physiological inhibitor of phosphatidylinositol-3 kinase (PI3-K)/ protein kinase B (Akt) signalling, however, the functional role of PTEN in the initial phase of angioplasty-induced vascular injury remains elusive. In the present study we sought to determine PTEN's effect on vascular smooth muscle cell (VSMC) apoptosis following acute injury in vivo and in vitro. Methods and Results: Immunohistochemistry indicated a faint basal expression and equal distribution of PTEN in uninjured rat carotid arteries. 12 h following balloon-injury, PTEN expression was strongly increased in apoptotic (TUNEL+) VSMC. In vitro, stimulation with serum or different growth factors or subjecting VSMC to cyclic stretch had no effect on PTEN expression, whereas stimulation with H2O2 robustly increased PTEN expression in a time-and dose-dependent manner. To evaluate the functional role of PTEN expression, human VSMC were transduced with WT-PTEN. Overexpression of PTEN increased the number of apoptotic VSMC (19.8% +/- 64.4 vs. 5.6% +/- 62.3; P<0.001) as determined by TUNEL assay. In contrast, siRNA-mediated knock-down of PTEN attenuated the basal as well as H2O2-induced apoptosis of VSMC. Mechanistically, overexpression of PTEN prevented serum-induced Akt-phosphorylation, whereas siRNA-mediated knock down of PTEN augmented Akt-activation. Moreover, co-transfection of PTEN and a constitutive active Akt mutant prevented PTEN-dependent augmentation of VSMC apoptosis, indicating, that PTEN regulates VSMC apoptosis by inhibition of Akt phosphorylation/activation. Conclusion: By interfering with the PI3-K/Akt-dependent survival signalling, the oxidative stress-induced up regulation of PTEN in VSMC of injured arteries augments the sensitivity of VSMC to apoptotic stimuli in the early phase following vascular injury, augmenting the initial injury and cell loss of the injured vessel wall. Thus, these data add to our understanding of PTEN's role during vascular remodelling.	[Sedding, Daniel G.; Widmer-Teske, Rebecca; Mueller, Andreas; Daniel, Jan-Marcus; Guenduez, Dursun; Pullamsetti, Soni; Nef, Holger; Moellmann, Helge; Troidl, Christian; Hamm, Christian] Univ Giessen, Dept Internal Med 1, D-35390 Giessen, Germany; [Stieger, Philipp; Braun-Dullaeus, Ruediger] Univ Hosp Magdeburg, Div Cardiol, Magdeburg, Germany	Justus Liebig University Giessen; University Hospital Magdeburg	Sedding, DG (corresponding author), Univ Giessen, Dept Internal Med 1, D-35390 Giessen, Germany.	daniel.sedding@innere.med.uni-giessen.de	Stieger, Philipp/GPC-4492-2022; Braun-Dullaeus, Ruediger C/G-1844-2013; Hamm, Christian W./I-3155-2017	Braun-Dullaeus, Ruediger C/0000-0003-3888-6532; Hamm, Christian W./0000-0001-6763-4161; Pullamsetti, Soni Savai/0000-0003-0440-8831	German Excellence Cluster of the Cardio-Pulmonary System (ECCPS)	German Excellence Cluster of the Cardio-Pulmonary System (ECCPS)	This study was supported by a grant from the German Excellence Cluster of the Cardio-Pulmonary System (ECCPS) to D.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Braun-Dullaeus RC, 1999, J CLIN INVEST, V104, P815, DOI 10.1172/JCI5339; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cesaratto L, 2007, J MOL MED, V85, P1099, DOI 10.1007/s00109-007-0204-3; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Dong X, 2012, J CELLULAR BIOCH; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; HAN DKM, 1995, AM J PATHOL, V147, P267; Hou RR, 2010, APOPTOSIS, V15, P877, DOI 10.1007/s10495-010-0510-z; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Koide S, 2007, AM J PHYSIOL-HEART C, V292, pH2824, DOI 10.1152/ajpheart.01221.2006; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Nemenoff RA, ARTERIOSCLER THROMB, V31, P1300; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; Perlman H, 1997, CIRCULATION, V95, P981; Pines A, 2005, FREE RADICAL RES, V39, P269, DOI 10.1080/10715760400028423; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Sedding DG, 2008, FASEB J, V22, P579, DOI 10.1096/fj.07-8853com; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	32	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e55445	10.1371/journal.pone.0055445	http://dx.doi.org/10.1371/journal.pone.0055445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533567	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400005
J	Sun, YG; Wang, B; Jin, SH; Qu, XX; Li, YJ; Hou, BK				Sun, Yan-Guo; Wang, Bo; Jin, Shang-Hui; Qu, Xiao-Xia; Li, Yan-Jie; Hou, Bing-Kai			Ectopic Expression of Arabidopsis Glycosyltransferase UGT85A5 Enhances Salt Stress Tolerance in Tobacco	PLOS ONE			English	Article							LOW-TEMPERATURE; SIGNAL-TRANSDUCTION; FREEZING TOLERANCE; DROUGHT; ACID; GLUCOSYLTRANSFERASE; GENE; METABOLISM; RESPONSES; OVEREXPRESSION	Abiotic stresses greatly influence plant growth and productivity. While glycosyltransferases are widely distributed in plant kingdom, their biological roles in response to abiotic stresses are largely unknown. In this study, a novel Arabidopsis glycosyltransferase gene UGT85A5 was identified as significantly induced by salt stress. Ectopic expression of UGT85A5 in tobacco enhanced the salt stress tolerance in the transgenic plants. There were higher seed germination rates, better plant growth and less chlorophyll loss in transgenic lines compared to wild type plants under salt stress. This enhanced tolerance of salt stress was correlated with increased accumulations of proline and soluble sugars, but with decreases in malondialdehyde accumulation and Na+/K+ ratio in UGT85A5-expressing tobacco. Furthermore, during salt stress, expression of several carbohydrate metabolism-related genes including those for sucrose synthase, sucrose-phosphate synthase, hexose transporter and a group2 LEA protein were obviously upregulated in UGT85A5-expressing transgenic plants compared with wild type controls. Thus, these findings suggest a specific protective role of this glycosyltransferase against salt stress and provide a genetic engineering strategy to improve salt tolerance of crops.	[Sun, Yan-Guo] Educ Minist China, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China; Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Sun, YG (corresponding author), Educ Minist China, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China.	sunyanguo1987@126.com; bkhou@sdu.edu.cn			National Natural Science Foundation of China [30971543, 90917006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of National Natural Science Foundation of China (No. 30971543 and No. 90917006) to BKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bornke F, 2005, J PLANT PHYSIOL, V162, P161, DOI 10.1016/j.jplph.2004.09.006; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Grover A, 2001, CURR SCI INDIA, V80, P206; Hemm MR, 2004, PLANT J, V38, P765, DOI 10.1111/j.1365-313X.2004.02089.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jackson RG, 2002, PLANT J, V32, P573, DOI 10.1046/j.1365-313X.2002.01445.x; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kim IA, 2010, J PLANT BIOL, V53, P233, DOI 10.1007/s12374-010-9110-2; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; LAWLOR DW, 1995, ENV PLANT B, P129; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Liu JP, 1997, P NATL ACAD SCI USA, V94, P14960, DOI 10.1073/pnas.94.26.14960; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Papadakis AK, 2005, PLANTA, V220, P826, DOI 10.1007/s00425-004-1400-9; Parvanova D, 2004, PLANT PHYSIOL BIOCH, V42, P57, DOI 10.1016/j.plaphy.2003.10.007; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Song JT, 2008, PHYTOCHEMISTRY, V69, P1128, DOI 10.1016/j.phytochem.2007.12.010; STOREY R, 1995, AUST J PLANT PHYSIOL, V22, P101, DOI 10.1071/PP9950101; Szabolcs I, 1994, 15 WORLD C SOIL SCI, P123; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Vaistij FE, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P209, DOI 10.1007/978-0-387-85498-4_10; Verma DPS, 1999, BIOTECHNOL INTELL UN, P153; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wang J., 2009, FRONT BIOL, V4, P39, DOI [10.1007/s11515-008-0111-1, DOI 10.1007/S11515-008-0111-1]; Wang J, 2011, PLANT CELL PHYSIOL, V52, P2200, DOI 10.1093/pcp/pcr152; WARREN AP, 1989, J CELL PHYSIOL, V138, P323, DOI 10.1002/jcp.1041380215; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	56	43	49	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59924	10.1371/journal.pone.0059924	http://dx.doi.org/10.1371/journal.pone.0059924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533660	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400097
J	Gonzalez-Gomez, N; Poltrock, S; Nazzi, T				Gonzalez-Gomez, Nayeli; Poltrock, Silvana; Nazzi, Thierry			A "Bat" Is Easier to Learn than a "Tab": Effects of Relative Phonotactic Frequency on Infant Word Learning	PLOS ONE			English	Article							PHONETIC SPECIFICITY; VOCALIC INFORMATION; NATIVE LANGUAGE; LEXICAL ACCESS; 1ST YEAR; ACQUISITION; PROBABILITY; KNOWLEDGE; FRENCH; COMPREHENSION	Many studies have shown that during the first year of life infants start learning the prosodic, phonetic and phonotactic properties of their native language. In parallel, infants start associating sound sequences with semantic representations. However, the question of how these two processes interact remains largely unknown. The current study explores whether (and when) the relative phonotactic probability of a sound sequence in the native language has an impact on infants' word learning. We exploit the fact that Labial-Coronal (LC) words are more frequent than Coronal-Labial (CL) words in French, and that French-learning infants prefer LC over CL sequences at 10 months of age, to explore the possibility that LC structures might be learned more easily and thus at an earlier age than CL structures. Eye movements of French-learning 14- and 16-month-olds were recorded while they watched animated cartoons in a word learning task. The experiment involved four trials testing LC sequences and four trials testing CL sequences. Our data reveal that 16-month-olds were able to learn the LC and CL words, while14-month-olds were only able to learn the LC words, which are the words with the more frequent phonotactic pattern. The present results provide evidence that infants' knowledge of their native language phonotactic patterns influences their word learning: Words with a frequent phonotactic structure could be acquired at an earlier age than those with a lower probability. Developmental changes are discussed and integrated with previous findings.	[Gonzalez-Gomez, Nayeli; Poltrock, Silvana; Nazzi, Thierry] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Poltrock, Silvana; Nazzi, Thierry] CNRS, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gonzalez-Gomez, N (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	nayeli.gonzalez.gomez@gmail.com		Schmandt, Silvana/0000-0002-1592-2484; Nazzi, Thierry/0000-0002-4378-3661	CONACYT; ANR [07-BLAN-0014-01]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ANR(French National Research Agency (ANR))	This study was conducted with the support of a CONACYT grant to NGG, and an ANR grant #07-BLAN-0014-01 to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TM, 2001, J MEM LANG, V44, P568, DOI 10.1006/jmla.2000.2756; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; Corbetta D, 2012, INFANCY, V17, P102, DOI 10.1111/j.1532-7078.2011.00093.x; Curtin S, 2012, J EXP CHILD PSYCHOL, V112, P127, DOI 10.1016/j.jecp.2012.02.007; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Estes KG, 2011, INFANCY, V16, P180, DOI 10.1111/j.1532-7078.2010.00046.x; Fennell CT, 2012, INFANCY, V17, P339, DOI 10.1111/j.1532-7078.2011.00080.x; Fenson L., 1993, MACARTHUR COMMUNICAT; Fenson Larry, 1994, Monographs of the Society for Research in Child Development, V59, P1; Fernald A, 2008, DEVELOPMENTAL PSYCHOLINGUISTICS: ON-LINE METHODS IN CHILDREN'S LANGUAGE PROCESSING, P97; Finn AS, 2008, COGNITION, V108, P477, DOI 10.1016/j.cognition.2008.04.002; Floccia C, 2011, DEVELOPMENTAL SCI, V14, P602, DOI 10.1111/j.1467-7687.2010.01006.x; FRIEDERICI AD, 1993, PERCEPT PSYCHOPHYS, V54, P287, DOI 10.3758/BF03205263; Frisch SA, 2000, J MEM LANG, V42, P481, DOI 10.1006/jmla.1999.2692; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037/0278-7393.25.1.84; GATHERCOLE SE, 1995, MEM COGNITION, V23, P83, DOI 10.3758/BF03210559; Gogate LJ, 2001, DEVELOPMENTAL SCI, V4, P1, DOI 10.1111/1467-7687.00143; Goksun T, 2009, P 33 ANN BOST U C LA, P461; Golinkoff, 2000, MONOGRAPHS SOC RES C, V65, P1, DOI [10.1111/1540-5834.00091, DOI 10.1111/1540-5834.00091]; Gonzalez-Gomez N, CROSSLINGUISTI UNPUB; Gonzalez-Gomez N, 2013, J SPEECH LANG HEAR R, V56, P840, DOI 10.1044/1092-4388(2012/12-0138); Gonzalez-Gomez N, 2012, PROC ANN BUCLD, P202; Gonzalez-Gomez N, 2012, INFANCY, V17, P498, DOI 10.1111/j.1532-7078.2011.00104.x; Havy M, 2009, INFANCY, V14, P439, DOI 10.1080/15250000902996532; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Hollich G, 2002, PROC ANN BUCLD, P314; Ingram D, 1974, J CHILD LANG, Vi, P233, DOI DOI 10.1017/S0305000900000672; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; JUSCZYK PW, 1993, J MEM LANG, V32, P402, DOI 10.1006/jmla.1993.1022; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kern S., 2003, GLOSSA, V85, P48; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Legendre G, 2010, CHILD DEV, V81, P1859, DOI 10.1111/j.1467-8624.2010.01515.x; MacKenzie H, 2012, CHILD DEV, V83, P1129, DOI 10.1111/j.1467-8624.2012.01764.x; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MacNeilage PF, 1999, PSYCHOL SCI, V10, P459, DOI 10.1111/1467-9280.00187; Mani N, 2007, J MEM LANG, V57, P252, DOI 10.1016/j.jml.2007.03.005; Mani N, 2010, PSYCHOL SCI, V21, P908, DOI 10.1177/0956797610373371; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; Mattys SL, 2001, J EXP PSYCHOL HUMAN, V27, P644, DOI 10.1037//0096-1523.27.3.644; Mersad K, 2011, MEM COGNITION, V39, P1085, DOI 10.3758/s13421-011-0074-3; Moos H, 2006, INFANT BEHAV DEV, V29, P243, DOI 10.1016/j.infbeh.2005.12.006; Namy LL, 2004, J COGN DEV, V5, P37, DOI 10.1207/s15327647jcd0501_3; Namy LL, 2001, INFANCY, V2, P73, DOI 10.1207/S15327078IN0201_5; Namy LL, 1998, CHILD DEV, V69, P295, DOI 10.2307/1132165; Namy LL, 1998, 22ND ANNUAL BOSTON UNIVERSITY CONFERENCE ON LANGUAGE DEVELOPMENT, VOLS. 1 & 2, P546; Nazzi T, 2005, COGNITION, V98, P13, DOI 10.1016/j.cognition.2004.10.005; Nazzi T, 2009, LANG SPEECH, V52, P463, DOI 10.1177/0023830909336584; Nazzi T, 2009, J ACOUST SOC AM, V126, P1440, DOI 10.1121/1.3158931; Nazzi T, 2009, J EXP CHILD PSYCHOL, V102, P522, DOI 10.1016/j.jecp.2008.05.003; Nespor M., 2003, LINGUE LINGUAGGIO, V2, P221, DOI [10.1418/10879, DOI 10.1418/10879]; New B, 2001, ANN PSYCHOL, V101, P447; Puccini D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00101; Saffran JR, 2006, ADV CHILD DEV BEHAV, V34, P1, DOI 10.1016/S0065-2407(06)80003-0; Schafer G, 1998, CHILD DEV, V69, P309, DOI 10.2307/1132166; Sebastian-Galles N, 2002, J EXP PSYCHOL HUMAN, V28, P974, DOI 10.1037//0096-1523.28.4.974; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Stoel-Gammon C, 2011, J CHILD LANG, V38, P1, DOI 10.1017/S0305000910000425; Storkel HL, 2000, CLIN LINGUIST PHONET, V14, P407; Storkel HL, 2003, J SPEECH LANG HEAR R, V46, P1312, DOI 10.1044/1092-4388(2003/102); Storkel HL, 2001, J SPEECH LANG HEAR R, V44, P1321, DOI 10.1044/1092-4388(2001/103); Swingley D, 1999, COGNITION, V71, P73, DOI 10.1016/S0010-0277(99)00021-9; Swingley D, 2000, COGNITION, V76, P147, DOI 10.1016/S0010-0277(00)00081-0; Swingley D, 2002, PSYCHOL SCI, V13, P480, DOI 10.1111/1467-9280.00485; Swingley D, 2007, DEV PSYCHOL, V43, P454, DOI 10.1037/0012-1649.43.2.454; Tincoff R, 1999, PSYCHOL SCI, V10, P172, DOI 10.1111/1467-9280.00127; Tincoff R, 2012, INFANCY, V17, P432, DOI 10.1111/j.1532-7078.2011.00084.x; Treiman R., 2000, PAPERS LAB PHONOLOGY, P269; Tsuji S, 2012, COGNITION, V125, P413, DOI 10.1016/j.cognition.2012.07.017; Vitevitch MS, 1997, LANG SPEECH, V40, P47, DOI 10.1177/002383099704000103; Vitevitch MS, 2005, J MEM LANG, V52, P193, DOI 10.1016/j.jml.2004.10.003; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Von Holzen K, 2012, J EXP CHILD PSYCHOL, V113, P569, DOI 10.1016/j.jecp.2012.08.001; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Werker JF, 1998, PAPERS LAB PHONOLOGY, V5, P181; White KS, 2008, J MEM LANG, V59, P114, DOI 10.1016/j.jml.2008.03.001; Woodward AL, 1999, CHILD DEV, V70, P65, DOI 10.1111/1467-8624.00006; Yoshida KA, 2009, DEVELOPMENTAL SCI, V12, P412, DOI 10.1111/j.1467-7687.2008.00789.x; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x; Zamuner TS, 2009, J SPEECH LANG HEAR R, V52, P49, DOI 10.1044/1092-4388(2008/07-0138); Zamuner TS, 2004, J CHILD LANG, V31, P515, DOI 10.1017/S0305000904006233	85	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59601	10.1371/journal.pone.0059601	http://dx.doi.org/10.1371/journal.pone.0059601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527227	Green Published, gold			2022-12-27	WOS:000317562600079
J	Lopez-Malo, M; Querol, A; Guillamon, JM				Lopez-Malo, Maria; Querol, Amparo; Manuel Guillamon, Jose			Metabolomic Comparison of Saccharomyces cerevisiae and the Cryotolerant Species S. bayanus var. uvarum and S. kudriavzevii during Wine Fermentation at Low Temperature	PLOS ONE			English	Article							MANNOPROTEIN GENES; LIPID-COMPOSITION; NATURAL HYBRIDS; COLD ADAPTATION; CELL-WALL; YEAST; EXPRESSION; GROWTH; POPULATIONS; PRESSURE	Temperature is one of the most important parameters affecting the length and rate of alcoholic fermentation and final wine quality. Wine produced at low temperature is often considered to have improved sensory qualities. However, there are certain drawbacks to low temperature fermentations such as reduced growth rate, long lag phase, and sluggish or stuck fermentations. To investigate the effects of temperature on commercial wine yeast, we compared its metabolome growing at 12 degrees C and 28 degrees C in a synthetic must. Some species of the Saccharomyces genus have shown better adaptation at low temperature than Saccharomyces cerevisiae. This is the case of the cryotolerant yeasts Saccharomyces bayanus var. uvarum and Saccharomyces kudriavzevii. In an attempt to detect inter-specific metabolic differences, we characterized the metabolome of these species growing at 12 degrees C, which we compared with the metabolome of S. cerevisiae (not well adapted at low temperature) at the same temperature. Our results show that the main differences between the metabolic profiling of S. cerevisiae growing at 12 degrees C and 28 degrees C were observed in lipid metabolism and redox homeostasis. Moreover, the global metabolic comparison among the three species revealed that the main differences between the two cryotolerant species and S. cerevisiae were in carbohydrate metabolism, mainly fructose metabolism. However, these two species have developed different strategies for cold resistance. S. bayanus var. uvarum presented elevated shikimate pathway activity, while S. kudriavzevii displayed increased NAD(+) synthesis.	[Lopez-Malo, Maria; Querol, Amparo; Manuel Guillamon, Jose] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, E-46010 Valencia, Spain; [Lopez-Malo, Maria] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Fac Enol, Tarragona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Rovira i Virgili	Guillamon, JM (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	guillamon@iata.csic.es	López Malo, Maria/C-2789-2017; Querol, Amparo/AAW-7469-2020; Guillamon, Jose/I-2040-2015; Guillamon, Jose/AAB-4251-2019; Querol, Amparo/H-3782-2012	López Malo, Maria/0000-0002-8612-2118; Querol, Amparo/0000-0002-6478-6845; Guillamon, Jose/0000-0001-5414-0787; Guillamon, Jose/0000-0001-5414-0787; Querol, Amparo/0000-0002-6478-6845	Spanish government [AGL2010-22001-C02-01, AGL2009-12673-C02-01]; Generalitat Valenciana [PROMETEO/2009/019, ACOMP/2012/014]; Spanish government	Spanish government(Spanish GovernmentEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish government(Spanish GovernmentEuropean Commission)	This work has been financially supported by the grants AGL2010-22001-C02-01 and AGL2009-12673-C02-01, from the Spanish government, awarded to JMG and AQ, respectively; PROMETEO/2009/019 and ACOMP/2012/014 from Generalitat Valenciana, awarded to AQ and JMG, respectively. MLM also wishes to thank the Spanish government for her FPI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Abe F, 2007, FEBS LETT, V581, P4993, DOI 10.1016/j.febslet.2007.09.039; Abramova NE, 2001, GENETICS, V157, P1169; [Anonymous], 2010, R LANG ENV STAT COMP; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; Beltran G, 2006, FEMS YEAST RES, V6, P1167, DOI 10.1111/j.1567-1364.2006.00106.x; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Clement T, 2011, INT J FOOD MICROBIOL, V150, P42, DOI 10.1016/j.ijfoodmicro.2011.07.016; Combina M, 2012, INT J FOOD MICROBIOL, V157, P340, DOI 10.1016/j.ijfoodmicro.2012.06.001; Dukes BC, 1998, AM J ENOL VITICULT, V49, P125; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Henschke P.A., 1991, YEASTS, VIV, P297; Homma T, 2003, CRYOBIOLOGY, V46, P230, DOI 10.1016/S0011-2240(03)00028-2; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Masneuf-Pomarede I, 2010, INT J FOOD MICROBIOL, V139, P79, DOI 10.1016/j.ijfoodmicro.2010.01.038; Murata Y, 2006, EXTREMOPHILES, V10, P117, DOI 10.1007/s00792-005-0480-1; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Nielsen Jens, 2007, V18, P1, DOI 10.1007/4735_2007_0228; Arroyo-Lopez FN, 2010, FOOD MICROBIOL, V27, P628, DOI 10.1016/j.fm.2010.02.001; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Redon M, 2011, EUR FOOD RES TECHNOL, V232, P517, DOI 10.1007/s00217-010-1415-3; RUSSELL NJ, 1990, PHILOS T ROY SOC B, V326, P595, DOI 10.1098/rstb.1990.0034; Salvado Z, 2012, J APPL MICROBIOL, V113, P76, DOI 10.1111/j.1365-2672.2012.05308.x; Salvado Z, 2011, APPL ENVIRON MICROB, V77, P2292, DOI 10.1128/AEM.01861-10; Salvado Z, 2008, FEMS YEAST RES, V8, P1137, DOI 10.1111/j.1567-1364.2008.00389.x; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; Skogerson K, 2009, J AGR FOOD CHEM, V57, P6899, DOI 10.1021/jf9019322; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; Tronchoni J, 2012, INT J FOOD MICROBIOL, V155, P191, DOI 10.1016/j.ijfoodmicro.2012.02.004; Zhang L, 2003, BIOCHEM BIOPH RES CO, V307, P308, DOI 10.1016/S0006-291X(03)01168-9; [No title captured]; [No title captured]; [No title captured]	40	72	76	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60135	10.1371/journal.pone.0060135	http://dx.doi.org/10.1371/journal.pone.0060135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527304	Green Published, gold			2022-12-27	WOS:000317562600121
J	Becker, L; Peterson, J; Kulkarni, S; Pasricha, PJ				Becker, Laren; Peterson, Johann; Kulkarni, Subhash; Pasricha, Pankaj Jay			Ex Vivo Neurogenesis within Enteric Ganglia Occurs in a PTEN Dependent Manner	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NERVOUS-SYSTEM; TUMOR-SUPPRESSOR; SMOOTH-MUSCLE; NEURAL CREST; SELF-RENEWAL; IN-VIVO; GUT; NEURONS; GLIA	A population of multipotent stem cells capable of differentiating into neurons and glia has been isolated from adult intestine in humans and rodents. While these cells may provide a pool of stem cells for neurogenesis in the enteric nervous system (ENS), such a function has been difficult to demonstrate in vivo. An extensive study by Joseph et al. involving 108 rats and 51 mice submitted to various insults demonstrated neuronal uptake of thymidine analog BrdU in only 1 rat. Here we introduce a novel approach to study neurogenesis in the ENS using an ex vivo organotypic tissue culturing system. Culturing longitudinal muscle and myenteric plexus tissue, we show that the enteric nervous system has tremendous replicative capacity with the majority of neural crest cells demonstrating EdU uptake by 48 hours. EdU(+) cells express both neuronal and glial markers. Proliferation appears dependent on the PTEN/PI3K/Akt pathway with decreased PTEN mRNA expression and increased PTEN phosphorylation (inactivation) corresponding to increased Akt activity and proliferation. Inhibition of PTEN with bpV(phen) augments proliferation while LY294002, a PI3K inhibitor, blocks it. These data suggest that the ENS is capable of neurogenesis in a PTEN dependent manner.	[Becker, Laren] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Peterson, Johann] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Kulkarni, Subhash; Pasricha, Pankaj Jay] Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21218 USA	Stanford University; University of California System; University of California Davis; Johns Hopkins University	Pasricha, PJ (corresponding author), Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21218 USA.	ppasric1@jhmi.edu			NIH/NIDDK [1R01DK080920-01]; AGA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080920] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH/NIDDK 1R01DK080920-01 (PI: Pasricha) and AGA Fellowship to Faculty Transition Award (PI: Becker) (http://www.gastro.org/aga-foundation/grants/career-development-awards/fellowship-to-faculty-transition-awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Alva JA, 2011, STEM CELLS, V29, P1952, DOI 10.1002/stem.748; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Becker L, 2012, AM J PHYSIOL-GASTR L, V302, pG958, DOI 10.1152/ajpgi.00511.2011; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cracco C, 1997, ADV EXP MED BIOL, V429, P159; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hanani M, 2003, J COMP NEUROL, V462, P315, DOI 10.1002/cne.10721; Heanue TA, 2011, STEM CELLS, V29, P128, DOI 10.1002/stem.557; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; LASHNER BA, 1986, DIGEST DIS SCI, V31, P213, DOI 10.1007/BF01300711; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUCK MS, 1993, CELL TISSUE RES, V271, P363, DOI 10.1007/BF00318623; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Metzger M, 2010, ARCH ITAL BIOL, V148, P73; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Natarajan D, 1999, DEVELOPMENT, V126, P157; O'Donnell AM, 2011, PEDIATR SURG INT, V27, P491, DOI 10.1007/s00383-010-2828-6; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Poli E, 2001, NEUROCHEM RES, V26, P1085, DOI 10.1023/A:1012313424144; Puig I, 2009, J CLIN INVEST, V119, P3586, DOI 10.1172/JCI39929; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Schafer KH, 2003, PEDIATR SURG INT, V19, P340, DOI 10.1007/s00383-003-1007-4; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	52	23	26	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59452	10.1371/journal.pone.0059452	http://dx.doi.org/10.1371/journal.pone.0059452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527198	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100136
J	Cui, Y; Zheng, CH; Yang, J				Cui, Yan; Zheng, Chun-Hou; Yang, Jian			Identifying Subspace Gene Clusters from Microarray Data Using Low-Rank Representation	PLOS ONE			English	Article							TRANSCRIPTIONAL MODULES; EXPRESSION DATA; COEXPRESSION; INFORMATION; DISCOVERY; COREGULATION	Identifying subspace gene clusters from the gene expression data is useful for discovering novel functional gene interactions. In this paper, we propose to use low-rank representation (LRR) to identify the subspace gene clusters from microarray data. LRR seeks the lowest-rank representation among all the candidates that can represent the genes as linear combinations of the bases in the dataset. The clusters can be extracted based on the block diagonal representation matrix obtained using LRR, and they can well capture the intrinsic patterns of genes with similar functions. Meanwhile, the parameter of LRR can balance the effect of noise so that the method is capable of extracting useful information from the data with high level of background noise. Compared with traditional methods, our approach can identify genes with similar functions yet without similar expression profiles. Also, it could assign one gene into different clusters. Moreover, our method is robust to the noise and can identify more biologically relevant gene clusters. When applied to three public datasets, the results show that the LRR based method is superior to existing methods for identifying subspace gene clusters.	[Cui, Yan; Yang, Jian] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zheng, Chun-Hou] Anhui Univ, Coll Elect Engn & Automat, Hefei 230039, Anhui, Peoples R China	Nanjing University of Science & Technology; Anhui University	Yang, J (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China.	csjyang@mail.njust.edu.cn			National Science Fund for Distinguished Young Scholars [61125305, 61233011]; Key Project of Chinese Ministry of Education; National Natural Science Foundation of China [61272339]; Key Project of Anhui Educational Committee [KJ2012A005]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Anhui Educational Committee	This work was partially supported by the National Science Fund for Distinguished Young Scholars under Grant Nos. 61125305 and 61233011, the Key Project of Chinese Ministry of Education, the National Natural Science Foundation of China under Grant No. 61272339, and the Key Project of Anhui Educational Committee, under Grant No. KJ2012A005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1998, SIGMOD Record, V27, P94, DOI 10.1145/276305.276314; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Ben-Dor A, 2003, J COMPUT BIOL, V10, P803; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertsekas D., 1982, CONSTRAINED OPTIMIZA; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Candes  E., 2009, EXACT MATRIX COMPLET; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Clements Maarten, 2007, Genomics Proteomics & Bioinformatics, V5, P86, DOI 10.1016/S1672-0229(07)60019-9; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; Elhamifar Ehsan, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2790, DOI 10.1109/CVPRW.2009.5206547; Elhamifar E, 2010, INT CONF ACOUST SPEE, P1926, DOI 10.1109/ICASSP.2010.5495317; Fazel M., 2002, MATRIX RANK MINIMIZA; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goncalves JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035977; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Keshavan R, 2009, NIPS; Kiddle SJ, 2010, BIOINFORMATICS, V26, P355, DOI 10.1093/bioinformatics/btp673; Li H, 2007, BIOINFORMATICS, V23, P473, DOI 10.1093/bioinformatics/btl640; Lin Z, 2009, UILUENG092215 UIUC; Liu G., 2010, P INT C MACH LEARN; Liu G, 2012, INT CONF SOFTW ENG, P1; Ma Y, 2007, IEEE T PATTERN ANAL, V29, P1546, DOI [10.1109/TPAMI.2007.1085, 10.1109/TP'AMI.2007.1085]; Mclachian G, 1998, MIXTURE MODELS INFER; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Sherlock G, 2000, CURR OPIN IMMUNOL, V12, P201, DOI 10.1016/S0952-7915(99)00074-6; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tchagang AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-54; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vidal R., 2005, IEEE T PATTERN ANAL, V27, P1; Vidal R, 2011, IEEE SIGNAL PROC MAG, V28, P52, DOI 10.1109/MSP.2010.939739; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Zhang J, 2011, COMPUT BIOL MED, V41, P1041, DOI 10.1016/j.compbiomed.2011.09.003; Zheng CH, 2011, IEEE ACM T COMPUT BI, V8, P1592, DOI 10.1109/TCBB.2011.79	49	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59377	10.1371/journal.pone.0059377	http://dx.doi.org/10.1371/journal.pone.0059377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527177	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100121
J	Launay, D; Dutoit-Lefevre, V; Faure, E; Robineau, O; Hauspie, C; Sobanski, V; Hachulla, E; Labalette, M; Hatron, PY; Dubucquoi, S				Launay, David; Dutoit-Lefevre, Virginie; Faure, Emmanuel; Robineau, Olivier; Hauspie, Carine; Sobanski, Vincent; Hachulla, Eric; Labalette, Myriam; Hatron, Pierre-Yves; Dubucquoi, Sylvain			Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome	PLOS ONE			English	Article							MUCKLE-WELLS-SYNDROME; AUTOINFLAMMATORY DISEASE; INTERLEUKIN-1-BETA; INFLAMMASOME; INHIBITION; REMISSION; BLOCKADE; DEAFNESS; PATIENT; IL-1	IL-1 receptor antagonist anakinra is usually highly efficient in Schnitzler syndrome (SS), a rare inflammatory condition associating urticaria, fever, and IgM monoclonal gammopathy. In this study, we aimed to assess lipopolysaccharide (LPS)-induced production of inflammatory cytokines by peripheral blood mononuclear cells (PBMCs) before and after 1 month of anakinra in patients with SS. LPS-induced production of IL-1 beta, IL-6 and TNF alpha was assessed by enzyme-linked immunosorbent assay with and without anakinra in vitro, and before and after 1 month (in vivo condition) of treatment in 2 patients with SS. Spontaneous production of IL-1 beta, IL-6 and TNF-alpha by PBMCs was similar in the patients and the healthy controls and was almost undetectable. Stimulation with LPS caused a higher release of cytokines from the patients than from the healthy controls. Before in vivo anakinra start, in vitro adjunction of anakinra reduced the high LPS-induced production of IL-1 beta and TNF alpha in both patients and of IL-6 in one patient. After 1 month of treatment with anakinra, while the patients had dramatically improved, there was also a marked reduction in LPS-induced cytokines production, which was almost normalized in one patient. This study shows an abnormal LPS-induced inflammatory cytokines production in SS, which can be decreased or even normalized by in vitro and in vivo anakinra.	[Launay, David; Robineau, Olivier; Sobanski, Vincent; Hachulla, Eric; Hatron, Pierre-Yves] Lille Nord France Univ, Dept Internal Med & Clin Immunol, Reg Univ Hosp, Natl Reference Ctr Rare Autoimmune & Syst Dis, Lille, France; [Launay, David; Dutoit-Lefevre, Virginie; Hauspie, Carine; Sobanski, Vincent; Hachulla, Eric; Labalette, Myriam; Dubucquoi, Sylvain] Reg Univ Hosp, IMPRT IFR 114, EA2686, Lille, France; [Dutoit-Lefevre, Virginie; Hauspie, Carine; Labalette, Myriam; Dubucquoi, Sylvain] Lille Nord France Univ, Dept Immunol, Reg Univ Hosp, Lille, France; [Faure, Emmanuel] Lille Nord France Univ, Pseudomonas Aeruginosa Host Pathogen Translat Res, Reg Univ Hosp, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Launay, D (corresponding author), Lille Nord France Univ, Dept Internal Med & Clin Immunol, Reg Univ Hosp, Natl Reference Ctr Rare Autoimmune & Syst Dis, Lille, France.	david.launay@chru-lille.fr	Dubucquoi, Sylvain/I-5756-2018; Faure, Emmanuel/AAD-9412-2020; Launay, David/H-1674-2016; Sobanski, Vincent/U-5676-2019; LABALETTE, Myriam/M-4203-2018; Sobanski, Vincent/Q-6411-2016; Launay, David/A-5270-2018; HACHULLA, ERIC/R-8488-2018	Dubucquoi, Sylvain/0000-0002-8962-3719; Faure, Emmanuel/0000-0003-2618-2706; Launay, David/0000-0003-1840-1817; LABALETTE, Myriam/0000-0002-1524-9891; Sobanski, Vincent/0000-0003-3083-2441; Launay, David/0000-0003-1840-1817; HACHULLA, ERIC/0000-0001-7432-847X	Swedish Orphan Biovitrum (SOBI); Swedish Orphan Biovitrum	Swedish Orphan Biovitrum (SOBI); Swedish Orphan Biovitrum	Swedish Orphan Biovitrum (SOBI) provided anakinra for the experiments and grants for cytokine dosage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by a research grant from Swedish Orphan Biovitrum. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Crouch R, 2007, AUSTRALAS J DERMATOL, V48, P178, DOI 10.1111/j.1440-0960.2007.00375.x; de Koning HD, 2007, SEMIN ARTHRITIS RHEU, V37, P137, DOI 10.1016/j.semarthrit.2007.04.001; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Krause K, 2012, J ALLERGY CLIN IMMUN, V129, P848, DOI 10.1016/j.jaci.2011.10.031; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; Lipsker D, 2001, MEDICINE, V80, P37, DOI 10.1097/00005792-200101000-00004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Migliorini P, 2009, EUR CYTOKINE NETW, V20, P108, DOI 10.1684/ecn.2009.0164; Mirault T, 2006, ARTHRITIS RHEUM-US, V54, P1697, DOI 10.1002/art.21807; Pizzirani C, 2009, RHEUMATOLOGY, V48, P1304, DOI 10.1093/rheumatology/kep222; Ryan JG, 2008, J ALLERGY CLIN IMMUN, V121, P260, DOI 10.1016/j.jaci.2007.09.021; SAURAT JH, 1991, J ALLERGY CLIN IMMUN, V88, P244, DOI 10.1016/0091-6749(91)90335-L; Wastiaux H, 2009, J EUR ACAD DERMATOL, V23, P86, DOI 10.1111/j.1468-3083.2008.02708.x; Yamazaki T, 2008, ARTHRITIS RHEUM, V58, P864, DOI 10.1002/art.23261	22	29	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59327	10.1371/journal.pone.0059327	http://dx.doi.org/10.1371/journal.pone.0059327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527164	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100109
J	Desai, BM; Villanueva, J; Nguyen, TTK; Lioni, M; Xiao, M; Kong, J; Krepler, C; Vultur, A; Flaherty, KT; Nathanson, KL; Smalley, KSM; Herlyn, M				Desai, Brijal M.; Villanueva, Jessie; Nguyen, Thierry-Thien K.; Lioni, Mercedes; Xiao, Min; Kong, Jun; Krepler, Clemens; Vultur, Adina; Flaherty, Keith T.; Nathanson, Katherine L.; Smalley, Keiran S. M.; Herlyn, Meenhard			The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling	PLOS ONE			English	Article							MEK INHIBITION; MELANOMA-CELLS; MALIGNANT-MELANOMA; LINEAGE SURVIVAL; RAF KINASE; BRAF; RESISTANCE; GROWTH; EXPRESSION; MUTATIONS	Although cyclin dependent kinase (CDK)-2 is known to be dispensable for the growth of most tumors, it is thought to be important for the proliferation of melanoma cells, where its expression is controlled by the melanocyte-lineage specific transcription factor MITF. Treatment of a panel of melanoma cells with the CDK inhibitor dinaciclib led to a concentration-dependent inhibition of growth under both 2D adherent and 3D organotypic cell culture conditions. Dinaciclib targeted melanoma cell lines regardless of cdk2 or MITF levels. Inhibition of growth was associated with a rapid induction of G2/M cell arrest and apoptosis. Treatment of human melanoma mouse xenografts with dinaciclib led to tumor regression associated with reduced retinoblastoma protein phosphorylation and Bcl-2 expression. Further mechanistic studies revealed that dinaciclib induces p53 expression whilst simultaneously downregulating the expression of the anti-apoptotic factors Mcl-1 and XIAP. To clarify the role of p53 activation in the dinaciclib-induced cell death, we generated melanoma cell lines in which p53 expression was knocked down using a shRNA lentiviral vector. Knockdown of p53 completely abolished the induction of apoptosis seen following dinaciclib treatment as shown by a lack of annexin-V staining and caspase-3 cleavage. Altogether, these data show that dinaciclib induces apoptosis in a large panel of melanoma cell lines through a mechanism requiring p53 expression.	[Desai, Brijal M.; Villanueva, Jessie; Nguyen, Thierry-Thien K.; Lioni, Mercedes; Xiao, Min; Kong, Jun; Krepler, Clemens; Vultur, Adina; Herlyn, Meenhard] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nathanson, Katherine L.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Smalley, Keiran S. M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA	The Wistar Institute; Harvard University; Massachusetts General Hospital; University of Pennsylvania; H Lee Moffitt Cancer Center & Research Institute	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	herlynm@wistar.org		Smalley, Keiran/0000-0003-1089-9307; Nathanson, Katherine/0000-0002-6740-0901; Vultur, Adina/0000-0003-0068-9496	National Institutes of Health [CA 76674, CA 25874,, CA 10815,, CA 93372, CA 47159, CA 80999, CA 098101, CA117881, GM071695]; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; American Skin Association; Schering-Plough, Kenilworth, New Jersey; Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [P50CA093372, P01CA098101, R01CA080999, P30CA010815, R01CA076674, P30CA016520, P01CA025874, R01CA047159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; American Skin Association; Schering-Plough, Kenilworth, New Jersey; Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (CA 76674, CA 25874, CA 10815, CA 93372, CA 47159, CA 80999, CA 098101, CA117881, GM071695); funds from the Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; the American Skin Association; Schering-Plough, Kenilworth, New Jersey; and the Adelson Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah C, 2011, CELL CYCLE, V10, P977, DOI 10.4161/cc.10.6.15079; Arnbrosini G, 2008, CANCER RES, V68, P2312, DOI 10.1158/0008-5472.CAN-07-2395; Avery-Kiejda KA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-203; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brose MS, 2002, CANCER RES, V62, P6997; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Emanuel POM, 2008, J CUTAN PATHOL, V35, P292, DOI 10.1111/j.1600-0560.2007.00798.x; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gembarska A, 2012, NATURE MED; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ikediobi ON, 2008, MOL CANC THER; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kitada S, 2000, BLOOD, V96, P393; Kudchadkar R, 2012, CANCER J, V18, P124, DOI 10.1097/PPO.0b013e31824b436e; Lao CD, 2012, J CLIN ONCOLOGY, V30; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nikolaou V. A., 2012, J INVESTIGATIVE DERM; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Polsky D, 2001, CANCER RES, V61, P7642; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Sausville EA, 2002, TRENDS MOL MED, V8, pS32, DOI 10.1016/S1471-4914(02)02308-0; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023	51	49	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59588	10.1371/journal.pone.0059588	http://dx.doi.org/10.1371/journal.pone.0059588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527225	Green Submitted, gold, Green Published			2022-12-27	WOS:000316411600067
J	Figueira, FR; Umpierre, D; Casali, KR; Tetelbom, PS; Henn, NT; Ribeiro, JP; Schaan, BD				Figueira, Franciele R.; Umpierre, Daniel; Casali, Karina R.; Tetelbom, Pedro S.; Henn, Nicoli T.; Ribeiro, Jorge P.; Schaan, Beatriz D.			Aerobic and Combined Exercise Sessions Reduce Glucose Variability in Type 2 Diabetes: Crossover Randomized Trial	PLOS ONE			English	Article							TEMPERATURE CURVE COMPLEXITY; HEART PERIOD VARIABILITY; GLYCEMIC VARIABILITY; PHYSICAL-ACTIVITY; MICROVASCULAR COMPLICATIONS; OXIDATIVE STRESS; INDUCED INCREASE; INSULIN ACTION; BLOOD-GLUCOSE; ASSOCIATION	Purpose: To evaluate the effects of aerobic (AER) or aerobic plus resistance exercise (COMB) sessions on glucose levels and glucose variability in patients with type 2 diabetes. Additionally, we assessed conventional and non-conventional methods to analyze glucose variability derived from multiple measurements performed with continuous glucose monitoring system (CGMS). Methods: Fourteen patients with type 2 diabetes (56 +/- 2 years) wore a CGMS during 3 days. Participants randomly performed AER and COMB sessions, both in the morning (24 h after CGMS placement), and at least 7 days apart. Glucose variability was evaluated by glucose standard deviation, glucose variance, mean amplitude of glycemic excursions (MAGE), and glucose coefficient of variation (conventional methods) as well as by spectral and symbolic analysis (non-conventional methods). Results: Baseline fasting glycemia was 139 +/- 05 mg/dL and HbA1c 7.9 +/- 0.7%. Glucose levels decreased immediately after AER and COMB protocols by,16%, which was sustained for approximately 3 hours. Comparing the two exercise modalities, responses over a 24-h period after the sessions were similar for glucose levels, glucose variance and glucose coefficient of variation. In the symbolic analysis, increases in 0 V pattern (COMB, 67.0 +/- 7.1 vs. 76.0 +/- 6.3, P = 0.003) and decreases in 1 V pattern (COMB, 29.1 +/- 5.3 vs. 21.5 +/- 5.1, P = 0.004) were observed only after the COMB session. Conclusions: Both AER and COMB exercise modalities reduce glucose levels similarly for a short period of time. The use of non-conventional analysis indicates reduction of glucose variability after a single session of combined exercises.	[Figueira, Franciele R.; Umpierre, Daniel; Tetelbom, Pedro S.; Henn, Nicoli T.; Ribeiro, Jorge P.; Schaan, Beatriz D.] Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, Brazil; [Figueira, Franciele R.; Casali, Karina R.; Schaan, Beatriz D.] Univ Fed Rio Grande do Sul, Postgrad Program Endocrinol, Porto Alegre, RS, Brazil; [Umpierre, Daniel; Ribeiro, Jorge P.; Schaan, Beatriz D.] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil; [Casali, Karina R.] Fundacao Univ Cardiol Rio Grande Sul, Inst Cardiol, Porto Alegre, RS, Brazil; [Ribeiro, Jorge P.; Schaan, Beatriz D.] Univ Fed Rio Grande do Sul, Dept Internal Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Fundacao Universitaria de Cardiologia; Universidade Federal do Rio Grande do Sul	Schaan, BD (corresponding author), Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, Brazil.	beatrizschaan@gmail.com	Casali, Karina R/I-7677-2012; Schaan, Beatriz D./I-7518-2017; Umpierre, Daniel/G-9366-2013	Casali, Karina R/0000-0001-8281-0135; Schaan, Beatriz D./0000-0002-2128-8387; Umpierre, Daniel/0000-0001-6953-0163	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [131847/2009-0]; Fundacao de Apoio a Pesquisa do Rio Grande do Sul [05/1936-6]; Fundo de Apoio a Pesquisa do Hospital de Clinicas de Porto Alegre [08-180]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PNPD 2546/2009]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Rio Grande do Sul; Fundo de Apoio a Pesquisa do Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 131847/2009-0; Fundacao de Apoio a Pesquisa do Rio Grande do Sul, grant 05/1936-6; Fundo de Apoio a Pesquisa do Hospital de Clinicas de Porto Alegre, grant 08-180; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, PNPD 2546/2009. The sponsors of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Boland E, 2001, DIABETES CARE, V24, P1858, DOI 10.2337/diacare.24.11.1858; Boule NG, 2011, DIABETES CARE, V34, P1469, DOI 10.2337/dc10-2207; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buscemi S, 2009, ACTA DIABETOL, V46, P55, DOI 10.1007/s00592-008-0061-8; Casali KR, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066204; Cauza E, 2005, EUR J CLIN INVEST, V35, P745, DOI 10.1111/j.1365-2362.2005.01573.x; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Childs A, 2001, FREE RADICAL BIO MED, V31, P745, DOI 10.1016/S0891-5849(01)00640-2; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Churruca J, 2008, DIABETES METAB SYNDR, V1, P3; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Dreyer HC, 2008, J APPL PHYSIOL, V105, P1967, DOI 10.1152/japplphysiol.90562.2008; Figueira FR, 2012, DIABETES RES CLIN PR, V98, pE36, DOI 10.1016/j.diabres.2012.09.033; Hill NR, 2011, DIABETES TECHNOL THE, V13, P921, DOI 10.1089/dia.2010.0247; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Host HH, 1998, J APPL PHYSIOL, V85, P133, DOI 10.1152/jappl.1998.85.1.133; Howlett KF, 2008, AM J PHYSIOL-ENDOC M, V294, pE401, DOI 10.1152/ajpendo.00542.2007; Iscoe KE, 2006, DIABETES TECHNOL THE, V8, P627, DOI 10.1089/dia.2006.8.627; Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; KING DS, 1995, J APPL PHYSIOL, V78, P17, DOI 10.1152/jappl.1995.78.1.17; Larsen JJ, 1999, DIABETES CARE, V22, P1647, DOI 10.2337/diacare.22.10.1647; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A., 2006, COMPUTING CARDIOLOGY, V33, P77; Praet SF, 2006, MED SCI SPORT EXER, V38, P2037, DOI 10.1249/01.mss.0000235352.09061.1d; REN JM, 1994, J BIOL CHEM, V269, P14396; Rosa JS, 2010, J APPL PHYSIOL, V108, P334, DOI 10.1152/japplphysiol.01083.2009; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Sharoff CG, 2010, AM J PHYSIOL-ENDOC M, V298, pE815, DOI 10.1152/ajpendo.00517.2009; Shephard RJ, 2002, CRIT REV IMMUNOL, V22, P165; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Umpierre D, 2009, EUR J CARDIOV PREV R, V16, P53, DOI 10.1097/HJR.0b013e32831c8489; Varela M, 2005, CRIT CARE MED, V33, P2764, DOI 10.1097/01.CCM.0000190157.64486.03; Varela M, 2006, AM J RESP CRIT CARE, V174, P290, DOI 10.1164/rccm.200601-058OC; Whitelaw BC, 2008, DIABETOLOGIA, V51, pS436; Zaccardi Francesco, 2008, J Diabetes Sci Technol, V2, P1061	50	33	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57733	10.1371/journal.pone.0057733	http://dx.doi.org/10.1371/journal.pone.0057733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536769	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100015
J	Meznarich, J; Malchodi, L; Helterline, D; Ramsey, SA; Bertko, K; Plummer, T; Plawman, A; Gold, E; Stempien-Otero, A				Meznarich, Jessica; Malchodi, Laura; Helterline, Deri; Ramsey, Stephen A.; Bertko, Kate; Plummer, Tabitha; Plawman, Abigail; Gold, Elizabeth; Stempien-Otero, April			Urokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; ALTERNATIVE ACTIVATION; VIRAL MYOCARDITIS; UP-REGULATION; KAPPA-B; FIBROSIS; EXPRESSION; MICE; INHIBITION	Objective: Inflammation and fibrosis are intertwined in multiple disease processes. We have previously found that overexpression of urokinase plasminogen activator in macrophages induces spontaneous macrophage accumulation and fibrosis specific to the heart in mice. Understanding the relationship between inflammation and fibrosis in the heart is critical to developing therapies for diverse myocardial diseases. Therefore, we sought to determine if uPA induces changes in macrophage function that promote cardiac collagen accumulation. Methods and Results: We analyzed the effect of the uPA transgene on expression of pro-inflammatory (M1) and pro-fibrotic (M2) genes and proteins in hearts and isolated macrophages of uPA overexpressing mice. We found that although there was elevation of the pro-inflammatory cytokine IL-6 in hearts of transgenic mice, IL-6 is not a major effector of uPA induced cardiac fibrosis. However, uPA expressing bone marrow-derived macrophages are polarized to express M2 genes in response to IL-4 stimulation, and these M2 genes are upregulated in uPA expressing macrophages following migration to the heart. In addition, while uPA expressing macrophages express a transcriptional profile that is seen in tumor-associated macrophages, these macrophages promote collagen expression in cardiac but not embryonic fibroblasts. Conclusions: Urokinase plasminogen activator induces an M2/profibrotic phenotype in macrophages that is fully expressed after migration of macrophages into the heart. Understanding the mechanisms by which uPA modulates macrophage function may reveal insights into diverse pathologic processes.	[Meznarich, Jessica; Malchodi, Laura; Helterline, Deri; Bertko, Kate; Plummer, Tabitha; Plawman, Abigail; Stempien-Otero, April] Univ Washington, Sch Med, Div Cardiol, Seattle, WA 98195 USA; [Ramsey, Stephen A.; Gold, Elizabeth] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Stempien-Otero, A (corresponding author), Univ Washington, Sch Med, Div Cardiol, Seattle, WA 98195 USA.	april@uw.edu			National Heart, Lung and Blood Institute at the National Institutes of Health [K08HL70941]; American Heart Association [GRNT5270031]; Locke Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL070941, K25HL098807] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Locke Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute at the National Institutes of Health [K08HL70941 to ASO]; American Heart Association [GRNT5270031 to ASO]; and Locke Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Banerjee I, 2009, AM J PHYSIOL-HEART C, V296, pH1694, DOI 10.1152/ajpheart.00908.2008; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Cozen AE, 2004, CIRCULATION, V109, P2129, DOI 10.1161/01.CIR.0000127369.24127.03; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Devaux B, 1997, EUR HEART J, V18, P470; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Elsasser A, 2000, MOL CELL BIOCHEM, V213, P17, DOI 10.1023/A:1007182617215; Fuchs M, 2003, FASEB J, V17, P2118, DOI 10.1096/fj.03-0331fje; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Griffin MO, 2005, MOL CELL BIOCHEM, V270, P1, DOI 10.1007/s11010-005-2540-3; Gyetko MR, 2002, J IMMUNOL, V168, P801, DOI 10.4049/jimmunol.168.2.801; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; HART DA, 1994, CLIN INVEST MED, V17, P69; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Heymans S, 2005, AM J PATHOL, V166, P15, DOI 10.1016/S0002-9440(10)62228-6; Heymans S, 2006, CIRCULATION, V114, P565, DOI 10.1161/CIRCULATIONAHA.105.591032; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; KNOEPFLER PS, 1995, J MOL CELL CARDIOL, V27, P1317, DOI 10.1016/S0022-2828(05)82394-6; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; LIEBER A, 1995, P NATL ACAD SCI USA, V92, P6210, DOI 10.1073/pnas.92.13.6210; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Massare J, 2010, J CARDIOVASC ELECTR, V21, P1031, DOI 10.1111/j.1540-8167.2010.01736.x; Minami E., 2010, J MOL CELL CARDIOL; Moreo A, 2009, CIRC-CARDIOVASC IMAG, V2, P437, DOI 10.1161/CIRCIMAGING.108.838367; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 1999, J IMMUNOL, V163, P3771; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Pogwizd SM, 1998, CIRCULATION, V98, P2404, DOI 10.1161/01.CIR.98.22.2404; Sarkar S, 2004, AM J PHYSIOL-HEART C, V287, pH107, DOI 10.1152/ajpheart.00763.2003; Schaffer MR, 1997, J IMMUNOL, V158, P2375; Stempien-Otero A, 2006, J BIOL CHEM, V281, P15345, DOI 10.1074/jbc.M512818200; Sun Y, 2001, J MOL CELL CARDIOL, V33, P995, DOI 10.1006/jmcc.2001.1365; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704; Tyagi SC, 1996, J MOL CELL CARDIOL, V28, P1415, DOI 10.1006/jmcc.1996.0132; WEBER KT, 1993, CARDIOVASC RES, V27, P341, DOI 10.1093/cvr/27.3.341; WUNSCH M, 1991, J MOL CELL CARDIOL, V23, P1051, DOI 10.1016/0022-2828(91)91640-D; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yamaguchi I, 2007, AM J PHYSIOL-RENAL, V293, pF12, DOI 10.1152/ajprenal.00380.2006	51	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57837	10.1371/journal.pone.0057837	http://dx.doi.org/10.1371/journal.pone.0057837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536772	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100018
J	Ng, MC; Yang, YL; Lu, KT				Ng, Ming-Chong; Yang, Yi-Ling; Lu, Kwok-Tung			Behavioral and Synaptic Circuit Features in a Zebrafish Model of Fragile X Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; ADULT ZEBRAFISH; KNOCKOUT MICE; CGG REPEAT; FMR1 GENE; HIPPOCAMPUS; PLASTICITY; EXPRESSION	Fragile X syndrome (FXS) is the most frequent inherited form of human mental retardation. It is characterized by cognitive impairment and physical and behavioral problems and is caused by the silencing of fmr1 transcription and the absence of the fmr1 protein (FMRP). Recently, animal models of FXS have greatly facilitated the investigation of the molecular and cellular mechanisms of this loss-of-function disorder. The present study was aimed to further characterize the role of FMRP in behavior and synaptic function by using fmr1 knockout zebrafish. In adult zebrafish, we found that fmr1 knockout produces the anxiolytic-like responses of increased exploratory behavior in light/dark and open-field tests and avoidance learning impairment. Furthermore, electrophysiological recordings from telencephalic slice preparations of knockout fish displayed markedly reduced long-term potentiation and enhanced long-term depression compared to wild-type fish; however, basal glutamatergic transmission and presynaptic function at the lateral (Dl) and medial (Dm) division of the dorsal telencephalon synapse remained normal. Taken together, our study not only evaluates the mechanism of FRMP but also suggests that zebrafish have valuable potential as a complementary vertebrate model in studying the molecular pathogenesis of human fragile X syndrome.	[Ng, Ming-Chong; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	National Taiwan Normal University; National Chiayi University	Yang, YL (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw; ktlu@ntnu.edu.tw			National Science Council, Taiwan [NSC97-2320-B-003-001-MY3, NSC98-2321-B-003-004, 100-2320-B-003-004]; Hubrecht laboratory and the Sanger Institute Zebrafish Mutation Resource [LSHG-CT-2003-503496]; European Commission; Wellcome Trust [WT 077047/Z/05/Z]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Hubrecht laboratory and the Sanger Institute Zebrafish Mutation Resource; European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust)	This work was supported by a research grant from National Science Council, Taiwan NSC97-2320-B-003-001-MY3, NSC98-2321-B-003-004 and 100-2320-B-003-004. The authors gratitude also goes to the Academic Paper Editing Clinic, National Taiwan Normal University. For providing the zebrafish knockout alleles-fmr1hu2787 the authors thank the Hubrecht laboratory and the Sanger Institute Zebrafish Mutation Resource, (ZF-MODELS Integrated Project; contract number LSHG-CT-2003-503496; funded by the European Commission) also sponsored by the Wellcome Trust [grant number WT 077047/Z/05/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; Alfaro JM, 2011, EUR J NEUROSCI, V33, P1252, DOI 10.1111/j.1460-9568.2011.07622.x; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blank M, 2009, NEUROBIOL LEARN MEM, V92, P529, DOI 10.1016/j.nlm.2009.07.001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; de Diego-Otero Y, 2009, NEUROPSYCHOPHARMACOL, V34, P1011, DOI 10.1038/npp.2008.152; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eadie BD, 2009, NEUROBIOL DIS, V36, P361, DOI 10.1016/j.nbd.2009.08.001; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kim YH, 2010, NEUROSCI RES, V67, P156, DOI 10.1016/j.neures.2010.03.003; KITAJIMA T, 1990, BIOL CYBERN, V64, P33, DOI 10.1007/BF00203628; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Liu ZH, 2011, INT J NEUROPSYCHOPH, V14, P618, DOI 10.1017/S1461145710000520; MAREN S, 1995, J NEUROSCI, V15, P7548; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nam RH, 2004, NEUROSCI LETT, V370, P248, DOI 10.1016/j.neulet.2004.08.037; Ng MC, 2012, FISH PHYSIOL BIOCHEM, V38, P1099, DOI 10.1007/s10695-011-9595-8; Ng MC, 2012, NEUROSCI LETT, V512, P109, DOI 10.1016/j.neulet.2012.01.070; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ninkovic J, 2006, J NEUROBIOL, V66, P463, DOI 10.1002/neu.20231; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Pan L, 2008, MOL CELL NEUROSCI, V37, P747, DOI 10.1016/j.mcn.2008.01.003; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; Portavella M, 2002, BRAIN RES BULL, V57, P397, DOI 10.1016/S0361-9230(01)00699-2; Rawashdeh O, 2007, SCIENCE, V318, P1144, DOI 10.1126/science.1148564; Reiss AL, 2007, CHILD ADOL PSYCH CL, V16, P663, DOI 10.1016/j.chc.2007.03.001; Rupp B, 1996, ANAT EMBRYOL, V194, P187; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Souza BR, 2011, REV NEUROSCIENCE, V22, P107, DOI 10.1515/RNS.2011.012; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; van 't Padje S, 2005, DEV GENES EVOL, V215, P198, DOI 10.1007/s00427-005-0466-0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vogel G, 2008, SCIENCE, V322, P176, DOI 10.1126/science.322.5899.176; VORONIN LL, 1983, NEUROSCIENCE, V10, P1051, DOI 10.1016/0306-4522(83)90099-4; Vuaden FC, 2012, NEUROCHEM RES, V37, P1545, DOI 10.1007/s11064-012-0749-6; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Yun SH, 2011, J NEUROSCI RES, V89, P176, DOI 10.1002/jnr.22546; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	56	43	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e51456	10.1371/journal.pone.0051456	http://dx.doi.org/10.1371/journal.pone.0051456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536755	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100001
J	Fayed, N; Lopez del Hoyo, Y; Andres, E; Serrano-Blanco, A; Bellon, J; Aguilar, K; Cebolla, A; Garcia-Campayo, J				Fayed, Nicolas; Lopez del Hoyo, Yolanda; Andres, Eva; Serrano-Blanco, Antoni; Bellon, Juan; Aguilar, Keyla; Cebolla, Ausias; Garcia-Campayo, Javier			Brain Changes in Long-Term Zen Meditators Using Proton Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging: A Controlled Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER CHANGES; ALZHEIMERS-DISEASE; INOSITOL TREATMENT; ENERGY-METABOLISM; SPANISH VERSION; MINDFULNESS; GLUTAMATE; MICROGLIA; CHILDREN	Introduction: This work aimed to determine whether H-1 magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) are correlated with years of meditation and psychological variables in long-term Zen meditators compared to healthy non-meditator controls. Materials and Methods: Design. Controlled, cross-sectional study. Sample. Meditators were recruited from a Zen Buddhist monastery. The control group was recruited from hospital staff. Meditators were administered questionnaires on anxiety, depression, cognitive impairment and mindfulness. H-1-MRS (1.5 T) of the brain was carried out by exploring four areas: both thalami, both hippocampi, the posterior superior parietal lobule (PSPL) and posterior cingulate gyrus. Predefined areas of the brain were measured for diffusivity (ADC) and fractional anisotropy (FA) by MR-DTI. Results: Myo-inositol (mI) was increased in the posterior cingulate gyrus and Glutamate (Glu), N-acetyl-aspartate (NAA) and N-acetyl-aspartate/Creatine (NAA/Cr) was reduced in the left thalamus in meditators. We found a significant positive correlation between mI in the posterior cingulate and years of meditation (r = 0.518; p = .019). We also found significant negative correlations between Glu (r = -0.452; p = .045), NAA (r = -0.617; p = .003) and NAA/Cr (r = -0.448; P = .047) in the left thalamus and years of meditation. Meditators showed a lower Apparent Diffusion Coefficient (ADC) in the left posterior parietal white matter than did controls, and the ADC was negatively correlated with years of meditation (r = -0.4850, p = .0066). Conclusions: The results are consistent with the view that mI, Glu and NAA are the most important altered metabolites. This study provides evidence of subtle abnormalities in neuronal function in regions of the white matter in meditators.	[Fayed, Nicolas; Aguilar, Keyla] Hosp Quiron, Dept Radiol, Zaragoza, Spain; [Lopez del Hoyo, Yolanda] Univ Zaragoza, Dept Psychol & Sociol, Zaragoza, Spain; [Andres, Eva] Hosp 12 Octubre, Unidad Epidemiol Clin, CIBER Epidemiol & Salud Publ, E-28041 Madrid, Spain; [Serrano-Blanco, Antoni] Parc Sanitari St Joan de Deu, Barcelona, Spain; [Serrano-Blanco, Antoni] Fundacio St Joan de Deu, Barcelona, Spain; [Bellon, Juan] Univ Malaga, Ctr Salud El Palo, Unidad Invest Dist Atenc Primaria Malaga RedIAPP, Grp SAMSERAP,Dept Med Prevent, E-29071 Malaga, Spain; [Cebolla, Ausias] Univ Jaime I, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Castellon de La Plana, Spain; [Garcia-Campayo, Javier] Hosp Miguel Servet, Serv Psiquiatria, Zaragoza, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Inst Aragones Ciencias Salud, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat Jaume I; Miguel Servet University Hospital; University of Zaragoza	Garcia-Campayo, J (corresponding author), Inst Salud Carlos III, Red Invest Actividades Prevent & Promoc Salud Ate, Barcelona, Spain.	jgarcamp@gmail.com	Marti, Ausias Cebolla/E-8410-2012; PRISMA, Grupo/AAI-6753-2021; López del Hoyo, Yolanda/W-4602-2018; Serrano-Blanco, Antoni/H-4587-2012	Marti, Ausias Cebolla/0000-0002-3456-9743; López del Hoyo, Yolanda/0000-0002-1690-4130; Serrano-Blanco, Antoni/0000-0001-6123-0633; Bellon Saameno, Juan Angel/0000-0002-4268-4979; Garcia-Campayo, Javier/0000-0002-3797-4218				ADAIR JC, 1995, NEUROLOGY, V45, P241, DOI 10.1212/WNL.45.2.241; Armony J.L., 2000, NEW COGNITIVE NEUROS; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; BARABAN JM, 1989, AM J PSYCHIAT, V146, P1251; Baratti C, 1999, RADIOLOGY, V210, P133, DOI 10.1148/radiology.210.1.r99ja09133; BARKAI AI, 1978, BIOL PSYCHIAT, V13, P65; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Berry GT, 1999, J PEDIATR-US, V135, P94, DOI 10.1016/S0022-3476(99)70334-3; Biber K, 2008, J NEUROIMMUNOL, V198, P69, DOI 10.1016/j.jneuroim.2008.04.012; Bleich S, 2003, INT J GERIATR PSYCH, V18, pS33, DOI 10.1002/gps.933; Bloom FE, 2000, BIOCH BASIS NEUROPHA; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bucci DJ, 1999, NEUROREPORT, V10, P941, DOI 10.1097/00001756-199904060-00009; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Castillo M, 2005, ACAD RADIOL, V12, P533, DOI 10.1016/j.acra.2005.02.012; Chen L, 2013, HUM BRAIN MAPP, V34, P367, DOI 10.1002/hbm.21438; Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Engelbrecht V, 2002, RADIOLOGY, V222, P410, DOI 10.1148/radiol.2222010492; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fayed N., 2006, AM J APPL SCI, V3, P1836, DOI DOI 10.3844/AJASSP.2006.1836.1845; Fayed N, 2008, ACAD RADIOL, V15, P1089, DOI 10.1016/j.acra.2008.04.008; Fayed N, 2011, AM J ALZHEIMERS DIS, V26, P450, DOI 10.1177/1533317511421780; Fayed N, 2009, NEUROL RES, V31, P472, DOI 10.1179/174313209X395481; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FONNUM F, 1981, NEUROSCIENCE, V6, P863, DOI 10.1016/0306-4522(81)90168-8; Frey R, 1998, J PSYCHIAT RES, V32, P411, DOI 10.1016/S0022-3956(98)00033-8; Geissler A, 2003, EXP CLIN ENDOCR DIAB, V111, P421, DOI 10.1055/s-2003-44289; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; HERZOG H, 1991, NEUROPSYCHOBIOLOGY, V23, P182, DOI 10.1159/000119450; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Huppi PS, 1998, PEDIATR RES, V44, P584; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Joseph R, 1996, NEUROPSYCHOLOGY NEUR, P197; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kantarci K, 2001, RADIOLOGY, V219, P101, DOI 10.1148/radiology.219.1.r01ap14101; Krause J, 2006, WORLD J BIOL PSYCHIA, V7, P152, DOI 10.1080/15622970500518444; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; LEVINE J, 1993, BRAIN RES, V627, P168, DOI 10.1016/0006-8993(93)90761-B; LEVINE J, 1995, AM J PSYCHIAT, V152, P792; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Lou HC, 1999, HUM BRAIN MAPP, V7, P98; Luders E, 2011, NEUROIMAGE, V57, P1308, DOI 10.1016/j.neuroimage.2011.05.075; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Minati L, 2007, J GERIATR PSYCH NEUR, V20, P3, DOI 10.1177/0891988706297089; Murakami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046377; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Olbrich HM, 2008, WORLD J BIOL PSYCHIA, V9, P59, DOI 10.1080/15622970701227811; Olson BLB, 2008, ALZ DIS ASSOC DIS, V22, P269, DOI 10.1097/WAD.0b013e3181750a65; Otsuka H, 1999, NEURORADIOLOGY, V41, P517, DOI 10.1007/s002340050795; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Sandson TA, 1999, DEMENT GERIATR COGN, V10, P166, DOI 10.1159/000017099; SAWADA M, 1995, J NEUROCHEM, V64, P1973; Schneider P, 2012, BRAIN BEHAV IMMUN, V26, P277, DOI 10.1016/j.bbi.2011.09.011; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Soler J, 2012, ACTAS ESP PSIQUIATRI, V40, P19; Stanley JA, 2006, PSYCHIAT RES-NEUROIM, V148, P217, DOI 10.1016/j.pscychresns.2006.08.003; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Talairach J., 1998, COPLANAR STEREOTAXIC; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Tejero A., 1986, REV DEP PSIQUIATRIA, V13, P233; Thomas AG, 2000, J PHARMACOL EXP THER, V295, P16; Valdes M, 2010, ARTHRITIS RHEUM-US, V62, P1829, DOI 10.1002/art.27430; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	83	32	32	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58476	10.1371/journal.pone.0058476	http://dx.doi.org/10.1371/journal.pone.0058476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536796	Green Published, gold			2022-12-27	WOS:000317397200007
J	Ali, MW; Cacan, E; Liu, YY; Pierce, JY; Creasman, WT; Murph, MM; Govindarajan, R; Eblen, ST; Greer, SF; Hooks, SB				Ali, Mourad W.; Cacan, Ercan; Liu, Yuying; Pierce, Jennifer Young; Creasman, William T.; Murph, Mandi M.; Govindarajan, Rajgopal; Eblen, Scott T.; Greer, Susanna F.; Hooks, Shelley B.			Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells	PLOS ONE			English	Article							ANTICANCER ACTIVITY; TRICHOSTATIN-A; INHIBITOR; PATHWAYS; DRUG; RECEPTORS; INVASION; GROWTH; ALPHA; REEXPRESSION	RGS10 regulates ovarian cancer cell growth and survival, and RGS10 expression is suppressed in cell models of ovarian cancer chemoresistance. However, the mechanisms governing RGS10 expression in ovarian cancer are poorly understood. Here we report RGS10 suppression in primary ovarian cancer and CAOV-3 ovarian cancer cells compared to immortalized ovarian surface epithelial (IOSE) cells, and in A2780-AD chemoresistant cells compared to parental A2780 cells. RGS10-1 and RGS10-2 transcripts are expressed in ovarian cancer cells, but only RGS10-1 is suppressed in A2780-AD and CAOV-3 cells, and the RGS10-1 promoter is uniquely enriched in CpG dinucleotides. Pharmacological inhibition of DNA methyl-transferases (DNMTs) increased RGS10 expression, suggesting potential regulation by DNA methylation. Bisulfite sequencing analysis identified a region of the RGS10-1 promoter with significantly enhanced DNA methylation in chemoresistant A2780-AD cells relative to parental A2780 cells. DNA methylation in CAOV-3 and IOSE cells was similar to A2780 cells. More marked differences were observed in histone acetylation of the RGS10-1 promoter. Acetylated histone H3 associated with the RGS10-1 promoter was significantly lower in A2780-AD cells compared to parental cells, with a corresponding increase in histone deacetylase (HDAC) enzyme association. Similarly, acetylated histone levels at the RGS10-1 promoter were markedly lower in CAOV-3 cells compared to IOSE cells, and HDAC1 binding was doubled in CAOV-3 cells. Finally, we show that pharmacological inhibition of DNMT or HDAC enzymes in chemoresistant A2780-AD cells increases RGS10 expression and enhances cisplatin toxicity. These data suggest that histone de-acetylation and DNA methylation correlate with RGS10 suppression and chemoresistance in ovarian cancer. Markers for loss of RGS10 expression may identify cancer cells with unique response to therapeutics.	[Ali, Mourad W.; Murph, Mandi M.; Govindarajan, Rajgopal; Hooks, Shelley B.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Cacan, Ercan; Greer, Susanna F.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Liu, Yuying; Eblen, Scott T.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Pierce, Jennifer Young; Creasman, William T.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Pierce, Jennifer Young; Creasman, William T.; Eblen, Scott T.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	University System of Georgia; University of Georgia; University System of Georgia; Georgia State University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Hooks, SB (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	shooks@rx.uga.edu	Cacan, Ercan/I-7279-2019; Cacan, Ercan/AAC-1204-2019	Cacan, Ercan/0000-0002-3487-9493; Ali, Mourad Wagdy/0000-0003-3263-9055; Hooks, Shelley/0000-0003-4702-0490	National Institutes of Health (NIH) [CA151006, CA131200]; American Cancer Society; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA131200, R15CA151006] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by grants from the National Institutes of Health (NIH) (CA151006 to SBH and MM, CA131200 to STE), the American Cancer Society (to SFG), and the Marsha Rivkin Center for Ovarian Cancer Research (to SBH). (www.nih.gov/, www.cancer.org/, www.marsharivkin.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; AUERSPERG N, 1994, LAB INVEST, V71, P510; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Cheng YS, 2008, J CELL BIOCHEM, V105, P922, DOI 10.1002/jcb.21893; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; de Jong E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025192; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fong CW, 2000, BIOCHEM J, V352, P747, DOI 10.1042/0264-6021:3520747; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Growcott JW, 2009, ANTI-CANCER DRUG, V20, P83, DOI 10.1097/CAD.0b013e328320791c; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hooks SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-289; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Hurst JH, 2008, CELL SIGNAL, V20, P381, DOI 10.1016/j.cellsig.2007.10.026; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Hurst JH, 2009, PHARMACOLOGY, V83, P333, DOI 10.1159/000217582; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Koh E, 2007, CANCER LETT, V250, P53, DOI 10.1016/j.canlet.2006.09.017; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lech-Maranda E, 2007, MINI-REV MED CHEM, V7, P1062, DOI 10.2174/138955707782110178; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; LOUIE KG, 1985, CANCER RES, V45, P2110; Mackay HJ, 2010, EUR J CANCER, V46, P1573, DOI 10.1016/j.ejca.2010.02.047; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nepbew KP, 2009, CANCER TREAT RES, V149, P131, DOI 10.1007/978-0-387-98094-2_6; Nephew KP, 2003, CANCER LETT, V190, P125, DOI 10.1016/S0304-3835(02)00511-6; Pisano Carmela, 2009, Ther Clin Risk Manag, V5, P421; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shi HD, 2002, CANCER RES, V62, P3214; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Takai N, 2010, J ONCOL, V2010, DOI 10.1155/2010/458431; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Wang Y, 2004, BIOCHEM PHARMACOL, V68, P2031, DOI 10.1016/j.bcp.2004.07.017; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; Wolff DW, 2012, INT J CANCER, V130, P1521, DOI 10.1002/ijc.26138; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400	51	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60185	10.1371/journal.pone.0060185	http://dx.doi.org/10.1371/journal.pone.0060185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533674	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400111
J	Li, J; Imtiaz, MS; Beard, NA; Dulhunty, AF; Thorne, R; vanHelden, DF; Laver, DR				Li, Jiao; Imtiaz, Mohammad S.; Beard, Nicole A.; Dulhunty, Angela F.; Thorne, Rick; vanHelden, Dirk F.; Laver, Derek R.			beta-Adrenergic Stimulation Increases RyR2 Activity via Intracellular Ca2+ and Mg2+ Regulation	PLOS ONE			English	Article							CARDIAC RYANODINE RECEPTOR; CALCIUM-RELEASE CHANNEL; KINASE-A PHOSPHORYLATION; SARCOPLASMIC-RETICULUM; PKA PHOSPHORYLATION; HEART-FAILURE; PROTEIN; SITE; SERINE-2030; CALMODULIN	Here we investigate how beta-adrenergic stimulation of the heart alters regulation of ryanodine receptors (RyRs) by intracellular Ca2+ and Mg2+ and the role of these changes in SR Ca2+ release. RyRs were isolated from rat hearts, perfused in a Langendorff apparatus for 5 min and subject to 1 min perfusion with 1 mu M isoproterenol or without (control) and snap frozen in liquid N-2 to capture their phosphorylation state. Western Blots show that RyR2 phosphorylation was increased by isoproterenol, confirming that RyR2 were subject to normal beta-adrenergic signaling. Under basal conditions, S2808 and S2814 had phosphorylation levels of 69% and 15%, respectively. These levels were increased to 83% and 60%, respectively, after 60 s of beta-adrenergic stimulation consistent with other reports that beta-adrenergic stimulation of the heart can phosphorylate RyRs at specific residues including S2808 and S2814 causing an increase in RyR activity. At cytoplasmic [Ca2+],1 mM, beta-adrenergic stimulation increased luminal Ca2+ activation of single RyR channels, decreased luminal Mg2+ inhibition and decreased inhibition of RyRs by mM cytoplasmic Mg2+. At cytoplasmic [Ca2+] >1 mu M, beta-adrenergic stimulation only decreased cytoplasmic Mg2+ and Ca2+ inhibition of RyRs. The K-a and maximum levels of cytoplasmic Ca2+ activation site were not affected by beta-adrenergic stimulation. Our RyR2 gating model was fitted to the single channel data. It predicted that in diastole, beta-adrenergic stimulation is mediated by 1) increasing the activating potency of Ca2+ binding to the luminal Ca2+ site and decreasing its affinity for luminal Mg2+ and 2) decreasing affinity of the low-affinity Ca2+/Mg2+ cytoplasmic inhibition site. However in systole, beta-adrenergic stimulation is mediated mainly by the latter.	[Li, Jiao; Imtiaz, Mohammad S.; Thorne, Rick; vanHelden, Dirk F.; Laver, Derek R.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Li, Jiao; Imtiaz, Mohammad S.; Thorne, Rick; vanHelden, Dirk F.; Laver, Derek R.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Beard, Nicole A.; Dulhunty, Angela F.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Australian National University; John Curtin School of Medical Research	Laver, DR (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Derek.Laver@newcastle.edu.au	Dulhunty, Angela/AAO-5421-2020	Dulhunty, Angela/0000-0001-9493-4944; Thorne, Rick/0000-0001-7882-7081	New South Wales Health infrastructure grant through the Hunter Medical Research Institute; National Health and Medical Research Council Project grant [631052]; National Health and Medical Research Council Career Development Award [APP1003985]	New South Wales Health infrastructure grant through the Hunter Medical Research Institute; National Health and Medical Research Council Project grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by the New South Wales Health infrastructure grant through the Hunter Medical Research Institute, National Health and Medical Research Council Project grant (631052), and National Health and Medical Research Council Career Development Award (APP1003985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Carter S, 2006, CIRC RES, V98, P1506, DOI 10.1161/01.RES.0000227506.43292.df; Currie S, 2004, BIOCHEM J, V377, P357, DOI 10.1042/BJ20031043; Dulhunty AF, 2001, BIOPHYS J, V81, P3240, DOI 10.1016/S0006-3495(01)75959-0; Ferrero P, 2007, J MOL CELL CARDIOL, V43, P281, DOI 10.1016/j.yjmcc.2007.05.022; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; Laver DR, 2008, J GEN PHYSIOL, V132, P429, DOI 10.1085/jgp.200810001; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Laver DR, 2010, CURR TOP MEMBR, V66, P69, DOI 10.1016/S1063-5823(10)66004-8; Laver DR, 2009, EUR BIOPHYS J BIOPHY, V39, P19, DOI 10.1007/s00249-009-0417-1; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; LOKUTA AJ, 1995, J PHYSIOL-LONDON, V487, P609, DOI 10.1113/jphysiol.1995.sp020904; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Narayanan N, 1997, BASIC RES CARDIOL, V92, P25, DOI 10.1007/BF00794065; O'Neill ER, 2003, BIOPHYS J, V84, P1674, DOI 10.1016/S0006-3495(03)74976-5; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rodriguez P, 2003, J BIOL CHEM, V278, P38593, DOI 10.1074/jbc.C301180200; Sadeqzadeh E, 2011, J BIOL CHEM, V286, P28181, DOI 10.1074/jbc.M111.234419; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Uehara A, 2002, PFLUG ARCH EUR J PHY, V444, P202, DOI 10.1007/s00424-002-0791-3; Ullrich ND, 2012, J MOL CELLULAR CARDI; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Xiao BL, 2007, J BIOL CHEM, V282, P30256, DOI 10.1074/jbc.M703510200; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zissimopoulos S, 2012, J CELL SCI, V125, P1759, DOI 10.1242/jcs.098012	40	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58334	10.1371/journal.pone.0058334	http://dx.doi.org/10.1371/journal.pone.0058334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533585	gold, Green Published			2022-12-27	WOS:000316549400022
J	Masvidal, L; Iniesta, R; Casala, C; Galvan, P; Rodriguez, E; Lavarino, C; Mora, J; de Torres, C				Masvidal, Laia; Iniesta, Raquel; Casala, Carla; Galvan, Patricia; Rodriguez, Eva; Lavarino, Cinzia; Mora, Jaume; de Torres, Carmen			Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma	PLOS ONE			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; AUTOSOMAL-DOMINANT HYPOCALCEMIA; STOCHASTIC-EM ALGORITHM; CA2+-SENSING RECEPTOR; COLORECTAL-CANCER; COMMON VARIATION; COLON-CANCER; N-MYC; RISK	Background: Neuroblastic tumors include the neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Clinical behavior of these developmental malignancies varies from regression to aggressive growth with metastatic dissemination. Several clinical, histological, genetic, and biological features are associated with this diversity of clinical presentations. The calcium-sensing receptor (CaSR) is a G-protein coupled receptor with a key role in calcium homeostasis. We have previously reported that it is expressed in benign, differentiated neuroblastic tumors, but silenced by genetic and epigenetic events in unfavorable neuroblastomas. We have now analyzed three functionally relevant polymorphisms clustered at the signal transduction region of the CaSR (rs1801725, rs1042636 and rs1801726) to assess if genetic variants producing a less active receptor are associated with more aggressive disease course. Methods: Polymorphisms were analyzed in DNA samples from 65 patients using specific Taqman Genotyping Assays. Results: Mildly inactivating variant rs1801725 was associated with clinical stage 4 (P = 0.002) and the histological subgroup of undifferentiated neuroblastomas (P = 0.046). Patients harboring this polymorphism had significantly lower overall (P = 0.022) and event-free survival (P = 0.01) rates than those who were homozygous for the most common allele among Caucasians. However, this single locus genotype was not independently associated with outcome in multivariate analyses. Conversely, the tri-locus haplotype TAC was independently associated with an increased risk of death in the entire cohort (Hazard Ratio = 2.45; 95% Confidence Interval [1.14-5.29]; P=0.022) and also in patients diagnosed with neuroblastomas (Hazard Ratio = 2.74; 95% Confidence Interval [1.20-6.25]; P=0.016). Conclusions: The TAC haplotype includes the moderately inactivating variant rs1801725 and absence of the gain-of-function rs1042636 polymorphism. Thus, its association with metastatic disease and poor outcome would add to our previous data and further support that inactivation of the CaSR gene is a mechanism associated with neuroblastoma malignant behavior.	[Masvidal, Laia; Casala, Carla; Galvan, Patricia; Rodriguez, Eva; Lavarino, Cinzia; Mora, Jaume; de Torres, Carmen] Hosp St Joan de Deu, Dev Tumor Biol Lab, Barcelona, Spain; [Masvidal, Laia; Casala, Carla; Galvan, Patricia; Rodriguez, Eva; Lavarino, Cinzia; Mora, Jaume; de Torres, Carmen] Fundacio St Joan de Deu, Barcelona, Spain; [Iniesta, Raquel] Fundacio St Joan de Deu, Unitat Recerca & Desenvolupament, Barcelona, Spain	University of Barcelona	de Torres, C (corresponding author), Hosp St Joan de Deu, Dev Tumor Biol Lab, Barcelona, Spain.	cdetorres@hsjdbcn.org	Iniesta, Raquel/E-6127-2017	/0000-0003-1153-5417; Mora, Jaume/0000-0002-9386-5980; Galvan, Patricia/0000-0002-8153-0307	Fundacio Privada Cellex	Fundacio Privada Cellex	Fundacio Privada Cellex has supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacsi K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-317; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Capasso M, 2012, CARCINOGENE IN PRESS; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Casala C, 2013, CARCINOGENESIS, V34, P268, DOI 10.1093/carcin/bgs338; Chang WH, 2001, J BIOL CHEM, V276, P44129, DOI 10.1074/jbc.M104834200; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cole DEC, 1999, LANCET, V353, P112, DOI 10.1016/S0140-6736(98)06434-4; COX DR, 1972, J R STAT SOC B, V34, P187; de Torres C, 2009, CANCER-AM CANCER SOC, V115, P2792, DOI 10.1002/cncr.24304; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Dong LM, 2008, CANCER EPIDEM BIOMAR, V17, P2755, DOI 10.1158/1055-9965.EPI-08-0388; Fletcher JI, 2012, CANCER RES, V72, P845, DOI 10.1158/0008-5472.CAN-11-1885; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Garcia I, 2012, CLIN CANCER RES, V18, P2012, DOI 10.1158/1078-0432.CCR-11-2483; Heath H, 1996, J CLIN ENDOCR METAB, V81, P1312, DOI 10.1210/jcem.81.4.8636323; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Iniesta R, 2006, MONTE CARLO QUASIMON, P529; Jacobs ET, 2010, CARCINOGENESIS, V31, P1412, DOI 10.1093/carcin/bgq127; Jenab M, 2009, CANCER EPIDEM BIOMAR, V18, P2485, DOI 10.1158/1055-9965.EPI-09-0319; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Mantel N, 1996, CANC CHEMOTHER REP, V50, P163; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Miedlich S, 2001, EUR J ENDOCRINOL, V145, P421, DOI 10.1530/eje.0.1450421; Mora J, 2011, PEDIATR BLOOD CANCER, V57, P69, DOI 10.1002/pbc.22813; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Peters U, 2004, CANCER EPIDEM BIOMAR, V13, P2181; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Saidak Z, 2009, ENDOCR REV, V30, P178, DOI 10.1210/er.2008-0041; Schwartz GG, 2010, CANCER BIOL THER, V9, P994, DOI 10.4161/cbt.9.12.11689; Scillitani A, 2004, J CLIN ENDOCR METAB, V89, P5634, DOI 10.1210/jc.2004-0129; Scillitani A, 2007, J CLIN ENDOCR METAB, V92, P277, DOI 10.1210/jc.2006-0857; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stutterheim J, 2008, J CLIN ONCOL, V26, P5443, DOI 10.1200/JCO.2007.13.6531; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Yun FHJ, 2007, CLIN BIOCHEM, V40, P551, DOI 10.1016/j.clinbiochem.2006.12.011	54	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59762	10.1371/journal.pone.0059762	http://dx.doi.org/10.1371/journal.pone.0059762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533647	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400084
J	Rimoldi, V; Solda, G; Asselta, R; Spena, S; Stuani, C; Buratti, E; Duga, S				Rimoldi, Valeria; Solda, Giulia; Asselta, Rosanna; Spena, Silvia; Stuani, Cristiana; Buratti, Emanuele; Duga, Stefano			Dual Role of G-runs and hnRNP F in the Regulation of a Mutation-Activated Pseudoexon in the Fibrinogen Gamma-Chain Transcript	PLOS ONE			English	Article							EXONIC SPLICING ENHANCERS; MESSENGER-RNA; SR PROTEINS; DISEASE; GENE; MECHANISM; SEQUENCES; MULTIPLE; NONSENSE; SILENCER	Most pathological pseudoexon inclusion events originate from single activating mutations, suggesting that many intronic sequences are on the verge of becoming exons. However, the precise mechanisms controlling pseudoexon definition are still largely unexplored. Here, we investigated the cis-acting elements and trans-acting regulatory factors contributing to the regulation of a previously described fibrinogen gamma-chain (FGG) pseudoexon, which is activated by a deep-intronic mutation (IVS6-320A>T). This pseudoexon contains several G-run elements, which may be bound by heterogeneous nuclear ribonucleoproteins (hnRNPs) F and H. To explore the effect of these proteins on FGG pseudoexon inclusion, both silencing and overexpression experiments were performed in eukaryotic cells. While hnRNP H did not significantly affect pseudoexon splicing, hnRNP F promoted pseudoexon inclusion, indicating that these two proteins have only partially redundant functions. To verify the binding of hnRNP F and the possible involvement of other trans-acting splicing modulators, pulldown experiments were performed on the region of the pseudoexon characterized by both a G-run and enrichment for exonic splicing enhancers. This 25-bp-long region strongly binds hnRNP F/H and weakly interacts with Serine/Arginine-rich protein 40, which however was demonstrated to be dispensable for FGG pseudoexon inclusion in overexpression experiments. Deletion analysis, besides confirming the splicing-promoting role of the G-run within this 25-bp region, demonstrated that two additional hnRNP F binding sites might instead function as silencer elements. Taken together, our results indicate a major role of hnRNP F in regulating FGG pseudoexon inclusion, and strengthen the notion that G-runs may function either as splicing enhancers or silencers of the same exon.	[Rimoldi, Valeria; Solda, Giulia; Asselta, Rosanna; Spena, Silvia; Duga, Stefano] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Stuani, Cristiana; Buratti, Emanuele] ICGEB, Trieste, Italy	University of Milan; International Center for Genetic Engineering & Biotechnology (ICGEB)	Duga, S (corresponding author), Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy.	stefano.duga@unimi.it	Soldà, Giulia/AAG-3589-2020; Asselta, Rosanna/AAC-2367-2019; Duga, Stefano/F-8173-2014; Rimoldi, Valeria/AAB-4865-2020; Buratti, Emanuele/K-4691-2016; Solda', Giulia/A-4053-2011	Soldà, Giulia/0000-0003-0972-610X; Asselta, Rosanna/0000-0001-5351-0619; Duga, Stefano/0000-0003-3457-1410; Rimoldi, Valeria/0000-0002-5598-3986; Buratti, Emanuele/0000-0002-1356-9074; Solda', Giulia/0000-0003-0972-610X	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [2008RXFZ38_002]	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The financial support of PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale, Grant n. 2008RXFZ38_002) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Jensen CJ, 2009, BIOCHEM SOC T, V37, P1311, DOI 10.1042/BST0371311; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Mordes D, 2006, MOL VIS, V12, P1259; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Sevo M, 2004, J BACTERIOL, V186, P4903, DOI 10.1128/JB.186.15.4903-4909.2004; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Spena S, 2007, BRIT J HAEMATOL, V139, P128, DOI 10.1111/j.1365-2141.2007.06758.x; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Wang E, 2011, J BIOL CHEM, V286, P4059, DOI 10.1074/jbc.M110.199927; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Zhang XHF, 2005, GENOME RES, V15, P768, DOI 10.1101/gr.3217705; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59333	10.1371/journal.pone.0059333	http://dx.doi.org/10.1371/journal.pone.0059333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533617	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400054
J	Yang, F; Qian, XJ; Qin, W; Deng, R; Wu, XQ; Qin, J; Feng, GK; Zhu, XF				Yang, Fen; Qian, Xiao-Jun; Qin, Wei; Deng, Rong; Wu, Xiao-Qi; Qin, Juan; Feng, Gong-Kan; Zhu, Xiao-Feng			Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Has a Therapeutic Potential and Sensitizes Cisplatin in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PROGRESSION-FREE SURVIVAL; CANCER-CELLS; PI3K/MTOR INHIBITOR; CONCURRENT-CHEMOTHERAPY; INDUCED APOPTOSIS; PROTEIN-KINASE; ACTIVATES AKT; PHASE-III; C-MYC; PIK3CA	Phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells and thus has been considered as a promising drug target. To ascertain a therapeutical approach of nasopharyngeal carcinoma (NPC), we hypothesized NVP-BEZ235, a novel and potent imidazo[4,5-c] quinolone derivative, that dually inhibits both PI3K and mTOR kinases activities, had antitumor activity in NPC. Expectedly, we found that NVP-BEZ235 selectively inhibited proliferation of NPC cells rather than normal nasopharyngeal cells using MTT assay. In NPC cell lines, with the extended exposure, NVP-BEZ235 selectively inhibited proliferation of NPC cells harboring PIK3CA mutation, compared to cells with wild-type PIK3CA. Furthermore, exposure of NPC cells to NVP-BEZ235 resulted in G1 growth arrest by Propidium iodide uptake assay, reduction of cyclin D1and CDK4, and increased levels of P27 and P21 by Western blotting, but negligible apoptosis. Moreover, we found that cisplatin (CDDP) activated PI3K/AKT and mTORC1 pathways and NVP-BEZ235 alleviated the activation by CDDP through dually targeting PI3K and mTOR kinases. Also, NVP-BEZ235 combining with CDDP synergistically inhibited proliferation and induced apoptosis in NPC cells. In CNE2 and HONE1 nude mice xenograft models, orally NVP-BEZ235 efficiently attenuated tumor growth with no obvious toxicity. In combination with NVP-BEZ235 and CDDP, there was dramatic synergy in shrinking tumor volumes and inducing apoptosis through increasing Noxa, Bax and decreasing Mcl-1, Bcl-2. Based on the above results, NVP-BEZ235, which has entered phase I/II clinical trials in patients with advanced solid tumors, has a potential as a monotherapy or in combination with CDDP for NPC treatment.	[Yang, Fen; Qian, Xiao-Jun; Qin, Wei; Deng, Rong; Wu, Xiao-Qi; Qin, Juan; Feng, Gong-Kan; Zhu, Xiao-Feng] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Fen] Nanjing Med Univ, Dept Biochem & Mol Biol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Nanjing Medical University	Zhu, XF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn	Yang, Fen/AAE-8260-2021		Nature Science Foundation of China [81272895, 81001446]; Major Science and Technology Project of the National Basic Research Program (973 Program) of China [2012CB967004]; Natural Science Foundation of Guangdong in China [S2012010008761]; Foundation for Distinguished Young Scholars of Sun Yat-Sen University [10ykpy39]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project of the National Basic Research Program (973 Program) of China(National Basic Research Program of China); Natural Science Foundation of Guangdong in China; Foundation for Distinguished Young Scholars of Sun Yat-Sen University	This work was supported by grants from Nature Science Foundation of China (81272895, 81001446) (http://www.nsfc.gov.cn/Portal0/default166.htm), Major Science and Technology Project of the National Basic Research Program (973 Program) of China (2012CB967004), Natural Science Foundation of Guangdong in China (S2012010008761) and Foundation for Distinguished Young Scholars of Sun Yat-Sen University (Grant10ykpy39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; AU E, 1994, ANN ONCOL, V5, P87, DOI 10.1093/oxfordjournals.annonc.a058703; Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cai MB, 2012, INT J BIOL SCI, V8, P891, DOI 10.7150/ijbs.4383; Cao JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-237; Chan ATC, 2005, J NATL CANCER I, V97, P536, DOI 10.1093/jnci/dji084; Chan ATC, 2002, J CLIN ONCOL, V20, P2038, DOI 10.1200/JCO.2002.08.149; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen CY, 2009, BRIT J RADIOL, V82, P452, DOI 10.1259/bjr/72813246; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; Deng R, 2006, ONCOGENE, V25, P7070, DOI 10.1038/sj.onc.1209686; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Huang Pei-Yu, 2010, Chin J Cancer, V29, P131; Jiang HG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-34; Jin N, 2011, CLIN CANCER RES, V17, P6482, DOI 10.1158/1078-0432.CCR-11-0933; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Lee AW, J NATL CANC I, V102, P1188; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Li SS, 2008, CANCER BIOTHER RADI, V27, P88; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Liu Y, TUMOUR BIOL, V33, P241; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Or YY, 2005, INT J ONCOL, V26, P49; Or YYY, 2006, INT J CANCER, V118, P1065, DOI 10.1002/ijc.21444; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Sohn JH, 2008, BIOL PHARM BULL, V31, P273, DOI 10.1248/bpb.31.273; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003; Yip WK, 2008, ONCOL REP, V19, P319; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427; Zhao ZW, 2012, BIOCHEM J, V444, P291, DOI 10.1042/BJ20111855; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	50	45	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59879	10.1371/journal.pone.0059879	http://dx.doi.org/10.1371/journal.pone.0059879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533654	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400091
J	Buys, ES; Ko, YC; Alt, C; Hayton, SR; Jones, A; Tainsh, LT; Ren, RY; Giani, A; Clerte, M; Abernathy, E; Tainsh, RET; Oh, DJ; Malhotra, R; Arora, P; de Waard, N; Yu, BL; Turcotte, R; Nathan, D; Scherrer-Crosbie, M; Loomis, SJ; Kang, JH; Lin, CP; Gong, HY; Rhee, DJ; Brouckaert, P; Wiggs, JL; Gregory, MS; Pasquale, LR; Bloch, KD; Ksander, BR				Buys, Emmanuel S.; Ko, Yu-Chieh; Alt, Clemens; Hayton, Sarah R.; Jones, Alexander; Tainsh, Laurel T.; Ren, Ruiyi; Giani, Andrea; Clerte, Maeva; Abernathy, Emma; Tainsh, Robert E. T.; Oh, Dong-Jin; Malhotra, Rajeev; Arora, Pankaj; de Waard, Nadine; Yu, Binglan; Turcotte, Raphael; Nathan, Daniel; Scherrer-Crosbie, Marielle; Loomis, Stephanie J.; Kang, Jae H.; Lin, Charles P.; Gong, Haiyan; Rhee, Douglas J.; Brouckaert, Peter; Wiggs, Janey L.; Gregory, Meredith S.; Pasquale, Louis R.; Bloch, Kenneth D.; Ksander, Bruce R.			Soluble Guanylate Cyclase alpha(1)-Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OCULAR PERFUSION-PRESSURE; HUMOR OUTFLOW FACILITY; BLOOD-FLOW; INTRAOCULAR-PRESSURE; CLINICAL-TRIAL; HYPERTENSION; BRIMONIDINE; VARIANTS; SYSTEM	Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved in the pathogenesis of POAG remains unknown. Here, we report that mice lacking the alpha(1) subunit of the nitric oxide receptor soluble guanylate cyclase represent a novel and translatable animal model of POAG, characterized by thinning of the retinal nerve fiber layer and loss of optic nerve axons in the context of an open iridocorneal angle. The optic neuropathy associated with soluble guanylate cyclase alpha(1)-deficiency was accompanied by modestly increased intraocular pressure and retinal vascular dysfunction. Moreover, data from a candidate gene association study suggests that a variant in the locus containing the genes encoding for the alpha(1) and beta(1) subunits of soluble guanylate cyclase is associated with POAG in patients presenting with initial paracentral vision loss, a disease subtype thought to be associated with vascular dysregulation. These findings provide new insights into the pathogenesis and genetics of POAG and suggest new therapeutic strategies for POAG.	[Buys, Emmanuel S.; Hayton, Sarah R.; Tainsh, Laurel T.; Tainsh, Robert E. T.; Yu, Binglan; Nathan, Daniel; Bloch, Kenneth D.] Harvard Univ, Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Dept Anesthesia Crit Care & Pain Med,Med Sch, Boston, MA 02215 USA; [Ko, Yu-Chieh; Jones, Alexander; Abernathy, Emma; de Waard, Nadine; Gregory, Meredith S.; Pasquale, Louis R.; Ksander, Bruce R.] Harvard Univ, Schepens Eye Res Inst, Dept Ophthalmol, Sch Med, Boston, MA USA; [Ko, Yu-Chieh] Natl Yang Ming Univ, Sch Med, Dept Ophthalmol, Taipei 112, Taiwan; [Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Ren, Ruiyi; Gong, Haiyan] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Giani, Andrea; Oh, Dong-Jin; Loomis, Stephanie J.; Rhee, Douglas J.; Wiggs, Janey L.; Gregory, Meredith S.; Pasquale, Louis R.; Ksander, Bruce R.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Clerte, Maeva; Malhotra, Rajeev; Arora, Pankaj; Scherrer-Crosbie, Marielle; Bloch, Kenneth D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiol Div,Dept Med, Boston, MA USA; [Turcotte, Raphael] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kang, Jae H.; Pasquale, Louis R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Brouckaert, Peter] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Schepens Eye Research Institute; National Yang Ming Chiao Tung University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Flanders Institute for Biotechnology (VIB); Ghent University	Buys, ES (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Dept Anesthesia Crit Care & Pain Med,Med Sch, Boston, MA 02215 USA.	Ebuys@partners.org	Gregory-Ksander, Meredith/AAG-1413-2019; Arora, Pankaj/F-3437-2011; Giani, Andrea/L-5926-2017	Gregory-Ksander, Meredith/0000-0002-7193-0032; Arora, Pankaj/0000-0003-2420-3550; Gong, Haiyan/0000-0002-7204-5019; Malhotra, Rajeev/0000-0003-0120-4630; Giani, Andrea/0000-0003-0682-1945; Turcotte, Raphael/0000-0002-2257-4190	Harvard Catalyst-the Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Harvard University; Shaffer Fund Grant from the Glaucoma Research Foundation; NEI [R21 EY020987, R01 EY022746-01, R01 EY015872, R01 EY015473]; American Heart Association Fellow-to-Faculty Transition Award [11FTF7290032]; NCRR [1S10RR022586]; NIH [CA87969, CA49449, EY09611, CA055075]; Massachusetts Lions Eye Research Fund; FWO-Flanders fund; UGent-GOA fund; Harvard Glaucoma Center of Excellence; Harvard Ophthalmology Scholar award; Physician-Scientist award from Research to Prevent Blindness in NYC; Allergan Horizon grant; NHGRI [5U01HG004728]; NATIONAL CANCER INSTITUTE [R01CA049449, P01CA087969, U01CA049449] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022586, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009611, R21EY018712, R01EY022746, R01EY015872, R01EY015473, P30EY014104, R21EY022766, R21EY020987, R01EY022634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728] Funding Source: NIH RePORTER	Harvard Catalyst-the Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; Shaffer Fund Grant from the Glaucoma Research Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Heart Association Fellow-to-Faculty Transition Award(American Heart Association); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; FWO-Flanders fund; UGent-GOA fund; Harvard Glaucoma Center of Excellence; Harvard Ophthalmology Scholar award; Physician-Scientist award from Research to Prevent Blindness in NYC; Allergan Horizon grant; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was conducted with support from Harvard Catalyst-the Harvard Clinical and Translational Science Center (NIH Award #UL1 RR 025758, and financial contributions from Harvard University and its affiliated academic health care centers) (ESB, BRK); a Shaffer Fund Grant from the Glaucoma Research Foundation (ESB); NEI R21 EY020987 (ESB, BRK); NEI R01 EY022746-01 (ESB); an American Heart Association Fellow-to-Faculty Transition Award #11FTF7290032 (RM); NCRR 1S10RR022586 (MSC); NIH CA87969, CA49449, EY09611, CA055075 (JHK); the Massachusetts Lions Eye Research Fund (HG, RR); the FWO-Flanders and UGent-GOA funds (PB); NEI R01 EY015872 (JLW); the Harvard Glaucoma Center of Excellence (LRP and JLW); a Harvard Ophthalmology Scholar award (LRP); a Physician-Scientist award from Research to Prevent Blindness in NYC (LRP); an Allergan Horizon grant (LRP); NEI R01 EY015473 (LRP); and NHGRI 5U01HG004728 (LRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P1581, DOI 10.1167/iovs.02-0759; Alt C, 2012, PROC SPIE, V8209, DOI 10.1117/12.909141; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Atochin DN, 2010, STROKE, V41, P1815, DOI 10.1161/STROKEAHA.109.577635; Avila MY, 2003, INVEST OPHTH VIS SCI, V44, P722, DOI 10.1167/iovs.02-0386; Blute TA, 1998, VISUAL NEUROSCI, V15, P485; Brown AS, 2005, CURR EYE RES, V30, P45, DOI 10.1080/02713680490894315; Burdon KP, 2012, CLIN EXP OPHTHALMOL, V40, P358, DOI 10.1111/j.1442-9071.2011.02744.x; Buys ES, 2008, CARDIOVASC RES, V79, P179, DOI 10.1093/cvr/cvn068; Buys ES, 2012, J CLIN INVEST, V122, P2316, DOI 10.1172/JCI60119; Chang CJ, 2000, J OCUL PHARMACOL TH, V16, P399, DOI 10.1089/jop.2000.16.399; Chen J, 2011, CLIN OPHTHALMOL, V5, P667, DOI 10.2147/OPTH.S15971; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; da Silva TM, 2012, GENE, V502, P142, DOI 10.1016/j.gene.2012.04.047; Dai Y, 2009, INVEST OPHTH VIS SCI, V50, P5749, DOI 10.1167/iovs.08-3367; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellis DZ, 2010, INVEST OPHTH VIS SCI, V51, P5817, DOI 10.1167/iovs.09-5072; Ellis DZ, 2009, INVEST OPHTH VIS SCI, V50, P1808, DOI 10.1167/iovs.08-2750; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; Feke GT, 2011, J OCUL PHARMACOL TH, V27, P347, DOI 10.1089/jop.2011.0014; Fernandez-Durango R, 2008, INVEST OPHTH VIS SCI, V49, P2506, DOI 10.1167/iovs.07-1363; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Galassi F, 2004, BRIT J OPHTHALMOL, V88, P757, DOI 10.1136/bjo.2003.028357; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Haberecht MF, 1998, VISUAL NEUROSCI, V15, P881, DOI 10.1017/S0952523898155104; Haddadin RI, 2009, INVEST OPHTH VIS SCI, V50, P3771, DOI 10.1167/iovs.08-2489; Henry E, 1999, INVEST OPHTH VIS SCI, V40, P1710; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kajimura M, 2003, FASEB J, V17, P506, DOI 10.1096/fj.02-0359fje; Kang JH, 2010, INVEST OPHTH VIS SCI, V51, P971, DOI 10.1167/iovs.09-4266; Kass MA, 2010, ARCH OPHTHALMOL-CHIC, V128, P276, DOI 10.1001/archophthalmol.2010.20; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khoobehi B, 2011, J OCUL PHARMACOL TH, V27, P115, DOI 10.1089/jop.2010.0150; Konstas AGP, 2012, J OCUL PHARMACOL TH, V28, P26, DOI 10.1089/jop.2011.0081; Kotikoski H, 2003, CURR EYE RES, V26, P119, DOI 10.1076/ceyr.26.2.119.14511; Krauss AHP, 2011, EXP EYE RES, V93, P250, DOI 10.1016/j.exer.2011.03.001; KRUG J, 1995, AM J OPHTHALMOL, V120, P718; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P1841, DOI 10.1167/iovs.03-1008; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Marini M, 2011, EUR J OPHTHALMOL, V21, P258, DOI 10.5301/EJO.2010.5767; McKie Paul M, 2010, Curr Heart Fail Rep, V7, P93, DOI 10.1007/s11897-010-0016-6; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; NATHANSON JA, 1992, J PHARMACOL EXP THER, V260, P956; NATHANSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1774; NATHANSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1765; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Nimmegeers S, 2007, CARDIOVASC RES, V76, P149, DOI 10.1016/j.cardiores.2007.06.002; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Pasquale LR, 2012, EXPERT REV OPHTHALMO, V7, P295, DOI 10.1586/EOP.12.36; Polak K, 2007, ARCH OPHTHALMOL-CHIC, V125, P494, DOI 10.1001/archopht.125.4.494; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; REILLY PM, 1993, CRIT CARE MED, V21, pS55, DOI 10.1097/00003246-199302001-00011; Rosa RH, 2006, AM J PHYSIOL-HEART C, V291, pH231, DOI 10.1152/ajpheart.01281.2005; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Sandbach JM, 2001, INVEST OPHTH VIS SCI, V42, P2173; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Vajaranant TS, 2012, MENOPAUSE, V19, P942, DOI 10.1097/gme.0b013e3182443137; Weinreb RN, 2005, J GLAUCOMA, V14, P302, DOI 10.1097/01.ijg.0000169395.47921.02; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2009, INVEST OPHTH VIS SCI, V50, P1497, DOI 10.1167/iovs.08-2843; Weiss J, 2012, MOL VIS, V18, P2174; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Wiggs JL, 2012, J GLAUCOMA; Wu RY, 2012, CHINESE MED J-PEKING, V125, P129, DOI 10.3760/cma.j.issn.0366-6999.2012.01.024; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	82	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60156	10.1371/journal.pone.0060156	http://dx.doi.org/10.1371/journal.pone.0060156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527308	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600124
J	Frischknecht, M; Niehof-Oellers, H; Jagannathan, V; Owczarek-Lipska, M; Drogemuller, C; Dietschi, E; Dolf, G; Tellhelm, B; Lang, J; Tiira, K; Lohi, H; Leeb, T				Frischknecht, Mirjam; Niehof-Oellers, Helena; Jagannathan, Vidhya; Owczarek-Lipska, Marta; Droegemueller, Cord; Dietschi, Elisabeth; Dolf, Gaudenz; Tellhelm, Bernd; Lang, Johann; Tiira, Katriina; Lohi, Hannes; Leeb, Tosso			A COL11A2 Mutation in Labrador Retrievers with Mild Disproportionate Dwarfism	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; GENOME; GENE; CHONDRODYSPLASIA; ASSOCIATION; VARIANTS; DOMINANT; GROWTH; LOCUS	We describe a mild form of disproportionate dwarfism in Labrador Retrievers, which is not associated with any obvious health problems such as secondary arthrosis. We designate this phenotype as skeletal dysplasia 2 (SD2). It is inherited as a monogenic autosomal recessive trait with incomplete penetrance primarily in working lines of the Labrador Retriever breed. Using 23 cases and 37 controls we mapped the causative mutation by genome-wide association and homozygosity mapping to a 4.44 Mb interval on chromosome 12. We re-sequenced the genome of one affected dog at 30x coverage and detected 92 non-synonymous variants in the critical interval. Only two of these variants, located in the lymphotoxin A (LTA) and collagen alpha-2(XI) chain gene (COL11A2), respectively, were perfectly associated with the trait. Previously described COL11A2 variants in humans or mice lead to skeletal dysplasias and/or deafness. The dog variant associated with disproportionate dwarfism, COL11A2:c.143G>C or p.R48P, probably has only a minor effect on collagen XI function, which might explain the comparatively mild phenotype seen in our study. The identification of this candidate causative mutation thus widens the known phenotypic spectrum of COL11A2 mutations. We speculate that non-pathogenic COL11A2 variants might even contribute to the heritable variation in height.	[Frischknecht, Mirjam; Jagannathan, Vidhya; Owczarek-Lipska, Marta; Droegemueller, Cord; Dietschi, Elisabeth; Dolf, Gaudenz; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Tellhelm, Bernd] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, D-35390 Giessen, Germany; [Lang, Johann] Univ Bern, Dept Clin Vet Med, Div Clin Radiol, Vetsuisse Fac, Bern, Switzerland; [Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland	University of Bern; Justus Liebig University Giessen; University of Bern; University of Helsinki; University of Helsinki; University of Helsinki	Leeb, T (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019; Lohi, Hannes/F-4596-2011; Leeb, Tosso/G-3187-2014; Tiira, Katriina/U-4035-2018	Jagannathan, Vidhya/0000-0002-8155-0041; Lohi, Hannes/0000-0003-1087-5532; Leeb, Tosso/0000-0003-0553-4880; Tiira, Katriina/0000-0002-2253-8755; Drogemuller, Cord/0000-0001-9773-522X; Lang, Johann/0000-0003-3869-8224	Albert-Heim Foundation; European Commission (LUPA) [GA-201370]; Academy of Finland	Albert-Heim Foundation; European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland)	This work was funded in part by grants from the Albert-Heim Foundation, the European Commission (LUPA, GA-201370), and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alanay Y, 2011, J CLIN RES PEDIATR E, V3, P163, DOI 10.4274/jcrpe.463; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; Chen W, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032615; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Goldstein O, 2010, MAMM GENOME, V21, P398, DOI 10.1007/s00335-010-9276-4; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Owczarek-Lipska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039176; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Pihlajamaa T, 1998, AM J MED GENET, V80, P115, DOI 10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Smit JJ, 2011, VET J, V187, P269, DOI 10.1016/j.tvjl.2009.11.009; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tompson SW, 2012, AM J MED GENET A, V158A, P309, DOI 10.1002/ajmg.a.34406; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	35	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60149	10.1371/journal.pone.0060149	http://dx.doi.org/10.1371/journal.pone.0060149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527306	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600123
J	Sanchez, E; Frances, R; Soriano, G; Mirelis, B; Sancho, FJ; Gonzalez-Navajas, JM; Munoz, C; Song, XY; Perez-Mateo, M; Such, J; Guarner, C				Sanchez, Elisabet; Frances, Ruben; Soriano, German; Mirelis, Beatriz; Sancho, Francesc J.; Manuel Gonzalez-Navajas, Jose; Munoz, Carlos; Song, Xiao-yu; Perez-Mateo, Miguel; Such, Jose; Guarner, Carlos			Modulation of Inflammatory Response in a Cirrhotic Rat Model with Induced Bacterial Peritonitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; RENAL IMPAIRMENT; FACTOR-ALPHA; IMMUNE-RESPONSE; ASCITES; INTERLEUKIN-6; OVERPRODUCTION; TRANSLOCATION; MACROPHAGES	Bacterial peritonitis is a severe complication in patients with cirrhosis and ascites and despite antibiotic treatment, the inflammatory response to infection may induce renal dysfunction leading to death. This investigation evaluated the effect of TNF-alpha blockade on the inflammatory response and mortality in cirrhotic rats with induced bacterial peritonitis treated or not with antibiotics. Sprague-Dawley rats with carbon-tetrachloride-induced cirrhosis were treated with an intraperitoneal injection of 10(9) CFU of Escherichia coli diluted in 20 mL of sterile water to induce bacterial peritonitis and randomized to receive subcutaneously-administered placebo, ceftriaxone, anti-TNF-alpha mAb and ceftriaxone, or anti-TNF-alpha mAb alone. No differences were observed between groups at baseline in respect to renal function, liver hepatic tests, serum levels of nitrite/nitrate and TNF-alpha. Treatment with ceftriaxone reduced mortality (73.3%) but differences did not reach statistical significance as compared to placebo. Mortality in rats treated with ceftriaxone and anti-TNF-alpha mAb was significantly lower than in animals receiving placebo (53% vs. 100%, p<0.01). Serum TNF-alpha decreased significantly in surviving rats treated with ceftriaxone plus anti-TNF-alpha mAb but not in treated with antibiotics alone. Additional studies including more animals are required to assess if the association of antibiotic therapy and TNF-alpha blockade might be a possible approach to reduce mortality in cirrhotic patients with bacterial peritonitis.	[Sanchez, Elisabet; Soriano, German; Guarner, Carlos] Hosp Santa Creu & Sant Pau, Liver Sect, Dept Gastroenterol, Barcelona, Spain; [Sanchez, Elisabet; Frances, Ruben; Soriano, German; Manuel Gonzalez-Navajas, Jose; Such, Jose; Guarner, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Madrid, Spain; [Sanchez, Elisabet; Soriano, German; Guarner, Carlos] Inst Invest Biomed St Pau IIB, Barcelona, Spain; [Sanchez, Elisabet; Soriano, German; Mirelis, Beatriz; Guarner, Carlos] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Mirelis, Beatriz] Hosp Santa Creu & Sant Pau, Dept Microbiol, Barcelona, Spain; [Sancho, Francesc J.; Perez-Mateo, Miguel] Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona, Spain; [Frances, Ruben; Manuel Gonzalez-Navajas, Jose; Such, Jose] Univ Miguel Hernandez, Unidad Hepat, Hosp Gen Univ, Alicante, Spain; [Munoz, Carlos] Univ Miguel Hernandez, Dept Microbiol, Hosp Gen Univ, Alicante, Spain; [Song, Xiao-yu] Res & Dev Centocor, Malvern, PA USA	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Johnson & Johnson; Johnson & Johnson USA	Guarner, C (corresponding author), Hosp Santa Creu & Sant Pau, Liver Sect, Dept Gastroenterol, Barcelona, Spain.	cguarner@santpau.cat	González-Navajas, Jose Manuel/AAB-1575-2019; Sánchez, Elisabet/O-5383-2015; Frances, Ruben/V-4120-2019	González-Navajas, Jose Manuel/0000-0002-1591-939X; Sánchez, Elisabet/0000-0002-3280-9301; Frances, Ruben/0000-0001-5105-1201; Soriano, German/0000-0002-9267-6811; Guarner, Carlos/0000-0001-5957-9481	Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, CIBERehd (Madrid, Spain); Generalitat de Catalunya (AGAUR) [2005SGR01085]; Fondo de Investigaciones Sanitarias (FIS) [PI08-0262]; Fundacion de Investigacion del Hospital General Universitario de Alicante; Centocor (Malvern, PA, USA)	Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, CIBERehd (Madrid, Spain); Generalitat de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fundacion de Investigacion del Hospital General Universitario de Alicante; Centocor (Malvern, PA, USA)	CIBERehd is funded by the Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, CIBERehd (Madrid, Spain). We thank Carolyn Newey for English language revision.; This study was partially funded by unrestricted grants from the Generalitat de Catalunya (AGAUR) (2005SGR01085), Fondo de Investigaciones Sanitarias (FIS) PI08-0262 and from the Fundacion de Investigacion del Hospital General Universitario de Alicante. Centocor (Malvern, PA, USA) also provided funding to conduct this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bories PN, 1997, HEPATOLOGY, V25, P1328, DOI 10.1002/hep.510250604; BYL B, 1993, GASTROENTEROLOGY, V104, P1492, DOI 10.1016/0016-5085(93)90361-F; FELISART J, 1985, HEPATOLOGY, V5, P457, DOI 10.1002/hep.1840050319; FOLLO A, 1994, HEPATOLOGY, V20, P1495, DOI 10.1002/hep.1840200619; Frances R, 2004, GUT, V53, P860, DOI 10.1136/gut.2003.027425; Frances R, 2008, HEPATOLOGY, V47, P978, DOI 10.1002/hep.22083; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Garcia-Tsao G, 1998, HEPATOLOGY, V28, P17, DOI 10.1002/hep.510280104; Genesca J, 1999, AM J GASTROENTEROL, V94, P169; Guarner C, 1995, Gastroenterologist, V3, P311; LOPEZTALAVERA JC, 1995, GASTROENTEROLOGY, V108, P761, DOI 10.1016/0016-5085(95)90449-2; Marques LJ, 1999, AM J RESP CRIT CARE, V159, P508, DOI 10.1164/ajrccm.159.2.9804085; Navasa M, 1998, HEPATOLOGY, V27, P1227, DOI 10.1002/hep.510270507; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Runyon BA, 2004, HEPATOLOGY, V39, P841, DOI 10.1002/hep.20066; RUNYON BA, 1994, J HEPATOL, V21, P792, DOI 10.1016/S0168-8278(94)80241-6; RUNYON BA, 1991, GASTROENTEROLOGY, V100, P489, DOI 10.1016/0016-5085(91)90221-6; Sanchez E, 2007, AM J GASTROENTEROL, V102, P1230, DOI 10.1111/j.1572-0241.2007.01182.x; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Such J, 2004, EUR J GASTROEN HEPAT, V16, P571, DOI 10.1097/00042737-200406000-00010; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461	23	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59692	10.1371/journal.pone.0059692	http://dx.doi.org/10.1371/journal.pone.0059692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527251	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600089
J	Scocchia, L; Valsecchi, M; Gegenfurtner, KR; Triesch, J				Scocchia, Lisa; Valsecchi, Matteo; Gegenfurtner, Karl R.; Triesch, Jochen			Visual Working Memory Contents Bias Ambiguous Structure from Motion Perception	PLOS ONE			English	Article							TOP-DOWN; BINOCULAR-RIVALRY; VOLUNTARY CONTROL; NEURAL BASIS; ATTENTION; CORTEX; REVERSAL; ALTERNATIONS; INTENTION; SATIATION	The way we perceive the visual world depends crucially on the state of the observer. In the present study we show that what we are holding in working memory (WM) can bias the way we perceive ambiguous structure from motion stimuli. Holding in memory the percept of an unambiguously rotating sphere influenced the perceived direction of motion of an ambiguously rotating sphere presented shortly thereafter. In particular, we found a systematic difference between congruent dominance periods where the perceived direction of the ambiguous stimulus corresponded to the direction of the unambiguous one and incongruent dominance periods. Congruent dominance periods were more frequent when participants memorized the speed of the unambiguous sphere for delayed discrimination than when they performed an immediate judgment on a change in its speed. The analysis of dominance time-course showed that a sustained tendency to perceive the same direction of motion as the prior stimulus emerged only in the WM condition, whereas in the attention condition perceptual dominance dropped to chance levels at the end of the trial. The results are explained in terms of a direct involvement of early visual areas in the active representation of visual motion in WM.	[Scocchia, Lisa; Triesch, Jochen] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Scocchia, Lisa; Valsecchi, Matteo; Gegenfurtner, Karl R.] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany; [Scocchia, Lisa] Univ Milano Bicocca, Dept Psychol, Milan, Italy	Goethe University Frankfurt; Justus Liebig University Giessen; University of Milano-Bicocca	Scocchia, L (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany.	scocchia@fias.uni-frankfurt.de	Valsecchi, Matteo/M-3233-2019; valsecchi, matteo/A-3938-2010	Gegenfurtner, Karl/0000-0001-5390-0684	Johanna Quandt Foundation; Alexander von Humboldt Foundation	Johanna Quandt Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	LS and JT have been supported by the Johanna Quandt Foundation, MV has been supported by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2002, Q J EXP PSYCHOL-A, V55, P753, DOI 10.1080/02724980143000541; ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Balcetis E, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P109; Balcetis E, 2006, J PERS SOC PSYCHOL, V91, P612, DOI 10.1037/0022-3514.91.4.612; BEECH JR, 1978, PERCEPTION, V7, P129, DOI 10.1068/p070129; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Britz J, 2009, CEREB CORTEX, V19, P55, DOI 10.1093/cercor/bhn056; BUGELSKI BR, 1961, CAN J PSYCHOLOGY, V15, P205, DOI 10.1037/h0083443; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CARLSON VR, 1953, J EXP PSYCHOL, V45, P442, DOI 10.1037/h0054794; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Cocude, 1989, EUR J COGN PSYCHOL, V1, P293, DOI DOI 10.1080/09541448908403090; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Downing PE, 2004, VIS COGN, V11, P689, DOI 10.1080/13506280344000446; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; EPSTEIN W, 1960, AM J PSYCHOL, V73, P214, DOI 10.2307/1419898; GIRGUS JJ, 1977, PERCEPT PSYCHOPHYS, V22, P550, DOI 10.3758/BF03198762; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; HOCHBERG JE, 1950, J EXP PSYCHOL, V40, P682, DOI 10.1037/h0060078; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; HORLITZ KL, 1993, PERCEPT PSYCHOPHYS, V53, P668, DOI 10.3758/BF03211743; Jonides J, 1998, J NEUROSCI, V18, P5026; Kalarickal GJ, 2000, NEUROCOMPUTING, V32, P843, DOI 10.1016/S0925-2312(00)00252-6; Kanai R, 2005, VISION RES, V45, P3109, DOI 10.1016/j.visres.2005.05.014; Kang MS, 2011, PSYCHON B REV, V18, P860, DOI 10.3758/s13423-011-0126-5; Kang MS, 2010, ATTEN PERCEPT PSYCHO, V72, P179, DOI 10.3758/APP.72.1.179; Kohler A, 2008, VISION RES, V48, P1096, DOI 10.1016/j.visres.2007.11.020; KOSSLYN SM, 1973, PERCEPT PSYCHOPHYS, V14, P90, DOI 10.3758/BF03198621; Lack L.C., 1978, SELECTIVE ATTENTION; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LIEBERT RM, 1985, PERCEPT MOTOR SKILL, V61, P1307, DOI 10.2466/pms.1985.61.3f.1307; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Long GM, 2004, PSYCHOL BULL, V130, P748, DOI 10.1037/0033-2909.130.5.748; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mendoza D, 2011, J VISION, V11, DOI 10.1167/11.1.11; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; ORBACH J, 1963, Percept Mot Skills, V17, P439; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; PELTON LH, 1968, AM J PSYCHOL, V81, P585, DOI 10.2307/1421064; PETERSON MA, 1986, J EXP PSYCHOL HUMAN, V12, P50, DOI 10.1037/0096-1523.12.1.50; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Raemaekers M, 2009, BRAIN RES, V1252, P161, DOI 10.1016/j.brainres.2008.11.078; REISBERG D, 1984, PERCEPTION, V13, P461, DOI 10.1068/p130461; Robinson A, 2008, J VISION, V8, DOI 10.1167/8.16.7; ROCK I, 1992, PERCEPTION, V21, P39, DOI 10.1068/p210039; ROCK I, 1994, ACTA PSYCHOL, V87, P33, DOI 10.1016/0001-6918(94)90065-5; Scocchia L, 2013, VISION RES, V78, P46, DOI 10.1016/j.visres.2012.12.003; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Soto D, 2005, J EXP PSYCHOL HUMAN, V31, P248, DOI 10.1037/0096-1523.31.2.248; Soto D, 2010, J EXP PSYCHOL LEARN, V36, P441, DOI 10.1037/a0018686; Sterzer P, 2008, J COGNITIVE NEUROSCI, V20, P389, DOI 10.1162/jocn.2008.20039; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Struber D, 1999, PERCEPTION, V28, P1185, DOI 10.1068/p2973; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Suzuki S, 2000, PSYCHOL SCI, V11, P202, DOI 10.1111/1467-9280.00242; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Toppino TC, 2003, PERCEPT PSYCHOPHYS, V65, P1285, DOI 10.3758/BF03194852; Turatto M, 2008, J VISION, V8, DOI 10.1167/8.5.11; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363	78	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59217	10.1371/journal.pone.0059217	http://dx.doi.org/10.1371/journal.pone.0059217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527141	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100094
J	Suzuki, N; Nawa, D; Su, TH; Lin, CW; Khoo, KH; Yamamoto, K				Suzuki, Noriko; Nawa, Daisuke; Su, Tseng-Hsiung; Lin, Chia-Wei; Khoo, Kay-Hooi; Yamamoto, Kazuo			Distribution of the Gal beta 1-4Gal Epitope among Birds: Species-Specific Loss of the Glycan Structure in Chicken and Its Relatives	PLOS ONE			English	Article							N-GLYCOLYLNEURAMINIC ACID; ASPARAGINE-LINKED OLIGOSACCHARIDES; TANDEM MASS-SPECTROMETRY; PIGEON EGG-WHITE; MAJOR GLYCOPROTEINS; EVOLUTION; GAL-ALPHA-1-4GAL; EXPRESSION; YOLK; PHYLOGENY	The Gal beta 1-4Gal epitope is rarely found in mammals, and the natural antibody against Gal beta 1-4Gal is rich in human. In contrast, we have previously demonstrated the presence of Gal beta 1-4Gal in pigeon and ostrich, and the absence of this epitope in chicken. Here, to further investigate the expression of this glycan among birds, egg white glycoproteins and egg yolk IgG from nine species of birds, namely, chicken, duck, emu, guineafowl, ostrich, peafowl, pigeon, quail, and turkey, were analyzed by western blot using an anti-(Gal beta 1-4Gal) antibody. The results indicated that some egg white glycoproteins from emu, ostrich, and quail, and heavy chains of IgG from all of the birds, except chicken and quail, were stained with the antibody. The presence of Gal beta 1-4Gal on N-glycans of IgGs from guineafowl, peafowl, and turkey were confirmed by mass spectrometry (MS), MS/MS, and MSn analyses. In quail, the presence of Gal beta 1-4Gal was confirmed by detecting the activities of UDP-galactose: beta-galactoside beta 1,4-galactosyltransferase (beta 4GalT(Gal)) in various tissues, and by detecting Gal beta 1-4Gal by western blotting. In contrast, bamboo partridge, which is a close relative of chicken, did not show any detectable activities of beta 4GalT(Gal) or Gal beta 1-4Gal on glycoproteins. Because quail, peafowl, turkey, chicken, and bamboo partridge belong to the same family, i.e., Phasianidae, expression of Gal beta 1-4Gal was most likely differentiated within this family. Considering that Gal beta 1-4Gal is also expressed in ostrich, emu, and pigeon, which are phylogenetically distant relatives within modern birds, Gal beta 1-4Gal expression appears to be widely distributed among birds, but might have been abolished in the ancestors of chicken and bamboo partridge.	[Suzuki, Noriko; Nawa, Daisuke; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Su, Tseng-Hsiung; Lin, Chia-Wei; Khoo, Kay-Hooi] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	University of Tokyo; National Taiwan University; Academia Sinica - Taiwan	Suzuki, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	nrsuzuki@k.u-tokyo.ac.jp	Lin, Chia-wei/ABA-6065-2021; Khoo, Kay-Hooi/E-1989-2019	Lin, Chia-wei/0000-0003-4777-2916; Khoo, Kay-Hooi/0000-0003-2906-406X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18770081]; Hamaguchi Foundation for the Advancement of Biochemistry; Academia Sinica;  [NSC97-3112-B-001-018]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Academia Sinica(Academia Sinica - Taiwan); 	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (18770081, to NS), the Hamaguchi Foundation for the Advancement of Biochemistry (to NS), and Academia Sinica (to KHK). The MALDI-MS and MS/MS data were acquired at the NRPGM Core Facilities for Proteomics and Glycomics supported by Grant NSC97-3112-B-001-018. The nanoESI-MSn data were acquired on the LTQ-Orbitrap at the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonilla AJ, 2010, MOL PHYLOGENET EVOL, V56, P536, DOI 10.1016/j.ympev.2010.04.006; Bouhours D, 2000, GLYCOBIOLOGY, V10, P857, DOI 10.1093/glycob/10.9.857; Chen HS, 2008, FEBS J, V275, P3944, DOI 10.1111/j.1742-4658.2008.06540.x; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Dimcheff DE, 2002, MOL PHYLOGENET EVOL, V24, P203, DOI 10.1016/S1055-7903(02)00230-0; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HASE S, 1986, J BIOCHEM-TOKYO, V99, P1725, DOI 10.1093/oxfordjournals.jbchem.a135649; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; Kimball Rebecca T., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/423938; Kimball RT, 1999, MOL PHYLOGENET EVOL, V11, P38, DOI 10.1006/mpev.1998.0562; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEMOINE J, 1991, CARBOHYD RES, V221, P209, DOI 10.1016/0008-6215(91)80057-T; MATSUURA F, 1993, GLYCOCONJUGATE J, V10, P202, DOI 10.1007/BF00702201; Mindell David P., 1997, P213, DOI 10.1016/B978-012498315-1/50014-5; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; Prien JM, 2008, GLYCOBIOLOGY, V18, P353, DOI 10.1093/glycob/cwn010; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P111, DOI 10.1159/000078570; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Suzuki N, 2006, BBA-GEN SUBJECTS, V1760, P538, DOI 10.1016/j.bbagen.2005.10.005; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Suzuki N, 2003, J BIOL CHEM, V278, P46293, DOI 10.1074/jbc.M307132200; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Suzuki N, 2013, GLYCOBIOLOGY, V23, P91, DOI 10.1093/glycob/cws129; Suzuki N, 2011, GLYCOBIOLOGY, V21, P283, DOI 10.1093/glycob/cwq163; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Welsh RM, 1998, J VIROL, V72, P4650, DOI 10.1128/JVI.72.6.4650-4656.1998; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; Yu SY, 2008, GLYCOCONJUGATE J, V25, P199, DOI 10.1007/s10719-007-9071-y; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59291	10.1371/journal.pone.0059291	http://dx.doi.org/10.1371/journal.pone.0059291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527153	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100100
J	Yan, Y; Hong, N; Chen, TS; Li, MY; Wang, TS; Guan, GJ; Qiao, YK; Chen, SL; Schartl, M; Li, CM; Hong, YH				Yan, Yan; Hong, Ni; Chen, Tiansheng; Li, Mingyou; Wang, Tiansu; Guan, Guijun; Qiao, Yongkang; Chen, Songlin; Schartl, Manfred; Li, Chang-Ming; Hong, Yunhan			p53 Gene Targeting by Homologous Recombination in Fish ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MEDAKAFISH ORYZIAS-LATIPES; CHIMERA FORMATION; DRUG SELECTION; IN-VITRO; ZEBRAFISH; DIFFERENTIATION; CULTURES; PLURIPOTENCY; MOUSE	Background: Gene targeting (GT) provides a powerful tool for the generation of precise genetic alterations in embryonic stem (ES) cells to elucidate gene function and create animal models for human diseases. This technology has, however, been limited to mouse and rat. We have previously established ES cell lines and procedures for gene transfer and selection for homologous recombination (HR) events in the fish medaka (Oryzias latipes). Methodology and Principal Findings: Here we report HR-mediated GT in this organism. We designed a GT vector to disrupt the tumor suppressor gene p53 (also known as tp53). We show that all the three medaka ES cell lines, MES1 similar to MES3, are highly proficient for HR, as they produced detectable HR without drug selection. Furthermore, the positive-negative selection (PNS) procedure enhanced HR by similar to 12 folds. Out of 39 PNS-resistant colonies analyzed, 19 (48.7%) were positive for GT by PCR genotyping. When 11 of the PCR-positive colonies were further analyzed, 6 (54.5%) were found to be bona fide homologous recombinants by Southern blot analysis, sequencing and fluorescent in situ hybridization. This produces a high efficiency of up to 26.6% for p53 GT under PNS conditions. We show that p53 disruption and long-term propagation under drug selection conditions do not compromise the pluripotency, as p53-targeted ES cells retained stable growth, undifferentiated phenotype, pluripotency gene expression profile and differentiation potential in vitro and in vivo. Conclusions: Our results demonstrate that medaka ES cells are proficient for HR-mediated GT, offering a first model organism of lower vertebrates towards the development of full ES cell-based GT technology.	[Yan, Yan; Hong, Ni; Chen, Tiansheng; Li, Mingyou; Wang, Tiansu; Qiao, Yongkang; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Guan, Guijun] Natl Inst Basic Biol, Dept Bioresource, Okazaki, Aichi 444, Japan; [Chen, Songlin] Chinese Acad Fisheries Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Schartl, Manfred] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Li, Chang-Ming] Southwest Univ, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China; [Yan, Yan; Li, Chang-Ming] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 639798, Singapore	National University of Singapore; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; University of Wurzburg; Southwest University - China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Li, CM (corresponding author), Southwest Univ, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China.	ecmli@swu.edu.cn; dbshyh@nus.edu.sg	Chen, Tiansheng/V-7414-2019; Hong, Yunhan/D-4197-2009; Li, Chang Ming/N-8811-2019; Hong, Ni/Y-6114-2018; Li, Chang Ming/F-9340-2017	Li, Chang Ming/0000-0002-4041-2574; Hong, Ni/0000-0002-9404-3110; Li, Chang Ming/0000-0002-4041-2574; Schartl, Manfred/0000-0001-9882-5948; Li, Mingyou/0000-0002-8729-7964	National Research Foundation Singapore [NRF-CRP7-2010-03]	National Research Foundation Singapore(National Research Foundation, Singapore)	This work was supported by the National Research Foundation Singapore (NRF-CRP7-2010-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar J, 2003, DEVELOPMENT, V130, P6545, DOI 10.1242/dev.00872; Ben J, 2011, DEVELOPMENT, V138, P4969, DOI 10.1242/dev.070862; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen SL, 2002, AQUACULTURE, V214, P67, DOI 10.1016/S0044-8486(01)00811-0; Chen SL, 2001, GENE, V264, P197, DOI 10.1016/S0378-1119(01)00340-7; Chen Song-lin, 2002, Acta Zoologica Sinica, V48, P519; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fan LC, 2006, TRANSGENIC RES, V15, P21, DOI 10.1007/s11248-005-3225-0; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Hong N, 2012, STEM CELLS DEV, V21, P2333, DOI 10.1089/scd.2011.0630; Hong N, 2011, INT J BIOL SCI, V7, P392, DOI 10.7150/ijbs.7.392; Hong N, 2010, CELL MOL LIFE SCI, V67, P1189, DOI 10.1007/s00018-009-0247-4; Hong YH, 1998, DEV GENES EVOL, V208, P595, DOI 10.1007/s004270050220; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, MECH DEVELOP, V121, P933, DOI 10.1016/j.mod.2004.03.028; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 2004, TRANSGENIC RES, V13, P41, DOI 10.1023/B:TRAG.0000017172.71391.fa; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hong Yunhan, 2006, V329, P3; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li M, 2012, CURR MOL MED, V12, P1040, DOI 10.2174/156652412802480853; Li MY, 2009, MECH DEVELOP, V126, P366, DOI 10.1016/j.mod.2009.02.004; Li ZD, 2011, INT J BIOL SCI, V7, P418, DOI 10.7150/ijbs.7.418; Ma CG, 2001, P NATL ACAD SCI USA, V98, P2461, DOI 10.1073/pnas.041449398; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wang DK, 2011, INT J BIOL SCI, V7, P440, DOI 10.7150/ijbs.7.440; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yan Y, 2009, EXP CELL RES, V315, P2322, DOI 10.1016/j.yexcr.2009.04.015; Yi MS, 2010, NAT PROTOC, V5, P1418, DOI 10.1038/nprot.2010.104; Yi MS, 2010, SCI CHINA LIFE SCI, V53, P426, DOI 10.1007/s11427-010-0079-3; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zhao HB, 2012, ANAL CHEM, V84, P987, DOI 10.1021/ac202541t; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	44	12	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59400	10.1371/journal.pone.0059400	http://dx.doi.org/10.1371/journal.pone.0059400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527183	Green Published, gold			2022-12-27	WOS:000317562100125
J	Ghanbarian, E; Motamedi, F				Ghanbarian, Elham; Motamedi, Fereshteh			Ventral Tegmental Area Inactivation Suppresses the Expression of CA1 Long Term Potentiation in Anesthetized Rat	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; HIPPOCAMPAL CA1; REVERSIBLE INACTIVATION; DOPAMINE-RECEPTOR; MEMORY FORMATION; EPISODIC MEMORY; LOCUS-COERULEUS; LTP INDUCTION; REGION	The hippocampus receives dopaminergic projections from the ventral tegmental area (VTA). Modulatory effect of dopamine on hippocampal long term potentiation (LTP) has been studied before, but there are conflicting results and some limitations in previous reports. Most of these studies show a significant effect of dopamine on the late phase of LTP in CA1 area of the hippocampus, while few reports show an effect on the early phase. Moreover, they generally manipulated dopamine receptors in the hippocampus and there are few studies investigating influence of the VTA neural activity on hippocampal LTP in the intact brain. Besides, VTA neurons contain other neurotransmitters such as glutamate and GABA that may modify the net effect of dopamine. In this study we examined the effect of VTA reversible inactivation on the induction and maintenance of early LTP in the CA1 area of anesthetized rats, and also on different phases of learning of a passive avoidance (PA) task. We found that inactivation of the VTA by lidocaine had no effect on CA1 LTP induction and paired-pulse facilitation, but its inactivation immediately after tetanic stimulation transiently suppressed the expression of LTP. Blockade of the VTA 20 min after tetanic stimulation had no effect on the magnitude of LTP. Moreover, VTA inactivation immediately after training impaired memory in the passive avoidance task, while its blockade before or 20 min after training produced no memory deficit. It can be concluded that VTA activity has no effect on CA1 LTP induction and acquisition of PA task, but involves in the expression of LTP and PA memory consolidation.	[Ghanbarian, Elham; Motamedi, Fereshteh] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran; [Ghanbarian, Elham; Motamedi, Fereshteh] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Fac Med, Tehran, Iran; [Ghanbarian, Elham; Motamedi, Fereshteh] Shahid Beheshti Univ Med Sci, Dept Physiol, Fac Med, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Motamedi, F (corresponding author), Inst Res Fundamental Sci IPM, SCS, Tehran, Iran.	motamedi@ams.ac.ir		Motamedi, Fereshteh/0000-0003-4030-8627	Institute for Research in Fundamental Sciences (IPM), Tehran, Iran	Institute for Research in Fundamental Sciences (IPM), Tehran, Iran	This work was supported in part by a grant from Institute for Research in Fundamental Sciences (IPM), Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOEIJINGA PH, 1993, NEUROSCIENCE, V53, P1049, DOI 10.1016/0306-4522(93)90488-2; Buschler A, 2012, HIPPOCAMPUS, V22, P2238, DOI 10.1002/hipo.22041; CASTELLANO C, 1991, BEHAV NEURAL BIOL, V56, P283, DOI 10.1016/0163-1047(91)90439-W; Chowdhury R, 2012, J NEUROSCI, V32, P14193, DOI 10.1523/JNEUROSCI.1278-12.2012; CORRADETTI R, 1992, NEUROSCIENCE, V46, P511, DOI 10.1016/0306-4522(92)90140-W; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; da Silva WCN, 2012, NEUROBIOL LEARN MEM, V97, P271, DOI 10.1016/j.nlm.2012.01.005; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Davoodi FG, 2011, BEHAV BRAIN RES, V221, P1, DOI 10.1016/j.bbr.2011.02.020; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; GASBARRI A, 1994, BRAIN RES BULL, V33, P445, DOI 10.1016/0361-9230(94)90288-7; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hansen N, 2012, CEREB CORTE IN PRESS; Hefco V, 2003, EUR J PHARMACOL, V475, P55, DOI 10.1016/S0014-2999(03)02115-0; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Kahn I, 2013, HIPPOCAMPUS, V23, P187, DOI 10.1002/hipo.22077; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Lapish CC, 2006, ALCOHOL CLIN EXP RES, V30, P1451, DOI 10.1111/j.1530-0277.2006.00176.x; Lashgari R, 2008, NEUROBIOL LEARN MEM, V90, P309, DOI 10.1016/j.nlm.2008.05.012; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Lemon N, 2009, CEREB CORTEX, V19, P2827, DOI 10.1093/cercor/bhp065; Levita L, 2002, BEHAV BRAIN RES, V137, P115, DOI 10.1016/S0166-4328(02)00287-5; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Malpeli JG, 1999, J NEUROSCI METH, V86, P119, DOI 10.1016/S0165-0270(98)00161-7; MALPELI JG, 1979, J NEUROSCI METH, V1, P143, DOI 10.1016/0165-0270(79)90011-6; Martig AK, 2011, HIPPOCAMPUS, V21, P172, DOI 10.1002/hipo.20734; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; O'Carroll CM, 2004, NEUROPHARMACOLOGY, V47, P324, DOI 10.1016/j.neuropharm.2004.04.005; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; Ortiz O, 2010, J NEUROSCI, V30, P12288, DOI 10.1523/JNEUROSCI.2655-10.2010; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Scheiderer CL, 2004, J NEUROPHYSIOL, V91, P1071, DOI 10.1152/jn.00420.2003; Shakesby AC, 2002, J NEUROSCI, V22, P3638; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; SPENCER PM, 1990, J PHYSIOL-LONDON, V423, P77, DOI 10.1113/jphysiol.1990.sp018012; STAUBLI U, 1995, J NEUROSCI, V15, P2445, DOI 10.1523/JNEUROSCI.15-03-02445.1995; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Wang RY, 1998, BRAIN RES, V779, P309, DOI 10.1016/S0006-8993(97)01174-8; Wisman LAB, 2008, J NEUROSCI, V28, P7797, DOI 10.1523/JNEUROSCI.1885-08.2008; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	63	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58844	10.1371/journal.pone.0058844	http://dx.doi.org/10.1371/journal.pone.0058844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536829	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100094
J	Kang, C; Jin, YB; Kwak, J; Jung, H; Yoon, WD; Yoon, TJ; Kim, JS; Kim, E				Kang, Changkeun; Jin, Yeung Bae; Kwak, Jeongsoo; Jung, Hongseok; Yoon, Won Duk; Yoon, Tae-Jin; Kim, Jong-Shu; Kim, Euikyung			Protective Effect of Tetracycline against Dermal Toxicity Induced by Jellyfish Venom	PLOS ONE			English	Article							NEMOPILEMA-NOMURAI SCYPHOZOA; CHIRONEX-FLECKERI VENOM; MATRIX METALLOPROTEINASES; SNAKE-VENOM; ANTIVENOM; ENVENOMATION; STINGS; CYTOTOXICITY; NEMATOCYSTS; INHIBITION	Background: Previously, we have reported that most, if not all, of the Scyphozoan jellyfish venoms contain multiple components of metalloproteinases, which apparently linked to the venom toxicity. Further, it is also well known that there is a positive correlation between the inflammatory reaction of dermal tissues and their tissue metalloproteinase activity. Based on these, the use of metalloproteinase inhibitors appears to be a promising therapeutic alternative for the treatment of jellyfish envenomation. Methodology and Principal Findings: Tetracycline (a metalloproteinase inhibitor) has been examined for its activity to reduce or prevent the dermal toxicity induced by Nemopilema nomurai (Scyphozoa: Rhizostomeae) jellyfish venom (NnV) using in vitro and in vivo models. HaCaT (human keratinocyte) and NIH3T3 (mouse fibroblast) incubated with NnV showed decreases in cell viability, which is associated with the inductions of metalloproteinase-2 and -9. This result suggests that the use of metalloproteinase inhibitors, such as tetracycline, may prevent the jellyfish venom-mediated local tissue damage. In vivo experiments showed that comparing with NnV-alone treatment, tetracycline pre-mixed NnV demonstrated a significantly reduced progression of dermal toxicity upon the inoculation onto rabbit skin. Conclusions/Significance: It is believed that there has been no previous report on the therapeutic agent of synthetic chemical origin for the treatment of jellyfish venom-induced dermonecrosis based on understanding its mechanism of action except the use of antivenom treatment. Furthermore, the current study, for the first time, has proposed a novel mechanism-based therapeutic intervention for skin damages caused by jellyfish stings.	[Kang, Changkeun; Jin, Yeung Bae; Kwak, Jeongsoo; Jung, Hongseok; Kim, Jong-Shu; Kim, Euikyung] Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea; [Yoon, Won Duk] Natl Fisheries Res & Dev Inst, Headquarters Marine Environm, Pusan, South Korea; [Yoon, Won Duk] Gyeongsang Natl Univ, Sch Med, Dept Dermatol, Jinju, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea; [Kim, Euikyung] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Kim, E (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea.	ekim@gnu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20110004233]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 20110004233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MR, 2004, DRUG RESIST UPDATE, V7, P195, DOI 10.1016/j.drup.2004.04.002; Birsa LM, 2010, COMP BIOCHEM PHYS C, V151, P426, DOI 10.1016/j.cbpc.2010.01.007; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Bloom DA, 1999, TOXICON, V37, P1621, DOI 10.1016/S0041-0101(98)00245-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke W. A., 2002, DERMATOL THER, V15, P18, DOI DOI 10.1046/J.1529-8019.2002.01508.X; Carrette T, 2004, TOXICON, V44, P135, DOI 10.1016/j.toxicon.2004.04.008; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Edwards L, 2000, TOXICON, V38, P1015, DOI 10.1016/S0041-0101(99)00213-5; ENDEAN R, 1988, TOXICON, V26, P425, DOI 10.1016/0041-0101(88)90181-X; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Garbisa S, 2001, CANCER-AM CANCER SOC, V91, P822, DOI 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G; Garcia RA, 2005, MOL PHARMACOL, V67, P1128, DOI 10.1124/mol.104.006346; Howes JM, 2007, TOXICON, V49, P734, DOI 10.1016/j.toxicon.2006.11.020; Kang C, 2011, J PHARMACOL TOX MET, V64, P173, DOI 10.1016/j.vascn.2011.07.004; Kang C, 2009, COMP BIOCHEM PHYS C, V150, P85, DOI 10.1016/j.cbpc.2009.03.003; Kawahara M, 2006, TOXICON, V48, P713, DOI 10.1016/j.toxicon.2006.06.015; Kim E, 2006, TOXICOL LETT, V167, P205, DOI 10.1016/j.toxlet.2006.09.009; Konstantakopoulos Nicki, 2009, Journal of Pharmacological and Toxicological Methods, V59, P166, DOI 10.1016/j.vascn.2009.02.003; Lee H, 2011, TOXICON, V58, P277, DOI 10.1016/j.toxicon.2011.06.007; Little M, 2001, ANAESTH INTENS CARE, V29, P178, DOI 10.1177/0310057X0102900212; Nomura JT, 2002, AM J EMERG MED, V20, P624, DOI 10.1053/ajem.2002.35710; Paixao-Cavalcante D, 2007, J INVEST DERMATOL, V127, P1410, DOI 10.1038/sj.jid.5700688; Ramasamy S, 2005, TOXICOL LETT, V155, P219, DOI 10.1016/j.toxlet.2004.09.018; Rucavado A, 2000, AM J TROP MED HYG, V63, P313, DOI 10.4269/ajtmh.2000.63.313; Silfen R, 2003, BURNS, V29, P868, DOI 10.1016/S0305-4179(03)00162-1; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P40, DOI 10.1177/0310057X9802600105; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Uye Siain-Icth, 2008, Plankton & Benthos Research, V3, P125, DOI 10.3800/pbr.3.125; Veraldi S, 2000, INT J DERMATOL, V39, P28, DOI 10.1046/j.1365-4362.2000.00823.x; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Watters Michael R., 2004, Curr Treat Options Neurol, V6, P115, DOI 10.1007/s11940-004-0021-8; Watters MR, 2005, SEMIN NEUROL, V25, P278, DOI 10.1055/s-2005-917664; Winter KL, 2009, TOXICOL LETT, V187, P94, DOI 10.1016/j.toxlet.2009.02.008	36	15	16	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57658	10.1371/journal.pone.0057658	http://dx.doi.org/10.1371/journal.pone.0057658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536767	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100013
J	Lotteau, S; Ducreux, S; Romestaing, C; Legrand, C; Van Coppenolle, F				Lotteau, Sabine; Ducreux, Sylvie; Romestaing, Caroline; Legrand, Claude; Van Coppenolle, Fabien			Characterization of Functional TRPV1 Channels in the Sarcoplasmic Reticulum of Mouse Skeletal Muscle	PLOS ONE			English	Article							POTENTIAL CATION CHANNELS; CONGENITAL DISTAL SMA; CA2+ RELEASE CHANNELS; CENTRAL CORE DISEASE; MALIGNANT HYPERTHERMIA; CAPSAICIN RECEPTOR; RYANODINE RECEPTOR; VANILLOID RECEPTOR-1; CALCIUM-RELEASE; EXPRESSION	TRPV1 represents a non-selective cation channel activated by capsaicin, acidosis and high temperature. In the central nervous system where TRPV1 is highly expressed, its physiological role in nociception is clearly identified. In skeletal muscle, TRPV1 appears implicated in energy metabolism and exercise endurance. However, how as a Ca2+ channel, it contributes to intracellular calcium concentration ([Ca2+](i)) maintenance and muscle contraction remains unknown. Here, as in rats, we report that TRPV1 is functionally expressed in mouse skeletal muscle. In contrast to earlier reports, our analysis show TRPV1 presence only at the sarcoplasmic reticulum (SR) membrane (preferably at the longitudinal part) in the proximity of SERCA1 pumps. Using intracellular Ca2+ imaging, we directly accessed to the channel functionality in intact FDB mouse fibers. Capsaicin and resiniferatoxin, both agonists as well as high temperature (45 degrees C) elicited an increase in [Ca2+](i). TRPV1-inhibition by capsazepine resulted in a strong inhibition of TRPV1-mediated functional responses and abolished channel activation. Blocking the SR release (with ryanodine or dantrolene) led to a reduced capsaicin-induced Ca2+ elevation suggesting that TRPV1 may participate to a secondary SR Ca2+ liberation of greater amplitude. In conclusion, our experiments point out that TRPV1 is a functional SR Ca2+ leak channel and may crosstalk with RyR1 in adult mouse muscle fibers.	[Lotteau, Sabine; Ducreux, Sylvie; Legrand, Claude; Van Coppenolle, Fabien] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Lotteau, Sabine; Ducreux, Sylvie; Romestaing, Caroline; Legrand, Claude; Van Coppenolle, Fabien] Univ Lyon, Lyon, France; [Lotteau, Sabine; Ducreux, Sylvie; Van Coppenolle, Fabien] INSERM U1060 CarMeN Equipe 5, Lyon, France; [Romestaing, Caroline] Univ Lyon 1, CNRS, ENTPE, UMR Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Van Coppenolle, F (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France.	fabien.van-coppenolle@univ-lyon1.fr	romestaing, caroline/O-8794-2017; DUCREUX, SYLVIE/D-6257-2013	romestaing, caroline/0000-0002-6877-9626; DUCREUX, SYLVIE/0000-0003-3207-9537	University Claude Bernard Lyon1; Ministere de la Recherche et de l'Enseignement Superieur francais	University Claude Bernard Lyon1; Ministere de la Recherche et de l'Enseignement Superieur francais	This work was supported in part by grants from University Claude Bernard Lyon1 and the Ministere de la Recherche et de l'Enseignement Superieur francais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrea G, 2012, NEUROLOGY, V78, P364, DOI 10.1212/WNL.0b013e318245295a; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; Brinkmeier H, 2011, ADV EXP MED BIOL, V704, P749, DOI 10.1007/978-94-007-0265-3_39; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavuoto P, 2007, BIOCHEM BIOPH RES CO, V364, P105, DOI 10.1016/j.bbrc.2007.09.099; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; HAAN EA, 1990, HUM GENET, V86, P187; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Luo Z, 2011, CELL RES; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; Meyers JR, 2003, J NEUROSCI, V23, P4054; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Onozawa K, 2000, P JPN ACAD B-PHYS, V76, P68, DOI 10.2183/pjab.76.68; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Pritschow BW, 2010, PFLUGERS ARCH, V461, P115, DOI [DOI 10.1007/S00424-010-0883-4, 10.1007/s00424-010-0883-4]; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Szentesi P, 2004, BIOPHYS J, V86, P1436, DOI 10.1016/S0006-3495(04)74213-7; Toth A, 2002, BIOCHEM BIOPH RES CO, V293, P777, DOI 10.1016/S0006-291X(02)00293-0; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	41	62	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58673	10.1371/journal.pone.0058673	http://dx.doi.org/10.1371/journal.pone.0058673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536811	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100078
J	Parthsarathy, V; Holscher, C				Parthsarathy, Vadivel; Hoelscher, Christian			Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; ADULT NEUROGENESIS; DENTATE GYRUS; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; RODENT MODELS; GRANULE CELLS; BRAIN	Neurogenesis is a life long process, but the rate of cell proliferation and differentiation decreases with age. In Alzheimer's patients, along with age, the presence of Ab in the brain inhibits this process by reducing stem cell proliferation and cell differentiation. GLP-1 is a growth factor that has neuroprotective properties. GLP1 receptors are present on neuronal progenitor cells, and the GLP-1 analogue liraglutide has been shown to increase cell proliferation in an Alzheimer's disease (AD) mouse model. Here we investigated acute and chronic effects of liraglutide on progenitor cell proliferation, neuroblast differentiation and their subsequent differentiation into neurons in wild type and APP/PS-1 mice at different ages. APP/PS1 and their littermate controls, aged 3, 6, 12, 15 months were injected acutely or chronically with 25 nmol/kg liraglutide. Acute treatment with liraglutide showed an increase in cell proliferation in APP/PS1 mice, but not in controls whereas chronic treatment increased cell proliferation at all ages (BrdU and Ki67 markers). Moreover, numbers of immature neurons (DCX) were increased in both acute and chronic treated animals at all ages. Most newly generated cells differentiated into mature neurons (NeuN marker). A significant increase was observed with chronically treated 6, 12, 15 month APP/PS1 and WT groups. These results demonstrate that liraglutide, which is currently on the market as a treatment for type 2 diabetes (Victoza (TM)), increases neurogenesis, which may have beneficial effects in neurodegenerative disorders like AD.	[Parthsarathy, Vadivel; Hoelscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Holscher, C (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	c.holscher@ulster.ac.uk		Holscher, Christian/0000-0002-8159-3260; Parthsarathy, Vadivel/0000-0002-2037-7804	Alzheimer Research UK charity Trust; Vice Chancellor Research Studentship grant	Alzheimer Research UK charity Trust(Alzheimer's Research UK (ARUK)); Vice Chancellor Research Studentship grant	The work was funded in part by a grant of the Alzheimer Research UK charity Trust and a Vice Chancellor Research Studentship grant to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brinton Roberta Diaz, 2006, Current Alzheimer Research, V3, P185; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Faure A, 2011, NEUROBIOL AGING, V32, P407, DOI 10.1016/j.neurobiolaging.2009.03.009; Franklin K, 2004, MOUSE BRAIN STEREOTA; Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025; Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014; Greenberg David A., 2006, Current Alzheimer Research, V3, P25, DOI 10.2174/156720506775697106; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LI H, 2010, NEUROSCI LETT, V19, P1205; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Oka JI, 2000, BRAIN RES, V878, P194, DOI 10.1016/S0006-8993(00)02741-4; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry TA, 2004, CURR DRUG TARGETS, V5, P565, DOI 10.2174/1389450043345245; Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x; Porter WD, 2013, INT J OBESITY, V37, P678, DOI 10.1038/ijo.2012.91; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Schulte-Herbruggen O, 2007, CURR MED CHEM, V14, P2318, DOI 10.2174/092986707781745578; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vella A, 2002, DIABETOLOGIA, V45, P1410, DOI 10.1007/s00125-002-0924-4; Vilsboll T, 2009, DIABETES OBES METAB, V11, P11, DOI 10.1111/j.1463-1326.2009.01073.x; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; Yagita Y, 2006, NEUROSCI LETT, V409, P24, DOI 10.1016/j.neulet.2006.09.040; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	67	90	96	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58784	10.1371/journal.pone.0058784	http://dx.doi.org/10.1371/journal.pone.0058784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536825	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000316251100090
J	Barah, P; Winge, P; Kusnierczyk, A; Tran, DH; Bones, AM				Barah, Pankaj; Winge, Per; Kusnierczyk, Anna; Tran, Diem Hong; Bones, Atle M.			Molecular Signatures in Arabidopsis thaliana in Response to Insect Attack and Bacterial Infection	PLOS ONE			English	Article							APHID BREVICORYNE-BRASSICAE; ACTIVATED PROTEIN-KINASE; SYRINGAE PV. TOMATO; GENE ONTOLOGY; PLANT DEFENSE; TRANSCRIPTOME CHANGES; INFORMATION RESOURCE; SIGNALING PATHWAYS; TARGET TRANSCRIPTS; SIRNA BIOGENESIS	Background: Under the threat of global climatic change and food shortages, it is essential to take the initiative to obtain a comprehensive understanding of common and specific defence mechanisms existing in plant systems for protection against different types of biotic invaders. We have implemented an integrated approach to analyse the overall transcriptomic reprogramming and systems-level defence responses in the model plant species Arabidopsis thaliana (A. thaliana henceforth) during insect Brevicoryne brassicae (B. brassicae henceforth) and bacterial Pseudomonas syringae pv. tomato strain DC3000 (P. syringae henceforth) attacks. The main aim of this study was to identify the attacker-specific and general defence response signatures in A. thaliana when attacked by phloem-feeding aphids or pathogenic bacteria. Results: The obtained annotated networks of differentially expressed transcripts indicated that members of transcription factor families, such as WRKY, MYB, ERF, BHLH and bZIP, could be crucial for stress-specific defence regulation in Arabidopsis during aphid and P. syringae attack. The defence response pathways, signalling pathways and metabolic processes associated with aphid attack and P. syringae infection partially overlapped. Components of several important biosynthesis and signalling pathways, such as salicylic acid (SA), jasmonic acid (JA), ethylene (ET) and glucosinolates, were differentially affected during the two the treatments. Several stress-regulated transcription factors were known to be associated with stress-inducible microRNAs. The differentially regulated gene sets included many signature transcription factors, and our co-expression analysis showed that they were also strongly co-expressed during 69 other biotic stress experiments. Conclusions: Defence responses and functional networks that were unique and specific to aphid or P. syringae stresses were identified. Furthermore, our analysis revealed a probable link between biotic stress and microRNAs in Arabidopsis and, thus gives indicates a new direction for conducting large-scale targeted experiments to explore the detailed regulatory links between them. The presented results provide a comparative understanding of Arabidopsis - B. brassicae and Arabidopsis - P. syringae interactions at the transcriptomic level.	[Barah, Pankaj; Winge, Per; Kusnierczyk, Anna; Tran, Diem Hong; Bones, Atle M.] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bones, AM (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	atle.bones@bio.ntnu.no	Bones, Atle M/C-6202-2014	Bones, Atle M/0000-0003-0544-7437; Barah, Pankaj/0000-0001-7039-7996	Norwegian Research Council [NFR 184147/S10, 185173/V40, 184146/S10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council through grants NFR 184147/S10, 185173/V40 and 184146/S10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bethke G, 2009, PLANT SIGNAL BEHAV, V4, P672, DOI [10.4161/psb.4.7.9039, 10.1073/pnas.0810206106]; Bhardwaj V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026968; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Bulow L, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-7; Bulow L, 2009, NUCLEIC ACIDS RES, V37, pD983, DOI 10.1093/nar/gkn709; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; De Bodt S, 2010, PLANT PHYSIOL, V152, P1167, DOI 10.1104/pp.109.147215; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Foyer CH, 2007, INT J PEST MANAGE, V53, P175, DOI 10.1080/09670870701469146; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Fumiaki Katagiri RT, 2002, ARABIDOPSIS THALIANA, pe012; Ge Y, 2003, RESAMPLING BASED MUL; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Grant M, 2006, COMP BIOCHEM PHYS A, V143, pS137; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hornik K., 2011, R FAQ; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jorstad TS, 2007, TRENDS PLANT SCI, V12, P46, DOI 10.1016/j.tplants.2007.01.001; Jorstad TS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-117; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Kissen R, 2009, PHYTOCHEM REV, V8, P69, DOI 10.1007/s11101-008-9109-1; Kissen R, 2009, J BIOL CHEM, V284, P12057, DOI 10.1074/jbc.M807500200; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Konika Chawla PB, 2010, OMICS PLANT ABIOTIC; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Kusnierczyk A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-423; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lin W, 2009, ARABIDOPSIS DEFENSE, P1; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Munemasa S, 2011, PLANT PHYSIOL, V155, P553, DOI 10.1104/pp.110.162750; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Pajerowska-Mukhtar K, 2009, GENE DEV, V23, P2449, DOI 10.1101/gad.1861609; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pitzschke A, 2010, PLANT PHYSIOL, V152, P460, DOI 10.1104/pp.109.149583; Prandl R, 1998, MOL GEN GENET, V258, P269, DOI 10.1007/s004380050731; Preston GM, 2000, MOL PLANT PATHOL, V1, P263, DOI 10.1046/j.1364-3703.2000.00036.x; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SPILLER NJ, 1985, ENTOMOL EXP APPL, V38, P293, DOI 10.1007/BF00295266; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tarasenko VI, 2009, BIOCHEMISTRY-MOSCOW+, V74, P47, DOI 10.1134/S0006297909010076; Tardieu F, 2003, TRENDS PLANT SCI, V8, P9, DOI 10.1016/S1360-1385(02)00008-0; Theis N, 2003, INT J PLANT SCI, V164, pS93, DOI 10.1086/374190; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Ulland S, 2008, CHEM SENSES, V33, P35, DOI 10.1093/chemse/bjm061; Van Emden HF, 2007, APHIDS CROP PESTS, pxxviii; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Weston DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-16; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Wright AJ, 2002, PLANT PHYSIOL, V128, P1402, DOI 10.1104/pp.010660; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	98	50	54	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58987	10.1371/journal.pone.0058987	http://dx.doi.org/10.1371/journal.pone.0058987			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536844	Green Published, gold			2022-12-27	WOS:000317397200012
J	Chen, TS; Chen, M; Chen, JQ				Chen, Tongsheng; Chen, Min; Chen, Jingqin			Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis of A549 Cells via a Caspase-8-Dependent Pathway	PLOS ONE			English	Article							BAX TRANSLOCATION; DNA-DAMAGE; IN-VITRO; ARTEMISININ; BINDING	This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ionizing radiation (IR) induce apoptosis in human lung adenocarcinoma A549 cells. DHA treatment induced a concentration-and time-dependent reactive oxygen species (ROS)-mediated cell death with typical apoptotic characteristics such as breakdown of mitochondrial membrane potential (Delta psi(m)), caspases activation, DNA fragmentation and phosphatidylserine (PS) externalization. Inhibition of caspase-8 or -9 significantly blocked DHA-induced decrease of cell viability and activation of caspase-3, suggesting the dominant roles of caspase-8 and -9 in DHA-induced apoptosis. Silencing of proapoptotic protein Bax but not Bak significantly inhibited DHA-induced apoptosis in which Bax but not Bak was activated. In contrast to DHA treatment, low-dose (2 or 4 Gy) IR induced a long-playing generation of ROS. Interestingly, IR treatment for 24 h induced G2/M cell cycle arrest that disappeared at 36 h after treatment. More importantly, IR synergistically potentiated DHA-induced generation of ROS, activation of caspase-8 and -3, irreparable G(2)/M arrest and apoptosis, but did not enhance DHA-induced loss of Delta psi(m) and activation of caspase-9. Taken together, our results strongly demonstrate the remarkable synergistic efficacy of combination treatment with DHA and low-dose IR for A549 cells in which IR potentiates DHA-induced apoptosis largely by enhancing the caspase-8-mediated extrinsic pathway.	[Chen, Tongsheng] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, SATCM Grade Lab Chinese Med & Photon Technol 3, Coll Biophoton, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Chen, TS (corresponding author), S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.	chentsh@scnu.edu.cn			National Natural Science Foundation of China [31071218, 61178078]; Department of Education and Finance of Guangdong Province [cxzd115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education and Finance of Guangdong Province	This research was supported by the National Natural Science Foundation of China; Contract grant number: 31071218 and 61178078, and by the Key Project of the Department of Education and Finance of Guangdong Province; Contract grant number: cxzd115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Denissova NG, 2012, CARCINOGENESIS, V33, P149, DOI 10.1093/carcin/bgr236; Dey S, 2003, CLIN CANCER RES, V9, P1557; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Field JK, 2008, BRIT J CANCER, V99, P557, DOI 10.1038/sj.bjc.6604509; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Huang G, 2010, ANTICANCER RES, V30, P937; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kim SJ, 2006, J CANCER RES CLIN, V132, P129, DOI 10.1007/s00432-005-0052-x; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; Lu YY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3481141; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Popowich DA, 2010, AM J PHYSIOL-HEART C, V298, pH2192, DOI 10.1152/ajpheart.00535.2009; Pore MM, 2013, CANCER LETT, V332, P359, DOI 10.1016/j.canlet.2010.09.012; Thompson JS, 2010, APOPTOSIS, V15, P705, DOI 10.1007/s10495-010-0487-7; Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Xiao FL, 2012, APOPTOSIS, V17, P600, DOI 10.1007/s10495-012-0706-5; Zhang LL, 2010, J CELL PHYSIOL, V224, P218, DOI 10.1002/jcp.22123; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zhou HJ, 2010, CANCER CHEMOTH PHARM, V66, P21, DOI 10.1007/s00280-009-1129-z	26	25	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59827	10.1371/journal.pone.0059827	http://dx.doi.org/10.1371/journal.pone.0059827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536891	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200039
J	Sousa, SR; Vetter, I; Ragnarsson, L; Lewis, RJ				Sousa, Silmara R.; Vetter, Irina; Ragnarsson, Lotten; Lewis, Richard J.			Expression and Pharmacology of Endogenous Ca-v Channels in SH-SY5Y Human Neuroblastoma Cells	PLOS ONE			English	Article							NEURONAL CALCIUM-CHANNEL; RECOMBINANT N-TYPE; GATED ION CHANNELS; OMEGA-CONOTOXINS; FUNCTIONAL EXPRESSION; HIPPOCAMPAL-NEURONS; MIBEFRADIL BLOCK; CA(V)2.2; RAT; SUBUNIT	SH-SY5Y human neuroblastoma cells provide a useful in vitro model to study the mechanisms underlying neurotransmission and nociception. These cells are derived from human sympathetic neuronal tissue and thus, express a number of the Ca-v channel subtypes essential for regulation of important physiological functions, such as heart contraction and nociception, including the clinically validated pain target Ca(v)2.2. We have detected mRNA transcripts for a range of endogenous expressed subtypes Ca(v)1.3, Ca(v)2.2 (including two Ca(v)1.3, and three Ca(v)2.2 splice variant isoforms) and Ca(v)3.1 in SH-SY5Y cells; as well as Ca-v auxiliary subunits alpha(2)delta(1-3), beta(1), beta(3), beta(4), gamma(1), gamma(4-5), and gamma(7). Both high-and low-voltage activated Ca-v channels generated calcium signals in SH-SY5Y cells. Pharmacological characterisation using omega-conotoxins CVID and MVIIA revealed significantly (similar to 10-fold) higher affinity at human versus rat Ca(v)2.2, while GVIA, which interacts with Ca(v)2.2 through a distinct pharmacophore had similar affinity for both species. CVID, GVIA and MVIIA affinity was higher for SH-SY5Y membranes vs whole cells in the binding assays and functional assays, suggesting auxiliary subunits expressed endogenously in native systems can strongly influence Ca(v)2.2 channels pharmacology. These results may have implications for strategies used to identify therapeutic leads at Ca(v)2.2 channels.	[Sousa, Silmara R.; Vetter, Irina; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Lewis, Richard J/E-8674-2013; Vetter, Irina/A-6035-2010; Ragnarsson, Lotten/A-8632-2012	Lewis, Richard/0000-0003-3470-923X; Lewis, Richard J/0000-0003-3470-923X; Vetter, Irina/0000-0002-3594-9588; Ragnarsson, Lotten/0000-0002-7137-1656; Rodrigues de Sousa, Silmara/0000-0002-2130-4439	NHMRC; UQIRTA; ARC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQIRTA; ARC(Australian Research Council)	This work was supported by an NHMRC Program Grant (RJL), an UQIRTA scholarship to SRS and NHMRC fellowships to RJL and IV. The FLIPR was supported by an ARC Linkage Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD SN, 1988, BRAIN RES, V453, P247; Alicino I, 2012, PAIN, V153, P245, DOI 10.1016/j.pain.2011.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Benjamin ER, 2006, BIOCHEM PHARMACOL, V72, P770, DOI 10.1016/j.bcp.2006.06.003; Berecki G, 2010, MOL PHARMACOL, V77, P139, DOI 10.1124/mol.109.058834; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Catterall WA, 2011, COLD SPRING HARBOR P, V3; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chiou WF, 2006, NEUROCHEM INT, V49, P256, DOI 10.1016/j.neuint.2006.01.022; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; Dai G, 2008, ASSAY DRUG DEV TECHN, V6, P195, DOI 10.1089/adt.2008.136; DOLD KM, 1990, ANAL BIOCHEM, V184, P67, DOI 10.1016/0003-2697(90)90013-Y; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Feng ZP, 2001, J BIOL CHEM, V276, P15728, DOI 10.1074/jbc.M100406200; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Finley MFA, 2010, ASSAY DRUG DEV TECHN, V8, P685, DOI 10.1089/adt.2010.0311; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Kaneko S, 2002, J NEUROSCI, V22, P82, DOI 10.1523/JNEUROSCI.22-01-00082.2002; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; LAMBERT DG, 1990, MOL BRAIN RES, V8, P263, DOI 10.1016/0169-328X(90)90026-A; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Lipscombe D, 2007, CHANNELS, V1, P225, DOI 10.4161/chan.4809; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; MAUBECIN VA, 1995, J NEUROCHEM, V64, P2544; Maximov A, 2002, J NEUROSCI, V22, P6939; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Motin L, 2007, EUR J NEUROSCI, V25, P435, DOI 10.1111/j.1460-9568.2006.05299.x; Mould J, 2004, J BIOL CHEM, V279, P34705, DOI 10.1074/jbc.M310848200; Nielsen KJ, 2000, J MOL RECOGNIT, V13, P55, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<55::AID-JMR488>3.0.CO;2-O; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; REEVE HL, 1994, EUR J NEUROSCI, V6, P943, DOI 10.1111/j.1460-9568.1994.tb00588.x; REUVENY E, 1993, BRAIN RES, V603, P64, DOI 10.1016/0006-8993(93)91300-H; Sandoval A, 2007, CELL MOL NEUROBIOL, V27, P901, DOI 10.1007/s10571-007-9210-9; Schroeder CI, 2006, MAR DRUGS, V4, P193, DOI 10.3390/md403193; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Sonnier H, 2000, CELL MOL LIFE SCI, V57, P514, DOI 10.1007/PL00000712; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; Todorovic SM, 1998, J NEUROPHYSIOL, V79, P240, DOI 10.1152/jn.1998.79.1.240; TROMBLEY PQ, 1991, J NEUROSCI, V11, P435; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; WAGNER JA, 1988, J NEUROSCI, V8, P3354; Wallace MS, 2010, CLIN J PAIN, V26, P635, DOI 10.1097/AJP.0b013e3181e017df; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xie XM, 2007, ASSAY DRUG DEV TECHN, V5, P191, DOI 10.1089/adt.2006.054; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zamponi GW, 2004, NEURON, V41, P3, DOI 10.1016/S0896-6273(03)00846-8	63	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59293	10.1371/journal.pone.0059293	http://dx.doi.org/10.1371/journal.pone.0059293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536870	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200018
J	You, WC; Wang, CX; Pan, YX; Zhang, X; Zhou, XM; Zhang, XS; Shi, JX; Zhou, ML				You, Wan-Chun; Wang, Chun-xi; Pan, Yun-xi; Zhang, Xin; Zhou, Xiao-ming; Zhang, Xiang-sheng; Shi, Ji-xin; Zhou, Meng-liang			Activation of Nuclear Factor-kappa B in the Brain after Experimental Subarachnoid Hemorrhage and Its Potential Role in Delayed Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; RAT-BRAIN; PYRROLIDINE DITHIOCARBAMATE; DNA FRAGMENTATION; GLOBAL-ISCHEMIA; INHIBITION; APOPTOSIS; NEURONS; INFLAMMATION	It has been reported that inflammation is involved in brain injury after subarachnoid hemorrhage (SAH). Nuclear factor-kappa B (NF-kappa B) is a key transcriptional regulator of inflammatory genes. Here, we used pyrrolidine dithiocarbamate(PDTC), an inhibitor of NF-kappa B, through intracisternal injection to study the role of NF-kappa B in delayed brain injury after SAH. A total of 55 rabbits were randomly divided into five groups: the control group; the SAH groups including Day-3, 5, and 7 SAH groups (the rabbits in these groups were sacrificed at 3, 5, 7 days after SAH, respectively); and the PDTC group (n = 11 for each group). Electrophoretic mobility shift assay (EMSA) was performed to detect NF-kappa B DNA-binding activity. The mRNA levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and intercellular adhesion molecule (ICAM)-1 were evaluated by RT-PCR analysis. Deoxyribonucleic acid fragmentation was detected by TUNEL and p65 immunoactivity was assessed by immunohistochemistry. Our results showed the activation of NF-kappa B after SAH, especially at day 3 and 5. The activated p65 was detected in neurons. NF-kappa B DNA-binding activity was suppressed by intracisternal administration of PDTC. Increased levels of the TNF-alpha, IL-1 beta, and ICAM-1 mRNA were found in the brain at day 5 after SAH, and which were suppressed in the PDTC group. The number of TUNEL-positive cells also decreased significantly in the PDTC group compared with that in the Day-5 SAH group. These results demonstrated that the activated NF-kappa B in neurons after SAH plays an important role in regulating the expressions of inflammatory genes in the brain, and ultimately contributes to delayed brain injury.	[You, Wan-Chun; Wang, Chun-xi; Pan, Yun-xi; Zhang, Xin; Zhou, Xiao-ming; Zhang, Xiang-sheng; Shi, Ji-xin; Zhou, Meng-liang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhou, ML (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	mengliangzhou@yahoo.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of China (NSFC) [81000503, 81070921, 81271297]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (NSFC): No. 81000503(MZ), No. 81070921, and No. 81271297 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Aoki T, 2012, NEUROSURGERY, V70, P1534, DOI 10.1227/NEU.0b013e318246a390; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Bremner P, 2002, J PHARM PHARMACOL, V54, P453, DOI 10.1211/0022357021778637; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Calfee-Mason KG, 2004, TOXICOL APPL PHARM, V199, P1, DOI 10.1016/j.taap.2004.03.006; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Chabicovsky M, 2010, BASIC CLIN PHARMACOL, V107, P758, DOI 10.1111/j.1742-7843.2010.00573.x; Cheng AC, 2006, J AGR FOOD CHEM, V54, P4215, DOI 10.1021/jf060269n; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Clemens JA, 1998, STROKE, V29, P677, DOI 10.1161/01.STR.29.3.677; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gabriel C, 1999, MOL BRAIN RES, V65, P61, DOI 10.1016/S0169-328X(98)00330-1; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Isomura I, 2006, MICROBIOL IMMUNOL, V50, P559, DOI 10.1111/j.1348-0421.2006.tb03827.x; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Malaguarnera L, 2003, APOPTOSIS, V8, P539, DOI 10.1023/A:1025550726803; Manna SK, 2000, J IMMUNOL, V165, P5962, DOI 10.4049/jimmunol.165.10.5962; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Matz PG, 1996, J NEUROSURG, V85, P138, DOI 10.3171/jns.1996.85.1.0138; Matz PG, 2000, STROKE, V31, P2450, DOI 10.1161/01.STR.31.10.2450; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; Meyer S, 1997, FEBS LETT, V413, P354, DOI 10.1016/S0014-5793(97)00930-7; Nurmi A, 2004, J NEUROCHEM, V91, P755, DOI 10.1111/j.1471-4159.2004.02756.x; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Qin ZH, 1999, J NEUROSCI, V19, P4023; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Seegers H, 2000, NEUROSCI LETT, V288, P241, DOI 10.1016/S0304-3940(00)01245-3; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456; Zhou ML, 2007, J NEUROSCI METH, V159, P318, DOI 10.1016/j.jneumeth.2006.07.026; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	54	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60290	10.1371/journal.pone.0060290	http://dx.doi.org/10.1371/journal.pone.0060290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536907	gold, Green Submitted, Green Published			2022-12-27	WOS:000317397200055
J	Zhang, T; Zhao, XQ; Huang, LY; Liu, XY; Zong, Y; Zhu, LH; Yang, DC; Fu, BY				Zhang, Ting; Zhao, Xiuqin; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Yang, Daichang; Fu, Binying			Tissue-Specific Transcriptomic Profiling of Sorghum propinquum using a Rice Genome Array	PLOS ONE			English	Article							RHIZOME-SPECIFIC GENES; OLIGONUCLEOTIDE MICROARRAYS; DIFFERENTIAL EXPRESSION; SUCROSE TRANSPORTER; REGULATORY ELEMENTS; CDNA MICROARRAY; DOMAIN PROTEIN; CIS-ELEMENT; ARABIDOPSIS; IDENTIFICATION	Sorghum (Sorghum bicolor) is one of the world's most important cereal crops. S. propinquum is a perennial wild relative of S. bicolor with well-developed rhizomes. Functional genomics analysis of S. propinquum, especially with respect to molecular mechanisms related to rhizome growth and development, can contribute to the development of more sustainable grain, forage, and bioenergy cropping systems. In this study, we used a whole rice genome oligonucleotide microarray to obtain tissue-specific gene expression profiles of S. propinquum with special emphasis on rhizome development. A total of 548 tissue-enriched genes were detected, including 31 and 114 unique genes that were expressed predominantly in the rhizome tips (RT) and internodes (RI), respectively. Further GO analysis indicated that the functions of these tissue-enriched genes corresponded to their characteristic biological processes. A few distinct cis-elements, including ABA-responsive RY repeat CATGCA, sugar-repressive TTATCC, and GA-responsive TAACAA, were found to be prevalent in RT-enriched genes, implying an important role in rhizome growth and development. Comprehensive comparative analysis of these rhizome-enriched genes and rhizome-specific genes previously identified in Oryza longistaminata and S. propinquum indicated that phytohormones, including ABA, GA, and SA, are key regulators of gene expression during rhizome development. Co-localization of rhizome-enriched genes with rhizome-related QTLs in rice and sorghum generated functional candidates for future cloning of genes associated with rhizome growth and development.	[Zhang, Ting; Zhao, Xiuqin; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Fu, Binying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhang, Ting; Yang, Daichang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Wuhan University	Yang, DC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	dyang@whu.edu.cn; fubinying@caas.cn	zhang, ting/ABG-5784-2020	zhang, ting/0000-0001-9231-1604	National Natural Science Foundation of China [30760094, U0836605]; MOA [2008ZX001 003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOA	This work was supported by the National Natural Science Foundation of China (Grant No. 30760094 and U0836605) and the Key Project from MOA (Grant No. 2008ZX001 003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; CHITTENDEN LM, 1994, THEOR APPL GENET, V87, P925, DOI 10.1007/BF00225786; Clayton W.D., 2006, GRASSBASE ONLINE WOR; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; Degenhardt J, 1996, PLANT CELL, V8, P31, DOI 10.1105/tpc.8.1.31; Doggett H., 1988, ECON BOT, V2nd ed.; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; GASSER SM, 1989, INT REV CYTOL, V119, P57; GHESQUIERE A, 1991, RICE GENETICS II, P729; GHESQUIERE A, 1992, RGN, V9, P28; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Horvath DP, 2003, PLANT J, V34, P125, DOI 10.1046/j.1365-313X.2003.01706.x; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Hu FY, 2003, P NATL ACAD SCI USA, V100, P4050, DOI 10.1073/pnas.0630531100; HUANG N, 1990, PLANT MOL BIOL, V14, P655, DOI 10.1007/BF00016499; Jackson D. P, 1991, IN SITU HYBRIDIZATIO, P163; Jang CS, 2009, HEREDITY, V102, P266, DOI 10.1038/hdy.2008.119; Jang CS, 2006, PLANT PHYSIOL, V142, P1148, DOI 10.1104/pp.106.082891; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kang XJ, 2007, PLANT J, V52, P937, DOI 10.1111/j.1365-313X.2007.03295.x; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kassahn KS, 2007, MOL ECOL, V16, P1749, DOI 10.1111/j.1365-294X.2006.03178.x; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Maekawa M., 1998, J BREEDING GENET, V30, P69; Martin V, 2009, FEBS LETT, V583, P3425, DOI 10.1016/j.febslet.2009.09.055; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Planchais S, 2002, PLANT MOL BIOL, V50, P111, DOI 10.1023/A:1016018711532; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; SANDAL NN, 1987, NUCLEIC ACIDS RES, V15, P1507, DOI 10.1093/nar/15.4.1507; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Scofield GN, 2007, J EXP BOT, V58, P3155, DOI 10.1093/jxb/erm153; Scofield GN, 2007, J EXP BOT, V58, P483, DOI 10.1093/jxb/erl217; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Sun QW, 2008, P NATL ACAD SCI USA, V105, P13679, DOI 10.1073/pnas.0805901105; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; Volodarsky D, 2009, PLANT PHYSIOL, V150, P1796, DOI 10.1104/pp.109.138289; Walker SJ, 2006, J NEUROSCI METH, V152, P179, DOI 10.1016/j.jneumeth.2005.09.007; Wang KH, 2010, J EXP BOT, V61, P551, DOI 10.1093/jxb/erp334; Welchen E, 2005, PLANT PHYSIOL, V139, P88, DOI 10.1104/pp.105.065920; Yamaji N, 2009, PLANT CELL, V21, P2878, DOI 10.1105/tpc.109.069831; Yang SS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-85; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang T, 2012, J PLANT BIOL, V55, P33, DOI 10.1007/s12374-011-9187-2; Zhao XQ, 2012, J PLANT BIOL, V55, P73, DOI 10.1007/s12374-011-9192-5; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	86	5	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60202	10.1371/journal.pone.0060202	http://dx.doi.org/10.1371/journal.pone.0060202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536906	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200054
J	Leznicki, P; Roebuck, QP; Wunderley, L; Clancy, A; Krysztofinska, EM; Isaacson, RL; Warwicker, J; Schwappach, B; High, S				Leznicki, Pawel; Roebuck, Quentin P.; Wunderley, Lydia; Clancy, Anne; Krysztofinska, Ewelina M.; Isaacson, Rivka L.; Warwicker, Jim; Schwappach, Blanche; High, Stephen			The Association of BAG6 with SGTA and Tail-Anchored Proteins	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; GET4/GET5 COMPLEX; UBIQUITIN LIGASE; ER MEMBRANE; INSERTION; DEGRADATION; BIOGENESIS; ACETYLATION	Background: The BAG6 protein is a subunit of a heterotrimeric complex that binds a range of membrane and secretory protein precursors localized to the cytosol, enforcing quality control and influencing their subsequent fate. Methodology and Principal Findings: BAG6 has an N-terminal ubiquitin-like domain, and a C-terminal Bcl-2-associated athanogene domain, separated by a large central proline-rich region. We have used in vitro binding approaches to identify regions of BAG6 important for its interactions with: i) the small-glutamine rich tetratricopeptide repeat-containing protein alpha (SGTA) and ii) two model tail-anchored membrane proteins as a paradigm for its hydrophobic substrates. We show that the BAG6-UBL is essential for binding to SGTA, and find that the UBL of a second subunit of the BAG6-complex, ubiquitin-like protein 4A (UBL4A), competes for SGTA binding. Our data show that this binding is selective, and suggest that SGTA can bind either BAG6, or UBL4A, but not both at the same time. We adapted our in vitro binding assay to study the association of BAG6 with an immobilized tail-anchored protein, Sec61b, and find both the UBL and BAG domains are dispensable for binding this substrate. This conclusion was further supported using a heterologous subcellular localization assay in yeast, where the BAG6-dependent nuclear relocalization of a second tail-anchored protein, GFP-Sed5, also required neither the UBL, nor the BAG domain of BAG6. Significance: On the basis of these findings, we propose a working model where the large central region of the BAG6 protein provides a binding site for a diverse group of substrates, many of which expose a hydrophobic stretch of polypeptide. This arrangement would enable the BAG6 complex to bring together its substrates with potential effectors including those recruited via its N-terminal UBL. Such effectors may include SGTA, and the resulting assemblies influence the subsequent fate of the hydrophobic BAG6 substrates.	[Leznicki, Pawel; Roebuck, Quentin P.; Wunderley, Lydia; Warwicker, Jim; High, Stephen] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Clancy, Anne; Schwappach, Blanche] Univ Gottingen, Dept Biochem 1, Gottingen, Germany; [Krysztofinska, Ewelina M.; Isaacson, Rivka L.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	University of Manchester; University of Gottingen; Imperial College London	High, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	stephen.high@manchester.ac.uk		High, Stephen/0000-0002-4532-8152; Clancy, Anne/0000-0001-8873-0849; Isaacson, Rivka Leah/0000-0002-9978-8904; Schwappach, Blanche/0000-0003-0225-6432; Leznicki, Pawel/0000-0002-2687-107X; Warwicker, Jim/0000-0002-1302-0815	Wellcome Trust: [092107/Z/10/Z, 081671/B/06/Z, 088163/Z/09/Z]; Medical Research Council [G0900936]; MRC [G0900936] Funding Source: UKRI	Wellcome Trust:(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust: 092107/Z/10/Z, 081671/B/06/Z, and 088163/Z/09/Z (http://www.wellcome.ac.uk/); and the Medical Research Council: G0900936 (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Ast T, 2011, CURR BIOL, V21, pR692, DOI 10.1016/j.cub.2011.08.018; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Brachmann CB, 1998, YEAST, V14, P115; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Brodsky JL, 2010, MOL CELL, V40, P5, DOI 10.1016/j.molcel.2010.09.016; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaczmarek K, 2011, MOL BIOL CELL, V22, P1766, DOI 10.1091/mbc.E09-12-0993; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2011, BIOCHEM J, V436, P719, DOI 10.1042/BJ20101737; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Simon AC, 2013, P NATL ACAD SCI USA, V110, P1327, DOI 10.1073/pnas.1207518110; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Sun YJ, 2010, J BIOL CHEM IN PRESS; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Weinberger A, 2005, MOL BIOL CELL, V16, P4918, DOI 10.1091/mbc.E05-02-0101; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028	51	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59590	10.1371/journal.pone.0059590	http://dx.doi.org/10.1371/journal.pone.0059590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533635	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400072
J	Nag, A; Bochukova, EG; Kremeyer, B; Campbell, DD; Muller, H; Valencia-Duarte, AV; Cardona, J; Rivas, IC; Mesa, SC; Cuartas, M; Garcia, J; Bedoya, G; Cornejo, W; Herrera, LD; Romero, R; Fournier, E; Reus, VI; Lowe, TL; Farooqi, IS; Mathews, CA; McGrath, LM; Yu, DM; Cook, E; Wang, K; Scharf, JM; Pauls, DL; Freimer, NB; Plagnol, V; Ruiz-Linares, A				Nag, Abhishek; Bochukova, Elena G.; Kremeyer, Barbara; Campbell, Desmond D.; Muller, Heike; Valencia-Duarte, Ana V.; Cardona, Julio; Rivas, Isabel C.; Mesa, Sandra C.; Cuartas, Mauricio; Garcia, Jharley; Bedoya, Gabriel; Cornejo, William; Herrera, Luis D.; Romero, Roxana; Fournier, Eduardo; Reus, Victor I.; Lowe, Thomas L.; Farooqi, I. Sadaf; Mathews, Carol A.; McGrath, Lauren M.; Yu, Dongmei; Cook, Ed; Wang, Kai; Scharf, Jeremiah M.; Pauls, David L.; Freimer, Nelson B.; Plagnol, Vincent; Ruiz-Linares, Andres		Tourette Syndrome Assoc Int	CNV Analysis in Tourette Syndrome Implicates Large Genomic Rearrangements in COL8A1 and NRXN1	PLOS ONE			English	Article							COPY NUMBER VARIATION; NERVOUS-SYSTEM; VARIANTS; GENES; SCHIZOPHRENIA; ASSOCIATION; DISORDER; FAMILY; AUTISM; SUSCEPTIBILITY	Tourette syndrome (TS) is a neuropsychiatric disorder with a strong genetic component. However, the genetic architecture of TS remains uncertain. Copy number variation (CNV) has been shown to contribute to the genetic make-up of several neurodevelopmental conditions, including schizophrenia and autism. Here we describe CNV calls using SNP chip genotype data from an initial sample of 210 TS cases and 285 controls ascertained in two Latin American populations. After extensive quality control, we found that cases (N = 179) have a significant excess (P = 0.006) of large CNV (. 500 kb) calls compared to controls (N = 234). Amongst 24 large CNVs seen only in the cases, we observed four duplications of the COL8A1 gene region. We also found two cases with similar to 400kb deletions involving NRXN1, a gene previously implicated in neurodevelopmental disorders, including TS. Follow-up using multiplex ligation-dependent probe amplification (and including 53 more TS cases) validated the CNV calls and identified additional patients with rearrangements in COL8A1 and NRXN1, but none in controls. Examination of available parents indicates that two out of three NRXN1 deletions detected in the TS cases are de-novo mutations. Our results are consistent with the proposal that rare CNVs play a role in TS aetiology and suggest a possible role for rearrangements in the COL8A1 and NRXN1 gene regions.	[Nag, Abhishek; Kremeyer, Barbara; Campbell, Desmond D.; Muller, Heike; Plagnol, Vincent; Ruiz-Linares, Andres] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London, England; [Bochukova, Elena G.; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Valencia-Duarte, Ana V.; Cuartas, Mauricio; Garcia, Jharley; Bedoya, Gabriel] Univ Antioquia, Genet Mol Lab, SIU, Medellin, Colombia; [Valencia-Duarte, Ana V.; Cornejo, William] Univ Pontificia Bolivariana, Escuela Ciencias Salud, Medellin, Colombia; [Cardona, Julio; Rivas, Isabel C.; Mesa, Sandra C.; Cornejo, William] Univ Antioquia, Dept Pediat, Fac Med, Medellin, Colombia; [Herrera, Luis D.; Romero, Roxana; Fournier, Eduardo] Hosp Nacl Ninos Dr Carlos Saenz Herrera, San Jose, Costa Rica; [Reus, Victor I.; Lowe, Thomas L.; Mathews, Carol A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [McGrath, Lauren M.; Scharf, Jeremiah M.; Pauls, David L.] Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA USA; [McGrath, Lauren M.; Yu, Dongmei; Scharf, Jeremiah M.; Pauls, David L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Cook, Ed] Univ Illinois, Chicago, IL USA; [Wang, Kai] Univ So Calif, Los Angeles, CA USA; [Scharf, Jeremiah M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidad de Antioquia; Universidad Pontificia Bolivariana; Universidad de Antioquia; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Southern California; Harvard University; Massachusetts General Hospital; University of California System; University of California Los Angeles	Ruiz-Linares, A (corresponding author), UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London, England.	a.ruizlin@ucl.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; McGrath, Lauren M./AFP-3898-2022; Sander-Effron, Samuel/AAX-2231-2020; reus, victor i/I-7923-2015; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Mathews, Carol A A/M-8922-2017; Ruiz-Linares, Andres/AAR-1104-2021; Cuartas Arias, Jorge Mauricio/L-6765-2017	O'Rahilly, Stephen/0000-0003-2199-4449; McGrath, Lauren M./0000-0001-6928-9656; reus, victor i/0000-0002-8193-5697; Mathews, Carol A A/0000-0003-2208-7058; Ruiz-Linares, Andres/0000-0001-8372-1011; Yu, Dongmei/0000-0001-7901-4365; Farooqi, Sadaf/0000-0001-7609-3504; Cuartas Arias, Jorge Mauricio/0000-0001-9007-713X; Bochukova, Elena/0000-0003-0275-1548; Campbell, Desmond/0000-0003-1085-714X; Plagnol, Vincent/0000-0002-5597-9215	National Institutes of Health [NS043538, NS037484, MH085057, NS40024, NS16648]; CODI; Judah Foundation; Tourette Syndrome Association; United Kingdom Medical Research Council [G1001158]; NIHR Moorfields Biomedical Research Council; MRC [G1001158] Funding Source: UKRI; Medical Research Council [G1001158] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016259, K23MH085057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043538, R01NS040024, R01NS016648, R01NS037484, U01NS040024, P30NS062691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CODI; Judah Foundation; Tourette Syndrome Association; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Moorfields Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (http://www.nih.gov/) grants NS043538 (to ARL), NS037484 (to NBF), MH085057 (to JMS), NS40024 (to DLP and JMS) and NS16648 (the Tourette Syndrome Association International Consortium for Genetics), a CODI grant (http://www.udea.edu.co/portal/page/portal/Programas/GruposInvestigacion/h.Convocatorias/CODI/estrategiaSostenibilidad) (Sostenibilidad, Universidad de Antioquia), a grant from the Judah Foundation (http://www.judahfoundation.org/), and the Tourette Syndrome Association (http://tsa-usa.org/) (fellowship to BK and a grant to DLP). VP is supported by a grant from the United Kingdom Medical Research Council (http://www.mrc.ac.uk) (G1001158) and by the NIHR Moorfields Biomedical Research Council (http://www.brcophthalmology.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Clarke RA, 2009, CASE REP MED, V2009, DOI 10.1155/2009/361518; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Fox MA, 2008, CURR OPIN CELL BIOL, V20, P508, DOI 10.1016/j.ceb.2008.05.003; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Herzberg I, 2006, HUM MOL GENET, V15, P3146, DOI 10.1093/hmg/ddl254; Herzberg I, 2010, PSYCHIAT GENET, V20, P179, DOI 10.1097/YPG.0b013e32833a215a; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; O'Rourke JA, 2009, J PSYCHOSOM RES, V67, P533, DOI 10.1016/j.jpsychores.2009.06.006; Price AL, 2006, NATGENET; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Robertson MM, 2006, J PSYCHOSOM RES, V61, P365, DOI 10.1016/j.jpsychores.2006.06.011; Saccomani L, 2005, BRAIN DEV-JPN, V27, P349, DOI 10.1016/j.braindev.2004.09.007; Scharf JM, 2010, NEUROLOGY, V74, P1564, DOI 10.1212/WNL.0b013e3181e24161; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stewart SE, 2006, J AM ACAD CHILD PSY, V45, P1354, DOI 10.1097/01.chi.0000251211.36868.fe; Stewart SE, 2012, MOL PSYCHIAT; Sundaram SK, 2010, NEUROLOGY, V74, P1583, DOI 10.1212/WNL.0b013e3181e0f147; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	32	53	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59061	10.1371/journal.pone.0059061	http://dx.doi.org/10.1371/journal.pone.0059061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533600	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000316549400037
J	Penny, WD; Ridgway, GR				Penny, William D.; Ridgway, Gerard R.			Efficient Posterior Probability Mapping Using Savage-Dickey Ratios	PLOS ONE			English	Article							DYNAMIC CAUSAL-MODELS; FMRI TIME-SERIES; BAYESIAN-INFERENCE; SPATIAL PRIORS; CONNECTIVITY; FRAMEWORK; SELECTION	Statistical Parametric Mapping (SPM) is the dominant paradigm for mass-univariate analysis of neuroimaging data. More recently, a Bayesian approach termed Posterior Probability Mapping (PPM) has been proposed as an alternative. PPM offers two advantages: (i) inferences can be made about effect size thus lending a precise physiological meaning to activated regions, (ii) regions can be declared inactive. This latter facility is most parsimoniously provided by PPMs based on Bayesian model comparisons. To date these comparisons have been implemented by an Independent Model Optimization (IMO) procedure which separately fits null and alternative models. This paper proposes a more computationally efficient procedure based on Savage-Dickey approximations to the Bayes factor, and Taylor-series approximations to the voxel-wise posterior covariance matrices. Simulations show the accuracy of this Savage-Dickey-Taylor (SDT) method to be comparable to that of IMO. Results on fMRI data show excellent agreement between SDT and IMO for second-level models, and reasonable agreement for first-level models. This Savage-Dickey test is a Bayesian analogue of the classical SPM-F and allows users to implement model comparison in a truly interactive manner.	[Penny, William D.; Ridgway, Gerard R.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	University of London; University College London	Penny, WD (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	w.penny@ucl.ac.uk	Ridgway, Gerard/F-5145-2010	Ridgway, Gerard/0000-0002-7676-7860; Penny, William/0000-0001-9064-1191	Wellcome Trust [091593/Z/10/Z]; Medical Research Council [MR/J014257/1]; MRC [MR/J014257/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust [grant number 091593/Z/10/Z]; and the Medical Research Council [grant number MR/J014257/1]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [grant number 091593/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bishop C. M, 2006, PATTERN RECOGNITION; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bowman FD, 2008, NEUROIMAGE, V39, P146, DOI 10.1016/j.neuroimage.2007.08.012; Christensen R, 2002, PLANE ANSWERS COMPLE; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; DICKEY JM, 1971, ANN MATH STAT, V42, P204, DOI 10.1214/aoms/1177693507; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Flandin G, 2007, NEUROIMAGE, V34, P1108, DOI 10.1016/j.neuroimage.2006.10.005; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2011, NEUROIMAGE, V56, P2089, DOI 10.1016/j.neuroimage.2011.03.062; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gossl C, 2001, BIOMETRICS, V57, P554, DOI 10.1111/j.0006-341X.2001.00554.x; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Harrison LM, 2008, NEUROIMAGE, V41, P408, DOI 10.1016/j.neuroimage.2008.02.005; Harrison LM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00037; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; MacKay D. J. C., 2003, INFORM THEORY INFERE; Penny W, 2005, PHILOS T R SOC B, V360, P983, DOI 10.1098/rstb.2005.1642; Penny W, 2003, NEUROIMAGE, V19, P727, DOI 10.1016/S1053-8119(03)00071-5; Penny W, 2005, P JOINT STAT M JSM; Penny W, 2005, TECHNICAL REPORT; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2005, NEUROIMAGE, V24, P350, DOI 10.1016/j.neuroimage.2004.08.034; Penny W, 2007, HUM BRAIN MAPP, V28, P275, DOI 10.1002/hbm.20327; Ridgway GR, 2012, NEUROIMAGE, V59, P2131, DOI 10.1016/j.neuroimage.2011.10.027; Rosa MJ, 2012, J NEUROSCI METH, V208, P66, DOI 10.1016/j.jneumeth.2012.04.013; Rosa MJ, 2010, NEUROIMAGE, V49, P217, DOI 10.1016/j.neuroimage.2009.08.051; Smith JF, 2012, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00104; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; VERDINELLI I, 1995, J AM STAT ASSOC, V90, P614, DOI 10.2307/2291073; Wipf D, 2009, NEUROIMAGE, V44, P947, DOI 10.1016/j.neuroimage.2008.02.059; Woolrich MW, 2012, NEUROIMAGE, V62, P801, DOI 10.1016/j.neuroimage.2011.10.047; Woolrich MW, 2004, IEEE T MED IMAGING, V23, P213, DOI 10.1109/TMI.2003.823065; Woolrich MW, 2004, NEUROIMAGE, V21, P1748, DOI 10.1016/j.neuroimage.2003.12.024; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Zhang LJ, 2012, J NEUROSCI METH, V204, P133, DOI 10.1016/j.jneumeth.2011.10.025	45	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59655	10.1371/journal.pone.0059655	http://dx.doi.org/10.1371/journal.pone.0059655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533640	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400077
J	Zarrouk, M; Rolf, J; Cantrell, DA				Zarrouk, Marouan; Rolf, Julia; Cantrell, Doreen Ann			LKB1 Mediates the Development of Conventional and Innate T Cells via AMP-Dependent Kinase Autonomous Pathways	PLOS ONE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; C-MYC; THYMUS; ACTIVATION; PRECURSORS	The present study has examined the role of the serine/threonine kinase LKB1 in the survival and differentiation of CD4/8 double positive thymocytes. LKB1-null DPs can respond to signals from the mature alpha/beta T-cell-antigen receptor and initiate positive selection. However, in the absence of LKB1, thymocytes fail to mature to conventional single positive cells causing severe lymphopenia in the peripheral lymphoid tissues. LKB1 thus appears to be dispensable for positive selection but important for the maturation of positively selected thymocytes. LKB1 also strikingly prevented the development of invariant V alpha 14 NKT cells and innate TCR alpha beta gut lymphocytes. Previous studies with gain of function mutants have suggested that the role of LKB1 in T cell development is mediated by its substrate the AMP-activated protein kinase ( AMPK). The present study now analyses the impact of AMPK deletion in DP thymocytes and shows that the role of LKB1 during the development of both conventional and innate T cells is mediated by AMPK-independent pathways.	[Zarrouk, Marouan; Rolf, Julia; Cantrell, Doreen Ann] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland	University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	Zarrouk, Marouan/K-7541-2019	Cantrell, Doreen/0000-0001-7525-3350; Zarrouk, Marouan/0000-0002-3259-6123	Wellcome Trust [065975/Z/01/A, 097418/Z/11Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust Principal Research Fellowship grant 065975/Z/01/A and 097418/Z/11Z to DAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YH, 2011, EMBO J, V30, P2083, DOI 10.1038/emboj.2011.116; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Finlay DK, 2010, J IMMUNOL, V185, P5973, DOI 10.4049/jimmunol.1000827; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jiang W, 2010, BLOOD, V115, P4431, DOI 10.1182/blood-2009-11-254698; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	21	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60217	10.1371/journal.pone.0060217	http://dx.doi.org/10.1371/journal.pone.0060217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533675	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400112
J	Duarte, MD; Henriques, AM; Barros, SC; Fagulha, T; Mendonca, P; Carvalho, P; Monteiro, M; Fevereiro, M; Basto, MP; Rosalino, LM; Barros, T; Bandeira, V; Fonseca, C; Cunha, MV				Duarte, Margarida D.; Henriques, Ana Margarida; Barros, Silvia Carla; Fagulha, Teresa; Mendonca, Paula; Carvalho, Paulo; Monteiro, Madalena; Fevereiro, Miguel; Basto, Mafalda P.; Rosalino, Luis Miguel; Barros, Tania; Bandeira, Victor; Fonseca, Carlos; Cunha, Monica V.			Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CANINE-DISTEMPER VIRUS; RAPID DETECTION; PANTHERA-LEO; PCR ASSAY; RED FOX; EMERGENCE; ANTIBODIES; INFERENCE; ENTERITIS	The exposure of wild carnivores to viral pathogens, with emphasis on parvovirus (CPV/FPLV), was assessed based on the molecular screening of tissue samples from 128 hunted or accidentally road- killed animals collected in Portugal from 2008 to 2011, including Egyptian mongoose (Herpestes ichneumon, n = 99), red fox (Vulpes vulpes, n = 19), stone marten (Martes foina, n = 3), common genet (Genetta genetta, n = 3) and Eurasian badger (Meles meles, n = 4). A high prevalence of parvovirus DNA (63%) was detected among all surveyed species, particularly in mongooses (58%) and red foxes (79%), along with the presence of CPV/FPLV circulating antibodies that were identified in 90% of a subset of parvovirus- DNA positive samples. Most specimens were extensively autolysed, restricting macro and microscopic investigations for lesion evaluation. Whenever possible to examine, signs of active disease were not present, supporting the hypothesis that the parvovirus vp2 gene fragments detected by real- time PCR possibly correspond to viral DNA reminiscent from previous infections. The molecular characterization of viruses, based on the analysis of the complete or partial sequence of the vp2 gene, allowed typifying three viral strains of mongoose and four red fox's as feline panleukopenia virus (FPLV) and one stone marten's as newCPV- 2b type. The genetic similarity found between the FPLV viruses from free- ranging and captive wild species originated in Portugal and publicly available comparable sequences, suggests a closer genetic relatedness among FPLV circulating in Portugal. Although the clinical and epidemiological significance of infection could not be established, this study evidences that exposure of sympatric wild carnivores to parvovirus is common and geographically widespread, potentially carrying a risk to susceptible populations at the wildlife- domestic interface and to threatened species, such as the wildcat (Felis silvestris) and the critically endangered Iberian lynx (Lynx pardinus).	[Duarte, Margarida D.; Henriques, Ana Margarida; Barros, Silvia Carla; Fagulha, Teresa; Mendonca, Paula; Carvalho, Paulo; Monteiro, Madalena; Fevereiro, Miguel; Cunha, Monica V.] IP Inst Nacl Invest Agr & Vet, INIAV, Unidade Estrateg Prod & Saude Anim, Lisbon, Portugal; [Basto, Mafalda P.; Rosalino, Luis Miguel] Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias Lisboa, P-1699 Lisbon, Portugal; [Rosalino, Luis Miguel] Univ Sao Paulo, Lab Ecol Isotop CENA, Sao Paulo, Brazil; [Barros, Tania; Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Barros, Tania; Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV); Universidade de Lisboa; Universidade de Sao Paulo; Universidade de Aveiro; Universidade de Aveiro	Cunha, MV (corresponding author), IP Inst Nacl Invest Agr & Vet, INIAV, Unidade Estrateg Prod & Saude Anim, Lisbon, Portugal.	monica.cunha@iniav.pt	Fevereiro, Miguel/D-2534-2014; Bandeira, Victor/AAE-7487-2020; BARROS, TANIA/AAP-6798-2020; Cunha, Mónica V./AAH-6246-2019; Henriques, Ana M/J-2630-2013; Barros, Silvia C/I-6564-2013; Fonseca, Carlos MMS/D-9744-2011; Rosalino, Luís Miguel/B-9406-2009; Cunha, Monica V./D-5544-2011; Duarte, Margarida D/J-2640-2013; Barros, Tânia/E-1408-2019	Fevereiro, Miguel/0000-0003-1811-1414; Cunha, Mónica V./0000-0003-0401-0276; Henriques, Ana M/0000-0003-1835-3077; Barros, Silvia C/0000-0002-6246-1983; Fonseca, Carlos MMS/0000-0001-6559-7133; Rosalino, Luís Miguel/0000-0003-4186-7332; Cunha, Monica V./0000-0003-0401-0276; Duarte, Margarida D/0000-0003-1488-9659; Barros, Tânia/0000-0001-7541-2278; Bandeira, Victor/0000-0002-2181-3372; Fagulha, Teresa/0000-0002-6509-6651	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; "Ciencia 2008" Program, a post-doctoral fellowship [SFRH/BPD/14435/2003, SFRH/BD/38410/2007, SFRH/BD/ 71112/2010, SFRH/BD/51540/2011]; FCT through QREN-POFC-COMPETE program [PTDC/CVT/117794/2010, PTDC/BIA-BEC/ 104401/2008]; FAPESP [Proc. 2011/00408-4]; Fundação para a Ciência e a Tecnologia [PTDC/CVT/117794/2010, PTDC/BIA-BEC/104401/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); "Ciencia 2008" Program, a post-doctoral fellowship; FCT through QREN-POFC-COMPETE program; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundação para a Ciência e a Tecnologia	The authors are grateful to Fundacao para a Ciencia e Tecnologia (FCT), Portugal, for funding research contracts to MVC, AMH and SCB, in the framework of "Ciencia 2008" Program, a post-doctoral fellowship to LMR (SFRH/BPD/14435/2003), and PhD grants to MPB (SFRH/BD/38410/2007), TB (SFRH/BD/ 71112/2010), and VB (SFRH/BD/51540/2011). MVC and CF acknowledge FCT through QREN-POFC-COMPETE program (PTDC/CVT/117794/2010 and PTDC/BIA-BEC/ 104401/2008). LMR also acknowledges the financial support from FAPESP (Proc. 2011/00408-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2012, J VIROL, V86, P865, DOI 10.1128/JVI.06187-11; Baker DG, 2003, PATHOGENS LAB ANIMAL; Baneth G, 1998, AM J TROP MED HYG, V59, P722, DOI 10.4269/ajtmh.1998.59.722; BARKER IK, 1983, CAN J COMP MED, V47, P188; Barlow AM, 2012, VET REC, V170, DOI 10.1136/vr.100680; Barros Tania, 2011, Galemys, V23, P9; Barton K, 2020, MUMIN MULTIMODEL INF; BARTON LD, 1988, J WILDLIFE DIS, V24, P246, DOI 10.7589/0090-3558-24.2.246; Battilani M, 2007, VET RES COMMUN, V31, P209, DOI 10.1007/s11259-007-0007-6; Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606; Blanco JC, 1998, MAMIFEROS ESPANA INS; Borralho R, 1996, MAMMAL REV, V26, P1, DOI 10.1111/j.1365-2907.1996.tb00143.x; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burtscher H, 2007, J ZOO WILDLIFE MED, V38, P139, DOI 10.1638/05-016.1; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Carl G, 2007, ECOL MODEL, V207, P159, DOI 10.1016/j.ecolmodel.2007.04.024; COCKBURN A, 1947, Br Vet J, V103, P261; Decaro N, 2005, VET MICROBIOL, V105, P19, DOI 10.1016/j.vetmic.2004.09.018; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Driciru M, 2006, J WILDLIFE DIS, V42, P667, DOI 10.7589/0090-3558-42.3.667; Duarte MD, 2009, J ZOO WILDLIFE MED, V40, P354, DOI 10.1638/2008-0015.1; Ferroglio E, 2000, PREV VET MED, V43, P117, DOI 10.1016/S0167-5877(99)00090-2; Frolich K, 2005, J WILDLIFE DIS, V41, P231, DOI 10.7589/0090-3558-41.1.231; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Gut M, 1999, J VIROL METHODS, V77, P37, DOI 10.1016/S0166-0934(98)00129-3; Hammon WD, 1939, J EXP MED, V69, P327, DOI 10.1084/jem.69.3.327; Helps C, 2003, J CLIN MICROBIOL, V41, P2734, DOI 10.1128/JCM.41.6.2734-2736.2003; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Ma WJ, 2008, J VET DIAGN INVEST, V20, P440, DOI 10.1177/104063870802000405; Maddison WP, 2019, MESQUITE MODULAR SYS; Maldonado CG, 2009, AVALIACAO PREVALENCI; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McCaw DL, 2006, INFECT DIS DOG CAT, P63; Millan J, 2009, VET J, V182, P114, DOI 10.1016/j.tvjl.2008.04.005; Mochizuki M, 1996, J ZOO WILDLIFE MED, V27, P416; MOCHIZUKI M, 1993, VET MICROBIOL, V38, P1, DOI 10.1016/0378-1135(93)90070-N; Mochizuki M, 1996, J CLIN MICROBIOL, V34, P2101, DOI 10.1128/JCM.34.9.2101-2105.1996; Nakamura K, 2001, CLIN DIAGN LAB IMMUN, V8, P663, DOI 10.1128/CDLI.8.3.663-668.2001; Nowell K., 1996, WILDCATS STATUS SURV; Oliveira M, 2008, EUR J WILDLIFE RES, V54, P245, DOI 10.1007/s10344-007-0137-8; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARRISH CR, 1994, SEMIN VIROL, V5, P121, DOI 10.1006/smvy.1994.1013; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos N, 2009, J WILDLIFE DIS, V45, P221, DOI 10.7589/0090-3558-45.1.221; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sobrino R, 2008, VET MICROBIOL, V126, P251, DOI 10.1016/j.vetmic.2007.06.014; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPENCER JA, 1991, S AFR J WILDL RES, V21, P59; Steinel A, 2000, J GEN VIROL, V81, P345, DOI 10.1099/0022-1317-81-2-345; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; STUDDERT MJ, 1973, VET REC, V93, P156, DOI 10.1136/vr.93.6.156; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truyen U, 1996, VET REC, V138, P365, DOI 10.1136/vr.138.15.365; Truyen U, 1998, EPIDEMIOL INFECT, V121, P433, DOI 10.1017/S0950268898001319; TRUYEN U, 1992, J VIROL, V66, P5399, DOI 10.1128/JVI.66.9.5399-5408.1992; UTTENTHAL A, 1990, J VIROL, V64, P2768, DOI 10.1128/JVI.64.6.2768-2779.1990; Vieira MJ, 2008, J VET DIAGN INVEST, V20, P488, DOI 10.1177/104063870802000412; Zuur Alain F., 2009, P1	67	43	43	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59399	10.1371/journal.pone.0059399	http://dx.doi.org/10.1371/journal.pone.0059399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527182	Green Published, gold			2022-12-27	WOS:000317562600070
J	Gloudemans, AK; Plantinga, M; Guilliams, M; Willart, MA; Ozir-Fazalalikhan, A; van der Ham, A; Boon, L; Harris, NL; Hammad, H; Hoogsteden, HC; Yazdanbakhsh, M; Hendriks, RW; Lambrecht, BN; Smits, HH				Gloudemans, Anouk K.; Plantinga, Maud; Guilliams, Martin; Willart, Monique A.; Ozir-Fazalalikhan, Arifa; van der Ham, Alwin; Boon, Louis; Harris, Nicola L.; Hammad, Hamida; Hoogsteden, Henk C.; Yazdanbakhsh, Maria; Hendriks, Rudi W.; Lambrecht, Bart N.; Smits, Hermelijn H.			The Mucosal Adjuvant Cholera Toxin B Instructs Non-Mucosal Dendritic Cells to Promote IgA Production Via Retinoic Acid and TGF-beta	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSES; IMMUNOGLOBULIN-A; VITAMIN-A; INDUCTION; SUBUNIT; ANTIGEN; INFLAMMATION; GENERATION; TOLERANCE	It is currently unknown how mucosal adjuvants cause induction of secretory immunoglobulin A (IgA), and how T cell-dependent (TD) or -independent (TI) pathways might be involved. Mucosal dendritic cells (DCs) are the primary antigen presenting cells driving TI IgA synthesis, by producing a proliferation-inducing ligand (APRIL), B cell activating factor (BAFF), Retinoic Acid (RA), TGF-beta or nitric oxide (NO). We hypothesized that the mucosal adjuvant Cholera Toxin subunit B (CTB) could imprint non-mucosal DCs to induce IgA synthesis, and studied the mechanism of its induction. In vitro, CTB-treated bone marrow derived DCs primed for IgA production by B cells without the help of T cells, yet required co-signaling by different Toll-like receptor (TLR) ligands acting via the MyD88 pathway. CTB-DC induced IgA production was blocked in vitro or in vivo when RA receptor antagonist, TGF-beta signaling inhibitor or neutralizing anti-TGF-beta was added, demonstrating the involvement of RA and TGF-beta in promoting IgA responses. There was no major involvement for BAFF, APRIL or NO. This study highlights that synergism between CTB and MyD88-dependent TLR signals selectively imprints a TI IgA-inducing capacity in non-mucosal DCs, explaining how CTB acts as an IgA promoting adjuvant.	[Gloudemans, Anouk K.; Hoogsteden, Henk C.; Hendriks, Rudi W.; Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Plantinga, Maud; Guilliams, Martin; Willart, Monique A.; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, Dept Resp Med, B-9000 Ghent, Belgium; [Ozir-Fazalalikhan, Arifa; van der Ham, Alwin; Yazdanbakhsh, Maria; Smits, Hermelijn H.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Harris, Nicola L.] Ecole Polytech Fed Lausanne, Lab Intestinal Immunol, Lausanne, Switzerland; [Plantinga, Maud; Guilliams, Martin; Willart, Monique A.; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium	Erasmus University Rotterdam; Erasmus MC; Ghent University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Bioceros B.V.; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Flanders Institute for Biotechnology (VIB); Ghent University	Smits, HH (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.	H.H.Smits@lumc.nl	Ibrahim, Essam Hassan/G-1960-2018; Yazdanbakhsh, Maria/AAI-3996-2020; Smits, Hermelijn/V-4216-2018; van der Ham, Alwin/V-5466-2018; Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015; Ozir-Fazalalikhan, A/V-5436-2018; Boon, Laurence/HCI-3629-2022; harris, nicola/E-5342-2019; Guilliams, Martin/N-7803-2013	Ibrahim, Essam Hassan/0000-0003-0130-2257; Yazdanbakhsh, Maria/0000-0002-7666-1441; Smits, Hermelijn/0000-0001-9279-2890; van der Ham, Alwin/0000-0002-4532-9120; Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603; Ozir-Fazalalikhan, A/0000-0002-0613-8372; harris, nicola/0000-0003-2922-0210; Guilliams, Martin/0000-0003-3525-7570; Boon, Louis/0000-0002-0937-9171	Dutch Organization for Scientific Research (NWO) [ZONMW 40-40100-94-9024, STW 10725]; Netherlands Asthma Foundation (NAF) [06.043]; Odysseus Grant of the Fonds Wetenschappelijk Onderzoek (FWO) Flanders; European Research Council (ERC) grant of the EU; Ghent University (Group-ID consortium)	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation (NAF); Odysseus Grant of the Fonds Wetenschappelijk Onderzoek (FWO) Flanders; European Research Council (ERC) grant of the EU; Ghent University (Group-ID consortium)	This work was supported by the Dutch Organization for Scientific Research (NWO), Grant No ZONMW 40-40100-94-9024 (HHS), STW 10725 (YZ and HHS), the Netherlands Asthma Foundation (NAF) Grant No 06.043 (AKG). BNL is a recipient of an Odysseus Grant of the Fonds Wetenschappelijk Onderzoek (FWO) Flanders, a European Research Council (ERC) grant of the EU, and of a Multidisciplinary Research Partnerships (MRP) grant of Ghent University (Group-ID consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Anjuere F, 2003, J IMMUNOL, V170, P1586, DOI 10.4049/jimmunol.170.3.1586; Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Bemark M, 2012, ANN NY ACAD SCI, V1247, P97, DOI 10.1111/j.1749-6632.2011.06378.x; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chorny A, 2010, ADV IMMUNOL, V107, P31, DOI [10.1016/S0065-2776(10)07006-9, 10.1016/B978-0-12-381300-8.00002-2]; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Desch AN, 2013, IMMUNOL RES, V55, P178, DOI 10.1007/s12026-012-8359-6; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hardenberg G, 2007, EUR J IMMUNOL, V37, P2900, DOI 10.1002/eji.200737210; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lycke N, 2005, CURR MOL MED, V5, P591, DOI 10.2174/1566524054863898; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Naito T, 2008, AM J RESP CELL MOL, V38, P161, DOI 10.1165/rcmb.2007-0237OC; Pilette Charles, 2004, Proc Am Thorac Soc, V1, P125, DOI 10.1513/pats.2306032; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Schnitzler AC, 2007, INFECT IMMUN, V75, P3150, DOI 10.1128/IAI.00581-06; Schwarze J, 1998, AM J RESP CRIT CARE, V158, P519, DOI 10.1164/ajrccm.158.2.9801014; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stal P, 2010, ALIMENT PHARM THER, V31, P387, DOI 10.1111/j.1365-2036.2009.04185.x; Sun JB, 2010, SCAND J IMMUNOL, V71, P1, DOI 10.1111/j.1365-3083.2009.02321.x; Suzuki Y, 2012, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2011-0329OC, DOI 10.1165/RCMB.2011-03290C]; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2010, IMMUNOL REV, V234, P247, DOI 10.1111/j.0105-2896.2009.00872.x; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	46	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59822	10.1371/journal.pone.0059822	http://dx.doi.org/10.1371/journal.pone.0059822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527272	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600097
J	Ivanov, IA; Beshkov, D; Shankar, A; Hanson, DL; Paraskevis, D; Georgieva, V; Karamacheva, L; Taskov, H; Varleva, T; Elenkov, I; Stoicheva, M; Nikolova, D; Switzer, WM				Ivanov, Ivailo Alexiev; Beshkov, Danail; Shankar, Anupama; Hanson, Debra L.; Paraskevis, Dimitrios; Georgieva, Viara; Karamacheva, Lyudmila; Taskov, Hristo; Varleva, Tonka; Elenkov, Ivaylo; Stoicheva, Mariana; Nikolova, Daniela; Switzer, William M.			Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics	PLOS ONE			English	Article							FULL-LENGTH GENOME; TRANSMITTED DRUG-RESISTANCE; GENETIC DIVERSITY; TYPE-1 STRAINS; SUBTYPE I; VIRUS; IDENTIFICATION; RECOMBINANT; SUSCEPTIBILITY; PREVALENCE	Limited information is available to describe the molecular epidemiology of HIV-1 in Bulgaria. To better understand the genetic diversity and the epidemiologic dynamics of HIV-1 we analyzed 125 new polymerase (pol) sequences from Bulgarians diagnosed through 2009 and 77 pol sequences available from our previous study from persons infected prior to 2007. Epidemiologic and demographic information was obtained from each participant and phylogenetic analysis was used to infer HIV-1 evolutionary histories. 120 (59.5%) persons were infected with one of five different HIV-1 subtypes (A1, B, C, F1 and H) and 63 (31.2%) persons were infected with one of six different circulating recombinant forms (CRFs; 01_AE, 02_AG, 04_cpx, 05_DF, 14_BG, and 36_cpx). We also for the first time identified infection with two different clusters of unique A-like and F-like sub-subtype variants in 12 persons (5.9%) and seven unique recombinant forms (3.5%), including a novel J/C recombinant. While subtype B was the major genotype identified and was more prevalent in MSM and increased between 2000-2005, most non-B subtypes were present in persons >= 45 years old. CRF01_AE was the most common non-B subtype and was higher in women and IDUs relative to other risk groups combined. Our results show that HIV-1 infection in Bulgaria reflects the shifting distribution of genotypes coincident with the changing epidemiology of the HIV-1 epidemic among different risk groups. Our data support increased public health interventions targeting IDUs and MSM. Furthermore, the substantial and increasing HIV-1 genetic heterogeneity, combined with fluctuating infection dynamics, highlights the importance of sustained and expanded surveillance to prevent and control HIV-1 infection in Bulgaria.	[Ivanov, Ivailo Alexiev; Beshkov, Danail; Georgieva, Viara; Karamacheva, Lyudmila; Taskov, Hristo] Natl Ctr Infect & Parasit Dis, Natl Reference Lab HIV, Sofia, Bulgaria; [Shankar, Anupama; Hanson, Debra L.; Switzer, William M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Paraskevis, Dimitrios] Univ Athens, Sch Med, Natl Retrovirus Reference Ctr, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Varleva, Tonka] Minist Hlth, Program Prevent & Control HIV AIDS, Sofia, Bulgaria; [Elenkov, Ivaylo] Hosp Infect & Parasit Dis, Sofia, Bulgaria; [Stoicheva, Mariana] Med Univ, Plovdiv, Bulgaria; [Nikolova, Daniela] Med Univ, Clin Infect Dis, Varna, Bulgaria	Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Centers for Disease Control & Prevention - USA; Athens Medical School; National & Kapodistrian University of Athens; Ministry of Health Bulgaria; Medical University Plovdiv; Medical University Varna	Ivanov, IA (corresponding author), Natl Ctr Infect & Parasit Dis, Natl Reference Lab HIV, Sofia, Bulgaria.	Ivoalexiev@yahoo.com	Paraskevis, Dimitrios/H-5835-2019; Taskov, Hristo B/T-7680-2017; Varleva, Tonka/AAY-6476-2020	Paraskevis, Dimitrios/0000-0001-6167-7152; Taskov, Hristo B/0000-0002-7818-7587; Varleva, Tonka/0000-0003-0590-6744; Alexiev, Ivailo/0000-0002-3186-1124	Bulgarian Ministry of Health Directorate; European Commission [LSHPCT-2006-518211]	Bulgarian Ministry of Health Directorate; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded in part by the Bulgarian Ministry of Health Directorate "Management of Specialized Donor-funded Programs" and by the European Commission sixth framework supported programs EuropeHIVResistance, grant LSHPCT-2006-518211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 2000, SCAND J INFECT DIS, V32, P455, DOI 10.1080/003655400458695; Avi R, 2011, SCAND J INFECT DIS, V43, P122, DOI 10.3109/00365548.2010.526956; Babic DZ, 2006, J MED VIROL, V78, P997, DOI 10.1002/jmv.20654; Balode D, 2010, J MED VIROL, V82, P2013, DOI 10.1002/jmv.21921; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; BUONAGURO L., 2007, RETROVIR, V21, P4; Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138; Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]; Cornelissen M, 2000, J GEN VIROL, V81, P515, DOI 10.1099/0022-1317-81-2-515; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fernandez-Garcia A, 2009, AIDS RES HUM RETROV, V25, P1187, DOI 10.1089/aid.2009.0140; Gao F, 1998, J VIROL, V72, P10234, DOI 10.1128/JVI.72.12.10234-10241.1998; Gao F, 2001, AIDS RES HUM RETROV, V17, P675, DOI 10.1089/088922201750236951; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Julia C, 2007, AFRICAN MIGRATION EU; Kijak Gustavo H, 2005, Curr Infect Dis Rep, V7, P480, DOI 10.1007/s11908-005-0051-8; KOSTRIKIS LG, 1995, J VIROL, V69, P6122, DOI 10.1128/JVI.69.10.6122-6130.1995; Lepej SZ, 2009, AIDS RES HUM RETROV, V25, P1335, DOI 10.1089/aid.2009.0130; Liitsola K, 2000, AIDS RES HUM RETROV, V16, P1047, DOI 10.1089/08892220050075309; Liitsola K, 1996, SCAND J INFECT DIS, V28, P537, DOI 10.3109/00365549609037956; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; Magiorkinis M, 2009, THERAPY, V4, P369; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Nasioulas G, 1999, AIDS RES HUM RETROV, V15, P745, DOI 10.1089/088922299310836; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Pandrea I, 2001, AIDS RES HUM RETROV, V17, P1297, DOI 10.1089/088922201750461375; Papa A, 2002, VIRUS RES, V85, P85, DOI 10.1016/S0168-1702(02)00020-5; Paraschiv S, 2008, REV ANTIVIRAL THERAP, V2, P69; Paraskevis D, 2011, EUROSURVEILLANCE, V16, P2; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pirs M, 2006, COLLEGIUM ANTROPOL, V30, P47; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Riva C, 2008, AIDS RES HUM RETROV, V24, P1319, DOI 10.1089/aid.2008.0119; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Saad MD, 2006, AIDS RES HUM RETROV, V22, P709, DOI 10.1089/aid.2006.22.709; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181; Santoro MM, 2008, AIDS RES HUM RETROV, V24, P1133, DOI 10.1089/aid.2008.0042; Stanojevic M, 2002, AIDS RES HUM RETROV, V18, P519, DOI 10.1089/088922202317406673; Stanojevic M, 2012, AIDS REV, V14, P28; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Triques K, 2000, AIDS RES HUM RETROV, V16, P139, DOI 10.1089/088922200309485; UNAIDS, 2010, REP GLOB AIDS EP; Ustina V, 2001, AIDS RES HUM RETROV, V17, P81, DOI 10.1089/088922201750056816; Van der Auwera G, 2001, AIDS RES HUM RETROV, V17, P185, DOI 10.1089/08892220150217274; Yilmaz G, 2006, INT J INFECT DIS, V10, P286, DOI 10.1016/j.ijid.2005.06.011	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59666	10.1371/journal.pone.0059666	http://dx.doi.org/10.1371/journal.pone.0059666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527245	Green Published, gold			2022-12-27	WOS:000317562100156
J	Hodzic, A; Ristanovic, M; Zorn, B; Tulic, C; Maver, A; Novakovic, I; Peterlin, B				Hodzic, Alenka; Ristanovic, Momcilo; Zorn, Branko; Tulic, Cane; Maver, Ales; Novakovic, Ivana; Peterlin, Borut			Genetic Variation in Circadian Rhythm Genes CLOCK and ARNTL as Risk Factor for Male Infertility	PLOS ONE			English	Article							5-HYDROXYINDOLEACETIC ACID; OBESITY; TESTOSTERONE; FERTILITY; ASSOCIATION; MEN; VARIANTS	Background: The circadian system has a major role in maintaining homeostasis and proper body functions including reproductive capacity. The aim of this study was to examine whether there is an association between genetic variability in the primary clock genes CLOCK and ARNTL and male infertility in humans. Methodology/Principal Findings: We performed a case-control study, where we searched for an association between polymorphisms of CLOCK and ARNTL genes and male infertility in 961 Slovenian and Serbian Caucasian men. The study group consisted of 517 patients with idiopathic infertility and a control group of 444 fertile men. A statistically significant difference was found in genotype distribution between the two groups in the CLOCK gene: rs11932595 (p = 6.10(-5), q=4.10(-4), OR equaled 1.9 with 95%CI 1.4-2.7), rs6811520 (p=2.10(-3), q=8.10(-3), OR = 1.7 with 95%CI 1.2-2.2) and rs6850524 (p=0.01, q=0.02, OR=1.4 with 95%CI 1.1-1.9). Further analyses of haplotypes were consistent with genotyping results. Conclusions/Significance: We provide evidence that genetic variability in the CLOCK gene might be associated with male infertility warranting further confirmation and mechanistic investigations.	[Hodzic, Alenka; Zorn, Branko; Maver, Ales; Peterlin, Borut] Univ Med Ctr Ljubljana, Inst Med Genet, Ljubljana, Slovenia; [Hodzic, Alenka; Zorn, Branko; Maver, Ales; Peterlin, Borut] Univ Med Ctr Ljubljana, Dept Obstet & Gynecol, Ljubljana, Slovenia; [Ristanovic, Momcilo; Novakovic, Ivana] Univ Belgrade, Fac Med, Inst Human Genet, Belgrade 11001, Serbia; [Tulic, Cane] Univ Belgrade, Fac Med, Inst Urol & Nephrol, Belgrade 11001, Serbia	University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Belgrade; University of Belgrade	Peterlin, B (corresponding author), Univ Med Ctr Ljubljana, Inst Med Genet, Ljubljana, Slovenia.	borut.peterlin@guest.arnes.si	Peterlin, Borut/C-6086-2011	Peterlin, Borut/0000-0001-7824-4978; Maver, Ales/0000-0002-9826-0534	National Research Agency of the Republic of Slovenia [P3-0326]	National Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia)	This work was supported by National Research Agency of the Republic of Slovenia, grant no.: P3-0326 (http://www.arrs.gov.si/sl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Aragon MA, 2005, REPRODUCTION, V129, P717, DOI 10.1530/rep.1.00598; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Bribiescas RG, 2010, AM J HUM BIOL, V22, P216, DOI 10.1002/ajhb.21012; Cabler S, 2010, ASIAN J ANDROL, V12, P480, DOI 10.1038/aja.2010.38; Chu LW, 2008, CANCER EPIDEM BIOMAR, V17, P3268, DOI 10.1158/1055-9965.EPI-08-0073; COOKE RR, 1993, CLIN ENDOCRINOL, V39, P163, DOI 10.1111/j.1365-2265.1993.tb01769.x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; El-Helaly M, 2010, INT J OCCUP MED ENV, V23, P331, DOI 10.2478/v10001-010-0039-y; Hagenauer MH, 2011, ENDOCRINOLOGY, V152, P1727, DOI 10.1210/en.2011-0198; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Hwang Kathleen, 2010, Ann N Y Acad Sci, V1214, pE1, DOI 10.1111/j.1749-6632.2010.05917.x; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Kennaway DJ, 2012, MOL CELL ENDOCRINOL, V349, P56, DOI 10.1016/j.mce.2011.08.013; Kovanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010007; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Ortiz A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-138; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SEGAL S, 1975, FERTIL STERIL, V26, P314; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Tahira K, 2011, ARCH MED SCI, V7, P933, DOI [10.5114/AOM5.2011.26603, 10.5114/aoms.2011.26603]; Teo WP, 2011, J STRENGTH COND RES, V25, P1538, DOI 10.1519/JSC.0b013e3181da77b0; World Health Organization, 1999, WHO LAB MAN EX HUM S	28	25	27	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59220	10.1371/journal.pone.0059220	http://dx.doi.org/10.1371/journal.pone.0059220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527142	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600052
J	Vega-Rua, A; Zouache, K; Caro, V; Diancourt, L; Delaunay, P; Grandadam, M; Failloux, AB				Vega-Rua, Anubis; Zouache, Karima; Caro, Valerie; Diancourt, Laure; Delaunay, Pascal; Grandadam, Marc; Failloux, Anna-Bella			High Efficiency of Temperate Aedes albopictus to Transmit Chikungunya and Dengue Viruses in the Southeast of France	PLOS ONE			English	Article							LARVAL ENVIRONMENTAL-TEMPERATURE; METROPOLITAN FRANCE; DIPTERA-CULICIDAE; AEGYPTI MOSQUITOS; SKUSE DIPTERA; INFECTION; OUTBREAK; FEVER; ARBOVIRUSES; COMPETENT	Background: Since 2005, cases of chikungunya (CHIK) were caused by an unusual vector, Aedes albopictus. This mosquito, present in Europe since 1979, has gained importance since its involvement in the first CHIK outbreak in Italy in 2007. The species is capable of transmitting experimentally 26 arboviruses. However, the vectorial status of its temperate populations has remained little investigated. In 2010, autochthonous cases of CHIK and dengue (DEN) were reported in southeastern France. We evaluated the potential of a French population of Ae. albopictus in the transmission of both viruses. Methodology and Principal Findings: We used two strains of each virus, CHIK and DEN: one strain was isolated from an imported case, and one from an autochthonous case. We used as controls Aedes aegypti from India and Martinique, the source of the imported cases of CHIK and DEN, respectively. We showed that Ae. albopictus from Cagnes-sur-Mer (AL-CSM) was as efficient as the typical tropical vector Ae. aegypti from India to experimentally transmit both CHIK strains isolated from patients in Fre'jus, with around 35-67% of mosquitoes delivering up to 14 viral particles at day 3 post-infection (pi). The unexpected finding came from the high efficiency of AL-CSM to transmit both strains of DENV-1 isolated from patients in Nice. Almost 67% of Ae. albopictus AL-CSM which have ensured viral dissemination were able to transmit at day 9 pi when less than 21% of the typical DEN vector Ae. aegypti from Martinique could achieve transmission. Conclusions/Significance: Temperate Ae. albopictus behaves differently compared to its counterpart from tropical regions, where recurrent epidemic outbreaks occur. Its potential responsibility for outbreaks in Europe should not be minimized.	[Vega-Rua, Anubis; Zouache, Karima; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Paris, France; [Caro, Valerie; Diancourt, Laure] Inst Pasteur, Dept Infect & Epidemiol, Paris, France; [Delaunay, Pascal] Ctr Hosp Univ Nice, Hop Archet, Nice, France; [Delaunay, Pascal] Univ Nice Sophia Antipolis, INSERM, U1065, Lab Parasitol Mycol, Nice, France; [Grandadam, Marc] Inst Pasteur, Dept Virol, Natl Reference Ctr Arboviruses, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	anna-bella.failloux@pasteur.fr	GRANDADAM, Marc/GNP-7470-2022	DIANCOURT, Laure/0000-0002-9670-3274	European Commission Framework Program Seven Award `"InfraVec'' [228421]; European Community's Seventh Framework Programme under the project "VECTORIE'', EC grant [261466]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	European Commission Framework Program Seven Award `"InfraVec''; European Community's Seventh Framework Programme under the project "VECTORIE'', EC grant; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	AVR was supported by the European Commission Framework Program Seven Award `"InfraVec'' (project number 228421). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "VECTORIE'', EC grant agreement number 261466. This study has also received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant number ANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; Delaunay P, 2007, Med Trop (Mars), V67, P310; Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0; Gjenero-Margan I, 2011, EURO SURVEILL, V16; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x; Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209; Myles KM, 2003, J VIROL, V77, P8872, DOI 10.1128/JVI.77.16.8872-8881.2003; Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; PIERRE V, 2005, EP DENG REUN 2004 JO; Receveur M, 2010, EUROSURVEILLANCE, V15, P7; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rezza G, 2008, ANN I SUPER SANITA, V44, P315; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Schmidt-Chanasit J., 2010, EUROSURVEILLANCE, V15; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shrinet J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-100; Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035; Yebakima A, 2004, TROP MED INT HEALTH, V9, P582, DOI 10.1111/j.1365-3156.2004.01241.x	40	105	109	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59716	10.1371/journal.pone.0059716	http://dx.doi.org/10.1371/journal.pone.0059716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527259	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600076
J	Brewster, AL; Lugo, JN; Patil, VV; Lee, WL; Qian, Y; Vanegas, F; Anderson, AE				Brewster, Amy L.; Lugo, Joaquin N.; Patil, Vinit V.; Lee, Wai L.; Qian, Yan; Vanegas, Fabiola; Anderson, Anne E.			Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; TUBEROUS SCLEROSIS COMPLEX; MESSENGER-RNA TRANSLATION; CA1 PYRAMIDAL NEURONS; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; MOUSE MODEL; PHARMACOLOGICAL INHIBITION; HIPPOCAMPAL-NEURONS	Cognitive impairments are prominent sequelae of prolonged continuous seizures (status epilepticus; SE) in humans and animal models. While often associated with dendritic injury, the underlying mechanisms remain elusive. The mammalian target of rapamycin complex 1 (mTORC1) pathway is hyperactivated following SE. This pathway modulates learning and memory and is associated with regulation of neuronal, dendritic, and glial properties. Thus, in the present study we tested the hypothesis that SE-induced mTORC1 hyperactivation is a candidate mechanism underlying cognitive deficits and dendritic pathology seen following SE. We examined the effects of rapamycin, an mTORC1 inhibitor, on the early hippocampal-dependent spatial learning and memory deficits associated with an episode of pilocarpine-induced SE. Rapamycin-treated SE rats performed significantly better than the vehicle-treated rats in two spatial memory tasks, the Morris water maze and the novel object recognition test. At the molecular level, we found that the SE-induced increase in mTORC1 signaling was localized in neurons and microglia. Rapamycin decreased the SE-induced mTOR activation and attenuated microgliosis which was mostly localized within the CA1 area. These findings paralleled a reversal of the SE-induced decreases in dendritic Map2 and ion channels levels as well as improved dendritic branching and spine density in area CA1 following rapamycin treatment. Taken together, these findings suggest that mTORC1 hyperactivity contributes to early hippocampal-dependent spatial learning and memory deficits and dendritic dysregulation associated with SE.	[Brewster, Amy L.; Lugo, Joaquin N.; Patil, Vinit V.; Lee, Wai L.; Qian, Yan; Vanegas, Fabiola; Anderson, Anne E.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA; [Brewster, Amy L.; Lugo, Joaquin N.; Patil, Vinit V.; Lee, Wai L.; Qian, Yan; Vanegas, Fabiola; Anderson, Anne E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Anderson, Anne E.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Anderson, Anne E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Anderson, AE (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA.	annea@bcm.edu			National Institutes of Health [39943, 49427, 43124]; Epilepsy Foundation Postdoctoral Fellowship; Epilepsy Foundation Predoctoral Fellowship [F32 NS 56664]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS056664, R01NS039943, R01NS049427, T32NS043124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation Postdoctoral Fellowship; Epilepsy Foundation Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health, R01 NS, 39943; 49427 (AEA); T32 NS, 43124, Epilepsy Foundation Postdoctoral Fellowship (ALB); Epilepsy Foundation Predoctoral Fellowship (VVP); F32 NS 56664 (JNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Chachua T, 2012, EPILEPSIA, V53, P2015, DOI 10.1111/j.1528-1167.2012.03674.x; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dehmelt L, 2005, GENOME BIOL, V6; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fenoglio KA, 2005, ENDOCRINOLOGY, V146, P4090, DOI 10.1210/en.2004-1285; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hartman AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045156; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmes GL, 2004, MENT RETARD DEV D R, V10, P101, DOI 10.1002/mrdd.20019; Huang X, 2012, NEUROSCIENCE, V215, P90, DOI 10.1016/j.neuroscience.2012.04.011; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jensen FE, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02904.x; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kettenmann H, 2006, NAT NEUROSCI, V9, P1463, DOI 10.1038/nn1206-1463; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lang UE, 2009, TRANSPL P, V41, P4285, DOI 10.1016/j.transproceed.2009.08.050; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; McKay BE, 2004, PHARMACOL BIOCHEM BE, V78, P111, DOI 10.1016/j.pbb.2004.02.019; Milatovic D, 2003, J NEUROCHEM, V87, P1518, DOI 10.1046/j.1471-4159.2003.02120.x; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Nishimura M, 2008, NEUROBIOL DIS, V29, P267, DOI 10.1016/j.nbd.2007.08.018; Nishimura M, 2011, NEUROBIOL DIS, V44, P205, DOI 10.1016/j.nbd.2011.07.002; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Oliveira MS, 2010, BRAIN RES, V1348, P187, DOI 10.1016/j.brainres.2010.05.095; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sha LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039152; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Staley Kevin J, 2006, Epilepsy Curr, V6, P199, DOI 10.1111/j.1535-7511.2006.00145.x; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang HF, 2011, J CLIN INVEST, V121, P4820, DOI 10.1172/JCI45677; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	70	83	85	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57808	10.1371/journal.pone.0057808	http://dx.doi.org/10.1371/journal.pone.0057808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536771	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100017
J	Hwang, JH; Chen, JC; Chan, YC				Hwang, Juen-Haur; Chen, Jin-Cherng; Chan, Yin-Ching			Effects of C-phycocyanin and Spirulina on Salicylate-Induced Tinnitus, Expression of NMDA Receptor and Inflammatory Genes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MICROGLIA; ACTIVATION; PLASTICITY; DAMAGE; RATS	Effects of C-phycocyanin (C-PC), the active component of Spirulina platensis water extract on the expressions of N-methyl D-aspartate receptor subunit 2B (NR2B), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and cyclooxygenase type 2 (COX-2) genes in the cochlea and inferior colliculus (IC) of mice were evaluated after tinnitus was induced by intraperitoneal injection of salicylate. The results showed that 4-day salicylate treatment (unlike 4-day saline treatment) caused a significant increase in NR2B, TNF-alpha, and IL-1 beta mRNAs expression in the cochlea and IC. On the other hand, dietary supplementation with C-PC or Spirulina platensis water extract significantly reduced the salicylate-induced tinnitus and down-regulated the mRNAs expression of NR2B, TNF-alpha, IL-1 beta mRNAs, and COX-2 genes in the cochlea and IC of mice. The changes of protein expression levels were generally correlated with those of mRNAs expression levels in the IC for above genes.	[Hwang, Juen-Haur] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Hwang, Juen-Haur; Chen, Jin-Cherng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Jin-Cherng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Neurosurg, Chiayi, Taiwan; [Chan, Yin-Ching] Providence Univ, Dept Food & Nutr, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Providence University - Taiwan	Chan, YC (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	ycchan@pu.edu.tw		Chan, Yin Ching/0000-0001-9602-0775	National Science Council, Taiwan [NSC-95-231693-B-126-008, NSC-99-2314-B-303-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council, Taiwan (NSC-95-231693-B-126-008 and NSC-99-2314-B-303-001-MY3). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper J C Jr, 1994, J Am Acad Audiol, V5, P37; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Han PC, 2010, J NEUROTRAUM, V27, P287, DOI 10.1089/neu.2009.1016; Hwang JH, 2011, J NUTR SCI VITAMINOL, V57, P186, DOI 10.3177/jnsv.57.186; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Hwang JH, 2011, LARYNGOSCOPE, V121, P361, DOI 10.1002/lary.21283; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; McCarty MF, 2010, MED HYPOTHESES, V74, P601, DOI 10.1016/j.mehy.2008.09.061; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; Megwalu UC, 2006, OTOLARYNG HEAD NECK, V134, P210, DOI 10.1016/j.otohns.2005.10.007; Park HJ, 2009, HEARING RES, V257, P53, DOI 10.1016/j.heares.2009.08.001; PHOON WH, 1993, OCCUP MED-OXFORD, V43, P35, DOI 10.1093/occmed/43.1.35; Romay C, 1999, J PHARM PHARMACOL, V51, P641, DOI 10.1211/0022357991772646; Sanghvi Avani M, 2010, Recent Pat Food Nutr Agric, V2, P187, DOI 10.2174/1876142911002030187; Smith Paul F, 2005, Curr Opin Investig Drugs, V6, P712; Stromberg I, 2005, EXP NEUROL, V196, P298, DOI 10.1016/j.expneurol.2005.08.013; Wakabayashi K, 2010, NEUROSCI RES, V66, P345, DOI 10.1016/j.neures.2009.12.008; Wallhausser-Franke E, 2006, NEUROREPORT, V17, P1487, DOI 10.1097/01.wnr.0000230504.25102.26; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; Weber C, 2002, J PSYCHOSOM RES, V52, P29, DOI 10.1016/S0022-3999(01)00281-1; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023	23	49	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58215	10.1371/journal.pone.0058215	http://dx.doi.org/10.1371/journal.pone.0058215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533584	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400021
J	Duan, XF; Imai, T; Chou, B; Tu, LP; Himeno, K; Suzue, K; Hirai, M; Taniguchi, T; Okada, H; Shimokawa, C; Hisaeda, H				Duan, Xuefeng; Imai, Takashi; Chou, Bin; Tu, Liping; Himeno, Kunisuke; Suzue, Kazutomo; Hirai, Makoto; Taniguchi, Tomoyo; Okada, Hiroko; Shimokawa, Chikako; Hisaeda, Hajime			Resistance to Malaria by Enhanced Phagocytosis of Erythrocytes in LMP7-deficient Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; MHC-LINKED LMP; INTERFERON-GAMMA; PLASMODIUM-BERGHEI; BLOOD-STAGE; INFECTED ERYTHROCYTES; FUNCTIONAL DIVERSITY; PROTECTIVE IMMUNITY; CDNA CLONING; SUBUNIT-X	General cellular functions of proteasomes occur through protein degradation, whereas the specific function of immunoproteasomes is the optimization of antigen processing associated with MHC class I. We and others previously reported that deficiency in subunits of immunoproteasomes impaired the activation of antigen-specific CD8(+) T cells, resulting in higher susceptibility to tumor and infections. We demonstrated that CD8(+) T cells contributed to protection against malaria parasites. In this study, we evaluated the role of immunoproteasomes in the course of infection with rodent malaria parasites. Unexpectedly, Plasmodium yoelii infection of mice deficient in LMP7, a catalytic subunit of immunoproteasomes, showed lower parasite growth in the early phase of infection and lower lethality compared with control mice. The protective characteristics of LMP7-deficient mice were not associated with enhanced immune responses, as the mutant mice showed comparable or diminished activation of innate and acquired immunity. The remarkable difference was observed in erythrocytes instead of immune responses. Parasitized red blood cells (pRBCs) purified from LMP7-deficient mice were more susceptible to phagocytosis by macrophages compared with those from wild-type mice. The susceptibility of pRBC to phagocytosis appeared to correlate with deformity of the membrane structures that were only observed after infection. Our results suggest that RBCs of LMP7-deficient mice were more likely to deform in response to infection with malaria parasites, presumably resulting in higher susceptibility to phagocytosis and in the partial resistance to malaria.	[Duan, Xuefeng; Chou, Bin; Tu, Liping; Himeno, Kunisuke] Kyushu Univ, Dept Parasitol, Grad Sch Med Sci, Fukuoka 812, Japan; [Imai, Takashi; Suzue, Kazutomo; Hirai, Makoto; Taniguchi, Tomoyo; Okada, Hiroko; Shimokawa, Chikako; Hisaeda, Hajime] Gunma Univ, Dept Parasitol, Grad Sch Med, Maebashi, Gunma 371, Japan	Kyushu University; Gunma University	Hisaeda, H (corresponding author), Gunma Univ, Dept Parasitol, Grad Sch Med, Maebashi, Gunma 371, Japan.	hisa@gunma-u.ac.jp		Imai, Takashi/0000-0001-9049-8102; Suzue, Kazutomo/0000-0002-8959-5746	Strategic Fund for the Promotion of Science and Technology; Gunma University Operation Grants for the multi-drug resistance from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Memorial Foundation;  [24117504]	Strategic Fund for the Promotion of Science and Technology; Gunma University Operation Grants for the multi-drug resistance from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Memorial Foundation; 	This work was supported by grants-in-aid (24117504), the Strategic Fund for the Promotion of Science and Technology, and Gunma University Operation Grants for the multi-drug resistance from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Takeda Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; AKIYAMA K, 1994, FEBS LETT, V343, P85, DOI 10.1016/0014-5793(94)80612-8; AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Casale M, 2011, EXPERT REV HEMATOL, V4, P627, DOI 10.1586/EHM.11.51; Chou B, 2008, MICROBES INFECT, V10, P241, DOI 10.1016/j.micinf.2007.11.010; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Duan XF, 2006, INT IMMUNOL, V18, P679, DOI 10.1093/intimm/dxl005; EBISUI C, 1995, J BIOCHEM-TOKYO, V117, P1088, DOI 10.1093/oxfordjournals.jbchem.a124811; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Froment C, 2005, PROTEOMICS, V5, P2351, DOI 10.1002/pmic.200401281; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; ICHIHARA A, 1993, ADV ENZYME REGUL, V33, P173; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Ishii K, 2006, MICROBES INFECT, V8, P1045, DOI 10.1016/j.micinf.2005.10.023; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Koka S, 2008, CELL PHYSIOL BIOCHEM, V22, P261, DOI 10.1159/000149804; KUMAR S, 1989, J IMMUNOL, V143, P2017; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miyakoda M, 2008, J IMMUNOL, V181, P1420, DOI 10.4049/jimmunol.181.2.1420; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; SHIMBARA N, 1992, J BIOL CHEM, V267, P18100; Sijts A., 2001, Current Molecular Medicine (Hilversum), V1, P665, DOI 10.2174/1566524013363230; STEVENSON MM, 1989, PARASITE IMMUNOL, V11, P529, DOI 10.1111/j.1365-3024.1989.tb00687.x; SUSS G, 1988, INFECT IMMUN, V56, P3081; TOSTA CE, 1980, EXP PARASITOL, V50, P7, DOI 10.1016/0014-4894(80)90003-X; TSUKAHARA T, 1991, BIOCHIM BIOPHYS ACTA, V1079, P273, DOI 10.1016/0167-4838(91)90069-C; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; Zoeger A, 2006, CLIN CHEM, V52, P2079, DOI 10.1373/clinchem.2006.072496	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59633	10.1371/journal.pone.0059633	http://dx.doi.org/10.1371/journal.pone.0059633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527234	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100151
J	Nogueira, RT; Nogueira, AR; Pereira, MCS; Rodrigues, MM; Neves, PCD; Galler, R; Bonaldo, MC				Nogueira, Raquel Tayar; Nogueira, Alanderson Rocha; Souza Pereira, Mirian Claudia; Rodrigues, Mauricio Martins; da Costa Neves, Patricia Cristina; Galler, Ricardo; Bonaldo, Myrna Cristina			Recombinant Yellow Fever Viruses Elicit CD8(+) T Cell Responses and Protective Immunity against Trypanosoma cruzi	PLOS ONE			English	Article							AMASTIGOTE SURFACE PROTEIN-2; SUSCEPTIBLE MOUSE STRAIN; INDIAN RHESUS MACAQUES; GENETIC IMMUNIZATION; DISEASE SEVERITY; NITRIC-OXIDE; INFECTION; VACCINE; ANTIGEN; MICE	Chagas' disease is a major public health problem affecting nearly 10 million in Latin America. Despite several experimental vaccines have shown to be immunogenic and protective in mouse models, there is not a current vaccine being licensed for humans or in clinical trial against T. cruzi infection. Towards this goal, we used the backbone of Yellow Fever (YF) 17D virus, one of the most effective and well-established human vaccines, to express an immunogenic fragment derived from T. cruzi Amastigote Surface Protein 2 (ASP-2). The cDNA sequence of an ASP-2 fragment was inserted between E and NS1 genes of YF 17D virus through the construction of a recombinant heterologous cassette. The replication ability and genetic stability of recombinant YF virus (YF17D/ENS1/Tc) was confirmed for at least six passages in Vero cells. Immunogenicity studies showed that YF17D/ENS1/Tc virus elicited neutralizing antibodies and gamma interferon (IFN-gamma) producing-cells against the YF virus. Also, it was able to prime a CD8(+) T cell directed against the transgenic T. cruzi epitope (TEWETGQI) which expanded significantly as measured by T cell-specific production of IFN-gamma before and after T. cruzi challenge. However, most important for the purposes of vaccine development was the fact that a more efficient protective response could be seen in mice challenged after vaccination with the YF viral formulation consisting of YF17D/ENS1/Tc and a YF17D recombinant virus expressing the TEWETGQI epitope at the NS2B-3 junction. The superior protective immunity observed might be due to an earlier priming of epitope-specific IFN-gamma-producing T CD8(+) cells induced by vaccination with this viral formulation. Our results suggest that the use of viral formulations consisting of a mixture of recombinant YF 17D viruses may be a promising strategy to elicit protective immune responses against pathogens, in general.	[Nogueira, Raquel Tayar; da Costa Neves, Patricia Cristina; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol & Imunobiol, Rio De Janeiro, Brazil; [Nogueira, Alanderson Rocha; Souza Pereira, Mirian Claudia] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ultra Estrutura Celular, Rio De Janeiro, Brazil; [Rodrigues, Mauricio Martins] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Ctr Terapia Celular & Mol, Sao Paulo, Brazil; [da Costa Neves, Patricia Cristina] Fundacao Oswaldo Cruz, Inst Tecnol & Imunobiol, Lab Tecnol Imunol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz	Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.	mbonaldo@ioc.fiocruz.br	Rodrigues, Mauricio M./B-8512-2012; Galler, Ricardo/B-3280-2014; Bonaldo, Myrna/AAE-2799-2021; Nogueira, Raquel Tayar/F-6475-2019	Nogueira, Raquel Tayar/0000-0002-0581-763X; Pereira, Mirian Claudia/0000-0003-2223-3289	Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro; National Institute for Vaccine Science and Technology; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FIOCRUZ; CNPq	Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro; National Institute for Vaccine Science and Technology; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro, The National Institute for Vaccine Science and Technology, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and FIOCRUZ. RTN, MMR, MCB and RG are recipients of fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Albajar-Vinas P, 2011, EUROSURVEILLANCE, V16, P2; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003; BRENER Z, 1969, ANN TROP MED PARASIT, V63, P215, DOI 10.1080/00034983.1969.11686622; Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; de Alencar BCG, 2007, VACCINE, V25, P6018, DOI 10.1016/j.vaccine.2007.05.022; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011; Duan XF, 2009, VACCINE, V27, P6154, DOI 10.1016/j.vaccine.2009.08.026; Dumonteil E, 2009, INFECT GENET EVOL, V9, P1075, DOI 10.1016/j.meegid.2009.02.009; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; Eickhoff CS, 2010, MEM I OSWALDO CRUZ, V105, P687, DOI 10.1590/S0074-02762010000500015; Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3771; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889; Hoft DF, 2005, INFECT IMMUN, V73, P4934, DOI 10.1128/IAI.73.8.4934-4940.2005; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Lee BY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000916; Lefeuvre Anabelle, 2004, Curr Infect Dis Rep, V6, P96, DOI 10.1007/s11908-996-0005-9; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Low HP, 1997, MOL BIOCHEM PARASIT, V88, P137, DOI 10.1016/S0166-6851(97)00088-1; Low WP, 1998, J IMMUNOL, V160, P1817; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Martin DL, 2005, J IMMUNOL, V174, P1594, DOI 10.4049/jimmunol.174.3.1594; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Miyahira Y, 2005, INFECT IMMUN, V73, P7356, DOI 10.1128/IAI.73.11.7356-7365.2005; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6; Morell M, 2006, VACCINE, V24, P7046, DOI 10.1016/j.vaccine.2006.07.006; Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0; Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090; Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127; Perez Brandan C, 2012, BIOENGINEERED, P3; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Reyes-Sandoval A, 2012, MOL THER; RICE C M, 1989, New Biologist, V1, P285; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rodrigues MM, 2009, MEM I OSWALDO CRUZ, V104, P281, DOI 10.1590/S0074-02762009000900037; Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005; Sanchez-Burgos G, 2007, FEMS IMMUNOL MED MIC, V50, P333, DOI 10.1111/j.1574-695X.2007.00251.x; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Silveira ELV, 2008, CLIN VACCINE IMMUNOL, V15, P1292, DOI 10.1128/CVI.00142-08; Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071; TAIBI A, 1993, J IMMUNOL, V151, P2676; Takayama E, 2010, INT J PARASITOL, V40, P1549, DOI 10.1016/j.ijpara.2010.05.011; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Trindade GF, 2012, MEM I OSWALDO CRUZ, V107, P262, DOI 10.1590/S0074-02762012000200017; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878; Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835; Limon-Flores AY, 2010, VACCINE, V28, P7414, DOI 10.1016/j.vaccine.2010.08.104	81	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59347	10.1371/journal.pone.0059347	http://dx.doi.org/10.1371/journal.pone.0059347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527169	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100113
J	Connolly, CG; Bell, RP; Foxe, JJ; Garavan, H				Connolly, Colm G.; Bell, Ryan P.; Foxe, John J.; Garavan, Hugh			Dissociated Grey Matter Changes with Prolonged Addiction and Extended Abstinence in Cocaine Users	PLOS ONE			English	Article							BRAIN REWARD SYSTEM; COGNITIVE CONTROL; PREFRONTAL CORTEX; DECISION-MAKING; FRONTAL-CORTEX; DEPENDENT INDIVIDUALS; ALCOHOL DEPENDENCE; INHIBITORY CONTROL; WORKING-MEMORY; DRUG-ADDICTION	Extensive evidence indicates that current and recently abstinent cocaine abusers compared to drug-naive controls have decreased grey matter in regions such as the anterior cingulate, lateral prefrontal and insular cortex. Relatively little is known, however, about the persistence of these deficits in long-term abstinence despite the implications this has for recovery and relapse. Optimized voxel based morphometry was used to assess how local grey matter volume varies with years of drug use and length of abstinence in a cross-sectional study of cocaine users with various durations of abstinence (1-102 weeks) and years of use (0.3-24 years). Lower grey matter volume associated with years of use was observed for several regions including anterior cingulate, inferior frontal gyrus and insular cortex. Conversely, higher grey matter volumes associated with abstinence duration were seen in non-overlapping regions that included the anterior and posterior cingulate, insular, right ventral and left dorsal prefrontal cortex. Grey matter volumes in cocaine dependent individuals crossed those of drug-naive controls after 35 weeks of abstinence, with greater than normal volumes in users with longer abstinence. The brains of abstinent users are characterized by regional grey matter volumes, which on average, exceed drug-naive volumes in those users who have maintained abstinence for more than 35 weeks. The asymmetry between the regions showing alterations with extended years of use and prolonged abstinence suggest that recovery involves distinct neurobiological processes rather than being a reversal of disease-related changes. Specifically, the results suggest that regions critical to behavioral control may be important to prolonged, successful, abstinence.	[Connolly, Colm G.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Bell, Ryan P.] CUNY City Coll, Dept Psychol, New York, NY 10031 USA; [Bell, Ryan P.; Foxe, John J.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Bell, Ryan P.; Foxe, John J.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Bell, Ryan P.; Foxe, John J.; Garavan, Hugh] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Res Program, New York, NY USA; [Garavan, Hugh] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland; [Garavan, Hugh] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA	University of California System; University of California San Francisco; City University of New York (CUNY) System; City College of New York (CUNY); Yeshiva University; Yeshiva University; Nathan Kline Institute for Psychiatric Research; Trinity College Dublin; Trinity College Dublin; University of Vermont; University of Vermont	Connolly, CG (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Colm.Connolly@ucsf.edu	Connolly, Colm G./H-5917-2019	Connolly, Colm G./0000-0002-4051-3682; Foxe, John/0000-0002-4300-3098	NIMH [R01-DA014100]; Higher Education Authority; National Development Plan; Trinity Centre for High Performance Computing; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014100] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Higher Education Authority; National Development Plan; Trinity Centre for High Performance Computing; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIMH grant number R01-DA014100 awarded to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data analysis was supported by access to the IITAC high-performance computing cluster, funded by the Higher Education Authority, The National Development Plan and the Trinity Centre for High Performance Computing.	Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barros-Loscertales A, 2011, NEUROIMAGE, V56, P1021, DOI 10.1016/j.neuroimage.2011.02.035; Bartzokis G, 2000, PSYCHIAT RES-NEUROIM, V98, P93, DOI 10.1016/S0925-4927(99)00052-9; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brewer JA, 2008, BIOL PSYCHIAT, V64, P998, DOI 10.1016/j.biopsych.2008.05.024; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cardenas VA, 2011, BIOL PSYCHIAT, V70, P561, DOI 10.1016/j.biopsych.2011.04.003; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P177; Chanraud S, 2010, NEUROPSYCHOPHARMACOL, V35, P1868, DOI 10.1038/npp.2010.56; Clark L, 2002, TRENDS COGN SCI, V6, P361, DOI 10.1016/S1364-6613(02)01960-5; Clark VP, 2014, HUM BRAIN MAPP, V35, P414, DOI 10.1002/hbm.22184; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; Connolly CG, 2012, DRUG ALCOHOL DEPEN, V121, P45, DOI 10.1016/j.drugalcdep.2011.08.007; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Desmond JE, 2003, NEUROIMAGE, V19, P1510, DOI 10.1016/S1053-8119(03)00102-2; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; *EMCDDA, 2009, 2009 ANN REP STAT DR; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fein G, 2002, DRUG ALCOHOL DEPEN, V68, P87, DOI 10.1016/S0376-8716(02)00110-2; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; First MB, 2002, STRUCTURED CLIN INTE; Fox J, 2002, COX PROPORTIONAL HAZ; Franken IHA, 2005, EUR J PHARMACOL, V526, P199, DOI 10.1016/j.ejphar.2005.09.025; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Froeliger B, 2010, PSYCHOPHARMACOLOGY, V210, P577, DOI 10.1007/s00213-010-1862-3; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Hanlon CA, 2011, PSYCHOPHARMACOLOGY, V218, P681, DOI 10.1007/s00213-011-2360-y; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jia ZR, 2011, BIOL PSYCHIAT, V70, P553, DOI 10.1016/j.biopsych.2011.05.008; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kosten TR, 2006, NEUROPSYCHOPHARMACOL, V31, P644, DOI 10.1038/sj.npp.1300851; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Leri F, 2003, ADDICTION, V98, P7, DOI 10.1046/j.1360-0443.2003.00236.x; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Liu X, 1998, NEUROPSYCHOPHARMACOL, V18, P243; Lyoo IK, 2006, PSYCHOPHARMACOLOGY, V184, P139, DOI 10.1007/s00213-005-0198-x; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Matano S, 2001, AM J PHYS ANTHROPOL, V114, P163, DOI 10.1002/1096-8644(200102)114:2<163::AID-AJPA1016>3.0.CO;2-F; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; MILTON WJ, 1991, RADIOLOGY, V181, P715, DOI 10.1148/radiology.181.3.1947087; Narayana PA, 2010, DRUG ALCOHOL DEPEN, V111, P191, DOI 10.1016/j.drugalcdep.2010.04.012; Nestor L, 2011, NEUROIMAGE, V56, P2258, DOI 10.1016/j.neuroimage.2011.03.054; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; R Development Core Team, 2012, R LANG ENV STAT COMP; Rando K, 2011, AM J PSYCHIAT, V168, P183, DOI 10.1176/appi.ajp.2010.10020233; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Schilling C, 2013, HUM BRAIN MAPP, V34, P374, DOI 10.1002/hbm.21446; Scorzin JE, 2008, EPILEPSY RES, V82, P29, DOI 10.1016/j.eplepsyres.2008.06.012; Short EB, 2010, EVID-BASED COMPL ALT, V7, P121, DOI 10.1093/ecam/nem163; Sim ME, 2007, NEUROPSYCHOPHARMACOL, V32, P2229, DOI 10.1038/sj.npp.1301346; Simpson DD, 1999, ARCH GEN PSYCHIAT, V56, P507, DOI 10.1001/archpsyc.56.6.507; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER H, VSMA 10-4609; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Witkiewitz K, 2005, J COGN PSYCHOTHER, V19, P211, DOI 10.1891/jcop.2005.19.3.211; Wobrock T, 2009, EUR ARCH PSY CLIN N, V259, P143, DOI 10.1007/s00406-008-0846-3; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	91	65	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59645	10.1371/journal.pone.0059645	http://dx.doi.org/10.1371/journal.pone.0059645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527239	Green Published, gold			2022-12-27	WOS:000316411600071
J	Zhou, Y; Tian, L; Long, LZ; Quan, MF; Liu, F; Cao, JG				Zhou, Yuan; Tian, Li; Long, Lingzhi; Quan, Meifang; Liu, Fei; Cao, Jianguo			Casticin Potentiates TRAIL-Induced Apoptosis of Gastric Cancer Cells through Endoplasmic Reticulum Stress	PLOS ONE			English	Article							CCAAT/ENHANCER-BINDING-PROTEIN; LIGAND-INDUCED APOPTOSIS; DEATH RECEPTOR 5; UP-REGULATION; HOMOLOGOUS PROTEIN; CARCINOMA-CELLS; DOWN-REGULATION; DR5; INHIBITION; EXPRESSION	Background: Casticin is one of the main active components obtained from Fructus Viticis and has been reported to exert anti-carcinogenic activity on a variety of cancer cells but the precise mechanism underlying this activity remains unclear. Materials and Methods: Apoptotic activities of casticin (1.0 mmol/l) and TRAIL (25, 50 ng/ml) alone or in combination in the gastric cancer cell lines BGC-823, SGC-7901 and MGC-803 were detected by the use of a cell apoptosis ELISA detection kit, flow cytometry (FCM) with propidium iodide (PI) staining and activities of caspase-3, -8 and -9 by ELISA and cleavage of polyADP-ribose polymerase (PARP) protein using western blot analysis. Death receptors (DR) expression levels were evaluated using FCM analysis and western blotting. 2', 7'-dichlorofluorescein diacetate (DCFH-DA) was used as a probe to measure the increase in reactive oxygen species (ROS) levels in cells. Multiple interventions, such as siRNA transfection and pharmacological inhibitors were used to explore the mechanisms of these actions. Results: Subtoxic concentrations of casticin significantly potentiated TRAIL-induced cytotoxicity and apoptosis in BGC-823, SGC-7901 and MGC-803 cells. Casticin dramatically upregulated DR5 receptor expression but had no effects on DR4 or decoy receptors. Deletion of DR5 by siRNA significantly reduced the apoptosis induced by the co-application of TRAIL and casticin. Gene silencing of the CCAAT/enhancer binding protein homologous protein (CHOP) and pretreatment with salubrinal, an endoplasmic reticulum (ER) stress inhibitor, attenuated casticin-induced DR5 receptor expression, and apoptosis and ROS production. Casticin downregulated the expression levels of the cell survival proteins cFLIP, Bcl-2, XIAP, and survivin. In addition, casticin also induced the expressions of DR5 protein in other gastric cancer cells (SGC-7901 and MGC-803). Conclusion/Significance: Casticin enhances TRAIL-induced apoptosis through the downregulation of cell survival proteins and the upregulation of DR5 receptors through actions on the ROS-ER stress-CHOP pathway.	[Zhou, Yuan; Tian, Li; Long, Lingzhi; Quan, Meifang; Liu, Fei; Cao, Jianguo] Hunan Normal Univ, Coll Med, Changsha, Hunan, Peoples R China	Hunan Normal University	Cao, JG (corresponding author), Hunan Normal Univ, Coll Med, Changsha, Hunan, Peoples R China.	caojianguo2005@yahoo.com.cn			NSFC [30760248]; Project of Scientific Research of Hunan Province the Administration Bureau of Traditional Chinese Medicine [2010081]; Project of Scientific Research of Hunan Province, Department of Education [10C0975]; Major Project Item of Scientific Research of Hunan Province the Department of Education [09A054]; Project of Scientific Research of Changsha City Bureau of Science and Technology [K1104060-31]	NSFC(National Natural Science Foundation of China (NSFC)); Project of Scientific Research of Hunan Province the Administration Bureau of Traditional Chinese Medicine; Project of Scientific Research of Hunan Province, Department of Education; Major Project Item of Scientific Research of Hunan Province the Department of Education; Project of Scientific Research of Changsha City Bureau of Science and Technology	This work was supported by the Project of NSFC (number 30760248), the Project of Scientific Research of Hunan Province the Administration Bureau of Traditional Chinese Medicine (number 2010081), the Project of Scientific Research of Hunan Province, Department of Education (number 10C0975), Major Project Item of Scientific Research of Hunan Province the Department of Education (number 09A054) and the Project of Scientific Research of Changsha City Bureau of Science and Technology (number K1104060-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Azuhata T, 2006, J PEDIATR SURG, V41, P1431, DOI 10.1016/j.jpedsurg.2006.04.020; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen D, 2011, ONCOL REP, V26, P1287, DOI 10.3892/or.2011.1367; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Diaz F, 2003, J NAT PROD, V66, P865, DOI 10.1021/np0300784; Dixon-Shanies D, 1999, ONCOL REP, V6, P1383; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; He Q, 2002, ONCOGENE, V21, P2623, DOI 10.1038/sj.onc.1205345; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Imai M, 2009, CANCER LETT, V276, P74, DOI 10.1016/j.canlet.2008.10.036; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kobayakawa J, 2004, CANCER LETT, V208, P59, DOI 10.1016/j.canlet.2004.01.012; Koh DJ, 2011, J ETHNOPHARMACOL, V136, P399, DOI 10.1016/j.jep.2011.01.014; Kroemer G, 1998, CELL DEATH DIFFER, V5, P547, DOI 10.1038/sj.cdd.4400387; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Ohyama K, 2005, INT J BIOCHEM CELL B, V37, P1496, DOI 10.1016/j.biocel.2005.02.016; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Seol DW, 2001, CANCER RES, V61, P1138; Shen JK, 2009, ANN HEMATOL, V88, P743, DOI 10.1007/s00277-008-0677-3; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wang Hai-yan, 2005, Yaoxue Xuebao, V40, P27; Weisskopf M, 2005, PLANTA MED, V71, P910, DOI 10.1055/s-2005-871235; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang JF, 2012, CANCER CHEMOTH PHARM, V69, P195, DOI 10.1007/s00280-011-1686-9; Yang J, 2011, WORLD J GASTROENTERO, V17, P4298, DOI 10.3748/wjg.v17.i38.4298; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zeng X, 1996, ZHONGGUO ZHONG YAO Z, V21, P191; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhu HB, 2005, CANCER BIOL THER, V4, P393	38	35	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58855	10.1371/journal.pone.0058855	http://dx.doi.org/10.1371/journal.pone.0058855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536831	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100096
J	Li, SL; Meyer, NP; Quarto, N; Longaker, MT				Li, Shuli; Meyer, Nathaniel P.; Quarto, Natalina; Longaker, Michael T.			Integration of Multiple Signaling Regulates through Apoptosis the Differential Osteogenic Potential of Neural Crest-Derived and Mesoderm-Derived Osteoblasts	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; PARIETAL CALVARIAL BONES; BETA-INDUCED APOPTOSIS; STEM-CELLS; EPITHELIAL APOPTOSIS; SKELETAL REPAIR; IN-VIVO; ACTIVATION; EXPRESSION; PATHWAY	Neural crest-derived (FOb) and mesoderm-derived (POb) calvarial osteoblasts are characterized by distinct differences in their osteogenic potential. We have previously demonstrated that enhanced activation of endogenous FGF and Wnt signaling confers greater osteogenic potential to FOb. Apoptosis, a key player in bone formation, is the main focus of this study. In the current work, we have investigated the apoptotic activity of FOb and POb cells during differentiation. We found that lower apoptosis, as measured by caspase-3 activity is a major feature of neural crest-derived osteoblast which also have higher osteogenic capacity. Further investigation indicated TGF-beta signaling as main positive regulator of apoptosis in these two populations of calvarial osteoblasts, while BMP and canonical Wnt signaling negatively regulate the process. By either inducing or inhibiting these signaling pathways we could modulate apoptotic events and improve the osteogenic potential of POb. Taken together, our findings demonstrate that integration of multiple signaling pathways contribute to imparting greater osteogenic potential to FOb by decreasing apoptosis.	[Li, Shuli; Meyer, Nathaniel P.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy	Stanford University; University of Naples Federico II	Quarto, N (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Dept Surg, Sch Med, Stanford, CA 94305 USA.	quarto@unina.it; longaker@stanford.edu			National Institutes of Health [NIH-U01 HL099776, RC1 HL100490, RC2 DE020771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100490, U01HL099776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants: NIH-U01 HL099776; RC1 HL100490; RC2 DE020771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar MAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026371; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Bai L, 2011, RESP PHYSIOL NEUROBI, V177, P241, DOI 10.1016/j.resp.2011.04.016; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bran GM, 2008, ARCH MED RES, V39, P467, DOI 10.1016/j.arcmed.2008.02.007; Bustamante J, 2002, NITRIC OXIDE-BIOL CH, V6, P333, DOI 10.1006/niox.2001.0420; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Dai T, 2008, ACTA PHARMACOL SIN, V29, P1425, DOI 10.1111/j.1745-7254.2008.00904.x; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Fischer L, 2002, J CELL BIOCHEM, V84, P816, DOI 10.1002/jcb.10091; HARRIS SE, 1994, J BONE MINER RES, V9, P389; Heger J, 2011, J CELL PHYSIOL, V226, P2683, DOI 10.1002/jcp.22619; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Levi B, 2011, STEM CELLS, V29, P2018, DOI 10.1002/stem.757; Levi B, 2011, STEM CELLS DEV, V20, P243, DOI 10.1089/scd.2010.0250; Li S, 2007, AM J PHYSIOL-CELL PH, V293, pC1834, DOI 10.1152/ajpcell.00135.2007; Li SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014033; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Liu ZP, 2009, BBA-MOL CELL RES, V1793, P1819, DOI 10.1016/j.bbamcr.2009.09.012; Lu Q, 2008, AM J PHYSIOL-LUNG C, V295, pL123, DOI 10.1152/ajplung.00402.2007; Macias D, 1997, DEVELOPMENT, V124, P1109; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Manolagas SC, 1999, ENDOCRINOLOGY, V140, P4377, DOI 10.1210/en.140.10.4377; Nagase Y, 2010, ANN NY ACAD SCI, V1192, P330, DOI 10.1111/j.1749-6632.2009.05209.x; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Palumbo C, 2003, J ANAT, V203, P589, DOI 10.1046/j.1469-7580.2003.00247.x; Pecina-Slaus N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-22; Quarto N, 2012, STEM CELLS, V30, P2709, DOI 10.1002/stem.1250; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Quarto N, 2009, CELLS TISSUES ORGANS, V190, P158, DOI 10.1159/000202789; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Rice DPC, 1999, EUR J ORAL SCI, V107, P265, DOI 10.1046/j.0909-8836.1999.eos107406.x; Satoh Y, 2009, AM J PHYSIOL-GASTR L, V297, pG514, DOI 10.1152/ajpgi.90608.2008; Schuster N, 2002, GLIA, V40, P95, DOI 10.1002/glia.10110; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Sheng MHC, 2006, CALCIFIED TISSUE INT, V78, P293, DOI 10.1007/s00223-005-0303-5; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Tian XY, 2012, J MOL CELL CARDIOL, V52, P237, DOI 10.1016/j.yjmcc.2011.10.013; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	62	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58610	10.1371/journal.pone.0058610	http://dx.doi.org/10.1371/journal.pone.0058610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536803	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200008
J	Bai, J; Mei, PJ; Zhang, CP; Chen, FF; Li, C; Pan, ZQ; Liu, H; Zheng, JN				Bai, Jin; Mei, Pengjin; Zhang, Cuipeng; Chen, Feifei; Li, Chen; Pan, Zhenqiang; Liu, Hui; Zheng, Junnian			BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEXES; SWI-SNF COMPLEX; SWI/SNF COMPLEX; EXPRESSION; INVASION; PROLIFERATION; MIGRATION; COMPONENT; SUBUNITS; GLIOMA	BRG1, a core component of the SWI/SNF chromatin-remodeling complex, has been implicated in cancer development; however, the biological significance of BRG1 in breast cancer remains unknown. We explored the role of BRG1 in human breast cancer pathogenesis. Using tissue microarray and immunohistochemistry, we evaluated BRG1 staining in 437 breast cancer specimens and investigated its role in breast cancer cell proliferation, migration and invasion. Our Kaplan-Meier survival curves showed that high BRG1 expression is inversely correlated with both overall (P = 0.000) and disease-specific (P = 0.000) 5-year patient survival. Furthermore, we found that knockdown of BRG1 by RNA interference markedly inhibits cell proliferation and causes cessation of cell cycle. This reduced cell proliferation is due to G1 phase arrest as cyclin D1 and cyclin E are diminished whereas p27 is upregulated. Moreover, BRG1 depletion induces the expression of TIMP-2 but reduces MMP-2, thereby inhibiting the ability of cells to migrate and to invade. These results highlight the importance of BRG1 in breast cancer pathogenesis and BRG1 may serve as a prognostic marker as well as a potentially selective therapeutic target.	[Bai, Jin; Mei, Pengjin; Zhang, Cuipeng; Chen, Feifei; Pan, Zhenqiang; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Mei, Pengjin; Li, Chen; Liu, Hui; Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Li, Chen; Liu, Hui] Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China; [Pan, Zhenqiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Icahn School of Medicine at Mount Sinai	Liu, H (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	13952269920lhh@163.com; jnzheng@xzmc.edu.cn	Liu, Hui/AAJ-4339-2020	Liu, Hui/0000-0002-7669-9386	National Natural Science Foundation of China [81201636]; Science and Technology Department of Jiangsu province [BK2012139]; China Postdoctoral Science Foundation [2012M511323]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project is supported by grants from the National Natural Science Foundation of China (number 81201636), the Science and Technology Department of Jiangsu province (number BK2012139) and China Postdoctoral Science Foundation (number 2012M511323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bock VL, 2011, BRIT J DERMATOL, V164, P1221, DOI 10.1111/j.1365-2133.2011.10267.x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dal Molin M, 2012, HUM PATHOL, V43, P585, DOI 10.1016/j.humpath.2011.06.009; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; REMMELE W, 1987, PATHOLOGE, V8, P138; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Serber DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031346; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Wong AKC, 2000, CANCER RES, V60, P6171; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Zhang B, 2009, ONCOGENE, V28, P651, DOI 10.1038/onc.2008.419; Zhou YF, 2004, CARCINOGENESIS, V25, P399, DOI 10.1093/carcin/bgh020	34	58	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59772	10.1371/journal.pone.0059772	http://dx.doi.org/10.1371/journal.pone.0059772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533649	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400086
J	Bragaru, M; van Wilgen, CP; Geertzen, JHB; Ruijs, SGJB; Dijkstra, PU; Dekker, R				Bragaru, Mihai; van Wilgen, C. P.; Geertzen, Jan H. B.; Ruijs, Suzette G. J. B.; Dijkstra, Pieter U.; Dekker, Rienk			Barriers and Facilitators of Participation in Sports: A Qualitative Study on Dutch Individuals with Lower Limb Amputation	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; OF-LIFE; RECREATIONAL ACTIVITIES; BODY-IMAGE; EXERCISE; AMPUTEES; HEALTH; REHABILITATION; INTERVENTION	Introduction: Although individuals with lower limb amputation may benefit from participation in sports, less than 40% do so. Aim: To identify the barriers and facilitators that influence participation in sports for individuals with lower limb amputation. Design: Qualitative study. Participants: Twenty six individuals with lower limb amputation, all originating from the Dutch provinces of Groningen and Drenthe, of which 13 athletes. Methods: Semi-structured interviews were used to gather information. Following thematic analysis, emerging themes were organized in three categories Technical, Social and Personal. Results: Sport was perceived as enjoyable activity that would help participants to become and stay healthy, improve the number of social contacts, reduce phantom pain and decrease daily tension. Inadequate facilities, problematic transportation, trivialization from others, poor health and lack of motivation or the lack of a sports partner were barriers commonly mentioned by non-athletes. Remarkably, while all athletes were successful prosthetic users, the majority chose to participate in sports for which prosthesis was neither required nor needed. Conclusions: Each individual with lower limb amputation needs to be counselled according to the barriers and facilitators he/she personally experiences. Athletes appeared to be more proactive in searching for a solution and also appeared less discouraged by failing.	[Bragaru, Mihai; Geertzen, Jan H. B.; Dijkstra, Pieter U.; Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Dept Rehabil Med, Groningen, Netherlands; [van Wilgen, C. P.; Ruijs, Suzette G. J. B.] Univ Groningen, Fac Human Movement Sci, Groningen, Netherlands; [van Wilgen, C. P.] Transcare, Trans Disciplinary Pain Management Ctr, Groningen, Netherlands; [Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Bragaru, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Dept Rehabil Med, Groningen, Netherlands.	m.bragaru@umcg.nl						Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Blinde EM, 1997, ADAPT PHYS ACT Q, V14, P327, DOI 10.1123/apaq.14.4.327; Bragaru M, 2011, SPORTS MED, V41, P721, DOI 10.2165/11590420-000000000-00000; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chin T, 2002, AM J PHYS MED REHAB, V81, P321, DOI 10.1097/00002060-200205000-00001; Chin T, 2001, J REHABIL RES DEV, V38, P7; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Creswell J. W.., 2018, SAGE PUBLICATIONS; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; Deans SA, 2008, PROSTHET ORTHOT INT, V32, P186, DOI 10.1080/03093640802016514; European Commission, 2010, SPECIAL EUROBAROMETE, V334, P1; Faltermaier T, 1997, EUR J PUBLIC HEALTH, V7, P357, DOI 10.1093/eurpub/7.4.357; Geertzen JHB, 2001, PROSTHET ORTHOT INT, V25, P14, DOI 10.1080/03093640108726563; Hennink M., 2020, QUALITATIVE RES METH; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; Kars C, 2009, PROSTHET ORTHOT INT, V33, P356, DOI 10.3109/03093640902984579; KASHANI JH, 1983, J CLIN PSYCHIAT, V44, P256; KEGEL B, 1980, ARCH PHYS MED REHAB, V61, P258; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Legro MW, 2001, J REHABIL RES DEV, V38, P319; Morrison V, 2009, ANONYMOUS INTRO HLTH, P122; Moura VL, 2012, AM J PHYS MED REHAB, V91, P701, DOI 10.1097/PHM.0b013e3182466034; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Patel DR, 2010, PEDIATR CLIN N AM, V57, P795, DOI 10.1016/j.pcl.2010.03.002; PITETTI KH, 1987, J BONE JOINT SURG AM, V69A, P914, DOI 10.2106/00004623-198769060-00018; Pope C, 2006, QUALITATIVE RES HLTH; Rasinaho M, 2007, J AGING PHYS ACTIV, V15, P90, DOI 10.1123/japa.15.1.90; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Rimmer JH, 2002, AM J HEALTH PROMOT, V16, P220, DOI 10.4278/0890-1171-16.4.220; Sallis RE, 2009, BRIT J SPORT MED, V43, P3, DOI 10.1136/bjsm.2008.054825; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; SHEPHARD RJ, 1991, SCAND J REHABIL MED, V23, P51; Sjodahl C, 2004, DISABIL REHABIL, V26, P851, DOI 10.1080/09638280410001662996; Sousa AI, 2009, ADAPT PHYS ACT Q, V26, P236, DOI 10.1123/apaq.26.3.236; Sporner ML, 2009, DISABIL REHABIL, V31, P410, DOI 10.1080/09638280802030923; Tatar Y, 2010, SCI SPORT, V25, P312, DOI 10.1016/j.scispo.2010.02.001; Taub DE, 1999, HUM RELAT, V52, P1469, DOI 10.1023/A:1016928901982; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; VALLIANT PM, 1985, PSYCHOL REP, V56, P923, DOI 10.2466/pr0.1985.56.3.923; Wetterhahn KA, 2002, AM J PHYS MED REHAB, V81, P194, DOI 10.1097/00002060-200203000-00007; Yari P, 2008, CLIN REHABIL, V22, P1127, DOI 10.1177/0269215508095088; Yazicioglu K, 2007, AM J PHYS MED REHAB, V86, P800, DOI 10.1097/PHM.0b013e318151fc74	46	33	34	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59881	10.1371/journal.pone.0059881	http://dx.doi.org/10.1371/journal.pone.0059881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111VQ	23533655	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400092
J	De Martino, F; Zimmermann, J; Muckli, L; Ugurbil, K; Yacoub, E; Goebel, R				De Martino, Federico; Zimmermann, Jan; Muckli, Lars; Ugurbil, Kamil; Yacoub, Essa; Goebel, Rainer			Cortical Depth Dependent Functional Responses in Humans at 7T: Improved Specificity with 3D GRASE	PLOS ONE			English	Article							OCULAR DOMINANCE COLUMNS; HIGH-FIELD MRI; SPIN-ECHO; VISUAL-CORTEX; CEREBRAL-CORTEX; GRADIENT-ECHO; HUMAN-BRAIN; LAMINAR SPECIFICITY; BLOOD OXYGENATION; SIGNAL CHANGES	Ultra high fields (7T and above) allow functional imaging with high contrast-to-noise ratios and improved spatial resolution. This, along with improved hardware and imaging techniques, allow investigating columnar and laminar functional responses. Using gradient-echo (GE) (T2* weighted) based sequences, layer specific responses have been recorded from human (and animal) primary visual areas. However, their increased sensitivity to large surface veins potentially clouds detecting and interpreting layer specific responses. Conversely, spin-echo (SE) (T-2 weighted) sequences are less sensitive to large veins and have been used to map cortical columns in humans. T-2 weighted 3D GRASE with inner volume selection provides high isotropic resolution over extended volumes, overcoming some of the many technical limitations of conventional 2D SE-EPI, whereby making layer specific investigations feasible. Further, the demonstration of columnar level specificity with 3D GRASE, despite contributions from both stimulated echoes and conventional T-2 contrast, has made it an attractive alternative over 2D SE-EPI. Here, we assess the spatial specificity of cortical depth dependent 3D GRASE functional responses in human V1 and hMT by comparing it to GE responses. In doing so we demonstrate that 3D GRASE is less sensitive to contributions from large veins in superficial layers, while showing increased specificity (functional tuning) throughout the cortex compared to GE.	[De Martino, Federico; Ugurbil, Kamil; Yacoub, Essa] Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [De Martino, Federico; Zimmermann, Jan; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Fac Psychol & Neurosci, Maastricht, Netherlands; [De Martino, Federico; Zimmermann, Jan; Goebel, Rainer] Maastricht Univ, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Muckli, Lars] Univ Glasgow, Dept Psychol, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland; [Muckli, Lars] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Maastricht University; Maastricht University; University of Glasgow; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Zimmermann, J (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Fac Psychol & Neurosci, Maastricht, Netherlands.	jan.zimmermann@maastrichtuniversity.nl	De Martino, Federico/ABF-9850-2021; Muckli, Lars/B-3119-2009; Ugurbil, Kamil/AAD-6058-2022; De Martino, Federico/I-1817-2012; Yacoub, Essa/AAS-7757-2021	De Martino, Federico/0000-0002-0352-0648; Muckli, Lars/0000-0002-0143-4324; De Martino, Federico/0000-0002-0352-0648; Zimmermann, Jan/0000-0003-3345-6074; Goebel, Rainer/0000-0003-1780-2467	National Institutes of Health (NIH) [R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079]; W. M. Keck Foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN 375457-09]; European Research Council [ERC-2010-AdG, 269853]; National Science Foundation [DBI-9907842]; NIH [S10 RR1395]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076408, P30NS057091, R44NS063537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Research Council(European Research Council (ERC)European Commission); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work supported in part by the National Institutes of Health (NIH) (R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079), the W. M. Keck Foundation, Natural Sciences and Engineering Research Council of Canada (RGPIN 375457-09) and the European Research Council (ERC-2010-AdG, 269853). The 7 T magnet purchase was funded in part by National Science Foundation DBI-9907842 and NIH S10 RR1395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Annese J, 2004, NEUROIMAGE, V21, P15, DOI 10.1016/j.neuroimage.2003.08.024; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Bok ST, 1929, Z GESAMTE NEUROL PSY, V121, P682, DOI 10.1007/BF02864437; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Feinberg D.A., 2008, P INT SOC MAG RESON, V16, P2373; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Gardner JL, 2010, NEUROIMAGE, V49, P1953, DOI 10.1016/j.neuroimage.2009.07.004; Goense JBM, 2006, MAGN RESON IMAGING, V24, P381, DOI 10.1016/j.mri.2005.12.032; Goense JBM, 2007, MAGN RESON IMAGING, V25, P740, DOI 10.1016/j.mri.2007.02.013; Goerke U, 2007, MAGN RESON MED, V58, P754, DOI 10.1002/mrm.21369; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; Haacke E. M., 1999, MAGNETIC RESONANCE I; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Jin T, 2008, NEUROIMAGE, V43, P1, DOI 10.1016/j.neuroimage.2008.06.029; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Khan R, 2011, GRAPH MODELS, V73, P313, DOI 10.1016/j.gmod.2010.11.002; Kim T, 2010, NEUROIMAGE, V49, P1340, DOI 10.1016/j.neuroimage.2009.09.061; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Koopmans PJ, 2011, NEUROIMAGE, V56, P1276, DOI 10.1016/j.neuroimage.2011.02.042; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Norris DG, 2012, NEUROIMAGE, V62, P1109, DOI 10.1016/j.neuroimage.2012.01.003; Olman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032536; OSHIO K, 1991, MAGNET RESON MED, V20, P344, DOI 10.1002/mrm.1910200219; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Ress D, 2007, NEUROIMAGE, V34, P74, DOI 10.1016/j.neuroimage.2006.08.020; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Smirnakis SM, 2007, J CEREBR BLOOD F MET, V27, P1248, DOI 10.1038/sj.jcbfm.9600434; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Waehnert M, 2012, P INT SOC MAG RESON, V20, P1085; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang XL, 2001, MAGNET RESON MED, V46, P443, DOI 10.1002/mrm.1212; Zhao FQ, 2004, MAGN RESON MED, V51, P518, DOI 10.1002/mrm.10720; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013; Zimmermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028716	59	103	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60514	10.1371/journal.pone.0060514	http://dx.doi.org/10.1371/journal.pone.0060514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533682	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000316549400119
J	Ichihashi, T; Satoh, T; Sugimoto, C; Kajino, K				Ichihashi, Toru; Satoh, Toshifumi; Sugimoto, Chihiro; Kajino, Kiichi			Emulsified Phosphatidylserine, Simple and Effective Peptide Carrier for Induction of Potent Epitope-Specific T Cell Responses	PLOS ONE			English	Article							DENDRITIC CELLS; CHITOSAN; MOUSE; DELIVERY; RECOGNITION; ANTIGEN; SURFACE; ADJUVANT; RECEPTOR; PHAGOCYTOSIS	Background: To induce potent epitope-specific T cell immunity by a peptide-based vaccine, epitope peptides must be delivered efficiently to antigen-presenting cells (APCs) in vivo. Therefore, selecting an appropriate peptide carrier is crucial for the development of an effective peptide vaccine. In this study, we explored new peptide carriers which show enhancement in cytotoxic T lymphocyte (CTL) induction capability. Methodology/Principal Findings: Data from an epitope-specific in vivo CTL assay revealed that phosphatidylserine (PS) has a potent adjuvant effect among candidate materials tested. Further analyses showed that PS-conjugated antigens were preferentially and efficiently captured by professional APCs, in particular, by CD11c(+)CD11b(+)MHCII(+) conventional dendritic cells (cDCs) compared to multilamellar liposome-conjugates or unconjugated antigens. In addition, PS demonstrated the stimulatory capacity of peptide-specific helper T cells in vivo. Conclusions/Significance: This work indicates that PS is the easily preparable efficient carrier with a simple structure that delivers antigen to professional APCs effectively and induce both helper and cytotoxic T cell responses in vivo. Therefore, PS is a promising novel adjuvant for T cell-inducing peptide vaccines.	[Ichihashi, Toru; Sugimoto, Chihiro; Kajino, Kiichi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan; [Satoh, Toshifumi] Hokkaido Univ, Fac & Grad Sch Engn, Lab Polymer Funct Chem, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kajino, K (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan.	kiichi@czc.hokudai.ac.jp	Kajino, Kiichi/F-6873-2012; Sugimoto, Chihiro/F-6583-2012; Satoh, Toshifumi/A-5316-2012	Sugimoto, Chihiro/0000-0002-8708-0140; Satoh, Toshifumi/0000-0001-5449-9642	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infections Diseases (J-GRID) programmed by the MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infections Diseases (J-GRID) programmed by the MEXT, Japan	Financial support for this study was supported by the grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and also by the Japan Initiative for Global Research Network on Infections Diseases (J-GRID) programmed by the MEXT, Japan (http://www.crnid.riken.jp/jgrid/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI [10.1586/erv.09.47, 10.1586/ERV.09.47]; AUDIBERT FM, 1993, TRENDS PHARMACOL SCI, V14, P174, DOI 10.1016/0165-6147(93)90204-W; Bagby TR, 2012, EUR J PHARM SCI, V47, P287, DOI 10.1016/j.ejps.2012.04.016; Cai S, 2011, ADV DRUG DELIVER REV, V63, P901, DOI 10.1016/j.addr.2011.05.017; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; DUVALL E, 1985, IMMUNOLOGY, V56, P351; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Ghendon Y, 2008, ARCH VIROL, V153, P831, DOI 10.1007/s00705-008-0047-4; Ghendon Y, 2009, J MED VIROL, V81, P494, DOI 10.1002/jmv.21415; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hochrein H, 2002, HUM IMMUNOL, V63, P1103, DOI 10.1016/S0198-8859(02)00748-6; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Krop I, 1996, J IMMUNOL, V157, P48; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Martins S, 2007, INT J NANOMED, V2, P595; MIESCHER GC, 1989, IMMUNOL LETT, V23, P113, DOI 10.1016/0165-2478(89)90122-3; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata T, 2007, VACCINE, V25, P4914, DOI 10.1016/j.vaccine.2007.04.010; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nakano Y, 2001, BIOCONJUGATE CHEM, V12, P391, DOI 10.1021/bc0001185; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Sadler Kristen, 2002, J Biotechnol, V90, P195; Saenz L, 2009, INT J PHARMACEUT, V369, P64, DOI 10.1016/j.ijpharm.2008.10.033; Schaller E, 2002, MOL CELL BIOL, V22, P8035, DOI 10.1128/MCB.22.22.8035-8043.2002; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sinha VR, 2004, INT J PHARMACEUT, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026; Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; Tanaka Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015225, 10.1371/journal.pone.0015091]; Ugwoke MI, 2000, INT J PHARM, V202, P125, DOI 10.1016/S0378-5173(00)00434-8; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034	42	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60068	10.1371/journal.pone.0060068	http://dx.doi.org/10.1371/journal.pone.0060068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533665	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400102
J	Lin, SL; Pan, LL; Guo, SC; Wu, JJ; Jin, L; Wang, JC; Wang, SY				Lin, Shenglong; Pan, Lili; Guo, Shicheng; Wu, Junjie; Jin, Li; Wang, Jiu-Cun; Wang, Shaoyuan			Prognostic Role of MicroRNA-181a/b in Hematological Malignancies: A Meta-Analysis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DOWN-REGULATION; CELL-DIFFERENTIATION; BREAST-CANCER; EXPRESSION; GENES; MIR-181A; RNA; HSA-MIR-181B	Background: Emerging evidence has shown that miRNAs participate in human carcinogenesis as tumor suppressors or oncogenes, and have prognostic value for patients with cancers. In recent years, the miR-181 family was found dysregulated in a variety of human cancers and significantly associated with clinical outcome of cancerous patients. MiR-181a and miR-181b (miR-181a/b) were the most investigated members in the family. However, the results of miR-181a/b from different studies were inconsistent. Therefore, we performed a meta-analysis to summarize all the results from available studies, aiming to delineate the prognostic role of miR-181a/b in human cancers. Methods: The identified articles were retrieved from the two main on-line databases, PubMed and EMBASE. We extracted and estimated the hazard ratios (HRs) for overall survival (OS), which compared the high and low expression levels of miR-181a/b in patients of the available studies. Each individual HR was used to calculate the pooled HR. Results: Eleven studies of 1252 patients were selected into the final meta-analysis after a strict filtering and qualifying process. Fixed model or random model method was chosen depending on the heterogeneity between the studies. The subgroup analysis showed that high expressed miR-181a/b could prolong OS in patients with hematological malignancies rather than low expression level (HR = 0.717, P<0.0001). But the expression of miR-181a/b was not significantly relative to OS in patients with various cancers (HR = 0.861, p = 0.356). Conclusion: Our study indicates that the expression level of miR-181a/b is significantly associated with OS in hematological malignancies and can be an important clinical prognostic factor for those patients.	[Lin, Shenglong; Pan, Lili; Wang, Shaoyuan] Fujian Med Univ, Union Hosp, Dept Hematol, Fuzhou, Fujian Province, Peoples R China; [Guo, Shicheng; Wu, Junjie; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Natl Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Guo, Shicheng; Wu, Junjie; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wu, Junjie] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Pneumol, Shanghai, Peoples R China	Fujian Medical University; Fudan University; Fudan University; Naval Medical University	Wang, JC (corresponding author), Fudan Univ, Natl Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	theresajcwang@gmail.com; mdsy.wang@gmail.com	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Guo, Shicheng/A-1204-2016; Jin, Li/M-5063-2019	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Guo, Shicheng/0000-0002-7047-9972; PAN, LILI/0000-0001-6326-3260	National Natural Science Foundation of China [81270609, 30770909]; Major Science & Technology Project of Fujian Province [2003F003, 2012Y4012]; Fujian Medical University [09ZD008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science & Technology Project of Fujian Province; Fujian Medical University	This work was supported by the National Natural Science Foundation of China (81270609, 30770909) and the Major Science & Technology Project of Fujian Province (2003F003, 2012Y4012) and Fujian Medical University (09ZD008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HT, 2012, J CANCER RES CLIN, V138, P595, DOI 10.1007/s00432-011-1137-3; Beltran B, 2010, BLOOD, V116; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen L, 2012, IUBMB LIFE, V64, P628, DOI 10.1002/iub.1030; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Fei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032834; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023271; Kaur P, 2011, LAB INVEST, V91, p450A; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Lwin T, 2010, BLOOD, V116, P5228, DOI 10.1182/blood-2010-03-275925; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Ota D, 2011, INT J ONCOL, V38, P955, DOI 10.3892/ijo.2011.926; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Sivina M, 2012, LEUKEMIA, V26, P1812, DOI 10.1038/leu.2012.63; Srivastava S, 2012, LAB INVESTIGATION, V92, p372A; Sun SM, 2011, BRIT J HAEMATOL, V155, P395, DOI 10.1111/j.1365-2141.2011.08682.x; Tan LP, 2009, LAB INVEST, V89, P708, DOI 10.1038/labinvest.2009.26; Verga Falzacappa MV, 2011, BLOOD, V118; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Yang CC, 2011, J ORAL PATHOL MED, V40, P397, DOI 10.1111/j.1600-0714.2010.01003.x; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179	47	66	72	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59532	10.1371/journal.pone.0059532	http://dx.doi.org/10.1371/journal.pone.0059532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533632	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400069
J	Mahomed, H; Ehrlich, R; Hawkridge, T; Hatherill, M; Geiter, L; Kafaar, F; Abrahams, DA; Mulenga, H; Tameris, M; Geldenhuys, H; Hanekom, WA; Verver, S; Hussey, GD				Mahomed, Hassan; Ehrlich, Rodney; Hawkridge, Tony; Hatherill, Mark; Geiter, Lawrence; Kafaar, Fazlin; Abrahams, Deborah Ann; Mulenga, Humphrey; Tameris, Michele; Geldenhuys, Hennie; Hanekom, Willem Albert; Verver, Suzanne; Hussey, Gregory Dudley			TB Incidence in an Adolescent Cohort in South Africa	PLOS ONE			English	Article							SKIN-TEST; TUBERCULOSIS INFECTION; VACCINES; FEATURES; BCG	Background: Tuberculosis (TB) is a major public health problem globally. Little is known about TB incidence in adolescents who are a proposed target group for new TB vaccines. We conducted a study to determine the TB incidence rates and risk factors for TB disease in a cohort of school-going adolescents in a high TB burden area in South Africa. Methods: We recruited adolescents aged 12 to 18 years from high schools in Worcester, South Africa. Demographic and clinical information was collected, a tuberculin skin test (TST) performed and blood drawn for a QuantiFERON TB Gold assay at baseline. Screening for TB cases occurred at follow up visits and by surveillance of registers at public sector TB clinics over a period of up to 3.8 years after enrolment. Results: A total of 6,363 adolescents were enrolled (58% of the school population targeted). During follow up, 67 cases of bacteriologically confirmed TB were detected giving an overall incidence rate of 0.45 per 100 person years (95% confidence interval 0.29-0.72). Black or mixed race, maternal education of primary school or less or unknown, a positive baseline QuantiFERON assay and a positive baseline TST were significant predictors of TB disease on adjusted analysis. Conclusion: The adolescent TB incidence found in a high burden setting will help TB vaccine developers plan clinical trials in this population. Latent TB infection and low socio-economic status were predictors of TB disease.	[Mahomed, Hassan; Hatherill, Mark; Kafaar, Fazlin; Abrahams, Deborah Ann; Mulenga, Humphrey; Tameris, Michele; Geldenhuys, Hennie; Hanekom, Willem Albert] Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, Cape Town, South Africa; [Mahomed, Hassan; Hatherill, Mark; Kafaar, Fazlin; Abrahams, Deborah Ann; Mulenga, Humphrey; Tameris, Michele; Geldenhuys, Hennie; Hanekom, Willem Albert] Sch Child & Adolescent Hlth, Cape Town, South Africa; [Ehrlich, Rodney] Sch Publ Hlth & Family Med, Cape Town, South Africa; [Hawkridge, Tony; Hussey, Gregory Dudley] Vaccines Africa Initiat, Cape Town, South Africa; [Mahomed, Hassan; Ehrlich, Rodney; Hawkridge, Tony; Hatherill, Mark; Kafaar, Fazlin; Abrahams, Deborah Ann; Mulenga, Humphrey; Tameris, Michele; Geldenhuys, Hennie; Hanekom, Willem Albert; Verver, Suzanne; Hussey, Gregory Dudley] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Geiter, Lawrence] Otsuka Pharmaceut Dev & Commercializat Inc, Rockville, MD USA; [Verver, Suzanne] KNCV TB Fdn, The Hague, Netherlands; [Verver, Suzanne] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Cape Town; University of Cape Town; Otsuka Pharmaceutical; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Mahomed, H (corresponding author), Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, Cape Town, South Africa.	hmahomed799@gmail.com	Tameris, Michele/AAR-6663-2021; Ehrlich, Rodney/M-5654-2014; Geldenhuys, Hennie/G-7670-2014	Tameris, Michele/0000-0002-7983-7203; Hanekom, Willem/0000-0003-3070-6154; Ehrlich, Rodney/0000-0001-5736-9237; Geldenhuys, Hennie/0000-0002-2221-8997	Aeras Foundation; Gates Grand Challenge 6 and Gates Grand Challenge 12 grants for the QuantiFERON testing	Aeras Foundation; Gates Grand Challenge 6 and Gates Grand Challenge 12 grants for the QuantiFERON testing	This work was supported by the Aeras Foundation and the Gates Grand Challenge 6 and Gates Grand Challenge 12 grants for the QuantiFERON testing. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders (Aeras) were involved in study design and the design of the data colelction forms.	AIDSMAP, 2012, THIB TB COMM WID IPT; [Anonymous], 2011, GLOB TUB CONTR 2011; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Cobelens F, 2003, INT J TUBERC LUNG D, V7, P758; Corrigall J, 2006, VACCINATION COVERAGE; de Pontual L, 2006, PEDIATR INFECT DIS J, V25, P930, DOI 10.1097/01.inf.0000237919.53123.f4; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; Hatherill M, 2012, CLIN INFECT DIS, V54, P493, DOI 10.1093/cid/cir823; Kam A, 2007, PEDIATR INFECT DIS J, V26, P355, DOI 10.1097/01.inf.0000258700.86040.b6; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Mahomed H, 2012, TUBERCULOSIS, V92, pS21, DOI 10.1016/S1472-9792(12)70008-2; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; NEMIR RL, 1986, PEDIATRICS, V78, P399; Rani S H, 1998, Indian Pediatr, V35, P123; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Rustomjee R, 2012, TUBERCULOSIS, V92, P359, DOI 10.1016/j.tube.2012.05.001; Weber HC, 2000, ANN TROP PAEDIATR, V20, P5, DOI 10.1080/02724930091995; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098	24	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59652	10.1371/journal.pone.0059652	http://dx.doi.org/10.1371/journal.pone.0059652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533639	gold, Green Published			2022-12-27	WOS:000316549400076
J	Uribe, PM; Sun, HF; Wang, K; Asuncion, JD; Wang, Q; Chen, CW; Steyger, PS; Smith, ME; Matsui, JI				Uribe, Phillip M.; Sun, Huifang; Wang, Kevin; Asuncion, James D.; Wang, Qi; Chen, Chien-Wei; Steyger, Peter S.; Smith, Michael E.; Matsui, Jonathan I.			Aminoglycoside-Induced Hair Cell Death of Inner Ear Organs Causes Functional Deficits in Adult Zebrafish (Danio rerio)	PLOS ONE			English	Article							LATERAL-LINE NEUROMASTS; BRAIN-STEM RESPONSE; MACULA NEGLECTA; HEARING ABILITY; ATLANTIC COD; FISH EAR; REGENERATION; RECOVERY; GENTAMICIN; DAMAGE	Aminoglycoside antibiotics, like gentamicin, kill inner ear sensory hair cells in a variety of species including chickens, mice, and humans. The zebrafish (Danio rerio) has been used to study hair cell cytotoxicity in the lateral line organs of larval and adult animals. Little is known about whether aminoglycosides kill the hair cells within the inner ear of adult zebrafish. We report here the ototoxic effects of gentamicin on hair cells in the saccule, the putative hearing organ, and utricle of zebrafish. First, adult zebrafish received a single 30 mg/kg intraperitoneal injection of fluorescently-tagged gentamicin (GTTR) to determine the distribution of gentamicin within inner ear sensory epithelia. After 4 hours, GTTR was observed in hair cells throughout the saccular and utriclar sensory epithelia. To assess the ototoxic effects of gentamicin, adult zebrafish received a single 250 mg/kg intraperitoneal injection of gentamicin and, 24 hours later, auditory evoked potential recordings (AEPs) revealed significant shifts in auditory thresholds compared to untreated controls. Zebrafish were then euthanized, the inner ear fixed, and labeled for apoptotic cells (TUNEL reaction), and the stereociliary bundles of hair cells labeled with fluorescently-tagged phalloidin. Whole mounts of the saccule and utricle were imaged and cells counted. There were significantly more TUNEL-labeled cells found in both organs 4 hours after gentamicin injection compared to vehicle-njected controls. As expected, significantly fewer hair cell bundles were found along the rostral-caudal axis of the saccule and in the extrastriolar and striolar regions of the utricle in gentamicin-treated animals compared to untreated controls. Therefore, as in other species, gentamicin causes significant inner ear sensory hair cell death and auditory dysfunction in zebrafish.	[Uribe, Phillip M.; Wang, Kevin; Asuncion, James D.; Chen, Chien-Wei; Matsui, Jonathan I.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Sun, Huifang; Smith, Michael E.] Western Kentucky Univ, Dept Biol & Biotechnol Ctr, Bowling Green, KY 42101 USA; [Wang, Qi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA	Claremont Colleges; Pomona College; Western Kentucky University; Oregon Health & Science University	Matsui, JI (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	Jonathan.Matsui@pomona.edu	Smith, Michael/AAM-8542-2020; Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237; Smith, Michael/0000-0002-2174-9825; Uribe, Phillip/0000-0002-7396-8907	Pomona College SURP; Rose Hills Foundation Summer Science and Engineering Research Fellowship; National Institutes of Health [DC04555, P20RR16481, P20GM103436-12, DC010998]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC004555, R01DC004555, R01DC012588, R15DC010998] Funding Source: NIH RePORTER	Pomona College SURP; Rose Hills Foundation Summer Science and Engineering Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by a Pomona College SURP (KW), A Rose Hills Foundation Summer Science and Engineering Research Fellowship (CWC), and National Institutes of Health grants DC04555 (PSS), P20RR16481 and P20GM103436-12 (MES), and DC010998 (JIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakley BW, 2008, J OTOLARYNGOL-HEAD N, V37, P700, DOI 10.2310/7070.2008.070174; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; CORWIN JT, 1981, J COMP NEUROL, V201, P541, DOI 10.1002/cne.902010406; CORWIN JT, 1983, J COMP NEUROL, V217, P345, DOI 10.1002/cne.902170309; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; CORWIN JT, 1977, J MORPHOL, V152, P341, DOI 10.1002/jmor.1051520306; CORWIN JT, 1982, ELECTROEN CLIN NEURO, V54, P629, DOI 10.1016/0013-4694(82)90117-1; Dai CF, 2006, HEARING RES, V213, P64, DOI 10.1016/j.heares.2005.11.011; Faucher K, 2008, HEARING RES, V240, P12, DOI 10.1016/j.heares.2008.03.007; Faucher K, 2009, INT J AUDIOL, V48, P456, DOI 10.1080/14992020902738029; Giari L, 2012, J APPL TOXICOL, V32, P293, DOI 10.1002/jat.1691; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; GIROD DA, 1991, LARYNGOSCOPE, V101, P1139; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Higgs DM, 2003, J ACOUST SOC AM, V113, P1145, DOI 10.1121/1.1536185; Higgs DM, 2002, JARO-J ASSOC RES OTO, V3, P174, DOI 10.1007/s101620020035; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Janas JD, 1995, HEARING RES, V92, P17, DOI 10.1016/0378-5955(95)00190-5; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kinkel Mary D, 2010, J Vis Exp, DOI 10.3791/2126; Liang J, 2009, J VIS EXP, V27, pe1211; Liang J, 2012, J NEUROSCI, V32, P10662, DOI 10.1523/JNEUROSCI.5785-10.2012; Liu MJ, 2002, GENE, V298, P129, DOI 10.1016/S0378-1119(02)00932-0; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; MATSUURA S, 1971, JPN J PHYSIOL, V21, P579; Murakami SL, 2003, HEARING RES, V186, P47, DOI 10.1016/S0378-5955(03)00259-4; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2009, HEARING RES, V253, P32, DOI 10.1016/j.heares.2009.03.001; PLATT C, 1993, HEARING RES, V65, P133, DOI 10.1016/0378-5955(93)90208-I; POPPER AN, 1973, J ACOUST SOC AM, V53, P1515, DOI 10.1121/1.1913496; Popper Arthur N., 1999, Springer Handbook of Auditory Research, V11, P43; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Ramcharitar J, 2010, J APPL TOXICOL, V30, P536, DOI 10.1002/jat.1523; Ramcharitar JU, 2010, J CLIN NEUROSCI, V17, P103, DOI 10.1016/j.jocn.2009.08.003; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Schuck JB, 2009, HEARING RES, V253, P67, DOI 10.1016/j.heares.2009.03.008; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Smith ME, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-19; Song JK, 1995, HEARING RES, V91, P63, DOI 10.1016/0378-5955(95)00170-0; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Sun HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028372; TUCCI DL, 1990, OTOLARYNG HEAD NECK, V103, P443, DOI 10.1177/019459989010300317; Uribe PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055359; Van Trump WJ, 2010, HEARING RES, V261, P42, DOI 10.1016/j.heares.2010.01.001; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Wu WJ, 2001, HEARING RES, V158, P165, DOI 10.1016/S0378-5955(01)00303-3; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; YAN HY, 1991, P ROY SOC B-BIOL SCI, V245, P133, DOI 10.1098/rspb.1991.0099	62	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58755	10.1371/journal.pone.0058755	http://dx.doi.org/10.1371/journal.pone.0058755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533589	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400026
J	Bove, R; Secor, E; Healy, BC; Musallam, A; Vaughan, T; Glanz, BI; Greeke, E; Weiner, HL; Chitnis, T; Wicks, P; De Jager, PL				Bove, Riley; Secor, Elizabeth; Healy, Brian C.; Musallam, Alexander; Vaughan, Timothy; Glanz, Bonnie I.; Greeke, Emily; Weiner, Howard L.; Chitnis, Tanuja; Wicks, Paul; De Jager, Philip L.			Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; ADIPONECTIN; MS; COMORBIDITY; PREVALENCE; DISABILITY; OVERWEIGHT; SMOKING; LEPTIN; RISK	Objectives: To assess the potential of an online platform, PatientsLikeMe. com (PLM), for research in multiple sclerosis (MS). An investigation of the role of body mass index (BMI) on MS disease course was conducted to illustrate the utility of the platform. Methods: First, we compared the demographic characteristics of subjects from PLM and from a regional MS center. Second, we validated PLM's patient-reported outcome measure (MS Rating Scale, MSRS) against standard physician-rated tools. Finally, we analyzed the relation of BMI to the MSRS measure. Results: Compared with 4,039 MS Center patients, the 10,255 PLM members were younger, more educated, and less often male and white. Disease course was more often relapsing remitting, with younger symptom onset and shorter disease duration. Differences were significant because of large sample sizes but small in absolute terms. MSRS scores for 121 MS Center patients revealed acceptable agreement between patient-derived and physician-derived composite scores (weighted kappa = 0.46). The Walking domain showed the highest weighted kappa (0.73) and correlation (rs = 0.86) between patient and physician scores. Additionally, there were good correlations between the patient-reported MSRS composite and walking scores and physician-derived measures: Expanded Disability Status Scale (composite rs = 0.61, walking rs = 0.74), Timed 25 Foot Walk (composite rs = 0.70, walking rs = 0.69), and Ambulation Index (composite rs = 0.81, walking rs = 0.84). Finally, using PLM data, we found a modest correlation between BMI and cross-sectional MSRS (rho = 0.17) and no association between BMI and disease course. Conclusions: The PLM population is comparable to a clinic population, and its patient-reported MSRS is correlated with existing clinical instruments. Thus, this online platform may provide a venue for MS investigations with unique strengths (frequent data collection, large sample sizes). To illustrate its applicability, we assessed the role of BMI in MS disease course but did not find a clinically meaningful role for BMI in this setting.	[Bove, Riley; Secor, Elizabeth; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Dept Neurol, Inst Neurosci, Boston, MA 02115 USA; [Bove, Riley; Healy, Brian C.; Musallam, Alexander; Glanz, Bonnie I.; Greeke, Emily; Weiner, Howard L.; Chitnis, Tanuja; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Partners MS Ctr, Ctr Neurol Dis, Boston, MA 02115 USA; [Bove, Riley; Weiner, Howard L.; Chitnis, Tanuja; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Vaughan, Timothy; Wicks, Paul] PatientsLikeMe Inc, Cambridge, MA USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	De Jager, PL (corresponding author), Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Dept Neurol, Inst Neurosci, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Vaughan, Timothy E/A-9968-2009; Wicks, Paul/C-6128-2011	Vaughan, Timothy E/0000-0003-0744-1266; Wicks, Paul/0000-0002-2293-9284; Secor, Elizabeth/0000-0002-6957-5561	NIH [5T32AI074549]; National MS Society; Merck Serono; Abbott; Accorda; Avanir; Biogen; Merck; Novartis; Sanofi; UCB; PatientsLikeMe; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); Merck Serono(Merck & Company); Abbott(Abbott Laboratories); Accorda; Avanir; Biogen(Biogen); Merck(Merck & Company); Novartis(Novartis); Sanofi; UCB(UCB Pharma SA); PatientsLikeMe; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RB is supported by the NIH training grant 5T32AI074549. PLD is a National MS Society Harry Weaver Neuroscience Scholar Award Recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Vaughan and Dr. Wicks are employed by PatientsLikeMe, Inc. Dr. s Vaughan and Wicks hold stock options in the company. The PatientsLikeMe R& D team has received research support from Abbott, Accorda, Avanir, Biogen, Merck, Novartis, Sanofi, and UCB. PatientsLikeMe provided no financial support to the investigative team from Brigham & Women's Hospital. Dr. Bove and MS Secor report no disclosures. Dr. Healy, Dr. Glanz and Ms. Greeke have received research support from Merck Serono. Dr. Weiner has served as a consultant for Biogen-Idec, EMD Serono, Genentech, GSK, Nasvax, Novartis, and Teva Neurosicences. Dr. Chitnis has served as a consultant for Biogen- Idec, Sanofi Aventis, Novartis, EMDSerono, and Teva Neurosciences, and has received grant support from Merck- Serono for unrelated activities. Dr. De Jager has received research support and speaker honoraria from Biogen- Idec and consultation fees from Teva. He has received research support from Biogen- IDEC, GlaxoSmithKline, and Sanofi- Aventis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Brownstein CA, 2009, NAT BIOTECHNOL, V27, P888, DOI 10.1038/nbt1009-888; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Buchanan RJ, 2009, NEUROREHABILITATION, V25, P271, DOI 10.3233/NRE-2009-0525; Cantrell MA, 2007, J ADV NURS, V60, P544, DOI 10.1111/j.1365-2648.2007.04448.x; Doward LC, 2009, MULT SCLER J, V15, P1092, DOI 10.1177/1352458509106513; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gardener H, 2009, EPIDEMIOLOGY, V20, P611, DOI 10.1097/EDE.0b013e31819ed4b9; Ghadirian P, 1998, INT J EPIDEMIOL, V27, P845, DOI 10.1093/ije/27.5.845; Gholipour T, 2011, NEUROLOGY, V76, P1996, DOI 10.1212/WNL.0b013e31821e559d; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; Healy BC, 2009, ARCH NEUROL-CHICAGO, V66, P858, DOI 10.1001/archneurol.2009.122; Hedstrom AK, 2012, MULTIPLE SCLEROSIS; Hietaharju A, 2010, EUR J NEUROL, V17, P332, DOI 10.1111/j.1468-1331.2009.02701.x; Khurana SR, 2009, AM J PHYS MED REHAB, V88, P83, DOI 10.1097/PHM.0b013e318194f8b5; Kraszula L, 2012, NEUROL NEUROCHIR POL, V46, P22, DOI 10.5114/ninp.2012.27211; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Marrie RA, 2011, ACTA NEUROL SCAND, V124, P135, DOI 10.1111/j.1600-0404.2010.01436.x; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Mathew M, 2011, AM J HEALTH PROMOT, V26, P90, DOI 10.4278/ajhp.091001-QUAN-320; Munger KL, 2011, MULT SCLER J, V17, P1405, DOI 10.1177/1352458511425366; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Musabak U, 2011, NEUROIMMUNOMODULAT, V18, P57, DOI 10.1159/000317393; Nortvedt MW, 2005, NEUROL SCI, V26, P334, DOI 10.1007/s10072-005-0498-2; Salter AR, 2011, IS WEIGHT ASS DISABI; Schwartz CE, 2011, QUAL LIFE RES, V20, P1561, DOI 10.1007/s11136-011-0056-8; Turer CB, 2013, PEDIATRICS, V131, pE152, DOI 10.1542/peds.2012-1711; Turner MR, 2011, J NEUROL NEUROSUR PS, V82, P853, DOI 10.1136/jnnp.2010.208413; Twiss J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-117; Wicks P, 2008, EUR J NEUROL, V15, P497, DOI 10.1111/j.1468-1331.2008.02107.x; Wicks P, 2011, EPILEPSY BEHAV E B; Wicks P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-70; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Wicks P, 2011, J MED INTERNET RES, V13, P117, DOI 10.2196/jmir.1687; Wingerchuk DM, 2012, THER ADV NEUROL DISO, V5, P13, DOI 10.1177/1756285611425694	40	47	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59707	10.1371/journal.pone.0059707	http://dx.doi.org/10.1371/journal.pone.0059707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527256	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600090
J	Reintjes, N; Li, Y; Becker, A; Rohmann, E; Schmutzler, R; Wollnik, B				Reintjes, Nadine; Li, Yun; Becker, Alexandra; Rohmann, Edyta; Schmutzler, Rita; Wollnik, Bernd			Activating Somatic FGFR2 Mutations in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; GENOME-WIDE ASSOCIATION; SKELETAL DYSPLASIA; KINASE ACTIVATION; GENES; CRANIOSYNOSTOSIS; SUSCEPTIBILITY; SPECIFICITY; DISORDERS; PATTERNS	It is known that FGFR2 gene variations confer a risk for breast cancer. FGFR2 and FGF10, the main ligand of FGFR2, are both overexpressed in 5-10% of breast tumors. In our study, we sequenced the most important coding regions of FGFR2 in somatic tumor tissue of 140 sporadic breast cancer patients and performed MLPA analysis to detect copy number variations in FGFR2 and FGF10. We identified one somatic heterozygous missense mutation, p.K660N (c.1980G>C), within the tyrosine kinase domain of FGFR2 in tumor tissue of a sporadic breast cancer patient, which is likely mediated by the FGFR2-IIIb isoform. The presence of wild type and mutated alleles in equal quantities suggests that the mutation has driven clonal amplification of mutant cells. We have analyzed the tyrosine kinase activity of p.K660N and another recently described somatic breast cancer mutation in FGFR2, p.R203C, after expression in HEK293 cells and demonstrated that the intrinsic tyrosine kinase activity of both mutant proteins is strongly increased resulting in elevated phosphorylation and activity of downstream effectors. To our knowledge, this is the first report of functional analysis of somatic breast cancer mutations in FGFR2 providing evidence for the activating nature of FGFR2-mediated signalling in the pathogenesis of breast cancer.	[Reintjes, Nadine; Li, Yun; Rohmann, Edyta; Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Reintjes, Nadine; Li, Yun; Rohmann, Edyta; Wollnik, Bernd] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Reintjes, Nadine; Li, Yun; Rohmann, Edyta; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Becker, Alexandra; Schmutzler, Rita] Univ Cologne, Dept Mol Gynecol & Oncol, Gynecol & Obstet Clin, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Wollnik, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de	Wollnik, Bernd/GRY-6062-2022	Wollnik, Bernd/0000-0003-2589-0364; Reintjes, Nadine/0000-0003-3504-7098	German Federal Ministry of Education and Research (BMBF); SKELNET [01GM0880]; E-RARE network CRANIRARE [01GM0801]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); SKELNET; E-RARE network CRANIRARE	This work was supported by the German Federal Ministry of Education and Research (BMBF) (URL: http://www.bmbf.de/) by grant number 01GM0880 (SKELNET) (URL: http://www.skelnet.de/content/) and 01GM0801 (E-RARE network CRANIRARE) (URL: http://e-rare.eu/content/cranirare-2) to Bernd Wollnik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNANE J, 1991, ONCOGENE, V6, P659; ALARID ET, 1994, P NATL ACAD SCI USA, V91, P1074, DOI 10.1073/pnas.91.3.1074; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; Glaser RL, 2003, AM J HUM GENET, V73, P939, DOI 10.1086/378419; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2010, NAT REV GENET, V11, P589, DOI 10.1038/nrg2809-c1; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Iwata T, 2001, HUM MOL GENET, V10, P1255, DOI 10.1093/hmg/10.12.1255; Jang JH, 2001, CANCER RES, V61, P3541; Jaskoll T, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-11; Kato S, 1999, CELL MOL BIOL, V45, P631; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Ornitz DM, 2001, GENOME BIOL, V2; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yamashita Takeyoshi, 2005, Nihon Rinsho, V63 Suppl 10, P519; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	45	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60264	10.1371/journal.pone.0060264	http://dx.doi.org/10.1371/journal.pone.0060264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527311	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600127
J	Vanstechelman, I; Sabbe, K; Vyverman, W; Vanormelingen, P; Vuylsteke, M				Vanstechelman, Ives; Sabbe, Koen; Vyverman, Wim; Vanormelingen, Pieter; Vuylsteke, Marnik			Linkage Mapping Identifies the Sex Determining Region as a Single Locus in the Pennate Diatom Seminavis robusta	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; AVIRULENCE GENES; GENOME; REPRODUCTION; MAP; AFLP; BACILLARIOPHYCEAE; EVOLUTION; SEQUENCE; CLONES	The pennate diatom Seminavis robusta, characterized by an archetypical diatom life cycle including a heterothallic mating system, is emerging as a model system for studying the molecular regulation of the diatom cell and life cycle. One of its main advantages compared with other diatom model systems is that sexual crosses can be made routinely, offering unprecedented possibilities for forward genetics. To date, nothing is known about the genetic basis of sex determination in diatoms. Here, we report on the construction of mating type-specific linkage maps for S. robusta, and use them to identify a single locus sex determination system in this diatom. We identified 13 mating type plus and 15 mating type minus linkage groups obtained from the analysis of 463 AFLP markers segregating in a full-sib family, covering 963.7 and 972.2 cM, respectively. Five linkage group pairs could be identified as putative homologues. The mating type phenotype mapped as a monogenic trait, disclosing the mating type plus as the heterogametic sex. This study provides the first evidence for a genetic sex determining mechanism in a diatom.	[Vanstechelman, Ives; Sabbe, Koen; Vyverman, Wim; Vanormelingen, Pieter] Univ Ghent, Lab Protistol & Aquat Ecol, Dept Biol, B-9000 Ghent, Belgium; [Vanstechelman, Ives; Vuylsteke, Marnik] VIB Dept Plant Syst Biol, Ghent, Belgium; [Vanstechelman, Ives; Vuylsteke, Marnik] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Vuylsteke, M (corresponding author), VIB Dept Plant Syst Biol, Ghent, Belgium.	marnik.vuylsteke@psb.vib-ugent.be			Belspo; Ghent University [BOFGOA 01G01911, BOF BOF09/24J/103]	Belspo(Belgian Federal Science Policy Office); Ghent University(Ghent University)	PV is a postdoctoral research fellow with the Research Foundation - Flanders (FWO). The authors acknowledge Belspo for funding the Belgian Coordinated Culture Collections of Micro-organisms (BCCM) and Ghent University Research Funding (BOFGOA 01G01911 and BOF BOF09/24J/103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Chepurnov VA, 2004, PHYCOL RES, V52, P1; Chepurnov VA, 2002, J PHYCOL, V38, P1004, DOI 10.1046/j.1529-8817.2002.t01-1-01233.x; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2008, BIOESSAYS, V30, P692, DOI 10.1002/bies.20773; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Davidovich NA, 2010, FOTTEA, V10, P251, DOI 10.5507/fot.2010.016; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Foulongne-Oriol M, 2012, APPL MICROBIOL BIOT, V95, P891, DOI 10.1007/s00253-012-4228-4; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gillard J, 2012, ANGEW CHEM IN PRESS; Gillard J, 2008, PLANT PHYSIOL, V148, P1394, DOI 10.1104/pp.108.122176; Granum E, 2005, CAN J BOT, V83, P898, DOI 10.1139/B05-077; Heesch S, 2010, NEW PHYTOL, V188, DOI 10.1111/j.1469-8137.2010.03273.x; LEWIS WM, 1984, AM NAT, V123, P73, DOI 10.1086/284187; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mann DG, 1999, J PHYCOL, V35, P152, DOI 10.1046/j.1529-8817.1999.3510152.x; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; ROSHCHIN A.M., 1994, ZHIZNENNYE TSIKLY DI; Sicard D, 2003, FUNGAL GENET BIOL, V39, P16, DOI 10.1016/S1087-1845(03)00005-7; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Tierney MB, 2005, PLANT HLTH INSTRUCTO, DOI 10.1094/PHI-A-2005-1025-01; van der Lee T, 2004, GENETICS, V167, P1643, DOI 10.1534/genetics.104.029652; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VanderLee T, 1997, FUNGAL GENET BIOL, V21, P278, DOI 10.1006/fgbi.1997.0981; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Yang GP, 2009, J PHYCOL, V45, P873, DOI 10.1111/j.1529-8817.2009.00720.x	33	14	14	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60132	10.1371/journal.pone.0060132	http://dx.doi.org/10.1371/journal.pone.0060132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527302	gold, Green Published			2022-12-27	WOS:000317562600119
J	Blanco, EH; Lagos, CF; Andres, ME; Gysling, K				Blanco, Elias H.; Lagos, Carlos F.; Estela Andres, Maria; Gysling, Katia			An Amphipathic Alpha-Helix in the Prodomain of Cocaine and Amphetamine Regulated Transcript Peptide Precursor Serves as Its Sorting Signal to the Regulated Secretory Pathway	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NUCLEUS-ACCUMBENS; STRUCTURE PREDICTION; SPATIAL RESTRAINTS; CARBOXYPEPTIDASE-E; SEQUENCE-ANALYSIS; SECRETOGRANIN-II; CART; CELLS; GRANULES	Cocaine and Amphetamine Regulated Transcript (CART) peptides are anorexigenic neuropeptides. The L34F mutation in human CART peptide precursor (proCART) has been linked to obesity (Yanik et al. Endocrinology 147: 39, 2006). Decrease in CART peptide levels in individuals carrying the L34F mutation was attributed to proCART subcellular missorting. We studied proCART features required to enter the regulated secretory pathway. The subcellular localization and the secretion mode of monomeric EGFP fused to the full-length or truncated forms of human proCART transiently transfected in PC12 cells were analyzed. Our results showed that the N-terminal 1-41 fragment of proCART was necessary and sufficient to sort proCART to the regulated secretory pathway. In silico modeling predicted an alpha-helix structure located between residues 24-37 of proCART. Helical wheel projection of proCART alpha-helix showed an amphipathic configuration. The L34F mutation does not modify the amphipathicity of proCART alpha-helix and consistently proCART(L34F) was efficiently sorted to the regulated secretory pathway. However, four additional mutations to proCART(L34F) that reduced its alpha-helix amphipathicity resulted in the missorting of the mutated proCART toward the constitutive secretory pathway. These findings show that an amphipathic alpha-helix is a key cis-structure for the proCART sorting mechanism. In addition, our results indicate that the association between L34F mutation and obesity is not explained by proCART missorting.	[Blanco, Elias H.; Estela Andres, Maria; Gysling, Katia] Pontificia Univ Catolica Chile, Millennium Sci Nucleus Stress & Addict, Dept Cell & Mol Biol, Fac Biol Sci, Santiago, Chile; [Lagos, Carlos F.] Pontificia Univ Catolica Chile, Dept Pharm, Fac Chem, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Blanco, EH (corresponding author), Pontificia Univ Catolica Chile, Millennium Sci Nucleus Stress & Addict, Dept Cell & Mol Biol, Fac Biol Sci, Alameda 340, Santiago, Chile.	eblanco@uc.cl; kgysling@bio.puc.cl	Lagos, Carlos F./N-1445-2019	Lagos, Carlos F./0000-0002-5432-9747; Blanco, Elias/0000-0002-1709-9268	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110392]; Millennium Scientific Initiative [P10/063-F]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	This work was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.fondecyt.cl) grant No 1110392 and Millennium Scientific Initiative (http://www.iniciativamilenio.cl) grant No P10/063-F. EHB was a recipient of a doctoral fellowship of the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (www.conicyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2006, TRAFFIC, V7, P416, DOI 10.1111/j.1600-0854.2006.00394.x; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Blanco EH, 2011, NEUROPEPTIDES, V45, P273, DOI 10.1016/j.npep.2011.05.002; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Couceyro PR, 2003, PROTEIN EXPRES PURIF, V32, P185, DOI 10.1016/j.pep.2003.08.015; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; de Bree FM, 2000, FEBS LETT, V475, P175, DOI 10.1016/S0014-5793(00)01623-9; del Giudice EM, 2001, DIABETES, V50, P2157, DOI 10.2337/diabetes.50.9.2157; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Dikeakos JD, 2007, FEBS J, V274, P4094, DOI 10.1111/j.1742-4658.2007.05937.x; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dikeakos JD, 2007, J BIOL CHEM, V282, P1136, DOI 10.1074/jbc.M605718200; DITTIE AS, 1995, BIOCHEM J, V310, P777, DOI 10.1042/bj3100777; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Dylag T, 2006, PEPTIDES, V27, P1926, DOI 10.1016/j.peptides.2005.10.025; El Meskini R, 2001, ENDOCRINOLOGY, V142, P864, DOI 10.1210/endo.142.2.7929; Feliciangeli S, 2001, J BIOL CHEM, V276, P6140, DOI 10.1074/jbc.M009613200; Green JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-222; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Keller PA, 2006, PEPTIDES, V27, P1328, DOI 10.1016/j.peptides.2005.10.016; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 1999, SYNAPSE, V33, P163, DOI 10.1002/(SICI)1098-2396(19990901)33:3<163::AID-SYN1>3.0.CO;2-T; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YH, 2008, J NEUROCHEM, V106, P1314, DOI 10.1111/j.1471-4159.2008.05487.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; MANDERS EMM, 1992, J CELL SCI, V103, P857; MITRA A, 1994, J BIOL CHEM, V269, P19876; Molinete M, 2000, DIABETOLOGIA, V43, P1157, DOI 10.1007/s001250051507; Mouchantaf R, 2001, J BIOL CHEM, V276, P26308, DOI 10.1074/jbc.M102514200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Smith Y, 1997, SYNAPSE, V27, P90, DOI 10.1002/(SICI)1098-2396(199709)27:1<90::AID-SYN10>3.0.CO;2-V; Smith Y, 1999, J COMP NEUROL, V407, P491, DOI 10.1002/(SICI)1096-9861(19990517)407:4<491::AID-CNE3>3.0.CO;2-0; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; SPIESS J, 1981, BIOCHEMISTRY-US, V20, P1982, DOI 10.1021/bi00510a038; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; Thim L, 1999, P NATL ACAD SCI USA, V96, P2722, DOI 10.1073/pnas.96.6.2722; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang SC, 2005, NEUROSCIENCE, V133, P841, DOI 10.1016/j.neuroscience.2005.03.023; Yanik T, 2006, ENDOCRINOLOGY, V147, P39, DOI 10.1210/en.2005-0812; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	58	4	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59695	10.1371/journal.pone.0059695	http://dx.doi.org/10.1371/journal.pone.0059695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527253	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100160
J	Chen, K; Kobayashi, S; Xu, XM; Viollet, B; Liang, QR				Chen, Kai; Kobayashi, Satoru; Xu, Xianmin; Viollet, Benoit; Liang, Qiangrong			AMP Activated Protein Kinase Is Indispensable for Myocardial Adaptation to Caloric Restriction in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARDIAC-HYPERTROPHY; NEGATIVE REGULATORS; DIASTOLIC FUNCTION; SIGNALING PATHWAY; RHESUS-MONKEYS; AUTOPHAGY; HEART; DYSFUNCTION; SURVIVAL	Caloric restriction (CR) is a robust dietary intervention known to enhance cardiovascular health. AMP activated protein kinase (AMPK) has been suggested to mediate the cardioprotective effects of CR. However, this hypothesis remains to be tested by using definitive loss-of-function animal models. In the present study, we subjected AMPK alpha 2 knockout (KO) mice and their wild type (WT) littermates to a CR regimen that reduces caloric intake by 20%-40% for 4 weeks. CR decreased body weight, heart weight and serum levels of insulin in both WT and KO mice to the same degree, indicating the effectiveness of the CR protocol. CR activated cardiac AMPK signaling in WT mice, but not in AMPK alpha 2 KO mice. Correspondingly, AMPK alpha 2 KO mice had markedly reduced cardiac function during CR as determined by echocardiography and hemodynamic measurements. The compromised cardiac function was associated with increased markers of oxidative stress, endoplasmic reticulum stress and myocyte apoptosis. Mechanistically, CR down-regulated the expression of ATP5g2, a subunit of mitochondrial ATP synthase, and reduced ATP content in AMPK alpha 2 KO hearts, but not in WT hearts. In addition, CR accelerated cardiac autophagic flux in WT mice, but failed to do so in AMPK alpha 2 KO mice. These results demonstrated that without AMPK, CR triggers adverse effects that can lead to cardiac dysfunction, suggesting that AMPK signaling pathway is indispensible for energy homeostasis and myocardial adaptation to CR, a dietary intervention that normally produces beneficial cardiac effects.	[Chen, Kai; Kobayashi, Satoru; Xu, Xianmin; Liang, Qiangrong] Univ S Dakota, Cardiovasc Hlth Res Ctr, Sanford Res, Sioux Falls, SD USA; [Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR8104, Paris, France; [Viollet, Benoit] Univ Paris 05, Paris, France	Sanford Health; University of South Dakota; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Liang, QR (corresponding author), New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA.	Qiangrong.Liang@sanfordhealth.org	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	American Diabetes Association [1-09-CD-09]; National Center for Research Resources [5P20RR017662-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103455-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103455] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a Career Development Grant (1-09-CD-09) from the American Diabetes Association and by grants from the National Center for Research Resources (5P20RR017662-10) and the National Institute of General Medical Sciences (8 P20 GM103455-10) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Beauloye C, 2011, CARDIOVASC RES; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Cheng H, 2011, J MOL CELL CARDIOL, V51, P607, DOI 10.1016/j.yjmcc.2010.11.020; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001; Dhahbi JM, 2006, J GERONTOL A-BIOL, V61, P218, DOI 10.1093/gerona/61.3.218; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Edwards AG, 2010, MECH AGEING DEV, V131, P739, DOI 10.1016/j.mad.2010.09.007; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Gottlieb RA, 2010, BIOCHIM BIOPHYS ACTA, V1813, P1295; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Hepple RT, 2009, EXERC SPORT SCI REV, V37, P23, DOI 10.1097/JES.0b013e3181877dc5; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Katare RG, 2009, J MOL CELL CARDIOL, V46, P405, DOI 10.1016/j.yjmcc.2008.10.027; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim M, 2011, J MOL CELL CARDIOL; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lane Mark A, 2007, Methods Mol Biol, V371, P143; Lu J, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0326-9; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Martin Bronwen, 2007, IBS J Sci, V2, P35; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Masoro EJ, 2009, BIOCH BIOPHYS ACTA; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2007, AUTOPHAGY, V3; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Muthukumar A, 2003, J CLIN IMMUNOL, V23, P23, DOI 10.1023/A:1021996130672; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Raeini-Sarjaz M, 2001, AM J CLIN NUTR, V73, P262; Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006; Riordan MM, 2008, AM J PHYSIOL-HEART C, V294, pH1174, DOI 10.1152/ajpheart.01236.2007; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Shioji K, 2002, CIRCULATION, V106, P1403, DOI 10.1161/01.CIR.0000027817.55925.B4; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spindler SR, 2009, AGEING RES REV; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tang YD, 2005, CIRCULATION, V112, P3122, DOI 10.1161/CIRCULATIONAHA.105.572883; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Viljanen APM, 2009, AM J CARDIOL, V103, P1721, DOI 10.1016/j.amjcard.2009.02.025; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wan R, 2009, J NUTR BIOCH; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535; Wu SJ, 2009, CARDIOVASC RES, V84, P119, DOI 10.1093/cvr/cvp180; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	82	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59682	10.1371/journal.pone.0059682	http://dx.doi.org/10.1371/journal.pone.0059682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527250	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100158
J	Hou, HM; Li, J; Gao, M; Singer, SD; Wang, H; Mao, LY; Fei, ZJ; Wang, XP				Hou, Hongmin; Li, Jun; Gao, Min; Singer, Stacy D.; Wang, Hao; Mao, Linyong; Fei, Zhangjun; Wang, Xiping			Genomic Organization, Phylogenetic Comparison and Differential Expression of the SBP-Box Family Genes in Grape	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; WIDE IDENTIFICATION; ANTIRRHINUM-MAJUS; SHOOT MATURATION; ABSCISIC-ACID; SALT-STRESS; MICRORNAS; PROTEIN; DUPLICATION	Background: The SBP-box gene family is specific to plants and encodes a class of zinc finger-containing transcription factors with a broad range of functions. Although SBP-box genes have been identified in numerous plants including green algae, moss, silver birch, snapdragon, Arabidopsis, rice and maize, there is little information concerning SBP-box genes, or the corresponding miR156/157, function in grapevine. Methodology/Principal Findings: Eighteen SBP-box gene family members were identified in Vitis vinifera, twelve of which bore sequences that were complementary to miRNA156/157. Phylogenetic reconstruction demonstrated that plant SBP-domain proteins could be classified into seven subgroups, with the V. vinifera SBP-domain proteins being more closely related to SBP-domain proteins from dicotyledonous angiosperms than those from monocotyledonous angiosperms. In addition, synteny analysis between grape and Arabidopsis demonstrated that homologs of several grape SBP genes were found in corresponding syntenic blocks of Arabidopsis. Expression analysis of the grape SBP-box genes in various organs and at different stages of fruit development in V. quinquangularis 'Shang-24' revealed distinct spatiotemporal patterns. While the majority of the grape SBP-box genes lacking a miR156/157 target site were expressed ubiquitously and constitutively, most genes bearing a miR156/157 target site exhibited distinct expression patterns, possibly due to the inhibitory role of the microRNA. Furthermore, microarray data mining and quantitative real-time RT-PCR analysis identified several grape SBP-box genes that are potentially involved in the defense against biotic and abiotic stresses. Conclusion: The results presented here provide a further understanding of SBP-box gene function in plants, and yields additional insights into the mechanism of stress management in grape, which may have important implications for the future success of this crop.	[Hou, Hongmin; Li, Jun; Gao, Min; Wang, Hao; Wang, Xiping] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hou, Hongmin; Li, Jun; Gao, Min; Wang, Hao; Wang, Xiping] Northwest A&F Univ, Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat North, Yangling, Shaanxi, Peoples R China; [Singer, Stacy D.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Mao, Linyong; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Alberta; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Wang, XP (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wangxiping@nwsuaf.edu.cn	Fei, Zhangjun/H-5152-2012	Li, Jun/0000-0003-2845-2351	National Natural Science Foundation of China [31071782, 30671446]; 948 Project from Ministry of Agriculture of China [2012-S12]; Chinese Universities Scientific Fund [QN2011056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 Project from Ministry of Agriculture of China; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (31071782 and 30671446), 948 Project from Ministry of Agriculture of China (2012-S12) and Chinese Universities Scientific Fund (QN2011056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Azooz MM, 2009, INT J AGRIC BIOL, V11, P343; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Davies WJ, 1991, ABSCISIC ACID PHYSL; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Jung C, 2007, J PLANT BIOL, V50, P12, DOI 10.1007/BF03030594; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Kang DJ, 2005, J AGRON CROP SCI, V191, P273, DOI 10.1111/j.1439-037X.2005.00153.x; Khan M., 2012, PHYTOHORMONES ABIOTI, P277, DOI [10.1007/978-3-642-25829-9, DOI 10.1007/978-3-642-25829-9_12]; Khan N., 2010, INT J PLANT BIOL, V1, pe1, DOI [10.4081/pb.2010.e1, DOI 10.4081/pb.2010.e1]; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Lannenpaa M, 2004, PHYSIOL PLANTARUM, V120, P491, DOI 10.1111/j.0031-9317.2004.00254.x; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li HE, 2010, PLANTA, V232, P1325, DOI 10.1007/s00425-010-1258-y; Ling KS, 2004, J GEN VIROL, V85, P2099, DOI 10.1099/vir.0.80007-0; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin RC, 2010, SEED SCI RES, V20, P89, DOI 10.1017/S0960258510000073; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Preston JC, 2010, PLANT J, V62, P704, DOI 10.1111/j.1365-313X.2010.04184.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salinas M, 2011, PLANTA, P1; Schwab R, 2012, MICRORNAS PLANT DEV, P49; Schwab R, 2012, MICRORNAS PLANT DEV, P69; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shigyo M, 2007, PLANT CELL PHYSIOL, V48, P179, DOI 10.1093/pcp/pcl044; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Syeed S, 2011, ACTA PHYSIOL PLANT, V33, P877, DOI 10.1007/s11738-010-0614-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Usami T, 2009, DEVELOPMENT, V136, P955, DOI 10.1242/dev.028613; Velitchkova M, 1998, PHOTOSYNTHETICA, V35, P89, DOI 10.1023/A:1006878016556; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wang Y, 2010, RUSS J PLANT PHYSL+, V57, P273, DOI 10.1134/S1021443710020160; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wang YY, 2001, J CHEM ECOL, V27, P327, DOI 10.1023/A:1005632506230; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Wise Roger P., 2007, V406, P347; Wong FP, 2001, PLANT DIS, V85, P649, DOI 10.1094/PDIS.2001.85.6.649; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang JinJin, 2003, Journal of Fruit Science, V20, P178; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153	87	81	106	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59358	10.1371/journal.pone.0059358	http://dx.doi.org/10.1371/journal.pone.0059358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527172	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100116
J	Onabajo, OO; George, J; Lewis, MG; Mattapallil, JJ				Onabajo, Olusegun O.; George, Jeffy; Lewis, Mark G.; Mattapallil, Joseph J.			Rhesus Macaque Lymph Node PD-1(hi)CD4(+) T Cells Express High Levels of CXCR5 and IL-21 and Display a CCR7(lo)ICOS(+)Bcl6(+) T-Follicular Helper (Tfh) Cell Phenotype	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GERMINAL-CENTER FORMATION; B-CELLS; ANTIRETROVIRAL THERAPY; CHEMOKINE RECEPTOR-5; MEMORY; RESPONSES; HOMEOSTASIS; BCL6	CD4 T follicular helper (Tfh) cells play a unique and essential role in the generation of B cell responses in the lymph node microenvironment. Here we sought to determine if differential expression of PD-1 could be used to delineate Tfh cells in rhesus macaque lymph nodes (LN). CD3(+)CD4(+) T cells were found to harbor a unique subset of cells that expressed the Program death-1 (PD-1) receptor at significantly high levels that were enriched in the LN compartment as compared to peripheral blood. The LN CD4(+)PD1(hi) T cells expressed a predominantly CD28(+)CD95(+) central memory phenotype and were CCR7(lo)ICOS(hi)Bcl6(hi). Additionally, CD4(+)PD1(hi) T cells preferentially expressed high levels of CXCR5 and IL-21 and significantly correlated with Bcl6(+)Ki-67(+)IgG(+) B cells. As Bcl6 is primarily expressed by proliferating B cells within active germinal centers, our results suggest that LN CD4(+)PD1(hi) T cells likely localize to active GC regions, a characteristic that is attributable to Tfh cells. Overall, our findings suggest that high levels of PD-1 expression on CD4(+) T cells in LN of rhesus macaques can serve as a valuable marker to identify Tfh cells and has implications for studying the role of Tfh cells in Human immunodeficiency virus (HIV), Simian immunodeficiency virus (SIV) and other infectious diseases that use the rhesus macaque model.	[Onabajo, Olusegun O.; George, Jeffy; Mattapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD USA	Uniformed Services University of the Health Sciences - USA; BIOQUAL Inc.	Mattapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	joseph.mattapallil@usuhs.edu	GEORGE, JEFFY/M-9900-2019; GEORGE, JEFFY/A-1606-2010	GEORGE, JEFFY/0000-0003-1144-9244; Mattapallil, Joseph/0000-0002-7412-9507	National Institute for Dental and Craniofacial Research (NIDCR), Natianal Institutes of Health [DE019397]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019397] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research (NIDCR), Natianal Institutes of Health; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The described project was supported by DE019397 awarded to JJM from National Institute for Dental and Craniofacial Research (NIDCR), Natianal Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDCR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Caccamo N, 2006, J IMMUNOL, V177, P5290, DOI 10.4049/jimmunol.177.8.5290; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; George J, 2011, AIDS RES HUM RETROV, V27, P763, DOI [10.1089/aid.2010.0251, 10.1089/AID.2010.0251]; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Huang D, 2007, J INFECT DIS, V195, P55, DOI 10.1086/509895; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; KADER M, 2009, J MED PRIMA IN PRESS; Kader M, 2008, J VIROL, V82, P11467, DOI 10.1128/JVI.01143-08; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Krawtez S MS, 2000, PRIMER3 WWW GEN USER; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Moore AC, 2012, J VIROL, V86, P1069, DOI 10.1128/JVI.06372-11; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tonti E, 2012, J IMMUNOL, V188, P3217, DOI 10.4049/jimmunol.1103501; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	39	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59758	10.1371/journal.pone.0059758	http://dx.doi.org/10.1371/journal.pone.0059758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527264	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100164
J	Seurin, D; Lombet, A; Babajko, S; Godeau, F; Ricort, JM				Seurin, Danielle; Lombet, Alain; Babajko, Sylvie; Godeau, Francois; Ricort, Jean-Marc			Insulin-Like Growth Factor Binding Proteins Increase Intracellular Calcium Levels in Two Different Cell Lines	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RECEPTOR; INTEGRIN; IGFS; INHIBITION; ACTIVATION; MIGRATION; AFFINITY; DISEASE; FAMILY	Background: Insulin-like growth factor binding proteins (IGFBPs) are six related secreted proteins that share IGF-dependent and - independent functions. If the former functions begin to be well described, the latter are somewhat more difficult to investigate and to characterize. At the cellular level, IGFBPs were shown to modulate numerous processes including cell growth, differentiation and apoptosis. However, the molecular mechanisms implicated remain largely unknown. We previously demonstrated that IGFBP-3, but not IGFBP-1 or IGFBP-5, increase intracellular calcium concentration in MCF-7 cells (Ricort J-M et al. (2002) FEBS lett 527: 293-297). Methodology/Principal Findings: We perform a global analysis in which we studied, by two different approaches, the binding of each IGFBP isoform (i.e., IGFBP-1 to -6) to the surface of two different cellular models, MCF-7 breast adenocarcinoma cells and C2 myoblast proliferative cells, as well as the IGFBP-induced increase of intracellular calcium concentration. Using both confocal fluorescence microscopy and flow cytometry analysis, we showed that all IGFBPs bind to MCF-7 cell surface. By contrast, only four IGFBPs can bind to C2 cell surface since neither IGFBP-2 nor IGFBP-4 were detected. Among the six IGFBPs tested, only IGFBP-1 did not increased intracellular calcium concentration whatever the cellular model studied. By contrast, IGFBP-2, -3, -4 and -6, in MCF-7 cells, and IGFBP-3, -5 and -6, in C2 proliferative cells, induce a rapid and transient increase in intracellular free calcium concentration. Moreover, IGFBP-2 and -3 (in MCF-7 cells) and IGFBP-5 (in C2 cells) increase intracellular free calcium concentration by a pertussis toxin sensitive signaling pathway. Conclusions: Our results demonstrate that IGFBPs are able to bind to cell surface and increase intracellular calcium concentration. By characterizing the IGFBPs-induced cell responses and intracellular couplings, we highlight the cellular specificity and complexity of the IGF-independent actions of these IGF binding proteins.	[Seurin, Danielle; Godeau, Francois] Ctr Rech St Antoine, INSERM UMR S938, Paris, France; [Lombet, Alain] INSERM U999, Le Plessis Robinson, France; [Babajko, Sylvie] INSERM U872, Lab Physiopathol Orale Mol, Paris, France; [Ricort, Jean-Marc] CNRS, ENS Cachan, LBPA, Cachan, France; [Ricort, Jean-Marc] Univ Montpellier 2, UMR204, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier	Ricort, JM (corresponding author), CNRS, ENS Cachan, LBPA, Cachan, France.	jean-marc.ricort@um2.fr	Babajko, S/H-2073-2014	Babajko, S/0000-0001-9047-3490	Institut National de la Sante et de la Recherche Medicale; University of Montpellier 2	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 2	This work was supported by the Institut National de la Sante et de la Recherche Medicale and the University of Montpellier 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baserga R, 1999, CONT ENDOCRINOL, V17, P329; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Chesik D, 2010, J NEUROCHEM, V113, P1319, DOI 10.1111/j.1471-4159.2010.06703.x; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Colomer J., 2007, V45, P169; DROP SLS, 1992, GROWTH REGULAT, V2, P69; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Flynn RS, 2009, AM J PHYSIOL-GASTR L, V297, pG1232, DOI 10.1152/ajpgi.00323.2009; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Hoeflich A, 2001, CANCER RES, V61, P8601; Holly J, 2006, NEUROENDOCRINOLOGY, V83, P154, DOI 10.1159/000095523; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Iosef C, 2010, CELL SIGNAL, V22, P1033, DOI 10.1016/j.cellsig.2010.02.006; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Leal SM, 1997, J BIOL CHEM, V272, P20572, DOI 10.1074/jbc.272.33.20572; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Martin JL, 2011, GROWTH FACTORS, V29, P235, DOI 10.3109/08977194.2011.614237; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; OH YM, 1993, J BIOL CHEM, V268, P14964; Perks C, 2008, J MAMMARY GLAND BIOL, V13, P455, DOI 10.1007/s10911-008-9106-4; PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Ricort JM, 2004, GROWTH HORM IGF RES, V14, P277, DOI 10.1016/j.ghir.2004.02.002; Ricort JM, 2002, FEBS LETT, V527, P293, DOI 10.1016/S0014-5793(02)03250-7; Ricort JM, 2001, ENDOCRINOLOGY, V142, P108, DOI 10.1210/en.142.1.108; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Seurin D, 2002, EUR J CANCER, V38, P2058, DOI 10.1016/S0959-8049(02)00240-X; Uzoh CC, 2011, BRIT J CANCER, V104, P1587, DOI 10.1038/bjc.2011.127; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Yamada M, 1998, LIFE SCI, V62, pPL375; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	42	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59323	10.1371/journal.pone.0059323	http://dx.doi.org/10.1371/journal.pone.0059323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527161	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100106
J	Weissensteiner, H; Haun, M; Schonherr, S; Neuner, M; Forer, L; Specht, G; Kloss-Brandstatter, A; Kronenberg, F; Coassin, S				Weissensteiner, Hansi; Haun, Margot; Schoenherr, Sebastian; Neuner, Mathias; Forer, Lukas; Specht, Guenther; Kloss-Brandstaetter, Anita; Kronenberg, Florian; Coassin, Stefan			SNPflow: A Lightweight Application for the Processing, Storing and Automatic Quality Checking of Genotyping Assays	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MANAGEMENT SYSTEM; INTEGRATED-SYSTEM; HAPLOTYPE MAP; LOCI; GENETICS; COMMON; HYBRIDIZATION; METAANALYSIS; SOFTWARE	Single nucleotide polymorphisms (SNPs) play a prominent role in modern genetics. Current genotyping technologies such as Sequenom iPLEX, ABI TaqMan and KBioscience KASPar made the genotyping of huge SNP sets in large populations straightforward and allow the generation of hundreds of thousands of genotypes even in medium sized labs. While data generation is straightforward, the subsequent data conversion, storage and quality control steps are time-consuming, error-prone and require extensive bioinformatic support. In order to ease this tedious process, we developed SNPflow. SNPflow is a lightweight, intuitive and easily deployable application, which processes genotype data from Sequenom MassARRAY (iPLEX) and ABI 7900HT (TaqMan, KASPar) systems and is extendible to other genotyping methods as well. SNPflow automatically converts the raw output files to ready-to-use genotype lists, calculates all standard quality control values such as call rate, expected and real amount of replicates, minor allele frequency, absolute number of discordant replicates, discordance rate and the p-value of the HWE test, checks the plausibility of the observed genotype frequencies by comparing them to HapMap/1000-Genomes, provides a module for the processing of SNPs, which allow sex determination for DNA quality control purposes and, finally, stores all data in a relational database. SNPflow runs on all common operating systems and comes as both stand-alone version and multi-user version for laboratory-wide use. The software, a user manual, screenshots and a screencast illustrating the main features are available at http://genepi-snpflow.i-med.ac.at.	[Weissensteiner, Hansi; Haun, Margot; Schoenherr, Sebastian; Forer, Lukas; Kloss-Brandstaetter, Anita; Kronenberg, Florian; Coassin, Stefan] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Weissensteiner, Hansi; Schoenherr, Sebastian; Neuner, Mathias; Forer, Lukas; Specht, Guenther] Univ Innsbruck, Inst Comp Sci, Dept Database & Informat Syst, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck	Kronenberg, F (corresponding author), Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria.	Florian.Kronenberg@i-med.ac.at	Schoenherr, Sebastian/W-8761-2019; Forer, Lukas/ABE-6007-2020; Forer, Lukas/AAX-9577-2021; Schoenherr, Sebastian/ABB-3366-2020; Kronenberg, Florian/B-1736-2008; Weissensteiner, Hansi/AAT-1789-2021; Coassin, Stefan/J-2611-2018	Schoenherr, Sebastian/0000-0001-5909-9226; Forer, Lukas/0000-0003-2139-7329; Kronenberg, Florian/0000-0003-2229-1120; Weissensteiner, Hansi/0000-0002-2871-8669; Coassin, Stefan/0000-0001-5677-8979; Kloss-Brandstatter, Anita/0000-0002-0873-6704	Autonomous Province of Bozen/Bolzano (South Tyrol); University of Innsbruck [MIP10/2009/3]; Austrian Genome Research Programme GEN-AU	Autonomous Province of Bozen/Bolzano (South Tyrol); University of Innsbruck; Austrian Genome Research Programme GEN-AU	Hansi Weissensteiner was supported by a scholarship from the Autonomous Province of Bozen/Bolzano (South Tyrol) and Sebastian Schonherr by a scholarship from the University of Innsbruck (Doctoral grant for young researchers, MIP10/2009/3). The project was supported by grants from the "Standortagentur Tirol" and the "Genomics of Lipid-Associated Disorders-GOLD" of the Austrian Genome Research Programme GEN-AU to Florian Kronenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Atallah M.J., 2005, INT J INF SECUR, V4, P277; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Coassin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001239; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Fiddy S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-210; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holzapfel C, 2011, EUR J ENDOCRINOL, V164, P205, DOI 10.1530/EJE-10-0588; Jayashree B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-383; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kim JJ, 2010, INT J LEGAL MED, V124, P125, DOI 10.1007/s00414-009-0389-9; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kollerits B, 2010, J MED GENET, V47, P116, DOI 10.1136/jmg.2009.066597; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Li JL, 2001, GENOME RES, V11, P1304, DOI 10.1101/gr.159701; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Millis MP, 2011, METHODS MOL BIOL, V700, P61, DOI 10.1007/978-1-61737-954-3_5; Monnier S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-246; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Murabito JM, 2012, CIRC-CARDIOVASC GENE, V5, P100, DOI 10.1161/CIRCGENETICS.111.961292; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schonherr S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-139; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smith Albert Vernon, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5026; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; Teo YY, 2008, CURR OPIN LIPIDOL, V19, P133, DOI 10.1097/MOL.0b013e3282f5dd77; Truong CVC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-425; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wassel CL, 2012, ATHEROSCLER IN PRESS; Weissensteiner H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-122; Wendl MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-362; Yoo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-290; Zhao LJ, 2005, BIOINFORMATICS, V21, P266, DOI 10.1093/bioinformatics/bth486	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59508	10.1371/journal.pone.0059508	http://dx.doi.org/10.1371/journal.pone.0059508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527209	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100142
J	McGregor, DC; Kerr, SE; Krockenberger, AK				McGregor, Denise C.; Kerr, Sarah E.; Krockenberger, Andrew K.			The Distribution and Abundance of an Island Population of Koalas (Phascolarctos cinereus) in the Far North of Their Geographic Range	PLOS ONE			English	Article							SOUTH-WEST QUEENSLAND; EAST QUEENSLAND; PRIVATE LANDS; CONSERVATION; HABITAT; GOLDFUSS; DECLINE; DUNG; MULGALANDS; DENSITIES	Koalas are an iconic species of charismatic megafauna, of substantial social and conservation significance. They are widely distributed, often at low densities, and individuals can be difficult to detect, making population surveys challenging and costly. Consequently, koala population estimates have been limited and the results inconsistent. The aims of this study were to estimate the distribution, relative abundance and population size of the koalas on Magnetic Island, far north Queensland. Population densities were estimated in 18 different vegetation types present on the island using a Fecal Standing Crop Method. Koala density ranged from 0.404 ha(-1), recorded in forest red gum and bloodwood woodland, to absence from eight of the vegetation types surveyed. The second highest density of 0.297 koalas ha(-1) was recorded in mixed eucalypt woodland, which covers 45% of the island. The total abundance of koalas on Magnetic Island, not including those present in urban areas, was estimated at 825 +/- 175 (SEM). The large variation in koala density across vegetation types reinforces the need for sampling stratification when calculating abundance over large areas, as uniformity of habitat quality cannot be assumed. In this context, koala populations also occur in low densities in areas generally regarded as poor quality koala habitat. These results highlight the importance of protecting vegetation communities not traditionally considered to have high conservation value to koalas, as these habitats may be essential for maintaining viable, widespread, low-density populations. The results from this study provide a baseline to assess future trends in koala distribution, density and abundance on Magnetic Island.	[Krockenberger, Andrew K.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia	James Cook University; James Cook University	Krockenberger, AK (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	Andrew.Krockenberger@jcu.edu.au	Krockenberger, Andrew K/C-1323-2010	Krockenberger, Andrew/0000-0003-2872-9939	James Cook University	James Cook University	The study was not supported under any external grant funding, but relied on in-kind support (provision of accommodation) from the Magnetic Island Community Development Association and internal funds from James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian and New Zealand Environment and Conservation Council, 1998, NAT KOAL CONS STRAT; Bennett A., 2005, P450, DOI 10.1017/CBO9780511542084.027; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Cork S.J., 1990, P129; Cork SJ, 2000, CONSERV BIOL, V14, P702; Department of Environment and Resource Management, 2009, DECL KOAL COAST POP; Dique D, 2001, RES MANAGEMENT NONUR, P105; Dique DS, 2004, WILDLIFE RES, V31, P109, DOI 10.1071/WR02031; Dique DS, 2003, WILDLIFE RES, V30, P127, DOI 10.1071/WR02042; Ellis WAH, 1998, WILDLIFE RES, V25, P663, DOI 10.1071/WR97028; EVERY KR, 1986, AUST WILDLIFE RES, V13, P517; GALL BC, 1980, AUST WILDLIFE RES, V7, P167; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Gordon G., 1990, P85; Gordon Greg, 2006, Australian Zoologist, V33, P345; Handasyde KA, 2008, MAMMALS AUSTR; HASEGAWA M, 1995, THESIS U QUEENSLAND; Hindell MA, 1987, WILDLIFE RES, V12, P349; Hindell MA, 1984, THESIS MONASH U MELB; HUME ID, 1993, AUST J ZOOL, V41, P379, DOI 10.1071/ZO9930379; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P139; Knight RL, 1999, CONSERV BIOL, V13, P223; Krockenberger AK, 2007, FUNCT ECOL, V21, P748, DOI 10.1111/j.1365-2435.2007.01279.x; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Latham J, 1996, J ZOOL, V240, P285, DOI 10.1111/j.1469-7998.1996.tb05285.x; Lee AK, 1988, KOALA NATURAL HIST; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Marques FFC, 2001, J APPL ECOL, V38, P349, DOI 10.1046/j.1365-2664.2001.00584.x; Martin R, 1997, AUSTR BIOL, V10, P57; MARTIN R, 1999, BIOL KOALA, P75; MARTIN RW, 1985, AUST WILDLIFE RES, V12, P355; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; Maxwell S., 1996, 1996 ACTION PLAN AUS; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Melzer A., 1995, THESIS U QUEENSLAND; Melzer A, 2001, RES MANAGEMENT NONUR, P105; Melzer Alistair, 1994, Proceedings of the Royal Society of Queensland, V104, P89; Mitchell P., 1990, P97; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; Patterson R., 1996, KOALAS RES MANAGEMEN, P75; Penn AM, 2000, CONSERV BIOL, V14, P629, DOI 10.1046/j.1523-1739.2000.99385.x; PHILLIPS B, 1990, KOALAS LITTLE AUSTR; Phillips SS, 2000, CONSERV BIOL, V14, P650, DOI 10.1046/j.1523-1739.2000.99387.x; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Reed PC, 1990, 1986 1987 SURVEY KOA, P55; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Sandercoe C, 1990, TECHNICAL REPORT; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Smith AP, 1997, KOALA HABITAT ABUNDA; SMITH ARTHUR D., 1964, J WILDL MGMT, V28, P435, DOI 10.2307/3798195; St John B, 1997, AUSTR BIOL, V10, P47; Sullivan BJ, 2002, WILDLIFE RES, V29, P455, DOI 10.1071/WR00110; Sullivana BJ, 2004, WILDLIFE RES, V31, P19, DOI 10.1071/WR02037; Telfer WR, 2006, AUST J ZOOL, V54, P325, DOI 10.1071/ZO05074; Todd CR, 2008, J APPL ECOL, V45, P568, DOI 10.1111/j.1365-2664.2007.01434.x; Triggs B., 1996, TRACKS SCATS OTHER T; White N.A., 1990, P109; Witt G. B., 1995, ECOLOGICAL RES MANAG, P91; [No title captured]	61	6	6	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59713	10.1371/journal.pone.0059713	http://dx.doi.org/10.1371/journal.pone.0059713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527258	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000316411600075
J	Nichols, BE; Boucher, CAB; van Dijk, JH; Thuma, PE; Nouwen, JL; Baltussen, R; van de Wijgert, J; Sloot, PMA; van de Vijver, DAMC				Nichols, Brooke E.; Boucher, Charles A. B.; van Dijk, Janneke H.; Thuma, Phil E.; Nouwen, Jan L.; Baltussen, Rob; van de Wijgert, Janneke; Sloot, Peter M. A.; van de Vijver, David A. M. C.			Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; TRANSMISSION; WOMEN; STAGE; INTERVENTIONS; AFRICA; HEALTH; IMPACT; COHORT	Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infections. The optimal scenario for implementing PrEP where most infections are averted at the lowest cost is unknown. We determined the impact of different PrEP strategies on averting new infections, prevalence, drug resistance and cost-effectiveness in Macha, a rural setting in Zambia. Methods: A deterministic mathematical model of HIV transmission was constructed using data from the Macha epidemic (antenatal prevalence 7.7%). Antiretroviral therapy is started at CD4<350 cells/mm(3). We compared the number of infections averted, cost-effectiveness, and potential emergence of drug resistance of two ends of the prioritization spectrum: prioritizing PrEP to half of the most sexually active individuals (5-15% of the total population), versus randomly putting 40-60% of the total population on PrEP. Results: Prioritizing PrEP to individuals with the highest sexual activity resulted in more infections averted than a non-prioritized strategy over ten years (31% and 23% reduction in new infections respectively), and also a lower HIV prevalence after ten years (5.7%, 6.4% respectively). The strategy was very cost-effective at $323 per quality adjusted life year gained and appeared to be both less costly and more effective than the non-prioritized strategy. The prevalence of drug resistance due to PrEP was as high as 11.6% when all assumed breakthrough infections resulted in resistance, and as low as 1.3% when 10% of breakthrough infections resulted in resistance in both our prioritized and non-prioritized scenarios. Conclusions: Even in settings with low test rates and treatment retention, the use of PrEP can still be a useful strategy in averting infections. Our model has shown that PrEP is a cost-effective strategy for reducing HIV incidence, even when adherence is suboptimal and prioritization is imperfect.	[Nichols, Brooke E.; Boucher, Charles A. B.; Nouwen, Jan L.; van de Vijver, David A. M. C.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [van Dijk, Janneke H.; Thuma, Phil E.] Macha Mission Hosp & Macha Res Trust, Macha, Zambia; [Baltussen, Rob] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Sloot, Peter M. A.] Univ Amsterdam, Fac Sci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Liverpool; University of Amsterdam	Nichols, BE (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	b.nichols@erasmusmc.nl; d.vandevijver@erasmusmc.nl	Nichols, Brooke E./V-5496-2019; Baltussen, R.M.P.M./L-4181-2015; Sloot, Peter/B-3078-2014	Nichols, Brooke E./0000-0003-4682-4999; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Sloot, Peter/0000-0002-3848-5395; van de Vijver, David/0000-0001-5877-8526	Aids Fonds Netherlands [2010-035]; European Union [223131, 233847]	Aids Fonds Netherlands; European Union(European Commission)	This study was done with financial support from the Aids Fonds Netherlands (2010-035; http://aidsfonds.nl/), and has been partially funded by the European Union FP7 grants CHAIN (No. 223131; http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/185_en.htm) and DynaNets (no. 233847; http://www.dynanets.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018165; Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; C.H.A.I, 2010, ANT ARV PRIC LIST; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CREMIN I, 2009, AIDS BEHAV; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; ROSE KA, 1991, J FORECASTING, V10, P117, DOI 10.1002/for.3980100108; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Sachs JD, 2001, MACR HLTH INV HLTH E; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; The World Bank, 2011, ZAMB WORLD DEV IND; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS/WHO, 2008, EP FACT SHEET HIV AI; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van de Vijver DAMC, 2010, CURR OPIN INFECT DIS, V23, P621, DOI 10.1097/QCO.0b013e32833ff1e6; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO-CHOICE, 2011, CHOOSING INT AR COST	40	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59549	10.1371/journal.pone.0059549	http://dx.doi.org/10.1371/journal.pone.0059549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZS	23527217	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600062
J	Heinemann, D; Schomaker, M; Kalies, S; Schieck, M; Carlson, R; Escobar, HM; Ripken, T; Meyer, H; Heisterkamp, A				Heinemann, Dag; Schomaker, Markus; Kalies, Stefan; Schieck, Maximilian; Carlson, Regina; Escobar, Hugo Murua; Ripken, Tammo; Meyer, Heiko; Heisterkamp, Alexander			Gold Nanoparticle Mediated Laser Transfection for Efficient siRNA Mediated Gene Knock Down	PLOS ONE			English	Article							PLASMA-MEMBRANE PERMEABILITY; TARGETED TRANSFECTION; CELLS; SURFACE; SIZE; IRRADIATION; DEPENDENCE; ELEVATION; DELIVERY; FIELDS	Laser based transfection methods have proven to be an efficient and gentle alternative to established molecule delivery methods like lipofection or electroporation. Among the laser based methods, gold nanoparticle mediated laser transfection bears the major advantage of high throughput and easy usability. This approach uses plasmon resonances on gold nanoparticles unspecifically attached to the cell membrane to evoke transient and spatially defined cell membrane permeabilization. In this study, we explore the parameter regime for gold nanoparticle mediated laser transfection for the delivery of molecules into cell lines and prove its suitability for siRNA mediated gene knock down. The developed setup allows easy usage and safe laser operation in a normal lab environment. We applied a 532 nm Nd:YAG microchip laser emitting 850 ps pulses at a repetition rate of 20.25 kHz. Scanning velocities of the laser spot over the sample of up to 200 mm/s were tested without a decline in perforation efficiency. This velocity leads to a process speed of similar to 8 s per well of a 96 well plate. The optimal particle density was determined to be similar to 6 particles per cell using environmental scanning electron microscopy. Applying the optimized parameters transfection efficiencies of 88% were achieved in canine pleomorphic adenoma ZMTH3 cells using a fluorescent labeled siRNA while maintaining a high cell viability of >90%. Gene knock down of d2-EGFP was demonstrated and validated by fluorescence repression and western blot analysis. On basis of our findings and established mathematical models we suppose a mixed transfection mechanism consisting of thermal and multiphoton near field effects. Our findings emphasize that gold nanoparticle mediated laser transfection provides an excellent tool for molecular delivery for both, high throughput purposes and the transfection of sensitive cells types.	[Heinemann, Dag; Schomaker, Markus; Kalies, Stefan; Ripken, Tammo; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Schieck, Maximilian] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Carlson, Regina; Escobar, Hugo Murua] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Meyer, Heiko] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Heisterkamp, Alexander] Univ Jena, Inst Appl Opt, Jena, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Friedrich Schiller University of Jena	Heinemann, D (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.	d.heinemann@lzh.de	Heisterkamp, Alexander/V-5376-2017; Heinemann, Dag/A-2861-2019; Schieck, Maximilian/D-4121-2013; Heinemann, Dag/AAZ-9970-2021	Heisterkamp, Alexander/0000-0001-8770-0859; Schieck, Maximilian/0000-0001-5878-0546; Heinemann, Dag/0000-0003-3506-1762; Kalies, Stefan/0000-0003-3025-264X	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Cluster of Excellence "REBIRTH" (From Regenerative Biology to Reconstructive Therapy)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Cluster of Excellence "REBIRTH" (From Regenerative Biology to Reconstructive Therapy)(German Research Foundation (DFG))	This work is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Cluster of Excellence "REBIRTH" (From Regenerative Biology to Reconstructive Therapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak M, 2010, J BIOPHOTONICS, V3, P696, DOI 10.1002/jbio.201000052; Atanasov PA, 2007, APPL SURF SCI, V253, P8304, DOI 10.1016/j.apsusc.2007.02.108; Baumgart J, 2008, OPT EXPRESS, V16, P3021, DOI 10.1364/OE.16.003021; Baumgart J, 2012, BIOMATERIALS, V33, P2345, DOI 10.1016/j.biomaterials.2011.11.062; Bohren C. F., 1998, ABSORPTION SCATTERIN; Boulais E, 2012, NANO LETT, V12, P4763, DOI 10.1021/nl302200w; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chakravarty P, 2010, NAT NANOTECHNOL, V5, P607, DOI [10.1038/nnano.2010.126, 10.1038/NNANO.2010.126]; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Ekici O, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/18/185501; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; GOLDENBERG H, 1952, BRIT J APPL PHYS, V3, P296, DOI 10.1088/0508-3443/3/9/307; Hashimoto S, 2012, J PHOTOCH PHOTOBIO C, V13, P28, DOI 10.1016/j.jphotochemrev.2012.01.001; Inasawa S, 2006, J PHYS CHEM B, V110, P3114, DOI [10.1021/jp057175l, 10.1021/jp0571751]; JEE Y, 1988, J OPT SOC AM B, V5, P648, DOI 10.1364/JOSAB.5.000648; Kalies S, 2014, J BIOPHOTONICS, V7, P474, DOI 10.1002/jbio.201200200; Klar T, 1998, PHYS REV LETT, V80, P4249, DOI 10.1103/PhysRevLett.80.4249; Kuetemeyer K, 2010, BIOMED OPT EXPRESS, V1, P587, DOI 10.1364/BOE.1.000587; Link S, 1999, J PHYS CHEM B, V103, P4212, DOI 10.1021/jp984796o; Liu CB, 2009, J BIOL PHYS, V35, P175, DOI 10.1007/s10867-009-9138-z; Lukianova-Hleb E, 2010, ACS NANO, V4, P2109, DOI 10.1021/nn1000222; Lukianova-Hleb EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034537; Lukianova-Hleb EY, 2011, J CONTROL RELEASE, V152, P286, DOI 10.1016/j.jconrel.2011.02.006; MESSINGER BJ, 1981, PHYS REV B, V24, P649, DOI 10.1103/PhysRevB.24.649; Mthunzi P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430733; Myroshnychenko V, 2008, CHEM SOC REV, V37, P1792, DOI 10.1039/b711486a; Nedyalkov NN, 2011, J NANOPART RES, V13, P2181, DOI 10.1007/s11051-010-9976-4; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pelton M, 2008, LASER PHOTONICS REV, V2, P136, DOI 10.1002/lpor.200810003; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Pustovalov VK, 2008, LASER PHYS LETT, V5, P775, DOI 10.1002/lapl.200810072; Quinto-Su PA, 2007, METHOD CELL BIOL, V82, P113, DOI 10.1016/S0091-679X(06)82004-2; Rendall HA, 2012, LAB CHIP, V12, P4816, DOI 10.1039/c2lc40708f; Schafer J, 2012, J QUANT SPECTROSC RA, V113, P2113, DOI 10.1016/j.jqsrt.2012.05.019; Schafer, 2011, IMPLEMENTIERUNG ANWE; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schomaker M, 2009, P SOC PHOTO-OPT INS, V7192; Schomaker M, 2010, PROC SPIE, V7762, DOI 10.1117/12.869054; Stevenson DJ, 2010, SER MED PHYS BIOMED, P87; Stevenson DJ, 2010, J R SOC INTERFACE, V7, P863, DOI 10.1098/rsif.2009.0463; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Tsampoula X, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766835; Uchugonova A, 2008, OPT EXPRESS, V16, P9357, DOI 10.1364/OE.16.009357; Umebayashi Y, 2003, J BIOCHEM, V134, P219, DOI 10.1093/jb/mvg132; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Wu TH, 2010, OPT EXPRESS, V18, P938, DOI 10.1364/OE.18.000938; Yao CP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137321; Yao CP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253320	49	84	85	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58604	10.1371/journal.pone.0058604	http://dx.doi.org/10.1371/journal.pone.0058604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536802	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100069
J	Hugo, LE; Monkman, J; Dave, KA; Wockner, LF; Birrell, GW; Norris, EL; Kienzle, VJ; Sikulu, MT; Ryan, PA; Gorman, JJ; Kay, BH				Hugo, Leon E.; Monkman, James; Dave, Keyur A.; Wockner, Leesa F.; Birrell, Geoff W.; Norris, Emma L.; Kienzle, Vivian J.; Sikulu, Maggy T.; Ryan, Peter A.; Gorman, Jeffery J.; Kay, Brian H.			Proteomic Biomarkers for Ageing the Mosquito Aedes aegypti to Determine Risk of Pathogen Transmission	PLOS ONE			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; ANOPHELES-GAMBIAE-S.L.; FAT-BODY PROTEIN; DROSOPHILA-MELANOGASTER; GEL-ELECTROPHORESIS; WOLBACHIA INFECTION; AGE; INSECT; VIRUS; PROFILES	Biomarkers of the age of mosquitoes are required to determine the risk of transmission of various pathogens as each pathogen undergoes a period of extrinsic incubation in the mosquito host. Using the 2-D Difference Gel Electrophoresis (2-D DIGE) procedure, we investigated the abundance of up to 898 proteins from the Yellow Fever and dengue virus vector, Aedes aegypti, during ageing. By applying a mixed-effects model of protein expression, we identified five common patterns of abundance change during ageing and demonstrated an age-related decrease in variance for four of these. This supported a search for specific proteins with abundance changes that remain tightly associated with ageing for use as ageing biomarkers. Using MALDI-TOF/TOF mass spectrometry we identified ten candidate proteins that satisfied strict biomarker discovery criteria (identified in two out of three multivariate analysis procedures and in two cohorts of mosquitoes). We validated the abundances of the four most suitable candidates (Actin depolymerising factor; ADF, Eukaryotic initiation factor 5A; eIF5A, insect cuticle protein Q17LN8, and Anterior fat body protein; AFP) using semi-quantitative Western analysis of individual mosquitoes of six ages. The redox-response protein Manganese superoxide dismutase (SOD2) and electron shuttling protein Electron transfer oxidoreductase (ETO) were subject to post-translational modifications affecting their charge states with potential effects on function. For the four candidates we show remarkably consistent decreases in abundance during ageing, validating initial selections. In particular, the abundance of AFP is an ideal biomarker candidate for whether a female mosquito has lived long enough to be capable of dengue virus transmission. We have demonstrated proteins to be a suitable class of ageing biomarkers in mosquitoes and have identified candidates for epidemiological studies of dengue and the evaluation of new disease reduction projects targeting mosquito longevity.	[Hugo, Leon E.; Monkman, James; Kienzle, Vivian J.; Sikulu, Maggy T.; Kay, Brian H.] Queensland Inst Med Res, Mosquito Control Lab, Brisbane, Qld 4006, Australia; [Dave, Keyur A.; Norris, Emma L.; Gorman, Jeffery J.] Queensland Inst Med Res, Prot Discovery Ctr, Brisbane, Qld 4006, Australia; [Wockner, Leesa F.] Queensland Inst Med Res, Stat Unit, Brisbane, Qld 4006, Australia; [Birrell, Geoff W.] Australian Army Malaria Inst, Brisbane, Qld, Australia; [Sikulu, Maggy T.] Griffith Univ, Sch Environm, Brisbane, Qld 4111, Australia; [Ryan, Peter A.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Griffith University; Monash University	Hugo, LE (corresponding author), Queensland Inst Med Res, Mosquito Control Lab, Brisbane, Qld 4006, Australia.	Leon.Hugo@qimr.edu.au	Hugo, R. Leon E/O-3013-2018; Sikulu-Lord, Maggy/L-8158-2017; Dave, Keyur/L-2862-2016	Hugo, R. Leon E/0000-0002-6767-9850; Sikulu-Lord, Maggy/0000-0002-9346-2970; Ryan, Peter/0000-0003-0674-4441; Birrell, Geoff/0000-0002-6593-1514; Kienzle, Vivian/0000-0001-7234-5794; Wockner, Leesa/0000-0002-8921-9265; Dave, Keyur/0000-0002-6476-8399; monkman, james/0000-0002-7219-8402	National Health and Medical Research Council, Australia [496601]; Bioplatforms Australia; Queensland Government	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Bioplatforms Australia; Queensland Government	This work was supported by the National Health and Medical Research Council, Australia, Program grant (496601) (http://www.nhmrc.gov.au/); Bioplatforms Australia (http://www.bioplatforms.com.au/); and the Queensland Government (http://www.qld.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Arun P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016545; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; BECKMANN JD, 1985, BIOCHEMISTRY-US, V24, P3922, DOI 10.1021/bi00336a017; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caragata EP, 2011, INSECT MOL BIOL, V20, P215, DOI 10.1111/j.1365-2583.2010.01059.x; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; FLEMING JE, 1986, SCIENCE, V231, P1157, DOI 10.1126/science.3080809; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hansen IA, 2002, EUR J BIOCHEM, V269, P954, DOI 10.1046/j.0014-2956.2001.02736.x; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Helfand SL, 2003, ADV GENET, V49, P67, DOI 10.1016/S0065-2660(03)01002-2; Henderson A, 2011, CELL CYCLE, V10, P3617, DOI 10.4161/cc.10.21.17850; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Martins GF, 2011, MICROSC RES TECHNIQ, V74, P1032, DOI 10.1002/jemt.20990; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685; Ng SK, 2006, BIOINFORMATICS, V22, P1745, DOI 10.1093/bioinformatics/btl165; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Shih YT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-214; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Valledor L, 2011, J PROTEOMICS, V74, P1, DOI 10.1016/j.jprot.2010.07.007; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010	50	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58656	10.1371/journal.pone.0058656	http://dx.doi.org/10.1371/journal.pone.0058656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536806	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100073
J	Posimo, JM; Titler, AM; Choi, HJH; Unnithan, AS; Leak, RK				Posimo, Jessica M.; Titler, Amanda M.; Choi, Hailey J. H.; Unnithan, Ajay S.; Leak, Rehana K.			Neocortex and Allocortex Respond Differentially to Cellular Stress In Vitro and Aging In Vivo	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MILD COGNITIVE IMPAIRMENT; CORTICAL LEWY BODIES; NONDEMENTED PARKINSONS-DISEASE; CHAPERONE-MEDIATED AUTOPHAGY; NIGRA-PARS-COMPACTA; N-ACETYL CYSTEINE; ALZHEIMERS-DISEASE; OXIDATIVE-STRESS; NEURODEGENERATIVE DISORDERS	In Parkinson's and Alzheimer's diseases, the allocortex accumulates aggregated proteins such as synuclein and tau well before neocortex. We present a new high-throughput model of this topographic difference by microdissecting neocortex and allocortex from the postnatal rat and treating them in parallel fashion with toxins. Allocortical cultures were more vulnerable to low concentrations of the proteasome inhibitors MG132 and PSI but not the oxidative poison H2O2. The proteasome appeared to be more impaired in allocortex because MG132 raised ubiquitin-conjugated proteins and lowered proteasome activity in allocortex more than neocortex. Allocortex cultures were more vulnerable to MG132 despite greater MG132-induced rises in heat shock protein 70, heme oxygenase 1, and catalase. Proteasome subunits PA700 and PA28 were also higher in allocortex cultures, suggesting compensatory adaptations to greater proteasome impairment. Glutathione and ceruloplasmin were not robustly MG132-responsive and were basally higher in neocortical cultures. Notably, neocortex cultures became as vulnerable to MG132 as allocortex when glutathione synthesis or autophagic defenses were inhibited. Conversely, the glutathione precursor N-acetyl cysteine rendered allocortex resilient to MG132. Glutathione and ceruloplasmin levels were then examined in vivo as a function of age because aging is a natural model of proteasome inhibition and oxidative stress. Allocortical glutathione levels rose linearly with age but were similar to neocortex in whole tissue lysates. In contrast, ceruloplasmin levels were strikingly higher in neocortex at all ages and rose linearly until middle age. PA28 levels rose with age and were higher in allocortex in vivo, also paralleling in vitro data. These neo- and allocortical differences have implications for the many studies that treat the telencephalic mantle as a single unit. Our observations suggest that the topographic progression of protein aggregations through the cerebrum may reflect differential responses to low level protein-misfolding stress but also reveal impressive compensatory adaptations in allocortex.	[Posimo, Jessica M.; Titler, Amanda M.; Choi, Hailey J. H.; Unnithan, Ajay S.; Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15219 USA	Duquesne University	Leak, RK (corresponding author), Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15219 USA.	leakr@duq.edu	Leak, Rehana K./I-2607-2019	Leak, Rehana K./0000-0003-2817-7417	Parkinson's and Movement Disorders Foundation; Hunkele Dreaded Diseases Foundation; Duquesne University	Parkinson's and Movement Disorders Foundation; Hunkele Dreaded Diseases Foundation; Duquesne University	This work was supported by grants from the Parkinson's and Movement Disorders Foundation and the Hunkele Dreaded Diseases Foundation. http://www.pmdf.org/, http://www.duq.edu/research/office-of-research/hunkele-dreaded-disease-competition (internal grant from Duquesne University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Alam ZI, 1997, J NEUROCHEM, V69, P1326; Albert MS, 1996, P NATL ACAD SCI USA, V93, P13547, DOI 10.1073/pnas.93.24.13547; Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Aridon P, 2011, NEURODEGENER DIS, V8, P155, DOI 10.1159/000321548; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Aztatzi-Santillan Emmanuel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P310; Baldeiras I, 2008, J ALZHEIMERS DIS, V15, P117; Banaclocha MM, 2000, BRAIN RES, V859, P173, DOI 10.1016/S0006-8993(00)02005-9; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bayer S.A., 1991, NEOCORTICAL DEV; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Bharucha KJ, 2008, J NEUROL, V255, P1957, DOI 10.1007/s00415-009-0063-7; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2000, ANN NY ACAD SCI, V924, P53; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2000, ANN NY ACAD SCI, V911, P221; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Braak H, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P35; Bradley KM, 2002, BRAIN, V125, P1772, DOI 10.1093/brain/awf185; Brewer GJ, 2010, AM J ALZHEIMERS DIS, V25, P490, DOI 10.1177/1533317510375083; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; BRUN A, 1986, PROG NEURO-PSYCHOPH, V10, P297, DOI 10.1016/0278-5846(86)90009-6; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P1975, DOI 10.1089/ars.2006.8.1975; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Chacko SK, 2010, EXP CLIN ENDOCR DIAB, V118, P64, DOI 10.1055/s-0029-1225647; Chang YZ, 2005, J CELL PHYSIOL, V204, P623, DOI 10.1002/jcp.20321; Chu CC, 1997, CEREB CORTEX, V7, P86, DOI 10.1093/cercor/7.1.86; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; DEXTER D, 1986, LANCET, V2, P639; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Dickson DW, 2010, MOVEMENT DISORD, V25, pS78, DOI 10.1002/mds.22637; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Double KL, 1996, DEMENTIA, V7, P304, DOI 10.1159/000106896; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Emanuele S, 2002, INT J ONCOL, V21, P857; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Floor E, 1998, J NEUROCHEM, V70, P268; Fu AL, 2006, BRAIN RES, V1109, P201, DOI 10.1016/j.brainres.2006.06.042; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Giordano J, 2008, CRIT REV TOXICOL, V38, P623, DOI 10.1080/10408440802026356; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz M., 2001, ENCY LIFE SCI, P1, DOI DOI 10.1038/NPG.ELS.0000787; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hineno A, 2011, NEUROCHEM RES, V36, P2127, DOI 10.1007/s11064-011-0537-8; Hochstrasser H, 2005, FASEB J, V19, P1851, DOI 10.1096/fj.04-3486fje; Hochstrasser H, 2004, NEUROLOGY, V63, P1912, DOI 10.1212/01.WNL.0000144276.29988.C3; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Ibarretxe-Bilbao N, 2011, J NEUROL SCI, V310, P70, DOI 10.1016/j.jns.2011.07.054; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Jellinger KA, 2006, J NEUROL SCI, V248, P167, DOI 10.1016/j.jns.2006.05.002; Jellinger KA, 2011, J NEUROL SCI; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jin LR, 2011, BRAIN, V134, P50, DOI 10.1093/brain/awq319; Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalaitzakis ME, 2009, ACTA NEUROPATHOL, V118, P587, DOI 10.1007/s00401-009-0597-x; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Koren J, 2009, J CELL MOL MED, V13, P619, DOI 10.1111/j.1582-4934.2008.00557.x; Kovari E, 2003, ACTA NEUROPATHOL, V106, P83, DOI 10.1007/s00401-003-0705-2; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Leak RK, 2010, J NEUROSCI METH, V191, P234, DOI 10.1016/j.jneumeth.2010.06.023; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim SY, 2009, ARCH NEUROL-CHICAGO, V66, P167, DOI 10.1001/archneurol.2008.561; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Lirong J, 2009, EUR J NEUROL, V16, P1130, DOI 10.1111/j.1468-1331.2009.02733.x; Lloret A, 2009, J ALZHEIMERS DIS, V17, P143, DOI 10.3233/JAD-2009-1033; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Loeffler DA, 2001, FREE RADICAL RES, V35, P111, DOI 10.1080/10715760100300651; Louro MO, 2000, J TRACE ELEM MED BIO, V14, P174, DOI 10.1016/S0946-672X(00)80007-3; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Mattila PM, 1998, ACTA NEUROPATHOL, V95, P576, DOI 10.1007/s004010050843; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; Menzies FM, 2006, AUTOPHAGY, V2, P224, DOI 10.4161/auto.2696; Mezzetti A, 1996, J AM GERIATR SOC, V44, P823, DOI 10.1111/j.1532-5415.1996.tb03741.x; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mullett SJ, 2011, J NEUROCHEM, V117, P375, DOI 10.1111/j.1471-4159.2011.07175.x; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Olivieri S, 2011, J NEUROSCI, V31, P18568, DOI 10.1523/JNEUROSCI.3768-11.2011; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; PERRY TL, 1985, NEUROSCI LETT, V60, P109, DOI 10.1016/0304-3940(85)90229-0; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Pocernich CB, 2011, BIOCH BIOPHYSICA ACT; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Ramassamy C, 1999, FREE RADICAL BIO MED, V27, P544, DOI 10.1016/S0891-5849(99)00102-1; Reid WG, 2011, J NEUROL NEUROSURG P; Riekkinen P, 1998, NEUROREPORT, V9, P1507, DOI 10.1097/00001756-199805110-00048; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shang HF, 2006, MOVEMENT DISORD, V21, P2217, DOI 10.1002/mds.21121; Sharma A, 2007, CELL MOL BIOL, V53, P48, DOI 10.1170/T774; Shen DX, 2005, J BIOL CHEM, V280, P25305, DOI 10.1074/jbc.M500095200; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Squitti R, 2008, PRION, V2, P23, DOI 10.4161/pri.2.1.6297; Stranahan AM, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/108190; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Texel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025077; Thal Dietmar Rudolf, 2004, Sci Aging Knowledge Environ, V2004, ppe26; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Torsdottir G, 2010, J NEUROL SCI, V299, P51, DOI 10.1016/j.jns.2010.08.047; Tucker Stephanie, 2006, Current Alzheimer Research, V3, P221, DOI 10.2174/156720506777632835; Unnithan AS, 2012, NEUROCHEM INT, V61, P356, DOI 10.1016/j.neuint.2012.06.001; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Venkateshappa C, 2012, NEUROCHEMICAL RES; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Walker LC, 2000, MOL NEUROBIOL, V21, P83, DOI 10.1385/MN:21:1-2:083; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017	167	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58596	10.1371/journal.pone.0058596	http://dx.doi.org/10.1371/journal.pone.0058596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536801	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100068
J	Tapfer, A; Braren, R; Bech, M; Willner, M; Zanette, I; Weitkamp, T; Trajkovic-Arsic, M; Siveke, JT; Settles, M; Aichler, M; Walch, A; Pfeiffer, F				Tapfer, Arne; Braren, Rickmer; Bech, Martin; Willner, Marian; Zanette, Irene; Weitkamp, Timm; Trajkovic-Arsic, Marija; Siveke, Jens T.; Settles, Marcus; Aichler, Michaela; Walch, Axel; Pfeiffer, Franz			X-Ray Phase-Contrast CT of a Pancreatic Ductal Adenocarcinoma Mouse Model	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; TALBOT INTERFEROMETRY; HUMAN CEREBELLUM; RESOLUTION; MAMMOGRAPHY	To explore the potential of grating-based x-ray phase-contrast computed tomography (CT) for preclinical research, a genetically engineered mouse model of pancreatic ductal adenocarcinoma (PDAC) was investigated. One ex-vivo mouse specimen was scanned with different grating-based phase-contrast CT imaging setups covering two different settings: i) high-resolution synchrotron radiation (SR) imaging and ii) dose-reduced imaging using either synchrotron radiation or a conventional x-ray tube source. These experimental settings were chosen to assess the potential of phase-contrast imaging for two different types of application: i) high-performance imaging for virtual microscopy applications and ii) biomedical imaging with increased soft-tissue contrast for in-vivo applications. For validation and as a reference, histological slicing and magnetic resonance imaging (MRI) were performed on the same mouse specimen. For each x-ray imaging setup, attenuation and phase-contrast images were compared visually with regard to contrast in general, and specifically concerning the recognizability of lesions and cancerous tissue. To quantitatively assess contrast, the contrast-to-noise ratios (CNR) of selected regions of interest (ROI) in the attenuation images and the phase images were analyzed and compared. It was found that both for virtual microscopy and for in-vivo applications, there is great potential for phase-contrast imaging: in the SR-based benchmarking data, fine details about tissue composition are accessible in the phase images and the visibility of solid tumor tissue under dose-reduced conditions is markedly superior in the phase images. The present study hence demonstrates improved diagnostic value with phase-contrast CT in a mouse model of a complex endogenous cancer, promoting the use and further development of grating-based phase-contrast CT for biomedical imaging applications.	[Tapfer, Arne; Bech, Martin; Willner, Marian; Zanette, Irene; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Germany; [Tapfer, Arne; Bech, Martin; Willner, Marian; Zanette, Irene; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Braren, Rickmer; Settles, Marcus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Zanette, Irene; Weitkamp, Timm] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Weitkamp, Timm] Synchrotron Soleil, Gif Sur Yvette, France; [Trajkovic-Arsic, Marija; Siveke, Jens T.] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Inst Pathol, Res Unit Analyt Pathol, Oberschleissheim, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Lund University; European Synchrotron Radiation Facility (ESRF); SOLEIL Synchrotron; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Tapfer, A (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.	arne.tapfer@tum.de	Siveke, Jens/AAQ-6170-2021; Aichler, Michaela/B-5356-2014; Braren, Rickmer/U-3254-2018; Weitkamp, Timm/A-8975-2012; Bech, Martin/K-4331-2012; Walch, Axel/B-4554-2012	Braren, Rickmer/0000-0001-6039-6957; Weitkamp, Timm/0000-0002-0374-0472; Bech, Martin/0000-0001-9109-7175; Walch, Axel/0000-0001-5578-4023; Zanette, Irene/0000-0001-6096-6059	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC) [StG 240142]; French research network (RTRA) "Digiteo"; French research network (RTRA) "Triangle de la Physique" [2009-034T, 2009-79D]; DFG [824, SFB824]	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); French research network (RTRA) "Digiteo"; French research network (RTRA) "Triangle de la Physique"; DFG(German Research Foundation (DFG))	This study was supported by the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program, the European Research Council (ERC, FP7, StG 240142), the French research networks (RTRA) "Digiteo" and "Triangle de la Physique" (grants 2009-034T and 2009-79D), the DFG within the SFB-Initiative 824 "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" (SFB824, project C6, C4, TPZ02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Castelli E, 2011, RADIOLOGY, V259, P684, DOI 10.1148/radiol.11100745; Chen GH, 2011, MED PHYS, V38, P584, DOI 10.1118/1.3533718; Coan P, 2006, J SYNCHROTRON RADIAT, V13, P260, DOI 10.1107/S0909049506008983; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Engel KJ, 2011, NUCL INSTRUM METH A, V648, pS202, DOI 10.1016/j.nima.2010.11.169; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471; Germann M, 2008, J NEUROSCI METH, V170, P149, DOI 10.1016/j.jneumeth.2008.01.011; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoshino M, 2012, BIOL OPEN, V1, P269, DOI 10.1242/bio.2012430; Kohler T, 2011, MED PHYS, V38, pS106, DOI 10.1118/1.3532396; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Muller B, 2012, INT J MATER RES, V103, P242, DOI 10.3139/146.110663; Pfeiffer F, 2007, PHYS MED BIOL, V52, P6923, DOI 10.1088/0031-9155/52/23/010; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Press WH, 2007, ART SCI COMPUTING, V1; Schulz G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00826; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Tapfer A, 2011, MED PHYS, V38, P5910, DOI 10.1118/1.3644844; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, PROC SPIE, V7804, DOI 10.1117/12.860203; Weitkamp T, 2008, EUR J RADIOL, V68, pS13, DOI 10.1016/j.ejrad.2008.04.031; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109	33	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58439	10.1371/journal.pone.0058439	http://dx.doi.org/10.1371/journal.pone.0058439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536795	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100051
J	Hendriksma, HP; Kuting, M; Hartel, S; Nather, A; Dohrmann, AB; Steffan-Dewenter, I; Tebbe, CC				Hendriksma, Harmen P.; Kueting, Meike; Haertel, Stephan; Naether, Astrid; Dohrmann, Anja B.; Steffan-Dewenter, Ingolf; Tebbe, Christoph C.			Effect of Stacked Insecticidal Cry Proteins from Maize Pollen on Nurse Bees (Apis mellifera carnica) and Their Gut Bacteria	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; T-RFLP ANALYSIS; HONEY-BEES; BACILLUS-THURINGIENSIS; RISK-ASSESSMENT; MULTIVARIATE ANALYSES; CORN POLLEN; LARVAE; COMMUNITIES; CONSUMPTION	Honey bee pollination is a key ecosystem service to nature and agriculture. However, biosafety research on genetically modified crops rarely considers effects on nurse bees from intact colonies, even though they receive and primarily process the largest amount of pollen. The objective of this study was to analyze the response of nurse bees and their gut bacteria to pollen from Bt maize expressing three different insecticidal Cry proteins (Cry1A.105, Cry2Ab2, and Cry3Bb1). Naturally Cry proteins are produced by bacteria (Bacillus thuringiensis). Colonies of Apis mellifera carnica were kept during anthesis in flight cages on field plots with the Bt maize, two different conventionally bred maize varieties, and without cages, 1-km outside of the experimental maize field to allow ad libitum foraging to mixed pollen sources. During their 10-days life span, the consumption of Bt maize pollen had no effect on their survival rate, body weight and rates of pollen digestion compared to the conventional maize varieties. As indicated by ELISA-quantification of Cry1A.105 and Cry3Bb1, more than 98% of the recombinant proteins were degraded. Bacterial population sizes in the gut were not affected by the genetic modification. Bt-maize, conventional varieties and mixed pollen sources selected for significantly different bacterial communities which were, however, composed of the same dominant members, including Proteobacteria in the midgut and Lactobacillus sp. and Bifidobacterium sp. in the hindgut. Surprisingly, Cry proteins from natural sources, most likely B. thuringiensis, were detected in bees with no exposure to Bt maize. The natural occurrence of Cry proteins and the lack of detectable effects on nurse bees and their gut bacteria give no indication for harmful effects of this Bt maize on nurse honey bees.	[Hendriksma, Harmen P.; Haertel, Stephan; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany; [Kueting, Meike; Naether, Astrid; Dohrmann, Anja B.; Tebbe, Christoph C.] Fed Res Inst Rural Areas Forestry & Fisheries, Thunen Inst Biodivers, Braunschweig, Germany	University of Wurzburg; Johann Heinrich von Thunen Institute	Tebbe, CC (corresponding author), Fed Res Inst Rural Areas Forestry & Fisheries, Thunen Inst Biodivers, Braunschweig, Germany.	christoph.tebbe@ti.bund.de	Hendriksma, Harmen/AAB-9020-2019; Tebbe, Christoph/Q-8545-2017	Hendriksma, Harmen/0000-0002-3153-0392; Tebbe, Christoph/0000-0003-4861-0214; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Dohrmann, Anja Bettina/0000-0003-2544-2780	German Federal Ministry for Education and Research (BMBF) [0315215C, 31P5398]; AMIGA (European Union, 7th Framework Programme) [289706]	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); AMIGA (European Union, 7th Framework Programme)	The work was financially supported by the German Federal Ministry for Education and Research (BMBF) (Project numbers 0315215C and 31P5398) and by AMIGA (European Union, 7th Framework Programme, Grant agreement no. 289706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babendreier D, 2005, APIDOLOGIE, V36, P585, DOI 10.1051/apido:2005049; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bavykin SG, 2004, J CLIN MICROBIOL, V42, P3711, DOI 10.1128/jcm.42.8.3711-3730.2004; Bizzarri MF, 2008, MICROB ECOL, V56, P133, DOI 10.1007/s00248-007-9331-1; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CERA, 2010, GMO CROP DAT; Chen ML, 2002, J APPL MICROBIOL, V92, P912, DOI 10.1046/j.1365-2672.2002.01606.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1993, J INSECT PHYSIOL, V39, P369, DOI 10.1016/0022-1910(93)90024-L; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Crickmore N, 2011, BACILLUS THURINGIENS; Dai PL, 2012, ECOTOX ENVIRON SAFE, V79, P232, DOI 10.1016/j.ecoenv.2012.01.005; De Schrijver A, 2007, TRENDS FOOD SCI TECH, V18, P101, DOI 10.1016/j.tifs.2006.09.002; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; EFSA, 2010, EFSA J, V8, P1564, DOI [10.2903/j.efsa.2010.1564, DOI 10.2903/J.EFSA2010.1564]; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Felke M, 2002, J APPL ENTOMOL, V126, P320, DOI 10.1046/j.1439-0418.2002.00668.x; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanley AV, 2003, J APICULT RES, V42, P77, DOI 10.1080/00218839.2003.11101097; Helsel DR, 2005, ENVIRON SCI TECHNOL, V39, p419A, DOI 10.1021/es053368a; Hendriksma HP, 2012, APIDOLOGIE, V43, P549, DOI 10.1007/s13592-012-0123-3; Hendriksma HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028174; Hendriksma HP, 2011, METHODS ECOL EVOL, V2, P509, DOI 10.1111/j.2041-210X.2011.00099.x; James C., 2004, GLOBAL STATUS COMMER; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Langenbruch GA, 2005, IMPACT TRANSGENIC BT, V157; Lipinski Z, 2008, POL J ENVIRON STUD, V17, P957; Liu BA, 2009, ECOTOX ENVIRON SAFE, V72, P1163, DOI 10.1016/j.ecoenv.2009.02.002; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Naiem ES, 1999, J COMP PHYSIOL B, V169, P271, DOI 10.1007/s003600050221; R Core Team, 2021, R LANGUAGE ENV STAT; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Seeley T., 1995, WISDOM HIVE SOCIAL P; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; SZOLDERITS MJ, 1993, J INSECT PHYSIOL, V39, P877, DOI 10.1016/0022-1910(93)90120-G; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	57	34	37	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59589	10.1371/journal.pone.0059589	http://dx.doi.org/10.1371/journal.pone.0059589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533634	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400071
J	Hwang, IY; Hwang, KS; Park, C; Harrison, KA; Kehrl, JH				Hwang, Il-Young; Hwang, Kyung-Sun; Park, Chung; Harrison, Kathleen A.; Kehrl, John H.			Rgs13 Constrains Early B Cell Responses and Limits Germinal Center Sizes	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNE FUNCTION; LYMPH-NODES; PROTEINS; DIFFERENTIATION; LYMPHOCYTES; MIGRATION; DESENSITIZATION; RESPONSIVENESS; TRAFFICKING	Germinal centers (GCs) are microanatomic structures that develop in secondary lymphoid organs in response to antigenic stimulation. Within GCs B cells clonally expand and their immunoglobulin genes undergo class switch recombination and somatic hypermutation. Transcriptional profiling has identified a number of genes that are prominently expressed in GC B cells. Among them is Rgs13, which encodes an RGS protein with a dual function. Its canonical function is to accelerate the intrinsic GTPase activity of heterotrimeric G-protein alpha subunits at the plasma membrane, thereby limiting heterotrimeric G-protein signaling. A unique, non-canonical function of RGS13 occurs following translocation to the nucleus, where it represses CREB transcriptional activity. The functional role of RGS13 in GC B cells is unknown. To create a surrogate marker for Rgs13 expression and a loss of function mutation, we inserted a GFP coding region into the Rgs13 genomic locus. Following immunization GFP expression rapidly increased in activated B cells, persisted in GC B cells, but declined in newly generated memory B and plasma cells. Intravital microscopy of the inguinal lymph node (LN) of immunized mice revealed the rapid appearance of GFP(+) cells at LN interfollicular regions and along the T/B cell borders, and eventually within GCs. Analysis of WT, knock-in, and mixed chimeric mice indicated that RGS13 constrains extra-follicular plasma cell generation, GC size, and GC B cell numbers. Analysis of select cell cycle and GC specific genes disclosed an aberrant gene expression profile in the Rgs13 deficient GC B cells. These results indicate that RGS13, likely acting at cell membranes and in nuclei, helps coordinate key decision points during the expansion and differentiation of naive B cells.	[Hwang, Il-Young; Hwang, Kyung-Sun; Park, Chung; Harrison, Kathleen A.; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000738] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Cho H, 2009, PROG MOL BIOL TRANSL, V86, P249, DOI 10.1016/S1877-1173(09)86009-2; Corcione A, 2002, INT IMMUNOL, V14, P883, DOI 10.1093/intimm/dxf054; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Kaur K, 2011, METHODS MOL BIOL, V756, P75, DOI 10.1007/978-1-61779-160-4_4; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Park C, 2012, BLOOD, V119, P978, DOI 10.1182/blood-2011-06-364273; Park C, 2009, METHODS MOL BIOL, V571, P199, DOI 10.1007/978-1-60761-198-1_13; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sherman MH, 2010, MOL CELL, V39, P873, DOI 10.1016/j.molcel.2010.08.019; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Xie ZH, 2008, MOL CELL, V31, P660, DOI 10.1016/j.molcel.2008.06.024; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	36	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60139	10.1371/journal.pone.0060139	http://dx.doi.org/10.1371/journal.pone.0060139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533672	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400109
J	Sun, DC; Wang, B; Zhu, LH; Chen, MY; Zhan, LL				Sun, Dongchang; Wang, Bing; Zhu, Lihong; Chen, Mengyao; Zhan, Linlin			Block and Boost DNA Transfer: Opposite Roles of OmpA in Natural and Artificial Transformation of Escherichia coli	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MATING PAIR STABILIZATION; HORIZONTAL GENE-TRANSFER; PLASMID TRANSFORMATION; F-PLASMID; COMPETENCE; RECEPTOR; CHANNEL; COMPLEXES; REGIONS	Our previous work established that DNA is naturally transferable on agar plates through a new transformation system which is regulated by the stationary phase master regulator RpoS in Escherichia coli. In this transformation system, neither additional Ca2+ nor heat shock is required. Instead, transformation is stimulated by agar. The membrane protein OmpA, a gated pore permeable to ions and larger solutes, serves as a receptor for DNA transfer during bacteriophage infection and conjugation. However, it remains unknown how DNA transfers across membranes and whether OmpA is involved in transformation of E. coli. Here, we explored potential roles of OmpA in natural and chemical transformation of E. coli. We observed that ompA inactivation significantly improved natural transformation on agar plates, indicating that OmpA blocks DNA transfer. Transformation promotion by ompA inactivation also occurred on soft plates, indicating that OmpA blocks DNA transfer independent of agar. By contrast, compared with the wild-type strain, chemical transformation of the ompA mutant was lower, indicating that OmpA has a role in DNA transfer. Inactivation of ompA also reduced chemical transformation in solution containing less Ca2+ or with a shortened time for heat shock, suggesting that the promotion effect of OmpA on DNA transfer does not solely rely on Ca2+ or heat shock. We conclude that OmpA plays opposite roles in natural and chemical transformation: it blocks DNA uptake on agar plates but promotes DNA transfer in the liquid Ca2+ solution. Considering that no single factor was identified to reverse the function of OmpA, we propose that multiple factors may cooperate in the functional reversal of OmpA during natural and artificial transformation of E. coli. Finally, we observed that ompA transcription was not affected by the expression of RpoS, excluding the possibility that RpoS regulates DNA transfer by suppressing ompA transcription.	[Sun, Dongchang; Wang, Bing; Zhu, Lihong; Chen, Mengyao; Zhan, Linlin] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Sun, Dongchang; Wang, Bing; Zhu, Lihong; Chen, Mengyao; Zhan, Linlin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences	Sun, DC (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	sundongchang@yahoo.com	sun, dongchang/X-1148-2019; Zhu, Li/GXH-9801-2022		Natural Science Foundation of China [31100071]; Natural Science Foundation of Zhejiang Province [Y3110237]; China Postdoctoral Science Foundation [2012M521199]; Zhejiang Postdoctoral Grant [Bsh1202079]; Zhejiang Academy of Agricultural Sciences; Open Foundation of Key Laboratory in Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhejiang Postdoctoral Grant; Zhejiang Academy of Agricultural Sciences; Open Foundation of Key Laboratory in Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation	This work is supported by the Natural Science Foundation of China (31100071), Natural Science Foundation of Zhejiang Province (Y3110237), China Postdoctoral Science Foundation (2012M521199), Zhejiang Postdoctoral Grant (Bsh1202079), the Doctor's Start-up Grant from Zhejiang Academy of Agricultural Sciences, the Foresight Program from the Open Foundation of Key Laboratory in Zhejiang Academy of Agricultural Sciences and Zhejiang Open Foundation of the Most Important Subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; FOULDS J, 1978, J BACTERIOL, V133, P158, DOI 10.1128/JB.133.1.158-164.1978; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; HUANG RP, 1995, J BACTERIOL, V177, P486, DOI 10.1128/jb.177.2.486-490.1995; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Klimke WA, 2005, MICROBIOL-SGM, V151, P3527, DOI 10.1099/mic.0.28025-0; Klimke WA, 1998, J BACTERIOL, V180, P4036, DOI 10.1128/JB.180.16.4036-4043.1998; LEDERBERG EM, 1953, GENETICS, V38, P51; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LI AW, 1982, CAN J MICROBIOL, V28, P860, DOI 10.1139/m82-128; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; MANEEWANNAKUL S, 1992, J MOL BIOL, V225, P299, DOI 10.1016/0022-2836(92)90923-8; MONTAG D, 1987, J MOL BIOL, V196, P165, DOI 10.1016/0022-2836(87)90519-5; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; REUSCH RN, 1995, BIOPHYS J, V69, P754, DOI 10.1016/S0006-3495(95)79958-1; REUSCH RN, 1986, J BACTERIOL, V168, P553, DOI 10.1128/jb.168.2.553-562.1986; Reusch RN, 2012, FEBS J; RIEDE I, 1984, MOL GEN GENET, V195, P144, DOI 10.1007/BF00332737; SAINT N, 1993, BIOCHIM BIOPHYS ACTA, V1145, P119, DOI 10.1016/0005-2736(93)90388-G; SCHWARZ H, 1983, EMBO J, V2, P375, DOI 10.1002/j.1460-2075.1983.tb01433.x; Sinha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035620; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Smajs D, 1997, J BACTERIOL, V179, P4919, DOI 10.1128/jb.179.15.4919-4928.1997; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; SUGAWARA E, 1994, J BIOL CHEM, V269, P17981; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yamagishi H, 1970, Tanpakushitsu Kakusan Koso, V15, P902; Zakharian E, 2005, BIOCHEMISTRY-US, V44, P6701, DOI 10.1021/bi047278e; Zakharian E, 2003, FEBS LETT, V555, P229, DOI 10.1016/S0014-5793(03)01236-5; Zhang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033514	46	10	11	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59019	10.1371/journal.pone.0059019	http://dx.doi.org/10.1371/journal.pone.0059019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533598	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400035
J	Zelner, I; Kenna, K; Brien, JF; Bocking, A; Harding, R; Walker, D; Koren, G				Zelner, Irene; Kenna, Kelly; Brien, James F.; Bocking, Alan; Harding, Richard; Walker, David; Koren, Gideon			Meconium Fatty Acid Ethyl Esters as Biomarkers of Late Gestational Ethanol Exposure and Indicator of Ethanol-Induced Multi-Organ Injury in Fetal Sheep	PLOS ONE			English	Article							ALCOHOL EXPOSURE; GAS-CHROMATOGRAPHY; IN-UTERO; PREVALENCE; PREGNANCY; OUTCOMES; FETUS; WOMEN; MODEL; DRUG	Background: Meconium fatty acid ethyl esters (FAEE) constitute a biomarker of heavy fetal ethanol exposure. Our objective was to measure meconium FAEE in fetal sheep following daily, relatively moderate-dose ethanol exposure in late gestation, and to evaluate their utility in identifying fetal organ-system injury. Methods: Pregnant ewes received ethanol (0.75 g/kg; n = 14) or saline (n = 8) via 1-h IV infusion daily during the third trimester equivalent, while additional pregnant sheep served as untreated controls (n = 6). The daily ethanol regimen produced similar maximal maternal and fetal plasma ethanol concentrations of 0.11-0.12 g/dL. Ewes and fetuses were euthanized shortly before term, and meconium was collected and analyzed for FAEE (ethyl palmitate, stearate, linoleate, and oleate). Results: Meconium total FAEE concentration was significantly higher in ethanol-exposed fetuses compared with controls, and a positive cut-off of 0.0285 nmol total FAEE/g meconium had 93.3% sensitivity and specificity for detecting fetal ethanol exposure. When the studied animals (ethanol-exposed and controls) were classified according to meconium FAEE concentration, FAEE-positive and FAEE-negative groups frequently differed with respect to previously examined pathological endpoints, including nephron endowment, lung collagen deposition, cardiomyocyte maturation, and tropoelastin gene expression in cerebral vessels. Furthermore, in all studied animals as a group (ethanol-exposed and controls combined), meconium FAEE concentration was correlated with many of these pathological endpoints in fetal organs. Conclusions: We conclude that, in fetal sheep, meconium FAEE could serve as a biomarker of daily ethanol exposure in late gestation and could identify fetuses with subtle ethanol-induced toxic effects in various organs. This study illustrates the potential for using meconium FAEE to identify neonates at risk for dysfunction of major organs following in-utero ethanol exposure that does not result in overt physical signs of ethanol teratogenicity.	[Zelner, Irene; Koren, Gideon] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Zelner, Irene; Koren, Gideon] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Kenna, Kelly; Harding, Richard] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Brien, James F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Bocking, Alan] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Walker, David] Monash Univ, Monash Inst Med Res, Ritchie Ctr Infant Hlth, Clayton, Vic, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Monash University; Queens University - Canada; University of Toronto; Monash University	Koren, G (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	gkoren@sickkids.ca	Kenna, Kelly/C-4174-2011; Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875	Canadian Institutes of Health Research [NET-54014]; National Health and Medical Research Council of Australia; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Canadian Institutes of Health Research [NET-54014] and the National Health and Medical Research Council of Australia. IZ is supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1; Arvedson JC, 2006, GOYAL SHAKERS GI MOT; Bearer CF, 2005, J PEDIATR-US, V146, P824, DOI 10.1016/j.jpeds.2005.01.048; Bearer CF, 2003, J PEDIATR-US, V143, P463, DOI 10.1067/S0022-3476(03)00442-6; Best CA, 2003, FRONT BIOSCI-LANDMRK, V8, pE202, DOI 10.2741/931; BRIEN JF, 1991, J DEV PHYSIOL, V15, P21; Brien JF, 2006, THER DRUG MONIT, V28, P345, DOI 10.1097/01.ftd.0000211819.35182.82; Burd L, 2004, ADDICT BIOL, V9, P115, DOI 10.1080/13556210410001716962; Burd L, 2008, BIRTH DEFECTS RES A, V82, P487, DOI 10.1002/bdra.20464; Caprara DL, 2005, PEDIATR RES, V58, P1158, DOI 10.1203/01.pdr.0000185201.83801.ed; Chan D, 2004, J PHARMACOL EXP THER, V310, P75, DOI 10.1124/jpet.104.066597; Chan D, 2003, THER DRUG MONIT, V25, P271, DOI 10.1097/00007691-200306000-00004; Chang G, 2006, J STUD ALCOHOL, V67, P245, DOI 10.15288/jsa.2006.67.245; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; CLARKE DW, 1989, DEV PHARMACOL THERAP, V12, P35, DOI 10.1159/000480980; Cudd TA, 2005, EXP BIOL MED, V230, P389, DOI 10.1177/15353702-0323006-06; Derauf C, 2003, J DRUG ISSUES, V33, P1001, DOI 10.1177/002204260303300411; Drews C D, 2003, J Matern Fetal Neonatal Med, V13, P85; Gareri J, 2006, ALCOHOL CLIN EXP RES, V30, p110A; Goh JM, 2011, AM J PHYSIOL-HEART C, V300, pH645, DOI 10.1152/ajpheart.00689.2010; Goh YI, 2008, J POPUL THER CLIN PH, V15, pE344; Gray SP, 2008, AM J PHYSIOL-REG I, V295, pR568, DOI 10.1152/ajpregu.90316.2008; Hutson JR, 2011, ALCOHOL, V45, P193, DOI 10.1016/j.alcohol.2010.07.005; Jarvis GN, 1997, J APPL MICROBIOL, V83, P166, DOI 10.1046/j.1365-2672.1997.00217.x; JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102; JONES KL, 1973, LANCET, V2, P999; Kenna K, 2011, AM J PHYSIOL-REG I, V301, pR926, DOI 10.1152/ajpregu.00711.2010; Koren G, 2008, CLIN PHARMACOL THER, V83, P631, DOI 10.1038/sj.clpt.6100506; Littner Y, 2008, PEDIATR RES, V63, P164, DOI 10.1203/PDR.0b013e31815f651e; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Moore C, 2003, CLIN CHEM, V49, P133, DOI 10.1373/49.1.133; Moore S, 2007, ALCOHOL ALCOHOLISM, V42, P629, DOI 10.1093/alcalc/agm054; Noland JS, 2003, ALCOHOL CLIN EXP RES, V27, P647, DOI 10.1097/01.ALC.0000060525.10536.F6; Ostrea EM, 2006, ALCOHOL CLIN EXP RES, V30, P1152, DOI 10.1111/j.1530-0277.2006.00131.x; Peterson J, 2008, J PEDIATR, V152, P788, DOI 10.1016/j.jpeds.2007.11.009; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Roehsig M, 2010, J SEP SCI, V33, P2115, DOI 10.1002/jssc.201000118; Russell M, 1996, AM J PUBLIC HEALTH, V86, P1435, DOI 10.2105/AJPH.86.10.1435; SMITH GN, 1991, CAN J PHYSIOL PHARM, V69, P550, DOI 10.1139/y91-082; Sozo F, 2009, AM J PHYSIOL-LUNG C, V296, pL510, DOI 10.1152/ajplung.90532.2008; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59168	10.1371/journal.pone.0059168	http://dx.doi.org/10.1371/journal.pone.0059168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533604	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400041
J	Zha, BS; Wan, XS; Zhang, XX; Zha, WB; Zhou, J; Wabitsch, M; Wang, GJ; Lyall, V; Hylemon, PB; Zhou, HP				Zha, Beth S.; Wan, Xiaoshan; Zhang, Xiaoxuan; Zha, Weibin; Zhou, Jun; Wabitsch, Martin; Wang, Guangji; Lyall, Vijay; Hylemon, Phillip B.; Zhou, Huiping			HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; INFECTED PATIENTS; GENE-EXPRESSION; IN-VITRO; INSULIN SENSITIVITY; ANTIRETROVIRAL TREATMENT; ADIPOKINE SECRETION; CELLULAR MECHANISMS; HUMAN PREADIPOCYTES; P-GLYCOPROTEIN	Background: HIV protease inhibitors (PI) are core components of Highly Active Antiretroviral Therapy (HAART), the most effective treatment for HIV infection currently available. However, HIV PIs have now been linked to lipodystrophy and dyslipidemia, which are major risk factors for cardiovascular disease and metabolic syndrome. Our previous studies have shown that HIV PIs activate endoplasmic reticulum (ER) stress and disrupt lipid metabolism in hepatocytes and macrophages. Yet, little is known on how HIV PIs disrupt lipid metabolism in adipocytes, a major cell type involved in the pathogenesis of metabolic syndrome. Methodology and Principal Findings: Cultured and primary mouse adipocytes and human adipocytes were used to examine the effect of frequently used HIV PIs in the clinic, lopinavir/ritonavir, on adipocyte differentiation and further identify the underlying molecular mechanism of HIV PI-induced dysregulation of lipid metabolism in adipocytes. The results indicated that lopinavir alone or in combination with ritonavir, significantly activated the ER stress response, inhibited cell differentiation, and induced cell apoptosis in adipocytes. In addition, HIV PI-induced ER stress was closely linked to inhibition of autophagy activity. We also identified through the use of primary adipocytes of CHOP-/- mice that CHOP, the major transcriptional factor of the ER stress signaling pathway, is involved in lopinavir/ritonavir-induced inhibition of cell differentiation in adipocytes. In addition, lopinavir/ritonavir-induced ER stress appears to be associated with inhibition of autophagy activity in adipocytes. Conclusion and Significance: Activation of ER stress and impairment of autophagy activity are involved in HIV PI-induced dysregulation of lipid metabolism in adipocytes. The key components of ER stress and autophagy signaling pathways are potential therapeutic targets for HIV PI-induced metabolic side effects in HIV patients.	[Zha, Beth S.; Zha, Weibin; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Wan, Xiaoshan; Zhou, Jun; Zhou, Huiping] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaoxuan; Zha, Weibin; Wang, Guangji] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA USA; [Hylemon, Phillip B.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA	Virginia Commonwealth University; Wenzhou Medical University; China Pharmaceutical University; Ulm University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Zhou, HP (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA.	hzhou@vcu.edu	Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019	Zhou, Huiping/0000-0002-0050-372X	National Institutes of Health [R21 AI068432, R01 AT004148, 1F30DK085856-02]; VA Merit Award [1I01BX001390]; VCU Presidential Research Incentive Program Award; School of Medicine; VCU; National Science Foundation of China [81070245, 81270489]; VCU Department of Anatomy and Neurobiology Microscopy Facility; NIH-NINDS [5P30NS047463]; NIH [DC011569]; NIH-NINDS Center [5P30NS047463]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK085856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); VCU Presidential Research Incentive Program Award; School of Medicine; VCU; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); VCU Department of Anatomy and Neurobiology Microscopy Facility; NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by: National Institutes of Health grants to Huiping Zhou (R21 AI068432, R01 AT004148) and to Beth Zha (1F30DK085856-02); and VA Merit Award (1I01BX001390 to Huiping Zhou). This study is partially supported by the VCU Presidential Research Incentive Program Award (Huiping Zhou), School of Medicine, VCU Bridge funding (Huiping Zhou) and National Science Foundation of China (Grant 81070245 and 81270489 to Huiping Zhou). Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). The study was also supported by NIH DC011569 to Vijay Lyall and NIH-NINDS Center Core grant (5P30NS047463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Bays HE, 2008, INT J CLIN PRACT, V62, P1474, DOI 10.1111/j.1742-1241.2008.01848.x; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bobbert T, 2009, CLIN ENDOCRINOL, V71, P507, DOI 10.1111/j.1365-2265.2008.03519.x; Calza L, 2008, INT J STD AIDS, V19, P541, DOI 10.1258/ijsa.2008.007322; Capel E, 2012, ANTIVIR THER, V17, P549, DOI 10.3851/IMP1988; Carr A, 1998, NEW ENGL J MED, V339, P1296, DOI 10.1056/NEJM199810293391806; Cianflone K, 2006, ANTIVIR THER, V11, P681; Czaja MJ, 2011, AM J PHYSIOL-CELL PH, V298, pC973; Djedaini M, 2009, BIOCHEM BIOPH RES CO, V386, P96, DOI 10.1016/j.bbrc.2009.05.148; Dong HQ, 2011, TRENDS ENDOCRIN MET, V22, P234, DOI 10.1016/j.tem.2011.02.003; Elens L, 2009, PHARMACOGENOMICS, V10, P1589, DOI [10.2217/pgs.09.88, 10.2217/PGS.09.88]; Estrada Vicente, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 10, P10; Fiorenza CG, 2011, NAT REV ENDOCRINOL, V7, P137, DOI 10.1038/nrendo.2010.199; Flint OP, 2009, TOXICOL PATHOL, V37, P65, DOI 10.1177/0192623308327119; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gagnon A, 1998, LANCET, V352, P1032, DOI 10.1016/S0140-6736(05)60074-8; Gallego-Escuredo JM, 2010, CURR HIV RES, V8, P545, DOI 10.2174/157016210793499222; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gibellini L, 2012, AIDS, V26, P2017, DOI 10.1097/QAD.0b013e328359b8be; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Goudeau H, 1998, DEV BIOL, V193, P225, DOI 10.1006/dbio.1997.8799; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grigem S, 2005, HORM METAB RES, V37, P602, DOI 10.1055/s-2005-870526; Guallar JP, 2008, AIDS, V22, P575, DOI 10.1097/QAD.0b013e3282f56b40; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Hennessy M, 2004, ANTIVIR THER, V9, P115; Hennessy M, 2003, ANTIVIR THER, V8, P191; Jackson A, 2011, J ANTIMICROB CHEMOTH, V66, P635, DOI 10.1093/jac/dkq468; Jones SP, 2008, AIDS, V22, P1293, DOI 10.1097/QAD.0b013e3283021a4f; Jones SP, 2005, ANTIVIR THER, V10, P207; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Lafeuillade A, 2004, HIV CLIN TRIALS, V5, P392, DOI 10.1310/Q0TG-0V50-9JML-638U; Lagathu C, 2005, BIOCHIMIE, V87, P65, DOI 10.1016/j.biochi.2004.12.007; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lenhard JM, 2000, ANTIVIR RES, V47, P121, DOI 10.1016/S0166-3542(00)00102-9; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; McLean K, 2009, GYNECOL ONCOL, V112, P623, DOI 10.1016/j.ygyno.2008.11.028; Meaden ER, 2002, J ANTIMICROB CHEMOTH, V50, P583, DOI 10.1093/jac/dkf161; Mello AF, 2011, J ANTIMICROB CHEMOTH, V66, P1573, DOI 10.1093/jac/dkr151; Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Or-Tzadikario S, 2010, TISSUE ENG PART C-ME, V16, P1167, DOI [10.1089/ten.tec.2009.0755, 10.1089/ten.TEC.2009.0755]; Pacenti M, 2006, AIDS, V20, P1691, DOI 10.1097/01.aids.0000242815.80462.5a; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rhee MS, 2010, J CLIN PHARMACOL, V50, P392, DOI 10.1177/0091270009339739; Robenek M.J., 2010, J LIPIDS, V2011, P1; Roberts Esteban A., 2008, V445, P111, DOI 10.1007/978-1-59745-157-4_6; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Torres M, 2011, PLOS ONE, V5; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Vernochet C, 2005, J BIOL CHEM, V280, P2238, DOI 10.1074/jbc.M408687200; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang Y, 2012, HEPATOLOGY; Williams K, 2004, BIOCHEM PHARMACOL, V67, P255, DOI 10.1016/j.bcp.2003.08.044; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Zha WB, 2012, CURR DRUG METAB, V13, P1174, DOI 10.2174/138920012802850119; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, FUTURE LIPIDOL, V1, P163, DOI 10.2217/17460875.1.2.163; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou L, 2011, AUTOPHAGY, V6, P1196; Zhu L, 2010, ANTIVIR THER, V15, P1107, DOI 10.3851/IMP1673	79	52	53	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59514	10.1371/journal.pone.0059514	http://dx.doi.org/10.1371/journal.pone.0059514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533630	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400067
J	She, PX; Olson, KC; Kadota, Y; Inukai, A; Shimomura, Y; Hoppel, CL; Adams, SH; Kawamata, Y; Matsumoto, H; Sakai, R; Lang, CH; Lynch, CJ				She, Pengxiang; Olson, Kristine C.; Kadota, Yoshihiro; Inukai, Ayami; Shimomura, Yoshiharu; Hoppel, Charles L.; Adams, Sean H.; Kawamata, Yasuko; Matsumoto, Hideki; Sakai, Ryosei; Lang, Charles H.; Lynch, Christopher J.			Leucine and Protein Metabolism in Obese Zucker Rats	PLOS ONE			English	Article							BRANCHED-CHAIN AMINO; ACID DEHYDROGENASE KINASE; SKELETAL-MUSCLE; HYDROXYPROLINE EXCRETION; INSULIN; PLASMA; GLUCOSE; OXIDATION; TURNOVER; FAT	Branched-chain amino acids (BCAAs) are circulating nutrient signals for protein accretion, however, they increase in obesity and elevations appear to be prognostic of diabetes. To understand the mechanisms whereby obesity affects BCAAs and protein metabolism, we employed metabolomics and measured rates of [1-14C]-leucine metabolism, tissue-specific protein synthesis and branched-chain keto-acid (BCKA) dehydrogenase complex (BCKDC) activities. Male obese Zucker rats (11weeks old) had increased body weight (BW, 53%), liver (107%) and fat (, 300%), but lower plantaris and gastrocnemius masses (221-24%). Plasma BCAAs and BCKAs were elevated 45-69% and,100%, respectively, in obese rats. Processes facilitating these rises appeared to include increased dietary intake (23%), leucine (Leu) turnover and proteolysis [35% per g fat free mass (FFM), urinary markers of proteolysis: 3-methylhistidine (183%) and 4-hydroxyproline (766%)] and decreased BCKDC per g kidney, heart, gastrocnemius and liver (247-66%). A process disposing of circulating BCAAs, protein synthesis, was increased 23-29% by obesity in whole-body (FFM corrected), gastrocnemius and liver. Despite the observed decreases in BCKDC activities per gm tissue, rates of whole-body Leu oxidation in obese rats were 22% and 59% higher normalized to BW and FFM, respectively. Consistently, urinary concentrations of eight BCAA catabolism-derived acylcarnitines were also elevated. The unexpected increase in BCAA oxidation may be due to a substrate effect in liver. Supporting this idea, BCKAs were elevated more in liver (193-418%) than plasma or muscle, and per g losses of hepatic BCKDC activities were completely offset by increased liver mass, in contrast to other tissues. In summary, our results indicate that plasma BCKAs may represent a more sensitive metabolic signature for obesity than BCAAs. Processes supporting elevated BCAA] BCKAs in the obese Zucker rat include increased dietary intake, Leu and protein turnover along with impaired BCKDC activity. Elevated BCAAs/ BCKAs may contribute to observed elevations in protein synthesis and BCAA oxidation.	[She, Pengxiang; Olson, Kristine C.; Lang, Charles H.; Lynch, Christopher J.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Kadota, Yoshihiro; Inukai, Ayami; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Adams, Sean H.] Univ Calif Davis, Obes & Metab Res Unit, USDA ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kawamata, Yasuko; Matsumoto, Hideki; Sakai, Ryosei] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nagoya University; Case Western Reserve University; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Ajinomoto Co Inc	Lynch, CJ (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	clynch@psu.edu	ADAMS, SEAN/N-9262-2018; Sakai, Ryosei/AAW-4762-2021; Matsumoto, Hideki/AAA-5987-2021	ADAMS, SEAN/0000-0002-9515-2319; Matsumoto, Hideki/0000-0002-8057-9598; Lang, Charles/0000-0002-3260-7363; Sakai, Ryosei/0000-0001-5611-0821; Lynch, Christopher/0000-0003-2453-5838	Pennsylvania Department of Health using Tobacco CURE Funds; NIH [DK091784, DK062880, GM38032, DK078328]; USDA-ARS intramural Project [5306-51530-019-00]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK091784, R01DK062880, R01DK078328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038032, R29GM038032] Funding Source: NIH RePORTER	Pennsylvania Department of Health using Tobacco CURE Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-ARS intramural Project; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco CURE Funds. The Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Support for this project was also provided by NIH (DK091784, DK062880, GM38032, DK078328) and USDA-ARS intramural Project 5306-51530-019-00 (to SHA). The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; ADIBI SA, 1968, J APPL PHYSIOL, V25, P52, DOI 10.1152/jappl.1968.25.1.52; Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; ALLSOP JR, 1978, J APPL PHYSIOL, V45, P137, DOI 10.1152/jappl.1978.45.1.137; Aranibar N, 2011, ANAL BIOCHEM, V410, P84, DOI 10.1016/j.ab.2010.11.023; Argiles JM, 1999, J NUTR BIOCHEM, V10, P244, DOI 10.1016/S0955-2863(98)00098-9; ARGILES JM, 1989, PROG LIPID RES, V28, P53, DOI 10.1016/0163-7827(89)90007-6; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bajotto G, 2009, METABOLISM, V58, P1489, DOI 10.1016/j.metabol.2009.04.029; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; BORNSTEIN P, 1974, ANNU REV BIOCHEM, V43, P567, DOI 10.1146/annurev.bi.43.070174.003031; Bosma M, 2012, PROG LIPID RES, V51, P36, DOI 10.1016/j.plipres.2011.11.003; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; BROWN H, 1968, METABOLISM, V17, P345, DOI 10.1016/0026-0495(68)90103-0; BRUCE AC, 1990, INT J OBESITY, V14, P631; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; CHAN CP, 1985, J NUTR, V115, P959, DOI 10.1093/jn/115.8.959; Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; De Vogel-van den Bosch J, 2011, OBESITY, V19, P792, DOI 10.1038/oby.2010.152; Deo RC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000692; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; DURBINNALTCHAYAN S, 1983, HORM METAB RES, V15, P547, DOI 10.1055/s-2007-1018784; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; FELIG P, 1971, J CLIN INVEST, V50, P2703, DOI 10.1172/JCI106771; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Fluckey JD, 2004, AM J PHYSIOL-ENDOC M, V286, pE753, DOI 10.1152/ajpendo.00155.2003; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; GOLDBERG JR, 1988, ENDOCRINOLOGY, V122, P689, DOI 10.1210/endo-122-2-689; HARRIS RA, 1985, ARCH BIOCHEM BIOPHYS, V243, P542, DOI 10.1016/0003-9861(85)90531-4; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; HUTSON SM, 1978, J BIOL CHEM, V253, P8126; JENSEN MD, 1991, AM J CLIN NUTR, V53, P172, DOI 10.1093/ajcn/53.1.172; Jin ES, 2007, DIABETES, V56, P777, DOI 10.2337/db06-0717; Jin L, 2012, ANN NUTR METAB, V61, P117, DOI 10.1159/000341566; Jouvet P, 2000, MOL BIOL CELL, V11, P1919, DOI 10.1091/mbc.11.5.1919; Kand'ar R, 2009, CLIN CHEM LAB MED, V47, P565, DOI 10.1515/CCLM.2009.123; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167; LITVAK J, 1968, J CLIN ENDOCR METAB, V28, P311, DOI 10.1210/jcem-28-2-311; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Luzi L, 1996, AM J PHYSIOL-ENDOC M, V270, pE273, DOI 10.1152/ajpendo.1996.270.2.E273; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Lynch CJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE540, DOI [10.1152/ajpendo.00250.2011, 10.1152/ajpendo.00258.2011]; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Marchesini G, 2000, INT J OBESITY, V24, P552, DOI 10.1038/sj.ijo.0801195; Matsumoto H, 2010, ANAL BIOCHEM, V399, P1, DOI 10.1016/j.ab.2009.12.017; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Minkler PE, 2008, CLIN CHEM, V54, P1451, DOI 10.1373/clinchem.2007.099226; Minkler PE, 2005, ANAL CHEM, V77, P1448, DOI 10.1021/ac0487810; MURAKAMI DM, 1995, AM J PHYSIOL-REG I, V269, pR1038, DOI 10.1152/ajpregu.1995.269.5.R1038; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; NAIR KS, 1987, INT J OBESITY, V11, P537; NAIR KS, 1983, DIABETOLOGIA, V25, P400, DOI 10.1007/BF00282518; Nakai N, 2000, METHOD ENZYMOL, V324, P48; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishitani S, 2002, BIOCHEM BIOPH RES CO, V299, P693, DOI 10.1016/S0006-291X(02)02717-1; Norton LE, 2009, J NUTR, V139, P1103, DOI 10.3945/jn.108.103853; Oyarzabal A, 2012, HUMAN MUTATION; PALAIOLOGOS G, 1976, BIOCHEM J, V154, P709, DOI 10.1042/bj1540709; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; RUDERMAN NB, 1974, J BIOL CHEM, V249, P5500; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; SCHWENK WF, 1985, AM J PHYSIOL, V249, pE646, DOI 10.1152/ajpendo.1985.249.6.E646; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Su Y, 2012, DIABETES, V61, P85, DOI 10.2337/db11-0857; Sun HP, 2011, PEDIATR CARDIOL, V32, P305, DOI 10.1007/s00246-010-9856-9; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vary TC, 2006, AM J PHYSIOL-ENDOC M, V290, pE631, DOI 10.1152/ajpendo.00460.2005; Vary TC, 2005, AM J PHYSIOL-ENDOC M, V289, pE684, DOI 10.1152/ajpendo.00613.2004; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; VAZQUEZ JA, 1986, AM J PHYSIOL, V250, pE615, DOI 10.1152/ajpendo.1986.250.6.E615; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; WELLE S, 1990, AM J PHYSIOL, V258, pE990, DOI 10.1152/ajpendo.1990.258.6.E990; WELLE S, 1992, METABOLISM, V41, P1028, DOI 10.1016/0026-0495(92)90133-U; Wilson GJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE1236, DOI 10.1152/ajpendo.00242.2011; Wolfe RR, 2005, WHOLE BODY PROTEIN S, P299; Yang SM, 2007, J CHROMATOGR B, V857, P251, DOI 10.1016/j.jchromb.2007.07.027; Zelezniak A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000729; Zhou Y, 2010, J BIOL CHEM; ZUCKER LM, 1972, J LIPID RES, V13, P234	94	73	73	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59443	10.1371/journal.pone.0059443	http://dx.doi.org/10.1371/journal.pone.0059443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527196	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600073
J	Preziosa, E; Liu, SK; Terova, G; Gao, XY; Liu, H; Kucuktas, H; Terhune, J; Liu, ZJ				Preziosa, Elena; Liu, Shikai; Terova, Genciana; Gao, Xiaoyu; Liu, Hong; Kucuktas, Huseyin; Terhune, Jeffery; Liu, Zhanjiang			Effect of Nutrient Restriction and Re-Feeding on Calpain Family Genes in Skeletal Muscle of Channel Catfish (Ictalurus punctatus)	PLOS ONE			English	Article							CALCIUM-DEPENDENT PROTEOLYSIS; REAL-TIME PCR; ENDOGENOUS INHIBITOR; EXPRESSION; CALPASTATIN; ACTIVATION; PROTEINS; SYSTEMS; DEGRADATION; DENERVATION	Background: Calpains, a superfamily of intracellular calcium-dependent cysteine proteases, are involved in the cytoskeletal remodeling and wasting of skeletal muscle. Calpains are generated as inactive proenzymes which are activated by N-terminal autolysis induced by calcium-ions. Methodology/Principal Findings: In this study, we characterized the full-length cDNA sequences of three calpain genes, clpn1, clpn2, and clpn3 in channel catfish, and assessed the effect of nutrient restriction and subsequent re-feeding on the expression of these genes in skeletal muscle. The clpn1 cDNA sequence encodes a protein of 704 amino acids, Clpn2 of 696 amino acids, and Clpn3 of 741 amino acids. Phylogenetic analysis of deduced amino acid sequences indicate that catfish Clpn1 and Clpn2 share a sequence similarity of 61%; catfish Clpn1 and Clpn3 of 48%, and Clpn2 and Clpn3 of only 45%. The domain structure architectures of all three calpain genes in channel catfish are similar to those of other vertebrates, further supported by strong bootstrap values during phylogenetic analyses. Starvation of channel catfish (average weight, 15-20 g) for 35 days influenced the expression of clpn1 (2.3-fold decrease, P<0.05), clpn2 (1.3-fold increase, P<0.05), and clpn3 (13.0-fold decrease, P<0.05), whereas the subsequent refeeding did not change the expression of these genes as measured by quantitative real-time PCR analysis. Calpain catalytic activity in channel catfish skeletal muscle showed significant differences only during the starvation period, with a 1.2- and 1.4- fold increase (P<0.01) after 17 and 35 days of starvation, respectively. Conclusion/Significance: We have assessed that fasting and refeeding may provide a suitable experimental model to provide us insight into the role of calpains during fish muscle atrophy and how they respond to changes in nutrient supply.	[Preziosa, Elena; Liu, Shikai; Gao, Xiaoyu; Liu, Hong; Kucuktas, Huseyin; Terhune, Jeffery; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Preziosa, Elena; Liu, Shikai; Gao, Xiaoyu; Liu, Hong; Kucuktas, Huseyin; Terhune, Jeffery; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Aquat Genom Unit, Auburn, AL 36849 USA; [Preziosa, Elena; Terova, Genciana] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Preziosa, Elena; Terova, Genciana] Polytech Univ Milan, Interuniv Ctr Res Prot Biotechnol Prot Factor, Varese, Italy; [Preziosa, Elena; Terova, Genciana] Univ Insubria, Varese, Italy	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Insubria; Polytechnic University of Milan; University of Insubria	Liu, ZJ (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Shikai/D-4664-2013; Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021; Terova, Genciana/AAL-6412-2021; Terova, Genciana/G-1779-2010	Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X; Terova, Genciana/0000-0002-7532-7951; Terova, Genciana/0000-0002-7532-7951	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356, 2012-67015-19410]; China Scholarship Council	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture (NIFA); China Scholarship Council(China Scholarship Council)	This project was supported by grants of Agriculture and Food Research Initiative Competitive (Grant No.2009-35205-05101 and 2010-65205-20356, 2012-67015-19410) from the USDA National Institute of Food and Agriculture (NIFA). Shikai Liu was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Arthur GD, 1999, CAN J PHYSIOL PHARM, V77, P42, DOI 10.1139/cjpp-77-1-42; Baoprasertkul P, 2006, IMMUNOGENETICS, V58, P817, DOI 10.1007/s00251-006-0144-z; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Costelli P, 2000, Curr Opin Clin Nutr Metab Care, V3, P177, DOI 10.1097/00075197-200005000-00003; Cygler Miroslaw, 2002, Methods Mol Biol, V172, P243; Du J, 2005, INT J BIOCHEM CELL B, V37, P2147, DOI 10.1016/j.biocel.2005.03.012; Du M, 2004, J ANIM SCI, V82, P2541; Dudgeon WD, 2006, HIV MED, V7, P299, DOI 10.1111/j.1468-1293.2006.00380.x; Elce JS, 1997, J BIOL CHEM, V272, P11268; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; ILIAN MA, 1992, BIOCHEM J, V287, P163, DOI 10.1042/bj2870163; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jekely G, 1999, J MOL EVOL, V49, P272, DOI 10.1007/PL00006549; Jiang YL, 2010, DEV COMP IMMUNOL, V34, P590, DOI 10.1016/j.dci.2010.01.001; KOOHMARAIE M, 1991, J ANIM SCI, V69, P2463; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; KRETCHMAR DH, 1990, J ANIM SCI, V68, P1760; KUBOKI M, 1990, J BIOCHEM-TOKYO, V107, P776, DOI 10.1093/oxfordjournals.jbchem.a123124; KUMAMOTO T, 1995, ACTA NEUROPATHOL, V89, P399; Lepage SE, 2008, DEV DYNAM, V237, P819, DOI 10.1002/dvdy.21459; Liu S, 2012, BMC GENOMIC IN PRESS; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Macqueen DJ, 2010, GENE, V453, P45, DOI 10.1016/j.gene.2010.01.002; Melloni E, 1996, BIOCHEM BIOPH RES CO, V229, P193, DOI 10.1006/bbrc.1996.1779; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Nemova NN, 2010, RUSS J DEV BIOL+, V41, P318, DOI 10.1134/S1062360410050073; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Sarparanta J, 2010, J BIOL CHEM, V285, P30304, DOI 10.1074/jbc.M110.108720; Sha ZX, 2009, DEV COMP IMMUNOL, V33, P991, DOI 10.1016/j.dci.2009.04.004; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Stockholm D, 2001, AM J PHYSIOL-CELL PH, V280, pC1561, DOI 10.1152/ajpcell.2001.280.6.C1561; Sultan KR, 2001, AM J PHYSIOL-CELL PH, V280, pC239, DOI 10.1152/ajpcell.2001.280.2.C239; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Takano T, 2008, DEV COMP IMMUNOL, V32, P693, DOI 10.1016/j.dci.2007.10.008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935; Tripathi G, 2003, Z NATURFORSCH C, V58, P446; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; USDA, 2006, CATF PROC REP; Vermaelen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1723, DOI 10.1152/ajpcell.00398.2006; Wang L, 1998, SHOCK, V10, P298, DOI 10.1097/00024382-199810000-00011	61	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59404	10.1371/journal.pone.0059404	http://dx.doi.org/10.1371/journal.pone.0059404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527186	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100127
J	Robbins, B				Robbins, Blaine			Cooperation without Culture? The Null Effect of Generalized Trust on Intentional Homicide: A Cross-National Panel Analysis, 1995-2009	PLOS ONE			English	Article							INCOME INEQUALITY; SOCIAL TRUST; CRIME; ENFORCEMENT; COMMUNITY; RELIGION; MODELS; WORLD; SIZE	Sociologists, political scientists, and economists all suggest that culture plays a pivotal role in the development of large-scale cooperation. In this study, I used generalized trust as a measure of culture to explore if and how culture impacts intentional homicide, my operationalization of cooperation. I compiled multiple cross-national data sets and used pooled time-series linear regression, single-equation instrumental-variables linear regression, and fixed-and random-effects estimation techniques on an unbalanced panel of 118 countries and 232 observations spread over a 15-year time period. Results suggest that culture and large-scale cooperation form a tenuous relationship, while economic factors such as development, inequality, and geopolitics appear to drive large-scale cooperation.	Univ Washington, Dept Sociol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Robbins, B (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	adduct@uw.edu						[Anonymous], 1965, LOGIC COLLECTIVE ACT; Bergh A, 2011, TRUST WELFARE STATES, P45; Bergh A, 2011, KYKLOS, V64, P1, DOI 10.1111/j.1467-6435.2010.00492.x; Bjornskov C, 2008, EUR SOCIOL REV, V24, P271, DOI 10.1093/esr/jcn004; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Bjornskov C, 2010, PUBLIC CHOICE, V144, P323, DOI 10.1007/s11127-009-9522-z; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Clark T. S., 2012, 1315 SOC POL METH; Corcoran KE, 2012, J SCI STUD RELIG, V51, P542, DOI 10.1111/j.1468-5906.2012.01669.x; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Delhey J, 2005, EUR SOCIOL REV, V21, P311, DOI 10.1093/esr/jci022; Dohmen T, 2012, REV ECON STUD, V79, P645, DOI 10.1093/restud/rdr027; Durkheim Emile., 1964, DIVISION LABOR SOC; Elgar FJ, 2011, EUR J PUBLIC HEALTH, V21, P241, DOI 10.1093/eurpub/ckq068; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Freitag M, 2009, COMP POLIT STUD, V42, P1537, DOI 10.1177/0010414009332151; Fruhling Hugo, 2003, CRIME VIOLENCE LATIN; Godoy Angelina S., 2006, POPULAR INJUSTICE VI; Greif A, 2006, POLIT ECON I DECIS, P1, DOI 10.1017/CBO9780511791307; Guiso L, 2008, J EUR ECON ASSOC, V6, P295, DOI 10.1162/JEEA.2008.6.2-3.295; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herreros F, 2004, POLIT EVOL INST CHAN, P1, DOI 10.1057/9781403978806; Kennedy BP, 1998, SOC SCI MED, V47, P7, DOI 10.1016/S0277-9536(98)00097-5; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lederman D, 2002, ECON DEV CULT CHANGE, V50, P509, DOI 10.1086/342422; Messner SF, 2004, AM SOCIOL REV, V69, P882, DOI 10.1177/000312240406900607; Nivette AE, 2011, HOMICIDE STUD, V15, P103, DOI 10.1177/1088767911406397; Ouimet M, 2012, HOMICIDE STUD, V16, P238, DOI 10.1177/1088767912442500; Putnam RD., 2000, BOWLING ALONE COLLAP; Richerson PJ., 2005, NOT GENES ALONE CULT; Robbins B, 2012, SOC INDIC RES, V105, P519, DOI 10.1007/s11205-011-9785-x; Robbins BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035120; Robbins BG, 2012, SOC INDIC RES, V107, P235, DOI 10.1007/s11205-011-9838-1; Robbins BG, 2011, RATION SOC, V23, P304, DOI 10.1177/1043463111404665; Rose-Ackerman Bonnie J., 2016, CORRUPTION GOVT CAUS, DOI 10.1017/CBO9781139175098; Rosenfeld R, 2001, SOC FORCES, V80, P283, DOI 10.1353/sof.2001.0086; Roth F, 2009, KYKLOS, V62, P103, DOI 10.1111/j.1467-6435.2009.00424.x; Sapienza P, 2007, NBER WORKING PAPER S; Shariff AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039048; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Sovey AJ, 2011, AM J POLIT SCI, V55, P188, DOI 10.1111/j.1540-5907.2010.00477.x; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Tabellini G, 2008, Q J ECON, V123, P905, DOI 10.1162/qjec.2008.123.3.905; Taylor M., 1987, POSSIBILITY COOPERAT; Taylor Michael, 1982, COMMUNITY ANARCHY LI; Thoni C, 2012, J PUBLIC ECON, V96, P635, DOI 10.1016/j.jpubeco.2012.04.003; Tonnies F., 1963, COMMUNITY SOC; Uslaner E., 2002, MORAL FDN TRUST; Varadharajan-Krishnakumar, 1987, ECONOMET THEOR, V3, P223, DOI [DOI 10.1017/S0266466600010318, 10.1017/S0266466600010318]; Wilson SE, 2007, POLIT ANAL, V15, P101, DOI 10.1093/pan/mpl012; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	54	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59511	10.1371/journal.pone.0059511	http://dx.doi.org/10.1371/journal.pone.0059511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527211	gold, Green Published			2022-12-27	WOS:000317562100143
J	Sadot, A; Sarbu, S; Kesseli, J; Amir-Kroll, H; Zhang, W; Nykter, M; Shmulevich, I				Sadot, Avital; Sarbu, Septimia; Kesseli, Juha; Amir-Kroll, Hila; Zhang, Wei; Nykter, Matti; Shmulevich, Ilya			Information-Theoretic Analysis of the Dynamics of an Executable Biological Model	PLOS ONE			English	Article							REGULATORY T-CELLS; SIMULATION; NETWORKS; SYSTEMS; SUPPRESSION; MECHANISMS; PATHWAYS; PREDICTS	To facilitate analysis and understanding of biological systems, large-scale data are often integrated into models using a variety of mathematical and computational approaches. Such models describe the dynamics of the biological system and can be used to study the changes in the state of the system over time. For many model classes, such as discrete or continuous dynamical systems, there exist appropriate frameworks and tools for analyzing system dynamics. However, the heterogeneous information that encodes and bridges molecular and cellular dynamics, inherent to fine-grained molecular simulation models, presents significant challenges to the study of system dynamics. In this paper, we present an algorithmic information theory based approach for the analysis and interpretation of the dynamics of such executable models of biological systems. We apply a normalized compression distance (NCD) analysis to the state representations of a model that simulates the immune decision making and immune cell behavior. We show that this analysis successfully captures the essential information in the dynamics of the system, which results from a variety of events including proliferation, differentiation, or perturbations such as gene knock-outs. We demonstrate that this approach can be used for the analysis of executable models, regardless of the modeling framework, and for making experimentally quantifiable predictions.	[Sadot, Avital; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA; [Sarbu, Septimia; Kesseli, Juha; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Amir-Kroll, Hila] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Nykter, Matti] Tampere Univ Technol, Inst Biomed Technol, FIN-33101 Tampere, Finland	Institute for Systems Biology (ISB); Tampere University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Texas System; UTMD Anderson Cancer Center; Tampere University	Nykter, M (corresponding author), Tampere Univ Technol, Inst Biomed Technol, FIN-33101 Tampere, Finland.	matti.nykter@tut.fi; ilya.shmulevich@systemsbiology.org		Nykter, Matti/0000-0001-6956-2843	Academy of Finland [132877, 251937]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; GETA - Graduate School in Electronics, Telecommunications and Automation; Aalto University	Academy of Finland(Academy of Finland); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; GETA - Graduate School in Electronics, Telecommunications and Automation; Aalto University	This work was supported by the Academy of Finland project number 132877 (MN) and 251937 (JK) and by the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg and GETA - Graduate School in Electronics, Telecommunications and Automation, from Aalto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Amir-Kroll H, 2012, ANALYZING IMMUNE DEC; Amir-Kroll H, 2008, THEOR COMPUT SCI, V391, P276, DOI 10.1016/j.tcs.2007.11.014; Barjis J., 1999, Proceedings 1999 International Conference on Information Intelligence and Systems (Cat. No.PR00446), P4, DOI 10.1109/ICIIS.1999.810217; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Calder M, 2006, LECT NOTES COMPUT SC, V4210, P63; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Cilibrasi R, 2005, IEEE T INFORM THEORY, V51, P1523, DOI 10.1109/TIT.2005.844059; Cover T. M., 1991, ELEMENTS INFORM THEO; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; Fisher J, 2005, P NATL ACAD SCI USA, V102, P1951, DOI 10.1073/pnas.0409433102; Fisher J, 2007, PLOS COMPUT BIOL, V3, P862, DOI 10.1371/journal.pcbi.0030092; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Galas DJ, 2010, IEEE T INFORM THEORY, V56, P667, DOI 10.1109/TIT.2009.2037046; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D., 1985, LOGICS MODELS CONCUR, P477, DOI [10.1007/978-3-642-82453-1_17, DOI 10.1007/978-3-642-82453-1_17]; Harel D, 2003, EUROPEAN ASS THEORET, V81, P226; Ideker T E, 2000, Pac Symp Biocomput, P305; Kam N, 2001, PROC VISUAL LANGUAGE, P5; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Lakin MR, 2012, THEOR COMPUT SCI, V431, P181, DOI 10.1016/j.tcs.2011.12.057; Li C, 2007, J BIOSCIENCES, V32, P113; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Luque B, 2000, PHYSICA A, V284, P33, DOI 10.1016/S0378-4371(00)00184-9; Meiss J.D., 2007, DIFFERENTIAL DYNAMIC; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Priami C, 2001, INFORM PROCESS LETT, V80, P25, DOI 10.1016/S0020-0190(01)00214-9; Regev A, 2001, Pac Symp Biocomput, P459; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sadot A, 2008, ON SPECIFIC AND GENE; Sadot A, 2008, IEEE ACM T COMPUT BI, V5, P223, DOI 10.1109/TCBB.2007.1076; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Simao E, 2005, BIOINFORMATICS, V21, P190, DOI 10.1093/bioinformatics/bti1130; Vitanyi P., 2008, AN INTRODUCTION TO K; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423	46	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59303	10.1371/journal.pone.0059303	http://dx.doi.org/10.1371/journal.pone.0059303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527156	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100102
J	Stavropoulou, AV; Fostira, F; Pertesi, M; Tsitlaidou, M; Voutsinas, GE; Triantafyllidou, O; Bamias, A; Dimopoulos, MA; Timotheadou, E; Pectasides, D; Christodoulou, C; Klouvas, G; Papadimitriou, C; Makatsoris, T; Pentheroudakis, G; Aravantinos, G; Karydakis, V; Yannoukakos, D; Fountzilas, G; Konstantopoulou, I				Stavropoulou, Alexandra V.; Fostira, Florentia; Pertesi, Maroulio; Tsitlaidou, Marianthi; Voutsinas, Gerassimos E.; Triantafyllidou, Olga; Bamias, Aristotelis; Dimopoulos, Meletios A.; Timotheadou, Eleni; Pectasides, Dimitrios; Christodoulou, Christos; Klouvas, George; Papadimitriou, Christos; Makatsoris, Thomas; Pentheroudakis, George; Aravantinos, Gerasimos; Karydakis, Vassilis; Yannoukakos, Drakoulis; Fountzilas, George; Konstantopoulou, Irene			Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases	PLOS ONE			English	Article							GERM-LINE MUTATIONS; FALLOPIAN-TUBE; BREAST-CANCER; INHERITED MUTATIONS; WOMEN; CARCINOMA; SURVIVAL; SUSCEPTIBILITY; FREQUENCY; FEATURES	Germline mutations in the BRCA1 and BRCA2 genes contribute to approximately 18% of hereditary ovarian cancers conferring an estimated lifetime risk from 15% to 50%. A variable incidence of mutations has been reported for these genes in ovarian cancer cases from different populations. In Greece, six mutations in BRCA1 account for 63% of all mutations detected in both BRCA1 and BRCA2 genes. This study aimed to determine the prevalence of BRCA1 mutations in a Greek cohort of 106 familial ovarian cancer patients that had strong family history or metachronous breast cancer and 592 sporadic ovarian cancer cases. All 698 patients were screened for the six recurrent Greek mutations (including founder mutations c.5266dupC, p.G1738R and the three large deletions of exon 20, exons 23-24 and exon 24). In familial cases, the BRCA1 gene was consequently screened for exons 5, 11, 12, 20, 21, 22, 23, 24. A deleterious BRCA1 mutation was found in 43/106 (40.6%) of familial cancer cases and in 27/592 (4.6%) of sporadic cases. The variant of unknown clinical significance p.V1833M was identified in 9/698 patients (1.3%). The majority of BRCA1 carriers (71.2%) presented a high-grade serous phenotype. Identifying a mutation in the BRCA1 gene among breast and/or ovarian cancer families is important, as it enables carriers to take preventive measures. All ovarian cancer patients with a serous phenotype should be considered for genetic testing. Further studies are warranted to determine the prevalence of mutations in the rest of the BRCA1 gene, in the BRCA2 gene, and other novel predisposing genes for breast and ovarian cancer.	[Stavropoulou, Alexandra V.; Fostira, Florentia; Pertesi, Maroulio; Tsitlaidou, Marianthi; Triantafyllidou, Olga; Yannoukakos, Drakoulis; Konstantopoulou, Irene] Natl Ctr Sci Res Demokritos, INRaSTES, Mol Diagnost Lab, Athens, Greece; [Voutsinas, Gerassimos E.] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Lab Environm Mutagenesis & Carcinogenesis, Athens, Greece; [Bamias, Aristotelis; Dimopoulos, Meletios A.; Papadimitriou, Christos] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece; [Timotheadou, Eleni; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Christodoulou, Christos; Klouvas, George] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Makatsoris, Thomas] Univ Patras, Sch Med, Div Oncol, Dept Med,Univ Hosp, GR-26110 Patras, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Aravantinos, Gerasimos] Agii Anargiri Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Karydakis, Vassilis] Rhodes Gen Hosp, Dept Surg 1, Rhodes, Greece	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hippokration General Hospital; University of Patras; University Hospital Ioannina	Konstantopoulou, I (corresponding author), Natl Ctr Sci Res Demokritos, INRaSTES, Mol Diagnost Lab, Athens, Greece.	reena@rrp.demokritos.gr	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Bamias, Aristotelis/AAD-5332-2019; Fostira, Florentia/Z-5730-2019; TIMOTHEADOU, ELENI/AAM-6301-2020; Fountzilas, George/ABF-2139-2020; Konstantopoulou, Irene/B-5309-2009	Bamias, Aristotelis/0000-0002-5996-7262; Yannoukakos, Drakoulis/0000-0001-7509-3510; Aravantinos, Gerasimos/0000-0002-2106-1713; Fountzilas, George/0000-0001-8045-2186; Konstantopoulou, Irene/0000-0002-0470-0309; Dimopoulos, Meletios/0000-0001-8990-3254				Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Anagnostopoulos T, 2008, BREAST CANCER RES TR, V110, P377, DOI 10.1007/s10549-007-9729-y; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Armaou S, 2009, BRIT J CANCER, V101, P32, DOI 10.1038/sj.bjc.6605115; Armaou S, 2007, EUR J CANCER, V43, P443, DOI 10.1016/j.ejca.2006.09.021; Brozek I, 2008, GYNECOL ONCOL, V108, P433, DOI 10.1016/j.ygyno.2007.09.035; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carvalho M, 2009, MUTAT RES-FUND MOL M, V660, P1, DOI 10.1016/j.mrfmmm.2008.09.017; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Drew Y, 2008, ANN NY ACAD SCI, V1138, P136, DOI 10.1196/annals.1414.020; Finch A, 2012, WOMENS HEALTH, V8, P543, DOI [10.2217/WHE.12.41, 10.2217/whe.12.41]; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gaildrat P, 2010, J MED GENET, V47, P398, DOI 10.1136/jmg.2009.074047; Hamel N, 2011, EUR J HUM GENET, V19, P300, DOI 10.1038/ejhg.2010.203; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Konstantopoulou I, 2008, BREAST CANCER RES TR, V107, P431, DOI 10.1007/s10549-007-9571-2; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Malander S, 2004, EUR J CANCER, V40, P422, DOI 10.1016/j.ejca.2003.09.016; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Osher DJ, 2012, BRIT J CANCER, V106, P1460, DOI 10.1038/bjc.2012.87; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Pavlicek A, 2004, HUM MOL GENET, V13, P2737, DOI 10.1093/hmg/ddh301; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rodriguez AO, 2012, GYNECOL ONCOL, V124, P236, DOI 10.1016/j.ygyno.2011.10.027; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Soegaard M, 2008, CLIN CANCER RES, V14, P3761, DOI 10.1158/1078-0432.CCR-07-4806; Vencken PMLH, 2011, ANN ONCOL, V22, P1346, DOI 10.1093/annonc/mdq628; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Watson P, 2001, GYNECOL ONCOL, V82, P223, DOI 10.1006/gyno.2001.6279; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Zhang SY, 2011, GYNECOL ONCOL, V121, P353, DOI 10.1016/j.ygyno.2011.01.020	47	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58182	10.1371/journal.pone.0058182	http://dx.doi.org/10.1371/journal.pone.0058182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536787	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100030
J	Kuklinski, P; Taylor, PD; Denisenko, NV; Berning, B				Kuklinski, Piotr; Taylor, Paul D.; Denisenko, Nina V.; Berning, Bjoern			Atlantic Origin of the Arctic Biota? Evidence from Phylogenetic and Biogeographical Analysis of the Cheilostome Bryozoan Genus Pseudoflustra	PLOS ONE			English	Article							PHYLOGEOGRAPHY; BIODIVERSITY; PACIFIC; FAUNA; OCEAN; AGE	The intricate geological evolution of the Arctic Ocean is paralleled by complexities in the biogeographical and phylogenetical histories of the Arctic biota, including bryozoans. Here we present revised taxonomic descriptions for all known species of the bryozoan genus Pseudoflustra, and use the present-day distributions and phylogenetic relationships between these species to infer the historical biogeography of the genus. Nine species belonging to the genus Pseudoflustra are recognized in the Arctic and North Atlantic. One new species, previously identified as Ichthyaria aviculata, is described as Pseudoflustra radeki sp. nov. Another species, previously assigned to Smittoidea as S. perrieri, is transferred to Pseudoflustra. Biogeographical analysis of Pseudoflustra reveals that species distributions mostly match current patterns pertaining in the North Atlantic and Arctic Ocean. Distributions were probably shaped by recent geological history as present-day current directions in the Arctic Ocean are believed to have been similar for at least the last 120 000 years. Phylogenetic analysis of Pseudoflustra places the five Arctic-North Atlantic species in a clade crownward of a paraphyletic grouping of North Atlantic species. Given that the Arctic Ocean was fully glaciated until 18 000 years, the most likely explanation for this phylogeographical pattern is that species of Pseudoflustra colonized the Arctic relatively recently from North Atlantic sources. However, a fuller understanding of the origin of Pseudoflustra in the Arctic will require molecular and fossil data, neither of which are currently available.	[Kuklinski, Piotr] Polish Acad Sci, Inst Oceanol, Sopot, Poland; [Kuklinski, Piotr; Taylor, Paul D.] Nat Hist Museum, London SW7 5BD, England; [Denisenko, Nina V.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Berning, Bjoern] Upper Austrian State Museum, Leonding, Austria	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Natural History Museum London; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Kuklinski, P (corresponding author), Polish Acad Sci, Inst Oceanol, Sopot, Poland.	kuki@iopan.gda.pl	Denisenko, Nina/O-4087-2019	Kuklinski, Piotr/0000-0002-1507-215X; Taylor, Paul/0000-0002-3127-080X; Berning, Bjorn/0000-0002-0068-9739; Denisenko, Nina/0000-0003-0284-5026	Polish National Science Centre [E12AP004]; Russian Ministry of Education and Science; SYNTHESYS; European Community [FR-TAF-1902]; ArcOD mini grant	Polish National Science Centre; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); SYNTHESYS; European Community(European Commission); ArcOD mini grant	This study has been completed thanks to an ArcOD mini grant and funds from the Polish National Science Centre (E12AP004). The study was also supported by the Russian Ministry of Education and Science. PK and BB received support from the SYNTHESYS Project (http://www.synthesys.info/), which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program, and which allowed studying material at the MNHN (FR-TAF-1902) and at the NM (AT-TAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2005, EVOLUTION, V59, P532, DOI 10.1111/j.0014-3820.2005.tb01013.x; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Andersson KA., 1902, ZOOL JB ABT SYST GEO, V15, P537; Bidenkap O., 1897, ZOOLOGISCHE JB ABTEI, V10, P609; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Busk G, 1861, Q J MICROSC SCI, V1, P77, DOI DOI 10.1242/JCS.S2-1.1.77; Calvet Louis, 1906, Bulletin du Museum Paris, V12; Cheetham AH, 2006, J PALEONTOL, V80, P49, DOI 10.1666/0022-3360(2006)080[0049:MDOAAT]2.0.CO;2; COOK PL, 1981, CAH BIOL MAR, V22, P89; d'Hondt J.-L., 1973, Bulletin Mus Natn Hist Nat Paris (Zool), VNo. 92, P365; d'Hondt J.-L., 1975, B MUSEUM NATL HIST N, V299, P553; d'Hondt JL, 2004, CAH BIOL MAR, V45, P281; Darby DA, 2006, PROG OCEANOGR, V71, P129, DOI 10.1016/j.pocean.2006.09.009; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Denisenko NV, 1990, OCCURENCE ECOLOGY BR; Denisenko NV, 2010, EXPLORATIONS FAUNA S, V66, P89; dHondt J.-L., 2009, MEM SOC LINN BORDEAU, V11, P1; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Golikov A.N., 1989, P257; Gontar V.I., 1989, P341; Gontar VI, 2010, TUMEN I NO DEV SIBER, V10, P139; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Grischenko Andrei V., 2002, P97; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; HAYAMI T, 1975, Science Reports of the Tohoku University Second Series (Geology), V45, P83; Hayward P.J., 1999, SYNOPSES BRIT FAUNA, V14; HAYWARD PJ, 1978, J ZOOL, V184, P207; HAYWARD PJ, 1994, SARSIA, V79, P181, DOI 10.1080/00364827.1994.10413558; Hayward PJ, 1998, SYNOPSES BRIT FAUNA, V10; Hincks T., 1892, Annals of Natural History, Vix, P149; Hincks T, 1880, ANN MAGAZINE NATUR 5, V6, P277; Jones EP, 2001, POLAR RES, V20, P139, DOI 10.1111/j.1751-8369.2001.tb00049.x; Jullien J., 1883, B SOC ZOOLOGIQUE FRA, V7, P497, DOI DOI 10.5962/BHL.TITLE.4721; Jullien JL, 1903, RESULTATS CAMPAGNES, V23, P1; Kennett J., 1982, MARINE GEOLOGY; Kluge G.A., 1929, RABOTY MURMANSKOI BI, V3, P1; Kluge G.A., 1946, T DREIF EKSP GLAVS N, V3, P194; Kluge G.A., 1962, BRYOZOANS NO SEAS US; Kluge G.A., 1915, FAUNA KOLSKY GULF CO, V8, P376; Kluge GA., 1975, BRYOZOA NO SEAS USSR; Kuklinski P, 2005, J NAT HIST, V39, P539, DOI 10.1080/00222930400001350; Kuklinski P, 2006, POLAR BIOL, V29, P652, DOI 10.1007/s00300-005-0102-5; Lombardi C, 2010, ZOOL J LINN SOC-LOND, V160, P17, DOI 10.1111/j.1096-3642.2009.00594.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marcus E, 1919, NOTIZEN EINIGES MAT, P255; Marfenin NN, 1997, HYDROBIOLOGIA, V355, P153, DOI 10.1023/A:1003069831832; Mayer AG, 1918, BIOGR MEM NAT ACAD S, VVIII, P417; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Nelson RJ, 2009, MAR ECOL PROG SER, V381, P129, DOI 10.3354/meps07940; Nesis K.N., 1984, SOVIET J MARINE BIOL, V9, P235; PALUMBI SR, 1991, EVOLUTION, V45, P1790, DOI 10.1111/j.1558-5646.1991.tb02688.x; POWELL NA, 1968, J FISH RES BOARD CAN, V25, P2269, DOI 10.1139/f68-202; RIDER J, 1977, LETHAIA, V10, P29; Ryland J.S., 1974, Thalassia Jugosl, V10, P239; Ryland JS., 1991, NOAA TECHNICAL REPOR, V99, P1; Sars M, 1863, BESKRIVELSE NOGLE NO; Smitt FA, 1868, OFVERSIGT VETENSKAP, V6, P443; Smitt FA, 1868, KRITISK FORTECKNIN 4, V1867, P3; Stimpson W, 1854, SMITHSONIAN CONTRIBU, V5, P17; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; VANOPPEN MJH, 1995, MAR BIOL, V123, P179, DOI 10.1007/BF00350338; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Verrill AE, 1879, P US NAT MUS, V2, P188; VIGELIUS WJ, 1882, NIEDERL ARCH ZOOL S, V1, P1; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V62, P718, DOI 10.1016/j.ympev.2011.11.011; Wares JP, 2001, BIOL BULL-US, V201, P95, DOI 10.2307/1543530; Weider LJ, 2000, ANN ZOOL FENN, V37, P217	68	13	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59152	10.1371/journal.pone.0059152	http://dx.doi.org/10.1371/journal.pone.0059152			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536863	gold, Green Submitted, Green Published			2022-12-27	WOS:000317397200016
J	Baldoli, E; Castiglioni, S; Maier, JAM				Baldoli, Erika; Castiglioni, Sara; Maier, Jeanette A. M.			Regulation and Function of TRPM7 in Human Endothelial Cells: TRPM7 as a Potential Novel Regulator of Endothelial Function	PLOS ONE			English	Article							MAGNESIUM HOMEOSTASIS; NITRIC-OXIDE; CHANNELS; EXPRESSION; CALPAIN; CALCIUM; CANCER; DYSFUNCTION; DEFICIENCY; PHENOTYPE	TRPM7, a cation channel of the transient receptor potential channel family, has been identified as a ubiquitous magnesium transporter. We here show that TRPM7 is expressed in endothelial cells isolated from the umbilical vein ( HUVEC), widely used as a model of macrovascular endothelium. Quiescence and senescence do not modulate TRPM7 amounts, whereas oxidative stress generated by the addition of hydrogen peroxide increases TRPM7 levels. Moreover, high extracellular magnesium decreases the levels of TRPM7 by activating calpains, while low extracellular magnesium, known to promote endothelial dysfunction, stimulates TRPM7 accumulation partly through the action of free radicals. Indeed, the antioxidant trolox prevents TRPM7 increase by low magnesium. We also demonstrate the unique behaviour of HUVEC in responding to pharmacological and genetic inhibition of TRPM7 with an increase of cell growth and migration. Our results indicate that TRPM7 modulates endothelial behavior and that any condition leading to TRPM7 upregulation might impair endothelial function.	[Baldoli, Erika; Castiglioni, Sara; Maier, Jeanette A. M.] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy	University of Milan	Maier, JAM (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy.	jeanette.maier@unimi.it	castiglioni, sara/H-9289-2012; Maier, Jeanette Anne Marie/H-4820-2012; Stefanadis, Christodoulos/ABH-2232-2020	castiglioni, sara/0000-0002-8785-9891; Maier, Jeanette Anne Marie/0000-0002-6326-9221; Stefanadis, Christodoulos/0000-0001-5974-6454	Ministero Universita e Ricerca-PRIN	Ministero Universita e Ricerca-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Ministero Universita e Ricerca-PRIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2007, CELL PROLIFERAT, V40, P849, DOI 10.1111/j.1365-2184.2007.00476.x; Baldoli E, 2012, ANGIOGENESIS, V15, P47, DOI 10.1007/s10456-011-9242-0; Bolognese F, 2006, GENE, V374, P87, DOI 10.1016/j.gene.2006.01.030; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Ferre S, 2007, MAGNESIUM RES, V20, P66; Ferre S, 2010, BBA-MOL BASIS DIS, V1802, P952, DOI 10.1016/j.bbadis.2010.06.016; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; He Y, 2005, CIRC RES, V96, P207, DOI 10.1161/01.RES.0000152967.88472.3e; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Leidi M, 2010, EUR J CELL BIOL, V89, P654, DOI 10.1016/j.ejcb.2010.05.001; Libako P, 2012, MAGNESIUM RES, V25, P12, DOI 10.1684/mrh.2012.0302; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Nunez-Villena F, 2011, ANTIOXID REDOX SIGN, V15, P2425, DOI 10.1089/ars.2010.3825; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Paravicini TM, 2009, HYPERTENSION, V53, P423, DOI 10.1161/HYPERTENSIONAHA.108.124651; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Rybarczyk P, 2012, INT J CANCER, V131, pE851, DOI 10.1002/ijc.27487; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Thilo F, 2012, HYPERTENSION, V59, P1232, DOI 10.1161/HYPERTENSIONAHA.111.183608; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; WANG KKW, 1990, TRENDS PHARMACOL SCI, V11, P139, DOI 10.1016/0165-6147(90)90060-L; Wolf FI, 2008, MAGNESIUM RES, V21, P58; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Wolf FI, 2010, J CELL PHYSIOL, V222, P374, DOI 10.1002/jcp.21961; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Yee NS, 2012, CANCER LETT, V318, P99, DOI 10.1016/j.canlet.2011.12.007	33	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59891	10.1371/journal.pone.0059891	http://dx.doi.org/10.1371/journal.pone.0059891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533657	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400094
J	Chin, SO; Rhee, SY; Chon, S; Hwang, YC; Jeong, IK; Oh, S; Ahn, KJ; Chung, HY; Woo, JT; Kim, SW; Kim, JW; Kim, YS; Ahn, HY				Chin, Sang Ouk; Rhee, Sang Youl; Chon, Suk; Hwang, You-Cheol; Jeong, In-Kyung; Oh, Seungjoon; Ahn, Kyu Jeung; Chung, Ho Yeon; Woo, Jeong-taek; Kim, Sung-Woon; Kim, Jin-Woo; Kim, Young Seol; Ahn, Hong-Yup			Sarcopenia Is Independently Associated with Cardiovascular Disease in Older Korean Adults: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2009	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; ALTERNATIVE DEFINITIONS; FUNCTIONAL IMPAIRMENT; BODY-FAT; OBESITY; MEN; INFLAMMATION; PREVALENCE; MORTALITY; WOMEN	Background: The association between sarcopenia and cardiovascular disease (CVD) in elderly people has not been adequately assessed. The aim of this study was to investigate whether CVD is more prevalent in subjects with sarcopenia independent of other well-established cardiovascular risk factors in older Korean adults. Method: This study utilized the representative Korean population data from the Korea National Health and Nutrition Examination Survey (KNHANES) which was conducted in 2009. Subjects older than 65 years of age with appendicular skeletal muscle mass (ASM) determined by dual energy X-ray absorptiometry were selected. The prevalence of sarcopenia in the older Korean adults was investigated, and it was determined whether sarcopenia is associated with CVD independent of other well-known risk factors. Results: 1,578 subjects aged 65 years and older with the data for ASM were selected, and the overall prevalence of sarcopenia was 30.3% in men and 29.3% in women. Most of the risk factors for CVD such as age, waist circumference, body mass index, fasting plasma glucose and total cholesterol showed significant negative correlations with the ratio between appendicular skeletal muscle mass and body weight. Multiple logistic regression analysis demonstrated that sarcopenia was associated with CVD independent of other well-documented risk factors, renal function and medications (OR, 1.768; 95% CI, 1.075-2.909, P = 0.025). Conclusions: Sarcopenia was associated with the presence of CVD independent of other cardiovascular risk factors after adjusting renal function and medications.	[Chin, Sang Ouk; Rhee, Sang Youl; Chon, Suk; Oh, Seungjoon; Woo, Jeong-taek; Kim, Sung-Woon; Kim, Jin-Woo; Kim, Young Seol] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea; [Hwang, You-Cheol; Jeong, In-Kyung; Ahn, Kyu Jeung; Chung, Ho Yeon] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, Seoul, South Korea; [Ahn, Hong-Yup] Dongguk Univ, Dept Stat, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Dongguk University	Hwang, YC (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, Seoul, South Korea.	khmcilyong@naver.com	Rhee, Sang Youl/P-1895-2018; Ahn, Hongyup/M-5043-2017; Chung, Hoyeon/AAI-3103-2020; Jeong, In-Kyung/AAI-6488-2020; Hwang, You-Cheol/AAA-4616-2022	Rhee, Sang Youl/0000-0003-0119-5818; Ahn, Hongyup/0000-0001-8149-6981; Jeong, In-Kyung/0000-0001-7857-546X; Hwang, You-Cheol/0000-0003-4033-7874; Woo, Jeong-Taek/0000-0001-9201-0713; Ahn, Kyu Jeung/0000-0002-4648-3605				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Aubertin-Leheudre M, 2006, OBESITY, V14, P2277, DOI 10.1038/oby.2006.267; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Goulet EDB, 2007, APPL PHYSIOL NUTR ME, V32, P426, DOI 10.1139/H07-005; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Pedersen BK, 2010, J PHYSIOL-LONDON, V588, P21, DOI 10.1113/jphysiol.2009.184747; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; WANG J, 1989, AM J PHYSIOL, V256, pE829, DOI 10.1152/ajpendo.1989.256.6.E829; Woodrow G, 2009, CURR OPIN CLIN NUTR, V12, P8, DOI 10.1097/MCO.0b013e32831b9c5b	35	154	159	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e60119	10.1371/journal.pone.0060119	http://dx.doi.org/10.1371/journal.pone.0060119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111VQ	23533671	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400108
J	Drumond, BP; Mondini, A; Schmidt, DJ; Bronzoni, RVD; Bosch, I; Nogueira, ML				Drumond, Betania Paiva; Mondini, Adriano; Schmidt, Diane J.; de Morais Bronzoni, Roberta Vieira; Bosch, Irene; Nogueira, Mauricio Lacerda			Circulation of Different Lineages of Dengue Virus 2, Genotype American/Asian in Brazil: Dynamics and Molecular and Phylogenetic Characterization	PLOS ONE			English	Article							POPULATION-DYNAMICS; CO-CIRCULATION; SHOCK SYNDROME; TYPE-2; EPIDEMIOLOGY; EVOLUTION; INFECTION	The American/Asian genotype of Dengue virus type 2 (DENV-2) was introduced into the Americas in the 80's. Although there is no data showing when this genotype was first introduced into Brazil, it was first detected in Brazil in 1990. After which the virus spread throughout the country and major epidemics occurred in 1998, 2007/08 and 2010. In this study we sequenced 12 DENV-2 genomes obtained from serum samples of patients with dengue fever residing in Sao Jose do Rio Preto, Sao Paulo (SJRP/SP), Brazil, in 2008. The whole open reading frame or envelope sequences were used to perform phylogenetic, phylogeographic and evolutionary analyses. Isolates from SJRP/SP were grouped within one lineage (BR3) close to isolates from Rio de Janeiro, Brazil. Isolates from SJRP were probably introduced there at least in 2007, prior to its detection in the 2008 outbreak. DENV-2 circulation in Brazil is characterized by the introduction, displacement and circulation of three well-defined lineages in different times, most probably from the Caribbean. Thirty-seven unique amino acid substitutions were observed among the lineages, including seven amino acid differences in domains I to III of the envelope protein. Moreover, we dated here, for the first time, the introduction of American/Asian genotype into Brazil (lineage BR1) to 1988/89, followed by the introduction of lineages BR2 (1998-2000) and BR3 (2003-05). Our results show a delay between the introduction and detection of DENV-2 lineages in Brazil, reinforcing the importance and need for surveillance programs to detect and trace the evolution of these viruses. Additionally, Brazilian DENV-2 differed in genetic diversity, date of introduction and geographic origin and distribution in Brazil, and these are important factors for the evolution, dynamics and control of dengue.	[Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil; [Mondini, Adriano] Univ Estadual Paulista, Fac Ciencias Farmaceut, Lab Saude Publ, Sao Paulo, Brazil; [Schmidt, Diane J.] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA; [de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Sinop, Mato Grosso, Brazil; [Bosch, Irene] MIT, Genome Resources Dengue Consortium, Cambridge, MA 02139 USA; [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Lab Pesquisa Virol, Sao Paulo, Brazil	Universidade Federal de Juiz de Fora; Universidade Estadual Paulista; Tufts University; Universidade Federal de Mato Grosso; Massachusetts Institute of Technology (MIT)	Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.	betaniadrumond@ufjf.edu.br; mnogueira@famerp.br	Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/F-7446-2012; Mondini, Adriano/AAB-4358-2020	Nogueira, Mauricio L/0000-0003-1102-2419; Mondini, Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721	Instituto Nacional de Ciencia e Tecnologia (INCT)-Dengue/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP; PRONEX Dengue; CNPq; Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Instituto Nacional de Ciencia e Tecnologia (INCT)-Dengue/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX Dengue; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Instituto Nacional de Ciencia e Tecnologia (INCT)-Dengue/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), FAPESP, PRONEX Dengue and a CNPq Grant to MLN. This work was also supported by a Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG) grant to BPD. MLN is the recipient of a CNPq Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Centro de Vigilancia Epidemiologica, 2008, CAS AUT CONF DENG MU; Centro de Vigilancia Epidemiologica, 2007, CAS AUT CONF DENG MU; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; DATASUS-Ministry of Health, 2004, SIST INF AGR NOT; de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dettogni RS, 2012, MOL BIOL REP, V39, P71, DOI 10.1007/s11033-011-0711-8; dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387; Drummond A., 2002, BEAUTI BAYESIAN EVOL; Drummond A.J., 2002, BEAST BAYESIAN EVOLU; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4; de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Ministry of Health, 2007, INF EP DENG JAN DEZ; Ministry of Health, 2002, B EL EP; Ministry of Health, 2009, INF EP DENG JAN NOV; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Pan American Health Organization, 2008, NUMB REP CAS DENG DE; Pan American Health Organization, 2007, NUMB REP CAS DENG DE; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Rambaut A, 2002, TREEANOTATOR V1 6 1; Rambaut A., 2006, TREE FIGURE DRAWING; Rambaut A., 2003, TRACER MCMC TRACE AN; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salda LTD, 2005, AM J TROP MED HYG, V73, P796, DOI 10.4269/ajtmh.2005.73.796; Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel HJ, 2007, FIELDS VIROLOGY, P810; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	57	46	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59422	10.1371/journal.pone.0059422	http://dx.doi.org/10.1371/journal.pone.0059422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533624	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400061
J	Skak-Nielsen, H; Torp-Pedersen, C; Finer, N; Caterson, ID; Van Gaal, L; James, WPT; Maggioni, AP; Sharma, AM; Coutinho, W; Andersson, C				Skak-Nielsen, Helle; Torp-Pedersen, Christian; Finer, Nick; Caterson, Ian D.; Van Gaal, Luc; James, W. Philip T.; Maggioni, Aldo Pietro; Sharma, Arya M.; Coutinho, Walmir; Andersson, Charlotte			Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals	PLOS ONE			English	Article							ALLOPURINOL; SIBUTRAMINE	Background: The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity. Methods: The relationship between SUA and risk of cardiovascular adverse outcomes (nonfatal myocardial infarction, nonfatal stroke, resuscitated cardiac arrest or cardiovascular death) and all-cause mortality, respectively, was evaluated in a post-hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Participants enrolled in SCOUT were obese or overweight with pre-existing diabetes and/or cardiovascular disease (CVD). Cox models were used to assess the role of SUA as an independent risk factor. Results: 9742 subjects were included in the study; 83.6% had diabetes, and 75.1% had CVD. During an average follow-up time of 4.2 years, 1043 subjects had a primary outcome (myocardial infarction, resuscitated cardiac arrest, stroke, or cardiovascular death), and 816 died. In a univariate Cox model, the highest SUA quartile was associated with an increased risk of cardiovascular adverse outcomes compared with the lowest SUA quartile in women (hazard ratio [HR]: 1.59; 95% confidence interval [CI]: 1.20-2.10). In multivariate analyses, adjusting for known cardiovascular risk factors the increased risk for the highest SUA quartile was no longer statistically significant among women (HR: 0.99; 95% CI: 0.72-1.36) nor was it among men. Analyses of all-cause mortality found an interaction between sex and SUA. In a multivariate Cox model including women only, the highest SUA quartile was associated with an increased risk in all-cause mortality compared to the lowest SUA quartile (HR: 1.51; 95% CI: 1.08-2.12). No relationship was observed in men (HR: 1.06; 95% CI: 0.82-1.36). Conclusion: SUA was not an independent predictor of cardiovascular disease and death in these high-risk overweight/obese people. However, our results suggested that SUA was an independent predictor of all-cause mortality in women.	[Skak-Nielsen, Helle; Torp-Pedersen, Christian; Andersson, Charlotte] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Finer, Nick] UCL Inst Cardiovasc Sci, London, England; [Caterson, Ian D.] Univ Sydney, Boden Inst, Sydney, NSW 2006, Australia; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab Dis, Antwerp, Belgium; [James, W. Philip T.] London Sch Hyg & Trop Med, London WC1, England; [Maggioni, Aldo Pietro] Assoc Nazl Med Cardiol Osped ANMCO Res Ctr, Florence, Italy; [Sharma, Arya M.] Univ Alberta, Edmonton, AB, Canada; [Coutinho, Walmir] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, Brazil	University of Copenhagen; Herlev & Gentofte Hospital; University of London; University College London; University of Sydney; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); University of Alberta; Pontificia Universidade Catolica do Rio de Janeiro	Skak-Nielsen, H (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	helle.skak@gmail.com	Andersson, Charlotte/P-4849-2014; Maggioni, Aldo Pietro/AAL-5334-2020; Torp-Pedersen, Christian/E-5931-2013; Finer, Nicholas/B-9981-2009	Maggioni, Aldo Pietro/0000-0003-2764-6779; Finer, Nicholas/0000-0003-2468-6804	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	The SCOUT study was funded by Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersson C, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-42; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Filippatos TD, 2005, CURR MED RES OPIN, V21, P457, DOI 10.1185/030079905X38132; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Holme I, 2009, J INTERN MED, V266, P558, DOI 10.1111/j.1365-2796.2009.02133.x; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Numata Takeyuki, 2008, Diabetes Res Clin Pract, V80, pe1, DOI 10.1016/j.diabres.2007.10.031; Ong G, 2010, DIABETOLOGIA, V53, P1288, DOI 10.1007/s00125-010-1735-7; Rajendra NS, 2011, J AM COLL CARDIOL, V58, P820, DOI 10.1016/j.jacc.2010.12.052; Reyes AJ, 2005, EUR J HEART FAIL, V7, P461, DOI 10.1016/j.ejheart.2004.03.020; Struthers AD, 2002, HEART, V87, P229, DOI 10.1136/heart.87.3.229; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x	23	47	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59121	10.1371/journal.pone.0059121	http://dx.doi.org/10.1371/journal.pone.0059121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533601	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400038
J	Vanneste, S; De Ridder, D				Vanneste, Sven; De Ridder, Dirk			Brain Areas Controlling Heart Rate Variability in Tinnitus and Tinnitus-Related Distress	PLOS ONE			English	Article							ELECTROMAGNETIC TOMOGRAPHY LORETA; ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; PHYSIOLOGICAL CONDITION; ACTIVITY FLUCTUATIONS; EMOTIONAL RESPONSES; STIMULATION; HUMANS; MODULATION	Background: Tinnitus is defined as an intrinsic sound perception that cannot be attributed to an external sound source. Distress in tinnitus patients is related to increased beta activity in the dorsal part of the anterior cingulate and the amount of distress correlates with network activity consisting of the amygdala-anterior cingulate cortex-insula-parahippocampus. Previous research also revealed that distress is associated to a higher sympathetic (OS) tone in tinnitus patients and tinnitus suppression to increased parasympathetic (PS) tone. Methodology: The aim of the present study is to investigate the relationship between tinnitus distress and the autonomic nervous system and find out which cortical areas are involved in the autonomic nervous system influences in tinnitus distress by the use of source localized resting state electroencephalogram (EEG) recordings and electrocardiogram (ECG). Twenty-one tinnitus patients were included in this study. Conclusions: The results indicate that the dorsal and subgenual anterior cingulate, as well as the left and right insula are important in the central control of heart rate variability in tinnitus patients. Whereas the sympathovagal balance is controlled by the subgenual and pregenual anterior cingulate cortex, the right insula controls sympathetic activity and the left insula the parasympathetic activity. The perceived distress in tinnitus patients seems to be sympathetically mediated.	[Vanneste, Sven; De Ridder, Dirk] Univ Antwerp Hosp, Tinnitus Res Initiat Clin Antwerp, Brai2n, Antwerp, Belgium; [Vanneste, Sven; De Ridder, Dirk] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Vanneste, Sven] Univ Antwerp, Fac Med, Dept Translat Neurosci, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Vanneste, S (corresponding author), Univ Antwerp Hosp, Tinnitus Res Initiat Clin Antwerp, Brai2n, Antwerp, Belgium.	sven.vanneste@ua.ac.be		Vanneste, Sven/0000-0003-1513-5752	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	This work was supported by Research Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahs F, 2009, NEUROIMAGE, V47, P815, DOI 10.1016/j.neuroimage.2009.05.091; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Congedo M., 2002, EUREKA VERSION 3 0 C; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Datzov E, 1999, Int Tinnitus J, V5, P20; De Ridder D, 2012, J NEUROSURG SCI, V56, P323; De Ridder D, 2011, AUTON NEUROSCI; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; ERLANDSSON SI, 2001, NOISE HEALTH, V3, P39; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fifer R C, 1993, J Am Acad Audiol, V4, P364; FRYSZTAK RJ, 1994, BRAIN RES, V643, P181, DOI 10.1016/0006-8993(94)90024-8; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GOEBEL G, 1994, HNO, V42, P166; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hansel A, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-21; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; KAMATH MV, 1993, CRIT REV BIOMED ENG, V21, P245; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; MATSUSHIMA JI, 1996, INT TINNITUS J, V2, P67; Matthews SC, 2004, NEUROIMAGE, V22, P1151, DOI 10.1016/j.neuroimage.2004.03.005; Meeus O, 2007, B-ENT, P11; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nicotra A, 2006, BRAIN, V129, P718, DOI 10.1093/brain/awh699; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER S, 1993, STROKE, V24, pI3; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Scott B, 2000, PSYCHOSOMATICS, V41, P347, DOI 10.1176/appi.psy.41.4.347; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Suzuki H, 2009, PSYCHOSOM MED, V71, P619, DOI 10.1097/PSY.0b013e31819b69ca; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; Vanneste S, 2010, B ENT; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	87	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59728	10.1371/journal.pone.0059728	http://dx.doi.org/10.1371/journal.pone.0059728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533644	gold, Green Published, Green Submitted			2022-12-27	WOS:000316549400081
J	Gould, RK; Pejchar, L; Bothwell, SG; Brosi, B; Wolny, S; Mendenhall, CD; Daily, G				Gould, Rachelle K.; Pejchar, Liba; Bothwell, Sara G.; Brosi, Berry; Wolny, Stacie; Mendenhall, Chase D.; Daily, Gretchen			Forest Restoration and Parasitoid Wasp Communities in Montane Hawai'i	PLOS ONE			English	Article							ECOLOGICAL RESTORATION; ABUNDANCE; EDGE; HYMENOPTERA; MANAGEMENT; MODELS; INVERTEBRATES; PLANTATIONS; POPULATION; ARTHROPODS	Globally, most restoration efforts focus on re-creating the physical structure (flora or physical features) of a target ecosystem with the assumption that other ecosystem components will follow. Here we investigate that assumption by documenting biogeographical patterns in an important invertebrate taxon, the parasitoid wasp family Ichneumonidae, in a recently reforested Hawaiian landscape. Specifically, we test the influence of (1) planting configurations (corridors versus patches), (2) vegetation age, (3) distance from mature native forest, (4) surrounding tree cover, and (5) plant community composition on ichneumonid richness, abundance, and composition. We sampled over 7,000 wasps, 96.5% of which were not native to Hawai'i. We found greater relative richness and abundance of ichneumonids, and substantially different communities, in restored areas compared to mature forest and abandoned pasturelands. Non-native ichneumonids drive these differences; restored areas and native forest did not differ in native ichneumonid abundance. Among restored areas, ichneumonid communities did not differ by planting age or configuration. As tree cover increased within 120 m of a sampling point, ichneumonid community composition increasingly resembled that found in native forest. Similarly, native ichneumonid abundance increased with proximity to native forest. Our results suggest that restoration plantings, if situated near target forest ecosystems and in areas with higher local tree cover, can facilitate restoration of native fauna even in a highly invaded system.	[Gould, Rachelle K.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Gould, Rachelle K.; Mendenhall, Chase D.; Daily, Gretchen] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [Pejchar, Liba] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Bothwell, Sara G.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Brosi, Berry] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Wolny, Stacie] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [Mendenhall, Chase D.; Daily, Gretchen] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Colorado State University; University of California System; University of California Santa Cruz; Emory University; Stanford University; Stanford University	Gould, RK (corresponding author), Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA.	rgould@stanford.edu		Brosi, Berry/0000-0002-9233-1151; Pejchar, Liba/0000-0002-9253-9884	Moore Family Foundation; Stanford Center for Conservation Biology; Winslow Foundation; Peter and Helen Bing	Moore Family Foundation; Stanford Center for Conservation Biology; Winslow Foundation; Peter and Helen Bing	This study was funded by the Moore Family Foundation, the Stanford Center for Conservation Biology, the Winslow Foundation, and Peter and Helen Bing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2010, ENTOMOL EXP APPL, V137, P262, DOI 10.1111/j.1570-7458.2010.01063.x; Allison SK, 2007, RESTOR ECOL, V15, P601, DOI 10.1111/j.1526-100X.2007.00271.x; Anderson A, 2011, J APPL ECOL, V48, P382, DOI 10.1111/j.1365-2664.2010.01937.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bangert R, 2012, RESTORATION ECOLOGY; Beardsley JW, 1998, KEY HAWAIIAN ICHNEUM; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burger JC, 2003, CONSERV BIOL, V17, P460, DOI 10.1046/j.1523-1739.2003.01325.x; Camp R. J., 2009, HCSU011 U HAW HIL; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Choi YD, 2007, RESTOR ECOL, V15, P351, DOI 10.1111/j.1526-100X.2007.00224.x; Crawley MJ, 2007, GEN LINEAR MODELS; Cunningham SA, 2005, AUSTRAL ECOL, V30, P103, DOI 10.1111/j.1442-9993.2005.01429.x; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Didham Raphael K., 1997, P303; DigitalGlobe, 2010, WORLDVIEW 2 SATT IM; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2008, EVOL ECOL RES, V10, P931; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Gonzalez-Moreno A, 2012, ENVIRON ENTOMOL, V41, P587, DOI 10.1603/EN11194; Goulet H., 1993, AGR CAN RES BRANCH E, V7, P668; Grimbacher PS, 2007, BIOL CONSERV, V135, P107, DOI 10.1016/j.biocon.2006.10.002; Haslem A, 2008, ECOL APPL, V18, P185, DOI 10.1890/07-0692.1; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Hess Steven C., 2010, Pacific Conservation Biology, V16, P144; Hilderbrand RH, 2005, ECOL SOC, V10; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Horiuchi B., 2002, NAT P FOR CONS NURS, P233; Ingham DS, 1996, CONSERV BIOL, V10, P1353, DOI 10.1046/j.1523-1739.1996.10051353.x; Jansen A, 1997, RESTOR ECOL, V5, P115, DOI 10.1046/j.1526-100X.1997.09714.x; Kotze DJ, 2001, BIODIVERS CONSERV, V10, P443, DOI 10.1023/A:1016606209906; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Litton CM, 2006, FOREST ECOL MANAG, V231, P105, DOI 10.1016/j.foreco.2006.05.008; Lockwood Julie L., 1999, P363, DOI 10.1017/CBO9780511542237.014; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; Magura T, 2001, BIODIVERS CONSERV, V10, P287, DOI 10.1023/A:1008967230493; Majer JD, 2007, RESTOR ECOL, V15, pS104, DOI 10.1111/j.1526-100X.2007.00298.x; Maleque MA, 2006, J FOREST, V104, P113; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Moffatt C, 2008, RESTOR ECOL, V16, P50, DOI 10.1111/j.1526-100X.2007.00261.x; Moir ML, 2010, RESTOR ECOL, V18, P136, DOI 10.1111/j.1526-100X.2010.00654.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nishida GM, 2002, BISHOP MUSEUM HAWAII; Ostertag R, 2009, ECOSYSTEMS, V12, P503, DOI 10.1007/s10021-009-9239-3; Ovadia O, 2004, OECOLOGIA, V140, P398, DOI 10.1007/s00442-004-1604-5; PARMENTER RR, 1987, ENVIRON ENTOMOL, V16, P168, DOI 10.1093/ee/16.1.168; PEARSON DL, 1986, BIOTROPICA, V18, P244, DOI 10.2307/2388493; Peck RW, 2008, BIOL INVASIONS, V10, P1441, DOI 10.1007/s10530-008-9218-1; Peck RW, COMMUNICATION; Peck RW, 2009, HAW CONS C HON HAW; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ruhl HA, 2010, P NATL ACAD SCI USA, V107, P16566, DOI 10.1073/pnas.1003590107; Schuepp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052109; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Shaw MR, 2001, J INSECT CONSERV, V5, P253, DOI 10.1023/A:1013393229923; Shaw MR, 2006, J INSECT CONSERV, V10, P117, DOI 10.1007/s10841-006-6288-1; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Stewart A.J., 2007, INS CONS BIOL P ROYA; Summerville KS, 2005, RESTOR ECOL, V13, P120, DOI 10.1111/j.1526-100X.2005.00014.x; US Fish and Wildlife Service, 2010, HAK FOR NAT WILDL RE; van Nouhuys S, 2002, J ANIM ECOL, V71, P639, DOI 10.1046/j.1365-2656.2002.00627.x; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wass RC, 1988, HAKALAU FOREST NWR A; Williams Kathy S., 1993, Restoration Ecology, V1, P107, DOI 10.1111/j.1526-100X.1993.tb00016.x; Williams MR, 2010, J INSECT CONSERV, P1; Woodcock BA, 2010, RESTOR ECOL, V18, P638, DOI 10.1111/j.1526-100X.2008.00472.x; Woodcock BA, 2010, J APPL ECOL, V47, P366, DOI 10.1111/j.1365-2664.2010.01776.x; Young TP, 2000, BIOL CONSERV, V92, P73, DOI 10.1016/S0006-3207(99)00057-9; Zedler JB, 2002, RESTORATION ECOLOGY, V7, P69; Zuur Alain F., 2009, P1	79	15	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59356	10.1371/journal.pone.0059356	http://dx.doi.org/10.1371/journal.pone.0059356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527171	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100115
J	Biehl, M; Bunte, K; Schneider, P				Biehl, Michael; Bunte, Kerstin; Schneider, Petra			Analysis of Flow Cytometry Data by Matrix Relevance Learning Vector Quantization	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA	Flow cytometry is a widely used technique for the analysis of cell populations in the study and diagnosis of human diseases. It yields large amounts of high-dimensional data, the analysis of which would clearly benefit from efficient computational approaches aiming at automated diagnosis and decision support. This article presents our analysis of flow cytometry data in the framework of the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid Leukemia (AML) Challenge, 2011. In the challenge, example data was provided for a set of 179 subjects, comprising healthy donors and 23 cases of AML. The participants were asked to provide predictions with respect to the condition of 180 patients in a test set. We extracted feature vectors from the data in terms of single marker statistics, including characteristic moments, median and interquartile range of the observed values. Subsequently, we applied Generalized Matrix Relevance Learning Vector Quantization (GMLVQ), a machine learning technique which extends standard LVQ by an adaptive distance measure. Our method achieved the best possible performance with respect to the diagnoses of test set patients. The extraction of features from the flow cytometry data is outlined in detail, the machine learning approach is discussed and classification results are presented. In addition, we illustrate how GMLVQ can provide deeper insight into the problem by allowing to infer the relevance of specific markers and features for the diagnosis.	[Biehl, Michael] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Bunte, Kerstin] Univ Bielefeld, Fac Technol, CITEC, D-33615 Bielefeld, Germany; [Schneider, Petra] Univ Birmingham, Sch Clin & Expt Med, CEDAM, Birmingham, W Midlands, England	University of Groningen; University of Bielefeld; University of Birmingham	Biehl, M (corresponding author), Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands.	m.biehl@rug.nl	Bunte, Kerstin/A-6733-2012; Biehl, Michael/B-5105-2009	Bunte, Kerstin/0000-0002-2930-6172; Biehl, Michael/0000-0001-5148-4568; Schneider, Philipp/0000-0002-2121-5348	Medical Research Council UK [G0801473]; DFG [HA 2719/6-1]; CITEC Centre of Excellence at the University of Bielefeld; MRC [G0801473] Funding Source: UKRI; Medical Research Council [G0801473] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFG(German Research Foundation (DFG)); CITEC Centre of Excellence at the University of Bielefeld; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PS was supported by the Medical Research Council UK (Strategic Biomarker Grant G0801473). KB gratefully acknowledges funding by DFG (HA 2719/6-1) and the CITEC Centre of Excellence at the University of Bielefeld. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NATURE METHODS; Amar D, 2011, 6 ANN DREAM C REC DR; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; Biehl M., 2012, 2012 INT JOINT C NEU, P1, DOI [10.1109/IJCNN.2012.6252627, DOI 10.1109/IJCNN.2012.6252627]; Biehl M, 2013, RELEVANCE MATRIX ADA; Biehl M, 2007, J MACH LEARN RES, V8, P323; Bunte K, 2012, NEURAL NETWORKS, V26, P159, DOI 10.1016/j.neunet.2011.10.001; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feller N, 2003, LEUKEMIA, V17, P68, DOI 10.1038/sj.leu.2402781; Gorczyca W, 2005, ATLAS DIFFERENTIAL D; Grau J, 2012, J MACH LEARN RES, V13, P1967; Hammer B, 2002, NEURAL NETWORKS, V15, P1059, DOI 10.1016/S0893-6080(02)00079-5; Kohonen T, 1997, SELF ORGANIZING MAPS; Manninen T, 2011, 6 ANN DREAM C REC DR; Mwebaze E, 2011, NEUROCOMPUTING, V74, P1429, DOI 10.1016/j.neucom.2010.10.016; Nguyen D, 2007, FLOW CYTOMETRY HEMAT; Norel R, 2011, 6 ANN DREAM C REC DR; Papari G, 2011, MACHINE LEARNING REP, V6/2012, P16; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Promsuwicha O, 2009, ASIAN PAC J ALLERGY, V27, P209; Raspadori D, 2001, LEUKEMIA, V15, P1161, DOI 10.1038/sj.leu.2402174; Rogers W, 2011, 6 ANN DREAM C REC DR; Sato A, 1996, ADV NEUR IN, V8, P423; Schneider P, 2010, IEEE T NEURAL NETWOR, V21, P831, DOI 10.1109/TNN.2010.2042729; Schneider P, 2009, NEURAL COMPUT, V21, P3532, DOI 10.1162/neco.2009.11-08-908; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Strickert M, 2013, P IEEE S COMP INT IE, P8; Strickert M, 2011, CORRELATIVE MATRIX M; The DREAM Project: Dialogue for Reverse Engineering Assessments and Methods, 2011, DREAM6 FLOWCAP2 MOL; The FLowCAP initiative, 2011, FLOWCAP FLOW CYT CRI; Vilar J, 2011, 6 ANN DREAM C REC DR	32	32	32	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59401	10.1371/journal.pone.0059401	http://dx.doi.org/10.1371/journal.pone.0059401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527184	gold, Green Submitted, Green Published			2022-12-27	WOS:000316411600057
J	Chen, G; Noor, A; Kronenberger, P; Teugels, E; Umelo, IA; De Greve, J				Chen, Gang; Noor, Alfiah; Kronenberger, Peter; Teugels, Erik; Umelo, Ijeoma Adaku; De Greve, Jacques			Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; PHASE-III; HEPATOCYTE GROWTH; OPEN-LABEL; EGFR; MET; MUTATIONS; RNA; CETUXIMAB	Epidermal growth factor receptor (EGFR) and c-MET receptors are expressed on many non-small cell lung cancer (NSCLC) cells. Current single agent therapeutic targeting of a mutant EGFR has a high efficacy in the clinic, but is not curative. Here, we investigated the combination of targeting EGFR and c-MET pathways in NSCLC cells resistant to receptor tyrosine kinase inhibitors (TKIs), using RNA interference and inhibition by TKIs. Different NSCLC cell lines with various genomic characteristics (H358, H1650 and H1975) were transfected with EGFR-specific-siRNA, T790M-specific-siRNA, c-MET siRNA or the combination. Subsequently EGFR TKIs (gefitinib, erlotinib or afatinib) or monoclonal antibody cetuximab were combined respectively with the c-MET-specific TKI su11274 in NSCLC cell lines. The cell proliferation, viability, caspase-3/7 activity and apoptotic morphology were monitored by spectrophotometry, fluorimetry and fluorescence microscopy. The combined effect of EGFR TKIs, or cetuximab and su11274, was evaluated using a combination index. The results showed that the cell lines that were relatively resistant to EGFR TKIs, especially the H1975 cell line containing the resistance T790M mutation, were found to be more sensitive to EGFR-specific-siRNA. The combination of EGFR siRNA plus c-MET siRNA enhanced cell growth inhibition, apoptosis induction and inhibition of downstream signaling in EGFR TKI resistant H358, H1650 and H1975 cells, despite the absence of activity of the c-MET siRNA alone. EGFR TKIs or cetuximab plus su11274 were also consistently superior to either agent alone. The strongest biological effect was observed when afatinib, an irreversible pan-HER blocker was combined with su11274, which achieved a synergistic effect in the T790M mutant H1975 cells. In a conclusion, our findings offer preclinical proof of principle for combined inhibition as a promising treatment strategy for NSCLC, especially for patients in whom current EGFR-targeted treatments fail due to the presence of the T790M-EGFR-mutation or high c-MET expression.	[Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi, Peoples R China; [Chen, Gang; Noor, Alfiah; Kronenberger, Peter; Teugels, Erik; Umelo, Ijeoma Adaku; De Greve, Jacques] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Oncol, Lab Med & Mol Oncol,Dept Med Oncol, Brussels, Belgium; [Kronenberger, Peter] Erasmushgsk Brussel, Dept Gezondheidszorg, Biotechnol Lab, Brussels, Belgium	Guangxi Medical University; University Hospital Brussels; Vrije Universiteit Brussel	De Greve, J (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Oncol, Lab Med & Mol Oncol,Dept Med Oncol, Brussels, Belgium.	Jacques.Degreve@uzbrussel.be	De Greve, Jacques/J-4939-2012	De Greve, Jacques/0000-0002-2389-0742; Teugels, Erik/0000-0002-7828-4555; Umelo, Ijeoma/0000-0001-9841-2705	National Cancer Plan Belgium [NKP-29-011]; Stichting Tegen Kanker, Belgium; research fund of Boehringer Ingelheim GmbH; Chinese Scholarship Council (CSC); Vrije Universiteit Brussel (VUB) PhD scholarship	National Cancer Plan Belgium; Stichting Tegen Kanker, Belgium; research fund of Boehringer Ingelheim GmbH; Chinese Scholarship Council (CSC)(China Scholarship Council); Vrije Universiteit Brussel (VUB) PhD scholarship	The project was funded by the National Cancer Plan Belgium (Grant NKP-29-011), the Stichting Tegen Kanker, Belgium. This study was partly supported by the research fund of Boehringer Ingelheim GmbH. Gang Chen was supported by the Chinese Scholarship Council (CSC). Gang Chen and Ijeoma Adaku Umelo were supported by the Vrije Universiteit Brussel (VUB) PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 1996, CANCER GENE THER, V3, P296; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burnett JC, 2011, BIOTECHNOL J; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Chen G, 2012, BIOCH BIOPHYS RES CO; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Chen G, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-1; Chen G, 2010, ANAL BIOCHEM, V398, P266, DOI 10.1016/j.ab.2009.11.034; Chenau J, 2009, J PROTEOME RES, V8, P4579, DOI 10.1021/pr900383g; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cipriani NA, 2009, LUNG CANCER, V63, P169, DOI 10.1016/j.lungcan.2008.06.011; Deheuninck J, 2008, BIOCHEM BIOPH RES CO, V367, P573, DOI 10.1016/j.bbrc.2007.12.177; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Felip E, 2008, CLIN CANCER RES, V14, P3867, DOI 10.1158/1078-0432.CCR-07-5186; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Giovannetti E, 2008, MOL PHARMACOL, V73, P1290, DOI 10.1124/mol.107.042382; Griffin S, 2009, HEALTH TECHNOL ASSES, V13, P49, DOI 10.3310/hta13suppl1/08; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Hanna N, 2006, J CLIN ONCOL, V24, P5253, DOI 10.1200/JCO.2006.08.2263; Hickerson RP, 2011, J INVEST DERMATOL, V131, P1029, DOI 10.1038/jid.2010.372; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Janmaat ML, 2006, INT J CANCER, V118, P209, DOI 10.1002/ijc.21290; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Lin WH, 2008, ANAL BIOCHEM, V377, P89, DOI 10.1016/j.ab.2008.02.027; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Milton DI, 2006, CANCER-AM CANCER SOC, V107, P1034, DOI 10.1002/cncr.22088; Minkovsky N, 2008, CURR OPIN INVEST DR, V9, P1336; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Puri Neelu, 2008, J Carcinog, V7, P9; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rosell R, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7503; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Schuetze C, 2007, STRAHLENTHER ONKOL, V183, P256, DOI 10.1007/s00066-007-1696-z; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Siegfried JM, 1998, ANN THORAC SURG, V66, P1915, DOI 10.1016/S0003-4975(98)01165-5; Simoens C, 2006, CANCER CHEMOTH PHARM, V58, P210, DOI 10.1007/s00280-005-0147-8; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Spicer JF, 2010, TARGET ONCOL; Tabara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041017; Takezawa K, 2012, CANC DISCOV; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033160; Yamanaka S, 2008, PATHOBIOLOGY, V75, P2, DOI 10.1159/000113789; Yang JC, 2012, J CLIN ONCOL S, V30; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898; Zhou SW, 2009, RESPIROLOGY, V14, P709, DOI 10.1111/j.1440-1843.2009.01564.x; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	61	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59708	10.1371/journal.pone.0059708	http://dx.doi.org/10.1371/journal.pone.0059708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527257	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600074
J	Sanchez-Tena, S; Reyes-Zurita, FJ; Diaz-Moralli, S; Vinardell, MP; Reed, M; Garcia-Garcia, F; Dopazo, J; Lupianez, JA; Gunther, U; Cascante, M				Sanchez-Tena, Susana; Reyes-Zurita, Fernando J.; Diaz-Moralli, Santiago; Pilar Vinardell, Maria; Reed, Michelle; Garcia-Garcia, Francisco; Dopazo, Joaquin; Lupianez, Jose A.; Guenther, Ulrich; Cascante, Marta			Maslinic Acid-Enriched Diet Decreases Intestinal Tumorigenesis in Apc(Min/+) Mice through Transcriptomic and Metabolomic Reprogramming	PLOS ONE			English	Article							NF-KAPPA-B; COLON-CANCER CELLS; NATURAL TRITERPENE; COLORECTAL-CANCER; BETA-CATENIN; COX-2 EXPRESSION; APOPTOSIS; PATHWAY; GROWTH; DEGRADATION	Chemoprevention is a pragmatic approach to reduce the risk of colorectal cancer, one of the leading causes of cancer-related death in western countries. In this regard, maslinic acid (MA), a pentacyclic triterpene extracted from wax-like coatings of olives, is known to inhibit proliferation and induce apoptosis in colon cancer cell lines without affecting normal intestinal cells. The present study evaluated the chemopreventive efficacy and associated mechanisms of maslinic acid treatment on spontaneous intestinal tumorigenesis in Apc(Min/+) mice. Twenty-two mice were randomized into 2 groups: control group and MA group, fed with a maslinic acid-supplemented diet for six weeks. MA treatment reduced total intestinal polyp formation by 45% (P<0.01). Putative molecular mechanisms associated with suppressing intestinal polyposis in Apc(Min/+) mice were investigated by comparing microarray expression profiles of MA-treated and control mice and by analyzing the serum metabolic profile using NMR techniques. The different expression phenotype induced by MA suggested that it exerts its chemopreventive action mainly by inhibiting cell-survival signaling and inflammation. These changes eventually induce G1-phase cell cycle arrest and apoptosis. Moreover, the metabolic changes induced by MA treatment were associated with a protective profile against intestinal tumorigenesis. These results show the efficacy and underlying mechanisms of MA against intestinal tumor development in the Apc(Min/+) mice model, suggesting its chemopreventive potential against colorectal cancer.	[Sanchez-Tena, Susana; Diaz-Moralli, Santiago; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Sanchez-Tena, Susana; Diaz-Moralli, Santiago; Cascante, Marta] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Sanchez-Tena, Susana; Diaz-Moralli, Santiago; Cascante, Marta] CSIC Associated Unit, Barcelona, Spain; [Reyes-Zurita, Fernando J.; Lupianez, Jose A.] Univ Granada, Dept Biochem & Mol Biol, E-18071 Granada, Spain; [Pilar Vinardell, Maria] Univ Barcelona, Fac Pharm, Dept Physiol, Barcelona, Spain; [Reed, Michelle; Guenther, Ulrich] Univ Birmingham, CR UK Inst Canc Studies, Birmingham, W Midlands, England; [Garcia-Garcia, Francisco; Dopazo, Joaquin] Ctr Invest Pricipe Felipe, Natl Inst Bioinformat, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] Ctr Invest Pricipe Felipe, Dept Bioinformat, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] Ctr Invest Biomed Red Enfermedades Raras, Valencia, Spain	University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Barcelona; University of Birmingham; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain.	martacascante@ub.edu	García-García, Francisco/B-1929-2014; Reyes Zurita, Fernando Jesús/M-1244-2014; CASCANTE, MARTA/AAG-4355-2022; García-García, Francisco/N-2263-2019; CASCANTE, MARTA/AFK-5991-2022; Vinardell, Maria/I-2406-2014; Lupiáñez, José A./M-6664-2015; Dopazo, Joaquin/A-9270-2014	García-García, Francisco/0000-0001-8354-5636; Reyes Zurita, Fernando Jesús/0000-0003-3438-0753; CASCANTE, MARTA/0000-0002-2062-4633; García-García, Francisco/0000-0001-8354-5636; CASCANTE, MARTA/0000-0002-2062-4633; Vinardell, Maria/0000-0003-4533-5114; Lupiáñez, José A./0000-0001-9095-7145; Dopazo, Joaquin/0000-0003-3318-120X; Diaz-Moralli, Santiago/0000-0002-2729-0613	Spanish government [SAF2011-25726]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation; European Regional Development Fund "Una manera de hacer Europa'' (ISCIII-RTICC) [RD06/0020/004, RD06/0020/1019, BIO2011-27069]; AGAUR-Generalitat de Catalunya [2009SGR1308, 2009 CTP 00026]; Icrea Academia Award; European Commission [22263]; Bio-NMR EU project [261863]; Biomaslinic S.L. (Granada, Spain)	Spanish government(Spanish GovernmentEuropean Commission); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation; European Regional Development Fund "Una manera de hacer Europa'' (ISCIII-RTICC); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Icrea Academia Award(ICREA); European Commission(European CommissionEuropean Commission Joint Research Centre); Bio-NMR EU project; Biomaslinic S.L. (Granada, Spain)	Financial support was provided by grant SAF2011-25726 and personal financial support (FPU program) from the Spanish government and also from the Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation & European Regional Development Fund "Una manera de hacer Europa'' (ISCIII-RTICC grants RD06/0020/004 and RD06/0020/1019 and BIO2011-27069, MICINN). The authors have also received financial support from the AGAUR-Generalitat de Catalunya (grant 2009SGR1308, 2009 CTP 00026 and Icrea Academia Award 2010 granted to M. C.) and the European Commission (FP7) ETHERPATHS KBBE-grant agreement no. 22263. The authors thank the Bio-NMR EU project (Contract # 261863) for providing NMR access to the HWB-NMR facility. Finally, the authors are grateful for the financial support from Biomaslinic S.L. (Granada, Spain). Biomaslinic also supplied the Maslinic Acid required for the investigation purpose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Ban JO, 2010, CHEM-BIOL INTERACT, V188, P75, DOI 10.1016/j.cbi.2010.06.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brudvik KW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-149; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Erbach M, 2012, J DIABETES COMPLICAT, V26, P50, DOI 10.1016/j.jdiacomp.2011.11.003; Fernandez-Navarro M, 2008, COMP BIOCHEM PHYS C, V147, P158, DOI 10.1016/j.cbpc.2007.09.010; Franklin RA, 2000, LEUKEMIA, V14, P2019, DOI 10.1038/sj.leu.2401967; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Garcia-Granados A, 2003, J ORG CHEM, V68, P4833, DOI 10.1021/jo026832s; Guan T, 2011, J NEUROSCI RES, V89, P1829, DOI 10.1002/jnr.22671; Gunther RW, 2005, ROFO-FORTSCHR RONTG, V177, P632, DOI 10.1055/s-2005-858109; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hsum YW, 2011, PLANTA MED, V77, P152, DOI 10.1055/s-0030-1250203; Huang LF, 2011, EUR J PHARMACOL, V672, P169, DOI 10.1016/j.ejphar.2011.09.175; Iwuchukwu OF, 2008, DRUG METAB DISPOS, V36, P322, DOI 10.1124/dmd.107.018788; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Li CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-73; Lin CC, 2011, J AGR FOOD CHEM, V59, P755, DOI 10.1021/jf103904b; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Liu J, 2007, BIOL PHARM BULL, V30, P2075, DOI 10.1248/bpb.30.2075; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; McClellan JL, 2012, CYTOKINE, V57, P113, DOI 10.1016/j.cyto.2011.09.027; Min HJ, 2009, INT J ONCOL, V35, P617, DOI 10.3892/ijo_00000373; Mutoh M, 2011, GASTROENTEROLOGY, V140, P2000, DOI 10.1053/j.gastro.2011.02.019; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Parra A, 2011, EUR J MED CHEM, V46, P5991, DOI 10.1016/j.ejmech.2011.10.011; Parra A, 2009, BIOORGAN MED CHEM, V17, P1139, DOI 10.1016/j.bmc.2008.12.041; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Reyes-Zurita FJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-154; Roberti A, 2011, CELL CYCLE, V10, P127, DOI 10.4161/cc.10.1.14446; Rosano L, 2006, MOL CANCER THER, V5, P833, DOI 10.1158/1535-7163.MCT-05-0523; Shaik AH, 2012, J MED FOOD, V15, P741, DOI 10.1089/jmf.2012.2191; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tessitore L, 2000, CARCINOGENESIS, V21, P1619, DOI 10.1093/carcin/21.8.1619; Wu KK, 2009, METHODS MOL BIOL, V512, P295, DOI 10.1007/978-1-60327-530-9_16; Xu HX, 1996, J NAT PROD, V59, P643, DOI 10.1021/np960165e; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zhang M, 2003, MOL MED, V9, P18, DOI 10.1007/BF03402103; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698	53	44	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59392	10.1371/journal.pone.0059392	http://dx.doi.org/10.1371/journal.pone.0059392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527181	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600056
J	Elphick, MR; Achhala, S; Martynyuk, N				Elphick, Maurice R.; Achhala, Sufyan; Martynyuk, Natalia			The Evolution and Diversity of SALMFamide Neuropeptides	PLOS ONE			English	Article							STARFISH ASTERIAS-RUBENS; CUCUMBER HOLOTHURIA-GLABERRIMA; POLYCLONAL ANTIBODIES; TISSUE DISTRIBUTION; ECHINODERM; DROSOPHILA; MUSCLE; RELAXATION; S1; S2	The SALMFamides are a family of neuropeptides that act as muscle relaxants in echinoderms. Two types of SALMFamides have been identified: L-type (e. g. the starfish neuropeptides S1 and S2) with the C-terminal motif LxFamide (x is variable) and F-type with the C-terminal motif FxFamide. In the sea urchin Strongylocentrotus purpuratus (class Echinoidea) there are two SALMFamide genes, one encoding L-type SALMFamides and a second encoding F-type SALMFamides, but hitherto it was not known if this applies to other echinoderms. Here we report the identification of SALMFamide genes in the sea cucumber Apostichopus japonicus (class Holothuroidea) and the starfish Patiria miniata (class Asteroidea). In both species there are two SALMFamide genes: one gene encoding L-type SALMFamides (e. g. S1 in P. miniata) and a second gene encoding F-type SALMFamides plus one or more L-type SALMFamides (e. g. S2-like peptide in P. miniata). Thus, the ancestry of the two SALMFamide gene types traces back to the common ancestor of echinoids, holothurians and asteroids, although it is not clear if the occurrence of L-type peptides in F-type SALMFamide precursors is an ancestral or derived character. The gene sequences also reveal a remarkable diversity of SALMFamide neuropeptides. Originally just two peptides (S1 and S2) were isolated from starfish but now we find that in P. miniata, for example, there are sixteen putative SALMFamide neuropeptides. Thus, the SALMFamides would be a good model system for experimental analysis of the physiological significance of neuropeptide "cocktails" derived from the same precursor protein.	[Elphick, Maurice R.; Achhala, Sufyan; Martynyuk, Natalia] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Elphick, MR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	m.r.elphick@qmul.ac.uk		Elphick, Maurice/0000-0002-9169-0048				BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Deber CM, 2001, PROLINE RESIDUES PRO; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Elphick MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044492; Elphick MR, 2005, J EXP BIOL, V208, P4273, DOI 10.1242/jeb.01910; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, P ROY SOC B-BIOL SCI, V243, P121, DOI 10.1098/rspb.1991.0020; ELPHICK MR, 1991, PEPTIDES, V12, P455, DOI 10.1016/0196-9781(91)90083-2; Grimmelikhuijzen CJP, 2012, REGUL PEPTIDES, V177, pS6, DOI 10.1016/j.regpep.2012.05.001; Hewes RS, 1998, J NEUROSCI, V18, P7138; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; Melarange R, 1999, P ROY SOC B-BIOL SCI, V266, P1785, DOI 10.1098/rspb.1999.0847; Mita M, 2004, ZOOL SCI, V21, P299, DOI 10.2108/zsj.21.299; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P187, DOI 10.1098/rspb.1995.0135; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; Ohtani M, 1999, PEPTIDE SCIENCE - PRESENT AND FUTURE, P419; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Priyam A., SEQUENCESERVER UNPUB; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; Rowe ML, 2010, MAR GENOM, V3, P91, DOI 10.1016/j.margen.2010.08.003; Strand FL, 1999, NEUROPEPTIDES REGULA; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; WEISS KR, 1993, J PHYSIOLOGY-PARIS, V87, P141, DOI 10.1016/0928-4257(93)90025-O; Yun SS, 2007, COMP BIOCHEM PHYS A, V147, P536, DOI 10.1016/j.cbpa.2007.02.002	30	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59076	10.1371/journal.pone.0059076	http://dx.doi.org/10.1371/journal.pone.0059076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536859	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100119
J	Hall, JA; Bobe, G; Hunter, JK; Vorachek, WR; Stewart, WC; Vanegas, JA; Estill, CT; Mosher, WD; Pirelli, GJ				Hall, Jean A.; Bobe, Gerd; Hunter, Janice K.; Vorachek, William R.; Stewart, Whitney C.; Vanegas, Jorge A.; Estill, Charles T.; Mosher, Wayne D.; Pirelli, Gene J.			Effect of Feeding Selenium-Fertilized Alfalfa Hay on Performance of Weaned Beef Calves	PLOS ONE			English	Article							VITAMIN-E; CATTLE; SHEEP; MANAGEMENT; RESPONSES; ANIMALS; FEEDLOT; PLASMA; CROPS; BLOOD	Selenium (Se) is an essential micronutrient in cattle, and Se-deficiency can affect morbidity and mortality. Calves may have greater Se requirements during periods of stress, such as during the transitional period between weaning and movement to a feedlot. Previously, we showed that feeding Se-fertilized forage increases whole-blood (WB) Se concentrations in mature beef cows. Our current objective was to test whether feeding Se-fertilized forage increases WB-Se concentrations and performance in weaned beef calves. Recently weaned beef calves (n = 60) were blocked by body weight, randomly assigned to 4 groups, and fed an alfalfa hay based diet for 7 wk, which was harvested from fields fertilized with sodium-selenate at a rate of 0, 22.5, 45.0, or 89.9 g Se/ha. Blood samples were collected weekly and analyzed for WB-Se concentrations. Body weight and health status of calves were monitored during the 7-wk feeding trial. Increasing application rates of Se fertilizer resulted in increased alfalfa hay Se content for that cutting of alfalfa (0.07, 0.95, 1.55, 3.26 mg Se/kg dry matter for Se application rates of 0, 22.5, 45.0, or 89.9 g Se/ha, respectively). Feeding Se-fertilized alfalfa hay during the 7-wk preconditioning period increased WB-Se concentrations (P-Linear < 0.001) and body weights (P-Linear = 0.002) depending upon the Se-application rate. Based upon our results we suggest that soil-Se fertilization is a potential management tool to improve Se-status and performance in weaned calves in areas with low soil-Se concentrations.	[Hall, Jean A.; Vorachek, William R.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Bobe, Gerd; Hunter, Janice K.; Stewart, Whitney C.; Estill, Charles T.; Mosher, Wayne D.; Pirelli, Gene J.] Oregon State Univ, Coll Agr Sci, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Vanegas, Jorge A.; Estill, Charles T.] Oregon State Univ, Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu		Stewart, Whit/0000-0003-1928-0359	Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon, United States of America [97331-4802]	Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon, United States of America	Funded in part by Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon 97331-4802, United States of America (JAH, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AOAC, 2000, OFFICIAL METHODS ANA; Broadley MR, 2006, P NUTR SOC, V65, P169, DOI 10.1079/PNS2006490; COLE NA, 1985, VET CLIN N AM-FOOD A, V1, P401, DOI 10.1016/S0749-0720(15)31333-5; Davis TZ, 2012, J VET DIAGN INVEST, V24, P319, DOI 10.1177/1040638711435407; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; FDA, 2009, FOOD DRUGS FOOD ADD; Finch JM, 1996, RES VET SCI, V60, P97, DOI 10.1016/S0034-5288(96)90001-6; Gupta UC, 2002, COMMUN SOIL SCI PLAN, V33, P2537, DOI 10.1081/CSS-120014464; Hall JA, 2012, J ANIM SCI, V90, P568, DOI 10.2527/jas.2011-4075; Hall JA, 2011, ANIM FEED SCI TECH, V164, P184, DOI 10.1016/j.anifeedsci.2011.01.009; Hall JA, 2009, SMALL RUMINANT RES, V82, P40, DOI 10.1016/j.smallrumres.2009.01.010; KOLLER LD, 1983, CORNELL VET, V73, P323; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217, DOI 10.3168/jds.S0022-0302(82)82180-2; MAKELA AL, 1993, BIOL TRACE ELEM RES, V36, P151, DOI 10.1007/BF02783174; MWPS-6, 1987, BEEF HOUS EQ HDB; National Research Council (NRC), 1983, SEL NUTR; NRC, 1970, NUTR REQ BEEF CATTL, DOI DOI 10.17226/9791; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; PRITCHARD RH, 1990, J ANIM SCI, V68, P28; Qin SY, 2007, BIOL TRACE ELEM RES, V116, P91, DOI 10.1007/BF02685922; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rooke JA, 2004, J AGR SCI-CAMBRIDGE, V142, P253, DOI 10.1017/S0021859604004368; SAS Institute Inc, 2009, SAS US GUID STAT VER; STEVENS JB, 1985, AM J VET RES, V46, P1556; Stewart WC, 2012, J ANIM SCI, V90, P4536, DOI 10.2527/jas.2011-5019; Surai PF, 2008, CURRENT ADVANCES IN SELENIUM RESEARCH AND APPLICATIONS, VOL 1, P13; Surai PF, 2006, SELENIUM NUTR HLTH, P487; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang WC, 1998, EUR J CLIN NUTR, V52, P529, DOI 10.1038/sj.ejcn.1600602; Whanger PD, 2002, J AM COLL NUTR, V21, P223, DOI 10.1080/07315724.2002.10719214; WHELAN BR, 1994, AUST J AGR RES, V45, P863, DOI 10.1071/AR9940863; WHELAN BR, 1989, AUST J EXP AGR, V29, P517, DOI 10.1071/EA9890517; WHELAN BR, 1994, AUST J AGR RES, V45, P877, DOI 10.1071/AR9940877	34	39	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58188	10.1371/journal.pone.0058188	http://dx.doi.org/10.1371/journal.pone.0058188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536788	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100032
J	Jacquemyn, H; Lenaerts, M; Brys, R; Willems, K; Honnay, O; Lievens, B				Jacquemyn, Hans; Lenaerts, Marijke; Brys, Rein; Willems, Kris; Honnay, Olivier; Lievens, Bart			Among-Population Variation in Microbial Community Structure in the Floral Nectar of the Bee-Pollinated Forest Herb Pulmonaria officinalis L	PLOS ONE			English	Article							FEMALE REPRODUCTIVE SUCCESS; SPATIAL-DISTRIBUTION; POLLEN DEPOSITION; YEAST MYCOFLORA; BIODIVERSITY; PLANTS; DIVERSITY; BACTERIUM; FLOWERS; DESIGN	Background: Microbial communities in floral nectar have been shown to be characterized by low levels of species diversity, yet little is known about among-plant population variation in microbial community composition. Methodology/Principal Findings: We investigated the microbial community structure (yeasts and bacteria) in floral nectar of ten fragmented populations of the bee-pollinated forest herb Pulmonaria officinalis. We also explored possible relationships between plant population size and microbial diversity in nectar, and related microbial community composition to the distance separating plant populations. Culturable bacteria and yeasts occurring in the floral nectar of a total of 100 plant individuals were isolated and identified by partially sequencing the 16S rRNA gene and D1/D2 domains of the 26S rRNA gene, respectively. A total of 9 and 11 yeast and 28 and 39 bacterial OTUs was found, taking into account a 3% (OTU0.03) and 1% sequence dissimilarity cut-off (OTU0.01). OTU richness at the plant population level (i.e. the number of OTUs per population) was low for yeasts (mean: 1.7, range: 0-4 OTUs(0.01/0.03) per population), whereas on average 6.9 (range: 2-13) OTUs(0.03) and 7.9 (range 2-16) OTUs(0.01) per population were found for bacteria. Both for yeasts and bacteria, OTU richness was not significantly related to plant population size. Similarity in community composition among populations was low (average Jaccard index: 0.14), and did not decline with increasing distance between populations. Conclusions/Significance: We found low similarity in microbial community structure among populations, suggesting that the assembly of nectar microbiota is to a large extent context-dependent. Although the precise factors that affect variation in microbial community structure in floral nectar require further study, our results indicate that both local and regional processes may contribute to among-population variation in microbial community structure in nectar.	[Jacquemyn, Hans; Brys, Rein; Honnay, Olivier] Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium; [Lenaerts, Marijke; Willems, Kris; Lievens, Bart] KU Leuven Assoc, Thomas Moore Univ Coll, Dept Microbial & Mol Syst M2S, Lab Proc Microbial Ecol & Bioinspirat Management, St Katelijne Waver, Belgium; [Lenaerts, Marijke; Willems, Kris; Lievens, Bart] Scientia Terrae Res Inst, St Katelijne Waver, Belgium	KU Leuven; KU Leuven	Jacquemyn, H (corresponding author), Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium.	hans.jacquemyn@bio.kuleuven.be	Jacquemyn, Hans/AAC-4875-2019; Willems, Kris A./Y-7750-2019; Lievens, Bart/B-3339-2019; Honnay, Olivier/AAH-8625-2019	Jacquemyn, Hans/0000-0001-9600-5794; Willems, Kris A./0000-0003-4984-221X; Honnay, Olivier/0000-0002-4287-8511	Flemish Fund for Scientific Research (FWO) [G.0500.10, G.0652.13N]; European Research Council (ERC) [260601 - MYCASOR]	Flemish Fund for Scientific Research (FWO)(FWO); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the Flemish Fund for Scientific Research (FWO) (project G.0500.10 and G.0652.13N) and the European Research Council (ERC Starting Grant 260601 - MYCASOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Perez S, 2012, INT J SYST EVOL MICR, DOI [10.1099/ijs.0.043489-0, DOI 10.1099/IJS.0.043489-0.A]; Alvarez-Perez S, 2013, FEMS MICROB IN PRESS; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2015, PC ORD MULTIVARIATE; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Brys R, 2008, J EVOLUTION BIOL, V21, P1281, DOI 10.1111/j.1420-9101.2008.01569.x; Brys R, 2010, PLANT BIOLOGY, V12, P597, DOI 10.1111/j.1438-8677.2009.00259.x; Brys R, 2008, PLANT SYST EVOL, V273, P1, DOI 10.1007/s00606-008-0003-5; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Canto A, 2012, ANN BOT-LONDON, V110, P1173, DOI 10.1093/aob/mcs183; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2009, ESTIMATES STAT ESTIM; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; Ehlers BK, 1997, FLORA, V192, P223, DOI 10.1016/S0367-2530(17)30787-9; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; GILLIAM M, 1983, APIDOLOGIE, V14, P299, DOI 10.1051/apido:19830403; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GUILLIERMOND A, 1920, YEASTS; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2013, ECOLOGY, V94, P273, DOI 10.1890/12-0595.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Hood G.M., 2010, POPTOOLS VERSION 3 2; JIMBO TADAO, 1926, SCI REPT TOHOKU IMP UNIV, V2, P161; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lievens B, 2003, FEMS MICROBIOL LETT, V223, P113, DOI 10.1016/S0378-1097(03)00352-5; Liu HC, 2000, INT J SYST EVOL MICR, V50, P715, DOI 10.1099/00207713-50-2-715; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Meeus S, 2012, ANN BOT-LONDON, V109, P227, DOI 10.1093/aob/mcr272; Mushtaq M, 2007, PAK J BOT, V39, P1367; Mushtaq M, 2006, PAK J BOT, V38, P1279; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; OBERRATH R, 1995, FLORA, V190, P155, DOI 10.1016/S0367-2530(17)30645-X; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Pozo MI, 2012, FEMS MICROBIOL ECOL, V80, P281, DOI 10.1111/j.1574-6941.2011.01286.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss P. D., 2009, APPL ENVIRON MICROB, V75, P37; Simberloff D., 1978, BIOLOGICAL DATA WATE, P150; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Wuczkowski M, 2011, INT J SYST EVOL MICR, V61, P680, DOI 10.1099/ijs.0.019737-0	49	35	37	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e56917	10.1371/journal.pone.0056917	http://dx.doi.org/10.1371/journal.pone.0056917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536759	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100005
J	Long, MH; Berg, P; de Beer, D; Zieman, JC				Long, Matthew H.; Berg, Peter; de Beer, Dirk; Zieman, Joseph C.			In Situ Coral Reef Oxygen Metabolism: An Eddy Correlation Study	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COMMUNITY METABOLISM; WATER-FLOW; PHOTOSYNTHESIS; RESPIRATION; LIGHT; EXCHANGE; CO2; PHOTOINHIBITION; PHYTOPLANKTON	Quantitative studies of coral reefs are challenged by the three-dimensional hard structure of reefs and the high spatial variability and temporal dynamics of their metabolism. We used the non-invasive eddy correlation technique to examine respiration and photosynthesis rates, through O-2 fluxes, from reef crests and reef slopes in the Florida Keys, USA. We assessed how the photosynthesis and respiration of different reef habitats is controlled by light and hydrodynamics. Numerous fluxes (over a 0.25 h period) were as high as 4500 mmol O-2 m(-2) d(-1), which can only be explained by efficient light utilization by the phototrophic community and the complex canopy structure of the reef, having a many-fold larger surface area than its horizontal projection. Over diel cycles, the reef crest was net autotrophic, whereas on the reef slope oxygen production and respiration were balanced. The autotrophic nature of the shallow reef crests implies that the export of organics is an important source of primary production for the larger area. Net oxygen production on the reef crest was proportional to the light intensity, up to 1750 mu mol photons m(-2) s(-1) an d decreased thereafter as respiration was stimulated by high current velocities coincident with peak light levels. Nighttime respiration rates were also stimulated by the current velocity, through enhanced ventilation of the porous framework of the reef. Respiration rates were the highest directly after sunset, and then decreased during the night suggesting that highly labile photosynthates produced during the day fueled early-night respiration. The reef framework was also important to the acquisition of nutrients as the ambient nitrogen stock in the water had sufficient capacity to support these high production rates across the entire reef width. These direct measurements of complex reefs systems yielded high metabolic rates and dynamics that can only be determined through in situ, high temporal resolution measurements.	[Long, Matthew H.; Berg, Peter; Zieman, Joseph C.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [de Beer, Dirk] Max Plank Inst Marine Microbiol, Bremen, Germany	University of Virginia; Max Planck Society	Long, MH (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mhl4a@virgnia.edu	de Beer, Dirk/L-4840-2013	de Beer, Dirk/0000-0001-5274-1781; Long, Matthew/0000-0003-1359-0233	National Science Foundation [OCE-0536431]; Jones Environmental and Barley Scholars Program at the University of Virginia	National Science Foundation(National Science Foundation (NSF)); Jones Environmental and Barley Scholars Program at the University of Virginia	This study received financial support from the National Science Foundation (Chemical Oceanography grant OCE-0536431) and the Jones Environmental and Barley Scholars Program at the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalderink RH, 1997, J PLANKTON RES, V19, P1713, DOI 10.1093/plankt/19.11.1713; Al-Najjar MAA, 2012, ENVIRON MICROBIOL, V14, P982, DOI 10.1111/j.1462-2920.2011.02676.x; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; Berg P, 2003, MAR ECOL PROG SER, V261, P75, DOI 10.3354/meps261075; Berg P, 2007, LIMNOL OCEANOGR, V52, P1672, DOI 10.4319/lo.2007.52.4.1672; Berg P, 2009, LIMNOL OCEANOGR-METH, V7, P576, DOI 10.4319/lom.2009.7.576; Berg P, 2008, OCEANOGRAPHY, V21, P164, DOI 10.5670/oceanog.2008.13; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722, DOI 10.4319/lo.2006.51.6.2722; Bryant LD, 2010, LIMNOL OCEANOGR, V55, P950, DOI 10.4319/lo.2009.55.2.0950; Burke L., 2011, REEFS RISK REVISITED; CHALKER BE, 1983, J EXP MAR BIOL ECOL, V73, P37, DOI 10.1016/0022-0981(83)90004-7; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Cook PLM, 2006, LIMNOL OCEANOGR, V51, P1594, DOI 10.4319/lo.2006.51.4.1594; DAHL AL, 1973, MAR BIOL, V23, P239, DOI 10.1007/BF00389331; Dubinsky Z., 1994, Pacific Science, V48, P313; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Falter JL, 2001, LIMNOL OCEANOGR, V46, P1653, DOI 10.4319/lo.2001.46.7.1653; Finelli CM, 2007, MAR ECOL PROG SER, V349, P103, DOI 10.3354/meps07101; Frankovich TA, 1998, MAR CHEM, V60, P227, DOI 10.1016/S0304-4203(97)00100-X; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Genin A, 2009, LIMNOL OCEANOGR, V54, P938, DOI 10.4319/lo.2009.54.3.0938; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Glud RN, 2010, MAR ECOL PROG SER, V417, P1, DOI 10.3354/meps08795; GLYNN PW, 1973, MAR BIOL, V22, P1, DOI 10.1007/BF00388905; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kinsey D.W., 1985, P 5 INT COR REEF S, V4, P505; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; Kuhl M, 1996, J PHYCOL, V32, P799, DOI 10.1111/j.0022-3646.1996.00799.x; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Lee XH, 2004, ATMOS OCEAN SCI LIB, V29, P33; Leletkin VA, 1996, PHOTOSYNTHETICA, V32, P481; Lesser MP, 2001, MAR ECOL PROG SER, V212, P69, DOI 10.3354/meps212069; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; Long MH, 2012, BIOGEOSCIENCES, V9, P1957, DOI 10.5194/bg-9-1957-2012; Long MH, 2012, LIMNOL OCEANOGR-METH, V10, P416, DOI 10.4319/lom.2012.10.416; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McGillis WR, 2011, GEOPHYS RES LETT, V38, P1; Nakamura T, 2005, MAR ECOL PROG SER, V301, P109, DOI 10.3354/meps301109; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; Precht E, 2003, LIMNOL OCEANOGR, V48, P1674, DOI 10.4319/lo.2003.48.4.1674; Reaka, 1985, ECOLOGY CORAL REEFS, P163; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1956, DOI 10.4319/lo.2006.51.5.1956; Reimers CE, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007564; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Rosman JH, 2008, J ATMOS OCEAN TECH, V25, P286, DOI 10.1175/2007JTECHO525.1; Sand-Jensen K, 2007, OIKOS, V116, P280, DOI 10.1111/j.2006.0030-1299.15093.x; Santos IR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006510; Scheffers Sander R., 2010, Atoll Research Bulletin, P1; Schneider K, 2009, LIMNOL OCEANOGR, V54, P1995, DOI 10.4319/lo.2009.54.6.1995; SMITH SV, 1978, NATURE, V273, P225, DOI 10.1038/273225a0; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Trowbridge JH, 1998, J ATMOS OCEAN TECH, V15, P290, DOI 10.1175/1520-0426(1998)015<0290:OATFMO>2.0.CO;2; Vollenweider RA, 1965, MEM I ITAL IDROBIO S, V18, P427; Whipple A.C., 2006, OCEAN DYNAM, V56, P169, DOI [DOI 10.1007/S10236-005-0038-X, 10.1007/s10236-005-0038-x]	64	76	76	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58581	10.1371/journal.pone.0058581	http://dx.doi.org/10.1371/journal.pone.0058581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536798	Green Published, gold			2022-12-27	WOS:000316251100065
J	Yuajit, C; Homvisasevongsa, S; Chatsudthipong, L; Soodvilai, S; Muanprasat, C; Chatsudthipong, V				Yuajit, Chaowalit; Homvisasevongsa, Sureeporn; Chatsudthipong, Lisa; Soodvilai, Sunhapas; Muanprasat, Chatchai; Chatsudthipong, Varanuj			Steviol Reduces MDCK Cyst Formation and Growth by Inhibiting CFTR Channel Activity and Promoting Proteasome-Mediated CFTR Degradation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; REBAUDIOSIDE-A; CELLS; TRAFFICKING; SECRETION; TRANSPORT	Cyst enlargement in polycystic kidney disease (PKD) involves cAMP-activated proliferation of cyst-lining epithelial cells and transepithelial fluid secretion into the cyst lumen via cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. This study aimed to investigate an inhibitory effect and detailed mechanisms of steviol and its derivatives on cyst growth using a cyst model in Madin-Darby canine kidney (MDCK) cells. Among 4 steviol-related compounds tested, steviol was found to be the most potent at inhibiting MDCK cyst growth. Steviol inhibition of cyst growth was dose-dependent; steviol (100 microM) reversibly inhibited cyst formation and cyst growth by 72.5 +/- 3.6% and 38.2 +/- 8.5%, respectively. Steviol at doses up to 200 microM had no effect on MDCK cell viability, proliferation and apoptosis. However, steviol acutely inhibited forskolin-stimulated apical chloride current in MDCK epithelia, measured with the Ussing chamber technique, in a dose-dependent manner. Prolonged treatment (24 h) with steviol (100 microM) also strongly inhibited forskolin-stimulated apical chloride current, in part by reducing CFTR protein expression in MDCK cells. Interestingly, proteasome inhibitor, MG-132, abolished the effect of steviol on CFTR protein expression. Immunofluorescence studies demonstrated that prolonged treatment (24 h) with steviol (100 microM) markedly reduced CFTR expression at the plasma membrane. Taken together, the data suggest that steviol retards MDCK cyst progression in two ways: first by directly inhibiting CFTR chloride channel activity and second by reducing CFTR expression, in part, by promoting proteasomal degradation of CFTR. Steviol and related compounds therefore represent drug candidates for treatment of polycystic kidney disease.	[Yuajit, Chaowalit; Chatsudthipong, Lisa; Soodvilai, Sunhapas; Muanprasat, Chatchai; Chatsudthipong, Varanuj] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand; [Homvisasevongsa, Sureeporn] Huachiew Chalermprakiet Univ, Fac Sci & Technol, Div Phys Sci, Samut Prakan, Thailand; [Soodvilai, Sunhapas; Muanprasat, Chatchai; Chatsudthipong, Varanuj] Mahidol Univ, Fac Sci, Res Ctr Transport Prot Med Innovat, Bangkok 10400, Thailand	Mahidol University; Mahidol University	Chatsudthipong, V (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand.	varanuj.cha@mahidol.ac.th	Yuajit, Chaowalit/AAI-4700-2021		Thailand Research Fund [BRG5380005]; program Strategic Scholarships for Frontier Research Network for the Join Ph.D. Program from The Office of the Higher Education Commission; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative	Thailand Research Fund(Thailand Research Fund (TRF)); program Strategic Scholarships for Frontier Research Network for the Join Ph.D. Program from The Office of the Higher Education Commission; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative	This work was supported by Thailand Research Fund (grant BRG5380005 to VC), the program Strategic Scholarships for Frontier Research Network for the Join Ph.D. Program from The Office of the Higher Education Commission (to VC and CY), and the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (Grant to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebok Z, 2001, AM J PHYSIOL-CELL PH, V280, pC135, DOI 10.1152/ajpcell.2001.280.1.C135; Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Blazer-Yost BL, 2010, PPAR RES, V2010, DOI [10.1155/2010/785369, 10.1155/2010/274376]; Boonkaewwan C, 2006, J AGR FOOD CHEM, V54, P785, DOI 10.1021/jf0523465; Cardoso VN, 1996, NUCL MED BIOL, V23, P97, DOI 10.1016/0969-8051(95)02072-1; Chatsudthipong V, 2001, J PHARMACOL EXP THER, V298, P1120; Chatsudthipong V, 2009, PHARMACOL THERAPEUT, V121, P41, DOI 10.1016/j.pharmthera.2008.09.007; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; Fan WH, 2011, ACTA PHARMACOL SIN, V32, P619, DOI 10.1038/aps.2011.16; Gao JS, 2011, EUR J PHARMACOL, V654, P92, DOI 10.1016/j.ejphar.2010.12.008; Gardana C, 2003, J AGR FOOD CHEM, V51, P6618, DOI 10.1021/jf0303619; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Geuns JMC, 2003, PHYTOCHEMISTRY, V64, P913, DOI 10.1016/S0031-9422(03)00426-6; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; JECFA, 2008, WHO TECH REP SER, V952, P50; Jeppesen Per B, 2006, Rev Diabet Stud, V3, P189, DOI 10.1900/RDS.2006.3.189; Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V934, P1; Lee CN, 2001, PLANTA MED, V67, P796, DOI 10.1055/s-2001-18841; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Nakagawa H, 2011, J PHARM SCI-US, V100, P3602, DOI 10.1002/jps.22615; Nofziger C, 2009, AM J PHYSIOL-RENAL, V297, pF55, DOI 10.1152/ajprenal.00090.2009; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pariwat P, 2008, J PHARMACOL EXP THER, V324, P798, DOI 10.1124/jpet.107.129288; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Spadafora D, 2010, PHYSIOL GENOMICS, V42, P480, DOI 10.1152/physiolgenomics.00092.2010; Srimaroeng C, 2005, PHARM RES-DORDR, V22, P858, DOI 10.1007/s11095-005-4580-5; Stahl M, 2012, AM J PHYSIOL-CELL PH, V302, pC67, DOI 10.1152/ajpcell.00225.2011; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Taide M, 1996, EUR J CLIN INVEST, V26, P506, DOI 10.1046/j.1365-2362.1996.177306.x; Terryn S, 2011, BBA-MOL BASIS DIS, V1812, P1314, DOI 10.1016/j.bbadis.2011.01.011; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; WARD CL, 1994, J BIOL CHEM, V269, P25710; Wheeler A, 2008, FOOD CHEM TOXICOL, V46, pS54, DOI 10.1016/j.fct.2008.04.041; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828; You BR, 2011, ONCOL REP, V25, P1705, DOI 10.3892/or.2011.1211; Zhang Y, 2011, TOXICON, V57, P932, DOI 10.1016/j.toxicon.2011.03.008	48	20	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58871	10.1371/journal.pone.0058871	http://dx.doi.org/10.1371/journal.pone.0058871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536832	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100097
J	Yu, X; Driscoll, CT; Huang, JY; Holsen, TM; Blackwell, BD				Yu, Xue; Driscoll, Charles T.; Huang, Jiaoyan; Holsen, Thomas M.; Blackwell, Bradley D.			Modeling and Mapping of Atmospheric Mercury Deposition in Adirondack Park, New York	PLOS ONE			English	Article							DRY DEPOSITION; SCIENTIFIC UNCERTAINTIES; WET DEPOSITION; CMAQ MODEL; TRANSPORT; FOREST; PARTICLE; AIR; METHYLMERCURY; PRECIPITATION	The Adirondacks of New York State, USA is a region that is sensitive to atmospheric mercury (Hg) deposition. In this study, we estimated atmospheric Hg deposition to the Adirondacks using a new scheme that combined numerical modeling and limited experimental data. The majority of the land cover in the Adirondacks is forested with 47% of the total area deciduous, 20% coniferous and 10% mixed. We used litterfall plus throughfall deposition as the total atmospheric Hg deposition to coniferous and deciduous forests during the leaf-on period, and wet Hg deposition plus modeled atmospheric dry Hg deposition as the total Hg deposition to the deciduous forest during the leaf-off period and for the non-forested areas year-around. To estimate atmospheric dry Hg deposition we used the Big Leaf model. The average atmospheric Hg deposition to the Adirondacks was estimated as 17.4 mu g m(-2) yr(-1) with a range of -3.7-46.0 mu g m(-2) yr(-1). Atmospheric Hg dry deposition (370 kg yr(-1)) was found to be more important than wet deposition (210 kg yr(-1)) to the entire Adirondacks (2.4 million ha). The spatial pattern showed a large variation in atmospheric Hg deposition with scattered areas in the eastern Adirondacks having total Hg deposition greater than 30 mu g m(-2) yr(-1), while the southwestern and the northern areas received Hg deposition ranging from 25-30 mu g m(-2) yr(-1).	[Yu, Xue; Driscoll, Charles T.; Blackwell, Bradley D.] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Huang, Jiaoyan] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Holsen, Thomas M.] Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY USA	Syracuse University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Clarkson University	Yu, X (corresponding author), Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA.	xuyu@syr.edu	Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890; Huang, Jiaoyan/0000-0001-6148-238X; Holsen, Thomas/0000-0001-9599-6733	New York State Energy Research and Development Authority; U.S. Environmental Protection Agency	New York State Energy Research and Development Authority; U.S. Environmental Protection Agency(United States Environmental Protection Agency)	Support for this research was provided by New York State Energy Research and Development Authority and the U.S. Environmental Protection Agency. The website for New York State Energy Research and Development Authority is: http://www.nyserda.ny.gov/. The website for the U.S. Environmental Protection Agency is: http://www.epa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KH, 1998, BIOGEOCHEMISTRY, V40, P101, DOI 10.1023/A:1005983932240; Bullock OR, 2002, ATMOS ENVIRON, V36, P2135, DOI 10.1016/S1352-2310(02)00220-0; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Choi HD, 2008, ENVIRON SCI TECHNOL, V42, P5644, DOI 10.1021/es7028137; Choi HD, 2008, ATMOS ENVIRON, V42, P1818, DOI 10.1016/j.atmosenv.2007.11.036; Cohen M, 2004, ENVIRON RES, V95, P247, DOI 10.1016/j.envres.2003.11.007; Daly C, 1997, 10TH CONFERENCE ON APPLIED CLIMATOLOGY, P10; Dastoor AP, 2004, ATMOS ENVIRON, V38, P147, DOI 10.1016/j.atmosenv.2003.08.037; Demers JD, 2007, ECOL APPL, V17, P1341, DOI 10.1890/06-1697.1; Denkenberger JS, 2012, ENVIRON POLLUT, V161, P291, DOI 10.1016/j.envpol.2011.06.007; Driscoll C.T., 1991, P133; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; DRISCOLL CT, 1994, ENVIRON SCI TECHNOL, V28, pA136, DOI 10.1021/es00052a721; Ericksen JA, 2003, ATMOS ENVIRON, V37, P1613, DOI 10.1016/S1352-2310(03)00008-6; Esteban E, 2008, ENVIRON EXP BOT, V62, P316, DOI 10.1016/j.envexpbot.2007.10.006; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Fry J., 2009, TECHNICAL REPORT; Gardfeldt K, 2003, J PHYS CHEM A, V107, P4478, DOI 10.1021/jp0275342; Gbor PK, 2007, ATMOS ENVIRON, V41, P1135, DOI 10.1016/j.atmosenv.2006.10.005; Grigal D. F., 2002, Environmental Reviews, V10, P1, DOI 10.1139/a01-013; Gustin M, 2012, ENVIRON SCI TECHNOL, V44, P2222; Gustin MS, 2012, EXCHANGE MERCURY ATM; HICKS BB, 1987, WATER AIR SOIL POLL, V36, P311, DOI 10.1007/BF00229675; Holloway T, 2012, ATMOS CHEM PHYS, V12, P7117, DOI 10.5194/acp-12-7117-2012; Huang JY, 2012, J ENVIRON MONITOR, V14, P2976, DOI 10.1039/c2em30514c; Kolka RK, 1999, WATER AIR SOIL POLL, V113, P273, DOI 10.1023/A:1005020326683; Lawson ST, 2003, J ENVIRON MONITOR, V5, P578, DOI 10.1039/b210125d; Lee DS, 2001, ATMOS ENVIRON, V35, P5455, DOI 10.1016/S1352-2310(01)00284-9; Lin CJ, 2006, ATMOS ENVIRON, V40, P2911, DOI 10.1016/j.atmosenv.2006.01.009; Lin X, 2003, ATMOS CHEM PHYS, V3, P535, DOI 10.5194/acp-3-535-2003; Lindberg SE, 1998, ENVIRON SCI TECHNOL, V32, P49, DOI 10.1021/es970546u; Mao H, 2012, ATMOS CHEM PHYS, V12, P5099, DOI 10.5194/acp-12-5099-2012; Mao H., 2011, ATMOS CHEM PHYS DISC, V11, P28395, DOI [DOI 10.5194/ACPD-11-28395-2011, 10.5194/acpd-11-28395-2011]; Miller EK, 2005, ECOTOXICOLOGY, V14, P53, DOI 10.1007/s10646-004-6259-9; MILLER EK, 1993, ATMOS ENVIRON A-GEN, V27, P2121, DOI 10.1016/0960-1686(93)90042-W; MUNTHE J, 1995, WATER AIR SOIL POLL, V80, P363, DOI 10.1007/BF01189686; PETERSEN G, 1995, ATMOS ENVIRON, V29, P47, DOI 10.1016/1352-2310(94)00223-8; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; PLEIJEL K, 1995, ATMOS ENVIRON, V29, P1441; Pongprueksa P, 2008, ATMOS ENVIRON, V42, P1828, DOI 10.1016/j.atmosenv.2007.11.020; Prestbo EM, 2009, ATMOS ENVIRON, V43, P4223, DOI 10.1016/j.atmosenv.2009.05.028; Rea AW, 1996, ATMOS ENVIRON, V30, P3257, DOI 10.1016/1352-2310(96)00087-8; Rimmer CC, 2005, ECOTOXICOLOGY, V14, P223, DOI 10.1007/s10646-004-6270-1; Risch MR, 2012, ENVIRON POLLUT, V161, P284, DOI 10.1016/j.envpol.2011.06.005; Rutter AP, 2007, ATMOS ENVIRON, V41, P8647, DOI 10.1016/j.atmosenv.2007.07.024; Rutter AP, 2007, ENVIRON SCI TECHNOL, V41, P3934, DOI 10.1021/es062439i; Ryaboshapko A, 2002, ATMOS ENVIRON, V36, P3881, DOI 10.1016/S1352-2310(02)00351-5; Schmolke SR, 2003, ATMOS ENVIRON, V37, pS51, DOI 10.1016/S1352-2310(03)00250-4; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Seigneur C, 2004, FUEL PROCESS TECHNOL, V85, P441, DOI 10.1016/j.fuproc.2003.11.001; SHANNON JD, 1995, ATMOS ENVIRON, V29, P1649, DOI 10.1016/1352-2310(95)00075-A; Sheehan KD, 2006, WATER AIR SOIL POLL, V170, P249, DOI 10.1007/s11270-006-3034-y; Subir M, 2012, ATMOS ENVIRON, V46, P1, DOI 10.1016/j.atmosenv.2011.07.047; Subir M, 2011, ATMOS ENVIRON, V45, P5664, DOI 10.1016/j.atmosenv.2011.04.046; Swartzendruber PC, 2009, ENVIRON SCI TECHNOL, V43, P7484, DOI 10.1021/es901390t; Tipping E, 2011, ENVIRON POLLUT, V159, P3474, DOI 10.1016/j.envpol.2011.08.019; Townsend JM, 2012, ECOTOXICOLOGY; US EPA, 2012, DEP MAPP; Wesely ML, 2000, ATMOS ENVIRON, V34, P2261, DOI 10.1016/S1352-2310(99)00467-7; Witt EL, 2009, WATER AIR SOIL POLL, V199, P3, DOI 10.1007/s11270-008-9854-1; Xu XH, 1999, ATMOS ENVIRON, V33, P4345, DOI 10.1016/S1352-2310(99)00245-9; Yu X, 2011, ECOTOXICOLOGY, V20, P1543, DOI 10.1007/s10646-011-0717-y; Zhang L, 2012, ENVIRON POLLUT, V161, P272, DOI 10.1016/j.envpol.2011.06.003; Zhang L, 2003, ATMOS CHEM PHYS, V3, P2067, DOI 10.5194/acp-3-2067-2003; Zhang L., 2012, ATMOSPHERIC CHEM PHY, V12, P2783; Zhang LM, 2009, ATMOS ENVIRON, V43, P5853, DOI 10.1016/j.atmosenv.2009.08.019; Zhang LM, 2002, ATMOS ENVIRON, V36, P537, DOI 10.1016/S1352-2310(01)00447-2; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5	68	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59322	10.1371/journal.pone.0059322	http://dx.doi.org/10.1371/journal.pone.0059322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536871	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200019
J	Brown, EM; McTaggart, LR; Zhang, SX; Low, DE; Stevens, DA; Richardson, SE				Brown, Elizabeth M.; McTaggart, Lisa R.; Zhang, Sean X.; Low, Donald E.; Stevens, David A.; Richardson, Susan E.			Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp nov within the Human Pathogenic Fungus Blastomyces dermatitidis	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; CENOCOCCUM-GEOPHILUM; COCCIDIOIDES-IMMITIS; POPULATION-GENETICS; RECOMBINATION; EPIDEMIOLOGY; SPECIATION; RECOGNITION; MODEL; GENEALOGIES	Background: Analysis of the population genetic structure of microbial species is of fundamental importance to many scientific disciplines because it can identify cryptic species, reveal reproductive mode, and elucidate processes that contribute to pathogen evolution. Here, we examined the population genetic structure and geographic differentiation of the sexual, dimorphic fungus Blastomyces dermatitidis, the causative agent of blastomycosis. Methodology/Principal Findings: Criteria for Genealogical Concordance Phylogenetic Species Recognition (GCPSR) applied to seven nuclear loci (arf6, chs2, drk1, fads, pyrF, tub1, and its-2) from 78 clinical and environmental isolates identified two previously unrecognized phylogenetic species. Four of seven single gene phylogenies examined (chs2, drk1, pyrF, and its-2) supported the separation of Phylogenetic Species 1 (PS1) and Phylogenetic Species 2 (PS2) which were also well differentiated in the concatenated chs2-drk1-fads-pyrF-tub1-arf6-its2 genealogy with all isolates falling into one of two evolutionarily independent lineages. Phylogenetic species were genetically distinct with interspecific divergence 4-fold greater than intraspecific divergence and a high Fst value (0.772, P<0.001) indicative of restricted gene flow between PS1 and PS2. Whereas panmixia expected of a single freely recombining population was not observed, recombination was detected when PS1 and PS2 were assessed separately, suggesting reproductive isolation. Random mating among PS1 isolates, which were distributed across North America, was only detected after partitioning isolates into six geographic regions. The PS2 population, found predominantly in the hyper-endemic regions of northwestern Ontario, Wisconsin, and Minnesota, contained a substantial clonal component with random mating detected only among unique genotypes in the population. Conclusions/Significance: These analyses provide evidence for a genetically divergent clade within Blastomyces dermatitidis, which we use to describe a novel species, Blastomyces gilchristii sp. nov. In addition, we discuss the value of population genetic and phylogenetic analyses as a foundation for disease surveillance, understanding pathogen evolution, and discerning phenotypic differences between phylogenetic species.	[Brown, Elizabeth M.; McTaggart, Lisa R.; Low, Donald E.; Richardson, Susan E.] Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada; [Brown, Elizabeth M.; Low, Donald E.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Brown, Elizabeth M.; Low, Donald E.; Richardson, Susan E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Sean X.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA; [Stevens, David A.] Santa Clara Valley Med Ctr, Dept Med, Div Infect Dis, San Jose, CA 95128 USA; [Richardson, Susan E.] Hosp Sick Children, Dept Paediat Lab Med, Div Microbiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Johns Hopkins University; Santa Clara Valley Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McTaggart, LR (corresponding author), Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada.	lisa.mctaggart@oahpp.ca	Brown, Elizabeth M./AAI-2537-2019	Brown, Elizabeth M./0000-0003-1411-5792	Public Health Ontario	Public Health Ontario	This study was funded by Public Health Ontario (http://www.oahpp.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alastruey-Izquierdo A, 2010, J CLIN MICROBIOL, V48, P2154, DOI 10.1128/JCM.01744-09; [Anonymous], 1995, GLOBAL BIODIVERSITY; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Baumgardner D J, 1998, WMJ, V97, P44; Baumgardner DJ, 2001, MYCOPATHOLOGIA, V152, P51, DOI 10.1023/A:1012438029997; Baumgardner DJ, 1999, MED MYCOL, V37, P163, DOI 10.1046/j.1365-280X.1999.00214.x; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; Brandhorst TT, 2002, INT J MED MICROBIOL, V292, P363, DOI 10.1078/1438-4221-00219; BRASS C, 1982, SABOURAUDIA, V20, P145; BROWN AHD, 1980, GENETICS, V96, P523; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Carlos WG, 2010, CHEST, V138, P1377, DOI 10.1378/chest.10-0627; CARMAN WF, 1989, MYCOPATHOLOGIA, V107, P25, DOI 10.1007/BF00437587; Crampton TL, 2002, CLIN INFECT DIS, V34, P1310, DOI 10.1086/340049; DENTON JF, 1979, AM J TROP MED HYG, V28, P697, DOI 10.4269/ajtmh.1979.28.697; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Disalvo Arthur F., 1992, P75; Douhan GW, 2007, CURR GENET, V52, P191, DOI 10.1007/s00294-007-0150-1; Dwight P J, 2000, Can Commun Dis Rep, V26, P82; Dworkin MS, 2005, CLIN INFECT DIS, V41, pE107, DOI 10.1086/498152; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fisher MC, 2002, P NATL ACAD SCI USA, V99, P9067, DOI 10.1073/pnas.132178099; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fisher MC, 2000, J CLIN MICROBIOL, V38, P807, DOI 10.1128/JCM.38.2.807-813.2000; Fisher MC, 2000, MOL BIOL EVOL, V17, P1164, DOI 10.1093/oxfordjournals.molbev.a026399; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Gilchrist T C, 1898, J Exp Med, V3, P53, DOI 10.1084/jem.3.1.53; Gilchrist TC., 1894, J CUTAN GENITOURIN, V12, P496; Gueho E, 1997, MYCOSES, V40, P69, DOI 10.1111/j.1439-0507.1997.tb00191.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hussein R, 2009, CHEST, V135, P1019, DOI 10.1378/chest.08-1947; KANE J, 1984, J CLIN MICROBIOL, V20, P594, DOI 10.1128/JCM.20.3.594-596.1984; Kasuga T, 2003, MOL ECOL, V12, P3383, DOI 10.1046/j.1365-294X.2003.01995.x; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Klein BS, 1997, INFECT IMMUN, V65, P1505, DOI 10.1128/IAI.65.4.1505-1509.1997; Kluyver A.J., 1956, MICROBES CONTRIBUTIO; Koufopanou V, 1997, P NATL ACAD SCI USA, V94, P5478, DOI 10.1073/pnas.94.10.5478; Koufopanou V, 2001, MOL BIOL EVOL, V18, P1246, DOI 10.1093/oxfordjournals.molbev.a003910; Kralt D, 2009, MYCOPATHOLOGIA, V167, P115, DOI 10.1007/s11046-008-9163-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Light RB, 2008, MED MYCOL, V46, P835, DOI 10.1080/13693780802132763; LoBuglio KF, 2002, MYCOLOGIA, V94, P772, DOI 10.2307/3761692; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; McCullough MJ, 2000, CLIN INFECT DIS, V30, P328, DOI 10.1086/313649; Meece JK, 2011, APPL ENVIRON MICROB, V77, P5123, DOI 10.1128/AEM.00258-11; Meece JK, 2010, MED MYCOL, V48, P285, DOI [10.3109/13693780903103952, 10.1080/13693780903103952]; Morris SK, 2006, EMERG INFECT DIS, V12, P274; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pfister JR, 2011, CLIN MED RES, V9, P57, DOI 10.3121/cmr.2010.958; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stevens D A, 1997, Semin Respir Infect, V12, P189; SUDMAN MS, 1974, APPL MICROBIOL, V27, P496, DOI 10.1128/AEM.27.3.496-499.1974; Taylor JW, 2003, CURR OPIN MICROBIOL, V6, P351, DOI 10.1016/S1369-5274(03)00088-2; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Tibayrenc M, 2010, GENETICS EVOLUTION I, P48; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	79	79	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59237	10.1371/journal.pone.0059237	http://dx.doi.org/10.1371/journal.pone.0059237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533607	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400044
J	Libran-Perez, M; Lopez-Patino, MA; Miguez, JM; Soengas, JL				Libran-Perez, Marta; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.			Oleic Acid and Octanoic Acid Sensing Capacity in Rainbow Trout Oncorhynchus mykiss Is Direct in Hypothalamus and Brockmann Bodies	PLOS ONE			English	Article							SALMON SALMO-SALAR; FATTY-ACIDS; FOOD-INTAKE; GLUCOSE-METABOLISM; INTERMEDIARY METABOLISM; LIPID-METABOLISM; PROTEIN-KINASE; FEED-INTAKE; LIVER; LIPOGENESIS	In a previous study, we provided evidence for the presence in hypothalamus and Brockmann bodies (BB) of rainbow trout Oncorhynchus mykiss of sensing systems responding to changes in levels of oleic acid (long-chain fatty acid, LCFA) or octanoic acid (medium-chain fatty acid, MCFA). Since those effects could be attributed to an indirect effect, in the present study, we evaluated in vitro if hypothalamus and BB respond to changes in FA in a way similar to that observed in vivo. In a first set of experiments, we evaluated in hypothalamus and BB exposed to increased oleic acic or octanoic acid concentrations changes in parameters related to FA metabolism, FA transport, nuclear receptors and transcription factors, reactive oxygen species (ROS) effectors, components of the K-ATP channel, and (in hypothalamus) neuropeptides related to food intake. In a second set of experiments, we evaluated in hypothalamus the response of those parameters to oleic acid or octanoic acid in the presence of inhibitors of fatty acid sensing components. The responses observed in vitro in hypothalamus are comparable to those previously observed in vivo and specific inhibitors counteracted in many cases the effects of FA. These results support the capacity of rainbow trout hypothalamus to directly sense changes in MCFA or LCFA levels. In BB increased concentrations of oleic acid or octanoic acid induced changes that in general were comparable to those observed in hypothalamus supporting direct FA sensing in this tissue. However, those changes were not coincident with those observed in vivo allowing us to suggest that the FA sensing capacity of BB previously characterized in vivo is influenced by other neuroendocrine systems.	[Libran-Perez, Marta; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Fac Bioloxia, Dept Bioloxia Func & Ciencias Saude, Lab Fisioloxia Anim, Vigo 36310, Spain	Universidade de Vigo	Soengas, JL (corresponding author), Univ Vigo, Fac Bioloxia, Dept Bioloxia Func & Ciencias Saude, Lab Fisioloxia Anim, Vigo 36310, Spain.	jsoengas@uvigo.es	Miguez, J.M./M-3705-2014; Soengas, José L/M-1898-2014	Miguez, J.M./0000-0002-3474-2139; Soengas, José L/0000-0002-6847-3993; Lopez-Patino, Marcos A./0000-0002-1038-7419	Ministerio de Ciencia e Innovacion; European Fund for Regional Development [AGL2010-22247-C03-03]; Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia) [CN 2012/004]; Xunta de Galicia (Program Isidro Parga Pondal)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Fund for Regional Development(European Commission); Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia)(Xunta de Galicia); Xunta de Galicia (Program Isidro Parga Pondal)(Xunta de Galicia)	This study was supported by research grants from Ministerio de Ciencia e Innovacion and European Fund for Regional Development (AGL2010-22247-C03-03) and Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia, CN 2012/004). M.L-P. was recipient of a predoctoral fellowship from the Ministerio de Ciencia e Innovacion (Program FPI). M.A.L-P. was recipient of a postdoctoral scholarship from Xunta de Galicia (Program Isidro Parga Pondal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2000, BRIT J NUTR, V84, P619; Barma P, 2006, CURR SCI INDIA, V90, P188; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; BOUJARD T, 1993, FISH PHYSIOL BIOCHEM, V11, P337, DOI 10.1007/BF00004583; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Cho HK, 2012, GEN COMP ENDOCR, V175, P39, DOI 10.1016/j.ygcen.2011.08.026; Davis DA, 1999, FISH PHYSIOL BIOCHEM, V21, P235, DOI 10.1023/A:1007836612376; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Figueiredo-Silva AC, 2012, BRIT J NUTR, V107, P1714, DOI 10.1017/S0007114511004739; Figueiredo-Silva AC, 2012, PHYSIOL BEHAV, V106, P499, DOI 10.1016/j.physbeh.2012.03.027; Figueiredo-Silva AC, 2012, J EXP BIOL, V215, P169, DOI 10.1242/jeb.063933; Gelineau A, 2001, REPROD NUTR DEV, V41, P487, DOI 10.1051/rnd:2001103; Grove TJ, 2004, COMP BIOCHEM PHYS B, V139, P53, DOI 10.1016/j.cbpc.2004.06.005; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Johansen SJS, 2002, AQUAC RES, V33, P515, DOI 10.1046/j.1365-2109.2002.00736.x; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; Le Coutre J, 2010, FAT DETECTION TASTE, P507; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Libran-Perez M, 2013, COMP BIOCHEM PHYS A, V164, P241, DOI 10.1016/j.cbpa.2012.09.012; Libran-Perez M, 2012, AM J PHYSIOL-REG I, V302, pR1340, DOI 10.1152/ajpregu.00070.2012; Lopez M, 2005, PEPTIDES, V26, P1753, DOI 10.1016/j.peptides.2004.11.025; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; Migrenne S, 2006, DIABETES, V55, pS139, DOI 10.2337/db06-S017; Miyauchi S, 2010, J PHARMACOL SCI, V112, P19, DOI 10.1254/jphs.09R09FM; Morash AJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P625, DOI 10.1086/662552; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polakof S, 2011, LIPIDS, V46, P189, DOI 10.1007/s11745-010-3521-1; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2010, DOMEST ANIM ENDOCRIN, V39, P26, DOI 10.1016/j.domaniend.2010.01.003; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR1077, DOI 10.1152/ajpregu.90476.2008; Polakof S, 2007, AM J PHYSIOL-REG I, V293, pR1410, DOI 10.1152/ajpregu.00283.2007; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Polakof S, 2012, J COMP PHYSIOL B, V182, P507, DOI 10.1007/s00360-011-0636-5; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Prieto AI, 2009, ENVIRON TOXICOL, V24, P563, DOI 10.1002/tox.20458; Rasmussen RS, 2000, AQUACULT NUTR, V6, P17; Sanchez-Gurmaches J, 2010, AM J PHYSIOL-REG I, V299, pR562, DOI 10.1152/ajpregu.00696.2009; Shearer KD, 1997, COMP BIOCHEM PHYS A, V118, P1209, DOI 10.1016/S0300-9629(97)86801-6; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Trushenski JT, 2009, N AM J AQUACULT, V71, P363, DOI 10.1577/A09-001.1; Tseng YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018180, 10.1371/journal.pone.0024057]; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Zhou J, 2010, LIPIDS, V45, P301, DOI 10.1007/s11745-010-3396-1	51	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59507	10.1371/journal.pone.0059507	http://dx.doi.org/10.1371/journal.pone.0059507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533628	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400065
J	Muppala, S; Mudduluru, G; Leupold, JH; Buergy, D; Sleeman, JP; Allgayer, H				Muppala, Santoshi; Mudduluru, Giridhar; Leupold, Joerg H.; Buergy, Daniel; Sleeman, Jonathan P.; Allgayer, Heike			CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; GENE-EXPRESSION; COLORECTAL-CANCER; MICRORNA-21 TARGETS; THERAPEUTIC TARGETS; GLIOBLASTOMA CELLS; ADHESION MOLECULE; ENDOTHELIAL-CELLS; LUNG-CANCER; INVASION	Cancer is a complex disease process that evolves as a consequence of multiple malfunctions in key regulatory molecular networks. Understanding these networks will be essential to combat cancer. In this study, we focussed on central players in such networks. In a series of colon and breast cancer cell lines, we found that CD24 activates Src, and induces the activation of c-Jun and expression of c-Jun and c-Fos. Thereby CD24 increases the promoter activity and expression of miR-21, which in turn suppresses expression of Pdcd4 and PTEN. Co-transfection of a CD24 expression construct and an siRNA that silences Src showed that CD24-dependent upregulation of miR-21 is mediated by Src. Additionally, we found that miR-34a post-transcriptionally downregulates CD24 and Src expression, leading to the deactivation of c-Jun, reduced expression of c-Jun and c-Fos, inhibition of miR-21, and upregulation of Pdcd4 and PTEN. Furthermore, miR-34a-mediated inhibition of Src expression reduced migration and invasion of colorectal cancer cells. Resected tumor tissues from 26 colorectal patients showed significantly lower expression of Pdcd4 and miR-34a, and higher expression of CD24, Src and miR-21 compared to the corresponding normal tissues. Moreover, CD24 positively correlated with the amount of Src protein in tumor tissues, and a trend towards an inverse correlation between miR-34a and Src protein levels was also observed. Our results reveal essential players in the complex networks that regulate the progression of solid tumors such as colorectal cancer. These findings therefore identify novel therapeutic approaches for combating tumor growth and progression.	[Muppala, Santoshi; Mudduluru, Giridhar; Leupold, Joerg H.; Allgayer, Heike] Heidelberg Univ, Dept Expt Surg, Mannheim, Germany; [Muppala, Santoshi; Mudduluru, Giridhar; Leupold, Joerg H.; Allgayer, Heike] DKFZ, Heidelberg, Germany; [Buergy, Daniel] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Intens Care Med, Mannheim, Germany; [Sleeman, Jonathan P.] Heidelberg Univ, Univ Med Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany; [Sleeman, Jonathan P.] KIT Karlsruhe Campus Nord, Eggenstein Leopoldshafen, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Allgayer, H (corresponding author), Heidelberg Univ, Dept Expt Surg, Mannheim, Germany.	heike.allgayer@umm.de	Sleeman, Jonathan P/H-2515-2013; Muppala, Santoshi/K-6910-2019; Santoo/B-2423-2018; muppala, santoshi/AAK-2385-2020	Sleeman, Jonathan P/0000-0003-1718-7687; Muppala, Santoshi/0000-0001-7830-9591; Santoo/0000-0001-7830-9591; 	Medical Faculty Mannheim, University Heidelberg under the auspices of the Forschungsschwerpunkt Oncologie initiative; Stiftung fur krebs- und Scharlachforschung Mannheim; University of Heidelberg; European Union under the auspices of the FP7 collaborative project TuMIC [HEALTH-F2-2008-201662]; Alfried Krupp von Bohlen und Halbach Foundation; Essen; Hella-Buhler-Foundation; Heidelberg; Hector Foundation; Weinheim; FRONTIER Excellence Initiative of the University of Heidelberg; BMBF, Bonn; Walter Schulz Foundation; Munich; Deutsche Krebshilfe, Bonn, Germany; German-Israeli Cooperation (DKFZ-MOST)	Medical Faculty Mannheim, University Heidelberg under the auspices of the Forschungsschwerpunkt Oncologie initiative; Stiftung fur krebs- und Scharlachforschung Mannheim; University of Heidelberg; European Union under the auspices of the FP7 collaborative project TuMIC; Alfried Krupp von Bohlen und Halbach Foundation; Essen; Hella-Buhler-Foundation; Heidelberg; Hector Foundation; Weinheim; FRONTIER Excellence Initiative of the University of Heidelberg; BMBF, Bonn(Federal Ministry of Education & Research (BMBF)); Walter Schulz Foundation; Munich; Deutsche Krebshilfe, Bonn, Germany(Deutsche Krebshilfe); German-Israeli Cooperation (DKFZ-MOST)	SM was supported by a doctoral stipendium awarded to JPS and HA by the Medical Faculty Mannheim, University Heidelberg, under the auspices of the Forschungsschwerpunkt Oncologie initiative. GM was supported by the Stiftung fur krebs- und Scharlachforschung Mannheim, from the University of Heidelberg. JPS gratefully acknowledges funding from the European Union under the auspices of the FP7 collaborative project TuMIC, contract no. HEALTH-F2-2008-201662. HA was supported by the Alfried Krupp von Bohlen und Halbach Foundation (Award for Young Full Professors), Essen, Hella-Buhler-Foundation, Heidelberg, the Hector Foundation, Weinheim, the FRONTIER Excellence Initiative of the University of Heidelberg, the BMBF, Bonn, the Walter Schulz Foundation, Munich, Deutsche Krebshilfe, Bonn, Germany, and the German-Israeli Cooperation (DKFZ-MOST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; CELI A, 1991, P SOC EXP BIOL MED, V198, P703; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; CHANTRET I, 1988, CANCER RES, V48, P1936; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kong DJ, 2012, AM J TRANSL RES, V4, P14; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Leupold JH, 2007, MOL CANCER RES, V5, P485, DOI 10.1158/1541-7786.MCR-06-0211; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mudduluru G, 2011, BIOL CELL, V103, P21, DOI 10.1042/BC20100094; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Muppala S, 2011, CELL MOL LIFE SCI; Nestl A, 2001, CANCER RES, V61, P1569; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pedersen MW, 2001, BRIT J CANCER, V85, P1211, DOI 10.1054/bjoc.2001.2053; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	54	31	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59563	10.1371/journal.pone.0059563	http://dx.doi.org/10.1371/journal.pone.0059563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533633	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400070
J	Preisler, S; Rebolj, M; Untermann, A; Ejegod, DM; Lynge, E; Rygaard, C; Bonde, J				Preisler, Sarah; Rebolj, Matejka; Untermann, Anette; Ejegod, Ditte Moller; Lynge, Elsebeth; Rygaard, Carsten; Bonde, Jesper			Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay	PLOS ONE			English	Article							HYBRID CAPTURE 2; RISK HUMAN-PAPILLOMAVIRUS; ATYPICAL SQUAMOUS-CELLS; INTRAEPITHELIAL NEOPLASIA; UNDETERMINED SIGNIFICANCE; CANCER; WOMEN; TESTS; CYTOLOGY; TRIAGE	New commercially available Human Papillomavirus (HPV) assays need to be evaluated in a variety of cervical screening settings. Cobas HPV Test (cobas) is a real-time PCR-based assay allowing for separate detection of HPV genotypes 16 and 18 and a bulk of 12 other high-risk genotypes. The aim of the present study, Horizon, was to assess the prevalence of high-risk HPV infections in an area with a high background risk of cervical cancer, where women aged 23-65 years are targeted for cervical screening. We collected 6,258 consecutive cervical samples from the largest cervical screening laboratory in Denmark serving the whole of Copenhagen. All samples were stored in SurePath media. In total, 5,072 samples were tested with cobas, Hybrid Capture 2 High Risk HPV DNA test (HC2) and liquid-based cytology. Of these, 27% tested positive on cobas. This proportion decreased by age, being 43% in women aged 23-29 years and 10% in women aged 60-65 years. HC2 assay was positive in 20% of samples, and cytology was abnormal (>= atypical squamous cells of undetermined significance) for 7% samples. When only samples without recent abnormalities were taken into account, 24% tested positive on cobas, 19% on HC2, and 5% had abnormal cytology. The proportion of positive cobas samples was higher than in the ATHENA trial. The age-standardized cobas positivity vs. cytology abnormality was 3.9 in our study and 1.7 in ATHENA. If in Copenhagen the presently used cytology would be replaced by cobas in women above age 30 years, an extra 11% of women would based on historical data be expected to have a positive cobas test without an underlying cervical intraepithelial lesion grade 3 or worse. Countries with a high prevalence of HPV infections should therefore proceed to primary HPV-based cervical screening with caution.	[Preisler, Sarah; Untermann, Anette; Ejegod, Ditte Moller; Rygaard, Carsten; Bonde, Jesper] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark; [Preisler, Sarah; Untermann, Anette; Ejegod, Ditte Moller; Bonde, Jesper] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Rebolj, Matejka; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Bonde, J (corresponding author), Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark.	Jesper.Bonde@hvh.regionh.dk	Bonde, Jesper H/F-1478-2013; Bonde, Jesper/AAN-5930-2020	Bonde, Jesper/0000-0003-4853-6747; Lynge, Elsebeth/0000-0003-4785-5236; Rebolj, Matejka/0000-0001-9597-645X	Danish Strategic Research Council; University of Copenhagen; Olga and Esper Boel's Fund	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); University of Copenhagen; Olga and Esper Boel's Fund	Sarah Preisler and Matejka Rebolj: Danish Strategic Research Council. Elsebeth Lynge: University of Copenhagen and Olga and Esper Boel's Fund. Roche Diagnostics, the manufacturer of the cobas HPV Test and the cobas (R) 4800 HPV test instrumentation, and Qiagen, the manufacturer of the Hybrid Capture 2 assay, provided assays and instrumentations for the study. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers worked independently of the funders.	[Anonymous], QIASYMPHONY PACK INS; [Anonymous], COB HPV TEST PACK IN; Martinez SB, 2012, J VIROL METHODS, V180, P7, DOI 10.1016/j.jviromet.2011.12.002; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Castle PE, 2009, J CLIN MICROBIOL, V47, P3344, DOI 10.1128/JCM.00725-09; CLEMMESEN J, 1951, BRIT J CANCER, V5, P159, DOI 10.1038/bjc.1951.17; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Franceschi S, 2005, J NATL CANCER I, V97, P938, DOI 10.1093/jnci/dji159; Gage JC, 2012, J CLIN MICROBIOL, V50, P61, DOI 10.1128/JCM.05989-11; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Kinney W, 2010, AM J CLIN PATHOL, V134, P193, DOI 10.1309/AJCPRI8XPQUEAA3K; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Lapierre SG, 2012, J CLIN MICROBIOL, V50, P1240, DOI 10.1128/JCM.06656-11; Lynge E, 2009, NAT REV CLIN ONCOL, V6, P699, DOI 10.1038/nrclinonc.2009.167; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; Ovestad IT, 2011, GYNECOL ONCOL, V123, P278, DOI 10.1016/j.ygyno.2011.07.024; Park Y, 2012, J CLIN MICROBIOL, V50, P2359, DOI 10.1128/JCM.00337-12; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Styregruppen for DKLS, 2011, ARSR DKLS 2010 DANSK; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; Wong AA, 2012, J CLIN MICROBIOL, V50, P25, DOI 10.1128/JCM.05400-11; Wright TC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.024; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ	32	69	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59765	10.1371/journal.pone.0059765	http://dx.doi.org/10.1371/journal.pone.0059765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533648	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400085
J	Reinhardt, P; Glatza, M; Hemmer, K; Tsytsyura, Y; Thiel, CS; Hoing, S; Moritz, S; Parga, JA; Wagner, L; Bruder, JM; Wu, GM; Schmid, B; Ropke, A; Klingauf, J; Schwamborn, JC; Gasser, T; Scholer, HR; Sterneckert, J				Reinhardt, Peter; Glatza, Michael; Hemmer, Kathrin; Tsytsyura, Yaroslav; Thiel, Cora S.; Hoeing, Susanne; Moritz, Soeren; Parga, Juan A.; Wagner, Lydia; Bruder, Jan M.; Wu, Guangming; Schmid, Benjamin; Roepke, Albrecht; Klingauf, Juergen; Schwamborn, Jens C.; Gasser, Thomas; Schoeler, Hans R.; Sterneckert, Jared			Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ADULT HUMAN BRAIN; IN-VITRO; HUMAN ES; DOPAMINE NEURONS; NERVOUS-SYSTEM; MOTOR-NEURONS; SELF-RENEWAL; PATCH-CLAMP; DIFFERENTIATION	Phenotypic drug discovery requires billions of cells for high-throughput screening (HTS) campaigns. Because up to several million different small molecules will be tested in a single HTS campaign, even small variability within the cell populations for screening could easily invalidate an entire campaign. Neurodegenerative assays are particularly challenging because neurons are post-mitotic and cannot be expanded for implementation in HTS. Therefore, HTS for neuroprotective compounds requires a cell type that is robustly expandable and able to differentiate into all of the neuronal subtypes involved in disease pathogenesis. Here, we report the derivation and propagation using only small molecules of human neural progenitor cells (small molecule neural precursor cells; smNPCs). smNPCs are robust, exhibit immortal expansion, and do not require cumbersome manual culture and selection steps. We demonstrate that smNPCs have the potential to clonally and efficiently differentiate into neural tube lineages, including motor neurons (MNs) and midbrain dopaminergic neurons (mDANs) as well as neural crest lineages, including peripheral neurons and mesenchymal cells. These properties are so far only matched by pluripotent stem cells. Finally, to demonstrate the usefulness of smNPCs we show that mDANs differentiated from smNPCs with LRRK2 G2019S are more susceptible to apoptosis in the presence of oxidative stress compared to wild-type. Therefore, smNPCs are a powerful biological tool with properties that are optimal for large-scale disease modeling, phenotypic screening, and studies of early human development.	[Reinhardt, Peter; Glatza, Michael; Hoeing, Susanne; Moritz, Soeren; Parga, Juan A.; Wagner, Lydia; Bruder, Jan M.; Wu, Guangming; Schoeler, Hans R.; Sterneckert, Jared] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, North Rhine Wes, Germany; [Hemmer, Kathrin; Schwamborn, Jens C.] Univ Munster, Ctr Mol Biol Inflammat, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, D-48149 Munster, North Rhine Wes, Germany; [Tsytsyura, Yaroslav; Thiel, Cora S.; Klingauf, Juergen] Univ Munster, Inst Med Phys & Biophys, Cellular Biophys Grp, D-48149 Munster, North Rhine Wes, Germany; [Parga, Juan A.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis, Santiago De Compostela, Spain; [Schmid, Benjamin; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Baden Wurttembu, Germany; [Schmid, Benjamin; Gasser, Thomas] German Ctr Neurodegenerat Dis, Tubingen, Baden Wurttembu, Germany; [Roepke, Albrecht] Univ Munster, Inst Human Genet, D-48149 Munster, North Rhine Wes, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, North Rhine Wes, Germany	Max Planck Society; University of Munster; University of Munster; Universidade de Santiago de Compostela; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, North Rhine Wes, Germany.	office@mpi-muenster.mpg.de; jsternec@mpi-muenster.mpg.de	Parga, Juan A/H-4503-2015; Sterneckert, Jared/E-6802-2015; Gasser, Thomas/GNH-5293-2022; , HS/AAB-4434-2019; Bruder, Jan/AAM-4165-2021; Schwamborn, Jens C/F-9395-2011; Bruder, Jan/AGN-4025-2022	Parga, Juan A/0000-0003-2072-5642; Gasser, Thomas/0000-0002-1069-1146; , HS/0000-0003-2643-5136; Bruder, Jan/0000-0003-3126-0625; Schwamborn, Jens C/0000-0003-4496-0559; Bruder, Jan/0000-0003-3126-0625; Wu, Guangming/0000-0003-1923-7609; Sterneckert, Jared/0000-0002-7688-3124	Ministry of Innovation, Science and Research of North Rhine Westphalia; Max Planck Society	Ministry of Innovation, Science and Research of North Rhine Westphalia; Max Planck Society(Max Planck Society)	This work was generously supported by the Ministry of Innovation, Science and Research of North Rhine Westphalia as well as the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Coyne L, 2011, NEUROCHEM INT, V59, P404, DOI 10.1016/j.neuint.2011.01.022; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Driehaus JV, 2008, REGIONALISATION HUMA; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gale E, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-8; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007155; Inenaga K, 1998, J NEUROENDOCRINOL, V10, P1, DOI 10.1046/j.1365-2826.1998.00662.x; Karumbayaram S, 2009, DIS MODEL MECH, V2, P189, DOI 10.1242/dmm.002113; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Patthey C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001625; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; SIMARD JM, 1993, J NEUROSCI RES, V34, P170, DOI 10.1002/jnr.490340204; Sterneckert J, 2010, STEM CELLS, V28, P1772, DOI 10.1002/stem.498; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	36	240	250	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59252	10.1371/journal.pone.0059252	http://dx.doi.org/10.1371/journal.pone.0059252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533608	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000316549400045
J	Stevenson, KT; Peterson, MN; Bondell, HD; Mertig, AG; Moore, SE				Stevenson, Kathryn T.; Peterson, M. Nils; Bondell, Howard D.; Mertig, Angela G.; Moore, Susan E.			Environmental, Institutional, and Demographic Predictors of Environmental Literacy among Middle School Children	PLOS ONE			English	Article							GENDER; ACHIEVEMENT; EDUCATION; BEHAVIOR; STRATIFICATION; ORIENTATIONS; INEQUALITY; ATTITUDES; TERM	Building environmental literacy (EL) in children and adolescents is critical to meeting current and emerging environmental challenges worldwide. Although environmental education (EE) efforts have begun to address this need, empirical research holistically evaluating drivers of EL is critical. This study begins to fill this gap with an examination of school-wide EE programs among middle schools in North Carolina, including the use of published EE curricula and time outdoors while controlling for teacher education level and experience, student attributes (age, gender, and ethnicity), and school attributes (socio-economic status, student-teacher ratio, and locale). Our sample included an EE group selected from schools with registered school-wide EE programs, and a control group randomly selected from NC middle schools that were not registered as EE schools. Students were given an EL survey at the beginning and end of the spring 2012 semester. Use of published EE curricula, time outdoors, and having teachers with advanced degrees and mid-level teaching experience (between 3 and 5 years) were positively related with EL whereas minority status (Hispanic and black) was negatively related with EL. Results suggest that school-wide EE programs were not associated with improved EL, but the use of published EE curricula paired with time outdoors represents a strategy that may improve all key components of student EL. Further, investments in teacher development and efforts to maintain enthusiasm for EE among teachers with more than 5 years of experience may help to boost student EL levels. Middle school represents a pivotal time for influencing EL, as improvement was slower among older students. Differences in EL levels based on gender suggest boys and girls may possess complementary skills sets when approaching environmental issues. Our findings suggest ethnicity related disparities in EL levels may be mitigated by time spent in nature, especially among black and Hispanic students.	[Stevenson, Kathryn T.; Peterson, M. Nils] N Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA; [Bondell, Howard D.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Mertig, Angela G.] Middle Tennessee State Univ, Dept Sociol & Anthropol, Murfreesboro, TN 37130 USA; [Moore, Susan E.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Middle Tennessee State University; University of North Carolina; North Carolina State University	Stevenson, KT (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA.	ktate@ncsu.edu		Stevenson, Kathryn/0000-0002-5577-5861; Peterson, Nils/0000-0002-4246-1206; Bondell, Howard/0000-0001-7743-0840	North Carolina SeaGrant [(1504) 2012-0080]	North Carolina SeaGrant	This study was supported by a grant from North Carolina SeaGrant (http://www.ncseagrant.org, NCSU Project (1504) 2012-0080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Alexander KL, 2001, EDUC EVAL POLICY AN, V23, P171, DOI 10.3102/01623737023002171; [Anonymous], 2011, NATL ENV LIT ASSESSM; [Anonymous], 1999, TEACHER QUALITY STUD; Atchley RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051474; Bickford D, 2012, BIOL CONSERV, V151, P74, DOI 10.1016/j.biocon.2011.12.016; Bluhm W. J., 1995, ENV LITERACY NEEDS A; Blumstein DT, 2007, PLOS BIOL, V5, P973, DOI 10.1371/journal.pbio.0050120; Bradley Jennifer CAMPBELL, 1999, J ENVIRON EDUC, V30, P17, DOI [DOI 10.1080/00958969909601873, 10.1080/00958969909601873]; Brezonik P, 1994, J CONT WATER RES ED, V94, P47; Burdette HL, 2006, ARCH PEDIATR, V159, P46; Chawla L., 1999, J ENVIRON EDUC, V31, P15, DOI [10.1080/00958969909598628, DOI 10.1080/00958969909598628]; Cheng JCH, 2012, ENVIRON BEHAV, V44, P31, DOI 10.1177/0013916510385082; Clotfelter CT, 2007, ECON EDUC REV, V26, P673, DOI 10.1016/j.econedurev.2007.10.002; CONVENTION ON BIOLOGICAL DIVERSITY, 2010, GLOB BIOD OUTL 3; de Boer H, 2010, J EDUC PSYCHOL, V102, P168, DOI 10.1037/a0017289; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Eick CJ, 2010, ASTE SER SCI EDUC, P173, DOI 10.1007/978-90-481-9222-9_12; Ernst J., 2007, J ENVIRON EDUC, V38, P15, DOI DOI 10.3200/JOEE.38.3.15-32; Ernst J, 2009, ENVIRON EDUC RES, V15, P71, DOI 10.1080/13504620802710599; Finney C., 2005, BLACK FACES WHITE SP; Fouad NA, 1996, J COUNS PSYCHOL, V43, P338, DOI 10.1037/0022-0167.43.3.338; Fryer RG, 2004, REV ECON STAT, V86, P447, DOI 10.1162/003465304323031049; GAMBA RJ, 1994, ENVIRON BEHAV, V26, P587, DOI 10.1177/0013916594265001; Goldhaber D., 2002, ED NEXT, V2, P50; Goldhaber DD, 1996, DEV SCH FINANCE, P197; Gorey KM, 2001, SCHOOL PSYCHOL QUART, V16, P9, DOI 10.1521/scpq.16.1.9.19163; GUAGNANO GA, 1995, ENVIRON BEHAV, V27, P699, DOI 10.1177/0013916595275005; Henry GT, 2011, EDUC RESEARCHER, V40, P271, DOI 10.3102/0013189X11419042; Hines J.M., 1987, J ENVIRON EDUC, V18, P1, DOI [DOI 10.1080/00958964.1987.9943482, 10.1080/00958964.1987.9943482]; Hollweg K.S., 2011, DEV FRAMEWORK ASSESS; Hungerford H.R., 1990, J ENVIRON EDUC, V21, P8, DOI DOI 10.1080/00958964.1990.10753743; Kao G, 2003, ANNU REV SOCIOL, V29, P417, DOI 10.1146/annurev.soc.29.010202.100019; Karsh K, 2009, HORTTECHNOLOGY, V19, P813, DOI 10.21273/HORTSCI.19.4.813; Keene M, 2010, EVAL PROGRAM PLANN, V33, P201, DOI 10.1016/j.evalprogplan.2009.07.014; Larson LR, 2010, J PARK RECREAT ADM, V28, P95; Leeming F.C., 1995, J ENVIRON EDUC, V26, P22, DOI DOI 10.1080/00958964.1995.9941442; LISOWSKI M., 1991, J ENVIRON EDUC, V23, P19, DOI DOI 10.1080/00958964.1991.9943065; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Loeb S, 2008, TEACHER ATTRITION ST; Ma X, 2008, COMP EDUC REV, V52, P437, DOI 10.1086/588762; Mainieri T, 1997, J SOC PSYCHOL, V137, P189, DOI 10.1080/00224549709595430; MALONEY MP, 1975, AM PSYCHOL, V30, P787, DOI 10.1037/h0084394; May TS, 2000, J ENVIRON EDUC, V31, P4; McBeth B., 2008, NATL ENV LITERACY AS; National Center for Education Statistics, 2006, ID RUR LOC; NC Office of Environmental Education, 2011, EE SCH GUID; Neathery MF, 1997, ELECT J SCI ED; North American Association for Environmental Education, 2004, ENV ED MAT GUID EXC; Ogbu JU, 1998, ANTHROPOL EDUC QUART, V29, P155, DOI 10.1525/aeq.1998.29.2.155; Osborne JW, 2001, CONTEMP EDUC PSYCHOL, V26, P291, DOI 10.1006/ceps.2000.1052; Palmer J., 1998, ENV ED 21 CENTURY TH, DOI [10.4324/9780203012659, DOI 10.4324/9780203012659]; Palmer J.A., 1999, CAMB J EDUC, V29, P379, DOI [10.1080/0305764990290308, DOI 10.1080/0305764990290308]; Poortinga W, 2004, ENVIRON BEHAV, V36, P70, DOI 10.1177/0013916503251466; Potwarka LR, 2008, J COMMUN HEALTH, V33, P344, DOI 10.1007/s10900-008-9104-x; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rosenholtz SJ, 2008, AM J EDUC, V93, P352; SAMDAHL DM, 1989, ENVIRON BEHAV, V21, P57, DOI 10.1177/0013916589211004; Schamer L., 1996, ED CANADA, V36, P28; Schreurs MA, 2012, ENERG POLICY, V48, P5, DOI 10.1016/j.enpol.2012.04.044; Schwartz RM, 2012, ELEM SCHOOL J, V112, P547, DOI 10.1086/664490; Shores KA, 2007, LEISURE SCI, V29, P227, DOI 10.1080/01490400701257948; Skelly S. M., 1998, HORTTECHNOLOGY, V8, P579; State Education and Environment Roundtable (SEER), 2000, EFF ENV BAS ED STUD; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; STERN PC, 1993, ENVIRON BEHAV, V25, P322, DOI 10.1177/0013916593255002; Stock J. H., 2007, INTRO ECONOMETRICS, V2; Straughan RD, 1999, J CONSUM MARK, V16, P558, DOI 10.1108/07363769910297506; Strife S, 2009, ORGAN ENVIRON, V22, P99, DOI 10.1177/1086026609333340; Taylor AF, 2009, J ATTEN DISORD, V12, P402, DOI 10.1177/1087054708323000; The Pew Research Center for the People & the Press, 2011, MOR MOD REP SEE EV W; Tobler C, 2012, CLIMATIC CHANGE, V114, P189, DOI 10.1007/s10584-011-0393-1; Wells NM, 2003, ENVIRON BEHAV, V35, P311, DOI 10.1177/0013916503035003001; Wilke R, ENV ED LITERACY NEED, P30; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177	76	42	43	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59519	10.1371/journal.pone.0059519	http://dx.doi.org/10.1371/journal.pone.0059519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111VQ	23533631	Green Published, gold			2022-12-27	WOS:000316549400068
J	Bajekal, M; Scholes, S; O'Flaherty, M; Raine, R; Norman, P; Capewell, S				Bajekal, Madhavi; Scholes, Shaun; O'Flaherty, Martin; Raine, Rosalind; Norman, Paul; Capewell, Simon			Unequal Trends in Coronary Heart Disease Mortality by Socioeconomic Circumstances, England 1982-2006: An Analytical Study	PLOS ONE			English	Article							YOUNG-ADULTS; SOCIAL INEQUALITIES; RISK-FACTORS; HEALTH; DEPRIVATION; AUSTRALIA; CENSUS; WALES; RATES	Background: Coronary heart disease (CHD) remains a major public health burden, causing 80,000 deaths annually in England and Wales, with major inequalities. However, there are no recent analyses of age-specific socioeconomic trends in mortality. We analysed annual trends in inequalities in age-specific CHD mortality rates in small areas in England, grouped into deprivation quintiles. Methods: We calculated CHD mortality rates for 10-year age groups (from 35 to >= 85 years) using three year moving averages between 1982 and 2006. We used Joinpoint regression to identify significant turning points in age-sex-and deprivation-specific time trends. We also analysed trends in absolute and relative inequalities in age-standardised rates between the least and most deprived areas. Results: Between 1982 and 2006, CHD mortality fell by 62.2% in men and 59.7% in women. Falls were largest for the most deprived areas with the highest initial level of CHD mortality. However, a social gradient in the pace of fall was apparent, being steepest in the least deprived quintile. Thus, while absolute inequalities narrowed over the period, relative inequalities increased. From 2000, declines in mortality rates slowed or levelled off in the youngest groups, notably in women aged 45-54 in the least deprived groups. In contrast, from age 55 years and older, rates of fall in CHD mortality accelerated in the 2000s, likewise falling fastest in the least deprived quintile. Conclusions: Age-standardised CHD mortality rates have declined substantially in England, with the steepest falls in the most affluent quintiles. However, this concealed contrasting patterns in underlying age-specific rates. From 2000, mortality rates levelled off in the youngest groups but accelerated in middle aged and older groups. Mortality analyses by small areas could provide potentially valuable insights into possible drivers of inequalities, and thus inform future strategies to reduce CHD mortality across all social groups.	[Bajekal, Madhavi; Scholes, Shaun; Raine, Rosalind] UCL, Dept Appl Hlth Res, London, England; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Norman, Paul] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Liverpool; University of Leeds	Bajekal, M (corresponding author), UCL, Dept Appl Hlth Res, London, England.	m.bajekal@ucl.ac.uk	Norman, Paul D./I-4606-2016	Norman, Paul D./0000-0002-6211-1625; Raine, Rosalind/0000-0003-0904-749X; O'Flaherty, Martin/0000-0001-8944-4131; Scholes, Shaun/0000-0002-7865-5264	Legal & General Assurance Society Limited (L& G) as part of its wider research collaboration with UCL on longevity research; Higher Education Funding Council; National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre; UK Medical Research Council; European Community [223075]; Economic and Social Research Council [RES-189-25-0162, RES-163-25-0032]; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	Legal & General Assurance Society Limited (L& G) as part of its wider research collaboration with UCL on longevity research; Higher Education Funding Council(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MB and SS are honorary research staff at University College London, funded by Legal & General Assurance Society Limited (L& G) as part of its wider research collaboration with UCL on longevity research. RR and SC are supported by the Higher Education Funding Council and RR is partly funded by the National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre. MOF is partly funded by the UK Medical Research Council and by European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement no223075-the MedCHAMPS project. PN is partly funded by the Economic and Social Research Council (RES-189-25-0162 and RES-163-25-0032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi. disclosure. pdf and declare that:(1) MB and SS have support from Legal and General Assurance Society Limited for the submitted work; (2) MOF, PN, RR, SC have no relationships with Legal and General Assurance Society Limited that might have an interest in the submitted work in the previous 3 years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) MB, SS, MOF, PN, RR have no non-financial interests that may be relevant to the submitted work; SC was a member of the NICE Programme Development Group on CVD Prevention in Populations. However this article does not necessarily represent the views of NICE. The authors have declared that no other competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adams J, 2006, J PUBLIC HEALTH, V28, P379, DOI 10.1093/pubmed/fdl061; Allender S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-148; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bertuccio P, 2011, EUR J CARDIOV PREV R, V18, P627, DOI 10.1177/1741826710389393; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department for Communities and Local Government, 2007, ENGLISH INDICES DEPR; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; GOLDACRE MJ, 1993, J EPIDEMIOL COMMUN H, V47, P491, DOI 10.1136/jech.47.6.491; Gregory IN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3454; Hawkins NM, 2011, J EPIDEMIOL COMMUN H, V65, DOI 10.1136/jech.2011.143586.46; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Langford Ann, 2009, Health Stat Q, P7; Leyland AH, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2515; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Norman P, 2008, POPUL SPACE PLACE, V14, P449, DOI 10.1002/psp.492; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Office for National Statistics, 2002, HLTH STAT Q, V14, P75; Office for National Statistics, 2007, TRENDS IN LIFE EXPEC; Office for National Statistics, 2007, SMOKING AND DRINKING; Ramsay SE, 2008, J EPIDEMIOL COMMUN H, V62, P75, DOI 10.1136/jech.2006.053207; Scarborough P, 2008, REGIONAL AND SOCIAL; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Siegler Veronique, 2008, Health Stat Q, P6; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; The Marmot Review, 2010, FAIR SOCIETY HEALTHY; Tobias Martin, 2006, N Z Med J, V119, pU1932; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; WILSON A, 1995, INT J EPIDEMIOL, V24, P678, DOI 10.1093/ije/24.4.678	36	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59608	10.1371/journal.pone.0059608	http://dx.doi.org/10.1371/journal.pone.0059608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527228	Green Published, Green Accepted, gold			2022-12-27	WOS:000317562600080
J	Cristiano, MP; Cardoso, DC; Fernandes-Salomao, TM				Cristiano, Maykon Passos; Cardoso, Danon Clemes; Fernandes-Salomao, Tania Maria			Cytogenetic and Molecular Analyses Reveal a Divergence between Acromyrmex striatus (Roger, 1863) and Other Congeneric Species: Taxonomic Implications	PLOS ONE			English	Article							LEAF-CUTTING ANTS; BAYESIAN PHYLOGENETIC INFERENCE; KARYOTYPE EVOLUTION; HYMENOPTERA; FORMICIDAE; SEQUENCES; MRBAYES; GENUS	The leafcutter ants, which consist of Acromyrmex and Atta genera, are restricted to the New World and they are considered the main herbivores in the neotropics. Cytogenetic studies of leafcutter ants are available for five species of Atta and 14 species of Acromyrmex, both including subspecies. These two ant genera have a constant karyotype with a diploid number of 22 and 38 chromosomes, respectively. The most distinct Acromyrmex species from Brazil is A. striatus, which is restricted to the southern states of Santa Catarina and Rio Grande do Sul. Several cytogenetic and phylogenetic studies have been conducted with ants, but the karyotypic characterization and phylogenetic position of this species relative to leafcutter ants remains unknown. In this study, we report a diploid number of 22 chromosomes for A. striatus. The phylogenetic relationship between A. striatus and other leafcutter ants was estimated based on the four nuclear genes. A. striatus shared the same chromosome number as Atta species and the majority of metacentric chromosomes. Nuclear data generated a phylogenetic tree with a well-supported cluster, where A. striatus formed a different clade from other Acromyrmex spp. This combination of cytogenetic and molecular approaches provided interesting insights into the phylogenetic position of A. striatus among the leafcutter ants and the tribe Attini.	[Cristiano, Maykon Passos; Cardoso, Danon Clemes; Fernandes-Salomao, Tania Maria] Univ Fed Vicosa, Lab Biol Mol Insetos, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Cristiano, MP (corresponding author), Univ Fed Vicosa, Lab Biol Mol Insetos, Dept Biol Geral, Vicosa, MG, Brazil.	maykoncristiano@hotmail.com	Cardoso, Danon Clemes/D-2313-2009; Cristiano, Maykon Passos/H-7723-2012	Cardoso, Danon Clemes/0000-0002-2811-2536; Cristiano, Maykon Passos/0000-0001-7850-9155	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEMIG [CRA-APQ-00935-11]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research forms part of the DSc thesis of the first author, who was supported by a Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) studentship. Additional financial support was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and FAPEMIG (Process numbers: CRA-APQ-00935-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci M, 2009, MOL PHYLOGENET EVOL, V51, P427, DOI 10.1016/j.ympev.2008.11.005; Barros LAC, 2010, THESIS; Bolton B, 2006, BOLTONS CATALOGUE OF; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cabral-de-Mello DC, 2011, GENETICA, V139, P315, DOI 10.1007/s10709-011-9551-7; Barros LAC, 2010, SOCIOBIOLOGY, V56, P57; Delabie JH, 2011, FORMIGAS CORTADEIRAS, P80; Emery C, 1913, ANN SOC ENTOMOLOGIQU, V57, P250; Fadini MAM, 1996, BRAZ J GENET, V19, P53; Fernandes-Salomao TM, 2005, INSECT SOC, V52, P11, DOI 10.1007/s00040-004-0767-8; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; GONI B, 1983, CARYOLOGIA, V36, P363, DOI 10.1080/00087114.1983.10797677; Goodisman Michael A.D., 2008, Myrmecological News, V11, P107; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grutzmacher Douglas Daniel, 2007, Cienc. Rural, V37, P921, DOI 10.1590/S0103-84782007000400001; GUSTAVO A, 1994, J BIOGEOGR, V21, P391, DOI 10.2307/2845757; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1977, CHROMOSOMA, V59, P341, DOI 10.1007/BF00327974; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Mariano CSF, 2011, ANN SOC ENTOMOL FR, V47, P140, DOI 10.1080/00379271.2011.10697705; Mayh-Nunes AJ, 1991, THESIS, P120; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Mueller UG, 2008, P NATL ACAD SCI USA, V105, P5287, DOI 10.1073/pnas.0801464105; Murakami Takahiro, 1998, Chromosome Science, V2, P135; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; POMPOLO SG, 1990, INSECT SOC, V37, P251, DOI 10.1007/BF02224052; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2010, FIGTREE V131; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SantosColares MC, 1997, BRAZ J GENET, V20, P25, DOI 10.1590/S0100-84551997000100005; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Sumner AT, 2003, CHROMOSOMES ORGANIZA; Sumner S, 2004, INSECT SOC, V51, P37, DOI 10.1007/s00040-003-0723-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; Weber NA, 1972, GARDENING ANTS THE A; WHITE M J D, 1973, P961; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	44	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59784	10.1371/journal.pone.0059784	http://dx.doi.org/10.1371/journal.pone.0059784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527267	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600093
J	Keshav, S; Vanasek, T; Niv, Y; Petryka, R; Howaldt, S; Bafutto, M; Racz, I; Hetzel, D; Nielsen, OH; Vermeire, S; Reinisch, W; Karlen, P; Schreiber, S; Schall, TJ; Bekker, P				Keshav, Satish; Vanasek, Tomas; Niv, Yaron; Petryka, Robert; Howaldt, Stephanie; Bafutto, Mauro; Racz, Istvan; Hetzel, David; Nielsen, Ole Haagen; Vermeire, Severine; Reinisch, Walter; Karlen, Per; Schreiber, Stefan; Schall, Thomas J.; Bekker, Pirow		Prospective Randomized	A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease	PLOS ONE			English	Article							THYMUS-EXPRESSED CHEMOKINE; LYMPHOCYTES; LOCALIZATION; NATALIZUMAB; THERAPY; INDEX; CELLS	CCX282-B, also called vercirnon, is a specific, orally-administered chemokine receptor CCR9 antagonist that regulates migration and activation of inflammatory cells in the intestine. This randomized, placebo-controlled trial was conducted to evaluate the safety and efficacy of CCX282-B in 436 patients with Crohn's disease. Crohn's Disease Activity Index (CDAI) scores were 250-450 and C-reactive protein >7.5 mg/L at study entry. In addition to stable concomitant Crohn's medication (85% of subjects), subjects received placebo or CCX282-B (250 mg once daily, 250 mg twice daily, or 500 mg once daily) for 12 weeks. They then received 250 mg CCX282-B twice daily, open-label, through week 16. Subjects who had a clinical response (a >= 70 point drop in CDAI) at week 16 were randomly assigned to groups given placebo or CCX282-B (250 mg, twice daily) for 36 weeks. Primary endpoints were clinical response at Week 8 and sustained clinical response at Week 52. During the 12-week Induction period, the clinical response was highest in the group given 500 mg CCX282-B once daily. Response rates at week 8 were 49% in the placebo group, 52% in the group given CCX282-B 250 mg once daily (odds ratio [OR] = 1.12; p = .667 vs placebo), 48% in the group given CCX282-B 250 mg twice daily (OR = 0.95; p = .833), and 60% in the group given CCX282-B 500 mg once daily (OR = 1.53; p = .111). At week 12, response rates were 47%, 56% (OR = 1.44; p = .168), 49% (OR = 1.07; p = .792), and 61% (OR = 1.74; p = .039), respectively. At the end of the Maintenance period (week 52), 47% of subjects on CCX282-B were in remission, compared to 31% on placebo (OR = 2.01; p = .012); 46% showed sustained clinical responses, compared to 42% on placebo (OR = 1.14; p = .629). CCX282-B was well tolerated. Encouraging results from this clinical trial led to initiation of Phase 3 clinical trials in Crohn's disease.	[Keshav, Satish] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Vanasek, Tomas] Hepatogastroenterol HK, Hradec Kralove, Czech Republic; [Niv, Yaron] Rabin Med Ctr, Petah Tiqwa, Israel; [Petryka, Robert] NZOZ Vivamed, Zespol Lekarzy Specjalistow, Warsaw, Poland; [Bafutto, Mauro] Inst Goiano Gastroenterol & Endoscopia Digest Ltd, Goiania, Go, Brazil; [Racz, Istvan] Petz Aladar Cty & Teaching Hosp, Gyor, Hungary; [Hetzel, David] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Nielsen, Ole Haagen] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Vermeire, Severine] Univ Hosp Gasthuisberg, Louvain, Belgium; [Reinisch, Walter] Allgemeines Krankenhaus Wien, Univ Klin Innere Med 3, Klin Abt Gastroenterol & Hepatol, Vienna, Austria; [Karlen, Per] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Schreiber, Stefan] Univ Kiel, Dept Med 1, Univ Hosp Schleswig Holstein, Kiel, Germany; [Schall, Thomas J.; Bekker, Pirow] ChemoCentryx Inc, Mountain View, CA 94043 USA	University of Oxford; Rabin Medical Center; Royal Adelaide Hospital; University of Copenhagen; Herlev & Gentofte Hospital; KU Leuven; University Hospital Leuven; Karolinska Institutet; Sodersjukhuset Hospital; University of Kiel; Schleswig Holstein University Hospital	Bekker, P (corresponding author), ChemoCentryx Inc, Mountain View, CA 94043 USA.	pbekker@chemocentryx.com	Nielsen, Ole Haagen/AAK-2482-2021	Nielsen, Ole Haagen/0000-0003-4612-8635; Prof. Dr. Racz, Istvan/0000-0001-9740-6995; Vermeire, Severine/0000-0001-9942-3019; Keshav, Satish/0000-0003-0508-8665	ChemoCentryx; Medical Research Council [G0200231] Funding Source: researchfish; MRC [G0200231] Funding Source: UKRI	ChemoCentryx; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors have the following interests. P. Bekker is an employee and shareholder of ChemoCentryx, and T. Schall is an employee, shareholder, and holder of patent number US2005-0137179 on bis-aryl sulfonamides., the funder of this clinical trial. Robert Petryka, is an employee of NZOZ Vivamed, which is a network of medical care specialists. NZOZ Vivamed does not have any commercial interest or stake in the drug candidate, CCX282-B, tested in the clinical trial which is the subject of this manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Marsal J, 2002, EUR J IMMUNOL, V32, P3488, DOI 10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2001, GASTROENTEROLOGY, V121, P246, DOI 10.1053/gast.2001.27154; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Walters MJ, 2008, GUT, V57, pA39; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	20	105	114	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60094	10.1371/journal.pone.0060094	http://dx.doi.org/10.1371/journal.pone.0060094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527300	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600117
J	Koehler, SD; Shore, SE				Koehler, Seth D.; Shore, Susan E.			Stimulus-Timing Dependent Multisensory Plasticity in the Guinea Pig Dorsal Cochlear Nucleus	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DISCHARGE PATTERNS; RESPONSES; PROJECTIONS; NEURONS; INPUTS; TINNITUS; CELLS; INTEGRATION; MECHANISMS	Multisensory neurons in the dorsal cochlear nucleus (DCN) show long-lasting enhancement or suppression of sound-evoked responses when stimulated with combined somatosensory-auditory stimulation. By varying the intervals between sound and somatosensory stimuli we show for the first time in vivo that DCN bimodal responses are influenced by stimulus-timing dependent plasticity. The timing rules and time courses of the observed stimulus-timing dependent plasticity closely mimic those of spike-timing dependent plasticity that have been demonstrated in vitro at parallel-fiber synapses onto DCN principal cells. Furthermore, the degree of inhibition in a neuron influences whether that neuron has Hebbian or anti-Hebbian timing rules. As demonstrated in other cerebellar-like circuits, anti-Hebbian timing rules reflect adaptive filtering, which in the DCN would result in suppression of sound-evoked responses that are predicted by activation of somatosensory inputs, leading to the suppression of body-generated signals such as self-vocalization.	[Koehler, Seth D.; Shore, Susan E.] Univ Michigan, Dept Otolaryngol, Sch Med, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; [Shore, Susan E.] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI USA; [Koehler, Seth D.; Shore, Susan E.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shore, SE (corresponding author), Univ Michigan, Dept Otolaryngol, Sch Med, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA.	sushore@umich.edu			National Institutes of Health [R01DC004825, T32 DC001, P01DC00078]; American Tinnitus Association; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC000078, R01DC004825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Tinnitus Association; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health Grants R01DC004825 (SES) T32 DC001 (SDK), P01DC00078, and the American Tinnitus Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Dahmen Johannes C, 2008, J Neurosci, V28, P13629, DOI 10.1523/JNEUROSCI.4429-08.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Ding J, 1999, J NEUROPHYSIOL, V82, P3434, DOI 10.1152/jn.1999.82.6.3434; Doiron B, 2011, J NEUROSCI, V31, P10579, DOI 10.1523/JNEUROSCI.1592-11.2011; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Haenggeli CA, 2005, J COMP NEUROL, V484, P191, DOI 10.1002/cne.20466; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kanold PO, 2011, J NEUROPHYSIOL, V105, P1063, DOI 10.1152/jn.00807.2010; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Kanold PO, 1999, J NEUROSCI, V19, P2195; KIPKE DR, 1991, HEARING RES, V55, P24, DOI 10.1016/0378-5955(91)90088-Q; Koehler SD, 2011, EUR J NEUROSCI, V33, P409, DOI 10.1111/j.1460-9568.2010.07547.x; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Levine Robert Aaron, 2008, Trends Amplif, V12, P242, DOI 10.1177/1084713808321185; MANIS PB, 1989, J NEUROPHYSIOL, V61, P149, DOI 10.1152/jn.1989.61.1.149; MANIS PB, 1990, J NEUROSCI, V10, P2338; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Mellott JG, 2011, NEUROSCIENCE, V180, P138, DOI 10.1016/j.neuroscience.2011.02.010; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Pilati N, 2012, P NATL ACAD SCI USA, V109, P8292, DOI 10.1073/pnas.1116981109; Requarth T, 2011, CURR OPIN NEUROBIOL, V21, P602, DOI 10.1016/j.conb.2011.05.031; Rhode WS, 1999, J NEUROPHYSIOL, V82, P1019, DOI 10.1152/jn.1999.82.2.1019; RHODE WS, 1983, J COMP NEUROL, V213, P426, DOI 10.1002/cne.902130407; Roberts PD, 2008, BIOL CYBERN, V98, P491, DOI [10.1007/s00422-008-0217-1, 10.1007/S00422-008-0217-1]; Roberts PD, 2006, NEUROCOMPUTING, V69, P1191, DOI 10.1016/j.neucom.2005.12.073; Roberts PD, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00156; Sanchez TG, 2007, ANN OTO RHINOL LARYN, V116, P30, DOI 10.1177/000348940711600106; Sawtell NB, 2010, NEURON, V66, P573, DOI 10.1016/j.neuron.2010.04.018; Sedlacek M, 2011, J NEUROSCI, V31, P15807, DOI 10.1523/JNEUROSCI.4088-11.2011; SHERRIFF FE, 1994, NEUROSCIENCE, V58, P627, DOI 10.1016/0306-4522(94)90086-8; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; SHORE SE, 1991, HEARING RES, V52, P255, DOI 10.1016/0378-5955(91)90205-N; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Shore SE, 1998, HEARING RES, V116, P33, DOI 10.1016/S0378-5955(97)00207-4; SMITH PH, 1985, J COMP NEUROL, V237, P127, DOI 10.1002/cne.902370110; Stabler SE, 1996, J NEUROPHYSIOL, V76, P1667, DOI 10.1152/jn.1996.76.3.1667; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Weedman DL, 1996, J COMP NEUROL, V371, P311; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743, DOI 10.1152/jn.1995.73.2.743; Zeng CH, 2012, J NEUROSCI, V32, P15791, DOI 10.1523/JNEUROSCI.2598-12.2012; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhao YJ, 2011, J NEUROSCI, V31, P3158, DOI 10.1523/JNEUROSCI.5303-10.2011; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zhou JX, 2004, J NEUROSCI RES, V78, P901, DOI 10.1002/jnr.20343	53	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59828	10.1371/journal.pone.0059828	http://dx.doi.org/10.1371/journal.pone.0059828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527274	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600098
J	Nolan, A; Fajardo, E; Huie, ML; Condos, R; Pooran, A; Dawson, R; Dheda, K; Bateman, E; Rom, WN; Weiden, MD				Nolan, Anna; Fajardo, Elaine; Huie, Maryann L.; Condos, Rany; Pooran, Anil; Dawson, Rodney; Dheda, Keertan; Bateman, Eric; Rom, William N.; Weiden, Michael D.			Increased Production of IL-4 and IL-12p40 from Bronchoalveolar Lavage Cells Are Biomarkers of Mycobacterium tuberculosis in the Sputum	PLOS ONE			English	Article							T-CELLS; PULMONARY TUBERCULOSIS; MESSENGER-RNA; GENE-EXPRESSION; CALMETTE-GUERIN; SPLICE VARIANT; IN-VITRO; INFECTION; CYTOKINE; RESPONSES	Background: Tuberculosis (TB) causes 1.45 million deaths annually world wide, the majority of which occur in the developing world. Active TB disease represents immune failure to control latent infection from airborne spread. Acid-fast bacillus (AFB) seen on sputum smear is a biomarker for contagiousness. Methods: We enrolled 73 tuberculosis patients with extensive infiltrates into a research study using bronchoalveolar lavage (BAL) to sample lung immune cells and assay BAL cell cytokine production. All patients had sputum culture demonstrating Mycobacterium tuberculosis and 59/73 (81%) had AFB identified by microscopy of the sputum. Compared with smear negative patients, smear positive patients at presentation had a higher proportion with smoking history, a higher proportion with temperature >38.5 degrees C, higher BAL cells/ ml, lower percent lymphocytes in BAL, higher IL-4 and IL-12p40 in BAL cell supernatants. There was no correlation between AFB smear and other BAL or serum cytokines. Increasing IL-4 was associated with BAL PMN and negatively associated with BAL lymphocytes. Each 10-fold increase in BAL IL-4 and IL-12p40 increased the odds of AFB smear positivity by 7.4 and 2.2-fold, respectively, in a multi-variable logistic model. Conclusion: Increasing IL-4 and IL-12p40 production by BAL cells are biomarkers for AFB in sputum of patients who present with radiographically advanced TB. They likely reflect less effective immune control of pathways for controlling TB, leading to patients with increased infectiousness.	[Nolan, Anna; Fajardo, Elaine; Huie, Maryann L.; Condos, Rany; Rom, William N.; Weiden, Michael D.] NYU, Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA; [Pooran, Anil; Dawson, Rodney; Dheda, Keertan; Bateman, Eric] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit,CTBRI, ZA-7925 Cape Town, South Africa; [Pooran, Anil; Dawson, Rodney; Dheda, Keertan; Bateman, Eric] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa	New York University; University of Cape Town; University of Cape Town	Weiden, MD (corresponding author), NYU, Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA.	michael.weiden@nyumc.org	Nolan, Anna/C-2796-2012	Nolan, Anna/0000-0002-0631-1171; Rom, William/0000-0002-8793-7028	NIH;  [K23HL084191];  [K24A1080298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL084191, R01HL090316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the NIH. The grant numbers are K23HL084191 (A.N.), K24A1080298 (M.D.W.), and RO1HL090316 (M.D.W., R.D. and W.N.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; [Anonymous], 1978, Tubercle, V59, P245; [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P69; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Dawson R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006984; Dheda K, 2005, AIDS, V19, P1601, DOI 10.1097/01.aids.0000183520.52760.ef; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Dheda K, 2007, TUBERCULOSIS, V87, P237, DOI 10.1016/j.tube.2006.11.001; Fenhalls G, 2002, IMMUNOLOGY, V105, P325, DOI 10.1046/j.1365-2567.2002.01378.x; Fletcher HA, 2004, IMMUNOLOGY, V112, P669, DOI 10.1111/j.1365-2567.2004.01922.x; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Gunsten S, 2009, IMMUNOLOGY, V126, P500, DOI 10.1111/j.1365-2567.2008.02923.x; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Raju B, 2008, TUBERCULOSIS, V88, P39, DOI 10.1016/j.tube.2007.07.003; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sable SB, 2007, EUR RESPIR J, V29, P337, DOI 10.1183/09031936.00111205; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Sun YJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-105; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Wakeham J, 1998, J IMMUNOL, V160, P6101; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Weiden MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040016; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59461	10.1371/journal.pone.0059461	http://dx.doi.org/10.1371/journal.pone.0059461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527200	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600074
J	Altenburg, TM; Chinapaw, MJM; van der Knaap, ETW; Brug, J; Manios, Y; Singh, AS				Altenburg, Teatske M.; Chinapaw, Mai J. M.; van der Knaap, Elise T. W.; Brug, Johannes; Manios, Yannis; Singh, Amika S.			Longer Sleep - Slimmer Kids: The ENERGY-Project	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; CHILDHOOD OVERWEIGHT; DURATION; OBESITY; ADOLESCENTS; CHILDREN; WEIGHT; ASSOCIATIONS; RISK; LINK	Background: Few studies have differentiated between weekday and weekend day sleep duration in their association with indicators of weight status in children. Therefore, we examined the association of week and weekend day sleep duration with indicators of body composition in 10-12 year old European school children. Methods and Findings: Multi-level linear regression analysis was performed to examine the association between parent-reported week and weekend day sleep duration and objectively assessed child BMI and WC, adjusting for socio-demographic variables and energy balanced related behaviours EBRBs (i.e. dietary, physical and sedentary behaviour). Compared to sleeping 10 hrs/night or more, sleeping on average less than 10 hrs/night during weekdays was associated with higher BMI (for example, B = 0.86 and CI = [0.27; 1.45] when sleeping <= 7 hrs) and WC (for example, B = 1.99 and CI = [0.32; 3.65] when sleeping <= 7 hrs). Sleeping 9 hrs/night during weekend days, but not <= 8 hrs, was associated with higher WC (B = 0.66; CI = [0.04; 1.28]) compared to sleeping more than 10 hrs/night. Average (week and weekend) sleep duration less than 10 hrs/night was associated with higher values for BMI (B = 0.98; CI = [0.24; 1.73] and WC (B = 2.35; CI = [0.08; 4.31]). Conclusions: Weekday sleep duration seems more strongly associated with body composition in European school children than weekend day sleep duration. Promoting adequate sleep duration may contribute to healthy weight in children.	[Altenburg, Teatske M.; Chinapaw, Mai J. M.; van der Knaap, Elise T. W.; Singh, Amika S.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Brug, Johannes] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harokopio University Athens	Altenburg, TM (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	t.altenburg@vumc.nl	Brug, Johannes/A-8242-2018; Paw, Mai Chin A/N-1665-2019; Manios, Yannis/AAM-8953-2021; Altenburg, Teatske/S-2059-2016	Brug, Johannes/0000-0002-1904-7349; Paw, Mai Chin A/0000-0001-6259-2441; Manios, Yannis/0000-0001-6486-114X; Altenburg, Teatske/0000-0002-8764-5631	European Commission, HEALTH [FP7-HEALTH-2007-B]	European Commission, HEALTH	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7, http://cordis.europa.eu/fp7/home_en.html) of the European Commission, HEALTH (FP7-HEALTH-2007-B). The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug J, 2010, BMC PUBLIC HEALTH, V10; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; Danielsen YS, 2010, INT J PEDIATR OBES, V5, P214, DOI 10.3109/17477160903473739; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Guidolin M, 2012, SLEEP MED, V13, P779, DOI 10.1016/j.sleep.2012.03.016; Hart CN, 2008, BEHAV SLEEP MED, V6, P251, DOI 10.1080/15402000802371379; Hense S, 2011, SLEEP, V34, P633, DOI 10.1093/sleep/34.5.633; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Kong AP, 2011, SLEEP MED, V12, P659, DOI 10.1016/j.sleep.2010.12.015; Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; Lytle LA, 2011, OBESITY, V19, P324, DOI 10.1038/oby.2010.242; Magee CA, 2008, PUBLIC HEALTH, V122, P1373, DOI 10.1016/j.puhe.2008.05.010; Must A, 2009, INT J OBESITY, V33, pS82, DOI 10.1038/ijo.2009.23; Richelsen B, 1997, HORM RES, V48, P105, DOI 10.1159/000191338; Scheen AJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE261, DOI 10.1152/ajpendo.1996.271.2.E261; Seicean A, 2007, SLEEP BREATH, V11, P285, DOI 10.1007/s11325-007-0108-z; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singh Amika S, 2012, BMC Res Notes, V5, P434, DOI 10.1186/1756-0500-5-434; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; SZYMCZAK JT, 1993, SLEEP, V16, P433, DOI 10.1093/sleep/16.5.433; Taheri S, 2006, ARCH DIS CHILD, V91, P881, DOI 10.1136/adc.2005.093013; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Westerlund L, 2009, BRIT J NUTR, V102, P1531, DOI 10.1017/S0007114509990730; Wing YK, 2009, PEDIATRICS, V124, pE994, DOI 10.1542/peds.2008-3602	30	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59522	10.1371/journal.pone.0059522	http://dx.doi.org/10.1371/journal.pone.0059522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527213	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100144
J	Xiao, WC; Peng, YY; Liu, Y; Li, Z; Li, SL; Zheng, XF				Xiao, Weichun; Peng, Yanyan; Liu, Yong; Li, Zhi; Li, Senlin; Zheng, Xiaofeng			HSCARG Inhibits NADPH Oxidase Activity through Regulation of the Expression of p47phox	PLOS ONE			English	Article							NF-KAPPA-B; SENSOR PROTEIN; TUMOR-CELLS; ACTIVATION; DIPHENYLENEIODONIUM; MODULATION; INDUCTION; APOPTOSIS; INCREASE; ASSAY	Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase catalyzes the transfer of electrons from NADPH to O-2, which is the main source of reactive oxygen species (ROS) in nonphagocytic cells. Excess ROS are toxic; therefore, keeping ROS in homeostasis in cells can protect cells from oxidative damage. It is meaningful to further understand the molecular mechanism by which ROS homeostasis is mediated. Human protein HSCARG is a newly identified oxidative sensor and a negative regulator of NF-kappa B. Here, we find that HSCARG represses the cellular ROS generation through inhibiting mRNA and protein expression of p47phox, a subunit of NADPH oxidase. In contrast, shRNA-mediated HSCARG knockdown increases endogenous p47phox expression level. And HSCARG has no obvious effect on ROS production in p47phox-depleted cells. Furthermore, HSCARG regulates p47phox through inhibition of NF-kappa B activity. Our findings identify HSCARG as a novel regulator in regulation of the activity of NADPH oxidase and ROS homeostasis.	[Xiao, Weichun; Peng, Yanyan; Liu, Yong; Li, Zhi; Zheng, Xiaofeng] State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Xiao, Weichun; Peng, Yanyan; Liu, Yong; Li, Zhi; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Li, Senlin] South Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA	Peking University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Zheng, XF (corresponding author), State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.	xiaofengz@pku.edu.cn			National Science Foundation of China [30930020, 31170709]; National High Technology and Development Program of China 973 programs [2010CB911800]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology and Development Program of China 973 programs; International Centre for Genetic Engineering and Biotechnology	This work was supported by grants from the National Science Foundation of China (30930020 and 31170709) the National High Technology and Development Program of China 973 programs (No. 2010CB911800), and the International Centre for Genetic Engineering and Biotechnology (Project No. CRP/CHN09-01). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2004, AM J CLIN NUTR, V79, P682; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Balcerczyk A, 2005, BIOCHEM PHARMACOL, V69, P1263, DOI 10.1016/j.bcp.2005.01.010; Bechtel W, 2009, ANTICANCER RES, V29, P4541; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benicchi T, 2012, J BIOMOL SCREEN, V17, P933, DOI 10.1177/1087057112447873; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Connelly CM, 2012, J BIOMOL SCREEN, V17, P822, DOI 10.1177/1087057112439606; Crow MK, 2003, LUPUS, V12, P163, DOI 10.1191/0961203303lu349xx; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Deng J, 2012, J IMMUNOL, V188, P5734, DOI 10.4049/jimmunol.1101323; Dworakowski R, 2006, BIOCHEM SOC T, V34, P960, DOI 10.1042/BST0340960; Fridlyand LE, 2005, ANN NY ACAD SCI, V1066, P136, DOI 10.1196/annals.1363.019; Gan QN, 2009, J CELL SCI, V122, P4081, DOI 10.1242/jcs.054007; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; Li SL, 1997, J BIOL CHEM, V272, P17802, DOI 10.1074/jbc.272.28.17802; Lian M, 2009, J BIOL CHEM, V284, P17998, DOI 10.1074/jbc.M809752200; Liu GC, 2012, DIABETOLOGIA, V55, P2522, DOI 10.1007/s00125-012-2586-1; Marrero E, 2011, J BIOL CHEM, V286, P36492, DOI 10.1074/jbc.M111.285510; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Sumi D, 2003, BBA-MOL CELL RES, V1640, P113, DOI 10.1016/S0167-4889(03)00026-0; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Yang BX, 2011, MOL CANCER THER, V10, P615, DOI 10.1158/1535-7163.MCT-10-0863; Zhao YM, 2008, J BIOL CHEM, V283, P11004, DOI 10.1074/jbc.M708697200; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	33	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59301	10.1371/journal.pone.0059301	http://dx.doi.org/10.1371/journal.pone.0059301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527155	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100101
J	Archacki, R; Buszewicz, D; Sarnowski, TJ; Sarnowska, E; Rolicka, AT; Tohge, T; Fernie, AR; Jikumaru, Y; Kotlinski, M; Iwanicka-Nowicka, R; Kalisiak, K; Patryn, J; Halibart-Puzio, J; Kamiya, Y; Davis, SJ; Koblowska, MK; Jerzmanowski, A				Archacki, Rafal; Buszewicz, Daniel; Sarnowski, Tomasz J.; Sarnowska, Elzbieta; Rolicka, Anna T.; Tohge, Takayuki; Fernie, Alisdair R.; Jikumaru, Yusuke; Kotlinski, Maciej; Iwanicka-Nowicka, Roksana; Kalisiak, Katarzyna; Patryn, Jacek; Halibart-Puzio, Joanna; Kamiya, Yuji; Davis, Seth J.; Koblowska, Marta K.; Jerzmanowski, Andrzej			BRAHMA ATPase of the SWI/SNF Chromatin Remodeling Complex Acts as a Positive Regulator of Gibberellin-Mediated Responses in Arabidopsis	PLOS ONE			English	Article							SCARECROW-LIKE 3; FLORAL DEVELOPMENT; SEED-GERMINATION; GENETIC-ANALYSIS; DELLA; GROWTH; PLANT; THALIANA; ROLES; EXPRESSION	SWI/SNF chromatin remodeling complexes perform a pivotal function in the regulation of eukaryotic gene expression. Arabidopsis (Arabidopsis thaliana) mutants in major SWI/SNF subunits display embryo-lethal or dwarf phenotypes, indicating their critical role in molecular pathways controlling development and growth. As gibberellins (GA) are major positive regulators of plant growth, we wanted to establish whether there is a link between SWI/SNF and GA signaling in Arabidopsis. This study revealed that in brm-1 plants, depleted in SWI/SNF BRAHMA (BRM) ATPase, a number of GA-related phenotypic traits are GA-sensitive and that the loss of BRM results in markedly decreased level of endogenous bioactive GA. Transcriptional profiling of brm-1 and the GA biosynthesis mutant ga1-3, as well as the ga1-3/brm-1 double mutant demonstrated that BRM affects the expression of a large set of GA-responsive genes including genes responsible for GA biosynthesis and signaling. Furthermore, we found that BRM acts as an activator and directly associates with promoters of GA3ox1, a GA biosynthetic gene, and SCL3, implicated in positive regulation of the GA pathway. Many GA-responsive gene expression alterations in the brm-1 mutant are likely due to depleted levels of active GAs. However, the analysis of genetic interactions between BRM and the DELLA GA pathway repressors, revealed that BRM also acts on GA-responsive genes independently of its effect on GA level. Given the central position occupied by SWI/SNF complexes within regulatory networks controlling fundamental biological processes, the identification of diverse functional intersections of BRM with GA-dependent processes in this study suggests a role for SWI/SNF in facilitating crosstalk between GA-mediated regulation and other cellular pathways.	[Archacki, Rafal; Rolicka, Anna T.; Iwanicka-Nowicka, Roksana; Patryn, Jacek; Koblowska, Marta K.; Jerzmanowski, Andrzej] Univ Warsaw, Fac Biol, Dept Plant Mol Biol, Warsaw, Poland; [Buszewicz, Daniel; Sarnowski, Tomasz J.; Kotlinski, Maciej; Iwanicka-Nowicka, Roksana; Kalisiak, Katarzyna; Halibart-Puzio, Joanna; Koblowska, Marta K.; Jerzmanowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Sarnowska, Elzbieta; Davis, Seth J.] Max Planck Inst Plant Breeding, Cologne, Germany; [Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Jikumaru, Yusuke; Kamiya, Yuji] RIKEN, Plant Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Max Planck Society; Max Planck Society; RIKEN	Jerzmanowski, A (corresponding author), Univ Warsaw, Fac Biol, Dept Plant Mol Biol, Warsaw, Poland.	andyj@ibb.waw.pl	Kamiya, Yuji/F-9420-2010; Tohge, Takayuki/G-7924-2017; Iwanicka-Nowicka, Roksana/M-4910-2019	Kamiya, Yuji/0000-0003-4415-520X; Tohge, Takayuki/0000-0001-5555-5650; Buszewicz, Daniel/0000-0002-3566-6078; Archacki, Rafal/0000-0002-4843-3628; Kotlinski, Maciej/0000-0002-0821-077X; Iwanicka-Nowicka, Roksana/0000-0003-1595-2170; Koblowska, Marta/0000-0003-4497-6200; Rolicka, Anna/0000-0001-9589-0197; Sarnowska, Elzbieta/0000-0001-7723-1198	Ministerstwo Nauki i Szkolnictwa Wyzszego (MNiSW); National Science Centre [N N301 158735, 2011/01/D/NZ1/01614]; Marie Curie Reintegration Grant [FP7-PEOPLE-2010-RG 268313, W29/7. PR/2011 (MNiSW)]; Deutsche Forschunggemeinschaft-DFG-DA [1061/2-1]	Ministerstwo Nauki i Szkolnictwa Wyzszego (MNiSW)(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland); Marie Curie Reintegration Grant(European Commission); Deutsche Forschunggemeinschaft-DFG-DA	This work was supported by Ministerstwo Nauki i Szkolnictwa Wyzszego (MNiSW) and National Science Centre grants: N N301 158735 and 2011/01/D/NZ1/01614 for AJ and RA, Marie Curie Reintegration Grant FP7-PEOPLE-2010-RG 268313 and W29/7. PR/2011 (MNiSW) for TJS, and Deutsche Forschunggemeinschaft-DFG-DA grant 1061/2-1 for SJD. URLs: (http://www.nauka.gov.pl/home/) (http://www.ncn.gov.pl/?language=en) (http://cordis.europa.eu/mariecurie-actions/home.html) (http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Archacki R, 2009, PLANTA, V229, P1281, DOI 10.1007/s00425-009-0915-5; Ariizumi T, 2008, PLANT CELL, V20, P2447, DOI 10.1105/tpc.108.058487; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; Bai MY, 2012, NAT CELL BIOL, V14, P810, DOI 10.1038/ncb2546; Bezhani S, 2007, PLANT CELL, V19, P403, DOI 10.1105/tpc.106.048272; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Farrona S, 2007, J MOL BIOL, V373, P240, DOI 10.1016/j.jmb.2007.07.012; Farrona S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017997; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Gallego-Bartolome J, 2012, P NATL ACAD SCI USA, V109, P13446, DOI 10.1073/pnas.1119992109; Gallego-Bartolome J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023918; Gallego-Bartolome J, 2010, MOL BIOL EVOL, V27, P1247, DOI 10.1093/molbev/msq012; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Hurtado L, 2006, PLANT MOL BIOL, V62, P291, DOI 10.1007/s11103-006-9021-2; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jerzmanowski A, 2007, BBA-GENE STRUCT EXPR, V1769, P330, DOI 10.1016/j.bbaexp.2006.12.003; Josse EM, 2011, PLANT CELL, V23, P1337, DOI 10.1105/tpc.110.082594; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Middleton AM, 2012, P NATL ACAD SCI USA, V109, P7571, DOI 10.1073/pnas.1113666109; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; O'Neill DP, 2010, PLANTA, V232, P1141, DOI 10.1007/s00425-010-1248-0; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Saez A, 2008, PLANT CELL, V20, P2972, DOI 10.1105/tpc.107.056705; Sarnowski TJ, 2005, PLANT CELL, V17, P2454, DOI 10.1105/tpc.105.031203; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Silverstone AL, 1997, GENETICS, V146, P1087; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Silverstone AL, 2007, PLANT PHYSIOL, V143, P987, DOI 10.1104/pp.106.091025; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Sun Tai-Ping, 2008, Arabidopsis Book, V6, pe0103, DOI 10.1199/tab.0103; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Tang XR, 2008, PLANT PHYSIOL, V147, P1143, DOI 10.1104/pp.108.121996; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Wagner D, 2002, CURR BIOL, V12, P85, DOI 10.1016/S0960-9822(01)00651-0; Walley JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000237; Willige BC, 2011, PLANT CELL, V23, P2184, DOI 10.1105/tpc.111.086355; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108	70	52	55	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58588	10.1371/journal.pone.0058588	http://dx.doi.org/10.1371/journal.pone.0058588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536800	gold, Green Published			2022-12-27	WOS:000316251100067
J	Breig, O; Baklouti, F				Breig, Osman; Baklouti, Faouzi			Proteasome-Mediated Proteolysis of SRSF5 Splicing Factor Intriguingly Co-occurs with SRSF5 mRNA Upregulation during Late Erythroid Differentiation	PLOS ONE			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; SR PROTEIN FAMILY; GENE-EXPRESSION; ISOFORM EXPRESSION; FACTOR SRP40; BETA-II; ENHANCER; NUCLEAR; PHOSPHORYLATION; IDENTIFICATION	SR proteins exhibit diverse functions ranging from their role in constitutive and alternative splicing, to virtually all aspects of mRNA metabolism. These findings have attracted growing interest in deciphering the regulatory mechanisms that control the tissue-specific expression of these SR proteins. In this study, we show that SRSF5 protein decreases drastically during erythroid cell differentiation, contrasting with a concomitant upregulation of SRSF5 mRNA level. Proteasome chemical inhibition provided strong evidence that endogenous SRSF5 protein, as well as protein deriving from stably transfected SRSF5 cDNA, are both targeted to proteolysis as the cells undergo terminal differentiation. Consistently, functional experiments show that overexpression of SRSF5 enhances a specific endogenous pre-mRNA splicing event in proliferating cells, but not in differentiating cells, due to proteasome-mediated targeting of both endogenous and transfection-derived SRSF5. Further investigation of the relationship between SRSF5 structure and its post-translation regulation and function, suggested that the RNA recognition motifs of SRSF5 are sufficient to activate pre-mRNA splicing, whereas proteasome-mediated proteolysis of SRSF5 requires the presence of the C-terminal RS domain of the protein. Phosphorylation of SR proteins is a key post-translation regulation that promotes their activity and subcellular availability. We here show that inhibition of the CDC2-like kinase (CLK) family and mutation of the AKT phosphorylation site Ser86 on SRSF5, have no effect on SRSF5 stability. We reasoned that at least AKT and CLK signaling pathways are not involved in proteasome-induced turnover of SRSF5 during late erythroid development.	[Breig, Osman; Baklouti, Faouzi] Univ Lyon 1, CNRS, UMR, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Baklouti, F (corresponding author), Univ Lyon 1, CNRS, UMR, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France.	faouzi.baklouti@univ-lyon1.fr	BAKLOUTI, Faouzi/E-7670-2013	BAKLOUTI, Faouzi/0000-0002-2830-292X	Ligue Nationale Contre le Cancer, Comite de la Loire; INSERM	Ligue Nationale Contre le Cancer, Comite de la Loire; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the Ligue Nationale Contre le Cancer, Comite de la Loire. OB and FB were supported by the Ligue Nationale Contre le Cancer, Comite de la Loire and the INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; Baldin V, 2008, MOL BIOL CELL, V19, P1706, DOI 10.1091/mbc.E07-07-0637; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Breig O, 2010, ONCOGENE, V29, P2807, DOI 10.1038/onc.2010.29; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Chandler SD, 1997, P NATL ACAD SCI USA, V94, P3596, DOI 10.1073/pnas.94.8.3596; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Du KY, 1997, GENE, V204, P243, DOI 10.1016/S0378-1119(97)00552-0; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Han F, 2007, EXP CELL RES, V313, P1518, DOI 10.1016/j.yexcr.2007.01.028; Huang SC, 2012, MOL CELL BIOL, V32, P513, DOI 10.1128/MCB.06423-11; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kloc M, 2011, BIOCHIMIE, V93, P1955, DOI 10.1016/j.biochi.2011.07.008; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lee TL, 2010, P NATL ACAD SCI USA, V107, P52, DOI 10.1073/pnas.0909153107; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; McFarlane M, 2010, BIOCHEM SOC T, V38, P1116, DOI 10.1042/BST0381116; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Moriniere M, 2010, BLOOD CELL MOL DIS, V45, P284, DOI 10.1016/j.bcmd.2010.08.011; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Snow BE, 1997, GENOMICS, V43, P165, DOI 10.1006/geno.1997.4794; Soret J, 2006, PROG MOLEC, V44, P65; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Swanson CM, 2010, J VIROL, V84, P6748, DOI 10.1128/JVI.02526-09; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Theoleyre O, 2004, ONCOGENE, V23, P920, DOI 10.1038/sj.onc.1207206; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Yang G, 2005, BLOOD, V105, P2146, DOI 10.1182/blood-2004-05-1757; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	67	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59137	10.1371/journal.pone.0059137	http://dx.doi.org/10.1371/journal.pone.0059137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536862	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100122
J	Domenech, A; Ardanuy, C; Pallares, R; Grau, I; Santos, S; De la Campa, AG; Linares, J				Domenech, Arnau; Ardanuy, Carmen; Pallares, Roman; Grau, Immaculada; Santos, Salud; De la Campa, Adela G.; Linares, Josefina			Some Pneumococcal Serotypes Are More Frequently Associated with Relapses of Acute Exacerbations in COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STREPTOCOCCUS-PNEUMONIAE; INVASIVE-DISEASE; STRAINS	Objectives: To analyze the role of the capsular type in pneumococci causing relapse and reinfection episodes of acute exacerbation in COPD patients. Methods: A total of 79 patients with 116 recurrent episodes of acute exacerbations caused by S. pneumoniae were included into this study (1995-2010). A relapse episode was considered when two consecutive episodes were caused by the same strain (identical serotype and genotype); otherwise it was considered reinfection. Antimicrobial susceptibility testing (microdilution), serotyping (PCR, Quellung) and molecular typing (PFGE/MLST) were performed. Results: Among 116 recurrent episodes, 81 (69.8%) were reinfections, caused by the acquisition of a new pneumococcus, and 35 (30.2%) were relapses, caused by a pre-existing strain. Four serotypes (9V, 19F, 15A and 11A) caused the majority (60.0%) of relapses. When serotypes causing relapses and reinfection were compared, only two serotypes were associated with relapses: 9V (OR 8.0; 95% CI, 1.34-85.59) and 19F (OR 16.1; 95% CI, 1.84-767.20). Pneumococci isolated from relapses were more resistant to antimicrobials than those isolated from the reinfection episodes: penicillin (74.3% vs. 34.6%, p < 0.001), ciprofloxacin (25.7% vs. 9.9%, p < 0.027), levofloxacin (22.9% vs. 7.4%, p = 0.029), and co-trimoxazole (54.3% vs. 25.9%, p < 0.001). Conclusions: Although the acquisition of a new S. pneumoniae strain was the most frequent cause of recurrences, a third of the recurrent episodes were caused by a pre-existing strain. These relapse episodes were mainly caused by serotypes 9V and 19F, suggesting an important role for capsular type.	[Domenech, Arnau; Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Domenech, Arnau; Ardanuy, Carmen; Pallares, Roman; Grau, Immaculada; De la Campa, Adela G.; Linares, Josefina] ISCIII, CIBERES Ciber Enfermedades Resp, Madrid, Spain; [Grau, Immaculada] Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [De la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [De la Campa, Adela G.] CSIC, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC)	Ardanuy, C (corresponding author), Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	c.ardanuy@bellvitgehospital.cat	PALLARES, Roman/B-5710-2008; de la Campa, Adela G/K-1654-2014; Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014	PALLARES, Roman/0000-0003-3262-8508; de la Campa, Adela G/0000-0002-3598-2548; Santos, Salud/0000-0002-5835-1028; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X; Domenech, Arnau/0000-0002-0829-511X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI 0901904]; Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion [BIO2008-02154, BIO2011-25343]; CIBER de Enfermedades Respiratorias, CIBERES; Instituto de Salud Carlos III (ISCIII), Madrid, Spain [CB06/06/0037]; Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain); Wellcome Trust	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER de Enfermedades Respiratorias, CIBERES; Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain)(Spanish Government); Wellcome Trust(Wellcome Trust)	This work was supported by grants from the Fondo de Investigaciones Sanitarias de la Seguridad Social [PI 0901904], by grants [BIO2008-02154 and BIO2011-25343] from Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion, and by CIBER de Enfermedades Respiratorias, CIBERES; [CB06/06/0037], run by the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. A. D. was supported by a grant from Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the use of the Streptococcus pneumoniae MLST web site at Imperial College London, funded by the Wellcome Trust. We wish to thank all the staff of Microbiology Laboratory of Hospital Universitari de Bellvitge who contributed to this project on a daily basis.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Centers for Disease Control and Prevention, 2012, PCR DED PNEUM SER; Clinical Laboratory Standard Institute, 2011, M100S21 CLSINCCLS, V31; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; de la Campa AG, 2003, ANTIMICROB AGENTS CH, V47, P1419, DOI 10.1128/AAC.47.4.1419-1422.2003; Domenech A, 2012, J CLIN MICROBIOL, V50, P4047, DOI 10.1128/JCM.02056-12; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Schenkein JG, 2008, CHEST, V133, P767, DOI 10.1378/chest.07-0996; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; World Health Organization, 2012, CHRON OBSTR PULM DIS	14	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59027	10.1371/journal.pone.0059027	http://dx.doi.org/10.1371/journal.pone.0059027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536850	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100112
J	Nakamura, Y; Sasaki, N; Kobayashi, M; Ojima, N; Yasuike, M; Shigenobu, Y; Satomi, M; Fukuma, Y; Shiwaku, K; Tsujimoto, A; Kobayashi, T; Nakayama, I; Ito, F; Nakajima, K; Sano, M; Wada, T; Kuhara, S; Inouye, K; Gojobori, T; Ikeo, K				Nakamura, Yoji; Sasaki, Naobumi; Kobayashi, Masahiro; Ojima, Nobuhiko; Yasuike, Motoshige; Shigenobu, Yuya; Satomi, Masataka; Fukuma, Yoshiya; Shiwaku, Koji; Tsujimoto, Atsumi; Kobayashi, Takanori; Nakayama, Ichiro; Ito, Fuminari; Nakajima, Kazuhiro; Sano, Motohiko; Wada, Tokio; Kuhara, Satoru; Inouye, Kiyoshi; Gojobori, Takashi; Ikeo, Kazuho			The First Symbiont-Free Genome Sequence of Marine Red Alga, Susabi-nori (Pyropia yezoensis)	PLOS ONE			English	Article							NUCLEOMORPH GENOME; REVEALS; RHODOPHYTA; EVOLUTION; GENERATION; VITAMIN-B-12; ANNOTATION; EXPRESSION; BANGIALES; BLAST	Nori, a marine red alga, is one of the most profitable mariculture crops in the world. However, the biological properties of this macroalga are poorly understood at the molecular level. In this study, we determined the draft genome sequence of susabi-nori (Pyropia yezoensis) using next-generation sequencing platforms. For sequencing, thalli of P. yezoensis were washed to remove bacteria attached on the cell surface and enzymatically prepared as purified protoplasts. The assembled contig size of the P. yezoensis nuclear genome was approximately 43 megabases (Mb), which is an order of magnitude smaller than the previously estimated genome size. A total of 10,327 gene models were predicted and about 60% of the genes validated lack introns and the other genes have shorter introns compared to large-genome algae, which is consistent with the compact size of the P. yezoensis genome. A sequence homology search showed that 3,611 genes (35%) are functionally unknown and only 2,069 gene groups are in common with those of the unicellular red alga, Cyanidioschyzon merolae. As color trait determinants of red algae, light-harvesting genes involved in the phycobilisome were predicted from the P. yezoensis nuclear genome. In particular, we found a second homolog of phycobilisome-degradation gene, which is usually chloroplast-encoded, possibly providing a novel target for color fading of susabi-nori in aquaculture. These findings shed light on unexplained features of macroalgal genes and genomes, and suggest that the genome of P. yezoensis is a promising model genome of marine red algae.	[Nakamura, Yoji; Ojima, Nobuhiko; Yasuike, Motoshige; Shigenobu, Yuya; Satomi, Masataka; Sano, Motohiko] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Sasaki, Naobumi; Gojobori, Takashi; Ikeo, Kazuho] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Kobayashi, Masahiro] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Nagasaki, Japan; [Fukuma, Yoshiya; Shiwaku, Koji] Hitachi Solut Ltd, Shinagawa Ku, Tokyo, Japan; [Tsujimoto, Atsumi] Japan Software Management Co Ltd, Yokohama, Kanagawa, Japan; [Kobayashi, Takanori; Wada, Tokio; Inouye, Kiyoshi] Fisheries Res Agcy, Yokohama, Kanagawa, Japan; [Nakayama, Ichiro] Minist Agr Forestry & Fisheries, Chiyoda Ku, Tokyo, Japan; [Ito, Fuminari] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Nakajima, Kazuhiro] Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuou Ku, Niigata, Japan; [Kuhara, Satoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Mol Biosci,Higashi Ku, Fukuoka 812, Japan	Japan Fisheries Research & Education Agency (FRA); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Ministry of Agriculture Forestry & Fisheries - Japan; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Kyushu University	Nakamura, Y (corresponding author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan.	yojnakam@affrc.go.jp; tgojobor@nig.ac.jp	Ojima, Nobuhiko/I-5377-2016		Fisheries Agency, Ministry of Agriculture, Forestry and Fisheries, Japan; Fisheries Research Agency, Japan	Fisheries Agency, Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Fisheries Research Agency, Japan	This work was supported by grants from the Fisheries Agency, Ministry of Agriculture, Forestry and Fisheries, Japan, and from the Fisheries Research Agency, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKI T, 1994, J PHYCOL, V30, P1040, DOI 10.1111/j.0022-3646.1994.01040.x; Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BHATTACHARYA D, 1995, J PHYCOL, V31, P489, DOI 10.1111/j.1529-8817.1995.tb02542.x; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Brodie JA, 2003, SEAWEEDS BRIT ISLES, V1; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Colenso W, 1880, VEGETABLE FOOD ANCIE; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DREW KM, 1949, NATURE, V164, P748, DOI 10.1038/164748a0; DREW KM, 1954, NATURE, V173, P1243, DOI 10.1038/1731243a0; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Fulneckova J, 2012, GENOME BIOL EVOL, V4, P248, DOI 10.1093/gbe/evs007; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Hoffmann A., 1997, MARINE FLORA CENTRAL; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; KAPRAUN DF, 1991, PHYCOLOGIA, V30, P458, DOI 10.2216/i0031-8884-30-5-458.1; KAPRAUN DF, 1987, PHYCOLOGIA, V26, P82, DOI 10.2216/i0031-8884-26-1-82.1; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawakami T, 2009, BIOSCI BIOTECH BIOCH, V73, P740, DOI 10.1271/bbb.80662; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kurahashi M, 2004, INT J SYST EVOL MICR, V54, P693, DOI 10.1099/ijs.0.02778-0; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Matsuyama-Serisawa K, 2007, FISHERIES SCI, V73; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mumford TF., 1988, ALGAE HUMAN AFFAIRS, P87; Nakamura Y, 2007, MOL BIOL EVOL, V24, P110, DOI 10.1093/molbev/msl138; Namba A, 2010, FISHERIES SCI, V76, P873, DOI 10.1007/s12562-010-0273-z; Nikaido I, 2000, DNA RES, V7, P223, DOI 10.1093/dnares/7.3.223; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen Songdong, 2011, BMC Res Notes, V4, P428, DOI 10.1186/1756-0500-4-428; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Sobreira TJP, 2006, BIOINFORMATICS, V22, P361, DOI 10.1093/bioinformatics/bti809; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; Turner NJ, 2003, CAN J BOT, V81, P283, DOI [10.1139/B03-029, 10.1139/b03-029]; Waaland JR, 2004, J PHYCOL, V40, P26, DOI 10.1111/j.0022-3646.2003.03-148.x; WILLIAMS MD, 1979, SYESIS, V12, P63; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	52	121	124	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57122	10.1371/journal.pone.0057122	http://dx.doi.org/10.1371/journal.pone.0057122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536760	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100006
J	Ohnishi, K; Ohkura, S; Nakahata, E; Ishisaka, A; Kawai, Y; Terao, J; Mori, T; Ishii, T; Nakayama, T; Kioka, N; Matsumoto, S; Ikeda, Y; Akiyama, M; Irie, K; Murakami, A				Ohnishi, Kohta; Ohkura, Shinya; Nakahata, Erina; Ishisaka, Akari; Kawai, Yoshichika; Terao, Junji; Mori, Taiki; Ishii, Takeshi; Nakayama, Tsutomu; Kioka, Noriyuki; Matsumoto, Shinya; Ikeda, Yasutaka; Akiyama, Minoru; Irie, Kazuhiro; Murakami, Akira			Non-Specific Protein Modifications by a Phytochemical Induce Heat Shock Response for Self-Defense	PLOS ONE			English	Article							TROPICAL GINGER SESQUITERPENE; COVALENT BINDING; GENE-EXPRESSION; STRESS-RESPONSE; HEPATOMA-CELLS; IN-VITRO; ZERUMBONE; SULFORAPHANE; SUPPRESSES; MECHANISM	Accumulated evidence shows that some phytochemicals provide beneficial effects for human health. Recently, a number of mechanistic studies have revealed that direct interactions between phytochemicals and functional proteins play significant roles in exhibiting their bioactivities. However, their binding selectivities to biological molecules are considered to be lower due to their small and simple structures. In this study, we found that zerumbone, a bioactive sesquiterpene, binds to numerous proteins with little selectivity. Similar to heat-denatured proteins, zerumbone-modified proteins were recognized by heat shock protein 90, a constitutive molecular chaperone, leading to heat shock factor 1-dependent heat shock protein induction in hepa1c1c7 mouse hepatoma cells. Furthermore, oral administration of this phytochemical up-regulated heat shock protein expressions in the livers of Sprague-Dawley rats. Interestingly, pretreatment with zerumbone conferred a thermoresistant phenotype to hepa1c1c7 cells as well as to the nematode Caenorhabditis elegans. It is also important to note that several phytochemicals with higher hydrophobicity or electrophilicity, including phenethyl isothiocyanate and curcumin, markedly induced heat shock proteins, whereas most of the tested nutrients did not. These results suggest that non-specific protein modifications by xenobiotic phytochemicals cause mild proteostress, thereby inducing heat shock response and leading to potentiation of protein quality control systems. We considered these bioactivities to be xenohormesis, an adaptation mechanism against xenobiotic chemical stresses. Heat shock response by phytochemicals may be a fundamental mechanism underlying their various bioactivities.	[Ohnishi, Kohta; Ohkura, Shinya; Nakahata, Erina; Irie, Kazuhiro; Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Ishisaka, Akari; Kawai, Yoshichika; Terao, Junji] Univ Tokushima, Dept Food Sci, Tokushima, Japan; [Mori, Taiki; Ishii, Takeshi; Nakayama, Tsutomu] Univ Shizuoka, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; [Kawai, Yoshichika] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kawai, Yoshichika] Nagoya Univ, Sch Agr Sci, Nagoya, Aichi 4648601, Japan; [Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Matsumoto, Shinya] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan; [Ikeda, Yasutaka; Akiyama, Minoru] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan	Kyoto University; Tokushima University; University of Shizuoka; Nagoya University; Nagoya University; Kyoto University; Kyoto Womens University; Otsuka Pharmaceutical	Murakami, A (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.	cancer@kais.kyoto-u.ac.jp	Irie, Kazuhiro/A-6121-2014; Kawai, Yoshichika/G-3231-2011	Irie, Kazuhiro/0000-0001-7109-8568; Kioka, Noriyuki/0000-0002-2708-537X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by a Grant-in Aid for Scientific Research (C) (AM) and a grant from the Japan Society for the Promotion of Science Fellows (KO); URL: http://www.jsps.go.jp/english/index.html". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; ANGELIDIS CE, 1991, EUR J BIOCHEM, V199, P35, DOI 10.1111/j.1432-1033.1991.tb16088.x; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; BERNHARD HP, 1973, DEV BIOL, V35, P83, DOI 10.1016/0012-1606(73)90008-0; BRENNER S, 1974, GENETICS, V77, P71; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; Egner PA, 2008, CHEM RES TOXICOL, V21, P1991, DOI 10.1021/tx800210k; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Gan NQ, 2010, J BIOL CHEM, V285, P35528, DOI 10.1074/jbc.M110.152686; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gopal-Srivastava R, 1998, J BIOL CHEM, V273, P17954, DOI 10.1074/jbc.273.28.17954; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hatayama T, 1999, BIOCHEM BIOPH RES CO, V265, P763, DOI 10.1006/bbrc.1999.1751; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Jung JH, 2010, J CELL PHYSIOL, V223, P408, DOI 10.1002/jcp.22049; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kim M, 2010, BIOFACTORS, V36, P43, DOI 10.1002/biof.69; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Murakami A, 2005, J NUTR, V135, p2987S, DOI 10.1093/jn/135.12.2987S; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; Murakami A, 1999, BIOSCI BIOTECH BIOCH, V63, P1811, DOI 10.1271/bbb.63.1811; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; Nakamura Y, 2004, FEBS LETT, V572, P245, DOI 10.1016/j.febslet.2004.07.042; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Nishiumi Shin, 2011, Front Biosci (Schol Ed), V3, P1332; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Pernice R, 2009, MOL NUTR FOOD RES, V53, P1540, DOI 10.1002/mnfr.200900447; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Shibata T, 2011, J BIOL CHEM, V286, P42150, DOI 10.1074/jbc.M111.308049; Shim J, 2003, FEBS LETT, V537, P139, DOI 10.1016/S0014-5793(03)00111-X; Sibhatu MB, 2008, CARCINOGENESIS, V29, P807, DOI 10.1093/carcin/bgn013; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Surh YJ, 2011, ANN NY ACAD SCI, V1229, P1, DOI 10.1111/j.1749-6632.2011.06097.x; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tran PLCHB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-276; Uchiyama T, 2011, METABOLISM, V60, P789, DOI 10.1016/j.metabol.2010.07.029; VANRIJN J, 1995, INT J HYPERTHER, V11, P697, DOI 10.3109/02656739509022501; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang YS, 2012, CARCINOGENESIS, V33, P2, DOI 10.1093/carcin/bgr255	48	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58641	10.1371/journal.pone.0058641	http://dx.doi.org/10.1371/journal.pone.0058641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536805	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100072
J	Piel, AK; Stewart, FA; Pintea, L; Li, YY; Ramirez, MA; Loy, DE; Crystal, PA; Learn, GH; Knapp, LA; Sharp, PM; Hahn, BH				Piel, Alex K.; Stewart, Fiona A.; Pintea, Lilian; Li, Yingying; Ramirez, Miguel A.; Loy, Dorothy E.; Crystal, Patricia A.; Learn, Gerald H.; Knapp, Leslie A.; Sharp, Paul M.; Hahn, Beatrice H.			The Malagarasi River Does Not Form an Absolute Barrier to Chimpanzee Movement in Western Tanzania	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; GENETIC-STRUCTURE; EASTERN CHIMPANZEES; WILD CHIMPANZEES; DIVERSITY; BONOBOS	The Malagarasi River has long been thought to be a barrier to chimpanzee movements in western Tanzania. This potential geographic boundary could affect chimpanzee ranging behavior, population connectivity and pathogen transmission, and thus has implications for conservation strategies and government policy. Indeed, based on mitochondrial DNA sequence comparisons it was recently argued that chimpanzees from communities to the north and to the south of the Malagarasi are surprisingly distantly related, suggesting that the river prevents gene flow. To investigate this, we conducted a survey along the Malagarasi River. We found a ford comprised of rocks that researchers could cross on foot. On a trail leading to this ford, we collected 13 fresh fecal samples containing chimpanzee DNA, two of which tested positive for SIVcpz. We also found chimpanzee feces within the riverbed. Taken together, this evidence suggests that the Malagarasi River is not an absolute barrier to chimpanzee movements and communities from the areas to the north and south should be considered a single population. These results have important consequences for our understanding of gene flow, disease dynamics and conservation management.	[Piel, Alex K.] Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA; [Piel, Alex K.; Stewart, Fiona A.; Knapp, Leslie A.] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Pintea, Lilian] Jane Goodall Inst, Arlington, VA USA; [Li, Yingying; Ramirez, Miguel A.; Loy, Dorothy E.; Crystal, Patricia A.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Li, Yingying; Ramirez, Miguel A.; Loy, Dorothy E.; Crystal, Patricia A.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Sharp, Paul M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	University of California System; University of California San Diego; University of Cambridge; University of Pennsylvania; University of Pennsylvania; University of Edinburgh; University of Edinburgh	Piel, AK (corresponding author), Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA.	akp34@cam.ac.uk	Sharp, Paul/Y-3787-2019; Sharp, Paul M/F-5783-2010; Learn, Jerry/E-3356-2012; Sharp, Paul M/GPX-1497-2022	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Learn, Gerald/0000-0003-0434-7733; Loy, Dorothy/0000-0002-3207-0893; Hahn, Beatrice/0000-0002-9400-9887; Stewart, Fiona/0000-0002-4929-4711	Nature Conservancy; Frankfurt Zoological Society; Jane Goodall Institute; National Institutes of Health [R01 AI50529, R01 AI58715]; ARCUS Foundation; United States Fish & Wildlife Great Apes Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI050529, R01AI058715] Funding Source: NIH RePORTER	Nature Conservancy; Frankfurt Zoological Society; Jane Goodall Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCUS Foundation; United States Fish & Wildlife Great Apes Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank The Nature Conservancy, Frankfurt Zoological Society, and the Jane Goodall Institute for financial and logistical support during this work, and the National Institutes of Health (R01 AI50529, R01 AI58715), the ARCUS Foundation and the United States Fish & Wildlife Great Apes Fund for financial support. AKP & FAS are also grateful to CARTA (Center for Academic Research & Training in Anthropogeny) at UCSD for continued support of the long-term research in Ugalla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Beadle L.C., 1974, INLAND WATERS TROPIC, DOI [10.4319/lo.1977.22.5.0972b, DOI 10.4319/LO.1977.22.5.0972B]; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finnegan LA, 2012, EUR J WILDLIFE RES, V58, P415, DOI 10.1007/s10344-011-0590-2; Forbes SH, 1997, CONSERV BIOL, V11, P1226, DOI 10.1046/j.1523-1739.1997.96296.x; Gonder MK, 2006, INT J PRIMATOL, V27, P1103, DOI 10.1007/s10764-006-9063-y; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Hernandez-Aguilar RA, 2009, J HUM EVOL, V57, P350, DOI 10.1016/j.jhevol.2009.03.007; Inoue E, 2012, PRIMATE CONSERVATION, P26; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; KANO T, 1971, Primates, V12, P229, DOI 10.1007/BF01730413; Kano T, 1999, PRIMATE RES, P15; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHMAN N, 1991, GENETICS, V128, P405; Li YY, 2012, J VIROL, V86, P10776, DOI 10.1128/JVI.01498-12; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Michel E, 2008, RES REPORT; Mitani JC, 2002, ANIM BEHAV, V64, P727, DOI 10.1006/anbe.2002.4014; Moore Jim, 1992, P99; Morrogh-Bernard HC, 2011, INT J PRIMATOL, V32, P362, DOI 10.1007/s10764-010-9474-7; Moyer D, 2006, SURVEY CHIMPAZEES OT, P65; Ogawa H, 2011, PANAFRICA NEWS, P18; Ogawa H, 2006, PANAFRICA NEWS, P21; Pintea L, 2006, REMOTE SENSING CHIMP; Pintea L, 2003, PECORA 15 LAND SATEL; Pintea L, 2006, INT J PRIMATOLOGY; Plumptre AJ, 1997, INT J PRIMATOL, V18, P475, DOI 10.1023/A:1026302920674; Rudicell RS, 2011, J VIROL, V85, P9918, DOI 10.1128/JVI.05475-11; Rudicell RS, 2010, PLOS PATHOG, V6, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Schubert G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021514; Shimada MK, 2004, AM J PRIMATOL, V64, P261, DOI 10.1002/ajp.20077; Stewart FA, 2011, J HUMAN EVOLUTION; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Telfer PT, 2003, MOL ECOL, V12, P2019, DOI 10.1046/j.1365-294X.2003.01877.x; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wroblewski EE, 2009, ANIMAL BEHAV, P77; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269	50	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58965	10.1371/journal.pone.0058965	http://dx.doi.org/10.1371/journal.pone.0058965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536841	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000316251100106
J	Yao, XH; Ping, YF; Liu, Y; Chen, KQ; Yoshimura, T; Liu, MY; Gong, WH; Chen, C; Niu, Q; Guo, DY; Zhang, X; Wang, JM; Bian, XW				Yao, Xiaohong; Ping, Yifang; Liu, Ying; Chen, Kequiang; Yoshimura, Teizo; Liu, Mingyong; Gong, Wanghua; Chen, Chong; Niu, Qin; Guo, Deyu; Zhang, Xia; Wang, Ji Ming; Bian, Xiuwu			Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB PLUS IRINOTECAN; PRECURSOR CELLS; CANCER-CELLS; ANGIOGENESIS; RECEPTOR; IDENTIFICATION; ACTIVATION; VEGF; VASCULARIZATION	Human glioblastomas (GBM) are thought to be initiated by glioma stem-like cells (GSLCs). GSLCs also participate in tumor neovascularization by transdifferentiating into vascular endothelial cells. Here, we report a critical role of GSLCs in the formation of vasculogenic mimicry (VM), which defines channels lined by tumor cells to supply nutrients to early growing tumors and tumor initiation. GSLCs preferentially expressed vascular endothelial growth factor receptor-2 (VEGFR-2) that upon activation by VEGF, mediated chemotaxis, tubule formation and increased expression of critical VM markers by GSLCs. Knockdown of VEGFR-2 in GSLCs by shRNA markedly reduced their capacity of self-renewal, forming tubules, initiating xenograft tumors, promoting vascularization and the establishment of VM. Our study demonstrates VEGFR-2 as an essential molecule to sustain the "stemness" of GSLCs, their capacity to initiate tumor vasculature, and direct initiation of tumor.	[Yao, Xiaohong; Ping, Yifang; Chen, Chong; Niu, Qin; Guo, Deyu; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Yao, Xiaohong; Ping, Yifang; Chen, Chong; Niu, Qin; Guo, Deyu; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Canc Ctr, Chongqing, Peoples R China; [Yao, Xiaohong; Liu, Ying; Chen, Kequiang; Yoshimura, Teizo; Liu, Mingyong; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Liu, Mingyong] Third Mil Med Univ, Daping Hosp, Dept Spinal Surg, Chongqing, Peoples R China; [Gong, Wanghua] SAIC Frederick, Basic Res Program, Frederick, MD USA	Army Medical University; Army Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Army Medical University; Science Applications International Corporation (SAIC); SAIC-Frederick	Wang, JM (corresponding author), NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.	wangji@mail.nih.gov; bianxiuwu@263.net	Bian, Xiu-Wu/D-4736-2017; Zhang, Xia/B-8152-2008	Bian, Xiu-Wu/0000-0003-4383-0197; Zhang, Xia/0000-0002-9040-1486; Yoshimura, Teizo/0000-0002-3853-2075	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Foundation of China (NSFC) [30800421, 30870965]; Natural Science Foundation Project of CQ (CSTC) [2008BB5136]; National Cancer Institute (NCI), National Institutes of Health (NIH) [HHSN261200800001E]; NCI, NIH, United States of America	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ (CSTC)(Natural Science Foundation Project of CQ CSTC); National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH, United States of America	This project was supported in part by the National Basic Research Program of China (973 Program, No. 2010CB529403), the National Natural Science Foundation of China (NSFC, No. 30800421 and 30870965) and the Natural Science Foundation Project of CQ (CSTC, 2008BB5136). This project was also funded in part with Federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH), under Contract No. HHSN261200800001E and was supported in part by the Intramural Research Program of the NCI, NIH, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Medina MA, 2007, J CELL MOL MED, V11, P374, DOI 10.1111/j.1582-4934.2007.00056.x; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Carmeliet, 1999, Curr Interv Cardiol Rep, V1, P322; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; E H, 2001, Methods Mol Med, V57, P115, DOI 10.1385/1-59259-136-1:115; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Francescone R, 2012, J BIOL CHEM, V287, P24821, DOI 10.1074/jbc.M111.334540; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Hatiboglu MA, 2010, TARGET ONCOL, V5, P217, DOI 10.1007/s11523-010-0151-8; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hess AR, 2007, DEV DYNAM, V236, P3283, DOI 10.1002/dvdy.21190; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Kurz H, 2003, NEWS PHYSIOL SCI, V18, P65, DOI 10.1152/nips.01417.2002; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Liu ZC, 2011, PATHOL RES PRACT, V207, P645, DOI 10.1016/j.prp.2011.07.012; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ping YF, 2011, CURR MOL MED, V11, P69, DOI 10.2174/156652411794474383; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Ping Yi-fang, 2007, Chinese Journal of Pathology, V36, P179; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Santarelli JG, 2006, NEUROSURGERY, V59, P374, DOI 10.1227/01.NEU.0000222658.66878.CC; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scully S, 2012, J NEUROSCI, V32, P12950, DOI 10.1523/JNEUROSCI.2017-12.2012; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stratmann A, 2001, INT J CANCER, V91, P273, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Yang XJ, 1996, J NEUROSCI, V16, P6089; Yao XH, 2008, J PATHOL, V215, P369, DOI 10.1002/path.2356; Yao XH, 2008, J NEURO-ONCOL, V86, P47, DOI 10.1007/s11060-007-9443-y; Yao XH, 2011, PROTEIN CELL, V2, P266, DOI 10.1007/s13238-011-1041-2; Yi L, 2007, MODERN PATHOL, V20, P1061, DOI 10.1038/modpathol.3800942; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P823, DOI 10.1093/jnci/dji142	56	95	102	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57188	10.1371/journal.pone.0057188	http://dx.doi.org/10.1371/journal.pone.0057188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536763	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100009
J	Becker, J; Maes, F; Wehenkel, L				Becker, Julien; Maes, Francis; Wehenkel, Louis			On the Relevance of Sophisticated Structural Annotations for Disulfide Connectivity Pattern Prediction	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; RECURSIVE NEURAL-NETWORKS; BONDING STATE; IMPLEMENTATION; INFORMATION; CYSTEINES; MACHINE	Disulfide bridges strongly constrain the native structure of many proteins and predicting their formation is therefore a key sub-problem of protein structure and function inference. Most recently proposed approaches for this prediction problem adopt the following pipeline: first they enrich the primary sequence with structural annotations, second they apply a binary classifier to each candidate pair of cysteines to predict disulfide bonding probabilities and finally, they use a maximum weight graph matching algorithm to derive the predicted disulfide connectivity pattern of a protein. In this paper, we adopt this three step pipeline and propose an extensive study of the relevance of various structural annotations and feature encodings. In particular, we consider five kinds of structural annotations, among which three are novel in the context of disulfide bridge prediction. So as to be usable by machine learning algorithms, these annotations must be encoded into features. For this purpose, we propose four different feature encodings based on local windows and on different kinds of histograms. The combination of structural annotations with these possible encodings leads to a large number of possible feature functions. In order to identify a minimal subset of relevant feature functions among those, we propose an efficient and interpretable feature function selection scheme, designed so as to avoid any form of overfitting. We apply this scheme on top of three supervised learning algorithms: k-nearest neighbors, support vector machines and extremely randomized trees. Our results indicate that the use of only the PSSM (position-specific scoring matrix) together with the CSP (cysteine separation profile) are sufficient to construct a high performance disulfide pattern predictor and that extremely randomized trees reach a disulfide pattern prediction accuracy of 58.2% on the benchmark dataset SPX+, which corresponds to +3.2% improvement over the state of the art. A web-application is available at http://m24.giga.ulg.ac.be:81/x3CysBridges.	[Becker, Julien] Univ Liege, GIGA Res, Liege, Belgium; [Maes, Francis; Wehenkel, Louis] Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium; [Maes, Francis] Univ Louvain, Dept Comp Wetenschappen, DTAI, Louvain, Belgium	University of Liege; University of Liege	Wehenkel, L (corresponding author), Univ Liege, Inst Montefiore, Dept Elect Engn & Comp Sci, B-4000 Liege, Belgium.	L.Wehenkel@ulg.ac.be			FRIA fellowship from the FRS-FNRS	FRIA fellowship from the FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	Julien Becker is recipient of a FRIA fellowship from the FRS-FNRS (http://www.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZAK R, 2005, PROTEINS, DOI DOI 10.1016/J.JMB.2004.04.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Baldi P, 2005, ADV NEURAL INFORM PR, V17, P97, DOI DOI 10.1093/NAR/GKL266; BERMAN H, 2000, PROTEIN-STRUCT FUNCT, V9, P56, DOI DOI 10.1093/BIOINFORMATICS/BTR387; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camproux AC, 2004, J MOL BIOL, V339, P591, DOI 10.1016/j.jmb.2004.04.005; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Cohen WW, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P671; Elumalai P, 2010, J TAIWAN INST CHEM E, V41, P525, DOI 10.1016/j.jtice.2010.05.011; Fariselli P, 1999, PROTEINS, V36, P340; Fariselli P, 2001, BIOINFORMATICS, V17, P957, DOI 10.1093/bioinformatics/17.10.957; Ferre F, 2005, BIOINFORMATICS, V21, P2336, DOI 10.1093/bioinformatics/bti328; FISER A, 1992, FEBS LETT, V302, P117, DOI 10.1016/0014-5793(92)80419-H; Frasconi P, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P25, DOI 10.1109/NNSP.2002.1030014; GABOW HN, 1976, J ACM, V23, P221, DOI 10.1145/321941.321942; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLINK T, 2000, PROTEIN SCI, V2, P1551; Kolmogorov V, 2009, MATH PROGRAM COMPUT, V1, P43, DOI 10.1007/s12532-009-0002-8; LIN HH, 2009, WSEAS T COMPUT, V8, P1429; Lin HH, 2012, INFORM SCIENCES, V199, P167, DOI 10.1016/j.ins.2012.02.035; Lin HH, 2010, NUCLEIC ACIDS RES, V38, pW503, DOI 10.1093/nar/gkq514; Lu CH, 2007, PROTEINS, V67, P262, DOI 10.1002/prot.21309; MAES F, 2011, 17 EUR S ART NEUR NE, DOI DOI 10.1093/BIOINFORMATICS/BTM505; Martelli PL, 2004, PROTEOMICS, V4, P1665, DOI 10.1002/pmic.200300745; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Platt JC, 2000, ADV NEUR IN, P61; RAMA G, 2005, INT C INT SENS INF P, P48, DOI DOI 10.1002/PMIC.200300745; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Savojardo C, 2011, BIOINFORMATICS, V27, P2224, DOI 10.1093/bioinformatics/btr387; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Vincent M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-20; Vullo A, 2004, BIOINFORMATICS, V20, P653, DOI 10.1093/bioinformatics/btg463; Wu TF, 2004, J MACH LEARN RES, V5, P975; Zhao E, 2005, BIOINFORMATICS, V21, P1415, DOI 10.1093/bioinformatics/bti179	43	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56621	10.1371/journal.pone.0056621	http://dx.doi.org/10.1371/journal.pone.0056621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23533562	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700068
J	Tobar-Tosse, F; Rodriguez, AC; Velez, PE; Zambrano, MM; Moreno, PA				Tobar-Tosse, Fabian; Rodriguez, Adrian C.; Velez, Patricia E.; Zambrano, Maria M.; Moreno, Pedro A.			Exploration of Noncoding Sequences in Metagenomes	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; DNA; IDENTIFICATION; ADAPTATION; EVOLUTION; SELECTION; RNAS	Environment-dependent genomic features have been defined for different metagenomes, whose genes and their associated processes are related to specific environments. Identification of ORFs and their functional categories are the most common methods for association between functional and environmental features. However, this analysis based on finding ORFs misses noncoding sequences and, therefore, some metagenome regulatory or structural information could be discarded. In this work we analyzed 23 whole metagenomes, including coding and noncoding sequences using the following sequence patterns: (G+C) content, Codon Usage (Cd), Trinucleotide Usage (Tn), and functional assignments for ORF prediction. Herein, we present evidence of a high proportion of noncoding sequences discarded in common similarity-based methods in metagenomics, and the kind of relevant information present in those. We found a high density of trinucleotide repeat sequences (TRS) in noncoding sequences, with a regulatory and adaptive function for metagenome communities. We present associations between trinucleotide values and gene function, where metagenome clustering correlate with microorganism adaptations and kinds of metagenomes. We propose here that noncoding sequences have relevant information to describe metagenomes that could be considered in a whole metagenome analysis in order to improve their organization, classification protocols, and their relation with the environment.	[Tobar-Tosse, Fabian; Rodriguez, Adrian C.; Velez, Patricia E.; Zambrano, Maria M.; Moreno, Pedro A.] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia; [Velez, Patricia E.] FACNED Univ Cauca, Dept Biol, Popayan, Colombia; [Zambrano, Maria M.] Corp CorpoGen, Bogota, Colombia; [Moreno, Pedro A.] Univ Valle, Sch Comp & Syst Engn, Cali, Colombia; [Tobar-Tosse, Fabian; Zambrano, Maria M.; Moreno, Pedro A.] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Universidad del Cauca; Universidad del Valle	Moreno, PA (corresponding author), Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia.	pedro.moreno@correounivalle.edu.co	Zambrano, Maria Mercedes/AAD-2805-2019; Tobar-Tosse, Fabian/P-1710-2014	Zambrano, Maria Mercedes/0000-0002-0796-4473; Tobar-Tosse, Fabian/0000-0001-5334-4286; Moreno Tovar, Pedro Antonio/0000-0001-9154-7009; VELEZ VARELA, PATRICIA EUGENIA/0000-0003-3470-8704	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA [6570-392-19990]; MAVDT [15]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA; MAVDT; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The authors' study was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA, Project No 6570-392-19990 for GeBix (Colombian Center for Genomics and Bioinformatics of Extreme Environments). Fabian Tobar was also the recipient of a student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out under MAVDT contract no. 15, 2008 for access to genetic resources and UAESPNN Research permit no. DTNO-N-20/2007.; JGI Publication Policy: "The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231."	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohlin J, 2011, THESCIENTIFICWORLDJO, V11, P715, DOI 10.1100/tsw.2011.70; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flores M, 2000, P NATL ACAD SCI USA, V97, P9138, DOI 10.1073/pnas.97.16.9138; Frank AC, 2002, GENETICA, V115, P1; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Li WZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003375; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Otsuka Y, 2004, J CLIN MICROBIOL, V42, P3538, DOI 10.1128/JCM.42.8.3538-3548.2004; Park SH, 2007, BIOCHEM BIOPH RES CO, V356, P961, DOI 10.1016/j.bbrc.2007.03.090; Porceddu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022855; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/nar/gkf549; Seo J, 2002, COMPUTER, V35, P80; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	35	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59488	10.1371/journal.pone.0059488	http://dx.doi.org/10.1371/journal.pone.0059488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536879	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200027
J	Yang, ZH; Grinchuk, V; Urban, JF; Bohl, J; Sun, R; Notari, L; Yan, S; Ramalingam, T; Keegan, AD; Wynn, TA; Shea-Donohue, T; Zhao, AP				Yang, Zhonghan; Grinchuk, Viktoriya; Urban, Joseph F., Jr.; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Ramalingam, Thirumalai; Keegan, Achsah D.; Wynn, Thomas A.; Shea-Donohue, Terez; Zhao, Aiping			Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; SMALL-INTESTINE; CYTOKINE; EXPRESSION; RECEPTOR; IL-33; IL-25; IL-13; INFECTION; STAT6	Type 2 immunity is essential for host protection against nematode infection but is detrimental in allergic inflammation or asthma. There is a major research focus on the effector molecules and specific cell types involved in the initiation of type 2 immunity. Recent work has implicated an important role of epithelial-derived cytokines, IL-25 and IL-33, acting on innate immune cells that are believed to be the initial sources of type 2 cytokines IL-4/IL-5/IL-13. The identities of the cell types that mediate the effects of IL-25/IL-33, however, remain to be fully elucidated. In the present study, we demonstrate that macrophages as IL-25/IL-33-responsive cells play an important role in inducing type 2 immunity using both in vitro and in vivo approaches. Macrophages produced type 2 cytokines IL-5 and IL-13 in response to the stimulation of IL-25/IL-33 in vitro, or were the IL-13-producing cells in mice administrated with exogenous IL-33 or infected with Heligmosomoides bakeri. In addition, IL-33 induced alternative activation of macrophages primarily through autocrine IL-13 activating the IL-4R alpha-STAT6 pathway. Moreover, depletion of macrophages attenuated the IL-25/IL-33-induced type 2 immunity in mice, while adoptive transfer of IL-33-activated macrophages into mice with a chronic Heligmosomoides bakeri infection induced worm expulsion accompanied by a potent type 2 protective immune response. Thus, macrophages represent a unique population of the innate immune cells pivotal to type 2 immunity and a potential therapeutic target in controlling type 2 immunity-mediated inflammatory pathologies.	[Yang, Zhonghan; Grinchuk, Viktoriya; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Shea-Donohue, Terez; Zhao, Aiping] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Yang, Zhonghan; Grinchuk, Viktoriya; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Shea-Donohue, Terez; Zhao, Aiping] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Yang, Zhonghan] Sun Yat Sen Univ, Dept Biochem, Zhongshan Med Sch, Guangzhou 510275, Guangdong, Peoples R China; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Ramalingam, Thirumalai; Wynn, Thomas A.] NIAID, Div Parasitol, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sun Yat Sen University; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhao, AP (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	azhao@mbrc.umaryland.edu	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731; Urban, Joseph/0000-0002-1590-8869	NIH [R01-DK083418, R01-AI/DK49316, R01-AI038985]; USDA CRIS [1235-51000-055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829, R01AI049316, R01AI038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, T32DK067872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA CRIS(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01-DK083418 (AZ), R01-AI/DK49316 (T. S-D), R01-AI038985 (ADK), and USDA CRIS project #1235-51000-055 (JFU). The opinions and assertions in this article are those of the authors and do not necessarily represent those of the U. S. Department of Agriculture or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Caruso R, 2009, GASTROENTEROLOGY, V136, P2270, DOI 10.1053/j.gastro.2009.02.049; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Madden KB, 2004, J IMMUNOL, V172, P5616, DOI 10.4049/jimmunol.172.9.5616; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Morimoto M, 2009, J IMMUNOL, V183, P1934, DOI 10.4049/jimmunol.0804299; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Platt AM, 2008, IMMUNOL LETT, V119, P22, DOI 10.1016/j.imlet.2008.05.009; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rizzo A, 2012, INFLAMM BOWEL DIS, V18, P449, DOI 10.1002/ibd.21799; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shea-Donohue T, 2001, J IMMUNOL, V167, P2234, DOI 10.4049/jimmunol.167.4.2234; Shea-Donohue T, 2010, GUT MICROBES, V1, P316, DOI 10.4161/gmic.1.5.13329; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhang X, 2001, ISOLATION CHARACTERI, V14, P14; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2006, GASTROENTEROLOGY, V131, P568, DOI 10.1053/j.gastro.2006.05.013; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450; Zhao AP, 2005, J IMMUNOL, V175, P2563, DOI 10.4049/jimmunol.175.4.2563; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zhao AP, 2001, J PHARMACOL EXP THER, V299, P768	44	61	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59441	10.1371/journal.pone.0059441	http://dx.doi.org/10.1371/journal.pone.0059441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536877	gold, Green Submitted, Green Published			2022-12-27	WOS:000317397200025
J	Bessat, M; Knudsen, G; Burlingame, AL; Wang, CC				Bessat, Mohamed; Knudsen, Giselle; Burlingame, Alma L.; Wang, Ching C.			A Minimal Anaphase Promoting Complex/Cyclosome (APC/C) in Trypanosoma brucei	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; ANIMAL-CELL CYTOKINESIS; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; SHOTGUN PROTEOMICS; SPINDLE CHECKPOINT; CYCLIN PROTEOLYSIS; MASS-SPECTROMETRY; RNA INTERFERENCE	The anaphase-promoting complex/cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase that initiates chromosome segregation and mitotic exit by targeting critical cell-cycle regulators for proteolytic destruction. Previously, seven APC/C subunit homologues were identified in the genome of Trypanosoma brucei. In the present study, we tested five of them in yeast complementation studies and found none of them capable of complementing the yeast mutants lacking the corresponding subunits, suggesting significant discrepancies between the two APC/C's. Subunit homologues of mitotic checkpoint complex (MCC) have not yet been identified in T. brucei, raising the possibility that a MCC-APC/C complex equivalent may not exist in T. brucei. We performed tandem affinity purification of the protein complex containing a APC1 fusion protein expressed in the cells enriched in different phases of the cell cycle of procyclic form T. brucei, and compared their protein profiles using LC-MS/MS analyses. The seven putative APC/C subunits were identified in the protein complex throughout the cell cycle together with three additional proteins designated the associated proteins (AP) AP1, AP2 and AP3. Abundance of the 10 proteins remained relatively unchanged throughout the cell cycle, suggesting that they are the core subunits of APC/C. AP1 turned out to be a homologue of APC4. An RNAi knockdown of APC4 and AP3 showed no detectable cellular phenotype, whereas an AP2 knockdown enriched the cells in G2/M phase. The AP2-depleted cells showed stabilized mitotic cyclin B. An accumulation of poly-ubiquitinated cyclin B was indicated in the cells treated with the proteasome inhibitor MG132, demonstrating the involvement of proteasome in degrading poly-ubiquitinated cyclin B. In all, a 10-subunit APC/C machinery with a conserved function is identified in T. brucei without linking to a MCC-like complex, thus indicating a unique T. brucei APC/C.	[Bessat, Mohamed; Knudsen, Giselle; Burlingame, Alma L.; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wang, CC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu	bessat, mohamed/W-6396-2019	bessat, mohamed/0000-0002-4583-1604	National Institutes of Health [R01 AI21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 grant R01 AI21786 to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon A, 1997, EMBO J, V16, P2693, DOI 10.1093/emboj/16.10.2693; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dong Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-19; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Foe I, 2011, NATURE, V470, P182, DOI 10.1038/470182a; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kumar P, 2005, J BIOL CHEM, V280, P31783, DOI 10.1074/jbc.M504326200; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Nagy O, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-9; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; SIKORSKI RS, 1991, COLD SH Q B, V56, P663; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	70	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59258	10.1371/journal.pone.0059258	http://dx.doi.org/10.1371/journal.pone.0059258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533609	gold, Green Published			2022-12-27	WOS:000316549400046
J	Papa, R; Kapan, DD; Counterman, BA; Maldonado, K; Lindstrom, DP; Reed, RD; Nijhout, HF; Hrbek, T; McMillan, WO				Papa, Riccardo; Kapan, Durrell D.; Counterman, Brian A.; Maldonado, Karla; Lindstrom, Daniel P.; Reed, Robert D.; Nijhout, H. Frederik; Hrbek, Tomas; McMillan, W. Owen			Multi-Allelic Major Effect Genes Interact with Minor Effect QTLs to Control Adaptive Color Pattern Variation in Heliconius erato	PLOS ONE			English	Article							MULLERIAN MIMICRY; LINKAGE MAP; WARNING-COLOR; CONVERGENT EVOLUTION; NATURAL-SELECTION; BICYCLUS-ANYNANA; WING PATTERNS; DIVERSIFICATION; LEPIDOPTERA; ADAPTATION	Recent studies indicate that relatively few genomic regions are repeatedly involved in the evolution of Heliconius butterfly wing patterns. Although this work demonstrates a number of cases where homologous loci underlie both convergent and divergent wing pattern change among different Heliconius species, it is still unclear exactly how many loci underlie pattern variation across the genus. To address this question for Heliconius erato, we created fifteen independent crosses utilizing the four most distinct color pattern races and analyzed color pattern segregation across a total of 1271 F2 and backcross offspring. Additionally, we used the most variable brood, an F2 cross between H. himera and the east Ecuadorian H. erato notabilis, to perform a quantitative genetic analysis of color pattern variation and produce a detailed map of the loci likely involved in the H. erato color pattern radiation. Using AFLP and gene based markers, we show that fewer major genes than previously envisioned control the color pattern variation in H. erato. We describe for the first time the genetic architecture of H. erato wing color pattern by assessing quantitative variation in addition to traditional linkage mapping. In particular, our data suggest three genomic intervals modulate the bulk of the observed variation in color. Furthermore, we also identify several modifier loci of moderate effect size that contribute to the quantitative wing pattern variation. Our results are consistent with the two-step model for the evolution of mimetic wing patterns in Heliconius and support a growing body of empirical data demonstrating the importance of major effect loci in adaptive change.	[Papa, Riccardo; Maldonado, Karla; Hrbek, Tomas] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Papa, Riccardo; Maldonado, Karla; Hrbek, Tomas] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, Rio Piedras, PR 00931 USA; [Kapan, Durrell D.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Kapan, Durrell D.] Calif Acad Sci, Ctr Comparat Genom, San Francisco, CA 94118 USA; [Kapan, Durrell D.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Ctr Conservat & Res Training, Honolulu, HI 96822 USA; [Counterman, Brian A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Lindstrom, Daniel P.] Univ Guam, Dept Biol, Mangilao, GU USA; [Reed, Robert D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC USA; [Hrbek, Tomas] Univ Fed Amazonas, Inst Biol Sci, Dept Biol, Manaus, Amazonas, Brazil; [McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; California Academy of Sciences; California Academy of Sciences; University of Hawaii System; University of Hawaii Manoa; Mississippi State University; University of Guam; Cornell University; Duke University; Universidade Federal de Amazonas; Smithsonian Institution; Smithsonian Tropical Research Institute	Papa, R (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA.	rpapa.lab@gmail.com	Hrbek, Tomas/J-6988-2012	Hrbek, Tomas/0000-0003-3239-7068; Counterman, Brian/0000-0003-2724-071X; Reed, Robert/0000-0002-6065-6728; McMillan, W. Owen/0000-0003-2805-2745	National Science Foundation [IOS 1052541, DEB-0844244, DEB-9806792]; University of Puerto Rico Rio Piedras' Center for Applied Tropical Ecology and Conservation; Direct For Biological Sciences [0959864] Funding Source: National Science Foundation; Division Of Environmental Biology [1257839] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Puerto Rico Rio Piedras' Center for Applied Tropical Ecology and Conservation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by National Science Foundation grants (IOS 1052541, DEB-0844244, DEB-9806792) to WOM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministerio del Ambiente in Ecuador for permission to collect butterflies and Germania Estevez for help and guidance during collecting trips. We give a special thanks to Ana Maria Quiles and many volunteers of the butterfly rearing crew for help rearing larvae and maintaining the Heliconius insectaries at the University of Puerto Rico. Undergraduate and graduate students participating in this project were supported in part by the University of Puerto Rico Rio Piedras' Center for Applied Tropical Ecology and Conservation. AFLP's were generated the Genotyping and Sequencing Center at University of Puerto Rico Rio Piedras.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Balogh ACV, 2005, P ROY SOC B-BIOL SCI, V272, P2269, DOI 10.1098/rspb.2005.3227; Balogh ACV, 2010, EVOLUTION, V64, P810, DOI 10.1111/j.1558-5646.2009.00852.x; Baxter SW, 2009, HEREDITY, V102, P57, DOI 10.1038/hdy.2008.109; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Beavis William D., 1998, P145; Beldade P, 2008, J EXP ZOOL PART B, V310B, P191, DOI 10.1002/jez.b.21173; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; BROWN K S JR, 1974, Biotropica, V6, P205, DOI 10.2307/2989666; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; Brown KS, 1979, ECOLOGIA GEOGRAFICA; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Crane J, 1962, ZOOLOGICA, V1962, P141; Crooks L, 2011, G3-GENES GENOM GENET, V1, P57, DOI 10.1534/g3.111.000109; Cuthill JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036464; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Doerge RW, 1996, GENETICS, V142, P285; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher RA, 1930, GENETICAL THEORY NAT; Franks DW, 2007, J THEOR BIOL, V244, P631, DOI 10.1016/j.jtbi.2006.09.019; Gilbert L.E., 1988, Journal of Research on the Lepidoptera, V26, P141; Gilbert Lawrence E., 2003, P281; Hines HM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-288; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Jiggins CD, 1997, P ROY SOC B-BIOL SCI, V264, P1167, DOI 10.1098/rspb.1997.0161; Jones RT, 2012, P ROY SOC B-BIOL SCI, V279, P316, DOI 10.1098/rspb.2011.0882; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kapan DD, 2006, GENETICS, V173, P735, DOI 10.1534/genetics.106.057166; KOCH PB, 1991, INSECT BIOCHEM, V21, P785, DOI 10.1016/0020-1790(91)90120-4; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Lincoln SE, 1987, MAPMAKER 3 0; Linzen B., 1974, P117; MALLET J, 1989, PROC R SOC SER B-BIO, V236, P163, DOI 10.1098/rspb.1989.0019; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; McMillan WO, 2002, TRENDS ECOL EVOL, V17, P125, DOI 10.1016/S0169-5347(01)02427-2; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Monteiro A, 2001, ACTA BIOTHEOR, V49, P77, DOI 10.1023/A:1010226223287; Monteiro A, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-22; NICHOLSON A. J., 1927, AUSTRALIAN ZOOL, V5, P10; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; Nijhout HF, 2010, ADV INSECT PHYSIOL, V38, P219, DOI 10.1016/S0065-2806(10)38002-7; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; NIJHOUT HF, 1986, BIOL J LINN SOC, V28, P387, DOI 10.1111/j.1095-8312.1986.tb01766.x; NIJHOUT HF, 1988, BIOL J LINN SOC, V33, P345, DOI 10.1111/j.1095-8312.1988.tb00449.x; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; NIJHOUT HF, 1990, BIOL J LINN SOC, V40, P357, DOI 10.1111/j.1095-8312.1990.tb00545.x; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Papa R, 2005, J ANIM BREED GENET, V122, P62, DOI 10.1111/j.1439-0388.2004.00476.x; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Pohl N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-99; Punnett R.C., 1915, MIMICRY BUTTERFLIES; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Reed RD, 2008, P R SOC B, V275, P37, DOI 10.1098/rspb.2007.1115; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Ruxton GD, 2008, EVOLUTION, V62, P2913, DOI 10.1111/j.1558-5646.2008.00485.x; Schwanwitsch BN, 1924, P ZOOL SOC LOND, V1924, P509; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; SHEPPARP P. M., 1963, ZOOLOGICA [NEW YORK], V48, P145; SHI JR, 1995, GENET RES, V66, P109, DOI 10.1017/S0016672300034467; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stinchcombe JR, 2009, GENETICS, V182, P911, DOI 10.1534/genetics.108.097030; SUOMALAINEN E, 1973, HEREDITAS, V74, P302; Team R. D. C, 2011, R LANG ENV STAT COMP; Tobler A, 2005, HEREDITY, V94, P408, DOI 10.1038/sj.hdy.6800619; Turner J.R.G., 1985, Oxford Surveys in Evolutionary Biology, V2, P159; Turner J. R. G., 1977, Evolutionary Biol, V10, P163; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; TURNER JRG, 1975, HEREDITY, V34, P265, DOI 10.1038/hdy.1975.29; Turner JRG, 2005, ENCY LIFE SCI, P1; Turner JRG, 1988, AM NAT, V131, P42; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van't Hof AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003882; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S., 2011, WINDOWS QTL CARTOGRA; Wright S., 1978, EVOLUTION GENETIC PO	90	35	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e57033	10.1371/journal.pone.0057033	http://dx.doi.org/10.1371/journal.pone.0057033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533571	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400008
J	Yang, YM; Zhang, ZW; Liu, QM; Sun, YF; Yu, JR; Xu, WX				Yang, Yue-Ming; Zhang, Zhong-Wei; Liu, Qing-Meng; Sun, Yi-Feng; Yu, Ji-Ren; Xu, Wei-Xing			Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer	PLOS ONE			English	Article							TETRASPANIN PROTEINS; CLINICAL-SIGNIFICANCE; EXPRESSION; PROGRESSION; METASTASIS; SUBTYPES; DOMAINS	Purpose: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. Methods: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell lines were used to analyze CD151 expression. Short hairpin RNA-mediated downregulation of CD151 expression in HGC cells was performed to examine the role of CD151 in the proliferation and metastasis/invasion of HGC cells in vivo and in vitro. The relationship of CD151 with integrin alpha 3 in HGC cells was investigated by silencing integrin alpha 3 followed by co-immunoprecipitation and immunofluorescence staining. Finally, the prognostic value of CD151 and integrin alpha 3 was evaluated by immunohistochemistry in tissue microarrays of 76 HGC patients. Results: CD151 was expressed at higher levels in HGC tissues and HGC cells than in nontumor tissues and HGEC cells. Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151 formed a complex with integrin alpha 3 in HGC cells. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin alpha 3 cells in vitro. Clinically, CD151 overexpression was significantly correlated with high TNM stage, depth of invasion and positive lymph node involvement (p<0.05), and high levels of integrin alpha 3 were associated with large tumor size, high TNM stage, depth of invasion and lymph node involvement (p<0.05). Importantly, the postoperative 5-year overall survival of patients with CD151(low) and/or integrin alpha 3(low) was higher than that of patients with CD151(high) and/or integrin alpha 3(high). Conclusion: CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin alpha 3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets.	[Yang, Yue-Ming; Zhang, Zhong-Wei; Sun, Yi-Feng; Xu, Wei-Xing] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastrointestinal Surg,Shaoxing Hosp, Shaoxing, Peoples R China; [Yang, Yue-Ming; Zhang, Zhong-Wei; Liu, Qing-Meng; Sun, Yi-Feng; Xu, Wei-Xing] Shaoxing Second Hosp, Shaoxing, Peoples R China; [Liu, Qing-Meng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Pathol,Shaoxing Hosp, Shaoxing, Peoples R China; [Yu, Ji-Ren] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastrointestinal Surg, Shaoxing, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yang, YM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastrointestinal Surg,Shaoxing Hosp, Shaoxing, Peoples R China.	ymyang55@163.com			Academician Workstation Fund of Shaoxing Second People's Hospital	Academician Workstation Fund of Shaoxing Second People's Hospital	This work was supported by the Academician Workstation Fund of Shaoxing Second People's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman LK, 2002, J BIOL REG HOMEOS AG, V16, P223; Haeuw JF, 2011, BIOCHEM SOC T, V39, P553, DOI 10.1042/BST0390553; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Huang XY, 2010, CANCER-AM CANCER SOC, V116, P5440, DOI 10.1002/cncr.25485; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Kwon MJ, 2012, BRIT J CANCER, V106, P923, DOI 10.1038/bjc.2012.11; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Saito Y, 2010, CLIN EXP METASTAS, V27, P197, DOI 10.1007/s10585-010-9314-3; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Takatsuki H, 2004, CANCER RES, V64, P6065, DOI 10.1158/0008-5472.CAN-04-0321; Testa JE, 1999, CANCER RES, V59, P3812; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Wang YY, 2010, J CANCER RES CLIN, V136, P135, DOI 10.1007/s00432-009-0644-y; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Wu MS, 1997, GASTROENTEROLOGY, V112, P1457, DOI 10.1016/S0016-5085(97)70071-4; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhao ZS, 2010, CLIN CANCER RES, V16, P260, DOI 10.1158/1078-0432.CCR-09-1247; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	27	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58990	10.1371/journal.pone.0058990	http://dx.doi.org/10.1371/journal.pone.0058990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533596	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400033
J	Harrison, SJ; Thomson, IR; Grant, CM; Bertram, SM				Harrison, Sarah J.; Thomson, Ian R.; Grant, Caitlin M.; Bertram, Susan M.			Calling, Courtship, and Condition in the Fall Field Cricket, Gryllus pennsylvanicus	PLOS ONE			English	Article							FEMALE MATE CHOICE; CONDITION DEPENDENCE; PLUMAGE COLORATION; ACHETA-DOMESTICUS; SEXUAL SELECTION; BODY-SIZE; TRADE-OFF; SONG; AGE; SIGNALS	Theoretically, sexual signals should provide honest information about mating benefits and many sexually reproducing species use honest signals when signalling to potential mates. Male crickets produce two types of acoustic mating signals: a long-distance mate attraction call and a short-range courtship call. We tested whether wild-caught fall field cricket (Gryllus pennsylvanicus) males in high condition (high residual mass or large body size) produce higher effort calls (in support of the honest signalling hypothesis). We also tested an alternative hypothesis, whether low condition males produce higher effort calls (in support of the terminal investment hypothesis). Several components of long-distance mate attraction calls honestly reflected male body size, with larger males producing louder mate attraction calls at lower carrier frequencies. Long-distance mate attraction chirp rate dishonestly signalled body size, with small males producing faster chirp rates. Short-range courtship calls dishonestly reflected male residual mass, as chirp rate and pulse rate were best explained by a curvilinear function of residual mass. By producing long-distance mate attraction calls and courtship calls with similar or higher effort compared to high condition males, low condition males (low residual mass or small body size) may increase their effort in current reproductive success at the expense of their future reproductive success, suggesting that not all sexual signals are honest.	[Harrison, Sarah J.; Thomson, Ian R.; Grant, Caitlin M.; Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University	Bertram, SM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	sue_bertram@carleton.ca	Bertram, Susan M/L-6992-2013	Bertram, Susan M/0000-0002-6326-579X	NSERC (The Natural Sciences and Engineering Research Council of Canada) [RGPIN 327856-2012]; Canadian Foundation for Innovation; Ministry of Research and Innovation's Ontario Research Fund; NSERC	NSERC (The Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministry of Research and Innovation's Ontario Research Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided to SMB by an NSERC discovery grant (The Natural Sciences and Engineering Research Council of Canada) (RGPIN 327856-2012), the Canadian Foundation for Innovation, and the Ministry of Research and Innovation's Ontario Research Fund. Funding was provided to SJH by an NSERC undergraduate student research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Bertram SM, 2012, ETHOLOGY, V118, P360, DOI 10.1111/j.1439-0310.2011.02019.x; Bertram SM, 2011, ETHOLOGY, V117, P1050, DOI 10.1111/j.1439-0310.2011.01958.x; Bertram SM, 2009, ANIM BEHAV, V77, P525, DOI 10.1016/j.anbehav.2008.11.012; Brooks R, 2005, EVOLUTION, V59, P871, DOI 10.1111/j.0014-3820.2005.tb01760.x; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Copeland EK, 2012, P ROY SOC B-BIOL SCI, V279, P4740, DOI 10.1098/rspb.2012.1914; David P, 1998, P ROY SOC B-BIOL SCI, V265, P2211, DOI 10.1098/rspb.1998.0561; del Castillo RC, 2005, GENET MOL BIOL, V28, P843, DOI 10.1590/S1415-47572005000500030; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Gray DA, 2001, ANIM BEHAV, V62, P871, DOI 10.1006/anbe.2001.1825; HEDRICK AV, 1986, BEHAV ECOL SOCIOBIOL, V19, P73, DOI 10.1007/BF00303845; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hill GE, 2002, P ROY SOC B-BIOL SCI, V269, P1119, DOI 10.1098/rspb.2002.1980; Hoback WW, 1997, PHYSIOL ENTOMOL, V22, P286, DOI 10.1111/j.1365-3032.1997.tb01170.x; Holman L, 2012, EVOLUTION, V66, P2094, DOI 10.1111/j.1558-5646.2012.01603.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jang Y, 2008, BEHAV ECOL SOCIOBIOL, V62, P1397, DOI 10.1007/s00265-008-0568-6; Jeffery J, 2005, J EXP ZOOL PART A, V303A, P377, DOI 10.1002/jez.a.176; JOHNSTONE RA, 1993, ANIM BEHAV, V46, P759, DOI 10.1006/anbe.1993.1253; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kelly NB, 2010, J EVOLUTION BIOL, V23, P2461, DOI 10.1111/j.1420-9101.2010.02111.x; Klaus SP, 2011, ETHOLOGY, V117, P154, DOI 10.1111/j.1439-0310.2010.01857.x; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1998, P ROY SOC B-BIOL SCI, V265, P1871, DOI 10.1098/rspb.1998.0515; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Leonard AS, 2010, BIOL J LINN SOC, V100, P856, DOI 10.1111/j.1095-8312.2010.01472.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; MOUSSEAU TA, 1989, EVOLUTION, V43, P1483, DOI 10.1111/j.1558-5646.1989.tb02598.x; NICOLETTO PF, 1993, ANIM BEHAV, V46, P441, DOI 10.1006/anbe.1993.1213; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Polkki M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1002; PRICE T, 1993, BIOL J LINN SOC, V48, P187, DOI 10.1111/j.1095-8312.1993.tb00887.x; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Rebar D, 2009, BEHAV ECOL, V20, P1307, DOI 10.1093/beheco/arp143; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P129, DOI 10.1007/BF02395441; Stearns S.C., 1992, pi; Svensson O, 2004, J FISH BIOL, V64, P1425, DOI 10.1111/j.0022-1112.2004.00381.x; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; Wagner WE, 2000, ANIM BEHAV, V59, P1219, DOI 10.1006/anbe.1999.1428; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M	64	22	21	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60356	10.1371/journal.pone.0060356	http://dx.doi.org/10.1371/journal.pone.0060356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527313	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600129
J	Nejak-Bowen, K; Orr, A; Bowen, WC; Michalopoulos, GK				Nejak-Bowen, Kari; Orr, Anne; Bowen, William C., Jr.; Michalopoulos, George K.			Conditional Genetic Elimination of Hepatocyte Growth Factor in Mice Compromises Liver Regeneration after Partial Hepatectomy	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; STELLATE CELL-LINE; FACTOR/SCATTER FACTOR; RAT-LIVER; C-MET; MESSENGER-RNA; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; FACTOR EXPRESSION; DNA-SYNTHESIS; RECEPTOR	Hepatocyte growth factor (HGF) has been shown to be indispensable for liver regeneration because it serves as a main mitogenic stimulus driving hepatocytes toward proliferation. We hypothesized that ablating HGF in adult mice would have a negative effect on the ability of hepatocytes to regenerate. Deletion of the HGF gene was achieved by inducing systemic recombination in mice lacking exon 5 of HGF and carrying the Mx1-cre or Cre-ERT transgene. Analysis of liver genomic DNA from animals 10 days after treatment showed that a majority (70-80%) of alleles underwent cre-induced genetic recombination. Intriguingly, however, analysis by RT-PCR showed the continued presence of both unrecombined and recombined forms of HGF mRNA after treatment. Separation of liver cell populations into hepatocytes and non-parenchymal cells showed equal recombination of genomic HGF in both cell types. The presence of the unrecombined form of HGF mRNA persisted in the liver in significant amounts even after partial hepatectomy (PH), which correlated with insignificant changes in HGF protein and hepatocyte proliferation. The amount of HGF produced by stellate cells in culture was indirectly proportional to the concentration of HGF, suggesting that a decrease in HGF may induce de novo synthesis of HGF from cells with residual unrecombined alleles. Carbon tetrachloride (CCl4)-induced regeneration resulted in a substantial decrease in preexisting HGF mRNA and protein, and subsequent PH led to a delayed regenerative response. Thus, HGF mRNA persists in the liver even after genetic recombination affecting most cells; however, PH subsequent to CCl4 treatment is associated with a decrease in both HGF mRNA and protein and results in compromised liver regeneration, validating an important role of this mitogen in hepatic growth.	[Nejak-Bowen, Kari; Orr, Anne; Bowen, William C., Jr.; Michalopoulos, George K.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nejak-Bowen, K (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	knnst5@pitt.edu; michalopoulosgk@upmc.edu		Nejak-Bowen, Kari/0000-0001-6051-5338	National Institutes of Health [5R01CA035373-27, 5R01CA103958-05]; NATIONAL CANCER INSTITUTE [R01CA035373, R01CA103958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by National Institutes of Health grants 5R01CA035373-27 and 5R01CA103958-05 to GKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1002/hep.1840200231; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blanquaert F, 1999, ENDOCRINOLOGY, V140, P1069, DOI 10.1210/en.140.3.1069; Blanquaert F, 2000, AM J PHYSIOL-ENDOC M, V278, pE509, DOI 10.1152/ajpendo.2000.278.3.E509; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Chu SH, 2009, MOL BIOL REP, V36, P1967, DOI 10.1007/s11033-008-9406-1; Chung H, 2005, TOXICOL APPL PHARM, V206, P27, DOI 10.1016/j.taap.2004.11.004; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Delehedde M, 2001, EUR J BIOCHEM, V268, P4423, DOI 10.1046/j.1432-1327.2001.02363.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V250, P769, DOI 10.1006/bbrc.1998.9387; ISHII T, 1995, J BIOCHEM-TOKYO, V117, P1105, DOI 10.1093/oxfordjournals.jbchem.a124814; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LINDROOS PM, 1991, HEPATOLOGY, V13, P743, DOI 10.1002/hep.1840130422; LIU ML, 1994, HEPATOLOGY, V19, P1521; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; OKIGAKI M, 1992, BIOCHEMISTRY-US, V31, P9555, DOI 10.1021/bi00155a007; Ozaki I, 2002, J HEPATOL, V36, P169, DOI 10.1016/S0168-8278(01)00245-8; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Patijn GA, 1998, HEPATOLOGY, V28, P707, DOI 10.1002/hep.510280317; Pediaditakis P, 2001, HEPATOLOGY, V34, P688, DOI 10.1053/jhep.2001.27811; Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/dna.2004.23.592; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schirmacher P, 1993, EXS, V65, P285; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Stolz DB, 1999, CANCER RES, V59, P3954; TANI H, 2012, RNA BIOL, V9; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Vogel S, 2000, J LIPID RES, V41, P882; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K	42	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59836	10.1371/journal.pone.0059836	http://dx.doi.org/10.1371/journal.pone.0059836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527275	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600099
J	Shao, ZQ; Zhang, YM; Pan, XZ; Wang, B; Chen, JQ				Shao, Zhu-Qing; Zhang, Yan-Mei; Pan, Xiu-Zhen; Wang, Bin; Chen, Jian-Qun			Insight into the Evolution of the Histidine Triad Protein (HTP) Family in Streptococcus	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; POSITIVE SELECTION; SURFACE-PROTEINS; PNEUMOCOCCAL PROTEINS; COMPARATIVE GENOMICS; RECOMBINATION; PATHOGENESIS; PNEUMONIAE; PHTD; ANTIBODIES	The Histidine Triad Proteins (HTPs), also known as Pht proteins in Streptococcus pneumoniae, constitute a family of surface-exposed proteins that exist in many pathogenic streptococcal species. Although many studies have revealed the importance of HTPs in streptococcal physiology and pathogenicity, little is known about their origin and evolution. In this study, after identifying all htp homologs from 105 streptococcal genomes representing 38 different species/subspecies, we analyzed their domain structures, positions in genome, and most importantly, their evolutionary histories. By further projecting this information onto the streptococcal phylogeny, we made several major findings. First, htp genes originated earlier than the Streptococcus genus and gene-loss events have occurred among three streptococcal groups, resulting in the absence of the htp gene in the Bovis, Mutans and Salivarius groups. Second, the copy number of htp genes in other groups of Streptococcus is variable, ranging from one to four functional copies. Third, both phylogenetic evidence and domain structure analyses support the division of two htp subfamilies, designated as htp I and htp II. Although present mainly in the pyogenic group and in Streptococcus suis, htp II members are distinct from htp I due to the presence of an additional leucine-rich-repeat domain at the C-terminus. Finally, htp genes exhibit a faster nucleotide substitution rate than do housekeeping genes. Specifically, the regions outside the HTP domains are under strong positive selection. This distinct evolutionary pattern likely helped Streptococcus to easily escape from recognition by host immunity.	[Shao, Zhu-Qing; Zhang, Yan-Mei; Wang, Bin; Chen, Jian-Qun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Pan, Xiu-Zhen] Res Inst Med Nanjing Command, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, B (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	binwang@nju.edu.cn; chenjq@nju.edu.cn		Chen, Jian-Qun/0000-0003-4376-5655; Shao, Zhu-Qing/0000-0002-0431-0669	National Natural Science Foundation of China [30930008, 31000105, 31170210, 8117294]; National Postdoctoral Science Foundation of China [20090461092, 201003570]; Nanjing University Start Grant; Natural Science Foundation of Jiangsu Province [BK2010113]; Postgraduate Students Innovation Project of Jiangsu Province [CXZZ11_0038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Nanjing University Start Grant; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Postgraduate Students Innovation Project of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (30930008, 31000105, 31170210 and 8117294), National Postdoctoral Science Foundation of China (20090461092, 201003570), Nanjing University Start Grant, the Natural Science Foundation of Jiangsu Province (BK2010113) and Postgraduate Students Innovation Project of Jiangsu Province (CXZZ11_0038). http://www.nsfc.gov.cn/; http://210.79.234.200/V1/Manage/Login.aspx;www.nju.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Andrews TD, 2004, GENETICS, V166, P25, DOI 10.1534/genetics.166.1.25; Anisimova M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-154; Aranda J, 2012, CAN J VET RES, V76, P72; Aranda J, 2009, MICROBIOL-SGM, V155, P1580, DOI 10.1099/mic.0.026278-0; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bober M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020345; Boggs JM, 2012, INFECT GENET EVOL, V12, P1005, DOI 10.1016/j.meegid.2012.02.014; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Fabre A, 2011, GENE, V472, P37, DOI 10.1016/j.gene.2010.10.012; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Holmlund E, 2009, CLIN VACCINE IMMUNOL, V16, P916, DOI 10.1128/CVI.00050-09; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kakizawa S, 2006, J BACTERIOL, V188, P3424, DOI 10.1128/JB.188.9.3424-3428.2006; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; Lebon A, 2011, INFECT IMMUN, V79, P1680, DOI 10.1128/IAI.01379-10; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Liu CY, 2012, FEMS MICROBIOL LETT, V337, P104, DOI 10.1111/1574-6968.12013; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Marri PR, 2006, MOL BIOL EVOL, V23, P2379, DOI 10.1093/molbev/msl115; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maruvada R, 2009, FASEB J, V23, P3967, DOI 10.1096/fj.09-138149; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nogueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049403; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Riboldi-Tunnicliffe A, 2005, FEBS LETT, V579, P5353, DOI 10.1016/j.febslet.2005.08.066; Riboldi-Tunnicliffe A, 2004, ACTA CRYSTALLOGR D, V60, P926, DOI 10.1107/S0907444904004573; Richards VP, 2011, INFECT GENET EVOL, V11, P1263, DOI 10.1016/j.meegid.2011.04.019; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Shao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033547; Shao ZQ, 2011, FEMS MICROBIOL LETT, V314, P174, DOI 10.1111/j.1574-6968.2010.02162.x; Simell B, 2009, VACCINE, V27, P4615, DOI 10.1016/j.vaccine.2009.05.071; Soriani M, 2010, FUTURE MICROBIOL, V5, P735, DOI [10.2217/fmb.10.37, 10.2217/FMB.10.37]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022714; Xu ZF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-203; Zhang Y, 2001, INFECT IMMUN, V69, P3827, DOI 10.1128/IAI.69.6.3827-3836.2001	58	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60116	10.1371/journal.pone.0060116	http://dx.doi.org/10.1371/journal.pone.0060116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527301	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600118
J	Oukarroum, A; Goltsev, V; Strasser, RJ				Oukarroum, Abdallah; Goltsev, Vasilij; Strasser, Reto J.			Temperature Effects on Pea Plants Probed by Simultaneous Measurements of the Kinetics of Prompt Fluorescence, Delayed Fluorescence and Modulated 820 nm Reflection	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; CHLOROPLAST THYLAKOID MEMBRANES; PHOTOSYSTEM-II; IN-VIVO; BARLEY LEAVES; CHARGE ACCUMULATION; ELECTRON-TRANSPORT; THERMAL-STABILITY; LIGHT-EMISSION; INDUCTION	Simultaneous in vivo measurements of prompt fluorescence (PF), delayed fluorescence (DF) and 820-nm reflection (MR) were made to probe response of pea leaves to 40 s incubation at high temperatures (25-50 degrees C). We interpret our observation to suggest that heat treatment provokes an inhibition of electron donation by the oxygen evolving complex. DF, in a time range from several microseconds to milliseconds, has been thought to reflect recombination, in the dark, between the reduced primary electron acceptor Q(A)(-) and the oxidized donor (P680(+)) of photosystem II (PSII). The lower electron transport rate through PSII after 45 and 50 degrees C incubation also changed DF induction. We observed a decrease in the amplitude of the DF curve and a change in its shape and in its decay. Acceleration of P700(+) and PC+ re-reduction was induced by 45 degrees C treatment but after 50 degrees C its reduction was slower, indicating inhibition of photosystem I. We suggest that simultaneous PF, MR and DF might provide useful information on assessing the degree of plant tolerance to different environmental stresses.	[Oukarroum, Abdallah; Strasser, Reto J.] Univ Geneva, Bioenerget Lab, Geneva, Switzerland; [Oukarroum, Abdallah] Univ Quebec, Dept Chem & Biochem, Montreal, PQ H3C 3P8, Canada; [Goltsev, Vasilij] Univ Sofia, Dept Biophys & Radiobiol, BU-1126 Sofia, Bulgaria	University of Geneva; University of Quebec; University of Quebec Montreal; Bulgarian Academy of Sciences; Medical University Sofia; University of Sofia	Oukarroum, A (corresponding author), Univ Geneva, Bioenerget Lab, Geneva, Switzerland.	oukarroum.abdallah@uqam.ca	Oukarroum, Abdallah/AAW-2558-2021; Goltsev, Vasilij N/H-7423-2012	Goltsev, Vasilij N/0000-0003-4338-6671; Oukarroum, Abdallah/0000-0002-1942-5610	Swiss National Science Foundation [200021-116765]; Bulgarian National Science Fund [DO 02-137/15.12.2008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bulgarian National Science Fund(National Science Fund of Bulgaria)	Abdallah Oukarroum and Reto J. Strasser acknowledge support by the Swiss National Science Foundation, Project No. 200021-116765; Vasilij Goltsev acknowledges the Bulgarian National Science Fund, Project No. DO 02-137/15.12.2008 for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIERI G, 1970, PHOTOCHEM PHOTOBIOL, V12, P197, DOI 10.1111/j.1751-1097.1970.tb06051.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BILGER HW, 1984, OECOLOGIA, V63, P256, DOI 10.1007/BF00379886; Cajanek M, 1998, J PHOTOCH PHOTOBIO B, V47, P39, DOI 10.1016/S1011-1344(98)00197-3; Christen G, 2000, FEBS LETT, V475, P103, DOI 10.1016/S0014-5793(00)01641-0; Christen G, 1998, FEBS LETT, V429, P49, DOI 10.1016/S0014-5793(98)00552-3; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Ducruet JM, 2009, PHOTOSYNTH RES, V101, P195, DOI 10.1007/s11120-009-9436-0; DUCRUET JM, 1985, PLANT CELL PHYSIOL, V26, P419, DOI 10.1093/oxfordjournals.pcp.a076925; Enami I., 1994, BIOCHIM BIOPHYS ACTA, V118, P652; Goltsev V, 2005, PHOTOSYNTH RES, V84, P209, DOI 10.1007/s11120-004-6432-2; Goltsev V, 2003, J THEOR BIOL, V225, P171, DOI 10.1016/S0022-5193(03)00236-4; Goltsev V, 1997, PHOTOSYNTHETICA, V33, P571; Goltsev V, 2009, PHOTOSYNTH RES, V101, P217, DOI 10.1007/s11120-009-9451-1; GOUNARIS K, 1984, BIOCHIM BIOPHYS ACTA, V766, P198, DOI 10.1016/0005-2728(84)90232-9; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; GUISSE B, 1995, ARCH SCI, V48, P147; Havaux M, 2005, BBA-BIOENERGETICS, V1709, P203, DOI 10.1016/j.bbabio.2005.07.010; HAVAUX M, 1983, IRRIGATION SCI, V4, P147; Havaux M, 1996, PLANTA, V198, P324, DOI 10.1007/BF00620047; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; ITOH S, 1973, PHOTOCHEM PHOTOBIOL, V18, P209, DOI 10.1111/j.1751-1097.1973.tb06414.x; JOLIOT P, 1971, PHOTOCHEM PHOTOBIOL, V14, P287, DOI 10.1111/j.1751-1097.1971.tb06174.x; JURSINIC P, 1982, Photosynthesis Research, V3, P161, DOI 10.1007/BF00032254; Jursinic P.A., 1986, LIGHT EMISSION PLANT, V1st ed., P291; Kalaji HM, 2012, PHOTOSYNTH RES, V114, P69, DOI 10.1007/s11120-012-9780-3; LAVOREL J, 1975, BIOENERG PHOTOSYNTH, P223; Lazar D, 1999, BBA-BIOENERGETICS, V1412, P1, DOI 10.1016/S0005-2728(99)00047-X; Lazar D, 1997, PLANT SCI, V124, P159, DOI 10.1016/S0168-9452(97)04602-5; MALKIN S, 1978, BIOCHIM BIOPHYS ACTA, V502, P524, DOI 10.1016/0005-2728(78)90085-3; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; MUNDAY JC, 1969, BIOPHYS J, V9, P1, DOI 10.1016/S0006-3495(69)86365-4; Oukarroum A, 2009, PHYSIOL PLANTARUM, V137, P188, DOI 10.1111/j.1399-3054.2009.01273.x; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; RAISON JK, 1982, BIOCHIM BIOPHYS ACTA, V688, P218, DOI 10.1016/0005-2736(82)90597-1; SATOH K, 1981, BIOCHIM BIOPHYS ACTA, V638, P327, DOI 10.1016/0005-2728(81)90243-7; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2003, FUNCT PLANT BIOL, V30, P785, DOI 10.1071/FP03032; SCHREIBER U, 1977, PLANTA, V136, P233, DOI 10.1007/BF00385990; SCHREIBER U, 1978, BIOCHIM BIOPHYS ACTA, V502, P138, DOI 10.1016/0005-2728(78)90138-X; Srivastava A, 1999, PHOTOSYNTHETICA, V37, P365, DOI 10.1023/A:1007199408689; Srivastava A, 1995, ARCH SCI GENEVE, V8, P135; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Toth SZ, 2007, BBA-BIOENERGETICS, V1767, P295, DOI 10.1016/j.bbabio.2007.02.019; VANGORKOM HJ, 1973, PHOTOCHEM PHOTOBIOL, V17, P333; VELTHUYS BR, 1974, BIOCHIM BIOPHYS ACTA, V333, P85, DOI 10.1016/0005-2728(74)90165-0; VERMAAS WFJ, 1984, BIOCHIM BIOPHYS ACTA, V764, P194, DOI 10.1016/0005-2728(84)90028-8; Yamane Y, 1998, PHOTOSYNTH RES, V57, P51, DOI 10.1023/A:1006019102619; Yamane Y, 1997, PHOTOSYNTH RES, V52, P57, DOI 10.1023/A:1005884717655; Zaharieva I, 2003, PHOTOCHEM PHOTOBIOL, V77, P292, DOI 10.1562/0031-8655(2003)077&lt;0292:AOPIIB&gt;2.0.CO;2; Zaharieva I, 2011, J BIOL CHEM, V286, P18222, DOI 10.1074/jbc.M111.237941; Zaharieva Ivelina, 2001, Bulgarian Journal of Plant Physiology, V27, P3	57	84	89	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59433	10.1371/journal.pone.0059433	http://dx.doi.org/10.1371/journal.pone.0059433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527194	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100133
J	Sutoh, C; Nakazato, M; Matsuzawa, D; Tsuru, K; Niitsu, T; Iyo, M; Shimizu, E				Sutoh, Chihiro; Nakazato, Michiko; Matsuzawa, Daisuke; Tsuru, Kadushi; Niitsu, Tomihisa; Iyo, Masaomi; Shimizu, Eiji			Changes in Self-Regulation-Related Prefrontal Activities in Eating Disorders: A Near Infrared Spectroscopy Study	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; BRAIN ACTIVATION; BODY-IMAGE; INHIBITION; WOMEN; PERSONALITY; DEPRESSION; BEHAVIOR	Objective: The aim of this study is to clarify the symptomatology of the eating disorders examining the prefrontal function and activity associated with self-regulation among participants with or without eating disorders. Methods: Ten patients with anorexia nervosa, fourteen with bulimia nervosa, and fourteen healthy control participants performed two cognitive tasks assessing self-regulatory functions, an auditorily distracted word fluency task and a rock-paper-scissors task under the measurements on prefrontal oxyhemoglobin concentration with near infrared spectroscopy. The psychiatric symptoms of patient groups were assessed with several questionnaires. Results: Patients with bulimia nervosa showed decreased performances and prefrontal hyper activation patterns. Prefrontal activities showed a moderate negative correlation with task performances not in the patient groups but only in the healthy participants. The prefrontal activities of the patient groups showed positive correlations with some symptom scale aspects. Conclusions: The decreased cognitive abilities and characteristic prefrontal activation patterns associated with self-regulatory functions were shown in patients with bulimia nervosa, which correlated with their symptoms. These findings suggest inefficient prefrontal self-regulatory function of bulimia nervosa that associate with its symptoms.	[Sutoh, Chihiro; Matsuzawa, Daisuke; Shimizu, Eiji] Chiba Univ Chiba Chuo, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan; [Sutoh, Chihiro; Nakazato, Michiko; Niitsu, Tomihisa; Shimizu, Eiji] Chiba Univ Chiba Chuo, Grad Sch Med, Res Ctr Child Mental Dev, Chiba, Japan; [Nakazato, Michiko; Tsuru, Kadushi; Niitsu, Tomihisa; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan	Chiba University; Chiba University	Sutoh, C (corresponding author), Chiba Univ Chiba Chuo, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan.	csutoh@graduate.chiba-u.jp	Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Sutoh, Chihiro/0000-0002-5191-8220; Matsuzawa, Daisuke/0000-0003-0408-2608	Chiba Serum Institute Memorial Fund for Health Medical Welfare of Chiba prefecture, Japan	Chiba Serum Institute Memorial Fund for Health Medical Welfare of Chiba prefecture, Japan	Financial support for this study was provided by Chiba Serum Institute Memorial Fund for Health Medical Welfare of Chiba prefecture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate-Daga G, 2007, PSYCHOPATHOLOGY, V40, P261, DOI 10.1159/000101731; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beato-Fernandez L, 2009, PSYCHIAT RES-NEUROIM, V171, P129, DOI 10.1016/j.pscychresns.2008.01.001; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bruce Kenneth R, 2005, Eat Disord, V13, P93; Bruce KR, 2003, INT J EAT DISORDER, V33, P92, DOI 10.1002/eat.10116; CASANOVA GM, 1994, CHILD ABUSE NEGLECT, V18, P995, DOI 10.1016/0145-2134(94)90124-4; Cassin SE, 2005, CLIN PSYCHOL REV, V25, P895, DOI 10.1016/j.cpr.2005.04.012; Castro J, 2004, INT J EAT DISORDER, V35, P169, DOI 10.1002/eat.10249; Claes L, 2002, PERS INDIV DIFFER, V32, P707, DOI 10.1016/S0191-8869(01)00071-X; Corstorphine Emma, 2007, Eat Behav, V8, P91, DOI 10.1016/j.eatbeh.2006.02.003; Di Paola F, 2010, COMPR PSYCHIAT, V51, P401, DOI 10.1016/j.comppsych.2009.10.002; FAHY T, 1993, BRIT J PSYCHIAT, V162, P193, DOI 10.1192/bjp.162.2.193; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fassino S, 2004, PANMINERVA MED, V46, P189; Fassino S, 2002, INT J EAT DISORDER, V32, P412, DOI 10.1002/eat.10099; Frank GK, 2006, INT J EAT DISORDER, V39, P76, DOI 10.1002/eat.20210; Frank GK, 2004, CNS SPECTRUMS, V9, P539, DOI 10.1017/S1092852900009639; FRISTON KJ, 1991, P ROY SOC B-BIOL SCI, V244, P101, DOI 10.1098/rspb.1991.0057; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Garner D. M., 2004, EATING DISORDERS INV; Han SD, 2009, DEMENT GERIATR COGN, V27, P1, DOI 10.1159/000182420; HENDERSON M, 1987, BRIT J PSYCHIAT, V150, P18, DOI 10.1192/bjp.150.1.18; Isshiki M, 2003, RSVP EXPT VER 1 1; Kadota H, 2010, EXP BRAIN RES, V203, P593, DOI 10.1007/s00221-010-2269-4; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; LAESSLE RG, 1992, PSYCHONEUROENDOCRINO, V17, P475, DOI 10.1016/0306-4530(92)90006-S; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Marsh R, 2009, ARCH GEN PSYCHIAT, V66, P51, DOI 10.1001/archgenpsychiatry.2008.504; Matsubara M, 2004, J COGNITIVE NEUROSCI, V16, P944, DOI 10.1162/0898929041502643; Mitchell JE, 2005, INT J EAT DISORDER, V37, pS95, DOI 10.1002/eat.20125; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Mohr HM, 2011, NEUROIMAGE, V56, P1822, DOI 10.1016/j.neuroimage.2011.02.069; Neubert FX, 2010, J NEUROSCI, V30, P4830, DOI 10.1523/JNEUROSCI.0745-10.2010; Onishi Y, 2008, PSYCHIAT CLIN NEUROS, V62, P177, DOI 10.1111/j.1440-1819.2008.01752.x; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Rodriguez-Cano T, 2009, EUR PSYCHIAT, V24, P275, DOI 10.1016/j.eurpsy.2008.11.004; Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296; Sadock B.J., 2007, KAPLAN SADOCKS SYNOP, V10th; Senhorini MCT, 2011, J CLIN EXP NEUROPSYC, V33, P864, DOI 10.1080/13803395.2011.561299; Spinella M, 2004, INT J NEUROSCI, V114, P83, DOI 10.1080/00207450490249356; Suda M, 2010, J PSYCHIATR RES, V44, P547, DOI 10.1016/j.jpsychires.2009.11.005; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Tchanturia K, 2004, J INT NEUROPSYCH SOC, V10, P513, DOI 10.1017/S1355617704104086; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159; Weiss EM, 2003, NEUROSCI LETT, V352, P191, DOI 10.1016/j.neulet.2003.08.071; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59324	10.1371/journal.pone.0059324	http://dx.doi.org/10.1371/journal.pone.0059324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527162	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100107
J	Cleary, RT; Sun, HY; Huynh, T; Manning, SM; Li, YJ; Rotenberg, A; Talos, DM; Kahle, KT; Jackson, M; Rakhade, SN; Berry, G; Jensen, FE				Cleary, Ryan T.; Sun, Hongyu; Thanhthao Huynh; Manning, Simon M.; Li, Yijun; Rotenberg, Alexander; Talos, Delia M.; Kahle, Kristopher T.; Jackson, Michele; Rakhade, Sanjay N.; Berry, Gerard; Jensen, Frances E.			Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures	PLOS ONE			English	Article							NA-K-2CL COTRANSPORTER NKCC1; CRITICALLY ILL INFANTS; DEVELOPING BRAIN; ANTIEPILEPTIC DRUGS; APOPTOTIC NEURODEGENERATION; STATUS EPILEPTICUS; IMMATURE BRAIN; HIPPOCAMPUS; GABA; PHARMACOKINETICS	Neonatal seizures can be refractory to conventional anticonvulsants, and this may in part be due to a developmental increase in expression of the neuronal Na+-K+-2 Cl- cotransporter, NKCC1, and consequent paradoxical excitatory actions of GABA(A) receptors in the perinatal period. The most common cause of neonatal seizures is hypoxic encephalopathy, and here we show in an established model of neonatal hypoxia-induced seizures that the NKCC1 inhibitor, bumetanide, in combination with phenobarbital is significantly more effective than phenobarbital alone. A sensitive mass spectrometry assay revealed that bumetanide concentrations in serum and brain were dose-dependent, and the expression of NKCC1 protein transiently increased in cortex and hippocampus after hypoxic seizures. Importantly, the low doses of phenobarbital and bumetanide used in the study did not increase constitutive apoptosis, alone or in combination. Perforated patch clamp recordings from ex vivo hippocampal slices removed following seizures revealed that phenobarbital and bumetanide largely reversed seizure-induced changes in E-GABA. Taken together, these data provide preclinical support for clinical trials of bumetanide in human neonates at risk for hypoxic encephalopathy and seizures.	[Cleary, Ryan T.; Sun, Hongyu; Thanhthao Huynh; Manning, Simon M.; Rotenberg, Alexander; Talos, Delia M.; Jackson, Michele; Rakhade, Sanjay N.; Jensen, Frances E.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Li, Yijun; Berry, Gerard] Childrens Hosp, Div Genet & Metab, Boston, MA 02115 USA; [Manning, Simon M.] Brigham & Womens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Jensen, Frances E.] Harvard Univ, Sch Med, Program Neurobiol, Boston, MA USA; [Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Kahle, Kristopher T.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jensen, FE (corresponding author), Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	frances.jensen@uphs.upenn.edu		Berry, Gerard/0000-0001-5299-3313	National Institutes of Health (NIH) [NS 31718, 1R21NS080268]; National Institutes of Health (NIH) (Office of the Director) [DPI OD003347]; Intellectual Developmental Disabilities Center [P30 HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068938, R01NS031718, R56NS031718, R29NS031718, R21NS080268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003347] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) (Office of the Director)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual Developmental Disabilities Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) Grants: NS 31718 (NINDS) (FEJ), DPI OD003347 (from the Office of the Director) (FEJ), 1R21NS080268 (FEJ), and Intellectual Developmental Disabilities Center Grant P30 HD18655 (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla PK, 2009, EPILEPSIA IN PRESS; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bittigau P, 2003, ANN NY ACAD SCI, V993, P103, DOI 10.1111/j.1749-6632.2003.tb07517.x; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bragin DE, 2009, EUR J NEUROSCI, V30, P611, DOI 10.1111/j.1460-9568.2009.06863.x; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Cha BH, 2002, EPILEPSY RES, V51, P217, DOI 10.1016/S0920-1211(02)00157-2; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Feit P.W., 1990, CAMFORTH, P1; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Glier C, 2004, EXP NEUROL, V187, P403, DOI 10.1016/j.expneurol.2004.01.025; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Ibla JC, 2006, AM J PHYSIOL-CELL PH, V291, pC282, DOI 10.1152/ajpcell.00564.2005; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ives JR, 2005, J CLIN NEUROPHYSIOL, V22, P119, DOI 10.1097/01.WNP.0000152659.30753.47; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73, DOI 10.1152/jn.1998.79.1.73; Jensen FE, 2009, CLIN PERINATOL, V36, P881, DOI 10.1016/j.clp.2009.08.001; Kahle KT, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E22; Kim JS, 2007, EPILEPSIA, V48, P19, DOI 10.1111/j.1528-1167.2007.01285.x; Koh S, 2001, NEUROLOGY, V53; Lemonnier E, 2010, ACTA PAEDIATR, V99, P1885, DOI 10.1111/j.1651-2227.2010.01933.x; Li YJ, 2011, J CHROMATOGR B, V879, P998, DOI 10.1016/j.jchromb.2011.02.018; Liu YQ, 2012, PEDIATR RES, V71, P559, DOI 10.1038/pr.2012.7; LopezSamblas AM, 1997, BIOL NEONATE, V72, P265; Loscher W, 2012, NEUROPHARMACOLOGY; Mazarati A, 2009, EPILEPSIA, V50, P2117, DOI 10.1111/j.1528-1167.2009.02048.x; Nunez JL, 2007, DEV NEUROBIOL, V67, P1879, DOI 10.1002/dneu.20567; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Raol YH, 2009, ANN NEUROL, V65, P326, DOI 10.1002/ana.21593; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Rossetti F, 2006, EPILEPSY RES, V72, P192, DOI 10.1016/j.eplepsyres.2006.08.001; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sankar R, 2005, NEUROLOGY, V64, P776, DOI 10.1212/01.WNL.0000157320.78071.6D; Scher MS, 2003, PEDIATR NEUROL, V28, P277, DOI 10.1016/S0887-8994(02)00621-5; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Silverstein FS, 2008, J PEDIATR-US, V153, P12, DOI 10.1016/j.jpeds.2008.01.041; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Sipila ST, 2009, J NEUROSCI, V29, P6982, DOI 10.1523/JNEUROSCI.0443-09.2009; Sullivan JE, 1996, CLIN PHARMACOL THER, V60, P424, DOI 10.1016/S0009-9236(96)90199-X; Sullivan JE, 1996, CLIN PHARMACOL THER, V60, P405, DOI 10.1016/S0009-9236(96)90197-6; Talos DM, 2006, J COMP NEUROL, V497, P42, DOI 10.1002/cne.20972; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Talos DM, 2012, ANN NEUROL, V71, P539, DOI 10.1002/ana.22696; Volpe J.J., 2008, NEUROLOGY NEWBORN; White A, EPILEPSIA, V51, P371	56	96	98	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57148	10.1371/journal.pone.0057148	http://dx.doi.org/10.1371/journal.pone.0057148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536761	Green Published, gold			2022-12-27	WOS:000316251100007
J	Hane, F; Tran, G; Attwood, SJ; Leonenko, Z				Hane, Francis; Tran, Gary; Attwood, Simon J.; Leonenko, Zoya			Cu2+ Affects Amyloid-beta (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; OXIDATIVE STRESS; FIBRIL FORMATION; METAL-IONS; PROTEIN; COPPER; IRON; COMPLEXES	The link between metals, Alzheimer's disease (AD) and its implicated protein, amyloid-beta (A beta), is complex and highly studied. AD is believed to occur as a result of the misfolding and aggregation of A beta. The dyshomeostasis of metal ions and their propensity to interact with A beta has also been implicated in AD. In this work, we use single molecule atomic force spectroscopy to measure the rupture force required to dissociate two A beta (1-42) peptides in the presence of copper ions, Cu2+. In addition, we use atomic force microscopy to resolve the aggregation of A beta formed. Previous research has shown that metal ions decrease the lag time associated with A beta aggregation. We show that with the addition of copper ions the unbinding force increases notably. This suggests that the reduction of lag time associated with A beta aggregation occurs on a single molecule level as a result of an increase in binding forces during the very initial interactions between two A beta peptides. We attribute these results to copper ions acting as a bridge between the two peptide molecules, increasing the stability of the peptide-peptide complex.	[Hane, Francis; Tran, Gary; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Attwood, Simon J.; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Leonenko, Z (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca	attwood, simon J/N-7237-2014	attwood, simon J/0000-0002-2973-2059; Hane, Francis/0000-0002-2738-584X	Canadian Foundation of Innovation; Ontario Research Fund; Natural Science and Engineering Council of Canada	Canadian Foundation of Innovation(Canada Foundation for Innovation); Ontario Research Fund; Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by Canadian Foundation of Innovation), Ontario Research Fund and Natural Science and Engineering Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Azimi S, 2011, INT J ALZHEIMERS DIS, P1; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Cote S, 2012, J PHYS CHEM B, V116, P4043, DOI 10.1021/jp2126366; Curtain CC, 2003, J BIOL CHEM, V278, P2977, DOI 10.1074/jbc.M205455200; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Han DX, 2008, BIOMETALS, V21, P189, DOI 10.1007/s10534-007-9107-6; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; He XL, 2010, J MOL BIOL, V395, P134, DOI 10.1016/j.jmb.2009.10.019; Hewitt N, 2009, J PHYS CHEM B, V113, P1202, DOI 10.1021/jp807327a; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Karacsony O, 2011, LANGMUIR, V27, P11287, DOI 10.1021/la202530j; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu W, 2000, J CELL SCI, V113, P635; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lynch T, 2000, EXP GERONTOL, V35, P445, DOI 10.1016/S0531-5565(00)00112-1; Lyubchenko YL, 2010, WIRES NANOMED NANOBI, V2, P526, DOI 10.1002/wnan.102; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mothana B, 2009, ARKIVOC, P116, DOI 10.3998/ark.5550190.0010.511; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Roy S, 2005, MED HYPOTHESES, V65, P123, DOI 10.1016/j.mehy.2004.08.031; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Suwalsky M, 2009, J ALZHEIMERS DIS, V17, P81, DOI 10.3233/JAD-2009-1032; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006	55	88	88	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59005	10.1371/journal.pone.0059005	http://dx.doi.org/10.1371/journal.pone.0059005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536847	Green Published, gold			2022-12-27	WOS:000316251100109
J	Huang, P; Ma, X; Zhao, YM; Miao, L				Huang, Ping; Ma, Xuan; Zhao, Yanmei; Miao, Long			The C. elegans Homolog of RBBP6 (RBPL-1) Regulates Fertility through Controlling Cell Proliferation in the Germline and Nutrient Synthesis in the Intestine	PLOS ONE			English	Article							BINDING-PROTEIN; P2P-R PROTEIN; PACT; EXPRESSION; P53	RBBP6 (retinoblastoma binding protein 6, also known as PACT or P2P-R in humans) is a multi-domain protein that functions in multiple processes, such as mitosis, cell differentiation, and cell apoptosis. RBBP6 is evolutionarily conserved and is present in unicellular organisms to mammals. Studies of RBBP6 have mostly focused on its RB- and p53-binding domains, which are found exclusively in mammals. Here, we investigated the C. elegans homolog of RBBP6 to explore the functional roles of its other domains. We found that RBPL-1, the homolog of RBBP6 in C. elegans, is indispensable for worm development. RNAi silencing of rbpl-1 led to embryonic lethality, as well as defects in oocyte production and intestine development. rbpl-1 RNAi worms showed defects in germ cell proliferation, suggesting that RBPL-1 regulates mitosis. Moreover, RNAi silencing of rbpl-1 inhibited nutrient synthesis in the worm intestine. RBPL-1, as a nucleolus protein, was found to be expressed in diverse tissues and necessary for both germline and soma development. Using microarray analysis, we identified approximate to 700 genes whose expression levels were changed at least 10-fold in rbpl-1 worms. We propose that RBPL-1, like its yeast homolog, may regulate gene expression as an mRNA cleavage and polyadenylation factor. Taken together, the findings from this study reveal that RBPL-1 plays a pivotal role in C. elegans germline and soma development, suggesting that the functions of RBBP6 are conserved in diverse eukaryotic species.	[Huang, Ping; Ma, Xuan; Zhao, Yanmei; Miao, Long] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China; [Huang, Ping] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Miao, L (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China.	lmiao@moon.ibp.ac.cn		Miao, Long/0000-0002-0562-6681	Chinese Academy of Sciences; Chinese government [2012CB945002, 2010CB912303, 31171337, 2009CB825503]	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese government	This research was supported by the Chinese Academy of Sciences 100-talents program (http://www.cas.cn) and the grants 2012CB945002 and 2010CB912303 (www.most.gov.cn) and 31171337 (www.most.gov.cn) to LM, 2009CB825503 (www.most.gov.cn) and (www.nsfc.gov.cn) to YZ from the Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz LA, 2008, J VIS EXP, P835; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gao S, 2003, J CELL PHYSIOL, V197, P445, DOI 10.1002/jcp.10381; Gao SZ, 2002, J CELL PHYSIOL, V191, P145, DOI 10.1002/jcp.10084; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greenstein D, 2006, CONTROL OOCYTE MEIOT; Kappo MA, 2012, J BIOL CHEM, V287, P7146, DOI 10.1074/jbc.M110.217059; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Maciejowski J, 2006, DEV BIOL, V292, P142, DOI 10.1016/j.ydbio.2005.12.046; Nakatsura T, 2004, CLIN CANCER RES, V10, P8630, DOI 10.1158/1078-0432.CCR-04-1177; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Scott RE, 2005, J CELL PHYSIOL, V204, P99, DOI 10.1002/jcp.20263; Scott RE, 2003, J CELL BIOCHEM, V90, P6, DOI 10.1002/jcb.10618; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001; Witte MM, 1997, P NATL ACAD SCI USA, V94, P1212, DOI 10.1073/pnas.94.4.1212; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	25	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58736	10.1371/journal.pone.0058736	http://dx.doi.org/10.1371/journal.pone.0058736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536819	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100086
J	Liu, CC; Zhu, HY; Dong, XM; Ning, DL; Wang, HX; Li, WH; Yang, CP; Wang, BC				Liu, Chang-Cai; Zhu, Hang-Yong; Dong, Xiu-Mei; Ning, De-Li; Wang, Hong-Xia; Li, Wei-Hua; Yang, Chuan-Ping; Wang, Bai-Chen			Identification and Analysis of the Acetylated Status of Poplar Proteins Reveals Analogous N-Terminal Protein Processing Mechanisms with Other Eukaryotes	PLOS ONE			English	Article							HIGHLY SELECTIVE ENRICHMENT; ALPHA-ACETYLTRANSFERASE; PHOSPHORYLATED PEPTIDES; METHIONINE EXCISION; YEAST; DYNAMICS; GENOME; IMPACT; STROMA	Background: The N-terminal protein processing mechanism (NPM) including N-terminal Met excision (NME) and N-terminal acetylation (N-alpha-acetylation) represents a common protein co-translational process of some eukaryotes. However, this NPM occurred in woody plants yet remains unknown. Methodology/Principal Findings: To reveal the NPM in poplar, we investigated the N-alpha-acetylation status of poplar proteins during dormancy by combining tandem mass spectrometry with TiO2 enrichment of acetylated peptides. We identified 58 N-terminally acetylated (N-alpha-acetylated) proteins. Most proteins (47, >81%) are subjected to N-alpha-acetylation following the N-terminal removal of Met, indicating that N-alpha-acetylation and NME represent a common NPM of poplar proteins. Furthermore, we confirm that poplar shares the analogous NME and N-alpha-acetylation (NPM) to other eukaryotes according to analysis of N-terminal features of these acetylated proteins combined with genome-wide identification of the involving methionine aminopeptidases (MAPs) and N-terminal acetyltransferase (Nat) enzymes in poplar. The N-alpha-acetylated reactions and the involving enzymes of these poplar proteins are also identified based on those of yeast and human, as well as the subcellular location information of these poplar proteins. Conclusions/Significance: This study represents the first extensive investigation of N-alpha-acetylation events in woody plants, the results of which will provide useful resources for future unraveling the regulatory mechanisms of N-alpha-acetylation of proteins in poplar.	[Liu, Chang-Cai; Zhu, Hang-Yong; Dong, Xiu-Mei; Ning, De-Li; Yang, Chuan-Ping; Wang, Bai-Chen] Northeast Forestry Univ, State Key Lab Forest Genet & Tree Breeding, Harbin, Heilongjiang, Peoples R China; [Liu, Chang-Cai] Hubei Nanxing Gen Chem Factory, Lab Chem Def & Microscale Anal, Zhijiang, Hubei, Peoples R China; [Zhu, Hang-Yong] Bur Garden & Pk, Qitaihe, Heilongjiang, Peoples R China; [Wang, Hong-Xia; Li, Wei-Hua] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing, Peoples R China; [Wang, Bai-Chen] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China	Northeast Forestry University - China; Chinese Academy of Sciences; Institute of Botany, CAS	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Forest Genet & Tree Breeding, Harbin, Heilongjiang, Peoples R China.	yangcp5516@gmail.com; wangbc@ibcas.ac.cn			National Basic Research Priorities Program [2009CB119102]; State Key Program of the National Natural Science of China [31030017]; Northeast Forestry University [140-602055]	National Basic Research Priorities Program(National Basic Research Program of China); State Key Program of the National Natural Science of China(National Natural Science Foundation of China (NSFC)); Northeast Forestry University	This work was supported by the National Basic Research Priorities Program (Grant No. 2009CB119102), the State Key Program of the National Natural Science of China (Grant No. 31030017), the excellent doctor degree dissertation in Northeast Forestry University (Grant No. 140-602055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Arnesen Thomas, 2009, BMC Proc, V3 Suppl 6, pS1, DOI 10.1186/1753-6561-3-S6-S1; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dormeyer W, 2007, J PROTEOME RES, V6, P4634, DOI 10.1021/pr070375k; Eddy Sean R, 2009, Genome Inform, V23, P205; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2000, EMBO J, V19, P5916, DOI 10.1093/emboj/19.21.5916; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kamita M, 2011, J PROTEOMICS, V74, P431, DOI 10.1016/j.jprot.2010.12.007; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu CC, 2012, INT J MOL SCI, V13, P5112, DOI 10.3390/ijms13045112; Liu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-158; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; MICHEL H, 1988, J BIOL CHEM, V263, P1123; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2009, BMC P S6, pS2; Polevoda B, 2009, MOL CELL BIOL, V29, P2913, DOI 10.1128/MCB.00147-08; Rinalducci S, 2006, J PROTEOME RES, V5, P973, DOI 10.1021/pr050476n; Ross S, 2005, PLANT PHYSIOL, V137, P623, DOI 10.1104/pp.104.056861; Serero A, 2003, J BIOL CHEM, V278, P52953, DOI 10.1074/jbc.M309770200; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taouatas N, 2009, MOL CELL PROTEOMICS, V8, P190, DOI 10.1074/mcp.M800285-MCP200; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	46	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58681	10.1371/journal.pone.0058681	http://dx.doi.org/10.1371/journal.pone.0058681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536812	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100079
J	Polackwich, RJ; Koch, D; Arevalo, R; Miermont, AM; Jee, KJ; Lazar, J; Urbach, J; Mueller, SC; McAllister, RG				Polackwich, Robert J.; Koch, Daniel; Arevalo, Richard; Miermont, Anne M.; Jee, Kathleen J.; Lazar, John; Urbach, Jeffrey; Mueller, Susette C.; McAllister, Ryan G.			A Novel 3D Fibril Force Assay Implicates Src in Tumor Cell Force Generation in Collagen Networks	PLOS ONE			English	Article							TRACTION FORCE; EXTRACELLULAR PROTEOLYSIS; MECHANICAL FORCE; FAMILY KINASES; BREAST-CANCER; INVADOPODIA; MATRIX; ACTIN; PODOSOMES; CORTACTIN	New insight into the biomechanics of cancer cell motility in 3D extracellular matrix (ECM) environments would significantly enhance our understanding of aggressive cancers and help identify new targets for intervention. While several methods for measuring the forces involved in cell-matrix interactions have been developed, previous to this study none have been able to measure forces in a fibrillar environment. We have developed a novel assay for simultaneously measuring cell mechanotransduction and motility in 3D fibrillar environments. The assay consists of a controlled-density fibrillar collagen gel atop a controlled-stiffness polyacrylamide (PAA) surface. Forces generated by living cells and their migration in the 3D collagen gel were measured with the 3D motion of tracer beads within the PAA layer. Here, this 3D fibril force assay is used to study the role of the invasion-associated protein kinase Src in mechanotransduction and motility. Src expression and activation are linked with proliferation, invasion, and metastasis, and have been shown to be required in 2D for invadopodia membranes to direct and mediate invasion. Breast cancer cell line MDA-MD-231 was stably transfected with GFP-tagged constitutively active Src or wild-type Src. In 3D fibrillar collagen matrices we found that, relative to wild-type Src, constitutively active Src: 1) increased the strength of cell-induced forces on the ECM, 2) did not significantly change migration speed, and 3) increased both the duration and the length, but not the number, of long membrane protrusions. Taken together, these results support the hypothesis that Src controls invasion by controlling the ability of the cell to form long lasting cellular protrusions to enable penetration through tissue barriers, in addition to its role in promoting invadopodia matrix-degrading activity.	[Polackwich, Robert J.; Koch, Daniel; Arevalo, Richard; Urbach, Jeffrey; McAllister, Ryan G.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Miermont, Anne M.; Jee, Kathleen J.; Lazar, John; Mueller, Susette C.; McAllister, Ryan G.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Miermont, Anne M.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McAllister, RG (corresponding author), Georgetown Univ, Dept Phys, Washington, DC 20057 USA.	rmca@physics.georgetown.edu		Urbach, Jeffrey/0000-0002-1593-520X	National Cancer Institute [5K25CA126836]; National Science Foundation [DMR-0804782]; Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; U.S. Public Health Service [2P30-CA-51008, 1S10 RR15768-01, 1 S10 RR019291-01A2];  [9R01 CA112673]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA112673] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015768, S10RR019291] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported in part by Award Number 5K25CA126836 from the National Cancer Institute to RM and supported in part by Award number DMR-0804782 from the National Science Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This work was further supported in part by the Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource funded by U.S. Public Health Service Grants 2P30-CA-51008, 1S10 RR15768-01, and 1 S10 RR019291-01A2 and by 9R01 CA112673 to SCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; Artym VV, 2011, EUR J CELL BIOL, V90, P172, DOI 10.1016/j.ejcb.2010.06.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Artym VV, 2009, METHOD MOL BIOL, V522, P1; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Frey MT, 2007, METHOD CELL BIOL, V83, P47, DOI 10.1016/S0091-679X(07)83003-2; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gnoni A, 2011, CURR DRUG TARGETS, V12, P563, DOI 10.2174/138945011794751591; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Gulyani A, 2011, NAT CHEM BIOL, V7, P437, DOI [10.1038/NCHEMBIO.585, 10.1038/nchembio.585]; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kikuchi K, 2008, CANCER SCI, V99, P2252, DOI 10.1111/j.1349-7006.2008.00927.x; Kirmse R, 2011, J CELL SCI, V124, P1857, DOI 10.1242/jcs.079343; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Mierke CT, 2011, J BIOL CHEM, V286, P34858, DOI 10.1074/jbc.M111.245183; MONSKY WL, 1994, CANCER RES, V54, P5702; Mueller Susette C., 2008, P403, DOI 10.1007/978-0-387-69057-5_21; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parekh A, 2011, BIOPHYS J, V100, P573, DOI 10.1016/j.bpj.2010.12.3733; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109; Petroll WM, 2004, SCANNING, V26, P1, DOI 10.1002/sca.4950260102; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Puls LN, 2011, ONCOLOGIST, V16, P566, DOI 10.1634/theoncologist.2010-0408; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schoumacher M, 2011, EUR J CELL BIOL, V90, P93, DOI 10.1016/j.ejcb.2010.05.010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sung BH, 2011, CURR BIOL, V21, pR121, DOI 10.1016/j.cub.2010.12.024; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14964, DOI 10.1073/pnas.1005537107; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	78	11	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58138	10.1371/journal.pone.0058138	http://dx.doi.org/10.1371/journal.pone.0058138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536784	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100028
J	Simeone, R; Huet, G; Constant, P; Malaga, W; Lemassu, A; Laval, F; Daffe, M; Guilhot, C; Chalut, C				Simeone, Roxane; Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Lemassu, Anne; Laval, Francoise; Daffe, Mamadou; Guilhot, Christophe; Chalut, Christian			Functional Characterisation of Three O-methyltransferases Involved in the Biosynthesis of Phenolglycolipids in Mycobacterium tuberculosis	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; VIRULENCE; SMEGMATIS; STRAINS; COMPLEX; GENE; IDENTIFICATION; METHYLATION; BCG	Phenolic glycolipids are produced by a very limited number of slow-growing mycobacterial species, most of which are pathogen for humans. In Mycobacterium tuberculosis, the etiologic agent of tuberculosis, these molecules play a role in the pathogenicity by modulating the host immune response during infection. The major variant of phenolic glycolipids produced by M. tuberculosis, named PGL-tb, consists of a large lipid core terminated by a glycosylated aromatic nucleus. The carbohydrate part is composed of three sugar residues, two rhamnosyl units and a terminal fucosyl residue, which is per-O-methylated, and seems to be important for pathogenicity. While most of the genes responsible for the synthesis of the lipid core domain and the saccharide appendage of PGL-tb have been characterized, the enzymes involved in the O-methylation of the fucosyl residue of PGL-tb remain unknown. In this study we report the identification and characterization of the methyltransferases required for the O-methylation of the terminal fucosyl residue of PGL-tb. These enzymes are encoded by genes Rv2954c, Rv2955c and Rv2956. Mutants of M. tuberculosis harboring deletion within these genes were constructed. Purification and analysis of the phenolglycolipids produced by these strains, using a combination of mass spectrometry and NMR spectroscopy, revealed that Rv2954c, Rv2955c and Rv2956 encode the methyltransferases that respectively catalysed the O-methylation of the hydroxyl groups located at positions 3, 4 and 2 of the terminal fucosyl residue of PGL-tb. Our data also suggest that methylation at these positions is a sequential process, starting with position 2, followed by positions 4 and 3.	[Simeone, Roxane; Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Lemassu, Anne; Laval, Francoise; Daffe, Mamadou; Guilhot, Christophe; Chalut, Christian] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Simeone, Roxane; Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Lemassu, Anne; Laval, Francoise; Daffe, Mamadou; Guilhot, Christophe; Chalut, Christian] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Chalut, C (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	christian.chalut@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; SIMEONE, Roxane/0000-0002-7082-7842; Chalut, Christian/0000-0002-4849-1369; Lemassu, Anne/0000-0002-9323-2497	European Commission; French Minister of Teaching and Scientific Research; Centre National de la Recherche Scientifique	European Commission(European CommissionEuropean Commission Joint Research Centre); French Minister of Teaching and Scientific Research; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	R.S. and G. H. are recipients of fellowships from the European Commission and from the French Minister of Teaching and Scientific Research. This work was supported by the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Jeevarajah D, 2004, J BACTERIOL, V186, P6792, DOI 10.1128/JB.186.20.6792-6799.2004; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Malaga W, 2008, J BIOL CHEM, V283, P15177, DOI 10.1074/jbc.M710275200; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Patallo EP, 2001, J BIOL CHEM, V276, P18765, DOI 10.1074/jbc.M101225200; Patterson JH, 2000, J BIOL CHEM, V275, P24900, DOI 10.1074/jbc.M000147200; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; RIVIERE M, 1987, J BIOL CHEM, V262, P14879; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Stadthagen G, 2006, MICROBES INFECT, V8, P2245, DOI 10.1016/j.micinf.2006.04.008; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614	23	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58954	10.1371/journal.pone.0058954	http://dx.doi.org/10.1371/journal.pone.0058954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536839	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100104
J	Yu, YH; Li, JX; Wan, Y; Lu, JY; Gao, JM; Huang, CS				Yu, Yonghui; Li, Jingxia; Wan, Yu; Lu, Jianyi; Gao, Jimin; Huang, Chuanshu			GADD45 alpha Induction by Nickel Negatively Regulates JNKs/p38 Activation via Promoting PP2C alpha Expression	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; TERMINAL KINASE 2; NF-KAPPA-B; PROTEIN-KINASE; P38 ACTIVATION; EPITHELIAL-CELLS; BREAST-CANCER; LUNG-CANCER; JNK; STRESS	Growth arrest and DNA damage (GADD) 45 alpha is a member of GADD inducible gene family, and is inducible in cell response to oxidative stress. GADD45 alpha upregulation induces MKK4/JNK activation in some published experimental systems. However, we found here that the depletion of GADD45 alpha (GADD45 alpha-/-) in mouse embryonic fibroblasts (MEFs) resulted in an increase in the phosphorylation of MKK4/7, MKK3/6 and consequently specific up-regulated the activation of JNK/p38 and their downstream transcription factors, such as c-Jun and ATF2, in comparison to those in GADD45 alpha+/+ MEFs cell following nickel exposure. This up-regulation of MKK-JNK/p38 pathway in GADD45 alpha-/- cell could be rescued by the reconstitutional expression of HA-GADD45 alpha in GADD45 alpha-/- MEFs, GADD45 alpha-/-(HA-GADD45 alpha). Subsequent studies indicated that GADD45 alpha deletion repressed expression of PP2C alpha, the phosphotase of MKK3/6 and MKK4/7, whereas ectopic expression of HA-PP2C alpha in GADD45 alpha-/- cells attenuated activation of MKK3/6-p38 and MKK4/7-JNK pathways. Collectively, our results demonstrate a novel function and mechanism responsible for GADD45 alpha regulation of MKK/MAPK pathway, further provides insight into understanding the big picture of GADD45 alpha in the regulation of cellular responses to oxidative stress and environmental carcinogens.	[Yu, Yonghui; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Yu, Yonghui; Wan, Yu] Wuhan Univ, Med Res Ctr, Oversea Lab, Wuhan 430072, Hubei, Peoples R China; [Lu, Jianyi; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China	New York University; Wuhan University; Wenzhou Medical University	Gao, JM (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China.	jimingao@yahoo.com; chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096	NIHNCI [CA112557]; NIH/NIEHS [ES010344, ES000260];  [NSFC30928023];  [NSFC30971516]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260] Funding Source: NIH RePORTER	NIHNCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from NIHNCI CA112557, NIH/NIEHS ES010344 and ES000260, and NSFC30928023 and NSFC30971516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; ANN MB, 2007, MOL CARCINOG, V46, P591; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; CALawler S, 1998, CURR BIOL, V8, P1387; Chabaud-Riou M, 2004, AM J PATHOL, V164, P177, DOI 10.1016/S0002-9440(10)63108-2; Chen F, 2009, CELL CYCLE, V8, P1145, DOI 10.4161/cc.8.8.8200; Chen NY, 2001, CANCER RES, V61, P3908; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Ding J, 2009, CURR CANCER DRUG TAR, V9, P81, DOI 10.2174/156800909787313995; Ding J, 2006, J BIOL CHEM, V281, P39022, DOI 10.1074/jbc.M604798200; Dong M, 2007, J SURG ONCOL, V95, P332, DOI 10.1002/jso.20684; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Grimsrud TK, 2006, OCCUP ENVIRON MED, V63, P365, DOI 10.1136/oem.2005.026336; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Hildesheim J, 2002, CANCER RES, V62, P7305; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huang CS, 1999, CANCER RES, V59, P3053; Huang Y, 2002, ENVIRON HEALTH PERSP, V110, P835, DOI 10.1289/ehp.02110s5835; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Matrone A, 2010, INT J GYNECOL CANCER, V20, P203, DOI 10.1111/IGC.0b013e3181c8ca12; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Oller AR, 1997, TOXICOL APPL PHARM, V143, P152, DOI 10.1006/taap.1996.8075; Ouyang W, 2005, MOL CELL BIOCHEM, V279, P35, DOI 10.1007/s11010-005-8214-3; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tront JS, 2010, CANCER RES, V70, P9671, DOI 10.1158/0008-5472.CAN-10-2177; Voutsadakis IA, 2008, BBA-MOL BASIS DIS, V1782, P800, DOI 10.1016/j.bbadis.2008.06.007; Xu X, 1996, ONCOGENE, V13, P135; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhang DY, 2007, CARCINOGENESIS, V28, P883, DOI 10.1093/carcin/bgl186; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	51	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e57185	10.1371/journal.pone.0057185	http://dx.doi.org/10.1371/journal.pone.0057185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536762	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100008
J	Michelan, TS; Thomaz, SM; Bini, LM				Michelan, Thaisa S.; Thomaz, Sidinei M.; Bini, Luis M.			Native Macrophyte Density and Richness Affect the Invasiveness of a Tropical Poaceae Species	PLOS ONE			English	Article							INVASION-RESISTANCE; PLANT DIVERSITY; BIODIVERSITY; INVASIBILITY; COMPETITION; ECOSYSTEM; PATTERNS; SIGNALGRASS; ROOT	The role of the native species richness and density in ecosystem invasibility is a matter of concern for both ecologists and managers. We tested the hypothesis that the invasiveness of Urochloa arrecta (non-native in the Neotropics) is negatively affected by the species richness and abundance of native aquatic macrophytes in freshwater ecosystems. We first created four levels of macrophyte richness in a greenhouse (richness experiment), and we then manipulated the densities of the same native species in a second experiment (density experiment). When the native macrophytes were adults, fragments of U. arrecta were added, and their growth was assessed. Our results from the richness experiment corroborated the hypothesis of a negative relationship between the native species richness and the growth of U. arrecta, as measured by sprout length and root biomass. However, the resistance to invasion was not attributed to the presence of a particular native species with a greater competitive ability. In the density experiment, U. arrecta growth decreased significantly with an increased density of all five of the native species. Density strongly affected the performance of the Poaceae in a negative manner, suggesting that patches that are densely colonized by native macrophytes and less subject to disturbances will be more resistant to invasion than those that are poorly colonized and more commonly subjected to disturbances. Our density experiment also showed that some species exhibit a higher competitive ability than others (sampling effect). Although native richness and abundance clearly limit the colonization and establishment of U. arrecta, these factors cannot completely prevent the invasion of aquatic ecosystems by this Poaceae species.	[Michelan, Thaisa S.; Thomaz, Sidinei M.] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, ICB, Goiania, Go, Brazil	Universidade Estadual de Maringa; Universidade Federal de Goias	Michelan, TS (corresponding author), Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil.	thaisamichelan@gmail.com	Bini, Luis Mauricio/D-5865-2013; Michelan, Thaisa Sala/HGV-0299-2022; Thomaz, Sidinei Magela/A-7331-2013; Michelan, Thaisa S/I-5255-2012	Bini, Luis Mauricio/0000-0003-3398-9399; Michelan, Thaisa Sala/0000-0001-9416-0758; Michelan, Thaisa S/0000-0001-9416-0758	Brazilian Council of Research (CNPq); CNPq	Brazilian Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TS Michelan acknowledges the Brazilian Council of Research (CNPq) for providing a scholarship, and SM Thomaz and LM Bini are especially thankful to the CNPq for continuous funding through a Research Productivity Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Brown RL, 2003, OIKOS, V102, P15, DOI 10.1034/j.1600-0706.2003.12191.x; Paciullo DSC, 2011, REV BRAS ZOOTECN, V40, P270, DOI 10.1590/S1516-35982011000200006; Capers RS, 2007, ECOLOGY, V88, P3135, DOI 10.1890/06-1911.1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casatti L, 2009, HYDROBIOLOGIA, V632, P273, DOI 10.1007/s10750-009-9849-y; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Clark GF, 2011, ECOL LETT, V14, P52, DOI 10.1111/j.1461-0248.2010.01550.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Crawley MJ, 1999, ECOL LETT, V2, P140; Darwin C, 1859, ORIGIN SPECIES MEANS; Elton C. S., 1958, ECOLOGY INVASIONS AN; Goldberg D, 1993, DESIGN ANAL ECOLOGIC, P77; GOLDSBOROUGH WJ, 1988, ECOLOGY, V69, P1775, DOI 10.2307/1941156; Havel JE, 2005, BIOSCIENCE, V55, P518, DOI 10.1641/0006-3568(2005)055[0518:DRFIIL]2.0.CO;2; Hector A, 2001, ECOL RES, V16, P819, DOI 10.1046/j.1440-1703.2001.00443.x; Heino J, 2008, LIMNOL OCEANOGR, V53, P1446, DOI 10.4319/lo.2008.53.4.1446; Hershner C, 2008, CONSERV BIOL, V22, P544, DOI 10.1111/j.1523-1739.2008.00957.x; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Lanta V, 2008, PLANT ECOL, V198, P253, DOI 10.1007/s11258-008-9401-6; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2008, CURR BIOL, V18, pR57, DOI 10.1016/j.cub.2007.11.030; Li F, 2011, AQUAT ECOL, V45, P89, DOI 10.1007/s10452-010-9334-8; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lortie CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004823; MacArthur R.H., 1972, pvii; Michelan TS, 2010, NAT CONSERVACAO, V8, P133, DOI 10.4322/natcon.00802005; Michelan TS, 2010, FRESHWATER BIOL, V55, P1315, DOI 10.1111/j.1365-2427.2009.02355.x; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Palma-Silva C, 2000, PLANT ECOL, V148, P157, DOI 10.1023/A:1009823014111; Pott VJ, 2011, BRAZ J BIOL, V71, P255, DOI 10.1590/S1519-69842011000200004; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schiffers K, 2011, ECOLOGY, V92, P610, DOI 10.1890/10-1086.1; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Song MH, 2006, ACTA OECOL, V29, P214, DOI 10.1016/j.actao.2005.10.005; Teuton TC, 2004, WEED SCI, V52, P376, DOI 10.1614/WS-03-121R1; Thomaz SM, 2009, ACTA OECOL, V35, P614, DOI 10.1016/j.actao.2009.05.008; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van der Valk A. G., 2006, BIOL FRESHWATER WETL; Vila M, 2004, BIOL INVASIONS, V6, P59, DOI 10.1023/B:BINV.0000010122.77024.8a	45	27	38	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60004	10.1371/journal.pone.0060004	http://dx.doi.org/10.1371/journal.pone.0060004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536902	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200050
J	Singh, R; Kone, BC; Gounni, AS; Uzonna, JE				Singh, Rani; Kone, Bruce C.; Gounni, Abdelilah S.; Uzonna, Jude E.			Molecular Regulation of Trypanosoma congolense-Induced Nitric Oxide Production in Macrophages	PLOS ONE			English	Article							INTERFERON-GAMMA; GENE-EXPRESSION; AFRICAN TRYPANOSOMIASIS; SURFACE GLYCOPROTEIN; JAK/STAT PATHWAY; ALPHA GENE; RESISTANCE; INFECTION; BRUCEI; INNATE	BALB/c mice are highly susceptible while C57BL/6 mice are relatively resistant to experimental Trypanosoma congolense infection. Several reports show that an early interferon-gamma (IFN-gamma) response in infected mice is critically important for resistance via the activation of macrophages and production of nitric oxide (NO). NO is a pivotal effector molecule and possesses both cytostatic and cytolytic properties for the parasite. However, the molecular mechanisms leading to T. congolense (TC)-induced NO release from macrophages are not known. In this study, we investigated the signaling pathways induced by trypanosomes in immortalized macrophage cell lines from the highly susceptible BALB/c (BALB. BM) and relatively resistant C57Bl/6 (ANA-1) mice. We found that T. congolense whole cell extract (TC-WCE) induces significantly higher levels of NO production in IFN-gamma-primed ANA-1 than BALB. BM cells, which was further confirmed in primary bone marrow-derived macrophage (BMDM) cultures. NO production was dependent on mitogen-activated protein kinase (MAPK, including p38, Erk1/2, and JNK) phosphorylation and was significantly inhibited by specific MAPK inhibitors in BALB. BM, but not in ANA-1 cells. In addition, T. congolense-and IFN-gamma-induced NO production in ANA-1 and BALB. BM cells was dependent on STAT1 phosphorylation and was totally suppressed by the use of fludarabine (a specific STAT1 inhibitor). We further show that T. congolense induces differential iNOS transcriptional promoter activation in IFN-gamma-primed cells, which is dependent on the activation of both GAS1 and GAS2 transcription factors in BALB. BM but only on GAS1 in ANA-1 cells. Taken together, our findings show the existence of differential signalling events that lead to NO production in macrophages from the highly susceptible and relatively resistant mice following treatment with IFN-gamma and T. congolense. Understanding these pathways may help identify immunomodulatory mechanisms that regulate the outcome of infection during Trypanosome infections.	[Singh, Rani; Gounni, Abdelilah S.; Uzonna, Jude E.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; [Kone, Bruce C.] Univ Texas Med Sch, Houston, TX USA	University of Manitoba; University of Texas System; University of Texas Health Science Center Houston	Uzonna, JE (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	uzonna@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560	Natural Sciences and Engineering Council (NSERC); Manitoba Health Research Research Council (MHRC) Research Chairs program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Research Council (MHRC) Research Chairs program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Natural Sciences and Engineering Council (NSERC) and Manitoba Health Research Research Council (MHRC) Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; Bhat NR, 1998, J NEUROSCI, V18, P1633; BIRAGYN A, 1995, J IMMUNOL, V155, P674; Blanchette J, 2003, IMMUNOLOGY, V108, P513, DOI 10.1046/j.1365-2567.2003.01620.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Coller SP, 2003, J IMMUNOL, V171, P1466, DOI 10.4049/jimmunol.171.3.1466; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DESCOTEAUX A, 1990, J IMMUNOL, V145, P846; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; FORTIER AH, 2001, CURRENT PROTOCOLS IM; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Kaushik RS, 1999, EXP PARASITOL, V92, P131, DOI 10.1006/expr.1999.4408; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lopez R, 2008, J IMMUNOL, V181, P4908, DOI 10.4049/jimmunol.181.7.4908; Lu W., 2011, J PARASITOL RES, V2011, DOI DOI 10.1155/2011/316067; MABBOTT NA, 1994, PARASITOL RES, V80, P687, DOI 10.1007/BF00932954; Magez S, 2006, J INFECT DIS, V193, P1575, DOI 10.1086/503808; Magez S, 1998, J IMMUNOL, V160, P1949; Magez S, 2009, FUTURE MICROBIOL, V4, P1075, DOI 10.2217/FMB.09.65; Mansfield J. M., 1995, Molecular approaches to parasitology., P477; Marrero MB, 1998, BIOCHEM BIOPH RES CO, V252, P508, DOI 10.1006/bbrc.1998.9678; MATHIAS S, 1990, J IMMUNOL, V145, P3450; Meli R, 1996, IMMUNOPHARMACOLOGY, V34, P1, DOI 10.1016/0162-3109(95)00052-6; Mou ZR, 2010, INFECT IMMUN, V78, P5271, DOI 10.1128/IAI.00168-10; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Ogunremi O, 1995, J PARASITOL, V81, P876, DOI 10.2307/3284033; Paulnock DM, 2010, PARASITOLOGY, V137, P2051, DOI 10.1017/S0031182010001460; Schofield CJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-24; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; TABEL H, 1982, PARASITE IMMUNOL, V4, P329, DOI 10.1111/j.1365-3024.1982.tb00444.x; VINCENDEAU P, 1992, EXP PARASITOL, V75, P353, DOI 10.1016/0014-4894(92)90220-5; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59631	10.1371/journal.pone.0059631	http://dx.doi.org/10.1371/journal.pone.0059631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536884	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200032
J	Xu, N; Jia, DS; Chen, WF; Wang, H; Liu, FL; Ge, HY; Zhu, XD; Song, YL; Zhang, X; Zhang, D; Ge, D; Bai, CX				Xu, Nuo; Jia, Deshui; Chen, Wenfeng; Wang, Hao; Liu, Fanglei; Ge, Haiyan; Zhu, Xiaodan; Song, Yuanlin; Zhang, Xin; Zhang, David; Ge, Di; Bai, Chunxue			FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA-CELLS; EXPRESSION; TRANSCRIPTION; CARCINOMA; PROGRESSION; ACTIVATION; SURVIVAL; GROWTH; MMP-9	Background: FoxM1 has been reported to be important in initiation and progression of various tumors. However, whether FoxM1 has any indication for prognosis in non-small cell lung cancer patients remains unclear. Methodology/Principal Findings: In this study, FoxM1 expression in tumor cells was examined first by immunohistochemistry in 175 NSCLC specimens, the result of which showed that FoxM1 overexpression was significantly associated with positive smoking status (P = 0.001), poorer tissue differentiation (P = 0.0052), higher TNM stage (P<0.0001), lymph node metastasis (P<0.0001), advanced tumor stage (P<0.0001), and poorer prognosis (P<0.0001). Multivariable analysis showed that FoxM1 expression increased the hazard of death (hazard ratio, 1.899; 95% CI, 1.016-3.551). Furthermore, by various in vitro and in vivo experiments, we showed that targeted knockdown of FoxM1 expression could inhibit the migratory and invasive abilities of NSCLC cells, whereas enforced expression of FoxM1 could increased the invasion and migration of NSCLC cells. Finally, we found that one of the cellular mechanisms by which FoxM1 promotes tumor metastasis is through inducing epithelial-mesenchymal transition (EMT) program. Conclusions: These results suggested that FoxM1 overexpression in tumor tissues is significantly associated with the poor prognosis of NSCLC patients through promoting tumor metastasis.	[Xu, Nuo; Liu, Fanglei; Ge, Haiyan; Zhu, Xiaodan; Song, Yuanlin; Zhang, Xin; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Jia, Deshui] Fudan Univ, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Chen, Wenfeng] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China; [Wang, Hao; Ge, Di] Fudan Univ, Dept Thoracol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Zhang, David] Mt Sinai Sch Med, Dept Pathol, Mol Pathol Div, New York, NY USA	Fudan University; Fudan University; Fudan University; Fudan University; Icahn School of Medicine at Mount Sinai	Ge, D (corresponding author), Fudan Univ, Dept Thoracol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	Ge.di@zs-hospital.sh.cn; bai.chunxue@zs-hospital.sh.cn	Jia, Deshui/U-9732-2019	Bai, Chunxue/0000-0001-5798-3130	Shanghai Leading Academic Discipline Project [B115]; China National "985" project	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); China National "985" project	This work was supported by Shanghai Leading Academic Discipline Project, project number B115 and China National "985" project (phase III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2007, CANCER EPIDEM BIOMAR, V16, P1845, DOI 10.1158/1055-9965.EPI-07-0146; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Elzagallaai AA, 2011, J POPUL THER CLIN PH, V18, pE1; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Liu Yi-qian, 2011, Zhonghua Zhong Liu Za Zhi, V33, P426; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ruokolainen H, 2004, CLIN CANCER RES, V10, P3110, DOI 10.1158/1078-0432.CCR-03-0530; Saji H, 2011, J THORAC ONCOL, V6, P1865, DOI 10.1097/JTO.0b013e31822a35c3; Sobin LH., 2009, TNM CLASSIFICATION M, V7th ed, P136; Sun HC, 2011, CANCER LETT, V306, P214, DOI 10.1016/j.canlet.2011.03.009; Travis K, 2004, J NATL CANCER I, V96, P900, DOI 10.1093/jnci/96.12.900; Wu D, 2005, J AM SOC NEPHROL, V16, P646, DOI 10.1681/ASN.2004060445; Xia JT, 2012, PANCREAS, V41, P629, DOI 10.1097/MPA.0b013e31823bcef2; Yang DK, 2009, HUM PATHOL, V40, P464, DOI 10.1016/j.humpath.2008.10.001; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhou Lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P2424	39	63	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59412	10.1371/journal.pone.0059412	http://dx.doi.org/10.1371/journal.pone.0059412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536876	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200024
J	Shamaei, K; Sawicki, GS; Dollar, AM				Shamaei, Kamran; Sawicki, Gregory S.; Dollar, Aaron M.			Estimation of Quasi-Stiffness of the Human Knee in the Stance Phase of Walking	PLOS ONE			English	Article							ANKLE JOINT DYNAMICS; TRANSTIBIAL PROSTHESIS; POSITION DEPENDENCE; LIMB JOINTS; LOCOMOTION; MECHANICS; DESIGN; MODEL; SPEED; EXOSKELETON	Biomechanical data characterizing the quasi-stiffness of lower-limb joints during human locomotion is limited. Understanding joint stiffness is critical for evaluating gait function and designing devices such as prostheses and orthoses intended to emulate biological properties of human legs. The knee joint moment-angle relationship is approximately linear in the flexion and extension stages of stance, exhibiting nearly constant stiffnesses, known as the quasi-stiffnesses of each stage. Using a generalized inverse dynamics analysis approach, we identify the key independent variables needed to predict knee quasi-stiffness during walking, including gait speed, knee excursion, and subject height and weight. Then, based on the identified key variables, we used experimental walking data for 136 conditions (speeds of 0.75-2.63 m/s) across 14 subjects to obtain best fit linear regressions for a set of general models, which were further simplified for the optimal gait speed. We found R-2 > 86% for the most general models of knee quasi-stiffnesses for the flexion and extension stages of stance. With only subject height and weight, we could predict knee quasi-stiffness for preferred walking speed with average error of 9% with only one outlier. These results provide a useful framework and foundation for selecting subject-specific stiffness for prosthetic and exoskeletal devices designed to emulate biological knee function during walking.	[Shamaei, Kamran; Dollar, Aaron M.] Yale Univ, Dept Mech Engn & Mat Sci, Sch Engn & Appl Sci, New Haven, CT 06520 USA; [Sawicki, Gregory S.] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Sawicki, Gregory S.] Univ N Carolina Chapel Hill, Raleigh, NC USA	Yale University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Shamaei, K (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, Sch Engn & Appl Sci, New Haven, CT 06520 USA.	kamran.shamaei@yale.edu		Dollar, Aaron/0000-0002-2409-4668	US Defense Medical Research Development Program [W81XWH-11-2-0054]; US Army Natick Soldier Research Development and Engineering Center [W911NF-07-D-0001]	US Defense Medical Research Development Program; US Army Natick Soldier Research Development and Engineering Center	1. US Defense Medical Research Development Program, contract #W81XWH-11-2-0054, 2. US Army Natick Soldier Research Development and Engineering Center, contract #W911NF-07-D-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1983, J PHYSIOL-LONDON, V343, P323, DOI 10.1113/jphysiol.1983.sp014895; Cherry MS, 2006, P IDETC CIE ASME INT; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Crenna P, 2011, HUM MOVEMENT SCI, V30, P1185, DOI 10.1016/j.humov.2011.02.009; Davis RB, 1996, GAIT POSTURE, V4, P224, DOI 10.1016/0966-6362(95)01045-9; Dean JC, 2009, J R SOC INTERFACE, V6, P561, DOI 10.1098/rsif.2008.0415; DEVITA P, 1994, J BIOMECH, V27, P501, DOI 10.1016/0021-9290(94)90025-6; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Endo K, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4935, DOI 10.1109/IROS.2006.282454; Endo K, 2009, IEEE INT CONF ROBOT, P2790; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Ferris DP, 2009, IEEE ENG MED BIO, P2119, DOI 10.1109/IEMBS.2009.5333984; Frigo C, 1996, J ELECTROMYOGR KINES, V6, P177, DOI 10.1016/1050-6411(96)00030-2; Gard S.A., 2001, J PROSTHET ORTHOT, V13, P64, DOI [10.1097/00008526-200109000-00009, DOI 10.1097/00008526-200109000-00009]; Gard SA, 1999, ARCH PHYS MED REHAB, V80, P26, DOI 10.1016/S0003-9993(99)90303-9; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hansen AH, 2004, J BIOMECH, V37, P1467, DOI 10.1016/j.jbiomech.2004.01.017; Herr H, 2003, IND ROBOT, V30, P42, DOI 10.1108/01439910310457706; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Hortobagyi T, 2011, J APPL PHYSIOL, V111, P1391, DOI 10.1152/japplphysiol.00291.2011; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lark SD, 2003, CLIN BIOMECH, V18, P848, DOI 10.1016/S0268-0033(03)00150-5; Leurs F, 2011, J EXP BIOL, V214, P2276, DOI 10.1242/jeb.054452; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; Martinez-Vilialpando EC, 2009, J REHABIL RES DEV, V46, P361, DOI 10.1682/JRRD.2008.09.0131; McGeer T., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P1640, DOI 10.1109/ROBOT.1990.126245; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; Minetti AE, 2000, EUR J ENDOCRINOL, V142, P35, DOI 10.1530/eje.0.1420035; MOCHON S, 1980, MATH BIOSCI, V52, P241, DOI 10.1016/0025-5564(80)90070-X; Perry J., 1992, GAIT ANAL NORMAL PAT; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Ratcliffe RJ, 1997, GAIT POSTURE, V5, P93, DOI 10.1016/S0966-6362(96)01077-6; Rose J., 2006, HUMAN WALKING, V3rd ed.; Salsich GB, 2000, GAIT POSTURE, V11, P207, DOI 10.1016/S0966-6362(00)00047-3; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Shamaei Kamran, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975478, DOI 10.1109/ICORR.2011.5975478; Shamaei K, 2011, IEEE ENG MED BIO, P8135, DOI 10.1109/IEMBS.2011.6092007; Silder A, 2008, J BIOMECH, V41, P1520, DOI 10.1016/j.jbiomech.2008.02.016; SKINNER SR, 1985, ORTHOPEDICS, V8, P355; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/BF00204048; Walsh CJ, 2006, IEEE INT CONF ROBOT, P3485, DOI 10.1109/ROBOT.2006.1642234; WEISS PL, 1986, J BIOMECH, V19, P737, DOI 10.1016/0021-9290(86)90197-1; WEISS PL, 1986, J BIOMECH, V19, P727, DOI 10.1016/0021-9290(86)90196-X; Winter D, 2005, BIOMECHANICS MOTOR C; WINTER DA, 1978, BIOL CYBERN, V29, P137, DOI 10.1007/BF00337349; Winter DA., 1987, BIOMECHANICS MOTOR C; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	60	59	60	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59993	10.1371/journal.pone.0059993	http://dx.doi.org/10.1371/journal.pone.0059993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533662	Green Published, gold			2022-12-27	WOS:000316549400099
J	Attal, Y; Schwartz, D				Attal, Yohan; Schwartz, Denis			Assessment of Subcortical Source Localization Using Deep Brain Activity Imaging Model with Minimum Norm Operators: A MEG Study	PLOS ONE			English	Article							AUTOMATED SEGMENTATION; EEG; MAGNETOENCEPHALOGRAPHY; CONNECTIVITY; HIPPOCAMPAL; TOMOGRAPHY; AMYGDALA; NEURONS; ATLAS	Subcortical structures are involved in many healthy and pathological brain processes. It is crucial for many studies to use magnetoencephalography (MEG) to assess the ability to detect subcortical generators. This study aims to assess the source localization accuracy and to compare the characteristics of three inverse operators in the specific case of subcortical generators. MEG has a low sensitivity to subcortical sources mainly because of their distance from sensors and their complex cyto-architecture. However, we show that using a realistic anatomical and electrophysiological model of deep brain activity (DBA), the sources make measurable contributions to MEG sensors signals. Furthermore, we study the point-spread and cross-talk functions of the wMNE, sLORETA and dSPM inverse operators to characterize distortions in cortical and subcortical regions and to study how noise-normalization methods can improve or bias accuracy. We then run Monte Carlo simulations with neocortical and subcortical activations. In the case of single hippocampus patch activations, the results indicate that MEG can indeed localize the generators in the head and the body of the hippocampus with good accuracy. We then tackle the question of simultaneous cortical and subcortical activations. wMNE can detect hippocampal activations that are embedded in cortical activations that have less than double their amplitude, but it does not completely correct the bias to more superficial sources. dSPM and sLORETA can still detect hippocampal activity above this threshold, but such detection might include the creation of ghost deeper sources. Finally, using the DBA model, we showed that the detection of weak thalamic modulations of ongoing brain activity is possible.	[Attal, Yohan; Schwartz, Denis] Univ Paris 06, CRICM UMR S975, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Attal, Yohan; Schwartz, Denis] U975 Inserm, Paris, France; [Attal, Yohan; Schwartz, Denis] UMR7225 CNRS, Paris, France; [Attal, Yohan; Schwartz, Denis] ICM Inst Cerveau & Moelle Einiere, Paris, France; [Schwartz, Denis] CENIR Ctr Neuroimagerie Rech, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Attal, Y (corresponding author), Univ Paris 06, CRICM UMR S975, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France.	yohan.attal@upmc.fr		Schwartz, Denis/0000-0002-8557-2934	ANR - Agence National de la Recherche (National Research Agency) - project HM-TC [ANR-09-EMER-006]	ANR - Agence National de la Recherche (National Research Agency) - project HM-TC(French National Research Agency (ANR))	This work was supported by ANR - Agence National de la Recherche (National Research Agency) - project HM-TC, number ANR-09-EMER-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal Y, 2009, IRBM, V30, P133, DOI 10.1016/j.irbm.2009.01.005; Attal Y, 2012, REV NEUROSCIENCE, V23, P85, DOI [10.1515/RNS.2011.056, 10.1515/rns.2011.056]; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Baillet S, 2000, HYBRID MEG SOURCE CH, P709; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Benjamini Y, 2001, ANN STAT, V29, P1165; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Chupin M, 2002, DETECTION HIPPOCAMPU; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; David O, 2002, NEUROIMAGE, V17, P1277, DOI 10.1006/nimg.2002.1269; David O, 2011, J NEUROSCI, V31, P2712, DOI 10.1523/JNEUROSCI.3433-10.2011; DENO RL, 1947, J CELL COMPAR PHYSL, V29, P207, DOI 10.1002/jcp.1030290303; Dumas T, 2011, IRBM, V32, P42, DOI 10.1016/j.irbm.2010.11.001; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; Fisch B, 2003, FISCH SPEHLMANNS EEG; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; GUY CN, 1993, PHYSIOL MEAS, V14, pA99, DOI 10.1088/0967-3334/14/4A/018; Hamalainen M, 1984, INTERPRETING MEASURE; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jerbi K, 2004, NEUROIMAGE, V22, P779, DOI 10.1016/j.neuroimage.2004.02.010; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Menendez RGDP, 1997, HUM BRAIN MAPP, V5, P454, DOI 10.1002/(SICI)1097-0193(1997)5:6<454::AID-HBM6>3.0.CO;2-2; Menke W., 1989, GEOPHYS DATA ANAL DI; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Mills T, 2012, BRAIN TOPOGRAPHY; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Moses SN, 2007, BRAIN RES BULL, V71, P452, DOI 10.1016/j.brainresbull.2006.08.016; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Okada Y.C., 1996, INT C BIOM; Okada YC, 1997, ELECTROEN CLIN NEURO, V103, P474, DOI 10.1016/S0013-4694(97)00043-6; Papadelis C, 2012, NEUROIMAGE, V60, P1092, DOI 10.1016/j.neuroimage.2012.01.054; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Ramirez RR, 2010, COMPUTATIONAL NEUROS; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Riviere D., 2009, NEUROIMAGE, V47, pS163, DOI [10.1016/S1053-8119(09)71720-3, DOI 10.1016/S1053-8119(09)71720-3]; Shaw J.C, 2003, BRAINS ALPHA RHYTHMS; Stephen JM, 2005, J CLIN NEUROPHYSIOL, V22, P388; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tesche CD, 1996, BRAIN RES, V729, P253, DOI 10.1016/S0006-8993(96)00555-0; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Whalen P.J., 2009, HUMAN AMYGDALA; YELNIK J, 1984, J COMP NEUROL, V227, P200, DOI 10.1002/cne.902270206; YELNIK J, 1991, J COMP NEUROL, V313, P273, DOI 10.1002/cne.903130207; Yelnik J, 2006, ENCEPHALE, V32, P3; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042	63	104	105	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59856	10.1371/journal.pone.0059856	http://dx.doi.org/10.1371/journal.pone.0059856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527277	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600100
J	Mishra, BB; Li, Q; Steichen, AL; Binstock, BJ; Metzger, DW; Teale, JM; Sharma, J				Mishra, Bibhuti B.; Li, Qun; Steichen, Anthony L.; Binstock, Brandilyn J.; Metzger, Dennis W.; Teale, Judy M.; Sharma, Jyotika			Galectin-3 Functions as an Alarmin: Pathogenic Role for Sepsis Development in Murine Respiratory Tularemia	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; FRANCISELLA-TULARENSIS; NEUTROPHIL MIGRATION; PULMONARY INFECTION; ORGAN DYSFUNCTION; DENDRITIC CELLS; INNATE IMMUNITY; S100 PROTEINS; INFLAMMATION; MECHANISMS	Sepsis is a complex immune disorder with a mortality rate of 20-50% and currently has no therapeutic interventions. It is thus critical to identify and characterize molecules/factors responsible for its development. We have recently shown that pulmonary infection with Francisella results in sepsis development. As extensive cell death is a prominent feature of sepsis, we hypothesized that host endogenous molecules called alarmins released from dead or dying host cells cause a hyperinflammatory response culminating in sepsis development. In the current study we investigated the role of galectin-3, a mammalian beta-galactoside binding lectin, as an alarmin in sepsis development during F. novicida infection. We observed an upregulated expression and extracellular release of galectin-3 in the lungs of mice undergoing lethal pulmonary infection with virulent strain of F. novicida but not in those infected with a non-lethal, attenuated strain of the bacteria. In comparison with their wild-type C57Bl/6 counterparts, F. novicida infected galectin-3 deficient (galectin-3(-/-)) mice demonstrated significantly reduced leukocyte infiltration, particularly neutrophils in their lungs. They also exhibited a marked decrease in inflammatory cytokines, vascular injury markers, and neutrophil-associated inflammatory mediators. Concomitantly, in-vitro pre-treatment of primary neutrophils and macrophages with recombinant galectin-3 augmented F. novicida-induced activation of these cells. Correlating with the reduced inflammatory response, F. novicida infected galectin-3(-/-) mice exhibited improved lung architecture with reduced cell death and improved survival over wild-type mice, despite similar bacterial burden. Collectively, these findings suggest that galectin-3 functions as an alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.	[Mishra, Bibhuti B.; Steichen, Anthony L.; Binstock, Brandilyn J.; Sharma, Jyotika] Univ N Dakota, Dept Microbiol & Immunol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Li, Qun; Teale, Judy M.] Univ Texas San Antonio, South Texas Ctr Emerging Dis, San Antonio, TX USA; [Li, Qun; Teale, Judy M.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Metzger, Dennis W.] Albany Med Coll, Albany, NY 12208 USA	University of North Dakota Grand Forks; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Albany Medical College	Sharma, J (corresponding author), Univ N Dakota, Dept Microbiol & Immunol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	jyotika.sharma@med.und.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907	American Heart Association [10BGIA4300041]; ND EPSCoR [EPS-0814442, UND0017393]; National Institutes of Health [1R21AI101644-01]; National Institute of Health [1P01A10157986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101644, P01AI056320] Funding Source: NIH RePORTER; EPSCoR [0814442] Funding Source: National Science Foundation	American Heart Association(American Heart Association); ND EPSCoR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by American Heart Association grant 10BGIA4300041, ND EPSCoR start-up (Grant # EPS-0814442, project # UND0017393) and 1R21AI101644-01 from the National Institutes of Health to JS and National Institute of Health Grant 1P01A10157986 to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva LM, 2008, J IMMUNOL, V181, P1454, DOI 10.4049/jimmunol.181.2.1454; Alves CMOS, 2010, IMMUNOBIOLOGY, V215, P475, DOI 10.1016/j.imbio.2009.08.001; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cerliani JP, 2011, J CLIN IMMUNOL, V31, P10, DOI 10.1007/s10875-010-9494-2; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Fry DE, 2012, AM SURGEON, V78, P1; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Gundra UM, 2011, INFECT IMMUN, V79, P2586, DOI 10.1128/IAI.00920-10; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; John CM, 2002, CELL MICROBIOL, V4, P649, DOI 10.1046/j.1462-5822.2002.00219.x; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Mares CA, 2011, IMMUNOL CELL BIOL, V89, P167, DOI 10.1038/icb.2010.81; Mares CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014088; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Namas R, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.025; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Schwartz JT, 2012, J IMMUNOL, V188, P3351, DOI 10.4049/jimmunol.1102863; Sharma J, 2011, MICROB PATHOGENESIS, V51, P39, DOI 10.1016/j.micpath.2011.03.007; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Sharma J, 2009, CELL IMMUNOL, V257, P1, DOI 10.1016/j.cellimm.2009.03.011; Suda K, 2006, WORLD J SURG, V30, P1755, DOI 10.1007/s00268-005-0369-2; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Wheeler DS, 2007, INFLAMM RES, V56, P216, DOI 10.1007/s00011-007-6108-4; Wickstrum JR, 2009, INFECT IMMUN, V77, P4827, DOI 10.1128/IAI.00246-09; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	55	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59616	10.1371/journal.pone.0059616	http://dx.doi.org/10.1371/journal.pone.0059616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527230	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600082
J	Shanks, L; Klarkowski, D; O'Brien, DP				Shanks, Leslie; Klarkowski, Derryck; O'Brien, Daniel P.			False Positive HIV Diagnoses in Resource Limited Settings: Operational Lessons Learned for HIV Programmes	PLOS ONE			English	Article							INFECTIONS; UGANDA; TESTS; RISK	Background: Access to HIV diagnosis is life-saving; however the use of rapid diagnostic tests in combination is vulnerable to wrongly diagnosing HIV infection when both screening tests give a false positive result. Misclassification of HIV patients can also occur due to poor quality control, administrative errors and lack of supervision and training of staff. Medecins Sans Frontieres discovered in 2004 that HIV negative individuals were enrolled in some HIV programmes. This paper describes the result of an audit of three sites to review testing practices, implement improved testing algorithms and offer re-testing to clients enrolled in the HIV clinic. Findings: In the Democratic Republic of Congo (DRC), Burundi and Ethiopia patients were identified for HIV retesting. In total, 44 false-positive patients were identified in HIV programmes in DRC, two in Burundi and seven in Ethiopia. Some of those identified had been abandoned by partners or started on anti-retroviral therapy or prophylaxis. Despite potential damage to programme reputations, no impact in terms of testing uptake occurred with mean monthly testing volumes stable after introduction of re-testing. In order to prevent the problem, training, supervision and quality control of testing procedures were strengthened. A simple and feasible confirmation test was added to the test algorithm. Prevalence of false positives after introducing the changes varied from zero percent (95% CI 0%-8.2%) to 10.3 percent (95% CI: 7.2%-14.1%) in Burundi and DRC respectively. Conclusion: False HIV diagnoses were found in a variety of programme settings and had devastating individual consequences. We re-tested individuals in our programmes while instituting improved testing procedures without a negative impact on test uptake. Considering the importance of correct diagnosis to the individual, as well as the resources needed to care for someone with HIV, it is critical to ensure that all patients registered in HIV programmes are accurately diagnosed.	[Shanks, Leslie; Klarkowski, Derryck; O'Brien, Daniel P.] Med Sans Frontieres, Amsterdam, Netherlands; [O'Brien, Daniel P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia	Doctors Without Borders; Royal Melbourne Hospital; University of Melbourne	Shanks, L (corresponding author), Med Sans Frontieres, Amsterdam, Netherlands.	Leslie.Shanks@amsterdam.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330	M�decins Sans Fronti�res [OCA_pilot_02HIVfalsepos_OBrien] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], GUID US ANT AG HIV 1; Anzala O, 2008, East Afr Med J, V85, P500; Bird AG, 1996, J ANTIMICROB CHEMOTH, V37, P171, DOI 10.1093/jac/37.suppl_B.171; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; Constantine NT, 2005, INDIAN J MED RES, V121, P519; CRASKE J, 1990, VOX SANG, V59, P160, DOI 10.1111/j.1423-0410.1990.tb00851.x; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; FEENEY C, 1995, CRIT CARE MED, V23, P1680, DOI 10.1097/00003246-199510000-00012; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Kagulire SC, 2011, INT J STD AIDS, V22, P308, DOI 10.1258/ijsa.2009.009352; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; NG VL, 1991, CLIN CHEM, V37, P1667; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; United States Centers for Disease Control and Prevention, 1992, MMER MORB MORTAL WKL, V41, P541; World Health Organization, 2009, HIV ANT ANT ASS OP C; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization, 2006, ANT THER HIV INF AD	19	78	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59906	10.1371/journal.pone.0059906	http://dx.doi.org/10.1371/journal.pone.0059906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527284	Green Published, gold			2022-12-27	WOS:000317562600105
J	Sun, SQ; Sursal, T; Adibnia, Y; Zhao, C; Zheng, Y; Li, HP; Otterbein, LE; Hauser, CJ; Itagaki, K				Sun, Shiqin; Sursal, Tolga; Adibnia, Yasaman; Zhao, Cong; Zheng, Yi; Li, Haipeng; Otterbein, Leo E.; Hauser, Carl J.; Itagaki, Kiyoshi			Mitochondrial DAMPs Increase Endothelial Permeability through Neutrophil Dependent and Independent Pathways	PLOS ONE			English	Article							OPERATED CALCIUM-ENTRY; SPHINGOSINE 1-PHOSPHATE; GENE-EXPRESSION; DANGER SIGNALS; MAP KINASE; DNA; CELLS; INFLAMMATION; ACTIVATION; INFLUX	Trauma and sepsis can cause acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in part by triggering neutrophil (PMN)-mediated increases in endothelial cell (EC) permeability. We had shown that mitochondrial (mt) damage-associated molecular patterns (DAMPs) appear in the blood after injury or shock and activate human PMN. So we now hypothesized that mitochondrial DAMPs (MTD) like mitochondrial DNA (mtDNA) and peptides might play a role in increased EC permeability during systemic inflammation and proceeded to evaluate the underlying mechanisms. MtDNA induced changes in EC permeability occurred in two phases: a brief, PMN-independent 'spike' in permeability was followed by a prolonged PMN-dependent increase in permeability. Fragmented mitochondria (MTD) caused PMN-independent increase in EC permeability that were abolished with protease treatment. Exposure to mtDNA caused PMN-EC adherence by activating expression of adherence molecule expression in both cell types. Cellular activation was manifested as an increase in PMN calcium flux and EC MAPK phosphorylation. Permeability and PMN adherence were attenuated by endosomal TLR inhibitors. EC lacked formyl peptide receptors but were nonetheless activated by mt-proteins, showing that non-formylated mt-protein DAMPs can activate EC. Mitochondrial DAMPs can be released into the circulation by many processes that cause cell injury and lead to pathologic endothelial permeability. We show here that mitochondria contain multiple DAMP motifs that can act on EC and/or PMN via multiple pathways. This can enhance PMN adherence to EC, activate PMN-EC interactions and subsequently increase systemic endothelial permeability. Mitochondrial DAMPs may be important therapeutic targets in conditions where inflammation pathologically increases endothelial permeability.	[Sun, Shiqin; Sursal, Tolga; Adibnia, Yasaman; Zhao, Cong; Zheng, Yi; Li, Haipeng; Otterbein, Leo E.; Hauser, Carl J.; Itagaki, Kiyoshi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Li, Haipeng] Beijing Army Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hauser, CJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.	cjhauser@bidmc.harvard.edu; kitagaki@bidmc.harvard.edu	Sursal, Tolga/AAN-8585-2021; Hauser, Carl J./Y-1189-2019; Itagaki, Kiyoshi/M-5501-2015	Itagaki, Kiyoshi/0000-0002-6033-1122; Hauser, Carl/0000-0003-3167-1846	NIGMS/NIH [5R01GM089711-02]; Department of Defense [W81XWH-09-1-0472/DR0809]; Center for Integration of Medicine and Innovative Technology [W81XWH-09-2-0001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089711] Funding Source: NIH RePORTER	NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); Center for Integration of Medicine and Innovative Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	5R01GM089711-02 (NIGMS/NIH, CJH), W81XWH-09-1-0472/DR0809 (Department of Defense, CJH), W81XWH-09-2-0001 (Center for Integration of Medicine and Innovative Technology, CJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991; Hauser CJ, 2000, J TRAUMA, V48, P592, DOI 10.1097/00005373-200004000-00003; Hauser CJ, 2001, J LEUKOCYTE BIOL, V69, P63; Hopson KP, 2011, AM J PHYSIOL-CELL PH, V300, pC919, DOI 10.1152/ajpcell.00350.2010; Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2; Itagaki K, 2010, SHOCK, V33, P381, DOI 10.1097/SHK.0b013e3181c6bb75; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Tornquist K, 2012, ACTA PHYSIOL, V204, P151, DOI 10.1111/j.1748-1716.2011.02265.x; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	31	144	148	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59989	10.1371/journal.pone.0059989	http://dx.doi.org/10.1371/journal.pone.0059989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527291	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600109
J	Carvalho, JO; Silva, LP; Sartori, R; Dode, MAN				Carvalho, Jose O.; Silva, Luciano P.; Sartori, Roberto; Dode, Margot A. N.			Nanoscale Differences in the Shape and Size of X and Y Chromosome-Bearing Bovine Sperm Heads Assessed by Atomic Force Microscopy	PLOS ONE			English	Article							ACROSOME REACTION; PLASMA-MEMBRANE; SEXED SPERM; DNA-CONTENT; SPERMATOZOA; INSEMINATION; HEIFERS; COWS; FERTILIZATION; CAPACITATION	Sperm dimensions and the question of whether X and Y chromosome-bearing sperm differ in size or shape has been of great interest, especially for the development of alternative methods to sort or classify sperm cells. The aim of the present study was to evaluate possible differences in the shape and size of the sperm head between X and Y chromosome-bearing sperm by atomic force microscopy (AFM). One ejaculate per bull (n = 4) was used. Each ejaculate was separated into four fractions: non-sexed (NS), sexed for X-sperm (SX), sexed for Y-sperm (SY) and a pooling of SX and SY samples (SXY). Using AFM, 400 sperm heads per group were measured. Twenty three structural features were assessed including one-, two- and three-dimensional parameters and shape descriptors. These measurements determine the micro- to nanoscale features of X- and Y-bearing chromosomes in sperm cells. No differences were observed for any individual variables between SX and SY groups. Next, a simultaneous evaluation of all features using statistical discriminant analysis was performed to determine if it was possible to distinguish to which group belong each individual cells. This analysis clearly showed, a distinct separation of NS, SXY, SX and SY groups. The recognition of this structural possibility to distinguish between X and Y sperm cell might improve the understanding of sperm cells biology. These results indicated that the associations of several structural measurements of the sperm cell head are promising candidates for development of a new method of sperm sexing.	[Dode, Margot A. N.] Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil; [Silva, Luciano P.] Embrapa Genet Resources & Biotechnol, Lab Mass Spectrometry, Brasilia, DF, Brazil; [Carvalho, Jose O.; Sartori, Roberto] Univ Sao Paulo, Dept Anim Sci, Piracicaba, Brazil; [Dode, Margot A. N.] Univ Brasilia, Sch Agr & Vet, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade de Brasilia	Carvalho, JO (corresponding author), Univ Sao Paulo, Dept Anim Sci, Piracicaba, Brazil.	joseocneto@hotmail.com; margot.dode@embrapa.br	Carvalho, jose/U-5463-2019; Silva, Luciano Paulino/G-4915-2012; Carvalho, Jose/D-7800-2015; Dode, Margot/O-2486-2014; dode, margot alves nunes/S-6524-2019; Sartori, Roberto/I-3339-2013	Carvalho, jose/0000-0003-0369-9649; Silva, Luciano Paulino/0000-0001-9075-7725; Carvalho, Jose/0000-0003-0369-9649; Dode, Margot/0000-0002-1096-0457; dode, margot alves nunes/0000-0002-1096-0457; Sartori, Roberto/0000-0001-6917-0057	Brazilian agriculture research company, macro program 1 [-003.0709040000]; Fundation support research of the state of Sao Paulo [-2010/15054-0, 2010/000585-0]; FAPESP	Brazilian agriculture research company, macro program 1; Fundation support research of the state of Sao Paulo; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Brazilian agriculture research company, macro program 1 (grant number -003.0709040000) and Fundation support research of the state of Sao Paulo (grant number -2010/15054-0 and 2010/000585-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tiago Almeida de Oliveira for his contribution to the statistical analysis. We thank FAPESP for financial support for the first author.	Andersson M, 2006, REPROD DOMEST ANIM, V41, P95, DOI 10.1111/j.1439-0531.2006.00625.x; Berdyyeva T, 2005, ULTRAMICROSCOPY, V102, P189, DOI 10.1016/j.ultramic.2004.09.008; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bodmer M, 2005, THERIOGENOLOGY, V64, P1647, DOI 10.1016/j.theriogenology.2005.04.011; Bonatto CB, 2009, POLAR BIOL, V32, P7; Cui KH, 1996, MOL HUM REPROD, V2, P63, DOI 10.1093/molehr/2.1.63; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Ellis DJ, 2002, J STRUCT BIOL, V138, P187, DOI 10.1016/S1047-8477(02)00025-4; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; GARNER DL, 1983, BIOL REPROD, V28, P312, DOI 10.1095/biolreprod28.2.312; Ierardi V, 2008, MICROSC RES TECHNIQ, V71, P529, DOI 10.1002/jemt.20584; JOHNSON LA, 1989, BIOL REPROD, V41, P199, DOI 10.1095/biolreprod41.2.199; Jones R, 2007, ASIAN J ANDROL, V9, P438, DOI 10.1111/j.1745-7262.2007.00282.x; Joshi N, 2001, FERTIL STERIL, V75, P961, DOI 10.1016/S0015-0282(01)01755-1; Ke-hui c, 1993, NATURE, V366, P2; Klinc P, 2007, REPROD DOMEST ANIM, V42, P63, DOI 10.1111/j.1439-0531.2006.00730.x; Kumar Sunil, 2005, J Nanobiotechnology, V3, P9, DOI 10.1186/1477-3155-3-9; Mai A, 2002, MOL REPROD DEV, V63, P471, DOI 10.1002/mrd.10195; Moce E, 2006, THERIOGENOLOGY, V66, P929, DOI 10.1016/j.theriogenology.2006.01.063; Painter TS, 1923, SCIENCE, V58, P247, DOI 10.1126/science.58.1500.247; Peippo J, 2009, ANIM REPROD SCI, V111, P80, DOI 10.1016/j.anireprosci.2008.02.002; Penfold LM, 1998, MOL REPROD DEV, V50, P323, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;323::AID-MRD8&gt;3.0.CO;2-L; Saeki K, 2005, J REPROD DEVELOP, V51, P293, DOI 10.1262/jrd.16068; Sartori R., 2004, Animal Reproduction, V1, P86; Seidel GE, 1999, THERIOGENOLOGY, V52, P1407, DOI 10.1016/S0093-691X(99)00226-5; Underwood SL, 2010, ANIM REPROD SCI, V118, P171, DOI 10.1016/j.anireprosci.2009.08.007; Underwood SL, 2010, ANIM REPROD SCI, V118, P7, DOI 10.1016/j.anireprosci.2009.06.004; van Munster EB, 1999, CYTOMETRY, V35, P125, DOI 10.1002/(SICI)1097-0320(19990201)35:2<125::AID-CYTO3>3.0.CO;2-H; Zavaczki Z, 2006, FERTIL STERIL, V85, P121, DOI 10.1016/j.fertnstert.2005.07.1295	29	54	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59387	10.1371/journal.pone.0059387	http://dx.doi.org/10.1371/journal.pone.0059387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527178	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100122
J	Hokenson, MA; Wang, YL; Hawwa, RL; Huang, ZP; Sharma, S; Sanchez-Esteban, J				Hokenson, Michael A.; Wang, Yulian; Hawwa, Renda L.; Huang, Zheping; Sharma, Surendra; Sanchez-Esteban, Juan			Reduced IL-10 Production in Fetal Type II Epithelial Cells Exposed to Mechanical Stretch Is Mediated via Activation of IL-6-SOCS3 Signaling Pathway	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; LUNG INFLAMMATION; PRETERM INFANTS; INTERLEUKIN-10; EXPRESSION; DIFFERENTIATION; DISEASE; INJURY; SOCS	An imbalance between pro-inflammatory and anti-inflammatory cytokines is a key factor in the lung injury of premature infants exposed to mechanical ventilation. Previous studies have shown that lung cells exposed to stretch produces reduced amounts of the anti-inflammatory cytokine IL-10. The objective of these studies was to analyze the signaling mechanisms responsible for the decreased IL-10 production in fetal type II cells exposed to mechanical stretch. Fetal mouse type II epithelial cells isolated at embryonic day 18 were exposed to 20% stretch to simulate lung injury. We show that IL-10 receptor gene expression increased with gestational age. Mechanical stretch decreased not only IL-10 receptor gene expression but also IL-10 secretion. In contrast, mechanical stretch increased release of IL-6. We then investigated IL-10 signaling pathway-associated proteins and found that in wild-type cells, mechanical stretch decreased activation of JAK1 and TYK2 and increased STAT3 and SOCS3 activation. However, opposite effects were found in cells isolated from IL-10 knockout mice. Reduction in IL-6 secretion by stretch was observed in cells isolated from IL-10 null mice. To support the idea that stretch-induced SOCS3 expression via IL-6 leads to reduced IL-10 expression, siRNA-mediated inhibition of SOCS3 restored IL-10 secretion in cells exposed to stretch and decreased IL-6 secretion. Taken together, these studies suggest that the inhibitory effect of mechanical stretch on IL-10 secretion is mediated via activation of IL-6-STAT3-SOCS3 signaling pathway. SOCS3 could be a therapeutic target to increase IL-10 production in lung cells exposed to mechanical injury.	[Sanchez-Esteban, Juan] Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Providence, RI 02912 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University	Sanchez-Esteban, J (corresponding author), Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Providence, RI 02912 USA.	jsanchezesteban@wihri.org			National Institute of Health [R01 HD052670]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052670] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Health grant R01 HD052670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bhandari A, 2003, FRONT BIOSCI-LANDMRK, V8, pE370, DOI 10.2741/1060; Blahnik MJ, 2001, PEDIATR RES, V50, P726, DOI 10.1203/00006450-200112000-00016; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Fanaroff AA, 2007, AM J OBSTET GYNECOL, V196, DOI DOI 10.1016/J.AJ0G.2006.09.014; Garingo A, 2007, PEDIATR RES, V61, P197, DOI 10.1203/pdr.0b013e31802d8a1c; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Hawwa RL, 2011, PEDIATR PULM, V46, P640, DOI 10.1002/ppul.21433; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lee HS, 2008, AM J PHYSIOL-LUNG C, V294, pL225, DOI 10.1152/ajplung.00370.2007; McGowan EC, 2009, PEDIATR RES, V66, P455, DOI 10.1203/PDR.0b013e3181b3b0fa; Michel G, 1997, J IMMUNOL, V159, P6291; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Munshi UK, 1997, PEDIATR PULM, V24, P331; Oei J, 2002, ACTA PAEDIATR, V91, P1194; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Saadane A, 2005, J ALLERGY CLIN IMMUN, V115, P405, DOI 10.1016/j.jaci.2004.10.044; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Schultz C, 2003, BIOL NEONATE, V84, P64, DOI 10.1159/000071446; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Wang YL, 2006, AM J PHYSIOL-LUNG C, V291, pL820, DOI 10.1152/ajplung.00068.2006; Wang YL, 2010, AM J PHYSIOL-LUNG C, V298, pL775, DOI 10.1152/ajplung.00327.2009; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59598	10.1371/journal.pone.0059598	http://dx.doi.org/10.1371/journal.pone.0059598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527226	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100150
J	Qu, HR; Yang, LM; Meng, SS; Xu, L; Bi, YH; Jia, XJ; Li, J; Sun, L; Liu, WJ				Qu, Hongren; Yang, Limin; Meng, Shanshan; Xu, Lei; Bi, Yuhai; Jia, Xiaojuan; Li, Jing; Sun, Lei; Liu, Wenjun			The Differential Antiviral Activities of Chicken Interferon alpha (ChIFN-alpha) and ChIFN-beta are Related to Distinct Interferon-Stimulated Gene Expression	PLOS ONE			English	Article							INFLUENZA-VIRUS REPLICATION; BURSAL DISEASE VIRUS; IFN-BETA; IN-VITRO; NEWCASTLE-DISEASE; RECEPTOR-BINDING; HUMAN-CELLS; INDUCTION; INFECTION; MX	Chicken interferon alpha (ChIFN-alpha) and ChIFN-beta are type I IFNs that are important antiviral cytokines in the innate immune system. In the present study, we identified the virus-induced expression of ChIFN-alpha and ChIFN-beta in chicken fibroblast DF-1 cells and systematically evaluated the antiviral activities of recombinant ChIFN-alpha and ChIFN-beta by cytopathic-effect (CPE) inhibition assays. We found that ChIFN-alpha exhibited stronger antiviral activity than ChIFN-beta in terms of inhibiting the replication of vesicular stomatitis virus, Newcastle disease virus and avian influenza virus, respectively. To elucidate the mechanism of differential antiviral activities between the two ChIFNs, we measured the relative mRNA levels of IFN-stimulated genes (ISGs) in IFN-treated DF-1 cells by real-time PCR. ChIFN-alpha displayed greater induction potency than ChIFN-beta on several ISGs encoding antiviral proteins and MHC-I, whereas ChIFN-alpha was less potent than ChIFN-beta for inducing ISGs involved in signaling pathways. In conclusion, ChIFN-alpha and ChIFN-beta presented differential induction potency on various sets of ISGs, and the stronger antiviral activity of ChIFN-alpha is likely attributed to the greater expression levels of downstream antiviral ISGs.	[Qu, Hongren; Yang, Limin; Meng, Shanshan; Xu, Lei; Bi, Yuhai; Jia, Xiaojuan; Li, Jing; Sun, Lei; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Qu, Hongren; Meng, Shanshan; Xu, Lei; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, WJ (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	liuwj@im.ac.cn	yang, lm/AAE-3827-2019; SUN, LEI/B-3288-2018	yang, lm/0000-0002-1158-0800; SUN, LEI/0000-0003-0141-2093; Bi, Yuhai/0000-0002-5595-363X	National Natural Science Foundation of China (NSFC) [31100644]; Ministry of Science and Technology program of China [2011AA10A215, 2010GB24910698];  [81021003]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology program of China(Ministry of Science and Technology, China); 	This study was funded by the National Natural Science Foundation of China (NSFC) (www.nsfc.gov.cn, Grant No. 31100644), the Ministry of Science and Technology program of China (www.most.gov.cn, Grant No. 2011AA10A215, 2010GB24910698). Wenjun Liu is a principal investigator of the National Natural Science Foundation of China Innovative Research Group (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; Benfield CTO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012151; BORDEN EC, 1982, CANCER RES, V42, P4948; CLEARY CM, 1994, J BIOL CHEM, V269, P18747; Daviet S, 2009, VIRAL IMMUNOL, V22, P467, DOI 10.1089/vim.2009.0053; Burgi MD, 2012, J IMMUNOL METHODS, V381, P70, DOI 10.1016/j.jim.2012.04.010; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DOMANSKI P, 1995, J BIOL CHEM, V270, P21606, DOI 10.1074/jbc.270.37.21606; Erickson AK, 2008, CELL RES, V18, P433, DOI 10.1038/cr.2008.46; FISH EN, 1983, BIOCHEM BIOPH RES CO, V112, P537, DOI 10.1016/0006-291X(83)91498-5; Foster GR, 1996, J INTERF CYTOK RES, V16, P1027, DOI 10.1089/jir.1996.16.1027; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Han CS, 2001, P NATL ACAD SCI USA, V98, P6138, DOI 10.1073/pnas.111139598; Han QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027931; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jarosinski KW, 2001, J INTERF CYTOK RES, V21, P287, DOI 10.1089/107999001300177475; JOHNS TG, 1992, J NATL CANCER I, V84, P1185, DOI 10.1093/jnci/84.15.1185; Karpala AJ, 2008, J INTERF CYTOK RES, V28, P341, DOI 10.1089/jir.2007.0117; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Karpala AJ, 2012, VET IMMUNOL IMMUNOP, V148, P100, DOI 10.1016/j.vetimm.2011.05.031; Karpala AJ, 2012, J REPROD IMMUNOL, V94, P169, DOI 10.1016/j.jri.2012.02.008; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Li P, 2010, VET MICROBIOL, V143, P346, DOI 10.1016/j.vetmic.2009.12.008; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x; Lowenthal JW, 2001, J INTERF CYTOK RES, V21, P547, DOI 10.1089/10799900152434439; Marcus PI, 1999, J INTERF CYTOK RES, V19, P881, DOI 10.1089/107999099313406; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Mo CW, 2001, AVIAN DIS, V45, P389, DOI 10.2307/1592978; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Pei JW, 2001, J INTERF CYTOK RES, V21, P1071, DOI 10.1089/107999001317205204; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCHULTZ U, 1995, EUR J BIOCHEM, V229, P73, DOI 10.1111/j.1432-1033.1995.tb20439.x; Schusser B, 2011, J VIROL, V85, P8307, DOI 10.1128/JVI.00535-11; Sick C, 1996, J BIOL CHEM, V271, P7635, DOI 10.1074/jbc.271.13.7635; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; SOH JM, 1994, J BIOL CHEM, V269, P18102; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Thanthrige-Don N, 2010, VIRAL IMMUNOL, V23, P227, DOI 10.1089/vim.2009.0092; VIGNAUX F, 1977, J IMMUNOL, V118, P721; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Wang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022625; Xue QH, 2010, J INTERF CYTOK RES, V30, P81, DOI 10.1089/jir.2009.0031	64	43	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59307	10.1371/journal.pone.0059307	http://dx.doi.org/10.1371/journal.pone.0059307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527158	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100104
J	Shi, M; Wang, YN; Zhu, N; Chen, XX				Shi, Min; Wang, Ya-Na; Zhu, Ni; Chen, Xue-Xin			Four Heat Shock Protein Genes of the Endoparasitoid Wasp, Cotesia vestalis, and Their Transcriptional Profiles in Relation to Developmental Stages and Temperature	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; DIAMONDBACK MOTH; UP-REGULATION; MOLECULAR CHAPERONES; PTEROMALUS-PUPARUM; EXPRESSION; DROSOPHILA; CLONING; FAMILY; EVOLUTIONARY	Heat shock proteins (Hsps) play important roles in the environmental adaptation of various organisms. To explore the functions of Hsps in relation to heat stress and development in Cotesia vestalis, a solitary larval endoparasitoid of Plutella xylostella, four heat shock protein genes, CvHsp40, CvHsc70, CvHsp70 and CvHsp90, were cloned and sequenced from C. vestalis by real-time quantitative PCR and RACE. The cDNA sequence of CvHsp40, CvHsc70, CvHsp70 and CvHsp90 were 1473 bp, 2316 bp, 2279 bp and 2663 bp long, which encode proteins with calculated molecular weights (MW) of 39.1 kDa, 71.2 kDa, 70.1 kDa and 83.3 kDa, respectively. Furthermore, the analysis of genomic DNA confirmed that no introns existed in CvHsp40, CvHsp70 and CvHsp90 while two introns were present in CvHsc70. The amino acid sequence analysis of CvHsps indicated that CvHsp40 is a Type II Hsp40 homolog, CvHsp70 and CvHsc70 are the eukaryotic cytoplasmic Hsp70s, and CvHsp90 is the beta-isoform of Hsp90. The divergent transcriptional patterns of CvHsp40, CvHsp70 and CvHsp90 in the different developmental stages suggested that CvHsp transcripts were under different mechanisms of regulation during the development of parasitoid larvae. The dramatic increase of transcripts of CvHsp70 at the third-instar larva coincided with its developmental change in this stage, that is, from inside host to outside host. CvHsp40, CvHsc70 and CvHsp70 showed a trend of sex-specific differences of transcript abundance in the adult stage. All CvHsp transcripts in different developmental stages were significantly induced by heat stress, and the lowest transcript abundances appeared around the temperature 27 degrees C, which probably suggest that this is the most favorable temperature for the development of C. vestalis. Our results suggest that the expression of heat shock proteins reflects to some extent the developmental changes and environmental requirements of insects.	[Shi, Min; Wang, Ya-Na; Zhu, Ni; Chen, Xue-Xin] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Min; Wang, Ya-Na; Zhu, Ni; Chen, Xue-Xin] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Chen, XX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	xxchen@zju.edu.cn	Chen, Xue-xin/D-1592-2010	Chen, Xue-xin/0000-0002-9109-8853	973 Program [2013CB127603]; Zhejiang Key Program of Agriculture [2009C12048]; National Science Foundation of China [30971907]; Zhejiang Science Fund for Distinguished Young Scholars [R3110049]	973 Program(National Basic Research Program of China); Zhejiang Key Program of Agriculture; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Science Fund for Distinguished Young Scholars	Funding for this study was provided jointly by the 973 Program (2013CB127603) and Zhejiang Key Program of Agriculture (2009C12048) to XXC, the National Science Foundation of China (30971907) and the Zhejiang Science Fund for Distinguished Young Scholars (R3110049) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2003, J GEN VIROL, V84, P1165, DOI 10.1099/vir.0.19026-0; Bai Su-fen, 2005, Acta Phytophylacica Sinica, V32, P235; Bai Su-Fen, 2003, Acta Entomologica Sinica, V46, P401; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao Q, 2008, FISH SHELLFISH IMMUN, V24, P379, DOI 10.1016/j.fsi.2007.08.008; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; HAASS C, 1990, J CELL SCI, V96, P413; Joanisse DR, 1998, J BIOSCIENCES, V23, P369, DOI 10.1007/BF02936130; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURZIKDUMKE U, 1995, GENE, V154, P171, DOI 10.1016/0378-1119(94)00827-F; Liu SS, 2000, B ENTOMOL RES, V90, P221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahroof R, 2005, ANN ENTOMOL SOC AM, V98, P100, DOI 10.1603/0013-8746(2005)098[0100:CIEOHS]2.0.CO;2; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2002, J INVERTEBR PATHOL, V79, P62, DOI 10.1016/S0022-2011(02)00002-2; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; Shaw M. R., 2003, Entomologist's Gazette, V54, P187; Shi Zhuhua, 1999, Acta Phytophylacica Sinica, V26, P142; Shim JK, 2008, J INVERTEBR PATHOL, V97, P306, DOI 10.1016/j.jip.2007.10.001; Sonoda S, 2006, ARCH INSECT BIOCHEM, V62, P80, DOI 10.1002/arch.20124; Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vayssier M, 1999, PARASITOLOGY, V119, P81, DOI 10.1017/S0031182099004461; Wang H, 2012, ARCH INSECT BIOCHEM, V79, P247, DOI 10.1002/arch.21013; Yu RX, 2008, ANN ENTOMOL SOC AM, V101, P189, DOI 10.1603/0013-8746(2008)101[189:IDOCVH]2.0.CO;2; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013; Zhu JY, 2010, ARCH INSECT BIOCHEM, V75, P28, DOI 10.1002/arch.20380	42	27	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59721	10.1371/journal.pone.0059721	http://dx.doi.org/10.1371/journal.pone.0059721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527260	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600077
J	Oh, H; Quan, SA; Jeong, JY; Jang, SN; Lee, JE; Kim, DH				Oh, Hyunju; Quan, Shan Ai; Jeong, Jin-Young; Jang, Soong-Nang; Lee, Jung Eun; Kim, Dong-Hyun			Waist Circumference, Not Body Mass Index, Is Associated with Renal Function Decline in Korean Population: Hallym Aging Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; FAT DISTRIBUTION; OBESITY; PREVALENCE; ADIPOSITY; INFLAMMATION	Background: Prospective investigation of obesity and renal function decline in Asia is sparse. We examined the associations of body mass index (BMI) and waist circumference (WC) with renal function decline in a prospective study of Korean population. Methods: A total of 454 participants who had baseline estimated glomerular filtration rate (eGFR) levels of more than 60 mL/min/1.73 m(2) in Hallym Aging Study (HAS) were included and followed for 6 years. Renal function decline was defined as follows: (1) an eGFR decline >= 3 mL/min/1.73 m(2)/year (n = 82 cases); (2) an eGFR decrease of 20% or greater (n = 87 cases) at follow-up; (3) an eGFR decrease of 20% greater at follow-up or eGFR decline >= 3 mL/min/1.73 m(2)/year (n = 91 cases); and (4) an eGFR <60 mL/min/1.73 m(2) at follow-up (n = 54 cases). eGFR was determined based on the Modification of Diet in Renal Disease (MDRD) Study equation. Multivariate logistic regression model was used to determine the association between obesity and renal function decline. Results: We found that central obesity was associated with faster renal function decline. Comparing WC of >95 cm in men or >90 cm in women with <= 90 cm in men or <= 85 cm in women, ORs (95% CIs) ranged from 2.31 (1.14-4.69) to 2.78 (1.19-6.50) for the 4 definitions of renal function decline (all p-values for trend <0.05). Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) also was associated with renal function decline. There was no significant association of BMI with renal function decline. Conclusions: Central obesity, but not BMI, is associated with faster renal function decline in Korean population. Our results provide important evidence that simple measurement of central fat deposition rather than BMI could predict decline in renal function in Korean population.	[Oh, Hyunju; Lee, Jung Eun] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Quan, Shan Ai; Kim, Dong-Hyun] Hallym Univ, Dept Social & Prevent Med, Chunchon, South Korea; [Jeong, Jin-Young] Korea Hlth Promot Fdn, Seoul, South Korea; [Jang, Soong-Nang] Chung Ang Univ, Dept Nursing, Seoul 156756, South Korea; [Kim, Dong-Hyun] Hallym Res Inst Clin Epidemiol, Chunchon, South Korea	Sookmyung Women's University; Hallym University; Chung Ang University	Lee, JE (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	junglee@sm.ac.kr; dhkims@hallym.ac.kr	Lee, Jung Eun/AAC-5634-2020; Jang, Soong-nang/AAC-1322-2020	Lee, Jung Eun/0000-0003-1141-878X; Jang, Soong-nang/0000-0003-2621-945X	Hallym University [HRF-S-2012-5]	Hallym University	This study was supported by Hallym University Research Fund, 2012 (HRF-S-2012-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bavbek N, 2008, J NEPHROL, V21, P761; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Chang SH, 2012, MATURITAS; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Furukawa Y, 2010, STROKE, V41, P550, DOI 10.1161/STROKEAHA.109.569145; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Han SS, 2010, AM J NEPHROL, V31, P83, DOI 10.1159/000258660; Hsu CY, 2000, AM J KIDNEY DIS, V36, P272, DOI 10.1053/ajkd.2000.8971; Hu DS, 2000, OBES RES, V8, P411, DOI 10.1038/oby.2000.51; Huang B, 1997, INT J OBESITY, V21, P340, DOI 10.1038/sj.ijo.0800410; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kim I, 2010, J KOREAN MED SCI, V25, P293, DOI 10.3346/jkms.2010.25.2.293; 윤중, 2011, Journal of Obesity & Metabolic Syndrome, V20, P202; Kim Sejoong, 2008, Kidney Research and Clinical Practice, V27, P20; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Lee HaeJeung, 2002, Korean Journal of Community Nutrition, V7, P277; 최소연, 2007, Kidney Research and Clinical Practice, V26, P420; Lee JE, 2007, AM J HYPERTENS, V20, P1189, DOI 10.1016/j.amjhyper.2007.04.020; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lew SQ, 2005, SEMIN DIALYSIS, V18, P119, DOI 10.1111/j.1525-139X.2005.18215.x; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; MacGregor MS, 2007, NEPHROL DIAL TRANSPL, V22, P8, DOI 10.1093/ndt/gfm444; Miyatake N, 2011, ACTA MED OKAYAMA, V65, P363; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Park HC, 2010, CLIN NEPHROL, V73, P374; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; 정주석, 2004, [The Korean Journal of Medicine, 대한내과학회지], V67, P266; Singh NP, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-4; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Tesauro M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/653182; The International Association for the Study of Obesity and the International Obesity Task Force, 2000, AS PAC PERSP RED OB; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Trirogoff ML, 2007, AM J CLIN NUTR, V86, P1642, DOI 10.1093/ajcn/86.5.1642; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Yoshida T, 2008, INTERNAL MED, V47, P1859, DOI 10.2169/internalmedicine.47.1171	54	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59071	10.1371/journal.pone.0059071	http://dx.doi.org/10.1371/journal.pone.0059071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536858	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200015
J	Sanquer, S; Amrein, C; Grenet, D; Guillemain, R; Philippe, B; Boussaud, V; Herry, L; Lena, C; Diouf, A; Paunet, M; Billaud, EM; Loriaux, F; Jais, JP; Barouki, R; Stern, M				Sanquer, Sylvia; Amrein, Catherine; Grenet, Dominique; Guillemain, Romain; Philippe, Bruno; Boussaud, Veronique; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Paunet, Michelle; Billaud, Eliane M.; Loriaux, Francoise; Jais, Jean-Philippe; Barouki, Robert; Stern, Marc			Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; ALLOGRAFT-REJECTION; BLOOD-CONCENTRATION; RISK-FACTORS; RECIPIENTS; CYCLOSPORINE; IMMUNOSUPPRESSION; CA2+/CALCINEURIN; ACTIVATION; TACROLIMUS	The objective of this pharmacodynamic study was to longitudinally assess the activity of calcineurin during the first 2 years after lung transplantation. From March 2004 to October 2008, 107 patients were prospectively enrolled and their follow-up was performed until 2009. Calcineurin activity was measured in peripheral blood mononuclear cells. We report that calcineurin activity was linked to both acute and chronic rejection. An optimal activity for calcineurin with two thresholds was defined, and we found that the risk of rejection was higher when the enzyme activity was above the upper threshold of 102 pmol/mg/min or below the lower threshold of 12 pmol/mg/min. In addition, we report that the occurrence of malignancies and viral infections was significantly higher in patients displaying very low levels of calcineurin activity. Taken together, these findings suggest that the measurement of calcineurin activity may provide useful information for the management of the prevention therapy of patients receiving lung transplantation.	[Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] Hop Univ Necker Enfants Malad, AP HP, Serv Biochim Metabol & Prote, Paris, France; [Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] INSERM, UMR S 747, Paris, France; [Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] Univ Paris 05, Ctr Univ St Peres, Paris, France; [Amrein, Catherine; Guillemain, Romain; Boussaud, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Cardiovasc, Paris, France; [Grenet, Dominique; Philippe, Bruno; Stern, Marc] Hop Foch, Serv Pneumol, Paris, France; [Paunet, Michelle] Hop Foch, Biol Lab, Suresnes, France; [Billaud, Eliane M.] Hop Europeen Georges Pompidou, AP HP, Serv Pharmacol, Paris, France; [Billaud, Eliane M.; Jais, Jean-Philippe] Univ Paris 05, Paris, France; [Loriaux, Francoise] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Jais, Jean-Philippe] Hop Necker Enfants Malad, AP HP, Serv Biostat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Sanquer, S (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Serv Biochim Metabol & Prote, Paris, France.	sylvia.sanquer@gmail.com		STERN, Marc/0000-0001-5275-6959	French association Vaincre la Mucoviscidose	French association Vaincre la Mucoviscidose	Funding for this study was provided by the French association Vaincre la Mucoviscidose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Aris R, 1998, AM J RESP CRIT CARE, V158, P335; BANDO K, 1995, J THORAC CARDIOV SUR, V110, P4, DOI 10.1016/S0022-5223(05)80003-0; Batiuk TD, 1997, J CLIN INVEST, V100, P1894, DOI 10.1172/JCI119719; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Caruso R, 2001, CLIN CHEM, V47, P1679; Copeland CAF, 2010, AM J RESP CRIT CARE, V182, P784, DOI 10.1164/rccm.201002-0211OC; Crim C, 1996, AM J RESP CRIT CARE, V153, P1041, DOI 10.1164/ajrccm.153.3.8630543; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fukudo M, 2005, CLIN PHARMACOL THER, V78, P168, DOI 10.1016/j.clpt.2005.04.008; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; Hodge G, 2012, J HEART LUNG TRANSPL, V31, P538, DOI 10.1016/j.healun.2012.02.004; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; Martinu Tereza, 2009, Proc Am Thorac Soc, V6, P54, DOI 10.1513/pats.200808-080GO; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Sanquer S, 2004, TRANSPLANTATION, V77, P854, DOI 10.1097/01.TP.0000114612.55925.22; Schowengerdt KO, 2000, TRANSPLANTATION, V69, P2102, DOI 10.1097/00007890-200005270-00023; Sharples LD, 1996, TRANSPLANTATION, V61, P560, DOI 10.1097/00007890-199602270-00008; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TRULOCK EP, 1993, CHEST, V103, P1566, DOI 10.1378/chest.103.5.1566; Yano I, 2012, EUR J CLIN PHARMACOL, V68, P259, DOI 10.1007/s00228-011-1129-x; Yano I, 2008, DRUG METAB PHARMACOK, V23, P150, DOI 10.2133/dmpk.23.150; YOUSEM SA, 1992, AM J SURG PATHOL, V16, P877, DOI 10.1097/00000478-199209000-00006; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; YOUSEM SA, 1993, AM J SURG PATHOL, V17, P491, DOI 10.1097/00000478-199305000-00008	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59634	10.1371/journal.pone.0059634	http://dx.doi.org/10.1371/journal.pone.0059634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536885	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200033
J	Garren, MV; Sexauer, SB; Page, TL				Garren, Madeleine V.; Sexauer, Stephen B.; Page, Terry L.			Effect of Circadian Phase on Memory Acquisition and Recall: Operant Conditioning vs. Classical Conditioning	PLOS ONE			English	Article							LEARNING-TASK; TERM-MEMORY; TIME; MODULATION; RATS; PERFORMANCE; SENSITIZATION; AVOIDANCE; RETENTION; RHYTHMS	There have been several studies on the role of circadian clocks in the regulation of associative learning and memory processes in both vertebrate and invertebrate species. The results have been quite variable and at present it is unclear to what extent the variability observed reflects species differences or differences in methodology. Previous results have shown that following differential classical conditioning in the cockroach, Rhyparobia maderae, in an olfactory discrimination task, formation of the short-term and long-term memory is under strict circadian control. In contrast, there appeared to be no circadian regulation of the ability to recall established memories. In the present study, we show that following operant conditioning of the same species in a very similar olfactory discrimination task, there is no impact of the circadian system on either short-term or long-term memory formation. On the other hand, ability to recall established memories is strongly tied to the circadian phase of training. On the basis of these data and those previously reported for phylogenetically diverse species, it is suggested that there may be fundamental differences in the way the circadian system regulates learning and memory in classical and operant conditioning.	[Garren, Madeleine V.; Sexauer, Stephen B.; Page, Terry L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA	Vanderbilt University	Page, TL (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA.	Terry.L.Page@Vanderbilt.Edu			National Science Foundation [IOS-1145605]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant #IOS-1145605 to TLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter DA, 2006, LEARN MEMORY, V13, P669, DOI 10.1101/lm.339206; BELING INGEBORG, 1929, ZEITSCHR VERGLEICH PHYSIOL, V9, P259, DOI 10.1007/BF00340159; BIEBACH H, 1991, J BIOL RHYTHM, V6, P353, DOI 10.1177/074873049100600406; Brembs B, 2008, CURR BIOL, V18, P1168, DOI 10.1016/j.cub.2008.07.041; Cain SW, 2008, NEUROBIOL LEARN MEM, V89, P591, DOI 10.1016/j.nlm.2007.07.011; Cain SW, 2004, NEUROBIOL LEARN MEM, V81, P217, DOI 10.1016/j.nlm.2004.02.003; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Decker S, 2007, P NATL ACAD SCI USA, V104, P15905, DOI 10.1073/pnas.0702082104; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; FEKETE M, 1985, PHYSIOL BEHAV, V34, P883, DOI 10.1016/0031-9384(85)90008-3; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; Gomez-Laplaza LM, 2005, BEHAV PROCESS, V70, P177, DOI 10.1016/j.beproc.2005.02.021; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Lehmann M, 2011, BEHAV ECOL SOCIOBIOL, V65, P205, DOI 10.1007/s00265-010-1026-9; Lorenzetti FD, 2006, NAT NEUROSCI, V9, P17, DOI 10.1038/nn1593; Lyon LC, 2005, P NATL ACAD SCI USA, V102, P12589, DOI 10.1073/pnas.0503847102; Lyons LC, 2006, J NEUROSCI, V26, P8662, DOI 10.1523/JNEUROSCI.2307-06.2006; Lyons LC, 2009, LEARN MEMORY, V16, P19, DOI 10.1101/lm.1146009; Manrique T, 2004, NEUROBIOL LEARN MEM, V82, P77, DOI 10.1016/j.nlm.2004.04.003; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Petruso EJ, 2007, ANIM COGN, V10, P181, DOI 10.1007/s10071-006-0057-0; Philips GT, 2006, LEARN MEMORY, V13, P224, DOI 10.1101/lm.111506; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Ralph MR, 2002, BEHAV BRAIN RES, V136, P179, DOI 10.1016/S0166-4328(02)00131-6; Rawashdeh O, 2007, SCIENCE, V318, P1144, DOI 10.1126/science.1148564; Reebs SG, 1996, BEHAV PROCESS, V36, P253, DOI 10.1016/0376-6357(96)88023-5; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sakura M, 2001, ZOOL SCI, V18, P21, DOI 10.2108/zsj.18.21; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Valentinuzzi VS, 2008, NEUROBIOL LEARN MEM, V89, P604, DOI 10.1016/j.nlm.2007.08.002; Valentinuzzi VS, 2001, ANIM LEARN BEHAV, V29, P133, DOI 10.3758/BF03192822; Watanabe H, 2003, ZOOL SCI, V20, P1447, DOI 10.2108/zsj.20.1447; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Zhang YL, 2012, NAT NEUROSCI, V15, P294, DOI 10.1038/nn.2990	37	18	18	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58693	10.1371/journal.pone.0058693	http://dx.doi.org/10.1371/journal.pone.0058693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111VQ	23533587	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400024
J	Ghabooli, S; Zhan, AB; Sardina, P; Paolucci, E; Sylvester, F; Perepelizin, PV; Briski, E; Cristescu, ME; MacIsaac, HJ				Ghabooli, Sara; Zhan, Aibin; Sardina, Paula; Paolucci, Esteban; Sylvester, Francisco; Perepelizin, Pablo V.; Briski, Elizabeta; Cristescu, Melania E.; MacIsaac, Hugh J.			Genetic Diversity in Introduced Golden Mussel Populations Corresponds to Vector Activity	PLOS ONE			English	Article							DREISSENA-ROSTRIFORMIS-BUGENSIS; LIMNOPERNA-FORTUNEI MYTILIDAE; FRESH-WATER MUSSEL; RANGE EXPANSION; ZEBRA MUSSEL; BIOLOGICAL INVASIONS; GREAT-LAKES; DNA; PATTERNS; PHYLOGEOGRAPHY	We explored possible links between vector activity and genetic diversity in introduced populations of Limnoperna fortunei by characterizing the genetic structure in native and introduced ranges in Asia and South America. We surveyed 24 populations: ten in Asia and 14 in South America using the mitochondrial cytochrome c oxidase subunit I (COI) gene, as well as eight polymorphic microsatellite markers. We performed population genetics and phylogenetic analyses to investigate population genetic structure across native and introduced regions. Introduced populations in Asia exhibit higher genetic diversity (H-E = 0.667-0.746) than those in South America (H-E = 0.519-0.575), suggesting higher introduction effort for the former populations. We observed pronounced geographical structuring in introduced regions, as indicated by both mitochondrial and nuclear markers based on multiple genetic analyses including pairwise Phi(ST), F-ST, Bayesian clustering method, and three-dimensional factorial correspondence analyses. Pairwise F-ST values within both Asia (F-ST = 0.017-0.126, P = 0.000-0.009) and South America (F-ST = 0.004-0.107, P = 0.000-0.721) were lower than those between continents (F-ST = 0.180-0.319, P = 0.000). Fine-scale genetic structuring was also apparent among introduced populations in both Asia and South America, suggesting either multiple introductions of distinct propagules or strong post-introduction selection and demographic stochasticity. Higher genetic diversity in Asia as compared to South America is likely due to more frequent propagule transfers associated with higher shipping activities between source and donor regions within Asia. This study suggests that the intensity of human-mediated introduction vectors influences patterns of genetic diversity in non-indigenous species.	[Ghabooli, Sara; Zhan, Aibin; Paolucci, Esteban; Cristescu, Melania E.; MacIsaac, Hugh J.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Zhan, Aibin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [Sardina, Paula; Perepelizin, Pablo V.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Sardina, Paula] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Melbourne, Vic 3004, Australia; [Sylvester, Francisco; Perepelizin, Pablo V.] Univ Buenos Aires, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Sylvester, Francisco] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Briski, Elizabeta] Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, Burlington, ON, Canada	University of Windsor; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Monash University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fisheries & Oceans Canada	Ghabooli, S (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	ghabool@uwindsor.ca	Briski, Elizabeta/A-7910-2015; Sylvester, Francisco/AAX-4489-2021; macisaac, hugh/AAE-3742-2020; Briski, Elizabeta/P-4108-2019; Zhan, Aibin/A-7240-2011; Paolucci, Esteban/V-6211-2018	Sylvester, Francisco/0000-0001-7522-8956; Briski, Elizabeta/0000-0003-1896-3860; Paolucci, Esteban/0000-0001-7847-1484; Perepelizin, Pablo Victor/0000-0001-7866-6601; Cristescu, Melania/0000-0002-0854-4040	Chinese Academy of Sciences; Emerging Leaders in the Americas Program (Foreign Affairs Trade Canada); Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Research and Innovation; NSERC	Chinese Academy of Sciences(Chinese Academy of Sciences); Emerging Leaders in the Americas Program (Foreign Affairs Trade Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding sources: Emerging Leaders in the Americas Program (Foreign Affairs Trade Canada) grants to PVP and EP; "100 Talents Program" of the Chinese Academy of Sciences to AZ; Discovery grants from Natural Sciences and Engineering Research Council of Canada (NSERC) to MEC and HJM; Ontario Ministry of Research and Innovation Early Researcher Award to MEC; and NSERC Discovery Accelerator Supplement to HJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, TRADE STAT JAPAN MIN; Ashton GV, 2008, MOL ECOL, V17, P1293, DOI 10.1111/j.1365-294X.2007.03668.x; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Boltovskoy D, 2006, BIOL INVASIONS, V8, P947, DOI 10.1007/s10530-005-5107-z; Briski E, 2011, LIMNOL OCEANOGR, V56, P1929, DOI 10.4319/lo.2011.56.5.1929; Briski E, 2010, FRESHWATER BIOL, V55, P2414, DOI 10.1111/j.1365-2427.2010.02449.x; Brown JE, 2010, BIOL INVASIONS, V12, P3687, DOI 10.1007/s10530-010-9763-2; Carlton James T., 1993, P677; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; Chandler EA, 2008, MOL ECOL, V17, P4079, DOI 10.1111/j.1365-294X.2008.03897.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cristescu MEA, 2001, LIMNOL OCEANOGR, V46, P224, DOI 10.4319/lo.2001.46.2.0224; Darling JA, 2012, ECOL EVOL, V2, P2552, DOI 10.1002/ece3.362; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; DARRIGRAN G, 1995, VELIGER, V38, P171; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Elderkin CL, 2001, J N AM BENTHOL SOC, V20, P595, DOI 10.2307/1468090; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gelembiuk GW, 2006, MOL ECOL, V15, P1033, DOI 10.1111/j.1365-294X.2006.02816.x; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Ghabooli S, 2011, BIOL INVASIONS, V13, P679, DOI 10.1007/s10530-010-9859-8; GIESE AC, 1959, ANNU REV PHYSIOL, V21, P547, DOI 10.1146/annurev.ph.21.030159.002555; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Imo M, 2010, AQUAT ECOL, V44, P731, DOI 10.1007/s10452-009-9311-2; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kowarik I, 2012, DIVERS DISTRIB, V18, P1243, DOI 10.1111/ddi.12009; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lewis KM, 2000, CAN J FISH AQUAT SCI, V57, P637, DOI 10.1139/cjfas-57-3-637; Li CY, 1980, ACTA OCEANOL SIN, V2, P131; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Lunaschi L, 1993, NEOTROPICA, V39, P171; Magara Y, 2001, J WATER SUPPLY RES T, V50, P113, DOI 10.2166/aqua.2001.0011; May GE, 2006, MOL ECOL, V15, P1021, DOI 10.1111/j.1365-294X.2006.02814.x; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Nakai K, 1995, KANSAI SHIZENHOGO KI, V17, P49; Perepelizin PV, 2011, J AM WATER WORKS ASS, V103, P79; Pie MR, 2006, J MOLLUS STUD, V72, P218, DOI 10.1093/mollus/eyi070; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ricciardi A, 1998, BIOFOULING, V13, P97, DOI 10.1080/08927019809378374; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tchang S., 1965, ACTA ZOOL SINICA, V17, P212; Temcharoen Prasong, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P332; Therriault TW, 2004, MOL PHYLOGENET EVOL, V30, P479, DOI 10.1016/S1055-7903(03)00240-9; Therriault TW, 2005, HEREDITY, V95, P16, DOI 10.1038/sj.hdy.6800691; Tominaga Atsushi, 2009, BIODIVERSITY-OTTAWA, V10, P61; Uryu Y, 1996, J MOLLUS STUD, V62, P327, DOI 10.1093/mollus/62.3.327; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258	78	21	21	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59328	10.1371/journal.pone.0059328	http://dx.doi.org/10.1371/journal.pone.0059328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533614	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000316549400051
J	Luo, XM; Tang, JL; Hu, YH; Li, LM; Wang, YL; Wang, WZ; Yang, L; Ouyang, XH; Duan, GC				Luo, Xiao-Min; Tang, Jin-Ling; Hu, Yong-Hua; Li, Li-Ming; Wang, Yan-Ling; Wang, Wei-Zhong; Yang, Li; Ouyang, Xiao-hui; Duan, Guang-cai			How Often Are Ineffective Interventions Still Used in Clinical Practice? A Cross-Sectional Survey of 6,272 Clinicians in China	PLOS ONE			English	Article							DISEASE	Background: The World Health Organization reported in 2011 that irrational use of medicines was a serious global problem that is wasteful and harmful. The worst is use of ineffective or harmful interventions which should not be used at all. However, little is known about the changes that 20 years of evidence-based medicine has made particularly in reducing use of ineffective interventions. We surveyed clinicians in China to show how often ineffective interventions were still used in practice. Methods: 3,246 clinicians from 24 tertiary hospitals were surveyed in person and another 3,063 through an online survey between 2006-2007. The main outcomes are prescription by a clinician, and use in a patient of, an ineffective intervention and of a matched effective intervention in patients with the same disease. 129 ineffective interventions for 68 diseases were identified from the BMJ Clinical Evidence and included in the survey. One effective intervention was identified for each disease and a total of 68 effective interventions were thus also included. The frequency of use of effective interventions was used as a reference for that of ineffective intervention. Results: The mean prescription rate by clinicians is 59.0% (95% confidence interval (95% CI): 58.6% to 59.4%) and 81.0% (95% CI: 80.6% to 81.4%) respectively for ineffective and effective interventions. The mean frequency of use in patients is 31.2% (95% CI: 30.8% to 31.6%) and 56.4% (95% CI: 56.0% to 56.8%) for ineffective and effective interventions respectively. The relative reduction in use of ineffective interventions as compared with that of matched effective interventions is 27.2% (95% CI: 27.0% to 27.4%) and 44.7% (95% CI: 44.3% to 45.1%) for clinician's prescription and use in patients respectively. 8.6% ineffective interventions were still routinely used in practice. Conclusions: Ineffective interventions were still commonly used. Efforts are necessary to further reduce and eventually eliminate ineffective interventions from practice.	[Luo, Xiao-Min; Tang, Jin-Ling; Wang, Yan-Ling] Peking Univ, Hlth Sci Ctr, Ctr Evidence Based Med, Beijing 100871, Peoples R China; [Tang, Jin-Ling] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Luo, Xiao-Min; Hu, Yong-Hua; Li, Li-Ming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China; [Wang, Wei-Zhong] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Wang, Wei-Zhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Ouyang, Xiao-hui] Inner Mongolia Med Coll, Hohhot, Inner Mongolia, Peoples R China; [Duan, Guang-cai] Henan Univ Sci & Technol, Luoyang, Henan Province, Peoples R China	Peking University; Chinese University of Hong Kong; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangxi Medical University; Inner Mongolia Medical University; Henan University of Science & Technology	Tang, JL (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Evidence Based Med, Beijing 100871, Peoples R China.	jltang@cuhk.edu.hk	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021					[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 2006, CLIN EVIDENCE; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Botting J, 2002, DRUG NEWS PERSPECT, V15, P604, DOI 10.1358/dnp.2002.15.9.840066; China Pharmacopeia Committee, 2005, CHIN PHARM PEOPL REP; Clinard F, 2001, PHARMACOEPIDEM DR S, V10, P329, DOI 10.1002/pds.623; Enkin M, 1989, EFFECTIVE CURE PREGN; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Haynes R Brian, 2006, Evid Based Med, V11, P162; Holloway, 2011, WORLD MED SITUATION; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Lacy BE, 2005, J CLIN GASTROENTEROL, V39, P489, DOI 10.1097/01.mcg.0000165647.24748.04; McAlister FA, 1997, J HUM HYPERTENS, V11, P413, DOI 10.1038/sj.jhh.1000457; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Tang JL, 2004, EVIDENCE BASED DICIS; Tang JL, 2010, ESSENTIALS EVIDENCE; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6	17	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e52159	10.1371/journal.pone.0052159	http://dx.doi.org/10.1371/journal.pone.0052159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533565	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400003
J	Rosenberg, Y; Sack, M; Montefiori, D; Forthal, D; Mao, LJ; Hernandez-Abanto, S; Urban, L; Landucci, G; Fischer, R; Jiang, XM				Rosenberg, Yvonne; Sack, Markus; Montefiori, David; Forthal, Donald; Mao, Lingjun; Hernandez-Abanto, Segundo; Urban, Lori; Landucci, Gary; Fischer, Rainer; Jiang, Xiaoming			Rapid High-Level Production of Functional HIV Broadly Neutralizing Monoclonal Antibodies in Transient Plant Expression Systems	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; PASSIVE-IMMUNIZATION; TYPE-1; MACAQUES; PROTECTION; POTENT; 2G12; COMBINATION; INHIBITION	Passive immunotherapy using anti-HIV broadly neutralizing monoclonal antibodies (mAbs) has shown promise as an HIV treatment, reducing mother-to-child-transmission (MTCT) of simian/human immunodeficiency virus (SHIV) in non-human primates and decreasing viral rebound in patients who ceased receiving anti-viral drugs. In addition, a cocktail of potent mAbs may be useful as mucosal microbicides and provide an effective therapy for post-exposure prophylaxis. However, even highly neutralizing HIV mAbs used today may lose their effectiveness if resistance occurs, requiring the rapid production of new or engineered mAbs on an ongoing basis in order to counteract the viral resistance or the spread of a certain HIV-1 clade in a particular region or patient. Plant-based expression systems are fast, inexpensive and scalable and are becoming increasingly popular for the production of proteins and monoclonal antibodies. In the present study, Agrobacterium-mediated transient transfection of plants, utilizing two species of Nicotiana, have been tested to rapidly produce high levels of an HIV 89.6P Delta 140env and several well-studied anti-HIV neutralizing monoclonal antibodies (b12, 2G12, 2F5, 4E10, m43, VRC01) or a single chain antibody construct (m9), for evaluation in cell-based viral inhibition assays. The protein-A purified plant-derived antibodies were intact, efficiently bound HIV envelope, and were equivalent to, or in one case better than, their counterparts produced in mammalian CHO or HEK-293 cells in both neutralization and antibody dependent viral inhibition assays. These data indicate that transient plant-based transient expression systems are very adaptable and could rapidly generate high levels of newly identified functional recombinant HIV neutralizing antibodies when required. In addition, they warrant detailed cost-benefit analysis of prolonged incubation in plants to further increase mAb production.	[Rosenberg, Yvonne; Mao, Lingjun; Hernandez-Abanto, Segundo; Urban, Lori; Jiang, Xiaoming] PlantVax Corp, Rockville, MD USA; [Sack, Markus; Fischer, Rainer] RTWH Aachen Univ, Inst Mol Biotechnol, Aachen, Germany; [Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Forthal, Donald; Landucci, Gary] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA	RWTH Aachen University; Duke University; University of California System; University of California Irvine	Rosenberg, Y (corresponding author), PlantVax Corp, Rockville, MD USA.	yjr@plantvax.com	Sack, Markus/K-6681-2013; Sack, Markus/AAP-9252-2021	Sack, Markus/0000-0002-7380-9228; 	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621, R43AI070123]; European Research Council [269110]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI070123, R44AI081621] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grants #R44AI081621 and #R43AI070123 and in part by the European Research Council Advanced Grant "Future-Pharma", proposal number 269110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Fox Jeffrey L, 2011, Nat Biotechnol, V29, P852, DOI 10.1038/nbt1011-852; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Gomord W, 2005, TRENDS BIOTECHNOL, V23, P559, DOI 10.1016/j.tibtech.2005.09.003; Gorny MK, 2006, PLOS MED, V3, P966, DOI 10.1371/journal.pmed.0030259; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Holl V, 2009, VIRUSES-BASEL, V1, P1265, DOI 10.3390/v1031265; Kathuria S, 2002, HUM REPROD, V17, P2054, DOI 10.1093/humrep/17.8.2054; Lavine CL, 2012, J VIROL, V86, P2153, DOI 10.1128/JVI.06201-11; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Ma JKC, 2005, TRENDS PLANT SCI, V10, P580, DOI 10.1016/j.tplants.2005.10.009; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Morris G, 2010, DANCING TIMES, V100, P10; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ramessar K, 2008, P NATL ACAD SCI USA, V105, P3727, DOI 10.1073/pnas.0708841104; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Sack M, 2007, FASEB J, V21, P1655, DOI 10.1096/fj.06-5863com; Sainsbury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013976; Samleerat T, 2009, VIROLOGY, V387, P388, DOI 10.1016/j.virol.2009.02.024; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saxena P, 2011, PLANT BIOTECHNOL J, V9, P703, DOI 10.1111/j.1467-7652.2010.00574.x; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Scarlatti G, 2004, AIDS REV, V6, P67; Sexton A, 2009, FASEB J, V23, P3590, DOI 10.1096/fj.09-131995; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stoger Eva, 2004, Methods Mol Biol, V248, P301; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Whaley KJ, 2011, HUM VACCINES, V7, P349, DOI 10.4161/hv.7.3.14266; Wolbank S, 2003, J VIROL, V77, P4095, DOI 10.1128/JVI.77.7.4095-4103.2003; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241; Zhang MY, 2010, MABS-AUSTIN, V2, P266, DOI 10.4161/mabs.2.3.11416; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	54	55	59	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58724	10.1371/journal.pone.0058724	http://dx.doi.org/10.1371/journal.pone.0058724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533588	gold, Green Published			2022-12-27	WOS:000316549400025
J	Schick, UM; McDavid, A; Crane, PK; Weston, N; Ehrlich, K; Newton, KM; Wallace, R; Bookman, E; Harrison, T; Aragaki, A; Crosslin, DR; Wang, SS; Reiner, AP; Jackson, RD; Peters, U; Larson, EB; Jarvik, GP; Carlson, CS				Schick, Ursula M.; McDavid, Andrew; Crane, Paul K.; Weston, Noah; Ehrlich, Kelly; Newton, Katherine M.; Wallace, Robert; Bookman, Ebony; Harrison, Tabitha; Aragaki, Aaron; Crosslin, David R.; Wang, Sophia S.; Reiner, Alex P.; Jackson, Rebecca D.; Peters, Ulrike; Larson, Eric B.; Jarvik, Gail P.; Carlson, Christopher S.			Confirmation of the Reported Association of Clonal Chromosomal Mosaicism with an Increased Risk of Incident Hematologic Cancer	PLOS ONE			English	Article							ABNORMALITIES; MALIGNANCIES; MUTATIONS; BIRTH; TET2	Chromosomal abnormalities provide clinical utility in the diagnosis and treatment of hematologic malignancies, and may be predictive of malignant transformation in individuals without apparent clinical presentation of a hematologic cancer. In an effort to confirm previous reports of an association between clonal mosaicism and incident hematologic cancer, we applied the anomDetectBAF algorithm to call chromosomal anomalies in genotype data from previously conducted Genome Wide Association Studies (GWAS). The genotypes were initially collected from DNA derived from peripheral blood of 12,176 participants in the Group Health electronic Medical Records and Genomics study (eMERGE) and the Women's Health Initiative (WHI). We detected clonal mosaicism in 169 individuals (1.4%) and large clonal mosaic events (>2 mb) in 117 (1.0%) individuals. Though only 9.5% of clonal mosaic carriers had an incident diagnosis of hematologic cancer (multiple myeloma, myelodysplastic syndrome, lymphoma, or leukemia), the carriers had a 5.5-fold increased risk (95% CI: 3.3-9.3; p-value = 7.5 x 10(-11)) of developing these cancers subsequently. Carriers of large mosaic anomalies showed particularly pronounced risk of subsequent leukemia (HR = 19.2, 95% CI: 8.9-41.6; p-value = 7.3x10(-14)). Thus we independently confirm the association between detectable clonal mosaicism and hematologic cancer found previously in two recent publications.	[Schick, Ursula M.; McDavid, Andrew; Harrison, Tabitha; Aragaki, Aaron; Reiner, Alex P.; Peters, Ulrike; Carlson, Christopher S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Crane, Paul K.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Weston, Noah; Ehrlich, Kelly; Newton, Katherine M.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Newton, Katherine M.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Wallace, Robert] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Bookman, Ebony] NHGRI, NIH, Bethesda, MD 20892 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Dept Populat Sci, Div Canc Etiol, Duarte, CA USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Reiner, Alex P.; Carlson, Christopher S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol, Columbus, OH 43210 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University	Carlson, CS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	ccarlson@fhcrc.org	Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; Crane, Paul/0000-0003-4278-7465; Harrison, Tabitha/0000-0002-4173-7530; WANG, SOPHIA/0000-0003-2597-9393; McDavid, Andrew/0000-0002-6581-1213	National Institutes of Health (NIH) [HG004610, AG06781]; National Heart, Lung, and Blood Institute, NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; GARNET Collaborative Research Group; NHGRI Genomics and Randomized Trials Network (GARNET) [U01 HG005152]; NIH Genes, Environment and Health Initiative [GEI] [U01 HG004424]; National Cancer Institute [R25CA094880];  [U01AG06781];  [U01HG004438];  [U01CKA137088];  [R01CKA059045]; NATIONAL CANCER INSTITUTE [R25CA094880, P30CA016056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005157, U01HG004438, U01HG004610, U01HG005152, U01HG004424, U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032109, N01WH042113, N01WH042112, N01WH042117, N01WH042126, N01WH042109, N01WH032115, N01WH042131, N01WH042118, N01WH032105, N01WH042108, N01WH042129, N01WH032106, N01WH042115, N01WH032113, N01WH032119, N01WH032108, N01WH042107, N01WH032112, N01WH042114, N01WH032118, N01WH042116, N01WH022110, N01WH032122, N01WH042132, N01WH042124, N01WH042130, N01WH042120, N01WH042119, N01WH032100, N01WH042121, N01WH032111, N01WH032102, N01WH042122, N01WH032101, N01WH042110, N01WH042123, N01WH042125, N01WH042111] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Health and Human Services; GARNET Collaborative Research Group; NHGRI Genomics and Randomized Trials Network (GARNET); NIH Genes, Environment and Health Initiative [GEI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The initial ADPR was funded by U01AG06781 and the initial ACT study is also funded by U01AG06781. The eMERGE study was funded by National Institutes of Health (NIH) award HG004610, AG06781 (Group Health Cooperative). Genotyping of eMERGE samples was funded by grant U01HG004438. The WHI program is funded by the National Heart, Lung, and Blood Institute, NIH, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The authors thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at: http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf. WHI GECCO colorectal cancer study was funded by U01CKA137088 and R01CKA059045. The authors wish to acknowledge the support of the GARNET Collaborative Research Group. Funding support for WHI-GARNET was provided through the NHGRI Genomics and Randomized Trials Network (GARNET) (Grant Number U01 HG005152). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GARNET Coordinating Center (U01 HG005157). Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard, was provided by the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004424). Additional support for author UMS was provided by grant R25CA094880 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Chen Z, 2002, AM J MED GENET, V115, P130, DOI 10.1002/ajmg.10689; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Gogarten SM, 2011, CLASSES STORING VERY; Greaves M, 2005, EARLY HUM DEV, V81, P123, DOI 10.1016/j.earlhumdev.2004.10.004; Holmfeldt L, 2011, CANCER CELL, V20, P1, DOI 10.1016/j.ccr.2011.06.025; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; KALOUSEK DK, 1992, HUM GENET, V88, P642, DOI 10.1007/BF02265289; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson E B, 1990, Aging (Milano), V2, P404; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lichtman MA, 2008, ONCOLOGIST, V13, P126, DOI 10.1634/theoncologist.2007-0228; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; MACHNICKI JL, 1990, CLIN LAB MED, V10, P755; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Palamarchuk A, 2010, BLOOD, V115, P3916, DOI 10.1182/blood-2009-10-249367; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; ROWLEY JD, 1975, P NATL ACAD SCI USA, V72, P152, DOI 10.1073/pnas.72.1.152; Shao LN, 2010, J MOL DIAGN, V12, P670, DOI 10.2353/jmoldx.2010.090192; SYBERT VP, 1990, J PEDIATR-US, V116, P581, DOI 10.1016/S0022-3476(05)81606-3; Thoma CR, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13170; Trent RJ, 2005, MOL MED INTRO TEXT, Vvii; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Vorsanova SG, 2005, J HISTOCHEM CYTOCHEM, V53, P375, DOI 10.1369/jhc.4A6424.2005; WARBURTON D, 1978, AM J HUM GENET, V30, P609; Washington State Cancer Registry, 2011, CANC COD US REP; Yaghmaie M, 2009, INT J HEMATOLOGY ONC, V3, P28; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	36	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59823	10.1371/journal.pone.0059823	http://dx.doi.org/10.1371/journal.pone.0059823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533652	Green Submitted, gold, Green Published			2022-12-27	WOS:000316549400089
J	Lian, XJ; Selekman, J; Bao, XP; Hsiao, C; Zhu, KX; Palecek, SP				Lian, Xiaojun; Selekman, Joshua; Bao, Xiaoping; Hsiao, Cheston; Zhu, Kexian; Palecek, Sean P.			A Small Molecule Inhibitor of Src Family Kinases Promotes Simple Epithelial Differentiation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							BETA-CATENIN; SELF-RENEWAL; RETINOIC ACID; E-CADHERIN; WNT; KERATINOCYTES; MODULATION; ACTIVATION; TARGET; GROWTH	Human pluripotent stem cells (hPSCs) provide unprecedented opportunities to study the earliest stages of human development in vitro and have the potential to provide unlimited new sources of cells for regenerative medicine. Although previous studies have reported cytokeratin 14+/p63+ keratinocyte generation from hPSCs, the multipotent progenitors of epithelial lineages have not been described and the developmental pathways regulating epithelial commitment remain largely unknown. Here we report membrane localization of beta-catenin during retinoic acid (RA) - induced epithelial differentiation. In addition hPSC treatment with the Src family kinase inhibitor SU6656 modulated beta-catenin localization and produced an enriched population of simple epithelial cells under defined culture conditions. SU6656 strongly upregulated expression of cytokeratins 18 and 8 (K18/K8), which are expressed in simple epithelial cells, while repressing expression of the pluripotency gene Oct4. This homogeneous population of K18+K8+Oct42- simple epithelial precursor cells can further differentiate into cells expressing keratinocyte or corneal-specific markers. These enriched hPSC-derived simple epithelial cells may provide a ready source for development and toxicology cell models and may serve as a progenitor for epithelial cell transplantation applications.	[Lian, Xiaojun; Selekman, Joshua; Bao, Xiaoping; Hsiao, Cheston; Zhu, Kexian; Palecek, Sean P.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Palecek, SP (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	palecek@engr.wisc.edu	Lian, Xiaojun/G-2640-2012	Lian, Xiaojun/0000-0002-9161-1004; Bao, Xiaoping/0000-0003-0955-6868; Zhu, Kexian/0000-0002-2321-5085	National Science Foundation [CBET-1066311]; United States National Institutes of Health [R01EB007534]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007534] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Science Foundation grant CBET-1066311 and United States National Institutes of Health grant R01EB007534. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova I, 2011, J BIOL CHEM, V286, P36042, DOI 10.1074/jbc.M111.290825; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Azarin SM, 2012, BIOMATERIALS, V33, P2041, DOI 10.1016/j.biomaterials.2011.11.070; Bilousova G, 2011, J INVEST DERMATOL, V131, P857, DOI 10.1038/jid.2010.364; Chen CF, 2005, J BIOL CHEM, V280, P3012, DOI 10.1074/jbc.M411522200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Couffinhal T, 2006, CIRC RES, V99, P1287, DOI 10.1161/01.RES.0000253139.82251.31; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lian X, 2012, ADV STEM CELL RES, P29; Lian X, 2012, STEM CELLS; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Memezawa A, 2007, ONCOGENE, V26, P5038, DOI 10.1038/sj.onc.1210320; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metallo CM, 2010, TISSUE ENG PT A, V16, P213, DOI [10.1089/ten.tea.2009.0325, 10.1089/ten.TEA.2009.0325]; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Orsulic S, 1999, J CELL SCI, V112, P1237; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Shalom-Feuerstein R, 2011, CELL DEATH DIFFER, V18, P887, DOI 10.1038/cdd.2010.159; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V390, P1309, DOI 10.1016/j.bbrc.2009.10.143; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	46	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60016	10.1371/journal.pone.0060016	http://dx.doi.org/10.1371/journal.pone.0060016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527294	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600111
J	Nakamura, K; Shirato, M; Ikai, H; Kanno, T; Sasaki, K; Kohno, M; Niwano, Y				Nakamura, Keisuke; Shirato, Midori; Ikai, Hiroyo; Kanno, Taro; Sasaki, Keiichi; Kohno, Masahiro; Niwano, Yoshimi			Photo-Irradiation of Proanthocyanidin as a New Disinfection Technique via Reactive Oxygen Species Formation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTION; HYDROGEN-PEROXIDE; LIPID BILAYERS; GALLATE ESTERS; TEA CATECHINS; EXTRACT; PHOTOLYSIS; RESONANCE; SYSTEM	In the present study, the bactericidal effect of photo-irradiated proanthocyanidin was evaluated in relation to reactive oxygen species formation. Staphylococcus aureus suspended in proanthocyanidin aqueous solution was irradiated with light from a laser at 405 nm. The bactericidal effect of photo-irradiated proanthocyanidin depended on the concentration of proanthocyanidin, the laser irradiation time, and the laser output power. When proanthocyanidin was used at the concentration of 1 mg/mL, the laser irradiation of the bacterial suspension could kill the bacteria with >5-log reduction of viable cell counts. By contrast, bactericidal effect was not observed when proanthocyanidin was not irradiated. In electron spin resonance analysis, reactive oxygen species, such as hydroxyl radicals, superoxide anion radicals, and hydrogen peroxide, were detected in the photo-irradiated proanthocyanidin aqueous solution. The yields of the reactive oxygen species also depended on the concentration of proanthocyanidin, the laser irradiation time, and the laser output power as is the case with the bactericidal assay. Thus, it is indicated that the bactericidal effect of photo-irradiated proanthocyanidin is exerted via the reactive oxygen species formation. The bactericidal effect as well as the yield of the oxygen radicals increased with the concentration of proanthocyanidin up to 4 mg/mL, and then decreased with the concentration. These findings suggest that the antioxidative activity of proanthocyanidin might prevail against the radical generation potency of photo-irradiated proanthocyanidin resulting in the decreased bactericidal effect when the concentration is over 4 mg/mL. The present study suggests that photo-irradiated proanthocyanidin whenever used in an optimal concentration range can be a new disinfection technique.	[Nakamura, Keisuke; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Sendai, Miyagi 980, Japan; [Shirato, Midori; Ikai, Hiroyo; Kanno, Taro; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Dept Restorat Dent, Div Fixed Prosthodont, Sendai, Miyagi 980, Japan; [Kohno, Masahiro] Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Tohoku University; Tohoku University; Tokyo Institute of Technology	Nakamura, K (corresponding author), Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Sendai, Miyagi 980, Japan.	keisuke@m.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Economy, Trade, and Industry, Japan [2010FY]; Ministry of Education, Science, Sports and Culture, Japan [24791977]	Ministry of Economy, Trade, and Industry, Japan; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially funded by Ministry of Economy, Trade, and Industry, Japan as a part of the "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs (supplementary budget, 2010FY)" and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 24791977, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Al-Habib A, 2010, J TOXICOL SCI, V35, P357, DOI 10.2131/jts.35.357; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Bors W, 2000, ARCH BIOCHEM BIOPHYS, V374, P347, DOI 10.1006/abbi.1999.1606; Bors W, 1999, FREE RADICAL BIO MED, V27, P1413, DOI 10.1016/S0891-5849(99)00187-2; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Fine A M, 2000, Altern Med Rev, V5, P144; Halliwell B., 2007, FREE RADICAL BIO MED, P30; Hatano T, 2005, PHYTOCHEMISTRY, V66, P2047, DOI 10.1016/j.phytochem.2005.01.013; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; IKIGAI H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P132, DOI 10.1016/0005-2736(93)90323-R; Iwasawa A, 2009, BIOCONTROL SCI, V14, P107, DOI 10.4265/bio.14.107; Kajiya K, 2002, BIOSCI BIOTECH BIOCH, V66, P2330, DOI 10.1271/bbb.66.2330; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Kusuda M, 2006, BIOSCI BIOTECH BIOCH, V70, P1423, DOI 10.1271/bbb.50669; Mayer R, 2008, J AGR FOOD CHEM, V56, P6959, DOI 10.1021/jf800832r; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Vermeulen N, 2008, BIOTECHNOL BIOENG, V99, P550, DOI 10.1002/bit.21611; Xu LM, 2011, FOOD CHEM, V126, P911, DOI 10.1016/j.foodchem.2010.11.075; 2003, ALTERN MED REV, V8, P442	30	20	20	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e60053	10.1371/journal.pone.0060053	http://dx.doi.org/10.1371/journal.pone.0060053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527299	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600116
J	Sakkiah, S; Arooj, M; Cao, GP; Lee, KW				Sakkiah, Sugunadevi; Arooj, Mahreen; Cao, Guang Ping; Lee, Keun Woo			Insight the C-Site Pocket Conformational Changes Responsible for Sirtuin 2 Activity Using Molecular Dynamics Simulations	PLOS ONE			English	Article							THERAPEUTIC ROLE; DEACETYLASE; INHIBITORS; ACTIVATORS; DISEASE; NICOTINAMIDE; IDENTIFY; GROMACS; TARGETS; MODELS	Sirtuin belongs to a family of typical histone deacetylase which regulates the fundamental cellular biological processes including gene expression, genome stability, mitosis, nutrient metabolism, aging, mitochondrial function, and cell motility. Michael et. al. reported that B-site mutation (Q167A and H187A) decreased the SIRT2 activity but still the structural changes were not reported. Hence, we performed 5 ns molecular dynamics (MD) simulation on SIRT2 Apo-form and complexes with substrate/NAD(+) and inhibitor of wild type (WT), Q167A, and H187A. The results revealed that the assembly and disassembly of C-site induced by presence of substrate/NAD(+) and inhibitor, respectively. This assembly and disassembly was mainly due to the interaction between the substrate/NAD(+) and inhibitor and F96 and the distance between F96 and H187 which are present at the neck of the C-site. MD simulations suggest that the conformational change of L3 plays a major role in assembly and disassembly of C-site. Our current results strongly suggest that the distinct conformational change of L3 as well as the assembly and disassembly of C-site plays an important role in SIRT2 deacetylation function. Our study unveiled the structural changes of SIRT2 in presence of NAD(+) and inhibitor which should be helpful to improve the inhibitory potency of SIRT2.	[Sakkiah, Sugunadevi; Arooj, Mahreen; Cao, Guang Ping; Lee, Keun Woo] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, SSAC,PMBBRC,RINS, Jinju, South Korea; [Sakkiah, Sugunadevi] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Sakkiah, Sugunadevi] Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Kwangju, South Korea	Gyeongsang National University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Lee, KW (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, SSAC,PMBBRC,RINS, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Arooj, Mahreen/0000-0003-1975-5289; Sakkiah, Suguna Devi/0000-0002-8337-9348	Management of Climate Change Program through National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ008038]	Management of Climate Change Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen21 Program from Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Management of Climate Change Program (2010-0029084) through that National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delano W. L., 2004, PYMOL USERS GUIDE; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Outeiro TF, 2008, BBA-MOL BASIS DIS, V1782, P363, DOI 10.1016/j.bbadis.2008.02.010; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paul ES, 1994, J CHEM PHYS, V100, P3169; Sakkiah S, PLOS ONE IN PRESS; Sakkiah S, 2012, CHEM BIOL DRUG DES, V80, P315, DOI 10.1111/j.1747-0285.2012.01406.x; Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026; Sakkiah S, 2012, J MOL STRUCT, V1011, P66, DOI 10.1016/j.molstruc.2011.08.037; Sakkiah S, 2009, B KOREAN CHEM SOC, V30, P1152; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; SCHREIBER H, 1992, J MOL BIOL, V228, P909, DOI 10.1016/0022-2836(92)90874-J; SMELLIE A, 1995, J COMPUT CHEM, V16, P171, DOI 10.1002/jcc.540160205; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1987, GRONINGEN MOLECULAR; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Yoshida T, 2009, BBA-PROTEINS PROTEOM, V1794, P1693, DOI 10.1016/j.bbapap.2009.08.004; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	52	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59278	10.1371/journal.pone.0059278	http://dx.doi.org/10.1371/journal.pone.0059278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527151	Green Published, gold			2022-12-27	WOS:000317562600067
J	Di Noto, P; Uta, S; DeSouza, JFX				Di Noto, Paula; Uta, Sorin; DeSouza, Joseph F. X.			Eye Exercises Enhance Accuracy and Letter Recognition, but Not Reaction Time, in a Modified Rapid Serial Visual Presentation Task	PLOS ONE			English	Article							MOVEMENTS ENHANCE; PERFORMANCE; RETRIEVAL; ACTIVATION; ATTENTION; SACCADES	Eye exercises have been prescribed to resolve a multitude of eye-related problems. However, studies on the efficacy of eye exercises are lacking, mainly due to the absence of simple assessment tools in the clinic. Because similar regions of the brain are responsible for eye movements and visual attention, we used a modified rapid serial visual presentation (RSVP) to assess any measurable effect of short-term eye exercise in improvements within these domains. In the present study, twenty subjects were equally divided into control and experimental groups, each of which performed a pre-training RSVP assessment where target letters, to which subjects were asked to respond to by pressing a spacebar, were serially and rapidly presented. Response time to target letters, accuracy of correctly responding to target letters, and correct identification of target letters in each of 12 sessions was measured. The experimental group then performed active eye exercises, while the control group performed a task that minimized eye movements for 18.5 minutes. A final post-training RSVP assessment was performed by both groups and response time, accuracy, and letter identification were compared between and within subject groups both pre- and post-training. Subjects who performed eye exercises were more accurate in responding to target letters separated by one distractor and in letter identification in the post-training RSVP assessment, while latency of responses were unchanged between and within groups. This suggests that eye exercises may prove useful in enhancing cognitive performance on tasks related to attention and memory over a very brief course of training, and RSVP may be a useful measure of this efficacy. Further research is needed on eye exercises to determine whether they are an effective treatment for patients with cognitive and eye-related disorders.	[Di Noto, Paula; DeSouza, Joseph F. X.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Di Noto, Paula; DeSouza, Joseph F. X.] York Univ, Neurosci Grad Diploma Program, Toronto, ON M3J 2R7, Canada; [Di Noto, Paula; Uta, Sorin; DeSouza, Joseph F. X.] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [DeSouza, Joseph F. X.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [DeSouza, Joseph F. X.] Canadian Act & Percept Network CAPnet, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	DeSouza, JFX (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	desouza@yorku.ca	Di Nota, Paula/AAG-1473-2019; DeSouza, Joseph FX/B-5615-2009	Di Nota, Paula/0000-0003-4282-6129; DeSouza, Joseph FX/0000-0001-6931-0849	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work has been funded by NSERC to JFXD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates WH, 1920, CURE IMPERFECT SIGHT; BRAUN D, 1992, BRAIN, V115, P1359, DOI 10.1093/brain/115.5.1359; Brunye TT, 2009, BRAIN COGNITION, V70, P279, DOI 10.1016/j.bandc.2009.03.003; Callu D, 2005, BRAIN COGNITION, V58, P217, DOI 10.1016/j.bandc.2004.11.008; Chan JL, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/conf.fnins.2010.14.00067, DOI 10.3389/CONF.FNINS.2010.14.00067]; Christman SD, 2003, NEUROPSYCHOLOGY, V17, P221, DOI 10.1037/0894-4105.17.2.221; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Crisp WH, 1950, J SCH HLTH, V20, P20, DOI [10.1111/j.1746-1561.1950.tb09725.x, DOI 10.1111/J.1746-1561.1950.TB09725.X]; Daugherty K.M., 2007, OPTOMET VISION DEV, V38, P75; Demeyer M, 2009, J VISION, V9, DOI 10.1167/9.4.28; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Di Noto PM, 2012, CEREBRAL CORTEX; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Dorris MC, 2000, J NEUROSCI, V20; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dyckman K, 2005, EXP BRAIN RES, V162, P63, DOI 10.1007/s00221-004-2105-9; Gais S, 2008, NEUROBIOL LEARN MEM, V90, P610, DOI 10.1016/j.nlm.2008.07.016; Gallaway M, 1997, J Am Optom Assoc, V68, P81; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Helveston EM, 2005, AM J OPHTHALMOL, V140, P903, DOI 10.1016/j.ajo.2005.06.003; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; KARATZ MA, 1975, NEW YORK STATE J MED, V75, P1105; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; LASKY DI, 1990, PERCEPT MOTOR SKILL, V71, P1055, DOI 10.2466/PMS.71.7.1055-1058; LEARY PM, 1986, S AFR MED J, V70, P388; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Lyle KB, 2008, PSYCHON B REV, V15, P515, DOI 10.3758/PBR.15.3.515; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Murray RF, 2003, J OPT SOC AM A, V20, P1356, DOI 10.1364/JOSAA.20.001356; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Parker A, 2008, NEUROPSYCHOLOGY, V22, P136, DOI 10.1037/0894-4105.22.1.136; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; Rawstron JA, 2005, J PEDIAT OPHTH STRAB, V42, P82; Rodriguez SL, 2012, CAN J NEUROL SCI, V39, P196, DOI 10.1017/S0317167100013226; ROY FH, 1980, J PEDIAT OPHTH STRAB, V17, P198; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shobe ER, 2009, BRAIN COGNITION, V71, P204, DOI 10.1016/j.bandc.2009.08.017; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Thomas LE, 2006, PERCEPT PSYCHOPHYS, V68, P475, DOI 10.3758/BF03193691; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012	46	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59244	10.1371/journal.pone.0059244	http://dx.doi.org/10.1371/journal.pone.0059244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527146	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100097
J	Jokubaitis, VG; Spelman, T; Lechner-Scott, J; Barnett, M; Shaw, C; Vucic, S; Liew, D; Butzkueven, H; Slee, M				Jokubaitis, Vilija G.; Spelman, Tim; Lechner-Scott, Jeannette; Barnett, Michael; Shaw, Cameron; Vucic, Steve; Liew, Danny; Butzkueven, Helmut; Slee, Mark		Australian MSBase Study Grp	The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform	PLOS ONE			English	Article							INTERFERON BETA-1A; ADHERENCE; THERAPY; NATALIZUMAB; TRIAL	Objective: To prospectively characterise treatment persistence and predictors of treatment discontinuation in an Australian relapsing-remitting multiple sclerosis (RRMS) population. Methods: Tertiary MS treatment centres participating in the MSBase registry prospectively assessed treatment utilisation, persistence, predictors of treatment discontinuation and switch rates. Multivariable survival analyses were used to compare treatment persistence between drugs and to identify predictors of treatment discontinuation. Results: 1113 RRMS patients were studied. Patients persisted on their first disease-modifying therapy (DMT) for a median of 2.5 years. Treatment persistence on GA was shorter than on all IFN beta products (p<0.03). Younger age at treatment initiation and higher EDSS were predictive of DMT discontinuation. Patients persisted on subsequent DMTs, for 2.3 years. Patients receiving natalizumab (NAT) as a subsequent DMT persisted longer on treatment than those on IFN beta or GA (p<0.000). The primary reason for treatment discontinuation for any drug class was poor tolerability. Annualised switch or cessation rates were 9.5-12.5% for individual IFN beta products, 11.6% for GA and 4.4% for NAT. Conclusion: This multicentre MS cohort study is the first to directly compare treatment persistence on IFN beta and GA to NAT. We report that treatment persistence in our Australian RRMS population is short, although patients receiving IFN beta as a first DMT persisted longer on treatment than those on GA. Additionally, patients receiving NAT as a subsequent DMT were more likely to persist on treatment than those switched to IFN beta or GA. EDSS and age at DMT initiation were predictive of DMT discontinuation. Treatment intolerance was the principal reason for treatment cessation.	[Jokubaitis, Vilija G.; Liew, Danny; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne Brain Ctr RMH, Parkville, Vic 3052, Australia; [Jokubaitis, Vilija G.; Spelman, Tim; Butzkueven, Helmut] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Lechner-Scott, Jeannette] John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia; [Lechner-Scott, Jeannette] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Barnett, Michael] Brain Mind Res Inst, Sydney, NSW, Australia; [Shaw, Cameron] Geelong Hosp, Dept Neurosci, Geelong, Vic, Australia; [Vucic, Steve] Westmead Hosp, Dept Neurol, Westmead, NSW 2145, Australia; [Butzkueven, Helmut] Monash Univ, Dept Neurol, Box Hill Hosp, Box Hill, Vic, Australia; [Slee, Mark] Flinders Univ & Med Ctr, Adelaide, SA, Australia	University of Melbourne; Royal Melbourne Hospital; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Sydney; Geelong Hospital; University of Sydney; Box Hill Hospital; Monash University; Flinders University South Australia	Jokubaitis, VG (corresponding author), Univ Melbourne, Dept Med, Melbourne Brain Ctr RMH, Parkville, Vic 3052, Australia.	vilija.jokubaitis@unimelb.edu.au	Jokubaitis, Vilija G./AAD-5949-2019; Slee, Mark/J-4731-2015	Jokubaitis, Vilija G./0000-0002-3942-4340; Slee, Mark/0000-0003-4323-2453; Butzkueven, Helmut/0000-0003-3940-8727; Liew, Danny/0000-0002-0131-623X; Vucic, Steve/0000-0002-8323-873X; Lechner-Scott, Jeannette/0000-0002-3850-447X; Kilpatrick, Trevor/0000-0003-3999-085X	MSBase Foundation; Merck Serono; Biogen Idec; Novartis Pharma; Genzyme; CSL; Novartis Australia; Bayer Schering; Sanofi; Teva	MSBase Foundation; Merck Serono(Merck & Company); Biogen Idec(Biogen); Novartis Pharma; Genzyme(Sanofi-AventisGenzyme Corporation); CSL; Novartis Australia(Novartis); Bayer Schering(Bayer AG); Sanofi; Teva(Teva Pharmaceutical Industries)	This study was sponsored by the MSBase Foundation, a not-for-profit organisation. The MSBase Foundation receives financial support from Merck Serono, Biogen Idec, Novartis Pharma, Genzyme and CSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Jokubaitis reports no disclosures. Dr Spelman has received a travel grant from Novartis Australia. Dr Lechner-Scott's institution receives non-directed funding as well as honoraria for presentations and membership on advisory boards from CSL, Genzyme, Biogen Idec, Bayer Health Care, Merck Serono and Novartis Australia. Dr Barnett has received research support and/or honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis Pharma, Sanofi and Teva. Dr Shaw reports no disclosures. Dr Vucic serves on the scientific advisory board from Novartis Pharma, Merck Serono Australia and Bayer Schering Australia. Dr Vucic serves as a medical consultant for Merck Serono Australia. Dr Liew has received honoraria from Novartis and Sanofi. Dr Butzkueven has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi and has received conference travel support from Novartis, Biogen Idec and Sanofi. He serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. Dr Butzkueven has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. He is on the editorial board of Multiple Sclerosis International. Dr Slee reports participating in advisory boards for Sanofi, Merck Serono, Biogen Idec, Novartis Pharma and Bayer Schering. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Dor A, 2010, ADV HEALTH ECON HEAL, V22, P175, DOI 10.1108/S0731-2199(2010)0000022011; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Kappos L, 2006, NEUROLOGY, V67, P944, DOI 10.1212/01.wnl.0000237994.95410.ce; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; Meyniel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038661; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Miller AE, 2012, CURR OPIN NEUROL, V25, pS4, DOI 10.1097/01.wco.0000413319.87092.19; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Mohr DC, 1999, MULT SCLER, V5, P192, DOI 10.1191/135245899678846069; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds Matthew W, 2010, J Med Econ, V13, P90, DOI 10.3111/13696990903579501; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Wong J, 2011, CAN J NEUROL SCI, V38, P429, DOI 10.1017/S0317167100011823; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, 2008, ATL MULT SCLER RES W; Zhang J, 2011, CURR RHEUMATOL REP, V13, P273, DOI 10.1007/s11926-011-0168-8	23	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59694	10.1371/journal.pone.0059694	http://dx.doi.org/10.1371/journal.pone.0059694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527252	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100159
J	Roth, BL; Gibbons, S; Arunotayanun, W; Huang, XP; Setola, V; Treble, R; Iversen, L				Roth, Bryan L.; Gibbons, Simon; Arunotayanun, Warunya; Huang, Xi-Ping; Setola, Vincent; Treble, Ric; Iversen, Les			The Ketamine Analogue Methoxetamine and 3-and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor	PLOS ONE			English	Article								In this paper we determined the pharmacological profiles of novel ketamine and phencyclidine analogues currently used as 'designer drugs' and compared them to the parent substances via the resources of the National Institute of Mental Health Psychoactive Drug Screening Program. The ketamine analogues methoxetamine ((RS)-2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone) and 3-MeO-PCE (N-ethyl-1-(3-methoxyphenyl)cyclohexanamine) and the 3- and 4-methoxy analogues of phencyclidine, (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine and 1-[1-(4-methoxyphenyl) cyclohexyl] piperidine), were all high affinity ligands for the PCP-site on the glutamate NMDA receptor. In addition methoxetamine and PCP and its analogues displayed appreciable affinities for the serotonin transporter, whilst the PCP analogues exhibited high affinities for sigma receptors. Antagonism of the NMDA receptor is thought to be the key pharmacological feature underlying the actions of dissociative anaesthetics. The novel ketamine and PCP analogues had significant affinities for the NMDA receptor in radioligand binding assays, which may explain their psychotomimetic effects in human users. Additional actions on other targets could be important for delineating side-effects.	[Roth, Bryan L.; Huang, Xi-Ping; Setola, Vincent] Univ N Carolina, Chapel Hill Med Sch, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC USA; [Roth, Bryan L.; Huang, Xi-Ping; Setola, Vincent] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Gibbons, Simon; Arunotayanun, Warunya] UCL Sch Pharm, Dept Pharmaceut & Biol Chem, London, England; [Treble, Ric] LGC Forens, London, England; [Iversen, Les] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; University of Oxford	Iversen, L (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	les.iversen@pharm.ox.ac.uk	Roth, Bryan L/F-3928-2010	Setola, Vincent/0000-0002-9791-2270; Gibbons, Simon/0000-0003-1587-6809; Huang, Xi-Ping/0000-0002-2585-653X	NIMH Psychoactive Drug Screening Program; UK's Forensic Early Warning System; NIMH-PDSP [HHSN-271-2008-00025-C]	NIMH Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UK's Forensic Early Warning System; NIMH-PDSP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by the NIMH Psychoactive Drug Screening Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Production of analytical reference standards for 3-methoxy-PCP and 3-methoxy-PCE was funded by the UK's Forensic Early Warning System and the authors thank the UK Home Office Centre for Applied Science and Technology for permission to use these materials in this study. The NIMH-PDSP is supported by Contract # HHSN-271-2008-00025-C.	ACMD U. A. C. o. t. M. o. D, 2012, STAT EV METH; Advisory Council on the Misuse of Drugs (ACMD), 2011, CONS NOV PSYCH SUBST; Ahmadi A, 2011, ARZNEIMITTELFORSCH, V61, P296, DOI 10.1055/s-0031-1296202; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bey Tareg, 2007, Cal J Emerg Med, V8, P9; Casale J., 2011, MICROGRAM J, V8, P39; CHAUDIEU I, 1989, PHARMACOL BIOCHEM BE, V32, P699, DOI 10.1016/0091-3057(89)90020-8; Corazza O, 2012, HUM PSYCHOPHARM CLIN, V27, P145, DOI 10.1002/hup.1242; Dolgin E, 2013, NAT MED, V19, P8, DOI 10.1038/nm0113-8; EMCDDA, 2011, ANN REP 2010 2011 EM; Hofer KE, 2012, ANN EMERG MED, V60, P97, DOI 10.1016/j.annemergmed.2011.11.018; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646; Joannes T, 1994, LETT DRUG DES DISCOV, V7, P79; KALIR A, 1984, J MED CHEM, V27, P1267, DOI 10.1021/jm00376a006; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Moghaddam B, 2011, NEUROPSYCHOPHARMACOL; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Nishimura F, 1999, NEUROSCI LETT, V274, P131; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shields JE, 2012, CLIN TOXICOL, V50, P438, DOI 10.3109/15563650.2012.683437; Wood DM, 2012, EUR J CLIN PHARMACOL, V68, P853, DOI 10.1007/s00228-011-1199-9; Zarantonello P, 2011, BIOORG MED CHEM LETT, V21, P2059, DOI 10.1016/j.bmcl.2011.02.009; Zolkowska D, 2009, J PHARM EXP THER; Zukin SR, 1991, REV PSYCHIAT, P480	26	117	120	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59334	10.1371/journal.pone.0059334	http://dx.doi.org/10.1371/journal.pone.0059334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527166	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100111
J	Gautam, M; Mathur, A; Khan, MA; Majumdar, SS; Rai, U				Gautam, Mukesh; Mathur, Amitabh; Khan, Meraj Alam; Majumdar, Subeer S.; Rai, Umesh			Transcriptome Analysis of Spermatogenically Regressed, Recrudescent and Active Phase Testis of Seasonally Breeding Wall Lizards Hemidactylus flaviviridis	PLOS ONE			English	Article							NUCLEAR FACTOR-I; GENE-EXPRESSION; SQUAMATE REPTILES; BINDING PROTEIN; SERTOLI-CELLS; IDENTIFICATION; FAMILY; DIFFERENTIATION; ACTIVATION; COMPONENT	Background: Reptiles are phylogenically important group of organisms as mammals have evolved from them. Wall lizard testis exhibits clearly distinct morphology during various phases of a reproductive cycle making them an interesting model to study regulation of spermatogenesis. Studies on reptile spermatogenesis are negligible hence this study will prove to be an important resource. Methodology/Principal Findings: Histological analyses show complete regression of seminiferous tubules during regressed phase with retracted Sertoli cells and spermatognia. In the recrudescent phase, regressed testis regain cellular activity showing presence of normal Sertoli cells and developing germ cells. In the active phase, testis reaches up to its maximum size with enlarged seminiferous tubules and presence of sperm in seminiferous lumen. Total RNA extracted from whole testis of regressed, recrudescent and active phase of wall lizard was hybridized on Mouse Whole Genome 8660 K format gene chip. Microarray data from regressed phase was deemed as control group. Microarray data were validated by assessing the expression of some selected genes using Quantitative Real-Time PCR. The genes prominently expressed in recrudescent and active phase testis are cytoskeleton organization GO 0005856, cell growth GO 0045927, GTpase regulator activity GO: 0030695, transcription GO: 0006352, apoptosis GO: 0006915 and many other biological processes. The genes showing higher expression in regressed phase belonged to functional categories such as negative regulation of macromolecule metabolic process GO: 0010605, negative regulation of gene expression GO: 0010629 and maintenance of stem cell niche GO: 0045165. Conclusion/Significance: This is the first exploratory study profiling transcriptome of three drastically different conditions of any reptilian testis. The genes expressed in the testis during regressed, recrudescent and active phase of reproductive cycle are in concordance with the testis morphology during these phases. This study will pave the way for deeper insight into regulation and evolution of gene regulatory mechanisms in spermatogenesis.	[Gautam, Mukesh; Mathur, Amitabh; Rai, Umesh] Univ Delhi, Dept Zool, Comparat Immunoendocrinol Lab, Delhi 110007, India; [Majumdar, Subeer S.] Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi 110067, India; [Khan, Meraj Alam] All India Inst Med Sci, Dept Physiol, New Delhi, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); All India Institute of Medical Sciences (AIIMS) New Delhi	Rai, U (corresponding author), Univ Delhi, Dept Zool, Comparat Immunoendocrinol Lab, Delhi 110007, India.	rai_u@rediffmail.com	Gautam, Mukesh/AAB-9208-2020	Gautam, Mukesh/0000-0002-6595-3051; Majumdar, Subeer/0000-0003-1724-7483	Department of Biotechnology (DBT), India [BT/PR14644/AAQ/01/448/2010]; University Grants Commission (UGC), New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); University Grants Commission (UGC), New Delhi(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by Department of Biotechnology (DBT), India, grant number BT/PR14644/AAQ/01/448/2010. MG acknowledges fellowship support from University Grants Commission (UGC), New Delhi, and AM thanks Council of Scientific and Industrial Research (CSIR), New Delhi, for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Abdelhaleem M, 2002, LEUKEMIA RES, V26, P945, DOI 10.1016/S0145-2126(02)00040-1; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bicciato S, 2003, BIOINFORMATICS, V19, P571, DOI 10.1093/bioinformatics/btg051; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; Blackburn DG, 1998, J EXP ZOOL, V282, P560; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Bunnell TM, 2010, CYTOSKELETON, V67, P564, DOI 10.1002/cm.20467; Carotta S, 2006, CELL CYCLE, V5, P2452, DOI 10.4161/cc.5.21.3396; Castilho PC, 2009, MOL ECOL, V18, P2092, DOI 10.1111/j.1365-294X.2009.04174.x; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Cheng CY, 2010, MOL CELL ENDOCRINOL, V315, P49, DOI 10.1016/j.mce.2009.08.004; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Devi YS, 2006, J CLIN ENDOCR METAB, V91, P1062, DOI 10.1210/jc.2005-2072; DIMATTEO G, 1995, CELL GROWTH DIFFER, V6, P1213; Ding BX, 2012, J BIOL CHEM, V287, P14621, DOI 10.1074/jbc.M111.301523; Eddy Sean F., 2008, V410, P81; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Gilbert DC, 2009, J PATHOL, V217, P94, DOI 10.1002/path.2436; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; He ZP, 2006, REPRODUCTION, V132, P11, DOI 10.1530/rep.1.01070; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Holmes ML, 2008, IMMUNOL CELL BIOL, V86, P47, DOI 10.1038/sj.icb.7100134; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacinto A, 2003, MECH DEVELOP, V120, P1337, DOI 10.1016/j.mod.2003.06.006; Kassahn KS, 2007, MOL ECOL, V16, P1749, DOI 10.1111/j.1365-294X.2006.03178.x; Kirchner S, 2007, ANIM GENET, V38, P319, DOI 10.1111/j.1365-2052.2007.01615.x; Kwon MS, 2009, PFLUG ARCH EUR J PHY, V459, P183, DOI 10.1007/s00424-009-0696-5; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; LEEGWATER PAJ, 1985, EMBO J, V4, P1515, DOI 10.1002/j.1460-2075.1985.tb03811.x; LOFTS B, 1964, GEN COMP ENDOCR, V4, P550, DOI 10.1016/0016-6480(64)90064-4; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lu YR, 2008, TRANSPL P, V40, P598, DOI 10.1016/j.transproceed.2008.01.029; Magnan DR, 2009, MOL GENET METAB, V97, P155, DOI 10.1016/j.ymgme.2009.02.010; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Mishra J, 2012, FERTIL STERIL, V98, P1308, DOI 10.1016/j.fertnstert.2012.07.1124; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Murphy BF, 2011, J COMP PHYSIOL B, V181, P575, DOI 10.1007/s00360-011-0584-0; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Osuna-Jimenez I, 2009, FISH SHELLFISH IMMUN, V26, P699, DOI 10.1016/j.fsi.2009.02.020; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Peltopuro P, 2010, DEV BIOL, V343, P63, DOI 10.1016/j.ydbio.2010.04.015; Rai U, 1995, EUR J MORPHOL, V33, P443; REDDY PRK, 1970, GEN COMP ENDOCR, V14, P15, DOI 10.1016/0016-6480(70)90002-X; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shah GR, 2004, CLIN TRANSPLANT, V18, P76, DOI 10.1111/j.1399-0012.2004.00223.x; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Skotheim RI, 2003, AM J PATHOL, V163, P2149, DOI 10.1016/S0002-9440(10)63571-7; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; St Pierre L, 2005, CELL MOL LIFE SCI, V62, P2679, DOI 10.1007/s00018-005-5384-9; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; Tobler J B, 2002, Bioinformatics, V18 Suppl 1, pS164; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; UNSICKER K, 1975, CELL TISSUE RES, V163, P545; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Wong YW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r72; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Yum S, 2010, COMP BIOCHEM PHYS C, V151, P51, DOI 10.1016/j.cbpc.2009.08.007; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637; Zieseniss A, 2007, CELL TISSUE RES, V327, P583, DOI 10.1007/s00441-006-0322-1	88	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58276	10.1371/journal.pone.0058276	http://dx.doi.org/10.1371/journal.pone.0058276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536792	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100040
J	Hohoff, C; Gorji, A; Kaiser, S; Willscher, E; Korsching, E; Ambree, O; Arolt, V; Lesch, KP; Sachser, N; Deckert, J; Lewejohann, L				Hohoff, Christa; Gorji, Ali; Kaiser, Sylvia; Willscher, Edith; Korsching, Eberhard; Ambree, Oliver; Arolt, Volker; Lesch, Klaus-Peter; Sachser, Norbert; Deckert, Juergen; Lewejohann, Lars			Effect of Acute Stressor and Serotonin Transporter Genotype on Amygdala First Wave Transcriptome in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PRIMARY RESPONSE GENES; SPATIAL MEMORY; KNOCKOUT MICE; RAT-BRAIN; IN-VIVO; EXPRESSION; ANXIETY; EMOTION; PLASTICITY	The most prominent brain region evaluating the significance of external stimuli immediately after their onset is the amygdala. Stimuli evaluated as being stressful actuate a number of physiological processes as an immediate stress response. Variation in the serotonin transporter gene has been associated with increased anxiety- and depression-like behavior, altered stress reactivity and adaptation, and pathophysiology of stress-related disorders. In this study the instant reactions to an acute stressor were measured in a serotonin transporter knockout mouse model. Mice lacking the serotonin transporter were verified to be more anxious than their wild-type conspecifics. Genome-wide gene expression changes in the amygdala were measured after the mice were subjected to control condition or to an acute stressor of one minute exposure to water. The dissection of amygdalae and stabilization of RNA was conducted within nine minutes after the onset of the stressor. This extremely short protocol allowed for analysis of first wave primary response genes, typically induced within five to ten minutes of stimulation, and was performed using Affymetrix GeneChip Mouse Gene 1.0 ST Arrays. RNA profiling revealed a largely new set of differentially expressed primary response genes between the conditions acute stress and control that differed distinctly between wild-type and knockout mice. Consequently, functional categorization and pathway analysis indicated genes related to neuroplasticity and adaptation in wild-types whereas knockouts were characterized by impaired plasticity and genes more related to chronic stress and pathophysiology. Our study therefore disclosed different coping styles dependent on serotonin transporter genotype even directly after the onset of stress and accentuates the role of the serotonergic system in processing stressors and threat in the amygdala. Moreover, several of the first wave primary response genes that we found might provide promising targets for future therapeutic interventions of stress-related disorders also in humans.	[Hohoff, Christa; Ambree, Oliver; Arolt, Volker] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Inst Neurophysiol, D-48149 Munster, Germany; [Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Kaiser, Sylvia; Arolt, Volker; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Willscher, Edith] Interdisciplinary Ctr Clin Res IZKF, Core Unit, Munster, Germany; [Korsching, Eberhard] Univ Munster, Inst Bioinformat, D-48149 Munster, Germany; [Lesch, Klaus-Peter; Deckert, Juergen] Univ Wurzburg, Dept Psychiat, Wurzburg, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Wurzburg	Lewejohann, L (corresponding author), Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.	ljohann@phenotyping.de	Lesch, Klaus-Peter/J-4906-2013; Lewejohann, Lars/H-3717-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Lewejohann, Lars/0000-0002-0202-4351; Kaiser, Sylvia/0000-0003-2770-7367	fund "Innovative Medical Research" of the University of Muenster Medical School [HO 2 2 05 09]; German Research Foundation (DFG) [SFB/TRR58]	fund "Innovative Medical Research" of the University of Muenster Medical School; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the fund "Innovative Medical Research" of the University of Muenster Medical School (http://campus.uni-muenster.de/360.html?&L=1) to C. H. (HO 2 2 05 09) and by a grant from the German Research Foundation (DFG; http://www.dfg.de) to N.S. and K.P.L. (SFB/TRR58, Project A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108; Ali F, 2009, GENES BRAIN BEHAV, V8, P435, DOI 10.1111/j.1601-183X.2009.00489.x; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Brent D, 2010, PHARMACOGENOMICS, V11, P793, DOI [10.2217/pgs.10.64, 10.2217/PGS.10.64]; Breuner CW, 2006, HORM METAB RES, V38, P260, DOI 10.1055/s-2006-925347; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chaouloff F, 1999, NEUROPSYCHOPHARMACOL, V21, pS28, DOI 10.1016/S0893-133X(99)00008-1; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Comings DE, 2003, AM J MED GENET B, V118B, P110, DOI 10.1002/ajmg.b.10056; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eastwood SL, 2008, NEUROPSYCHOPHARMACOL, V33, P933, DOI 10.1038/sj.npp.1301457; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erhardt A, 2008, MOL PSYCHIATR, V13, P242, DOI 10.1038/sj.mp.4002094; Fabre V, 2011, EUR NEUROPSYCHOPHARM, V21, P33, DOI 10.1016/j.euroneuro.2010.10.004; Firouzabadi N, 2012, PSYCHIAT RE IN PRESS; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Haefner S, 2008, NEUROPSYCHOBIOLOGY, V58, P154, DOI 10.1159/000182891; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heils A, 1996, J NEUROCHEM, V66, P2621; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Johnson PL, 2011, J PSYCHOPHARMACOL, V25, P26, DOI 10.1177/0269881109353464; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Lisowski P, 2013, J MOL NEUROSCI, V50, P33, DOI 10.1007/s12031-012-9850-1; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Matsuoka T, 2008, SYNAPSE, V62, P1, DOI 10.1002/syn.20455; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; MOLLER C, 1994, CELL MOL NEUROBIOL, V14, P415, DOI 10.1007/BF02088828; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Nanda SA, 2008, GENES BRAIN BEHAV, V7, P639, DOI 10.1111/j.1601-183X.2008.00401.x; Need AC, 2012, AM J HUM GE IN PRESS; Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; RILEY V, 1981, SCIENCE, V212, P1100, DOI 10.1126/science.7233204; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rouwette T, 2011, NEUROSCIENCE, V183, P15, DOI 10.1016/j.neuroscience.2011.03.054; Savchenko VL, 2011, NEUROTOX RES, V20, P226, DOI 10.1007/s12640-010-9236-5; Shekhar A, 2005, STRESS, V8, P209, DOI 10.1080/10253890500504557; Stefanis NC, 2011, GENES BRAIN BEHAV, V10, P536, DOI 10.1111/j.1601-183X.2011.00690.x; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Van den Hove D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022715; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Zhang W, 2008, GENES BRAIN BEHAV, V7, P385, DOI 10.1111/j.1601-183X.2007.00361.x	67	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58880	10.1371/journal.pone.0058880	http://dx.doi.org/10.1371/journal.pone.0058880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536833	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100098
J	Mamtani, M; Kulkarni, H; Dyer, TD; Almasy, L; Mahaney, MC; Duggirala, R; Comuzzie, AG; Blangero, J; Curran, JE				Mamtani, Manju; Kulkarni, Hemant; Dyer, Thomas D.; Almasy, Laura; Mahaney, Michael C.; Duggirala, Ravindranath; Comuzzie, Anthony G.; Blangero, John; Curran, Joanne E.			Waist Circumference Independently Associates with the Risk of Insulin Resistance and Type 2 Diabetes in Mexican American Families	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL OBESITY; METABOLIC SYNDROME; PREDICTOR; GENETICS; RATIO	Objective: In spite of the growing recognition of the specific association of waist circumference (WC) with type 2 diabetes (T2D) and insulin resistance (IR), current guidelines still use body mass index (BMI) as a tool of choice. Our objective was to determine whether WC is a better T2D predictor than BMI in family-based settings. Research Design and Methods: Using prospectively collected data on 808 individuals from 42 extended Mexican American families representing 7617.92 person-years follow-up, we examined the performance of WC and BMI as predictors of cumulative and incident risk of T2D. We used robust statistical methods that accounted for the kinships and included polygenic models, discrete trait modeling, Akaike information criterion, odds ratio (OR), relative risk (RR) and Kullback-Leibler R-2. SOLAR software was used to conduct all the data analyses. Results: We found that in multivariate polygenic models, WC was an independent predictor of cumulative (OR = 2.76, p = 0.0002) and future risk of T2D (RR = 2.15, p = 3.56x10(-9)) and outperformed BMI when compared in a head-to-head fashion. High WC (>= 94.65 cm after adjusting for age and sex) was also associated with high fasting glucose, insulin and triglyceride levels and low high-density lipoprotein levels indicating a potential association with IR. Moreover, WC was specifically and significantly associated with insulin resistant T2D (OR = 4.83, p = 1.01x10(-13)). Conclusions: Our results demonstrate the value of using WC as a screening tool of choice for future risk of T2D in Mexican American families. Also, WC is specifically associated with insulin resistant T2D.				mmamtani@txbiomedgenetics.org	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Kulkarni, Hemant/AEM-5750-2022	Curran, Joanne/0000-0002-6898-155X	National Institutes of Health (NIH) [R01 DK082610, R01 DK079169]; NIH [R01 HL045522, R37 MH059450]; National Center for Research Resources [S10 RR029392]; National Center for Research Resources of the National Institutes of Health [C06 RR013556, C06 RR017515]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515, C06RR013556, S10RR029392] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082610, R01DK079169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH059450, R44MH059450] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK082610 and R01 DK079169. Data collection for the San Antonio Family Heart Study was supported by NIH grant R01 HL045522. The development of the analytical methods and software used in this study was supported by NIH grant R37 MH059450. The AT&T Genomics Computing Center supercomputing facilities used for this work were supported in part by a gift from the AT&T Foundation and with support from the National Center for Research Resources Grant Number S10 RR029392. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants C06 RR013556 and C06 RR017515 from the National Center for Research Resources of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Appel Susan J, 2004, J Am Acad Nurse Pract, V16, P335, DOI 10.1111/j.1745-7599.2004.tb00456.x; Bardini G, 2011, DIABETIC MED, V28, P1229, DOI 10.1111/j.1464-5491.2011.03332.x; Bastarrachea RA, 2007, MED CLIN-BARCELONA, V129, P11, DOI 10.1157/13106675; Bayoumi RA, 2007, OBESITY, V15, P551, DOI 10.1038/oby.2007.555; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gao Jian-Bo, 2011, Zhonghua Nei Ke Za Zhi, V50, P474, DOI 10.3760/cma.j.issn.0578-1426.2011.06.007; Garber AJ, 2012, DIABETES OBES METAB, V14, P399, DOI 10.1111/j.1463-1326.2011.01536.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Ginter E, 2010, BRATISL MED J, V111, P134; Gonzalez-Chavez Antonio, 2011, Cir Cir, V79, P126; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; He YN, 2009, PUBLIC HEALTH NUTR, V12, P1078, DOI 10.1017/S1368980008003856; Keller U, 2006, INT J VITAM NUTR RES, V76, P172, DOI 10.1024/0300-9831.76.4.172; Kim MK, 2011, DIABETES RES CLIN PR, V93, P174, DOI 10.1016/j.diabres.2011.04.009; Korsic Mirko, 2011, Lijec Vjesn, V133, P284; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Mamtani MR, 2005, ARCH MED RES, V36, P581, DOI 10.1016/j.arcmed.2005.03.049; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Naser KA, 2006, INT J CLIN PRACT, V60, P1093, DOI 10.1111/j.1742-1241.2006.01003.x; Osei Kwame, 2003, Ethnicity & Disease, V13; Pancoska P, 2009, CTS-CLIN TRANSL SCI, V2, P413, DOI 10.1111/j.1752-8062.2009.00162.x; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Tabata S, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-1; Voruganti VS, 2008, J MOL MED, V86, P303, DOI 10.1007/s00109-007-0273-3; Wahrenberg H, 2005, BRIT MED J, V330, P1363, DOI 10.1136/bmj.38429.473310.AE; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Warren TY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110170; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x	38	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59153	10.1371/journal.pone.0059153	http://dx.doi.org/10.1371/journal.pone.0059153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536864	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100123
J	van Schalkwyk, DA; Saliba, KJ; Biagini, GA; Bray, PG; Kirk, K				van Schalkwyk, Donelly A.; Saliba, Kevin J.; Biagini, Giancarlo A.; Bray, Patrick G.; Kirk, Kiaran			Loss of pH Control in Plasmodium falciparum Parasites Subjected to Oxidative Stress	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; INTRAERYTHROCYTIC MALARIA PARASITE; VINCKEI-INFECTED MICE; HYDROGEN-PEROXIDE; DIGESTIVE VACUOLE; SACCHAROMYCES-CEREVISIAE; BUTYL HYDROPEROXIDE; HUMAN ERYTHROCYTES; HEXOSE-TRANSPORT; DAMAGE	The intraerythrocytic malaria parasite is susceptible to oxidative stress and this may play a role in the mechanism of action of some antimalarial agents. Here we show that exposure of the intraerythrocytic malaria parasite to the oxidising agent hydrogen peroxide results in a fall in the intracellular ATP level and inhibition of the parasite's V-type H+-ATPase, causing a loss of pH control in both the parasite cytosol and the internal digestive vacuole. In contrast to the V-type H+-ATPase, the parasite's digestive vacuole H+-pyrophosphatase is insensitive to hydrogen peroxide-induced oxidative stress. This work provides insights into the effects of oxidative stress on the intraerythrocytic parasite, as well as providing an alternative possible explanation for a previous report that light-induced oxidative stress causes selective lysis of the parasite's digestive vacuole.	[van Schalkwyk, Donelly A.; Saliba, Kevin J.; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Saliba, Kevin J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Biagini, Giancarlo A.; Bray, Patrick G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Australian National University; Australian National University; Liverpool School of Tropical Medicine; University of Liverpool	Kirk, K (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	kiaran.kirk@anu.edu.au	Kirk, Kiaran/C-8299-2009; Biagini, Giancarlo A/F-3449-2011; Saliba, Kevin J/C-9166-2009; van Schalkwyk, Donelly/X-6771-2019; van Schalkwyk, Donelly A/A-2499-2008	Kirk, Kiaran/0000-0002-5613-2622; Biagini, Giancarlo A/0000-0001-6356-6595; Saliba, Kevin J/0000-0003-3345-8440; van Schalkwyk, Donelly/0000-0002-7375-3439; van Schalkwyk, Donelly A/0000-0002-7375-3439	Australian National Health and Medical Research Council [585473, 418055]; Wellcome Trust; Leverhulme Trust	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust)	This work was supported by Australian National Health and Medical Research Council Grants 585473 (KJS and KK) and 418055 (KK), the Wellcome Trust (PGB) and the Leverhulme Trust (GAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Baldeck JD, 2008, CAN J MICROBIOL, V54, P868, DOI 10.1139/w08-078; Barrand MA, 2012, BIOCHEM J, V448, P389, DOI 10.1042/BJ20121050; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; CLARK IA, 1984, CLIN EXP IMMUNOL, V56, P524; CLARK IA, 1989, FREE RADICAL BIO MED, V6, P315, DOI 10.1016/0891-5849(89)90058-0; CLARK IA, 1983, INFECT IMMUN, V39, P1; CLARK IA, 1984, BRIT J HAEMATOL, V57, P479, DOI 10.1111/j.1365-2141.1984.tb02922.x; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Crespo MD, 2008, ANTIMICROB AGENTS CH, V52, P98, DOI 10.1128/AAC.00609-07; Cui L, 2012, MOL MICROBIOL, V86, P111, DOI 10.1111/j.1365-2958.2012.08180.x; DOCKRELL HM, 1984, INFECT IMMUN, V43, P451, DOI 10.1128/IAI.43.2.451-456.1984; DOCKRELL HM, 1983, INFECT IMMUN, V39, P456, DOI 10.1128/IAI.39.1.456-459.1983; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; FENG Y, 1994, J BIOL CHEM, V269, P13224; Forgac M, 1999, J BIOL CHEM, V274, P1301, DOI 10.1074/jbc.274.3.1301; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; HEDRICH R, 1989, EMBO J, V8, P2835, DOI 10.1002/j.1460-2075.1989.tb08430.x; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; Krishna S, 2000, PARASITOL TODAY, V16, P516, DOI 10.1016/S0169-4758(00)01762-2; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; KRUNGKRAI SR, 1987, T ROY SOC TROP MED H, V81, P710, DOI 10.1016/0035-9203(87)90003-4; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Osorio H, 2003, EUR J BIOCHEM, V270, P1578, DOI 10.1046/j.1432-1033.2003.03529.x; Radfar A, 2008, FREE RADICAL BIO MED, V44, P2034, DOI 10.1016/j.freeradbiomed.2008.03.010; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2004, FEBS LETT, V570, P93, DOI 10.1016/j.febslet.2004.06.032; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; SCHUPPEKOISTINEN I, 1994, EUR J BIOCHEM, V221, P1033, DOI 10.1111/j.1432-1033.1994.tb18821.x; Sherman Irwin W., 1998, P135; Silverstein SC, 1980, BASIC CLIN ASPECTS G, P70; Slavic K, 2010, MOL MICROBIOL; Spector A, 2002, EXP EYE RES, V75, P573, DOI 10.1006/exer.2002.2045; Spillman NJ, 2008, MOL BIOCHEM PARASIT, V162, P96, DOI 10.1016/j.molbiopara.2008.07.001; Tavakoli N, 2001, PLANT J, V28, P51, DOI 10.1046/j.1365-313X.2001.01130.x; van Schalkwyk DA, 2008, J PHARMACOL EXP THER, V327, P511, DOI 10.1124/jpet.108.141929; van Schalkwyk DA, 2010, BIOCHEM PHARMACOL, V79, P1291, DOI 10.1016/j.bcp.2009.12.025; Wang YL, 1998, J NEUROCHEM, V70, P646; Wissing F, 2002, J BIOL CHEM, V277, P37747, DOI 10.1074/jbc.M204845200; WOZENCRAFT AO, 1984, INFECT IMMUN, V43, P664, DOI 10.1128/IAI.43.2.664-669.1984; WOZENCRAFT AO, 1986, PARASITOLOGY, V92, P559, DOI 10.1017/S0031182000065446	58	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58933	10.1371/journal.pone.0058933	http://dx.doi.org/10.1371/journal.pone.0058933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536836	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000316251100101
J	Pandey, R; Ter Beek, A; Vischer, NOE; Smelt, JPPM; Brul, S; Manders, EMM				Pandey, Rachna; Ter Beek, Alex; Vischer, Norbert O. E.; Smelt, Jan P. P. M.; Brul, Stanley; Manders, Erik M. M.			Live Cell Imaging of Germination and Outgrowth of Individual Bacillus subtilis Spores; the Effect of Heat Stress Quantitatively Analyzed with SporeTracker	PLOS ONE			English	Article							NONPROTEOLYTIC CLOSTRIDIUM-BOTULINUM; INTERFERENCE CONTRAST MICROSCOPY; DIPICOLINIC ACID RELEASE; WET-HEAT; BACTERIAL-SPORES; SINGLE SPORES; RESISTANCE; STABILITY; HETEROGENEITY; VARIABILITY	Spore-forming bacteria are a special problem for the food industry as some of them are able to survive preservation processes. Bacillus spp. spores can remain in a dormant, stress resistant state for a long period of time. Vegetative cells are formed by germination of spores followed by a more extended outgrowth phase. Spore germination and outgrowth progression are often very heterogeneous and therefore, predictions of microbial stability of food products are exceedingly difficult. Mechanistic details of the cause of this heterogeneity are necessary. In order to examine spore heterogeneity we made a novel closed air-containing chamber for live imaging. This chamber was used to analyze Bacillus subtilis spore germination, outgrowth, as well as subsequent vegetative growth. Typically, we examined around 90 starting spores/cells for >= 4 hours per experiment. Image analysis with the purposely built program "SporeTracker" allows for automated data processing from germination to outgrowth and vegetative doubling. In order to check the efficiency of the chamber, growth and division of B. subtilis vegetative cells were monitored. The observed generation times of vegetative cells were comparable to those obtained in well-aerated shake flask cultures. The influence of a heat stress of 85 degrees C for 10 min on germination, outgrowth, and subsequent vegetative growth was investigated in detail. Compared to control samples fewer spores germinated (41.1% less) and fewer grew out (48.4% less) after the treatment. The heat treatment had a significant influence on the average time to the start of germination (increased) and the distribution and average of the duration of germination itself (increased). However, the distribution and the mean outgrowth time and the generation time of vegetative cells, emerging from untreated and thermally injured spores, were similar.	[Pandey, Rachna; Ter Beek, Alex; Smelt, Jan P. P. M.; Brul, Stanley] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Vischer, Norbert O. E.; Manders, Erik M. M.] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Manders, Erik M. M.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium	University of Amsterdam; University of Amsterdam; Ghent University	Ter Beek, A (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	A.S.TerBeek@uva.nl			European Union ERASMUS MUDUS grant [EMECW 15 India]; Dutch Foundation for Applied Sciences [STW 10431]	European Union ERASMUS MUDUS grant; Dutch Foundation for Applied Sciences	RP is supported by a European Union ERASMUS MUDUS grant (EMECW 15 India) and ATB is supported by a grant from the Dutch Foundation for Applied Sciences (STW 10431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar W, 2011, PROTEOMICS, V11, P4541, DOI 10.1002/pmic.201100003; Brul S, 2012, TRENDS FOOD SCI TECH, V27, P12, DOI 10.1016/j.tifs.2012.04.004; Coleman WH, 2010, LETT APPL MICROBIOL, V50, P507, DOI 10.1111/j.1472-765X.2010.02827.x; Cuny C, 2007, APPL ENVIRON MICROB, V73, P885, DOI 10.1128/AEM.01874-06; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Eijlander RT, 2011, CURR OPIN BIOTECH, V22, P180, DOI 10.1016/j.copbio.2010.11.009; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; Hinc K, 2006, J BACTERIOL, V188, P4373, DOI 10.1128/JB.01877-05; Hornstra LM, 2009, INT J FOOD MICROBIOL, V134, P9, DOI 10.1016/j.ijfoodmicro.2009.02.011; Hu P, 1999, J BACTERIOL, V181, P5042, DOI 10.1128/JB.181.16.5042-5050.1999; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Kort R, 2005, APPL ENVIRON MICROB, V71, P3556, DOI 10.1128/AEM.71.7.3556-3564.2005; Magge A, 2008, J BACTERIOL, V190, P4798, DOI 10.1128/JB.00477-08; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moir A, 2003, TRENDS MICROBIOL, V11, P452, DOI 10.1016/j.tim.2003.08.001; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Smelt JPPM, 2008, INT J FOOD MICROBIOL, V128, P34, DOI 10.1016/j.ijfoodmicro.2008.08.023; Stewart KAV, 2012, J BACTERIOL, V194, P3156, DOI 10.1128/JB.00405-12; Stringer SC, 2011, FOOD MICROBIOL, V28, P228, DOI 10.1016/j.fm.2010.03.003; Stringer SC, 2009, APPL ENVIRON MICROB, V75, P2712, DOI 10.1128/AEM.02572-08; Stringer SC, 2005, APPL ENVIRON MICROB, V71, P4998, DOI 10.1128/AEM.71.9.4998-5003.2005; Ter Beek A, 2008, J BACTERIOL, V190, P1751, DOI 10.1128/JB.01516-07; Ter Beek A, 2011, FOOD MICROBIOL, V28, P678, DOI 10.1016/j.fm.2010.07.003; Wang GW, 2011, APPL ENVIRON MICROB, V77, P3368, DOI 10.1128/AEM.00046-11; WARTH AD, 1980, J BACTERIOL, V143, P27, DOI 10.1128/JB.143.1.27-34.1980; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhang PF, 2011, APPL ENVIRON MICROB, V77, P4754, DOI 10.1128/AEM.00194-11; Zhang PF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3494567; Zhang PF, 2010, J BACTERIOL, V192, P3608, DOI 10.1128/JB.00345-10	32	91	93	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e58972	10.1371/journal.pone.0058972	http://dx.doi.org/10.1371/journal.pone.0058972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536843	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200011
J	Proverbio, AM; Vanutelli, ME; Adorni, R				Proverbio, Alice Mado; Vanutelli, Maria Elide; Adorni, Roberta			Can You Catch a Liar? How Negative Emotions Affect Brain Responses when Lying or Telling the Truth	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECEPTIVE RESPONSES; EXECUTIVE PROCESSES; WORKING-MEMORY; REACTION-TIME; CONFLICT; ACTIVATION; ATTENTION; PAIN	The capacity to deceive others is a complex mental skill that requires the ability to suppress truthful information. The polygraph is widely used in countries such as the USA to detect deception. However, little is known about the effects of emotional processes (such as the fear of being found guilty despite being innocent) on the physiological responses that are used to detect lies. The aim of this study was to investigate the time course and neural correlates of untruthful behavior by analyzing electrocortical indexes in response to visually presented neutral and affective questions. Affective questions included sexual, shameful or disgusting topics. A total of 296 questions that were inherently true or false were presented to 25 subjects while ERPs were recorded from 128 scalp sites. Subjects were asked to lie on half of the questions and to answer truthfully on the remaining half. Behavioral and ERP responses indicated an increased need for executive control functions, namely working memory, inhibition and task switching processes, during deceptive responses. Deceptive responses also elicited a more negative N400 over the prefrontal areas and a smaller late positivity (LP 550-750 ms) over the prefrontal and frontal areas. However, a reduction in LP amplitude was also elicited by truthful affective responses. The failure to observe a difference in LP responses across conditions likely results from emotional interference. A swLORETA inverse solution was computed on the N400 amplitude (300-400 ms) for the dishonest - honest contrast. These results showed the activation of the superior, medial, middle and inferior frontal gyri (BA9, 11, 47) and the anterior cingulate cortex during deceptive responses. Our results conclude that the N400 amplitude is a reliable neural marker of deception.	[Proverbio, Alice Mado; Vanutelli, Maria Elide; Adorni, Roberta] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Milano-Bicocca	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Adorni, Roberta/GMW-9037-2022	Adorni, Roberta/0000-0002-2851-8376; Proverbio, Alice Mado/0000-0002-5138-1523; Vanutelli, Maria Elide/0000-0001-9349-1707	University of Milano-Bicocca; "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia	University of Milano-Bicocca; "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia	This research was supported by a FAR2011 grant from the University of Milano-Bicocca to AMP. AR was supported in part by "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Ding XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048639; Dong GH, 2010, NEUROSCI LETT, V479, P1, DOI 10.1016/j.neulet.2010.05.014; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Egner T., 2011, FRONT PSYCHOL, V2, P1; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Harnsberger JD, 2009, J FORENSIC SCI, V54, P642, DOI 10.1111/j.1556-4029.2009.01026.x; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Johnson R, 2004, NEUROPSYCHOLOGIA, V42, P878, DOI 10.1016/j.neuropsychologia.2003.12.005; Johnson R, 2003, BIOL PSYCHOL, V64, P217, DOI 10.1016/j.biopsycho.2003.07.006; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee TMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012291; Lee TMC, 2009, BRAIN COGNITION, V69, P406, DOI 10.1016/j.bandc.2008.09.002; Liu X, 2008, J COGNITIVE NEUROSCI, V20, P1711, DOI 10.1162/jocn.2008.20116; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Malcolm SR, 2005, LATERALITY, V10, P103, DOI 10.1080/13576500442000274; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Meijer EH, 2009, APPL PSYCHOPHYS BIOF, V34, P221, DOI 10.1007/s10484-009-9099-9; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Notebaert L, 2011, EMOTION, V11, P81, DOI 10.1037/a0021286; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Ruff CC, 2001, NEUROIMAGE, V14, P1150, DOI 10.1006/nimg.2001.0893; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Tu S, 2009, BRAIN RES, V1247, P142, DOI 10.1016/j.brainres.2008.09.090; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2	52	12	13	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59383	10.1371/journal.pone.0059383	http://dx.doi.org/10.1371/journal.pone.0059383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536874	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200022
J	Sato, W; Fujimura, T; Kochiyama, T; Suzuki, N				Sato, Wataru; Fujimura, Tomomi; Kochiyama, Takanori; Suzuki, Naoto			Relationships among Facial Mimicry, Emotional Experience, and Emotion Recognition	PLOS ONE			English	Article							EXPRESSIONS; PERCEPTION; FACE; IMITATION; CONTAGION; NETWORK	Background: The relationships between facial mimicry and subsequent psychological processes remain unclear. We hypothesized that the congruent facial muscle activity would elicit emotional experiences and that the experienced emotion would induce emotion recognition. Methodology/Principal Findings: To test this hypothesis, we re-analyzed data collected in two previous studies. We recorded facial electromyography (EMG) from the corrugator supercilii and zygomatic major and obtained ratings on scales of valence and arousal for experienced emotions (Study 1) and for experienced and recognized emotions (Study 2) while participants viewed dynamic and static facial expressions of negative and positive emotions. Path analyses showed that the facial EMG activity consistently predicted the valence ratings for the emotions experienced in response to dynamic facial expressions. The experienced valence ratings in turn predicted the recognized valence ratings in Study 2. Conclusion: These results suggest that facial mimicry influences the sharing and recognition of emotional valence in response to others' dynamic facial expressions.	[Sato, Wataru; Kochiyama, Takanori] Kyoto Univ, Primate Res Inst, Hakubi Project, Kyoto, Aichi, Japan; [Fujimura, Tomomi] Japan Sci & Technol Agcy, ERATO, Okanoya Emot Informat Project, Wako, Saitama, Japan; [Suzuki, Naoto] Doshisha Univ, Dept Psychol, Grad Sch Letters, Kamigyo Ku, Kyoto 602, Japan	Kyoto University; Japan Science & Technology Agency (JST); Doshisha University	Sato, W (corresponding author), Kyoto Univ, Primate Res Inst, Hakubi Project, Kyoto, Aichi, Japan.	sato.wataru.4v@kyoto-u.ac.jp	Sato, Wataru/E-7503-2017; Fujimura, Tomomi/N-6040-2016	Sato, Wataru/0000-0002-5335-1272; Fujimura, Tomomi/0000-0002-4506-4337; Kochiyama, Takanori/0000-0002-4023-0674	JSPS; JSPS Funding Program for Next Generation World-Leading Researchers; Benesse Corporation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Funding Program for Next Generation World-Leading Researchers; Benesse Corporation	This study was supported by funds from the JSPS Grants-in-Aid for Scientific Research, the JSPS Funding Program for Next Generation World-Leading Researchers, and the Benesse Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The authors have read the journal's policy and have the following conflicts: This study was supported by funds from the JSPS Grants-in-Aid for Scientific Research, the JSPS Funding Program for Next Generation World-Leading Researchers, and the Benesse Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Bould E, 2008, COGNITION EMOTION, V22, P1569, DOI 10.1080/02699930801921156; Bullock HE, 1994, STRUCT EQU MODELING, V1, P253, DOI 10.1080/10705519409539977; BUSH LK, 1989, MOTIV EMOTION, V13, P31, DOI 10.1007/BF00995543; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Diamantopoulos A., 2000, INTRO STAT METHODS I, DOI DOI 10.4135/9781849209359; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Duncan O. D., 1975, INTRO STRUCTURAL EQU; Foley E, 2012, J COGNITIVE NEUROSCI, V24, P507, DOI 10.1162/jocn_a_00120; Fujimura T, 2010, INT J PSYCHOPHYSIOL, V76, P88, DOI 10.1016/j.ijpsycho.2010.02.008; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Gump BB, 1997, J PERS SOC PSYCHOL, V72, P305, DOI 10.1037/0022-3514.72.2.305; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Hatfield E., 1994, REV PERSONALITY SOCI; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lipps T., 1903, GRUNDLEGUNG ASTHETIK; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564; MULAIK SA, 1986, PHILOS SCI, V53, P313, DOI 10.1086/289320; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Nietzsche Friedrich, 1881, MORGENROTHE GEDANKEN; Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Sato W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-99; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Tan JW, 2012, J AMB INTEL HUM COMP, V3, P3, DOI 10.1007/s12652-011-0084-9; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x	46	61	64	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e57889	10.1371/journal.pone.0057889	http://dx.doi.org/10.1371/journal.pone.0057889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536774	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200002
J	Arunajadai, SG; Cheng, W				Arunajadai, Srikesh G.; Cheng, Wei			Step Detection in Single-Molecule Real Time Trajectories Embedded in Correlated Noise	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; VIRUS NS3 HELICASE; HIGH-RESOLUTION; DNA; MOTORS; MECHANISM; TRANSLOCATION; COORDINATION; PROCESSIVITY; DYNAMICS	Single-molecule real time trajectories are embedded in high noise. To extract kinetic or dynamic information of the molecules from these trajectories often requires idealization of the data in steps and dwells. One major premise behind the existing single-molecule data analysis algorithms is the Gaussian 'white' noise, which displays no correlation in time and whose amplitude is independent on data sampling frequency. This so-called 'white' noise is widely assumed but its validity has not been critically evaluated. We show that correlated noise exists in single-molecule real time trajectories collected from optical tweezers. The assumption of white noise during analysis of these data can lead to serious over-or underestimation of the number of steps depending on the algorithms employed. We present a statistical method that quantitatively evaluates the structure of the underlying noise, takes the noise structure into account, and identifies steps and dwells in a single-molecule trajectory. Unlike existing data analysis algorithms, this method uses Generalized Least Squares (GLS) to detect steps and dwells. Under the GLS framework, the optimal number of steps is chosen using model selection criteria such as Bayesian Information Criterion (BIC). Comparison with existing step detection algorithms showed that this GLS method can detect step locations with highest accuracy in the presence of correlated noise. Because this method is automated, and directly works with high bandwidth data without pre-filtering or assumption of Gaussian noise, it may be broadly useful for analysis of single-molecule real time trajectories.	[Arunajadai, Srikesh G.] Columbia Univ, Dept Biostat, New York, NY 10027 USA; [Cheng, Wei] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	Columbia University; University of Michigan System; University of Michigan	Arunajadai, SG (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10027 USA.	sarunajadai@columbia.edu; chengwe@umich.edu			National Science Foundation [CHE 1149670]; NIH [1DP2OD008693-01]; March of Dimes Foundation [5-FY10-490]; University of Michigan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008693] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); University of Michigan(University of Michigan System); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Science Foundation Faculty Early Career Development (CAREER) Award CHE 1149670 (W.C.), NIH grant 1DP2OD008693-01 (W.C.), and also in part by the March of Dimes Foundation Research Grant No. 5-FY10-490 (W.C.). W.C. thanks start-up funding support from the University of Michigan at Ann Arbor and the Ara Paul Professorship fund at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Arunajadai SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006937; Arunajadai SG, 2009, MATH BIOSCI, V220, P57, DOI 10.1016/j.mbs.2009.04.003; BLOOMFIELD P, 1975, BIOMETRIKA, V62, P121, DOI 10.1093/biomet/62.1.121; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bustamante C, 2009, COLD SPRING HARB PRO, ppdb, DOI 10.1101/pdb.ip73; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Cheng W, 2010, OPT LETT, V35, P2988, DOI 10.1364/OL.35.002988; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; De Los Rios P, 1999, PHYS REV LETT, V82, P472, DOI 10.1103/PhysRevLett.82.472; Dekker NH, 2002, P NATL ACAD SCI USA, V99, P12126, DOI 10.1073/pnas.132378799; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Gimzewski JK, 1999, SCIENCE, V283, P1683, DOI 10.1126/science.283.5408.1683; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lee G, 2012, SCIENCE, V336, P1726, DOI 10.1126/science.1216848; Lee J, 2004, BIOMETRIKA, V91, P240, DOI 10.1093/biomet/91.1.240; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Milescu LS, 2006, BIOPHYS J, V91, P3135, DOI 10.1529/biophysj.105.079517; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Mullner FE, 2010, BIOPHYS J, V99, P3684, DOI 10.1016/j.bpj.2010.09.067; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Neuman KC, 2005, J PHYS-CONDENS MAT, V17, pS3811, DOI 10.1088/0953-8984/17/47/012; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Pinheiro JC, 2009, MIXED EECTS MODELS S; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Syed S, 2010, BIOPHYS J, V99, P3696, DOI 10.1016/j.bpj.2010.09.066; Team RDC, 2012, LANG ENV STAT COMP; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	44	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59279	10.1371/journal.pone.0059279	http://dx.doi.org/10.1371/journal.pone.0059279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533612	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400049
J	Brombin, C; Diomede, L; Tudor, D; Drillet, AS; Pastori, C; Poli, E; Riva, A; Uberti-Foppa, C; Galli, M; Di Serio, C; Bomsel, M; Lopalco, L				Brombin, Chiara; Diomede, Lorenzo; Tudor, Daniela; Drillet, Anne Sophie; Pastori, Claudia; Poli, Elena; Riva, Agostino; Uberti-Foppa, Caterina; Galli, Massimo; Di Serio, Clelia; Bomsel, Morgane; Lopalco, Lucia			A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG-TERM NONPROGRESSORS; NEUTRALIZING ANTIBODIES; REGRESSION TREES; IN-VIVO; INDIVIDUALS; CLASSIFICATION; GP41; SPECIFICITY; SUPPRESSORS	This work aims at identifying a set of humoral immunologic parameters that improve prediction of the activation process in HIV patients. Starting from the well-known impact of humoral immunity in HIV infection, there is still a lack of knowledge in defining the role of the modulation of functional activity and titers of serum antibodies from early stage of infection to the development of AIDS. We propose an integrated approach that combines humoral and clinical parameters in defining the host immunity, implementing algorithms associated with virus control. A number of humoral parameters were simultaneously evaluated in a whole range of serum samples from HIV-positive patients. This issue has been afforded accounting for estimation problems typically related to "feasibility" studies where small sample size in each group and large number of parameters are jointly estimated. We used nonparametric statistical procedures to identify biomarkers in our study which included 42 subjects stratified on five different stages of HIV infection, i.e., Elite Controllers (EC), Long Term Non Progressors (LTNP), HAART, AIDS and Acute Infection (AI). The main goal of the paper is to illustrate a novel profiling method for helping to design a further confirmatory study. A set of seventeen different HIV-specific blood humoral factors were analyzed in all subjects, i.e. IgG and IgA to gp120IIIB, to gp120Bal, to whole gp41, to P1 and T20 gp41 epitopes of the MPER-HR2 region, to QARILAV gp41 epitope of the HR1 region and to CCR5; neutralization activity against five different virus strains and ADCC were also evaluated. Patients were selected on the basis of CD4 cell counts, HIV/RNA and clinical status. The Classification and Regression Trees (CART) approach has been used to uncover specific patterns of humoral parameters in different stages of HIV disease. Virus neutralization of primary virus strains and antibodies to gp41 were required to classify patients, suggesting that clinical profiles strongly rely on functional activity against HIV.	[Brombin, Chiara; Poli, Elena; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy; [Diomede, Lorenzo; Pastori, Claudia; Lopalco, Lucia] Ist Sci San Raffaele, Immunobiol HIV Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Tudor, Daniela; Drillet, Anne Sophie; Bomsel, Morgane] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Tudor, Daniela; Drillet, Anne Sophie; Bomsel, Morgane] CNRS, Joint Res Unit 8104, Paris, France; [Tudor, Daniela; Drillet, Anne Sophie; Bomsel, Morgane] Univ Paris Descartes Cite Paris Sorbonne, Entree Muqueuse VIH & Immunite Muqueuse Inst Coch, Paris, France; [Riva, Agostino] Univ Milan, Milan, Italy; [Uberti-Foppa, Caterina; Galli, Massimo] Ist Sci San Raffaele, Dept Infect Dis, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Di Serio, C (corresponding author), Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy.	diserio.clelia@hsr.it; lopalco.lucia@hsr.it	Foppa, Caterina Uberti/ABH-3089-2020; , Lopalco/AAN-2429-2020; Di Serio, Clelia/AAO-5494-2020; Bomsel, Morgane/GSN-1948-2022; Brombin, Chiara/AAB-9926-2019; Tudor, Daniela/GSN-1837-2022; GALLI, MASSIMO/L-7282-2017	Foppa, Caterina Uberti/0000-0001-5271-9138; Brombin, Chiara/0000-0002-8215-6206; Lopalco, Lucia/0000-0003-3812-1759; Riva, Agostino/0000-0003-3171-3049; GALLI, MASSIMO/0000-0001-8887-6215; Tudor, Daniela/0000-0002-8281-4600; Dangeard, Anne-Sophie/0000-0002-8974-9012; Bomsel, Morgane/0000-0002-9577-7474; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	Italian Ministry of Health; National Program on AIDS [40H15]; Bill and Melinda Gates Foundation [53030, PP1008144, 2009/05/OPP53030]	Italian Ministry of Health(Ministry of Health, Italy); National Program on AIDS; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by the Italian Ministry of Health, National Program on AIDS (grant 40H15 to LL) and the Bill and Melinda Gates Foundation (Grant 53030 to LL and PP1008144 to CP; http://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2009/05/OPP53030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmal M, 2011, J VIROL, V85, P5465, DOI 10.1128/JVI.00313-11; Attaluri PK, 2009, COMM COM INF SC, V35, P52, DOI 10.1007/978-3-642-02298-2_8; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Barassi C, 2004, BLOOD, V104, P2205, DOI 10.1182/blood-2004-06-2134; Baum Linda L, 2010, Curr HIV/AIDS Rep, V7, P11, DOI 10.1007/s11904-009-0036-6; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Breiman L., 1984, CLASSIFICATION REGRE; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; Clerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004; Coutant J, 2008, FASEB J, V22, P4338, DOI 10.1096/fj.08-113142; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Diomede L, 2012, J VIROL, V86, P4129, DOI 10.1128/JVI.06359-11; Donadoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009920; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Florese RH, 2011, VACCINE; Guyre CA, 2008, J IMMUNOL METHODS, V333, P51, DOI 10.1016/j.jim.2008.01.002; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lopalco L, 2000, J IMMUNOL, V164, P3426, DOI 10.4049/jimmunol.164.6.3426; Madec Y, 2009, JAIDS-J ACQ IMM DEF, V50, P19, DOI 10.1097/QAI.0b013e31818ce709; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Pastori C, 2006, BLOOD, V107, P4825, DOI 10.1182/blood-2005-06-2463; R Development Core Team, 2012, R LANG ENV STAT COMP; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Riedel DJ, 2009, AIDS, V23, P1955, DOI 10.1097/QAD.0b013e32832ff1ff; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Therneau T.M., 1997, TECHNICAL REPORT; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Visciano ML, 2011, VACCINE, V29, P4903, DOI 10.1016/j.vaccine.2011.05.005	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58768	10.1371/journal.pone.0058768	http://dx.doi.org/10.1371/journal.pone.0058768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533590	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400027
J	Thakral, D; Coman, MM; Bandyopadhyay, A; Martin, S; Riley, JL; Kavathas, PB				Thakral, Deepshi; Coman, Maria M.; Bandyopadhyay, Arunima; Martin, Sunil; Riley, James L.; Kavathas, Paula B.			The Human CD8 beta M-4 Isoform Dominant in Effector Memory T Cells Has Distinct Cytoplasmic Motifs That Confer Unique Properties	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-BINDING DOMAINS; ANTIGEN RECEPTOR; MOLECULAR-MECHANISM; SIGNAL-TRANSDUCTION; CORECEPTOR FUNCTION; CD8; TCR; ACTIVATION; EXPRESSION	The CD8 co-receptor influences T cell recognition and responses in both anti-tumor and anti-viral immunity. During evolution in the ancestor of humans and chimpanzees, the CD8B gene acquired two additional exons. As a result, in humans, there are four CD8 beta splice variants (M1 to M4) that differ in their cytoplasmic tails. The M-1 isoform which is the equivalent of murine CD8 beta, is predominantly expressed in naive T cells, whereas, the M-4 isoform is predominantly expressed in effector memory T cells. The characteristics of the M-4 isoform conferred by its unique 36 amino acid cytoplasmic tail are not known. In this study, we identified a dihydrophobic leucine-based receptor internalization motif in the cytoplasmic tail of M-4 that regulated its cell surface expression and downregulation after activation. Further the M-4 cytoplasmic tail was able to associate with ubiquitinated targets in 293T cells and mutations in the amino acids NPW, a potential EH domain binding site, either enhanced or inhibited the interaction. In addition, the M-4 tail was itself mono-ubiquitinated on a lysine residue in both 293T cells and a human T cell line. When peripheral blood human T cells expressed CD8 alpha beta M-4, the frequency of MIP-1 beta secreting cells responding to antigen presenting cells was two-fold higher as compared to CD8 alpha beta M-1 expressing T cells. Thus, the cytoplasmic tail of the CD8 beta M-4 isoform has unique characteristics, which likely contributed to its selective expression and function in human effector memory T cells.	[Thakral, Deepshi; Coman, Maria M.; Bandyopadhyay, Arunima; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Thakral, Deepshi; Coman, Maria M.; Bandyopadhyay, Arunima; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Martin, Sunil; Riley, James L.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Martin, Sunil; Riley, James L.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Yale University; Yale University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Kavathas, PB (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.	paula.kavathas@yale.edu		Riley, James/0000-0002-1057-576X	National Cancer Institute of the National Institutes of Health (NIH) [RO1CA48511, RO1, CA147795]; National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024139]; NATIONAL CANCER INSTITUTE [R01CA147795] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR), a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Cancer Institute of the National Institutes of Health (NIH) under award number RO1CA48511 to PBK, RO1 and CA147795 to JLR, and National Center for Research Resources (NCRR), a component of the NIH. [UL1 RR024139 to Yale CTSA]. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; Chwae YJ, 2008, IMMUNOL CELL BIOL, V86, P372, DOI 10.1038/icb.2008.5; Couedel C, 1999, J IMMUNOL, V162, P6351; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DISANTO JP, 1993, EUR J IMMUNOL, V23, P320, DOI 10.1002/eji.1830230203; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; DREXLER HG, 1987, BLUT, V54, P79, DOI 10.1007/BF00321034; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; HOU D, 1994, J BIOL CHEM, V269, P14244; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; IRIE HY, 1995, J EXP MED, V181, P1267, DOI 10.1084/jem.181.4.1267; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Kim TK, 2009, J IMMUNOL, V183, P6167, DOI 10.4049/jimmunol.0902068; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; NAKAYAMA KI, 1992, J IMMUNOL, V148, P1919; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Pang DJ, 2007, J BIOL CHEM, V282, P13884, DOI 10.1074/jbc.M701027200; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Plesa G, 2012, BLOOD, V119, P3420, DOI 10.1182/blood-2011-09-377051; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Thakral D, 2008, J IMMUNOL, V180, P7431, DOI 10.4049/jimmunol.180.11.7431; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e59374	10.1371/journal.pone.0059374	http://dx.doi.org/10.1371/journal.pone.0059374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533620	Green Published, Green Submitted, gold			2022-12-27	WOS:000316549400057
J	Hockett, KL; Burch, AY; Lindow, SE				Hockett, Kevin L.; Burch, Adrien Y.; Lindow, Steven E.			Thermo-Regulation of Genes Mediating Motility and Plant Interactions in Pseudomonas syringae	PLOS ONE			English	Article							BIOFILM FORMATION; YERSINIA-ENTEROCOLITICA; FLAGELLAR MOTILITY; SWARMING MOTILITY; PUTISOLVIN-II; PV SYRINGAE; VIRULENCE; EXPRESSION; IDENTIFICATION; TEMPERATURE	Pseudomonas syringae is an important phyllosphere colonist that utilizes flagellum-mediated motility both as a means to explore leaf surfaces, as well as to invade into leaf interiors, where it survives as a pathogen. We found that multiple forms of flagellum-mediated motility are thermo-suppressed, including swarming and swimming motility. Suppression of swarming motility occurs between 28 degrees and 30 degrees C, which coincides with the optimal growth temperature of P. syringae. Both fliC (encoding flagellin) and syfA (encoding a non-ribosomal peptide synthetase involved in syringafactin biosynthesis) were suppressed with increasing temperature. RNA-seq revealed 1440 genes of the P. syringae genome are temperature sensitive in expression. Genes involved in polysaccharide synthesis and regulation, phage and IS elements, type VI secretion, chemosensing and chemotaxis, translation, flagellar synthesis and motility, and phytotoxin synthesis and transport were generally repressed at 30 degrees C, while genes involved in transcriptional regulation, quaternary ammonium compound metabolism and transport, chaperone/heat shock proteins, and hypothetical genes were generally induced at 30 degrees C. Deletion of flgM, a key regulator in the transition from class III to class IV gene expression, led to elevated and constitutive expression of fliC regardless of temperature, but did not affect thermo-regulation of syfA. This work highlights the importance of temperature in the biology of P. syringae, as many genes encoding traits important for plant-microbe interactions were thermo-regulated.	[Hockett, Kevin L.; Burch, Adrien Y.; Lindow, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lindow, SE (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	icelab@berkeley.edu		Hockett, Kevin/0000-0002-0997-4712	Hildebrand-Laumeister fund for research in plant pathology	Hildebrand-Laumeister fund for research in plant pathology	Support for KH provided by the Hildebrand-Laumeister fund for research in plant pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; ALM RA, 1993, J BACTERIOL, V175, P4448, DOI 10.1128/JB.175.14.4448-4455.1993; Bereswill S, 1997, PHYSIOL MOL PLANT P, V51, P215, DOI 10.1006/pmpp.1997.0117; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Budde IP, 2000, MOL PLANT MICROBE IN, V13, P951, DOI 10.1094/MPMI.2000.13.9.951; Burch AY, 2012, J BACTERIOL, V194, P1287, DOI 10.1128/JB.06058-11; Burch AY, 2010, APPL ENVIRON MICROB, V76, P5363, DOI 10.1128/AEM.00592-10; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chen C, 2008, J BACTERIOL, V190, P2717, DOI 10.1128/JB.01585-07; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Chen CL, 2010, MOL MICROBIOL, V75, P29, DOI 10.1111/j.1365-2958.2009.06962.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Dubern JF, 2006, FEMS MICROBIOL LETT, V263, P169, DOI 10.1111/j.1574-6968.2006.00406.x; Dubern JF, 2005, J BACTERIOL, V187, P5967, DOI 10.1128/JB.187.17.5967-5976.2005; Dulla G. F. J., 2007, BACTERIAL BABEL BREA; Fitzsimmons LF, 2012, J BACTERIOL, V194, P4718, DOI 10.1128/JB.00596-12; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; HAEFELE DM, 1987, APPL ENVIRON MICROB, V53, P2528, DOI 10.1128/AEM.53.10.2528-2533.1987; HATTERMANN DR, 1989, PHYTOPATHOLOGY, V79, P284, DOI 10.1094/Phyto-79-284; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Horne SM, 2006, ARCH MICROBIOL, V185, P115, DOI 10.1007/s00203-005-0077-1; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jacques MA, 2005, APPL ENVIRON MICROB, V71, P2008, DOI 10.1128/AEM.71.4.2008-2015.2005; Kapatral V, 1996, MOL MICROBIOL, V19, P1061, DOI 10.1046/j.1365-2958.1996.452978.x; Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kelm O, 1997, MOL GEN GENET, V256, P72, DOI 10.1007/s004380050547; KING EO, 1954, J LAB CLIN MED, V44, P301; Kitten T, 1998, MOL MICROBIOL, V28, P917, DOI 10.1046/j.1365-2958.1998.00842.x; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HQ, 2006, FEMS MICROBIOL LETT, V265, P178, DOI 10.1111/j.1574-6968.2006.00486.x; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Lu SE, 2005, MOL PLANT MICROBE IN, V18, P324, DOI 10.1094/MPMI-18-0324; Lu SE, 2002, MOL PLANT MICROBE IN, V15, P43, DOI 10.1094/MPMI.2002.15.1.43; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; PANOPOULOS NJ, 1974, PHYTOPATHOLOGY, V64, P1389, DOI 10.1094/Phyto-64-1389; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; RAYMUNDO AK, 1981, PHYTOPATHOLOGY, V71, P45, DOI 10.1094/Phyto-71-45; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Rivero RM, 2004, PLANT BIOLOGY, V6, P702, DOI 10.1055/s-2004-821293; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P9; ROHDE JR, 1994, MOL MICROBIOL, V12, P187, DOI 10.1111/j.1365-2958.1994.tb01008.x; ROUSE DI, 1985, PHYTOPATHOLOGY, V75, P505, DOI 10.1094/Phyto-75-505; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Schonherr J, 2006, J EXP BOT, V57, P2471, DOI 10.1093/jxb/erj217; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SINDEN SL, 1971, PHYSIOL PLANT PATHOL, V1, P199, DOI 10.1016/0048-4059(71)90029-4; Smirnova A, 2001, ARCH MICROBIOL, V176, P393, DOI 10.1007/s002030100344; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; WEI ZM, 1992, J BACTERIOL, V174, P1875, DOI 10.1128/jb.174.6.1875-1882.1992; Wosten MMSM, 2010, MOL MICROBIOL, V75, P1577, DOI 10.1111/j.1365-2958.2010.07079.x; YOUNG JM, 1991, ANN APPL BIOL, V118, P283, DOI 10.1111/j.1744-7348.1991.tb05629.x	77	47	48	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59850	10.1371/journal.pone.0059850	http://dx.doi.org/10.1371/journal.pone.0059850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527276	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100169
J	Nie, YM; Liu, HD; Sun, X				Nie, Yumin; Liu, Hongde; Sun, Xiao			The Patterns of Histone Modifications in the Vicinity of Transcription Factor Binding Sites in Human Lymphoblastoid Cell Lines	PLOS ONE			English	Article							CHIP-SEQ DATA; HUMAN GENOME; REGULATORY ELEMENTS; GENE-REGULATION; DNA-BINDING; CHROMATIN; NUCLEOSOME; IDENTIFICATION; RESOLUTION; DYNAMICS	Transcription factor (TF) binding at specific DNA sequences is the fundamental step in transcriptional regulation and is highly dependent on the chromatin structure context, which may be affected by specific histone modifications and variants, known as histone marks. The lack of a global binding map for hundreds of TFs means that previous studies have focused mainly on histone marks at binding sites for several specific TFs. We therefore studied 11 histone marks around computationally-inferred and experimentally-determined TF binding sites (TFBSs), based on 164 and 34 TFs, respectively, in human lymphoblastoid cell lines. For H2A.Z, methylation of H3K4, and acetylation of H3K27 and H3K9, the mark patterns exhibited bimodal distributions and strong pairwise correlations in the 600-bp region around enriched TFBSs, suggesting that these marks mainly coexist within the two nucleosomes proximal to the TF sites. TFs competing with nucleosomes to access DNA at most binding sites, contributes to the bimodal distribution, which is a common feature of histone marks for TF binding. Mark H3K79me2 showed a unimodal distribution on one side of TFBSs and the signals extended up to 4000 bp, indicating a longer-distance pattern. Interestingly, H4K20me1, H3K27me3, H3K36me3 and H3K9me3, which were more diffuse and less enriched surrounding TFBSs, showed unimodal distributions around the enriched TFBSs, suggesting that some TFs may bind to nucleosomal DNA. Besides, asymmetrical distributions of H3K36me3 and H3K9me3 indicated that repressors might establish a repressive chromatin structure in one direction to repress gene expression. In conclusion, this study demonstrated the ranges of histone marks associated with TF binding, and the common features of these marks around the binding sites. These findings have epigenetic implications for future analysis of regulatory elements.	[Nie, Yumin; Liu, Hongde; Sun, Xiao] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Sun, X (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.	xsun@seu.edu.cn			National Basic Research Program of China [2012CB316501]; National Natural Science Foundation of China [61073141]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Basic Research Program of China (No. 2012CB316501) and the National Natural Science Foundation of China (No. 61073141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov D, 2004, J BIOL CHEM, V279, P42374, DOI 10.1074/jbc.M407235200; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dowell RD, 2010, TRENDS GENET, V26, P468, DOI 10.1016/j.tig.2010.08.005; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Ernst J, 2010, GENOME RES, V20, P526, DOI 10.1101/gr.096305.109; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Field Y, 2011, SUBCELL BIOCHEM, V52, P193, DOI 10.1007/978-90-481-9069-0_9; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Huda A, 2011, GENE, V475, P39, DOI 10.1016/j.gene.2010.12.010; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Won KJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r7; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	49	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e60002	10.1371/journal.pone.0060002	http://dx.doi.org/10.1371/journal.pone.0060002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527292	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100175
J	Nucci, M; Queiroz-Telles, F; Alvarado-Matute, T; Tiraboschi, IN; Cortes, J; Zurita, J; Guzman-Blanco, M; Santolaya, ME; Thompson, L; Sifuentes-Osornio, J; Echevarria, JI; Colombo, AL				Nucci, Marcio; Queiroz-Telles, Flavio; Alvarado-Matute, Tito; Nora Tiraboschi, Iris; Cortes, Jorge; Zurita, Jeannete; Guzman-Blanco, Manuel; Elena Santolaya, Maria; Thompson, Luis; Sifuentes-Osornio, Jose; Echevarria, Juan I.; Colombo, Arnaldo L.		Latin Amer Invasive Mycosis Networ	Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; SECULAR TRENDS; ANTIFUNGAL SUSCEPTIBILITY; EUROPEAN CONFEDERATION; SPECIES DISTRIBUTION; CARE; SURVEILLANCE; HOSPITALS; MULTICENTER; CANDIDAEMIA	Background: The epidemiology of candidemia varies depending on the geographic region. Little is known about the epidemiology of candidemia in Latin America. Methods: We conducted a 24-month laboratory-based survey of candidemia in 20 centers of seven Latin American countries. Incidence rates were calculated and the epidemiology of candidemia was characterized. Results: Among 672 episodes of candidemia, 297 (44.2%) occurred in children (23.7% younger than 1 year), 36.2% in adults between 19 and 60 years old and 19.6% in elderly patients. The overall incidence was 1.18 cases per 1,000 admissions, and varied across countries, with the highest incidence in Colombia and the lowest in Chile. Candida albicans (37.6%), C. parapsilosis (26.5%) and C. tropicalis (17.6%) were the leading agents, with great variability in species distribution in the different countries. Most isolates were highly susceptible to fluconazole, voriconazole, amphotericin B and anidulafungin. Fluconazole was the most frequent agent used as primary treatment (65.8%), and the overall 30-day survival was 59.3%. Conclusions: This first large epidemiologic study of candidemia in Latin America showed a high incidence of candidemia, high percentage of children, typical species distribution, with C. albicans, C. parapsilosis and C. tropicalis accounting for the majority of episodes, and low resistance rates.	[Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil; [Queiroz-Telles, Flavio] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Alvarado-Matute, Tito] Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; [Nora Tiraboschi, Iris] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina; [Cortes, Jorge] Univ Nacl Colombia, Dept Internal Med, Bogota, Colombia; [Zurita, Jeannete] Pontificia Univ Catolica Ecuador, Fac Med, Hosp Vozandes, Quito, Ecuador; [Guzman-Blanco, Manuel] Hosp Vargas de Caracas, Caracas, Venezuela; [Guzman-Blanco, Manuel] Ctr Med Caracas, Caracas, Venezuela; [Elena Santolaya, Maria] Univ Chile, Fac Med, Dept Pediat, Hosp Luis Calvo Mackenna, Santiago 7, Chile; [Thompson, Luis] Univ Desarrollo, Clin Alemana, Dept Med, Infect Dis Unit, Santiago, Chile; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Echevarria, Juan I.] Univ Peruana Cayetano Heredia, Dept Med, Lima, Peru; [Colombo, Arnaldo L.] Univ Fed Sao Paulo, Escola Paulista Med, Div Infect Dis, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Parana; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Universidad Nacional de Colombia; Pontificia Universidad Catolica del Ecuador; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Peruana Cayetano Heredia; Universidade Federal de Sao Paulo (UNIFESP)	Nucci, M (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil.	mnucci@hucff.ufrj.br	Colombo, Arnaldo Lopes/H-4397-2012; Colombo, Arnaldo Lopes/V-4417-2019; Nucci, Marcio/G-4515-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Cortes, Jorge/0000-0002-0882-9652; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Nucci, Marcio/0000-0003-4867-0014; Bizerra, Fernando Cesar/0000-0002-5070-1089; Rosso, Fernando/0000-0002-2684-9489	independent medical grant from Pfizer Inc.	independent medical grant from Pfizer Inc.	This study was supported by an independent medical grant from Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Antunes Ana Graciela Ventura, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P239, DOI 10.1590/S0036-46652004000500001; Aquino Valério Rodrigues, 2005, Braz J Infect Dis, V9, P411, DOI 10.1590/S1413-86702005000500009; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Chalmers C, 2011, MYCOSES, V54, pE795, DOI 10.1111/j.1439-0507.2011.02027.x; Cleveland AA, 2012, CLIN INFECT DIS, V55, P1352, DOI 10.1093/cid/cis697; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI S; Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2013, MED MYCOL, V51, P38, DOI 10.3109/13693786.2012.698024; Cordoba S, 2011, REV ARGENT MICROBIOL, V43, P176, DOI 10.1590/S0325-75412011000300003; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Howard SJ, 2011, ANTIMICROB AGENTS CH, V55, P4880, DOI 10.1128/AAC.00621-11; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Liu CY, 2010, J MICROBIOL IMMUNOL, V43, P416, DOI 10.1016/S1684-1182(10)60065-5; Moral LL, 2012, REV IBEROAM MICOL, V29, P144, DOI 10.1016/j.riam.2011.11.001; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Malani A, 2005, CLIN INFECT DIS, V41, P975, DOI 10.1086/432939; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Moretti ML, 2012, MED MYCOL; Motta AL, 2010, BRAZ J INFECT DIS, V14, P441, DOI 10.1590/S1413-86702010000500004; Nguyen MH, 1998, J INFECT DIS, V177, P425, DOI 10.1086/514193; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Passos XS, 2007, MYCOPATHOLOGIA, V163, P145, DOI 10.1007/s11046-007-0094-5; Pereira GH, 2010, MED MYCOL, V48, P839, DOI 10.3109/13693780903580121; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Poikonen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-312; Richet H, 2002, CLIN MICROBIOL INFEC, V8, P405, DOI 10.1046/j.1469-0691.2002.00446.x; Rodero L., 2005, Rev. argent. microbiol., V37, P189; Camargo TZS, 2010, AM J INFECT CONTROL, V38, P546, DOI 10.1016/j.ajic.2009.12.012; Medeiros EA, 2007, J CLIN MICROBIOL, V45, P942, DOI 10.1128/JCM.01878-06; St-Germain G, 2008, CAN J INFECT DIS MED, V19, P55, DOI 10.1155/2008/634046; Duran-Valle MT, 2012, ANTIMICROB AGENTS CH, V56, P3417, DOI 10.1128/AAC.06100-11; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Tortorano AM, 2002, J HOSP INFECT, V51, P297, DOI 10.1053/jhin.2002.1261; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zilberberg MD, 2008, INFECT CONT HOSP EP, V29, P978, DOI 10.1086/591033	42	216	235	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59373	10.1371/journal.pone.0059373	http://dx.doi.org/10.1371/journal.pone.0059373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527176	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100120
J	Gama, JA; Reis, AM; Domingues, I; Mendes-Soares, H; Matos, AM; Dionisio, F				Gama, Joao Alves; Reis, Ana Maria; Domingues, Iolanda; Mendes-Soares, Helena; Matos, Ana Margarida; Dionisio, Francisco			Temperate Bacterial Viruses as Double-Edged Swords in Bacterial Warfare	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; REPRODUCTIVE FITNESS; RIBOSOMAL-PROTEIN; SPITEFUL BEHAVIOR; COMPETITION; EVOLUTION; LYSOGENIZATION; POPULATION; MUTATIONS	It has been argued that bacterial cells may use their temperate viruses as biological weapons. For instance, a few bacterial cells among a population of lysogenic cells could release the virus and kill susceptible non-lysogenic competitors, while their clone mates would be immune. Because viruses replicate inside their victims upon infection, this process would amplify their number in the arena. Sometimes, however, temperate viruses spare recipient cells from death by establishing themselves in a dormant state inside cells. This phenomenon is called lysogenization and, for some viruses such as the lambda virus, the probability of lysogenization increases with the multiplicity of infection. Therefore, the amplification of viruses leads to conflicting predictions about the efficacy of temperate viruses as biological weapons: amplification can increase the relative advantage of clone mates of lysogens but also the likelihood of saving susceptible cells from death, because the probability of lysogenization is higher. To test the usefulness of viruses as biological weapons, we performed competition experiments between lysogenic Escherichia coli cells carrying the lambda virus and susceptible lambda-free E. coli cells, either in a structured or unstructured habitat. In structured and sometimes in unstructured habitats, the lambda virus qualitatively behaved as a "replicating toxin". However, such toxic effect of lambda viruses ceased after a few days of competition. This was due to the fact that many of initially susceptible cells became lysogenic. Massive lysogenization of susceptible cells occurred precisely under the conditions where the amplification of the virus was substantial. From then on, these cells and their descendants became immune to the lambda virus. In conclusion, if at short term bacterial cells may use temperate viruses as biological weapons, after a few days only the classical view of temperate bacterial viruses as parasitic agents prevails.	[Gama, Joao Alves; Domingues, Iolanda; Dionisio, Francisco] Gulbenkian Inst Sci, Oeiras, Portugal; [Gama, Joao Alves; Domingues, Iolanda; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1200 Lisbon, Portugal; [Reis, Ana Maria; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1200 Lisbon, Portugal; [Reis, Ana Maria; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Ctr Biodivers Funct & Integrat Genom, P-1200 Lisbon, Portugal; [Mendes-Soares, Helena] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Mendes-Soares, Helena] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Idaho; University of Idaho; Idaho; University of Idaho	Dionisio, F (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	francisco.dionisio@gmail.com	Gama, Joao/T-2905-2019; Dionisio, Francisco/A-2129-2009; Matos, Ana MFP/U-5810-2017; Reis, Ana Maria/P-6419-2015	Gama, Joao/0000-0003-0967-6616; Dionisio, Francisco/0000-0002-3653-1511; Matos, Ana MFP/0000-0002-0160-256X; Reis, Ana Maria/0000-0003-3363-5953; Mendes Soares, Helena/0000-0002-6727-4327	Fundacao para a Ciencia e Tecnologia [SFRH/BD/82375/2011, EXPL/BIA-EVF/1281/2012, PTDC/BIA-BDE/66180/2006, TECH/2007/0001]; TECT-European Science Foundation program	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); TECT-European Science Foundation program	This work was supported by Fundacao para a Ciencia e Tecnologia (http://alfa.fct.mctes.pt/): a Ph.D. fellowship to ILD (SFRH/BD/82375/2011) and projects EXPL/BIA-EVF/1281/2012, PTDC/BIA-BDE/66180/2006 and TECH/2007/0001, as well to the TECT-European Science Foundation program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 1998, TRENDS MICROBIOL, V6, P66, DOI 10.1016/S0966-842X(97)01196-7; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Brown SP, 2006, CURR BIOL, V16, P2048, DOI 10.1016/j.cub.2006.08.089; Brown SP, 2009, PHILOS T R SOC B, V364, P3157, DOI 10.1098/rstb.2009.0055; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Campbell A. M., 1996, ESCHERICHIA COLI SAL; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Chumpolkulwong N, 2004, EUR J BIOCHEM, V271, P1127, DOI 10.1111/j.1432-1033.2004.04016.x; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; DEATH A, 1993, J BACTERIOL, V175, P1475, DOI 10.1128/JB.175.5.1475-1483.1993; Dionisio F, 2002, GENETICS, V162, P1525; Dionisio F, 2007, EVOL ECOL RES, V9, P1199; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976; EDLIN G, 1975, NATURE, V255, P735, DOI 10.1038/255735a0; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Erickson M, 2009, FEMS MICROBIOL LETT, V294, P37, DOI 10.1111/j.1574-6968.2009.01554.x; Foster KR, 2000, TRENDS ECOL EVOL, V15, P469, DOI 10.1016/S0169-5347(00)01978-9; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; Gallet R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-241; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; GORDON DM, 1992, J GEN MICROBIOL, V138, P17, DOI 10.1099/00221287-138-1-17; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Iwasa Y, 1998, EVOL ECOL, V12, P785, DOI 10.1023/A:1006590431483; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; Joo J, 2006, P ROY SOC B-BIOL SCI, V273, P1843, DOI 10.1098/rspb.2006.3512; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; LECOCQ JP, 1976, MOL GEN GENET, V145, P53, DOI 10.1007/BF00331557; Li MY, 1998, SCI CHINA SER C, V41, P29, DOI 10.1007/BF02882703; LIN L, 1977, J VIROL, V21, P554, DOI 10.1128/JVI.21.2.554-559.1977; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Rozsa L, 1999, J PARASITOL, V85, P1032, DOI 10.2307/3285664; Rozsa L, 2000, OIKOS, V91, P396, DOI 10.1034/j.1600-0706.2000.910220.x; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SUMMERS WC, 2006, BACTERIOPHAGES, P3; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wiener P, 2000, ECOL LETT, V3, P122, DOI 10.1046/j.1461-0248.2000.00129.x; YATES JL, 1977, P NATL ACAD SCI USA, V74, P689, DOI 10.1073/pnas.74.2.689; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	55	42	42	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59043	10.1371/journal.pone.0059043	http://dx.doi.org/10.1371/journal.pone.0059043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536852	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100114
J	Hays, AG; Stuber, M; Hirsch, GA; Yu, J; Schar, M; Weiss, RG; Gerstenblith, G; Kelle, S				Hays, Allison G.; Stuber, Matthias; Hirsch, Glenn A.; Yu, Jing; Schaer, Michael; Weiss, Robert G.; Gerstenblith, Gary; Kelle, Sebastian			Non-Invasive Detection of Coronary Endothelial Response to Sequential Handgrip Exercise in Coronary Artery Disease Patients and Healthy Adults	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; COLD PRESSOR TEST; NITRIC-OXIDE; BLOOD-FLOW; VESSEL WALL; INTRAVASCULAR ULTRASOUND; ACUTE HYPERGLYCEMIA; ISOMETRIC-EXERCISE; BREATH-HOLD; IN-VIVO	Objectives: Our objective is to test the hypothesis that coronary endothelial function (CorEndoFx) does not change with repeated isometric handgrip (IHG) stress in CAD patients or healthy subjects. Background: Coronary responses to endothelial-dependent stressors are important measures of vascular risk that can change in response to environmental stimuli or pharmacologic interventions. The evaluation of the effect of an acute intervention on endothelial response is only valid if the measurement does not change significantly in the short term under normal conditions. Using 3.0 Tesla (T) MRI, we non-invasively compared two coronary artery endothelial function measurements separated by a ten minute interval in healthy subjects and patients with coronary artery disease (CAD). Methods: Twenty healthy adult subjects and 12 CAD patients were studied on a commercial 3.0 T whole-body MR imaging system. Coronary cross-sectional area (CSA), peak diastolic coronary flow velocity (PDFV) and blood-flow were quantified before and during continuous IHG stress, an endothelial-dependent stressor. The IHG exercise with imaging was repeated after a 10 minute recovery period. Results: In healthy adults, coronary artery CSA changes and blood-flow increases did not differ between the first and second stresses (mean % change +/- SEM, first vs. second stress CSA: 14.8%+/- 3.3% vs. 17.8%+/- 3.6%, p = 0.24; PDFV: 27.5%+/- 4.9% vs. 24.2% +/- 4.5%, p = 0.54; blood-flow: 44.3%+/- 8.3 vs. 44.8%+/- 8.1, p = 0.84). The coronary vasoreactive responses in the CAD patients also did not differ between the first and second stresses (mean % change +/- SEM, first stress vs. second stress: CSA: -6.4%+/- 2.0% vs. -5.0%+/- 2.4%, p = 0.22; PDFV: -4.0%+/- 4.6% vs. -4.2%+/- 5.3%, p = 0.83; blood-flow: -9.7%+/- 5.1% vs. -8.7%+/- 6.3%, p = 0.38). Conclusion: MRI measures of CorEndoFx are unchanged during repeated isometric handgrip exercise tests in CAD patients and healthy adults. These findings demonstrate the repeatability of noninvasive 3T MRI assessment of CorEndoFx and support its use in future studies designed to determine the effects of acute interventions on coronary vasoreactivity.	[Hays, Allison G.; Stuber, Matthias; Hirsch, Glenn A.; Weiss, Robert G.; Gerstenblith, Gary; Kelle, Sebastian] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA; [Stuber, Matthias; Yu, Jing; Schaer, Michael; Weiss, Robert G.; Gerstenblith, Gary; Kelle, Sebastian] Johns Hopkins Univ, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD 21218 USA; [Stuber, Matthias; Yu, Jing] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Stuber, Matthias] CHU Vaudois, Dept Radiol, Ctr Biomed Imaging CIBM, CH-1011 Lausanne, Switzerland; [Stuber, Matthias] Univ Lausanne, Lausanne, Switzerland; [Hirsch, Glenn A.] Univ Louisville, Dept Med, Div Cardiol, Louisville, KY 40292 USA; [Schaer, Michael] Philips Healthcare, Cleveland, OH USA; [Kelle, Sebastian] Deutsch Herzzentrum Berlin, Div Cardiol, Dept Med, Berlin, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Louisville; Philips; Philips Healthcare; German Heart Center Berlin	Kelle, S (corresponding author), Johns Hopkins Univ, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD 21218 USA.	kelle@dhzb.de	Stuber, Matthias/B-2949-2010; Schär, Michael/C-8087-2015; Kelle, Sebastian/ABH-7348-2020	Stuber, Matthias/0000-0001-9843-2028; Schär, Michael/0000-0002-7044-9941; Kelle, Sebastian/0000-0001-8105-6599	National Institutes of Health [R01-HL084186, HL61912]; Donald W. Reynolds Foundation; German Cardiac Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061912, R01HL084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; German Cardiac Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health grants R01-HL084186 and HL61912 and by the Donald W. Reynolds Foundation. Dr. Kelle is supported by a scholarship from the German Cardiac Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Bank A J, 1998, J Card Fail, V4, P193, DOI 10.1016/S1071-9164(98)80006-7; Botnar RM, 2000, CIRCULATION, V102, P2582; BROWN BG, 1984, CIRCULATION, V70, P18, DOI 10.1161/01.CIR.70.1.18; Ceriello A, 2010, DIABETIC MED, V27, P911, DOI 10.1111/j.1464-5491.2009.02928.x; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; Fayad ZA, 2000, CIRCULATION, V102, P506; Gielen Stephan, 2003, Am Heart J, V145, pE3; Gould KL, 2000, CIRCULATION, V101, P1931, DOI 10.1161/01.CIR.101.16.1931; Grassi D, 2012, HYPERTENSION, V60, P827, DOI 10.1161/HYPERTENSIONAHA.112.193995; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Green DJ, 1996, SPORTS MED, V21, P119, DOI 10.2165/00007256-199621020-00004; GREEN DJ, 1994, J APPL PHYSIOL, V77, P1829, DOI 10.1152/jappl.1994.77.4.1829; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hambrecht R, 1998, CIRCULATION, V98, P2709, DOI 10.1161/01.CIR.98.24.2709; Hays AG, 2012, CIRC-CARDIOVASC IMAG, V5, P341, DOI 10.1161/CIRCIMAGING.111.969691; Hays AG, 2010, J AM COLL CARDIOL, V56, P1657, DOI 10.1016/j.jacc.2010.06.036; Hundley WG, 1996, CIRCULATION, V93, P1502, DOI 10.1161/01.CIR.93.8.1502; Keegan J, 2004, J MAGN RESON IMAGING, V20, P953, DOI 10.1002/jmri.20208; Kelle S, 2011, AM J CARDIOL, V108, P491, DOI 10.1016/j.amjcard.2011.03.078; Kim WY, 2001, J MAGN RESON IMAGING, V14, P383, DOI 10.1002/jmri.1198; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MANNING WJ, 1993, CIRCULATION, V87, P94, DOI 10.1161/01.CIR.87.1.94; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; NABEL EG, 1988, CIRCULATION, V77, P43, DOI 10.1161/01.CIR.77.1.43; Nagel E, 1999, MAGN RESON MED, V41, P544, DOI 10.1002/(SICI)1522-2594(199903)41:3<544::AID-MRM17>3.0.CO;2-S; Nitenberg A, 2004, ATHEROSCLEROSIS, V173, P115, DOI 10.1016/j.atherosclerosis.2003.12.030; Rudolph TK, 2007, AM J CLIN NUTR, V86, P334, DOI 10.1093/ajcn/86.2.334; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Scheidegger MB, 1996, HERZ, V21, P90; Schindler TH, 2003, J AM COLL CARDIOL, V42, P814, DOI 10.1016/S0735-1097(03)00851-9; Schindler TH, 2009, EUR J NUCL MED MOL I, V36, P219, DOI 10.1007/s00259-008-0885-z; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Targonski PV, 2003, CIRCULATION, V107, P2805, DOI 10.1161/01.CIR.0000072765.93106.EE; Terashima M, 2005, J AM COLL CARDIOL, V45, P104, DOI 10.1016/j.jacc.2004.09.057; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; von Birgelen C, 2001, J AM COLL CARDIOL, V37, P1864, DOI 10.1016/S0735-1097(01)01234-7; WANG J, 1993, CIRC RES, V73, P829, DOI 10.1161/01.RES.73.5.829; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304; Woodman CR, 1997, AM J PHYSIOL-HEART C, V273, pH2575, DOI 10.1152/ajpheart.1997.273.6.H2575	43	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58047	10.1371/journal.pone.0058047	http://dx.doi.org/10.1371/journal.pone.0058047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536782	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100026
J	Kover, K; Tong, PY; Watkins, D; Clements, M; Stehno-Bittel, L; Novikova, L; Bittel, D; Kibiryeva, N; Stuhlsatz, J; Yan, Y; Ye, SQ; Moore, WV				Kover, Karen; Tong, Pei Ying; Watkins, Dara; Clements, Mark; Stehno-Bittel, Lisa; Novikova, Lesya; Bittel, Doug; Kibiryeva, Nataliya; Stuhlsatz, Jacob; Yan, Yun; Ye, Shui Qing; Moore, Wayne V.			Expression and Regulation of Nampt in Human Islets	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; GESTATIONAL DIABETES-MELLITUS; PLASMA VISFATIN; NICOTINAMIDE MONONUCLEOTIDE; INSULIN-SECRETION; GENE-EXPRESSION; SERUM VISFATIN; BETA-CELLS; GLUCOSE; PATHWAY	Nicotinamide phosphoribosyltransferase (Nampt) is a rate-limiting enzyme in the mammalian NAD+ biosynthesis of a salvage pathway and exists in 2 known forms, intracellular Nampt (iNampt) and a secreted form, extracellular Nampt (eNampt). eNampt can generate an intermediate product, nicotinamide mononucleotide (NMN), which has been reported to support insulin secretion in pancreatic islets. Nampt has been reported to be expressed in the pancreas but islet specific expression has not been adequately defined. The aim of this study was to characterize Nampt expression, secretion and regulation by glucose in human islets. Gene and protein expression of Nampt was assessed in human pancreatic tissue and isolated islets by qRT-PCR and immunofluorescence/confocal imaging respectively. Variable amounts of Nampt mRNA were detected in pancreatic tissue and isolated islets. Immunofluorescence staining for Nampt was found in the exocrine and endocrine tissue of fetal pancreas. However, in adulthood, Nampt expression was localized predominantly in beta cells. Isolated human islets secreted increasing amounts of eNampt in response to high glucose (20 mM) in a static glucose-stimulated insulin secretion assay (GSIS). In addition to an increase in eNampt secretion, exposure to 20 mM glucose also increased Nampt mRNA levels but not protein content. The secretion of eNampt was attenuated by the addition of membrane depolarization inhibitors, diazoxide and nifedipine. Islet-secreted eNampt showed enzymatic activity in a reaction with increasing production of NAD+/NADH over time. In summary, we show that Nampt is expressed in both exocrine and endocrine tissue early in life but in adulthood expression is localized to endocrine tissue. Enzymatically active eNampt is secreted by human islets, is regulated by glucose and requires membrane depolarization.	[Kover, Karen; Tong, Pei Ying; Watkins, Dara; Clements, Mark; Stuhlsatz, Jacob; Yan, Yun; Moore, Wayne V.] Childrens Mercy Hosp, Sect Endocrine Diabet, Kansas City, MO 64108 USA; [Kover, Karen; Tong, Pei Ying; Watkins, Dara; Clements, Mark; Bittel, Doug; Kibiryeva, Nataliya; Stuhlsatz, Jacob; Yan, Yun; Ye, Shui Qing; Moore, Wayne V.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Stehno-Bittel, Lisa; Novikova, Lesya] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [Bittel, Doug; Kibiryeva, Nataliya; Ye, Shui Qing] Childrens Mercy Hosp, Sect Genet Res, Kansas City, MO 64108 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital	Kover, K (corresponding author), Childrens Mercy Hosp, Sect Endocrine Diabet, Kansas City, MO 64108 USA.	kkover@cmh.edu		Clements, Mark/0000-0002-2368-0331; Stehno-Bittel, Lisa/0000-0002-8879-6124				Akturk M, 2008, J ENDOCRINOL INVEST, V31, P610, DOI 10.1007/BF03345611; Bittel DC, 2007, AM J MED GENET A, V143A, P430, DOI 10.1002/ajmg.a.31606; Bittel DC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-1; Brown JEP, 2010, J MOL ENDOCRINOL, V44, P171, DOI 10.1677/JME-09-0071; Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0; Chan TF, 2006, J SOC GYNECOL INVEST, V13, P364, DOI 10.1016/j.jsgi.2006.04.007; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Clayton H, 2001, PANCREAS, V22, P72, DOI 10.1097/00006676-200101000-00013; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Haider DG, 2006, DIABETOLOGIA, V49, P1909, DOI 10.1007/s00125-006-0303-7; Hug C, 2005, SCIENCE, V307, P366, DOI 10.1126/science.1106933; Jian WX, 2006, DIABETIC MED, V23, P967, DOI 10.1111/j.1464-5491.2006.01909.x; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Krzyzanowska K, 2006, CLIN SCI, V110, P605, DOI 10.1042/CS20050363; Lopez-Bermejo A, 2006, DIABETES, V55, P2871, DOI 10.2337/db06-0259; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; McGlothlin JR, 2005, BIOCHEM GENET, V43, P127, DOI 10.1007/s10528-005-1505-2; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Palin MF, 2008, DOMEST ANIM ENDOCRIN, V35, P58, DOI 10.1016/j.domaniend.2008.01.008; Retnakaran R, 2008, CLIN ENDOCRINOL, V69, P885, DOI 10.1111/j.1365-2265.2008.03264.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Stephens JM, 2006, CURR OPIN LIPIDOL, V17, P128, DOI 10.1097/01.mol.0000217893.77746.4b; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Tanaka M, 2007, BIOCHEM BIOPH RES CO, V359, P194, DOI 10.1016/j.bbrc.2007.05.096; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Yonezawa T, 2006, FEBS LETT, V580, P6635, DOI 10.1016/j.febslet.2006.11.014; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	35	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58767	10.1371/journal.pone.0058767	http://dx.doi.org/10.1371/journal.pone.0058767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536823	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100089
J	Wei, ZF; Tong, B; Xia, YF; Lu, Q; Chou, GX; Wang, ZT; Dai, Y				Wei, Zhi-feng; Tong, Bei; Xia, Yu-feng; Lu, Qian; Chou, Gui-xin; Wang, Zheng-tao; Dai, Yue			Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-kappa B/c-Fos/NFATc1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; BONE-RESORPTION; RADIX LINDERAE; RANKL; MAPK; MACROPHAGES; EXPRESSION; PROTEIN	Norisoboldine (NOR) is the main alkaloid constituent in the dry root of Lindera aggregata (Sims) Kosterm. (L. strychnifolia Vill.). As reported previously, orally administered NOR displayed a robust inhibition of joint bone destruction present in both mouse collagen-induced arthritis and rat adjuvant-induced arthritis with lower efficacious doses than that required for ameliorating systemic inflammation. This attracted us to assess the effects of NOR on differentiation and function of osteoclasts, primary effector cells for inflammatory bone destruction, to get insight into its anti-rheumatoid arthritis mechanisms. Both RAW264.7 cells and mouse bone marrow-derived macrophages (BMMs) were stimulated with RANKL (100 ng/mL) to establish osteoclast differentiation models. ELISA, RT-PCR, gelatin zymography, western blotting, immunoprecipitation and EMSA were used to reveal related signalling pathways. NOR (10 and 30 mu M), without significant cytotoxicity, showed significant reduction of the number of osteoclasts and the resorption pit areas, and it targeted osteoclast differentiation at the early stage. In conjunction with the anti-resorption effect of NOR, mRNA levels of cathepsin K and MMP-9 were decreased, and the activity of MMP-9 was attenuated. Furthermore, our mechanistic studies indicated that NOR obviously suppressed the ubiquitination of TRAF6, the accumulation of TRAF6-TAK1 complexes and the activation of ERK and p38 MAPK, and reduced the nuclear translocation of NF-kappa B-p65 and DNA-binding activity of NF-kappa B. However, NOR had little effect on expressions of TRAF6 or the phosphorylation and degradation of I kappa B alpha. Moreover, NOR markedly inhibited expressions of transcription factor NFATc1, but not c-Fos. Intriguingly, the subsequent nuclear translocations of c-Fos and NFATc1 were substantially down-regulated. Hence, we demonstrated for the first time that preventing the differentiation and function of osteoclasts at the early stage was an important anti-bone destruction mechanism of NOR, which might be attributed to inhibition of ubiquitination of TRAF6, the accumulation of TRAF6-TAK1 complexes and the activation of MAPKs/NF-kappa B/c-Fos/NFATc1 pathways.	[Wei, Zhi-feng; Tong, Bei; Xia, Yu-feng; Lu, Qian; Dai, Yue] China Pharmaceut Univ, State Key Lab Nat Med, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China; [Chou, Gui-xin; Wang, Zheng-tao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China	China Pharmaceutical University; Shanghai University of Traditional Chinese Medicine	Dai, Y (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China.	yuedaicpu@hotmail.com	Wang, Zhengtao/AAH-7360-2019; Tong, Bei/HGE-8171-2022	Wang, Zhengtao/0000-0003-2797-4625; 	Specialized Research Fund for the Doctoral Program of Higher Education [20090096110007]; Innovative Training Plan for Graduate Students of Jiangsu Province [CXLX12_0326]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovative Training Plan for Graduate Students of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Specialized Research Fund for the Doctoral Program of Higher Education (NO. 20090096110007), Innovative Training Plan for Graduate Students of Jiangsu Province (CXLX12_0326) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, and was partially funded by Program for Changjiang Scholars and Innovative Research Team in University (IRT1193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Berthelot JM, 2010, JOINT BONE SPINE, V77, P537, DOI 10.1016/j.jbspin.2010.04.015; Blair HC, 2006, REV ENDOCR METAB DIS, V7, P23, DOI 10.1007/s11154-006-9010-4; Blair JM, 2007, INT J BIOCHEM CELL B, V39, P1077, DOI 10.1016/j.biocel.2006.11.008; Braun T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3380; Broadhead ML, 2011, EXPERT OPIN THER TAR, V15, P169, DOI 10.1517/14728222.2011.546351; Cheng BB, 2012, FOOD CHEM TOXICOL, V50, P1610, DOI 10.1016/j.fct.2012.02.019; Chou Gui-Xin, 2005, Chinese Journal of Natural Medicines, V3, P272; Chou Guixin, 1999, Journal of Plant Resources and Environment, V8, P1; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Ishii J, 2008, J CELL BIOCHEM, V105, P896, DOI 10.1002/jcb.21886; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314; Lewiecki E Michael, 2009, Curr Rheumatol Rep, V11, P196; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Luo Y, 2010, PHYTOMEDICINE, V17, P726, DOI 10.1016/j.phymed.2010.01.013; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Ngian GS, 2010, AUST FAM PHYSICIAN, V39, P626; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Okamoto K, 2011, INT IMMUNOPHARMACOL, V11, P543, DOI 10.1016/j.intimp.2010.11.010; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2166; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Sharp JT, 2010, ARTHRIT CARE RES, V62, P537, DOI 10.1002/acr.20172; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2007, J ETHNOPHARMACOL, V111, P322, DOI 10.1016/j.jep.2006.11.031; Wei ZF, 2012, J CELL BIOCHEM, V113, P2785, DOI 10.1002/jcb.24156; Wilson TJ, 2008, CANCER RES, V68, P5803, DOI 10.1158/0008-5472.CAN-07-5889; Xu S, 2011, RHEUMATOL INT; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	41	41	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59171	10.1371/journal.pone.0059171	http://dx.doi.org/10.1371/journal.pone.0059171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536866	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100126
J	Whitehorn, J; Chau, TNB; Nguyet, NM; Kien, DTH; Quyen, NTH; Trung, DT; Pang, JX; Wills, B; Chau, NVV; Farrar, J; Hibberd, ML; Khor, CC; Simmons, CP				Whitehorn, James; Tran Nguyen Bich Chau; Nguyen Minh Nguyet; Duong Thi Hue Kien; Nguyen Than Ha Quyen; Dinh The Trung; Pang, Junxiong; Wills, Bridget; Nguyen Van Vinh Chau; Farrar, Jeremy; Hibberd, Martin L.; Khor, Chiea Chuen; Simmons, Cameron P.			Genetic Variants of MICB and PLCE1 and Associations with Non-Severe Dengue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SHOCK SYNDROME; SUSCEPTIBILITY; INFECTION; FEVER; LOCUS	Background: A recent genome-wide association study (GWAS) identified susceptibility loci for dengue shock syndrome (DSS) at MICB rs3132468 and PLCE1 rs3740360. The aim of this study was to define the extent to which MICB (rs3132468) and PLCE1 (rs3740360) were associated with less severe clinical phenotypes of pediatric and adult dengue. Methods: 3961 laboratory-confirmed dengue cases and 5968 controls were genotyped at MICB rs3132468 and PLCE1 rs3740360. Per-allele odds ratios (OR) with 95% confidence intervals (CI) were calculated for each patient cohort. Pooled analyses were performed for adults and paediatrics respectively using a fixed effects model. Results: Pooled analysis of the paediatric and adult cohorts indicated a significant association between MICB rs3132468 and dengue cases without shock (OR = 1.15; 95% CI: 1.07 -1.24; P = 0.0012). Similarly, pooled analysis of pediatric and adult cohorts indicated a significant association between dengue cases without shock and PLCE1 rs3740360 (OR = 0.92; 95% CI: 0.85 -0.99; P = 0.018). We also note significant association between both SNPs (OR = 1.48; P = 0.0075 for MICB rs3132468 and OR = 0.75, P = 0.041 for PLCE1 rs3740360) and dengue in infants. Discussion: This study confirms that the MICB rs3132468 and PLCE1 rs3740360 risk genotypes are not only associated with DSS, but are also associated with less severe clinical phenotypes of dengue, as well as with dengue in infants. These findings have implications for our understanding of dengue pathogenesis.	[Whitehorn, James] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Whitehorn, James; Tran Nguyen Bich Chau; Nguyen Minh Nguyet; Duong Thi Hue Kien; Nguyen Than Ha Quyen; Dinh The Trung; Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Pang, Junxiong; Hibberd, Martin L.; Khor, Chiea Chuen] Genome Inst Singapore, Singapore, Singapore; [Pang, Junxiong; Hibberd, Martin L.; Khor, Chiea Chuen] Natl Univ Singapore, Sch Publ Hlth, Singapore 117548, Singapore; [Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Ctr Trop Med, Oxford, England; [Nguyen Van Vinh Chau] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore	University of London; London School of Hygiene & Tropical Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Oxford; National University of Singapore; National University of Singapore	Whitehorn, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	james.whitehorn@lshtm.ac.uk	Simmons, Cameron P/ABA-3896-2021; Pang, Junxiong/AAI-5115-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Hibberd, Martin/0000-0001-8587-1849; Farrar, Jeremy/0000-0002-2700-623X; Pang, Junxiong, Vincent/0000-0002-9788-701X; Nguyen, Nguyet/0000-0002-5960-7849; Khor, Chiea Chuen/0000-0002-1128-4729; Whitehorn, James/0000-0003-0789-5954; Wills, Bridget/0000-0001-9086-8804	Wellcome Trust of Great Britain; Genome Institute of Singapore	Wellcome Trust of Great Britain(Wellcome Trust); Genome Institute of Singapore	This work was supported by the Wellcome Trust of Great Britain (www.wellcome.ac.uk) and the Genome Institute of Singapore intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Khor CC, 2011, NAT GENET; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lye DC, 2010, INT J INFECT DIS, V14, pE410, DOI 10.1016/j.ijid.2009.06.026; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5; Vasanwala FF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-212; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	21	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59067	10.1371/journal.pone.0059067	http://dx.doi.org/10.1371/journal.pone.0059067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536857	Green Published, Green Accepted, gold			2022-12-27	WOS:000316251100118
J	Zhang, Q; Zhu, YX; Zhou, WB; Gao, L; Yuan, L; Han, X				Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao			Serotonin Receptor 2C and Insulin Secretion	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELLS; PANCREATIC-ISLETS; 5-HT RECEPTORS; IN-VIVO; MICE; ACID; BIOSYNTHESIS; EXPRESSION; DOPAMINE	Type 2 diabetes mellitus (T2DM) describes a group of metabolic disorders characterized by defects in insulin secretion and insulin sensitivity. Insulin secretion from pancreatic beta-cells is an important factor in the etiology of T2DM, though the complex regulation and mechanisms of insulin secretion from beta-cells remains to be fully elucidated. High plasma levels of serotonin (5-hydroxytryptamine; 5-HT) have been reported in T2DM patients, though the potential effect on insulin secretion is unclear. However, it is known that the 5-HT receptor 2C (5-HT2CR) agonist, mCPP, decreases plasma insulin concentration in mice. As such, we aimed to investigate the expression of the 5-HT2CR in pancreatic islets of diabetic mice and the role of 5-HT2CR signaling in insulin secretion from pancreatic beta-cells. We found that 5-HT2CR expression was significantly increased in pancreatic islets of db/db mice. Furthermore, treatment with a 5-HT2CR antagonist (SB242084) increased insulin secretion from pancreatic islets isolated from db/db mice in a dose-dependent manner, but had no effect in islets from control mice. The effect of a 5-HT2CR agonist (mCPP) and antagonist (SB242084) were further studied in isolated pancreatic islets from mice and Min-6 cells. We found that mCPP significantly inhibited insulin secretion in Min-6 cells and isolated islets in a dose-dependent manner, which could be reversed by SB242084 or RNA interference against 5-HT2CR. We also treated Min-6 cells with palmitic acid for 24 h, and found that the expression of 5-HT2CR increased in a dose-dependent manner; furthermore, the inhibition of insulin secretion in Min-6 cells induced by palmitic acid could be reversed by SB242084 or RNA interference against 5-HT2CR. Taken together, our data suggests that increased expression of 5-HT2CR in pancreatic beta-cells might inhibit insulin secretion. This unique observation increases our understanding of T2DM and suggests new avenues for potential treatment.	[Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, L (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	Yuanli621@sohu.com; hanxiao@njmu.edu.cn	Zhu, Yunxia/G-6273-2014		National Basic Research Program of China (973 Program) [2011CB504003, 2012CB524901]; National Natural Science Foundation of China [30971403]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Basic Research Program of China (973 Program, 2011CB504003 and 2012CB524901, to XH, http://www.973.gov.cn), and the National Natural Science Foundation of China (30971403, http://www.nsfc.gov.cn) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Andreazzi AE, 2011, EXP DIABETES RES, DOI 10.1155/2011/947917; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Baruah MP, 2012, RECENT PATENTS ENDOC, V6, P129, DOI 10.2174/187221412800604563; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Deeney JT, 2007, FEBS LETT, V581, P4080, DOI 10.1016/j.febslet.2007.07.052; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Di Giovanni G, 2000, SYNAPSE, V35, P53, DOI 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2; Du J, 2010, PHARMAZIE, V65, P231, DOI 10.1691/ph.2010.9607; Erdmann J, 2012, HORM METAB RES, V44, P60, DOI 10.1055/s-0031-1295414; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; GRAHAMES.DG, 1967, BIOCHEM J, V105, P351, DOI 10.1042/bj1050351; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hara K, 2011, DIABETES RES CLIN PR, V94, P167, DOI 10.1016/j.diabres.2011.06.020; Harvey JA, 2004, PSYCHOPHARMACOLOGY, V172, P435, DOI 10.1007/s00213-003-1687-4; HASHIMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V841, P283, DOI 10.1016/0304-4165(85)90070-4; Hattersley AT, 2004, J CLIN INVEST, V114, P314, DOI 10.1172/jcj200422506; Hay-Schmidt A, 2000, P ROY SOC B-BIOL SCI, V267, P1071, DOI 10.1098/rspb.2000.1111; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Holness MJ, 2011, CURR DIABETES REV, V7, P336, DOI 10.2174/157339911797415602; Huang XF, 2004, MOL BRAIN RES, V127, P39, DOI 10.1016/j.molbrainres.2004.05.008; Iwasawa Takamasa, 2002, J Cardiol, V40, P19; Jiang ZE, 2011, KOREAN J PHYSIOL PHA, V15, P307, DOI 10.4196/kjpp.2011.15.5.307; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kolar J, 2005, J PINEAL RES, V39, P333, DOI 10.1111/j.1600-079X.2005.00276.x; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; LECHIN F, 1975, ACTA PHYSIOL LAT AM, V25, P339; Marchetti P, 2010, ADV EXP MED BIOL, V654, P501, DOI 10.1007/978-90-481-3271-3_22; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Nonogaki K, 2006, ENDOCRINOLOGY, V147, P5893, DOI 10.1210/en.2006-0418; Pozzi L, 2002, J NEUROCHEM, V82, P93, DOI 10.1046/j.1471-4159.2002.00947.x; PRISCO S, 1994, J PHARMACOL EXP THER, V271, P83; QUICKEL KE, 1971, ENDOCRINOLOGY, V89, P1295, DOI 10.1210/endo-89-5-1295; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Roep BO, 2007, NATURE, V450, P799, DOI 10.1038/450799a; Saini V, 2010, WORLD J DIABETES, V1, P68, DOI 10.4239/wjd.v1.i3.68; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Watanabe RLH, 2010, CELL MOL NEUROBIOL, V30, P1025, DOI 10.1007/s10571-010-9533-9; Weiger WA, 1997, BIOL REV, V72, P61, DOI 10.1017/S0006323196004975; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; ZHANG HJ, 1989, DIABETES, V38, P44, DOI 10.2337/diabetes.38.1.44; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	52	147	153	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54250	10.1371/journal.pone.0054250	http://dx.doi.org/10.1371/journal.pone.0054250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349838	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900058
J	Oliver, RE; Tinker, NA; Lazo, GR; Chao, SM; Jellen, EN; Carson, ML; Rines, HW; Obert, DE; Lutz, JD; Shackelford, I; Korol, AB; Wight, CP; Gardner, KM; Hattori, J; Beattie, AD; Bjornstad, A; Bonman, JM; Jannink, JL; Sorrells, ME; Brown-Guedira, GL; Fetch, JWM; Harrison, SA; Howarth, CJ; Ibrahim, A; Kolb, FL; McMullen, MS; Murphy, JP; Ohm, HW; Rossnagel, BG; Yan, WK; Miclaus, KJ; Hiller, J; Maughan, PJ; Hulse, RRR; Anderson, JM; Islamovic, E; Jackson, EW				Oliver, Rebekah E.; Tinker, Nicholas A.; Lazo, Gerard R.; Chao, Shiaoman; Jellen, Eric N.; Carson, Martin L.; Rines, Howard W.; Obert, Donald E.; Lutz, Joseph D.; Shackelford, Irene; Korol, Abraham B.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Beattie, Aaron D.; Bjornstad, Asmund; Bonman, J. Michael; Jannink, Jean-Luc; Sorrells, Mark E.; Brown-Guedira, Gina L.; Fetch, Jennifer W. Mitchell; Harrison, Stephen A.; Howarth, Catherine J.; Ibrahim, Amir; Kolb, Frederic L.; McMullen, Michael S.; Murphy, J. Paul; Ohm, Herbert W.; Rossnagel, Brian G.; Yan, Weikai; Miclaus, Kelci J.; Hiller, Jordan; Maughan, Peter J.; Hulse, Rachel R. Redman; Anderson, Joseph M.; Islamovic, Emir; Jackson, Eric W.			SNP Discovery and Chromosome Anchoring Provide the First Physically-Anchored Hexaploid Oat Map and Reveal Synteny with Model Species	PLOS ONE			English	Article							LINKAGE MAP; C-GENOME; MARKERS; IDENTIFICATION; MONOSOMICS; ASSIGNMENT; BARLEY	A physically anchored consensus map is foundational to modern genomics research; however, construction of such a map in oat (Avena sativa L., 2n = 6x = 42) has been hindered by the size and complexity of the genome, the scarcity of robust molecular markers, and the lack of aneuploid stocks. Resources developed in this study include a modified SNP discovery method for complex genomes, a diverse set of oat SNP markers, and a novel chromosome-deficient SNP anchoring strategy. These resources were applied to build the first complete, physically-anchored consensus map of hexaploid oat. Approximately 11,000 high-confidence in silico SNPs were discovered based on nine million inter-varietal sequence reads of genomic and cDNA origin. GoldenGate genotyping of 3,072 SNP assays yielded 1,311 robust markers, of which 985 were mapped in 390 recombinant-inbred lines from six bi-parental mapping populations ranging in size from 49 to 97 progeny. The consensus map included 985 SNPs and 68 previously-published markers, resolving 21 linkage groups with a total map distance of 1,838.8 cM. Consensus linkage groups were assigned to 21 chromosomes using SNP deletion analysis of chromosome-deficient monosomic hybrid stocks. Alignments with sequenced genomes of rice and Brachypodium provide evidence for extensive conservation of genomic regions, and renewed encouragement for orthology-based genomic discovery in this important hexaploid species. These results also provide a framework for high-resolution genetic analysis in oat, and a model for marker development and map construction in other species with complex genomes and limited resources.	[Oliver, Rebekah E.; Lutz, Joseph D.; Jackson, Eric W.] Gen Mills Crop Biosci, Kannapolis, NC USA; [Tinker, Nicholas A.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Yan, Weikai] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Lazo, Gerard R.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Jellen, Eric N.; Maughan, Peter J.; Hulse, Rachel R. Redman] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Carson, Martin L.] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Rines, Howard W.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Obert, Donald E.] Limagrain Cereal Seeds, Lafayette, IN USA; [Shackelford, Irene; Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Korol, Abraham B.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Beattie, Aaron D.; Rossnagel, Brian G.] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Saskatoon, SK S7N 0W0, Canada; [Bjornstad, Asmund; Islamovic, Emir] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Jannink, Jean-Luc] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Sorrells, Mark E.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Brown-Guedira, Gina L.] N Carolina State Univ, USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Fetch, Jennifer W. Mitchell] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Harrison, Stephen A.] Louisiana State Univ, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Howarth, Catherine J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Ibrahim, Amir] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Kolb, Frederic L.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [McMullen, Michael S.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Murphy, J. Paul] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Ohm, Herbert W.; Anderson, Joseph M.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Miclaus, Kelci J.; Hiller, Jordan] SAS Inst Inc, JMP, Cary, NC USA	Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Brigham Young University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Haifa; University of Haifa; University of Saskatchewan; Norwegian University of Life Sciences; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Agriculture & Agri Food Canada; Louisiana State University System; Louisiana State University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; North Dakota State University Fargo; University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; SAS Institute Inc	Tinker, NA (corresponding author), Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada.	Nick.Tinker@agr.gc.ca	Lazo, Gerard/A-8900-2009; Jellen, Eric/S-1166-2019; Jellen, Eric/K-4443-2019; Maughan, Peter/G-1600-2013; Columbus, Linda/F-5877-2010	Lazo, Gerard/0000-0002-9160-2052; Jellen, Eric/0000-0002-7906-4845; Jannink, Jean-Luc/0000-0003-4849-628X; Tinker, Nicholas/0000-0002-2452-4779; Brown-Guedira, Gina/0000-0002-1958-2827; Oliver, Ryan/0000-0003-4489-0861; Yan, Weikai/0000-0003-2399-1452; Howarth, Catherine/0000-0001-9364-0880; Bonman, John/0000-0002-7414-044X; Lipfert, Jan/0000-0003-3613-7896; Columbus, Linda/0000-0002-2574-0561	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project [301]; Agriculture and Agri-Food Canada; General Mills; Biotechnology and Biological Sciences Research Council [BBS/E/W/10962A01C, BBS/E/W/10962A01D, BBS/E/G/00003012, BB/H009582/1] Funding Source: researchfish; BBSRC [BBS/E/W/10962A01D, BB/H009582/1, BBS/E/W/10962A01C] Funding Source: UKRI	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); General Mills; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the United States Department of Agriculture National Food Research Initiative, the North American Millers' Association, the Prairie Oat Growers Association, General Mills Inc., the United States Department of Agriculture - Agricultural Research Service CRIS project 301, and by Agriculture and Agri-Food Canada. Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. Staff Scientists KJM and JH from SAS Institute Inc. contributed scientific input and data analysis. In no other way did the funders play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding from General Mills and the contributions of employees from General Mills, Limagrain and SAS does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. The funding from General Mills and the contributions of employees from General Mills and Limagrain does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andon MB, 2008, AM J LIFESTYLE MED, V2, P51, DOI [10.1177/1559827607309130., 10.1177/1559827607309130]; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Fox SL, 2001, THEOR APPL GENET, V102, P320, DOI 10.1007/s001220051648; Gutierrez-Gonzalez JJ, 2011, PLANT GENOME-US, V4, P178, DOI 10.3835/plantgenome2011.01.0004; HELENTJARIS T, 1986, P NATL ACAD SCI USA, V83, P6035, DOI 10.1073/pnas.83.16.6035; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Jannink JL, 2005, CROP SCI, V45, P2383, DOI 10.2135/cropsci2005.0285; JELLEN EN, 1993, GENOME, V36, P962, DOI 10.1139/g93-126; JELLEN EN, 1994, GENOME, V37, P613, DOI 10.1139/g94-087; JELLEN EN, 1993, GENOME, V36, P1129, DOI 10.1139/g93-151; Jellen EN, 1997, THEOR APPL GENET, V95, P1190, DOI 10.1007/s001220050680; Jellen EN, 2000, CROP SCI, V40, P256, DOI 10.2135/cropsci2000.401256x; Kianian SF, 1997, GENOME, V40, P386, DOI 10.1139/g97-052; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; LADIZINSKY G, 1970, HEREDITY, V25, P457, DOI 10.1038/hdy.1970.46; LEGGETT JM, 1995, GENOME, V38, P747, DOI 10.1139/g95-094; Mester DI, 2003, THEOR APPL GENET, V107, P1102, DOI 10.1007/s00122-003-1305-1; Mochida K., 2003, MGG Molecular Genetics and Genomics, V270, P371, DOI 10.1007/s00438-003-0939-7; MORIKAWA T, 1985, THEOR APPL GENET, V70, P271, DOI 10.1007/BF00304911; ODONOUGHUE LS, 1995, GENOME, V38, P368, DOI 10.1139/g95-048; Oliver RE, 2010, GENOME, V53, P458, DOI [10.1139/G10-021, 10.1139/g10-021]; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Portyanko VA, 2001, GENOME, V44, P249, DOI 10.1139/gen-44-2-249; Rajhathy T., 1974, MISC PUBL GENET SOC, V2, P1; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Sanz MJ, 2010, THEOR APPL GENET, V121, P1541, DOI 10.1007/s00122-010-1409-3; SEARS ER, 1969, ANNU REV GENET, V3, P451, DOI 10.1146/annurev.ge.03.120169.002315; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Van Ooijen JW., 2006, JOINMAP 4 SOFTWARE C, V4; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wight CP, 2003, GENOME, V46, P28, DOI [10.1139/g02-099, 10.1139/G02-099]; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]	41	99	104	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58068	10.1371/journal.pone.0058068	http://dx.doi.org/10.1371/journal.pone.0058068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533580	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400017
J	de Carvalho, AL; Nelson, BW; Bianchini, MC; Plagnol, D; Kuplich, TM; Daly, DC				de Carvalho, Anelena L.; Nelson, Bruce W.; Bianchini, Milton C.; Plagnol, Daniela; Kuplich, Tatiana M.; Daly, Douglas C.			Bamboo-Dominated Forests of the Southwest Amazon: Detection, Spatial Extent, Life Cycle Length and Flowering Waves	PLOS ONE			English	Article							TROPICAL FOREST; LONG	We map the extent, infer the life-cycle length and describe spatial and temporal patterns of flowering of sarmentose bamboos (Guadua spp) in upland forests of the southwest Amazon. We first examine the spectra and the spectral separation of forests with different bamboo life stages. False-color composites from orbital sensors going back to 1975 are capable of distinguishing life stages. These woody bamboos flower produce massive quantities of seeds and then die. Life stage is synchronized, forming a single cohort within each population. Bamboo dominates at least 161,500 km(2) of forest, coincident with an area of recent or ongoing tectonic uplift, rapid mechanical erosion and poorly drained soils rich in exchangeable cations. Each bamboo population is confined to a single spatially continuous patch or to a core patch with small outliers. Using spatial congruence between pairs of mature-stage maps from different years, we estimate an average life cycle of 27-28 y. It is now possible to predict exactly where and approximately when new bamboo mortality events will occur. We also map 74 bamboo populations that flowered between 2001 and 2008 over the entire domain of bamboo-dominated forest. Population size averaged 330 km(2). Flowering events of these populations are temporally and/or spatially separated, restricting or preventing gene exchange. Nonetheless, adjacent populations flower closer in time than expected by chance, forming flowering waves. This may be a consequence of allochronic divergence from fewer ancestral populations and suggests a long history of widespread bamboo in the southwest Amazon.	[de Carvalho, Anelena L.] Natl Inst Amazon Res, Grad Program Forest Sci, Cruzeiro Do Sul, Brazil; [Bianchini, Milton C.] Natl Inst Amazon Res, Grad Program Ecol, Inst Criminalist Amazonas IC, Dept Policia Tecn Cient DPTC Policia Civil Estado, Manaus, Amazonas, Brazil; [Nelson, Bruce W.; Plagnol, Daniela] Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil; [Kuplich, Tatiana M.] So Reg INPE CRS, Natl Inst Space Res, Santa Maria, RS, Brazil; [Daly, Douglas C.] New York Bot Garden, Bronx, NY 10458 USA	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Instituto Nacional de Pesquisas Espaciais (INPE); New York Botanical Garden	Nelson, BW (corresponding author), Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil.	bnelsonbr@gmail.com	Kuplich, Tatiana/C-6429-2013; Kuplich, Tatiana M/U-1112-2018; Nelson, Bruce/G-4562-2013; Gomes de Carvalho, Andre Luiz/M-9503-2017; Fernandes, Daniel/D-7168-2013	Kuplich, Tatiana M/0000-0003-0657-4024; Nelson, Bruce/0000-0002-0488-6895; Gomes de Carvalho, Andre Luiz/0000-0002-2528-6274; Fernandes, Daniel/0000-0001-6155-6246	Brazilian National Research Council (CNPq) [52.3102/96]; National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	CLASlite image-processing software was developed by the Carnegie Institution of Washington, with support from The Gordon and Betty Moore Foundation and The John D. and Catherine T. MacArthur Foundation. Petrobras provided a low-level helicopter flight over senescing Guadua sarcocarpa. Brazil's National Institute for Space Research (INPE) provided the aircraft and 150 km low-level flight over juvenile bamboo populations. Funding for this research was provided by the Brazilian National Research Council (CNPq) via grant 52.3102/96, by CNPq via the GEOMA environmental modelling network and by the National Institute for Amazon Research (INPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D, 1962, EVOLUTIONARY RELATIO; [Anonymous], J ED, DOI [DOI 10.1080/01619569509538834, DOI 10.1080/10106048809354132]; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Balee W., 1989, Advances in Economic Botany, V7, P1; Barlow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033373; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Deering DW, 1999, REMOTE SENS ENVIRON, V67, P205, DOI 10.1016/S0034-4257(98)00087-X; Espirito-Santo FB, 2003, DETECCAO DINAMICA FL, P649; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; GADGIL M, 1984, BIOTROPICA, V16, P161, DOI 10.2307/2388050; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Hill RA, 1999, INT J REMOTE SENS, V20, P1039, DOI 10.1080/014311699213082; IBGE EMBRAPA, 2001, MAP SOL BRAS; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; Kratter AW, 1997, BIOTROPICA, V29, P100, DOI 10.1111/j.1744-7429.1997.tb00011.x; LONDONO X, 1991, SYST BOT, V16, P630, DOI 10.2307/2418866; Mascarenhas Artur Fernando Silva, 2004, Acta Amaz., V34, P61, DOI 10.1590/S0044-59672004000100008; Nelson B., 1994, REMOTE SENSING REV, V10, P105, DOI [10.1080/02757259409532239, DOI 10.1080/02757259409532239]; NELSON BW, 2006, AN SEM NAC BAMB FAC, P49; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Regard V, 2009, GEOMORPHOLOGY, V107, P107, DOI 10.1016/j.geomorph.2008.12.003; Santos H.G., 2018, BRAZILIAN SOIL CLASS, V5th edition, DOI [10.1016/j.eja.2021.126308, DOI 10.1016/J.EJA.2021.126308]; SANTOS U D M, 1988, Acta Amazonica, V18, P145; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Silveira M., 1999, Ecotropica, V5, P213; SINGH A, 1987, INT J REMOTE SENS, V8, P971, DOI 10.1080/01431168708954741; Smith M, 2011, J TROP ECOL, V27, P59, DOI 10.1017/S026646741000057X; Toivonen T, 2006, REMOTE SENS ENVIRON, V100, P550, DOI 10.1016/j.rse.2005.11.006; Williams KS, 1995, ANNU REV ENTOMOL, V40, P36	35	84	92	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54852	10.1371/journal.pone.0054852	http://dx.doi.org/10.1371/journal.pone.0054852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359438	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600123
J	Wang, Z; Cao, RZ; Taylor, K; Briley, A; Caldwell, C; Cheng, JL				Wang, Zheng; Cao, Renzhi; Taylor, Kristen; Briley, Aaron; Caldwell, Charles; Cheng, Jianlin			The Properties of Genome Conformation and Spatial Gene Interaction and Regulation Networks of Normal and Malignant Human Cell Types	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; CHROMOSOME CONFORMATION; MAMMALIAN-CELLS; CHROMATIN; ARCHITECTURE; BIOLOGY; TRANSCRIPTION; TERRITORIES; DYNAMICS; ELEMENTS	The spatial conformation of a genome plays an important role in the long-range regulation of genome-wide gene expression and methylation, but has not been extensively studied due to lack of genome conformation data. The recently developed chromosome conformation capturing techniques such as the Hi-C method empowered by next generation sequencing can generate unbiased, large-scale, high-resolution chromosomal interaction (contact) data, providing an unprecedented opportunity to investigate the spatial structure of a genome and its applications in gene regulation, genomics, epigenetics, and cell biology. In this work, we conducted a comprehensive, large-scale computational analysis of this new stream of genome conformation data generated for three different human leukemia cells or cell lines by the Hi-C technique. We developed and applied a set of bioinformatics methods to reliably generate spatial chromosomal contacts from high-throughput sequencing data and to effectively use them to study the properties of the genome structures in one-dimension (1D) and two-dimension (2D). Our analysis demonstrates that Hi-C data can be effectively applied to study tissue-specific genome conformation, chromosome-chromosome interaction, chromosomal translocations, and spatial gene-gene interaction and regulation in a three-dimensional genome of primary tumor cells. Particularly, for the first time, we constructed genome-scale spatial gene-gene interaction network, transcription factor binding site (TFBS) - TFBS interaction network, and TFBS-gene interaction network from chromosomal contact information. Remarkably, all these networks possess the properties of scale-free modular networks.	[Wang, Zheng; Cao, Renzhi; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Taylor, Kristen; Briley, Aaron; Caldwell, Charles] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO USA; [Cheng, Jianlin] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Cheng, JL (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	chengji@missouri.edu	SHI, JIE/GXG-3394-2022; Cheng, Jianlin/N-8209-2013; Fan, Jia/C-6689-2017; Shi, Ying-Hong/B-7063-2017	Ke, Ai-Wu/0000-0002-7964-6909; Taylor, Kristen/0000-0001-9336-9824; Zhou, Jian/0000-0002-7650-7540; Cheng, Jianlin/0000-0003-0305-2853; Gao, Qiang/0000-0002-6695-9906	NSF [DBI1149224]; United States National Institutes of Health (NIH) [R01GM093123]; NIH [K99CA132784]; Shumaker bioinformatics fellowship	NSF(National Science Foundation (NSF)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shumaker bioinformatics fellowship	The research was partially supported by a NSF (www.nsf.gov) CAREER award (DBI1149224) and a United States National Institutes of Health (NIH) (www.nih.gov) grant (R01GM093123) to JC and a NIH grant (K99CA132784) to KT. ZW was partially supported by Shumaker bioinformatics fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Cherkassky V, 2004, NEURAL NETWORKS, V17, P113, DOI 10.1016/S0893-6080(03)00169-2; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hopf T, 2012, CELL; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Sanyal A, 2011, CURR OPIN CELL BIOL, V23, P325, DOI 10.1016/j.ceb.2011.03.009; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; TOMECZKOWSKI J, 1995, BRIT J HAEMATOL, V89, P771; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017906; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	32	44	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58793	10.1371/journal.pone.0058793	http://dx.doi.org/10.1371/journal.pone.0058793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536826	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100091
J	Huang, WT; Yang, HW; Liao, TL; Wu, WJ; Yang, SE; Chih, YC; Chuang, JH				Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Yang, Shu-Er; Chih, Yi-Chien; Chuang, Jen-Hsiang			Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; EVENT REPORTING SYSTEM; ADVERSE EVENTS; DATALINK PROJECT; UNITED-STATES; BELLS-PALSY; VACCINATION; RISK; SURVEILLANCE	In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59 (R) adjuvant were used in the nationwide vaccination campaign beginning on November 1, 2009. From November 2009 through February 2010, the authors identified recipients of H1N1 vaccines who were diagnosed with adverse events of special interest (AESIs) in a large-linked safety database, and used the self-controlled case series (SCCS) method to examine the risk of each AESI in the 0-42 days after H1N1 vaccination. Of the 3.5 million doses of H1N1 vaccines administered and captured in the linked database, the SCCS analysis of Guillain-Barre syndrome (GBS) found an incidence rate ratio of 3.81 (95% confidence interval 0.43-33.85) within 0-42 days after nonadjuvanted H1N1 vaccination and no cases after MF59 (R)-adjuvanted H1N1 vaccination. The risks of other AESIs were, in general, not increased in any of the predefined postvaccination risk periods and age groups. The databases and infrastructure created for H1N1 vaccine safety evaluation may serve as a model for safety, effectiveness and coverage studies of licensed vaccines in Taiwan.	[Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Yang, Shu-Er; Chih, Yi-Chien] Taiwan Ctr Dis Control, Div 4, Taipei, Taiwan		Huang, WT (corresponding author), Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.	muagi@cdc.gov.tw	Huang, Wan-Ting/E-3497-2010; Chuang, Jen-Hsiang/G-4356-2010; Huang, Wei-Chien/D-1740-2012	Huang, Wan-Ting/0000-0002-4344-9567; Chuang, Jen-Hsiang/0000-0002-7114-3418; Chen, Chia-Hung/0000-0003-1158-9722; Huang, Wei-Chien/0000-0001-6467-8716	Taiwan Centers for Disease Control [DOH99-DC-2038]	Taiwan Centers for Disease Control	This study was supported by a grant (DOH99-DC-2038) from the Taiwan Centers for Disease Control (http://www.cdc.gov.tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], NAT HLTH INS TAIW 20; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Campbell KE, 2002, AM J EPIDEMIOL, V156, P32, DOI 10.1093/aje/kwf009; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman Jeanne, 2011, BMJ, V343, pd3908, DOI 10.1136/bmj.d3908; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; Glaser CA, 2012, CLIN INFECT DIS, V55, P514, DOI 10.1093/cid/cis454; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Greene SK, 2010, AM J EPIDEMIOL, V171, P177, DOI 10.1093/aje/kwp345; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Hambidge SJ, 2006, JAMA-J AM MED ASSOC, V296, P1990, DOI 10.1001/jama.296.16.1990; Huang WT, 2012, VACCINE, V30, P2168, DOI 10.1016/j.vaccine.2012.01.013; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Kung HC, 2010, VACCINE, V28, P7337, DOI 10.1016/j.vaccine.2010.08.073; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; McMahon AW, 2005, PEDIATRICS, V115, P453, DOI 10.1542/peds.2004-1519; Rowhani-Rahbar A, 2012, VACCINE, V31, P271, DOI 10.1016/j.vaccine.2012.07.024; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Tse A, 2012, VACCINE, V30, P2024, DOI 10.1016/j.vaccine.2012.01.027; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	36	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58827	10.1371/journal.pone.0058827	http://dx.doi.org/10.1371/journal.pone.0058827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536827	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100092
J	Li, DT; Wang, LW; Liu, X; Cui, DZ; Chen, TT; Zhang, H; Jiang, C; Xu, CY; Li, P; Li, S; Zhao, L; Chen, HB				Li, Detao; Wang, Liwen; Liu, Xu; Cui, Dezhou; Chen, Tingting; Zhang, Hua; Jiang, Chuan; Xu, Chunyan; Li, Peng; Li, Song; Zhao, Li; Chen, Huabang			Deep Sequencing of Maize Small RNAs Reveals a Diverse Set of MicroRNA in Dry and Imbibed Seeds	PLOS ONE			English	Article							GENE-REGULATION CASCADES; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; COMPUTATIONAL IDENTIFICATION; DISTINCT ROLES; ABSCISIC-ACID; AUXIN; GERMINATION	Seed germination plays a pivotal role during the life cycle of plants. As dry seeds imbibe water, the resumption of energy metabolism and cellular repair occur and miRNA-mediated gene expression regulation is involved in the reactivation events. This research was aimed at understanding the role of miRNA in the molecular control during seed imbibition process. Small RNA libraries constructed from dry and imbibed maize seed embryos were sequenced using the Illumina platform. Twenty-four conserved miRNA families were identified in both libraries. Sixteen of them showed significant expression differences between dry and imbibed seeds. Twelve miRNA families, miR156, miR159, miR164, miR166, miR167, miR168, miR169, miR172, miR319, miR393, miR394 and miR397, were significantly down-regulated; while four families, miR398, miR408, miR528 and miR529, were significantly up-regulated in imbibed seeds compared to that in dry seeds. Furthermore, putative novel maize miRNAs and their target genes were predicted. Target gene GO analysis was performed for novel miRNAs that were sequenced more than 50 times in the normalized libraries. The result showed that carbohydrate catabolic related genes were specifically enriched in the dry seed, while in imbibed seed target gene enrichment covered a broad range of functional categories including genes in amino acid biosynthesis, isomerase activity, ligase activity and others. The sequencing results were partially validated by quantitative RT-PCR for both conserved and novel miRNAs and the predicted target genes. Our data suggested that diverse and complex miRNAs are involved in the seed imbibition process. That miRNA are involved in plant hormone regulation may play important roles during the dry-imbibed seed transition.	[Li, Detao; Wang, Liwen; Liu, Xu; Cui, Dezhou; Chen, Tingting; Zhang, Hua; Jiang, Chuan; Xu, Chunyan; Li, Peng; Li, Song] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhao, Li; Chen, Huabang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhao, L (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	hbchen@genetics.ac.cn; zhaoli@genetics.ac.cn			National Science Foundation of China [31071424]; Shandong Pivotal Project for Elite Agricultural Variety Development	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Pivotal Project for Elite Agricultural Variety Development	This work was partially supported by the National Science Foundation of China (31071424) and by the Shandong Pivotal Project for Elite Agricultural Variety Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Banu NA, 2009, J PLANT PHYSIOL, V166, P146, DOI 10.1016/j.jplph.2008.03.002; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Freudenberg K, 1959, BIOCH WOOD, P121; Fu CX, 2012, PLANT BIOTECHNOLOGY, P1; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kimura M, 2010, PLANT MOL BIOL, V73, P119, DOI 10.1007/s11103-010-9603-x; Kinoshita N, 2010, PLANT CELL PHYSIOL, V51, P239, DOI 10.1093/pcp/pcp183; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Martin RC, 2005, SEED SCI RES, V15, P319, DOI 10.1079/SSR2005220; Martin RC, 2006, CAN J BOT, V84, P189, DOI 10.1139/B05-141; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Martin RC, 2010, SEED SCI RES, V20, P89, DOI 10.1017/S0960258510000073; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sreenivasulu N, 2010, INT REV CEL MOL BIO, V281, P49, DOI 10.1016/S1937-6448(10)81002-0; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yamagishi K, 2009, PLANT CELL PHYSIOL, V50, P330, DOI 10.1093/pcp/pcn201; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	93	83	92	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55107	10.1371/journal.pone.0055107	http://dx.doi.org/10.1371/journal.pone.0055107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23527173	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600154
J	Smith, CE; Blake, PR; Harris, PL				Smith, Craig E.; Blake, Peter R.; Harris, Paul L.			I Should but I Won't: Why Young Children Endorse Norms of Fair Sharing but Do Not Follow Them	PLOS ONE			English	Article							INHIBITORY CONTROL; PRESCHOOLERS; VICTIMIZERS; ALLOCATION; COGNITION; BEHAVIOR	Young children endorse fairness norms related to sharing, but often act in contradiction to those norms when given a chance to share. This phenomenon has rarely been explored in the context of a single study. Using a novel approach, the research presented here offers clear evidence of this discrepancy and goes on to examine possible explanations for its diminution with age. In Study 1, 3-8-year-old children readily stated that they themselves should share equally, asserted that others should as well, and predicted that others had shared equally with them. Nevertheless, children failed to engage in equal sharing until ages 7-8. In Study 2, 7-8-year-olds correctly predicted that they would share equally, and 3-6-year-olds correctly predicted that they would favor themselves, ruling out a failure-of-willpower explanation for younger children's behavior. Similarly, a test of inhibitory control in Study 1 also failed to explain the shift with age toward adherence to the endorsed norm. The data suggest that, although 3-year-olds know the norm of equal sharing, the weight that children attach to this norm increases with age when sharing involves a cost to the self.	[Smith, Craig E.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Blake, Peter R.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Harris, Paul L.] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; Boston University; Harvard University	Smith, CE (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	999craig@gmail.com	Blake, Peter/HGD-6519-2022; Smith, Craig E./AFN-5030-2022	Smith, Craig/0000-0001-6215-5161	Templeton Foundation	Templeton Foundation	PRB was supported by a postdoctoral award from the Templeton Foundation, and wishes to thank the Foundation its support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENIO WF, 1992, CHILD DEV, V63, P915, DOI 10.2307/1131243; Atance C. M., 2005, FIRST LANG, V25, P6, DOI DOI 10.1177/0142723705045678; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Batson CD, 2001, CURR DIR PSYCHOL SCI, V10, P54, DOI 10.1111/1467-8721.00114; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P1335, DOI 10.1037/0022-3514.72.6.1335; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; BIRCH LL, 1986, CHILD DEV, V57, P387, DOI 10.1111/j.1467-8624.1986.tb00038.x; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; BLASI A, 1983, DEV REV, V3, P178, DOI 10.1016/0273-2297(83)90029-1; Burford HC, 1996, J SOC BEHAV PERS, V11, P17; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Damon W., 1977, SOCIAL WORLD CHILD; EISENBERGBERG N, 1979, CHILD DEV, V50, P356, DOI 10.1111/j.1467-8624.1979.tb04116.x; Engelmann JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048433; Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gerson R. P., 1978, NEW DIRECTIONS CHILD, V2, P41; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; Hughes C, 2000, J CHILD PSYCHOL PSYC, V41, P169, DOI 10.1017/S0021963099005193; Kanngiesser P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043979; Keller M, 2003, BRIT J DEV PSYCHOL, V21, P1, DOI 10.1348/026151003321164582; Keller M, 2012, SIMPLE HEURISTICS SO; Kochanska G, 1996, CHILD DEV, V67, P490, DOI 10.1111/j.1467-8624.1996.tb01747.x; KUCZAJ SA, 1979, J CHILD LANG, V6, P563, DOI 10.1017/S0305000900002543; Leimgruber KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048292; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; McGuire S, 2000, SOC DEV, V9, P173, DOI 10.1111/1467-9507.00118; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; NUNNERWINKLER G, 1988, CHILD DEV, V59, P1323, DOI 10.2307/1130495; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; PETERSON C, 1975, CHILD DEV, V46, P942, DOI 10.2307/1128401; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Sommerville JA, 2013, INFANCY, V18, P40, DOI 10.1111/j.1532-7078.2012.00129.x; Valdesolo P, 2007, PSYCHOL SCI, V18, P689, DOI 10.1111/j.1467-9280.2007.01961.x; Walker LJ, 2004, MORAL DEVELOPMENT, SELF, AND IDENTITY, P1	44	210	222	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59510	10.1371/journal.pone.0059510	http://dx.doi.org/10.1371/journal.pone.0059510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	29220847	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600077
J	Hu, GX; Lin, H; Lian, QQ; Zhou, SH; Guo, JJ; Zhou, HY; Chu, YH; Ge, RS				Hu, Guo-Xin; Lin, Han; Lian, Qing-Quan; Zhou, Shu-Hua; Guo, Jingjing; Zhou, Hong-Yu; Chu, Yanhui; Ge, Ren-Shan			Curcumin as a Potent and Selective Inhibitor of 11 beta-Hydroxysteroid Dehydrogenase 1: Improving Lipid Profiles in High-Fat-Diet-Treated Rats	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; METABOLIC SYNDROME; LEYDIG-CELLS; VISCERAL OBESITY; ADIPOSE-TISSUE; BLOOD-GLUCOSE; TYPE-1; MICE; LIVER; INSULIN	Background: 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) activates glucocorticoid locally in liver and fat tissues to aggravate metabolic syndrome. 11 beta-HSD1 selective inhibitor can be used to treat metabolic syndrome. Curcumin and its derivatives as selective inhibitors of 11 beta-HSD1 have not been reported. Methodology: Curcumin and its 12 derivatives were tested for their potencies of inhibitory effects on human and rat 11 beta-HSD1 with selectivity against 11 beta-HSD2. 200 mg/kg curcumin was gavaged to adult male Sprague-Dawley rats with high-fat-diet-induced metabolic syndrome for 2 months. Results and Conclusions: Curcumin exhibited inhibitory potency against human and rat 11 beta-HSD1 in intact cells with IC50 values of 2.29 and 5.79 mu M, respectively, with selectivity against 11 beta-HSD2 (IC50, 14.56 and 11.92 mu M). Curcumin was a competitive inhibitor of human and rat 11 beta-HSD1. Curcumin reduced serum glucose, cholesterol, triglyceride, low density lipoprotein levels in high-fat-diet-induced obese rats. Four curcumin derivatives had much higher potencies for Inhibition of 11 beta-HSD1. One of them is (1E, 4E)-1,5-bis(thiophen-2-yl) penta-1,4-dien-3-one (compound 6), which had IC50 values of 93 and 184 nM for human and rat 11 beta-HSD1, respectively. Compound 6 did not inhibit human and rat kidney 11 beta-HSD2 at 100 mu M. In conclusion, curcumin is effective for the treatment of metabolic syndrome and four novel curcumin derivatives had high potencies for inhibition of human 11 beta-HSD1 with selectivity against 11 beta-HSD2.	[Hu, Guo-Xin; Zhou, Shu-Hua; Zhou, Hong-Yu] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Lin, Han; Lian, Qing-Quan; Guo, Jingjing; Ge, Ren-Shan] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China; [Chu, Yanhui] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang, Heilongjiang, Peoples R China; [Ge, Ren-Shan] Populat Council, New York, NY 10021 USA	Wenzhou Medical University; Wenzhou Medical University; Mudanjiang Medical University; Population Council	Ge, RS (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China.	r_ge@yahoo.com	; Li, Fu-Li/B-5894-2015	Yuan, Cheng/0000-0001-9517-5206; Li, Fu-Li/0000-0003-0381-2234	Wenzhou Science & Technology Funding [Y20090003, 2008H0121]; Natural Science Foundation of China (NSFC) [81102149]	Wenzhou Science & Technology Funding; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was partially supported by the Wenzhou Science & Technology Funding (Y20090003 to R.S.G. 2008H0121 to HYZ) and Natural Science Foundation of China (NSFC) (81102149 to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Barf T, 2002, J MED CHEM, V45, P3813, DOI 10.1021/jm025530f; Chen BB, 2009, J STEROID BIOCHEM, V113, P177, DOI 10.1016/j.jsbmb.2008.12.006; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chiu J, 2009, NUTRITION, V25, P964, DOI 10.1016/j.nut.2008.12.007; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Dominguez JM, METABOLISM, V60, P1775; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; Ge R., 2009, CURR MED CHEM; Ge RS, 1997, ENDOCRINOLOGY, V138, P2435, DOI 10.1210/en.138.6.2435; Ge RS, 2000, J ANDROL, V21, P303; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Kempaiah RK, 2004, ANN NUTR METAB, V48, P314, DOI 10.1159/000081198; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; LAKSHMI V, 1985, J STEROID BIOCHEM, V22, P331, DOI 10.1016/0022-4731(85)90435-2; LIANG G, 2009, J CELL MOL MED; Liang G, 2008, BIOORG MED CHEM LETT, V18, P1525, DOI 10.1016/j.bmcl.2007.12.068; Livingstone DEW, 2000, J ENDOCRINOL, V167, P533, DOI 10.1677/joe.0.1670533; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MONDER C, 1988, Steroids, V52, P515, DOI 10.1016/0039-128X(88)90118-3; MONDER C, 1994, STEROIDS, V59, P69, DOI 10.1016/0039-128X(94)90078-7; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Munoz R, 2009, OBES SURG, V19, P764, DOI 10.1007/s11695-008-9616-6; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; PATIL TN, 1971, INDIAN J EXP BIOL, V9, P167; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; RAO DS, 1970, J NUTR, V100, P1307, DOI 10.1093/jn/100.11.1307; Salva A, 2001, J ANDROL, V22, P665; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Stewart PM, 2009, DIABETES, V58, P14, DOI 10.2337/db08-1404; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Wake DJ, 2004, MOL CELL ENDOCRINOL, V215, P45, DOI 10.1016/j.mce.2003.11.015; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Zhao BH, 2010, CHEM-BIOL INTERACT, V183, P79, DOI 10.1016/j.cbi.2009.09.014	40	51	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e49976	10.1371/journal.pone.0049976	http://dx.doi.org/10.1371/journal.pone.0049976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533564	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400002
J	Yuan, ZR; Zeng, X; Yang, D; Wang, WL; Liu, ZH				Yuan, Zhengrong; Zeng, Xu; Yang, Dan; Wang, Weilu; Liu, Zhihua			Effects of Common Polymorphism rs11614913 in Hsa-miR-196a2 on Lung Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC-VARIANTS; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; FUNCTIONAL POLYMORPHISM; SUSCEPTIBILITY; METAANALYSIS; EXPRESSION; ASSOCIATION; BIOGENESIS	Background: Emerging evidence suggests that single nucleotide polymorphisms (SNPs) in microRNA-coding genes may participate in the pathogenesis of lung cancer by altering the expression of tumor-related microRNAs. Several studies were investigated in recent years to evaluate the association between hsa-miR-196a2 rs11614913 polymorphism and increased/decreased lung cancer risk. In the present study, we performed a meta-analysis to systematically summarize the possible association. Methodology/Principal Findings: We performed a meta-analysis of 4 case-control studies that included 2219 lung-cancer cases and 2232 cancer-free controls. We evaluated the strength of the association using odds ratios (ORs) with 95% confidence intervals (CIs). In the overall analysis, it was found that the rs11614913 polymorphism significantly elevated the risk of lung cancer (CC versus (vs.) TT OR = 1.26, 95% CI 1.07-1.49, P = 0.007; CC/CT vs. TT: OR = 1.13, 95% CI 0.98-1.29, P = 0.007; C vs. T: OR = 1.12, 95% CI 1.03-1.22, P = 0.008). In the subgroup analysis by ethnicity, statistically significantly increased cancer risk was found among Asians (CC vs. TT: OR = 1.30, 95% CI 1.10-1.54, P = 0.003; CT vs. TT: OR = 1.16, 95% CI 1.01-1.34, P = 0.039; CC vs. CT/TT: OR = 1.21, 95% CI 1.04-1.41, P = 0.012; C vs. T: OR = 1.14, 95% CI 1.05-1.25, P = 0.002). For Europeans, a significant association with lung cancer risk was found in recessive model (CC vs. CT/TT: OR = 0.63, 95% CI 0.40-0.98, P = 0.040). No publication bias was found in this study. Conclusions/Significance: Our meta-analysis suggests that the rs11614913 polymorphism is significant associated with the increased risk of lung cancer, especially in Asians. Besides, the C allele of rs11614913 polymorphism may contribute to increased lung cancer risk.	[Yuan, Zhengrong; Zeng, Xu; Yang, Dan; Wang, Weilu; Liu, Zhihua] Chinese Acad Med Sci, Peking Union Med Coll, Dept Computat Biol & Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Liu, Zhihua] Nanjing Forestry Univ, Nanjing, Jiangsu, Peoples R China; [Wang, Weilu] Beijing City Univ, Dept Biotechnol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Nanjing Forestry University	Liu, ZH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Dept Computat Biol & Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	zhliu@implad.ac.cn	Ahuja, Anil T/H-4031-2017; Chow, Steven Kwok Keung/GNH-4779-2022; Yuan, Jing/E-4236-2013; King, Ann D/C-9845-2011	Ahuja, Anil T/0000-0002-0726-5402; Yuan, Jing/0000-0001-8112-3608; King, Ann D/0000-0002-5280-8349; Chow, Kwok Keung/0000-0002-7201-4888	National Natural Science Foundation of China [81102746, 81100077, 31201768]; Beijing Natural Science Foundation [5113033]; China Postdoctoral Science Foundation [2012M510011]; Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars; New Star Project of Peking Union Medical College; Youth Foundation of Peking Union Medical College; Research Fund for the Doctoral Program of Higher Education [20111106120028]; "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" [2012ZX09301-002-001]; China Medical Board of New York [A2009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars; New Star Project of Peking Union Medical College; Youth Foundation of Peking Union Medical College; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); "Major Drug Discovery" major science and technology research "12nd Five-Year Plan"; China Medical Board of New York	This work was supported by National Natural Science Foundation of China (81102746, 81100077, 31201768), Beijing Natural Science Foundation (5113033), China Postdoctoral Science Foundation funded project (2012M510011), Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry for Returned Chinese Scholars, New Star Project of Peking Union Medical College, Youth Foundation of Peking Union Medical College, the Research Fund for the Doctoral Program of Higher Education (20111106120028), "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" (2012ZX09301-002-001), China Medical Board of New York (A2009001) granted to Zhihua Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; He BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125; Hu RF, 2013, MOL BIOL REP, V40, P1181, DOI 10.1007/s11033-012-2160-4; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jian Guo, 2012, International Journal of Mechatronics and Automation, V2, P15, DOI 10.1504/IJMA.2012.046583; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Liu ZH, 2013, MOL BIOL REP, V40, P2491, DOI 10.1007/s11033-012-2330-4; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Liu ZH, 2010, BIOCHEM BIOPH RES CO, V400, P34, DOI 10.1016/j.bbrc.2010.07.132; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyerson M, 2005, J CLIN ONCOL, V23, P3219, DOI 10.1200/JCO.2005.15.511; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Ren GM, 2013, BIOINFORMATICS, V29, P279, DOI 10.1093/bioinformatics/bts666; Rong BX, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-170; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Vinci S, 2011, CLIN CHEM LAB MED, V49, P2073, DOI 10.1515/CCLM.2011.708; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; Wang PY, 2012, EXP THER MED, V3, P324, DOI 10.3892/etm.2011.399; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040039; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042076; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; Yuan ZR, 2012, MOL BIOL REP, V39, P6625, DOI 10.1007/s11033-012-1467-5	73	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61047	10.1371/journal.pone.0061047	http://dx.doi.org/10.1371/journal.pone.0061047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23527281	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300044
J	Wang, ZC; Gao, Q; Shi, JY; Yang, LX; Zhou, J; Wang, XY; Shi, YH; Ke, AW; Shi, GM; Ding, ZB; Dai, Z; Qiu, SJ; Fan, J				Wang, Zhi-Chao; Gao, Qiang; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Wang, Xiao-Ying; Shi, Ying-Hong; Ke, Ai-Wu; Shi, Guo-Ming; Ding, Zhen-Bin; Dai, Zhi; Qiu, Shuang-Jian; Fan, Jia			Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; MUTATIONAL ANALYSIS; HEPATITIS; 1P36; METAANALYSIS	Background: Frequent deletions of the kinesin-like protein gene 1B (KIF1B) have been reported in neural tumors. Recently, a genome-wide association study revealed an association between polymorphisms in the KIF1B gene and the risk of hepatocellular carcinoma (HCC), and several case-control studies have further investigated this relationship. However, these studies have yielded controversial results. We therefore performed a meta-analysis to derive a more precise estimation of the association between the KIF1B gene polymorphisms and HCC risk. Methodology/Principal Finding: PubMed, EMBASE, the ISI Web of Science and the CNKI databases were systematically searched to identify relevant studies. A total of 5 studies containing 13 cohorts with 5,773 cases and 6,404 controls were included. Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the associations. Subgroup analyses were conducted based on ethnicities, sample sizes and quality scores. Overall, the G allele at rs17401966 of the KIF1B gene was associated with a significantly decreased risk for HCC (OR = 0.81, 95% CI: 0.70-0.93; P = 0.003). Furthermore, subgroup analyses showed that the G allele at rs17401966 of the KIF1B gene significantly reduced the risk for HCC in Chinese cohorts (OR = 0.76, 95% CI: 0.64-0.90; P = 0.002), large-sample-size cohorts (OR = 0.80, 95% CI: 0.73-0.88, P < 0.01) and high-quality cohorts (OR = 0.78, 95% CI: 0.71-0.87, P < 0.01). However, no significant associations were found in small-sample-size cohorts, studies with low-quality scores and when excluding the cohorts from the study reporting the original discovery. Conclusion/Significance: These findings demonstrate that the presence of the G allele at rs17401966 of the KIF1B gene may decrease the risk for HCC and suggest that KIF1B may play a critical role in the development of HCC. High-quality studies with larger sample sizes and different ethnic populations will be of great value to further confirm these findings.	[Wang, Zhi-Chao; Gao, Qiang; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Wang, Xiao-Ying; Shi, Ying-Hong; Ke, Ai-Wu; Shi, Guo-Ming; Ding, Zhen-Bin; Dai, Zhi; Qiu, Shuang-Jian; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Wang, Zhi-Chao; Gao, Qiang; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Wang, Xiao-Ying; Shi, Ying-Hong; Ke, Ai-Wu; Shi, Guo-Ming; Ding, Zhen-Bin; Dai, Zhi; Qiu, Shuang-Jian; Fan, Jia] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Zhou, Jian; Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	fan.jia@zs-hospital.sh.cn	SHI, JIE/GXG-3394-2022; Cheng, Jianlin/N-8209-2013; Fan, Jia/C-6689-2017; Shi, Ying-Hong/B-7063-2017	Ke, Ai-Wu/0000-0002-7964-6909; Taylor, Kristen/0000-0001-9336-9824; Zhou, Jian/0000-0002-7650-7540; Cheng, Jianlin/0000-0003-0305-2853; Gao, Qiang/0000-0002-6695-9906	Major Program of NSFC [81030038]; National Key Sci-Tech Project [2012ZX10002011-002]; China National Funds for Distinguished Young Scientists [812250125]; National Natural Science Foundation of China [81071992, 81272725]; FANEDD [201183]; Fok Ying-Tong Education Foundation [132029]	Major Program of NSFC; National Key Sci-Tech Project; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FANEDD(Foundation for the Author of National Excellent Doctoral Dissertation of China); Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the Major Program of NSFC (No.81030038), National Key Sci-Tech Project (2012ZX10002011-002), China National Funds for Distinguished Young Scientists (No. 812250125), National Natural Science Foundation of China (Nos. 81071992, 81272725), FANEDD (No. 201183), the Fok Ying-Tong Education Foundation (No. 132029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045128; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Chen YY, 2003, INT J ONCOL, V23, P737; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fugger L, 2012, NEW ENGL J MED, V367, P2370, DOI 10.1056/NEJMp1212285; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Jiang DK, 2012, NAT GENET; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Koutsis G, 2011, J NEUROL, V258, P1726, DOI 10.1007/s00415-011-6004-2; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin CW, 2012, J HEPATOL; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Peters U, 2012, GASTROENTEROLOGY; Sawai H, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-47; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	35	44	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62571	10.1371/journal.pone.0062571	http://dx.doi.org/10.1371/journal.pone.0062571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23536826	Green Published, Green Submitted, gold			2022-12-27	WOS:000318341400061
J	Yuan, J; Chow, SKK; Zhang, QW; Yeung, DKW; Ahuja, AT; King, AD				Yuan, Jing; Chow, Steven Kwok Keung; Zhang, Qinwei; Yeung, David Ka Wai; Ahuja, Anil T.; King, Ann D.			The Use of Dynamic Tracer Concentration in Veins for Quantitative DCE-MRI Kinetic Analysis in Head and Neck	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; ARTERIAL INPUT FUNCTION; FAST GRADIENT-ECHO; T-1-WEIGHTED MRI; CLINICAL-TRIALS; PARAMETERS; BLOOD; PREDICTOR; INFLOW; BREAST	Background: Head and neck Magnetic Resonance (MR) Images are vulnerable to the arterial blood in-flow effect. To compensate for this effect and enhance accuracy and reproducibility, dynamic tracer concentration in veins was proposed and investigated for quantitative dynamic contrast-enhanced (DCE) MRI analysis in head and neck. Methodology: 21 patients with head and neck tumors underwent DCE-MRI at 3T. An automated method was developed for blood vessel selection and separation. Dynamic concentration-time-curves (CTCs) in arteries and veins were used for the Tofts model parameter estimations. The estimation differences by using CTCs in arteries and veins were compared. Artery and vein voxels were accurately separated by the automated method. Remarkable inter-slice tracer concentration differences were found in arteries while the inter-slice concentration differences in veins were moderate. Tofts model fitting by using the CTCs in arteries and veins produced significantly different parameter estimations. The individual artery CTCs resulted in large (>50% generally) inter-slice parameter estimation variations. Better inter-slice consistency was achieved by using the vein CTCs. Conclusions: The use of vein CTCs helps to compensate for arterial in-flow effect and reduce kinetic parameter estimation error and inconsistency for head and neck DCE-MRI.	[Yuan, Jing; Chow, Steven Kwok Keung; Zhang, Qinwei; Yeung, David Ka Wai; Ahuja, Anil T.; King, Ann D.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Yuan, Jing] CUHK Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Chinese University of Hong Kong	Yuan, J (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	jyuanbwh@gmail.com	Ahuja, Anil T/H-4031-2017; Chow, Steven Kwok Keung/GNH-4779-2022; Yuan, Jing/E-4236-2013; King, Ann D/C-9845-2011	Ahuja, Anil T/0000-0002-0726-5402; Yuan, Jing/0000-0001-8112-3608; King, Ann D/0000-0002-5280-8349; Chow, Kwok Keung/0000-0002-7201-4888	Hong Kong GRF [CUHK4660088, SEG_CUHK02]	Hong Kong GRF(Hong Kong Research Grants Council)	This work was supported by contract grant sponsor: Hong Kong GRF grant CUHK4660088 and SEG_CUHK02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisdas S, 2010, EUR RADIOL, V20, P2358, DOI 10.1007/s00330-010-1803-x; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Brookes JA, 1996, BRIT J RADIOL, V69, P206, DOI 10.1259/0007-1285-69-819-206; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P1073, DOI 10.1002/jmri.20898; Di Giovanni P, 2010, PHYS MED BIOL, V55, P121, DOI 10.1088/0031-9155/55/1/008; Donaldson SB, 2011, INT J RADIAT ONCOL, V81, P1176, DOI 10.1016/j.ijrobp.2010.09.039; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Foottit C, 2010, MAGN RESON MED, V63, P772, DOI 10.1002/mrm.22253; Hansen AE, 2009, MAGN RESON MED, V62, P1055, DOI 10.1002/mrm.22098; HEYWANGKOBRUNNER SH, 1994, RADIOLOGY, V191, P639, DOI 10.1148/radiology.191.3.8184040; Holdsworth DW, 1999, PHYSIOL MEAS, V20, P219, DOI 10.1088/0967-3334/20/3/301; Hoskin PJ, 1999, BRIT J RADIOL, V72, P1093, DOI 10.1259/bjr.72.863.10700827; Ivancevic MK, 2003, MAGNET RESON MED, V50, P885, DOI 10.1002/mrm.10633; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Lavini C, 2010, MAGN RESON IMAGING, V28, P1420, DOI 10.1016/j.mri.2010.06.017; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Noeske R, 2000, MAGN RESON MED, V44, P978, DOI 10.1002/1522-2594(200012)44:6<978::AID-MRM22>3.0.CO;2-9; Noworolski SM, 2003, J MAGN RESON IMAGING, V17, P455, DOI 10.1002/jmri.10280; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Peeters F, 2004, MAGN RESON MED, V51, P710, DOI 10.1002/mrm.20032; Qin Q, 2011, MAGN RESON MED, V65, P1297, DOI 10.1002/mrm.22723; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Roberts C, 2011, MAGN RESON MED, V65, P108, DOI 10.1002/mrm.22593; Schabel MC, 2009, PHYS MED BIOL, V54, pN1, DOI 10.1088/0031-9155/54/1/N01; Shukla-Dave A, 2012, INT J RADIAT ONCOL, V82, P1837, DOI 10.1016/j.ijrobp.2011.03.006; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Yuan J, 2012, CLIN RADIOL, V67, P216, DOI 10.1016/j.crad.2011.07.052; Yuan J, 2012, QUANT IMAGING MED SU, V2, P21, DOI [10.3978/j.issn.2223-4292.2012.01.06, 10.3978/j.issn.2223-4292.2012.11.04]; Yuan J, 2012, J MAGN RESON IMAGING, V35, P916, DOI 10.1002/jmri.22885; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	35	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59885	10.1371/journal.pone.0059885	http://dx.doi.org/10.1371/journal.pone.0059885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527281	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600102
J	Huang, HZ; Ding, Y; Sun, XZS; Nguyen, TA				Huang, Hongzhou; Ding, Ying; Sun, Xiuzhi S.; Nguyen, Thu A.			Peptide Hydrogelation and Cell Encapsulation for 3D Culture of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; SCAFFOLDS; DESIGN; BETA; DIFFERENTIATION; NANOFIBERS; MEDICINE; BIOLOGY; TISSUES; GROWTH	Three-dimensional (3D) cell culture plays an invaluable role in tumor biology by providing in vivo like microenviroment and responses to therapeutic agents. Among many established 3D scaffolds, hydrogels demonstrate a distinct property as matrics for 3D cell culture. Most of the existing pre-gel solutions are limited under physiological conditions such as undesirable pH or temperature. Here, we report a peptide hydrogel that shows superior physiological properties as an in vitro matrix for 3D cell culture. The 3D matrix can be accomplished by mixing a self-assembling peptide directly with a cell culture medium without any pH or temperature adjustment. Results of dynamic rheological studies showed that this hydrogel can be delivered multiple times via pipetting without permanently destroying the hydrogel architecture, indicating the deformability and remodeling ability of the hydrogel. Human epithelial cancer cells, MCF-7, are encapsulated homogeneously in the hydrogel matrix during hydrogelation. Compared with two-dimensional (2D) monolayer culture, cells residing in the hydrogel matrix grow as tumor-like clusters in 3D formation. Relevant parameters related to cell morphology, survival, proliferation, and apoptosis were analyzed using MCF-7 cells in 3D hydrogels. Interestingly, treatment of cisplatin, an anti-cancer drug, can cause a significant decrease of cell viability of MCF-7 clusters in hydrogels. The responses to cisplatin were dose- and time-dependent, indicating the potential usage of hydrogels for drug testing. Results of confocal microscopy and Western blotting showed that cells isolated from hydrogels are suitable for downstream proteomic analysis. The results provided evidence that this peptide hydrogel is a promising 3D cell culture material for drug testing.	[Huang, Hongzhou; Sun, Xiuzhi S.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Ding, Ying] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Nguyen, Thu A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Sun, XZS (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	xss@k-state.edu; tnguyen@vet.k-state.edu	Ding, Ying/M-8060-2017	Ding, Ying/0000-0001-8600-9740	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station [12-181-J]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; Directorate For Engineering [1321261] Funding Source: National Science Foundation	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was partially funded by KSU Targeted Excellence Program and KSU Research Foundation Scholarship Program as well as the contribution (no. 12-181-J) from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a; Chawla K, 2011, BIOMACROMOLECULES, V12, P560, DOI 10.1021/bm100980w; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; Feder-Mengus C, 2008, TRENDS MOL MED, V14, P333, DOI 10.1016/j.molmed.2008.06.001; GORLACH A, 1994, INT J CANCER, V56, P249, DOI 10.1002/ijc.2910560218; Gurski LA, 2010, BIOMATERIALS, V31, P4248, DOI 10.1016/j.biomaterials.2010.01.141; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Huang HZ, 2011, SOFT MATTER, V7, P8905, DOI 10.1039/c1sm05157a; Kelter G, 2005, ANTI-CANCER DRUG, V16, P1091, DOI 10.1097/00001813-200511000-00008; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Liu SQ, 2010, SOFT MATTER, V6, P67, DOI 10.1039/b916705f; Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8; Rapaport H, 2008, ADV FUNCT MATER, V18, P2889, DOI 10.1002/adfm.200800117; Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	40	158	163	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59482	10.1371/journal.pone.0059482	http://dx.doi.org/10.1371/journal.pone.0059482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527204	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600075
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500075
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300065
